PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Murata, S; Takahama, Y; Kasahara, M; Tanaka, K				Murata, Shigeo; Takahama, Yousuke; Kasahara, Masanori; Tanaka, Keiji			The immunoproteasome and thymoproteasome: functions, evolution and human disease	NATURE IMMUNOLOGY			English	Review							T-CELL DEVELOPMENT; PROTEASOME SUBUNIT BETA-5T; INTERFERON-GAMMA; 26S PROTEASOME; CHROMOSOMAL DUPLICATION; SELECTIVE INHIBITOR; NEGATIVE SELECTION; 20S PROTEASOME; MHC; GENERATION	The basic principle of adaptive immunity is to strictly discriminate between self and non-self, and a central challenge to overcome is the enormous variety of pathogens that might be encountered. In cell-mediated immunity, immunological discernment takes place at a molecular or cellular level. Central to both mechanisms of discernment is the generation of antigenic peptides associated with MHC class I molecules, which is achieved by a proteolytic complex called the proteasome. To adequately accomplish the discrimination between self and non-self that is essential for adaptive immunity and self-tolerance, two proteasome subtypes have evolved via gene duplication: the immunoproteasome and the thymoproteasome. In this Review, we describe various aspects of these immunity-dedicated proteasomes, from their discovery to recent findings.	[Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Takahama, Yousuke] NCI, Expt Immunol Branch, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA; [Takahama, Yousuke] Univ Tokushima, Inst Adv Med Sci, Tokushima, Japan; [Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Fac Med, Sapporo, Hokkaido, Japan; [Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo, Japan	University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tokushima University; Hokkaido University; Hokkaido University; Tokyo Metropolitan Institute of Medical Science	Murata, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.; Takahama, Y (corresponding author), NCI, Expt Immunol Branch, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.; Takahama, Y (corresponding author), Univ Tokushima, Inst Adv Med Sci, Tokushima, Japan.; Kasahara, M (corresponding author), Hokkaido Univ, Dept Pathol, Fac Med, Sapporo, Hokkaido, Japan.; Kasahara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.; Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo, Japan.	smurata@mol.f.u-tokyo.ac.jp; yousuke.takahama@nih.gov; mkasaha@med.hokudai.ac.jp; tanaka-kj@igakuken.or.jp	Takahama, Yousuke/A-5863-2010; Murata, Shigeo/A-1426-2010; Kasahara, Masanori/G-7651-2011	Takahama, Yousuke/0000-0002-4992-9174; Murata, Shigeo/0000-0002-3177-3503; 	NATIONAL CANCER INSTITUTE [ZIABC011806] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Althof N, 2018, EMBO MOL MED, V10, P200, DOI 10.15252/emmm.201708089; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Basler M, 2018, BRIT J PHARMACOL, V175, P38, DOI 10.1111/bph.14069; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Boehm T, 2018, ANNU REV IMMUNOL, V36, P19, DOI 10.1146/annurev-immunol-042617-053028; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; CHEN CH, 1994, POULTRY SCI, V73, P1012, DOI 10.3382/ps.0731012; Chen SB, 2016, P NATL ACAD SCI USA, V113, P12991, DOI 10.1073/pnas.1614614113; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dalet A, 2011, EUR J IMMUNOL, V41, P39, DOI 10.1002/eji.201040750; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Eggensperger S, 2015, BIOL CHEM, V396, P1059, DOI 10.1515/hsz-2014-0320; Erath S, 2015, IMMUNOGENETICS, V67, P51, DOI 10.1007/s00251-014-0814-1; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Granados DP, 2015, CURR OPIN IMMUNOL, V34, P1, DOI 10.1016/j.coi.2014.10.012; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Huber EM, 2017, STRUCTURE, V25, P1473, DOI 10.1016/j.str.2017.07.013; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; Kalim KW, 2012, J IMMUNOL, V189, P4182, DOI 10.4049/jimmunol.1201183; Karreci ES, 2016, P NATL ACAD SCI USA, V113, pE8425, DOI 10.1073/pnas.1618548114; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; Kasahara M, 2010, PROG MOL BIOL TRANSL, V92, P7, DOI 10.1016/S1877-1173(10)92002-4; Kaufman J, 2015, CURR OPIN IMMUNOL, V34, P35, DOI 10.1016/j.coi.2015.01.001; Kincaid EZ, 2016, NAT IMMUNOL, V17, P938, DOI 10.1038/ni.3480; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kniepert A, 2014, TRENDS BIOCHEM SCI, V39, P17, DOI 10.1016/j.tibs.2013.10.004; Koerner J, 2017, ONCOTARGET, V8, P50873, DOI 10.18632/oncotarget.15141; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li J, 2018, KIDNEY INT, V93, P670, DOI 10.1016/j.kint.2017.09.023; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; Marx A, 2015, J THORAC ONCOL, V10, P1383, DOI 10.1097/JTO.0000000000000654; Mayer CE, 2016, EUR J IMMUNOL, V46, P846, DOI 10.1002/eji.201545995; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; McDermott A, 2015, INT J DERMATOL, V54, P121, DOI 10.1111/ijd.12695; Mishto M, 2017, TRENDS IMMUNOL, V38, P904, DOI 10.1016/j.it.2017.07.011; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Moritz KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09715-y; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nitta T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5165; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Ohigashi I, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93664; Ohigashi I, 2015, CELL REP, V13, P1432, DOI 10.1016/j.celrep.2015.10.012; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Palmowski MJ, 2006, J IMMUNOL, V177, P983, DOI 10.4049/jimmunol.177.2.983; Richy N, 2018, EUR J MED CHEM, V145, P570, DOI 10.1016/j.ejmech.2018.01.013; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Santos RDA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01760-5; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; Schmidtke G, 2019, MOL IMMUNOL, V113, P22, DOI 10.1016/j.molimm.2017.11.030; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Sledz P, 2016, ANNU REV PHARMACOL, V56, P191, DOI 10.1146/annurev-pharmtox-010814-124727; Starck SR, 2016, IMMUNOL REV, V272, P8, DOI 10.1111/imr.12434; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sutoh Y, 2012, IMMUNOGENETICS, V64, P49, DOI 10.1007/s00251-011-0558-0; Takada K, 2015, NAT IMMUNOL, V16, P1069, DOI 10.1038/ni.3237; Takahama Y, 2008, TRENDS IMMUNOL, V29, P251, DOI 10.1016/j.it.2008.03.003; Takahama Y, 2010, SEMIN IMMUNOL, V22, P287, DOI 10.1016/j.smim.2010.04.012; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka K, 1998, IMMUNOL REV, V163, P161; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Uddin MM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14419; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vachharajani N, 2017, ONCOTARGET, V8, P50447, DOI 10.18632/oncotarget.14579; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Vigneron N, 2017, J BIOL CHEM, V292, P21170, DOI 10.1074/jbc.R117.807560; Vigneron N, 2011, CELL MOL LIFE SCI, V68, P1503, DOI 10.1007/s00018-011-0658-x; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wei JJ, 2019, MOL IMMUNOL, V113, P38, DOI 10.1016/j.molimm.2017.12.026; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; Yamada Y, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201930; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; Zaiss DMW, 2008, INFECT IMMUN, V76, P1207, DOI 10.1128/IAI.01134-07; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	122	139	142	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					923	931		10.1038/s41590-018-0186-z	http://dx.doi.org/10.1038/s41590-018-0186-z			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30104634				2022-12-18	WOS:000442365100014
J	Wolf, Y; Boura-Halfon, S; Cortese, N; Haimon, Z; Shalom, HS; Kuperman, Y; Kalchenko, V; Brandis, A; David, E; Segal-Hayoun, Y; Chappell-Maor, L; Yaron, A; Jung, S				Wolf, Yochai; Boura-Halfon, Sigalit; Cortese, Nina; Haimon, Zhana; Shalom, Hadas Sar; Kuperman, Yael; Kalchenko, Vyacheslav; Brandis, Alexander; David, Eyal; Segal-Hayoun, Yifat; Chappell-Maor, Louise; Yaron, Avraham; Jung, Steffen			Brown-adipose-tissue macrophages control tissue innervation and homeostatic energy expenditure	NATURE IMMUNOLOGY			English	Article							DIET-INDUCED THERMOGENESIS; RETT-SYNDROME; UNCOUPLING PROTEIN; MESSENGER-RNA; BODY-WEIGHT; BEIGE FAT; OBESITY; MICE; EXPRESSION; SEMAPHORINS	Tissue macrophages provide immunological defense and contribute to the establishment and maintenance of tissue homeostasis. Here we used constitutive and inducible mutagenesis to delete the nuclear transcription regulator Mecp2 in macrophages. Mice that lacked the gene encoding Mecp2, which is associated with Rett syndrome, in macrophages did not show signs of neurodevelopmental disorder but displayed spontaneous obesity, which was linked to impaired function of brown adipose tissue (BAT). Specifically, mutagenesis of a BAT-resident Cx(3)Cr1(+) macrophage subpopulation compromised homeostatic thermogenesis but not acute, cold-induced thermogenesis. Mechanistically, malfunction of BAT in pre-obese mice with mutant macrophages was associated with diminished sympathetic innervation and local titers of norepinephrine, which resulted in lower expression of thermogenic factors by adipocytes. Mutant macrophages overexpressed the signaling receptor and ligand PlexinA4, which might contribute to the phenotype by repulsion of sympathetic axons expressing the transmembrane semaphorin Sema6A. Collectively, we report a previously unappreciated homeostatic role for macrophages in the control of tissue innervation. Disruption of this circuit in BAT resulted in metabolic imbalance.	[Wolf, Yochai; Boura-Halfon, Sigalit; Cortese, Nina; Haimon, Zhana; Kuperman, Yael; David, Eyal; Segal-Hayoun, Yifat; Chappell-Maor, Louise; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Cortese, Nina] Humanitas Clin & Res Ctr, Dept Immunol & Inflammat, Rozzano, Italy; [Shalom, Hadas Sar; Yaron, Avraham] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Kuperman, Yael; Kalchenko, Vyacheslav] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel; [Brandis, Alexander] Weizmann Inst Sci, Dept Biol Serv, Rehovot, Israel	Weizmann Institute of Science; IRCCS Humanitas Research Hospital; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	s.jung@weizmann.ac.il	Cortese, Nina/ABI-1314-2020; Kalchenko, Vyacheslav/F-2924-2012; Jung, Steffen/K-1409-2012	Cortese, Nina/0000-0003-3680-7167; Jung, Steffen/0000-0003-4290-5716; Kalchenko, Vyacheslav/0000-0002-3166-7049; Wolf, Yochai/0000-0003-0270-2025	Israeli Science Foundation; European Research Council [340345]; University of Michigan-Israel Partnership for Research; Lombroso fund; Perlman Family Foundation; Sarah and Rolando Uziel Research Associate Chair	Israeli Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); University of Michigan-Israel Partnership for Research; Lombroso fund; Perlman Family Foundation; Sarah and Rolando Uziel Research Associate Chair	We thank the members of the Jung laboratory for discussion; R. Goldner for technical assistance; A. Rudich and M. Jastroch for advice and comments on the manuscript; G. Shakhar and R. Eilam for help with imaging and immunofluorescence; Z. Kam for writing an algorithm for the axon counting; and the Amit laboratory for advice on profiling. Supported by the Israeli Science Foundation (Jung laboratory), the European Research Council (340345 for the Jung laboratory), the University of Michigan-Israel Partnership for Research (Jung laboratory), the Lombroso fund (N.C.). the Perlman Family Foundation (Y.K.) and the Sarah and Rolando Uziel Research Associate Chair (Y.K.).	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; BARTNESS TJ, 1984, BEHAV NEUROSCI, V98, P674, DOI 10.1037/0735-7044.98.4.674; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Greenman Y, 2013, MOL ENDOCRINOL, V27, P1091, DOI 10.1210/me.2012-1344; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hesselbarth N, 2015, BIOCHEM BIOPH RES CO, V464, P724, DOI 10.1016/j.bbrc.2015.07.015; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KLINGENSPOR M, 1994, J COMP PHYSIOL B, V163, P664, DOI 10.1007/BF00369517; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nisoli E, 1996, ENDOCRINOLOGY, V137, P495, DOI 10.1210/en.137.2.495; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Perez-Branguli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158686; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; Ryu V, 2015, J NEUROSCI, V35, P2181, DOI 10.1523/JNEUROSCI.3306-14.2015; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	60	139	144	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					665	+		10.1038/ni.3746	http://dx.doi.org/10.1038/ni.3746			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28459435	Green Accepted			2022-12-18	WOS:000401520900011
J	Angeletti, D; Gibbs, JS; Angel, M; Kosik, I; Hickman, HD; Frank, GM; Das, SR; Wheatley, AK; Prabhakaran, M; Leggat, DJ; McDermott, AB; Yewdell, JW				Angeletti, Davide; Gibbs, James S.; Angel, Matthew; Kosik, Ivan; Hickman, Heather D.; Frank, Gregory M.; Das, Suman R.; Wheatley, Adam K.; Prabhakaran, Madhu; Leggat, David J.; McDermott, Adrian B.; Yewdell, Jonathan W.			Defining B cell immunodominance to viruses	NATURE IMMUNOLOGY			English	Article							ANTIGENIC SIN RESPONSES; ANTIBODY-RESPONSE; INFLUENZA-VIRUSES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSE; HEMAGGLUTININ; INFECTION; GENERATION; MEMORY; MICE	Immunodominance (ID) defines the hierarchical immune response to competing antigens in complex immunogens. Little is known regarding B cell and antibody ID despite its importance in immunity to viruses and other pathogens. We show that B cells and serum antibodies from inbred mice demonstrate a reproducible ID hierarchy to the five major antigenic sites in the influenza A virus hemagglutinin globular domain. The hierarchy changed as the immune response progressed, and it was dependent on antigen formulation and delivery. Passive antibody transfer and sequential infection experiments demonstrated 'original antigenic suppression', a phenomenon in which antibodies suppress memory responses to the priming antigenic site. Our study provides a template for attaining deeper understanding of antibody ID to viruses and other complex immunogens.	[Angeletti, Davide; Gibbs, James S.; Angel, Matthew; Kosik, Ivan; Hickman, Heather D.; Frank, Gregory M.; Das, Suman R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Das, Suman R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Wheatley, Adam K.; Prabhakaran, Madhu; Leggat, David J.; McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	jyewdell@mail.nih.gov	Das, Suman/ABB-7273-2020; Angeletti, Davide/H-7350-2019; Prabhakaran, Madhu/AEY-7127-2022; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Das, Suman/0000-0003-2496-9724; Angeletti, Davide/0000-0002-5256-1972; Kosik, Ivan/0000-0001-5756-5182; McDermott, Adrian/0000-0003-0616-9117; Leggat, David/0000-0003-4019-7170; Wheatley, Adam/0000-0002-5593-9387; Hickman, Heather/0000-0003-4168-4894	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001225, ZIAAI001211] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the NIAID Comparative Medicine Branch for maintaining the mice used in this study, and P. Palese and F. Krammer (Icahn School of Medicine at Mount Sinai) for the chimeric HA virus construct. Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (J.W.Y. and A.B.M.).	Altman MO, 2015, ELIFE, V4, DOI 10.7554/eLife.07467; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; BENNINK JR, 1981, CELL IMMUNOL, V61, P220, DOI 10.1016/0008-8749(81)90368-3; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Frank GM, 2015, MBIO, V6, DOI 10.1128/mBio.01156-15; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; HOLLOWOOD K, 1992, EUR J IMMUNOL, V22, P261, DOI 10.1002/eji.1830220138; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; JAMIESON BD, 1989, J EXP MED, V169, P1993, DOI 10.1084/jem.169.6.1993; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; KAVALER J, 1990, J IMMUNOL, V145, P2312; Kim JH, 2012, P NATL ACAD SCI USA, V109, P13751, DOI 10.1073/pnas.0912458109; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; LUBECK M, 1982, VIROLOGY, V118, P1, DOI 10.1016/0042-6822(82)90313-0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Marshall D, 1999, J IMMUNOL, V163, P4673; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Mozdzanowska K, 2005, J VIROL, V79, P5943, DOI 10.1128/JVI.79.10.5943-5951.2005; Pieri L, 2002, EUR J HISTOCHEM, V46, P365; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; TSILIBARY EC, 1987, AM J ANAT, V180, P195, DOI 10.1002/aja.1001800209; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wheatley AK, 2015, EXPERT REV VACCINES, V14, P1227, DOI 10.1586/14760584.2015.1068125; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; YEWDELL JW, 1981, ANNU REV MICROBIOL, V35, P185, DOI 10.1146/annurev.mi.35.100181.001153; YEWDELL JW, 1979, NATURE, V279, P246, DOI 10.1038/279246a0; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	45	139	148	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					456	+		10.1038/ni.3680	http://dx.doi.org/10.1038/ni.3680			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28192417	Green Accepted			2022-12-18	WOS:000396815800013
J	Ramirez-Ortiz, ZG; Pendergraft, WF; Prasad, A; Byrne, MH; Iram, T; Blanchette, CJ; Luster, AD; Hacohen, N; El Khoury, J; Means, TK				Ramirez-Ortiz, Zaida G.; Pendergraft, William F., III; Prasad, Amit; Byrne, Michael H.; Iram, Tal; Blanchette, Christopher J.; Luster, Andrew D.; Hacohen, Nir; El Khoury, Joseph; Means, Terry K.			The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity	NATURE IMMUNOLOGY			English	Article							EVOLUTIONARILY CONSERVED RECOGNITION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INNATE IMMUNITY; SURFACE CALRETICULIN; FUNGAL PATHOGENS; SREC-I; ENGULFMENT; PHOSPHATIDYLSERINE; C1Q; COMPLEMENT	The clearance of apoptotic cells is critical for the control of tissue homeostasis; however, the full range of receptors on phagocytes responsible for the recognition of apoptotic cells remains to be identified. Here we found that dendritic cells (DCs), macrophages and endothelial cells used the scavenger receptor SCARF1 to recognize and engulf apoptotic cells via the complement component C1q. Loss of SCARF1 impaired the uptake of apoptotic cells. Consequently, in SCARF1-deficient mice, dying cells accumulated in tissues, which led to a lupus-like disease, with the spontaneous generation of autoantibodies to DNA-containing antigens, activation of cells of the immune system, dermatitis and nephritis. The discovery of such interactions of SCARF1 with C1q and apoptotic cells provides insight into the molecular mechanisms involved in the maintenance of tolerance and prevention of autoimmune disease.	[Ramirez-Ortiz, Zaida G.; Pendergraft, William F., III; Prasad, Amit; Byrne, Michael H.; Iram, Tal; Blanchette, Christopher J.; Luster, Andrew D.; Hacohen, Nir; El Khoury, Joseph; Means, Terry K.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Ramirez-Ortiz, Zaida G.; Pendergraft, William F., III; Prasad, Amit; Byrne, Michael H.; Iram, Tal; Blanchette, Christopher J.; Luster, Andrew D.; Hacohen, Nir; El Khoury, Joseph; Means, Terry K.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Ramirez-Ortiz, Zaida G.; Pendergraft, William F., III; Prasad, Amit; Byrne, Michael H.; Iram, Tal; Blanchette, Christopher J.; Luster, Andrew D.; Hacohen, Nir; El Khoury, Joseph; Means, Terry K.] Harvard Univ, Sch Med, Charlestown, MA USA; [Pendergraft, William F., III] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Pendergraft, William F., III; Hacohen, Nir; Means, Terry K.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Iram, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tel Aviv University; Harvard University; Massachusetts General Hospital	Means, TK (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA.	means.terry@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Iram, Tal/GSE-3876-2022	Luster, Andrew/0000-0001-9679-7912; Ramirez Ortiz, Zaida/0000-0002-0253-0473	National Institute of Allergy and Infectious Diseases [R01-AI084884, U24 AI082660, T32-AI007061]; National Institute of Arthritis, Musculoskeletal and Skin Diseases [K01-AR051367]; National Institute of Diabetes and Digestive and Kidney Diseases [F32-DK097891]; Lupus Research Institute; Alliance for Lupus Research; American Society of Nephrology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082660, R01AI084884, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK097891, P30DK043351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lupus Research Institute; Alliance for Lupus Research; American Society of Nephrology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y.F. Peng (University of Washington) for Mfge8<SUP>-/-</SUP> mice; M. Michalak (University of Alberta) for K41 (calreticulin-sufficient) and K42 (calreticulin-deficient) MEFs; and M.J. Shlomchik and P. Mundel and members of their laboratories for technical assistance and discussions. Supported by the National Institute of Allergy and Infectious Diseases (R01-AI084884 to T. K. M.; U24 AI082660 to J.E.K.; and T32-AI007061 to Z.G.R.-O.), the National Institute of Arthritis, Musculoskeletal and Skin Diseases (K01-AR051367 to T. K. M.), the National Institute of Diabetes and Digestive and Kidney Diseases (F32-DK097891 to W. F. P.), the Lupus Research Institute (T. K. M. and N.H.), the Alliance for Lupus Research (T. K. M. and N.H.) and the American Society of Nephrology (W.F.P.).	Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FADOK VA, 1992, J IMMUNOL, V148, P2207; Galvan MD, 2012, J LEUKOCYTE BIOL, V92, P489, DOI 10.1189/jlb.0212099; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Holzl MA, 2011, CELL IMMUNOL, V267, P88, DOI 10.1016/j.cellimm.2010.12.001; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Means TK, 2010, VIRULENCE, V1, P37, DOI 10.4161/viru.1.1.10228; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Mukhopadhyay S, 2009, ADV EXP MED BIOL, V653, P1, DOI 10.1109/TENCON.2009.5396176; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; Murshid A, 2010, J IMMUNOL, V185, P2903, DOI 10.4049/jimmunol.0903635; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Scheib JL, 2012, J NEUROSCI, V32, P13022, DOI 10.1523/JNEUROSCI.6350-11.2012; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yoshiizumi K, 2002, BIOORGAN MED CHEM, V10, P2445, DOI 10.1016/S0968-0896(02)00120-7; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P366, DOI 10.1016/j.autrev.2006.10.001; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	50	139	139	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					917	+		10.1038/ni.2670	http://dx.doi.org/10.1038/ni.2670			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23892722	Green Submitted, Green Accepted			2022-12-18	WOS:000323377700009
J	Kang, SG; Liu, WH; Lu, PW; Jin, HY; Lim, HW; Shepherd, J; Fremgen, D; Verdin, E; Oldstone, MBA; Qi, H; Teijaro, JR; Xiao, CC				Kang, Seung Goo; Liu, Wen-Hsien; Lu, Peiwen; Jin, Hyun Yong; Lim, Hyung W.; Shepherd, Jovan; Fremgen, Daniel; Verdin, Eric; Oldstone, Michael B. A.; Qi, Hai; Teijaro, John R.; Xiao, Changchun			MicroRNAs of the miR-17 similar to 92 family are critical regulators of T-FH differentiation	NATURE IMMUNOLOGY			English	Article							CHRONIC VIRAL-INFECTION; FOLLICULAR-HELPER-CELLS; PHOSPHOINOSITIDE 3-KINASE; IMMUNE-SYSTEM; B-CELLS; EXPRESSION; INTERLEUKIN-21; AUTOIMMUNITY; RESPONSES; ROLES	Follicular helper T cells (T-FH cells) provide critical help to B cells during humoral immune responses. Here we report that mice with T cell-specific deletion of the miR-17 similar to 92 family of microRNAs (miRNAs) had substantially compromised T-FH differentiation, germinal-center formation and antibody responses and failed to control chronic viral infection. Conversely, mice with T cell-specific expression of a transgene encoding miR-17 similar to 92 spontaneously accumulated T-FH cells and developed a fatal immunopathology. Mechanistically, the miR-17 similar to 92 family controlled the migration of CD4(+) T cells into B cell follicles by regulating signaling intensity from the inducible costimulator ICOS and kinase PI(3) K by suppressing expression of the phosphatase PHLPP2. Our findings demonstrate an essential role for the miR-17 similar to 92 family in T-FH differentiation and establish PHLPP2 as an important mediator of their function in this process.	[Kang, Seung Goo; Liu, Wen-Hsien; Jin, Hyun Yong; Shepherd, Jovan; Fremgen, Daniel; Oldstone, Michael B. A.; Teijaro, John R.; Xiao, Changchun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lu, Peiwen; Qi, Hai] Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Jin, Hyun Yong] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Lim, Hyung W.; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	Scripps Research Institute; Tsinghua University; Scripps Research Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes	Xiao, CC (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	teijaro@scripps.edu; cxiao@scripps.edu	Verdin, Eric/AAB-7999-2019; Jin, Hyun Yong/I-6464-2013	Lu, Peiwen/0000-0001-6118-872X; Kang, Seung Goo/0000-0003-3981-1399; Shepherd, Jovan/0000-0003-2067-550X; Qi, Hai/0000-0001-5475-3989; Verdin, Eric/0000-0003-3703-3183	Pew Charitable Trusts; Cancer Research Institute; Lupus Research Institute; American Heart Association [11POST7430106]; US National Institutes of Health [R01AI019484, R01AI087634]; National Natural Science Foundation of China [81161120405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087634, R01AI009484] Funding Source: NIH RePORTER	Pew Charitable Trusts; Cancer Research Institute; Lupus Research Institute; American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Zheng, C. Fine and B. Rezner for technical assistance; I. Tobias and A. Newton (University of California, San Diego) for the plasmid pcDNA3-HA-PHLPP2; C.H. Kim, E. Stone, S.M. Hedrick, K. Sauer and members of Xiao laboratory for discussion and critical reading of the manuscript. Supported by the Pew Charitable Trusts, the Cancer Research Institute, the Lupus Research Institute, the American Heart Association (11POST7430106 to J.R.T.), the US National Institutes of Health (R01AI019484 to M.B.A.O. and R01AI087634 to C.X.) and National Natural Science Foundation of China (81161120405 to H.Q.).	AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Jiang P, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-100; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	39	139	154	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					849	+		10.1038/ni.2648	http://dx.doi.org/10.1038/ni.2648			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23812097	Green Accepted, Green Submitted			2022-12-18	WOS:000322010600014
J	Ji, Y; Pos, Z; Rao, M; Klebanoff, CA; Yu, ZY; Sukumar, M; Reger, RN; Palmer, DC; Borman, ZA; Muranski, P; Wang, E; Schrump, DS; Marincola, FM; Restifo, NP; Gattinoni, L				Ji, Yun; Pos, Zoltan; Rao, Mahadev; Klebanoff, Christopher A.; Yu, Zhiya; Sukumar, Madhusudhanan; Reger, Robert N.; Palmer, Douglas C.; Borman, Zachary A.; Muranski, Pawel; Wang, Ena; Schrump, David S.; Marincola, Francesco M.; Restifo, Nicholas P.; Gattinoni, Luca			Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							EFFECTOR; DIFFERENTIATION; EXPRESSION; CANCER; E2A; PROLIFERATION; AMPLIFICATION; LYMPHOCYTES; MAINTENANCE; MATURATION	The transcriptional repressor Blimp-1 promotes the differentiation of CD8(+) T cells into short-lived effector cells (SLECs) that express the lectin-like receptor KLRG-1, but how it operates remains poorly defined. Here we show that Blimp-1 bound to and repressed the promoter of the gene encoding the DNA-binding inhibitor Id3 in SLECs. Repression of Id3 by Blimp-1 was dispensable for SLEC development but limited the ability of SLECs to persist as memory cells. Enforced expression of Id3 was sufficient to restore SLEC survival and enhanced recall responses. Id3 function was mediated in part through inhibition of the transcriptional activity of E2A and induction of genes regulating genome stability. Our findings identify the Blimp-1-Id3-E2A axis as a key molecular switch that determines whether effector CD8(+) T cells are programmed to die or enter the memory pool.	[Ji, Yun; Rao, Mahadev; Klebanoff, Christopher A.; Yu, Zhiya; Sukumar, Madhusudhanan; Reger, Robert N.; Palmer, Douglas C.; Borman, Zachary A.; Muranski, Pawel; Schrump, David S.; Restifo, Nicholas P.; Gattinoni, Luca] NCI, US Natl Inst Hlth, Ctr Canc Res, Bethesda, MD 20892 USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Dept Transfus Med, Ctr Clin, Infect Dis & Immunogenet Sect, Bethesda, MD USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Ctr Human Immunol, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Restifo, NP (corresponding author), NCI, US Natl Inst Hlth, Ctr Canc Res, Bethesda, MD 20892 USA.	restifo@nih.gov; gattinol@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021; Gattinoni, Luca/A-2281-2008; Pós, Zoltán/C-3623-2014; Ji, Yun/B-7245-2009; Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/M-6549-2019; Palmer, Douglas/B-9454-2008	Waldmann, Thomas/0000-0003-4500-6660; Gattinoni, Luca/0000-0003-2239-3282; Pós, Zoltán/0000-0002-2574-7616; Ji, Yun/0000-0001-6340-7009; Palmer, Douglas/0000-0001-5018-5734; Klebanoff, Christopher/0000-0001-9645-3896; Restifo, Nicholas P./0000-0003-4229-4580	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	We thank A. Mixon and S. Farid of the Flow Cytometry Unit for help with flow cytometry analyses and sorting, and M. Bachinski for help with editing the manuscript. Supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091; Belz GT, 2010, CURR OPIN IMMUNOL, V22, P279, DOI 10.1016/j.coi.2010.03.008; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Greenbaum S, 2004, J BIOL CHEM, V279, P45028, DOI 10.1074/jbc.M400061200; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Jarvinen TAH, 2003, CYTOPATHOLOGY, V14, P309, DOI 10.1046/j.0956-5507.2003.00105.x; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Warner SL, 2006, SEMIN ONCOL, V33, P436, DOI 10.1053/j.seminoncol.2006.04.007; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165	49	139	142	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1230	U126		10.1038/ni.2153	http://dx.doi.org/10.1038/ni.2153			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22057288	Green Accepted			2022-12-18	WOS:000297202700018
J	Ely, LK; Fischer, S; Garcia, KC				Ely, Lauren K.; Fischer, Suzanne; Garcia, K. Christopher			Structural basis of receptor sharing by interleukin 17 cytokines	NATURE IMMUNOLOGY			English	Article							NERVE GROWTH-FACTOR; CRYSTAL-STRUCTURE; IL-17 RECEPTOR; CUTTING EDGE; T-CELLS; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; HOST-DEFENSE; IDENTIFICATION; LIGAND	Interleukin 17 (IL-17)-producing helper T cells (T-H-17 cells), together with their effector cytokines, including members of the IL-17 family, are emerging as key mediators of chronic inflammatory and autoimmune disorders. Here we present the crystal structure of a complex of IL-17 receptor A (IL-17RA) bound to IL-17F in a 1:2 stoichiometry. The mechanism of complex formation was unique for cytokines and involved the engagement of IL-17 by two fibronectin-type domains of IL-17RA in a groove between the IL-17 homodimer interface. Binding of the first receptor to the IL-17 cytokines modulated the affinity and specificity of the second receptor-binding event, thereby promoting heterodimeric versus homodimeric complex formation. IL-17RA used a common recognition strategy to bind to several members of the IL-17 family, which allows it to potentially act as a shared receptor in multiple different signaling complexes.	[Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			National Health and Medical Research Council of Australia; US National Institutes of Health [AI51321]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321, R37AI051321] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Juo for assistance with data collection and structure determination; E. Ozkan for discussions; D. Gorman (DNAX) for cDNA reagents; and the beamline staff of the Stanford Synchrotron Radiation Lightsource, Advanced Light Source and Advanced Photon Source for assistance with data collection. Supported by the National Health and Medical Research Council of Australia (L. K. E.), the US National Institutes of Health (AI51321 to K. C. G.) and the Howard Hughes Medical Institute (K. C. G.).	Afonine P., 2005, CCP4 NEWSLETTER, V42; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barton WA, 2006, PROTEIN SCI, V15, P2008, DOI 10.1110/ps.062244206; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W. L, 2002, PYMOL MOL GENETICS G; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAFFEN SL, 2009, NAT REV IMMUNOL; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kramer JM, 2007, J IMMUNOL, V179, P6379, DOI 10.4049/jimmunol.179.10.6379; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li TS, 2006, CELL SIGNAL, V18, P1287, DOI 10.1016/j.cellsig.2005.10.010; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; You ZB, 2006, CANCER RES, V66, P175, DOI 10.1158/0008-5472.CAN-05-1130; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	50	139	156	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1245	U3		10.1038/ni.1813	http://dx.doi.org/10.1038/ni.1813			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19838198	Green Accepted			2022-12-18	WOS:000271872800007
J	Shaw, MH; Reimer, T; Sanchez-Valdepenas, C; Warner, N; Kim, YG; Fresno, M; Nunez, G				Shaw, Michael H.; Reimer, Thornik; Sanchez-Valdepenas, Carmen; Warner, Neil; Kim, Yun-Gi; Fresno, Manuel; Nunez, Gabriel			T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; C-REL; ADAPTIVE IMMUNITY; MICE LACKING; ACTIVATION; RESPONSES; CD28; PROLIFERATION; EXPRESSION	Nod2 belongs to the nucleotide-binding oligomerization domain receptor (NLR) family of proteins, which function as intracellular pathogen sensors in innate immune cells. Nod2 deficiency results in an impaired immune response to bacterial pathogens. However, how this protein promotes host defense against intracellular parasites is unknown. Here we found that Nod2(-/-) mice had less clearance of Toxoplasma gondii and lower interferon-gamma(IFN-gamma) production. Reconstitution of T cell-deficient mice with Nod2(-/-) T cells followed by T. gondii infection demonstrated a T cell-intrinsic defect. Nod2(-/-) CD4(+) T cells had poor helper T cell differentiation, which was associated with impaired production of interleukin 2 (IL-2) and nuclear accumulation of the transcription factor subunit c-Rel. Our data demonstrate a T cell-intrinsic role for Nod2 signaling that is critical for host defense against T. gondii.	[Shaw, Michael H.; Reimer, Thornik; Warner, Neil; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Shaw, Michael H.; Reimer, Thornik; Warner, Neil; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Sanchez-Valdepenas, Carmen; Fresno, Manuel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol, Madrid, Spain	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014; SANZ, MAGDALENA/L-4825-2013; Warner, Neil/ABE-7329-2020	SANZ, MAGDALENA/0000-0002-3106-2680; Warner, Neil/0000-0002-9207-5979; Fresno Escudero, Manuel/0000-0002-9223-5477	US National Institutes of Health [R01 DK61707, T32-HL007517]; Swiss National Science Foundation; University of Michigan Comprehensive Cancer Center; Spanish Ministerio de Cienciae Innovacion [SAF2007-61716]; European Union; Comunidad de Madrid [S-SAL-0159/2006]; La Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares [RD06/0014/1013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Michigan Comprehensive Cancer Center; Spanish Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission); Comunidad de Madrid(Comunidad de Madrid); La Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Weiss (University of California, San Francisco) for the pCD28RE/AP-1 luc reporter plasmid; G.Y. Chen for critically reading the manuscript; S. Koonse for assistance with managing mice colonies; the University of Michigan Flow Cytometry and the immunology core facilities for assistance with flow cytometry and enzyme-linked immunosorbent assay (ELISA); and G. S. Yap for discussions. Supported by the US National Institutes of Health (R01 DK61707; and T32-HL007517 to M. H. S.), the Swiss National Science Foundation (T. R.), the University of Michigan Comprehensive Cancer Center (Y.-G.K.), the Spanish Ministerio de Cienciae Innovacion (SAF2007-61716 to M. F.), European Union (Eicosanox, for M. F.), Comunidad de Madrid (S-SAL-0159/2006 to M. F.) and La Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RD06/0014/1013 to M. F.).	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Civil A, 1999, J BIOL CHEM, V274, P34369, DOI 10.1074/jbc.274.48.34369; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gudmundsdottir H, 2001, J IMMUNOL, V167, P3699, DOI 10.4049/jimmunol.167.7.3699; Hagen KA, 2004, J IMMUNOL, V173, P3909, DOI 10.4049/jimmunol.173.6.3909; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liu ZJ, 2001, J IMMUNOL, V167, P1830, DOI 10.4049/jimmunol.167.3.1830; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Moreira LO, 2008, VACCINE, V26, P5808, DOI 10.1016/j.vaccine.2008.08.038; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Nembrini C, 2008, MICROBES INFECT, V10, P522, DOI 10.1016/j.micinf.2008.01.016; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; SHER A, 1993, J IMMUNOL, V150, P3982; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Villegas EN, 2002, INFECT IMMUN, V70, P4757, DOI 10.1128/IAI.70.9.4757-4761.2002; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yen MH, 2002, J IMMUNOL, V169, P722, DOI 10.4049/jimmunol.169.2.722; Zhou XY, 2002, J IMMUNOL, V168, P3847, DOI 10.4049/jimmunol.168.8.3847	47	139	144	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1267	U6		10.1038/ni.1816	http://dx.doi.org/10.1038/ni.1816			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19881508	Green Accepted			2022-12-18	WOS:000271872800010
J	Fazilleau, N; Eisenbraun, MD; Malherbe, L; Ebright, JN; Pogue-Caley, RR; McHeyzer-Williams, LJ; McHeyzer-Williams, MG				Fazilleau, Nicolas; Eisenbraun, Michael D.; Malherbe, Laurent; Ebright, Jessica N.; Pogue-Caley, Rebecca R.; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.			Lymphoid reservoirs of antigen-specific memory T helper cells	NATURE IMMUNOLOGY			English	Article							CXC CHEMOKINE RECEPTOR-5; IN-VIVO; B-CELLS; REPERTOIRE SELECTION; DRIVEN SELECTION; GENERATION; EXPRESSION; MICE; ACTIVATION; MATURATION	How vaccines control the development of antigen-specific effector and memory T helper cells is central to protective immunity but remains poorly understood. Here we found that protein vaccination selected high-affinity, CXCR5(+)ICOS(hi) follicular B-helper T cells (T-FH cells) that developed in draining lymphoid tissue to regulate B cell responses. In the memory phase, reservoirs of antigen-specific CXCR5(+)ICOS(lo) T-FH cells persisted with less effector activity but accelerated antigen-recall ability. This new compartment of memory T-FH cells was retained in draining lymphoid sites with antigen-specific memory B cells, persistent complexes of peptide and major histocompatibility complex class II and continued expression of CD69. Thus, protein vaccination promotes B cell immunity by selecting high-affinity effector T-FH cells and creating lymphoid reservoirs of antigen-specific memory T-FH cells in vivo.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Duke Univ, Ctr Med, Dept Immunol, Durham, NC 27706 USA; INC Res, Raleigh, NC 27609 USA	Scripps Research Institute; Duke University	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Fazilleau, Nicolas/J-9883-2014	Fazilleau, Nicolas/0000-0002-3574-5614	NIAID NIH HHS [AI059475, AI040215, AI47231] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059475, R01AI040215, R01AI047231] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; FORSTER R, 1994, BLOOD, V84, P830; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MITCHELL J, 1965, NATURE, V208, P500, DOI 10.1038/208500b0; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	50	139	143	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					753	761		10.1038/ni1472	http://dx.doi.org/10.1038/ni1472			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17529982				2022-12-18	WOS:000247718100016
J	Scharping, NE; Rivadeneira, DB; Menk, AV; Vignali, PDA; Ford, BR; Rittenhouse, NL; Peralta, R; Wang, YY; Wang, YP; DePeaux, K; Poholek, AC; Delgoffe, GM				Scharping, Nicole E.; Rivadeneira, Dayana B.; Menk, Ashley, V; Vignali, Paolo D. A.; Ford, B. Rhodes; Rittenhouse, Natalie L.; Peralta, Ronal; Wang, Yiyang; Wang, Yupeng; DePeaux, Kristin; Poholek, Amanda C.; Delgoffe, Greg M.			Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion	NATURE IMMUNOLOGY			English	Article							TUMOR MICROENVIRONMENT; CHECKPOINT; EFFECTOR; DYSFUNCTION; TRANSCRIPTION; METABOLISM; APOPTOSIS; SUBSETS; RESPOND; PD-1	Delgoffe and colleagues show that continuous TCR signaling and hypoxia increase Blimp-1, which suppresses PGC-1 alpha-dependent mitochondrial reprogramming and increases reactive oxygen species generation. Such conditions promote T cell exhaustion. Cancer and chronic infections induce T cell exhaustion, a hypofunctional fate carrying distinct epigenetic, transcriptomic and metabolic characteristics. However, drivers of exhaustion remain poorly understood. As intratumoral exhausted T cells experience severe hypoxia, we hypothesized that metabolic stress alters their responses to other signals, specifically, persistent antigenic stimulation. In vitro, although CD8(+) T cells experiencing continuous stimulation or hypoxia alone differentiated into functional effectors, the combination rapidly drove T cell dysfunction consistent with exhaustion. Continuous stimulation promoted Blimp-1-mediated repression of PGC-1 alpha-dependent mitochondrial reprogramming, rendering cells poorly responsive to hypoxia. Loss of mitochondrial function generated intolerable levels of reactive oxygen species (ROS), sufficient to promote exhausted-like states, in part through phosphatase inhibition and the consequent activity of nuclear factor of activated T cells. Reducing T cell-intrinsic ROS and lowering tumor hypoxia limited T cell exhaustion, synergizing with immunotherapy. Thus, immunologic and metabolic signaling are intrinsically linked: through mitigation of metabolic stress, T cell differentiation can be altered to promote more functional cellular fates.	[Scharping, Nicole E.; Rivadeneira, Dayana B.; Menk, Ashley, V; Vignali, Paolo D. A.; Peralta, Ronal; DePeaux, Kristin; Delgoffe, Greg M.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Dept Immunol, Pittsburgh, PA 15232 USA; [Scharping, Nicole E.; Rivadeneira, Dayana B.; Menk, Ashley, V; Vignali, Paolo D. A.; Peralta, Ronal; DePeaux, Kristin; Delgoffe, Greg M.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Ford, B. Rhodes; Rittenhouse, Natalie L.; Poholek, Amanda C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Wang, Yiyang; Wang, Yupeng] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University	Delgoffe, GM (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Dept Immunol, Pittsburgh, PA 15232 USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	gdelgoffe@pitt.edu	Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135; Scharping, Nicole/0000-0001-9373-4617; DePeaux, Kristin/0000-0001-8460-727X; Peralta, Ronal/0000-0002-2863-0157	NCI [F99CA222711, T32CA082084, F30CA247034, F31CA247129, T32AI089443]; NIH [DP2AI136598, R21AI135367]; UPMC Hillman Cancer Center Melanoma/Skin Cancer [P50CA121973]; Head and Neck Cancer SPORE [P50CA097190]; SU2C-AACR Innovative Research grant [SU2C-AACR-IRG-04-16]; Alliance for Cancer Gene Therapy; Mark Foundation for Cancer Research Emerging Leader Award; Cancer Research Institute Lloyd J. Old STAR Award; Sy Holzer Endowed Cancer Immunotherapy Fund; US Army/Department of Defense [CA170483];  [P30CA047904]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPMC Hillman Cancer Center Melanoma/Skin Cancer; Head and Neck Cancer SPORE; SU2C-AACR Innovative Research grant; Alliance for Cancer Gene Therapy; Mark Foundation for Cancer Research Emerging Leader Award; Cancer Research Institute Lloyd J. Old STAR Award; Sy Holzer Endowed Cancer Immunotherapy Fund; US Army/Department of Defense(United States Department of Defense); 	We thank members of the Delgoffe Laboratory for helpful discussions, as well as K. M. Vignali and D. A. A. Vignali for the gift of E8I-GFP-Cre<SUP>ERT2</SUP> mice. Trainees on this work were supported by the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) (no. F99CA222711 to N.E.S.), T32CA082084 to P.D.A.V. and K.D, F30CA247034 to P.D.A.V., F31CA247129 to. K.D. and T32AI089443 to R.P. This work was supported by an NIH New Innovator Award (nos. DP2AI136598 and R21AI135367), the UPMC Hillman Cancer Center Melanoma/Skin Cancer (no. P50CA121973) and Head and Neck Cancer SPORE (no. P50CA097190), a SU2C-AACR Innovative Research grant (no. SU2C-AACR-IRG-04-16), the US Army/Department of Defense (no. CA170483), the Alliance for Cancer Gene Therapy, the Mark Foundation for Cancer Research Emerging Leader Award, the Cancer Research Institute Lloyd J. Old STAR Award and the Sy Holzer Endowed Cancer Immunotherapy Fund (all to G.M.D.). This work utilized flow cytometry and animal facilities at UPMC Hillman Cancer Center, supported by grant no. P30CA047904.	BACIK I, 1994, J IMMUNOL, V152, P381; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Gropper Y, 2017, CELL REP, V20, P2547, DOI 10.1016/j.celrep.2017.08.071; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Horton BL, 2018, CANCER IMMUNOL RES, V6, P14, DOI 10.1158/2326-6066.CIR-17-0249; Hurst KE, 2019, CANCER IMMUNOL RES, V7, P476, DOI 10.1158/2326-6066.CIR-18-0182; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li YL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01591; Liu C, 2020, NAT IMMUNOL, V21, P1010, DOI 10.1038/s41590-020-0733-2; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Mann TH, 2019, NAT IMMUNOL, V20, P1092, DOI 10.1038/s41590-019-0478-y; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Palazon A, 2017, CANCER CELL, V32, P669, DOI 10.1016/j.ccell.2017.10.003; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Poholek AC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8612; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sawant DV, 2019, NAT IMMUNOL, V20, P724, DOI 10.1038/s41590-019-0346-9; Schaaf MB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0061-0; Scharping NE, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040046; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004	56	138	138	16	105	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					205	U190		10.1038/s41590-020-00834-9	http://dx.doi.org/10.1038/s41590-020-00834-9		JAN 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398183	Green Accepted			2022-12-18	WOS:000604865800007
J	Rouxel, O; Da Silva, J; Beaudoin, L; Nel, I; Tard, C; Cagninacci, L; Kiaf, B; Oshima, M; Diedisheim, M; Salou, M; Corbett, A; Rossjohn, J; McCluskey, J; Scharfmann, R; Battaglia, M; Polak, M; Lantz, O; Beltrand, J; Lehuen, A				Rouxel, Ophelie; Da Silva, Jennifer; Beaudoin, Lucie; Nel, Isabelle; Tard, Celine; Cagninacci, Lucie; Kiaf, Badr; Oshima, Masaya; Diedisheim, Marc; Salou, Marion; Corbett, Alexandra; Rossjohn, Jamie; McCluskey, James; Scharfmann, Raphael; Battaglia, Manuela; Polak, Michel; Lantz, Olivier; Beltrand, Jacques; Lehuen, Agnes			Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; MAIT CELLS; PROINFLAMMATORY IL-17(+); INTESTINAL MICROBIOTA; GUT MICROBIOME; MR1 TETRAMERS; AUTOIMMUNE; PERMEABILITY; MOUSE; ONSET	Type 1 diabetes (T1D) is an autoimmune disease that results from the destruction of pancreatic b-cells by the immune system that involves innate and adaptive immune cells. Mucosal-associated invariant T cells (MAIT cells) are innate-like T-cells that recognize derivatives of precursors of bacterial riboflavin presented by the major histocompatibility complex (MHC) class I-related molecule MR1. Since T1D is associated with modification of the gut microbiota, we investigated MAIT cells in this pathology. In patients with T1D and mice of the non-obese diabetic (NOD) strain, we detected alterations in MAIT cells, including increased production of granzyme B, which occurred before the onset of diabetes. Analysis of NOD mice that were deficient in MR1, and therefore lacked MAIT cells, revealed a loss of gut integrity and increased anti-islet responses associated with exacerbated diabetes. Together our data highlight the role of MAIT cells in the maintenance of gut integrity and the control of anti-islet autoimmune responses. Monitoring of MAIT cells might represent a new biomarker of T1D, while manipulation of these cells might open new therapeutic strategies.	[Rouxel, Ophelie; Da Silva, Jennifer; Beaudoin, Lucie; Nel, Isabelle; Tard, Celine; Cagninacci, Lucie; Kiaf, Badr; Oshima, Masaya; Diedisheim, Marc; Scharfmann, Raphael; Polak, Michel; Beltrand, Jacques; Lehuen, Agnes] Inst Cochin, INSERM, U1016, Paris, France; [Rouxel, Ophelie; Da Silva, Jennifer; Beaudoin, Lucie; Nel, Isabelle; Tard, Celine; Cagninacci, Lucie; Kiaf, Badr; Oshima, Masaya; Diedisheim, Marc; Scharfmann, Raphael; Polak, Michel; Beltrand, Jacques; Lehuen, Agnes] Univ Paris 05, Paris, France; [Rouxel, Ophelie; Da Silva, Jennifer; Beaudoin, Lucie; Nel, Isabelle; Tard, Celine; Cagninacci, Lucie; Kiaf, Badr; Oshima, Masaya; Diedisheim, Marc; Scharfmann, Raphael; Polak, Michel; Beltrand, Jacques; Lehuen, Agnes] CNRS, UMR8104, Paris, France; [Rouxel, Ophelie; Da Silva, Jennifer; Beaudoin, Lucie; Nel, Isabelle; Tard, Celine; Cagninacci, Lucie; Kiaf, Badr; Lehuen, Agnes] Sorbonne Paris Cite, Lab Excellence INFLAMEX, Paris, France; [Salou, Marion; Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Corbett, Alexandra; McCluskey, James] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Corbett, Alexandra; McCluskey, James] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Cardiff, S Glam, Wales; [Rossjohn, Jamie] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Battaglia, Manuela] IRCCS, San Raffaele Sci Inst, Diabet Res Inst, Milan, Italy; [Battaglia, Manuela] Hosp San Raffaele, TrialNet Clin Ctr, Milan, Italy; [Polak, Michel; Beltrand, Jacques] Hop Univ Necker Enfants Malad, AP HP, Serv Endocrinol Gynecol & Diabetol Pediat, Paris, France; [Beltrand, Jacques] Univ Sorbonne Paris Cite, Fac Med Paris Descartes, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Monash University; Monash University; Monash University; Cardiff University; University of Melbourne; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lehuen, A (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.; Lehuen, A (corresponding author), Univ Paris 05, Paris, France.	agnes.lehuen@inserm.fr	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; scharfmann, raphael/L-3296-2017; beltrand, jacques/AAV-6455-2021; Corbett, Alexandra/A-1225-2019; Diedisheim, Marc/ABC-6996-2020	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; beltrand, jacques/0000-0002-3759-3490; Corbett, Alexandra/0000-0003-1618-4337; Scharfmann, Raphael/0000-0001-7619-337X; Salou, Marion/0000-0003-3546-0886; Kiaf, Badr/0000-0001-8194-7543; Lantz, olivier/0000-0003-3161-7719; Battaglia, Manuela/0000-0003-4535-3152	Societe Francophone de Diabetologie; Foundation Bettencourt Schueller; Laboratoire d'Excellence REVIVE; Fondation pour la Recherche Medicale; Type 1 Diabetes TrialNet; Agence Nationale de la Recherche [NR-11-IDEX-0005-02]; Fondation pour la Recherche Medicale [DEQ20140329520]; INSERM crosscutting program on microbiota; European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Lilly; Departement Hospitalo-Universitaire on Autoimmune and Hormonal Diseases; Ministry of Research; Aide aux Jeunes Diabetiques; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061042, U01DK061010, U01DK107014, U01DK085476, U01DK103153] Funding Source: NIH RePORTER	Societe Francophone de Diabetologie; Foundation Bettencourt Schueller; Laboratoire d'Excellence REVIVE; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Type 1 Diabetes TrialNet; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM crosscutting program on microbiota; European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Lilly; Departement Hospitalo-Universitaire on Autoimmune and Hormonal Diseases; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Aide aux Jeunes Diabetiques; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the patients and the medical staff of Necker hospital; A. Toubal for critical reading of the manuscript; F. Letourneur and A. Stabilini for technical help; the mouse, Cybio and HistIM facilities of the Cochin Institute; G, Eberl (Institut Pasteur, Paris) for the bacterial artificial chromosome expressing ROR gamma t-GFP; the US National Institutes of Health tetramer core facility; and H. Fohrer-Ting, R. Porcher and M. Laanani for help in statistical analyses. Supported by the Societe Francophone de Diabetologie (R.S.), the Foundation Bettencourt Schueller (R.S.), the Laboratoire d'Excellence REVIVE (R.S.), Fondation pour la Recherche Medicale (C.T., M.O. and M.D.), Type 1 Diabetes TrialNet (M.B.), Agence Nationale de la Recherche (NR-11-IDEX-0005-02 Laboratory of Excellence INFLAMEX to A.L.), Fondation pour la Recherche Medicale (DEQ20140329520 to A.L.), the INSERM crosscutting program on microbiota (A.L.), the European Foundation for the Study of Diabetes-Juvenile Diabetes Research Foundation-Lilly (A.L.), the Departement Hospitalo-Universitaire on Autoimmune and Hormonal Diseases (A.L.), the Ministry of Research (O. R.) and Aide aux Jeunes Diabetiques (I.N.).	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Alam C, 2010, DIABETES, V59, P2237, DOI 10.2337/db10-0147; Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Costa FRC, 2016, J EXP MED, V213, P1223, DOI 10.1084/jem.20150744; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeffery HC, 2016, J HEPATOL, V64, P1118, DOI 10.1016/j.jhep.2015.12.017; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Komulainen J, 1999, DIABETES CARE, V22, P1950, DOI 10.2337/diacare.22.12.1950; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Magalhaes I, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00341; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mahon JL, 2009, PEDIATR DIABETES, V10, P97, DOI 10.1111/j.1399-5448.2008.00464.x; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Toubal A, 2016, J HEPATOL, V64, P1008, DOI 10.1016/j.jhep.2016.02.003; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; TrialNet, 2017, INF LPAT; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Vatanen T, 2016, CELL, V165, P1551, DOI 10.1016/j.cell.2016.05.056; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	55	138	142	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1321	+		10.1038/ni.3854	http://dx.doi.org/10.1038/ni.3854			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	28991267	Green Accepted			2022-12-18	WOS:000415324900010
J	Yu, BF; Zhang, K; Milner, JJ; Toma, C; Chen, RQ; Scott-Browne, JP; Pereira, RM; Crotty, S; Chang, JT; Pipkin, ME; Wang, W; Goldrath, AW				Yu, Bingfei; Zhang, Kai; Milner, J. Justin; Toma, Clara; Chen, Runqiang; Scott-Browne, James P.; Pereira, Renata M.; Crotty, Shane; Chang, John T.; Pipkin, Matthew E.; Wang, Wei; Goldrath, Ananda W.			Epigenetic landscapes reveal transcription factors that regulate CD8(+) T cell differentiation	NATURE IMMUNOLOGY			English	Article							TERMINAL DIFFERENTIATION; MEMORY-PRECURSOR; IMMUNE-RESPONSE; EFFECTOR; BET; EXPRESSION; CHROMATIN; NETWORK; INFLAMMATION; INFECTION	Dynamic changes in the expression of transcription factors (TFs) can influence the specification of distinct CD8(+) T cell fates, but the observation of equivalent expression of TFs among differentially fated precursor cells suggests additional underlying mechanisms. Here we profiled the genome-wide histone modifications, open chromatin and gene expression of naive, terminal-effector, memory-precursor and memory CD8(+) T cell populations induced during the in vivo response to bacterial infection. Integration of these data suggested that the expression and binding of TFs contributed to the establishment of subset-specific enhancers during differentiation. We developed a new bioinformatics method using the PageRank algorithm to reveal key TFs that influence the generation of effector and memory populations. The TFs YY1 and Nr3c1, both constitutively expressed during CD8(+) T cell differentiation, regulated the formation of terminal-effector cell fates and memory-precursor cell fates, respectively. Our data define the epigenetic landscape of differentiation intermediates and facilitate the identification of TFs with previously unappreciated roles in CD8(+) T cell differentiation.	[Yu, Bingfei; Milner, J. Justin; Toma, Clara; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zhang, Kai; Wang, Wei] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Chen, Runqiang] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Chen, Runqiang; Pipkin, Matthew E.] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL USA; [Scott-Browne, James P.; Pereira, Renata M.] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Pereira, Renata M.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology; Scripps Research Institute; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Universidade Federal do Rio de Janeiro	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.; Wang, W (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.; Wang, W (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Wang, W (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	wei-wang@ucsd.edu; agoldrath@ucsd.edu	Zhang, Kai/D-6501-2016; Zhang, Kai/E-5426-2010; Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Pereira, Renata/V-6194-2019	Zhang, Kai/0000-0003-3454-7357; Zhang, Kai/0000-0003-3454-7357; Crotty, Shane/0000-0002-6484-6262; Chang, John/0000-0003-0873-6218; Chen, Runqiang/0000-0002-6997-495X; Goldrath, Ananda/0000-0002-5900-508X; Pereira, Renata/0000-0002-7719-8356; Pipkin, Matthew/0000-0002-9688-0190	University of California, San Diego; US National Institutes of Health [A1067545, A1072117, U19AI109976, U54HG006997, AR070310, R01 AI109842, AI40127]; Leukemia and Lymphoma Society; Pew Scholars Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Damon Runyon Cancer Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009626, U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109842, R01AI067545, R01AI040127, U19AI109976, R01AI072117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR070310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016262] Funding Source: NIH RePORTER	University of California, San Diego(University of California System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pew Scholars Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Damon Runyon Cancer Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Immgen core team for help in gene-expression data processing; and C. Murre, A. Phan, K. Omilusik, L. A. Shaw, K. Brennan and members of the Goldrath laboratory for critical discussions and review of the manuscript. Supported by the University of California, San Diego (Dr. Huang Memorial Scholarship to B.Y.), the US National Institutes of Health (A1067545 and A1072117 to A.W.G.; U19AI109976 to A.W.G, S.C. and M.E.P.; U54HG006997 and AR070310 to W.W.; and R01 AI109842 and AI40127 to A.R. for research by R.M.P. and J.P.S.-B.), the Leukemia and Lymphoma Society (A.W.G.), the Pew Scholars Fund (A.W.G.), the Pew Latin American Fellows Program in the Biomedical Sciences (R.M.P.) and the Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation (J.P.S.-B.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Best J. A., 2013, NAT IMMUNOL, V29, P997; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chaix J, 2014, J IMMUNOL, V193, P1013, DOI 10.4049/jimmunol.1400488; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; D'Cruz LM, 2012, EUR J IMMUNOL, V42, P2031, DOI 10.1002/eji.201242497; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Hwang SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10789; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Ma CY, 2015, P NATL ACAD SCI USA, V112, P11013, DOI 10.1073/pnas.1510119112; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Page Lawrence, 1998, WORLD WIDE WEB, V54, P1; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Winter DR, 2015, NAT REV IMMUNOL, V15, P585, DOI 10.1038/nri3884; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhang K., 2016, NAT COMMUN, V7, P1; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10812	50	138	140	5	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					573	582		10.1038/ni.3706	http://dx.doi.org/10.1038/ni.3706			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28288100	Green Accepted			2022-12-18	WOS:000399378700014
J	Sun, J; Dodd, H; Moser, EK; Sharma, R; Braciale, TJ				Sun, Jie; Dodd, Haley; Moser, Emily K.; Sharma, Rahul; Braciale, Thomas J.			CD4(+) T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs	NATURE IMMUNOLOGY			English	Article							C-MAF; DIFFERENTIATION; INTERLEUKIN-10; PROMOTE; BLIMP-1; MEMORY; INFLAMMATION; ACTIVATION; GENERATION; INFECTION	Interleukin (IL)-10 is an important regulatory cytokine that can modulate excessive immune mediated injury. Several distinct cell types have been demonstrated to produce IL-10, including most recently CD8(+) cytotoxic T lymphocytes (CTLs) responding to respiratory virus infection. Here we report that CD4(+) T cell help in the form of IL-2 is required for IL-10 production by CTLs, but not for the induction of CTL effector cytokines. We show that IL-2 derived from CD4(+) helper T cells cooperates with innate immune cell-derived IL-27 to amplify IL-10 production by CTLs through a Blimp-1-dependent mechanism. These findings reveal a previously unrecognized pathway that coordinates signals derived from innate and helper T cells to control the production of a regulatory cytokine by CTLs during acute viral infection.	[Sun, Jie; Dodd, Haley; Moser, Emily K.; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Sun, Jie; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Sharma, Rahul] Univ Virginia, Dept Med, Charlottesville, VA USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu	Moser, Emily/AAS-6618-2020	Moser, Emily/0000-0001-6386-5894	US National Institutes of Health [AI-15608, HL-33391, AI-37293, U19 AI-083024]; University of Virginia Center for Immunity, Inflammation and Regenerative Medicine; American Lung Association [RN-123000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071875, R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015608, R01AI037293, U19AI083024, R01AI015608, T32AI007496] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Center for Immunity, Inflammation and Regenerative Medicine; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the rest of Braciale laboratory for critical comments and B. Small for excellent technical assistance. We thank C.L. Karp (Cincinnati Children's Hospital Medical Center), M. Mohrs (Trudeau Institute), W. Leonard (US National Institutes of Health) and T.R. Malek (University of Miami) for reagents. This work was supported by the US National Institutes of Health (grants AI-15608, HL-33391, AI-37293 and U19 AI-083024 to T.J.B.), University of Virginia Center for Immunity, Inflammation and Regenerative Medicine start-up funds to R.S. and an American Lung Association Postdoctoral Fellowship (RN-123000) to J.S.	Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Belz GT, 2010, IMMUNITY, V32, P7, DOI 10.1016/j.immuni.2010.01.009; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Zhang S, 2009, BIOCHEM BIOPH RES CO, V384, P405, DOI 10.1016/j.bbrc.2009.04.134	42	138	144	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					327	U80		10.1038/ni.1996	http://dx.doi.org/10.1038/ni.1996			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21297642	Green Accepted			2022-12-18	WOS:000288593400011
J	Gur, C; Porgador, A; Elboim, M; Gazit, R; Mizrahi, S; Stern-Ginossar, N; Achdout, H; Ghadially, H; Dor, Y; Nir, T; Doviner, V; Hershkovitz, O; Mendelson, M; Naparstek, Y; Mandelboim, O				Gur, Chamutal; Porgador, Angel; Elboim, Moran; Gazit, Roi; Mizrahi, Saar; Stern-Ginossar, Noam; Achdout, Hagit; Ghadially, Hormas; Dor, Yuval; Nir, Tomer; Doviner, Victoria; Hershkovitz, Oren; Mendelson, Michal; Naparstek, Yaakov; Mandelboim, Ofer			The activating receptor NKp46 is essential for the development of type 1 diabetes	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELL; VIRUS-INFECTED CELLS; NOD MICE; NK CELLS; PANCREATIC-ISLETS; STREPTOZOTOCIN; LYSIS; MODEL; MELLITUS; BETA	The mechanism of action of natural killer (NK) cells in type 1 diabetes is still unknown. Here we show that the activating receptor NKp46 recognizes mouse and human ligands on pancreatic beta cells. NK cells appeared in the pancreas when insulitis progressed to type 1 diabetes, and NKp46 engagement by beta cells led to degranulation of NK cells. NKp46-deficient mice had less development of type 1 diabetes induced by injection of a low dose of streptozotocin. Injection of soluble NKp46 proteins into nonobese diabetic mice during the early phase of insulitis and the prediabetic stage prevented the development of type 1 diabetes. Our findings demonstrate that NKp46 is essential for the development of type 1 diabetes and highlight potential new therapeutic modalities for this disease.	[Gur, Chamutal; Elboim, Moran; Gazit, Roi; Mizrahi, Saar; Stern-Ginossar, Noam; Achdout, Hagit; Ghadially, Hormas; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Gur, Chamutal; Naparstek, Yaakov] Hadassah Hebrew Univ Hosp, Dept Med, Jerusalem, Israel; [Porgador, Angel; Hershkovitz, Oren; Mendelson, Michal] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Porgador, Angel; Hershkovitz, Oren; Mendelson, Michal] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Doviner, Victoria] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	angel@bgumail.bgu.ac.il; oferm@ekmd.huji.ac	Dor, Yuval/C-2405-2011; Gazit, Roi/J-3352-2017	Mandelboim, Ofer/0000-0002-9354-1855; , Noam/0000-0003-3583-5932; Gazit, Roi/0000-0002-0548-2147; Porgador, Angel/0000-0003-1540-4449	Juvenile Diabetes Research Foundation; Israel Science Foundation; Leifermann Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Leifermann Foundation	We thank E. Pikarsky for help and advice; E. Horowitz for assistance; members of the Mandelboim laboratory for discussions and the Physician Research Program of Hadassah Hospital for assistance. Supported by the Juvenile Diabetes Research Foundation (O. M.), the Israel Science Foundation (Morasha grant to C. G.) and the Leifermann Foundation (Y. N.).	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alba A, 2008, CLIN EXP IMMUNOL, V151, P467, DOI 10.1111/j.1365-2249.2007.03580.x; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Flodstrom M, 2002, SCAND J IMMUNOL, V55, P432, DOI 10.1046/j.1365-3083.2002.01084.x; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Foulis AK, 1997, DIABETOLOGIA, V40, P53, DOI 10.1007/s001250050642; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; HANSSON M, 1981, EUR J IMMUNOL, V11, P8, DOI 10.1002/eji.1830110103; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; KITAGAWA Y, 1991, J AUTOIMMUN, V4, P703, DOI 10.1016/0896-8411(91)90167-B; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Lodde BM, 2006, ORAL DIS, V12, P566, DOI 10.1111/j.1601-0825.2006.01241.x; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; MACKAY P, 1986, J CLIN INVEST, V77, P916, DOI 10.1172/JCI112390; Maier LM, 2008, J IMMUNOL, V181, P7073, DOI 10.4049/jimmunol.181.10.7073; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Matsumoto S, 2007, CLONING STEM CELLS, V9, P176, DOI 10.1089/clo.2006.0022; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Moretta L, 2005, CURR OPIN IMMUNOL, V17, P303, DOI 10.1016/j.coi.2005.04.011; Morse RHA, 2001, J NEUROIMMUNOL, V116, P107, DOI 10.1016/S0165-5728(01)00289-2; NAKAMURA N, 1990, DIABETES, V39, P836, DOI 10.2337/diabetes.39.7.836; OBrien BA, 1996, J PATHOL, V178, P176; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935	37	138	146	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					121	U37		10.1038/ni.1834	http://dx.doi.org/10.1038/ni.1834			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20023661				2022-12-18	WOS:000273730200008
J	Venuprasad, K; Huang, H; Harada, Y; Elly, C; Subramaniam, M; Spelsberg, T; Su, J; Liu, YC				Venuprasad, K.; Huang, Haining; Harada, Yousuke; Elly, Chris; Subramaniam, Malayannan; Spelsberg, Thomas; Su, Jin; Liu, Yun-Cai			The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; TGF-BETA; IMMUNE-RESPONSES; INHALED ANTIGEN; CUTTING EDGE; IN-VITRO; TOLERANCE; MICE; FAMILY; PHOSPHORYLATION	Transforming growth factor-beta (TGF-beta) signaling in naive T cells induces expression of the transcription factor Foxp3, a 'master' regulator of regulatory T cells (T-reg cells). However, the molecular mechanisms leading to Foxp3 induction remain unclear. Here we show that Itch(-/-) T cells were resistant to TGF-beta treatment and had less Foxp3 expression. The E3 ubiquitin ligase Itch associated with and promoted conjugation of ubiquitin to the transcription factor TIEG1. Itch cooperated with TIEG1 to induce Foxp3 expression, which was reversed by TIEG1 deficiency. Functionally, 'TGF-beta-converted' T-reg cells generated from TIEG1-deficient mice were unable to suppress airway inflammation in vivo. These results suggest TIEG and Itch contribute to a ubiquitin-dependent nonproteolytic pathway that regulates inducible Foxp3 expression and the control of allergic responses.	[Venuprasad, K.; Huang, Haining; Harada, Yousuke; Elly, Chris; Su, Jin; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Subramaniam, Malayannan; Spelsberg, Thomas] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	La Jolla Institute for Immunology; Mayo Clinic	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	yuncail@liai.org	Su, Jin/H-9027-2016	Su, Jin/0000-0002-2134-4895; poojary, venuprasd/0000-0001-8986-9092; LIU, YUN-CAI/0000-0002-0996-7109; Harada, Yohsuke/0000-0002-8023-1030	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI062969-03, R01 AI062969] Funding Source: Medline; NIDCR NIH HHS [R01 DE014036] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014	42	138	152	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					245	253		10.1038/ni1564	http://dx.doi.org/10.1038/ni1564			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18278048	Green Accepted			2022-12-18	WOS:000253406700010
J	Hoffmann, A; Kerr, S; Jellusova, J; Zhang, JQ; Weisel, F; Wellmann, U; Winkler, TH; Kneitz, B; Crocker, PR; Nitschke, L				Hoffmann, Anja; Kerr, Sheena; Jellusova, Julia; Zhang, Jiquan; Weisel, Florian; Wellmann, Ute; Winkler, Thomas H.; Kneitz, Burkhard; Crocker, Paul R.; Nitschke, Lars			Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; B-1 CELLS; CD22-DEFICIENT MICE; NEGATIVE REGULATION; MONOCLONAL-ANTIBODIES; IMMUNE-SYSTEM; MARGINAL ZONE; LIFE-SPAN; CD22; GENE	B1 cells are an important cell population for the production of natural antibodies and for antibacterial immunoglobulin responses. Here we identified the mouse protein Siglec-G as a B1 cell inhibitory receptor. Siglec-G was expressed in a B cell restricted way, with large amounts present in B1 cells. When overexpressed, Siglec-G inhibited B cell receptor-mediated calcium signaling. Siglec-G-deficient mice had massive expansion of the B1a cell population, which began early in development and was B cell intrinsic. Siglec-G- deficient mice had higher titers of natural IgM antibodies but not a higher penetrance of IgG autoantibodies. Siglec-G-deficient B1 cells showed a strongly enhanced calcium signaling. Our results demonstrate that Siglec-G-dependent negative regulation exists in B1 cells, which may explain the naturally muted signaling response of B1 cells.	Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Germany; Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Univ Erlangen Nurnberg, Nikolaus Fiebiger Zentrum, Dept Genet, D-91054 Erlangen, Germany; Univ Wurzburg, Zentrum Operat Med, D-97080 Wurzburg, Germany	University of Erlangen Nuremberg; University of Dundee; University of Erlangen Nuremberg; University of Wurzburg	Nitschke, L (corresponding author), Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Germany.	nitschke@biologie.uni-erlangen.de		Crocker, Paul/0000-0001-6230-0293				Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Angata T, 2006, MOL DIVERS, V10, P555, DOI 10.1007/s11030-006-9029-1; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; CONG YZ, 1991, INT IMMUNOL, V3, P467; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; FORSTER I, 1991, EUR J IMMUNOL, V21, P1779, DOI 10.1002/eji.1830210732; Gerlach J, 2003, EUR J IMMUNOL, V33, P3418, DOI 10.1002/eji.200324290; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; Lajaunias F, 2002, J IMMUNOL, V168, P6078, DOI 10.4049/jimmunol.168.12.6078; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lentz VM, 1998, J IMMUNOL, V160, P3743; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; MURAKAMI M, 1995, INT IMMUNOL, V7, P877, DOI 10.1093/intimm/7.5.877; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; Oetke C, 2006, IMMUNOL LETT, V106, P96, DOI 10.1016/j.imlet.2006.04.004; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PAO L, IN PRESS IMMUNITY; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Sen G, 1999, EUR J IMMUNOL, V29, P3319; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; STEINBERG BJ, 1982, J CLIN INVEST, V70, P587, DOI 10.1172/JCI110651; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Wellmann U, 2001, EUR J IMMUNOL, V31, P2800, DOI 10.1002/1521-4141(200109)31:9<2800::AID-IMMU2800>3.0.CO;2-E; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x	49	138	144	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					694	704		10.1038/ni1480	http://dx.doi.org/10.1038/ni1480			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17572677				2022-12-18	WOS:000247718100010
J	Goldmit, M; Ji, YH; Skok, J; Roldan, E; Jung, S; Cedar, H; Bergman, Y				Goldmit, M; Ji, YH; Skok, J; Roldan, E; Jung, S; Cedar, H; Bergman, Y			Epigenetic ontogeny of the Igk locus during B cell development	NATURE IMMUNOLOGY			English	Article							DNASE-I SENSITIVITY; V(D)J RECOMBINATION; ALLELIC EXCLUSION; IMMUNE-SYSTEM; LYMPHOCYTE DEVELOPMENT; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; KAPPA LOCUS; GENE; IKAROS	To become accessible for rearrangement, the immunoglobulin kappa locus must undergo a series of epigenetic changes. This begins in pro-B cells with the relocation of both immunoglobulin kappa alleles from the periphery to the center of the nucleus. In pre-B cells, one allele became preferentially packaged into an active chromatin structure characterized by histone acetylation and methylation of histone H3 lysine 4, while the other allele was recruited to heterochromatin, where it was associated with heterochromatin protein-gamma and Ikaros. These events in cis made only one allele accessible to trans-acting factors, such as RelB, which mediated DNA demethylation, to facilitate rearrangement. These results suggest that early B lymphoid epigenetic changes generate differential structures that serve as the basis for allelic exclusion.	Hebrew Univ Jerusalem, Sch Med, Dept Expt Med, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel; UCL, Dept Immunol & Mol Pathol, London W1T 4JF, England; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of London; University College London; Weizmann Institute of Science	Bergman, Y (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Expt Med, IL-91120 Jerusalem, Israel.	yberg@md.huji.ac.il	Skok, Jane/ABF-7249-2020; Jung, Steffen/K-1409-2012	Skok, Jane/0000-0002-4145-1516; Jung, Steffen/0000-0003-4290-5716				Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Bergman Y, 2003, CURR OPIN IMMUNOL, V15, P176, DOI 10.1016/S0952-7915(03)00016-5; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Gellert M, 1996, GENES CELLS, V1, P269, DOI 10.1046/j.1365-2443.1996.22023.x; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Ji YH, 2003, P NATL ACAD SCI USA, V100, P7557, DOI 10.1073/pnas.0932635100; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; MATHER EL, 1983, P NATL ACAD SCI-BIOL, V80, P4689, DOI 10.1073/pnas.80.15.4689; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Mostoslavsky R, 1999, COLD SPRING HARB SYM, V64, P197, DOI 10.1101/sqb.1999.64.197; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Strom L, 2003, MOL IMMUNOL, V39, P771, DOI 10.1016/S0161-5890(03)00004-X; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601	47	138	138	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					198	203		10.1038/ni1154	http://dx.doi.org/10.1038/ni1154			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15619624				2022-12-18	WOS:000226468100023
J	Maier, H; Ostraat, R; Gao, H; Fields, S; Shinton, SA; Medina, KL; Ikawa, T; Murre, C; Singh, H; Hardy, RR; Hagman, J				Maier, H; Ostraat, R; Gao, H; Fields, S; Shinton, SA; Medina, KL; Ikawa, T; Murre, C; Singh, H; Hardy, RR; Hagman, J			Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription	NATURE IMMUNOLOGY			English	Article							GENE-TRANSCRIPTION; V(D)J RECOMBINASE; PAX-5 BSAP; DIFFERENTIATION; PROTEINS; PROMOTER; E2A; ACTIVATION; BINDING; EXPRESSION	Cd79a (called mb-1 here) encodes the Ig-alpha signaling component of the B cell receptor. The early B cell-specific mb-1 promoter was hypermethylated at CpG dinucleotides in hematopoietic stem cells but became progressively unmethylated as B cell development proceeded. The transcription factor Pax5 activated endogenous mb-1 transcription in a plasmacytoma cell line, but could not when the promoter was methylated. In this context, early B cell factor (EBF), a transcription factor required for B lymphopoiesis, potentiated activation of mb-1 by Pax5. EBF and the basic helix-loop-helix transcription factor E47 each contributed to epigenetic modifications of the mb-1 promoter, including CpG demethylation and nucleosomal remodeling. EBF function was enhanced by interaction with the transcription factor Runx1. These data suggest a molecular basis for the hierarchical dependence of Pax5 function on EBF and E2A in B lymphocyte development.	Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA; Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Fox Chase Cancer Center; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California San Diego	Hagman, J (corresponding author), Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA.	hagmanj@njc.org	Hagman, James/R-7013-2019	Hagman, James/0000-0002-5436-8455	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054661, R01AI056322, T32AI007405, R01AI040946, R01AI026782, P01AI022295] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI26782, R01 AI056322, R01 AI054661, P01 AI22295, T32 AI07405, R01 AI40946] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Gisler R, 2002, J IMMUNOL, V168, P5130, DOI 10.4049/jimmunol.168.10.5130; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAWLEY RG, 1994, GENE THER, V1, P136; HOMBACH J, 1988, J EXP MED, V167, P652, DOI 10.1084/jem.167.2.652; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; JULIUS MH, 1988, J IMMUNOL, V140, P1366; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Libermann TA, 1999, J BIOL CHEM, V274, P24671, DOI 10.1074/jbc.274.35.24671; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; MEDINA KL, IN PRESS DEV CELL; Meyers S, 1996, ONCOGENE, V13, P303; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Sigvardsson M, 2000, MOL CELL BIOL, V20, P3640, DOI 10.1128/MCB.20.10.3640-3654.2000; SWIFT S, 2003, CURRENT PROTOCOLS IM; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TRAVIS A, 1991, MOL CELL BIOL, V11, P5756, DOI 10.1128/MCB.11.11.5756; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wagner DH, 1996, J EXP MED, V184, P1631, DOI 10.1084/jem.184.5.1631; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	46	138	138	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1069	1077		10.1038/ni1119	http://dx.doi.org/10.1038/ni1119			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15361869				2022-12-18	WOS:000224156600031
J	Lau, CM; Adams, NM; Geary, CD; Weizman, OE; Rapp, M; Pritykin, Y; Leslie, CS; Sun, JC				Lau, Colleen M.; Adams, Nicholas M.; Geary, Clair D.; Weizman, Orr-El; Rapp, Moritz; Pritykin, Yuri; Leslie, Christina S.; Sun, Joseph C.			Epigenetic control of innate and adaptive immune memory	NATURE IMMUNOLOGY			English	Article							NK CELL-DEVELOPMENT; TRANSCRIPTION FACTORS; T-CELLS; TERMINAL DIFFERENTIATION; ACTIVATION; CHROMATIN; CYTOMEGALOVIRUS; IDENTITY; TCF-1; SPECIFICATION	Clonal expansion and immunological memory are hallmark features of the mammalian adaptive immune response and essential for prolonged host control of pathogens. Recent work demonstrates that natural killer (NK) cells of the innate immune system also exhibit these adaptive traits during infection. Here we demonstrate that differentiating and 'memory' NK cells possess distinct chromatin accessibility states and that their epigenetic profiles reveal a 'poised' regulatory program at the memory stage. Furthermore, we elucidate how individual STAT transcription factors differentially control epigenetic and transcriptional states early during infection. Finally, concurrent chromatin profiling of the canonical CD8(+) T cell response against the same infection demonstrated parallel and distinct epigenetic signatures defining NK cells and CD8(+) T cells. Overall, our study reveals the dynamic nature of epigenetic modifications during the generation of innate and adaptive lymphocyte memory.	[Lau, Colleen M.; Adams, Nicholas M.; Geary, Clair D.; Weizman, Orr-El; Rapp, Moritz; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Pritykin, Yuri; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org	Pritykin, Yuri/ACA-0558-2022	Pritykin, Yury/0000-0001-6589-981X; Sun, Joseph/0000-0001-8062-9033; Rapp, Moritz/0000-0001-5104-7683; Adams, Nicholas/0000-0001-5751-0480	Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NIH [CA009149, U01 HG007893, AI100874, AI130043, P30CA008748]; National Institute of General Medical Sciences of the NIH [T32GM007739]; NIH National Institute of Allergy and Infectious Diseases [F30 AI136239]; German Academic Exchange Service (DAAD; Germany); Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009149, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI136239, R01AI100874, R01AI130043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Academic Exchange Service (DAAD; Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sun laboratory for comments, discussions, technical support, and experimental assistance. We thank S. Chhangawala, L. Fairchild, and C. Krishna for discussions and technical support. The Integrated Genomics Operation Core was supported by Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. C.M.L. was supported by a T32 award from the NIH (CA009149). N.M.A. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program and an F30 Predoctoral Fellowship from the NIH National Institute of Allergy and Infectious Diseases (F30 AI136239). M.R. was supported by a fellowship from the German Academic Exchange Service (DAAD; Germany). C. S. L. was supported by NIH grant U01 HG007893. J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the Burroughs Wellcome Fund, the American Cancer Society, and grants from the NIH (AI100874, AI130043, and P30CA008748).	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Freund-Brown J, 2017, J IMMUNOL, V199, P1973, DOI 10.4049/jimmunol.1700340; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tassi I, 2008, BLOOD, V112, P4109, DOI 10.1182/blood-2008-02-139527; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	60	137	145	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					963	+		10.1038/s41590-018-0176-1	http://dx.doi.org/10.1038/s41590-018-0176-1			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30082830	Green Accepted			2022-12-18	WOS:000442365100018
J	Van Dyken, SJ; Nussbaum, JC; Lee, J; Molofsky, AB; Liang, HE; Pollack, JL; Gate, RE; Haliburton, GE; Ye, CJ; Marson, A; Erle, DJ; Locksley, RM				Van Dyken, Steven J.; Nussbaum, Jesse C.; Lee, Jinwoo; Molofsky, Ari B.; Liang, Hong-Erh; Pollack, Joshua L.; Gate, Rachel E.; Haliburton, Genevieve E.; Ye, Chun J.; Marson, Alexander; Erle, David J.; Locksley, Richard M.			A tissue checkpoint regulates type 2 immunity	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; CD4(+) T-CELLS; IL-13; IDENTIFICATION; RESPONSES	Group 2 innate lymphoid cells (ILC2s) and CD4(+) type 2 helper T cells (T(H)2 cells) are defined by their similar effector cytokines, which together mediate the features of allergic immunity. We found that tissue ILC2s and T(H)2 cells differentiated independently but shared overlapping effector function programs that were mediated by exposure to the tissue-derived cytokines interleukin 25 (IL-25), IL-33 and thymic stromal lymphopoietin (TSLP). Loss of these three tissue signals did not affect lymph node priming, but abrogated the terminal differentiation of effector T(H)2 cells and adaptive lung inflammation in a T cell intrinsic manner. Our findings suggest a mechanism by which diverse perturbations can activate type 2 immunity and reveal a shared local-tissue elicited checkpoint that can be exploited to control both innate and adaptive allergic inflammation.	[Van Dyken, Steven J.; Nussbaum, Jesse C.; Lee, Jinwoo; Liang, Hong-Erh; Pollack, Joshua L.; Haliburton, Genevieve E.; Marson, Alexander; Erle, David J.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Pollack, Joshua L.; Erle, David J.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Gate, Rachel E.; Ye, Chun J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Haliburton, Genevieve E.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif Berkeley, IGI, Berkeley, CA 94720 USA; [Marson, Alexander; Locksley, Richard M.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA.	richard.locksley@ucsf.edu	Lee, Jinwoo/AAA-9510-2020; Ye, Chun/AAK-4868-2021	Lee, Jinwoo/0000-0003-2991-4183; Ye, Chun/0000-0001-6560-3783; Molofsky, Ari/0000-0003-0764-3175; Van Dyken, Steven/0000-0002-9787-0883	Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco; US National Institutes of Health [AI026918, AI030663, HL107202, HL128903, K08AI113143, DP5-OD12178]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL128903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI113143, T32AI007334, R01AI030663, R01AI026918, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, T32GM067547] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ji, K. Davis, M. Consengco and Z. Wang for technical expertise, A. Barczak and R. Barbeau for assistance with RNA-Seq, A. McKenzie, S. Akira, S. Ziegler and the US National Institutes of Health Tetramer Core Facility for reagents, and A. Abbas and M. Ansel for comments on the manuscript. Supported by the US National Institutes of Health (AI026918, AI030663, HL107202, HL128903, K08AI113143 and DP5-OD12178), the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at the University of California San Francisco.	Bando Jennifer K, 2015, Nat Immunol, V16, P153, DOI 10.1038/ni.3057; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Pelly VS, 2016, MUCOSAL IMMUNOL, V9, P1407, DOI 10.1038/mi.2016.4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; von Moltke J, 2014, CURR OPIN IMMUNOL, V31, P58, DOI 10.1016/j.coi.2014.09.009; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wang Q, 2015, J ALLERGY CLIN IMMUN, V135, P781, DOI 10.1016/j.jaci.2014.09.015; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208	42	137	138	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1381	1387		10.1038/ni.3582	http://dx.doi.org/10.1038/ni.3582			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27749840	Green Accepted			2022-12-18	WOS:000388056400008
J	Lindner, C; Thomsen, I; Wahl, B; Ugur, M; Sethi, MK; Friedrichsen, M; Smoczek, A; Ott, S; Baumann, U; Suerbaum, S; Schreiber, S; Bleich, A; Gaboriau-Routhiau, V; Cerf-Bensussan, N; Hazanov, H; Mehr, R; Boysen, P; Rosenstiel, P; Pabst, O				Lindner, Cornelia; Thomsen, Irene; Wahl, Benjamin; Ugur, Milas; Sethi, Maya K.; Friedrichsen, Michaela; Smoczek, Anna; Ott, Stephan; Baumann, Ulrich; Suerbaum, Sebastian; Schreiber, Stefan; Bleich, Andre; Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine; Hazanov, Helena; Mehr, Ramit; Boysen, Preben; Rosenstiel, Philip; Pabst, Oliver			Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota	NATURE IMMUNOLOGY			English	Article							SOMATIC HYPERMUTATION; INTESTINAL IGA; REPERTOIRE; RECEPTOR; BACTERIA; INTEGRATION; GENERATION; SECONDARY; SELECTION; SYSTEM	Secretory immunoglobulin A (SIgA) shields the gut epithelium from luminal antigens and contributes to host-microbe symbiosis. However, how antibody responses are regulated to achieve sustained host-microbe interactions is unknown. We found that mice and humans exhibited longitudinal persistence of clonally related B cells in the IgA repertoire despite major changes in the microbiota during antibiotic treatment or infection. Memory B cells recirculated between inductive compartments and were clonally related to plasma cells in gut and mammary glands. Our findings suggest that continuous diversification of memory B cells constitutes a central process for establishing symbiotic host-microbe interactions and offer an explanation of how maternal antibodies are optimized throughout life to protect the newborn.	[Lindner, Cornelia; Thomsen, Irene; Wahl, Benjamin; Ugur, Milas; Sethi, Maya K.; Friedrichsen, Michaela; Pabst, Oliver] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Smoczek, Anna; Bleich, Andre] Hannover Med Sch, Lab Anim Sci, Hannover, Germany; [Ott, Stephan; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Baumann, Ulrich] Hannover Med Sch, Pediat Gastroenterol, Hannover, Germany; [Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol, Hannover, Germany; [Suerbaum, Sebastian] Hannover Med Sch, Hosp Epidemiol, Hannover, Germany; [Schreiber, Stefan; Rosenstiel, Philip] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] INSERM, Inst Imagine, Lab Intestinal Immun, UMR1163, Paris, France; [Hazanov, Helena; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Boysen, Preben] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Food Safety & Infect Biol, Oslo, Norway; [Pabst, Oliver] Rhein Westfal TH Aachen, Inst Mol Med, D-52062 Aachen, Germany	Hannover Medical School; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Bar Ilan University; Norwegian University of Life Sciences; RWTH Aachen University	Pabst, O (corresponding author), Hannover Med Sch, Inst Immunol, Hannover, Germany.	opabst@ukaachen.de	Lindner, Benjamin/L-2179-2014; Ott, Stephan J/G-1965-2010; Boysen, Preben/C-5238-2013; Pabst, Oliver/H-5014-2016; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; Cerf-Bensussan, nadine/H-9505-2017; Rosenstiel, Philip/A-5137-2009	Lindner, Benjamin/0000-0002-4609-3105; Boysen, Preben/0000-0002-0084-1251; Pabst, Oliver/0000-0002-5533-883X; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; Cerf-Bensussan, nadine/0000-0003-0665-1245; Rosenstiel, Philip/0000-0002-9692-8828; Ugur, Milas/0000-0003-2115-5389; Mehr, Ramit/0000-0002-4303-6834	DFG; BMBF [SysINFLAME (TP3/4)]; Israel Science Foundation [270/09]; German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft [PA921/4-1, SFB621-Z]	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation(Israel Science Foundation); German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank U. Kalinke (TWINCORE, Hannover, Germany), A. Krueger, I. Prinz, O. Schulz, S. Woltemate (Hannover Medical School, Hannover, Germany), M. Bemark (University of Gothenburg, Gothenburg, Sweden), B. Wabakken Hognestad and D. Olsner (both at the Norwegian University of Life Sciences, Oslo, Norway), and R. Bharti (IKMB, University of Kiel, Kiel, Germany). This work was supported by the DFG Cluster of Excellence Inflammation at Interfaces (CL VIII to P.R., S.O. and S. Schreiber), the BMBF (grant SysINFLAME (TP3/4) to P.R.), the Israel Science Foundation (grant 270/09 to R.M.), the German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig and Deutsche Forschungsgemeinschaft (grants PA921/4-1 (to O.P.) and SFB621-Z).	Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Ben-Hamo R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-27; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Boysen P, 2011, MOL ECOL, V20, P5103, DOI 10.1111/j.1365-294X.2011.05269.x; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; DunnWalters DK, 1997, EUR J IMMUNOL, V27, P2959, DOI 10.1002/eji.1830271131; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenne CN, 2006, DEV COMP IMMUNOL, V30, P165, DOI 10.1016/j.dci.2005.06.009; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Larimore K, 2012, J IMMUNOL, V189, P3221, DOI 10.4049/jimmunol.1201303; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Naumov YN, 2003, J IMMUNOL, V170, P3994, DOI 10.4049/jimmunol.170.8.3994; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schulz O, 2014, MUCOSAL IMMUNOL, V7, P892, DOI 10.1038/mi.2013.105; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spencer J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00108; Suzuki K, 2010, IMMUNOL REV, V237, P180, DOI 10.1111/j.1600-065X.2010.00941.x; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Ugur M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5821; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166	50	137	145	1	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					880	+		10.1038/ni.3213	http://dx.doi.org/10.1038/ni.3213			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147688				2022-12-18	WOS:000358299200015
J	Piccirillo, CA; Bjur, E; Topisirovic, I; Sonenberg, N; Larsson, O				Piccirillo, Ciriaco A.; Bjur, Eva; Topisirovic, Ivan; Sonenberg, Nahum; Larsson, Ola			Translational control of immune responses: from transcripts to translatomes	NATURE IMMUNOLOGY			English	Review							P70 S6 KINASE; MESSENGER-RNA TRANSLATION; INITIATION-FACTOR EIF-4E; GENOME-WIDE ANALYSIS; CAP-BINDING PROTEIN; GAMMA-INTERFERON; GENE-EXPRESSION; DIFFERENTIAL TRANSLATION; MACROPHAGE POLARIZATION; DEPENDENT TRANSLATION	Selective translational control of gene expression is emerging as a principal mechanism for the regulation of protein abundance that determines a variety of functions in both the adaptive immune system and the innate immune system. The translation-initiation factor elF4E acts as a node for such regulation, but non-elF4E mechanisms are also prevalent. Studies of 'translatomes' (genome-wide pools of translated mRNA) have facilitated mechanistic discoveries by identifying key regulatory components, including transcription factors, that are under translational control. Here we review the current knowledge on mechanisms that regulate translation and thereby modulate immunological function. We further describe approaches for measuring and analyzing translatomes and how such powerful tools can facilitate future insights on the role of translational control in the immune system.	[Piccirillo, Ciriaco A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Ctr Hlth, FOCIS Ctr Excellence, Montreal, PQ, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Ctr Hlth, Res Inst, Ctr Translat Biol, Montreal, PQ, Canada; [Bjur, Eva; Larsson, Ola] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Topisirovic, Ivan] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Topisirovic, Ivan] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Karolinska Institutet; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Piccirillo, CA (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	ciro.piccirillo@mcgill.ca; ola.larsson@ki.se	Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762; Larsson, Ola/0000-0003-1412-1308	Canadian Institutes for Health Research [MOP 67211]; Canada Research Chair program (C.A.P.); Swedish Research Council; Swedish Cancer Society; Wallenberg Academy Fellows program	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program (C.A.P.); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Academy Fellows program	Supported by the Canadian Institutes for Health Research (I.T., and MOP 67211 to C.A.P.), the Canada Research Chair program (C.A.P.), the Swedish Research Council (O.L.), the Swedish Cancer Society (O.L.) and the Wallenberg Academy Fellows program (O.L.).	Araki K, 2011, CURR OPIN CELL BIOL, V23, P707, DOI 10.1016/j.ceb.2011.08.006; AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Bjur E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003494; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Ceppi Maurizio, 2009, Immunome Res, V5, P5, DOI 10.1186/1745-7580-5-5; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Colman H, 2013, J VIROL, V87, P6668, DOI 10.1128/JVI.00538-13; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Cook KD, 2010, J IMMUNOL, V185, P3209, DOI 10.4049/jimmunol.0902544; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dhamija S, 2013, J BIOL CHEM, V288, P19250, DOI 10.1074/jbc.M113.452649; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eliseeva IA, 2013, TRANSLATION, V1, DOI 10.4161/trla.27469; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gigoux M, 2014, MOL IMMUNOL, V59, P46, DOI 10.1016/j.molimm.2014.01.008; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kitamura H, 2008, PHYSIOL GENOMICS, V33, P121, DOI 10.1152/physiolgenomics.00095.2007; KLEBANOFF SJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P302, DOI 10.1016/0003-9861(92)90522-X; Kleijn M, 1996, VIROLOGY, V217, P486, DOI 10.1006/viro.1996.0143; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; Larsson O, 2013, TRANSLATION, V1, DOI 10.4161/trla.24557; Larsson O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012302; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Olshen AB, 2013, BIOINFORMATICS, V29, P2995, DOI 10.1093/bioinformatics/btt533; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shama Silvian, 1995, Gene Expression, V4, P241; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Tebaldi T, 2014, BIOINFORMATICS, V30, P289, DOI 10.1093/bioinformatics/btt634; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tominaga Y, 2005, MOL CELL BIOL, V25, P8465, DOI 10.1128/MCB.25.19.8465-8475.2005; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zimmer SG, 2000, ANTICANCER RES, V20, P1343; Zoschke R, 2013, PLANT CELL, V25, P2265, DOI 10.1105/tpc.113.111567	132	137	138	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					503	511		10.1038/ni.2891	http://dx.doi.org/10.1038/ni.2891			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840981	Green Published			2022-12-18	WOS:000336419300004
J	Arsenio, J; Kakaradov, B; Metz, PJ; Kim, SH; Yeo, GW; Chang, JT				Arsenio, Janilyn; Kakaradov, Boyko; Metz, Patrick J.; Kim, Stephanie H.; Yeo, Gene W.; Chang, John T.			Early specification of CD8(+) T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses	NATURE IMMUNOLOGY			English	Article							PROTECTIVE IMMUNITY; MEMORY; EFFECTOR; BET; NAIVE; GENERATION; INFECTION; EXPANSION; PRECURSOR; SUBSETS	T lymphocytes responding to microbial infection give rise to effector cells that mediate acute host defense and memory cells that provide long-lived immunity, but the fundamental question of when and how these cells arise remains unresolved. Here we combined single-cell gene-expression analyses with 'machine-learning' approaches to trace the transcriptional 'roadmap' of individual CD8(+) T lymphocytes throughout the course of an immune response in vivo. Gene-expression signatures predictive of eventual fates could be discerned as early as the first T lymphocyte division and may have been influenced by asymmetric partitioning of the receptor for interleukin 2 (IL-2R alpha) during mitosis. Our findings emphasize the importance of single-cell analyses in understanding fate determination and provide new insights into the specification of divergent lymphocyte fates early during an immune response to microbial infection.	[Arsenio, Janilyn; Metz, Patrick J.; Kim, Stephanie H.; Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kakaradov, Boyko; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Kakaradov, Boyko; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, Bioinformat Program, La Jolla, CA 92093 USA; [Kakaradov, Boyko; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Yeo, Gene W.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Yeo, Gene W.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR)	Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu; changj@ucsd.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Chang, John/0000-0003-0873-6218	US National Institutes of Health [DK080949, OD008469, AI095277, HG004659, NS075449]; UCSD Digestive Diseases Research Development Center [DK80506]; California Institute for Regenerative Medicine [RB1-01413, RB3-05009]; National Science Foundation; Alfred P. Sloan Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, T32DK007202, K08DK080949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Digestive Diseases Research Development Center; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Hedrick, J. Bui, A. Goldrath, S. Schoenberger and members of the Chang and Yeo laboratories for discussions and critical reading of the manuscript. Supported by the US National Institutes of Health (DK080949, OD008469 and AI095277 to J.T.C., and HG004659 and NS075449 to G.W.Y.), the UCSD Digestive Diseases Research Development Center (DK80506), the California Institute for Regenerative Medicine (RB1-01413 and RB3-05009 to G.W.Y.), the National Science Foundation (B.K.), the Alfred P. Sloan Foundation (G.W.Y.) and the Howard Hughes Medical Institute (J.T.C.).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Beerenwinkel N, 2007, BIOSTATISTICS, V8, P53, DOI 10.1093/biostatistics/kxj033; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bulla J, 2006, COMPUT STAT DATA AN, V51, P2192, DOI 10.1016/j.csda.2006.07.021; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y, 2009, P 26 ANN INT C MACH, V162; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	48	137	138	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					365	+		10.1038/ni.2842	http://dx.doi.org/10.1038/ni.2842			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24584088	Green Accepted, Green Submitted			2022-12-18	WOS:000333252000011
J	Huse, M; Quann, EJ; Davis, MM				Huse, Morgan; Quann, Emily J.; Davis, Mark M.			Shouts, whispers and the kiss of death: directional secretion in T cells	NATURE IMMUNOLOGY			English	Review							MICROTUBULE-ORGANIZING CENTER; LYTIC GRANULE POLARIZATION; TUMOR-NECROSIS-FACTOR; SPLENIC B-CELLS; IMMUNOLOGICAL SYNAPSE; CYTOKINE SECRETION; TUBULIN CYTOSKELETON; SNARE COMPLEXES; MEMBRANE-FUSION; CUTTING EDGE	T cells use secreted soluble factors for highly specific intercellular communication and targeted cell killing. This specificity is achieved first through T cell receptor-mediated recognition of complexes of peptide and major histocompatibility complex displayed by appropriate antigen-presenting cells and then by the directed secretion of cytokines and lytic factors into the immunological synapse between the T cell and antigen-presenting cell. Studies have begun to probe the molecular basis for this synaptic secretion and have also shown that T cells release chemokines and certain inflammatory factors through a multidirectional pathway directed away from the synapse. Thus, the mode of secretion seems to be tailored to the intended function of the secreted molecule.	[Huse, Morgan; Quann, Emily J.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Stanford University; Howard Hughes Medical Institute; Stanford University	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	husem@mskcc.org; mdavis@pmgm2.stanford.edu		Davis, Mark/0000-0001-6868-657X	National Institutes of Health [AI057229]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Z. Chai for discussions. Supported by the National Institutes of Health (AI057229 to M. M. D.) and the Howard Hughes Medical Institute (M. M. D.).	ALBERTS B, 2007, MOL BIOL CELL, P711; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Boisvert J, 2004, J IMMUNOL, V173, P3647, DOI 10.4049/jimmunol.173.6.3647; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Krzewski K, 2008, P NATL ACAD SCI USA, V105, P2568, DOI 10.1073/pnas.0711593105; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Martin-Cofreces NB, 2006, J IMMUNOL, V176, P4201, DOI 10.4049/jimmunol.176.7.4201; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; OKADA T, 2005, PLOS BIOL; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Sancho D, 2000, J CELL BIOL, V149, P1249, DOI 10.1083/jcb.149.6.1249; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; Taylor PC, 2004, CURR OPIN BIOTECH, V15, P557, DOI 10.1016/j.copbio.2004.09.005; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	60	137	139	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1105	1111		10.1038/ni.f.215	http://dx.doi.org/10.1038/ni.f.215			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800163	Green Accepted			2022-12-18	WOS:000259315600008
J	Ogasawara, K; Benjamin, J; Takaki, R; Phillips, JH; Lanier, LL				Ogasawara, K; Benjamin, J; Takaki, R; Phillips, JH; Lanier, LL			Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts	NATURE IMMUNOLOGY			English	Article							MURINE NK CELLS; F1 HYBRID MICE; SURFACE PROTEINS; NOD MICE; T-CELLS; ALLOGRAFTS; MOLECULES; ANTIGEN; RESISTANCE; RECEPTOR	Irradiation- resistant natural killer ( NK) cells in an F-1 recipient can reject parental bone marrow, and host NK cells can also prevent engraftment of allogeneic bone marrow. We show here that repopulating bone marrow cells in certain mouse strains expressed retinoic acid early inducible 1 proteins, which are ligands for the activating NKG2D NK cell receptor. Treatment with a neutralizing antibody to NKG2D prevented rejection of parental BALB/ c bone marrow in ( C57BL/ 6 x BALB/ c) F1 recipients and allowed engraftment of allogeneic BALB. B bone marrow in C57BL/ 6 recipients. Additionally, bone marrow from C57BL/ 6 mice transgenic for retinoic acid early inducible 1 epsilon was rejected by syngeneic mice but was accepted after treatment with antibody to NKG2D. If other stem cells or tissues upregulate expression of NKG2D ligands after transplantation, NKG2D may contribute to graft rejection in immunocompetent hosts.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Int Med Ctr Japan, Res Inst, Div Clin Immunol, Dept Intractable Dis,Shinjuku Ku, Tokyo 1628655, Japan; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; Schering Plough BioPharma, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Center for Global Health & Medicine - Japan; University of California System; University of California San Francisco; Merck & Company	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Lanier, Lewis L/E-2139-2014; Ogasawara, Kouetsu/G-9892-2011	Lanier, Lewis L/0000-0003-1308-3952; Benjamin, Jonathan/0000-0002-6078-616X	NCI NIH HHS [R01 CA095137, CA95137] Funding Source: Medline; NIDDK NIH HHS [P30-DK26743, P30 DK026743] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2003, TISSUE ANTIGENS, V61, P335, DOI 10.1034/j.1399-0039.2003.00070.x; CUDKOWICZ G, 1964, NATURE, V204, P450, DOI 10.1038/204450a0; CUDKOWICZ G, 1971, J EXP MED, V134, P1513, DOI 10.1084/jem.134.6.1513; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; DRIZLIKH G, 1984, J EXP MED, V159, P1070, DOI 10.1084/jem.159.4.1070; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; George TC, 1999, J IMMUNOL, V163, P1859; George TC, 1999, J IMMUNOL, V162, P2035; KIESSLING R, 1977, EUR J IMMUNOL, V7, P655, DOI 10.1002/eji.1830070915; LANIER LL, 1988, J IMMUNOL, V141, P3478; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIN J, 2000, J IMMUNOL, V164, P1793; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Lodoen MB, 2004, J EXP MED, V200, P1075, DOI 10.1084/jem.20040583; LOTZOVA E, 1983, TRANSPLANTATION, V35, P490, DOI 10.1097/00007890-198305000-00019; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; MURPHY WJ, 1990, EUR J IMMUNOL, V20, P1729, DOI 10.1002/eji.1830200816; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Raziuddin A, 1998, J IMMUNOL, V160, P87; Raziuddin A, 1996, INT IMMUNOL, V8, P1833, DOI 10.1093/intimm/8.12.1833; REMBECKI RM, 1988, J IMMUNOL, V141, P2253; SENTMAN CL, 1991, EUR J IMMUNOL, V21, P2821, DOI 10.1002/eji.1830211125; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	40	137	150	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					938	945		10.1038/ni1236	http://dx.doi.org/10.1038/ni1236			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16086018	Green Submitted, Green Accepted			2022-12-18	WOS:000231369800024
J	Weiss, ST				Weiss, ST			Obesity: insight into the origins of asthma	NATURE IMMUNOLOGY			English	Editorial Material							GASTROESOPHAGEAL-REFLUX DISEASE; ADULT-ONSET ASTHMA; LUNG-FUNCTION; BIRTH-WEIGHT; LEPTIN; RISK; POPULATION; OVERWEIGHT; COHORT; STATES		Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Weiss, ST (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	scott.weiss@channing.harvard.edu						BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; BRITTON JR, 1995, AM J RESP CRIT CARE, V151, P1383, DOI 10.1164/ajrccm.151.5.7735589; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Bunout D, 1996, AM J CLIN NUTR, V63, P373, DOI 10.1093/ajcn/63.3.373; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Dhabuwala A, 2000, OBES SURG, V10, P428, DOI 10.1381/096089200321594291; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Kaplowitz P, 1998, J PEDIATR-US, V133, P745, DOI 10.1016/S0022-3476(98)70144-1; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; PARKER DJP, 1992, J EPIDEMIOL COMMUN H, V46, P8, DOI 10.1136/jech.46.1.8; Ruhl CE, 1999, ANN EPIDEMIOL, V9, P424, DOI 10.1016/S1047-2797(99)00020-4; Sontag SJ, 2000, J CLIN GASTROENTEROL, V30, pS9; Stenius-Aarniala B, 2000, BRIT MED J, V320, P827, DOI 10.1136/bmj.320.7238.827; Svanes C, 1998, EUR RESPIR J, V12, P1366, DOI 10.1183/09031936.98.12061366; Tang C, 1999, EUR RESPIR J, V14, P106, DOI 10.1034/j.1399-3003.1999.14a18.x; Tataranni PA, 1997, OBES RES, V5, P341, DOI 10.1002/j.1550-8528.1997.tb00562.x; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; TROISI RJ, 1995, AM J RESP CRIT CARE, V152, P1183, DOI 10.1164/ajrccm.152.4.7551368; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Weiss ST, 2004, AM J RESP CRIT CARE, V169, P963, DOI 10.1164/rccm.200303-403WS; Young JB, 1998, DIABETES CARE, V21, pB156; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	24	137	142	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					537	539		10.1038/ni0605-537	http://dx.doi.org/10.1038/ni0605-537			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908930				2022-12-18	WOS:000229385900003
J	Ato, M; Stager, S; Engwerda, CR; Kaye, PM				Ato, M; Stager, S; Engwerda, CR; Kaye, PM			Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; SECONDARY LYMPHOID ORGANS; T-CELL; CHEMOKINE RECEPTORS; DONOVANI INFECTION; GRANULOMA-FORMATION; DEPENDENT AREAS; VIRUS-INFECTION; MARGINAL ZONE	Interaction between dendritic cells (DCs) and T cells is essential for the generation of cell-mediated immunity. Here we show that DCs from mice with chronic Leishmania donovani infection fail to migrate from the marginal zone to the periarteriolar region of the spleen. Stromal cells were fewer, which was associated with loss of CCL21 and CCL19 expression. The residual stromal cells and endothelium produced sufficient CCL21 to direct the migration of DCs transferred from naive mice. However, DCs from infected mice had impaired migration both in naive recipients and in vitro, in response to CCL21 and CCL19. Defective localization was attributable to tumor necrosis factor-dependent, interleukin 10-mediated inhibition of CCR7 expression. Effective immunotherapy was achieved with CCR7-expressing DCs, without the need to identify protective Leishmania antigens. Thus defective DC migration plays a major role in the pathogenesis of this disease and the immunosuppression is mediated, at least in part, through the spatial segregation of DCs and T cells.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Kaye, PM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	paul.kaye@lshtm.ac.uk	Engwerda, Christian/I-3072-2015; Ato, Manabu/K-6452-2019	Engwerda, Christian/0000-0003-2813-4804; Kaye, Paul/0000-0002-8796-4755; Ato, Manabu/0000-0002-3178-2645				Alexander CE, 2001, EUR J IMMUNOL, V31, P1199, DOI 10.1002/1521-4141(200104)31:4&lt;1199::AID-IMMU1199&gt;3.0.CO;2-6; AUSTYN JM, 1988, J EXP MED, V167, P646, DOI 10.1084/jem.167.2.646; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z; Basu A, 2000, IMMUNOLOGY, V99, P305, DOI 10.1046/j.1365-2567.2000.00939.x; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Boring L, 1996, J BIOL CHEM, V271, P7551, DOI 10.1074/jbc.271.13.7551; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 1996, EXP PARASITOL, V84, P195, DOI 10.1006/expr.1996.0105; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; GAO JL, 1995, J BIOL CHEM, V270, P17494, DOI 10.1074/jbc.270.29.17494; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Gorak PMA, 1998, EUR J IMMUNOL, V28, P687, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;687::AID-IMMU687&gt;3.0.CO;2-N; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HO M, 1983, CLIN EXP IMMUNOL, V51, P207; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; HUNTER MG, 1995, BLOOD, V86, P4400, DOI 10.1182/blood.V86.12.4400.bloodjournal86124400; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; KAYE PM, 1987, IMMUNOLOGY, V61, P345; Kellermann SA, 1999, J IMMUNOL, V162, P3859; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; MERCER JA, 1988, J VIROL, V62, P987, DOI 10.1128/JVI.62.3.987-997.1988; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1992, J IMMUNOL, V148, P1858; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; NICKOL AD, 1985, INFECT IMMUN, V50, P169, DOI 10.1128/IAI.50.1.169-174.1985; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smelt SC, 1997, J IMMUNOL, V158, P3813; Smith D, 1997, IMMUNOLOGY, V92, P413, DOI 10.1046/j.1365-2567.1997.00384.x; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Takayama T, 2001, J IMMUNOL, V166, P7136, DOI 10.4049/jimmunol.166.12.7136; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; WEISS L, 1989, AM J TROP MED HYG, V41, P144, DOI 10.4269/ajtmh.1989.41.144; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	56	137	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1185	1191		10.1038/ni861	http://dx.doi.org/10.1038/ni861			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12436111				2022-12-18	WOS:000179467800017
J	Keating, R; Hertz, T; Wehenkel, M; Harris, TL; Edwards, BA; McClaren, JL; Brown, SA; Surman, S; Wilson, ZS; Bradley, P; Hurwitz, J; Chi, HB; Doherty, PC; Thomas, PG; McGargill, MA				Keating, Rachael; Hertz, Tomer; Wehenkel, Marie; Harris, Tarsha L.; Edwards, Benjamin A.; McClaren, Jennifer L.; Brown, Scott A.; Surman, Sherri; Wilson, Zachary S.; Bradley, Philip; Hurwitz, Julia; Chi, Hongbo; Doherty, Peter C.; Thomas, Paul G.; McGargill, Maureen A.			The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus	NATURE IMMUNOLOGY			English	Article							PEPTIDE ARRAYS; TRANSMISSION; MEMORY; NEUTRALIZATION; CONSEQUENCES; CYTOTOXICITY; ACTIVATION; CELLS; H5N1; AID	Highly pathogenic avian influenza viruses pose a continuing global threat. Current vaccines will not protect against newly evolved pandemic viruses. The creation of 'universal' vaccines has been unsuccessful because the immunological mechanisms that promote heterosubtypic immunity are incompletely defined. We found here that rapamycin, an immunosuppressive drug that inhibits the kinase mTOR, promoted cross-strain protection against lethal infection with influenza virus of various subtypes when administered during immunization with influenza virus subtype H3N2. Rapamycin reduced the formation of germinal centers and inhibited class switching in B cells, which yielded a unique repertoire of antibodies that mediated heterosubtypic protection. Our data established a requirement for the mTORC1 complex in B cell class switching and demonstrated that rapamycin skewed the antibody response away from high-affinity variant epitopes and targeted more conserved elements of hemagglutinin. Our findings have implications for the design of a vaccine against influenza virus.	[Keating, Rachael; Wehenkel, Marie; Harris, Tarsha L.; Edwards, Benjamin A.; McClaren, Jennifer L.; Brown, Scott A.; Chi, Hongbo; Doherty, Peter C.; Thomas, Paul G.; McGargill, Maureen A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Hertz, Tomer; Wilson, Zachary S.; Bradley, Philip] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Surman, Sherri; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital	McGargill, MA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	maureen.mcgargill@stjude.org	Wehenkel, Marie/AAT-7614-2021; Hurwitz, Julia/N-2301-2018; Thomas, Paul G./H-1063-2018; McGargill, Maureen/N-8131-2018; Chi, Hongbo/M-9397-2018; Hertz, Tomer/S-5744-2016; Doherty, Peter Charles/C-4185-2013	Wehenkel, Marie/0000-0002-8103-221X; Thomas, Paul G./0000-0001-7955-0256; McGargill, Maureen/0000-0002-0916-0372; Chi, Hongbo/0000-0002-9997-2496; Hertz, Tomer/0000-0002-0561-1578; Doherty, Peter Charles/0000-0002-5028-3489	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI087397] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health, Department of Health and Human Services; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Zeng (St. Jude Children's Research Hospital) for mice with inducible deletion of Rptor in B cells; B. Creasy and T. Oguin for technical support; P. Vogel and the Veterinary Pathology Core at St. Jude for histology; and S. Patrick and the staff of the Shared Animal Resource Center at St. Jude Children's Research Hospital for animal husbandry. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health, Department of Health and Human Services (HHSN266200700005C) and American Lebanese Syrian Associated Charities.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Andreansky SS, 2005, J VIROL, V79, P4329, DOI 10.1128/JVI.79.7.4329-4339.2005; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Duda R.O., 2000, PATTERN CLASSIFICATI; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Feng JQ, 2002, J VIROL, V76, P1369, DOI 10.1128/JVI.76.3.1369-1378.2002; HASHIMOTO G, 1983, J INFECT DIS, V148, P785, DOI 10.1093/infdis/148.5.785; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/B978-0-12-381270-4.00019-6, 10.1016/S0076-6879(11)87019-9]; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Osterholm MT, 2012, MBIO, V3, DOI 10.1128/mBio.00045-12; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rutigliano JA, 2010, J VIROL, V84, P1047, DOI 10.1128/JVI.01535-09; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thomas PG, 2007, J IMMUNOL, V178, P3091, DOI 10.4049/jimmunol.178.5.3091; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Turner AP, 2011, AM J TRANSPLANT, V11, P613, DOI 10.1111/j.1600-6143.2010.03407.x; Venturi V, 2012, IMMUNOL CELL BIOL, V90, P216, DOI 10.1038/icb.2011.36; VERBONITZ MW, 1978, J EXP MED, V147, P265, DOI 10.1084/jem.147.1.265; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang Y, 2011, BRIT J CANCER, V104, P643, DOI 10.1038/bjc.2011.15; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Winkler DFH, 2009, METHODS MOL BIOL, V570, P157, DOI 10.1007/978-1-60327-394-7_5; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	48	136	140	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1266	+		10.1038/ni.2741	http://dx.doi.org/10.1038/ni.2741			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24141387	Green Accepted			2022-12-18	WOS:000327149400012
J	Glasmacher, E; Hoefig, KP; Vogel, KU; Rath, N; Du, LR; Wolf, C; Kremmer, E; Wang, XZ; Heissmeyer, V				Glasmacher, Elke; Hoefig, Kai P.; Vogel, Katharina U.; Rath, Nicola; Du, Lirui; Wolf, Christine; Kremmer, Elisabeth; Wang, Xiaozhong; Heissmeyer, Vigo			Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression	NATURE IMMUNOLOGY			English	Article							HELPER T-CELLS; ICOS EXPRESSION; P-BODIES; TRANSLATION; PROTEINS; AGGREGATION; ACTIVATION; GRANULES; RECEPTOR; REGIONS	The molecular mechanism by which roquin controls the expression of inducible costimulator (ICOS) to prevent autoimmunity remains unsolved. Here we show that in helper T cells, roquin localized to processing (P) bodies and downregulated ICOS expression. The repression was dependent on the RNA helicase Rck, and roquin interacted with Rck and the enhancer of decapping Edc4, which act together in mRNA decapping. Sequences in roquin that confer P-body localization were essential for roquin-mediated ICOS repression. However, this process did not require microRNAs or the RNA-induced silencing complex (RISC). Instead, roquin bound ICOS mRNA directly, showing an intrinsic preference for a previously unrecognized sequence in the 3' untranslated region (3' UTR). Our results support a model in which roquin controls ICOS expression through binding to the 3' UTR of ICOS mRNA and by interacting with proteins that confer post-transcriptional repression.	[Glasmacher, Elke; Hoefig, Kai P.; Vogel, Katharina U.; Rath, Nicola; Du, Lirui; Wolf, Christine; Kremmer, Elisabeth; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, Munich, Germany; [Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Northwestern University	Heissmeyer, V (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, Munich, Germany.	vigo.heissmeyer@helmholtz-muenchen.de	Hoefig, Kai/AAV-2169-2021; Glasmacher, Elke/B-8939-2015; Rath, Nicola/M-6766-2015	Hoefig, Kai/0000-0002-0701-454X; Glasmacher, Elke/0000-0003-1265-2543; Rath, Nicola/0000-0002-2342-6843; Heissmeyer, Vigo/0000-0002-2263-8545	Deutsche Forschungsgemeinschaft [SFB 571]; Fritz Thyssen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Foundation	We thank M. Schmidt-Supprian and D. Niessing for critical reading of the manuscript and discussions; G. Stoecklin for unpublished observations and advice; C. Vinuesa (The John Curtin School of Medical Research, Canberra, Australia) for ICOS and roquin cDNA; G. Hannon (Cold Spring Harbor Laboratory) for Dicer1<SUP>f1/+</SUP> mice; C. Wilson (University of Washington) for Tg(Cd4-cre) mice; N. Kedersha and P. Anderson (Brigham and Women's Hospital) for TIA-1-knockout MEFs; U. Fischer (Biozentrum Wurzburg) for anti-FMRP; H. Sarioglu for mass-spectrometry analysis; and C. Thirion and L. Behrend (Sirion Biotech) for advice and reagents for adenoviral infection. Supported by Deutsche Forschungsgemeinschaft (SFB 571 to V. H.) and Fritz Thyssen Foundation (V. H.).	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cougot N, 2004, TRENDS BIOCHEM SCI, V29, P436, DOI 10.1016/j.tibs.2004.06.008; Didiot MC, 2009, MOL BIOL CELL, V20, P428, DOI 10.1091/mbc.E08-07-0737; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Heissmeyer V, 2005, NAT IMMUNOL, V6, P642, DOI 10.1038/ni1214; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; IAFURI A, 2001, NATURE, V409, P105; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Oberdoerffer P, 2005, MOL CELL BIOL, V25, P3896, DOI 10.1128/MCB.25.10.3896-3905.2005; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	35	136	144	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					725	U94		10.1038/ni.1902	http://dx.doi.org/10.1038/ni.1902			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20639877	Green Submitted			2022-12-18	WOS:000280149400014
J	Dolan, MJ; Kulkarni, H; Camargo, JF; He, W; Smith, A; Anaya, JM; Miura, T; Hecht, FM; Mamtani, M; Pereyra, F; Marconi, V; Mangano, A; Sen, L; Bologna, R; Clark, RA; Anderson, SA; Delmar, J; O'Connell, RJ; Lloyd, A; Martin, J; Ahuja, SS; Agan, BK; Walker, BD; Deeks, SG; Ahuja, SK				Dolan, Matthew J.; Kulkarni, Hemant; Camargo, Jose F.; He, Weijing; Smith, Alison; Anaya, Juan-Manuel; Miura, Toshiyuki; Hecht, Frederick M.; Mamtani, Manju; Pereyra, Florencia; Marconi, Vincent; Mangano, Andrea; Sen, Luisa; Bologna, Rosa; Clark, Robert A.; Anderson, Stephanie A.; Delmar, Judith; O'Connell, Robert J.; Lloyd, Andrew; Martin, Jeffrey; Ahuja, Seema S.; Agan, Brian K.; Walker, Bruce D.; Deeks, Steven G.; Ahuja, Sunil K.			CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; TYPE-1 INFECTION; DISEASE PROGRESSION; IN-VITRO; HYPERSENSITIVITY; CHEMOKINES; PLASMA; RNA; SUSCEPTIBILITY	Although host defense against human immunodeficiency virus 1 (HIV- 1) relies mainly on cell-mediated immunity (CMI), the determinants of CMI in humans are poorly understood. Here we demonstrate that variations in the genes encoding the chemokine CCL3L1 and HIV coreceptor CCR5 influence CMI in both healthy and HIV- infected individuals. CCL3L1-CCR5 genotypes associated with altered CMI in healthy subjects were similar to those that influence the risk of HIV transmission, viral burden and disease progression. However, CCL3L1-CCR5 genotypes also modify HIV clinical course independently of their effects on viral load and CMI. These results identify CCL3L1 and CCR5 as major determinants of CMI and demonstrate that these host factors influence HIV pathogenesis through their effects on both CMI and other viral entry-independent mechanisms.	Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; Wilford Hall USAF Med Ctr, Infect Dis Clin Res Program, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Infect Dis Serv, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX 78236 USA; Univ Western Sydney, Sch Psychol, Penrith, NSW 1797, Australia; Univ Rosario, Corporac Invest Biol, Cellular Biol & Immunogenet Unit, Medellin, Colombia; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div AIDS, Boston, MA 02114 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 20815 USA; San Francisco Gen Hosp, San Francisco, CA 20815 USA; Hosp Pediat JP Garrahan, Lab Biol Celular & Retrovirus, RA-1245 Buenos Aires, DF, Argentina; Hosp Pediat JP Garrahan, Serv Infectol, RA-1245 Buenos Aires, DF, Argentina; Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; Western Sydney University; Universidad del Rosario; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; University of New South Wales Sydney; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Howard Hughes Medical Institute	Ahuja, SK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA.	mdolan@hjf.org; ahujas@uthscsa.edu	Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Marconi, Vincent/N-3210-2014; Clark, Robert/Q-6764-2019; Lloyd, Andrew/AFJ-8960-2022; Marconi, Vincent/GRJ-4553-2022; Kulkarni, Hemant/AEM-5750-2022; Marconi, Vincent/AFK-5812-2022; Anaya, Juan-Manuel/J-1960-2016	Lloyd, Andrew/0000-0001-6277-8887; Marconi, Vincent/0000-0001-8409-4689; Clark, Robert/0000-0002-4892-3619; Lloyd, Andrew/0000-0001-6277-8887; Marconi, Vincent/0000-0001-8409-4689; Anaya, Juan-Manuel/0000-0002-6444-1249; Agan, Brian/0000-0002-5114-1669; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Hecht, Frederick/0000-0002-5782-1171				Abel L, 2006, SEMIN IMMUNOL, V18, P327, DOI 10.1016/j.smim.2006.07.002; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248; BLATT SP, 1993, ANN INTERN MED, V119, P177, DOI 10.7326/0003-4819-119-3-199308010-00001; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Duggal P, 2005, JAIDS-J ACQ IMM DEF, V38, P584, DOI 10.1097/01.qai.0000134741.49208.03; Dunham R, 2006, BLOOD, V108, P209, DOI 10.1182/blood-2005-12-4897; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; GORDIN FM, 1994, J INFECT DIS, V169, P893, DOI 10.1093/infdis/169.4.893; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873; KNIKER WT, 1984, ANN ALLERGY, V52, P75; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maas JJ, 1998, J INFECT DIS, V178, P1024, DOI 10.1086/515655; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pinto LA, 2000, EUR J IMMUNOL, V30, P2048, DOI 10.1002/1521-4141(200007)30:7<2048::AID-IMMU2048>3.0.CO;2-I; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Smith A, 2005, BRAIN BEHAV IMMUN, V19, P147, DOI 10.1016/j.bbi.2004.06.005; Taub DD, 1996, J LEUKOCYTE BIOL, V59, P81, DOI 10.1002/jlb.59.1.81; van Asten L, 2004, AIDS, V18, P1885, DOI 10.1097/00002030-200409240-00004; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017; Zou WP, 2000, J IMMUNOL, V165, P4388, DOI 10.4049/jimmunol.165.8.4388	53	136	137	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1324	1336		10.1038/ni1521	http://dx.doi.org/10.1038/ni1521			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17952079				2022-12-18	WOS:000251267000013
J	Sansonetti, PJ				Sansonetti, Philippe J.			The innate signaling of dangers and the dangers of innate signaling	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; C-TYPE LECTINS; ADAPTIVE IMMUNITY; CARD15 MUTATIONS; LIPID-A; KAPPA-B; RECOGNITION; ACTIVATION; NOD1; INFLAMMATION	The innate immune system of mammals has been forged by coevolution with microbes in response to the double constraint of preserving a symbiotic interaction with commensal flora and eliminating intrusion of those commensals or invasion by pathogens. Thus, a 'sensing' network, accompanied by or lacking inflammatory responses, is controlled by elaborate mechanisms of regulation that maintain balance in the basal state. A growing number of non-Toll-like innate immune receptors is recognized as part of this surveillance network.	Inst Pasteur, INSERM, Unite 786, Unite Pathogenie Microbienne, F-75724 Paris, France; Inst Pasteur, Howard Hughes Med Inst, Int Program, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sansonetti, PJ (corresponding author), Inst Pasteur, INSERM, Unite 786, Unite Pathogenie Microbienne, F-75724 Paris, France.	psanson@pasteur.fr						Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brunn GJ, 2006, TRENDS MOL MED, V12, P10, DOI 10.1016/j.molmed.2005.11.002; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GURCEL L, IN PRESS CELL; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305; KUFER T, IN PRESS CURR OPIN M; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; METCHNIKOFF E, 1895, ANN I PASTEUR, V9, P433; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Neyrolles O, 2006, TRENDS MICROBIOL, V14, P383, DOI 10.1016/j.tim.2006.07.007; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463	61	136	158	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1237	1242		10.1038/ni1420	http://dx.doi.org/10.1038/ni1420			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110939				2022-12-18	WOS:000242125200002
J	Coffman, RL				Coffman, RL			Origins of the T(H)1-T(H)2 model: a personal perspective	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-CLONE; STIMULATORY FACTOR-I; MEDIATED-IMMUNITY; TH1 CLONES; B-CELLS; SECRETION; MOUSE; GROWTH; LINES	Robert L. Coffman recounts how his work on immunoglobulin E regulation along with data from Tim Mosmann on the functional heterogeneity of T cell clones led to the T helper type 1-T helper type 2 hypothesis.	Dynavax Technol, Berkeley, CA 94710 USA		Coffman, RL (corresponding author), Dynavax Technol, Berkeley, CA 94710 USA.	rcoffman@dvax.com						BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x; CHER DJ, 1987, J IMMUNOL, V138, P3688; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; LIEW FY, 1974, J EXP MED, V139, P779, DOI 10.1084/jem.139.3.779; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654; MOSMANN TR, 1987, IMMUNOL TODAY, V8, P223, DOI 10.1016/0167-5699(87)90171-X; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; VITETTA ES, 1984, IMMUNOL REV, V78, P137, DOI 10.1111/j.1600-065X.1984.tb00480.x; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388	19	136	143	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					539	541		10.1038/ni0606-539	http://dx.doi.org/10.1038/ni0606-539			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715060				2022-12-18	WOS:000237751200003
J	Kawashima, H; Petryniak, B; Hiraoka, N; Mitoma, J; Huckaby, V; Nakayama, J; Uchimura, K; Kadomatsu, K; Muramatsu, T; Lowe, JB; Fukuda, M				Kawashima, H; Petryniak, B; Hiraoka, N; Mitoma, J; Huckaby, V; Nakayama, J; Uchimura, K; Kadomatsu, K; Muramatsu, T; Lowe, JB; Fukuda, M			N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules	NATURE IMMUNOLOGY			English	Article							SIALYL-LEWIS-X; KERATAN SULFATE GAL-6-SULFOTRANSFERASE; NONOBESE DIABETIC MICE; VASCULAR ADDRESSIN; MOLECULAR-CLONING; N-ACETYLGLUCOSAMINE; O-GLYCANS; FUC-TVII; NODES; SULFOTRANSFERASES	Lymphocyte homing is mediated by specific interactions between L-selectin on lymphocytes and sulfated carbohydrates restricted to high endothelial venules in lymph nodes. Here we generated mice deficient in both N-acetylglucosamine-6-O- sulfotransferase 1 (GlcNAc6ST-1) and GlcNAc6ST-2 and found that mutant mice had approximately 75% less homing of lymphocytes to the peripheral lymph nodes than did wild-type mice. Consequently, these mice had lower contact hypersensitivity responses than those of wild-type mice. Carbohydrate structural analysis showed that 6-sulfo sialyl Lewis X, a dominant ligand for L-selectin, was almost completely absent from the high endothelial venules of these mutant mice, whereas the amount of unsulfated sialyl Lewis X was much greater. These results demonstrate the essential function of GlcNAc6ST-1 and GlcNAc6ST-2 in L-selectin ligand biosynthesis in high endothelial venules and their importance in immune surveillance.	Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Inst Life Sci, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Shinshu University; Nagoya University	Fukuda, M (corresponding author), Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA.	minoru@burnham.org	Uchimura, Kenji/AFV-1802-2022; Kadomatsu, Kenji/G-8083-2012; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X	NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA71932] Funding Source: Medline; NIGMS NIH HHS [U54 GM62116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bhakta S, 2000, J BIOL CHEM, V275, P40226, DOI 10.1074/jbc.M006414200; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; de Graffenried CL, 2003, J BIOL CHEM, V278, P40282, DOI 10.1074/jbc.M304928200; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fox JG, 1996, GASTROENTEROLOGY, V110, P155, DOI 10.1053/gast.1996.v110.pm8536852; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; IMAI Y, 1993, NATURE, V361, P555; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MICHIE SA, 1995, AM J PATHOL, V147, P412; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; PHANUPHAK P, 1974, J IMMUNOL, V112, P115; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 2005, AM J PATHOL, V166, P935, DOI 10.1016/S0002-9440(10)62313-9; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Singer MS, 1996, J IMMUNOL METHODS, V196, P153, DOI 10.1016/0022-1759(96)00106-8; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Uchimura K, 2000, BIOCHEM BIOPH RES CO, V274, P291, DOI 10.1006/bbrc.2000.3141; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; UCHIMURA K, 2005, NAT IMMUNOL; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15	54	136	140	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1096	1104		10.1038/ni1259	http://dx.doi.org/10.1038/ni1259			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16227985				2022-12-18	WOS:000232833300010
J	Krangel, MS				Krangel, MS			Gene segment selection in V(D)J recombination: accessibility and beyond	NATURE IMMUNOLOGY			English	Review							TCR-BETA LOCUS; CHAIN INTRONIC ENHANCER; HISTONE ACETYLATION; B-CELL; ALLELIC EXCLUSION; ALPHA-ENHANCER; V-BETA; ASYNCHRONOUS REPLICATION; GERMLINE TRANSCRIPTION; CHROMATIN STRUCTURE	V(D)J recombination assembles genes encoding antigen receptors according to defined developmental programs in immature B and T lymphocytes. The 'accessibility hypothesis' was initially invoked to explain how a single recombinase complex could control the locus and allele specificity of V(D)J recombination. It has been since shown that recombination signal sequences themselves influence recombination efficiency and specificity in ways that had not been previously appreciated. Recent developments have increased our understanding of how the chromatin barrier to V(D)J recombination is regulated, and how chromatin control and the properties of the underlying recombination signal sequences may cooperate to create diverse, lineage-restricted and allelically excluded repertoires of antigen receptors.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	krang001@mc.duke.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041052, R37GM041052] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 49934] Funding Source: Medline; NIGMS NIH HHS [GM 41052] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; Baker JE, 1998, IMMUNITY, V9, P159, DOI 10.1016/S1074-7613(00)80598-1; Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Chang Y, 1999, J EXP MED, V189, P1295, DOI 10.1084/jem.189.8.1295; Cherry SR, 2000, P NATL ACAD SCI USA, V97, P8467, DOI 10.1073/pnas.150218497; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cowell LG, 2003, J EXP MED, V197, P207, DOI 10.1084/jem.20020250; Feeney AJ, 2000, IMMUNOL REV, V175, P59, DOI 10.1111/j.1600-065X.2000.imr017508.x; FERNEX C, 1995, MOL CELL BIOL, V15, P3217; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hempel WM, 1998, GENE DEV, V12, P2305, DOI 10.1101/gad.12.15.2305; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; Huang JQ, 2001, J IMMUNOL, V167, P6073, DOI 10.4049/jimmunol.167.11.6073; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jung D, 2003, IMMUNITY, V18, P65, DOI 10.1016/S1074-7613(02)00507-1; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LAUSTER R, 1993, EMBO J, V12, P4615, DOI 10.1002/j.1460-2075.1993.tb06150.x; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Mauvieux L, 2001, EUR J IMMUNOL, V31, P2080, DOI 10.1002/1521-4141(200107)31:7<2080::AID-IMMU2080>3.3.CO;2-8; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Melchers F, 1999, SEMIN IMMUNOL, V11, P307, DOI 10.1006/smim.1999.0187; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pan PY, 1997, INT IMMUNOL, V9, P515, DOI 10.1093/intimm/9.4.515; Schubeler D, 2000, GENE DEV, V14, P940; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; SLECKMAN BP, 2001, IMMUNOLOGY, V102; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tillman RE, 2003, J IMMUNOL, V170, P5, DOI 10.4049/jimmunol.170.1.5; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Tripathi RK, 2000, MOL CELL BIOL, V20, P42, DOI 10.1128/MCB.20.1.42-53.2000; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VanDyk LF, 1996, J IMMUNOL, V157, P4005; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Wu C, 2003, IMMUNITY, V18, P75, DOI 10.1016/S1074-7613(02)00515-0; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yu KF, 2002, J BIOL CHEM, V277, P5040, DOI 10.1074/jbc.M109772200; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002	94	136	136	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					624	630		10.1038/ni0703-624	http://dx.doi.org/10.1038/ni0703-624			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830137				2022-12-18	WOS:000183952500005
J	Toney, LM; Cattoretti, G; Graf, JA; Merghoub, T; Pandolfi, PP; Dalla-Favera, R; Ye, BH; Dent, AL				Toney, LM; Cattoretti, G; Graf, JA; Merghoub, T; Pandolfi, PP; Dalla-Favera, R; Ye, BH; Dent, AL			BCL-6 regulates chemokine gene transcription in macrophages	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER FORMATION; NON-HODGKINS-LYMPHOMA; FINGER ENCODING GENE; CENTER B-CELLS; EXPRESSION; LYMPHOCYTES; PROTEIN; MICE; REARRANGEMENTS; INTERLEUKIN-4	The transcriptional repressor protein BCL-6, implicated in the pathogenesis of B cell lymphoma, regulates lymphocyte differentiation and inflammation. We investigated the mechanism for the T helper cell subset 2 (T(H)2)-type inflammation that occurs in BCL-6(-/-) mice. Using chimeric mice we found that the T(H)2-type inflammation is dependent upon nonlymphoid cells. We identified three chemokines, MCP-1, MCP-3 and MRP-1,which are negatively regulated by BCL-6 in macrophages. Promoter analysis revealed that BCL-6 is a potent repressor of MCP-1 transcription. Our results provide a mechanism for the regulation of T(H)2-type inflammation by BCL-6 and link TH2 differentiation to innate immunity.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Oncol Ctr, Indianapolis, IN 46208 USA; Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Sloan Kettering Div,Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Sloan Kettering Div,Mol Biol Program, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Comprehens Canc, Bronx, NY 10461 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute; Columbia University; Columbia University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dent, AL (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	adent2@iupui.edu	Cattoretti, Giorgio/H-2340-2011	Cattoretti, Giorgio/0000-0003-3799-3221	NCI NIH HHS [CA-37295] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA037295, R37CA037295, R01CA037295] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BASTARD C, 1994, BLOOD, V83, P2423; Biswas P, 1998, BLOOD, V91, P258, DOI 10.1182/blood.V91.1.258.258_258_265; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; DALLAFAVERA R, 1994, ANN ONCOL, V5, pS55, DOI 10.1093/annonc/5.suppl_1.S55; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Huynh KD, 2000, GENE DEV, V14, P1810; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Li L, 1999, J IMMUNOL, V162, P2477; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; Lukacs NW, 1997, AM J PATHOL, V150, P1861; MOMBAERTS P, 1992, NATURE, V360, P491; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SCHOOK LB, 1994, J LEUKOCYTE BIOL, V56, P514, DOI 10.1002/jlb.56.4.514; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seyfert VL, 1996, ONCOGENE, V12, P2331; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Yamochi T, 1997, LEUKEMIA, V11, P694, DOI 10.1038/sj.leu.2400631; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang SM, 2000, J IMMUNOL, V165, P10, DOI 10.4049/jimmunol.165.1.10	39	136	138	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					214	220		10.1038/79749	http://dx.doi.org/10.1038/79749			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973278				2022-12-18	WOS:000089815100019
J	Sharma, BR; Kanneganti, TD				Sharma, Bhesh Raj; Kanneganti, Thirumala-Devi			NLRP3 inflammasome in cancer and metabolic diseases	NATURE IMMUNOLOGY			English	Review								The NLRP3 inflammasome is a central operator in inflammation. Sharma and Kanneganti review the varied roles played by the NLRP3 inflammasome in cancer and metabolic diseases. The NLRP3 inflammasome is a multimeric cytosolic protein complex that assembles in response to cellular perturbations. This assembly leads to the activation of caspase-1, which promotes maturation and release of the inflammatory cytokines interleukin-1 beta (IL-1 beta) and IL-18, as well as inflammatory cell death (pyroptosis). The inflammatory cytokines contribute to the development of systemic low-grade inflammation, and aberrant NLRP3 activation can drive a chronic inflammatory state in the body to modulate the pathogenesis of inflammation-associated diseases. Therefore, targeting NLRP3 or other signaling molecules downstream, such as caspase-1, IL-1 beta or IL-18, has the potential for great therapeutic benefit. However, NLRP3 inflammasome-mediated inflammatory cytokines play dual roles in mediating human disease. While they are detrimental in the pathogenesis of inflammatory and metabolic diseases, they have a beneficial role in numerous infectious diseases and some cancers. Therefore, fine tuning of NLRP3 inflammasome activity is essential for maintaining proper cellular homeostasis and health. In this Review, we will cover the mechanisms of NLRP3 inflammasome activation and its divergent roles in the pathogenesis of inflammation-associated diseases such as cancer, atherosclerosis, diabetes and obesity, highlighting the therapeutic potential of targeting this pathway.	[Sharma, Bhesh Raj; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Sharma, Bhesh Raj/H-3782-2014	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Sharma, Bhesh Raj/0000-0003-3609-833X	National Institutes of Health [AI101935, AI124346, AR056296, CA253095]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	We thank the members of the T.-D.K. laboratory for helpful feedback during the editing of this Review and R. Tweedell for scientific editing and writing support. T.-D.K. is supported by funding from the National Institutes of Health (grants AI101935, AI124346, AR056296 and CA253095) and the American Lebanese Syrian Associated Charities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bae JY, 2017, ONCOTARGET, V8, P48972, DOI 10.18632/oncotarget.16903; Bando S, 2015, ATHEROSCLEROSIS, V242, P407, DOI 10.1016/j.atherosclerosis.2015.07.043; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Briard B, 2020, NATURE, V588, P688, DOI 10.1038/s41586-020-2996-z; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Camell CD, 2015, J BIOL CHEM, V290, P29402, DOI 10.1074/jbc.M115.680199; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chen L, 2018, CELL MOL LIFE SCI, V75, P2045, DOI 10.1007/s00018-017-2720-9; Chow MT, 2012, IMMUNOL CELL BIOL, V90, P983, DOI 10.1038/icb.2012.46; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Christgen S, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00237; Christgen S, 2020, CURR OPIN IMMUNOL, V62, P39, DOI 10.1016/j.coi.2019.11.007; Christgen S, 2020, CELL RES, V30, P315, DOI 10.1038/s41422-020-0295-8; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Das S, 2020, CANCER RES, V80, P1088, DOI 10.1158/0008-5472.CAN-19-2080; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Dmitrieva-Posocco O, 2019, IMMUNITY, V50, P166, DOI 10.1016/j.immuni.2018.11.015; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Du QM, 2016, BIOCHEM PHARMACOL, V105, P42, DOI 10.1016/j.bcp.2016.02.017; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupaul-Chicoine J, 2015, IMMUNITY, V43, P751, DOI 10.1016/j.immuni.2015.08.013; Esser N, 2013, DIABETOLOGIA, V56, P2487, DOI 10.1007/s00125-013-3023-9; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Guo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36107; Guo WJ, 2014, AUTOPHAGY, V10, P972, DOI 10.4161/auto.28374; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Gurung P, 2015, J IMMUNOL, V194, P2064, DOI 10.4049/jimmunol.1402951; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hendrikx T, 2015, FEBS J, V282, P2327, DOI 10.1111/febs.13279; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2476-2; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jin BR, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9020024; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Ju MY, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa345; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Karki R, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136720; Karki R, 2020, J IMMUNOL, V204, P2514, DOI 10.4049/jimmunol.1901508; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kesavardhana S, 2020, J BIOL CHEM, V295, P8325, DOI 10.1074/jbc.RA120.013752; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kong H, 2015, TUMOR BIOL, V36, P7501, DOI 10.1007/s13277-015-3473-4; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Kursawe R, 2016, DIABETES, V65, P610, DOI 10.2337/db15-1478; Lukens JR, 2011, DISCOV MED, V11, P65; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Malik A, 2017, J CELL SCI, V130, P3955, DOI 10.1242/jcs.207365; Malireddi RKS, 2020, J EXP MED, V217, DOI 10.1084/jem.20191644; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mathur A, 2018, J LEUKOCYTE BIOL, V103, P233, DOI 10.1189/jlb.3MR0617-250R; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Miskiewicz A, 2015, ARCH IMMUNOL THER EX, V63, P485, DOI 10.1007/s00005-015-0355-9; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Pandey A, 2019, YALE J BIOL MED, V92, P481; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Ringling RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161939; Robblee MM, 2016, CELL REP, V14, P2611, DOI 10.1016/j.celrep.2016.02.053; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Segovia M, 2019, CANCER CELL, V35, P767, DOI 10.1016/j.ccell.2019.04.003; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; SHI HX, 2016, NAT IMMUNOL, V17, P250, DOI DOI 10.1038/NI.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi X, 2015, J STROKE CEREBROVASC, V24, P2455, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.024; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shojaie L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249682; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Sorrentino R, 2015, AM J PATHOL, V185, P3115, DOI 10.1016/j.ajpath.2015.07.009; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theivanthiran B, 2020, J CLIN INVEST, V130, P2570, DOI 10.1172/JCI133055; Toldo S, 2018, NAT REV CARDIOL, V15, P203, DOI 10.1038/nrcardio.2017.161; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Tuominen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060939; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Verma D, 2012, PIGM CELL MELANOMA R, V25, P506, DOI 10.1111/j.1755-148X.2012.01008.x; WALLE LV, 2014, NATURE, V512, P69, DOI DOI 10.1038/NATURE13322; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wei Q, 2015, LAB INVEST, V95, P804, DOI 10.1038/labinvest.2015.63; Wei Q, 2014, LAB INVEST, V94, P52, DOI 10.1038/labinvest.2013.126; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yao XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01917-2; Yin Z, 2014, MOL CELL ENDOCRINOL, V394, P80, DOI 10.1016/j.mce.2014.06.018; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang A, 2018, HUM IMMUNOL, V79, P57, DOI 10.1016/j.humimm.2017.10.013; Zhang SY, 2018, EBIOMEDICINE, V31, P202, DOI 10.1016/j.ebiom.2018.04.022; Zhao X, 2017, ONCOTARGET, V8, P108571, DOI 10.18632/oncotarget.21010; Zheng M, 2020, CELL, V181, P674, DOI 10.1016/j.cell.2020.03.040	135	135	140	33	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					550	559		10.1038/s41590-021-00886-5	http://dx.doi.org/10.1038/s41590-021-00886-5		MAR 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33707781	Green Accepted			2022-12-18	WOS:000627707900002
J	Li, XX; Bechara, R; Zhao, JJ; McGeachy, MJ; Gaffen, SL				Li, Xiaoxia; Bechara, Rami; Zhao, Junjie; McGeachy, Mandy J.; Gaffen, Sarah L.			IL-17 receptor-based signaling and implications for disease	NATURE IMMUNOLOGY			English	Review							KAPPA-B-ZETA; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA; T-CELL; KERATINOCYTE PROLIFERATION; INTERLEUKIN-17 RECEPTOR; AUTOIMMUNE INFLAMMATION; NEGATIVE REGULATION; ADAPTER PROTEIN; INBORN-ERRORS	IL-17 is a highly versatile pro-inflammatory cytokine crucial for a variety of processes, including host defense, tissue repair, the pathogenesis of inflammatory disease and the progression of cancer. In contrast to its profound impact in vivo, IL-17 exhibits surprisingly moderate activity in cell-culture models, which presents a major knowledge gap about the molecular mechanisms of IL-17 signaling. Emerging studies are revealing a new dimension of complexity in the IL-17 pathway that may help explain its potent and diverse in vivo functions. Discoveries of new mRNA stabilizers and receptor-directed mRNA metabolism have provided insights into the means by which IL-17 cooperates functionally with other stimuli in driving inflammation, whether beneficial or destructive. The integration of IL-17 with growth-receptor signaling in specific cell types offers new understanding of the mitogenic effect of IL-17 on tissue repair and cancer. This Review summarizes new developments in IL-17 signaling and their pathophysiological implications.	[Li, Xiaoxia; Zhao, Junjie] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Bechara, Rami; McGeachy, Mandy J.; Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, XX (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA.; Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	lix@ccf.org; sarah.gaffen@pitt.edu	Gaffen, Sarah L/B-1560-2009; Zhao, Junjie/AAH-1152-2021	Gaffen, Sarah L/0000-0001-8511-2041; Bechara, Rami/0000-0002-1611-0242	US National Institutes of Health [DE022550, AI107825, P01CA062220, P01HL103453, R01AI110822-01]; National Multiple Sclerosis Society [RG5130A2/1]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109250, P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825, R01AI110822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022550, R37DE022550] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by US National Institutes of Health grants DE022550 and AI107825 (S.L.G.), P01CA062220 and P01HL103453 (X.L.) and R01AI110822-01 (M.J.M.), and by the National Multiple Sclerosis Society grant RG5130A2/1 (X.L.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ahlgren KM, 2011, EUR J IMMUNOL, V41, P235, DOI 10.1002/eji.200939883; Amatya N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat4617; Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Buckley KM, 2017, ELIFE, V6, DOI 10.7554/eLife.23481; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Cai G, 2018, P NATL ACAD SCI USA, V115, P11531, DOI 10.1073/pnas.1809599115; Calcinotto A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07305-8; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen X, 2019, J EXP MED, V216, P195, DOI 10.1084/jem.20171849; Christenson SA, 2019, J CLIN INVEST, V129, P169, DOI 10.1172/JCI121087; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Deepe GS, 2018, VACCINE, V36, P3359, DOI 10.1016/j.vaccine.2018.04.047; Eddens T, 2017, CELL REP, V18, P3078, DOI 10.1016/j.celrep.2017.03.016; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Finegan KG, 2015, CANCER RES, V75, P742, DOI 10.1158/0008-5472.CAN-13-3043; Garg AV, 2015, IMMUNITY, V43, P475, DOI 10.1016/j.immuni.2015.07.021; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Guerra ES, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006175; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Herjan T, 2018, NAT IMMUNOL, V19, P354, DOI 10.1038/s41590-018-0071-9; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Hernandez-Santos N, 2018, CELL HOST MICROBE, V23, P511, DOI 10.1016/j.chom.2018.02.011; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Ho AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070168; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hung CY, 2011, INFECT IMMUN, V79, P4511, DOI 10.1128/IAI.05726-11; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kaiko GE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat0852; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li J, 2018, MUCOSAL IMMUNOL, V11, P581, DOI 10.1038/mi.2017.97; Li J, 2017, CURR OPIN MICROBIOL, V40, P46, DOI 10.1016/j.mib.2017.10.016; Ling Y, 2015, J EXP MED, V212, P619, DOI 10.1084/jem.20141065; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Liu FL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005663; Maekawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9272; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Majumder S, 2019, NAT IMMUNOL, V20, P534, DOI 10.1038/s41590-019-0367-4; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Monin L, 2017, J IMMUNOL, V198, P767, DOI 10.4049/jimmunol.1601551; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Ostling J, 2019, J ALLERGY CLIN IMMUN, V144, P1198, DOI 10.1016/j.jaci.2019.03.027; Onishi RM, 2010, J BIOL CHEM, V285, P32751, DOI 10.1074/jbc.M110.121418; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Peng T, 2017, J EXP MED, V214, P2315, DOI 10.1084/jem.20160581; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rich HE, 2018, AM J RESP CELL MOL, V58, P669, DOI 10.1165/rcmb.2018-0078ED; Rousseau A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001726; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schweppe RE, 2006, J BIOL CHEM, V281, P20993, DOI 10.1074/jbc.M604208200; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Shao XR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07597-8; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Singh R, 2018, J CLIN INVEST, V128, P3129, DOI 10.1172/JCI96060; Somma D, 2015, J IMMUNOL, V194, P3286, DOI 10.4049/jimmunol.1401589; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Sun C, 2016, DIGEST DIS SCI, V61, P474, DOI 10.1007/s10620-015-3888-1; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tanaka H, 2019, J EXP MED, V216, P1431, DOI 10.1084/jem.20181078; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Verma AH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8834; Wan Q, 2015, J INTERF CYTOK RES, V35, P917, DOI 10.1089/jir.2014.0146; Wang CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15508; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang MC, 2018, IMMUNITY, V49, P66, DOI 10.1016/j.immuni.2018.05.012; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Whibley N, 2016, J LEUKOCYTE BIOL, V99, P1153, DOI 10.1189/jlb.4A0915-428R; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu L, 2015, J EXP MED, V212, P1571, DOI 10.1084/jem.20150204; Wu NL, 2015, J INVEST DERMATOL, V135, P490, DOI 10.1038/jid.2014.383; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zepp JA, 2017, J IMMUNOL, V199, P3849, DOI 10.4049/jimmunol.1601540; Zepp JA, 2012, J IMMUNOL, V189, P33, DOI 10.4049/jimmunol.1200470; Zhang B, 2013, J IMMUNOL, V190, P2320, DOI 10.4049/jimmunol.1202922; Zhang Y, 2018, GASTROENTEROLOGY, V155, P210, DOI 10.1053/j.gastro.2018.03.041; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	120	135	141	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1594	1602		10.1038/s41590-019-0514-y	http://dx.doi.org/10.1038/s41590-019-0514-y			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745337	Green Accepted			2022-12-18	WOS:000497949800014
J	Roychoudhuri, R; Clever, D; Li, P; Wakabayashi, Y; Quinn, KM; Klebanoff, CA; Ji, Y; Sukumar, M; Eil, RL; Yu, ZY; Spolski, R; Palmer, DC; Pan, JH; Patel, SJ; Macallan, DC; Fabozzi, G; Shih, HY; Kanno, Y; Muto, A; Zhu, J; Gattinoni, L; O'Shea, JJ; Okkenhaug, K; Igarashi, K; Leonard, WJ; Restifo, NP				Roychoudhuri, Rahul; Clever, David; Li, Peng; Wakabayashi, Yoshiyuki; Quinn, Kylie M.; Klebanoff, Christopher A.; Ji, Yun; Sukumar, Madhusudhanan; Eil, Robert L.; Yu, Zhiya; Spolski, Rosanne; Palmer, Douglas C.; Pan, Jenny H.; Patel, Shashank J.; Macallan, Derek C.; Fabozzi, Giulia; Shih, Han-Yu; Kanno, Yuka; Muto, Akihiko; Zhu, Jun; Gattinoni, Luca; O'Shea, John J.; Okkenhaug, Klaus; Igarashi, Kazuhiko; Leonard, Warren J.; Restifo, Nicholas P.			BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; MEMORY PHENOTYPE; EFFECTOR; GENE; REPRESSES; LYMPHOCYTES; ACTIVATION; GENERATION; PROTEINS	T cell antigen receptor (TCR) signaling drives distinct responses depending on the differentiation state and context of CD8(+) T cells. We hypothesized that access of signal-dependent transcription factors (TFs) to enhancers is dynamically regulated to shape transcriptional responses to TCR signaling. We found that the TF BACH2 restrains terminal differentiation to enable generation of long-lived memory cells and protective immunity after viral infection. BACH2 was recruited to enhancers, where it limited expression of TCR-driven genes by attenuating the availability of activator protein-1 (AP-1) sites to Jun family signal-dependent TFs. In naive cells, this prevented TCR-driven induction of genes associated with terminal differentiation. Upon effector differentiation, reduced expression of BACH2 and its phosphorylation enabled unrestrained induction of TCR-driven effector programs.	[Roychoudhuri, Rahul; Clever, David; Klebanoff, Christopher A.; Ji, Yun; Sukumar, Madhusudhanan; Eil, Robert L.; Yu, Zhiya; Palmer, Douglas C.; Pan, Jenny H.; Patel, Shashank J.; Fabozzi, Giulia; Gattinoni, Luca; Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA; [Roychoudhuri, Rahul; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Clever, David] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA; [Li, Peng; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Li, Peng; Spolski, Rosanne; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Wakabayashi, Yoshiyuki; Zhu, Jun] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Quinn, Kylie M.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Macallan, Derek C.] St Georges Univ London, Inst Infect & Immun, London, England; [Shih, Han-Yu; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Dept Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan; [Restifo, Nicholas P.] Georgetown Univ, Med Ctr, Grad Program Microbiol & Immunol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Georges University London; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Tohoku University; Georgetown University	Roychoudhuri, R; Restifo, NP (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.; Roychoudhuri, R (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.; Restifo, NP (corresponding author), Georgetown Univ, Med Ctr, Grad Program Microbiol & Immunol, Washington, DC 20007 USA.	rahul.roychoudhuri@babraham.ac.uk; restifo@nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Kanno, Yuka/B-5802-2013; Leonard, Warren/AAA-1397-2022; Waldmann, Thomas/AAT-5972-2021; Restifo, Nicholas Phillip/Z-1614-2019; Ji, Yun/B-7245-2009; Roychoudhuri, Rahul/A-7442-2010; Quinn, Kylie/AAJ-5066-2021; Okkenhaug, Klaus/H-3154-2019; Gattinoni, Luca/A-2281-2008; Palmer, Douglas/B-9454-2008	Kanno, Yuka/0000-0001-5668-9319; Waldmann, Thomas/0000-0003-4500-6660; Ji, Yun/0000-0001-6340-7009; Roychoudhuri, Rahul/0000-0002-5392-1853; Okkenhaug, Klaus/0000-0002-9432-4051; Gattinoni, Luca/0000-0003-2239-3282; Quinn, Kylie/0000-0002-0417-3625; Clever, David/0000-0002-9137-8177; Palmer, Douglas/0000-0001-5018-5734; Macallan, Derek/0000-0002-3014-7148; Restifo, Nicholas P./0000-0003-4229-4580; Shih, Han-Yu/0000-0002-7525-5433; Klebanoff, Christopher/0000-0001-9645-3896; Patel, Shashank/0000-0001-6973-6997; Igarashi, Kazuhiko/0000-0002-2470-2475	Intramural Research Program of the NCI; Intramural Research Program of the NHLBI; Wellcome Trust/Royal Society grant [105663/Z/14/Z]; UK Biotechnology and Biological Sciences Research Council [BB/N007794/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/N007794/1, BBS/E/B/000C0409] Funding Source: researchfish; BBSRC [BBS/E/B/000C0409, 1642652, BBS/E/B/000C0407, BB/N007794/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006230, ZIAHL005402, ZICHL006058, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H02506] Funding Source: KAKEN	Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust/Royal Society grant; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S.A. Rosenberg, K. Hanada, K. Hirahara, K. Mousavi, H. Zare, V. Sartorelli, N. Van Panhuys, S. Kerkar and A. Restifo for ideas and discussion, A. Mixon and S. Farid for expertise with cell sorting, members of the NHLBI sequencing core facility for help with sequencing, L. Samsel for help with ImageStream imaging flow cytometry and G. McMullen for expertise with mouse handling. Supported by the Intramural Research Programs of the NCI and NHLBI, Wellcome Trust/Royal Society grant 105663/Z/14/Z (R.R.) and UK Biotechnology and Biological Sciences Research Council grant BB/N007794/1 (R.R. and K.O.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Belz GT, 2010, CURR OPIN IMMUNOL, V22, P279, DOI 10.1016/j.coi.2010.03.008; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; CIPPITELLI M, 1995, J BIOL CHEM, V270, P12548, DOI 10.1074/jbc.270.21.12548; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychoudhuri R, 2015, VACCINE, V33, P914, DOI 10.1016/j.vaccine.2014.10.007; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yoshida C, 2007, BLOOD, V109, P1211, DOI 10.1182/blood-2005-12-040972; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	135	136	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					851	+		10.1038/ni.3441	http://dx.doi.org/10.1038/ni.3441			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27158840	Green Accepted, Green Submitted			2022-12-18	WOS:000378283200018
J	Raetz, M; Hwang, SH; Wilhelm, CL; Kirkland, D; Benson, A; Sturge, CR; Mirpuri, J; Vaishnava, S; Hou, BD; DeFranco, AL; Gilpin, CJ; Hooper, LV; Yarovinsky, F				Raetz, Megan; Hwang, Sun-hee; Wilhelm, Cara L.; Kirkland, Donna; Benson, Alicia; Sturge, Carolyn R.; Mirpuri, Julie; Vaishnava, Shipra; Hou, Baidong; DeFranco, Anthony L.; Gilpin, Christopher J.; Hooper, Lora V.; Yarovinsky, Felix			Parasite-induced T(H)1 cells and intestinal dysbiosis cooperate in IFN-gamma-dependent elimination of Paneth cells	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; TOXOPLASMA-GONDII INFECTION; ADAPTIVE IMMUNITY; DENDRITIC CELLS; COMMENSAL BACTERIA; INTERFERON-GAMMA; T-CELLS; HOST; ABSENCE; INNATE	Activation of Toll-like receptors (TLRs) by pathogens triggers cytokine production and T cell activation, immune defense mechanisms that are linked to immunopathology. Here we show that IFN-gamma production by CD4(+) T(H)1 cells during mucosal responses to the protozoan parasite Toxoplasma gondii resulted in dysbiosis and the elimination of Paneth cells. Paneth cell death led to loss of antimicrobial peptides and occurred in conjunction with uncontrolled expansion of the Enterobacteriaceae family of Gram-negative bacteria. The expanded intestinal bacteria were required for the parasite-induced intestinal pathology. The investigation of cell type-specific factors regulating T(H)1 polarization during T. gondii infection identified the T cell-intrinsic TLR pathway as a major regulator of IFN-gamma production in CD4(+) T cells responsible for Paneth cell death, dysbiosis and intestinal immunopathology.	[Raetz, Megan; Hwang, Sun-hee; Wilhelm, Cara L.; Kirkland, Donna; Benson, Alicia; Sturge, Carolyn R.; Mirpuri, Julie; Vaishnava, Shipra; Hooper, Lora V.; Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hou, Baidong; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Hou, Baidong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Gilpin, Christopher J.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Hooper, Lora V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Yarovinsky, F (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	felix.yarovinsky@UTSouthwestern.edu		Hou, Baidong/0000-0002-0892-0181; Mirpuri, Julie/0000-0003-4255-3474; Yarovinsky, Felix/0000-0001-5825-8002	US National Institutes of Health (NIH) [R01 AI085263, R01 DK070855]; Howard Hughes Medical Institute; NIH [A1005284-33]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health (NIH) grants R01 AI085263 to F.Y. and R01 DK070855 to L.V.H. and by the Howard Hughes Medical Institute (L.V.H.). C.R.S. was supported in part by NIH grant A1005284-33. We would also like to thank C. Behrendt and C. Clements for germ-free mouse husbandry.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Han JH, 2006, NAT IMMUNOL, V7, P370, DOI 10.1038/ni0406-370; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sukhumavasi W, 2008, J IMMUNOL, V181, P3464, DOI 10.4049/jimmunol.181.5.3464; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	40	135	142	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					136	142		10.1038/ni.2508	http://dx.doi.org/10.1038/ni.2508			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23263554	Green Accepted, Green Submitted			2022-12-18	WOS:000313918400008
J	Morris, GP; Allen, PM				Morris, Gerald P.; Allen, Paul M.			How the TCR balances sensitivity and specificity for the recognition of self and pathogens	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-MHC COMPLEXES; KINASE-C-THETA; ALPHA-BETA; POSITIVE SELECTION; DIFFERENTIAL REQUIREMENTS; THYMOCYTE DEVELOPMENT; LINEAGE COMMITMENT; THYMIC SELECTION	The T cell repertoire is generated during thymic development in preparation for the response to antigens from pathogens. The T cell repertoire is shaped by positive selection, which requires recognition by the T cell antigen receptor (TCR) of complexes of self peptide and major histocompatibility complex proteins (self-pMHC) with low affinity, and negative selection, which eliminates T cells with TCRs that recognize self-pMHC with high affinity. This generates a repertoire with low affinity for self-pMHC but high affinity for foreign antigens. The TCR must successfully engage both of these ligands for development, homeostasis and immune responses. This review discusses mechanisms underlying the interaction of the TCR with peptide-major histocompatibility complex ligands of varying affinity and highlights signaling mechanisms that enable the TCR to generate different responses to very distinct ligands.	[Morris, Gerald P.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu	Morris, Gerald P/I-3680-2016	Morris, Gerald P/0000-0002-1097-4453	NIAID NIH HHS [R21 AI126150, R01 AI024157, K08 AI085039] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126150, R01AI024157, K08AI085039] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Filbert EL, 2010, EUR J IMMUNOL, V40, P3226, DOI 10.1002/eji.201040349; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haks MC, 2003, J IMMUNOL, V170, P2853, DOI 10.4049/jimmunol.170.6.2853; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Ishikawa E, 2010, P NATL ACAD SCI USA, V107, P19979, DOI 10.1073/pnas.1011228107; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 2000, J IMMUNOL, V164, P5675, DOI 10.4049/jimmunol.164.11.5675; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mallaun M, 2010, J RECEPT SIG TRANSD, V30, P430, DOI 10.3109/10799893.2010.518151; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morris GP, 2011, P NATL ACAD SCI USA, V108, P3695, DOI 10.1073/pnas.1017015108; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Singer A, 2004, ADV IMMUNOL, V83, P91; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vidal K, 1999, J IMMUNOL, V163, P4811; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	118	135	137	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					121	128		10.1038/ni.2190	http://dx.doi.org/10.1038/ni.2190			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261968				2022-12-18	WOS:000299315000008
J	Masternak, K; Peyraud, N; Krawczyk, M; Barras, E; Reith, W				Masternak, K; Peyraud, N; Krawczyk, M; Barras, E; Reith, W			Chromatin remodeling and extragenic transcription at the MHC class II locus control region	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RNA-POLYMERASE-II; BARE LYMPHOCYTE SYNDROME; HLA-DRA GENE; HISTONE ACETYLATION; INTERGENIC TRANSCRIPTION; HYPERSENSITIVE SITES; SELF-ASSOCIATION; UPSTREAM REGION; CIITA	In vivo, a wild-type pattern of major histocompatibility complex (MHC) class II expression requires a locus control region (LCR). Whereas the role of promoter-proximal MHC class II regulatory sequences is well established, the function of the distal LCR remained obscure. We show here that this LCR is bound by the MHC class II-specific transactivators regulatory factor X (RFX) and class II transactivator (CIITA). Binding of these factors induces long-range histone acetylation, RNA polymerase II recruitment and the synthesis of extragenic transcripts within the LCR. The finding that RFX and CIITA regulate the function of the MHC class II LCR reveals an unexpected degree of complexity in the mechanisms controlling MHC class II gene expression.	Univ Geneva, Sch Med, CMU, CH-1211 Geneva, Switzerland	University of Geneva	Reith, W (corresponding author), Univ Geneva, Sch Med, CMU, CH-1211 Geneva, Switzerland.	walter.reith@medecine.unige.ch	Krawczyk, Michal/W-2538-2018	Krawczyk, Michal/0000-0001-9646-3779				ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Brown JA, 1996, IMMUNOGENETICS, V43, P88; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; CARSON S, 1993, NUCLEIC ACIDS RES, V21, P2065, DOI 10.1093/nar/21.9.2065; CARSON S, 1991, NUCLEIC ACIDS RES, V19, P5007, DOI 10.1093/nar/19.18.5007; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DORN A, 1988, MOL CELL BIOL, V8, P3975, DOI 10.1128/MCB.8.10.3975; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; FERIOTTO G, 1995, NUCLEIC ACIDS RES, V23, P1671, DOI 10.1093/nar/23.10.1671; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HUME CR, 1989, HUM IMMUNOL, V25, P1, DOI 10.1016/0198-8859(89)90065-7; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; KOCH W, 1989, MOL CELL BIOL, V9, P303, DOI 10.1128/MCB.9.1.303; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2002, EMBO J, V21, P1379, DOI 10.1093/emboj/21.6.1379; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Mischiati C, 1999, BIOCHIMIE, V81, P219, DOI 10.1016/S0300-9084(99)80055-8; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Schubeler D, 2001, P NATL ACAD SCI USA, V98, P11432, DOI 10.1073/pnas.201394698; Sisk TJ, 2001, MOL CELL BIOL, V21, P4919, DOI 10.1128/MCB.21.15.4919-4928.2001; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; Viret C, 1999, Rev Immunogenet, V1, P91; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219	45	135	142	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					132	137		10.1038/ni883	http://dx.doi.org/10.1038/ni883			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12524537				2022-12-18	WOS:000180686500012
J	Wilkinson, B; Chen, JYF; Han, P; Rufner, KM; Goularte, OD; Kaye, J				Wilkinson, B; Chen, JYF; Han, P; Rufner, KM; Goularte, OD; Kaye, J			TOX: an HMG box protein implicated in the regulation of thymocyte selection	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; SEX-DETERMINING REGION; DNA-BINDING MOTIF; CD4+ T-CELLS; TRANSCRIPTION FACTOR; POSITIVE SELECTION; DEFICIENT MICE; CD4(+)8(+) THYMOCYTES; SIGNALING PATHWAYS; ALPHA-ENHANCER	In the thymus, pre-T cell receptor (pre-TCR)-mediated signaling and then TCR-mediated signaling initiate changes in gene expression that result in the maturation of CD4 and CD8 lineage T cells from common precursors. Using gene chip technology, we isolated a murine gene, designated Tox, that encodes a member of the HMG (high-mobility group) box family of DNA-binding proteins. TOX expression is up-regulated by both pre-TCR and TCR activation of immature thymocytes but not by TCR activation of mature naive T cells. Transgenic mice that express TOX show expanded CD8(+) and reduced CD4(+) single positive thymocyte subpopulations. We present evidence here that this phenotype results from a perturbation in lineage commitment due to reduced sensitivity to TCR-mediated signaling. This molecular marker of thymic selection events may therefore play a role in establishing the activation threshold of developing T cells and patterning changes in gene expression.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Kaye, J (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.			Kaye, Jonathan/0000-0002-1634-9069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044110] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44110] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DUTZ JP, 1995, J IMMUNOL, V154, P2588; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; JAMESON SC, 1990, J IMMUNOL, V145, P1324; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; OHAKA Y, 1997, J IMMUNOL, V158, P5707; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; PENIT C, 1995, J IMMUNOL, V154, P5103; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; RENAROSSI C, 1999, J IMMUNOL, V163, P6494; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Shao H, 1999, J IMMUNOL, V163, P603; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Takahama Y, 1996, J IMMUNOL, V157, P1508; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; UTSUNOMIYA Y, 1989, J IMMUNOL, V143, P2602; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; WEN L, 1989, NUCLEIC ACIDS RES, V17, P1197, DOI 10.1093/nar/17.3.1197; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	61	135	142	5	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					272	280		10.1038/ni767	http://dx.doi.org/10.1038/ni767			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11850626				2022-12-18	WOS:000174074000016
J	Sun, H; Lu, BF; Li, RQ; Flavell, RA; Taneja, R				Sun, H; Lu, BF; Li, RQ; Flavell, RA; Taneja, R			Defective T cell activation and autoimmune disorder in Stra13-deficient mice	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER FORMATION; FAS LIGAND; NF-AT; EXPRESSION; INTERLEUKIN-2; DISEASE; ANTIGEN; STRA13; DEATH; DIFFERENTIATION	Stra13, a basic helix-loop-helix transcription factor, is up-regulated upon activation of CD4(+) T cells. Here we show that Stra13-deficient mice exhibit defects in several phases of CD4(+) T cell activation. In vivo, Stra13 deficiency results in ineffective elimination of activated T and B cells, which accumulate progressively, leading to lymphoid organ hyperplasia. Consequently, aging Stra13(-/-) mice develop autoimmune disease characterized by accumulation of spontaneously activated T and B cells, circulating autoantibodies, infiltration of T and B lymphocytes in several organs and immune complex deposition in glomeruli. Our studies identify Stra13 as a key regulator of lymphocyte activation that is vital for maintenance of self-tolerance and for constraint of autoimmunity.	CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Yale University	Taneja, R (corresponding author), CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA.	Reshma.Taneja@mssm.edu	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhar M, 2001, ONCOGENE, V20, P4750, DOI 10.1038/sj.onc.1204637; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Fisher M., 1995, HDBK OPER R, V8, P1; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Glimcher LH, 2000, GENE DEV, V14, P1693; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245; Noble A, 2000, IMMUNOLOGY, V101, P289, DOI 10.1046/j.1365-2567.2000.00133.x; Oberg HH, 1997, CELL IMMUNOL, V181, P93, DOI 10.1006/cimm.1997.1200; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 1999, CYTOGENET CELL GENET, V87, P211, DOI 10.1159/000015470; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; [No title captured]	38	135	140	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1040	1047		10.1038/ni721	http://dx.doi.org/10.1038/ni721			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668339				2022-12-18	WOS:000172049800017
J	Girkontaite, I; Missy, K; Sakk, V; Harenberg, A; Tedford, K; Potzel, T; Pfeffer, K; Fischer, HD				Girkontaite, I; Missy, K; Sakk, V; Harenberg, A; Tedford, K; Potzel, T; Pfeffer, K; Fischer, HD			Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses	NATURE IMMUNOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; GTP-BINDING PROTEIN; FACTOR-KAPPA-B; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; CYTOSKELETAL REORGANIZATION; RHO-GTPASES; P115 RHOGEF; ACTIVATION; RECEPTOR	Lsc (the murine homolog of human p115 Rho GEF) is a member of the Dbl-homology family of GTP exchange factors and is a specific activator of Rho. Lsc is activated by the G alpha (13) subunit of heterotrimeric G proteins and contains a regulator of G protein signaling domain that downmodulates G alpha (12) and G alpha (13). Lsc is expressed primarily in the hematopoietic system and links the activation of G alpha (12) and G alpha (13)-coupled receptors to actin polymerization in B and T cells. Lsc is essential for marginal zone B (MZB) cell homeostasis and for the generation of immune responses. Although I-sc-deficient lymphocytes show reduced basal motility, MZB cells show enhanced migration after serum activation. Thus, Lsc is a critical regulator of MZB cells and immune functions.	Univ Ulm, Abt Physiol Chem, D-89069 Ulm, Germany; Inst Biotechnol, LT-2028 Vilnius, Lithuania; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Tech Univ Munich, Inst Med Mikrobiol & Hyg, D-81675 Munich, Germany	Ulm University; Vilnius University; University of Wurzburg; Technical University of Munich	Fischer, HD (corresponding author), Univ Ulm, Abt Physiol Chem, Albert Einstein Allee 11, D-89069 Ulm, Germany.	klaus.fischer@medizin.uni-ulm.de	Girkontaite, Irute/K-9017-2013	Girkontaite, Irute/0000-0002-3659-3202; Pfeffer, Klaus/0000-0002-5652-6330				Aasheim HC, 1997, ONCOGENE, V14, P1747, DOI 10.1038/sj.onc.1200994; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kabarowski JHS, 2000, P NATL ACAD SCI USA, V97, P12109, DOI 10.1073/pnas.97.22.12109; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; LANE PJL, 1986, EUR J IMMUNOL, V16, P1569, DOI 10.1002/eji.1830161216; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Martin F, 1999, CURR TOP MICROBIOL, V246, P45; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643	44	135	136	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					855	862		10.1038/ni0901-855	http://dx.doi.org/10.1038/ni0901-855			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526402				2022-12-18	WOS:000170781200026
J	Kalekar, LA; Schmiel, SE; Nandiwada, SL; Lam, WY; Barsness, LO; Zhang, N; Stritesky, GL; Malhotra, D; Pauken, KE; Linehan, JL; O'Sullivan, MG; Fife, BT; Hogquist, KA; Jenkins, MK; Mueller, DL				Kalekar, Lokesh A.; Schmiel, Shirdi E.; Nandiwada, Sarada L.; Lam, Wing Y.; Barsness, Laura O.; Zhang, Na; Stritesky, Gretta L.; Malhotra, Deepali; Pauken, Kristen E.; Linehan, Jonathan L.; O'Sullivan, M. Gerard; Fife, Brian T.; Hogquist, Kristin A.; Jenkins, Marc K.; Mueller, Daniel L.			CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors	NATURE IMMUNOLOGY			English	Article							INTESTINAL INFLAMMATION; EPIGENETIC CHANGES; MAMMALIAN TARGET; FOXP3 EXPRESSION; CLONAL ANERGY; CUTTING EDGE; TRANSCRIPTION; INDUCTION; MEMORY; ROLES	The role of anergy, an acquired state of T cell functional unresponsiveness, in natural peripheral tolerance remains unclear. In this study, we found that anergy was selectively induced in fetal antigen-specific maternal CD4(+) T cells during pregnancy. A naturally occurring subpopulation of anergic polyclonal CD4(+) T cells, enriched for self antigen-specific T cell antigen receptors, was also present in healthy hosts. Neuropilin-1 expression in anergic conventional CD4(+) T cells was associated with hypomethylation of genes related to thymic regulatory T cells (T-reg cells), and this correlated with their ability to differentiate into Foxp3(+) T-reg cells that suppressed immunopathology. Thus, our data suggest that not only is anergy induction important in preventing autoimmunity but also it generates the precursors for peripheral T-reg cell differentiation.	[Kalekar, Lokesh A.; Schmiel, Shirdi E.; Nandiwada, Sarada L.; Lam, Wing Y.; Barsness, Laura O.; Zhang, Na; Pauken, Kristen E.; Fife, Brian T.; Mueller, Daniel L.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Kalekar, Lokesh A.; Schmiel, Shirdi E.; Nandiwada, Sarada L.; Lam, Wing Y.; Barsness, Laura O.; Zhang, Na; Stritesky, Gretta L.; Malhotra, Deepali; Pauken, Kristen E.; Linehan, Jonathan L.; Fife, Brian T.; Hogquist, Kristin A.; Jenkins, Marc K.; Mueller, Daniel L.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Stritesky, Gretta L.; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Malhotra, Deepali; Linehan, Jonathan L.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, DL (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.; Mueller, DL (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	muell002@umn.edu	Jenkins, Marc K/G-1063-2012; Pauken, Kristen E./ABA-9363-2020; Fife, Brian/D-2042-2013	Jenkins, Marc K/0000-0001-8009-7655; Malhotra, Deepali/0000-0002-8215-7639; Fife, Brian/0000-0001-9826-5637; Mueller, Daniel/0000-0003-1621-0419	Rheumatology Research Foundation (Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign grant); US National Institutes of Health [01 AI35296]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, T32AI007313, F32AI114050] Funding Source: NIH RePORTER	Rheumatology Research Foundation (Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign grant); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.A. Bluestone (University of California, San Francisco) for spleen and lymph node cells from Foxp3-Cre-GFP x R26-YFP mice and discussions; D. Mathis and C. Benoist (Harvard Medical School) and the Institut de Genetique et de Biologie Moleculaire et Cellulaire (Strasbourg, France) for B6.g7 mice and KRN B6 mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) for B6 Foxp3<SUP>DTR</SUP> knock-in mice; S.S. Way (University of Cincinnati) for B6 Foxp3<SUP>GFP</SUP> and Foxp3<SUP>DTR</SUP> CD45.1 mice; J.A. Bluestone (University of San Francisco) for cells from the spleen and all lymph nodes of Foxp3-Cre-GFP x R26-YFP mice; S.C. Jameson, M. Mescher and M.A. Farrar for discussions; P.J. Titcombe for technical support; and N. Shah, T. Martin and J. Motl for assistance in cell sorting. Supported by the Rheumatology Research Foundation (Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign grant to D.L.M.) and the US National Institutes of Health (01 AI35296 to D.L.M., B.T.F., K.A.H. and M.K.J.).	Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Chappert P, 2010, CURR OPIN IMMUNOL, V22, P552, DOI 10.1016/j.coi.2010.08.005; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kline J, 2008, CLIN CANCER RES, V14, P3156, DOI 10.1158/1078-0432.CCR-07-4696; Knoechel B, 2005, J IMMUNOL, V175, P21, DOI 10.4049/jimmunol.175.1.21; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pape KA, 1998, J IMMUNOL, V160, P4719; Pauken KE, 2013, J IMMUNOL, V191, P4913, DOI 10.4049/jimmunol.1301927; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Vanasek TL, 2001, J IMMUNOL, V167, P5636, DOI 10.4049/jimmunol.167.10.5636; Vanasek TL, 2006, J IMMUNOL, V176, P5880, DOI 10.4049/jimmunol.176.10.5880; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	45	134	139	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					304	314		10.1038/ni.3331	http://dx.doi.org/10.1038/ni.3331			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26829766	Green Accepted			2022-12-18	WOS:000370469300015
J	Sutherland, TE; Logan, N; Ruckerl, D; Humbles, AA; Allan, SM; Papayannopoulos, V; Stockinger, B; Maizels, RM; Allen, JE				Sutherland, Tara E.; Logan, Nicola; Rueckerl, Dominik; Humbles, Alison A.; Allan, Stuart M.; Papayannopoulos, Venizelos; Stockinger, Brigitta; Maizels, Rick M.; Allen, Judith E.			Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ACUTE LUNG INJURY; T-CELLS; HELMINTH INFECTION; STRONGYLOIDES-STERCORALIS; INTESTINAL INFLAMMATION; ALVEOLAR MACROPHAGES; AIRWAY INFLAMMATION; GAMMA-DELTA; RESPONSES	Enzymatically inactive chitinase-like proteins (CLPs) such as BRP-39, Ym1 and Ym2 are established markers of immune activation and pathology, yet their functions are essentially unknown. We found that Yml and Ym2 induced the accumulation of neutrophils through the expansion of gamma delta T cell populations that produced interleukin 17 (IL-17). While BRP-39 did not influence neutrophilia, it was required for IL-17 production in gamma delta T cells, which suggested that regulation of IL-17 is an inherent feature of mouse CLPs. Analysis of a nematode infection model, in which the parasite migrates through the lungs, revealed that the IL-17 and neutrophilic inflammation induced by Yml limited parasite survival but at the cost of enhanced lung injury. Our studies describe effector functions of CLPs consistent with innate host defense traits of the chitinase family.	[Sutherland, Tara E.; Logan, Nicola; Rueckerl, Dominik; Maizels, Rick M.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Humbles, Alison A.] MedImmune, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [Allan, Stuart M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Papayannopoulos, Venizelos; Stockinger, Brigitta] Natl Inst Med Res, Med Res Council, Div Mol Immunol, London NW7 1AA, England	University of Edinburgh; AstraZeneca; Medimmune; University of Manchester; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Allen, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	tara.sutherland@ed.ac.uk; j.allen@ed.ac.uk	Allen, Judith E/C-9198-2011; Sutherland, Tara/S-1427-2019; Allan, Stuart/AAL-1245-2020	Allen, Judith E/0000-0002-3829-066X; Sutherland, Tara/0000-0001-9334-8206; Ruckerl, Dominik/0000-0002-0206-1451; Stockinger, Brigitta/0000-0001-8781-336X; Papayannopoulos, Venizelos/0000-0002-3741-8190; Allan, Stuart/0000-0001-9646-4456	Medical Research Council United Kingdom [MRC-UK MR/J001929/1, MR/K01207X/1, U117512792, MC_UP_1202/13]; Asthma UK [06/057, 10/040]; Wellcome Trust; MRC [MR/K01207X/1, MC_UP_1202/13, MC_U117512792, MR/J001929/1] Funding Source: UKRI; Medical Research Council [MR/K01207X/1, MC_U117512792, MR/J001929/1, MC_UP_1202/13] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Duncan and Y. Harcus for technical assistance and R. Zamoyska for discussions. Supported by the Medical Research Council United Kingdom (MRC-UK MR/J001929/1, MR/K01207X/1 and U117512792 to B.S., and MC_UP_1202/13 for V.P.) and Asthma UK (06/057 & 10/040), with support from the Wellcome Trust funded Centre for Immunity, Infection and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Aujla SJ, 2011, BBA-GEN SUBJECTS, V1810, P1066, DOI 10.1016/j.bbagen.2011.02.002; Barone R, 2003, CLIN CHIM ACTA, V331, P79, DOI 10.1016/S0009-8981(03)00089-5; Bonne-Annee S, 2013, INFECT IMMUN, V81, P3346, DOI 10.1128/IAI.00625-13; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024399; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Konradsen JR, 2013, J ALLERGY CLIN IMMUN, V132, P328, DOI 10.1016/j.jaci.2013.03.003; Labadaridis I, 2005, ARCH DIS CHILD-FETAL, V90, pF531, DOI 10.1136/adc.2004.051284; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; Nielsen MM, 2014, J IMMUNOL, V192, P2975, DOI 10.4049/jimmunol.1301689; Nikota JK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-39; O'Connell AE, 2011, INFECT IMMUN, V79, P2770, DOI 10.1128/IAI.00931-10; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pittman K, 2013, J INNATE IMMUN, V5, P315, DOI 10.1159/000347132; Prakash M, 2013, CELL SIGNAL, V25, P1567, DOI 10.1016/j.cellsig.2013.03.016; Raz E, 2007, NAT IMMUNOL, V8, P3, DOI 10.1038/ni0107-3; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Sakazaki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024177; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Tran HT, 2011, HISTOL HISTOPATHOL, V26, P1453, DOI 10.14670/HH-26.1453; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vind I, 2003, SCAND J GASTROENTERO, V38, P599, DOI 10.1080/00365520310000537; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang M, 2013, CLIN EXP ALLERGY, V43, P956, DOI 10.1111/cea.12123; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	56	134	139	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1116	1125		10.1038/ni.3023	http://dx.doi.org/10.1038/ni.3023			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25326751	Green Accepted			2022-12-18	WOS:000344841900008
J	Motomura, Y; Kitamura, H; Hijikata, A; Matsunaga, Y; Matsumoto, K; Inoue, H; Atarashi, K; Hori, S; Watarai, H; Zhu, JF; Taniguchi, M; Kubo, M				Motomura, Yasutaka; Kitamura, Hiroshi; Hijikata, Atsushi; Matsunaga, Yuko; Matsumoto, Koichiro; Inoue, Hiromasa; Atarashi, Koji; Hori, Shohei; Watarai, Hiroshi; Zhu, Jinfang; Taniguchi, Masaru; Kubo, Masato			The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; IFN-GAMMA; HUMAN TH1; TGF-BETA; RESPONSES; CYTOKINE; LINEAGE; GATA-3; MICE; HYPERRESPONSIVENESS	The immunoregulatory cytokine interleukin 10 (IL-10) is expressed mainly by T helper type 2 (T(H)2) cells but also by T(H)1 cells during chronic infection. Here we observed plasticity in the expression of IL-10 and IL-13 after chronic T(H)1 stimulation; furthermore, the expression of Il10 and Il13 was regulated by the transcription factor E4BP4. Chronically stimulated E4BP4-deficient (Nfil3(-/-); called 'E4bp4(-/-)' here) T(H)1 cells, regulatory T cells (T-reg cells) and natural killer T cells (NKT cells) had attenuated expression of IL-10 and IL-13. Enforced expression of E4bp4 initiated the production of IL-10 and IL-13 by conventional T(H)1 cells. E4bp4(-/-) T(H)2 cells showed impairment of IL-10 production with no effect on IL-13. Our results indicate that E4BP4 has multiple functions in controlling the plasticity of IL-13 in T(H)1 cells and IL-10 in T(H)1 cells, T(H)2 cells, T-reg cells and NKT cells.	[Motomura, Yasutaka; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Motomura, Yasutaka; Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba, Japan; [Kitamura, Hiroshi; Hijikata, Atsushi] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immunogenom, Yokohama, Kanagawa, Japan; [Matsunaga, Yuko; Matsumoto, Koichiro; Inoue, Hiromasa] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; [Atarashi, Koji] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Hori, Shohei] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immune Homeostasis, Yokohama, Kanagawa, Japan; [Watarai, Hiroshi; Taniguchi, Masaru] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immune Regulat, Yokohama, Kanagawa, Japan; [Zhu, Jinfang] NIAID, NIH, Bethesda, MD 20892 USA	RIKEN; Tokyo University of Science; RIKEN; Kyushu University; University of Tokyo; RIKEN; RIKEN; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kubo, M (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan.	raysolfc@rcai.riken.jp	Hori, Shohei/O-6163-2019; Atarashi, Koji/I-5363-2014; Kubo, Masato/A-5918-2016; Zhu, Jinfang/B-7574-2012; Watarai, Hiroshi/G-9894-2012; Taniguchi, Masaru/N-7932-2015	Hori, Shohei/0000-0001-8770-4593; Atarashi, Koji/0000-0001-5422-0736; Zhu, Jinfang/0000-0002-0117-4745; Watarai, Hiroshi/0000-0003-1511-2593; Taniguchi, Masaru/0000-0001-7821-7179; Hijikata, Atsushi/0000-0003-4297-8368	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, ZIAAI000493] Funding Source: NIH RePORTER	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Murphy (Washington University) for DO11.10 mice on the BALB/c background; S. Akira (Osaka University) for Stat6<SUP>-/-</SUP> mice; F. Brombacher (University of Cape Town) for Il4r<SUP>-/-</SUP> mice; C. Wilson (Washington University) for Cd4-Cre mice; R. Abe (Tokyo University of Science) for the PV-1 mAb to CD28; T. Kitamura (Tokyo University) for Platinum-E packaging cells; H. Fujimoto, Y. Suzuki, K. Ikari and E. Hayashi for technical assistance; and P. Burrows for comments on the manuscript. Supported by RIKEN (Y. Motomura), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hata H, 2004, INT IMMUNOL, V16, P1733, DOI 10.1093/intimm/dxh174; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Li L, 1998, J IMMUNOL, V161, P3128; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Lund R, 2003, J IMMUNOL, V171, P5328, DOI 10.4049/jimmunol.171.10.5328; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mohrs M, 1999, J IMMUNOL, V162, P7302; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nishimura Y, 2001, J BIOL CHEM, V276, P19921, DOI 10.1074/jbc.M010332200; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Smart JM, 2002, CLIN EXP ALLERGY, V32, P796, DOI 10.1046/j.1365-2222.2002.01391.x; SMIRNOV DV, 1995, GENE, V155, P277, DOI 10.1016/0378-1119(94)00720-D; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yagi R, 2002, INT IMMUNOL, V14, P1, DOI 10.1093/intimm/14.1.1; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	50	134	140	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					450	U111		10.1038/ni.2020	http://dx.doi.org/10.1038/ni.2020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21460847	Green Accepted			2022-12-18	WOS:000289666600016
J	Chang, SJ; Aune, TM				Chang, Shaojing; Aune, Thomas M.			Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells	NATURE IMMUNOLOGY			English	Article							CYTOKINE GENE-EXPRESSION; IFN-GAMMA; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; SELECTIVE EXPRESSION; POLYCOMB COMPLEXES; CELLULAR MEMORY; NATURAL-KILLER; CUTTING EDGE; FACTOR YY1	The 'histone-code' hypothesis proposes that cell fate 'decisions' are achieved through the creation of stable epigenetic histone 'marks' at gene loci. Here we explored the formation of marks of repressive methylation of histone 3 at lysine 9 (H3-K9) and of H3-K27 at the locus encoding interferon-gamma (Ifng locus) during the commitment of naive T cells to the T helper type 1 (T(H)1) and T(H)2 lineages. Methylation of H3-K9 across the Ifng locus was rapidly induced in differentiating T(H)1 and T(H)2 cells and was sustained in TH1 cells. In contrast, TH2 differentiation caused loss of methylation of H3-K9 and gain of methylation of H3-K27 by mechanisms dependent on the transcription factors GATA-3 and STAT6. Thus, histone-methylation marks at the Ifng locus are highly dynamic, which may ensure higher-order transcriptional regulation during early lineage commitment.	Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Immunol & Microbiol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Aune, TM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol, 221 Kirkland Hall, Nashville, TN 37232 USA.	tom.aune@vanderbilt.edu			NIAID NIH HHS [AI 44924] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044924, R56AI044924] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Calestagne-Morelli A, 2006, BIOCHEM CELL BIOL, V84, P518, DOI 10.1139/O06-067; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dutnall RN, 2003, MOL CELL, V12, P3, DOI 10.1016/S1097-2765(03)00282-X; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Soutto M, 2002, J IMMUNOL, V169, P4205, DOI 10.4049/jimmunol.169.8.4205; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Holde K.E., 1988, CHROMATIN; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou WS, 2004, P NATL ACAD SCI USA, V101, P2440, DOI 10.1073/pnas.0306002101	54	134	137	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					723	731		10.1038/ni1473	http://dx.doi.org/10.1038/ni1473			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17546034				2022-12-18	WOS:000247718100013
J	Uchimura, K; Gauguet, JM; Singer, MS; Tsay, D; Kannagi, R; Muramatsu, T; von Andrian, UH; Rosen, SD				Uchimura, K; Gauguet, JM; Singer, MS; Tsay, D; Kannagi, R; Muramatsu, T; von Andrian, UH; Rosen, SD			A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules	NATURE IMMUNOLOGY			English	Article							SIALYL-LEWIS-X; CORE-2 BRANCHING BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; PERIPHERAL LYMPH-NODES; P-SELECTIN; CARBOHYDRATE SULFOTRANSFERASES; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; T-LYMPHOCYTES; CAPPING GROUP; O-GLYCANS	The interaction of L-selectin on lymphocytes with sulfated ligands on high endothelial venules leads to rolling and is critical for recruitment of lymphocytes into peripheral lymph nodes. Peripheral node addressin represents a class of L-selectin ligands recognized by the function-blocking monoclonal antibody MECA-79. Its epitope overlaps with sialyl 6-sulfo Lewis X, an L-selectin recognition determinant. Here, mice lacking two N-acetylglucosamine-6-O-sulfotransferases (GlcNAc6ST-1 and GlcNAc6ST-2) demonstrated elimination of both peripheral node addressin and sialyl 6-sulfo Lewis X in high endothelial venules, considerably reduced lymphocyte homing to peripheral lymph nodes and reduced sticking of lymphocytes along high endothelial venules. Our results establish an essential function for the sulfotransferases in L-selectin ligand synthesis and may have relevance for therapy of inflammatory diseases.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Program Immunol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Aichi Canc Ctr, Res Inst, Program Mol Pathol, Nagoya, Aichi 4648681, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 464, Japan	University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Aichi Cancer Center; Nagoya University	Rosen, SD (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Program Immunol, Box 0130, San Francisco, CA 94143 USA.	sdr@itsa.ucsf.edu	Uchimura, Kenji/C-9635-2014; Uchimura, Kenji/AFV-1802-2022; von Andrian, Ulrich H/A-5775-2008; Kannagi, Reiji/Q-6459-2018	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X; Kannagi, Reiji/0000-0003-4202-2921; Rosen, Steven/0000-0002-6245-701X	NHLBI NIH HHS [HL56949, P01 HL056949, HL54936] Funding Source: Medline; NIAID NIH HHS [AI061663] Funding Source: Medline; NIGMS NIH HHS [R01-GM57411, R37-GM23547] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057411, R37GM023547] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bistrup A, 2004, AM J PATHOL, V164, P1635, DOI 10.1016/S0002-9440(10)63722-4; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; de Graffenried CL, 2003, J BIOL CHEM, V278, P40282, DOI 10.1074/jbc.M304928200; DUIJVESTIJN AM, 1986, P NATL ACAD SCI USA, V83, P9114, DOI 10.1073/pnas.83.23.9114; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Grunwell JR, 2002, BIOCHEMISTRY-US, V41, P13117, DOI 10.1021/bi020507h; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4830, DOI 10.1021/bi00182a011; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4820, DOI 10.1021/bi00182a010; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; IMAI Y, 1993, NATURE, V361, P555; Izawa M, 2000, CANCER RES, V60, P1410; KAWASHIMA H, 2005, NAT IMMUNOL; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Lee JK, 2003, GLYCOBIOLOGY, V13, P245, DOI 10.1093/glycob/cwg018; Li XA, 1999, GENOMICS, V55, P345, DOI 10.1006/geno.1998.5653; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; MEBIUS RE, 1993, J IMMUNOL, V151, P3252; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; NELSON RM, 1993, BLOOD, V82, P3253; PRIES AR, 1988, INT J MICROCIRC, V7, P327; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 2005, AM J PATHOL, V166, P935, DOI 10.1016/S0002-9440(10)62313-9; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Satomaa T, 2002, BLOOD, V99, P2609, DOI 10.1182/blood.V99.7.2609; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; van Zante A, 2003, J EXP MED, V198, P1289, DOI 10.1084/jem.20030057; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	56	134	138	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1105	1113		10.1038/ni1258	http://dx.doi.org/10.1038/ni1258			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16227986				2022-12-18	WOS:000232833300011
J	Yamagata, T; Mathis, D; Benoist, C				Yamagata, T; Mathis, D; Benoist, C			Self-reactivity in thymic double-positive cells commits cells to a CD8 alpha alpha lineage with characteristics of innate immune cells	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL AVIDITY MODEL; NATURAL-KILLER-CELLS; MHC CLASS-I; T-CELLS; TRANSGENIC MICE; INTRAEPITHELIAL LYMPHOCYTES; ANTIGEN RECEPTOR; SELECTION; CD8; AGONIST	Thymocytes displaying self-reactive T cell receptors usually undergo negative selection in the thymus. Here we demonstrate that agonist peptides can promote positive selection of immature double-positive thymocytes into distinct lineages, varying with the agonist concentration and the animal's age. Microarray gene expression analyses showed broad transcriptional alterations in a set of transcripts associated with the innate immune system, as well as silencing of CD8beta expression. The resulting CD8alphaalpha T cells showed a rapid effector cytokine response. Hence, T cells displaying self-reactive receptors can have the gene expression profile and phenotypic characteristics of innate immune cells.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu			NIAID NIH HHS [1R01AI51530] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buch T, 2002, IMMUNITY, V16, P707, DOI 10.1016/S1074-7613(02)00312-6; Burnet F M, 1976, CA Cancer J Clin, V26, P119, DOI 10.3322/canjclin.26.2.119; Capone M, 2003, EUR J IMMUNOL, V33, P1471, DOI 10.1002/eji.200323754; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Gao GF, 2002, TRENDS IMMUNOL, V23, P408, DOI 10.1016/S1471-4906(02)02282-2; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Girao C, 1997, J IMMUNOL, V159, P4205; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hogquist KA, 1998, J IMMUNOL, V161, P3896; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAWAI K, 1995, NATURE, V374, P68, DOI 10.1038/374068a0; Kersh GJ, 2000, J IMMUNOL, V164, P5675, DOI 10.4049/jimmunol.164.11.5675; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kraj P, 2001, J EXP MED, V194, P407, DOI 10.1084/jem.194.4.407; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; Schulz RJ, 1996, J IMMUNOL, V157, P4379; Schwartz R., 1999, FUNDAMENTAL IMMUNOLO, P701; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Wang RF, 1998, P NATL ACAD SCI USA, V95, P3804, DOI 10.1073/pnas.95.7.3804; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	47	134	135	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					597	605		10.1038/ni1070	http://dx.doi.org/10.1038/ni1070			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15133507				2022-12-18	WOS:000221664000018
J	Irles, C; Symons, A; Michel, F; Bakker, TR; van der Merwe, PA; Acuto, O				Irles, C; Symons, A; Michel, F; Bakker, TR; van der Merwe, PA; Acuto, O			CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; PROTEIN-TYROSINE-PHOSPHATASE; LEUKOCYTE-COMMON ANTIGEN; MEMBRANE DOMAINS; NEGATIVE REGULATION; INHIBITORY WEDGE; LIPID RAFTS; KINASE CSK; RECEPTOR; FAMILY	The transmembrane phosphatase CD45 regulates both Lck activity and T cell receptor (TCR) signaling. Here we have tested whether the large ectodomain of CD45 has a role in this regulation. A CD45 chimera containing the large ectodomain of CD43 efficiently rescues TCR signaling in CD45-null T cells, whereas CD45 chimeras containing small ectodomains from other phosphatases do not. Both basal Lck activity in unstimulated cells and the TCR-induced increase in tyrosine phosphorylation of the TCR zeta-chain and in Lck activity depend on the expression of CD45 with a large ectodomain. Unlike CD45 chimeras containing small ectodomains, both the CD45 chimera with a large ectodomain and wild-type CD45 itself are partially localized to glycosphingolipid-enriched membranes (GEMs). Taken together, these data show that the large CD45 ectodomain is required for optimal TCR signaling.	Inst Pasteur, Dept Immunol, Mol Immunol Unit, F-75724 Paris 15, France; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Acuto, O (corresponding author), Inst Pasteur, Dept Immunol, Mol Immunol Unit, 25 Rue Dr Roux, F-75724 Paris 15, France.		Irles, Claudine/AAA-4538-2022; van der Merwe, P. Anton/F-8539-2011	Irles, Claudine/0000-0003-3952-4007; Michel, Frederique/0000-0002-3524-2232				Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; BARCLAY NA, 1997, LEUCOCYTE ANTIGEN FA; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; D'Oro U, 1999, J IMMUNOL, V162, P1879; DANIELIAN S, 1992, EUR J IMMUNOL, V22, P2915, DOI 10.1002/eji.1830221124; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 2001, ADV IMMUNOL, V77, P45, DOI 10.1016/S0065-2776(01)77014-9; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; HOVIS RR, 1993, SCIENCE, V260, P544, DOI 10.1126/science.8475387; Ilangumaran S, 1999, MOL BIOL CELL, V10, P891, DOI 10.1091/mbc.10.4.891; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Millan J, 2002, BLOOD, V99, P978, DOI 10.1182/blood.V99.3.978; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SGROI D, 1993, J BIOL CHEM, V268, P7011; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Stone JD, 1997, J IMMUNOL, V158, P5773; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Symons A, 2000, GLYCOBIOLOGY, V10, P559, DOI 10.1093/glycob/10.6.559; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TIVERON MC, 1994, J CELL SCI, V107, P1783; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; VOLAREVIC S, 1993, SCIENCE, V260, P541, DOI 10.1126/science.8475386; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	57	134	142	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					189	197		10.1038/ni877	http://dx.doi.org/10.1038/ni877			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12496963				2022-12-18	WOS:000180686500020
J	Xia, P; Ye, BQ; Wang, S; Zhu, XX; Du, Y; Xiong, Z; Tian, Y; Fan, ZS				Xia, Pengyan; Ye, Buqing; Wang, Shuo; Zhu, Xiaoxiao; Du, Ying; Xiong, Zhen; Tian, Yong; Fan, Zusen			Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity	NATURE IMMUNOLOGY			English	Article							GMP-AMP SYNTHASE; CYTOSOLIC DNA; I INTERFERONS; PROTEIN; ENZYMES; 2ND-MESSENGER; FAMILY; ROLES; CELLS; INFLAMMASOME	Cyclic GMP-AMP synthase (cGAS) senses cytosolic DNA during viral infection and catalyzes synthesis of the dinucleotide cGAMP, which activates the adaptor STING to initiate antiviral responses. Here we found that deficiency in the carboxypeptidase CCP5 or CCP6 led to susceptibility to DNA viruses. CCP5 and CCP6 were required for activation of the transcription factor IRF3 and interferons. Polyglutamylation of cGAS by the enzyme TTLL6 impeded its DNA-binding ability, whereas TTLL4-mediated monoglutamylation of cGAS blocked its synthase activity. Conversely, CCP6 removed the polyglutamylation of cGAS, whereas CCP5 hydrolyzed the monoglutamylation of cGAS, which together led to the activation of cGAS. Therefore, glutamylation and deglutamylation of cGAS tightly modulate immune responses to infection with DNA viruses.	[Xia, Pengyan; Ye, Buqing; Wang, Shuo; Du, Ying; Xiong, Zhen; Fan, Zusen] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Zhu, Xiaoxiao] Chinese Acad Sci, Inst Biophys, Anim Res Ctr, Beijing 100080, Peoples R China; [Xiong, Zhen; Fan, Zusen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tian, Yong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing 100080, Peoples R China; [Tian, Yong] Chinese Acad Sci, Inst Biophys, Beijing Key Lab Noncoding RNA, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing 100080, Peoples R China.; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing Key Lab Noncoding RNA, Beijing 100080, Peoples R China.	ytian@ibp.ac.cn; fanz@moon.ibp.ac.cn	Zhu, Xiaoxiao/AAD-1561-2019; TIAN, YONG/L-2414-2019; TIAN, YONG/ABF-4406-2021	TIAN, YONG/0000-0002-8790-1148; 	National Natural Science Foundation of China [31530093, 91419308, 31300645, 31471386, 31570892]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407, XDA01020203]; Youth Innovation Promotion Association of Chinese Academy of Sciences; China Postdoctoral Science Foundation [2015M571141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences; Youth Innovation Promotion Association of Chinese Academy of Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank S. Meng, J. Cheng, M. Ding, J. Wang, X. Gao, X. Zhang, L. Zhou, X. Wu, J. Hao, D. Liu, J. Jia, C. Jiang and. Teng for technical support; J. Bennink (National Institute of Allergy and Infectious Diseases) for vesicular stomatits virus and VACV strains; H. Peng (Institute of Biophysics, Chinese Academy of Sciences) for Vero cells and HSV-1f virus. Supported by the National Natural Science Foundation of China (31530093, 91419308, 31300645, 31471386 and 31570892), the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDA01010407 and XDA01020203), the Youth Innovation Promotion Association of Chinese Academy of Sciences (S.W.) and the China Postdoctoral Science Foundation (2015M571141 to P.X.).	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2014, CURR OPIN IMMUNOL, V31, P121, DOI 10.1016/j.coi.2014.10.009; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Otazo MRD, 2013, FASEB J, V27, P424, DOI 10.1096/fj.12-209080; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Ye BQ, 2014, J EXP MED, V211, P2439, DOI 10.1084/jem.20141123; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	45	133	148	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					369	+		10.1038/ni.3356	http://dx.doi.org/10.1038/ni.3356			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26829768				2022-12-18	WOS:000372508000009
J	Heikamp, EB; Patel, CH; Collins, S; Waickman, A; Oh, MH; Sun, IH; Illei, P; Sharma, A; Naray-Fejes-Toth, A; Fejes-Toth, G; Misra-Sen, J; Horton, MR; Powell, JD				Heikamp, Emily B.; Patel, Chirag H.; Collins, Sam; Waickman, Adam; Oh, Min-Hee; Sun, Im-Hong; Illei, Peter; Sharma, Archna; Naray-Fejes-Toth, Aniko; Fejes-Toth, Geza; Misra-Sen, Jyoti; Horton, Maureen R.; Powell, Jonathan D.			The AGC kinase SGK1 regulates T(H)1 and T(H)2 differentiation downstream of the mTORC2 complex	NATURE IMMUNOLOGY			English	Article							SELECTIVE ACTIVATION; T-CELLS; PHOSPHORYLATION; RICTOR; MICE; AKT; EXPRESSION; INDUCTION; NEDD4-2; CANCER	SGK1 is an AGC kinase that regulates the expression of membrane sodium channels in renal tubular cells in a manner dependent on the metabolic checkpoint kinase complex mTORC2. We hypothesized that SGK1 might represent an additional mTORC2dependent regulator of the differentiation and function of T cells. Here we found that after activation by mTORC2, SGK1 promoted T helper type 2 (T(H)2) differentiation by negatively regulating degradation of the transcription factor JunB mediated by the E3 ligase Nedd4-2. Simultaneously, SGK1 repressed the production of interferon-gamma (IFN-gamma) by controlling expression of the long isoform of the transcription factor TCF-1. Consistent with those findings, mice with selective deletion of SGK1 in T cells were resistant to experimentally induced asthma, generated substantial IFN-g in response to viral infection and more readily rejected tumors.	[Heikamp, Emily B.; Patel, Chirag H.; Waickman, Adam; Sun, Im-Hong; Powell, Jonathan D.] Johns Hopkins Univ Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21218 USA; [Collins, Sam; Oh, Min-Hee; Horton, Maureen R.] Johns Hopkins Univ Sch Med, Dept Med, Baltimore, MD USA; [Illei, Peter] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA; [Sharma, Archna; Misra-Sen, Jyoti] NIA, Immune Cells & Inflammat Sect, Immunol Lab, NIH, Baltimore, MD 21224 USA; [Naray-Fejes-Toth, Aniko; Fejes-Toth, Geza] Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Dartmouth College	Powell, JD (corresponding author), Johns Hopkins Univ Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21218 USA.	poweljo@jhmi.edu	Waickman, Adam/AHB-5028-2022; Sharma, Archna/R-9377-2016; Heikamp, Emily/K-7158-2016	Sharma, Archna/0000-0003-4745-0220; Heikamp, Emily/0000-0002-4591-4477; Waickman, Adam/0000-0002-4536-6714; Oh, Min-Hee/0000-0003-1581-4288; Sun, Im Hong/0000-0003-0288-2062	US National Institutes of Health [R01 AI77610, NHLBI P01HL010342, NHLBI R21HL111783, DK 41481, DK 58898]; American Asthma Foundation (J.D.P.); Intramural Research Program of the NIH; National Institute on Aging (J.M.S.); FAMRI Center of Excellence [108595]; American Medical Association (E.B.H.); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342, R21HL111783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R01AI091481, R01AI077610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000772] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation (J.D.P.); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (J.M.S.); FAMRI Center of Excellence; American Medical Association (E.B.H.); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Pardoll, C. Gamper and members of the Powell Lab for discussions, and the Magnuson laboratory for Rictor<SUP>-/-</SUP>mice. Supported by the US National Institutes of Health (R01 AI77610 to J.D.P., NHLBI P01HL010342 and NHLBI R21HL111783 to M.R.H., DK 41481 to A.N.-F.-T. and DK 58898 to G.F.-T.), the American Asthma Foundation (J.D.P.), the Intramural Research Program of the NIH, National Institute on Aging (J.M.S.), the FAMRI Center of Excellence 108595 (M.R.H.) and the American Medical Association (E.B.H.).	Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Huang TJ, 2001, J IMMUNOL, V166, P207, DOI 10.4049/jimmunol.166.1.207; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; LITTENBERG B, 1986, NEW ENGL J MED, V314, P150, DOI 10.1056/NEJM198601163140304; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu M, 2011, J BIOL CHEM, V286, P30647, DOI 10.1074/jbc.M111.257592; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	133	138	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					457	+		10.1038/ni.2867	http://dx.doi.org/10.1038/ni.2867			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24705297	Bronze, Green Accepted			2022-12-18	WOS:000334667900011
J	Aksoy, E; Taboubi, S; Torres, D; Delbauve, S; Hachani, A; Whitehead, MA; Pearce, WP; Berenjeno-Martin, I; Nock, G; Filloux, A; Beyaert, R; Flamand, V; Vanhaesebroeck, B				Aksoy, Ezra; Taboubi, Salma; Torres, David; Delbauve, Sandrine; Hachani, Abderrahman; Whitehead, Maria A.; Pearce, Wayne P.; Berenjeno-Martin, Inma; Nock, Gemma; Filloux, Alain; Beyaert, Rudi; Flamand, Veronique; Vanhaesebroeck, Bart			The p110 delta isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock	NATURE IMMUNOLOGY			English	Article							MAMMALIAN TARGET; MEMBRANE FISSION; IIFN PRODUCTION; I INTERFERON; RECEPTOR; LIPOPOLYSACCHARIDE; PI3K; CELL; RAPAMYCIN; PATHWAY	Lipopolysaccharide activates plasma-membrane signaling and endosomal signaling by Toll-like receptor 4 (TLR4) through the TIRAP-MyD88 and TRAM-TRIF adaptor complexes, respectively, but it is unclear how the signaling switch between these cell compartments is coordinated. In dendritic cells, we found that the p110 delta isoform of phosphatidylinositol-3-OH kinase (PI(3)K) induced internalization of TLR4 and dissociation of TIRAP from the plasma membrane, followed by calpain-mediated degradation of TIRAP. Accordingly, inactivation of p110 delta prolonged TIRAP-mediated signaling from the plasma membrane, which augmented proinflammatory cytokine production while decreasing TRAM-dependent endosomal signaling that generated anti-inflammatory cytokines (interleukin 10 and interferon-beta). In line with that altered signaling output, p110 delta-deficient mice showed enhanced endotoxin-induced death. Thus, by controlling the 'topology' of TLR4 signaling complexes, p110 delta balances overall homeostasis in the TLR4 pathway.	[Aksoy, Ezra; Taboubi, Salma; Whitehead, Maria A.; Pearce, Wayne P.; Berenjeno-Martin, Inma; Nock, Gemma; Vanhaesebroeck, Bart] Univ London, Ctr Cell Signaling, Barts Inst Canc, London, England; [Torres, David; Delbauve, Sandrine; Flamand, Veronique] Free Univ Brussels, Inst Med Immunol, Gosselies, Belgium; [Hachani, Abderrahman; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London, England; [Beyaert, Rudi] VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	University of London; Queen Mary University London; Imperial College London; Flanders Institute for Biotechnology (VIB); Ghent University	Vanhaesebroeck, B (corresponding author), Univ London, Ctr Cell Signaling, Barts Inst Canc, London, England.	e.aksoy@qmul.ac.uk; bart.vanh@qmul.ac.uk	Hachani, Abderrahman/AAV-3320-2020; Hachani, Abderrahman/H-1801-2013; Beyaert, Rudi/B-2589-2009; Aksoy, Ezra/ABH-1337-2021	Hachani, Abderrahman/0000-0001-8032-2154; Aksoy, Ezra/0000-0002-6962-1572; Beyaert, Rudi/0000-0002-5704-582X; Pearce, Wayne/0000-0001-5407-4767; Flamand, Veronique/0000-0002-8906-3758	European Union [IEF-041713, IEF-274749]; European Molecular Biology Organization [ALTF 1083-2007]; Fondation ARC pour la Recherche sur la Cancer [SAE P2009]; Fund for Scientific Research Flanders; Hercules Foundation; University of Ghent Multidisciplinary Research Partnership; European Union Marie Curie International Graduate Program in Molecular Medicine; Cancer Research UK [C23338/A10200]; Ludwig Institute for Cancer Research; Queen Mary University of London	European Union(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fondation ARC pour la Recherche sur la Cancer; Fund for Scientific Research Flanders(FWO); Hercules Foundation; University of Ghent Multidisciplinary Research Partnership; European Union Marie Curie International Graduate Program in Molecular Medicine; Cancer Research UK(Cancer Research UK); Ludwig Institute for Cancer Research; Queen Mary University of London	We thank R. Medzhitov (Yale University) for expression vectors encoding GST-TIRAP, GFP-TIRAP and GST-TIRAP-4x; S. Akira (Osaka University) and L. O'Neill (Trinity College, Dublin) for TLR4-, MyD88-, TRIF- or TIRAP-deficient mice; L. Stephens (Babraham Institute) for SHIP-1-deficient mice; L. Baud (Hopital Tenon) for mice with transgenic expression of calpastatin; G. Schiavo (London Cancer Research Institute) for the 2C11 mouse monoclonal antibody to PtdIns(4,5)P<INF>2</INF>; T. Kinashi (Kyoto University) for the 5' Myc membrane-targeted version of p110 delta in the pMX-neo vector; T. Maffucci (Queen Mary, University of London) for GST-PLC-delta-PH and GST-Akt-PH; H. Stenmark (Oslo University Hospital) for GST-Hrs-FYVE; D. Gray (University of Edinburgh) for the XL-60 cell line; and B. Manoury, N. Leslie and members of the Centre for Cell Signalling for comments. Supported by the European Union Marie Curie (IEF-041713 to E.A. and IEF-274749 to S.T); the European Molecular Biology Organization (ALTF 1083-2007 to E.A.); the Fondation ARC pour la Recherche sur la Cancer (SAE P2009); the Fund for Scientific Research Flanders; the Hercules Foundation and University of Ghent Multidisciplinary Research Partnership (for work in the laboratory of R.B.); the European Union Marie Curie International Graduate Program in Molecular Medicine (M.A.W.); and Cancer Research UK (C23338/A10200), the Ludwig Institute for Cancer Research and Queen Mary University of London (for work in the laboratory of B.V.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; BEUTLER B, 1988, ANNU REV MED, V39, P75, DOI 10.1146/annurev.med.39.1.75; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Leslie NR, 2011, ADV ENZYME REGUL, V52, P205; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Okkenhaug K, 2002, SCIENCE, V297, P1031; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sly LM, 2009, BLOOD, V113, P2945, DOI 10.1182/blood-2008-06-166082; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Uno JK, 2010, GASTROENTEROLOGY, V139, P1642, DOI 10.1053/j.gastro.2010.07.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013	54	133	145	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1045	1054		10.1038/ni.2426	http://dx.doi.org/10.1038/ni.2426			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23023391	Green Accepted			2022-12-18	WOS:000310091700007
J	Chodaczek, G; Papanna, V; Zal, MA; Zal, T				Chodaczek, Grzegorz; Papanna, Veena; Zal, M. Anna; Zal, Tomasz			Body-barrier surveillance by epidermal gamma delta TCRs	NATURE IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; ANTIGEN RECEPTORS; SKIN; SELECTION; MICE; PHOSPHORYLATION; REORGANIZATION; MICROCLUSTERS; LOCALIZATION; RECOGNITION	The surveillance of body barriers relies on resident T cells whose repertoires are biased toward particular gamma delta T cell antigen receptors (TCRs) according to location. These gamma delta TCRs can recognize ligands that emerge after stress. Through the use of intravital dynamics-immunosignal correlative microscopy, we found that gamma-chain variable region 5 (V(gamma)5) TCRs expressed by epidermal T cells were constitutively clustered and functionally activated in vivo at steady state, forming true immunological synapses that polarized and anchored T cell projections at squamous keratinocyte tight junctions. This synaptogenesis depended on TCR variable domains, the kinase Lck and the integrin alpha(E)beta(7) but not the gamma delta lineage or the receptor NKG2D. In response to tissue stress, TCR-proximal signals did not increase substantially but underwent stress mode-dependent relocalization toward the basal epidermis and Langerhans cells. Thus, the gamma delta TCR orchestrates barrier surveillance proactively, presumably by recognizing tissue ligands expressed in the steady state.	[Chodaczek, Grzegorz; Papanna, Veena; Zal, M. Anna; Zal, Tomasz] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Zal, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	tzal@mdanderson.org	Chodaczek, Grzegorz/G-4073-2014; Papanna, Veena/E-8698-2016; Chodaczek, Grzegorz/AFL-9576-2022; Chodaczek, Grzegorz/AAH-1681-2022	Zal, Tomasz/0000-0002-3469-4261	National Institute of Allergy and Infection Diseases [K22-AI065688]; MD Anderson Cancer Center [3-0026138]; National Cancer Institute [CA016672]; institutional startup funds; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI065688] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MD Anderson Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); institutional startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Havran (The Scripps Research Institute) for the 7-17 cell line and advice; E. Rothenberg and M. Yui (Caltech) for IL-2p8-GFP mice; M. Nussenzweig (The Rockefeller University) for CD11c-YFP; L. Lanier, J. Beilke and M. Orr (University of California, San Francisco) for tissue samples from DAP10-DAP12-deficient mice; N.R.J. Gascoigne and G. Fu (The Scripps Research Institute), D. Zhou (MD Anderson Cancer Center) and W. Swat (Washington University School of Medicine) for other mutant mice (data not shown); A. Fukunaga for help with tissue processing; D. Nevozhay for help with statistical analysis; and M. Kripke, S. Watowich, C. Zhu, S. Ullrich, K. Newberry and W. Pagel for comments on the manuscript. Supported by the National Institute of Allergy and Infection Diseases (K22-AI065688 to T. Z.), MD Anderson Cancer Center (3-0026138 to T. Z.), the National Cancer Institute (CA016672 to MD Anderson) and institutional startup funds (T. Z.).	BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hara H, 2000, J IMMUNOL, V165, P3695, DOI 10.4049/jimmunol.165.7.3695; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Minagawa M, 2001, J DERMATOL SCI, V25, P150, DOI 10.1016/S0923-1811(00)00119-5; Mobius W, 1999, J HISTOCHEM CYTOCHEM, V47, P1005; Mohamadzadeh M, 1996, J INVEST DERMATOL, V107, P738, DOI 10.1111/1523-1747.ep12365634; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Schlickum S, 2008, BLOOD, V112, P619, DOI 10.1182/blood-2008-01-134833; Schon MP, 1999, J IMMUNOL, V162, P6641; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691	42	133	141	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					272	U96		10.1038/ni.2240	http://dx.doi.org/10.1038/ni.2240			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22327568	Green Accepted			2022-12-18	WOS:000300510600014
J	Papadopoulou, AS; Dooley, J; Linterman, MA; Pierson, W; Ucar, O; Kyewski, B; Zuklys, S; Hollander, GA; Matthys, P; Gray, DHD; De Strooper, B; Liston, A				Papadopoulou, Aikaterini S.; Dooley, James; Linterman, Michelle A.; Pierson, Wim; Ucar, Olga; Kyewski, Bruno; Zuklys, Saulius; Hollander, Georg A.; Matthys, Patrick; Gray, Daniel H. D.; De Strooper, Bart; Liston, Adrian			The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-alpha receptor	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; T-CELLS; DICER; DIFFERENTIATION; MICE; ACTIVATION; EXPRESSION; ABSENCE	Thymic output is a dynamic process, with high activity at birth punctuated by transient periods of involution during infection. Interferon-alpha (IFN-alpha) is a critical molecular mediator of pathogen-induced thymic involution, yet despite the importance of thymic involution, relatively little is known about the molecular integrators that establish sensitivity. Here we found that the microRNA network dependent on the endoribonuclease Dicer, and specifically microRNA miR-29a, was critical for diminishing the sensitivity of the thymic epithelium to simulated infection signals, protecting the thymus against inappropriate involution. In the absence of Dicer or the miR-29a cluster in the thymic epithelium, expression of the IFN-a receptor by the thymic epithelium was higher, which allowed suboptimal signals to trigger rapid loss of thymic cellularity.	[Papadopoulou, Aikaterini S.; Dooley, James; Pierson, Wim; De Strooper, Bart; Liston, Adrian] VIB, Louvain, Belgium; [Papadopoulou, Aikaterini S.; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Dooley, James; Pierson, Wim; Liston, Adrian] Katholieke Univ Leuven, Autoimmune Genet Lab, Louvain, Belgium; [Linterman, Michelle A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Linterman, Michelle A.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Ucar, Olga; Kyewski, Bruno] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Zuklys, Saulius; Hollander, Georg A.] Univ Basel, Basel, Switzerland; [Matthys, Patrick] Katholieke Univ Leuven, Rega Inst, Immunobiol Lab, Louvain, Belgium; [Gray, Daniel H. D.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Cambridge; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel; KU Leuven; Walter & Eliza Hall Institute	Liston, A (corresponding author), VIB, Louvain, Belgium.	james.dooley@vib-kuleuven.be; adrian.liston@vib.be	Gray, Daniel HD/A-3293-2013; De Strooper, Bart/F-6507-2012; Papadopoulou, Aikaterini S./AAM-5270-2020; Liston, Adrian/G-8606-2013; de+Strooper, Bart/Z-1638-2019; Linterman, Michelle/AAN-4210-2021; Matthys, Patrick/B-4813-2018	Gray, Daniel HD/0000-0002-8457-8242; De Strooper, Bart/0000-0001-5455-5819; Papadopoulou, Aikaterini S./0000-0002-4939-8756; Liston, Adrian/0000-0002-6272-4085; Linterman, Michelle/0000-0001-6047-1996; Matthys, Patrick/0000-0002-9685-6836; Pierson, Wim/0000-0003-1369-4606; Hollander, Georg/0000-0002-8790-0874; Dooley, James/0000-0003-3154-4708	VIB; Fonds Wetenschappelijk; European Research Council; Agentschap voor Innovtie door Wetenschap en Technologie; Australian National Health and Medical Research Council; European Union consortium "Tolerage"; Deutsches Krebsforschungszentrum; NATIONAL INSTITUTE ON AGING [R01AG034874] Funding Source: NIH RePORTER	VIB; Fonds Wetenschappelijk; European Research Council(European Research Council (ERC)European Commission); Agentschap voor Innovtie door Wetenschap en Technologie; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Union consortium "Tolerage"; Deutsches Krebsforschungszentrum; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Tarakhovsky (Rockefeller University) for Dicer<SUP>fl</SUP> mice; N. Manley (University of Georgia) for Foxn1<SUP>Cre</SUP> mice; A. Farr (University of Washington) for hybridomas; S. Schonefeldt for mouse colony support and D. Anz for discussions. Supported by the VIB and Fonds Wetenschappelijk Onderzoek (A. L.), Methusalem financing (KULeuven and Flemish government), European Research Council (B. D. S.), Agentschap voor Innovtie door Wetenschap en Technologie (W. P.), the Australian National Health and Medical Research Council (D. H. D. G.), the European Union consortium "Tolerage" and the Deutsches Krebsforschungszentrum (B. K.).	Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Anz D, 2009, J IMMUNOL, V182, P6044, DOI 10.4049/jimmunol.0803809; ARONSON M, 1991, THYMUS, V18, P7; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dowling MR, 2009, TRENDS IMMUNOL, V30, P295, DOI 10.1016/j.it.2009.04.006; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Flomerfelt FA, 2000, GENES IMMUN, V1, P391, DOI 10.1038/sj.gene.6363695; FU YX, 1989, J IMMUNOL, V143, P4300; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; GERPE LD, 1997, LIFE SCI, V61, P1019; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Itoh M, 1999, J IMMUNOL, V162, P5317; KING CC, 1992, J VIROL, V66, P3155, DOI 10.1128/JVI.66.5.3155-3160.1992; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuipers H, 2010, J IMMUNOL, V185, P400, DOI 10.4049/jimmunol.0903912; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; MILLER JF, 1961, LANCET, V2, P748; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sasaki S, 2008, INFLAMMATION, V31, P319, DOI 10.1007/s10753-008-9081-3; Sato T, 2001, CELL IMMUNOL, V211, P71, DOI 10.1006/cimm.2001.1823; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	40	133	140	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					181	187		10.1038/ni.2193	http://dx.doi.org/10.1038/ni.2193			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22179202	Green Accepted			2022-12-18	WOS:000299315000015
J	Poe, JC; Fujimoto, Y; Hasegawa, M; Haas, KM; Miller, AS; Sanford, IG; Bock, CB; Fujimoto, M; Tedder, TF				Poe, JC; Fujimoto, Y; Hasegawa, M; Haas, KM; Miller, AS; Sanford, IG; Bock, CB; Fujimoto, M; Tedder, TF			CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; TYROSINE-PHOSPHATASE 1C; ACID-BINDING LECTIN; IMMUNOGLOBULIN SUPERFAMILY; CD22-DEFICIENT MICE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; ADHESION MOLECULE; BONE-MARROW; MURINE CD22	The interaction of CD22 with alpha2,6-linked sialic acid ligands has been widely proposed to regulate B lymphocyte function and migration. Here, we generated gene-targeted mice that express mutant CD22 molecules that do not interact with these ligands. CD22 ligand binding regulated the expression of cell surface CD22, immunoglobulin M and major histocompatibility complex class II on mature B cells, maintenance of the marginal zone B cell population, optimal B cell antigen receptor-induced proliferation, and B cell turnover rates. However, CD22 negative regulation of calcium mobilization after B cell antigen receptor ligation, CD22 phosphorylation, recruitment of SHP-1 to CD22 and B cell migration did not require CD22 ligand engagement. These observations resolve longstanding questions regarding the physiological importance of CD22 ligand binding in the regulation of B cell function in vivo.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	thomas.tedder@duke.edu		Fujimoto, Manabu/0000-0002-3062-4872; Poe, Jonathan/0000-0002-7789-1564	NATIONAL CANCER INSTITUTE [R01CA096547, R01CA081776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER; NCI NIH HHS [CA96547, CA81776] Funding Source: Medline; NIAID NIH HHS [AI56363] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2002, GLYCOBIOLOGY, V12, P563, DOI 10.1093/glycob/cwf067; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; ENGEL P, 1993, J IMMUNOL, V150, P4719; ENGEL P, 1995, J EXP MED, V181, P1581, DOI 10.1084/jem.181.4.1581; Erickson LD, 1996, INT IMMUNOL, V8, P1121, DOI 10.1093/intimm/8.7.1121; Floyd H, 2000, IMMUNOLOGY, V101, P342, DOI 10.1046/j.1365-2567.2000.00103.x; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Lajaunias F, 1999, IMMUNOGENETICS, V49, P991, DOI 10.1007/s002510050584; LANKESTER AC, 1995, J BIOL CHEM, V270, P20305, DOI 10.1074/jbc.270.35.20305; Lanoue A, 2002, EUR J IMMUNOL, V32, P348, DOI 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5; LAW CL, 1995, J IMMUNOL, V155, P3368; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; Poe JC, 2004, J IMMUNOL, V172, P2100, DOI 10.4049/jimmunol.172.4.2100; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1996, J IMMUNOL, V157, P4371; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; SGROI D, 1993, J BIOL CHEM, V268, P7011; STAMENKOVIC I, 1990, NATURE, V345, P74, DOI 10.1038/345074a0; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; Steeber DA, 1996, J IMMUNOL, V157, P1096; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Tuscano JM, 1999, BLOOD, V94, P1382, DOI 10.1182/blood.V94.4.1382.416k14_1382_1392; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; Tuscano JM, 2003, BLOOD, V101, P3641, DOI 10.1182/blood-2002-08-2629; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769	47	133	140	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1078	1087		10.1038/ni1121	http://dx.doi.org/10.1038/ni1121			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15378059				2022-12-18	WOS:000224156600032
J	Lin, CY; Graca, L; Cobbold, SP; Waldmann, H				Lin, CY; Graca, L; Cobbold, SP; Waldmann, H			Dominant transplantation tolerance impairs CD8(+) T cell function but not expansion	NATURE IMMUNOLOGY			English	Article							INCOMPATIBLE CARDIAC ALLOGRAFTS; MONOCLONAL-ANTIBODIES; IMMUNOREGULATORY CELLS; INFECTIOUS TOLERANCE; CROSS-PRESENTATION; EFFECTOR FUNCTION; REGULATORY CELLS; IN-VIVO; B-CELLS; INDUCTION	Alloreactive CD8(+) T cells may persist in animals made tolerant of transplanted tissues; their function is controlled through continuous censorship by regulatory CD4(+) T cells. We sought to establish the stage at which such censorship operates. We found that monospecific CD8(+) T cells introduced into tolerant animals responded to the tolerated tissue antigen as if they had received CD4(+) T cell "help": they proliferated and accumulated normally. However, they did show compromised graft rejection, interferon-gamma production and cell-mediated cytotoxicity. These findings suggest that tolerance mediated by regulatory T cells acts by censoring immune effector functions rather than by limiting the induction of T cell responses.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Waldmann, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		waldmann, herman/W-8051-2019; waldmann, herman/F-7412-2011; Graca, Luis/B-8887-2008	Graca, Luis/0000-0001-6935-8500; Cobbold, Stephen/0000-0003-1206-4880; Waldmann, Herman/0000-0001-7519-6720; Lin, Chun-Yen/0000-0003-3007-3190				Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; BACH FH, 1976, NATURE, V259, P273, DOI 10.1038/259273a0; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bushell A, 1999, J IMMUNOL, V162, P1359; CANTOR H, 1975, J EXP MED, V141, P1390, DOI 10.1084/jem.141.6.1390; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hall BM, 1998, J IMMUNOL, V161, P5147; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; HUA C, 1986, J IMMUNOL, V136, P1937; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Marshall SE, 1996, TRANSPLANTATION, V62, P1614, DOI 10.1097/00007890-199612150-00015; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MONACO AP, 1966, J IMMUNOL, V96, P229; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Onodera K, 1996, J IMMUNOL, V157, P1944; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Polanski M, 1997, J AUTOIMMUN, V10, P339, DOI 10.1006/jaut.1997.0148; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tarazona R, 1996, INT IMMUNOL, V8, P351, DOI 10.1093/intimm/8.3.351; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran HM, 1997, J IMMUNOL, V159, P2232; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069; Zelenika D, 2001, IMMUNOL REV, V182, P164, DOI 10.1034/j.1600-065X.2001.1820113.x	50	133	137	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1208	1213		10.1038/ni853	http://dx.doi.org/10.1038/ni853			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12415266				2022-12-18	WOS:000179467800020
J	Ermann, J; Fathman, CG				Ermann, J; Fathman, CG			Autoimmune diseases: genes, bugs and failed regulation	NATURE IMMUNOLOGY			English	Editorial Material							APOPTOSIS	In this Overview, common themes of the accompanying News & Views on RA, SLE, IDDM, thyroiditis and MS are discussed. A unifying concept for the development of these and other autoimmune diseases should incorporate genetic predisposition, environmental factors and immune dysregulation.	Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Stanford University	Ermann, J (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.	cfathman@leland.stanford.edu	Ermann, Joerg/ABE-4495-2021	Ermann, Joerg/0000-0003-3836-9404				Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; James JA, 1998, IMMUNOL REV, V164, P185, DOI 10.1111/j.1600-065X.1998.tb01220.x; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Refaeli Y, 1999, IMMUNOL REV, V169, P273, DOI 10.1111/j.1600-065X.1999.tb01322.x; Ridgway WM, 1999, SCIENCE, V284, P749, DOI 10.1126/science.284.5415.749; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Steere AC, 2001, J AUTOIMMUN, V16, P263, DOI 10.1006/jaut.2000.0495; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stockinger B, 1999, Adv Immunol, V71, P229; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Weetman AP, 2001, NAT IMMUNOL, V2, P769, DOI 10.1038/ni0901-769; Wucherpfennig KW, 2001, NAT IMMUNOL, V2, P767, DOI 10.1038/ni0901-767	17	133	139	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					759	761		10.1038/ni0901-759	http://dx.doi.org/10.1038/ni0901-759			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526377				2022-12-18	WOS:000170781200003
J	Oestreich, KJ; Read, KA; Gilbertson, SE; Hough, KP; McDonald, PW; Krishnamoorthy, V; Weinmann, AS				Oestreich, Kenneth J.; Read, Kaitlin A.; Gilbertson, Sarah E.; Hough, Kenneth P.; McDonald, Paul W.; Krishnamoorthy, Veena; Weinmann, Amy S.			Bcl-6 directly represses the gene program of the glycolysis pathway	NATURE IMMUNOLOGY			English	Article							CD8(+) T-CELLS; HYPOXIA-INDUCIBLE FACTOR-1; TRANSCRIPTION FACTOR; EFFECTOR RESPONSES; MEMORY DEVELOPMENT; B-CELLS; DIFFERENTIATION; EXPRESSION; METABOLISM; BET	Despite the increasing knowledge of the molecular events that induce the glycolysis pathway in effector T cells, very little is known about the transcriptional mechanisms that dampen the glycolysis program in quiescent cell populations such as memory T cells. Here we found that the transcription factor Bcl-6 directly repressed genes encoding molecules involved in the glycolysis pathway, including Slc2a1, Slc2a3, Pkm and Hk2, in type 1 helper T cells (T(H)1 cells) exposed to low concentrations of interleukin 2 (IL-2). Thus, Bcl-6 had a role opposing the IL-2-sensitive glycolytic transcriptional program that the transcription factors c-Myc and HIF-1 alpha promote in effector T cells. Additionally, the T(H)1 lineage-specifying factor T-bet functionally antagonized the Bcl-6-dependent repression of genes encoding molecules in the glycolysis pathway, which links the molecular balance of these two factors to regulation of the metabolic gene program.	[Oestreich, Kenneth J.; Gilbertson, Sarah E.; Weinmann, Amy S.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Oestreich, Kenneth J.; Read, Kaitlin A.; McDonald, Paul W.] Virginia Tech Caril Res Inst, Roanoke, VA USA; [Oestreich, Kenneth J.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Hough, Kenneth P.; Krishnamoorthy, Veena; Weinmann, Amy S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA	University of Washington; University of Washington Seattle; Virginia Polytechnic Institute & State University; University of Alabama System; University of Alabama Birmingham	Weinmann, AS (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	oestrk@vtc.vt.edu; weinmann@uab.edu		Hough, Kenneth/0000-0002-8446-0084; Read, Kaitlin/0000-0001-5704-5064	National Institute of Allergy and Infectious Diseases [AI061061]; American Cancer Society [RSG-09-045-01-DDC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061061, R01AI061061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Rawlings (University of Washington) for human Ramos B cells; the preclinical repository of the National Cancer Institute for IL-2 and anti-IL-4; M. Wijaranakula for technical assistance; D. Chisolm for critical reading of the manuscript; and A. Ballesteros-Tato, B. Leon and T. Dadali-Abel for advice and assistance. Supported by the National Institute of Allergy and Infectious Diseases (AI061061 to A.S.W.) and the American Cancer Society (RSG-09-045-01-DDC to A.S.W.).	[Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	52	132	134	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					957	U201		10.1038/ni.2985	http://dx.doi.org/10.1038/ni.2985			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25194422	Green Accepted			2022-12-18	WOS:000342564800011
J	Bell, BD; Kitajima, M; Larson, RP; Stoklasek, TA; Pang, K; Sakamoto, K; Wagner, KU; Reizis, B; Hennighausen, L; Ziegler, SF				Bell, Bryan D.; Kitajima, Masayuki; Larson, Ryan P.; Stoklasek, Thomas A.; Pang, Kristen; Sakamoto, Kazuhito; Wagner, Kay-Uwe; Reizis, Boris; Hennighausen, Lothar; Ziegler, Steven F.			The transcription factor STAT5 is critical in dendritic cells for the development of T(H)2 but not T(H)1 responses	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; MEDIATED SIGNAL-TRANSDUCTION; ATOPIC-DERMATITIS; T-CELLS; FLUORESCEIN ISOTHIOCYANATE; CONTACT HYPERSENSITIVITY; IMMUNE-RESPONSES; TSLP; INFLAMMATION; SKIN	Dendritic cells (DCs) are critical in immune responses, linking innate and adaptive immunity. We found here that DC-specific deletion of the transcription factor STAT5 was not critical for development but was required for T helper type 2 (T(H)2), but not T(H)1, allergic responses in both the skin and lungs. Loss of STAT5 in DCs led to the inability to respond to thymic stromal lymphopoietin (TSLP). STAT5 was required for TSLP-dependent DC activation, including upregulation of the expression of costimulatory molecules and chemokine production. Furthermore, T(H)2 responses in mice with DC-specific loss of STAT5 resembled those seen in mice deficient in the receptor for TSLP. Our results show that the TSLP-STAT5 axis in DCs is a critical component for the promotion of type 2 immunity at barrier surfaces.	[Bell, Bryan D.; Kitajima, Masayuki; Larson, Ryan P.; Stoklasek, Thomas A.; Pang, Kristen; Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA USA; [Bell, Bryan D.; Kitajima, Masayuki; Larson, Ryan P.; Stoklasek, Thomas A.; Ziegler, Steven F.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Sakamoto, Kazuhito; Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Hennighausen, Lothar] US Natl Inst Hlth, Lab Genet & Physiol, Bethesda, MD USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Medical Center; Columbia University; National Institutes of Health (NIH) - USA	Ziegler, SF (corresponding author), Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA USA.	sziegler@benaroyaresearch.org		Hennighausen, Lothar/0000-0001-8319-9841; Wagner, Kay-Uwe/0000-0002-5081-0226; Dang, Kristen/0000-0002-7512-4476; Reizis, Boris/0000-0003-1140-7853	US National Institutes of Health [R01-AI068731, R01-AR056113, R01-AR055695, P01-HL098067, 5T32AI007411-19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007411, R01AI068731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055695, R01AR056113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Kaplan (University of Minnesota) for langerin-Cre mice; I. Forster (University of Bonn) for mice with a transgene encoding GFP in the Ccl17locus; T. Nakayama (Chiba University) for pMX-Cre-IRES-GFP; D. Rawlings and H. Kerns (Seattle Children's Research Institute) for Btk- and Tec-deficient bone marrow; J. Hamerman and D. Campbell for discussions of the manuscript; S. Ma and W Xu for technical support; and M. Warren and S. McCarty for administrative support. Supported by the US National Institutes of Health (R01-AI068731, R01-AR056113, R01-AR055695 and P01-HL098067 to S.F.Z., and 5T32AI007411-19 to B.D.B.).	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Dearman RJ, 2000, IMMUNOLOGY, V101, P442, DOI 10.1046/j.1365-2567.2000.00126.x; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Gorbachev AV, 2001, CRIT REV IMMUNOL, V21, P451; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Levin SD, 1999, J IMMUNOL, V162, P677; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	40	132	138	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					364	371		10.1038/ni.2541	http://dx.doi.org/10.1038/ni.2541			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23435120	Green Accepted			2022-12-18	WOS:000316648700011
J	Kanaya, T; Hase, K; Takahashi, D; Fukuda, S; Hoshino, K; Sasaki, I; Hemmi, H; Knoop, KA; Kumar, N; Sato, M; Katsuno, T; Yokosuka, O; Toyooka, K; Nakai, K; Sakamoto, A; Kitahara, Y; Jinnohara, T; McSorley, SJ; Kaisho, T; Williams, IR; Ohno, H				Kanaya, Takashi; Hase, Koji; Takahashi, Daisuke; Fukuda, Shinji; Hoshino, Katsuaki; Sasaki, Izumi; Hemmi, Hiroaki; Knoop, Kathryn A.; Kumar, Nachiket; Sato, Mayuko; Katsuno, Tatsuro; Yokosuka, Osamu; Toyooka, Kiminori; Nakai, Kumiko; Sakamoto, Ayako; Kitahara, Yuuki; Jinnohara, Toshi; McSorley, Stephen J.; Kaisho, Tsuneyasu; Williams, Ifor R.; Ohno, Hiroshi			The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells	NATURE IMMUNOLOGY			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; PEYERS-PATCHES; LYMPHOID FOLLICLES; T-CELLS; STEM-CELLS; MICE; EXPRESSION; INFECTION; PROTEIN; LYMPHOCYTES	Intestinal microfold cells (M cells) are an enigmatic lineage of intestinal epithelial cells that initiate mucosal immune responses through the uptake and transcytosis of luminal antigens. The mechanisms of M-cell differentiation are poorly understood, as the rarity of these cells has hampered analysis. Exogenous administration of the cytokine RANKL can synchronously activate M-cell differentiation in mice. Here we show the Ets transcription factor Spi-B was induced early during M-cell differentiation. Absence of Spi-B silenced the expression of various M-cell markers and prevented the differentiation of M cells in mice. The activation of T cells via an oral route was substantially impaired in the intestine of Spi-B-deficient (Spib(-/-)) mice. Our study demonstrates that commitment to the intestinal M-cell lineage requires Spi-B as a candidate master regulator.	[Hoshino, Katsuaki; Sasaki, Izumi; Hemmi, Hiroaki; Kaisho, Tsuneyasu] RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Kanagawa, Japan; [Kanaya, Takashi; Hase, Koji; Fukuda, Shinji; Jinnohara, Toshi; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa, Japan; [Kanaya, Takashi; Hase, Koji; Takahashi, Daisuke; Fukuda, Shinji; Nakai, Kumiko; Sakamoto, Ayako; Kitahara, Yuuki; Jinnohara, Toshi; Ohno, Hiroshi] RIKEN, Inst Phys & Chem Res, RCAI, Lab Epithelial Immunobiol, Yokohama, Kanagawa, Japan; [Hoshino, Katsuaki; Sasaki, Izumi; Hemmi, Hiroaki; Kaisho, Tsuneyasu] Osaka Univ, Lab Immune Regulat, World Premier Int Res Ctr Initiat WPI Immunol Fro, Osaka, Japan; [Sasaki, Izumi; Kaisho, Tsuneyasu] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Osaka, Japan; [Knoop, Kathryn A.; Kumar, Nachiket; Williams, Ifor R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Sato, Mayuko; Toyooka, Kiminori] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Katsuno, Tatsuro; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol K1, Chiba, Japan; [Kitahara, Yuuki; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Dept Immune Regulat, Chiba, Japan; [McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA	RIKEN; Yokohama City University; RIKEN; Osaka University; Osaka University; Emory University; RIKEN; Chiba University; Chiba University; University of California System; University of California Davis	Kaisho, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Kanagawa, Japan.	tkaisho@ifrec.osaka-u.ac.jp; irwilli@emory.edu; ohno@rcai.riken.jp	Toyooka, Kiminori/B-5027-2011; Hoshino, Katsuaki/L-9162-2014; Sato, Mayuko/D-4601-2017; Williams, Ifor R/D-3648-2011; Knoop, Kathryn/AAM-3570-2020; Hoshino, Katsuaki/AAE-2830-2022; Kaisho, Tsuneyasu/B-4130-2012; Ohno, Hiroshi/L-7899-2014; Takahashi, Daisuke/C-3799-2019	Hoshino, Katsuaki/0000-0003-0493-4815; Sato, Mayuko/0000-0002-9876-5612; Williams, Ifor R/0000-0002-8810-2911; Hoshino, Katsuaki/0000-0003-0493-4815; Ohno, Hiroshi/0000-0001-8776-9661; Takahashi, Daisuke/0000-0001-8624-1160; Hase, Koji/0000-0001-9550-2334; Fukuda, Shinji/0000-0001-5161-9880; Knoop, Kathryn/0000-0003-2007-3066; McSorley, Stephen/0000-0002-6363-3222; Kanaya, Takashi/0000-0002-9863-1673	RIKEN; Kishimoto Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [21022049, 20060033, 21022048, 21117003, 20113003]; Japan Society for the Promotion of Science [22689017, 23790550, 21390155, 20390146, 23390124, 18590483]; Japan Science and Technology Agency; Japan Science Society; Takeda Science Foundation; Mitsubishi Foundation; Uehara Memorial Foundation; US National Institutes of Health [DK64730]; Bill & Melinda Gates Foundation [OPP1006977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064730] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20113003, 24117723, 24117524, 21117003, 24658129] Funding Source: KAKEN	RIKEN; Kishimoto Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Science Society; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Z. Guo, Y. Obata, Y. Oohara, Y. Fujimura, M. Ohmae, C. Uetake, Y. Usami and S. Kimura for technical support; T. Kawai for electron microscopy analysis; and H. Matsui (Kitasato University) for S. Typhimurium. Supported by RIKEN (T.Kan., D.T. and I.S.), the Kishimoto Foundation (K.Ho., I.S., H.H. and T.Kai.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (21022049 to K.Ha.; 20060033, 21022048 and 21117003 to T.Kai.; and 20113003 to H.O.), the Japan Society for the Promotion of Science (22689017 to K.Ha.; 23790550 to T.Kan.; 21390155 to H.O.; and 20390146, 23390124 and 18590483 to T.Kai.), the Japan Science and Technology Agency (K.Ha.), The Japan Science Society (K.Ha.), The Takeda Science Foundation (H.O.), The Mitsubishi Foundation (H.O.), The Uehara Memorial Foundation (T.Kai.), the US National Institutes of Health (DK64730 to I.R.W.) and the Bill & Melinda Gates Foundation (OPP1006977 to I.R.W.).	Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; CARTER PB, 1974, INFECT IMMUN, V9, P851, DOI 10.1128/IAI.9.5.851-857.1974; DeKoter RP, 2010, J IMMUNOL, V185, P7374, DOI 10.4049/jimmunol.1001413; Ebisawa M, 2011, INT IMMUNOL, V23, P261, DOI 10.1093/intimm/dxq478; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gebert A, 1999, AM J PATHOL, V154, P1573, DOI 10.1016/S0002-9440(10)65410-7; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gulig PA, 1998, INFECT IMMUN, V66, P2471, DOI 10.1128/IAI.66.6.2471-2485.1998; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jedlicka P, 2008, HISTOL HISTOPATHOL, V23, P1417, DOI 10.14670/HH-23.1417; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Mach J, 2005, IMMUNOL REV, V206, P177, DOI 10.1111/j.0105-2896.2005.00281.x; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Taylor RT, 2007, J IMMUNOL, V178, P5659, DOI 10.4049/jimmunol.178.9.5659; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	44	132	134	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					729	+		10.1038/ni.2352	http://dx.doi.org/10.1038/ni.2352			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22706340	Green Accepted			2022-12-18	WOS:000306569600008
J	Shulman, Z; Cohen, SJ; Roediger, B; Kalchenko, V; Jain, R; Grabovsky, V; Klein, E; Shinder, V; Stoler-Barak, L; Feigelson, SW; Meshel, T; Nurmi, SM; Goldstein, I; Hartley, O; Gahmberg, CG; Etzioni, A; Weninger, W; Ben-Baruch, A; Alon, R				Shulman, Ziv; Cohen, Shmuel J.; Roediger, Ben; Kalchenko, Vyacheslav; Jain, Rohit; Grabovsky, Valentin; Klein, Eugenia; Shinder, Vera; Stoler-Barak, Liat; Feigelson, Sara W.; Meshel, Tsipi; Nurmi, Susanna M.; Goldstein, Itamar; Hartley, Olivier; Gahmberg, Carl G.; Etzioni, Amos; Weninger, Wolfgang; Ben-Baruch, Adit; Alon, Ronen			Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots	NATURE IMMUNOLOGY			English	Article							CD8(+) T-CELLS; ENDOTHELIAL-CELLS; LYMPH-NODES; DENDRITIC CELLS; FLOW CONDITIONS; MEMORY CELLS; ACTIVATION; ADHESION; EXOCYTOSIS; EFFECTOR	Chemokines presented by the endothelium are critical for integrin-dependent adhesion and transendothelial migration of naive and memory lymphocytes. Here we found that effector lymphocytes of the type 1 helper T cell (T(H)1 cell) and type 1 cytotoxic T cell (T(C)1 cell) subtypes expressed adhesive integrins that bypassed chemokine signals and established firm arrests on variably inflamed endothelial barriers. Nevertheless, the transendothelial migration of these lymphocytes strictly depended on signals from guanine nucleotide-binding proteins of the G(i) type and was promoted by multiple endothelium-derived inflammatory chemokines, even without outer endothelial surface exposure. Instead, transendothelial migration-promoting endothelial chemokines were stored in vesicles docked on actin fibers beneath the plasma membranes and were locally released within tight lymphocyte-endothelial synapses. Thus, effector T lymphocytes can cross inflamed barriers through contact-guided consumption of intraendothelial chemokines without surface-deposited chemokines or extraendothelial chemokine gradients.	[Shulman, Ziv; Cohen, Shmuel J.; Grabovsky, Valentin; Stoler-Barak, Liat; Feigelson, Sara W.; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Roediger, Ben; Jain, Rohit; Weninger, Wolfgang] Centenary Inst, Newtown, NSW, Australia; [Klein, Eugenia; Shinder, Vera] Weizmann Inst Sci, Irving & Cherna Moskowitz Ctr Nano & Bionano Imag, IL-76100 Rehovot, Israel; [Meshel, Tsipi; Ben-Baruch, Adit] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Nurmi, Susanna M.; Gahmberg, Carl G.] Univ Helsinki, Fac Biosci, Div Biochem, FIN-00014 Helsinki, Finland; [Goldstein, Itamar] Chaim Sheba Med Ctr, Canc Res Ctr, Program Immunol, Ramat Gan, Israel; [Hartley, Olivier] Univ Geneva, Fac Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva 4, Switzerland; [Etzioni, Amos] Technion Israel Inst Technol, Rambam Med Ctr, Meyer Children Hosp, Dept Pediat, Haifa, Israel; [Etzioni, Amos] Technion Israel Inst Technol, B Rappaport Sch Med, Haifa, Israel; [Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Discipline Dermatol, Sydney, NSW 2006, Australia	Weizmann Institute of Science; University of Sydney; Centenary Institute; Weizmann Institute of Science; Tel Aviv University; University of Helsinki; Chaim Sheba Medical Center; University of Geneva; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Sydney	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	Gahmberg, Carl/AAE-1876-2019; Kalchenko, Vyacheslav/F-2924-2012; ALON, RONEN/GRX-6987-2022; Jain, Rohit/O-2015-2019	Jain, Rohit/0000-0002-4905-462X; Roediger, Ben/0000-0002-4593-091X; Jaffe Cohen, Shmuel/0000-0001-8741-9784; Kalchenko, Vyacheslav/0000-0002-3166-7049; Gahmberg, Carl/0000-0001-9892-9296; Alon, Ronen/0000-0001-9161-6369; Weninger, Wolfgang/0000-0003-3133-8699; Goldstein, Itamar/0000-0001-5393-186X	Linda Jacobs Chair in Immune and Stem Cell Research; Israel Science Foundation; Minerva Foundation; Flight Attendant Medical Research Institute Foundation; Germany-Israel Science Foundation	Linda Jacobs Chair in Immune and Stem Cell Research; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Flight Attendant Medical Research Institute Foundation; Germany-Israel Science Foundation	We thank R. Wedlich-Soeldner (Max-Planck Institute for Biochemistry) for Lifeact-mRFP; A. Bershadsky (Weizmann Institute) for alpha-tubulin-mCherry; B. Geiger (Weizmann Institute) for paxillin-CFP; F. Sanchez-Madrid (Universidad Autonoma de Madrid) for ICAM-1-EGFP; Y. Kloog (Tel-Aviv University) for eGFP-th; R. Pardi (Dibit-Scientific Institute San Raffaele) for Rab11-DsRed; G. Shakhar and M. Fernandez-Borja for discussions, and S. Schwarzbaum for editorial assistance. Supported by The Linda Jacobs Chair in Immune and Stem Cell Research (R.A.), the Israel Science Foundation (R.A.), the Minerva Foundation, the Flight Attendant Medical Research Institute Foundation (R.A.) and the Germany-Israel Science Foundation (R.A.).	Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Baker RG, 2008, IMMUNOL RES, V42, P132, DOI 10.1007/s12026-008-8047-8; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Sauty A, 1999, J IMMUNOL, V162, P3549; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shulman Z, 2009, METHOD ENZYMOL, V461, P311, DOI 10.1016/S0076-6879(09)05414-7; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; Zhang HH, 2010, J IMMUNOL, V185, P6646, DOI 10.4049/jimmunol.0904156	48	132	132	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					67	U94		10.1038/ni.2173	http://dx.doi.org/10.1038/ni.2173			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22138716				2022-12-18	WOS:000298412800013
J	Quintana-Murci, L; Alcais, A; Abel, L; Casanova, JL				Quintana-Murci, Lluis; Alcais, Alexandre; Abel, Laurent; Casanova, Jean-Laurent			Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases	NATURE IMMUNOLOGY			English	Article							MANNOSE-BINDING LECTIN; HETEROZYGOTE ADVANTAGE; POPULATION-GENETICS; BALANCING SELECTION; POSITIVE SELECTION; VIRUS INFECTION; INNATE-IMMUNITY; INBORN-ERRORS; T-LYMPHOCYTES; HOST-DEFENSE	The field of human genetics of infectious diseases defines the genes and alleles rendering individuals (clinical genetics) and populations (epidemiological genetics) vulnerable to infection, and studies those selected by previous infections (evolutionary genetics). These disciplines - clinical, epidemiological and evolutionary genetics - delineate the redundant and nonredundant functions of host defense genes for past and present survival in natura - in natural ecosystems governed by natural selection. These disciplines, in other words, assess the ecologically relevant and evolutionarily selected roles of human genes and alleles in protective immunity to diverse and evolving microorganisms. The genetic dissection of human immunity to infection in natura provides unique immunological insight, making it an indispensable complement to experimental immunology in vitro and in vivo in plants and animals.	Necker Med Sch, INSERM, Lab Human Genet Infect Dis, U550, F-75015 Paris, France; Inst Pasteur, CNRS, URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France; Univ Paris 05, Necker Med Sch, F-75015 Paris, France; Necker Childrens Hosp, Pediat Hematol & Immunol Unit, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Necker Med Sch, INSERM, Lab Human Genet Infect Dis, U550, F-75015 Paris, France.	casanova@necker.fr	Alcais, Alexandre/J-5882-2017; Quintana-Murci, Lluis/AAB-7468-2022; Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017	Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493; Casanova, Jean-Laurent/0000-0002-7782-4169; Quintana-Murci, Lluis/0000-0003-2429-6320				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABEL L, 1988, AM J HUM GENET, V42, P256; Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; ALCAIS A, 2004, SUSCEPTIBILITY INFEC, P7; ALCAIS A, IN PRESS HUMAN GENET; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Allison AC, 2004, GENETICS, V166, P1591, DOI 10.1534/genetics.166.4.1591; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bradbury J, 2004, LANCET, V363, P952, DOI 10.1016/S0140-6736(04)15824-8; BROWN KE, 1994, NEW ENGL J MED, V330, P1192, DOI 10.1056/NEJM199404283301704; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeffery KJM, 2000, J IMMUNOL, V165, P7278, DOI 10.4049/jimmunol.165.12.7278; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khoury M, 1993, FUNDAMENTALS GENETIC; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KU CL, IN PRESS J EXP MED; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Mathew S, 2006, PEDIATR INFECT DIS J, V25, P255, DOI 10.1097/01.inf.0000209215.65445.04; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Neyrolles O, 2006, TRENDS MICROBIOL, V14, P383, DOI 10.1016/j.tim.2006.07.007; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; OCHS HD, 2007, PRIMARY IMMUNODEFICI; Oldstone MBA, 2007, NAT IMMUNOL, V8, P325, DOI 10.1038/ni0407-325; Olson S, 2002, SCIENCE, V298, P1324, DOI 10.1126/science.298.5597.1324; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pradel E, 2004, ANNU REV GENET, V38, P347, DOI 10.1146/annurev.genet.38.072902.092528; Reith W, 2007, PRIMARY IMMUNODEFICI, P227; Roesler J, 1999, EXP HEMATOL, V27, P1368, DOI 10.1016/S0301-472X(99)00077-6; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sanal O, 2007, PEDIATR INFECT DIS J, V26, P366, DOI 10.1097/01.inf.0000258696.64507.0f; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schurr E, 2006, SEMIN IMMUNOL, V18, P404, DOI 10.1016/j.smim.2006.07.005; Selye H., 1967, CASE SUPRAMOLECULAR; Seyfarth J, 2005, HUM MOL GENET, V14, P2859, DOI 10.1093/hmg/ddi318; SHULTZ LD, 1991, AM J ANAT, V191, P303, DOI 10.1002/aja.1001910310; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Snow J., 1855, MODE COMMUNICATION C; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAKAHATA N, 1992, GENETICS, V130, P925; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VALLERYRADOT R, 1926, LIFE PASTEUR, V21; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Verdu P, 2006, HUM MOL GENET, V15, P2650, DOI 10.1093/hmg/ddl193; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	100	132	138	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1165	1171		10.1038/ni1535	http://dx.doi.org/10.1038/ni1535			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952041				2022-12-18	WOS:000250338900006
J	Lewis, JM; Girardi, M; Roberts, SJ; Barbee, SD; Hayday, AC; Tigelaar, RE				Lewis, Julia M.; Girardi, Michael; Roberts, Scott J.; Barbee, Susannah D.; Hayday, Adrian C.; Tigelaar, Robert E.			Selection of the cutaneous intraepithelial gamma delta(+) T cell repertoire by a thymic stromal determinant	NATURE IMMUNOLOGY			English	Article							GAMMA-DELTA CELLS; POSITIVE SELECTION; NATURAL ANTIBODIES; RECEPTOR; SPECIFICITY; SKIN; PRECURSORS; EXPRESSION; MATURATION; NKG2D	Intraepithelial lymphocytes constitute a group of T cells that express mainly monospecific or oligoclonal T cell receptors (TCRs). Like adaptive TCR alpha beta(+) T cells, intraepithelial lymphocytes, a subset enriched in TCR gamma delta(+) T cells, are proposed to be positively selected by thymically expressed self agonists, yet no direct evidence for this exists at present. Mouse dendritic epidermal T cells are prototypic intraepithelial lymphocytes, displaying an almost monoclonal TCR gamma delta(+) repertoire. Here we describe an FVB substrain of mice in which this repertoire was uniquely depleted, resulting in cutaneous pathology. This phenotype was due to failure of dendritic epidermal T cell progenitors to mature because of a heritable defect in a dominant gene used by the thymic stroma to 'educate' the natural, skin- associated intraepithelial lymphocyte repertoire to be of physiological use.	Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06511 USA; Yale Univ, Sch Med, Yale Skin Dis Res Core Ctr, New Haven, CT 06511 USA; Kings Coll London, Guys Hosp, Sch Med, Dept Immunobiol, London SE1 9RT, England; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06511 USA	Yale University; Yale University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University	Tigelaar, RE (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06511 USA.	robert.tigelaar@yale.edu		Girardi, Michael/0000-0003-1887-9343; HAYDAY, ADRIAN/0000-0002-9495-5793	NIAMS NIH HHS [R01-AR49282, P30-AR041942] Funding Source: Medline; Wellcome Trust [071534] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041942, R01AR049282] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Born W, 1999, Adv Immunol, V71, P77; Dandekar AA, 2005, J VIROL, V79, P9388, DOI 10.1128/JVI.79.15.9388-9396.2005; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Girardi Michael, 2005, V86, P136, DOI 10.1159/000086658; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GOODMAN T, 1992, IMMUNOGENETICS, V35, P65; Hara H, 2000, J IMMUNOL, V165, P3695, DOI 10.4049/jimmunol.165.7.3695; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Jenkinson E J, 1990, Semin Immunol, V2, P51; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kabelitz D, 2005, INT ARCH ALLERGY IMM, V137, P73, DOI 10.1159/000085107; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; KYES S, 1991, P NATL ACAD SCI USA, V88, P7830, DOI 10.1073/pnas.88.17.7830; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; LECLERCQ G, 1993, J EXP MED, V178, P309, DOI 10.1084/jem.178.1.309; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Moore TA, 1996, J IMMUNOL, V157, P2366; Nitahara A, 2006, J INVEST DERMATOL, V126, P1052, DOI 10.1038/sj.jid.5700112; Paloczi K, 1998, BONE MARROW TRANSPL, V22, pS89; Parker W, 1997, J CLIN IMMUNOL, V17, P311, DOI 10.1023/A:1027378716015; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PAYER E, 1991, J IMMUNOL, V146, P2536; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; ROCHA B, 1995, CURR OPIN IMMUNOL, V7, P235, DOI 10.1016/0952-7915(95)80008-5; TATSUMI Y, 1993, J IMMUNOL, V151, P3030; TIGELAAR RE, 1995, J INVEST DERMATOL, V105, pS43, DOI 10.1111/1523-1747.ep12315280; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Wang HS, 2004, IMMUNOL REV, V197, P51, DOI 10.1111/j.0105-2896.2004.0098.x; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	50	132	133	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					843	850		10.1038/ni1363	http://dx.doi.org/10.1038/ni1363			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16829962				2022-12-18	WOS:000239147200020
J	Cosma, CL; Humbert, O; Ramakrishnan, L				Cosma, CL; Humbert, O; Ramakrishnan, L			Superinfecting mycobacteria home to established tuberculous granulomas	NATURE IMMUNOLOGY			English	Article							CHRONIC PULMONARY TUBERCULOSIS; EXOGENOUS REINFECTION; GENE-EXPRESSION; IN-VIVO; DC-SIGN; INFECTION; MARINUM; PATHOGENESIS; PERSISTENCE; CELL	A central paradox of tuberculosis immunity is that reinfection and bacterial persistence occur despite vigorous host immune responses concentrated in granulomas, which are organized structures that form in response to infection. Prevailing models attribute reinfection and persistence to bacterial avoidance of host immunity via establishment of infection outside primary granulomas. Alternatively, persistence is attributed to a gradual bacterial adaptation to evolving host immune responses. We show here that superinfecting Mycobacterium marinum traffic rapidly into preexisting granulomas, including their caseous ( necrotic) centers, through specific mycobacterium-directed and host cell-mediated processes, yet adapt quickly to persist long term therein. These findings demonstrate a failure of established granulomas, concentrated foci of activated macrophages and antigen-specific immune effector cells, to eradicate newly deposited mycobacteria not previously exposed to host responses.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Ramakrishnan, Lalita/0000-0003-0692-5533	NIAID NIH HHS [R01 AI 36396] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS DO, 1976, AM J PATHOL, V84, P164; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Janeway CA, 2001, IMMUNOBIOLOGY; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Ramakrishnan L, 1997, INFECT IMMUN, V65, P767, DOI 10.1128/IAI.65.2.767-773.1997; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ramakrishnan L, 2004, CURR SCI INDIA, V86, P82; Repique CJ, 2002, INFECT IMMUN, V70, P3318, DOI 10.1128/IAI.70.7.3318-3323.2002; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Roach DR, 1999, INFECT IMMUN, V67, P5473, DOI 10.1128/IAI.67.10.5473-5476.1999; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Traver D, 2003, ADV IMMUNOL, V81, P253; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; ZIEGLER JE, 1985, TUBERCLE, V66, P121, DOI 10.1016/0041-3879(85)90077-7	44	132	138	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					828	835		10.1038/ni1091	http://dx.doi.org/10.1038/ni1091			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15220915				2022-12-18	WOS:000222955600014
J	Ohnishi, K; Melchers, F				Ohnishi, K; Melchers, F			The nonimmunoglobulin portion of lambda 5 mediates cell-autonomous pre-B cell receptor signaling	NATURE IMMUNOLOGY			English	Article							SURROGATE LIGHT-CHAIN; MU-HEAVY-CHAIN; BONE-MARROW; REPERTOIRE SELECTION; ALLELIC EXCLUSION; DEFICIENT MICE; SURFACE; COMPLEX; MOUSE; DIFFERENTIATION	The pre-B cell receptor (preBCR), composed of mu immunoglobulin (Ig) and surrogate light chains, signals large 'preB-II' cells to proliferate in the apparent absence of ligands or cooperating cells. We deleted the N-terminal, nonimmunoglobulin (nonlg) portion of lambda5, or mutated seven arginine residues in it to serine residues. PreBCRs with such mutant lambda5 proteins showed increased cell surface representation and a diminished rate of aggregation and internalization. Tyrosine phosphorylation of preBCR complexes containing mutant lambda5 proteins was abolished. These results indicate that the nonIg portion of lambda5, and the seven arginine residues in it, are needed for signal transduction, and that signaling could be cell autonomous. We propose two models to explain the apparently constitutive, ligand-independent signal-transducing capacity of the preBCR.	Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland	National Institute of Infectious Diseases (NIID); University of Basel	Ohnishi, K (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.							Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403; Ceredig R, 2000, EUR J IMMUNOL, V30, P759, DOI 10.1002/1521-4141(200003)30:3<759::AID-IMMU759>3.0.CO;2-M; CHAMBERS JD, 1993, J LEUKOCYTE BIOL, V53, P462, DOI 10.1002/jlb.53.4.462; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Gauthier L, 1999, J IMMUNOL, V162, P41; GUELPAFONLUPT V, 1994, MOL IMMUNOL, V31, P1099, DOI 10.1016/0161-5890(94)90105-8; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; OHNISHI K, 1994, J BIOL CHEM, V269, P28347; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Silverman GJ, 2000, J EXP MED, V192, P87, DOI 10.1084/jem.192.1.87; TAKEMORI T, 1987, EMBO J, V6, P951, DOI 10.1002/j.1460-2075.1987.tb04844.x; tenBoekel E, 1997, IMMUNITY, V7, P357; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045	38	132	140	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					849	856		10.1038/ni959	http://dx.doi.org/10.1038/ni959			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12897780				2022-12-18	WOS:000185002200011
J	Keller, AN; Eckle, SBG; Xu, WJ; Liu, LG; Hughes, VA; Mak, JYW; Meehan, BS; Pediongco, T; Birkinshaw, RW; Chen, ZJ; Wang, HM; D'Souza, C; Kjer-Nielsen, L; Gherardin, NA; Godfrey, DI; Kostenko, L; Corbett, AJ; Purcell, AW; Fairlie, DP; McCluskey, J; Rossjohn, J				Keller, Andrew N.; Eckle, Sidonia B. G.; Xu, Weijun; Liu, Ligong; Hughes, Victoria A.; Mak, Jeffrey Y. W.; Meehan, Bronwyn S.; Pediongco, Troi; Birkinshaw, Richard W.; Chen, Zhenjun; Wang, Huimeng; D'Souza, Criselle; Kjer-Nielsen, Lars; Gherardin, Nicholas A.; Godfrey, Dale I.; Kostenko, Lyudmila; Corbett, Alexandra J.; Purcell, Anthony W.; Fairlie, David P.; McCluskey, James; Rossjohn, Jamie			Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells	NATURE IMMUNOLOGY			English	Article							VITAMIN-B METABOLITES; RECEPTOR HETEROGENEITY; RHEUMATOID-ARTHRITIS; MAIT CELLS; METHOTREXATE; RECOGNITION; ANTIGENS; DICLOFENAC; REACTIVITY; DISEASE	The major-histocompatibility-complex-(MHC)-class-I-related molecule MR1 can present activating and non-activating vitamin-B-based ligands to mucosal-associated invariant T cells (MAIT cells). Whether MR1 binds other ligands is unknown. Here we identified a range of small organic molecules, drugs, drug metabolites and drug-like molecules, including salicylates and diclofenac, as MR1-binding ligands. Some of these ligands inhibited MAIT cells ex vivo and in vivo, while others, including diclofenac metabolites, were agonists. Crystal structures of a T cell antigen receptor (TCR) from a MAIT cell in complex with MR1 bound to the non-stimulatory and stimulatory compounds showed distinct ligand orientations and contacts within MR1, which highlighted the versatility of the MR1 binding pocket. The findings demonstrated that MR1 was able to capture chemically diverse structures, spanning mono-and bicyclic compounds, that either inhibited or activated MAIT cells. This indicated that drugs and drug-like molecules can modulate MAIT cell function in mammals.	[Keller, Andrew N.; Hughes, Victoria A.; Birkinshaw, Richard W.; Purcell, Anthony W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Keller, Andrew N.; Hughes, Victoria A.; Birkinshaw, Richard W.; Purcell, Anthony W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Keller, Andrew N.; Hughes, Victoria A.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Eckle, Sidonia B. G.; Meehan, Bronwyn S.; Pediongco, Troi; Chen, Zhenjun; Wang, Huimeng; D'Souza, Criselle; Kjer-Nielsen, Lars; Gherardin, Nicholas A.; Godfrey, Dale I.; Kostenko, Lyudmila; Corbett, Alexandra J.; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Xu, Weijun; Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Xu, Weijun; Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld, Australia; [Gherardin, Nicholas A.; Godfrey, Dale I.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Melbourne, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales	Monash University; Monash University; Monash University; University of Melbourne; University of Queensland; University of Queensland; University of Melbourne; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia.; McCluskey, J (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia.; Fairlie, DP (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.; Fairlie, DP (corresponding author), Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales.	d.fairlie@imb.uq.edu.au; jamesm1@unimelb.edu.au; jamie.rossjohn@monash.edu	Eckle, Sidonia BG/O-8146-2014; Rossjohn, Jamie/F-9032-2013; Wang, Huimeng/AAE-6554-2022; Xu, Weijun/C-9741-2017; Gherardin, Nicholas/P-6853-2019; Birkinshaw, Richard/AAC-7809-2019; McCluskey, James/A-1291-2007; Fairlie, David P/F-8865-2014; liu, ligong/B-1690-2010; Purcell, Anthony/AAH-1942-2019; Mak, Jeffrey YW/E-8764-2011; Corbett, Alexandra/A-1225-2019	Eckle, Sidonia BG/0000-0003-0766-171X; Rossjohn, Jamie/0000-0002-2020-7522; Xu, Weijun/0000-0002-3566-1082; Birkinshaw, Richard/0000-0003-1825-0182; McCluskey, James/0000-0002-8597-815X; Fairlie, David P/0000-0002-7856-8566; liu, ligong/0000-0002-2693-1896; Purcell, Anthony/0000-0003-0532-8331; Mak, Jeffrey YW/0000-0002-8011-4539; Corbett, Alexandra/0000-0003-1618-4337; Wang, Huimeng/0000-0003-0226-3982; Gherardin, Nicholas/0000-0003-4690-2571; Dsouza, Criselle/0000-0003-2257-6388; Meehan, Bronwyn/0000-0001-7368-2979; Godfrey, Dale/0000-0002-3009-5472	University of Melbourne; Australian National Health and Medical Research Council [1020770, 1027369, 1044215, 1113293, 1125493]; Australian Research Council [CE140100011, DE170100407, FT160100083, FL160100049]; Leukaemia Foundation of Australia; Cancer Council Victoria	University of Melbourne(University of Melbourne); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leukaemia Foundation of Australia; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	We thank the staff at the Australian Synchrotron for assistance with data collection; the staff at the Monash Macromolecular crystallization facility; and T. Hansen (University of Washington) and W.J. Yankelevich (US Food and Drug Administration) for the 26.5 hybridoma. Supported by The University of Melbourne (S.E.), the Australian National Health and Medical Research Council (1020770 and 1027369 to D.I.G and D.P.F.; 1044215 to A.W.P.; 1113293 to J.M.; and 1125493 to J.R.), the Australian Research Council (CE140100011 and DE170100407 to S.E.; FT160100083 to A.J.C.; and FL160100049 to J.R.), the Leukaemia Foundation of Australia (N.A.G.) and Cancer Council Victoria (N.A.G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; CHATTERJI DC, 1978, J PHARM SCI, V67, P526, DOI 10.1002/jps.2600670422; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Chua BY, 2014, IMMUNOL CELL BIOL, V92, P377, DOI 10.1038/icb.2013.102; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Davies NM, 1997, CLIN PHARMACOKINET, V33, P184, DOI 10.2165/00003088-199733030-00003; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2015, J BIOL CHEM, V290, P30204, DOI 10.1074/jbc.R115.685990; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEHLNER PF, 1987, J IMMUNOL METHODS, V101, P141, DOI 10.1016/0022-1759(87)90227-4; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hashkes PJ, 2014, J PEDIATR-US, V164, P231, DOI 10.1016/j.jpeds.2013.10.029; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Krasniqi V, 2016, ARH HIG RADA TOKSIKO, V67, P1, DOI 10.1515/aiht-2016-67-2754; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Romao VC, 2014, IMMUNOL RES, V60, P289, DOI 10.1007/s12026-014-8564-6; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Skypala IJ, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0078-3; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zelcer S, 2005, PEDIATR BLOOD CANCER, V44, P638, DOI 10.1002/pbc.20314	48	131	136	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					402	+		10.1038/ni.3679	http://dx.doi.org/10.1038/ni.3679			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28166217	Green Accepted			2022-12-18	WOS:000396815800008
J	Murray, PJ				Murray, Peter J.			Amino acid auxotrophy as a system of immunological control nodes	NATURE IMMUNOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; T-CELL RESPONSES; L-ARGININE; MACROPHAGE ACTIVATION; ARGINASE 1; INDOLEAMINE 2,3-DIOXYGENASE; TRANSLATIONAL CONTROL; MURINE MACROPHAGES; GLUTAMINE UPTAKE; L-ASPARAGINASE	Cells of the immune system are auxotrophs for most amino acids, including several nonessential ones. Arginine and tryptophan are used within the regulatory immune networks to control proliferation and function through pathways that actively deplete the amino acid from the microenvironment or that create regulatory molecules such as nitric oxide or kynurenines. How immune cells integrate information about essential amino acid supplies and then transfer these signals to growth and activation pathways remains unclear but has potential for pathway discovery about amino sensing. In applied research, strategies to harness amino acid auxotrophy so as to block cancerous lymphocyte growth have been attempted for decades with limited success. Emerging insights about amino acid metabolism may lead to new strategies in clinical medicine whereby both amino acid auxotrophy and the immunoregulatory pathways controlled by amino acids can be manipulated.	[Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.; Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	US National Institutes of Health; Calithera Biosciences; National Cancer Institute Cancer Core grant [P30 CA21765]; American Lebanese Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Calithera Biosciences; National Cancer Institute Cancer Core grant; American Lebanese Associated Charities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research in the author's laboratory is supported by grants from the US National Institutes of Health, Calithera Biosciences, National Cancer Institute Cancer Core grant P30 CA21765 and the American Lebanese Associated Charities.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.iy.02.040184.001435; ALBINA JE, 1990, J IMMUNOL, V144, P3877; Barron L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061961; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; BROOME JD, 1968, J EXP MED, V127, P1055, DOI 10.1084/jem.127.6.1055; Cama E, 2003, BIOCHEMISTRY-US, V42, P8445, DOI 10.1021/bi034340j; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen SH, 2011, LEUKEMIA, V25, P66, DOI 10.1038/leu.2010.256; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cousin C, 2015, EUR J IMMUNOL, V45, P1772, DOI 10.1002/eji.201445000; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; CURRIE GA, 1978, NATURE, V273, P758, DOI 10.1038/273758a0; CURRIE GA, 1979, BRIT J CANCER, V39, P613, DOI 10.1038/bjc.1979.112; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duque-Correa MA, 2014, P NATL ACAD SCI USA, V111, pE4024, DOI 10.1073/pnas.1408839111; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Esser-von Bieren Julia, 2013, PLoS Pathog, V9, pe1003771, DOI 10.1371/journal.ppat.1003771; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Fletcher M, 2015, CANCER RES, V75, P275, DOI 10.1158/0008-5472.CAN-14-1491; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; KELLER R, 1990, CANCER RES, V50, P1421; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mason JM, 2004, J IMMUNOL, V173, P4561, DOI 10.4049/jimmunol.173.7.4561; McGaha TL, 2012, IMMUNOL REV, V249, P135, DOI 10.1111/j.1600-065X.2012.01149.x; Meltzer M S, 1979, Adv Exp Med Biol, V121B, P381; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; MILLS CD, 1991, J IMMUNOL, V146, P2719; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Munder M, 1999, J IMMUNOL, V163, P3771; Munder M, 1998, J IMMUNOL, V160, P5347; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Mussai F, 2015, CANCER RES, V75, P3043, DOI 10.1158/0008-5472.CAN-14-3443; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Rapovy SM, 2015, J IMMUNOL, V195, P3293, DOI 10.4049/jimmunol.1500800; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rohrig U.F., 2015, J MED CHEM; RUCO LP, 1978, J IMMUNOL, V121, P2035; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Sahin E, 2014, J IMMUNOL, V193, P1717, DOI 10.4049/jimmunol.1302167; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Schindler H, 2001, INT IMMUNOPHARMACOL, V1, P1443, DOI 10.1016/S1567-5769(01)00089-3; Schmidt SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044797; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Thomas S, 2014, J CELL BIOCHEM, V115, P391, DOI 10.1002/jcb.24674; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yau T, 2013, INVEST NEW DRUG, V31, P99, DOI 10.1007/s10637-012-9807-9; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	113	131	134	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					132	139		10.1038/ni.3323	http://dx.doi.org/10.1038/ni.3323			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784254	Green Accepted			2022-12-18	WOS:000368571500006
J	Hukelmann, JL; Anderson, KE; Sinclair, LV; Grzes, KM; Murillo, AB; Hawkins, PT; Stephens, LR; Lamond, AI; Cantrell, DA				Hukelmann, Jens L.; Anderson, Karen E.; Sinclair, Linda V.; Grzes, Katarzyna M.; Murillo, Alejandro Brenes; Hawkins, Phillip T.; Stephens, Len R.; Lamond, Angus I.; Cantrell, Doreen A.			The cytotoxic T cell proteome and its shaping by the kinase mTOR	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; ACTIVATION; EFFECTOR; QUANTIFICATION; REVEALS; PDK1; AKT; IDENTIFICATION; INDUCTION; INFECTION	We used high-resolution mass spectrometry to map the cytotoxic T lymphocyte (CTL) proteome and the effect of the metabolic checkpoint kinase mTORC1 on CTLs. The CTL proteome was dominated by metabolic regulators and granzymes, and mTORC1 selectively repressed and promoted expression of a subset of CTL proteins (similar to 10%). These included key CTL effector molecules, signaling proteins and a subset of metabolic enzymes. Proteomic data highlighted the potential for negative control of the production of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) by mTORC1 in CTLs. mTORC1 repressed PtdIns(3,4,5) P3 production and determined the requirement for mTORC2 in activation of the kinase Akt. Our unbiased proteomic analysis thus provides comprehensive understanding of CTL identity and the control of CTL function by mTORC1.	[Hukelmann, Jens L.; Sinclair, Linda V.; Grzes, Katarzyna M.; Cantrell, Doreen A.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Hukelmann, Jens L.; Murillo, Alejandro Brenes; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [Anderson, Karen E.; Hawkins, Phillip T.; Stephens, Len R.] Babraham Inst, Inositide Lab, Cambridge, England	University of Dundee; University of Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Cantrell, DA (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dow St, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk		Hukelmann, Jens/0000-0001-8360-9062; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Anderson, Karen/0000-0002-7394-6660	Wellcome Trust [093713/Z/10/A, 073980/Z/03/Z, 105024/Z/14/Z, 065975/Z/01/A, 097418/Z/11/Z]; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BBS/E/B/000C0415] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank past and present colleagues of the Cantrell Group for advice and discussions; C. Feijoo-Carnero for help with microarray analysis; T. Ly for help with peptide fractionation using hSAX; and D. Lamont and the team of the MS facility at the College of Life Sciences of the University of Dundee and the Finnish DNA microarray Centre at the Centre for Biotechnology (Turku, Finland). Supported by the Wellcome Trust (093713/Z/10/A to J.L.H., 073980/Z/03/Z and 105024/Z/14/Z to A.I.L., 065975/Z/01/A and 097418/Z/11/Z to D.A.C.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Larance M, 2015, NAT REV MOL CELL BIO, V16, P269, DOI 10.1038/nrm3970; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Yang P, 2014, CELL SIGNAL, V26, P1853, DOI 10.1016/j.cellsig.2014.03.020; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	49	131	134	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					104	+		10.1038/ni.3314	http://dx.doi.org/10.1038/ni.3314			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26551880	Green Accepted			2022-12-18	WOS:000366675800016
J	Mandal, M; Powers, SE; Maienschein-Cline, M; Bartom, ET; Hamel, KM; Kee, BL; Dinner, AR; Clark, MR				Mandal, Malay; Powers, Sarah E.; Maienschein-Cline, Mark; Bartom, Elizabeth T.; Hamel, Keith M.; Kee, Barbara L.; Dinner, Aaron R.; Clark, Marcus R.			Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; LIGHT-CHAIN RECOMBINATION; KAPPA LOCUS; GENE RECOMBINATION; ALLELIC EXCLUSION; INTRONIC ENHANCER; PRO-B; RECEPTOR; TRANSCRIPTION; STAT5	During B lymphopoiesis, recombination of the locus encoding the immunoglobulin kappa-chain complex (Igk) requires expression of the precursor to the B cell antigen receptor (pre-BCR) and escape from signaling via the interleukin 7 receptor (IL-7R). By activating the transcription factor STAT5, IL-7R signaling maintains proliferation and represses Igk germline transcription by unknown mechanisms. We demonstrate that a STAT5 tetramer bound the Igk intronic enhancer (E-kappa i), which led to recruitment of the histone methyltransferase Ezh2. Ezh2 marked trimethylation of histone H3 at Lys27 (H3K27me3) throughout the kappa-chain joining region (J(kappa)) to the kappa-chain constant region (C-kappa). In the absence of Ezh2, IL-7 failed to repress Igk germline transcription. H3K27me3 modifications were lost after termination of IL-7R-STAT5 signaling, and the transcription factor E2A bound E-kappa i, which resulted in acquisition of H3K4me1 and acetylated histone H4 (H4Ac). Genome-wide analyses showed a STAT5 tetrameric binding motif associated with transcriptional repression. Our data demonstrate how IL-7R signaling represses Igk germline transcription and provide a general model for STAT5-mediated epigenetic transcriptional repression.	[Mandal, Malay; Powers, Sarah E.; Hamel, Keith M.; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Mandal, Malay; Powers, Sarah E.; Hamel, Keith M.; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Maienschein-Cline, Mark; Dinner, Aaron R.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Maienschein-Cline, Mark; Dinner, Aaron R.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Bartom, Elizabeth T.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu	; Bartom, Elizabeth/S-4475-2017	Powers, Sarah/0000-0002-6812-4312; Bartom, Elizabeth/0000-0002-5618-2582	US National Institutes of Health [GM088847, CA099978]; US Department of Energy; Chicago National Institutes of Health Systems Biology Center [P50 GM081892]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847, P50GM081892] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); Chicago National Institutes of Health Systems Biology Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Singh and U. Storb for discussions; R. Duggan and D. Leclerc for cell-sorting services; and the ImmGen Consortium for data assembly. Supported by the US National Institutes of Health (GM088847 to M. R. C. and CA099978 to B. L. K.), the US Department of Energy (M. M.-C.), the Chicago National Institutes of Health Systems Biology Center (P50 GM081892 to A. R. D.) and the Leukemia and Lymphoma Society (B.L.K.).	ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Amin RH, 2009, P NATL ACAD SCI USA, V106, P522, DOI 10.1073/pnas.0808895106; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Clark MR, 2005, CURR TOP MICROBIOL, V290, P87; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Erlandsson L, 2005, EUR J IMMUNOL, V35, P1969, DOI 10.1002/eji.200425821; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kornfeld JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6237, DOI 10.2741/3151; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Spicuglia S, 2000, EMBO J, V19, P2034, DOI 10.1093/emboj/19.9.2034; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Vettermann C, 2010, IMMUNOL REV, V237, P22, DOI 10.1111/j.1600-065X.2010.00935.x; Xu CR, 2009, J IMMUNOL, V182, P1362, DOI 10.4049/jimmunol.182.3.1362; Xu SL, 2007, BLOOD, V109, P3377, DOI 10.1182/blood-2006-07-036418; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003	50	131	133	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1212	U107		10.1038/ni.2136	http://dx.doi.org/10.1038/ni.2136			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22037603	Green Accepted			2022-12-18	WOS:000297202700016
J	Mueller, P; Massner, J; Jayachandran, R; Combaluzier, B; Albrecht, I; Gatfield, J; Blum, C; Ceredig, R; Rodewald, HR; Rolink, AG; Pieters, J				Mueller, Philipp; Massner, Jan; Jayachandran, Rajesh; Combaluzier, Benoit; Albrecht, Imke; Gatfield, John; Blum, Carmen; Ceredig, Rod; Rodewald, Hans-Reimer; Rolink, Antonius G.; Pieters, Jean			Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; ACTIN POLYMERIZATION; PHOSPHOLIPASE-C; ACTIVATION; MEMORY; COMPLEX; PROTEIN; TCR; MYCOBACTERIA; CYTOSKELETON	T cell homeostasis is essential for the functioning of the vertebrate immune system, but the intracellular signals required for T cell homeostasis are largely unknown. We here report that the WD-repeat protein family member coronin-1, encoded by the gene Coro1a, is essential in the mouse for T cell survival through its promotion of Ca2+ mobilization from intracellular stores. Upon T cell receptor triggering, coronin-1 was essential for the generation of inositol-1,4,5-trisphosphate from phosphatidylinositol-4,5-bisphosphate. The absence of coronin-1, although it did not affect T cell development, resulted in a profound defect in Ca2+ mobilization, interleukin-2 production, T cell proliferation and T cell survival. We conclude that coronin-1, through activation of Ca2+ release from intracellular stores, is an essential regulator of peripheral lymphocyte survival.	[Mueller, Philipp; Massner, Jan; Jayachandran, Rajesh; Combaluzier, Benoit; Albrecht, Imke; Gatfield, John; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Blum, Carmen; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89069 Ulm, Germany; [Ceredig, Rod; Rolink, Antonius G.] Univ Basel, Dept Clin Biol Sci, CH-4056 Basel, Switzerland	University of Basel; Ulm University; University of Basel	Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	jean.pieters@unibas.ch	Ceredig, Rhodri/A-7077-2010	Ceredig, Rhodri/0000-0002-4393-727X; Pieters, Jean/0000-0002-5284-9757				Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Denys A, 2004, FEBS LETT, V564, P177, DOI 10.1016/S0014-5793(04)00361-8; Ebinu JO, 2000, BLOOD, V95, P3199; Farber DL, 1998, J IMMUNOL, V160, P535; Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JAYACHANDRAN J, MOL BIOL CELL; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lee WT, 1996, J IMMUNOL, V157, P5300; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Okumura M, 1998, DNA CELL BIOL, V17, P779, DOI 10.1089/dna.1998.17.779; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; ROEDERER M, 1995, CYTOMETRY, V21, P187, DOI 10.1002/cyto.990210211; Saparov A, 1999, INT IMMUNOL, V11, P1253, DOI 10.1093/intimm/11.8.1253; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; YANG LJ, 1994, J BIOL CHEM, V269, P7156; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004	45	131	139	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					424	431		10.1038/ni1570	http://dx.doi.org/10.1038/ni1570			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18345003				2022-12-18	WOS:000254123200018
J	van Vliet, C; Bukczynska, PE; Puryer, MA; Sadek, CM; Shields, BJ; Tremblay, ML; Tiganis, T				van Vliet, C; Bukczynska, PE; Puryer, MA; Sadek, CM; Shields, BJ; Tremblay, ML; Tiganis, T			Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; GROWTH-FACTOR RECEPTOR; C-SRC; LIPID RAFTS; ENDOPLASMIC-RETICULUM; DEATH DECISIONS; MOTH-EATEN; ALPHA; TCPTP; TRANSDUCTION	The proinflammatory cytokine tumor necrosis factor (TNF) modulates cellular responses through the mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) signaling pathways, but the molecular mechanisms underlying MAPK activation are unknown. T cell protein tyrosine phosphatase (TCPTP) is essential for hematopoietic development and negatively regulates inflammatory responses. Using TCPTP-deficient fibroblasts, we show here that TCPTP regulates TNF-induced MAPK but not NF-kappaB signaling. TCPTP interacted with the adaptor protein TRAF2, and dephosphorylated and inactivated Src tyrosine kinases to suppress downstream signaling through extracellular signal-regulated kinases and production of interleukin 6. These results link TCPTP and Src tyrosine kinases to the selective regulation of TNF-induced MAPK signaling and identify a previously unknown mechanism for modulating inflammatory responses mediated by TNF.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Monash University; McGill University	Tiganis, T (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	Tony.Tiganis@med.monash.edu.au	Sadek, Christine/A-7356-2010; Tiganis, Tony/AAV-3495-2020	Tiganis, Tony/0000-0002-8065-9942				Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Doan JES, 2004, J IMMUNOL, V172, P7654, DOI 10.4049/jimmunol.172.12.7654; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Huang S, 2003, J BIOL CHEM, V278, P8326, DOI 10.1074/jbc.M208264200; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Kyriakis JM, 2001, NATURE, V414, P265, DOI 10.1038/35104735; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; TAYLOR SJ, 1995, J BIOL CHEM, V270, P10120, DOI 10.1074/jbc.270.17.10120; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Thomas RM, 2004, IMMUNITY, V20, P181, DOI 10.1016/S1074-7613(04)00023-8; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tobin D, 1998, P NATL ACAD SCI USA, V95, P565, DOI 10.1073/pnas.95.2.565; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	54	131	136	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					253	260		10.1038/ni1169	http://dx.doi.org/10.1038/ni1169			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15696169				2022-12-18	WOS:000227117400017
J	He, YW; Li, H; Zhang, J; Hsu, CL; Lin, E; Zhang, N; Guo, J; Forbush, KA; Bevan, MJ				He, YW; Li, H; Zhang, J; Hsu, CL; Lin, E; Zhang, N; Guo, J; Forbush, KA; Bevan, MJ			The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens	NATURE IMMUNOLOGY			English	Article							MANNOSE-BINDING PROTEIN; TOLL-LIKE RECEPTOR-4; INNATE IMMUNE-RESPONSE; NF-KAPPA-B; MAST-CELLS; F-SPONDIN; HOST-DEFENSE; LIPOPOLYSACCHARIDE; ACTIVATION; LECTIN	Microbial pathogens use a variety of their surface molecules to bind to host extracellular matrix (ECM) components to establish an effective infection. However, ECM components can also serve as an integral part of the innate immunity. Mice lacking expression of mindin (spondin 2), a highly conserved ECM protein, have an impaired ability to clear bacterial infection, and mindin-deficient macrophages show defective responses to a broad spectrum of microbial stimuli. Moreover, mindin binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. Thus, mindin is essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the ECM for microbial pathogens.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	He, YW (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.		Li, Hong/ABE-3959-2021	Zhang, Nu/0000-0001-9695-210X; Hsu, Chia-Lin/0000-0001-9383-6330	NIAID NIH HHS [R01 AI54685] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JC, 2000, DEV DYNAM, V218, P280; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; CAMPBELL PA, 1996, CURRENT PROTOCOLS IM; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Currie AJ, 2000, J IMMUNOL, V164, P3878, DOI 10.4049/jimmunol.164.7.3878; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Feizi T, 2000, IMMUNOL REV, V173, P79, DOI 10.1034/j.1600-065X.2000.917310.x; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; HAY ED, 1991, CELL BIOL EXTRACELLU, P1; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JIANG GZ, 1995, INFECT IMMUN, V63, P2537, DOI 10.1128/IAI.63.7.2537-2540.1995; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; MALAVIYA R, 1995, METHOD ENZYMOL, V253, P27; Malaviya R, 2001, IMMUNOL REV, V179, P16, DOI 10.1034/j.1600-065X.2001.790102.x; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Takahashi K, 2002, MICROBES INFECT, V4, P773, DOI 10.1016/S1286-4579(02)01597-6; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; Umemiya T, 1997, DEV BIOL, V186, P165, DOI 10.1006/dbio.1997.8591; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x	49	131	137	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					88	97		10.1038/ni1021	http://dx.doi.org/10.1038/ni1021			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14691481				2022-12-18	WOS:000187635800018
J	Muljo, SA; Schlissel, MS				Muljo, SA; Schlissel, MS			A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN GENE REARRANGEMENT; V(D)J RECOMBINASE ACTIVITY; MURINE LEUKEMIA-VIRUS; TYROSINE KINASE; IN-VIVO; SPI-B; C-ABL; LYMPHOCYTE DEVELOPMENT; MICE LACKING; IG-KAPPA	Abelson murine leukemia virus-transformed cell lines have provided a critical model system for studying the regulation of B cell development. However, transformation by v-Abl blocks B cell development, resulting in the arrest of these transformants in an early pre-B cell-like state. We report here that treatment of Abelson virus-transformed pre-B cell lines with the small molecule Abl kinase inhibitor (STI571) results in their differentiation to a late pre- B cell-like state characterized by induction of immunoglobulin (Ig) light chain gene rearrangement. DNA microarray analyses enabled us to identify two genes inhibited by v-Abl that encode the Igk 3' enhancer-binding transcription factors Spi-B and IRF-4. We show that enforced expression of these two factors is sufficient to induce germline Igk transcription in Abelson-transformed pro-B cell lines. This suggests a key role for these factors, and perhaps for c-Abl itself, in the regulated activation of Ig light chain gene rearrangement.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; Johns Hopkins University	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 439 Life Sci Addit, Berkeley, CA 94720 USA.	mss@uclink.berkeley.edu	Muljo, Stefan A/F-5671-2015	Muljo, Stefan A/0000-0003-1013-446X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL48702] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Banerjee A, 1998, J IMMUNOL, V161, P4611; Bendall HH, 2001, J IMMUNOL, V167, P264, DOI 10.4049/jimmunol.167.1.264; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brown L, 1997, NATURE, V387, P450, DOI 10.1038/387450a0; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dahl R, 2002, EMBO J, V21, P2220, DOI 10.1093/emboj/21.9.2220; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDIN JD, 1995, CELL IMMUNOL, V165, P44, DOI 10.1006/cimm.1995.1185; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; Marshall AJ, 1998, J IMMUNOL, V161, P6038; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; Muljo SA, 2000, IMMUNOL REV, V175, P80, DOI 10.1034/j.1600-065X.2000.017509.x; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Rao S, 1999, J BIOL CHEM, V274, P11115, DOI 10.1074/jbc.274.16.11115; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; ROSENBERG N, 1994, CURR OPIN IMMUNOL, V6, P203, DOI 10.1016/0952-7915(94)90093-0; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zou X, 1997, CURR TOP MICROBIOL, V224, P57	57	131	132	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					31	37		10.1038/ni870	http://dx.doi.org/10.1038/ni870			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12469118				2022-12-18	WOS:000180053000011
J	Young, D; Hussell, T; Dougan, G				Young, D; Hussell, T; Dougan, G			Chronic bacterial infections: living with unwanted guests	NATURE IMMUNOLOGY			English	Review							ENTERICA SEROVAR TYPHIMURIUM; INFLAMMATORY-BOWEL-DISEASE; COMPLETE GENOME SEQUENCE; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; TUBERCLE-BACILLI; TYPHOID-FEVER; CHLAMYDIA-PNEUMONIAE; PROTECTIVE IMMUNITY	Some bacterial pathogens can establish life-long chronic infections in their hosts. Persistence is normally established after an acute infection period involving activation of both the innate and acquired immune systems. Bacteria have evolved specific pathogenic mechanisms and harbor sets of genes that contribute to the establishment of a persistent lifestyle that leads to chronic infection. Persistent bacterial infection may involve occupation of a particular tissue type or organ or modification of the intracellular environment within eukaryotic cells. Bacteria appear to adapt their immediate environment to favor survival and may hijack essential immunoregulatory mechanisms designed to minimize immune pathology or the inappropriate activation of immune effectors.	Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Dougan, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.		Hussell, Tracy/O-4630-2014	Hussell, Tracy/0000-0001-7186-6141				Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Byrne GI, 2001, INFECT IMMUN, V69, P5423, DOI 10.1128/IAI.69.9.5423-5429.2001; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Dunstan SJ, 2001, J INFECT DIS, V183, P1156, DOI 10.1086/319289; Dunstan SJ, 2001, J INFECT DIS, V183, P261, DOI 10.1086/317940; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hess J, 1996, J IMMUNOL, V156, P3321; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hughes EA, 2002, IMMUNITY, V16, P325, DOI 10.1016/S1074-7613(02)00293-5; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kingsley RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/j.1365-2958.2002.02805.x; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MA A, 1995, J EXP MED, V182, P1567, DOI 10.1084/jem.182.5.1567; MacDonald TT, 2001, TRENDS IMMUNOL, V22, P244, DOI 10.1016/S1471-4906(01)01892-0; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; Moreira AL, 2002, INFECT IMMUN, V70, P2100, DOI 10.1128/IAI.70.4.2100-2107.2002; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; OBRIEN AD, 1982, J IMMUNOL, V129, P1349; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Panwala CM, 1998, J IMMUNOL, V161, P5733; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Porcella SF, 2001, J CLIN INVEST, V107, P651, DOI 10.1172/JCI12484; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RICH AR, 2002, PATHOGENESIS TUBERCU; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Sansonetti P, 2001, SEMIN IMMUNOL, V13, P381, DOI 10.1006/smim.2001.0335; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Strober W, 2001, J CLIN INVEST, V107, P667, DOI 10.1172/JCI12559; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Ting LM, 1999, J IMMUNOL, V163, P3898; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Ulrichs T, 2000, Rev Immunogenet, V2, P416; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; VANDIVIERE H M, 1956, Am J Med Sci, V232, P30, DOI 10.1097/00000441-195607000-00006; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Via LE, 1998, J CELL SCI, V111, P897; Virji M, 1996, ANN NY ACAD SCI, V797, P273, DOI 10.1111/j.1749-6632.1996.tb52976.x; Wain J, 1999, J CLIN MICROBIOL, V37, P2466, DOI 10.1128/JCM.37.8.2466-2472.1999; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; Warren J, 2002, INFECT IMMUN, V70, P551, DOI 10.1128/IAI.70.2.551-557.2002; WAYNE LG, 1902, ANNU REV MICROBIOL, V55, P139; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	96	131	132	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1026	1032		10.1038/ni1102-1026	http://dx.doi.org/10.1038/ni1102-1026			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407411				2022-12-18	WOS:000179073000008
J	Hachim, A; Kavian, N; Cohen, CA; Chin, AWH; Chu, DKW; Mok, CKP; Tsang, OTY; Yeung, YC; Perera, RAPM; Poon, LLM; Peiris, JSM; Valkenburg, SA				Hachim, Asmaa; Kavian, Niloufar; Cohen, Carolyn A.; Chin, Alex W. H.; Chu, Daniel K. W.; Mok, Chris K. P.; Tsang, Owen T. Y.; Yeung, Yiu Cheong; Perera, Ranawaka A. P. M.; Poon, Leo L. M.; Peiris, J. S. Malik; Valkenburg, Sophie A.			ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article								Accurate serology testing is urgently needed to help diagnose SARS-CoV-2 infection. Here Valkenburg and colleagues use a luciferase immunoprecipitation system to assess the antibody responses to 15 different SARS-CoV-2 antigens in patients with COVID-19 and find ORF8 and ORF3b antibodies, taken together as a cluster of points, identified 96.5% of COVID-19 samples at early and late time points of disease with 99.5% specificity The SARS-CoV-2 virus emerged in December 2019 and has caused a worldwide pandemic due to the lack of any pre-existing immunity. Accurate serology testing is urgently needed to help diagnose infection, determine past exposure of populations and assess the response to a future vaccine. The landscape of antibody responses to SARS-CoV-2 is unknown. In this study, we utilized the luciferase immunoprecipitation system to assess the antibody responses to 15 different SARS-CoV-2 antigens in patients with COVID-19. We identified new targets of the immune response to SARS-CoV-2 and show that nucleocapsid, open reading frame (ORF)8 and ORF3b elicit the strongest specific antibody responses. ORF8 and ORF3b antibodies, taken together as a cluster of points, identified 96.5% of COVID-19 samples at early and late time points of disease with 99.5% specificity. Our findings could be used to develop second-generation diagnostic tests to improve serological assays for COVID-19 and are important in understanding pathogenicity.	[Hachim, Asmaa; Kavian, Niloufar; Cohen, Carolyn A.; Mok, Chris K. P.; Poon, Leo L. M.; Peiris, J. S. Malik; Valkenburg, Sophie A.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China; [Kavian, Niloufar] Univ Paris 05, Ctr Hosp Univ Cochin, AP HP, Fac Med,Sorbonne Paris Cite,Hop Univ Paris Ctr, Paris, France; [Kavian, Niloufar] Univ Paris 05, Inst Cochin, INSERM U1016, Sorbonne Paris Cite, Paris, France; [Chin, Alex W. H.; Chu, Daniel K. W.; Perera, Ranawaka A. P. M.; Poon, Leo L. M.; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Publ Hlth Lab Sci, Hong Kong, Peoples R China; [Tsang, Owen T. Y.; Yeung, Yiu Cheong] Princess Margaret Hosp, Hosp Author Hong Kong, Infect Dis Ctr, Hong Kong, Peoples R China	University of Hong Kong; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong	Kavian, N; Valkenburg, SA (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China.; Kavian, N (corresponding author), Univ Paris 05, Ctr Hosp Univ Cochin, AP HP, Fac Med,Sorbonne Paris Cite,Hop Univ Paris Ctr, Paris, France.; Kavian, N (corresponding author), Univ Paris 05, Inst Cochin, INSERM U1016, Sorbonne Paris Cite, Paris, France.	niloufar@hku.hk; sophiev@hku.hk	Poon, Leo/AAP-6887-2020; Mok, Chris Ka Pun/ABD-2667-2021; -, Ranawaka A.P.M Perera/N-8263-2015	-, Ranawaka A.P.M Perera/0000-0003-3936-1535; Kavian, Niloufar/0000-0003-2829-3311	Research Grants Scheme [GRF 17113718]; Health and Medical Research Fund [HMRF COVID190115]; Hong Kong Health and Medical Research Fund [COVID190115]; General Research Fund [17113718]	Research Grants Scheme; Health and Medical Research Fund; Hong Kong Health and Medical Research Fund; General Research Fund	This study was partly supported by the Research Grants Scheme (GRF 17113718) and Health and Medical Research Fund (HMRF COVID190115). We thank L.-F. Wang (Duke NUS, Singapore) for technical advice for establishing the LIPS assay. We thank J.T. Wu and K. Leung for providing access to the blood donor plasma as controls. The authors thank O. Kavian and H. Hagen for their help with the ConTeXt software used in Figs. 3f and 4d. This project was supported by the Hong Kong Health and Medical Research Fund (COVID190115, from S.A.V.) and General Research Fund (17113718, from S.A.V.). The study of the patients with COVID-19 was approved by the Institutional Review Board of the Hong Kong West Cluster of the Hospital Authority of Hong Kong (approval no. UW20-169). The collection of plasma from blood donors serving as controls was approved by the Institutional Review Board of The Hong Kong University and the Hong Kong Island West Cluster (reference no. UW16-254).	Burbelo PD, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-22; Burbelo PD, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030089; Burbelo PD, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0545-y; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Keng CT, 2006, VIROLOGY, V354, P132, DOI 10.1016/j.virol.2006.06.026; Lv Huibin, 2020, bioRxiv, DOI 10.1101/2020.03.15.993097; McBride R, 2012, VIRUSES-BASEL, V4, P2902, DOI 10.3390/v4112902; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Perera RAPM, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.16.2000421; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Wang X., 2020, PREPRINT, DOI 10.20944/preprints202003.0360.v2; Weissleder R, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc1931; Wu F, 2020, PREPRINT, DOI 10.1101/2020.03.30.20047365; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yong SEF, 2020, LANCET INFECT DIS, V20, P809, DOI 10.1016/S1473-3099(20)30273-5; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zeng WH, 2020, BIOCHEM BIOPH RES CO, V527, P618, DOI 10.1016/j.bbrc.2020.04.136; Zhang CX, 2020, J PROTEOME RES, V19, P1351, DOI 10.1021/acs.jproteome.0c00129; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zhang Y, 2020, BIORXIV, DOI [10.1101/2020.05.24.111823, DOI 10.1101/2020.05.24.111823]	28	130	133	3	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1293	+		10.1038/s41590-020-0773-7	http://dx.doi.org/10.1038/s41590-020-0773-7		AUG 2020	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32807944	Green Submitted, Bronze			2022-12-18	WOS:000561014100001
J	Casero, D; Sandoval, S; Seet, CS; Scholes, J; Zhu, YH; Ha, VL; Luong, A; Parekh, C; Crooks, GM				Casero, David; Sandoval, Salemiz; Seet, Christopher S.; Scholes, Jessica; Zhu, Yuhua; Ha, Vi Luan; Luong, Annie; Parekh, Chintan; Crooks, Gay M.			Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; EXPRESSION; EVOLUTION; PATTERNS	To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (IncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by IncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring IncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global IncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus.	[Casero, David; Sandoval, Salemiz; Zhu, Yuhua; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Seet, Christopher S.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Dept Med, Los Angeles, CA 90095 USA; [Scholes, Jessica; Crooks, Gay M.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Ha, Vi Luan; Luong, Annie; Parekh, Chintan] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA; [Parekh, Chintan] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Crooks, Gay M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Crooks, GM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	cparekh@chla.usc.edu; gcrooks@mednet.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Seet, Christopher/0000-0002-4821-1400	US National Institutes of Health [AI-28697, K12 HD052954, K12 HD034610, P01HL073104, T32HL066992, T32 HL086345]; UCLA AIDS Institute; UCLA Council of Bioscience Resources; St. Baldrick's Foundation; Nautica Foundation; Tower Cancer Research Foundation; Couples Against Leukemia Foundation; Joseph Drown Foundation; UCLA Broad Stem Cell Research Center; California Institute for Regenerative Medicine [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610, K12HD052954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086345, P01HL073104, T32HL066992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA AIDS Institute; UCLA Council of Bioscience Resources; St. Baldrick's Foundation; Nautica Foundation; Tower Cancer Research Foundation; Couples Against Leukemia Foundation; Joseph Drown Foundation; UCLA Broad Stem Cell Research Center; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Codrea, A. George and S. Feng for technical assistance; M. Pellegrini and R. D'Auria for computational support; the Broad Stem Cell Research Center high-throughput sequencing facility and the Broad Stem Cell Research Center and Children's Hospital Los Angeles flow cytometry facilities; and the Center for AIDS Research Virology Core Lab (supported by the US National Institutes of Health (AI-28697), the UCLA AIDS Institute and the UCLA Council of Bioscience Resources) for reagents. Supported by St. Baldrick's Foundation (C.F.), the US National Institutes of Health (K12 HD052954 and K12 HD034610 to C.P.; P01HL073104 to G.M.C.; T32HL066992 to C.S.S.; and T32 HL086345 to S.S.), the Nautica Foundation (C.F.), the Tower Cancer Research Foundation (C.P.), the Couples Against Leukemia Foundation (C.P.), the Joseph Drown Foundation (C.P.), UCLA Broad Stem Cell Research Center (G.M.C. and D.C.) and the California Institute for Regenerative Medicine (TG2-01169 for S.S.).	Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/EPI.12.18, 10.2217/epi.12.18]; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Durinck K, 2014, HAEMATOLOGICA, V99, P1808, DOI 10.3324/haematol.2014.115683; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Plum J, 2008, SEMIN IMMUNOPATHOL, V30, P411, DOI 10.1007/s00281-008-0135-2; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Si YQ, 2014, BIOINFORMATICS, V30, P197, DOI 10.1093/bioinformatics/btt632; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412	32	130	132	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1282	1291		10.1038/ni.3299	http://dx.doi.org/10.1038/ni.3299			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26502406	Green Accepted, Green Submitted			2022-12-18	WOS:000365062100012
J	Kidder, BL; Hu, GQ; Zhao, K				Kidder, Benjamin L.; Hu, Gangqing; Zhao, Keji			ChIP-Seq: technical considerations for obtaining high-quality data	NATURE IMMUNOLOGY			English	Article							GENOMIC REGIONS; CELLS; MODEL	Chromatin immunoprecipitation followed by next-generation sequencing analysis (ChIP-Seq) is a powerful method with which to investigate the genome-wide distribution of chromatin-binding proteins and histone modifications in any genome with a known sequence. The application of this technique to a variety of developmental and differentiation systems has provided global views of the cis-regulatory elements, transcription factor function and epigenetic processes involved in the control of gene transcription. Here we describe several technical aspects of the ChIP-Seq assay that diminish bias and background noise and allow the consistent generation of high-quality data.	[Kidder, Benjamin L.; Hu, Gangqing; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kidder, BL (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	benjamin.kidder@nih.gov; zhaok@nhlbi.nih.gov	Hu, Gangqing/ABA-3507-2020; HU, GANGQING/K-5849-2012	HU, GANGQING/0000-0001-5453-6888	Division of Intramural Research of the National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Abraham and D. Northrup for critical reading of the manuscript, and K. Cui for discussions. Supported by the Division of Intramural Research of the National Heart, Lung and Blood Institute.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Kao WC, 2011, GENOME RES, V21, P1181, DOI 10.1101/gr.111351.110; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Kolodziej KE, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-6; Ledergerber C, 2011, BRIEF BIOINFORM, V12, P489, DOI 10.1093/bib/bbq077; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Szalkowski AM, 2011, BRIEF BIOINFORM, V12, P626, DOI 10.1093/bib/bbq068; Taslim C, 2011, BIOINFORMATICS, V27, P1569, DOI 10.1093/bioinformatics/btr165; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	25	130	135	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					918	922		10.1038/ni.2117	http://dx.doi.org/10.1038/ni.2117			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934668	Green Accepted			2022-12-18	WOS:000295084500003
J	Mohan, JF; Levisetti, MG; Calderon, B; Herzog, JW; Petzold, SJ; Unanue, ER				Mohan, James F.; Levisetti, Matteo G.; Calderon, Boris; Herzog, Jeremy W.; Petzold, Shirley J.; Unanue, Emil R.			Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes	NATURE IMMUNOLOGY			English	Article							CLASS-II MHC; NOD MICE; DENDRITIC CELLS; SELF-ANTIGEN; HUMAN THYMUS; TOLERANCE; MOUSE; COMPLEXES; EPITOPE; EXPRESSION	In addition to the genetic framework, there are two other critical requirements for the development of tissue-specific autoimmune disease. First, autoreactive T cells need to escape thymic negative selection. Second, they need to find suitable conditions for autoantigen presentation and activation in the target tissue. We show here that these two conditions are fulfilled in diabetic mice of the nonobese diabetic (NOD) strain. A set of autoreactive CD4(+) T cells specific for an insulin peptide, with the noteworthy feature of not recognizing the insulin protein when processed by antigen-presenting cells (APCs), escaped thymic control, participated in diabetes and caused disease. Moreover, APCs in close contact with beta cells in the islets of Langerhans bore vesicles with the antigenic insulin peptides and activated peptide-specific T cells. Our findings may be relevant for other cases of endocrine autoimmunity.	[Mohan, James F.; Levisetti, Matteo G.; Calderon, Boris; Herzog, Jeremy W.; Petzold, Shirley J.; Unanue, Emil R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	unanue@pathbox.wustl.edu		Calderon, Boris/0000-0003-1575-0739	NIAID NIH HHS [R01 AI024742-24, R01 AI024742, AI024742] Funding Source: Medline; NIDDK NIH HHS [R01 DK058177, P60 DK020579-309002, R01 DK058177-11, P30 DK020579, DK058177, P60 DK020579, P60DK20579] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024742, R01AI024742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R01DK058177] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abiru N, 2001, DIABETES, V50, P1274, DOI 10.2337/diabetes.50.6.1274; Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Catalfamo M, 1999, INT IMMUNOL, V11, P269, DOI 10.1093/intimm/11.2.269; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Croizet K, 2000, LAB INVEST, V80, P1215, DOI 10.1038/labinvest.3780129; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Garcia CA, 2005, J IMMUNOL, V175, P2111, DOI 10.4049/jimmunol.175.4.2111; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jasinski JM, 2006, DIABETES, V55, P1978, DOI 10.2337/db06-0058; Kawamura K, 2008, J IMMUNOL, V181, P3202, DOI 10.4049/jimmunol.181.5.3202; Levisetti MG, 2008, DIABETES, V57, P1852, DOI 10.2337/db08-0068; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lovitch SB, 2003, J IMMUNOL, V170, P4155, DOI 10.4049/jimmunol.170.8.4155; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nakayama M, 2007, J CLIN INVEST, V117, P1835, DOI 10.1172/JCI31368; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Pu Z, 2002, P NATL ACAD SCI USA, V99, P8844, DOI 10.1073/pnas.092260499; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	36	130	132	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					350	U32		10.1038/ni.1850	http://dx.doi.org/10.1038/ni.1850			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20190756	Green Accepted			2022-12-18	WOS:000275849500015
J	Wang, HB; Wang, JT; Zhang, L; Geng, ZH; Xu, WL; Xu, T; Huo, YQ; Zhu, XL; Plow, EF; Chen, M; Geng, JG				Wang, Hai-Bo; Wang, Jin-Tao; Zhang, Lei; Geng, Zhen H.; Xu, Wei-Li; Xu, Tao; Huo, Yuqing; Zhu, Xueliang; Plow, Edward F.; Chen, Ming; Geng, Jian-Guo			P-selectin primes leukocyte integrin activation during inflammation	NATURE IMMUNOLOGY			English	Article							GLYCOPROTEIN LIGAND 1; FIRM ADHESION; SRC KINASES; CELL; BINDING; NEUTROPHILS; PROTEIN; EXPRESSION; MEMBRANE; PLATELETS	Selectins mediate leukocyte rolling and prime leukocytes for integrin-mediated leukocyte adhesion. However, neither the in vivo importance of nor the signaling pathway by which selectin-mediated integrin activation occurs has been determined. We report here that P-selectin-deficient mice manifested impaired leukocyte adhesion, which was 'rescued' by soluble P-selectin. Mechanistically, the cytoplasmic domain of P-selectin glycoprotein ligand 1 formed a constitutive complex with Nef-associated factor 1. After binding of P-selectin, Src kinases phosphorylated Nef-associated factor 1, which recruited the phosphoinositide-3-OH kinase p85-p110 delta heterodimer and resulted in activation of leukocyte integrins. Inhibition of this signal-transduction pathway diminished the adhesion of leukocytes to capillary venules and suppressed peritoneal infiltration of leukocytes. Our data demonstrate the functional importance of this newly identified signaling pathway mediated by P-selectin glycoprotein ligand 1.	Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,Lab Mol Cell Biol, Shanghai 200031, Peoples R China; Univ Minnesota, Sch Med, Vasc Biol Ctr, Div Hematol,Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Div Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Div Cardiol, Dept Med, Minneapolis, MN 55455 USA; Cleveland Clin Fdn, Dept Mol Cardiol, Josephs J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation	Geng, JG (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,Lab Mol Cell Biol, Shanghai 200031, Peoples R China.	chenm@sibs.ac.cn; genglab@gmail.com	Xu, Weili/AAB-6530-2020; Xu, Tao/I-1561-2014	Xu, Tao/0000-0002-3436-3024; Xu, Tao/0000-0002-4085-6191	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064743] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50HL081011] Funding Source: Medline; NIAID NIH HHS [R01AI064743] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Barkalow FJ, 2000, BLOOD, V96, P3070; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Blanks JE, 1998, EUR J IMMUNOL, V28, P433, DOI 10.1002/(SICI)1521-4141(199802)28:02<433::AID-IMMU433>3.0.CO;2-U; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Croce K, 1998, BIOCHEMISTRY-US, V37, P16472, DOI 10.1021/bi981341g; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; FORSYTH KD, 1990, J IMMUNOL METHODS, V128, P159, DOI 10.1016/0022-1759(90)90206-B; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; FURIE B, 1995, THROMB HAEMOSTASIS, V74, P224; Geng JG, 1997, J CELL BIOL, V137, P743, DOI 10.1083/jcb.137.3.743; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; GLASSER L, 1990, AM J CLIN PATHOL, V93, P662, DOI 10.1093/ajcp/93.5.662; Gupta K, 2000, J VIROL, V74, P11811, DOI 10.1128/JVI.74.24.11811-11824.2000; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; KUIJPERS TW, 1991, BLOOD, V78, P1105; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; MA L, 1994, J BIOL CHEM, V269, P27739; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; NOLTE D, 1994, AM J PHYSIOL-HEART C, V267, pH1637, DOI 10.1152/ajpheart.1994.267.4.H1637; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Piccardoni P, 2001, BLOOD, V98, P108, DOI 10.1182/blood.V98.1.108; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Reedquist KA, 2006, BIOCHEM SOC T, V34, P727, DOI 10.1042/BST0340727; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Wagner DD, 2005, ARTERIOSCL THROM VAS, V25, P1321, DOI 10.1161/01.ATV.0000166521.90532.44; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Woollard KJ, 2006, CIRC RES, V98, P149, DOI 10.1161/01.RES.0000199295.14073.69; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	50	130	141	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					882	892		10.1038/ni1491	http://dx.doi.org/10.1038/ni1491			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17632516				2022-12-18	WOS:000248169400016
J	Mathas, S; Janz, M; Hummel, F; Hummel, M; Wollert-Wulf, B; Lusatis, S; Anagnostopoulos, I; Lietz, A; Sigvardsson, M; Jundt, F; Johrens, K; Bommert, K; Stein, H; Dorken, B				Mathas, S; Janz, M; Hummel, F; Hummel, M; Wollert-Wulf, B; Lusatis, S; Anagnostopoulos, I; Lietz, A; Sigvardsson, M; Jundt, F; Johrens, K; Bommert, K; Stein, H; Dorken, B			Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma	NATURE IMMUNOLOGY			English	Article							REED-STERNBERG CELLS; LOOP-HELIX PROTEINS; GENE-EXPRESSION; IMMUNOGLOBULIN TRANSCRIPTION; DNA-BINDING; KAPPA-B; PAX5; DIFFERENTIATION; DISEASE; LINES	B cell differentiation is controlled by a complex network of lineage-restricted transcription factors. How perturbations to this network alter B cell fate remains poorly understood. Here we show that classical Hodgkin lymphoma tumor cells, which originate from mature B cells, have lost the B cell phenotype as a result of aberrant expression of transcriptional regulators. The B cell-specific transcription factor program was disrupted by overexpression of the helix-loop-helix proteins ABF-1 and Id2. Both factors antagonized the function of the B cell-determining transcription factor E2A. As a result, expression of genes specific to B cells was lost and expression of genes not normally associated with the B lineage was upregulated. These data demonstrate the plasticity of mature human lymphoid cells and offer an explanation for the unique classical Hodgkin lymphoma phenotype.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Med Univ Berlin, Charite, D-13353 Berlin, Germany; Med Univ Berlin, Inst Pathol, D-12200 Berlin, Germany; Lund Univ, Sterncell Ctr, Dept Hematopoiet Stemcell Biol, S-22184 Lund, Sweden	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Lund University	Mathas, S (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	smathas@mdc-berlin.de	Bommert, Kurt/G-9247-2011; Jundt, Franziska/E-9748-2014; Mathas, Stephan/I-5589-2015	Jundt, Franziska/0000-0002-8661-7110; Janz, Martin/0000-0002-1127-0044; Sigvardsson, Mikael/0000-0001-8527-7276; Hummel, Michael/0000-0001-6717-605X				Arguello M, 2003, ONCOGENE, V22, P964, DOI 10.1038/sj.onc.1206270; Becker-Herman S, 2002, J IMMUNOL, V168, P5507, DOI 10.4049/jimmunol.168.11.5507; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Doerr JR, 2005, J MOL BIOL, V350, P631, DOI 10.1016/j.jmb.2005.05.032; Dorfman DM, 2005, HUM PATHOL, V36, P10, DOI 10.1016/j.humpath.2004.10.006; Gisler R, 2000, BLOOD, V96, P1457, DOI 10.1182/blood.V96.4.1457.h8001457_1457_1464; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Hertel CB, 2002, ONCOGENE, V21, P4908, DOI 10.1038/sj.onc.1205629; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Honda H, 1999, BLOOD, V93, P2780; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x; Knight JC, 2004, NAT GENET, V36, P394, DOI 10.1038/ng1331; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; Leithauser F, 2001, BLOOD, V98, P2762, DOI 10.1182/blood.V98.9.2762; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Mathas S, 2004, J EXP MED, V199, P1041, DOI 10.1084/jem.20031080; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Rivera R, 2001, ONCOGENE, V20, P8308, DOI 10.1038/sj.onc.1205091; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Sigvardsson M, 2000, MOL CELL BIOL, V20, P3640, DOI 10.1128/MCB.20.10.3640-3654.2000; Stein H, 2001, BLOOD, V97, P496, DOI 10.1182/blood.V97.2.496; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Ushmorov A, 2004, BLOOD, V104, P3326, DOI 10.1182/blood-2003-04-1197; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zhao F, 2003, MOL CELL BIOL, V23, P3837, DOI 10.1128/MCB.23.11.3837-3846.2003; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	49	130	146	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					207	215		10.1038/ni1285	http://dx.doi.org/10.1038/ni1285			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16369535				2022-12-18	WOS:000234801700022
J	Soares, L; Seroogy, C; Skrenta, H; Anandasabapathy, N; Lovelace, P; Chung, CD; Engleman, E; Fathman, CG				Soares, L; Seroogy, C; Skrenta, H; Anandasabapathy, N; Lovelace, P; Chung, CD; Engleman, E; Fathman, CG			Two isoforms of otubain 1 regulate T cell anergy via GRAIL	NATURE IMMUNOLOGY			English	Article							DEUBIQUITINATING ENZYMES; CYSTEINE PROTEASES; CBL-B; UBIQUITIN; PATHWAY; PROTEINS; FAMILY; UBPY; P53	The active ubiquitin E3 ligase GRAIL is crucial in the induction of CD4 T cell anergy. Here we show that GRAIL is associated with and regulated by two isoforms of the ubiquitin-specific protease otubain 1. In lethally irradiated mice reconstituted with bone marrow cells from T cell receptor-transgenic mice retrovirally transduced to express the genes encoding these proteases, otubain 1-expressing cells contained negligible amounts of endogenous GRAIL, proliferated well and produced large amounts of interleukin 2 after antigenic stimulation. In contrast, cells expressing the alternatively spliced isoform, otubain 1 alternative reading frame 1, contained large amounts of endogenous GRAIL and were functionally anergic, and they proliferated poorly and produced undetectable interleukin 2 when stimulated in a similar way. Thus, these two proteins have opposing epistatic functions in controlling the stability of GRAIL expression and the resultant anergy phenotype in T cells.	Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Fathman, CG (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.			Anandasabapathy, Niroshana/0000-0002-0473-8358	NCI NIH HHS [CA85774, CA65237-14] Funding Source: Medline; NIAID NIH HHS [5T32 AI07290-18, AI-49903-02, AI01731-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065237, R01CA085774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049903, T32AI007290] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Dove SL, 2001, J BACTERIOL, V183, P6413, DOI 10.1128/JB.183.21.6413-6421.2001; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gnesutta N, 2001, J BIOL CHEM, V276, P39448, DOI 10.1074/jbc.M103454200; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li TW, 2001, FEBS LETT, V488, P201, DOI 10.1016/S0014-5793(00)02436-4; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Nakajima A, 2001, J CLIN INVEST, V107, P1293, DOI 10.1172/JCI12037; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; QUILL H, 1987, J IMMUNOL, V138, P3704; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Yang L, 2002, P NATL ACAD SCI USA, V99, P6204, DOI 10.1073/pnas.092154599; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	24	130	141	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					45	54		10.1038/ni1017	http://dx.doi.org/10.1038/ni1017			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14661020				2022-12-18	WOS:000187635800013
J	Ujike, A; Takeda, K; Nakamura, A; Ebihara, S; Akiyama, K; Takai, T				Ujike, A; Takeda, K; Nakamura, A; Ebihara, S; Akiyama, K; Takai, T			Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B-/- mice	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; COLONY-STIMULATING FACTOR; INHIBITORY RECEPTORS; GAMMA-CHAIN; SUPERFAMILY MEMBERS; MYELOID CELLS; MAST-CELLS; HLA-C	Mice deficient for paired immunoglobulin (Ig)-like receptor B (PIR-B) show defective regulation of receptor-mediated activation in antigen-presenting cells. Older PIR-B-/- mice had an increased number of peritoneal B1 cells. Splenic PIR-B-/- B2 cells were constitutively activated and proliferated much more than those from wild-type mice upon B cell receptor ligation. T helper type 2 (T(H)2)-prone humoral responses were augmented in PIR-B-/- mice upon immunization with T-dependent antigens, including increased interleukin 4 and decreased interferon-gamma responses, as well as enhanced IgGI and IgE production. Impaired maturation of dendritic cells (DCs), possibly due to perturbed intracellular signaling, was responsible for the skewed responses. Thus, PIR-B is critical for B cell suppression, DC maturation and for balancing T(H)1 and T(H)2 immune responses.	Tohoku Univ, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Inst Dev Aging & Canc, JST, CREST Program, Sendai, Miyagi 9808575, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Takai, T (corresponding author), Tohoku Univ, Dept Expt Immunol, Seiryo 4-1, Sendai, Miyagi 9808575, Japan.		Ebihara, Satoru/GYD-3723-2022					ARM JP, 1991, J BIOL CHEM, V266, P15966; Arm JP, 1997, J IMMUNOL, V159, P2342; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Borges L, 1997, J IMMUNOL, V159, P5192; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Dennis G, 1999, J IMMUNOL, V163, P6371; Dennis G, 2000, P NATL ACAD SCI USA, V97, P13245, DOI 10.1073/pnas.230442897; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Mul Al-F, 1995, EMBO J, V14, P1166; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; Nakajima H, 1999, J IMMUNOL, V162, P5; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Olcese L, 1997, J IMMUNOL, V158, P5083; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rojo S, 2000, MOL CELL BIOL, V20, P7178, DOI 10.1128/MCB.20.19.7178-7182.2000; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wheadon H, 2002, CELL SIGNAL, V14, P219, DOI 10.1016/S0898-6568(01)00241-8; Yamashita Y, 1998, J IMMUNOL, V161, P4042; Yamashita Y, 1998, J BIOCHEM-TOKYO, V123, P358, DOI 10.1093/oxfordjournals.jbchem.a021945	51	130	140	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					542	548		10.1038/ni801	http://dx.doi.org/10.1038/ni801			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021780				2022-12-18	WOS:000175874700013
J	Moody, DB; Briken, V; Cheng, TY; Roura-Mir, C; Guy, MR; Geho, DH; Tykocinski, ML; Besra, GS; Porcelli, SA				Moody, DB; Briken, V; Cheng, TY; Roura-Mir, C; Guy, MR; Geho, DH; Tykocinski, ML; Besra, GS; Porcelli, SA			Lipid length controls antigen entry into endosomal and nonendosomal pathways for CDIb presentation	NATURE IMMUNOLOGY			English	Article							T-CELL RECOGNITION; PRESENTING MOLECULES; LIPOGLYCAN ANTIGENS; STRUCTURAL REQUIREMENTS; CYTOPLASMIC TAIL; SELF-GLYCOLIPIDS; HUMAN CD1B; MOUSE CD1; BINDING; LYMPHOCYTES	CD I proteins present various glycolipid antigens to T cells, but the cellular mechanisms that control which particular glycolipids generate T cell responses are not understood. We show here that T cell recognition of glucose monomycolate antigens with long (C-80) alkyl chains involves the delivery of CD Ib proteins and antigens to late endosomes in a process that takes several hours. In contrast, analogs of the same antigen with shorter (C-32) alkyl chains are rapidly, but inefficiently, presented by cell surface CD Ib proteins. Dendritic cells (DCs) preferentially present long-chain glycolipids, which results, in part, from their rapid internalization and selective delivery of antigens to endosomal compartments. Nonprofessional antigen-presenting cells, however, preferentially present short-chain glycolipids because of their lack of prominent endosomal presentation pathways. Because long alkyl chain length distinguishes certain microbial glycolipids from common mammalian glycolipids, these findings suggest that DCs use a specialized endosomal-loading pathway to promote preferential recognition of glycolipids with a more intrinsically foreign structure.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Univ Newcastle Upon Tyne, Sch Med, Dept Microbiol & Immunol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg Room 514,1 Jimmy Fund Way, Boston, MA 02115 USA.		Roura-Mir, Carme/D-4538-2013	Roura-Mir, Carme/0000-0003-0514-337X; Briken, Volker/0000-0001-5830-6107; Besra, Gurdyal/0000-0002-5605-0395	NCI NIH HHS [CA74958] Funding Source: Medline; NIAID NIH HHS [AI 31044, AI48933, AI49313, AI 38960, AI45889] Funding Source: Medline; NIAMS NIH HHS [ARO1988] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038960, R01AI049313, R01AI031044, R21AI131044, R01AI045889, R01AI048933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001988] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Calabi F, 2000, SEMIN IMMUNOL, V12, P503, DOI 10.1006/smim.2000.0271; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DATTA AK, 1991, CARBOHYD RES, V218, P95, DOI 10.1016/0008-6215(91)84089-W; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Geho DH, 2000, J IMMUNOL, V165, P1272, DOI 10.4049/jimmunol.165.3.1272; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; KAUFMANN SHE, 1995, IMMUNOL TODAY, V16, P338, DOI 10.1016/0167-5699(95)80151-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; MARTIN LH, 1987, P NATL ACAD SCI USA, V84, P9189, DOI 10.1073/pnas.84.24.9189; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moody DB, 1999, IMMUNOL LETT, V65, P85, DOI 10.1016/S0165-2478(98)00129-1; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Niazi KR, 2001, J IMMUNOL, V166, P2562, DOI 10.4049/jimmunol.166.4.2562; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; SACCHETTINI JC, 1993, J BIOL CHEM, V268, P18399; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; TYKOCINSKI ML, 1988, P NATL ACAD SCI USA, V85, P3555, DOI 10.1073/pnas.85.10.3555; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	45	130	132	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					435	442		10.1038/ni780	http://dx.doi.org/10.1038/ni780			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11938350				2022-12-18	WOS:000175411200011
J	Kaya, Z; Afanasyeva, M; Wang, Y; Dohmen, KM; Schlichting, J; Tretter, T; Fairweather, D; Holers, VM; Rose, NR				Kaya, Z; Afanasyeva, M; Wang, Y; Dohmen, KM; Schlichting, J; Tretter, T; Fairweather, D; Holers, VM; Rose, NR			Contribution of the innate immune system to autoimmune myocarditis: a role for complement	NATURE IMMUNOLOGY			English	Article							VIRUS B3-INDUCED MYOCARDITIS; HUMAN-IMMUNODEFICIENCY-VIRUS; TUMOR-NECROSIS-FACTOR; CARDIAC MYOSIN; IMMUNOPATHOGENIC MECHANISMS; MONOCLONAL-ANTIBODIES; B-3 MYOCARDITIS; LYMPHOCYTES-B; C3 PRODUCTION; BALB/C MICE	Myocarditis is a principal cause of heart disease among young adults and is often a precursor of heart failure due to dilated cardiomyopathy. We show here that complement is critical for the induction of experimental autoimmune myocarditis and that it acts through complement receptor type 1 (CRI) and type 2 (CR2). We also found a subset of CD44(hi)CD62L(lo)T cells that expresses CR 1 and CR2 and propose that both receptors are involved in the expression of B and T cell activation markers, T cell proliferation and cytokine production. These findings provide a mechanism by which activated complement, a key product of the innate immune response, modulates the induction of an autoimmune disease.	Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rose, NR (corresponding author), Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL065100, R01HL033878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031105] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33878, HL65100] Funding Source: Medline; NIAID NIH HHS [AI31105] Funding Source: Medline; NIEHS NIH HHS [ES07141] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Afanasyeva M, 2001, AM J PATHOL, V159, P193, DOI 10.1016/S0002-9440(10)61685-9; Baiu DC, 1999, J IMMUNOL, V162, P3125; BROOIMANS RA, 1990, J IMMUNOL, V144, P3835; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; Davoust N, 1999, J IMMUNOL, V163, P6551; DELIBRIAS CC, 1994, EUR J IMMUNOL, V24, P2784, DOI 10.1002/eji.1830241131; DELIBRIAS CC, 1992, J IMMUNOL, V149, P768; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; ERICKSON RP, 1964, J IMMUNOL, V92, P611; ESTRIN M, 1987, AM J PATHOL, V127, P335; Fang YF, 1998, J IMMUNOL, V160, P5273; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FISCHER E, 1991, J IMMUNOL, V146, P865; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; HUBER SA, 1986, AM J PATHOL, V122, P284; HUBER SA, 1980, AM J PATHOL, V98, P681; Kacani L, 2000, J VIROL, V74, P7997, DOI 10.1128/JVI.74.17.7997-8002.2000; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kerekes K, 1998, INT IMMUNOL, V10, P1923, DOI 10.1093/intimm/10.12.1923; KINOSHITA T, 1990, INT IMMUNOL, V2, P651, DOI 10.1093/intimm/2.7.651; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; Kuan AP, 2000, CIRC RES, V86, P281, DOI 10.1161/01.RES.86.3.281; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; LANE JR, 1993, J IMMUNOL, V151, P1682; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; LODGE PA, 1987, AM J PATHOL, V128, P455; Malkiel S, 1996, MOL MED TODAY, V2, P336, DOI 10.1016/1357-4310(96)81799-0; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; NEU N, 1987, J IMMUNOL, V138, P2488; NEU N, 1987, J IMMUNOL, V139, P3630; NEUMANN DA, 1993, CLIN IMMUNOL IMMUNOP, V68, P181, DOI 10.1006/clin.1993.1116; NEWMAN S L, 1984, Complement, V1, P213; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; PUMMERER C, 1991, LAB INVEST, V65, P538; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; SMITH SC, 1992, P NATL ACAD SCI USA, V89, P9131, DOI 10.1073/pnas.89.19.9131; SMITH SC, 1991, J IMMUNOL, V147, P2141; Terui T, 1997, J INVEST DERMATOL, V108, P62, DOI 10.1111/1523-1747.ep12285633; Wang S, 1999, OPT LASER TECHNOL, V31, P151, DOI 10.1016/S0030-3992(99)00020-1; Wang Y, 2000, J AM COLL CARDIOL, V36, P1992, DOI 10.1016/S0735-1097(00)00939-6; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; WANG YC, 1991, HUM IMMUNOL, V31, P123, DOI 10.1016/0198-8859(91)90015-2; WIERSMA EJ, 1991, EUR J IMMUNOL, V21, P2501, DOI 10.1002/eji.1830211029; WOLFGRAM LJ, 1985, J EXP MED, V161, P1112, DOI 10.1084/jem.161.5.1112; WOLFGRAM LJ, 1986, J IMMUNOL, V136, P1846	50	130	138	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					739	745		10.1038/90686	http://dx.doi.org/10.1038/90686			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477411				2022-12-18	WOS:000170230100017
J	Chang, DH; Angelin-Duclos, C; Calame, K				Chang, DH; Angelin-Duclos, C; Calame, K			BLIMP-I: trigger for differentiation of myeloid lineage	NATURE IMMUNOLOGY			English	Article							SEQUENCE-BINDING-PROTEIN; C-MYC TRANSCRIPTION; MOUSE BONE-MARROW; MONOCYTE/MACROPHAGE DIFFERENTIATION; TERMINAL DIFFERENTIATION; CELL-DIFFERENTIATION; RETROVIRAL VECTORS; MONOBLASTIC CELLS; GENE-EXPRESSION; HIGH-TITER	B lymphocyte-induced maturation protein-1 (BLIMP-1 or PRDI-BF1) is induced when bone marrow-derived progenitors differentiate in response to macrophage-colony stimulating factor (M-CSF) and is present in peripheral blood monocytes and granulocytes. BLIMP-1 is also induced during differentiation of U937 and HL-60 cells into macrophages or granulocytes. Induction of BLIMP-1 mRNA during macrophage differentiation of U937 and HL-60 shows a biphasic pattern. Overexpression of BLIMP-1 is sufficient to initiate macrophage differentiation of U937 cells whereas blocking endogenous BLIMP-1 inhibits differentiation. One target of BLIMP-1-dependent transcriptional repression in U937 cells is c-myc, providing an explanation for cessation of cell division. Thus BLIMP-1 is a key regulator of terminal differentiation in two separate hematopoietic lineages: myeloid cells and B lymphocytes.	Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University; Columbia University	Calame, K (corresponding author), Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, 630 W 168th St, New York, NY 10032 USA.				NCI NIH HHS [2 T32 CA09503-14] Funding Source: Medline; NIAID NIH HHS [R01-AI43576] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043576] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Anderson MT, 1996, P NATL ACAD SCI USA, V93, P8508, DOI 10.1073/pnas.93.16.8508; Angelin-Duclos C, 1999, COLD SPRING HARB SYM, V64, P61, DOI 10.1101/sqb.1999.64.61; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Coligan J.E., 1996, CURRENT PROTOCOLS IM; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; COLLINS SJ, 1987, BLOOD, V70, P1233; Dannaeus K, 1999, EXP HEMATOL, V27, P1646, DOI 10.1016/S0301-472X(99)00106-X; de Souza FSJ, 1999, EMBO J, V18, P6062, DOI 10.1093/emboj/18.21.6062; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; GABRIELE L, 1999, J EXP MED, V6, P190; Garcia A, 1999, EXP HEMATOL, V27, P353, DOI 10.1016/S0301-472X(98)00038-1; GIDLUND M, 1981, NATURE, V292, P848, DOI 10.1038/292848a0; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAWAKAMI K, 1995, IMMUNOL LETT, V46, P143, DOI 10.1016/0165-2478(95)00034-3; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LARSSON LG, 1988, P NATL ACAD SCI USA, V85, P2638, DOI 10.1073/pnas.85.8.2638; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Maniatis T, 1982, MOL CLONING LAB MANU, V10, P545; Manzella L, 1999, EUR J IMMUNOL, V29, P3009, DOI 10.1002/(SICI)1521-4141(199909)29:09<3009::AID-IMMU3009>3.0.CO;2-H; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; MILLER LJ, 1986, J IMMUNOL, V137, P2891; Momiyama N, 1996, CELL GROWTH DIFFER, V7, P1005; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NAITO M, 1993, ARCH HISTOL CYTOL, V56, P331, DOI 10.1679/aohc.56.331; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SKERKA C, 1993, ONCOGENE, V8, P2135; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TARELLA C, 1982, CANCER RES, V42, P445; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; WARREN MK, 1985, J IMMUNOL, V134, P982; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	46	130	132	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					169	176		10.1038/77861	http://dx.doi.org/10.1038/77861			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248811				2022-12-18	WOS:000089814900019
J	Weyand, CM; Goronzy, JJ				Weyand, Cornelia M.; Goronzy, Jorg J.			The immunology of rheumatoid arthritis	NATURE IMMUNOLOGY			English	Review							CD4(+)CD28(-) T-CELLS; METABOLIC-CONTROL; TELOMERIC LOSS; ACTIVATION; PROLIFERATION; AUTOIMMUNITY; DAMAGE; ONSET; IMMUNOMETABOLISM; DIFFERENTIATION	Weyand and Goronzy discuss how the progressive loss of immune cell tolerance underlies the immunopathology associated with rheumatoid arthritis. The immunopathogenesis of rheumatoid arthritis (RA) spans decades, beginning with the production of autoantibodies against post-translationally modified proteins (checkpoint 1). After years of asymptomatic autoimmunity and progressive immune system remodeling, tissue tolerance erodes and joint inflammation ensues as tissue-invasive effector T cells emerge and protective joint-resident macrophages fail (checkpoint 2). The transition of synovial stromal cells into autoaggressive effector cells converts synovitis from acute to chronic destructive (checkpoint 3). The loss of T cell tolerance derives from defective DNA repair, causing abnormal cell cycle dynamics, telomere fragility and instability of mitochondrial DNA. Mitochondrial and lysosomal anomalies culminate in the generation of short-lived tissue-invasive effector T cells. This differentiation defect builds on a metabolic platform that shunts glucose away from energy generation toward the cell building and motility programs. The next frontier in RA is the development of curative interventions, for example, reprogramming T cell defects during the period of asymptomatic autoimmunity.	[Weyand, Cornelia M.; Goronzy, Jorg J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Weyand, Cornelia M.; Goronzy, Jorg J.] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Weyand, CM (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Weyand, CM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	National Institutes of Health [R01 AR042527, R01 HL117913, R01 AI108906, R01 HL142068, P01 HL129941, R01 AI108891, R01 AG045779, U19 AI057266, R01 AI129191, IO1 BX001669]; Encrantz Family Discovery Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Encrantz Family Discovery Fund	This work was supported by the National Institutes of Health (R01 AR042527, R01 HL117913, R01 AI108906, R01 HL142068 and P01 HL129941 to C.M.W.; and R01 AI108891, R01 AG045779, U19 AI057266, R01 AI129191 and IO1 BX001669 to J.J.G.) and the Encrantz Family Discovery Fund.	AHO K, 1991, J RHEUMATOL, V18, P1282; ALARCON GS, 1995, RHEUM DIS CLIN N AM, V21, P589; Amariuta T, 2020, IMMUNOL REV, V294, P188, DOI 10.1111/imr.12827; Amsen D, 2013, ADV EXP MED BIOL, V785, P107, DOI 10.1007/978-1-4614-6217-0_12; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bader L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01488; Balsa A, 2018, RHEUMATOLOGY, V57, P688, DOI 10.1093/rheumatology/kex474; Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187; Bocharnikov AV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130062; Burger K, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00061; Burgoyne CH, 2008, ANN RHEUM DIS, V67, P750, DOI 10.1136/ard.2007.073833; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Choi SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06686-0; Colmegna I, 2008, ARTHRITIS RHEUM, V58, P990, DOI 10.1002/art.23287; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Croft AP, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1156-1; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Deane KD, 2010, RHEUM DIS CLIN N AM, V36, P213, DOI 10.1016/j.rdc.2010.02.001; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fasth AER, 2010, EUR J IMMUNOL, V40, P378, DOI 10.1002/eji.200939399; Fernandez D, 2009, AUTOIMMUN REV, V8, P184, DOI 10.1016/j.autrev.2008.07.041; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Finch R, 2019, ANN RHEUM DIS, V78, P189, DOI 10.1136/annrheumdis-2019-eular.3028; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Ge CR, 2019, NAT REV RHEUMATOL, V15, P503, DOI 10.1038/s41584-019-0244-4; Gerlag DM, 2019, ANN RHEUM DIS, V78, P179, DOI 10.1136/annrheumdis-2017-212763; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Goronzy JJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00131; Goronzy JJ, 2019, NAT REV IMMUNOL, V19, P573, DOI 10.1038/s41577-019-0180-1; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Goronzy JJ, 2010, RHEUM DIS CLIN N AM, V36, P297, DOI 10.1016/j.rdc.2010.03.001; Grumbach IM, 2019, ARTERIOSCL THROM VAS, V39, P991, DOI 10.1161/ATVBAHA.118.312196; Herenius MMJ, 2011, ANN RHEUM DIS, V70, P1160, DOI 10.1136/ard.2010.141549; Holers VM, 2018, NAT REV RHEUMATOL, V14, P542, DOI 10.1038/s41584-018-0070-0; Hu XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004404; Humby F, 2019, ANN RHEUM DIS, V78, P761, DOI 10.1136/annrheumdis-2018-214539; Johansson M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1868; Kang YM, 2002, J EXP MED, V195, P1325, DOI 10.1084/jem.20011565; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kissel T, 2020, ANN RHEUM DIS, V79, P472, DOI 10.1136/annrheumdis-2019-216499; Kissel T, 2019, ANN RHEUM DIS, V78, P1616, DOI 10.1136/annrheumdis-2019-215698; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Kono M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127395; Kono M, 2018, P NATL ACAD SCI USA, V115, P9288, DOI 10.1073/pnas.1805717115; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Law ST, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104497; Lewis MJ, 2019, CELL REP, V28, P2455, DOI 10.1016/j.celrep.2019.07.091; Li YY, 2019, CELL METAB, V30, P477, DOI 10.1016/j.cmet.2019.06.016; Li YY, 2018, EXP GERONTOL, V105, P118, DOI 10.1016/j.exger.2017.10.027; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Ligier S, 1998, BRIT J RHEUMATOL, V37, P1307; Ling GS, 2018, SCIENCE, V360, P558, DOI 10.1126/science.aao4555; Liuzzo G, 2001, CIRCULATION, V103, P1509; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Liuzzo G, 1999, CIRCULATION, V100, P2135, DOI 10.1161/01.CIR.100.21.2135; Mahler M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102506; Makowski L, 2020, IMMUNOL REV, V295, P5, DOI 10.1111/imr.12858; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Mathur A, 2018, J LEUKOCYTE BIOL, V103, P233, DOI 10.1189/jlb.3MR0617-250R; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Mehta P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00589; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Molawi K, 2015, IMMUNITY, V42, P10, DOI 10.1016/j.immuni.2014.12.032; Murray PJ, 2018, SEMIN IMMUNOL, V35, P12, DOI 10.1016/j.smim.2017.12.005; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Myasoedova E, 2020, ANN RHEUM DIS, V79, P440, DOI 10.1136/annrheumdis-2019-216694; Nygaard G, 2020, NAT REV RHEUMATOL, V16, P316, DOI 10.1038/s41584-020-0413-5; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Ormseth MJ, 2016, J RHEUMATOL, V43, P1469, DOI 10.3899/jrheum.151115; Orr C, 2017, NAT REV RHEUMATOL, V13, P463, DOI 10.1038/nrrheum.2017.115; Pereira BI, 2020, NAT IMMUNOL, V21, P684, DOI 10.1038/s41590-020-0643-3; Pitaksalee R, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00837-1; Ponchel F, 2005, ARTHRITIS RES THER, V7, pR80, DOI 10.1186/ar1452; Ponchel F, 2002, BLOOD, V100, P4550, DOI 10.1182/blood-2002-03-0671; Ponchel F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60314-w; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Raposo B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02763-y; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Schonland SO, 2003, P NATL ACAD SCI USA, V100, P13471, DOI 10.1073/pnas.2233561100; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Snyder MR, 2004, J IMMUNOL, V173, P3725, DOI 10.4049/jimmunol.173.6.3725; Snyder MR, 2003, J EXP MED, V197, P437, DOI 10.1084/jem.20020383; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Taylor PC, 2019, BEST PRACT RES CL RH, V33, DOI 10.1016/j.berh.2019.101479; Tinajero MG, 2020, AM J PATHOL, V190, P520, DOI 10.1016/j.ajpath.2019.10.021; Tuncel J, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2104-7; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; van Delft MAM, 2020, J AUTOIMMUN, V110, DOI 10.1016/j.jaut.2019.102392; Verburg RJ, 2005, ANN RHEUM DIS, V64, P1397, DOI 10.1136/ard.2004.033332; Viatte S, 2015, JAMA-J AM MED ASSOC, V313, P1645, DOI 10.1001/jama.2015.3435; Waase I, 1996, ARTHRITIS RHEUM, V39, P904, DOI 10.1002/art.1780390606; Wadey K, 2018, CARDIOVASC RES, V114, P601, DOI 10.1093/cvr/cvy021; Wagner UG, 1998, P NATL ACAD SCI USA, V95, P14447, DOI 10.1073/pnas.95.24.14447; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Warrington KJ, 2001, ARTHRITIS RHEUM, V44, P13, DOI 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Weyand CM, 1998, MECH AGEING DEV, V102, P131, DOI 10.1016/S0047-6374(97)00161-9; Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1; Weyand CM, 2020, CURR OPIN RHEUMATOL, V32, P159, DOI 10.1097/BOR.0000000000000683; Weyand CM, 2018, FREE RADICAL BIO MED, V125, P36, DOI 10.1016/j.freeradbiomed.2018.03.004; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Wu B, 2020, IMMUNOMETABOLISM, V2, pe200017; Wu B, CELL METAB; Yamada H, 2007, CLIN IMMUNOL, V124, P328, DOI 10.1016/j.clim.2007.06.001; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0542-4; Yang Z, 2014, AUTOPHAGY, V10, P382, DOI 10.4161/auto.27345; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	119	129	139	6	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					10	18		10.1038/s41590-020-00816-x	http://dx.doi.org/10.1038/s41590-020-00816-x		NOV 2020	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33257900	Green Accepted			2022-12-18	WOS:000594801400001
J	Botta, D; Fuller, MJ; Marquez-Lago, TT; Bachus, H; Bradley, JE; Weinmann, AS; Zajac, AJ; Randall, TD; Lund, FE; Leon, B; Ballesteros-Tato, A				Botta, Davide; Fuller, Michael J.; Marquez-Lago, Tatiana T.; Bachus, Holly; Bradley, John E.; Weinmann, Amy S.; Zajac, Allan J.; Randall, Troy D.; Lund, Frances E.; Leon, Beatriz; Ballesteros-Tato, Andre			Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; TGF-BETA; HELPER; STAT5; IL-2; ANTIGEN; DIFFERENTIATION; EXPRESSION; EXPANSION; MICE	Interleukin 2 (IL-2) promotes Foxp(3+) regulatory T (T-reg) cell responses, but inhibits T follicular helper (T-FH) cell development. However, it is not clear how IL-2 affects T follicular regulatory (T-FR) cells, a cell type with properties of both T-reg and TFH cells. Using an influenza infection model, we found that high IL-2 concentrations at the peak of the infection prevented TFR cell development by a Blimp-1-dependent mechanism. However, once the immune response resolved, some T-reg cells downregulated CD25, upregulated Bcl-6 and differentiated into T-FR cells, which then migrated into the B cell follicles to prevent the expansion of self-reactive B cell clones. Thus, unlike its effects on conventional T-reg cells, IL-2 inhibits T-FR cell responses.	[Botta, Davide; Weinmann, Amy S.; Zajac, Allan J.; Lund, Frances E.; Leon, Beatriz] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Fuller, Michael J.; Bachus, Holly; Bradley, John E.; Randall, Troy D.; Ballesteros-Tato, Andre] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Marquez-Lago, Tatiana T.] Univ Alabama Birmingham, Informat Inst, Birmingham, AL USA; [Marquez-Lago, Tatiana T.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ballesteros-Tato, A (corresponding author), Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	aballest@uab.edu		Botta, Davide/0000-0003-3926-0662; Ballesteros-Tato, Andre/0000-0002-4833-593X	University of Alabama at Birmingham (UAB); National Institutes of Health [1R01 AI110480, R01 AI116584, AI097357, AI109962, AIAI109962, AI061061, AI049360]; National Center for Research Resources, National Institutes of Health [1 G20RR022807-01];  [P30 AR048311];  [P30 AI027767]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR022807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110480, R01AI097357, R56AI049360, R01AI116584, U19AI109962, R01AI049360, R01AI061061, P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	University of Alabama at Birmingham (UAB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank W.J. Leonard (US National Institutes of Health) for providing the Il21-mCherry-Il2-emGFP dual reporter transgenic mice, E. Meffre (Yale University) for providing the Blimp-1 reporter mice, A. Rudensky (Memorial Sloan-Kettering Cancer Center) for providing the Foxp3-DTR-GFP mice, and T.S. Simpler and U. Mudunuru for animal husbandry. This work was supported by University of Alabama at Birmingham (UAB) and National Institutes of Health grants 1R01 AI110480 to A.B.-T., R01 AI116584 to B.L., AI097357 and AI109962 to T.D.R., AIAI109962 to F.E.L., AI061061 to A.S.W., and AI049360 to A.J.Z. The X-RAD 320 unit was purchased using a Research Facility Improvement Grant, 1 G20RR022807-01, from the National Center for Research Resources, National Institutes of Health. Support for the UAB flow cytometry core was provided by grants P30 AR048311 and P30 AI027767.	Aloulou M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10579; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bar-Joseph Z, 2001, BIOINFORMATICS S1, V17, pS22, DOI [10.1093/bioinformatics/17.suppl_1.S22, DOI 10.1093/BIOINFORMATICS/17.SUPPL_1.S22]; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Bedoya F, 2013, J IMMUNOL, V190, P6115, DOI 10.4049/jimmunol.1203302; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cheng GY, 2013, J IMMUNOL, V190, P1567, DOI 10.4049/jimmunol.1201218; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Maceiras AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15067; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; McDonald PW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10285; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Raynor J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00161; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wang L, 2011, P NATL ACAD SCI USA, V108, P9542, DOI 10.1073/pnas.1018182108; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yuan XM, 2014, IMMUNOL REV, V259, P103, DOI 10.1111/imr.12163; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	54	129	139	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1249	+		10.1038/ni.3837	http://dx.doi.org/10.1038/ni.3837			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28892471	Green Accepted			2022-12-18	WOS:000413457300011
J	Delacher, M; Imbusch, CD; Weichenhan, D; Breiling, A; Hotz-Wagenblatt, A; Trager, U; Hofer, AC; Kagebein, D; Wang, Q; Frauhammer, F; Mallm, JP; Bauer, K; Herrmann, C; Lang, PA; Brors, B; Plass, C; Feuerer, M				Delacher, Michael; Imbusch, Charles D.; Weichenhan, Dieter; Breiling, Achim; Hotz-Wagenblatt, Agnes; Traeger, Ulrike; Hofer, Ann-Cathrin; Kaegebein, Danny; Wang, Qi; Frauhammer, Felix; Mallm, Jan-Philipp; Bauer, Katharina; Herrmann, Carl; Lang, Philipp A.; Brors, Benedikt; Plass, Christoph; Feuerer, Markus			Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues	NATURE IMMUNOLOGY			English	Article							ADIPOSE-TISSUE; CANNABINOID RECEPTOR; READ ALIGNMENT; TRANSCRIPTION; POPULATION; MACROPHAGE; VISUALIZATION; ACCUMULATION; EXPRESSION; BATF	Regulatory T cells (T-reg cells) perform two distinct functions: they maintain self-tolerance, and they support organ homeostasis by differentiating into specialized tissue T-reg cells. We found that epigenetic modifications defined the molecular characteristics of tissue T-reg cells. Tagmentation-based whole-genome bisulfite sequencing revealed more than 11,000 regions that were methylated differentially in pairwise comparisons of tissue T-reg cell populations and lymphoid T cells. Similarities in the epigenetic landscape led to the identification of a common tissue T-reg cell population that was present in many organs and was characterized by gain and loss of DNA methylation that included many gene sites associated with the T(H)2 subset of helper T cells, such as the gene encoding cytokine IL-33 receptor ST2, as well as the production of tissue-regenerative factors. Furthermore, the ST2-expressing population was dependent on the transcriptional regulator BATF and could be expanded by IL-33. Thus, tissue T-reg cells integrate multiple waves of epigenetic reprogramming that define their tissue-restricted specialization.	[Delacher, Michael; Traeger, Ulrike; Hofer, Ann-Cathrin; Kaegebein, Danny; Feuerer, Markus] German Canc Res Ctr, Immune Tolerance Res Grp, Heidelberg, Germany; [Imbusch, Charles D.; Wang, Qi; Frauhammer, Felix; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Weichenhan, Dieter; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Breiling, Achim] German Canc Res Ctr, Div Epigenet, Heidelberg, Germany; [Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Mallm, Jan-Philipp] German Canc Res Ctr, Res Grp Genome Org & Funct, Heidelberg, Germany; [Mallm, Jan-Philipp; Bauer, Katharina] German Canc Res Ctr, Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Herrmann, Carl] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Lang, Philipp A.] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Mol Med 2, Dusseldorf, Germany; [Brors, Benedikt] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Feuerer, Markus] Univ Regensburg, Regensburg Ctr Intervent Immunol RCI, Inst Immunol, Regensburg, Germany; [Feuerer, Markus] Univ Hosp Regensburg, Regensburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; University of Regensburg	Feuerer, M (corresponding author), German Canc Res Ctr, Immune Tolerance Res Grp, Heidelberg, Germany.; Feuerer, M (corresponding author), Univ Regensburg, Regensburg Ctr Intervent Immunol RCI, Inst Immunol, Regensburg, Germany.; Feuerer, M (corresponding author), Univ Hosp Regensburg, Regensburg, Germany.	m.feuerer@dkfz-heidelberg.de	Brors, Benedikt/E-5620-2013; Herrmann, Carl/AAR-3167-2020; Delacher, Michael/AAA-5224-2019; Delacher, Michael/AAM-9710-2021	Brors, Benedikt/0000-0001-5940-3101; Herrmann, Carl/0000-0003-4989-4722; Hotz-Wagenblatt, Agnes/0000-0003-1523-2093; Breiling, Achim/0000-0002-7928-299X; Wang, Qi/0000-0002-6420-1720; Mallm, Jan-Philipp/0000-0002-7059-4030	Helmholtz Association of German Research Centers [HZ-NG-505]; European Research Council (ERC-CoG) [648145 REGiREG]; German-Israeli Helmholtz Research School in Cancer Biology; German Ministry of Research and Education [031L0076A, 01KU1216B]	Helmholtz Association of German Research Centers(Helmholtz Association); European Research Council (ERC-CoG); German-Israeli Helmholtz Research School in Cancer Biology; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	We thank A. Rudensky (Memorial Sloan-Kettering Cancer Center) for mice; F. Lyko for help with amplicon sequencing; Z. Gu for bioinformatics support; S. Schmitt, M. Wuhl and F. Ilmberger for laboratory support; and the DKFZ core facilities Preclinical Research, Flow Cytometry and Genomics & Proteomics for technical support. Supported by the Helmholtz Association of German Research Centers (HZ-NG-505 to M. F.), the European Research Council (ERC-2015-CoG, #648145 REGiREG to M. F.), the German-Israeli Helmholtz Research School in Cancer Biology (M.D.) and the German Ministry of Research and Education (031L0076A and 01KU1216B to B.B.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Barth SD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv224; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edinger M, 2016, J CLIN INVEST, V126, P1248, DOI 10.1172/JCI86827; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R83, 10.1186/gb-2012-13-10-r83]; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu HL, 2015, EPIGENOMICS-UK, V7, P47, DOI [10.2217/EPI.14.76, 10.2217/epi.14.76]; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mallona I, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-11; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang Hyewon, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P297, DOI 10.1515/jbcpp-2015-0080; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715	49	129	129	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1160	+		10.1038/ni.3799	http://dx.doi.org/10.1038/ni.3799			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28783152	Green Accepted			2022-12-18	WOS:000411134000020
J	Geng, J; Yu, SJ; Zhao, H; Sun, XF; Li, X; Wang, P; Xiong, XL; Hong, LX; Xie, CC; Gao, JH; Shi, YR; Peng, JQ; Johnson, RL; Xiao, NM; Lu, LR; Han, JH; Zhou, DW; Chen, LF				Geng, Jing; Yu, Shujuan; Zhao, Hao; Sun, Xiufeng; Li, Xun; Wang, Ping; Xiong, Xiaolin; Hong, Lixin; Xie, Changchuan; Gao, Jiahui; Shi, Yiran; Peng, Jiaqi; Johnson, Randy L.; Xiao, Nengming; Lu, Linrong; Han, Jiahuai; Zhou, Dawang; Chen, Lanfen			The transcriptional coactivator TAZ regulates reciprocal differentiation of T(H)17 cells and T-reg cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO PATHWAY; TGF-BETA; LYMPHOCYTE TRAFFICKING; KINASE MST1; TH17 CELLS; IN-VIVO; CANCER; FOXP3	An imbalance in the lineages of immunosuppressive regulatory T cells (T-reg cells) and the inflammatory T(H)17 subset of helper T cells leads to the development of autoimmune and/ or inflammatory disease. Here we found that TAZ, a coactivator of TEAD transcription factors of Hippo signaling, was expressed under T(H)17 cell-inducing conditions and was required for T(H)17 differentiation and T(H)17 cell-mediated inflammatory diseases. TAZ was a critical co-activator of the T(H)17-defining transcription factor ROR gamma t. In addition, TAZ attenuated T-reg cell development by decreasing acetylation of the T-reg cell master regulator Foxp3 mediated by the histone acetyltransferase Tip60, which targeted Foxp3 for proteasomal degradation. In contrast, under T-reg cell-skewing conditions, TEAD1 expression and sequestration of TAZ from the transcription factors ROR gamma t and Foxp3 promoted T-reg cell differentiation. Furthermore, deficiency in TAZ or overexpression of TEAD1 induced T-reg cell differentiation, whereas expression of a transgene encoding TAZ or activation of TAZ directed T(H)17 cell differentiation. Our results demonstrate a pivotal role for TAZ in regulating the differentiation of T-reg cells and T(H)17 cells.	[Geng, Jing; Yu, Shujuan; Zhao, Hao; Sun, Xiufeng; Wang, Ping; Xiong, Xiaolin; Hong, Lixin; Xie, Changchuan; Gao, Jiahui; Shi, Yiran; Peng, Jiaqi; Xiao, Nengming; Han, Jiahuai; Zhou, Dawang; Chen, Lanfen] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Li, Xun] Xiamen Univ, Med Coll, Affiliated Hosp 1, Dept Lab Med, Xiamen, Fujian, Peoples R China; [Johnson, Randy L.] Univ Texas Houston, Dept Canc Biol, Maryland Anderson Canc Ctr, Houston, TX USA; [Lu, Linrong] Zhejiang Univ, Sch Med, Innovat Ctr Cell Signaling Network, Inst Immunol, Hangzhou, Zhejiang, Peoples R China; [Lu, Linrong] Zhejiang Univ, Sch Med, Zhejiang Univ Univ Edinburgh Inst, Hangzhou, Zhejiang, Peoples R China	Xiamen University; Xiamen University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Zhejiang University; Zhejiang University	Zhou, DW; Chen, LF (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	dwzhou@xmu.edu.cn; chenlanfen@xmu.edu.cn	Geng, Jing/I-7130-2018; xie, chang/GYJ-2493-2022; Chen, Lanfen/B-7975-2016	Geng, Jing/0000-0002-0568-7345; Zhou, Dawang/0000-0002-9053-5249; Chen, Lanfen/0000-0002-9413-1284	National Basic Research Program (973) of China [2015CB910502]; National Natural Science Foundation of China [81422018, 31625010, U1505224, U1405225, 81372617, J1310027, 81472229, 31600698]; 111 Projects [B12001, B06016]; China's 1000 Young Talents Program; Fundamental Research Funds for the Central Universities of China-Xiamen University [20720160071, 20720160054]; Major disease research projects of Xiamen [3502Z20149029]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Projects(Ministry of Education, China - 111 Project); China's 1000 Young Talents Program; Fundamental Research Funds for the Central Universities of China-Xiamen University; Major disease research projects of Xiamen	We thank J. Avruch for comments on the manuscript. Supported by the National Basic Research Program (973) of China (2015CB910502 to L.C.), the National Natural Science Foundation of China (81422018 to L.C.; 31625010 and U1505224 to D.Z.; U1405225 and 81372617 to L.C.; J1310027 to D.Z.; 81472229 to L.H.; and 31600698 to J. Geng), the 111 Projects (B12001 and B06016), China's 1000 Young Talents Program (D.Z., and L.C.), the Fundamental Research Funds for the Central Universities of China-Xiamen University (20720160071 to D.Z. and 20720160054 to L.H.) and Major disease research projects of Xiamen (3502Z20149029 to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Arnir A. D., 2013, NAT BIOTECHNOL, V31, P515; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; fang F., 2015, SCI SIGNAL, V8, pra100; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Haller G., 2012, NAT REV MOL CELL BIO, V13, P591; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2011, IMMUNITY, V34, P24, DOI 10.1016/j.immuni.2010.12.010; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li J, 2015, J BIOL CHEM, V290, P30762, DOI 10.1074/jbc.M115.668442; Li WY, 2015, J CLIN INVEST, V125, P4239, DOI 10.1172/JCI81203; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Nishikimi A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005199; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	53	129	140	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					800	+		10.1038/ni.3748	http://dx.doi.org/10.1038/ni.3748			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28504697				2022-12-18	WOS:000403676300015
J	Sage, PT; Ron-Harel, N; Juneja, VR; Sen, DR; Maleri, S; Sungnak, W; Kuchroo, VK; Haining, WN; Chevrier, N; Haigis, M; Sharpe, AH				Sage, Peter T.; Ron-Harel, Noga; Juneja, Vikram R.; Sen, Debattama R.; Maleri, Seth; Sungnak, Waradon; Kuchroo, Vijay K.; Haining, W. Nicholas; Chevrier, Nicolas; Haigis, Marcia; Sharpe, Arlene H.			Suppression by T-FR\ cells leads to durable and selective inhibition of B cell effector function	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; GERMINAL CENTER; C-MYC; IMMUNE-RESPONSES; DIFFERENTIATION; REGULATOR; SIGNATURE; ENHANCERS; DEFINES; BLIMP-1	Follicular regulatory T cells (T-FR cells) inhibit follicular helper T cell (T-FH cell)-mediated antibody production. The mechanisms by which T-FR cells exert their key immunoregulatory functions are largely unknown. Here we found that T-FR cells induced a distinct suppressive state in T-FH cells and B cells, in which effector transcriptional signatures were maintained but key effector molecules and metabolic pathways were suppressed. The suppression of B cell antibody production and metabolism by T-FR cells was durable and persisted even in the absence of T-FR cells. This durable suppression was due in part to epigenetic changes. The cytokine IL-21 was able to overcome T-FR cell-mediated suppression and inhibited T-FR cells and stimulated B cells. By determining mechanisms of T-FR cell-mediated suppression, we have identified methods for modulating the function of T-FR cells and antibody production.	[Sage, Peter T.; Juneja, Vikram R.; Maleri, Seth; Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sage, Peter T.; Juneja, Vikram R.; Maleri, Seth; Sungnak, Waradon; Kuchroo, Vijay K.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Sage, Peter T.; Juneja, Vikram R.; Maleri, Seth; Sungnak, Waradon; Kuchroo, Vijay K.; Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Ron-Harel, Noga; Haigis, Marcia] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Sen, Debattama R.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Sungnak, Waradon; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Chevrier, Nicolas] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Brigham & Women's Hospital	Sharpe, AH (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu	Sen, Debattama/AAC-5679-2020	Sen, Debattama/0000-0002-0947-8284	US National Institute of Health [T32HL007627, R37AI38310, P01AI56299, P01AI065687]; Evergrande Center for Immunologic Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038310, P01AI056299, R01AI040614, P01AI065687] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evergrande Center for Immunologic Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Nikon Imaging Center at Harvard Medical School for help with light microscopy and the MBIB flow cytometry core for help with flow cytometry. Supported by the US National Institute of Health (T32HL007627 to P.T.S.; and R37AI38310, P01AI56299 and P01AI065687 to A.H.S.) and the Evergrande Center for Immunologic Diseases.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Fabrizi M, 2014, DIABETES, V63, P2086, DOI 10.2337/db13-0939; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Huang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069056; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kunisawa J, 2015, CELL REP, V13, P122, DOI 10.1016/j.celrep.2015.08.063; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Sage PT, 2015, METHODS MOL BIOL, V1291, P151, DOI 10.1007/978-1-4939-2498-1_13; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Wang JD, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0226-x; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328	47	129	137	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1436	1446		10.1038/ni.3578	http://dx.doi.org/10.1038/ni.3578			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27695002	Green Accepted			2022-12-18	WOS:000388056400014
J	Altfeld, M; Gale, M				Altfeld, Marcus; Gale, Michael, Jr.			Innate immunity against HIV-1 infection	NATURE IMMUNOLOGY			English	Review							CYCLIC GMP-AMP; NATURAL-KILLER-CELLS; T-CELLS; NK CELLS; DISEASE PROGRESSION; INTERFERON RESPONSE; ACCESSORY PROTEINS; IFITM PROTEINS; I INTERFERONS; VIRAL CONTROL	During acute HIV-1 infection, viral pathogen-associated molecular patterns are recognized by pathogen-recognition receptors (PRRs) of infected cells, which triggers a signaling cascade that initiates innate intracellular antiviral defenses aimed at restricting the replication and spread of the virus. This cell-intrinsic response propagates outward via the action of secreted factors such as cytokines and chemokines that activate innate immune cells and attract them to the site of infection and to local lymphatic tissue. Antiviral innate effector cells can subsequently contribute to the control of viremia and modulate the quality of the adaptive immune response to HIV-1. The concerted actions of PRR signaling, specific viral-restriction factors, innate immune cells, innate-adaptive immune crosstalk and viral evasion strategies determine the outcome of HIV-1 infection and immune responses.	[Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany; [Gale, Michael, Jr.] Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98195 USA	Heinrich Pette Institute; University of Washington; University of Washington Seattle	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany.	marcus.altfeld@hpi.uni-hamburg.de; mgale@uw.edu	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997; Gale, Michael/0000-0002-6332-7436	National Institutes of Health [AI10065, AI060389, AI083019, AI067031, AI104715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067031, P01AI104715, R56AI060389, U19AI083019, R01AI060389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health (grants AI10065, AI060389 and AI083019 to M.G. and grants AI067031 and AI104715 to M.A.).	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Blondot ML, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0117-5; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Crouse J, 2015, TRENDS IMMUNOL, V36, P49, DOI 10.1016/j.it.2014.11.001; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Doehle BP, 2012, J VIROL, V86, P8499, DOI 10.1128/JVI.00424-12; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Esbjornsson J, 2012, NEW ENGL J MED, V367, P224, DOI 10.1056/NEJMoa1113244; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Freed EO, 2014, J MOL BIOL, V426, P1129, DOI 10.1016/j.jmb.2014.01.005; Fribourgh JL, 2014, CELL HOST MICROBE, V16, P627, DOI 10.1016/j.chom.2014.09.021; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Horowitz A, 2012, J IMMUNOL, V188, P5054, DOI 10.4049/jimmunol.1102710; Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844; Hotter D, 2013, J MOL BIOL, V425, P4956, DOI 10.1016/j.jmb.2013.09.029; Hotter D, 2013, J VIROL, V87, P7160, DOI 10.1128/JVI.00526-13; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kelly MN, 2013, J IMMUNOL, V190, P285, DOI 10.4049/jimmunol.1200861; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Korner C, 2014, EUR J IMMUNOL, V44, P2938, DOI 10.1002/eji.201444751; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; McLaren PJ, 2015, NAT IMMUNOL, V16, P577, DOI 10.1038/ni.3147; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Park SY, 2014, J BIOL CHEM, V289, P35102, DOI 10.1074/jbc.M114.597062; Parsons MS, 2014, AIDS, V28, P2781, DOI 10.1097/QAD.0000000000000489; Parsons MS, 2012, J VIROL, V86, P4488, DOI 10.1128/JVI.06112-11; PEDERSEN C, 1989, BRIT MED J, V299, P154, DOI 10.1136/bmj.299.6692.154; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Peruzzi M, 1996, J EXP MED, V184, P1585, DOI 10.1084/jem.184.4.1585; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Robbins SH, 2007, PLOS PATHOG, V3, P1152, DOI 10.1371/journal.ppat.0030123; Rustagi A, 2014, J MOL BIOL, V426, P1161, DOI 10.1016/j.jmb.2013.12.003; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Song RJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003867; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y; Thananchai H, 2009, AIDS, V23, P189, DOI 10.1097/QAD.0b013e32831fb55a; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Towers GJ, 2014, CELL HOST MICROBE, V16, P10, DOI 10.1016/j.chom.2014.06.009; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Vaidya SA, 2014, J INFECT DIS, V210, P1042, DOI 10.1093/infdis/jiu206; van Montfoort N, 2014, CYTOKINE GROWTH F R, V25, P657, DOI 10.1016/j.cytogfr.2014.08.006; van Teijlingen NH, 2014, AIDS, V28, P1399, DOI 10.1097/QAD.0000000000000284; Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yaciuk JC, 2014, J VIROL, V88, P12992, DOI 10.1128/JVI.01914-14; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	104	129	135	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					554	562		10.1038/ni.3157	http://dx.doi.org/10.1038/ni.3157			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988887	Bronze			2022-12-18	WOS:000354751900003
J	Gatto, D; Wood, K; Caminschi, I; Murphy-Durland, D; Schofield, P; Christ, D; Karupiah, G; Brink, R				Gatto, Dominique; Wood, Katherine; Caminschi, Irina; Murphy-Durland, Danielle; Schofield, Peter; Christ, Daniel; Karupiah, Gunasegaran; Brink, Robert			The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells	NATURE IMMUNOLOGY			English	Article							STEADY-STATE; T-CELLS; CROSS-PRESENTATION; B-CELLS; ANTIGEN; MIGRATION; EXPRESSION; CD8(+); MOUSE; ACTIVATION	Spleen-resident dendritic cell (DC) populations occupy sentinel positions for the capture and presentation of blood-borne antigens. Here we found a difference in expression of the chemotactic receptor EBI2 (GPR183) on splenic DC subsets and that EBI2 regulated the positioning and homeostasis of DCs in the spleen. EBI2 and its main ligand, 7 alpha,25-OHC, were required for the generation of the splenic CD4(+) DC subset and the localization of DCs in bridging channels. Absence of EBI2 from DCs resulted in defects in both the activation of CD4(+) T cells and the induction of antibody responses. Regulated expression of EBI2 on DC populations is therefore critical for the generation and correct positioning of splenic DCs and the initiation of immune responses.	[Gatto, Dominique; Wood, Katherine; Murphy-Durland, Danielle; Schofield, Peter; Christ, Daniel; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Immunol Dis Div, Darlinghurst, NSW 2010, Australia; [Gatto, Dominique; Christ, Daniel; Brink, Robert] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Caminschi, Irina] Burnet Inst, Prahran, Vic, Australia; [Karupiah, Gunasegaran] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Burnet Institute; Australian National University; John Curtin School of Medical Research	Brink, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Immunol Dis Div, Darlinghurst, NSW 2010, Australia.	d.gatto@garvan.org.au; r.brink@garvan.org.au	Brink, Robert/B-7910-2010; Karupiah, Gunasegaran/J-4707-2013; Christ, Daniel/C-1861-2018; Karupiah, Gunasegaran/S-3561-2019; Schofield, Peter/C-9669-2011	Brink, Robert/0000-0002-9586-3655; Christ, Daniel/0000-0002-7313-3977; Karupiah, Gunasegaran/0000-0001-6306-4405; Caminschi, Irina/0000-0002-9027-2098; Schofield, Peter/0000-0003-2967-9662	National Health and Medical Research Council of Australia [427620, 1003025]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the MLC Garvan Flow Cytometry Facility for cell sorting; the staff of Australian Bioresources and the Garvan Institute animal facilities; and J. Villadangos, K. Shortman and S. Tangye for comments on the manuscript. Supported by the National Health and Medical Research Council of Australia (427620 to R. B. and 1003025 to D.G.)	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brink R, 2008, IMMUNOL CELL BIOL, V86, P31, DOI 10.1038/sj.icb.7100143; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Czeloth N, 2007, J IMMUNOL, V179, P5855, DOI 10.4049/jimmunol.179.9.5855; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	47	129	134	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					446	+		10.1038/ni.2555	http://dx.doi.org/10.1038/ni.2555			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23502855				2022-12-18	WOS:000317732100009
J	Henao-Mejia, J; Elinav, E; Strowig, T; Flavell, RA				Henao-Mejia, Jorge; Elinav, Eran; Strowig, Till; Flavell, Richard A.			Inflammasomes: far beyond inflammation	NATURE IMMUNOLOGY			English	Review							NLRP3 INFLAMMASOME; INSULIN-RESISTANCE; ACTIVATION; OBESITY; NLRC4; MICE; CASPASE-1; RECEPTORS; CRYSTALS; DEFENSE	Nearly a decade ago, the concept of inflammasomes was introduced. Since then, the biochemical characterization of the inflammasomes has led to a richer understanding of innate immune responses in the context of infection and sterile inflammation. This has provided the rationale for successful clinical therapies for a spectrum of hereditary periodic fever syndromes and potentially for some metabolic pathologies.	[Henao-Mejia, Jorge; Elinav, Eran; Strowig, Till; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Henao-Mejia, J (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110; Strowig, Till/0000-0003-0185-1459	Cancer Research Institute; Israel-US Educational Foundation; American Physicians for Medicine in Israel Foundation; Leukemia and Lymphoma Society; United States-Israel Binational Foundation; Howard Hughes Medical Institute	Cancer Research Institute; Israel-US Educational Foundation; American Physicians for Medicine in Israel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); United States-Israel Binational Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank F. Manzo for technical assistance. Supported by the Cancer Research Institute (E.E.), the Israel-US Educational Foundation (E.E.), the American Physicians for Medicine in Israel Foundation (E.E.), the Leukemia and Lymphoma Society (J.H.-M. and T.S.), the United States-Israel Binational Foundation (E.E. and R.A.F.) and the Howard Hughes Medical Institute (R.A.F.).	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	32	129	135	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					321	324		10.1038/ni.2257	http://dx.doi.org/10.1038/ni.2257			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430784				2022-12-18	WOS:000301886800005
J	Zhang, JW; Jackson, AF; Naito, T; Dose, M; Seavitt, J; Liu, FF; Heller, EJ; Kashiwagi, M; Yoshida, T; Gounari, F; Petrie, HT; Georgopoulos, K				Zhang, Jiangwen; Jackson, Audrey F.; Naito, Taku; Dose, Marei; Seavitt, John; Liu, Feifei; Heller, Elizabeth J.; Kashiwagi, Mariko; Yoshida, Toshimi; Gounari, Fotini; Petrie, Howard T.; Georgopoulos, Katia			Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; GENE-EXPRESSION; POLYCOMB GROUP; CELL-FATE; CHROMATIN; IKAROS; TRANSCRIPTION; NETWORK; COHESIN	Cell fate depends on the interplay between chromatin regulators and transcription factors. Here we show that activity of the Mi-2 beta nucleosome-remodeling and histone-deacetylase (NuRD) complex was controlled by the Ikaros family of lymphoid lineage-determining proteins. Ikaros, an integral component of the NuRD complex in lymphocytes, tethered this complex to active genes encoding molecules involved in lymphoid differentiation. Loss of Ikaros DNA-binding activity caused a local increase in chromatin remodeling and histone deacetylation and suppression of lymphoid cell-specific gene expression. Without Ikaros, the NuRD complex also redistributed to transcriptionally poised genes that were not targets of Ikaros (encoding molecules involved in proliferation and metabolism), which induced their reactivation. Thus, release of NuRD from Ikaros regulation blocks lymphocyte maturation and mediates progression to a leukemic state by engaging functionally opposing epigenetic and genetic networks.	[Jackson, Audrey F.; Naito, Taku; Seavitt, John; Liu, Feifei; Heller, Elizabeth J.; Kashiwagi, Mariko; Yoshida, Toshimi; Georgopoulos, Katia] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cuteneous Biol Res Ctr, Charlestown, MA USA; [Zhang, Jiangwen] Harvard Univ, Fac Arts & Sci Res Comp, Cambridge, MA 02138 USA; [Petrie, Howard T.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Petrie, Howard T.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Chicago; Scripps Research Institute	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cuteneous Biol Res Ctr, Charlestown, MA USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Yoshida, Toshimi/GSN-8717-2022; Zhang, Jiangwen/A-7654-2013	Yoshida, Toshimi/0000-0001-7080-6913; Zhang, Jiangwen/0000-0002-2911-8446; Liu, Feifei/0000-0002-4577-1744; Dose, Marei/0000-0001-5394-9779	US National Institutes of Health [2T32AI007529, 5R01AI042254, R01CA158006]; NATIONAL CANCER INSTITUTE [R01CA162092, R01CA158006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254, R37AI033062, T32AI007529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Gomez for analysis of the expression of Mi-2 beta protein in thymocytes; the Kingston laboratory (Massachusetts General Hospital) for the hSWI-SNF complex and help with setting up the mononucleosome and 5S array assays; I. Joshi for help with cell sorting; B. Czyzewski for mouse husbandry; and B. Morgan for discussions of the project and critical review of the manuscript. Protein microsequencing was done at the Microchemistry and Proteomics Facility of Harvard University, Cambridge, and at the Taplin Mass Spectrometry Facility of Harvard Medical School, Boston, and high-throughput DNA sequencing and RNA profiling were done at the Bauer Center for Genomic Research of Harvard University, Cambridge. Supported by the US National Institutes of Health (2T32AI007529 to A.F.J.; and 5R01AI042254 and R01CA158006 to K.G.).	Aichinger E, 2011, PLANT CELL, V23, P1047, DOI 10.1105/tpc.111.083352; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Jones ME, 2011, IMMUNOL RES, V49, P202, DOI 10.1007/s12026-010-8182-x; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaufmann C, 2003, EMBO J, V22, P2211, DOI 10.1093/emboj/cdg186; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Masetti R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/148046; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	129	130	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					86	U132		10.1038/ni.2150	http://dx.doi.org/10.1038/ni.2150			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22080921	Green Accepted, Green Submitted			2022-12-18	WOS:000298412800015
J	Chang, M; Jin, W; Chang, JH; Xiao, YC; Brittain, GC; Yu, JY; Zhou, XF; Wang, YH; Cheng, XH; Li, PW; Rabinovich, BA; Hwu, P; Sun, SC				Chang, Mikyoung; Jin, Wei; Chang, Jae-Hoon; Xiao, Yichuan; Brittain, George C.; Yu, Jiayi; Zhou, Xiaofei; Wang, Yi-Hong; Cheng, Xuhong; Li, Pingwei; Rabinovich, Brian A.; Hwu, Patrick; Sun, Shao-Cong			The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity	NATURE IMMUNOLOGY			English	Article							B-INDUCING KINASE; C-REL; PELLINO PROTEINS; LYMPHOCYTE-PROLIFERATION; IL-2 PROMOTER; TGF-BETA; INTERLEUKIN-2; MECHANISMS; TOLERANCE; CD28	T cell activation is subject to tight regulation to avoid inappropriate responses to self antigens. Here we show that genetic deficiency in the ubiquitin ligase Peli1 caused hyperactivation of T cells and rendered T cells refractory to suppression by regulatory T cells and transforming growth factor-beta (TGF-beta). As a result, Peli1-deficient mice spontaneously developed autoimmunity characterized by multiorgan inflammation and autoantibody production. Peli1 deficiency resulted in the nuclear accumulation of c-Rel, a member of the NF-kappa B family of transcription factors with pivotal roles in T cell activation. Peli1 negatively regulated c-Rel by mediating its Lys48 (K48) ubiquitination. Our results identify Peli1 as a critical factor in the maintenance of peripheral T cell tolerance and demonstrate a previously unknown mechanism of c-Rel regulation.	[Chang, Mikyoung; Jin, Wei; Chang, Jae-Hoon; Xiao, Yichuan; Brittain, George C.; Yu, Jiayi; Zhou, Xiaofei; Wang, Yi-Hong; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Rabinovich, Brian A.] Univ Texas MD Anderson Canc Ctr, Immunol Lab Phys Sci, Houston, TX 77030 USA; [Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Yu, Jiayi/I-5923-2014; zhou, xiaofei/A-9844-2013		US National Institutes of Health [AI057555, AI064639, GM84459, GM84459-S1, T32CA009598]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057555, R01AI064639, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Texas Institute for Genomic Medicine for Peli1<SUP>-/-</SUP> mice; S.H. Park (Sungkyunkwan University) for hemagglutinin-tagged Peli1 and Peli1 Delta C expression vectors; R. Beyaert (Ghent University) for E-tag-Peli1; X. Qin (MD Anderson Cancer Center) for lentiviral packaging vectors; Z. Chen (University of Texas Southwestern Medical Center) for the hemagglutinin-tagged K48R and K63R ubiquitin mutants; and K. Dwyer, K. Ramirez and K. Ackin from the flow cytometry core facility and S. Mudd from the histology core facility of MD Anderson Cancer Center for technical assistance. Supported by the US National Institutes of Health (AI057555, AI064639, GM84459 and GM84459-S1 to S.-C. S. and T32CA009598 to G.C.B).	Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chang M, 2009, J IMMUNOL, V182, P3131, DOI 10.4049/jimmunol.0803637; Chen E, 1998, J BIOL CHEM, V273, P35201, DOI 10.1074/jbc.273.52.35201; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Deenick EK, 2010, EUR J IMMUNOL, V40, P867, DOI 10.1002/eji.200939445; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lee YS, 2010, BIOCHEM BIOPH RES CO, V393, P836, DOI 10.1016/j.bbrc.2010.02.094; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Liou HC, 2011, IMMUNOL CELL BIOL, V89, P27, DOI 10.1038/icb.2010.120; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Loeser S, 2007, SEMIN IMMUNOL, V19, P206, DOI 10.1016/j.smim.2007.02.004; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Maggirwar SB, 1997, MOL CELL BIOL, V17, P2605, DOI 10.1128/MCB.17.5.2605; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sen R., 2009, COLD SPRING HARB PER, V2; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2010, CELL MOL IMMUNOL, V7, P204, DOI 10.1038/cmi.2010.20; Wells AD, 2009, J IMMUNOL, V182, P7331, DOI 10.4049/jimmunol.0803917; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhou XY, 2002, J IMMUNOL, V168, P3847, DOI 10.4049/jimmunol.168.8.3847	50	129	136	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					1002	U112		10.1038/ni.2090	http://dx.doi.org/10.1038/ni.2090			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21874024	Green Accepted			2022-12-18	WOS:000295084500016
J	Feng, XM; Wang, HK; Takata, H; Day, TJ; Willen, J; Hu, H				Feng, Xiaoming; Wang, Haikun; Takata, Hiroshi; Day, Timothy J.; Willen, Jessica; Hu, Hui			Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells	NATURE IMMUNOLOGY			English	Article							HOMEOSTATIC PROLIFERATION; RECEPTOR EXPRESSION; IL-7 RECEPTOR; ACTIVATION; THYMOCYTE; SURVIVAL; ALPHA; FOXO1; DEFICIENT; EXPANSION	The molecular mechanisms that underlie T cell quiescence are poorly understood. Here we report that mature naive CD8(+) T cells lacking the transcription factor Foxp1 gained effector phenotype and function and proliferated directly in response to interleukin 7 (IL-7) in vitro. Foxp1 repressed expression of the IL-7 receptor alpha-chain (IL-7R alpha) by antagonizing Foxo1 and negatively regulated signaling by the kinases MEK and Erk. Acute deletion of Foxp1 induced naive T cells to gain an effector phenotype and proliferate in lympho-replete mice. Foxp1-deficient naive CD8(+) T cells proliferated even in lymphopenic mice deficient in major histocompatibility complex class I. Our results demonstrate that Foxp1 exerts essential cell-intrinsic regulation of naive T cell quiescence, providing direct evidence that lymphocyte quiescence is achieved through actively maintained mechanisms that include transcriptional regulation.	[Feng, Xiaoming; Wang, Haikun; Takata, Hiroshi; Day, Timothy J.; Willen, Jessica; Hu, Hui] Wistar Inst Anat & Biol, Philadelphia, PA USA	The Wistar Institute	Hu, H (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	hhu@wistar.org		wang, hai kun/0000-0002-4714-4672; Takata, Hiroshi/0000-0003-1457-6919	National Institutes of Health [1K22AI070317-01A1]; American Cancer Society [114937-IRG-96-153-07-IRG]; Wistar Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI070317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R.A. DePinho (Harvard Medical School) for Foxo1<SUP>f/f</SUP> mice; W. Pear (University of Pennsylvania) for the retroviral vector MigR1-GFP; N.A. Speck (University of Pennsylvania) for the retroviral vector MigR1-Cre-GFP; E. Pure and J.R. Conejo-Garcia for critical reading of the manuscript; A.J. Caton and A. Bhandoola for discussions; J.S. Faust, D.E. Ambrose and D.J. Hussey for technical help with flow cytometry; and M.S. Wright, M. Houston-Leslie and D. DiFrancesco for help at the Animal Facility of the Wistar Institute. Supported by the National Institutes of Health (1K22AI070317-01A1 to H.H.), American Cancer Society (114937-IRG-96-153-07-IRG to H.H.) and the Wistar Cancer Center (P30 CA10815).	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kindler T, 2008, BLOOD, V112, P3373, DOI 10.1182/blood-2008-03-147587; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; Zhang J, 1999, J IMMUNOL, V162, P3819; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	50	129	134	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					544	U246		10.1038/ni.2034	http://dx.doi.org/10.1038/ni.2034			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21532575	Green Accepted			2022-12-18	WOS:000290707100015
J	Hammel, M; Sfyroera, G; Ricklin, D; Magotti, P; Lambris, JD; Geisbrecht, BV				Hammel, Michal; Sfyroera, Georgia; Ricklin, Daniel; Magotti, Paola; Lambris, John D.; Geisbrecht, Brian V.			A structural basis for complement inhibition by Staphylococcus aureus	NATURE IMMUNOLOGY			English	Article							FIBRINOGEN-BINDING PROTEIN; CONFORMATIONAL-CHANGES; COMPONENT C3; FACTOR-H; ACTIVATION; PEPTIDOGLYCAN; ADHERENCE; INSIGHTS; INNATE; DOMAIN	To provide insight into bacterial suppression of complement-mediated immunity, we present here structures of a bacterial complement inhibitory protein, both free and bound to its complement target. The 1.25-angstrom structure of the complement component C3-inhibitory domain of Staphylococcus aureus extracellular fibrinogen-binding protein ( Efb-C) demonstrated a helical motif involved in complement regulation, whereas the 2.2-angstrom structure of Efb-C bound to the C3d domain of human C3 allowed insight into the recognition of complement proteins by invading pathogens. Our structure-function studies provided evidence for a previously unrecognized mode of complement inhibition whereby Efb-C binds to native C3 and alters the solution conformation of C3 in a way that renders it unable to participate in successful 'downstream' activation of the complement response.	Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Missouri System; University of Missouri Kansas City; University of Pennsylvania	Geisbrecht, BV (corresponding author), Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA.	geisbrechtB@umkc.edu	Lambris, John/Q-5633-2018; Magotti, Paola/A-2903-2012; Ricklin, Daniel/F-5104-2011	Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233; Hammel, Michal/0000-0002-5610-9289	NIAID NIH HHS [AI30040] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029; BREDIUS RGM, 1992, INFECT IMMUN, V60, P4838, DOI 10.1128/IAI.60.11.4838-4847.1992; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; HACK CE, 1988, J IMMUNOL, V141, P1602; Hammel M, 2006, ACTA CRYSTALLOGR F, V62, P285, DOI 10.1107/S1744309106005926; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; ISENMAN DE, 1981, BIOCHEMISTRY-US, V20, P4458, DOI 10.1021/bi00518a034; ISENMAN DE, 1983, J BIOL CHEM, V258, P4238; ISENMAN DE, 1981, MOL IMMUNOL, V18, P331, DOI 10.1016/0161-5890(81)90057-2; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWASAKI A, 1987, MICROBIOL IMMUNOL, V31, P551, DOI 10.1111/j.1348-0421.1987.tb03117.x; Kraus D, 1998, INFECT IMMUN, V66, P399, DOI 10.1128/IAI.66.2.399-405.1998; LAMBRIS JD, 2000, THERAPEUTIC INTERVEN; Lee LY, 2002, J CLIN INVEST, V110, P1461, DOI 10.1172/JC1200216318; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7; MORIKIS D, 2005, STRUCTURAL BIOL COMP; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON B, 1992, BIOCHEM J, V282, P715, DOI 10.1042/bj2820715; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sakiniene E, 1999, CLIN EXP IMMUNOL, V115, P95; Sfyroera G, 2005, J IMMUNOL, V174, P2143, DOI 10.4049/jimmunol.174.4.2143; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VERBRUGH HA, 1979, IMMUNOLOGY, V37, P615; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; WILKINSON BJ, 1978, INFECT IMMUN, V20, P388, DOI 10.1128/IAI.20.2.388-392.1978; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	45	129	138	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					430	437		10.1038/ni1450	http://dx.doi.org/10.1038/ni1450			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17351618				2022-12-18	WOS:000245075900018
J	Zarrin, AA; Alt, FW; Chaudhuri, J; Stokes, N; Kaushal, D; Du Pasquier, L; Tian, M				Zarrin, AA; Alt, FW; Chaudhuri, J; Stokes, N; Kaushal, D; Du Pasquier, L; Tian, M			An evolutionarily conserved target motif for immunoglobulin class-switch recombination	NATURE IMMUNOLOGY			English	Article							SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; NOVO PROTEIN-SYNTHESIS; SOMATIC HYPERMUTATION; TANDEM REPEATS; REGION; TRANSCRIPTION; URACIL; MUTATIONS; REPAIR	Immunoglobulin H class-switch recombination (CSR) occurs between switch regions and requires transcription and activation-induced cytidine deaminase (AID). Transcription through mammalian switch regions, because of their GC-rich composition, generates stable R-loops, which provide single-stranded DNA substrates for AID. However, we show here that the Xenopus laevis switch region S-mu, which is rich in AT and not prone to form R-loops, can functionally replace a mouse switch region to mediate CSR in vivo. X. laevis S-mu-mediated CSR occurred mostly in a region of AGCT repeats targeted by the AID-replication protein A complex when transcribed in vitro. We propose that AGCT is a primordial CSR motif that targets AID through a non-R-loop mechanism involving an AID-replication protein A complex.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Basel	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CBR Inst Biomed Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu			NIAID NIH HHS [AI31541, AI07512] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Pasqualucci L, 2000, CANCER RES, V60, P5644; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Seidl KJ, 1998, INT IMMUNOL, V10, P1683, DOI 10.1093/intimm/10.11.1683; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zeng XM, 2004, J EXP MED, V199, P917, DOI 10.1084/jem.20032022	50	129	132	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1275	1281		10.1038/ni1137	http://dx.doi.org/10.1038/ni1137			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15531884				2022-12-18	WOS:000225353500017
J	Urdahl, KB; Sun, JC; Bevan, MJ				Urdahl, KB; Sun, JC; Bevan, MJ			Positive selection of MHC class Ib-restricted CD8(+) T cells on hematopoietic cells	NATURE IMMUNOLOGY			English	Article							N-FORMYLATED PEPTIDES; MYCOBACTERIUM-TUBERCULOSIS; LYMPHOCYTES-T; MOLECULES; ANTIGEN; THYMOCYTES; INFECTION; THYMUS; MICE; RESPONSES	Unlike conventional CD8(+) T cells, major histocompatibility complex (MHC) class Ib-restricted CD8(+) T cells show an activated phenotype in uninfected mice and respond rapidly to foreign invaders. The underlying factors that contribute to these differences are not well understood. We show here that the activated phenotype of MHC class Ib-restricted CD8(+) T cells was partially acquired as a result of interactions in the thymus and reflected an increased capacity to be selected via interactions with MHC molecules on hematopoietic cells. Using bone marrow-chimeric mice, we have shown that MHC class Ib-restricted, but not MHC class Ia-restricted, CD8(+) T cells specific for Listeria monocytogenes were efficiently selected when MHC class I was expressed only on hematopoietic cells. Thus, the distinct functional properties of MHC class Ib-restricted versus MHC class Ia-restricted CD8(+) T cells may result, at least in part, from the different ways in which they are positively selected in the thymus.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Div Infect Dis, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Urdahl, Kevin/0000-0003-0088-1066	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-20, AI19335] Funding Source: Medline; NICHD NIH HHS [K12 HD000850, K12-HD00850] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019335, R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Berg RE, 2000, J IMMUNOL, V165, P4209, DOI 10.4049/jimmunol.165.8.4209; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Bouwer HGA, 1997, J IMMUNOL, V159, P2795; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; CEREDIG R, 1983, J EXP MED, V158, P1654, DOI 10.1084/jem.158.5.1654; Chiu NM, 1999, J EXP MED, V190, P1869, DOI 10.1084/jem.190.12.1869; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; CRISPE IN, 1987, J IMMUNOL, V138, P2013; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; LINDAHL KF, 1991, ANNU REV IMMUNOL, V9, P351, DOI 10.1146/annurev.iy.09.040191.002031; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; MARKOWITZ JS, 1993, P NATL ACAD SCI USA, V90, P2779, DOI 10.1073/pnas.90.7.2779; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Shinkai K, 2000, J EXP MED, V191, P907, DOI 10.1084/jem.191.6.907; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Zerrahn J, 1999, P NATL ACAD SCI USA, V96, P11470, DOI 10.1073/pnas.96.20.11470	44	129	131	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					772	779		10.1038/ni814	http://dx.doi.org/10.1038/ni814			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12089507	Green Accepted			2022-12-18	WOS:000177118500017
J	Linke, M; Pham, HTT; Katholnig, K; Schnolller, T; Miller, A; Demel, F; Schutz, B; Rosner, M; Kovacic, B; Sukhbaatar, N; Niederreiter, B; Bluml, S; Kuess, P; Sexl, V; Muller, M; Mikula, M; Weckwerth, W; Haschemi, A; Susani, M; Hengstschlager, M; Gambello, MJ; Weichhart, T				Linke, Monika; Ha Thi Thanh Pham; Katholnig, Karl; Schnoelller, Thomas; Miller, Anne; Demel, Florian; Schuetz, Birgit; Rosner, Margit; Kovacic, Boris; Sukhbaatar, Nyamdelger; Niederreiter, Birgit; Blueml, Stephan; Kuess, Peter; Sexl, Veronika; Mueller, Mathias; Mikula, Mario; Weckwerth, Wolfram; Haschemi, Arvand; Susani, Martin; Hengstschlaeger, Markus; Gambello, Michael J.; Weichhart, Thomas			Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression	NATURE IMMUNOLOGY			English	Article							LOCAL PROLIFERATION; CELL; INNATE; GROWTH; FATE; TSC2	The aggregation of hypertrophic macrophages constitutes the basis of all granulomatous diseases, such as tuberculosis or sarcoidosis, and is decisive for disease pathogenesis. However, macrophage-intrinsic pathways driving granuloma initiation and maintenance remain elusive. We found that activation of the metabolic checkpoint kinase mTORC1 in macrophages by deletion of the gene encoding tuberous sclerosis 2 (Tsc2) was sufficient to induce hypertrophy and proliferation, resulting in excessive granuloma formation in vivo. TSC2-deficient macrophages formed mTORC1-dependent granulomatous structures in vitro and showed constitutive proliferation that was mediated by the neo-expression of cyclin-dependent kinase 4 (CDK4). Moreover, mTORC1 promoted metabolic reprogramming via CDK4 toward increased glycolysis while simultaneously inhibiting NF-KB signaling and apoptosis. Inhibition of mTORC1 induced apoptosis and completely resolved granulomas in myeloid TSC2-deficient mice. In human sarcoidosis patients, mTORC1 activation, macrophage proliferation and glycolysis were identified as hallmarks that correlated with clinical disease progression. Collectively, TSC2 maintains macrophage quiescence and prevents mTORC1dependent granulomatous disease with clinical implications for sarcoidosis.	[Linke, Monika; Ha Thi Thanh Pham; Katholnig, Karl; Schnoelller, Thomas; Demel, Florian; Schuetz, Birgit; Rosner, Margit; Kovacic, Boris; Sukhbaatar, Nyamdelger; Mikula, Mario; Hengstschlaeger, Markus; Weichhart, Thomas] Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria; [Miller, Anne; Haschemi, Arvand] Med Univ Vienna, Dept Lab Med KILM, Vienna, Austria; [Schuetz, Birgit; Rosner, Margit] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria; [Kuess, Peter] Med Univ Vienna, Div Med Radiat Phys, Dept Radiat Oncol, Vienna, Austria; [Sexl, Veronika] Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria; [Mueller, Mathias] Univ Vet Med, Biomodels Austria, Vienna, Austria; [Mueller, Mathias] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria; [Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria; [Weckwerth, Wolfram] Univ Vienna, Vienna Metabol Ctr VIME, Vienna, Austria; [Susani, Martin] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Gambello, Michael J.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna; Medical University of Vienna; Emory University	Weichhart, T (corresponding author), Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria.	thomas.weichhart@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014; Weckwerth, Wolfram/G-5811-2010; Kovacic, Boris/J-1871-2016; Kuess, Peter/AAT-1178-2020; Sexl, Veronika/B-8657-2016	Weichhart, Thomas/0000-0002-4349-0797; Kovacic, Boris/0000-0002-1148-4149; Kuess, Peter/0000-0003-2961-1692; Bluml, Stephan/0000-0002-2758-4400; Haschemi, Arvand/0000-0001-9532-3205; Sexl, Veronika/0000-0001-9363-0412; Muller, Mathias/0000-0002-7879-3552; Weckwerth, Wolfram/0000-0002-9719-6358; Mikula, Mario/0000-0001-5782-0681; Miller, Anne/0000-0002-5587-7497	Austrian Science Fund (FWF) [FWF-P27701-B20]; Else-Kroner-Fresenius-Stiftung [P2013_A149]; Herzfelder'sche Familienstiftung; [DOC] Doctoral Fellowship Programme of the Austrian Academy of Sciences; FWF [SFB F28, SBF F47, P25336-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Else-Kroner-Fresenius-Stiftung; Herzfelder'sche Familienstiftung; [DOC] Doctoral Fellowship Programme of the Austrian Academy of Sciences; FWF(Austrian Science Fund (FWF))	We thank U. Reichart and T. Kolbe for support in mouse breeding. We are grateful to D. Georg for the possibility of using the XYLON Maxishot. We would also like to thank M. Stadler and H. Dolznig (Medical University of Vienna) for providing human-monocyte-derived macrophages. Tsc1<SUP>+/+</SUP> MEFs were a kind gift of D.J. Kwiatkowski (Harvard Medical School). T.W. is supported by grants from the Austrian Science Fund (FWF) grant FWF-P27701-B20, the Else-Kroner-Fresenius-Stiftung (P2013_A149), and the Herzfelder'sche Familienstiftung. M.L. is supported by the [DOC] Doctoral Fellowship Programme of the Austrian Academy of Sciences. V.S. is funded by FWF SFB F28 and SBF F47. M. Muller is funded by FWF SFB F28. M. Mikula is supported by the FWF grant P25336-B13.	Beegle SH, 2013, DRUG DES DEV THER, V7, P325, DOI 10.2147/DDDT.S31064; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; de Marval PLM, 2001, AM J PATHOL, V159, P369, DOI 10.1016/S0002-9440(10)61703-8; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Fang CM, 2015, CELL PHYSIOL BIOCHEM, V36, P1406, DOI 10.1159/000430306; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hofmann S, 2013, EUR RESPIR J, V41, P888, DOI 10.1183/09031936.00033812; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Huaux F, 2015, J PATHOL, V235, P698, DOI 10.1002/path.4487; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Judson MA, 2014, CURR OPIN PULM MED, V20, P508, DOI 10.1097/MCP.0000000000000082; LAN HY, 1995, AM J PATHOL, V147, P1214; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lebwohl D, 2013, ANN NY ACAD SCI, V1291, P14, DOI 10.1111/nyas.12122; Lockstone HE, 2010, AM J RESP CRIT CARE, V181, P1367, DOI 10.1164/rccm.200912-1855OC; Manzia TM, 2011, TRANSPL INT, V24, pE69, DOI 10.1111/j.1432-2277.2011.01256.x; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Petersen HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00120; Petzmann S, 2006, SARCOIDOSIS VASC DIF, V23, P190; PFORTE A, 1993, EUR RESPIR J, V6, P951; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Teirtein AS, 2007, CHEST, V132, P1949, DOI 10.1378/chest.07-1178; Wang YY, 2013, P NATL ACAD SCI USA, V110, pE4894, DOI 10.1073/pnas.1308905110; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zissel G, 2015, CLIN CHEST MED, V36, P549, DOI 10.1016/j.ccm.2015.08.016	49	128	131	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					293	302		10.1038/ni.3655	http://dx.doi.org/10.1038/ni.3655			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28092373	Green Accepted			2022-12-18	WOS:000394413400009
J	Laidlaw, BJ; Cui, WG; Amezquita, RA; Gray, SM; Guan, TX; Lu, YS; Kobayashi, Y; Flavell, RA; Kleinstein, SH; Craft, J; Kaech, SM				Laidlaw, Brian J.; Cui, Weiguo; Amezquita, Robert A.; Gray, Simon M.; Guan, Tianxia; Lu, Yisi; Kobayashi, Yasushi; Flavell, Richard A.; Kleinstein, Steven H.; Craft, Joe; Kaech, Susan M.			Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							PROTECTIVE IMMUNITY; DENDRITIC CELLS; EFFECTOR; INTERLEUKIN-10; EXPRESSION; RESPONSES; FOXP3(+); VIRUS; INFLAMMATION; LIPOPOLYSACCHARIDE	Memory CD8(+) T cells are critical for host defense upon reexposure to intracellular pathogens. We found that interleukin 10 (IL-10) derived from CD4(+) regulatory T cells (T-reg cells) was necessary for the maturation of memory CD8(+) T cells following acute infection with lymphocytic choriomeningitis virus (LCMV). Treg cell-derived IL-10 was most important during the resolution phase, calming inflammation and the activation state of dendritic cells. Adoptive transfer of IL-10-sufficient Treg cells during the resolution phase 'restored' the maturation of memory CD8(+) T cells in IL-10-deficient mice. Our data indicate that Treg cell-derived IL-10 is needed to insulate CD8(+) T cells from inflammatory signals, and reveal that the resolution phase of infection is a critical period that influences the quality and function of developing memory CD8(+) T cells.	[Laidlaw, Brian J.; Cui, Weiguo; Amezquita, Robert A.; Gray, Simon M.; Guan, Tianxia; Lu, Yisi; Kobayashi, Yasushi; Flavell, Richard A.; Kleinstein, Steven H.; Craft, Joe; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Amezquita, Robert A.; Flavell, Richard A.; Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdepartmental Program Computat Biol & Bioinfo, New Haven, CT 06510 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	joseph.craft@yale.edu; susan.kaech@yale.edu	Guan, Tianxia/B-5559-2017	Guan, Tianxia/0000-0001-6187-5431; Lu, Yisi/0000-0002-7960-5445	US National Institutes of Health [RO1AI066232, R01AI07469, R01AR40072, P30AR053495, R21AR063942, T32AI07019, F31AG07777, T32GM07205]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074699, R37AI066232, T32AI007019, R01AI066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, R21AR063942, P30AR053495, R37AR040072, R21AR068662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047777] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J.M.M. den Haan (UV University Medical Center, Amsterdam) for mAb ES5-2A5; and all members of the Kaech and Craft laboratories for discussions and critical reading of the manuscript. Supported by the US National Institutes of Health (RO1AI066232 and R01AI074699 to S.M.K.; R01AR40072, P30AR053495 and R21AR063942 to J.C.; T32AI07019 and F31AG07777 to B.J.L.; and T32GM07205 to S.M.G.) and the Howard Hughes Medical Institute (S.M.K., B.J.L., R.A.F. and T.G.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Cui WG, 2014, J IMMUNOL, V192, P4221, DOI 10.4049/jimmunol.1302569; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; de Herve MGD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1992; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Girard-Madoux MJH, 2012, J ALLERGY CLIN IMMUN, V129, P143, DOI 10.1016/j.jaci.2011.08.032; Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Maharshak N, 2013, GUT MICROBES, V4, P316, DOI 10.4161/gmic.25486; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Stelekati E, 2014, IMMUNITY, V40, P801, DOI 10.1016/j.immuni.2014.04.010; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	55	128	134	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					871	+		10.1038/ni.3224	http://dx.doi.org/10.1038/ni.3224			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147684	Green Accepted			2022-12-18	WOS:000358299200014
J	Netea, MG; Latz, E; Mills, KHG; O'Neill, LAJ				Netea, Mihai G.; Latz, Eicke; Mills, Kingston H. G.; O'Neill, Luke A. J.			Innate immune memory: a paradigm shift in understanding host defense	NATURE IMMUNOLOGY			English	Editorial Material								Researchers gathered at the Wellcome Trust Genome Campus in Hinxton, Cambridge, for the first Innate Immune Memory Conference dedicated to the adaptive characteristics of innate immunity, to further the understanding of this newly described immunological process that probably has a central role in host defense and inflammation.	[Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Mills, Kingston H. G.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Trinity College Dublin	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.	mihai.netea@radboudumc.nl	Mills, Kingston H/F-5684-2013; Netea, Mihai/N-5155-2014; Latz, Eicke/H-3951-2014	Mills, Kingston H/0000-0003-3646-8222; Latz, Eicke/0000-0003-1488-5666; O'Neill, Luke/0000-0002-4333-2748				Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Luna E, 2012, PLANT SIGNAL BEHAV, V7, P615, DOI 10.4161/psb.20155; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Murphy M, 2007, JANEWAYS IMMUNOBIOLO; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Schaafsma W, 2015, BRAIN BEHAV IMMUN, V48, P205, DOI 10.1016/j.bbi.2015.03.013; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Yanez A, 2013, EUR J IMMUNOL, V43, P2114, DOI 10.1002/eji.201343403	28	128	137	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					675	679		10.1038/ni.3178	http://dx.doi.org/10.1038/ni.3178			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB7VQ	26086132				2022-12-18	WOS:000417418700001
J	Eckard, SC; Rice, GI; Fabre, A; Badens, C; Gray, EE; Hartley, JL; Crow, YJ; Stetson, DB				Eckard, Sterling C.; Rice, Gillian I.; Fabre, Alexandre; Badens, Catherine; Gray, Elizabeth E.; Hartley, Jane L.; Crow, Yanick J.; Stetson, Daniel B.			The SKIV2L RNA exosome limits activation of the RIG-I-like receptors	NATURE IMMUNOLOGY			English	Article							AICARDI-GOUTIERES-SYNDROME; UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE PROTEIN; MESSENGER-RNAS; RECOGNITION; MECHANISM; MUTATIONS; TREX1; ER; REVEAL	Sensors of the innate immune system that detect intracellular nucleic acids must be regulated to prevent inappropriate activation by endogenous DNA and RNA. The exonuclease Trex1 regulates the DNA-sensing pathway by metabolizing potential DNA ligands that trigger it. However, an analogous mechanism for regulating the RIG-I-like receptors (RLRs) that detect RNA remains unknown. We found here that the SKIV2L RNA exosome potently limited the activation of RLRs. The unfolded protein response (UPR), which generated endogenous RLR ligands through the cleavage of cellular RNA by the endonuclease IRE-1, triggered the production of type I interferons in cells depleted of SKIV2L. Humans with deficiency in SKIV2L had a type I interferon signature in their peripheral blood. Our findings reveal a mechanism for the intracellular metabolism of immunostimulatory RNA, with implications for specific autoimmune disorders.	[Eckard, Sterling C.; Gray, Elizabeth E.; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Fabre, Alexandre; Badens, Catherine] Aix Marseille Univ, INSERM, Fac Med, UMR S 910, Marseille, France; [Fabre, Alexandre] Hop Enfants La Timone, Serv Pediat Multidisciplinaire, AP HM, Marseille, France; [Badens, Catherine] Hop Enfants La Timone, Lab Genet Mol, AP HM, Marseille, France; [Hartley, Jane L.] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England	University of Washington; University of Washington Seattle; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Birmingham	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	stetson@uw.edu	Rice, Gillian I/G-3128-2015; Crow, Yanick J/N-6120-2014; Badens, Catherine/J-8727-2016; FABRE, Alexandre JM/M-3457-2016	Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; Badens, Catherine/0000-0001-9024-310X; FABRE, Alexandre JM/0000-0001-5155-6437	National Institute of Allergy and Infectious Disease [Al084914]; Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL) project of the European Union Seventh Framework Programme [241779]; Lupus Research Institute; Cancer Research Institute; Rita Allen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084914] Funding Source: NIH RePORTER; MRC [G0601347] Funding Source: UKRI	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL) project of the European Union Seventh Framework Programme; Lupus Research Institute; Cancer Research Institute; Rita Allen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Gale, Jr. (University of Washington) for Mavs<SUP>-/-</SUP> mice, and members of the Stetson laboratory for discussions. Supported by the National Institute of Allergy and Infectious Disease (Al084914 to D.B.S.), the Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL) project of the European Union Seventh Framework Programme 2007-2013 (241779 to Y.J.C. and D.B.S.), the Lupus Research Institute (D.B.S.), the Cancer Research Institute (E.E.G.) and the Rita Allen Foundation (D.B.S.).	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Fabre A, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-5; Fabre A, 2012, AM J HUM GENET, V90, P689, DOI 10.1016/j.ajhg.2012.02.009; Fabre A, 2011, HUM MUTAT, V32, P277, DOI 10.1002/humu.21420; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hartley JL, 2010, GASTROENTEROLOGY, V138, P2388, DOI 10.1053/j.gastro.2010.02.010; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; MORI K, 1993, CELL, V74, P743; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	44	128	128	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					839	845		10.1038/ni.2948	http://dx.doi.org/10.1038/ni.2948			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25064072	Green Accepted			2022-12-18	WOS:000340739400011
J	Zhang, N; Bevan, MJ				Zhang, Nu; Bevan, Michael J.			TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; NEGATIVE SELECTION; CUTTING EDGE; MICE; HOMEOSTASIS; EXPRESSION; DISEASE; INFLAMMATION; DISRUPTION; MECHANISMS	T cell-specific deletion of the receptor for transforming growth factor-beta (TGF-beta) mediated by Cre recombinase expressed early in T cell development leads to early-onset lethal autoimmune disease that cannot be controlled by regulatory T cells. However, when we deleted that receptor through the use of Cre driven by a promoter that is active much later in T cell development, adult mice in which most peripheral CD4(+) or CD8(+) T cells lacked the receptor for TGF-beta showed no signs of autoimmunity. Because of their enhanced responses to weak stimulation of the T cell antigen receptor, when transferred into lymphopenic recipients, naive TGF-beta-unresponsive T cells underwent much more proliferation and differentiation into effector cells and induced lymphoproliferative disease. We propose that TGF-beta signaling controls the self-reactivity of peripheral T cells but that in the absence of TGF-beta signals, an added trigger such as lymphopenia is needed to drive overt autoimmune disease.	[Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@uw.edu		Zhang, Nu/0000-0001-9695-210X	US National Institutes of Health [AI19335]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335, R37AI019335] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Karlsson (Lund University) for Tgfbr2<SUP>f/f</SUP> mice; P.J. Fink (University of Washington, Seattle) for mice with transgenic expression of Cre from the distal Lck promoter; A. G. Farr for help with histology, T. Bergsbaken for help with the immunofluorescence microscopy; and P.J. Fink for comments on the manuscript. Supported by US National Institutes of Health (AI19335) and the Howard Hughes Medical Institute.	Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bommireddy R, 2004, CELL IMMUNOL, V232, P96, DOI 10.1016/j.cellimm.2005.02.004; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hale JS, 2010, J IMMUNOL, V184, P5964, DOI 10.4049/jimmunol.1000876; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Le Campion A, 2009, BLOOD, V114, P1784, DOI 10.1182/blood-2008-12-192120; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Rudner LA, 2003, J IMMUNOL, V170, P4785, DOI 10.4049/jimmunol.170.9.4785; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	37	128	130	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					667	+		10.1038/ni.2319	http://dx.doi.org/10.1038/ni.2319			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22634866	Green Accepted			2022-12-18	WOS:000305483800012
J	Nachmani, D; Lankry, D; Wolf, DG; Mandelboim, O				Nachmani, Daphna; Lankry, Dikla; Wolf, Dana G.; Mandelboim, Ofer			The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; I-RELATED CHAIN; NKG2D LIGANDS; RECOGNITION; TUMOR; EXPRESSION; MOLECULES; RECEPTOR; MIR-155; EVASION	Although approximately 200 viral microRNAs are known, only very few share similar targets with their host's microRNAs. A notable example of this is the stress-induced ligand MICB, which is targeted by several distinct viral and cellular microRNAs. Through the investigation of the microRNA-mediated immune-evasion strategies of herpesviruses, we initially identified two new cellular microRNAs that targeted MICB and were expressed differently both in healthy tissues and during melanocyte transformation. We show that coexpression of various pairs of cellular microRNAs interfered with the downregulation of MICB, whereas the viral microRNAs optimized their targeting ability to efficiently downregulate MICB. Moreover, we demonstrate that through site proximity and possibly inhibition of translation, a human cytomegalovirus (HCMV) microRNA acts synergistically with a cellular microRNA to suppress MICB expression during HCMV infection.	[Nachmani, Daphna; Lankry, Dikla; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, BioMed Res Inst Israel Canada, Lautenberg Ctr Gen & Tumor Immunol,Fac Med, IL-91010 Jerusalem, Israel; [Wolf, Dana G.] Hebrew Univ Jerusalem, Hadassah Med Sch, Virol Unite, Hadassah Hosp, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, BioMed Res Inst Israel Canada, Lautenberg Ctr Gen & Tumor Immunol,Fac Med, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il		Mandelboim, Ofer/0000-0002-9354-1855	Israeli Science Foundation; Israeli Science Foundation, Morasha; Croatia-Israel Research; Ministry of Science and Technology-Deutsches Krebsforschungszentrum; European Consortium [MRTN-CT-2005]; Rosetrees Trust; Israel Cancer Association [20100003]; Association for International Cancer Research; Worldwide Cancer Research [10-0003] Funding Source: researchfish	Israeli Science Foundation(Israel Science Foundation); Israeli Science Foundation, Morasha(Israel Science Foundation); Croatia-Israel Research; Ministry of Science and Technology-Deutsches Krebsforschungszentrum; European Consortium; Rosetrees Trust(Rosetrees Trust); Israel Cancer Association; Association for International Cancer Research; Worldwide Cancer Research	We thank A. Bernard (Hopital de lArchet, Nice, France) for monoclonal anti-CD99 (12E7); Y. Livneh, D. Davis and S. Jonjic and all members of the Mandelboim laboratory for suggestions and discussions and for critical reading of the manuscript; S. Diederichs and W. Filipowicz for discussions and suggestions; and M. Lotem and team (Hadassah Hospital) for primary melanocytes and nevi. Supported by the Israeli Science Foundation (O.M.), The Israeli Science Foundation (Morasha, to O.M.), Croatia-Israel Research (O.M.), Ministry of Science and Technology-Deutsches Krebsforschungszentrum (O.M.), The European Consortium (MRTN-CT-2005 to O.M.), Rosetrees Trust (O.M.), the Israel Cancer Association (20100003 to O.M.) and the Association for International Cancer Research (O.M.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Choy MK, 2010, TRENDS MOL MED, V16, P97, DOI 10.1016/j.molmed.2010.01.002; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Dranoff G, 2009, ANN NY ACAD SCI, V1174, P74, DOI 10.1111/j.1749-6632.2009.04938.x; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eissmann P, 2010, J IMMUNOL, V184, P6901, DOI 10.4049/jimmunol.0903985; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Stern-Ginossar N, 2009, J VIROL, V83, P10684, DOI 10.1128/JVI.01292-09; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400	47	128	138	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					806	U57		10.1038/ni.1916	http://dx.doi.org/10.1038/ni.1916			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20694010				2022-12-18	WOS:000281115500008
J	Alder, MN; Herrin, BR; Sadlonova, A; Stockard, CR; Grizzle, WE; Gartland, LA; Gartland, GL; Boydston, JA; Turnbough, CL; Cooper, MD				Alder, Matthew N.; Herrin, Brantley R.; Sadlonova, Andrea; Stockard, Cecil R.; Grizzle, William E.; Gartland, Lanier A.; Gartland, G. Larry; Boydston, Jeremy A.; Turnbough, Charles L., Jr.; Cooper, Max D.			Antibody responses of variable lymphocyte receptors in the lamprey	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSE; PETROMYZON-MARINUS; SEA LAMPREY; BACILLUS-ANTHRACIS; IMMUNOLOGIC RESPONSES; PACIFIC HAGFISH; PLASMA-CELLS; EVOLUTION; ANTIGEN; IMMUNOGLOBULIN	Lamprey and hagfish, the living representatives of jawless vertebrates, use genomic leucine-rich-repeat cassettes for the combinatorial assembly of diverse antigen receptor genes encoding variable lymphocyte receptors of two types: VLRA and VLRB. We describe here the VLRB-bearing lineage of lymphocytes in sea lamprey. These cells responded to repetitive carbohydrate or protein determinants on bacteria or mammalian cells with lymphoblastoid transformation, proliferation and differentiation into plasmacytes that secreted multimeric antigen-specific VLRB antibodies. Lacking a thymus and the ability to respond to soluble protein antigens, lampreys seem to have evolved a B cell-like system for adaptive humoral responses.	[Alder, Matthew N.; Herrin, Brantley R.; Sadlonova, Andrea; Gartland, Lanier A.; Cooper, Max D.] Univ Alabama, Off Fundamental Immunol Res, Birmingham, AL 35294 USA; [Alder, Matthew N.; Herrin, Brantley R.; Sadlonova, Andrea; Gartland, Lanier A.; Gartland, G. Larry; Boydston, Jeremy A.; Turnbough, Charles L., Jr.; Cooper, Max D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Stockard, Cecil R.; Grizzle, William E.; Cooper, Max D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Cooper, Max D.] Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cooper, MD (corresponding author), Univ Alabama, Off Fundamental Immunol Res, Birmingham, AL 35294 USA.	max.cooper@ccc.uab.edu		Herrin, Brantley/0000-0002-1842-6806; Alder, Matthew/0000-0003-2879-6576	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, P01AI057699, R01AI072435] Funding Source: NIH RePORTER; NIAID NIH HHS [AI57699, AI72435, T32 AI007051] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACTON RT, 1969, J BACTERIOL, V99, P626, DOI 10.1128/JB.99.2.626-628.1969; ACTON RT, 1971, INFECT IMMUN, V4, P160, DOI 10.1128/IAI.4.2.160-166.1971; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BOFFA GA, 1967, NATURE, V214, P700, DOI 10.1038/214700b0; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; FINSTAD J, 1964, LAB INVEST, V13, P490; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; FUJII T, 1979, DEV COMP IMMUNOL, V3, P441, DOI 10.1016/S0145-305X(79)80040-3; FUJII T, 1979, DEV COMP IMMUNOL, V3, P609, DOI 10.1016/S0145-305X(79)80056-7; FUJII T, 1982, J MORPHOL, V173, P87, DOI 10.1002/jmor.1051730108; HAGEN M, 1985, COMP BIOCHEM PHYS A, V82, P207, DOI 10.1016/0300-9629(85)90727-3; HAGEN M, 1983, IMMUNOL LETT, V6, P87, DOI 10.1016/0165-2478(83)90086-X; HERRIN BR, 2008, P NATL ACAD SCI US; HUNDT M, 1992, EUR J IMMUNOL, V22, P811, DOI 10.1002/eji.1830220327; Igarashi H, 2005, INT IMMUNOL, V17, P501, DOI 10.1093/intimm/dxh230; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Kasamatsu J, 2007, IMMUNOGENETICS, V59, P329, DOI 10.1007/s00251-007-0200-3; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KILARSKI W, 1981, DEV COMP IMMUNOL, V5, P361, DOI 10.1016/0145-305X(81)90045-8; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; KROCZEK RA, 1986, NATURE, V322, P181, DOI 10.1038/322181a0; LINTHICUM DS, 1970, J IMMUNOL, V105, P912; LITMAN GW, 1970, J IMMUNOL, V105, P1278; MARCHALONIS JJ, 1968, J EXP MED, V127, P891, DOI 10.1084/jem.127.5.891; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; POLLARA B, 1970, J IMMUNOL, V105, P738; POTTER IC, 1982, MORPHOLOGY DEV PHYSL, P233; Prieto PA, 1997, J BIOL CHEM, V272, P2089; PURVIS HA, 1979, 35136 GREAT LAK FISH; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; RUSU VM, 1975, J IMMUNOL, V115, P1370; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; ZAPATA A, 1981, CELL TISSUE RES, V221, P203, DOI 10.1007/BF00216582	44	128	148	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					319	327		10.1038/ni1562	http://dx.doi.org/10.1038/ni1562			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18246071				2022-12-18	WOS:000253406700018
J	Sebzda, E; Zou, ZY; Lee, JS; Wang, T; Kahn, ML				Sebzda, Eric; Zou, Zhiying; Lee, John S.; Wang, Tao; Kahn, Mark L.			Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns	NATURE IMMUNOLOGY			English	Article							KRUPPEL-LIKE FACTOR; LYMPHOCYTE EGRESS; L-SELECTIN; IN-VITRO; SPHINGOSINE-1-PHOSPHATE; LKLF; INFLAMMATION; TRAFFICKING; EOTAXIN; BLOOD	The migration patterns of naive and activated T cells are associated with the expression of distinct sets of chemokine receptors, but the molecular basis for this regulation is unknown. Here we identify Krupple-like factor 2 (KLF2) as a key transcriptional factor needed to prevent naive T cells from expressing inflammatory chemokine receptors and acquiring the migration patterns of activated T cells. Lineage-specific deletion of KLF2 resulted in fewer naive T cells in the blood and secondary lymphoid organs, whereas it expanded naive T cell numbers in nonlymphoid tissues; these effects were associated with altered expression of inflammatory chemokine receptors on naive T cells. KLF2 repressed the expression of several chemokine receptors, including CCR3 and CCR5. We thus conclude that KLF2 maintains proper T cell migration patterns by linking T cell movement and transcriptional regulation of chemokine receptor expression patterns.	[Sebzda, Eric; Zou, Zhiying; Lee, John S.; Wang, Tao; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Sebzda, E (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	eric.sebzda@vanderbilt.edu; markkahn@mail.med.upenn.edu						Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chiba K, 1998, J IMMUNOL, V160, P5037; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Endrizzi BT, 2003, INT IMMUNOL, V15, P1341, DOI 10.1093/intimm/dxg133; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Guignard F, 1998, J IMMUNOL, V160, P985; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; KACZYNSKI J, 2003, GENOME BIOL, V4; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V278, P788; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu R, 1998, AIDS RES HUM RETROV, V14, P1509, DOI 10.1089/aid.1998.14.1509; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Schober SL, 1999, J IMMUNOL, V163, P3662; Scotet E, 2001, BLOOD, V98, P2568, DOI 10.1182/blood.V98.8.2568; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843	44	128	134	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					292	300		10.1038/ni1565	http://dx.doi.org/10.1038/ni1565			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18246069				2022-12-18	WOS:000253406700015
J	Roy, CR; Mocarski, ES				Roy, Craig R.; Mocarski, Edward S.			Pathogen subversion of cell-intrinsic innate immunity	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; INTERFERON REGULATORY FACTOR-3; ACTIVATED PROTEIN-KINASE; ANTHRAX LETHAL FACTOR; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-5; RIG-I; SIGNALING PATHWAYS; DENDRITIC CELLS	The mammalian immune system has evolved under continuous selective pressure from a wide range of microorganisms that colonize and replicate in animal hosts. A complex set of signaling networks initiate both innate and adaptive immunity in response to the diverse pathogens that mammalian hosts encounter. In response, viral and microbial pathogens have developed or acquired sophisticated mechanisms to avoid, counteract and subvert sensors, signaling networks and a range of effector functions that constitute the host immune response. This balance of host response and pathogen countermeasures contributes to chronic infection in highly adapted pathogens that have coevolved with their host. In this review we outline some of the themes that are beginning to emerge in the mechanisms by which pathogens subvert the early innate immune response.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06535 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Yale University; Emory University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06535 USA.	craig.roy@yale.edu	Mocarski, Edward/ABC-2893-2020	Roy, Craig/0000-0003-4490-440X				Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bowie AG, 2007, TRENDS IMMUNOL, V28, P147, DOI 10.1016/j.it.2007.02.002; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Ciesiolka LD, 1999, MOL PLANT MICROBE IN, V12, P35, DOI 10.1094/MPMI.1999.12.1.35; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cunnac S, 2007, PLANT CELL, V19, P688, DOI 10.1105/tpc.106.048710; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jaaskelainen KM, 2007, J MED VIROL, V79, P1527, DOI 10.1002/jmv.20948; Jankovic D, 2006, CHEM IMMUNOL ALLERGY, V90, P65, DOI 10.1159/000088881; Jarvis MA, 2006, J VIROL, V80, P5588, DOI 10.1128/JVI.00060-06; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Johnson LM, 2007, J IMMUNOL, V178, P7259, DOI 10.4049/jimmunol.178.11.7259; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; MARINEZSOBRIDO L, 2007, J VIROL, DOI DOI 10.1128/JVI.00882-07; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pearce EJ, 2006, CHEM IMMUNOL ALLERGY, V90, P82, DOI 10.1159/000088882; Peng T, 2006, J VIROL, V80, P5021, DOI 10.1128/JVI.80.10.5021-5031.2006; PINE R, 1988, NUCLEIC ACIDS RES, V16, P1371, DOI 10.1093/nar/16.4.1371; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pulendran B, 2007, NEW ENGL J MED, V356, P1776, DOI 10.1056/NEJMcibr070454; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Schromm AB, 1998, J IMMUNOL, V161, P5464; Sen GC, 2007, ADV VIRUS RES, V70, P233, DOI 10.1016/S0065-3527(07)70006-4; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2005, ADV EXP MED BIOL, V560, P1; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zamboni DS, 2004, J BIOL CHEM, V279, P54405, DOI 10.1074/jbc.M410340200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	134	128	131	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1179	1187		10.1038/ni1528	http://dx.doi.org/10.1038/ni1528			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952043				2022-12-18	WOS:000250338900008
J	Scott-Browne, JP; Matsuda, JL; Mallevaey, T; White, J; Borg, NA; McCluskey, J; Rossjohn, J; Kappler, J; Marrack, P; Gapin, L				Scott-Browne, James P.; Matsuda, Jennifer L.; Mallevaey, Thierry; White, Janice; Borg, Natalie A.; McCluskey, James; Rossjohn, Jamie; Kappler, John; Marrack, Philippa; Gapin, Laurent			Germline-encoded recognition of diverse glycolipids by natural killer T cells	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTOR-ALPHA-CHAIN; V-ALPHA-14I NKT CELLS; ANTIGEN RECOGNITION; HIGH-AFFINITY; BINDING; CD1D; GALACTOSYLCERAMIDE; SPECIFICITY; REPERTOIRE	Natural killer T cells expressing 'invariant' T cell receptor a-chains (TCR alpha chains) containing variable M and joining M region V(alpha)14-J(alpha)18 (V(alpha)14i) rearrangements recognize both endogenous and microbial glycolipids in the context of CD1d. How cells expressing an invariant TCRa chain and a restricted set of TCRP chains recognize structurally diverse antigens is not clear. Here we show that a V(alpha)14i TCR recognized many alpha-linked glycolipids by means of a 'hot-spot' of germline-encoded amino acids in complementarity-determining regions 3 alpha, 1 alpha and 2 beta. This hot-spot did not shift during the recognition of structurally distinct antigens, suggesting that the V(alpha)14i TCR functions as a pattern - recognition receptor, conferring on natural killer T cells the ability to sense and respond in an innate way to pathogens displaying antigenic a-linked glycolipids.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Resp Ctr, Dept Immunol, Denver, CO 80206 USA; Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Sch Biomed Sci, Dept Biochem & Mol Biol,Protein Crystallog Unit, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Immunol & Microbiol, Parkville, Vic 3010, Australia; Univ Colorado, Hlth Sci Ctr, Howard Hughes Med Inst, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80220 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Monash University; University of Melbourne; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gapin, L (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Resp Ctr, Dept Immunol, 4200 E 9th Ave, Denver, CO 80206 USA.	gapinl@njc.org	McCluskey, James/A-1291-2007; Marrack, Philippa/AHE-6316-2022; Mallevaey, Thierry/AAH-4499-2020; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Borg, Natalie/0000-0002-8677-9056; Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018785, R37AI018785, R37AI017134, R56AI018785, R56AI017134, R01AI017134, R01AI057485] Funding Source: NIH RePORTER; NIAID NIH HHS [AI17134, AI18785, R01 AI057485, AI057485, R01 AI057485-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Arden Bernhard, 1995, Immunogenetics, V42, P455; Arden Bernhard, 1995, Immunogenetics, V42, P501; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2004, IMMUNOL CELL BIOL, V82, P285, DOI 10.1111/j.0818-9641.2004.01257.x; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; IMAI K, 1986, P NATL ACAD SCI USA, V83, P8708, DOI 10.1073/pnas.83.22.8708; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Parekh VV, 2005, CRIT REV IMMUNOL, V25, P183, DOI 10.1615/CritRevImmunol.v25.i3.20; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Seibel JL, 1997, J EXP MED, V185, P1919, DOI 10.1084/jem.185.11.1919; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Sim BC, 2003, IMMUNOGENETICS, V54, P874, DOI 10.1007/s00251-002-0532-y; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Wang B, 2000, J IMMUNOL, V164, P739, DOI 10.4049/jimmunol.164.2.739; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	54	128	132	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1105	1113		10.1038/ni1510	http://dx.doi.org/10.1038/ni1510			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17828267				2022-12-18	WOS:000249691400025
J	Evans, EJ; Esnouf, RM; Manso-Sancho, R; Gilbert, RJC; James, JR; Yu, C; Fennelly, JA; Vowles, C; Hanke, T; Walse, B; Hunig, T; Sorensen, P; Stuart, DI; Davis, SJ				Evans, EJ; Esnouf, RM; Manso-Sancho, R; Gilbert, RJC; James, JR; Yu, C; Fennelly, JA; Vowles, C; Hanke, T; Walse, B; Hunig, T; Sorensen, P; Stuart, DI; Davis, SJ			Crystal structure of a soluble CD28-Fab complex	NATURE IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; CD28-DEFICIENT MICE; CO-STIMULATION; PROTEIN INTERFACES; IMMUNE-RESPONSES; CTLA-4; COSTIMULATION; ANTIGEN; RECOGNITION; EXPRESSION	Naive T cell activation requires signaling by the T cell receptor and by nonclonotypic cell surface receptors. The most important costimulatory protein is the monovalent homodimer CD28, which interacts with CD80 and CD86 expressed on antigen-presenting cells. Here we present the crystal structure of a soluble form of CD28 in complex with the Fab fragment of a mitogenic antibody. Structural comparisons redefine the evolutionary relationships of CD28-related proteins, antigen receptors and adhesion molecules and account for the distinct ligand-binding and stoichiometric properties of CD28 and the related, inhibitory homodimer CTLA-4. Cryo-electron microscopy-based comparisons of complexes of CD28 with mitogenic and nonmitogenic antibodies place new constraints on models of antibody-induced receptor triggering. This work completes the initial structural characterization of the CD28-CTLA-4-CD80-CD86 signaling system.	Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; TeGenero AG, D-97076 Wurzburg, Germany; Act Biotech Res AB, SE-22007 Lund, Sweden; Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Wurzburg	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk; simon.davis@ndm.ox.ac.uk	James, John/AAP-3607-2021; James, John R/B-5547-2008	James, John/0000-0003-1452-7578; James, John R/0000-0003-1452-7578; Stuart, David/0000-0002-3426-4210; Walse, Bjorn/0000-0003-1513-9040; Gilbert, Robert/0000-0001-9336-5604				Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DAVIS SJ, 1992, NATURE, V358, P76, DOI 10.1038/358076a0; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gilbert RJC, 2004, MOL CELL, V14, P57, DOI 10.1016/S1097-2765(04)00163-7; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King CL, 1996, EUR J IMMUNOL, V26, P2448, DOI 10.1002/eji.1830261027; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LAFFERTY KJ, 1974, NATURE, V249, P275, DOI 10.1038/249275a0; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Margulies DH, 2003, J EXP MED, V197, P949, DOI 10.1084/jem.20030303; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; O'Regan MN, 1999, IMMUNOGENETICS, V49, P68, DOI 10.1007/s002510050464; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sorensen P, 2004, J IMMUNOL, V172, P6803, DOI 10.4049/jimmunol.172.11.6803; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Walter TS, 2003, J APPL CRYSTALLOGR, V36, P308, DOI 10.1107/S0021889803001997; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2	53	128	146	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					271	279		10.1038/ni1170	http://dx.doi.org/10.1038/ni1170			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15696168				2022-12-18	WOS:000227117400019
J	Levine, MM; Sztein, MB				Levine, MM; Sztein, MB			Vaccine development strategies for improving immunization: the role of modern immunology	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOGENICITY; EFFICACY; VIRUS	An ideal vaccine has certain biological and physical characteristics. Technological advances have provided new strategies that may help the design of such a vaccine.	Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Levine, MM (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	mlevine@medicine.umaryland.edu						Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Agren LC, 1999, J IMMUNOL, V162, P2432; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Guerena-Burgueno F, 2002, INFECT IMMUN, V70, P1874, DOI 10.1128/IAI.70.4.1874-1880.2002; Hariharan MJ, 1998, J VIROL, V72, P950, DOI 10.1128/JVI.72.2.950-958.1998; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Levine MM, 2002, BRIT MED BULL, V62, P1, DOI 10.1093/bmb/62.1.1; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Lowell GH, 1996, INFECT IMMUN, V64, P4686, DOI 10.1128/IAI.64.11.4686-4693.1996; Mills KHG, 2003, INFECT IMMUN, V71, P726, DOI 10.1128/IAI.71.2.726-732.2003; Pasetti MF, 2003, J VIROL, V77, P5209, DOI 10.1128/JVI.77.9.5209-5217.2003; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126	16	128	140	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					460	464		10.1038/ni0504-460	http://dx.doi.org/10.1038/ni0504-460			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116108	Bronze			2022-12-18	WOS:000221101100004
J	Wan, T; Beavil, RL; Fabiane, SM; Beavil, AJ; Sohi, MK; Keown, M; Young, RJ; Henry, AJ; Owens, RJ; Gould, HJ; Sutton, BJ				Wan, T; Beavil, RL; Fabiane, SM; Beavil, AJ; Sohi, MK; Keown, M; Young, RJ; Henry, AJ; Owens, RJ; Gould, HJ; Sutton, BJ			The crystal structure of IgE Fc reveals an asymmetrically bent conformation	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNOGLOBULIN-E; EPSILON-RI-ALPHA; X-RAY; DISULFIDE BONDS; BINDING-SITE; RECEPTOR; FRAGMENT; FLEXIBILITY; COMPLEX; IDENTIFICATION	The distinguishing structural feature of immunoglobulin E (IgE), the antibody responsible for allergic hypersensitivity, is the Cepsilon2 domain pair that replaces the hinge region of IgG. The crystal structure of the IgE Fc (constant fragment) at a 2.6-Angstrom resolution has revealed these domains. They display a distinctive, disulfide-linked Ig domain interface and are folded back asymmetrically onto the Cepsilon3 and Cepsilon4 domains, which causes an acute bend in the IgE molecule. The structure implies that a substantial conformational change involving Cepsilon2 must accompany binding to the mast cell receptor FcepsilonRI. This may be the basis of the exceptionally slow dissociation rate of the IgE-FcepsilonRI complex and, thus, of the ability of IgE to cause persistent allergic sensitization of mast cells.	Kings Coll London, Randall Ctr, London SE1 1UL, England; Celltech Grp Plc, Slough SL1 3WE, Berks, England	University of London; King's College London; Celltech Group Ltd	Sutton, BJ (corresponding author), Kings Coll London, Randall Ctr, Nre Hunts House, London SE1 1UL, England.	brian.sutton@kcl.ac.uk	Beavil, Andrew/B-5624-2009	Beavil, Andrew/0000-0002-0768-122X; Gould, Hannah/0000-0003-0411-688X; Owens, Ray/0000-0002-3705-2993				BAENZIGER J, 1974, J BIOL CHEM, V249, P1889; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU M, 1993, J BIOL CHEM, V268, P13118; BEAVIL AJ, 1995, BIOCHEMISTRY-US, V34, P14449, DOI 10.1021/bi00044a023; BENNICH H, 1974, PROGR IMMUNOLOGY 2, V1, P49; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; DAVIS KG, 1990, BIOCHEM SOC T, V18, P935, DOI 10.1042/bst0180935; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Fridriksson EK, 2000, BIOCHEMISTRY-US, V39, P3369, DOI 10.1021/bi9919091; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GEHA RS, 1985, NATURE, V315, P577, DOI 10.1038/315577a0; HELM BA, 1991, EUR J IMMUNOL, V21, P1543, DOI 10.1002/eji.1830210631; Helm BA, 1996, J BIOL CHEM, V271, P7494, DOI 10.1074/jbc.271.13.7494; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; ISHIZAKA T, 1986, P NATL ACAD SCI USA, V83, P8323, DOI 10.1073/pnas.83.21.8323; Keown MB, 1997, EUR BIOPHYS J BIOPHY, V25, P471, DOI 10.1007/s002490050062; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Nechansky A, 1999, INT ARCH ALLERGY IMM, V120, P295, DOI 10.1159/000024282; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; ORTEGA E, 1991, BIOCHEMISTRY-US, V30, P3473, DOI 10.1021/bi00228a018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1986, MOL IMMUNOL, V23, P1063, DOI 10.1016/0161-5890(86)90005-2; PERKINS SJ, 1991, J MOL BIOL, V221, P1345; PRESTA L, 1994, J BIOL CHEM, V269, P26368; PUMPHREY R, 1986, IMMUNOL TODAY, V7, P174, DOI 10.1016/0167-5699(86)90169-6; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Sayers I, 1998, BIOCHEMISTRY-US, V37, P16152, DOI 10.1021/bi981456k; Sechi S, 1996, J BIOL CHEM, V271, P19256, DOI 10.1074/jbc.271.32.19256; SHERIFF S, 1993, IMMUNOMETHODS, V3, P191; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; STANWORTH DR, 1990, LANCET, V336, P1279, DOI 10.1016/0140-6736(90)92963-I; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; TAKATSU K, 1975, J IMMUNOL, V114, P1838; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004; ZHENG Y, 1991, BIOCHEMISTRY-US, V30, P9125, DOI 10.1021/bi00102a002	49	128	138	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					681	686		10.1038/ni811	http://dx.doi.org/10.1038/ni811			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12068291				2022-12-18	WOS:000176441700019
J	Gonzalez, A; Andre-Schmutz, I; Carnaud, C; Mathis, D; Benoist, C				Gonzalez, A; Andre-Schmutz, I; Carnaud, C; Mathis, D; Benoist, C			Damage control, rather than unresponsiveness, effected by protective DX5+T cells in autoimmune diabetes	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; REGULATORY CELLS; NKT CELLS; MICE; DEFICIENCY; INITIATION; REPERTOIRE; MOLECULES; INSULITIS; ANTIGENS	The progression of autoimmune diabetes is regulated. We examined here the cellular controls exerted on disease that developed in the BDC2.5 T cell receptor-transgenic model. We found that all BDC2.5 mice with a monoclonal, beta cell-reactive,T cell repertoire developed diabetes before 4 weeks of age; transfer of splenocytes from young standard NOD (nonobese diabetic) mice into perinatal monoclonal BDC2.5 animals protected them from diabetes. The protective activity was generated by CD4(+) alpha beta T cells, which operated for a short time at disease initiation, could be partitioned according to DX5 cell surface marker expression and split into two components. Protection did not involve clonal deletion or anergy of the autoreactive BDC2.5 cells, permitting their full activation and attack of pancreatic islets; rather, it tempered the aggressiveness of the insulitic lesion and the extent of beta cell destruction.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France; Hop Necker Enfants Malad, INSERM U25, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mathis, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Joslin Diabet Ctr, Dept Med,Sect Immunol & Immunogenet, Boston, MA 02115 USA.	cbdm@joslin.harvard.edu	Andre-Schmutz, Isabelle/M-1279-2016; Gonzalez, Antonio/C-4444-2008; Andre, Isabelle/F-6263-2013	Gonzalez, Antonio/0000-0002-2624-0606; Andre, Isabelle/0000-0002-3905-9910				Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Balasa B, 2000, CLIN IMMUNOL, V95, P93, DOI 10.1006/clim.2000.4855; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Behar SM, 2000, SEMIN IMMUNOL, V12, P551, DOI 10.1006/smim.2000.0273; Benoist C, 2000, CURR OPIN IMMUNOL, V12, P661, DOI 10.1016/S0952-7915(00)00159-X; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Fritz RB, 2001, J IMMUNOL, V166, P4209, DOI 10.4049/jimmunol.166.6.4209; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; HILPOTT KL, 1992, SCIENCE, V256, P1448; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Itoh M, 1999, J IMMUNOL, V162, P5317; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Ludewig B, 2000, J EXP MED, V191, P795, DOI 10.1084/jem.191.5.795; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Luhder F, 1998, J EXP MED, V187, P379, DOI 10.1084/jem.187.3.379; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moodycliffe AM, 1999, J IMMUNOL, V162, P5156; Olivares-Villagomez D, 2000, J IMMUNOL, V164, P5499, DOI 10.4049/jimmunol.164.10.5499; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Ortaldo JR, 1998, J IMMUNOL, V160, P1158; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Wang B, 1998, DIABETES, V47, P1207, DOI 10.2337/diabetes.47.8.1207; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815	52	128	133	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1117	1125		10.1038/ni738	http://dx.doi.org/10.1038/ni738			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11713466				2022-12-18	WOS:000172473200013
J	Fonseca, R; Beura, LK; Quarnstrom, CF; Ghoneim, HE; Fan, YP; Zebley, CC; Scott, MC; Fares-Frederickson, NJ; Wijeyesinghe, S; Thompson, EA; da Silva, HB; Vezys, V; Youngblood, B; Masopust, D				Fonseca, Raissa; Beura, Lalit K.; Quarnstrom, Clare F.; Ghoneim, Hazem E.; Fan, Yiping; Zebley, Caitlin C.; Scott, Milcah C.; Fares-Frederickson, Nancy J.; Wijeyesinghe, Sathi; Thompson, Emily A.; Borges da Silva, Henrique; Vezys, Vaiva; Youngblood, Benjamin; Masopust, David			Developmental plasticity allows outside-in immune responses by resident memory T cells	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; TISSUE; PROTECTION; MIGRATION; SUBSETS; CD4(+); NAIVE; DIFFERENTIATION; ACTIVATION; GENERATION	Central memory T (T-CM) cells patrol lymph nodes and perform conventional memory responses on restimulation: proliferation, migration and differentiation into diverse T cell subsets while also self-renewing. Resident memory T (T-RM) cells are parked within single organs, share properties with terminal effectors and contribute to rapid host protection. We observed that reactivated T-RM cells rejoined the circulating pool. Epigenetic analyses revealed that T-RM cells align closely with conventional memory T cell populations, bearing little resemblance to recently activated effectors. Fully differentiated T-RM cells isolated from small intestine epithelium exhibited the potential to differentiate into T-CM cells, effector memory T cells and T-RM cells on recall. Ex-T-RM cells, former intestinal T-RM cells that rejoined the circulating pool, heritably maintained a predilection for homing back to their tissue of origin on subsequent reactivation and a heightened capacity to redifferentiate into T-RM cells. Thus, T-RM cells can rejoin the circulation but are advantaged to re-form local T-RM when called on. Tissue-resident memory (T-RM) cells are generally stably maintained in discrete tissues or organs. Masopust and colleagues show that T-RM cells can reenter the circulation, and exhibit considerable plasticity, although they retain a proclivity to reestablish themselves in their tissue of origin.	[Fonseca, Raissa; Beura, Lalit K.; Quarnstrom, Clare F.; Scott, Milcah C.; Fares-Frederickson, Nancy J.; Wijeyesinghe, Sathi; Thompson, Emily A.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA; [Ghoneim, Hazem E.; Zebley, Caitlin C.; Youngblood, Benjamin] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Borges da Silva, Henrique] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Fonseca, Raissa] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Fonseca, Raissa] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Beura, Lalit K.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Ghoneim, Hazem E.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Melbourne; Brown University; University System of Ohio; Ohio State University	Masopust, D (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Vezys, Vaiva/N-3144-2013; Fonseca, Raissa/AAF-8940-2021	Wijeyesinghe, Sathi/0000-0002-8819-2654; Fonseca, Raissa/0000-0001-8202-4871; Scott, Milcah/0000-0003-2151-7335; Borges da Silva, Henrique/0000-0001-9424-3326; Zebley, Caitlin/0000-0002-8419-4660	National Institutes of Health [R01AI084913]; Howard Hughes Medical Institute Scholars program; FAPESP-BEPE fellowship [2015/00680-7]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Scholars program; FAPESP-BEPE fellowship	We thank the members of the Masopust laboratory and the University of Minnesota Center for Immunology for helpful discussions. We were funded by a National Institutes of Health grant (no. R01AI084913), the Howard Hughes Medical Institute Scholars program (to D.M.) and an FAPESP-BEPE (2015/00680-7) fellowship (to R.F).	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; CAHILL RNP, 1977, J EXP MED, V145, P420, DOI 10.1084/jem.145.2.420; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Diani M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47310-5; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Kadoki M, 2017, CELL, V171, P398, DOI 10.1016/j.cell.2017.08.024; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nguyen QP, 2019, IMMUNOLOGY, V157, P3, DOI 10.1111/imm.13059; Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Silva KA, 2013, COMPARATIVE MED, V63, P392; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sokolov A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004790; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Thompson EA, 2016, J IMMUNOL, V196, P3054, DOI 10.4049/jimmunol.1501797; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144	58	127	127	6	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					412	+		10.1038/s41590-020-0607-7	http://dx.doi.org/10.1038/s41590-020-0607-7		FEB 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32066954	Green Accepted			2022-12-18	WOS:000514067400010
J	Zhang, Q; Pan, Y; Yan, RQ; Zeng, BH; Wang, HF; Zhang, XW; Li, WX; Wei, H; Liu, ZH				Zhang, Qin; Pan, Ying; Yan, Ruiqing; Zeng, Benhua; Wang, Haifang; Zhang, Xinwen; Li, Wenxia; Wei, Hong; Liu, Zhihua			Commensal bacteria direct selective cargo sorting to promote symbiosis	NATURE IMMUNOLOGY			English	Article							INTESTINAL PANETH CELLS; CORE VESICLE MATURATION; GENE ATG16L1; RAB GTPASES; NOD2; SUSCEPTIBILITY; LRRK2; MICROBIOTA; AUTOPHAGY; INNATE	Mucosal immunity protects a host from intestinal inflammation and infection and is profoundly influenced by symbiotic bacteria. Here we report that in mice symbiotic bacteria directed selective cargo sorting in Paneth cells to promote symbiosis through Nod2, a cytosolic bacterial sensor, and the multifunctional protein kinase LRRK2, both encoded by inflammatory bowel disease (IBD)-associated genes. Commensals recruited Nod2 onto lysozyme-containing dense core vesicles (DCVs), which was required for DCV localization of LRRK2 and a small GTPase, Rab2a. Deficiency of Nod2, LRRK2 or Rab2a or depletion of commensals resulted in lysosomal degradation of lysozyme. Thus, commensal bacteria and host factors orchestrate the lysozyme-sorting process to protect the host from enteric infection, implicating Paneth cell dysfunction in IBD pathogenesis.	[Zhang, Qin; Pan, Ying; Yan, Ruiqing; Wang, Haifang; Zhang, Xinwen; Liu, Zhihua] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Zeng, Benhua; Li, Wenxia; Wei, Hong] Third Mil Med Univ, Coll Basic Med Sci, Dept Lab Anim Sci, Chongqing, Peoples R China; [Liu, Zhihua] Chinese Acad Sci, Ctr Excellence Biomacromol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Army Medical University; Chinese Academy of Sciences	Liu, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	weihong63528@163.com; zhihualiu@ibp.ac.cn		Liu, Zhihua/0000-0002-0269-0901	National Natural Science Foundation of China [31271521, 31422019, 81370906]; National Basic Research Program of China [2013CB531405, 2013CB531406]; Thousand Young Talents Program of China; Chinese Academy of Sciences Novo Nordisk Foundation [NNCASGWP-2012-2]; National Science Foundation of China [81101923]; Beijing Natural Science Foundation [13G20203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Thousand Young Talents Program of China(Chinese Academy of Sciences); Chinese Academy of Sciences Novo Nordisk Foundation; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The authors thank M. Cookson (National Institutes of Health, Bethesda, Maryland, USA) for the LRRK2 expression vector, T. Kufer (Universitat Hohenheim, Stuttgart, Germany) for the Nod2 expression vector, H. Tang (Chinese Academy of Sciences, Beijing, China) for L. monocytogenes strain 10403s, and Z. Chang (Tsinghua University, Beijing, China) for yeast two-hybrid screening reagents. The authors thank H. Zhang (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China) for helpful discussions. This work was supported by the National Natural Science Foundation of China (31271521, 31422019, 81370906), the National Basic Research Program of China (2013CB531405, 2013CB531406), the Thousand Young Talents Program of China, and the Chinese Academy of Sciences Novo Nordisk Foundation (NNCASGWP-2012-2). Z.Q. was supported by National Science Foundation of China (81101923) and the Beijing Natural Science Foundation (13G20203).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alenghat T, 2014, TRENDS IMMUNOL, V35, P518, DOI 10.1016/j.it.2014.09.007; Aloisi AL, 2013, HISTOL HISTOPATHOL, V28, P839, DOI 10.14670/HH-28.839; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bowman G. R., 2009, BIOGENESIS DENSE COR; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furusawa Y, 2015, SEMIN IMMUNOPATHOL, V37, P17, DOI 10.1007/s00281-014-0455-3; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sasidharan N, 2012, P NATL ACAD SCI USA, V109, P18944, DOI 10.1073/pnas.1203306109; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1986, DIGESTION, V34, P115, DOI 10.1159/000199319; Shanahan MT, 2014, GUT, V63, P903, DOI 10.1136/gutjnl-2012-304190; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; Waschbusch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111632; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yun HJ, 2015, J BIOCHEM, V157, P485, DOI 10.1093/jb/mvv005; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	127	143	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					918	926		10.1038/ni.3233	http://dx.doi.org/10.1038/ni.3233			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26237551				2022-12-18	WOS:000359876900009
J	Valdor, R; Mocholi, E; Botbol, Y; Guerrero-Ros, I; Chandra, D; Koga, H; Gravekamp, C; Cuervo, AM; Macian, F				Valdor, Rut; Mocholi, Enric; Botbol, Yair; Guerrero-Ros, Ignacio; Chandra, Dinesh; Koga, Hiroshi; Gravekamp, Claudia; Cuervo, Ana Maria; Macian, Fernando			Chaperone-mediated autophagy regulates T cell responses through targeted degradation of negative regulators of T cell activation	NATURE IMMUNOLOGY			English	Article							SELECTIVE PATHWAY; RAT-LIVER; PROTEIN; EXPRESSION; RECEPTOR; MAINTENANCE; PROTEOLYSIS; THRESHOLD; ITCH; TFEB	Chaperone-mediated autophagy (CMA) targets soluble proteins for lysosomal degradation. Here we found that CMA was activated in T cells in response to engagement of the T cell antigen receptor (TCR), which induced expression of the CMA-related lysosomal receptor LAMP-2A. In activated T cells, CMA targeted the ubiquitin ligase Itch and the calcineurin inhibitor RCAN1 for degradation to maintain activation-induced responses. Consequently, deletion of the gene encoding LAMP-2A in T cells caused deficient in vivo responses to immunization or infection with Listeria monocytogenes. Impaired CMA activity also occurred in T cells with age, which negatively affected their function. Restoration of LAMP-2A in T cells from old mice resulted in enhancement of activation-induced responses. Our findings define a role for CMA in regulating T cell activation through the targeted degradation of negative regulators of T cell activation.	[Valdor, Rut; Mocholi, Enric; Botbol, Yair; Guerrero-Ros, Ignacio; Macian, Fernando] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Chandra, Dinesh; Gravekamp, Claudia] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Gravekamp, Claudia; Cuervo, Ana Maria; Macian, Fernando] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Macian, F (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	fernando.macian@einstein.yu.edu	Mocholi, Enric/ABH-5275-2020; Chandra, Dinesh/P-4377-2014; Valdor, Rut/AAM-6174-2020; Valdor, Rut/B-5447-2019	Chandra, Dinesh/0000-0001-5763-1645; Valdor, Rut/0000-0002-2681-0779; Valdor, Rut/0000-0002-2681-0779; Macian, Fernando/0000-0003-2666-035X; Mocholi Gimeno, Enric/0000-0002-6614-3173; Cuervo, Ana Maria/0000-0002-0771-700X	US National Institutes of Health [AG031782]; Glenn Foundation; Einstein Nathan Shock Center in Basic Research in Aging [AG038072]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031782, P30AG038072] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; Einstein Nathan Shock Center in Basic Research in Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Ryeom (University of Pennsylvania) for the RCAN1 expression vector; G. Nolan (Stanford University) for Phoenix Ecotropic cells; S. Kaushik for help in the preparation of lysosomal fractions; and S. Bandyopadhyay for assistance in chromatin immunoprecipitation experiments. Supported by the US National Institutes of Health (AG031782), the Glenn Foundation (F.M. and A.M.C.) and the Einstein Nathan Shock Center in Basic Research in Aging (AG038072, for the use of specific research cores).	Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Bhattacharyya S, 2011, J EXP MED, V208, P823, DOI 10.1084/jem.20100945; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Chou JP, 2013, CURR PHARM DESIGN, V19, P1680; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Eisenbraun MD, 2000, J IMMUNOL, V164, P6105, DOI 10.4049/jimmunol.164.12.6105; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Koga H, 2011, J NEUROSCI, V31, P18492, DOI 10.1523/JNEUROSCI.3219-11.2011; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kwon J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000976; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Narayan AV, 2005, FREE RADICAL BIO MED, V39, P719, DOI 10.1016/j.freeradbiomed.2005.03.036; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236	50	127	132	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1046	1054		10.1038/ni.3003	http://dx.doi.org/10.1038/ni.3003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25263126	Green Accepted			2022-12-18	WOS:000343640700010
J	Kafasla, P; Skliris, A; Kontoyiannis, DL				Kafasla, Panagiota; Skliris, Antonis; Kontoyiannis, Dimitris L.			Post-transcriptional coordination of immunological responses by RNA-binding proteins	NATURE IMMUNOLOGY			English	Review							T-CELL DEVELOPMENT; MESSENGER-RNA; TNF-ALPHA; GENE-EXPRESSION; TEMPORAL-ORDER; HUR; TRISTETRAPROLIN; DECAY; STABILITY; PATHWAY	Immunological reactions are propelled by ever-changing signals that alter the translational ability of the RNA in the cells involved. Such alterations are considered to be consequential modifications in the transcriptomic decoding of the genetic blueprint. The identification of RNA-binding protein (RBP) assemblies engaged in the coordinative regulation of state-specific RNAs indicates alternative and exclusive means for determining the activation, plasticity and tolerance of cells of the immune system. Here we review current knowledge about RBP-regulated post-transcriptional events involved in the reactivity of cells of the immune system and the importance of their alteration during chronic inflammatory pathology and autoimmunity.	[Kafasla, Panagiota; Skliris, Antonis; Kontoyiannis, Dimitris L.] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Kontoyiannis, DL (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Vari, Greece.	kontoyiannis@fleming.gr	Kafasla, Panagiota/GRR-3951-2022; , Panagiota/AAZ-2732-2021; Skliris, Antonios/M-1731-2019; Kafasla, Panagiota/B-9187-2009	Kafasla, Panagiota/0000-0002-9730-0397; Kontoyiannis, Dimitris/0000-0003-4682-9490	Hellenic General Secretariat for Research and Technology ARISTEIA I program [1096-PRECISE]; Seventh Framework Programme of the European Union [PEOPLE-2010-IEF 274837, HEALTH-F2-2008-223404-MASTERSWITCH]	Hellenic General Secretariat for Research and Technology ARISTEIA I program; Seventh Framework Programme of the European Union	We thank G. Panayotou, E. Remboutsika, L. Kioussi and N. Lourou for comments. Supported by the Hellenic General Secretariat for Research and Technology ARISTEIA I program (1096-PRECISE) and the Seventh Framework Programme of the European Union (PEOPLE-2010-IEF 274837, HEALTH-F2-2008-223404-MASTERSWITCH).	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bjur E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003494; Blanco FF, 2014, MOL CELL BIOL, V34, P180, DOI 10.1128/MCB.01020-13; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Corrionero A, 2011, RNA, V17, P401, DOI 10.1261/rna.2444811; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; De Arras L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003855; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Filipovska A, 2011, RNA BIOL, V8, P978, DOI 10.4161/rna.8.6.17907; Frischmeyer-Guerrerio PA, 2011, P NATL ACAD SCI USA, V108, P10638, DOI 10.1073/pnas.1019352108; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gaudreau MC, 2012, J IMMUNOL, V188, P5377, DOI 10.4049/jimmunol.1103142; George CX, 2011, J VIROL, V85, P8338, DOI 10.1128/JVI.02666-10; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gonzalez-Teran B, 2013, J CLIN INVEST, V123, P164, DOI 10.1172/JCI65124; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hao SL, 2013, P NATL ACAD SCI USA, V110, P11934, DOI 10.1073/pnas.1309990110; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Izquierdo JM, 2008, MOL BIOL CELL, V19, P3299, DOI 10.1091/mbc.E07-11-1125; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lloyd RE, 2013, WIRES RNA, V4, P317, DOI 10.1002/wrna.1162; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mallory MJ, 2011, MOL CELL BIOL, V31, P2184, DOI 10.1128/MCB.05170-11; Maruyama T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004822; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Mazan-Mamczarz K, 2011, BLOOD, V117, P2441, DOI 10.1182/blood-2010-09-310987; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Oh HK, 2013, APOPTOSIS, V18, P825, DOI 10.1007/s10495-013-0824-8; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Poddar D, 2013, J IMMUNOL, V190, P3600, DOI 10.4049/jimmunol.1201933; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Rajayer SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079430; Sadri N, 2009, J INVEST DERMATOL, V129, P657, DOI 10.1038/jid.2008.298; Sarkar S, 2011, MOL CELL BIOL, V31, P602, DOI 10.1128/MCB.00835-10; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Simarro M, 2012, IMMUNOL LETT, V146, P8, DOI 10.1016/j.imlet.2012.04.001; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Vavassori S, 2009, RNA BIOL, V6, P259, DOI 10.4161/rna.6.3.8581; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Yoon OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002882; Zhang JG, 2012, AM J PATHOL, V180, P1751, DOI 10.1016/j.ajpath.2011.12.025; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	110	127	128	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					492	502		10.1038/ni.2884	http://dx.doi.org/10.1038/ni.2884			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840980				2022-12-18	WOS:000336419300003
J	Ota, N; Wong, K; Valdez, PA; Zheng, Y; Crellin, NK; Diehl, L; Ouyang, WJ				Ota, Naruhisa; Wong, Kit; Valdez, Patricia A.; Zheng, Yan; Crellin, Natasha K.; Diehl, Lauri; Ouyang, Wenjun			IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; SUFFICIENT B-LYMPHOCYTES; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; BETA-RECEPTOR; FOLLICLE FORMATION; INDUCED COLITIS; NKP46(+) CELLS; INFLAMMATION; MICE	Colonic patches (CLPs) and isolated lymphoid follicles (ILFs) are two main lymphoid structures in the colon. Lymphoid tissue-inducer cells (LTi cells) are indispensable for the development of ILFs. LTi cells also produce interleukin 17 (IL-17) and IL-22, signature cytokines secreted by IL-17-producing helper T cells. Here we report that IL-22 acted downstream of the lymphotoxin pathway and regulated the organization and maintenance of mature CLPs and ILFs in the colon during infection with Citrobacter rodentium. Lymphotoxin (LT alpha(1)beta(2)) regulated the production of IL-22 during infection with C. rodentium, but the lymphotoxin-like protein LIGHT did not. IL-22 signaling was sufficient to restore the organization of CLPs and ILFs and host defense against infection with C. rodentium in mice lacking lymphotoxin signals, which suggests that IL-22 connects the lymphotoxin pathway to mucosal epithelial defense mechanisms.	[Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Ota, Naruhisa; Wong, Kit; Valdez, Patricia A.; Zheng, Yan; Crellin, Natasha K.; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020; Zheng, Yan/A-6993-2008	Zheng, Yan/0000-0002-7002-277X; Ouyang, Wenjun/0000-0002-1811-5864				Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Dohi T, 1999, J EXP MED, V189, P1169, DOI 10.1084/jem.189.8.1169; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee AY, 2008, EUR J IMMUNOL, V38, P1127, DOI 10.1002/eji.200737442; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2006, ANN NY ACAD SCI, V1072, P210, DOI 10.1196/annals.1326.015; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; McDonald KG, 2005, J IMMUNOL, V174, P5720, DOI 10.4049/jimmunol.174.9.5720; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spahn TW, 2004, GASTROENTEROLOGY, V127, P1463, DOI 10.1053/j.gastro.2004.08.022; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; Taylor RT, 2005, IMMUNOL RES, V33, P167, DOI 10.1385/IR:33:2:167; Taylor RT, 2004, J IMMUNOL, V173, P7183, DOI 10.4049/jimmunol.173.12.7183; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	50	127	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					941	948		10.1038/ni.2089	http://dx.doi.org/10.1038/ni.2089			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21874025				2022-12-18	WOS:000295084500009
J	Berger, SB; Romero, X; Ma, CY; Wang, GX; Faubion, WA; Liao, GX; Compeer, E; Keszei, M; Rameh, L; Wang, NH; Boes, M; Regueiro, JR; Reinecker, HC; Terhorst, C				Berger, Scott B.; Romero, Xavier; Ma, Chunyan; Wang, Guoxing; Faubion, William A.; Liao, Gongxian; Compeer, Ewoud; Keszei, Marton; Rameh, Lucia; Wang, Ninghai; Boes, Marianne; Regueiro, Jose R.; Reinecker, Hans-Christian; Terhorst, Cox			SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages	NATURE IMMUNOLOGY			English	Article							ESCHERICHIA-COLI; T-CELL; AUTOPHAGY; MATURATION; RECEPTOR; INNATE; ROLES; ACTIVATION; ENGULFMENT; PATHWAY	Phagocytosis is a pivotal process by which macrophages eliminate microorganisms after recognition by pathogen sensors. Here we unexpectedly found that the self ligand and cell surface receptor SLAM functioned not only as a costimulatory molecule but also as a microbial sensor that controlled the killing of Gram-negative bacteria by macrophages. SLAM regulated activity of the NADPH oxidase NOX2 complex and phagolysosomal maturation after entering the phagosome, following interaction with the bacterial outer membrane proteins OmpC and OmpF. SLAM recruited a complex containing the intracellular class III phosphatidylinositol kinase Vps34, its regulatory protein kinase Vps15 and the autophagy-associated molecule beclin-1 to the phagosome, which was responsible for inducing the accumulation of phosphatidylinositol-3-phosphate, a regulator of both NOX2 function and phagosomal or endosomal fusion. Thus, SLAM connects the Gram-negative bacterial phagosome to ubiquitous cellular machinery responsible for the control of bacterial killing.	[Berger, Scott B.; Romero, Xavier; Ma, Chunyan; Wang, Guoxing; Faubion, William A.; Liao, Gongxian; Compeer, Ewoud; Keszei, Marton; Wang, Ninghai; Regueiro, Jose R.; Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA; [Faubion, William A.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Rameh, Lucia] Boston Biomed Res Inst, Watertown, MA USA; [Boes, Marianne] Harvard Univ, Dept Dermatol, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; [Regueiro, Jose R.] Univ Complutense, Fac Med, E-28040 Madrid, Spain; [Reinecker, Hans-Christian] Harvard Univ, Dept Med, Gastrointestinal Unit, Sch Med, Boston, MA 02215 USA; [Reinecker, Hans-Christian] Harvard Univ, Ctr Study Inflammatory Bowel Dis, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Mayo Clinic; Boston Biomedical Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Complutense University of Madrid; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Berger, SB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA.	sberger@bidmc.harvard.edu; terhorst@bidmc.harvard.edu	Regueiro, José R./B-5499-2014; Compeer, Ewoud Bernardus/E-8553-2015; Wang, Guoxing/G-6586-2013; Keszei, Marton/F-3295-2014	Regueiro, José R./0000-0001-8442-7762; Compeer, Ewoud Bernardus/0000-0002-3050-7633; Keszei, Marton/0000-0002-1158-2179; Boes, Marianne/0000-0003-2590-1692	US National Institutes of Health [AI-15066, DK-068181, DK-003506-20]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015066, R56AI015066, P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068181, P30DK084567, R01DK052510, P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Remold, P. Klebba and members of the Terhorst lab for critical review of the manuscript; S. Laroux for help with initial oxidative burst experiments; A. Nohturft, M. Yaffe, P. Klebba and G. Pier for discussions; B. McCormick (University of Massachusetts) for E. coli F18; C. Nagler (University of Chicago) and P. Klemm (Technical University of Denmark) for eGFP-expressing bacteria; H. Nikaido (University of California Berkeley), P. Klebba (University of Oklahoma) and G. Pier (Harvard Medical School) for mutant strains of E. coli and S. aureus; M. Yaffe (Massachusetts Institute of Technology) for the p40-eGFP construct; L. Cantley (Harvard Medical School) for Vps34-Myc; R. Tsien (University of California San Diego) for the mCherry construct; J. Backer (Albert Einstein College of Medicine) for the Vps34-Vps15-V5 construct; P. Hawkins (Babraham Institute) for p40<SUP>phox</SUP>-deficient mice; and S. Targan (Cedars-Sinai) for the highly purified OmpC preparation. Supported by the US National Institutes of Health (AI-15066 to C. T., and DK-068181 and DK-003506-20 to H. C. R.) and the Crohn's and Colitis Foundation of America (S.B. and X.R.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Desjardins M, 1997, J CELL SCI, V110, P2303; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Lindmo K, 2008, AUTOPHAGY, V4, P500, DOI 10.4161/auto.5829; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Psachoulia E, 2009, BIOCHEMISTRY-US, V48, P5090, DOI 10.1021/bi900435m; Rethi B, 2006, BLOOD, V107, P2821, DOI 10.1182/blood-2005-06-2265; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Stockinger W, 2006, MOL BIOL CELL, V17, P1697, DOI 10.1091/mbc.E05-12-1140; Stockinger W, 2004, J LIPID RES, V45, P2151, DOI 10.1194/jlr.D400011-JLR200; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; TRIVEDI V, 2007, SCI STKE, P13; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Yan Y, 2007, BIOCHEM SOC T, V35, P239, DOI 10.1042/BST0350239; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	43	127	135	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					920	U70		10.1038/ni.1931	http://dx.doi.org/10.1038/ni.1931			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20818396	Green Accepted, Green Published			2022-12-18	WOS:000281926900011
J	O'Connor, W; Zenewicz, LA; Flavell, RA				O'Connor, William, Jr.; Zenewicz, Lauren A.; Flavell, Richard A.			The dual nature of T(H)17 cells: shifting the focus to function	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; TRANSCRIPTION FACTOR FOXP3; GROWTH-FACTOR-BETA; INDUCER-LIKE CELLS; HOST-DEFENSE; TH17 CELLS; TGF-BETA; INTESTINAL INFLAMMATION; DIFFERENTIAL ROLES	Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) have been broadly linked to the pathogenesis of multiple autoimmune diseases. In the few short years since the discovery of T(H)17 cells, new paradigms about their prominence in chronic inflammation and human autoimmunity have emerged. Recent findings that T(H)17 cells might be capable of regulatory functions and that the associated effector molecules IL-17 and IL-22 aid in restricting tissue destruction during inflammatory episodes illuminate the complexities of IL-17 and T(H)17 biology. In this Perspective we highlight critical differences between IL-17 itself and T(H)17 cells and discuss the protective nature of IL-17 and T(H)17 cells.	[O'Connor, William, Jr.; Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Howard Hughes Medical Institute; Yale University	O'Connor, W (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	william.oconnor@yale.edu; richard.flavell@yale.edu		Zenewicz, Lauren/0000-0002-8787-5955				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Betti M, 2006, ANN ONCOL, V17, P235; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KA, 2008, CELL IMMUNOL, V251, P50, DOI 10.1016/j.cellimm.2008.03.004; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shin HCK, 1998, CYTOKINE, V10, P841, DOI 10.1006/cyto.1998.0375; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vanden Eijnden S, 2005, EUR J IMMUNOL, V35, P469, DOI 10.1002/eji.200425677; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zhang JP, 2006, POLYM ADVAN TECHNOL, V17, P12, DOI 10.1002/pat.676; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	93	127	133	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					471	476		10.1038/ni.1882	http://dx.doi.org/10.1038/ni.1882			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485275				2022-12-18	WOS:000277821300007
J	Ise, W; Kohyama, M; Nutsch, KM; Lee, HM; Suri, A; Unanue, ER; Murphy, TL; Murphy, KM				Ise, Wataru; Kohyama, Masako; Nutsch, Katherine M.; Lee, Hyang Mi; Suri, Anish; Unanue, Emil R.; Murphy, Theresa L.; Murphy, Kenneth M.			CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; IN-VITRO; ACTIVATION; ABSENCE; LYMPHOCYTE; ENGAGEMENT; TOLERANCE; CD28; HOMEOSTASIS; DEFICIENT	The inhibitory immunoregulatory receptor CTLA-4 is critical in maintaining self-tolerance, but the mechanisms of its actions have remained controversial. Here we examined the antigen specificity of tissue-infiltrating CD4(+) T cells in Ctla4(-/-) mice. After adoptive transfer, T cells isolated from tissues of Ctla4(-/-) mice showed T cell antigen receptor (TCR)-dependent accumulation in the tissues from which they were derived, which suggested reactivity to tissue-specific antigens. We identified the pancreas-specific enzyme PDIA2 as an autoantigen in Ctla4(-/-) mice. CTLA-4 expressed either on PDIA2-specific effector cells or on regulatory T cells was sufficient to control tissue destruction mediated by PDIA2-specific T cells. Our results demonstrate that both cell-intrinsic and non-cell-autonomous actions of CTLA-4 operate to maintain T cell tolerance to a self antigen.	[Ise, Wataru; Kohyama, Masako; Nutsch, Katherine M.; Lee, Hyang Mi; Suri, Anish; Unanue, Emil R.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Ise, Wataru; Kohyama, Masako; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu			Howard Hughes Medical Institute; US National Institutes of Health [AI031238, AI070489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238, U19AI070489] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Sha (University of California Berkeley) for the MSCV IRES-Thy-1.1 retrovirus; M. Iwashima (Medical College of Georgia) for pKS-NFAT-GFP; and M. Hurchla, M. Sandau and B. Schraml for critically reading the manuscript. Supported by the Howard Hughes Medical Institute (K. M. M.) and the US National Institutes of Health (AI031238 and AI070489 to K. M. M.).	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; ALLISON JP, 1998, NOVART FDN SYMP, P92; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Chambers CA, 1999, P NATL ACAD SCI USA, V96, P8603, DOI 10.1073/pnas.96.15.8603; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Eggena MP, 2004, J EXP MED, V199, P1725, DOI 10.1084/jem.20040124; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Gozalo-Sanmillan S, 2001, J IMMUNOL, V166, P727, DOI 10.4049/jimmunol.166.2.727; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hueber AJ, 2006, IMMUNOL CELL BIOL, V84, P51, DOI 10.1111/j.1440-1711.2005.01402.x; Kataoka H, 2005, INT IMMUNOL, V17, P421, DOI 10.1093/intimm/dxh221; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Okazaki K, 2001, J GASTROENTEROL, V36, P293, DOI 10.1007/s005350170094; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; SHIMIZU J, 1993, J IMMUNOL, V151, P1723; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tivol EA, 2002, J IMMUNOL, V169, P1852, DOI 10.4049/jimmunol.169.4.1852; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VIJAYAKRISHNAN L, 2005, NOVART FDN SYMP, P200; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yin L, 2003, J LEUKOCYTE BIOL, V73, P178, DOI 10.1189/jlb.0702365; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	50	127	131	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					129	U45		10.1038/ni.1835	http://dx.doi.org/10.1038/ni.1835			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20037585	Green Accepted			2022-12-18	WOS:000273730200009
J	Park, JH; Adoro, S; Lucas, PJ; Sarafova, SD; Alag, AS; Doan, LL; Erman, B; Liu, XL; Ellmeier, W; Bosselut, R; Feigenbaum, L; Singer, A				Park, Jung-Hyun; Adoro, Stanley; Lucas, Philip J.; Sarafova, Sophia D.; Alag, Amala S.; Doan, Loretta L.; Erman, Batu; Liu, Xiaolong; Ellmeier, Wilfried; Bosselut, Remy; Feigenbaum, Lionel; Singer, Alfred			'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; POSITIVELY SELECTED THYMOCYTES; CD4/CD8 LINEAGE DECISION; TRANSGENIC MICE; IN-VIVO; NEGATIVE SELECTION; HOMEOSTATIC PROLIFERATION; SURFACE EXPRESSION; GENE-EXPRESSION; GAMMA-CHAIN	T cell immunity requires the long-term survival of T cells that are capable of recognizing self antigens but are not overtly autoreactive. How this balance is achieved remains incompletely understood. Here we identify a homeostatic mechanism that transcriptionally tailors CD8 coreceptor expression in individual CD8+ T cells to the self-specificity of their clonotypic T cell receptor (TCR). 'Coreceptor tuning' results from interplay between cytokine and TCR signals, such that signals from interleukin 7 and other common gamma-chain cytokines transcriptionally increase CD8 expression and thereby promote TCR engagement of self ligands, whereas TCR signals impair common gamma-chain cytokine signaling and thereby decrease CD8 expression. This dynamic interplay induces individual CD8+ T cells to express CD8 in quantities appropriate for the self-specificity of their TCR, promoting the engagement of self ligands, yet avoiding autoreactivity.	NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; NCI, NIH, Expt Transplant & Immunol Branch, Bethesda, MD 20892 USA; Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey; NCI, NIH, Immunol Cell Biol Branch, Bethesda, MD 20892 USA; Med Univ Veinna, Inst Immunol, Vienna, Austria; Canc Res & Dev Ctr, NCI, SAIC, Ft Detrick, MD 21702 USA; Davidson Coll, Dept Biol, Davidson, NC 28035 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sabanci University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Davidson College	Singer, A (corresponding author), NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA.	singera@njh.gov	erman, batu/AAE-1963-2020; Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055; Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund FWF [Y 163] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Guimond M, 2005, J IMMUNOTHER, V28, P289, DOI 10.1097/01.cji.0000165356.03924.e7; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; KALDJIAN E, 1988, FASEB J, V2, P2801, DOI 10.1096/fasebj.2.12.3261700; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Marquez ME, 2005, J IMMUNOL, V175, P7388, DOI 10.4049/jimmunol.175.11.7388; MCCARTHY SA, 1988, J IMMUNOL, V141, P3737; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; ROBEY EA, 1992, INT IMMUNOL, V4, P969, DOI 10.1093/intimm/4.9.969; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Singer A, 2004, ADV IMMUNOL, V83, P91; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Tai XG, 2007, P NATL ACAD SCI USA, V104, P13756, DOI 10.1073/pnas.0706509104; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Teague TK, 1997, J IMMUNOL, V158, P5791; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	60	127	128	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1049	1059		10.1038/ni1512	http://dx.doi.org/10.1038/ni1512			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17873878				2022-12-18	WOS:000249691400019
J	Gomez, TS; Hamann, MJ; McCarney, S; Savoy, DN; Lubking, CM; Heldebrant, MP; Labno, CM; McKean, DJ; McNiven, MA; Burkhardt, JK; Billadeau, DD				Gomez, TS; Hamann, MJ; McCarney, S; Savoy, DN; Lubking, CM; Heldebrant, MP; Labno, CM; McKean, DJ; McNiven, MA; Burkhardt, JK; Billadeau, DD			Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTING CELLS; APC CONTACT SITE; NF-KAPPA-B; RECEPTOR SIGNALS; MEDIATED CYTOTOXICITY; PROTEIN-KINASE; VAV PROTEINS; SH3 DOMAINS; ENDOCYTOSIS; LYMPHOCYTES	Actin reorganization at the immunological synapse is required for the amplification and generation of a functional immune response. Using small interfering RNA, we show here that dynamin 2 (Dyn2), a large GTPase involved in receptor-mediated internalization, did not alter antibody-mediated T cell receptor internalization but considerably affected T cell receptor-stimulated T cell activation by regulating multiple biochemical signaling pathways and the accumulation of F-actin at the immunological synapse. Moreover, Dyn2 interacted directly with the Rho family guanine nucleotide exchange factor Vav1, and this interaction was required for T cell activation. These data identify a functionally important interaction between Dyn2 and Vav1 that regulates actin reorganization and multiple signaling pathways in T lymphocytes.	Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Chicago; Mayo Clinic	Billadeau, DD (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu			NCI NIH HHS [CA47752] Funding Source: Medline; NIAID NIH HHS [AI44959] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044959] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Finkelstein LD, 2004, TRENDS CELL BIOL, V14, P443, DOI 10.1016/j.tcb.2003.07.001; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Houlard M, 2002, J EXP MED, V195, P1115, DOI 10.1084/jem.20011701; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Jevremovic D, 1999, J IMMUNOL, V162, P2453; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; SEEDORF K, 1994, J BIOL CHEM, V269, P16009; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; So CW, 2000, LEUKEMIA, V14, P594, DOI 10.1038/sj.leu.2401692; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	49	127	130	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					261	270		10.1038/ni1168	http://dx.doi.org/10.1038/ni1168			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15696170				2022-12-18	WOS:000227117400018
J	Plas, DR; Rathmell, JC; Thompson, CB				Plas, DR; Rathmell, JC; Thompson, CB			Homeostatic control of lymphocyte survival: potential origins and implications	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; HEMATOPOIETIC-CELL SURVIVAL; RECEPTOR-DEFICIENT MICE; BCL-2 FAMILY MEMBERS; PROTEIN-KINASE-B; GROWTH-FACTOR; T-CELLS; CYTOCHROME-C; PHOSPHATIDYLINOSITOL 3-KINASE/AKT	Lymphocytes depend on extracellular ligands to maintain their viability. Structurally diverse lymphocyte receptors transmit survival signals through separate signal transduction cascades, which all share the ability to sustain viability by maintaining the sequestration of apoptogenic factors within mitochondria. Receptors can induce cellular survival either by promoting the expression and/or function of anti-apoptotic Bcl-2 family proteins or by activating the phosphatidylinositol-3 kinase-Akt pathway. Either of these events represses the function of the proapoptotic proteins Bax and Bak, which are required for mitochondrial release of cytochrome c. As we discuss here, the apparently redundant functions of Bax and Bak may have evolved to prevent lymphocyte mitochondria from adapting to loss of receptor-mediated signal transduction and thus keep lymphocytes from accumulating in a cell-autonomous manner.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.							Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Heymann D, 2000, CYTOKINE, V12, P1455, DOI 10.1006/cyto.2000.0747; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; KAN O, 1994, BIOCHEM SOC T, V22, pS275, DOI 10.1042/bst022275s; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Nagaoka H, 2000, J EXP MED, V192, P171, DOI 10.1084/jem.192.2.171; Nakajima H, 2000, IMMUNOL TODAY, V21, P88, DOI 10.1016/S0167-5699(99)01555-8; Narimatsu M, 2001, MOL CELL BIOL, V21, P6615, DOI 10.1128/MCB.21.19.6615-6625.2001; Nicholls D, 1992, BIOENERGETICS, V2, P23; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Sprent J, 2001, IMMUNOL CELL BIOL, V79, P199, DOI 10.1046/j.1440-1711.2001.00999.x; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Teague TK, 1997, J IMMUNOL, V158, P5791; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Vander Heiden MG, 1999, MOL CELL, V3, P159; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; WHETTON AD, 1983, NATURE, V303, P629, DOI 10.1038/303629a0; WHETTON AD, 1984, EMBO J, V3, P409, DOI 10.1002/j.1460-2075.1984.tb01821.x; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	89	127	131	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					515	521		10.1038/ni0602-515	http://dx.doi.org/10.1038/ni0602-515			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032565				2022-12-18	WOS:000175874700009
J	Srivastava, PK				Srivastava, PK			Immunotherapy of human cancer: lessons from mice	NATURE IMMUNOLOGY			English	Editorial Material							HEAT-SHOCK PROTEINS; METASTATIC MELANOMA; T-LYMPHOCYTES; ANTIGEN; GENERATION; PEPTIDES; TUMORS	Translating mouse models into clinical therapies has never been easy. Immunotherapies for cancer also have to contend with an approval process designed for testing drugs. It may be necessary to consider different endpoints and objectives when evaluating the efficacy of these newer approaches.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis MC1601, Farmington, CT 06030 USA	University of Connecticut	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis MC1601, Farmington, CT 06030 USA.							AMATO RJ, 2000, AM SOC CLIN ONCOL; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; BASU S, 2000, IN PRESS INT IMMUNOL, V12; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; BLINDER RJ, 2000, IN PRESS J IMMUNOL; DeVita VT, 1997, CANC PRINCIPLES PRAC; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Janetzki S, 1998, J IMMUNOTHER, V21, P269, DOI 10.1097/00002371-199807000-00004; JANETZKI S, 2000, IN PRESS INT J CANC; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LEWIS JJ, 1999, AM SOC CLIN ONCOL; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Old LJ, 1998, J EXP MED, V187, P1163, DOI 10.1084/jem.187.8.1163; RAMARATHINAM L, 1995, J IMMUNOL, V155, P5323; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1984, INT J CANCER, V33, P417, DOI 10.1002/ijc.2910330321; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; WANG XY, 2000, IN PRESS J IMMUNOL; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	26	127	154	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					363	366		10.1038/80795	http://dx.doi.org/10.1038/80795			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062489				2022-12-18	WOS:000165076100003
J	Fulton, RB; Hamilton, SE; Xing, Y; Best, JA; Goldrath, AW; Hogquist, KA; Jameson, SC				Fulton, Ross B.; Hamilton, Sara E.; Xing, Yan; Best, J. Adam; Goldrath, Ananda W.; Hogquist, Kristin A.; Jameson, Stephen C.			The TCR's sensitivity to self peptide-MHC dictates the ability of naive CD8(+) T cells to respond to foreign antigens	NATURE IMMUNOLOGY			English	Article							MEMORY; EXPRESSION; EFFECTOR; SURVIVAL; DIFFERENTIATION; REPERTOIRE; AFFINITY; STRENGTH; SIGNALS; RESPONSIVENESS	The strength with which complexes of self peptide and major histocompatibility complex (MHC) proteins are recognized by the T cell antigen receptor (TCR) dictates the homeostasis of naive CD8(+) T cells, but its effect on reactivity to foreign antigens is controversial. As expression of the negative regulator CD5 correlates with self-recognition, we studied CD5(lo) and CD5(hi) naive CD8(+) T cells. Gene-expression characteristics suggested CD5(hi) cells were better poised for reactivity and differentiation than were CD5(lo) cells, and we found that the CD5(hi) pool also exhibited more efficient clonal recruitment and expansion, as well as enhanced reactivity to inflammatory cues, during the recognition of foreign antigen. However, the recognition of complexes of foreign peptide and MHC was similar for both subsets. Thus, CD8(+) T cells with higher self-reactivity dominate the immune response to foreign antigens, with implications for T cell repertoire diversity and autoimmunity.	[Fulton, Ross B.; Hamilton, Sara E.; Xing, Yan; Hogquist, Kristin A.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Best, J. Adam; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687	US National Institutes of Health [R37 AI-38903, P30 CA77598]; National Center for Advancing Translational Sciences [UL1TR000114]; Irvington Institute Fellowship Program of the Cancer Research Institute; Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota; NATIONAL CANCER INSTITUTE [T32CA009138, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067545, R37AI039560, R37AI038903] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Irvington Institute Fellowship Program of the Cancer Research Institute; Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Masopust (University of Minnesota) for Il15<SUP>-/-</SUP> mice, P14 mice and LCMV Armstrong strain; L. Cauley (University of Connecticut) for F5 mice deficient in recombination-activating gene 1; J. Zhu (National Institute of Allergy and Infectious Diseases) for T-bet-ZsGreen reporter mice; J. Harty (University of Iowa) for L. monocytogenes strain Delta actA (DP-L1942) and OVA-expressing L. monocytogenes Delta actA; R. Kedl (National Jewish Medical Research Center) for LM-B8R (virulent and Delta actA); M. Prlic and M. Bevan (University of Washington) and J. Harty (University of Iowa) for Flt3L-expressing B16 cells; R. Kroczek (Robert Koch-Institute) for the conjugated monoclonal antibody MTAC-2; the University of Minnesota Flow Core personnel for flow-cytometry support and cell sorting; M. Jenkins and M. Mescher for critical review of the manuscript; G. Stritesky for insight on the analysis of Nur77 mice; J. Ding and S. Peery for technical assistance with mice; and members of the Jamequist laboratory for discussions. Supported by the US National Institutes of Health (R37 AI-38903 to S.C.J.; P30 CA77598, with the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota; UL1TR000114 from the National Center for Advancing Translational Sciences) and the Irvington Institute Fellowship Program of the Cancer Research Institute (R.B.F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnson LDS, 2010, J IMMUNOL, V184, P5604, DOI 10.4049/jimmunol.1000109; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kieper WC, 2001, J IMMUNOL, V166, P5515, DOI 10.4049/jimmunol.166.9.5515; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Maile R, 2001, J IMMUNOL, V167, P3708, DOI 10.4049/jimmunol.167.7.3708; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Starbeck-Miller GR, 2014, J EXP MED, V211, P105, DOI 10.1084/jem.20130901; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	56	126	127	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					107	+		10.1038/ni.3043	http://dx.doi.org/10.1038/ni.3043			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25419629	Green Accepted			2022-12-18	WOS:000346494200014
J	Spooner, CJ; Lesch, J; Yan, DH; Khan, AA; Abbas, A; Ramirez-Carrozzi, V; Zhou, MJ; Soriano, R; Eastham-Anderson, J; Diehl, L; Lee, WP; Modrusan, Z; Pappu, R; Xu, M; DeVoss, J; Singh, H				Spooner, Chauncey J.; Lesch, Justin; Yan, Donghong; Khan, Aly A.; Abbas, Alex; Ramirez-Carrozzi, Vladimir; Zhou, Meijuan; Soriano, Robert; Eastham-Anderson, Jeffrey; Diehl, Lauri; Lee, Wyne P.; Modrusan, Zora; Pappu, Rajita; Xu, Min; DeVoss, Jason; Singh, Harinder			Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1	NATURE IMMUNOLOGY			English	Article							NATURAL HELPER-CELLS; LYMPHOID-CELLS; EXPRESSION; CYTOKINES; IDENTIFICATION; NETWORK; PROTEIN; PRODUCE; SUBSET; IL-17A	Type 2 innate lymphoid cells (ILC2 cells) participate in host defense against helminth parasites and in allergic inflammation. Given their functional relatedness to type 2 helper T cells (TH2 cells), we explored whether Gfi1 acts as a shared transcriptional determinant in ILC2 cells. Gfi1 promoted the development of ILC2 cells and controlled their responsiveness during infection with Nippostrongylus brasiliensis and protease allergen-induced lung inflammation. Gfi1 'preferentially' regulated the responsiveness of ILC2 cells to interleukin 33 (IL-33) by directly activating Il1rl1, which encodes the IL-33 receptor (ST2). Loss of Gfi1 in activated ILC2 cells resulted in impaired expression of the transcription factor GATA-3 and a dysregulated genome-wide effector state characterized by coexpression of IL-13 and IL-17. Our findings establish Gfi1 as a shared determinant that reciprocally regulates the type 2 and IL-17 effector states in cells of the innate and adaptive immune systems.	[Spooner, Chauncey J.; Ramirez-Carrozzi, Vladimir; Pappu, Rajita; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Lesch, Justin; Yan, Donghong; Zhou, Meijuan; Lee, Wyne P.; Xu, Min; DeVoss, Jason] Genentech Inc, Translat Immunol, San Francisco, CA 94080 USA; [Khan, Aly A.] Univ Chicago, Inst Syst & Genom Biol, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Abbas, Alex] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Soriano, Robert; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA 94080 USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of Chicago; University of Chicago; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Spooner, CJ (corresponding author), Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA.	spooner.chauncey@gene.com; harinder.singh@cchmc.org						Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	37	126	136	1	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1229	+		10.1038/ni.2743	http://dx.doi.org/10.1038/ni.2743			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24141388				2022-12-18	WOS:000327149400008
J	Pardoll, DM				Pardoll, Drew M.			Immunology beats cancer: a blueprint for successful translation	NATURE IMMUNOLOGY			English	Article							T-CELL PROLIFERATION; ANTIGEN-4 BLOCKADE; B7 FAMILY; CTLA-4; RECEPTOR; MEMBER; PD-1; ANTIBODY; SAFETY; CD28	Immunology offers an unprecedented opportunity for the science-driven development of therapeutics. The successes of antibodies to the immunomodulatory receptor CTLA-4 and blockade of the immunoinhibitory receptor PD-1 in cancer immunotherapy, from gene discovery to patient benefit, have created a paradigm for driving such endeavors.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	dpardoll@jhmi.edu			NCI NIH HHS [P30 CA006973, P30 CA021765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Flexner Abraham, 2002, Bull World Health Organ, V80, P594; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	30	126	137	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1129	1132		10.1038/ni.2392	http://dx.doi.org/10.1038/ni.2392			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160205	Green Accepted			2022-12-18	WOS:000311217900001
J	Shih, VFS; Davis-Turak, J; Macal, M; Huang, JQ; Ponomarenko, J; Kearns, JD; Yu, T; Fagerlund, R; Asagiri, M; Zuniga, EI; Hoffmann, A				Shih, Vincent F-S; Davis-Turak, Jeremy; Macal, Monica; Huang, Jenny Q.; Ponomarenko, Julia; Kearns, Jeffrey D.; Yu, Tony; Fagerlund, Riku; Asagiri, Masataka; Zuniga, Elina I.; Hoffmann, Alexander			Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappa B pathways	NATURE IMMUNOLOGY			English	Article							NEGATIVE FEEDBACK; IMMUNE-RESPONSES; TEMPORAL CONTROL; IKK-ALPHA; EXPRESSION; SPECIFICITY; MODULATION; TYPE-1; KINASE; DIMERS	The NF-kappa B protein RelB controls dendritic cell (DC) maturation and may be targeted therapeutically to manipulate T cell responses in disease. Here we report that RelB promoted DC activation not as the expected RelB-p52 effector of the noncanonical NF-kappa B pathway, but as a RelB-p50 dimer regulated by canonical I kappa Bs, I kappa B alpha and I kappa B epsilon. I kappa B control of RelB minimized spontaneous maturation but enabled rapid pathogen-responsive maturation. Computational modeling of the NF-kappa B signaling module identified control points of this unexpected cell type-specific regulation. Fibroblasts that we engineered accordingly showed DC-like RelB control. Canonical pathway control of RelB regulated pathogen-responsive gene expression programs. This work illustrates the potential utility of systems analyses in guiding the development of combination therapeutics for modulating DC-dependent T cell responses.	[Shih, Vincent F-S; Davis-Turak, Jeremy; Huang, Jenny Q.; Kearns, Jeffrey D.; Yu, Tony; Fagerlund, Riku; Asagiri, Masataka; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Shih, Vincent F-S; Davis-Turak, Jeremy; Huang, Jenny Q.; Kearns, Jeffrey D.; Yu, Tony; Fagerlund, Riku; Asagiri, Masataka; Hoffmann, Alexander] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Macal, Monica; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Asagiri, Masataka] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat & Therapeut, Sakyo Ku, Kyoto, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyoto University	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu	Davis-Turak, Jeremy/B-8000-2014; Ponomarenko, Julia/K-8105-2015	Davis-Turak, Jeremy/0000-0002-4462-5171; Ponomarenko, Julia/0000-0002-1477-9444	 [GM085763];  [GM071573];  [AI090935];  [GM085325];  [AI081923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083453, R01AI081923, P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071573, P01GM071862, P50GM085764, R01GM085325] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Tao and G. Ghosh (University of California San Diego) for plasmids and recombinant proteins, S. Basak, A. Wu, P. Loriaux, R. Tsui for computational modeling advice, and C. Brown and M. Karin (University of California San Diego) for Traf3<SUP>-/-</SUP> embryos. This study was supported by GM085763 (A.H.), GM071573 (A.H.), AI090935 (A.H.), GM085325 (J.P.) and AI081923 (E.I.Z.).	Ammon C, 2000, BIOCHEM BIOPH RES CO, V268, P99, DOI 10.1006/bbrc.1999.2083; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; DOBRZANSKI P, 1994, EMBO J, V13, P4608, DOI 10.1002/j.1460-2075.1994.tb06782.x; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gasparini C, 2009, EUR J IMMUNOL, V39, P2215, DOI 10.1002/eji.200939209; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Li M, 2007, J IMMUNOL, V178, P5480, DOI 10.4049/jimmunol.178.9.5480; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasaki CY, 2011, J BIOL CHEM, V286, P1093, DOI 10.1074/jbc.M110.119438; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Weih F, 1997, J IMMUNOL, V158, P5211; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wuerzberger-Davis SM, 2011, IMMUNITY, V34, P188, DOI 10.1016/j.immuni.2011.01.014; Yang H, 2010, INFLAMM RES, V59, P197, DOI 10.1007/s00011-009-0087-6; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x	47	126	128	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1162	+		10.1038/ni.2446	http://dx.doi.org/10.1038/ni.2446			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23086447	Green Accepted, Green Submitted			2022-12-18	WOS:000311217900009
J	Kim, S; Lee, S; Shin, J; Kim, Y; Evnouchidou, I; Kim, D; Kim, YK; Kim, YE; Ahn, JH; Riddell, SR; Stratikos, E; Kim, VN; Ahn, K				Kim, Sungchul; Lee, Sanghyun; Shin, Jinwook; Kim, Youngkyun; Evnouchidou, Irini; Kim, Donghyun; Kim, Young-Kook; Kim, Young-Eui; Ahn, Jin-Hyun; Riddell, Stanley R.; Stratikos, Efstratios; Kim, V. Narry; Ahn, Kwangseog			Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; PRESENTED PEPTIDES; ENCODED MICRORNAS; TRIMS PRECURSORS; BINDING-SITES; HEAVY-CHAINS; RNA; IDENTIFICATION; EXPRESSION	Major histocompatibility complex (MHC) class I molecules present peptides on the cell surface to CD8(+) T cells, which is critical for the killing of virus-infected or transformed cells. Precursors of MHC class I-presented peptides are trimmed to mature epitopes by the aminopeptidase ERAP1. The US2-US11 genomic region of human cytomegalovirus (HCMV) is dispensable for viral replication and encodes three microRNAs (miRNAs). We show here that HCMV miR-US4-1 specifically downregulated ERAP1 expression during viral infection. Accordingly, the trimming of HCMV-derived peptides was inhibited, which led to less susceptibility of infected cells to HCMV-specific cytotoxic T lymphocytes (CTLs). Our findings identify a previously unknown viral miRNA-based CTL-evasion mechanism that targets a key step in the MHC class I antigen-processing pathway.	[Kim, Sungchul; Lee, Sanghyun; Kim, Youngkyun; Kim, Donghyun; Ahn, Kwangseog] Seoul Natl Univ, Natl Creat Res Initiat Ctr Antigen Presentat, Dept Biol Sci, Seoul, South Korea; [Shin, Jinwook] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Evnouchidou, Irini; Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece; [Kim, Young-Eui; Ahn, Jin-Hyun] Sungkyunkwan Univ, Dept Mol Cell Biol, Samsung Biomed Res Inst, Sch Med, Seoul, South Korea; [Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	Seoul National University (SNU); Duke University; National Centre of Scientific Research "Demokritos"; Sungkyunkwan University (SKKU); Samsung Medical Center; Fred Hutchinson Cancer Center	Ahn, K (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Antigen Presentat, Dept Biol Sci, Seoul, South Korea.	ksahn@snu.ac.kr	Kim, Young-Kook/AAE-8306-2020; Stratikos, Efstratios/N-2969-2014; Evnouchidou, Irini/Z-3072-2019; Kim, Sungchul/O-8910-2015; Shin, Jinwook/AAG-6004-2019	Kim, Young-Kook/0000-0001-6434-2235; Stratikos, Efstratios/0000-0002-3566-2309; Kim, Sungchul/0000-0001-9148-6904; Shin, Jinwook/0000-0003-3476-7595; Kim, Young Kook/0000-0002-6037-8449; kim, donghyun/0000-0001-7863-7384	Ministry of Science and Technology; Korea Science and Engineering Foundation; Ministry of Education, Science and Technology of the Republic of Korea; US National Institutes of Health [CA18029, AI053193]; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053193] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tsujimoto (RIKEN, Wako) for recombinant human ERAP1 cDNA and polyclonal antibody to ERAP1; P. van Endert and L. Saveanu (Institut National de la Sante et de la Recherche Medicale, Paris) for monoclonal antibody 6H9 to ERAP1; I. York (Michigan State University) and K. Rock (University of Massachusetts Medical School) for pUG1-based vectors and technical help; N. Shastri (University of California, Berkeley) for the B3Z T cell hybridoma; T. Shenk (Princeton University) for pAD/Cre BAC; and C.-Y. Kang and T.-K. Kim for technical help. Supported by the Creative Research Initiatives Program of the Ministry of Science and Technology and the Korea Science and Engineering Foundation (K.A.), the Brain Korea 21 project of the Ministry of Education, Science and Technology of the Republic of Korea (S.K., S.L. and D.K.) and the US National Institutes of Health (CA18029 and AI053193 to S.R.R.).	Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Evnouchidou I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003658; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Fruci D, 2008, J CELL PHYSIOL, V216, P742, DOI 10.1002/jcp.21454; Georgiadou D, 2010, J IMMUNOL, V185, P1584, DOI 10.4049/jimmunol.0902502; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Gruhler A, 2000, TRAFFIC, V1, P318, DOI 10.1034/j.1600-0854.2000.010405.x; Gustems M, 2006, J VIROL, V80, P9899, DOI 10.1128/JVI.00640-06; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Kanaseki T, 2008, J IMMUNOL, V181, P6275, DOI 10.4049/jimmunol.181.9.6275; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Machold RP, 1997, J EXP MED, V185, P363, DOI 10.1084/jem.185.2.363; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moore LM, 2010, EXPERT OPIN THER TAR, V14, P1247, DOI 10.1517/14728222.2010.527334; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Stern-Ginossar N, 2009, J VIROL, V83, P10684, DOI 10.1128/JVI.01292-09; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wu J, 1998, J VIROL, V72, P236, DOI 10.1128/JVI.72.1.236-244.1998; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103	47	126	145	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					984	U92		10.1038/ni.2097	http://dx.doi.org/10.1038/ni.2097			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21892175	Green Accepted			2022-12-18	WOS:000295084500014
J	Kawagoe, T; Takeuchi, O; Takabatake, Y; Kato, H; Isaka, Y; Tsujimura, T; Akira, S				Kawagoe, Tatsukata; Takeuchi, Osamu; Takabatake, Yoshitsugu; Kato, Hiroki; Isaka, Yoshitaka; Tsujimura, Tohru; Akira, Shizuo			TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INTERFERON ANTIVIRAL RESPONSE; DEUBIQUITINATING ENZYME; UBIQUITIN LIGASE; ACTIVATION; KINASE; INNATE; RECOGNITION; PROTEIN; FAMILY	The intensity and duration of immune responses are controlled by many proteins that modulate Toll-like receptor (TLR) signaling. TANK has been linked to positive regulation of the transcription factors IRF3 and NF-kappa B. Here we demonstrate that TANK is not involved in interferon responses and is a negative regulator of proinflammatory cytokine production induced by TLR signaling. TLR-induced polyubiquitination of the ubiquitin ligase TRAF6 was upregulated in Tank(-/-) macrophages. Notably, Tank(-/-) mice spontaneously developed fatal glomerulonephritis owing to deposition of immune complexes. Autoantibody production in Tank(-/-) mice was abrogated by antibiotic treatment or the absence of interleukin 6 (IL-6) or the adaptor MyD88. Our results demonstrate that constitutive TLR signaling by intestinal commensal microflora is suppressed by TANK.	[Kawagoe, Tatsukata; Takeuchi, Osamu; Kato, Hiroki; Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Kawagoe, Tatsukata; Takeuchi, Osamu; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Takabatake, Yoshitsugu] Osaka Univ, Grad Sch Med, Dept Nephrol, Osaka, Japan; [Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Osaka, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Hyogo College of Medicine	Akira, S (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Global Center of Excellence Program of Japan; US National Institutes of Health [P01 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Yasui (Osaka University) for Il6<SUP>-/-</SUP> mice and plasmids; colleagues in our laboratories; E. Kamada for secretarial assistance; Y. Fujiwara, M. Kumagai and R. Abe for technical assistance; and S. Sato for discussions. Supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and grants from the Ministry of Health, Labour and Welfare in Japan, the Global Center of Excellence Program of Japan, and the US National Institutes of Health (P01 AI070167).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chendrasekhar A, 1996, J TRAUMA, V40, P963, DOI 10.1097/00005373-199606000-00016; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li CL, 2002, STRUCTURE, V10, P403, DOI 10.1016/S0969-2126(02)00733-5; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nomura F, 2000, GENES CELLS, V5, P191; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	50	126	132	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					965	U53		10.1038/ni.1771	http://dx.doi.org/10.1038/ni.1771			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19668221	Green Accepted			2022-12-18	WOS:000269120900010
J	Zugasti, O; Ewbank, JJ				Zugasti, Olivier; Ewbank, Jonathan J.			Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-SYSTEM; GENOME-WIDE ANALYSIS; BODY-SIZE; DROSOPHILA; INFECTION; RESPONSES; HOST; PROTEIN; GENES; MODEL	After being infected by the fungus Drechmeria coniospora, Caenorhabditis elegans produces antimicrobial peptides in its epidermis, some regulated by a signaling cascade involving a p38 mitogen-activated protein kinase. Here we show that infection-induced expression of peptides of the Caenacin family occurred independently of the p38 pathway. The caenacin (cnc) genes enhanced survival after fungal infection, and neuronal expression of the transforming growth factor-beta homolog DBL-1 promoted cnc-2 expression in the epidermis in a dose-dependent paracrine way. Our results lead to a model in which antifungal defenses are coordinately regulated by a cell-autonomous p38 cascade and a distinct cytokine-like transforming growth factor-b signal from the nervous system, each of which controls distinct sets of antimicrobial peptide-encoding genes in the epidermis.	[Ewbank, Jonathan J.] Univ Mediterranee, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; INSERM, U631, F-13288 Marseille, France; CNRS, UMR6102, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Ewbank, JJ (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille 9, France.	ewbank@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010; Zugasti, Olivier/P-1352-2017	Ewbank, Jonathan J/0000-0002-1257-6862; Zugasti, Olivier/0000-0002-5616-734X	National Institutes of Health National Center; National Bioresource; Tokyo Women's Medical University School of Medicine; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Agence National de Recherches (Droselegans, Fungenomics); Union Biometrica	National Institutes of Health National Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Bioresource; Tokyo Women's Medical University School of Medicine; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de Recherches (Droselegans, Fungenomics)(French National Research Agency (ANR)); Union Biometrica	We thank A. Chisholm, P. Golstein, J. Hodgkin, J.-L. Imler and members of the Ewbank laboratory for discussion and comments on the manuscript, and R. W. Padgett (Rutgers University) for the wt;ctIs40 strain; some other nematode strains were provided by the Caenorhabditis Genetics Center (funded by the National Institutes of Health National Center for Research Resources) or by the National Bioresource Project coordinated by S. Mitani (Tokyo Women's Medical University School of Medicine). Worm sorter analyses were done in the facilities of Marseille-Nice Genopole. Supported by the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, the Agence National de Recherches (Droselegans, Fungenomics) and Union Biometrica. The Ewbank lab is an Equipe Labellisee Fondation pour la Recherche Medicale.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DIJKSTERHUIS J, 1990, MYCOL RES, V94, P1, DOI 10.1016/S0953-7562(09)81257-4; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Morita K, 1999, DEVELOPMENT, V126, P1337; MURRAY GT, 1993, MATER ENGN, V2, P1; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Savage-Dunn C, 2003, GENESIS, V35, P239, DOI 10.1002/gene.10184; Savage-Dunn Cathy, 2005, WormBook, P1; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulenburg H, 2007, MOL MICROBIOL, V66, P563, DOI 10.1111/j.1365-2958.2007.05946.x; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tan MW, 2001, PEDIAT PULMONOL, V32, P96; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Watanabe N, 2007, GENES CELLS, V12, P603, DOI 10.1111/j.1365-2443.2007.01077.x; Zhang Y, 2008, CURR OPIN MICROBIOL, V11, P257, DOI 10.1016/j.mib.2008.04.003	50	126	151	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					249	256		10.1038/ni.1700	http://dx.doi.org/10.1038/ni.1700			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19198592				2022-12-18	WOS:000263456500008
J	Laurence, A; O'Shea, JJ				Laurence, Arian; O'Shea, John J.			T-H-17 differentiation: of mice and men	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; T(H)17	A new subset of interleukin 17-producing CD4(+) helper T cells with diverse functions has now been identified. New work by three groups substantially broadens the understanding of these cells in both mice and humans.	NIAMSD, NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAMSD, NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov	Laurence, Arian/A-8770-2009	Laurence, Arian/0000-0003-0942-8292	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, Z01AR041159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; CHEN Z, IN PRESS ARTHRITIS R; KORN T, 2007, NATURE          0726; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NURIEVA R, 2007, NATURE          0726; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; ZHOU L, 2007, NAT IMMUNOL     0620	15	126	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					903	905		10.1038/ni0907-903	http://dx.doi.org/10.1038/ni0907-903			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712339				2022-12-18	WOS:000248918200004
J	Scheeren, FA; Naspetti, M; Diehl, S; Schotte, R; Nagasawa, M; Wijnands, E; Gimeno, R; Vyth-Dreese, FA; Blom, B; Spits, H				Scheeren, FA; Naspetti, M; Diehl, S; Schotte, R; Nagasawa, M; Wijnands, E; Gimeno, R; Vyth-Dreese, FA; Blom, B; Spits, H			STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER FORMATION; GENE-EXPRESSION; PLASMA-CELLS; T-CELL; C-MYC; TERMINAL DIFFERENTIATION; SIGNAL TRANSDUCER; IN-VITRO; TRANSCRIPTION; LYMPHOCYTE	It is unknown how B cells that mature during a germinal center reaction 'decide' between plasma or memory cell fate. Here we describe a previously unknown subpopulation of B cells in the human germinal center that is characterized by tyrosine phosphorylated transcriptional activator STAT5. These cells had an activated centrocyte phenotype and had abundant expression of BCL6 but low expression of PRDM1, both encoding transcriptional repression proteins. Using RNA interference and ectopic expression of constitutively activated forms of STAT5, we demonstrate here a function for STAT5 in the self-renewal of B cells in vitro. STAT5b isoform seemed to directly upregulate Bcl-6, and ectopic expression of Bcl-6 in B cells resulted in self-renewal and inhibition of plasma cell differentiation. These data indicate that activation of STAT5 is involved in regulation of memory B cell differentiation.	Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Diehl, Sean/C-7166-2008; Diehl, Sean/AAE-2779-2020; Spits, Hergen/N-2581-2019	Diehl, Sean/0000-0001-9700-235X; Diehl, Sean/0000-0001-9700-235X; Spits, Hergen/0000-0003-3269-8338; Scheeren, Ferenc/0000-0002-8304-9023	NIAID NIH HHS [F32 AI063846] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063846] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Guikema JEJ, 1999, BRIT J HAEMATOL, V104, P748, DOI 10.1046/j.1365-2141.1999.01233.x; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Karras JG, 1996, J IMMUNOL, V157, P39; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; OHASHI K, 1995, BIOCHEM BIOPH RES CO, V214, P461, DOI 10.1006/bbrc.1995.2309; Raman VS, 2000, J IMMUNOL, V165, P6809, DOI 10.4049/jimmunol.165.12.6809; Raman VS, 2003, J IMMUNOL, V171, P5876, DOI 10.4049/jimmunol.171.11.5876; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Usui T, 1997, J IMMUNOL, V158, P3197; VYTHDREESE FA, 1995, EUR J IMMUNOL, V25, P3023, DOI 10.1002/eji.1830251106; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	49	126	141	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					303	313		10.1038/ni1172	http://dx.doi.org/10.1038/ni1172			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15711548				2022-12-18	WOS:000227117400023
J	Makar, KW; Perez-Melgosa, M; Shnyreva, M; Weaver, WM; Fitzpatrick, DR; Wilson, CB				Makar, KW; Perez-Melgosa, M; Shnyreva, M; Weaver, WM; Fitzpatrick, DR; Wilson, CB			Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells	NATURE IMMUNOLOGY			English	Article							CHROMATIN-STRUCTURE; HISTONE ACETYLATION; LINEAGE COMMITMENT; GENE-EXPRESSION; CUTTING EDGE; IFN-GAMMA; METHYLATION; IL-4; TRANSCRIPTION; DNMT1	How T cells regulate interleukin 4 (IL-4) expression is not completely understood. We show here that single-positive thymocytes express IL-4, but attenuate GATA-3 expression, recruit DNA methyltransferases(Dnmts) to the Il4-Il13 locus and downregulate IL-4 expression as they mature into T cells. Type 2 polarization blocks Dnmt1 recruitment, enhances histone H3 Lys4 methylation (indicative of accessible chromatin) and initiates DNA demethylation of the locus. Dnmt1(-/-) CD4 and CD8 T cells derepress IL-4 expression considerably, demethylate DNA and increase H3 Lys4 methylation without affecting GATA-3 expression, demonstrating that Dnmt1 and DNA methylation are essential for proper Il4 regulation. These results indicate that Dnmts, DNA and histone methylation, and transcription factors 'collaborate' to determine appropriate Il4 expression patterns.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Amgen Corp, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle	Wilson, CB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	cbwilson@u.washington.edu			NICHD NIH HHS [HD39454, HD18184] Funding Source: Medline; NIGMS NIH HHS [GM20865] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039454, R01HD018184, R37HD018184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020865] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Glimcher LH, 2000, GENE DEV, V14, P1693; Goll MG, 2002, GENE DEV, V16, P1739, DOI 10.1101/gad.1013902; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Meehan RR, 2003, SEMIN CELL DEV BIOL, V14, P53, DOI 10.1016/S1084-9521(02)00137-4; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	51	126	131	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1183	1190		10.1038/ni1004	http://dx.doi.org/10.1038/ni1004			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14595437				2022-12-18	WOS:000186769500011
J	Holze, C; Michaudel, C; Mackowiak, C; Haas, DA; Benda, C; Hubel, P; Pennemann, FL; Schnepf, D; Wettmarshausen, J; Braun, M; Leung, DW; Amarasinghe, GK; Perocchi, F; Staeheli, P; Ryffel, B; Pichlmair, A				Holze, Cathleen; Michaudel, Chloe; Mackowiak, Claire; Haas, Darya A.; Benda, Christian; Hubel, Philipp; Pennemann, Friederike L.; Schnepf, Daniel; Wettmarshausen, Jennifer; Braun, Marianne; Leung, Daisy W.; Amarasinghe, Gaya K.; Perocchi, Fabiana; Staeheli, Peter; Ryffel, Bernhard; Pichlmair, Andreas			Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway	NATURE IMMUNOLOGY			English	Article							OXIDATIVE STRESS; MOLECULAR-MECHANISMS; HYDROGEN-PEROXIDE; NADPH OXIDASE; VIRUS; PROTEIN; KEAP1; NECROPTOSIS; PGAM5; NRF2	Reactive oxygen species (ROS) are generated by virus-infected cells; however, the physiological importance of ROS generated under these conditions is unclear. Here we found that the inflammation and cell death induced by exposure of mice or cells to sources of ROS were not altered in the absence of canonical ROS-sensing pathways or known cell-death pathways. ROS-induced cell-death signaling involved interactions among the cellular ROS sensor and antioxidant factor KEAP1, the phosphatase PGAM5 and the proapoptotic factor AIFM1. Pgam5(-/-) mice showed exacerbated lung inflammation and proinflammatory cytokines in an ozone-exposure model. Similarly, challenge with influenza A virus led to increased infiltration of the virus, lymphocytic bronchiolitis and reduced survival of Pgam5(-/-) mice. This pathway, which we have called 'oxeiptosis', was a ROS-sensitive, caspase independent, non-inflammatory cell-death pathway and was important for protection against inflammation induced by ROS or ROS-generating agents such as viral pathogens.	[Holze, Cathleen; Haas, Darya A.; Hubel, Philipp; Pennemann, Friederike L.; Pichlmair, Andreas] Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany; [Michaudel, Chloe; Mackowiak, Claire; Ryffel, Bernhard] UMR7355 CNRS, INEM, Expt Mol Immunol, Orleans, France; [Michaudel, Chloe; Mackowiak, Claire; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Benda, Christian] Max Planck Inst Biochem, Dept Struct Cell Biol, Martinsried, Germany; [Schnepf, Daniel; Staeheli, Peter] Univ Freiburg, Inst Virol, Freiburg, Germany; [Schnepf, Daniel] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Wettmarshausen, Jennifer; Perocchi, Fabiana] Gene Ctr Munich, Dept Biochem, Munich, Germany; [Wettmarshausen, Jennifer; Perocchi, Fabiana] Helmholtz Zentrum Munchen, Inst Diabet & Obes, Neuherberg, Germany; [Braun, Marianne] Max Planck Inst Neurobiol, EM Histo Lab, Martinsried, Germany; [Leung, Daisy W.; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Staeheli, Peter] Univ Freiburg, Fac Med, Freiburg, Germany; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Pichlmair, Andreas] Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany; [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Max Planck Society; University of Freiburg; University of Freiburg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Washington University (WUSTL); University of Freiburg; University of Cape Town; Technical University of Munich; German Center for Infection Research	Pichlmair, A (corresponding author), Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany.; Pichlmair, A (corresponding author), Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany.; Pichlmair, A (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.	andreas.pichlmair@tum.de		Schnepf, Daniel/0000-0002-7528-981X; Hubel, Philipp/0000-0003-3053-3046; Michaudel, Chloe/0000-0001-7189-2729; perocchi, fabiana/0000-0002-1102-6500; Haas, Darya/0000-0001-5543-4875; Benda, Christian/0000-0001-5551-1332; Mackowiak, Claire/0000-0003-1267-5905	Max-Planck Free Floater program; German research foundation [PI 1084/2, TRR179, SFB 1160]; European Research Council [311339]; Infect-Era; German Federal Ministry of Education and Research (ERASE); US National Institutes of Health [R01 AI107056, 1R41AI127009]; Centre National de la Recherche Scientifique; European Regional Development Fund (BIO-TARGET) [2016-00110366]; la Region Centre [2014-00091905]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI127009, R01AI107056, P01AI120943] Funding Source: NIH RePORTER	Max-Planck Free Floater program; German research foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Infect-Era; German Federal Ministry of Education and Research (ERASE); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Regional Development Fund (BIO-TARGET); la Region Centre(Region Centre-Val de Loire); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Weber (Veterinary University Giessen) for pI.18_3xFlag_NSs and pI.18_3xFlag_DMx_1xFlag; F. Meissner (Max-Planck Institute of Biochemistry, Munich) for Jurkat cells; R. Klein (Max-Planck Institute of Neurobiology, Munich) for SKN-BE2 cells; A. Bowie (Trinity College Dublin) for HEK293 cells; A. Musacchio (Max-Planck Institute of Cell Biology, Dresden) for HeLa FlpIn cells; G. Kochs (University of Freiburg) for antibody to FluAV NS1; A. Chaikuad and S. Knapp (University of Oxford) for amino-terminal His-tagged PGAM5 (pNIC28-Bsa4-PGAM5(Delta 2-28); the innate immunity laboratory for critical discussions and suggestions; A. Mann for technical assistance; the MPI-B core facility for technical assistance with protein purification, analysis and imaging; M. Wilson and ECM Biosciences for raising the antibody to AIFM1 phosphorylated at Ser116; K. Mayr, I. Paron and G. Sowa for maintaining mass spectrometers; and S. Kaphengst and the MPI-B animal facility for breeding mice. Supported by the Max-Planck Free Floater program (A. P.), the German research foundation (PI 1084/2 and TRR179 to A. P. and SFB 1160, project 13) to P. S.), the European Research Council (starting grant ERC-StG iVIP, 311339 to A. P.), Infect-Era and the German Federal Ministry of Education and Research (ERASE) (A. P.), the US National Institutes of Health (R01 AI107056 and 1R41AI127009 (Moir) to D.W.L and G. K. A.), the Centre National de la Recherche Scientifique (B.R.) and the European Regional Development Fund (BIO-TARGET 2016-00110366 to Region Centre Val de Loire and la Region Centre (Respir_Ozone, 2014-00091905) (Valerie Quesniaux), to B.R.).	Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Ano Y, 2010, NEUROSCI LETT, V469, P39, DOI 10.1016/j.neulet.2009.11.040; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Bottero V, 2013, J VIROL, V87, P1733, DOI 10.1128/JVI.02958-12; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Ceh-Pavia E, 2013, INT J MOL SCI, V14, P16685, DOI 10.3390/ijms140816685; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Edwards MR, 2014, CELL REP, V6, P1017, DOI 10.1016/j.celrep.2014.01.043; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Johnson B, 2016, J MOL BIOL, V428, P3483, DOI 10.1016/j.jmb.2016.07.020; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kajitani N, 2007, BIOSCI BIOTECH BIOCH, V71, P2701, DOI 10.1271/bbb.70304; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kosmider B, 2010, FREE RADICAL BIO MED, V48, P1513, DOI 10.1016/j.freeradbiomed.2010.02.032; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Marconett CN, 2010, CANCER BIOL THER, V10, P397, DOI 10.4161/cbt.10.4.12424; Medvedev R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9012580; Moriwaki K, 2016, J IMMUNOL, V196, P407, DOI 10.4049/jimmunol.1501662; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566; Page A, 2014, CELL REP, V6, P1026, DOI 10.1016/j.celrep.2014.02.027; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Radogna F, 2016, ONCOGENE, V35, P3839, DOI 10.1038/onc.2015.455; Ravindran J, 2011, APOPTOSIS, V16, P145, DOI 10.1007/s10495-010-0554-0; Ren JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150961; Rosca MG, 2012, DIABETES, V61, P2074, DOI 10.2337/db11-1437; Sandalio Luisa M, 2013, Subcell Biochem, V69, P231, DOI 10.1007/978-94-007-6889-5_13; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Shen C, 2017, BBA-MOL BASIS DIS, V1863, P1912, DOI 10.1016/j.bbadis.2016.11.016; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046; Wilkins JM, 2014, J BIOL CHEM, V289, P25137, DOI 10.1074/jbc.M114.565549; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	57	125	129	7	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					130	+		10.1038/s41590-017-0013-y	http://dx.doi.org/10.1038/s41590-017-0013-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29255269	Green Accepted			2022-12-18	WOS:000423435200013
J	Broggi, A; Tan, Y; Granucci, F; Zanoni, I				Broggi, Achille; Tan, Yunhao; Granucci, Francesca; Zanoni, Ivan			IFN-lambda suppresses intestinal inflammation by non-translational regulation of neutrophil function	NATURE IMMUNOLOGY			English	Article							INTERFERON-STIMULATED GENES; ANTIVIRAL PROTECTION; MITOCHONDRIAL STAT3; BOWEL-DISEASE; P47(PHOX); PHOSPHORYLATION; ACTIVATION; EXPRESSION; INFECTION; RESPONSES	Interferon-lambda (IFN-lambda) is a central regulator of mucosal immunity; however, its signaling specificity relative to that of type I interferons is poorly defined. IFN-lambda can induce antiviral interferon-stimulated genes (ISGs) in epithelia, while the effect of IFN-lambda in non-epithelial cells remains unclear. Here we report that neutrophils responded to IFN-lambda. We found that in addition to inducing ISG transcription, IFN-lambda (but not IFN-beta) specifically activated a translation-independent signaling pathway that diminished the production of reactive oxygen species and degranulation in neutrophils. In mice, IFN-lambda was elicited by enteric viruses and acted on neutrophils to decrease oxidative stress and intestinal damage. Thus, IFN-lambda acted as a unique immunomodulatory agent by modifying transcriptional and non-translational neutrophil responses, which might permit a controlled development of the inflammatory process.	[Broggi, Achille; Tan, Yunhao; Zanoni, Ivan] Harvard Med Sch, Boston, MA 02115 USA; [Broggi, Achille; Tan, Yunhao; Zanoni, Ivan] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Granucci, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Milano-Bicocca	Zanoni, I (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Zanoni, I (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Granucci, F (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	francesca.granucci@unimib.it; ivan.zanoni@childrens.harvard.edu	Broggi, Achille/AAC-2276-2019; GRANUCCI, Francesca/K-6150-2019	Broggi, Achille/0000-0002-7244-2401; Zanoni, Ivan/0000-0002-3423-7474; granucci, francesca/0000-0002-7046-4914	US National Institutes of Health [1R01DK115217, 1R01AI121066-01A1]; Harvard Digestive Diseases Center [P30 DK034854]; Harvard Medical School; Crohn's and Colitis Foundation of America; Cariplo Foundation; Associazione Italiana per la Ricerca sul Cancro; Fondazione Italiana di Ricerca per la SLA-Sclerosi Laterale Amiotrofica (ARISLA); Fondazione Regionale per la Ricerca Biomedica; Jane Coffin Child's Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115217, P30DK034854] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Harvard Medical School; Crohn's and Colitis Foundation of America; Cariplo Foundation(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana di Ricerca per la SLA-Sclerosi Laterale Amiotrofica (ARISLA); Fondazione Regionale per la Ricerca Biomedica; Jane Coffin Child's Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S.B. Snapper (Harvard Medical School) for Stat1<SUP>-/-</SUP> and LysM<SUP>cre</SUP>Stat3<SUP>fl/fl</SUP> mice; the Wellcome Trust Sanger Institute Mouse Genetics Project (Sanger MGP) and its funders for the mutant mouse line Ifnlr 1<SUP>tm1a(EUCOMM)Wtsi</SUP>; H.W. Virgin (Washington University) for the Ifnlr 1<SUP>tm1a(EUCOMM)Wtsi</SUP> mouse line backcrossed to Villin<SUP>cre</SUP>-recombinase-expressing mice; and J.C. Kagan, L.R. Marek-Kagan, the Kagan Lab, S.B. Snapper, the Snapper Lab, A. Mocsai and H.W. Virgin for discussions, help and support. Supported by the US National Institutes of Health (1R01DK115217, 1R01AI121066-01A1 to I.Z.), the Harvard Digestive Diseases Center (P30 DK034854 to I.Z.), the Harvard Medical School Milton Fund (to I.Z.), Crohn's and Colitis Foundation of America (I.Z.), the Cariplo Foundation (I.Z. and F.G.), the Associazione Italiana per la Ricerca sul Cancro (F.G.), Fondazione Italiana di Ricerca per la SLA-Sclerosi Laterale Amiotrofica (ARISLA) (F.G.), Fondazione Regionale per la Ricerca Biomedica (F.G.) and the Jane Coffin Child's Memorial Fund for Medical Research (Y.T.).	Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Chiriac MT, 2017, GASTROENTEROLOGY, V153, P123, DOI 10.1053/j.gastro.2017.03.015; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR; de Groen RA, 2015, EUR J IMMUNOL, V45, P250, DOI 10.1002/eji.201444903; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Finotti G, 2016, J LEUKOCYTE BIOL, V99, P107, DOI 10.1189/jlb.3VMA0415-144R; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	45	125	132	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1084	+		10.1038/ni.3821	http://dx.doi.org/10.1038/ni.3821			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28846084	Green Accepted			2022-12-18	WOS:000411134000013
J	Hedrick, SM				Hedrick, Stephen M.			The cunning little vixen: Foxo and the cycle of life and death	NATURE IMMUNOLOGY			English	Review							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE-B; NF-KAPPA-B; OXIDATIVE-STRESS; T-CELLS; TGF-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; FACTOR AFX; PROMOTES TUMORIGENESIS; IMMUNOLOGICAL SYNAPSE	A screen for increased longevity in Caenorhabditis elegans has identified a transcription factor that programs cells for resistance to oxidative stress, DNA repair and cell cycle control. The mammalian orthologs of this factor are referred to as 'Foxo' for 'Forkhead box', with the second 'o' in the name denoting a subfamily of four members related by sequence. This family of factors is regulated by growth factors, oxidative stress or nutrient deprivation. Thus, it might readily control the inflammatory conflagration associated with infection-driven lymphocyte proliferation. Surprisingly, the first insights into Foxo-mediated immune regulation have instead revealed direct control of highly specialized genes of the adaptive immune system.	[Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073885] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI073885-01A2, R01 AI073885] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukuoka M, 2003, INT J MOL MED, V12, P503; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Hinman RM, 2009, INT IMMUNOL, V21, P831, DOI 10.1093/intimm/dxp049; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li G, 2006, J BIOL CHEM, V281, P10663, DOI 10.1074/jbc.M512509200; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Patra AK, 2004, J IMMUNOL, V172, P4812, DOI 10.4049/jimmunol.172.8.4812; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Santiago-Raber ML, 2001, J IMMUNOL, V167, P4067, DOI 10.4049/jimmunol.167.7.4067; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	97	125	127	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1057	1063		10.1038/ni.1784	http://dx.doi.org/10.1038/ni.1784			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19701188	Green Accepted			2022-12-18	WOS:000270006900008
J	Gutcher, I; Urich, E; Wolter, K; Prinz, M; Becher, B				Gutcher, Ilona; Urich, Eduard; Wolter, Karina; Prinz, Marco; Becher, Burkhard			Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IFN-GAMMA PRODUCTION; T-CELL POPULATION; IL-18 RECEPTOR; DEFICIENT MICE; EFFECTOR PHASE; INTERFERON-GAMMA; HOST-DEFENSE; TH1 CELLS	T helper type 1 (T(H)1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As interleukin 18 (IL-18) is a cofactor with IL-12 in promoting T(H)1 cell development, we examined the function of IL-18 and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice, IL-18-deficient mice were susceptible to experimental autoimmune encephalomyelitis. In contrast, IL-18R alpha-deficient mice were resistant to experimental autoimmune encephalomyelitis, indicating involvement of an IL-18R alpha ligand other than IL-18 with encephalitogenic properties. Moreover, engagement of IL-18R alpha on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus, IL-18 and T(H)1 cells are dispensable, whereas IL-18R alpha and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.	Univ Zurich, Neuroimmunol Unit, Neurol Clin, CH-8057 Zurich, Switzerland; Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany	University of Zurich; University of Gottingen	Becher, B (corresponding author), Univ Zurich, Neuroimmunol Unit, Neurol Clin, CH-8057 Zurich, Switzerland.	burkhard.becher@neuroimm.unizh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boraschi Diana, 1998, European Cytokine Network, V9, P205; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Ferber IA, 1996, J IMMUNOL, V156, P5; Frei K, 1997, J EXP MED, V185, P2177, DOI 10.1084/jem.185.12.2177; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Hoshino K, 1999, J IMMUNOL, V162, P5041; Jiang HR, 2001, INVEST OPHTH VIS SCI, V42, P177; Kaser A, 2004, BLOOD, V103, P648, DOI 10.1182/blood-2002-07-2322; Kinjo Y, 2002, J IMMUNOL, V169, P323, DOI 10.4049/jimmunol.169.1.323; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McColl SR, 1998, J IMMUNOL, V161, P6421; MERRILL JE, 1992, P NATL ACAD SCI USA, V89, P574, DOI 10.1073/pnas.89.2.574; O'Garra A, 1997, CURR OPIN IMMUNOL, V9, P872, DOI 10.1016/S0952-7915(97)80192-6; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; RENNO T, 1995, J IMMUNOL, V154, P944; Santos LL, 2006, IMMUNOL CELL BIOL, V84, P166, DOI 10.1111/j.1440-1711.2005.01406.x; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; STOCKINGER B, 1994, INT IMMUNOL, V6, P247, DOI 10.1093/intimm/6.2.247; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Suzuki N, 2003, J IMMUNOL, V170, P4031, DOI 10.4049/jimmunol.170.8.4031; Tomura M, 1998, J IMMUNOL, V160, P3759; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; VANDERVEEN RC, 1993, J NEUROIMMUNOL, V48, P213, DOI 10.1016/0165-5728(93)90194-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermot-Desroches C, 2005, CELL IMMUNOL, V236, P101, DOI 10.1016/j.cellimm.2005.08.014; Wei XQ, 1999, J IMMUNOL, V163, P2821; WEKERLE H, 1987, J EXP BIOL, V132, P43; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	52	125	129	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					946	953		10.1038/ni1377	http://dx.doi.org/10.1038/ni1377			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16906165	Green Accepted			2022-12-18	WOS:000239942300013
J	Bevan, MJ				Bevan, MJ			Cross-priming	NATURE IMMUNOLOGY			English	Editorial Material							CYTOTOXIC-T-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR H-ANTIGENS; IN-VIVO; SPECIFICITY; LYMPHOCYTES; COMPONENTS; INVIVO; CD8(+); REACT		Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu						BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; BEVAN MJ, 1977, J IMMUNOL, V118, P1370; BEVAN MJ, 1975, NATURE, V256, P419, DOI 10.1038/256419a0; BEVAN MJ, 1976, EUR J IMMUNOL, V6, P150, DOI 10.1002/eji.1830060303; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; GORDON RD, 1975, J EXP MED, V142, P1108, DOI 10.1084/jem.142.5.1108; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; SHEARER GM, 1975, J EXP MED, V141, P1348, DOI 10.1084/jem.141.6.1348; SNELL GD, 1957, TRANSPLAN B, V4, P18; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	14	125	129	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					363	365		10.1038/ni0406-363	http://dx.doi.org/10.1038/ni0406-363			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550200	Green Published			2022-12-18	WOS:000236171000007
J	Janssen, E; Zhu, MH; Zhang, WJ; Koonpaew, S; Zhang, WG				Janssen, E; Zhu, MH; Zhang, WJ; Koonpaew, S; Zhang, WG			LAB: A new membrane-associated adaptor molecule in B cell activation	NATURE IMMUNOLOGY			English	Article							ANTIGEN RECEPTOR; RNA INTERFERENCE; TYROSINE KINASE; LIPID RAFTS; LINKER PROTEIN; BLNK; PHOSPHORYLATION; EXPRESSION; SLP-76; GADS	The adaptor molecule, linker for activation of T cells (LAT), is essential in T cell activation and development; a similar molecule in B cells has not yet been identified. Here, we report the identification of a new adaptor protein, linker for activation of B cells (LAB). Like LAT, LAB was localized to lipid rafts. Upon activation via the B cell receptor (BCR), LAB was phosphorylated and interacted with the adaptor protein Grb2. Decreased LAB expression led to a reduction in BCR-mediated calcium flux and Erk activation. LAB rescued thymocyte development but not normal T cell activation in LAT(-/-) mice. Our data suggest that LAB links BCR engagement to downstream signaling pathways.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Harvard Univ, Sch Med, Div Genet, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Duke University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Zhang, WJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Koonpaew, Surapong/C-8295-2011	Janssen, Erin/0000-0002-0687-2550	NIAID NIH HHS [R01 AI056156, 1R01 AI48674-01, R01 AI048674] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R01AI056156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Doyle JL, 2000, CYTOGENET CELL GENET, V90, P285, DOI 10.1159/000056790; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujimoto M, 1998, SEMIN IMMUNOL, V10, P267, DOI 10.1006/smim.1998.9999; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wong J, 2000, J BIOL CHEM, V275, P33116, DOI 10.1074/jbc.M004467200; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872	33	125	141	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					117	123		10.1038/ni882	http://dx.doi.org/10.1038/ni882			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12514734				2022-12-18	WOS:000180686500010
J	Volkov, Y; Long, A; McGrath, S; Eidhin, DN; Kelleher, D				Volkov, Y; Long, A; McGrath, S; Eidhin, DN; Kelleher, D			Crucial importance of PKC-beta(I) in LFA-I-mediated locomotion of activated T cells	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE-C; FUNCTION-ASSOCIATED ANTIGEN-1; ACTIN CYTOSKELETON; CROSS-LINKING; MOTILITY; LYMPHOCYTES; ADHESION; EXPRESSION; MOLECULES; RECEPTOR	Crawling T cell locomotion in which activated lymphocyte function-associated antigen I (LFA-I) integrins participate is associated with translocation of the protein kinase C-beta (PKC-beta) isoenzyme to the microtubule cytoskeleton. In normal T cells and T lymphoma cell lines, this type of motility is accompanied by PKC-beta -sensitive cytoskeletal rearrangements and the formation of trailing cell extensions, which are supported by microtubules. Expression of PKC-beta (I) and enhanced green fluorescent protein (EGFP) in nonmotile PKC-beta -deficient T cells restored their locomotory behavior in response to a triggering stimulus delivered via LFA-I and correlated directly with the degree of cell polarization. We have also shown that PKC-beta (I) is a component of the tubulin-enriched LFA-I-cytoskeletal complex assembled upon LFA-I cross-linking. These observations may have physiological equivalents at advanced (post-integrin activation) stages of lymphocyte extravasation.	Univ Ireland Trinity Coll, Dublin Mol Med Ctr, Dublin 8, Ireland; Univ Ireland Trinity Coll, Dept Clin Med, Dublin 8, Ireland; Royal Coll Surg Ireland, Dept Biochem, Dublin 2, Ireland	Trinity College Dublin; University College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Volkov, Y (corresponding author), Univ Ireland Trinity Coll, Dublin Mol Med Ctr, Dublin 8, Ireland.		Volkov, Yuri/N-6774-2014	Volkov, Yuri/0000-0001-7406-518X				BERSHADSKY AD, 1991, CELL MOTIL CYTOSKEL, V19, P152, DOI 10.1002/cm.970190303; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Entschladen F, 1997, J IMMUNOL, V159, P3203; Hauzenberger D, 1995, CRIT REV IMMUNOL, V15, P285, DOI 10.1615/CritRevImmunol.v15.i3-4.60; Hauzenberger D, 1997, J IMMUNOL, V158, P76; KELLEHER D, 1995, J LEUKOCYTE BIOL, V58, P539, DOI 10.1002/jlb.58.5.539; KELLEHER D, 1992, FEBS LETT, V301, P310, DOI 10.1016/0014-5793(92)80264-H; Kiley SC, 1997, CELL GROWTH DIFFER, V8, P231; LONG A, 1993, FEBS LETT, V333, P243, DOI 10.1016/0014-5793(93)80662-E; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nesic D, 1998, INT IMMUNOL, V10, P1741, DOI 10.1093/intimm/10.11.1741; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Ratner S, 1997, J IMMUNOL, V159, P1063; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Siegelman M, 2001, J CLIN INVEST, V107, P159, DOI 10.1172/JCI11919; Soll DR, 1998, MOTION ANAL LIVING C; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stewart MP, 1996, J IMMUNOL, V156, P1810; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Thorp KM, 1996, IMMUNOLOGY, V87, P434, DOI 10.1046/j.1365-2567.1996.486567.x; VERSCHUEREN H, 1994, CELL BIOL INT, V18, P11, DOI 10.1006/cbir.1994.1002; Volkov Y, 1998, J IMMUNOL, V161, P6487; Walker GR, 1997, J CELL SCI, V110, P1373; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	31	125	133	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					508	514		10.1038/88700	http://dx.doi.org/10.1038/88700			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376337				2022-12-18	WOS:000169078000013
J	Murray, PJ; Smale, ST				Murray, Peter J.; Smale, Stephen T.			Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; TOLL-LIKE RECEPTORS; GENE-SPECIFIC CONTROL; ANTIINFLAMMATORY RESPONSE; SOCS PROTEINS; PROTECTS MICE; ACTIVATION; EXPRESSION; CYTOKINE; TRANSCRIPTION	Activation of Toll-like receptor (TLR) signaling and related pathways by microbial products drives inflammatory responses, host-defense pathways and adaptive immunity. The cost of excessive inflammation is cell and tissue damage, an underlying cause of many acute and chronic diseases. Coincident with activation of TLR signaling, a plethora of anti-inflammatory pathways and mechanisms begin to modulate inflammation until tissue repair is complete. Whereas most studies have focused on the signaling components immediately downstream of the TLRs, this Review summarizes the different levels of anti-inflammatory pathways that have evolved to abate TLR signaling and how they are integrated to prevent cell and tissue destruction.	[Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California Los Angeles	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	petermurray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	US National Institutes of Health [R01 AI073868, R01 CA127279, R01 GM086372, P30 CA21765]; Hartwell Foundation; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA127279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Kratochvill, P. Ward and G. Hajishengallis for comments. Supported by the US National Institutes of Health (R01 AI073868, R01 CA127279, R01 GM086372 and P30 CA21765), The Hartwell Foundation and The American Lebanese Syrian Associated Charities.	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chinenov Y, 2012, P NATL ACAD SCI USA, V109, P11776, DOI 10.1073/pnas.1206059109; CHRIST M, 1994, J IMMUNOL, V153, P1936; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Colotta F, 1996, J IMMUNOL, V156, P2534; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Delgoffe GM, 2011, CURR OPIN IMMUNOL, V23, P632, DOI 10.1016/j.coi.2011.07.013; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dower SK, 2000, NAT IMMUNOL, V1, P367, DOI 10.1038/80799; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Into T, 2012, CELL SIGNAL, V24, P1150, DOI 10.1016/j.cellsig.2012.01.020; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kapetanovic R, 2012, J IMMUNOL, V188, P3382, DOI 10.4049/jimmunol.1102649; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Mancek-Keber M, 2012, J IMMUNOL, V188, P3893, DOI 10.4049/jimmunol.1003605; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marteyn BS, 2012, GUT MICROBES, V3, P104, DOI 10.4161/gmic.19325; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; Smith AM, 2011, J BIOL CHEM, V286, P23582, DOI 10.1074/jbc.M111.249235; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Yanada M, 2002, BLOOD, V99, P2455, DOI 10.1182/blood.V99.7.2455; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou JR, 2011, P NATL ACAD SCI USA, V108, pE998, DOI 10.1073/pnas.1106232108; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	119	124	129	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					916	924		10.1038/ni.2391	http://dx.doi.org/10.1038/ni.2391			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990889	Green Accepted			2022-12-18	WOS:000309038600004
J	Schajnovitz, A; Itkin, T; D'Uva, G; Kalinkovich, A; Golan, K; Ludin, A; Cohen, D; Shulman, Z; Avigdor, A; Nagler, A; Kollet, O; Seger, R; Lapidot, T				Schajnovitz, Amir; Itkin, Tomer; D'Uva, Gabriele; Kalinkovich, Alexander; Golan, Karin; Ludin, Aya; Cohen, Dror; Shulman, Ziv; Avigdor, Abraham; Nagler, Arnon; Kollet, Orit; Seger, Rony; Lapidot, Tsvee			CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELL; MIMETIC PEPTIDES; PROGENITOR CELLS; NOD/SCID MICE; EXPRESSION; CXCR4; NICHE; SDF-1; MICROENVIRONMENT; MOBILIZATION	The chemokine CXCL12 is essential for the function of hematopoietic stem and progenitor cells. Here we report that secretion of functional CXCL12 from human bone marrow stromal cells (BMSCs) was a cell contact-dependent event mediated by connexin-43 (Cx43) and Cx45 gap junctions. Inhibition of connexin gap junctions impaired the secretion of CXCL12 and homing of leukocytes to mouse bone marrow. Purified human CD34(+) progenitor cells did not adhere to noncontacting BMSCs, which led to a much smaller pool of immature cells. Calcium conduction activated signaling by cAMP-protein kinase A (PKA) and induced CXCL12 secretion mediated by the GTPase RalA. Cx43 and Cx45 additionally controlled Cxcl12 transcription by regulating the nuclear localization of the transcription factor Sp1. We suggest that BMSCs form a dynamic syncytium via connexin gap junctions that regulates CXC12 secretion and the homeostasis of hematopoietic stem cells.	[Schajnovitz, Amir; Itkin, Tomer; D'Uva, Gabriele; Kalinkovich, Alexander; Golan, Karin; Ludin, Aya; Shulman, Ziv; Avigdor, Abraham; Kollet, Orit; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [D'Uva, Gabriele] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy; [Cohen, Dror] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Avigdor, Abraham; Nagler, Arnon] Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; University of Bologna; Weizmann Institute of Science; Chaim Sheba Medical Center; Weizmann Institute of Science	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Kollet, Orit/A-6861-2008; Lapidot, Tsvee/A-1812-2010; D'Uva, Gabriele/A-6252-2015	D'Uva, Gabriele/0000-0001-9622-9288	Israeli Science Foundation [ISF 544/09]; European Union [HEALTH-F5-2010-261387]; Edith Arnoff Stein Professorial Chair in Stem Cell Research	Israeli Science Foundation(Israel Science Foundation); European Union(European Commission); Edith Arnoff Stein Professorial Chair in Stem Cell Research	We thank J. Von Maltzen and K. Willecke (Institute of Genetics Division of Molecular Genetics, University of Bonn, Bonn, Germany) for BMSCs with loxP-flanked Cx45 that express Cre from the myxovirus promoter; G. Lalli (King's College London) for plasmids encoding Myc tag alone or Myc-tagged dominant negative RalA; M. Segal for helping with real-time calcium imaging; R. Alon, N. Dekel and I. H. Oh for discussions; and C. M. Sorensen for advice on connexin mimetic peptides. Supported by the Israeli Science Foundation (ISF 544/09), the European Union (Advance Cell-based Therapies for the Treatment of Primary Immunodeficiency HEALTH-F5-2010-261387) and The Edith Arnoff Stein Professorial Chair in Stem Cell Research (T. L.).	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Cancelas JA, 2000, BLOOD, V96, P498; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Glimm H, 2002, BLOOD, V99, P3454, DOI 10.1182/blood.V99.9.3454; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Krieger NS, 2004, CURR OPIN NEPHROL HY, V13, P423, DOI 10.1097/01.mnh.0000133975.32559.6b; Li X, 2001, AM J PHYSIOL-HEART C, V281, pH1890, DOI 10.1152/ajpheart.2001.281.5.H1890; Ljubicic S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007770; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Presley CA, 2005, CELL COMMUN ADHES, V12, P307, DOI 10.1080/15419060500514200; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; ROSENDAAL M, 1994, J CELL SCI, V107, P29; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Sorensen CM, 2008, AM J PHYSIOL-REG I, V295, pR840, DOI 10.1152/ajpregu.00491.2007; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Szumilas P, 2005, CELL PROLIFERAT, V38, P47, DOI 10.1111/j.1365-2184.2005.00329.x; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200	50	124	129	5	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					391	U130		10.1038/ni.2017	http://dx.doi.org/10.1038/ni.2017			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21441933				2022-12-18	WOS:000289666600009
J	Maruyama, T; Li, J; Vaque, JP; Konkel, JE; Wang, WF; Zhang, BJ; Zhang, P; Zamarron, BF; Yu, DY; Wu, YT; Zhuang, YA; Gutkind, JS; Chen, WJ				Maruyama, Takashi; Li, Jun; Vaque, Jose P.; Konkel, Joanne E.; Wang, Weifeng; Zhang, Baojun; Zhang, Pin; Zamarron, Brian F.; Yu, Dongyang; Wu, Yuntao; Zhuang, Yuan; Gutkind, J. Silvio; Chen, WanJun			Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; ROR-GAMMA-T; GROWTH-FACTOR-BETA; TGF-BETA; CD3-SPECIFIC ANTIBODY; GENE-EXPRESSION; TOLERANCE; PROTEINS; RECEPTOR; LINEAGE	The molecular mechanisms that direct transcription of the gene encoding the transcription factor Foxp3 in CD4(+) T cells remain ill-defined. We show here that deletion of the DNA-binding inhibitor Id3 resulted in the defective generation of Foxp3(+) regulatory T cells (T-reg cells). We identify two transforming growth factor-beta 1 (TGF-beta 1)-dependent mechanisms that were vital for activation of Foxp3 transcription and were defective in Id3(-/-) CD4(+) T cells. Enhanced binding of the transcription factor E2A to the Foxp3 promoter promoted Foxp3 transcription. Id3 was required for relief of inhibition by the transcription factor GATA-3 at the Foxp3 promoter. Furthermore, Id3(-/-) T cells showed greater differentiation into the T(H)17 subset of helper T cells in vitro and in a mouse asthma model. Therefore, a network of factors acts in a TGF-beta-dependent manner to control Foxp3 expression and inhibit the development of T(H)17 cells.	[Maruyama, Takashi; Li, Jun; Konkel, Joanne E.; Zhang, Pin; Zamarron, Brian F.; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD USA; [Vaque, Jose P.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Wang, Weifeng; Yu, Dongyang; Wu, Yuntao] George Mason Univ, Dept Microbiol & Mol Biol, Manassas, VA USA; [Zhang, Baojun; Zhuang, Yuan] Duke Univ, Dept Immunol, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); George Mason University; Duke University	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD USA.	wchen@dir.nidcr.nih.gov	Gutkind, J. Silvio/A-1053-2009; Li, Jun/N-6267-2015; wang, weifeng/N-4140-2013; Gutkind, J. Silvio/J-1201-2016; Leon, Javier/K-4615-2014; Vaqué, José P/H-8413-2015; Zhang, Baojun/AAN-8246-2020; MaruYama, Takashi/N-5994-2014; ZHANG, BAOJUN/N-3863-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Vaqué, José P/0000-0002-3913-2495; MaruYama, Takashi/0000-0003-0820-3219; ZHANG, BAOJUN/0000-0002-7786-4304; zhuang, yuan/0000-0002-2964-3654; Zamarron, Brian/0000-0001-6549-4230	National Institute of Dental and Craniofacial Research (US National Institutes of Health); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101, ZIADE000551] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Y.H. Chen, Q. Ruan and M. Tone (University of Pennsylvania) for Foxp3 constructs and EL4 LAF cells. Supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research (US National Institutes of Health).	Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Ghosh I, 2001, J PEPT RES, V57, P354, DOI 10.1034/j.1399-3011.2001.00846.x; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones ME, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-51; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Perruche S, 2009, J IMMUNOL, V183, P953, DOI 10.4049/jimmunol.0804076; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	49	124	129	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					86	U114		10.1038/ni.1965	http://dx.doi.org/10.1038/ni.1965			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21131965	Green Accepted			2022-12-18	WOS:000285465100017
J	O'Garra, A; Murphy, KM				O'Garra, Anne; Murphy, Kenneth M.			From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development	NATURE IMMUNOLOGY			English	Article							INHIBITS CYTOKINE PRODUCTION; INTERFERON-GAMMA PRODUCTION; CD4+ T-CELLS; TH1 CELLS; PHENOTYPE DEVELOPMENT; DENDRITIC CELLS; INTERLEUKIN-10; MACROPHAGES; CLONES; GENE	The authors recount their discovery of how pathogen-induced interleukin 12 production leads to T(H)1 T cell polarization. Simultaneously they discovered the suppressive cytokine interleukin 10 inhibits antigen-presenting cells, thus regulating development of T(H)1 cells.	[O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA	MRC National Institute for Medical Research; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk; kmurphy@wustl.edu		O'Garra, Anne/0000-0001-9845-6134	Medical Research Council [MC_U117565642] Funding Source: Medline; MRC [MC_U117565642] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; MEDZHITOV R, 1997, NATURE, V388, P397; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; OGARRA A, 1988, IMMUNOL TODAY, V9, P45, DOI 10.1016/0167-5699(88)91259-5; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WOLF SF, 1991, J IMMUNOL, V146, P3074	38	124	126	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					929	932		10.1038/ni0909-929	http://dx.doi.org/10.1038/ni0909-929			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692989				2022-12-18	WOS:000269120900002
J	Hazenberg, MD; Borghans, JAM; de Boer, RJ; Miedema, F				Hazenberg, MD; Borghans, JAM; de Boer, RJ; Miedema, F			Thymic output: a bad TREC record	NATURE IMMUNOLOGY			English	Editorial Material							STEM-CELL TRANSPLANTATION; HIV-1 INFECTION; IMMUNODEFICIENCY; RECONSTITUTION; ACTIVATION; DIVISION; THERAPY; MEMORY; ADULT; NAIVE		CLB, Dept Clin Viroimmunol, Sanquin Res, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Utrecht, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	Hazenberg, MD (corresponding author), CLB, Dept Clin Viroimmunol, Sanquin Res, Amsterdam, Netherlands.		de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X				Clark DR, 1999, ADV IMMUNOL, V73, P301, DOI 10.1016/S0065-2776(08)60789-0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Haynes BF, 1999, J CLIN INVEST, V103, P453, DOI 10.1172/JCI5201; Hazenberg MD, 2002, BLOOD, V99, P3449, DOI 10.1182/blood.V99.9.3449; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Richardson MW, 2000, BIOMED PHARMACOTHER, V54, P21, DOI 10.1016/S0753-3322(00)88637-0; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	16	124	127	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					97	99		10.1038/ni0203-97	http://dx.doi.org/10.1038/ni0203-97			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555089	Green Published			2022-12-18	WOS:000180686500003
J	Rengarajan, J; Tang, B; Glimcher, LH				Rengarajan, J; Tang, B; Glimcher, LH			NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naive T-H cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; TH2 DIFFERENTIATION; DEFICIENT MICE; COSTIMULATION; ACTIVATION; EXPRESSION; RESPONSES; GENERATION; MECHANISM; FAMILY	The NFAT family of transcription factors are key regulators of inducible gene expression in the immune system. We examined the function of two NFAT proteins after naive T helper (T-H) cell activation. We found that naive T-H precursors that are doubly deficient in NFATc2 and NFATc3 intrinsically differentiate into T(H)2-secreting cells, even in the absence of interleukin 4 (IL-4) production. We also found that lack of NFATc2 and NFATc3 obviates the necessity for engagement of CD28 on naive cells and controls the time required to reach the first cell division upon activation. These results demonstrate a key role for NFATc2 and NFATc3 in modulating T cell receptor responsiveness and regulating subsequent cell division and T(H)2 differentiation.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Rengarajan, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave,FXB-2, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NIAID NIH HHS [AI31541-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kubo M, 1999, J IMMUNOL, V163, P2432; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rulifson IC, 1997, J IMMUNOL, V158, P658; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	33	124	127	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					48	54		10.1038/ni744	http://dx.doi.org/10.1038/ni744			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11740499				2022-12-18	WOS:000173148700014
J	McGargill, MA; Derbinski, JM; Hogquist, KA				McGargill, MA; Derbinski, JM; Hogquist, KA			Receptor editing in developing T cells	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; NEGATIVE SELECTION; TRANSGENIC MICE; ALLELIC EXCLUSION; CHAIN GENE; TCR-ALPHA; EXPRESSION; ANTIGEN; THYMOCYTES; DELETION	A central tenet of T cell development postulates that if a developing thymocyte encounters self-antigen, it is induced to die via apoptosis, thereby protecting the organism from autoreactive T cells. We created transgenic mice that expressed a peptide antigen in the cortical epithelial cells of the thymus,This did not, however, result in deletion of specific T cells, Instead, antigen presentation by epithelial cells caused T cell receptor (TCR) internalization and increased gene rearrangement at the endogenous TCR alpha locus, or receptor editing,This editing mechanism in immature T cells parallels that which occurs in immature B cells, and has important implications for understanding positive and negative selection signaling in the thymus, and the limits of self-tolerance.	Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.		McGargill, Maureen/N-8131-2018	McGargill, Maureen/0000-0002-0916-0372; Hogquist, Kristin/0000-0001-9963-5687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07313-12, AI35296-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1998, J IMMUNOL, V160, P3883; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; BACIK I, 1994, J IMMUNOL, V152, P381; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HORGQUIST KA, 1994, CELL, V76, P17; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KOUSKOFF V, 1995, EUR J IMMUNOL, V25, P54, DOI 10.1002/eji.1830250111; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lo D, 1997, IMMUNOL RES, V16, P3, DOI 10.1007/BF02786320; LORENZ RG, 1989, NATURE, V340, P557, DOI 10.1038/340557a0; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; McGargill MA, 1999, J IMMUNOL, V162, P1237; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; PAGE DM, 1993, J IMMUNOL, V151, P1868; PANOSKALTSISMORTARI A, 1995, BIOTECHNIQUES, V18, P300; Penit C, 1997, J IMMUNOL, V159, P4848; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Schuurman HJ, 1997, MICROSC RES TECHNIQ, V38, P216; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; STEPHANISKI H, UNPUB J IMMUNOL; Stockinger B, 1999, Adv Immunol, V71, P229; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Volkmann A, 1997, J IMMUNOL, V158, P693; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	40	124	128	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					336	341		10.1038/79790	http://dx.doi.org/10.1038/79790			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017106				2022-12-18	WOS:000089869700017
J	Divangahi, M; Aaby, P; Khader, SA; Barreiro, LB; Bekkering, S; Chavakis, T; van Crevel, R; Curtis, N; DiNardo, AR; Dominguez-Andres, J; Duivenwoorden, R; Fanucchi, S; Fayad, Z; Fuchs, E; Hamon, M; Jeffrey, KL; Khan, N; Joosten, LAB; Kaufmann, E; Latz, E; Matarese, G; van der Meer, JWM; Mhlanga, M; Moorlag, SJCFM; Mulder, WJM; Naik, S; Novakovic, B; O'Neill, L; Ochando, J; Ozato, K; Riksen, NP; Sauerwein, R; Sherwood, ER; Schlitzer, A; Schultze, JL; Sieweke, MH; Benn, CS; Stunnenberg, H; Sun, J; van de Veerdonk, FL; Weis, S; Williams, DL; Xavier, R; Netea, MG				Divangahi, Maziar; Aaby, Peter; Khader, Shabaana Abdul; Barreiro, Luis B.; Bekkering, Siroon; Chavakis, Triantafyllos; van Crevel, Reinout; Curtis, Nigel; DiNardo, Andrew R.; Dominguez-Andres, Jorge; Duivenwoorden, Raphael; Fanucchi, Stephanie; Fayad, Zahi; Fuchs, Elaine; Hamon, Melanie; Jeffrey, Kate L.; Khan, Nargis; Joosten, Leo A. B.; Kaufmann, Eva; Latz, Eicke; Matarese, Giuseppe; van der Meer, Jos W. M.; Mhlanga, Musa; Moorlag, Simone J. C. F. M.; Mulder, Willem J. M.; Naik, Shruti; Novakovic, Boris; O'Neill, Luke; Ochando, Jordi; Ozato, Keiko; Riksen, Niels P.; Sauerwein, Robert; Sherwood, Edward R.; Schlitzer, Andreas; Schultze, Joachim L.; Sieweke, Michael H.; Benn, Christine Stabell; Stunnenberg, Henk; Sun, Joseph; van de Veerdonk, Frank L.; Weis, Sebastian; Williams, David L.; Xavier, Ramnik; Netea, Mihai G.			Trained immunity, tolerance, priming and differentiation: distinct immunological processes	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; ALVEOLAR MACROPHAGES; BCG; INNATE; MYELOPOIESIS; VACCINATION; INFECTION; PROTECTS; MEMORY	The similarities and differences between trained immunity and other immune processes are the subject of intense interrogation. Therefore, a consensus on the definition of trained immunity in both in vitro and in vivo settings, as well as in experimental models and human subjects, is necessary for advancing this field of research. Here we aim to establish a common framework that describes the experimental standards for defining trained immunity.	[Divangahi, Maziar; Khan, Nargis; Kaufmann, Eva] McGill Univ, Dept Microbiol & Immunol, Meakins Christie Labs, Dept Med,Hlth Ctr,Dept Pathol, Montreal, PQ, Canada; [Divangahi, Maziar; Khan, Nargis; Kaufmann, Eva] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Aaby, Peter] Bandim Hlth Project, Bissau, Guinea Bissau; [Khader, Shabaana Abdul] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; [Barreiro, Luis B.] Dept Med, Genet Sect, Chicago, IL USA; [Barreiro, Luis B.] Univ Chicago, Chicago, IL 60637 USA; [Bekkering, Siroon; van Crevel, Reinout; Dominguez-Andres, Jorge; Joosten, Leo A. B.; Moorlag, Simone J. C. F. M.; Riksen, Niels P.; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Bekkering, Siroon; Riksen, Niels P.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Nijmegen, Netherlands; [Chavakis, Triantafyllos] Tech Univ Dresden, Univ Hosp, Inst Clin Chem & Lab Med, Dresden, Germany; [van Crevel, Reinout; Dominguez-Andres, Jorge; Joosten, Leo A. B.; Moorlag, Simone J. C. F. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Curtis, Nigel] Univ Melbourne, Murdoch Childrens Res Inst, Dept Paediat, Infect Dis Res Grp, Parkville, Vic, Australia; [DiNardo, Andrew R.] Texas Childrens Hosp, Baylor Coll Med, Global TB Program, Immigrant & Global Hlth,Dept Pediat, Houston, TX 77030 USA; [Duivenwoorden, Raphael; Fayad, Zahi; Mulder, Willem J. M.] Icahn Sch Med Mt Sinai, Biomed Engn & Imaging Inst, New York, NY 10029 USA; [Duivenwoorden, Raphael; Mulder, Willem J. M.; Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Duivenwoorden, Raphael; Mulder, Willem J. M.] Eindhoven Univ Technol, Dept Biochem Engn, Lab Chem Biol, Eindhoven, Netherlands; [Fanucchi, Stephanie; Mhlanga, Musa] Univ Cape Town, Div Chem & Syst Biol, Dept Integrat Biomed Sci, Fac Hlth Sci,Inst Infect Dis & Mol Med, Cape Town, South Africa; [Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10021 USA; [Hamon, Melanie] Inst Pasteur, Chromatine & Infect G5, Paris, France; [Jeffrey, Kate L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; [Joosten, Leo A. B.; Netea, Mihai G.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02115 USA; [Joosten, Leo A. B.; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands; [Latz, Eicke; Moorlag, Simone J. C. F. M.] Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke; Moorlag, Simone J. C. F. M.] German Ctr Neurodegenerat Dis, Bonn, Germany; [Matarese, Giuseppe] Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Matarese, Giuseppe] CNR, Ist Endocrinol & Oncol Sperimentale, IEOS, Naples, Italy; [van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Naik, Shruti] NYU, Sch Med, Dept Pathol, Dept Med, New York, NY USA; [Naik, Shruti] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA; [Novakovic, Boris] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic, Australia; [Novakovic, Boris] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic, Australia; [O'Neill, Luke] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Ozato, Keiko] NICHHD, Mol Genet Immun Sect, Div Dev Biol, NIH, Bethesda, MD 20892 USA; [Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Radboudumc Ctr Infect Dis, Nijmegen, Netherlands; [Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Schlitzer, Andreas] Univ Bonn, Quantitat Syst Biol Life & Med Sci Inst, Bonn, Germany; [Schlitzer, Andreas] German Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit, Bonn, Germany; [Schlitzer, Andreas] Univ Bonn, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Genom & Immunoregulat, Life & Med Sci Bonn, Bonn, Germany; [Sieweke, Michael H.] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Sieweke, Michael H.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med Helmholtzgemeinschaft MD, Berlin, Germany; [Benn, Christine Stabell] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Bandim Hlth Project,OPEN, Odense, Denmark; [Benn, Christine Stabell] Univ Southern Denmark, Danish Inst Adv Study, Odense, Denmark; [Stunnenberg, Henk] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen, Netherlands; [Sun, Joseph] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Sun, Joseph] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY USA; [Weis, Sebastian] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Weis, Sebastian] Jena Univ Hosp, Inst Infect Dis & Infect Control, Jena, Germany; [Williams, David L.] East Tennessee State Univ, Dept Surg, Quillen Coll Med, Johnson City, TN USA; [Williams, David L.] East Tennessee State Univ, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN USA; [Xavier, Ramnik] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Xavier, Ramnik] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Med Sch, Boston, MA 02115 USA; [Netea, Mihai G.] Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci Inst LIMES, Bonn, Germany	McGill University; McGill University; Washington University (WUSTL); University of Chicago; Radboud University Nijmegen; Radboud University Nijmegen; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Radboud University Nijmegen; Murdoch Children's Research Institute; University of Melbourne; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Eindhoven University of Technology; University of Cape Town; Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Radboud University Nijmegen; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Radboud University Nijmegen; New York University; New York University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Radboud University Nijmegen; Vanderbilt University; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Radboud University Nijmegen; Memorial Sloan Kettering Cancer Center; Cornell University; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; East Tennessee State University; East Tennessee State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bonn	Divangahi, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Meakins Christie Labs, Dept Med,Hlth Ctr,Dept Pathol, Montreal, PQ, Canada.; Divangahi, M (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.; Netea, MG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02115 USA.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands.; Netea, MG (corresponding author), Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci Inst LIMES, Bonn, Germany.	maziar.divangahi@mcgill.ca; mihai.netea@radboudumc.nl	Matarese, Giuseppe/AAO-4077-2021; van de Veerdonk, Frank L/C-7256-2008; Bekkering, Siroon/T-3694-2017; Mulder, Willem J.M./B-7232-2009; Novakovic, Boris/D-8018-2013; Moorlag, Simone JCFM/F-4519-2018; Riksen, Niels P/G-8260-2015; Fuchs, Elaine/G-1565-2016; van Crevel, reinout/A-6636-2010; Schultze, Joachim L./ABA-8176-2020; Dinardo, Andrew/GXW-2154-2022; Latz, Eicke/H-3951-2014; Dominguez-Andres, Jorge/S-6211-2017; Ochando, Jordi/B-6219-2008; Weis, Sebastian/P-9016-2014	Matarese, Giuseppe/0000-0001-9429-0616; van de Veerdonk, Frank L/0000-0002-1121-4894; Bekkering, Siroon/0000-0003-1149-466X; Mulder, Willem J.M./0000-0001-8665-3878; Novakovic, Boris/0000-0002-5623-9008; Moorlag, Simone JCFM/0000-0001-8884-8417; Riksen, Niels P/0000-0001-9197-8124; van Crevel, reinout/0000-0002-6233-6410; Schultze, Joachim L./0000-0003-2812-9853; Latz, Eicke/0000-0003-1488-5666; Dominguez-Andres, Jorge/0000-0002-9091-1961; Sieweke, Michael/0000-0002-3228-9537; Ochando, Jordi/0000-0001-7037-1681; Kaufmann, Eva/0000-0001-7965-9200; Barreiro, Luis/0000-0001-9456-367X; A Khader, Shabaana/0000-0002-9545-4982; Weis, Sebastian/0000-0003-3201-2375				Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; DILUZIO NR, 1978, INFECT IMMUN, V20, P804, DOI 10.1128/IAI.20.3.804-810.1978; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Kachroo A, 2013, CURR OPIN PLANT BIOL, V16, P527, DOI 10.1016/j.pbi.2013.06.019; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; KRAHENBUHL JL, 1981, INFECT IMMUN, V31, P716, DOI 10.1128/IAI.31.2.716-722.1981; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Minassian AM, 2012, J INFECT DIS, V205, P1035, DOI 10.1093/infdis/jis012; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Moorlag SJCFM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107634; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Ristori G, 2018, CURR OPIN IMMUNOL, V55, P89, DOI 10.1016/j.coi.2018.09.016; Russell DG, 2019, NAT REV IMMUNOL, V19, P291, DOI 10.1038/s41577-019-0124-9; Walk J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08659-3; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042	25	123	125	9	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					2	6		10.1038/s41590-020-00845-6	http://dx.doi.org/10.1038/s41590-020-00845-6		DEC 2020	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33293712	Bronze, Green Accepted			2022-12-18	WOS:000599021400001
J	Chakraborty, S; Gonzalez, J; Edwards, K; Mallajosyula, V; Buzzanco, AS; Sherwood, R; Buffone, C; Kathale, N; Providenza, S; Xie, MM; Andrews, JR; Blish, CA; Singh, U; Dugan, H; Wilson, PC; Pham, TD; Boyd, SD; Nadeau, KC; Pinsky, BA; Zhang, S; Memoli, MJ; Taubenberger, JK; Morales, T; Schapiro, JM; Tan, GS; Jagannathan, P; Wang, TT				Chakraborty, Saborni; Gonzalez, Joseph; Edwards, Karlie; Mallajosyula, Vamsee; Buzzanco, Anthony S.; Sherwood, Robert; Buffone, Cindy; Kathale, Nimish; Providenza, Susan; Xie, Markus M.; Andrews, Jason R.; Blish, Catherine A.; Singh, Upinder; Dugan, Haley; Wilson, Patrick C.; Pham, Tho D.; Boyd, Scott D.; Nadeau, Kari C.; Pinsky, Benjamin A.; Zhang, Sheng; Memoli, Matthew J.; Taubenberger, Jeffery K.; Morales, Tasha; Schapiro, Jeffrey M.; Tan, Gene S.; Jagannathan, Prasanna; Wang, Taia T.			Proinflammatory IgG Fc structures in patients with severe COVID-19	NATURE IMMUNOLOGY			English	Article							GLYCOSYLATION; ANTIBODIES	COVID-19 is often characterized by a hyperinflammatory syndrome. Wang and colleagues show that low levels of IgG fucosylation enhance interactions with activating Fc gamma receptors, boosting the inflammatory cytokines associated with severe COVID-19. Severe acute respiratory syndrome coronavirus 2 infections can cause coronavirus disease 2019 (COVID-19), which manifests with a range of severities from mild illness to life-threatening pneumonia and multi-organ failure. Severe COVID-19 is characterized by an inflammatory signature, including high levels of inflammatory cytokines, alveolar inflammatory infiltrates and vascular microthrombi. Here we show that patients with severe COVID-19 produced a unique serologic signature, including an increased likelihood of IgG1 with afucosylated Fc glycans. This Fc modification on severe acute respiratory syndrome coronavirus 2 IgGs enhanced interactions with the activating Fc gamma receptor Fc gamma RIIIa; when incorporated into immune complexes, Fc afucosylation enhanced production of inflammatory cytokines by monocytes, including interleukin-6 and tumor necrosis factor. These results show that disease severity in COVID-19 correlates with the presence of proinflammatory IgG Fc structures, including afucosylated IgG1.	[Chakraborty, Saborni; Gonzalez, Joseph; Edwards, Karlie; Buzzanco, Anthony S.; Buffone, Cindy; Kathale, Nimish; Providenza, Susan; Xie, Markus M.; Andrews, Jason R.; Blish, Catherine A.; Singh, Upinder; Jagannathan, Prasanna; Wang, Taia T.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Mallajosyula, Vamsee] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Sherwood, Robert; Zhang, Sheng] Cornell Univ, Inst Biotechnol, Prote Facil, Ithaca, NY USA; [Blish, Catherine A.; Wang, Taia T.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Singh, Upinder; Jagannathan, Prasanna; Wang, Taia T.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Dugan, Haley; Wilson, Patrick C.] Univ Chicago, Dept Med, Sect Rheumatol, Gwen Knapp Ctr Lupus & Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Pham, Tho D.] Stanford Blood Ctr, Palo Alto, CA USA; [Boyd, Scott D.; Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Boyd, Scott D.; Nadeau, Kari C.] Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA USA; [Memoli, Matthew J.; Taubenberger, Jeffery K.] NIAID, LID Clin Studies Unit, Lab Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Taubenberger, Jeffery K.] NIAID, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Morales, Tasha; Schapiro, Jeffrey M.] Kaiser Permanente Northern Calif, TPMG Reg Reference Lab, Berkeley, CA USA; [Tan, Gene S.] J Craig Venter Inst, La Jolla, CA USA; [Tan, Gene S.] Univ Calif San Diego, Dept Infect Dis, La Jolla, CA 92093 USA	Stanford University; Stanford University; Cornell University; Stanford University; University of Chicago; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kaiser Permanente; J. Craig Venter Institute; University of California System; University of California San Diego	Wang, TT (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.; Wang, TT (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA USA.; Wang, TT (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	taiawang@stanford.edu	Chakraborty, Saborni/AAE-5870-2021; Taubenberger, Jeffery/AAQ-1407-2021; Jagannathan, Prasanna/AAC-4176-2022; Wilson, Patrick/HGC-3157-2022	Chakraborty, Saborni/0000-0003-0502-3757; Jagannathan, Prasanna/0000-0001-6305-758X; Xie, Markus/0000-0003-1350-7364; Parsonnet, Julie/0000-0001-7342-5366; Blish, Catherine/0000-0001-6946-7627; Andrews, Jason/0000-0002-5967-251X; Buzzanco, Anthony/0000-0002-6698-4060; Singh, Upinder/0000-0003-0630-0306; Pinsky, Benjamin/0000-0001-8751-4810; buffone, cindy/0000-0003-1286-7245; Mallajosyula, Vamsee/0000-0002-0658-3652	Stanford University; Chan Zuckerberg Biohub; Searle Scholars Program; Fast Grants; CEND COVID Catalyst Fund; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI111825, U54CA260517, R01AI139119, R01AI130398, R01AI127877]; Rockefeller University Center for Clinical and Translational Science [UL1 TR001866]	Stanford University(Stanford University); Chan Zuckerberg Biohub; Searle Scholars Program; Fast Grants; CEND COVID Catalyst Fund; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rockefeller University Center for Clinical and Translational Science	Support was received from Stanford University, the Chan Zuckerberg Biohub and the Searle Scholars Program. Research reported in this publication was supported by Fast Grants and the CEND COVID Catalyst Fund. Additional funding was received from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers U19AI111825, U54CA260517, R01AI139119, R01AI130398 and R01AI127877. Clinical samples were obtained with support from the Rockefeller University Center for Clinical and Translational Science (grant no. UL1 TR001866). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. T.T.W. thanks C. Kopel for exceptional technical support.	Bakovic MP, 2013, J PROTEOME RES, V12, P821, DOI 10.1021/pr300887z; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bournazos S., 2016, MYELOID CELLS HLTH D; Bournazos S, 2017, ANNU REV IMMUNOL, V35, P285, DOI 10.1146/annurev-immunol-051116-052433; Bournazos S, 2015, IMMUNOL REV, V268, P88, DOI 10.1111/imr.12343; Chen GQ, 2012, J PROTEOMICS, V75, P2824, DOI 10.1016/j.jprot.2012.02.001; de Haan N, 2016, J PROTEOME RES, V15, P1853, DOI 10.1021/acs.jproteome.6b00038; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Jagannathan P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002606; Kapur R, 2014, BLOOD, V123, P471, DOI 10.1182/blood-2013-09-527978; Kramer PR, 2009, EUR J IMMUNOL, V39, P561, DOI 10.1002/eji.200838801; Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114; Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Thulin NK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107642; Wang TT, 2019, CURR TOP MICROBIOL, V423, P63, DOI 10.1007/82_2019_152; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269	26	123	123	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					67	73		10.1038/s41590-020-00828-7	http://dx.doi.org/10.1038/s41590-020-00828-7		NOV 2020	7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	32511463	Bronze, Green Accepted			2022-12-18	WOS:000587948700002
J	Akula, MK; Shi, M; Jiang, ZZ; Foster, CE; Miao, D; Li, AS; Zhang, XM; Gavin, RM; Forde, SD; Germain, G; Carpenter, S; Rosadini, CV; Gritsman, K; Chae, JJ; Hampton, R; Silverman, N; Gravallese, EM; Kagan, JC; Fitzgerald, KA; Kastner, DL; Golenbock, DT; Bergo, MO; Wang, DH				Akula, Murali K.; Shi, Man; Jiang, Zhaozhao; Foster, Celia E.; Miao, David; Li, Annie S.; Zhang, Xiaoman; Gavin, Ruth M.; Forde, Sorcha D.; Germain, Gail; Carpenter, Susan; Rosadini, Charles V.; Gritsman, Kira; Chae, Jae Jin; Hampton, Randolph; Silverman, Neal; Gravallese, Ellen M.; Kagan, Jonathan C.; Fitzgerald, Katherine A.; Kastner, Daniel L.; Golenbock, Douglas T.; Bergo, Martin O.; Wang, Donghai			Control of the innate immune response by the mevalonate pathway	NATURE IMMUNOLOGY			English	Article							PHOSPHOINOSITIDE 3-KINASE; PROTEIN PRENYLATION; KINASE-DEFICIENCY; CANCER-THERAPY; RAS; ACTIVATION; CELLS; LIPOPOLYSACCHARIDE; INFLAMMASOME; PHOSPHORYLATION	Deficiency in mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate, a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, a protein post-translational modification that is catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin is an innate immune sensor that forms an active inflammasome in response to bacterial toxins. Mutations in MEFV (encoding human PYRIN) result in autoinflammatory familial Mediterranean fever syndrome. We found that protein geranylgeranylation enabled Toll-like receptor (TLR)-induced activation of phosphatidylinositol-3-OH kinase (PI(3)K) by promoting the interaction between the small GTPase Kras and the PI(3)K catalytic subunit p110 delta. Macrophages that were deficient in GGTase I or p110 delta exhibited constitutive release of interleukin 1 beta that was dependent on MEFV but independent of the NLRP3, AIM2 and NLRC4 inflammasomes. In the absence of protein geranylgeranylation, compromised PI(3)K activity allows an unchecked TLR-induced inflammatory responses and constitutive activation of the Pyrin inflammasome.	[Akula, Murali K.; Shi, Man; Miao, David; Wang, Donghai] Duke Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Durham, NC 27706 USA; [Akula, Murali K.; Shi, Man; Miao, David; Wang, Donghai] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27706 USA; [Akula, Murali K.; Bergo, Martin O.] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Jiang, Zhaozhao; Foster, Celia E.; Li, Annie S.; Zhang, Xiaoman; Gavin, Ruth M.; Forde, Sorcha D.; Germain, Gail; Carpenter, Susan; Silverman, Neal; Fitzgerald, Katherine A.; Golenbock, Douglas T.; Wang, Donghai] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Rosadini, Charles V.; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Rosadini, Charles V.; Kagan, Jonathan C.] Harvard Med Sch, Boston, MA USA; [Gritsman, Kira] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Gritsman, Kira] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Chae, Jae Jin; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, NIH, New York, NY USA; [Hampton, Randolph] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Akula, Murali K.; Shi, Man; Jiang, Zhaozhao; Foster, Celia E.] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA USA	Duke University; Duke University; University of Gothenburg; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester	Wang, DH (corresponding author), Duke Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Durham, NC 27706 USA.; Wang, DH (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27706 USA.; Wang, DH (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.	donghai.wang@duke.edu	Gritsman, Kira/J-8644-2019; Fitzgerald, Katherine/ABE-6317-2020	Gritsman, Kira/0000-0002-1367-1167; akula, naga venkata muralikrishna/0000-0002-6418-8300; Fitzgerald, Kate/0000-0003-3175-609X; Silverman, Neal/0000-0002-4259-456X; Germain, Gail/0000-0002-3972-7755	US National Institutes of Health (National Institute of Allergy and Infectious Diseases) [1R01AI110695-01A1]; Arthritis Foundation; Swedish Research Council; Heart and Lung Foundation; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, T32DK007477] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Abusneineh for technical support, K. Halmen for lab management, and colleagues in the Golenbock, Fitzgerald and Kastner laboratories for helpful discussions. We also thank M. Birnbaum (University of Pennsylvania) for the Akt1-deficient mice femurs and M. Trombly for editing the manuscript. We are in debt to R. Finberg and E. St. Clair for critical reading of the manuscript. This work was supported in part by funds from the US National Institutes of Health (National Institute of Allergy and Infectious Diseases 1R01AI110695-01A1 to D.W.), an Innovative Research Grant from the Arthritis Foundation (D.W. and E.M.G.), the Swedish Research Council, and the Heart and Lung Foundation (M.B. and M.A.).	Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Frenkel J, 2000, CLIN EXP RHEUMATOL, V18, P525; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Galeotti C, 2012, RHEUMATOLOGY, V51, P1855, DOI 10.1093/rheumatology/kes097; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Papin S, 2003, J BIOL CHEM, V278, P48839, DOI 10.1074/jbc.M305166200; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	46	123	125	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					922	+		10.1038/ni.3487	http://dx.doi.org/10.1038/ni.3487			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27270400	Green Submitted, Green Published, Green Accepted			2022-12-18	WOS:000380647000009
J	Benezech, C; Luu, NT; Walker, JA; Kruglov, AA; Loo, Y; Nakamura, K; Zhang, Y; Nayar, S; Jones, LH; Flores-Langarica, A; McIntosh, A; Marshall, J; Barone, F; Besra, G; Miles, K; Allen, JE; Gray, M; Kollias, G; Cunningham, AF; Withers, DR; Toellner, KM; Jones, ND; Veldhoen, M; Nedospasov, SA; McKenzie, ANJ; Caamano, JH				Benezech, Cecile; Luu, Nguyet-Thin; Walker, Jennifer A.; Kruglov, Andrei A.; Loo, Yunhua; Nakamura, Kyoko; Zhang, Yang; Nayar, Saba; Jones, Lucy H.; Flores-Langarica, Adriana; McIntosh, Alistair; Marshall, Jennifer; Barone, Francesca; Besra, Gurdyal; Miles, Katherine; Allen, Judith E.; Gray, Mohini; Kollias, George; Cunningham, Adam F.; Withers, David R.; Toellner, Kai Michael; Jones, Nick D.; Veldhoen, Marc; Nedospasov, Sergei A.; McKenzie, Andrew N. J.; Caamano, Jorge H.			Inflammation-induced formation of fat-associated lymphoid clusters	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; LYMPHOTOXIN ALPHA; IMMUNOGLOBULIN-M; INNATE; RECEPTOR; LYMPHOCYTES	Fat-associated lymphoid clusters (FALCs) are a type of lymphoid tissue associated with visceral fat. Here we found that the distribution of FALCs was heterogeneous, with the pericardium containing large numbers of these clusters. FALCs contributed to the retention of B-1 cells in the peritoneal cavity through high expression of the chemokine CXCL13, and they supported B cell proliferation and germinal center differentiation during peritoneal immunological challenges. FALC formation was induced by inflammation, which triggered the recruitment of myeloid cells that expressed tumor-necrosis factor (TNF) necessary for signaling via the TNF receptors in stromal cells. Natural killer T cells (NKT cells) restricted by the antigen-presenting molecule CD1d were likewise required for the inducible formation of FALCs. Thus, FALCs supported and coordinated the activation of innate B cells and T cells during serosal immune responses.	[Benezech, Cecile; Luu, Nguyet-Thin; Nakamura, Kyoko; Zhang, Yang; Nayar, Saba; Flores-Langarica, Adriana; McIntosh, Alistair; Marshall, Jennifer; Barone, Francesca; Cunningham, Adam F.; Withers, David R.; Toellner, Kai Michael; Jones, Nick D.; Caamano, Jorge H.] Univ Birmingham, Coll Med & Dent Sci, IBR MRC Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England; [Walker, Jennifer A.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Kruglov, Andrei A.; Nedospasov, Sergei A.] German Rheumatism Res Ctr, Leibniz Inst, Inflammat Biol, Berlin, Germany; [Kruglov, Andrei A.; Nedospasov, Sergei A.] Engelhardt Inst Mol Biol, Moscow, Russia; [Kruglov, Andrei A.; Nedospasov, Sergei A.] Lomonosov Moscow State Univ, Moscow, Russia; [Loo, Yunhua; Veldhoen, Marc] Babraham Inst, Lymphocyte Signalling & Dev Programme, Cambridge, England; [Jones, Lucy H.; Allen, Judith E.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Besra, Gurdyal] Univ Birmingham, Coll Life & Environm Sci, Birmingham, W Midlands, England; [Miles, Katherine; Gray, Mohini] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Vari, Greece; [Kollias, George] Univ Athens, Dept Expt Physiol Natl & Kapodistrian, Athens, Greece	University of Birmingham; MRC Laboratory Molecular Biology; Deutsches Rheuma-Forschungszentrum (DRFZ); Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Edinburgh; University of Birmingham; University of Edinburgh; Alexander Fleming Biomedical Sciences Research Center; National & Kapodistrian University of Athens	Benezech, C (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, BHF UoE, Edinburgh, Midlothian, Scotland.	cbenezec@exseed.ed.ac.uk; j.caamano@bham.ac.uk	Caamano, Jorge/O-7530-2019; Kruglov, Andrey A/F-7543-2017; Allen, Judith E/C-9198-2011; Nedospasov, Sergei/Q-7319-2016; Nedospasov, Sergei/C-3043-2018; Kruglov, Andrey/AAP-2023-2021; Veldhoen, Marc/AAM-5357-2021; Toellner, Kai-Michael/F-1519-2011; Veldhoen, Marc/AAJ-2759-2020; Caamano, Jorge/I-6778-2012; Kollias, George/A-7079-2012; Nedospasov, Sergei/L-1990-2015; Withers, David/C-7055-2015	Caamano, Jorge/0000-0003-3530-7056; Kruglov, Andrey A/0000-0002-4597-2087; Allen, Judith E/0000-0002-3829-066X; Toellner, Kai-Michael/0000-0001-8404-645X; Veldhoen, Marc/0000-0002-1478-9562; Caamano, Jorge/0000-0003-3530-7056; Kollias, George/0000-0003-1867-3150; NAYAR, SABA/0000-0002-4350-110X; Jackson-Jones, Lucy/0000-0003-0608-8966; Benezech, Cecile/0000-0002-2613-1418; Barone, Francesca/0000-0002-5287-9614; Zhang, Yang/0000-0002-4201-3702; Flores-Langarica, Adriana/0000-0003-2183-4437; Marshall, Jennifer/0000-0002-1727-8290; Cunningham, Adam/0000-0003-0248-964X; Besra, Gurdyal/0000-0002-5605-0395; Withers, David/0000-0003-3757-7594	European Union; Biotechnology and Biological Sciences Research Council [BB/K004900/1]; College of Medical and Dental Sciences of the University of Birmingham; American Asthma Foundation; UK Medical Research Council; Wellcome Trust [100963/Z/13/Z]; European Research Council [280307, 340217-MCs_inTEST]; Agency for Science, Technology and Research; Deutsche Forschungsgemeinschaf [NE1466/2-1]; Russian Science Foundation [14-50-00060]; Russian Foundation for Basic Research [13-04-40268]; Medical Research Council; UK Medical Research Council [MRC/K01207X/1]; Lifelong Health and Wellbeing cross council initiative [G1001390]; BBSRC [BBS/E/B/000C0407, BB/M025292/1, BBS/E/B/0000S042, BB/L009986/1, BB/K009400/1] Funding Source: UKRI; MRC [MC_U105178805, G1001390, MR/K01207X/1, MR/J009555/1, G9818340, G1001750] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/L009986/1, BBS/E/B/0000S042, BB/K009400/1, BB/M025292/1] Funding Source: researchfish; British Heart Foundation [PG/13/40/30297] Funding Source: researchfish; Cancer Research UK [20035] Funding Source: researchfish; Medical Research Council [MR/K01207X/1, MC_U105178805, G1001750, 1407665, G1001390, G9818340, MR/J009555/1] Funding Source: researchfish	European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); College of Medical and Dental Sciences of the University of Birmingham; American Asthma Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lifelong Health and Wellbeing cross council initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the personnel of the Biomedical Services Unit of the University of Birmingham for animal colony care; E. Jenkinson for support; G. Anderson, P. Lane, and A. Rot for comments on the manuscript; C. Buckley for facilitating animal procedures; R. Bird for cell sorting; K. Pfeffer (Heinrich Heine University) for Ltbr<SUP>-/-</SUP> mice; G. Eberl (Institut Pasteur) for tissues from germ-free mice; D. Finke (University of Basel) for tissues from Cxcr5<SUP>-/-</SUP> mice; A. Diefenback (University of Mainz) for tissues from Id2Cre<SUP>Ert2/+</SUP>Gt(ROSA)26Sor<SUP>YFP/+</SUP>Gata3<SUP>f/f</SUP> mice; and the US National Institutes of Health Tetramer Facility for CD1d-PBS-57 loaded tetramers. Supported by the European Union Framework Programme 7 integrated project INFLACARE (J.H.C.); the Biotechnology and Biological Sciences Research Council (BB/K004900/1 to J.H.C.) and the College of Medical and Dental Sciences of the University of Birmingham (J.H.C.); the American Asthma Foundation, the UK Medical Research Council and the Wellcome Trust (100963/Z/13/Z) for work in the A. McKenzie laboratory; the Biotechnology and Biological Sciences Research Council institute synergy programme, the European Research Council (280307) and the Agency for Science, Technology and Research (to Y.L.) for work in the M. Veldhoen laboratory; Deutsche Forschungsgemeinschaf (NE1466/2-1), the Russian Science Foundation (14-50-00060) and the Russian Foundation for Basic Research (13-04-40268 to A.A.K.) for work in the S. Nedospasov laboratory; the European Research Council (340217-MCs_inTEST) for work in the G. Kollias laboratory; the Medical Research Council (S.N.); the UK Medical Research Council (MRC/K01207X/1 to L.H.J.); and the Lifelong Health and Wellbeing cross council initiative (Topjabs G1001390 for K.M.T., Y.Z. and J.M.).	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Elewa YHA, 2014, CELL TISSUE RES, V357, P731, DOI 10.1007/s00441-014-1889-6; Foote JB, 2009, J IMMUNOL, V183, P6359, DOI 10.4049/jimmunol.0902473; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gil-Ortega M, 2013, STEM CELLS, V31, P1309, DOI 10.1002/stem.1375; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Koni PA, 1998, J EXP MED, V187, P1977, DOI 10.1084/jem.187.12.1977; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Marshall JL, 2012, J IMMUNOL, V189, P5527, DOI 10.4049/jimmunol.1103166; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsumoto M, 1997, J EXP MED, V186, P1997, DOI 10.1084/jem.186.12.1997; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Platell C, 2000, WORLD J GASTROENTERO, V6, P169; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Silverman Gregg J, 2009, Discov Med, V8, P151; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109	54	123	124	0	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					819	+		10.1038/ni.3215	http://dx.doi.org/10.1038/ni.3215			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147686	Green Submitted, Green Accepted			2022-12-18	WOS:000358299200009
J	Swaminathan, S; Klemm, L; Park, E; Papaemmanuil, E; Ford, A; Kweon, SM; Trageser, D; Hasselfeld, B; Henke, N; Mooster, J; Geng, HM; Schwarz, K; Kogan, SC; Casellas, R; Schatz, DG; Lieber, MR; Greaves, MF; Muschen, M				Swaminathan, Srividya; Klemm, Lars; Park, Eugene; Papaemmanuil, Elli; Ford, Anthony; Kweon, Soo-Mi; Trageser, Daniel; Hasselfeld, Brian; Henke, Nadine; Mooster, Jana; Geng, Huimin; Schwarz, Klaus; Kogan, Scott C.; Casellas, Rafael; Schatz, David G.; Lieber, Michael R.; Greaves, Mel F.; Mueschen, Markus			Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia	NATURE IMMUNOLOGY			English	Article							CYTIDINE DEAMINASE AID; B-CELL DEVELOPMENT; CHROMOSOME TRANSLOCATIONS; CLASS SWITCH; DAY-CARE; RECOMBINATION; EXPRESSION; GENE; ORIGINS; TRANSCRIPTION	Childhood acute lymphoblastic leukemia (ALL) can often be traced to a pre-leukemic clone carrying a prenatal genetic lesion. Postnatally acquired mutations then drive clonal evolution toward overt leukemia. The enzymes RAG1-RAG2 and AID, which diversify immunoglobulin-encoding genes, are strictly segregated in developing cells during B lymphopoiesis and peripheral mature B cells, respectively. Here we identified small pre-BII cells as a natural subset with increased genetic vulnerability owing to concurrent activation of these enzymes. Consistent with epidemiological findings on childhood ALL etiology, susceptibility to genetic lesions during B lymphopoiesis at the transition from the large pre-BII cell stage to the small pre-BII cell stage was exacerbated by abnormal cytokine signaling and repetitive inflammatory stimuli. We demonstrated that AID and RAG1-RAG2 drove leukemic clonal evolution with repeated exposure to inflammatory stimuli, paralleling chronic infections in childhood.	[Swaminathan, Srividya; Klemm, Lars; Park, Eugene; Geng, Huimin; Kogan, Scott C.; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Klemm, Lars] Univ Freiburg, Fac Biol, Freiburg, Germany; [Park, Eugene] Univ Cambridge, Dept Haematol, Cambridge, England; [Papaemmanuil, Elli] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Ford, Anthony; Greaves, Mel F.] Inst Canc Res, Ctr Evolut & Canc, London, England; [Kweon, Soo-Mi; Trageser, Daniel; Hasselfeld, Brian; Lieber, Michael R.] Univ So Calif, Los Angeles, CA USA; [Henke, Nadine; Mooster, Jana] Univ Dusseldorf, Dusseldorf, Germany; [Schwarz, Klaus] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany; [Casellas, Rafael] NIAMS, Genom & Immun, NIH, Bethesda, MD USA; [Schatz, David G.] Yale Univ, New Haven, CT USA	University of California System; University of California San Francisco; University of Freiburg; University of Cambridge; Wellcome Trust Sanger Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Southern California; Heinrich Heine University Dusseldorf; Ulm University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Yale University	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu		Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909; Nickel, Nadine/0000-0002-0609-0735; Kogan, Scott/0000-0002-2395-8479	National Cancer Institute of the US National Institutes of Health [R01CA137060, R01CA139032, R01CA157644, R01CA169458, R01CA172558]; Leukemia and Lymphoma Society [1479-11, 6132-09, 6097-10, 6221-12]; William Lawrence and Blanche Hughes Foundation; California Institute for Regenerative Medicine [TR2-01816]; Leukaemia, Lymphoma Research UK; Cancer Research UK [CRUK 18131]; Wellcome Trust [WT105104/Z/14/Z, WT101880AIA]; Cancer Research UK [18131] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA169458, R01CA139032, R01CA157644, R01CA172558, R01CA137060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); William Lawrence and Blanche Hughes Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Leukaemia, Lymphoma Research UK; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J.L. Wiemels and C. Gawad for encouragement and critical discussions; D.B. Kohn (University of California, Los Angeles) for the envelope and packaging vectors for lentivirus and retrovirus productions; and H. Hanenberg (Indiana University) for the plasmid pCL6-IRES-eGFP-wo. Supported by the National Cancer Institute of the US National Institutes of Health (R01CA137060, R01CA139032, R01CA157644, R01CA169458 and R01CA172558 to M.M.), the Leukemia and Lymphoma Society (1479-11, 6132-09, 6097-10 and 6221-12 to M.M.), the William Lawrence and Blanche Hughes Foundation, the California Institute for Regenerative Medicine (TR2-01816 to M.M.), Leukaemia, Lymphoma Research UK (M.F.G. and A.F.), Cancer Research UK (CRUK 18131 to M.M.) and The Wellcome Trust (WT105104/Z/14/Z to M.F.G. and WT101880AIA to M.M.).	Alpar D, 2015, LEUKEMIA, V29, P839, DOI 10.1038/leu.2014.322; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Auvinen A, 2000, BRIT J CANCER, V83, P956, DOI 10.1054/bjoc.2000.1382; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dorner T, 1997, J IMMUNOL, V158, P2779; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Gilham C, 2005, BMJ-BRIT MED J, V330, P1294, DOI 10.1136/bmj.38428.521042.8F; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greaves M, 2009, PROG INFLAMM RES SER, P239, DOI 10.1007/978-3-7643-8903-1_13; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Groves FD, 2001, BRIT J CANCER, V85, P337, DOI 10.1054/bjoc.2001.1903; Gruber TA, 2010, CANCER RES, V70, P7411, DOI 10.1158/0008-5472.CAN-10-1438; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Height SE, 1996, BLOOD, V87, P5242, DOI 10.1182/blood.V87.12.5242.bloodjournal87125242; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kumar S, 2013, GENE DEV, V27, P2439, DOI 10.1101/gad.227165.113; Kurth J, 2003, P NATL ACAD SCI USA, V100, P4730, DOI 10.1073/pnas.2627966100; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Ma XM, 2005, INT J EPIDEMIOL, V34, P1100, DOI 10.1093/ije/dyi113; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Tobollik S, 2006, BLOOD, V108, P3859, DOI 10.1182/blood-2006-05-021303; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Urayama KY, 2010, INT J EPIDEMIOL, V39, P718, DOI 10.1093/ije/dyp378; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5	54	123	126	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					766	+		10.1038/ni.3160	http://dx.doi.org/10.1038/ni.3160			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	25985233	Green Accepted, Green Submitted, Green Published			2022-12-18	WOS:000356445600013
J	Ahmed, N; Zeng, MH; Sinha, I; Polin, L; Wei, WZ; Rathinam, C; Flavell, R; Massoumi, R; Venuprasad, K				Ahmed, Neesar; Zeng, Minghui; Sinha, Indrajit; Polin, Lisa; Wei, Wei-Zen; Rathinam, Chozhavendan; Flavell, Richard; Massoumi, Ramin; Venuprasad, K.			The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR CYLD; UBIQUITIN-DEPENDENT KINASE; IL-1 SIGNALING PATHWAY; CELL LUNG-CANCER; NEGATIVE REGULATOR; PHARMACOLOGICAL INHIBITION; AIRWAY INFLAMMATION; PROTEIN LIGASE; MAPK KINASE	Chronic inflammation has been strongly associated with tumor progression, but the underlying mechanisms remain elusive. Here we demonstrate that E3 ligase Itch and deubiquitinase Cyld formed a complex via interaction through 'WW-PPXY' motifs. The Itch-Cyld complex sequentially cleaved Lys63-linked ubiquitin chains and catalyzed Lys48-linked ubiquitination on the kinase Tak1 to terminate inflammatory signaling via tumor necrosis factor. Reconstitution of wild-type Cyld but not the mutant Cyld(Y485A), which cannot associate with Itch, blocked sustained Tak1 activation and proinflammatory cytokine production by Cyld(-/-) bone marrow-derived macrophages. Deficiency in Itch or Cyld led to chronic production of tumor-promoting cytokines by tumor-associated macrophages and aggressive growth of lung carcinoma. Thus, we have identified an Itch-Cyld-mediated regulatory mechanism in innate inflammatory cells.	[Ahmed, Neesar; Zeng, Minghui; Sinha, Indrajit; Polin, Lisa; Wei, Wei-Zen; Venuprasad, K.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA; [Ahmed, Neesar; Zeng, Minghui; Sinha, Indrajit; Polin, Lisa; Wei, Wei-Zen; Venuprasad, K.] Wayne State Univ, Sch Med, Dept Immunol, Detroit, MI USA; [Rathinam, Chozhavendan] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY USA; [Flavell, Richard] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Massoumi, Ramin] Lund Univ, Dept Lab Med, Malmo, Sweden; [Ahmed, Neesar; Zeng, Minghui; Sinha, Indrajit; Polin, Lisa; Wei, Wei-Zen; Venuprasad, K.] Wayne State Univ, Sch Med, Dept Microbiol, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Columbia University; Yale University; Lund University; Wayne State University	Venuprasad, K (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA.	poojaryv@karmanos.org	Ahmed, Neesar/AAW-5473-2021; 高, 雨莉/HGU-8187-2022; Zeng, Minghui/N-3634-2014; Zeng, Minghui/B-1005-2015; Massoumi, Ramin/AAG-4786-2019	Ahmed, Neesar/0000-0002-7367-2188; poojary, venuprasd/0000-0001-8986-9092	US National Cancer Institute [1RC1CA146576-01]; NATIONAL CANCER INSTITUTE [RC1CA146576] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. C. Hahn (Dana-Farber Cancer Institute, Boston) for Myc-Cyld; J. Ashwell (US National Cancer Institute) for HA-tagged TRAF2 Delta; A. Raz (Karmanos Cancer Institute) for pET30a; and Y.-C.M. Kong and R. Mathur for discussions. Supported by the US National Cancer Institute (1RC1CA146576-01 to K.V.).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Peng DJ, 2011, J IMMUNOL, V186, P5638, DOI 10.4049/jimmunol.1003801; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Van den Heuvel MM, 2009, CLIN LUNG CANCER, V10, P99, DOI 10.3816/CLC.2009.n.012; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858; Venuprasad K, 2010, CANCER RES, V70, P3009, DOI 10.1158/0008-5472.CAN-09-4076; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	49	123	127	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1176	U1		10.1038/ni.2157	http://dx.doi.org/10.1038/ni.2157			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22057290	Green Accepted			2022-12-18	WOS:000297202700012
J	McKenzie, JL; Gan, OI; Doedens, M; Wang, JCY; Dick, JE				McKenzie, Joby L.; Gan, Olga I.; Doedens, Monica; Wang, Jean C. Y.; Dick, John E.			Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment	NATURE IMMUNOLOGY			English	Article							LONG-TERM; INTRAFEMORAL TRANSPLANTATION; GENE-TRANSFER; IN-VIVO; ENGRAFT; PROGENITORS; KINETICS; MICE; DIFFERENTIATION; REPOPULATION	Hematopoiesis requires tight regulation of the hematopoietic stem cell ( HSC) population; however, the dynamics of HSC use at steady state are uncertain. Over 3 - 7 months, we evaluated the repopulation and self-renewal of more than 600 individual human 'severe combined immunodeficiency mouse - repopulating cells' ( SRCs), tracked on the basis of lentiviral integration sites, in serially transplanted immune-deficient mice, as well as of SRC daughter cells that migrated to different marrow locations in a single mouse. Our data demonstrate maintenance by self-renewing SRCs after an initial period of clonal instability, a result inconsistent with the clonal succession model. We found wide variation in proliferation kinetics and self-renewal among SRCs, as well as between SRC daughter cells that repopulated equivalently, suggesting that SRC fate is unpredictable before SRCs enter more rigid 'downstream' developmental programs.	Univ Toronto, Div Cell & Mol Biol, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Dick, JE (corresponding author), Univ Toronto, Div Cell & Mol Biol, Univ Hlth Network, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Wang, Jean/0000-0001-7543-3917; Dick, John/0000-0002-9527-8317				Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Ailles L, 2002, MOL THER, V6, P615, DOI 10.1006/mthe.2002.0720; [Anonymous], J MEC THEOR APPL; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dao MA, 1997, EXP HEMATOL, V25, P1357; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Herrbrich PE, 2002, BLOOD, V100, p610A; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; HUMPHRIES RK, 1981, P NATL ACAD SCI-BIOL, V78, P3629, DOI 10.1073/pnas.78.6.3629; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KAY HEM, 1965, LANCET, V2, P418; Kerre TCC, 2001, J IMMUNOL, V167, P3692, DOI 10.4049/jimmunol.167.7.3692; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LAJTHA LG, 1963, J CELL COMPAR PHYSL, V62, P143; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; MCKENZIE JL, IN PRESS BLOOD; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; OGAWA M, 1993, BLOOD, V81, P2844; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TANAKA T, 1991, J IMMUNOL, V147, P2222; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; VORMOOR J, 1994, BLOOD, V83, P2489; WANG JC, 2001, HEMATOPOIESIS DEV AP, P99; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; YAHATA T, 2006, BLOOD ADV ONLINE PUB, DOI DOI 10.1182/BLOOD-2006-02-002204	49	123	125	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1225	1233		10.1038/ni1393	http://dx.doi.org/10.1038/ni1393			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17013390				2022-12-18	WOS:000241437200018
J	Friedman, RS; Jacobelli, J; Krummel, MF				Friedman, Rachel S.; Jacobelli, Jordan; Krummel, Matthew F.			Surface-bound chemokines capture and prime T cells for synapse formation	NATURE IMMUNOLOGY			English	Article							SECONDARY LYMPHOID ORGANS; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; GLYCOSAMINOGLYCAN BINDING; CC-CHEMOKINE; IN-VIVO; ACTIVATION; MOTILITY; RECEPTOR; ANTIGEN	T cell activation in vivo occurs in a lymphoid milieu that presents chemotactic and T cell receptor signals concurrently. Here we demonstrate that T cell zone chemokines such as CCL21 are bound to the surface of lymph node dendritic cells. Contact with antigen-presenting cells bearing chemokines costimulated T cells by a previously unknown two-step contact mechanism. T cells initially formed an antigen-independent `tethered' adhesion on chemokine-bearing antigen-presenting cells. The formation of those tethers superseded T cell receptor signaling and immunological synapse formation. However, chemokine-tethered T cells were hyper-responsive to subsequent contacts with antigen-presenting cells. Thus, T cells are costimulated `in trans' and sequentially after initial engagement with their chemokine-rich environment.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu		Friedman, Rachel/0000-0001-7549-6387				Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Flanagan K, 2004, CELL IMMUNOL, V231, P75, DOI 10.1016/j.cellimm.2004.12.006; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedman RS, 2005, SEMIN IMMUNOL, V17, P387, DOI 10.1016/j.smim.2005.09.006; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Langenkamp A, 2003, EUR J IMMUNOL, V33, P474, DOI 10.1002/immu.200310023; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	36	123	129	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1101	1108		10.1038/ni1384	http://dx.doi.org/10.1038/ni1384			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16964261				2022-12-18	WOS:000241437100019
J	Stassi, G; Di Liberto, D; Todaro, M; Zeuner, A; Ricci-Vitiani, L; Stoppacciaro, A; Ruco, L; Farina, F; Zummo, G; De Maria, R				Stassi, G; Di Liberto, D; Todaro, M; Zeuner, A; Ricci-Vitiani, L; Stoppacciaro, A; Ruco, L; Farina, F; Zummo, G; De Maria, R			Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TH2 CELLS; FAS; HASHIMOTOS; DEATH; LIGAND; PATHOGENESIS; EXPRESSION; INDUCTION; LYMPHOCYTES	After autoimmune inflammation, interactions between CD95 and its ligand (CD95L) mediate thyrocyte destruction in Hashimoto's thyroiditis (HT). Conversely, thyroid autoimmune processes that lead to Graves' disease (GD) result in autoantibody-mediated thyrotropin receptor stimulation without thyrocyte depletion,We found that GD thyrocytes expressed CD95 and CD95L in a similar manner to HT thyrocytes, but did not undergo CD95-induced apoptosis either in vivo or in vitro. This pattern was due to the differential production of T(H)1 and T(H)2 cytokines. Interferon gamma promoted caspase up-regulation and CD95-induced apoptosis in HT thyrocytes, whereas interleukin 4 and interleukin 10 protected GD thyrocytes by potent up-regulation of cFLIP and Bcl-x(L), which prevented CD95-induced apoptosis in sensitized thyrocytes. Thus, modulation of apoptosis-related proteins by T(H)1 and T(H)2 cytokines controls thyrocyte survival in thyroid autoimmunity.	Univ Catania, Inst Gen Pathol, Catania, Italy; Univ Palermo, Dept Surg Anat & Oncol Sci, Human Anat Sect, Palermo, Italy; Ist Super Sanita, Lab Hematol & Oncol, Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	University of Catania; University of Palermo; Istituto Superiore di Sanita (ISS); Sapienza University Rome	De Maria, R (corresponding author), Univ Catania, Inst Gen Pathol, Catania, Italy.	rdemaria@tin.it	Zeuner, Ann/K-8607-2016; Ricci Vitiani, Lucia/J-8320-2016; De Maria, Ruggero/S-6385-2019; Stassi, Giorgio/AAC-1175-2022; Zeuner, Ann/A-8529-2010	Ricci Vitiani, Lucia/0000-0001-7336-5615; De Maria, Ruggero/0000-0003-2255-0583; Zeuner, Ann/0000-0002-8295-3715; stoppacciaro, antonella/0000-0002-8506-3363	Telethon [E.0735] Funding Source: Medline	Telethon(Fondazione Telethon)		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bretz JD, 1999, J BIOL CHEM, V274, P25433, DOI 10.1074/jbc.274.36.25433; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; CATUREGLI P, 1994, CLIN EXP IMMUNOL, V98, P464; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; De Maria R, 1998, IMMUNOL TODAY, V19, P121, DOI 10.1016/S0167-5699(97)01202-4; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dibbert B, 1998, BLOOD, V92, P778, DOI 10.1182/blood.V92.3.778.415k38_778_783; Gallichan WS, 1999, J IMMUNOL, V163, P1696; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grignani F, 1998, CANCER RES, V58, P14; Hammond LJ, 1997, J PATHOL, V182, P138, DOI 10.1002/(SICI)1096-9896(199706)182:2<138::AID-PATH810>3.0.CO;2-F; IWATANI Y, 1993, CLIN EXP IMMUNOL, V93, P430, DOI 10.1111/j.1365-2249.1993.tb08196.x; Kawakami A, 1996, ENDOCRINOLOGY, V137, P3163, DOI 10.1210/en.137.8.3163; Krammer P H, 1999, Adv Immunol, V71, P163; LEITHAUSER F, 1993, J IMMUNOL, V69, P415; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; Mitsiades N, 1998, J CLIN ENDOCR METAB, V83, P2199, DOI 10.1210/jc.83.6.2199; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; PUJOLBORRELL R, 1987, NATURE, V326, P304, DOI 10.1038/326304a0; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Roura-Mir C, 1997, EUR J IMMUNOL, V27, P3290, DOI 10.1002/eji.1830271228; Sabelko KA, 1997, J IMMUNOL, V159, P3096; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Stassi G, 1999, J IMMUNOL, V162, P263; Stohlman SA, 1999, J IMMUNOL, V163, P6338; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; VANDERVEEN RC, 1993, J NEUROIMMUNOL, V48, P213, DOI 10.1016/0165-5728(93)90194-4; Waldner H, 1997, J IMMUNOL, V159, P3100; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788	37	123	130	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					483	488		10.1038/82725	http://dx.doi.org/10.1038/82725			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101869	Green Published			2022-12-18	WOS:000165724600011
J	Serhan, N; Basso, L; Sibilano, R; Petitfils, C; Meixiong, J; Bonnart, C; Reber, LL; Marichal, T; Starkl, P; Cenac, N; Dong, XZ; Tsai, M; Galli, SJ; Gaudenzio, N				Serhan, Nadine; Basso, Lilian; Sibilano, Riccardo; Petitfils, Camille; Meixiong, James; Bonnart, Chrystelle; Reber, Laurent L.; Marichal, Thomas; Starkl, Philipp; Cenac, Nicolas; Dong, Xinzhong; Tsai, Mindy; Galli, Stephen J.; Gaudenzio, Nicolas			House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation	NATURE IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; SUBSTANCE-P; ASTHMA; COLONIZATION; MECHANISMS; EXPRESSION; FILAGGRIN; NERVES	Allergic skin diseases, such as atopic dermatitis, are clinically characterized by severe itching and type 2 immunity-associated hypersensitivity to widely distributed allergens, including those derived from house dust mites (HDMs). Here we found that HDMs with cysteine protease activity directly activated peptidergic nociceptors, which are neuropeptide-producing nociceptive sensory neurons that express the ion channel TRPV1 and Tac1, the gene encoding the precursor for the neuropeptide substance P. Intravital imaging and genetic approaches indicated that HDM-activated nociceptors drive the development of allergic skin inflammation by inducing the degranulation of mast cells contiguous to such nociceptors, through the release of substance P and the activation of the cationic molecule receptor MRGPRB2 on mast cells. These data indicate that, after exposure to HDM allergens, activation of TRPV1(+)Tac1(+) nociceptor-MRGPRB2(+) mast cell sensory clusters represents a key early event in the development of allergic skin reactions.	[Serhan, Nadine; Basso, Lilian; Gaudenzio, Nicolas] Univ Toulouse, INSERM, UMR 1056, Unite Differentiat Epitheliale & Autoimmunite Rhu, Toulouse, France; [Sibilano, Riccardo; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sibilano, Riccardo; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Sch Med, Stanford, CA 94305 USA; [Petitfils, Camille; Bonnart, Chrystelle; Cenac, Nicolas] Univ Toulouse 3 Paul Sabatier, INSERM, IRSD, INRA,INP ENVT, Toulouse, France; [Meixiong, James; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Reber, Laurent L.] INSERM, UMR1222, Inst Pasteur, Unit Antibodies Therapy & Pathol, Paris, France; [Reber, Laurent L.] Toulouse III Univ, INSERM, U1043, Ctr Pathophysiol Toulouse Purpan,CNRS,UMR 5282, Toulouse, France; [Marichal, Thomas] Univ Liege, GIGA Inst, Liege, Belgium; [Marichal, Thomas] Univ Liege, Fac Vet Med, Liege, Belgium; [Marichal, Thomas] WELBIO, Walloon Excellence Life Sci & Biotechnol, Wallonia, Belgium; [Starkl, Philipp] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Starkl, Philipp] Med Univ Vienna, Dept Med 1, Lab Infect Biol, Vienna, Austria; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; Stanford University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; University of Liege; WELBIO; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Howard Hughes Medical Institute; Johns Hopkins University; Stanford University	Gaudenzio, N (corresponding author), Univ Toulouse, INSERM, UMR 1056, Unite Differentiat Epitheliale & Autoimmunite Rhu, Toulouse, France.; Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Sch Med, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu; nicolas.gaudenzio@inserm.fr	BONNART, Chrystelle/A-1309-2011; Cenac, Nicolas/P-4557-2017; Reber, Laurent L/K-4148-2014	Cenac, Nicolas/0000-0002-1552-7812; Reber, Laurent L/0000-0003-3384-6769; Gaudenzio, Nicolas/0000-0002-5648-509X; Serhan, Nadine/0000-0001-9870-9875; Meixiong, James/0000-0001-6776-3975; petitfils, camille/0000-0002-6884-300X; Starkl, Philipp/0000-0001-7521-129X; Tsai, Mindy/0000-0002-8421-4721	NIH [U19 AI104209, R01 AR067145, R01 AI32494, NS069375]; 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS [F.4508.18]; FRFS-WELBIO [CR-2017s-04]; Acteria Foundation; ERC [IM-ID 801823]; Austrian Science Fund [P31113-B30]; European Commission [H2020-MSCA-IF-2014 656086]; INSERM ATIPAvenir program; United States-Israel Binational Science Foundation [2013263]; Sean N. Parker Center for Allergy and Asthma Research, Stanford University; Societe Francaise de Dermatologie; Societe Francaise d'Allergologie; Marie Sklodowska-Curie Individual Fellowship [749629]; European Research Council (ERC-2018-STG) [802041]; INSERM ATIP-Avenir program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132494, U19AI104209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS; FRFS-WELBIO(WELBIO); Acteria Foundation; ERC(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); INSERM ATIPAvenir program; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Sean N. Parker Center for Allergy and Asthma Research, Stanford University; Societe Francaise de Dermatologie; Societe Francaise d'Allergologie; Marie Sklodowska-Curie Individual Fellowship; European Research Council (ERC-2018-STG); INSERM ATIP-Avenir program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Galli and Gaudenzio laboratories for discussions, and C. Liu for technical assistance. We thank A. Olson and the Stanford Neuroscience Microscopy Service (supported by NIH No. NS069375); this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH. We thank F. L'Faqihi (IFR30, Plateau Technique Cytometrie, Toulouse) and S. Allart (IFR30, Plateau Technique Imagerie Cellulaire, Toulouse) for technical assistance. T.M. is a Research Associate of the F.R.S.-FNRS and is supported by an 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS (No. F.4508.18), by the FRFS-WELBIO under grant No. CR-2017s-04, by the Acteria Foundation and by an ERC Starting Grant (No. IM-ID 801823). P.S. acknowledges support from and the Austrian Science Fund (No. P31113-B30). L.L.R. acknowledges support from the European Commission (Marie Sklodowska-Curie Individual Fellowship No. H2020-MSCA-IF-2014 656086) and the INSERM ATIPAvenir program. This work was supported by grants from NIH (S.J.G., grant Nos. U19 AI104209, R01 AR067145 and R01 AI32494), the United States-Israel Binational Science Foundation (No. 2013263) and the Sean N. Parker Center for Allergy and Asthma Research, Stanford University (to S.J.G.); and by the Societe Francaise de Dermatologie, the Societe Francaise d'Allergologie, the Marie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2016, No. 749629), the European Research Council (ERC-2018-STG, No. 802041) and the INSERM ATIP-Avenir program (to N.G.).	ALVING K, 1991, CELL TISSUE RES, V264, P529, DOI 10.1007/BF00319042; Ando T, 2013, J INVEST DERMATOL, V133, P2695, DOI 10.1038/jid.2013.250; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Buhner S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00971; Bunikowski R, 2000, J ALLERGY CLIN IMMUN, V105, P814, DOI 10.1067/mai.2000.105528; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Che DL, 2018, CELL IMMUNOL, V332, P121, DOI 10.1016/j.cellimm.2018.08.005; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Hagiyama M, 2013, BRIT J DERMATOL, V168, P771, DOI 10.1111/bjd.12108; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Langer K, 2007, EXP DERMATOL, V16, P124, DOI 10.1111/j.1600-0625.2006.00523.x; Lansu K, 2017, NAT CHEM BIOL, V13, P529, DOI [10.1038/NCHEMBIO.2334, 10.1038/nchembio.2334]; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Marichal T, 2016, J CLIN INVEST, V126, P4497, DOI 10.1172/JCI86359; MCFADDEN JP, 1993, BRIT J DERMATOL, V128, P631, DOI 10.1111/j.1365-2133.1993.tb00257.x; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Monti G, 1996, DERMATOLOGY, V193, P83, DOI 10.1159/000246218; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Oyoshi MK, 2009, ADV IMMUNOL, V102, P135, DOI 10.1016/S0065-2776(09)01203-6; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pang X, 1996, UROLOGY, V47, P436, DOI 10.1016/S0090-4295(99)80469-5; Park HY, 2013, ANN DERMATOL, V25, P410, DOI 10.5021/ad.2013.25.4.410; Reber LL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92900; Reithofer M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071368; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; SAGER N, 1992, J ALLERGY CLIN IMMUN, V89, P801, DOI 10.1016/0091-6749(92)90434-4; Salomon J, 2008, J EUR ACAD DERMATOL, V22, P223, DOI 10.1111/j.1468-3083.2007.02399.x; Stewart GA, 1996, CLIN EXP ALLERGY, V26, P1020, DOI 10.1111/j.1365-2222.1996.tb00641.x; Suzuki R, 1999, J IMMUNOL, V163, P2410; Takamori A, 2019, J ALLERGY CLIN IMMUN, V143, P1231, DOI 10.1016/j.jaci.2018.10.034; Toyoda M, 2002, BRIT J DERMATOL, V147, P71, DOI 10.1046/j.1365-2133.2002.04803.x; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Wallrapp A, 2017, NATURE, V551, DOI 10.1038/nature24480; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	50	122	124	5	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1435	+		10.1038/s41590-019-0493-z	http://dx.doi.org/10.1038/s41590-019-0493-z			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591569	Green Submitted, Green Accepted			2022-12-18	WOS:000492309600014
J	Chiang, JJ; Sparrer, KMJ; van Gent, M; Lassig, C; Huang, T; Osterrieder, N; Hopfner, KP; Gack, MU				Chiang, Jessica J.; Sparrer, Konstantin M. J.; van Gent, Michiel; Laessig, Charlotte; Huang, Teng; Osterrieder, Nikolaus; Hopfner, Karl-Peter; Gack, Michaela U.			Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity	NATURE IMMUNOLOGY			English	Article							VIRION HOST SHUTOFF; PROTEIN-SYNTHESIS; UBIQUITIN LIGASE; CYTOSOLIC DNA; STRANDED-RNA; VIRUS; RECOGNITION; SENSOR; ACTIVATION; CELLS	The sensor RIG-I detects double-stranded RNA derived from RNA viruses. Although RIG-I is also known to have a role in the antiviral response to DNA viruses, physiological RNA species recognized by RIG-I during infection with a DNA virus are largely unknown. Using next-generation RNA sequencing (RNAseq), we found that host-derived RNAs, most prominently 5S ribosomal RNA pseudogene 141 (RNA5SP141), bound to RIG-I during infection with herpes simplex virus 1 (HSV-1). Infection with HSV-1 induced relocalization of RNA5SP141 from the nucleus to the cytoplasm, and virus-induced shutoff of host protein synthesis downregulated the abundance of RNA5SP141-interacting proteins, which allowed RNA5SP141 to bind RIG-I and induce the expression of type I interferons. Silencing of RNA5SP141 strongly dampened the antiviral response to HSV-1 and the related virus Epstein-Barr virus (EBV), as well as influenza A virus (IAV). Our findings reveal that antiviral immunity can be triggered by host RNAs that are unshielded following depletion of their respective binding proteins by the virus.	[Chiang, Jessica J.; Gack, Michaela U.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sparrer, Konstantin M. J.; van Gent, Michiel; Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Laessig, Charlotte; Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Laessig, Charlotte; Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Huang, Teng; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci Munich, Munich, Germany	Harvard University; Harvard Medical School; University of Chicago; University of Munich; University of Munich; Free University of Berlin; University of Munich	Gack, MU (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgack@uchicago.edu	Sparrer, Konstantin/AAF-5371-2019; Hopfner, Karl-Peter/B-6864-2014	Sparrer, Konstantin/0000-0002-8682-1779; Hopfner, Karl-Peter/0000-0002-4528-8357; Lassig, Charlotte/0000-0001-6253-7880; Osterrieder, Nikolaus/0000-0002-5313-2176; van Gent, Michiel/0000-0003-3798-5360	US National Institutes of Health [R21 AI133361, R01 AI087846]; German Research Foundation [SP 1600/1-1, HO2489-8]; BioSysNet; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087846, R21AI133361] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); BioSysNet; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Roizman (University of Chicago) for HSV-1<INF>Delta vhs</INF> mutant and revertant; Y. Kawaguchi (University of Tokyo) for the bacterial artificial chromosome clone of HSV-1; A. Garcia-Sastre (Mount Sinai) for IAV wild-type and Delta NS1 recombinant virus; N. Raab-Traub (UNC-Chapel Hill) for AGS-EBV cells; D. Knipe (Harvard University) for the antibody to ICP8; W. Azab for help with manuscript preparation; and K. Waraska and A. Diallo for discussions. Supported by the US National Institutes of Health (R21 AI133361 and R01 AI087846 to M.U.G.), the German Research Foundation (fellowship SP 1600/1-1 to K.M.J.S.; and HO2489-8 to K.-P.H.) and BioSysNet (K.-P.H. and C.L.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Andrews S., 2010, FASTQC QUALITY CONTR; Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dillon PJ, 2013, CELL HOST MICROBE, V13, P204, DOI 10.1016/j.chom.2012.12.005; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Glaunsinger BA, 2006, ADV VIRUS RES, V66, P337, DOI 10.1016/S0065-3527(06)66007-7; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Niazi AK, 2013, MITOCHONDRION, V13, P548, DOI 10.1016/j.mito.2012.05.004; Peri P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-140; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poon APW, 1997, VIROLOGY, V229, P98, DOI 10.1006/viro.1996.8425; R Development Core Team, 2018, R LANG ENV STAT COMP; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Simonin D, 1997, J GEN VIROL, V78, P435, DOI 10.1099/0022-1317-78-2-435; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156	57	122	127	1	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					53	+		10.1038/s41590-017-0005-y	http://dx.doi.org/10.1038/s41590-017-0005-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29180807	Green Accepted, Green Submitted			2022-12-18	WOS:000419765300013
J	Seehus, CR; Aliahmad, P; de la Torre, B; Iliev, ID; Spurka, L; Funari, VA; Kaye, J				Seehus, Corey R.; Aliahmad, Parinaz; de la Torre, Brian; Iliev, Iliyan D.; Spurka, Lindsay; Funari, Vincent A.; Kaye, Jonathan			The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; TISSUE-INDUCER CELL; ROR-GAMMA-T; PLZF CONTROLS; DIFFERENTIATION; EXPRESSION; NFIL3; NOTCH; POPULATIONS; PROTECTION	Diverse innate lymphoid cell (ILC) subtypes have been defined on the basis of effector function and transcription factor expression. ILCs derive from common lymphoid progenitors, although the transcriptional pathways that lead to ILC-lineage specification remain poorly characterized. Here we found that the transcriptional regulator TOX was required for the in vivo differentiation of common lymphoid progenitors into ILC lineage-restricted cells. In vitro modeling demonstrated that TOX deficiency resulted in early defects in the survival or proliferation of progenitor cells, as well as ILC differentiation at a later stage. In addition, comparative transcriptome analysis of bone marrow progenitors revealed that TOX-deficient cells failed to upregulate many genes of the ILC program, including genes that are targets of Notch, which indicated that TOX is a key determinant of early specification to the ILC lineage.	[Seehus, Corey R.; Aliahmad, Parinaz; de la Torre, Brian; Kaye, Jonathan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA; [Seehus, Corey R.; Aliahmad, Parinaz; de la Torre, Brian; Kaye, Jonathan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Los Angeles, CA 90048 USA; [Iliev, Iliyan D.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA; [Iliev, Iliyan D.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Spurka, Lindsay] Cedars Sinai Med Ctr, Genom Core Facil, Los Angeles, CA 90048 USA; [Kaye, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaye, J (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA.	kayej@csmc.edu		Kaye, Jonathan/0000-0002-1634-9069; Seehus, Corey/0000-0002-8647-8579	NIH Tetramer Core Facility [HHSN272201300006C]; US National Institutes of Health [DK098310, 5R01AI054977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK098310] Funding Source: NIH RePORTER	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Cedars-Sinai Medical Center Flow Cytometry Core, especially G. Hultin and L. Dieu, for assistance with cell isolation; G. Martins for assistance with the generation of T<INF>H</INF>2 cells; A. Seksenyan and A. Kadavallore for discussions; the Cedars-Sinai Medical Center Biomedical Sciences and Translational Medicine Graduate Program; the NIH Tetramer Core Facility (contract HHSN272201300006C) for CD1d tetramers; and J.C. Zuniga-Pflucker (University of Toronto) for OP9-DL1 cells. Supported by the US National Institutes of Health (DK098310 to I.D.I., and 5R01AI054977 to J.K.).	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2012, CURR OPIN IMMUNOL, V24, P173, DOI 10.1016/j.coi.2011.12.001; Aliahmad P, 2011, J IMMUNOL, V187, P5931, DOI 10.4049/jimmunol.1101474; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Artegiani B, 2015, EMBO J, V34, P896, DOI 10.15252/embj.201490061; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gleimer M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00374; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597	48	122	129	4	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					599	+		10.1038/ni.3168	http://dx.doi.org/10.1038/ni.3168			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25915732	Green Accepted			2022-12-18	WOS:000354751900012
J	Seumois, G; Chavez, L; Gerasimova, A; Lienhard, M; Omran, N; Kalinke, L; Vedanayagam, M; Ganesan, APV; Chawla, A; Djukanovic, R; Ansel, KM; Peters, B; Rao, A; Vijayanand, P				Seumois, Gregory; Chavez, Lukas; Gerasimova, Anna; Lienhard, Matthias; Omran, Nada; Kalinke, Lukas; Vedanayagam, Maria; Ganesan, Asha Purnima V.; Chawla, Ashu; Djukanovic, Ratko; Ansel, K. Mark; Peters, Bjoern; Rao, Anjana; Vijayanand, Pandurangan			Epigenomic analysis of primary human T cells reveals enhancers associated with T(H)2 memory cell differentiation and asthma susceptibility	NATURE IMMUNOLOGY			English	Article							IMMUNITY; ACTIVATION; PLASTICITY; GENETICS; DATABASE; DISEASE; ALLERGY; SCALE; MYC	A characteristic feature of asthma is the aberrant accumulation, differentiation or function of memory CD4(+) T cells that produce type 2 cytokines (T(H)2 cells). By mapping genome-wide histone modification profiles for subsets of T cells isolated from peripheral blood of healthy and asthmatic individuals, we identified enhancers with known and potential roles in the normal differentiation of human T(H)1 cells and T(H)2 cells. We discovered disease-specific enhancers in T cells that differ between healthy and asthmatic individuals. Enhancers that gained the histone H3 Lys4 dimethyl (H3K4me2) mark during T(H)2 cell development showed the highest enrichment for asthma-associated single nucleotide polymorphisms (SNPs), which supported a pathogenic role for T(H)2 cells in asthma. In silico analysis of cell-specific enhancers revealed transcription factors, microRNAs and genes potentially linked to human T(H)2 cell differentiation. Our results establish the feasibility and utility of enhancer profiling in well-defined populations of specialized cell types involved in disease pathogenesis.	[Seumois, Gregory; Chavez, Lukas; Gerasimova, Anna; Lienhard, Matthias; Chawla, Ashu; Peters, Bjoern; Rao, Anjana; Vijayanand, Pandurangan] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Seumois, Gregory; Omran, Nada; Kalinke, Lukas; Vedanayagam, Maria; Ganesan, Asha Purnima V.; Djukanovic, Ratko; Rao, Anjana; Vijayanand, Pandurangan] Univ Southampton, Fac Med, Southampton Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Seumois, Gregory; Ansel, K. Mark; Rao, Anjana; Vijayanand, Pandurangan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Peters, Bjoern] Sanford Consortium Regenerat Med, La Jolla, CA USA; Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Rao, Anjana] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	La Jolla Institute for Immunology; University of Southampton; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Vijayanand, P (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	bpeters@liai.org; arao@liai.org; vijay@liai.org		Seumois, Gregory/0000-0002-8164-6852; Chavez, Lukas/0000-0002-8718-8848; Djukanovic, Ratko/0000-0001-6039-5612	Alexander von Humboldt Foundation; Dana Foundation; GlaxoSmithKline National Clinician Scientist Fellowship Award; Peel Travel Fellowship Award [R01 HL114093, U19 AI100275]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100275, R01AI040127] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Dana Foundation; GlaxoSmithKline National Clinician Scientist Fellowship Award; Peel Travel Fellowship Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the Wellcome Trust Clinical Research Facility (University of Southampton) where samples were acquired from volunteers; M. North for assisting in patient recruitment, assessment and sample collection; R. Jewel and C. McGuire for providing assistance in the flow cytometry facility (University of Southampton; J. Day for assistance with high-throughput sequencing at the La Jolla Institute for Allergy and Immunology sequencing facility, and A. Moghaddas Gholami at the La Jolla Institute for Allergy and Immunology bioinformatics core for help with the SNP enrichment analysis. L.C. is funded by a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation. This work was supported by the Dana Foundation (K.M.A.), GlaxoSmithKline National Clinician Scientist Fellowship Award and Peel Travel Fellowship Award (P.V.), R01 HL114093 (to B.P., A.R. and P.V.) and U19 AI100275 (to B.P., A.R. and P.V.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gerasimova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054359; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mikhak Z, 2013, J EXP MED, V210, P1855, DOI 10.1084/jem.20130091; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Seumois G, 2012, AM J CLIN EXP IMMUNO, V1, P70; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wenzel SE, 2013, NEW ENGL J MED, V369, P1276, DOI 10.1056/NEJMc1309809; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	51	122	128	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					777	+		10.1038/ni.2937	http://dx.doi.org/10.1038/ni.2937			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24997565	Green Accepted, Green Published			2022-12-18	WOS:000339323000013
J	Wang, NS; McHeyzer-Williams, LJ; Okitsu, SL; Burris, TP; Reiner, SL; McHeyzer-Williams, MG				Wang, Nathaniel S.; McHeyzer-Williams, Louise J.; Okitsu, Shinji L.; Burris, Thomas P.; Reiner, Steven L.; McHeyzer-Williams, Michael G.			Divergent transcriptional programming of class-specific B cell memory by T-bet and ROR alpha	NATURE IMMUNOLOGY			English	Article							HELPER; EXPRESSION; IMMUNOGLOBULIN; IGG; DIFFERENTIATION; RESPONSES; GAMMA; DIVISION; BLIMP-1; CD4	Antibody class defines function in B cell immunity, but how class is propagated into B cell memory remains poorly understood. Here we demonstrate that memory B cell subsets unexpectedly diverged across antibody class through differences in the effects of major transcriptional regulators. Conditional genetic deletion of the gene encoding the transcription factor T-bet selectively blocked the formation and antigen-specific response of memory B cells expressing immunoglobulin G2a (IgG2a) in vivo. Cell-intrinsic expression of T-bet regulated expression of the transcription factor STAT1, steady-state cell survival and transcription of IgG2a-containing B cell antigen receptors (BCRs). In contrast, the transcription factor ROR alpha and not T-bet was expressed in IgA(+) memory B cells, with evidence that knockdown of ROR alpha mRNA expression and chemical inhibition of transcriptional activity also resulted in lower survival and BCR expression of IgA(+) memory B cells. Thus, divergent transcriptional regulators dynamically maintain subset integrity to promote specialized immune function in class-specific memory B cells.	[Wang, Nathaniel S.; McHeyzer-Williams, Louise J.; Okitsu, Shinji L.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Reiner, Steven L.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Reiner, Steven L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY USA	Scripps Research Institute; Scripps Research Institute; Columbia University; Columbia University	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	US National Institutes of Health [TL1 RR025772-03, AI042370, AI076458, DK080201, MH092769, AI047231, AI040215, AI071182]; Swiss National Science Foundation; Novartis Jubliaeumsstiftung; Roche Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370, R01AI071182, R01AI047231, R01AI061699, R01AI076458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Jubliaeumsstiftung(Novartis); Roche Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Beutler (The Scripps Research Institute) for mice with the Domino mutation of Stat1; and N. Cereb, S.Y. Yang and L. Boring for assistance with construction of the loxP-flanked Tbx21 allele. Supported by the US National Institutes of Health (TL1 RR025772-03 to N.S.W.; AI042370 and AI076458 to S. L. R; DK080201 and MH092769 to T. P. B.; and AI047231, AI040215 and AI071182 to M.G.M.-W.), the Swiss National Science Foundation (S.L.O.), Novartis Jubliaeumsstiftung (S.L.O.) and the Roche Research Foundation (S.L.O.). This is manuscript 21154 from The Scripps Research Institute.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; LEBMAN DA, 1990, P NATL ACAD SCI USA, V87, P3962, DOI 10.1073/pnas.87.10.3962; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Mondal A, 2010, J IMMUNOL, V184, P4123, DOI 10.4049/jimmunol.0901242; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	50	122	126	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					604	+		10.1038/ni.2294	http://dx.doi.org/10.1038/ni.2294			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22561605	Green Accepted			2022-12-18	WOS:000304203900015
J	Bulek, AM; Cole, DK; Skowera, A; Dolton, G; Gras, S; Madura, F; Fuller, A; Miles, JJ; Gostick, E; Price, DA; Drijfhout, JW; Knight, RR; Huang, GC; Lissin, N; Molloy, PE; Wooldridge, L; Jakobsen, BK; Rossjohn, J; Peakman, M; Rizkallah, PJ; Sewell, AK				Bulek, Anna M.; Cole, David K.; Skowera, Ania; Dolton, Garry; Gras, Stephanie; Madura, Florian; Fuller, Anna; Miles, John J.; Gostick, Emma; Price, David A.; Drijfhout, Jan W.; Knight, Robin R.; Huang, Guo C.; Lissin, Nikolai; Molloy, Peter E.; Wooldridge, Linda; Jakobsen, Bent K.; Rossjohn, Jamie; Peakman, Mark; Rizkallah, Pierre J.; Sewell, Andrew K.			Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; RECEPTOR RECOGNITION; CROSS-REACTIVITY; HIGH-AFFINITY; SELF-PEPTIDE; TCR-BINDING; MHC; INSULIN; SUSCEPTIBILITY	The structural characteristics of the engagement of major histocompatibility complex (MHC) class II-restricted self antigens by autoreactive T cell antigen receptors (TCRs) is established, but how autoimmune TCRs interact with complexes of self peptide and MHC class I has been unclear. Here we examined how CD8(+) T cells kill human islet beta cells in type 1 diabetes via recognition of a human leukocyte antigen HLA-A*0201-restricted glucose-sensitive preproinsulin peptide by the autoreactive TCR 1E6. Rigid 'lock-and-key' binding underpinned the 1E6-HLA-A*0201-peptide interaction, whereby 1E6 docked similarly to most MHC class I-restricted TCRs. However, this interaction was extraordinarily weak because of limited contacts with MHC class I. TCR binding was highly peptide centric, dominated by two residues of the complementarity-determining region 3 (CDR3) loops that acted as an 'aromatic-cap' over the complex of peptide and MHC class I (pMHCI). Thus, highly focused peptide-centric interactions associated with suboptimal TCR-pMHCI binding affinities might lead to thymic escape and potential CD8(+) T cell-mediated autoreactivity.	[Bulek, Anna M.; Cole, David K.; Dolton, Garry; Madura, Florian; Fuller, Anna; Miles, John J.; Gostick, Emma; Price, David A.; Wooldridge, Linda; Rossjohn, Jamie; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Skowera, Ania; Knight, Robin R.; Peakman, Mark] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England; [Skowera, Ania; Peakman, Mark] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia; [Miles, John J.] Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4006, Australia; [Drijfhout, Jan W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Lissin, Nikolai; Molloy, Peter E.; Jakobsen, Bent K.] Immunocore, Abingdon, Oxon, England	Cardiff University; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Monash University; QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sewell, AK (corresponding author), Cardiff Univ Sch Med, Inst Infect & Immun, Heath Pk, Cardiff, S Glam, Wales.	sewellak@cardiff.ac.uk	Drijfhout, Jan Wouter/ABA-6318-2021; Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022; Knight, Robin/ABA-6399-2020; Rossjohn, Jamie/F-9032-2013; Price, David A/C-7876-2013; gras, stephanie/C-8307-2013; Cole, David/C-8387-2012; Rizkallah, Pierre J/A-5367-2012	Drijfhout, Jan Wouter/0000-0003-4808-5296; Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Knight, Robin/0000-0002-9480-6675; Rossjohn, Jamie/0000-0002-2020-7522; Price, David A/0000-0001-9416-2737; Rizkallah, Pierre J/0000-0002-9290-0369; Molloy, Peter/0000-0002-0238-4744; Cole, David/0000-0003-0028-9396; gras, stephanie/0000-0001-7416-038X; Wooldridge, Linda/0000-0002-6213-347X; Fuller, Anna/0000-0002-8655-6741; Peakman, Mark/0000-0003-3328-3513	Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Wellcome Trust [WT086716, WT079848, WT095767]; Juvenile Diabetes Research Foundation [7-2005-877, 1-20071803, 17-2009-806]; European Union [241447]; National Institute for Health Research Comprehensive Biomedical Research Center at Guy's & St. Thomas' National Health Service Foundation Trust; King's College London, Research Councils UK; National Health and Medical Research Council; Welsh Office of Research and Development; Medical Research Council; Medical Research Council [MR/J006742/1] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); National Institute for Health Research Comprehensive Biomedical Research Center at Guy's & St. Thomas' National Health Service Foundation Trust; King's College London, Research Councils UK; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Welsh Office of Research and Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Tenovus Cancer Care; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the staff at Diamond Light Source for facilities and support; M. Zhao for help preparing human islets; and J. Todd for INS genotyping. Supported by the Biotechnology and Biological Sciences Research Council (BB/H001085/1), the Wellcome Trust (WT086716 to A. K. S.; WT079848 to L. W.; and WT095767 to D. K. C.), the Juvenile Diabetes Research Foundation (7-2005-877 and 1-20071803 to M. P.; and 17-2009-806 to A. K. S., M. P., D. A. P. and A. S.), the European Union Seventh Framework Programme (241447 NAIMIT), the National Institute for Health Research Comprehensive Biomedical Research Center at Guy's & St. Thomas' National Health Service Foundation Trust and King's College London, Research Councils UK (P. J. R.), the National Health and Medical Research Council (J. R.), the Welsh Office of Research and Development (J. J. M.) and the Medical Research Council (D. A.P).	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DeLano W. L, 2002, PYMOL MOL GENETICS G; DiLorenzo TP, 2005, IMMUNOL REV, V204, P250, DOI 10.1111/j.0105-2896.2005.00244.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FOULIS AK, 1987, DIABETOLOGIA, V30, P333, DOI 10.1007/BF00299027; FOULIS AK, 1987, LANCET, V2, P1423; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Huang GC, 2004, TRANSPLANTATION, V77, P143, DOI 10.1097/01.TP.0000100401.62912.B2; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2011, SEMIN IMMUNOL, V23, P84, DOI 10.1016/j.smim.2011.01.007; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	50	122	133	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					283	U1521		10.1038/ni.2206	http://dx.doi.org/10.1038/ni.2206			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22245737	Green Accepted			2022-12-18	WOS:000300510600015
J	Park, SH; Park-Min, KH; Chen, J; Hu, XY; Ivashkiv, LB				Park, Sung Ho; Park-Min, Kyung-Hyun; Chen, Janice; Hu, Xiaoyu; Ivashkiv, Lionel B.			Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3-BETA; GENE-SPECIFIC CONTROL; RHEUMATOID-ARTHRITIS; TNF-ALPHA; INFLAMMATORY RESPONSE; TEMPORAL CONTROL; DENDRITIC CELLS; I INTERFERON; EXPRESSION	Endotoxin tolerance, a key mechanism for suppressing excessive inflammatory cytokine production, is induced by prior exposure of macrophages to Toll-like receptor (TLR) ligands. Induction of cross-tolerance to endotoxin by endogenous cytokines has not been investigated. Here we show that prior exposure to tumor necrosis factor (TNF) induced a tolerant state in macrophages, with less cytokine production after challenge with lipopolysaccharide (LPS) and protection from LPS-induced death. TNF-induced cross-tolerization was mediated by suppression of LPS-induced signaling and chromatin remodeling. TNF-induced cross-tolerance was dependent on the kinase GSK3, which suppressed chromatin accessibility and promoted rapid termination of signaling via the transcription factor NF-kappa B by augmenting negative feedback by the signaling inhibitors A20 and I kappa B alpha. Our results demonstrate an unexpected homeostatic function for TNF and a GSK3-mediated mechanism for the prevention of prolonged and excessive inflammation.	[Park, Sung Ho; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Park, Sung Ho; Park-Min, Kyung-Hyun; Chen, Janice; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713, R01AR056729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank G.D. Kalliolias and A. Yarilina for discussions and J. Woodgett (University of Toronto) for mice with loxP-flanked alleles encoding GSK3 beta. Supported by the National Institutes of Health (L.B.I.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bluml S, 2010, ARTHRITIS RHEUM-US, V62, P1608, DOI 10.1002/art.27399; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Hassett S, 2006, PEDIATR SURG INT, V22, P24, DOI 10.1007/s00383-005-1574-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jafferany M, 2008, INT J DERMATOL, V47, P1101, DOI 10.1111/j.1365-4632.2008.03873.x; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2001, ANESTH ANALG, V92, P1322; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Langdale LA, 2003, SHOCK, V19, P553, DOI 10.1097/01.shk.0000055238.25446.64; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Shen E, 2008, J CELL BIOCHEM, V104, P329, DOI 10.1002/jcb.21629; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Williams-Skipp C, 2009, ARTHRITIS RHEUM-US, V60, P408, DOI 10.1002/art.24260; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024	49	122	129	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					607	U158		10.1038/ni.2043	http://dx.doi.org/10.1038/ni.2043			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21602809	Green Accepted			2022-12-18	WOS:000291936400008
J	Muroi, S; Naoe, Y; Miyamoto, C; Akiyama, K; Ikawa, T; Masuda, K; Kawamoto, H; Taniuchi, I				Muroi, Sawako; Naoe, Yoshinori; Miyamoto, Chizuko; Akiyama, Kaori; Ikawa, Tomokatsu; Masuda, Kyoko; Kawamoto, Hiroshi; Taniuchi, Ichiro			Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate	NATURE IMMUNOLOGY			English	Article							CD4-CD8 LINEAGE DIFFERENTIATION; POSITIVE SELECTION; CD4 SILENCER; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; REGULATES CD4; TYPE-1 CELLS; COMMITMENT; REPRESSION	CD4 and the transcription factor ThPOK are essential for the differentiation of major histocompatibility complex class II restricted thymocytes into the helper T cell lineage; their genes (Cd4 and Zbtb7b (called 'ThPOK' here)) are repressed by transcriptional silencer elements in cytotoxic T cells. The molecular mechanisms regulating expression of these genes during helper T cell lineage differentiation remain unknown. Here we showed that inefficient upregulation of ThPOK, induced by removal of the proximal enhancer from the ThPOK locus, resulted in the transdifferentiation of helper lineage-specified cells into the cytotoxic T cell lineage. Furthermore, direct antagonism by ThPOK of the Cd4 and ThPOK silencers generated two regulatory loops that initially inhibited Cd4 downregulation and later stabilized ThPOK expression. Our results show how an initial lineage-specification signal can be amplified and stabilized during the lineage-commitment process.	[Muroi, Sawako; Naoe, Yoshinori; Miyamoto, Chizuko; Akiyama, Kaori; Taniuchi, Ichiro] RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Muroi, Sawako; Taniuchi, Ichiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Ikawa, Tomokatsu; Masuda, Kyoko; Kawamoto, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN	Taniuchi, I (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	taniuchi@rcai.riken.jp	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank D. J. Kappes (Fox Chase Cancer Center) for cDNA encoding helper-deficient mutant ThPOK; Y. Nakatani (Dana-Farber Cancer Institute) for the pOZ-FH-N vector; M. Matsuda for aggregation of embryonic stem cells; I. Hisanaga for microinjection of transgenes; H. Fujimoto and Y. Hachiman for cell sorting; and W. Ellmeier and S. L. Reiner for critical reading of the manuscript. Supported by Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (I. T.).	Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Kappes DJ, 2006, IMMUNOL REV, V209, P237, DOI 10.1111/j.0105-2896.2006.00344.x; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2004, ADV IMMUNOL, V83, P91; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	40	122	124	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1113	1121		10.1038/ni.1650	http://dx.doi.org/10.1038/ni.1650			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18776907				2022-12-18	WOS:000259315600009
J	Kuwajima, S; Sato, T; Ishida, K; Tada, H; Tezuka, H; Ohteki, T				Kuwajima, Seiichi; Sato, Taku; Ishida, Kazuto; Tada, Hiroyuki; Tezuka, Hiroyuki; Ohteki, Toshiaki			Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation	NATURE IMMUNOLOGY			English	Article							BACTERIAL-DNA; NATURAL-KILLER; CUTTING EDGE; T-CELLS; IN-VIVO; CD40; RESPONSES; MICE; INNATE; MOTIFS	The function of interleukin 15 (IL-15) in unmethylated CpG oligodeoxynucleotide (CpG)-induced immune responses remains unknown. Here, in response to CpG, both wild-type and natural killer cell-depleted mice produced IL-12 and became resistant to a lethal dose of Listeria monocytogenes. In contrast, CpG-treated IL-15-deficient mice produced little IL-12 and succumbed to L. monocytogenes. CpG-stimulated conventional dendritic cells (cDCs) were the main producers of both IL-15 and IL-12, but cDCs did not produce IL-12 in the absence of plasmacytoid DCs (pDCs). The cDC-derived IL-15 induced CD40 expression by cDCs. Interaction between CD40 on cDCs and CD40 ligand on pDCs led to IL-12 production by cDCs. Thus, IL-15-dependent crosstalk between cDCs and pDCs is essential for CpG-induced immune activation.	Akita Univ, Sch Med, Dept Immunol, Akita 0108543, Japan	Akita University	Ohteki, T (corresponding author), Akita Univ, Sch Med, Dept Immunol, Akita 0108543, Japan.	tohteki@med.akita-u.ac.jp						Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpentier AF, 2003, FRONT BIOSCI, V8, pE115, DOI 10.2741/934; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dittmer U, 2003, CURR OPIN MICROBIOL, V6, P472, DOI 10.1016/j.mib.2003.09.007; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Elkins KL, 1999, J IMMUNOL, V162, P2291; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Fontana S, 2003, BLOOD, V102, P4099, DOI 10.1182/blood-2003-04-1244; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Ishii KJ, 2005, EUR J IMMUNOL, V35, P2397, DOI 10.1002/eji.200425795; Jahrsdorfer Bernd, 2003, Curr Opin Investig Drugs, V4, P686; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kline JN, 1998, J IMMUNOL, V160, P2555; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, J IMMUNOL, V161, P2428; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Mackey MF, 1998, J IMMUNOL, V161, P2094; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Weiss Richard, 2005, Current Drug Targets - Inflammation and Allergy, V4, P585, DOI 10.2174/156801005774322171; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	53	122	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					740	746		10.1038/ni1348	http://dx.doi.org/10.1038/ni1348			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16715101				2022-12-18	WOS:000238377700019
J	Ahonen, CL; Manning, EM; Erickson, LD; O'Connor, BP; Lind, EF; Pullen, SS; Kehry, MR; Noelle, RJ				Ahonen, CL; Manning, EM; Erickson, LD; O'Connor, BP; Lind, EF; Pullen, SS; Kehry, MR; Noelle, RJ			The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR RECEPTOR; KAPPA-B ACTIVATION; N-TERMINAL KINASE; CYTOPLASMIC DOMAIN; TARGETED DISRUPTION; FAMILY PROTEINS; CD40 LIGAND; MICE; EXPRESSION; INDUCTION	Affinity maturation of the immune response and the generation of long-lived bone marrow (BM) plasma cells are hallmarks of CD40-dependent, thymus-dependent (TD) humoral immunity. Through disruption of the tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6)-binding site within the CD40 cytoplasmic domain, we selectively ablated affinity maturation and the generation of plasma cells after immunization. Mutagenesis of both the TRAF6 and TRAF2-TRAF3 sites was essential for arresting germinal center formation in response to immunization. CD40-induced B cell proliferation and early immunoglobulin production occurred even when all TRAF sites were ablated. These studies show that specific CD40-RAF associations control well defined aspects of humoral immunity. In addition, they define the roles that TRAF-dependent and TRAF-independent pathways play in regulating antigen-driven B cell differentiation.	Dartmouth Coll, Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Dartmouth College; Boehringer Ingelheim	Noelle, RJ (corresponding author), Dartmouth Coll, Sch Med, Dept Microbiol & Immunol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.			Lind, Evan/0000-0001-7026-2012	NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026296, R01AI026296] Funding Source: NIH RePORTER; NCI NIH HHS [CA 23108, P30 CA023108-315667, P30 CA023108] Funding Source: Medline; NIAID NIH HHS [R01 AI026296-09, R01 AI026296, AI26296, R37 AI026296] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Chendrasekhar A, 1996, J TRAUMA, V40, P963, DOI 10.1097/00005373-199606000-00016; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hsing Y, 1997, J IMMUNOL, V159, P4898; HU HM, 1994, J BIOL CHEM, V269, P30069; INUI S, 1990, EUR J IMMUNOL, V20, P1747, DOI 10.1002/eji.1830200819; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO;2-E; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Manning E, 2002, EUR J IMMUNOL, V32, P39, DOI 10.1002/1521-4141(200201)32:1<39::AID-IMMU39>3.0.CO;2-Y; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Siepmann K, 2001, IMMUNOLOGY, V102, P263, DOI 10.1046/j.1365-2567.2001.01162.x; Sutherland CL, 1999, J IMMUNOL, V162, P4720; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	32	122	129	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					451	456		10.1038/ni792	http://dx.doi.org/10.1038/ni792			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11967542	Green Accepted			2022-12-18	WOS:000175411200013
J	Rodriguez-Ruiz, ME; Vitale, I; Harrington, KJ; Melero, I; Galluzzi, L				Esperanza Rodriguez-Ruiz, Maria; Vitale, Ilio; Harrington, Kevin J.; Melero, Ignacio; Galluzzi, Lorenzo			Immunological impact of cell death signaling driven by radiation on the tumor microenvironment	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; LOW-DOSE IRRADIATION; IONIZING-RADIATION; IMMUNE-SYSTEM; ANTICANCER CHEMOTHERAPY; INFLAMMASOME ACTIVATION; NUCLEAR-DNA; LUNG-CANCER; T-CELLS; RADIOTHERAPY	Radiation therapy has for decades been a standard form of treatment for many cancers. A Review by Galluzzi and colleagues explores the effects of radiation therapy in the context of the immune response. Therapeutic irradiation of the tumor microenvironment causes differential activation of pro-survival and pro-death pathways in malignant, stromal, endothelial and immune cells, hence causing a profound cellular and biological reconfiguration via multiple, non-redundant mechanisms. Such mechanisms include the selective elimination of particularly radiosensitive cell types and consequent loss of specific cellular functions, the local release of cytokines and danger signals by dying radiosensitive cells, and altered cytokine secretion by surviving radioresistant cells. Altogether, these processes create chemotactic and immunomodulatory cues for incoming and resident immune cells. Here we discuss how cytoprotective and cytotoxic signaling modules activated by radiation in specific cell populations reshape the immunological tumor microenvironment.	[Esperanza Rodriguez-Ruiz, Maria; Melero, Ignacio] Univ Navarra Clin, Dept Radiat Oncol, Pamplona, Spain; [Esperanza Rodriguez-Ruiz, Maria; Melero, Ignacio] CIMA, Pamplona, Spain; [Vitale, Ilio] IRCCS Candiolo, Italian Inst Genom Med, Turin, Italy; [Vitale, Ilio] FPO IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Harrington, Kevin J.] Inst Canc Res, Div Radiotherapy & Imaging, London, England; [Harrington, Kevin J.] Royal Marsden Hosp, Inst Canc Res, Natl Inst Hlth Biomed Res Ctr, London, England; [Melero, Ignacio] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Melero, Ignacio] Navarra Inst Hlth Res IDISNA, Pamplona, Spain; [Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA; [Galluzzi, Lorenzo] Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Galluzzi, Lorenzo] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Galluzzi, Lorenzo] Yale Sch Med, Dept Dermatol, New Haven, CT USA; [Galluzzi, Lorenzo] Univ Paris, Paris, France	University of Navarra; IRCCS Fondazione del Piemonte per l'Oncologia; Italian Institute for Genomic Medicine (IIGM); IRCCS Fondazione del Piemonte per l'Oncologia; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Cornell University; Cornell University; Yale University; UDICE-French Research Universities; Universite Paris Cite	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY USA.; Galluzzi, L (corresponding author), Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA.; Galluzzi, L (corresponding author), Yale Sch Med, Dept Dermatol, New Haven, CT USA.; Galluzzi, L (corresponding author), Univ Paris, Paris, France.	deadoc80@gmail.com	Rodriguez-Ruiz, Maria Esperanza/K-7227-2017; Melero, Ignacio/T-7600-2019; Galluzzi, Lorenzo/AAH-3286-2021; VITALE, ILIO/M-3960-2017	Rodriguez-Ruiz, Maria Esperanza/0000-0002-9765-2499; Melero, Ignacio/0000-0002-1360-348X; Harrington, Kevin/0000-0002-6014-348X; VITALE, ILIO/0000-0002-5918-1841	FEOR/CRIS Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 2017) [20417]; Italian Institute for Genomic Medicine (Turin, Italy); Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre; Oracle Cancer Trust; Rosetrees Trust; Mark Donegan Foundation; Breakthrough Level 2 grant from the US Department of Defense, Breast Cancer Research Program [BC180476P1]; Department of Radiation Oncology at Weill Cornell Medicine (New York, US); Lytix (Oslo, Norway); Phosplatin (New York, US)	FEOR/CRIS Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 2017)(Fondazione AIRC per la ricerca sul cancro); Italian Institute for Genomic Medicine (Turin, Italy); Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre; Oracle Cancer Trust; Rosetrees Trust(Rosetrees Trust); Mark Donegan Foundation; Breakthrough Level 2 grant from the US Department of Defense, Breast Cancer Research Program(United States Department of Defense); Department of Radiation Oncology at Weill Cornell Medicine (New York, US); Lytix (Oslo, Norway); Phosplatin (New York, US)	We are indebted to G. Manic (Regina Elena National Cancer Institute, Rome, Italy) for help with the preparation of display items. M.E.R.R. is supported by the FEOR/CRIS Foundation. I.V. is supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 2017, grant number 20417) and a startup grant from the Italian Institute for Genomic Medicine (Turin, Italy). K.J.H. acknowledges support from the Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre, Oracle Cancer Trust, Rosetrees Trust and The Mark Donegan Foundation. L.G. is supported by a Breakthrough Level 2 grant from the US Department of Defense, Breast Cancer Research Program (#BC180476P1); by a startup grant from the Department of Radiation Oncology at Weill Cornell Medicine (New York, US); by industrial collaborations with Lytix (Oslo, Norway) and Phosplatin (New York, US); and by donations from Phosplatin (New York, US), the Luke Heller TECPR2 Foundation (Boston, US) and Sotio a.s. (Prague, Czech Republic).	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Acebes-Huerta A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1074378; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arina A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11906-2; Arshad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115447; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Basit F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.133; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; Baumann M, 2016, NAT REV CANCER, V16, P234, DOI 10.1038/nrc.2016.18; Belka C, 1999, RADIOTHER ONCOL, V50, P199, DOI 10.1016/S0167-8140(98)00130-3; Bezu L, 2018, CELL DEATH DIFFER, V25, P1375, DOI 10.1038/s41418-017-0044-9; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bogdandi EN, 2010, RADIAT RES, V174, P480, DOI 10.1667/RR2160.1; Buque A, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655364; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Chabanon RM, 2019, J CLIN INVEST, V129, P1211, DOI 10.1172/JCI123319; Chen JC, 2019, J BIOL CHEM, V294, P11994, DOI 10.1074/jbc.RA118.007161; Chen YC, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0534-1; Christmann M, 2010, NUCLEIC ACIDS RES, V38, P6418, DOI 10.1093/nar/gkq455; Chun SH, 2013, DOSE-RESPONSE, V11, P374, DOI 10.2203/dose-response.12-041.Lee; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Clarke N, 2018, LANCET ONCOL, V19, P975, DOI 10.1016/S1470-2045(18)30365-6; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corbet C, 2017, NAT REV CANCER, V17, P577, DOI 10.1038/nrc.2017.77; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Das A, 2016, TUMOR BIOL, V37, P7525, DOI 10.1007/s13277-015-4621-6; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Demaria S, 2016, TRENDS CANCER, V2, P286, DOI 10.1016/j.trecan.2016.05.002; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Deutsch E, 2019, LANCET ONCOL, V20, pE452, DOI 10.1016/S1470-2045(19)30171-8; Di Virgilio F, 2018, NAT REV CANCER, V18, P601, DOI 10.1038/s41568-018-0037-0; Diamond JM, 2018, CANCER IMMUNOL RES, V6, P910, DOI 10.1158/2326-6066.CIR-17-0581; Dillon MT, 2019, CLIN CANCER RES, V25, P3392, DOI 10.1158/1078-0432.CCR-18-1821; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Dunphy G, 2018, MOL CELL, V71, P745, DOI 10.1016/j.molcel.2018.07.034; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Endo S, 2017, GASTROENTEROLOGY, V152, P1492, DOI 10.1053/j.gastro.2017.01.010; Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2; Falcke SE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113574; Feng X, 2015, ONCOTARGET, V6, P32353, DOI 10.18632/oncotarget.5898; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fokas E, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-48; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Fulda S, 1998, CELL DEATH DIFFER, V5, P884, DOI 10.1038/sj.cdd.4400419; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2018, NAT REV MOL CELL BIO, V19, P731, DOI 10.1038/s41580-018-0068-0; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ghosh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194611; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28518; Good JS, 2013, CLIN ONCOL-UK, V25, P569, DOI 10.1016/j.clon.2013.06.009; Gorchs L, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00087; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Grossenbacher SK, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0124-2; Guipaud O, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170762; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; He H, 2017, MOL MED REP, V16, P1216, DOI 10.3892/mmr.2017.6689; He XY, 2015, CELL REP, V13, P888, DOI 10.1016/j.celrep.2015.09.045; Heijink AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07927-y; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; Hendry SA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00621; Heylmann D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1095-7; Hill RP, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160474; Hou YZ, 2018, IMMUNITY, V49, P490, DOI 10.1016/j.immuni.2018.07.008; Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jahns J, 2011, MUTAT RES-FUND MOL M, V709-10, P32, DOI 10.1016/j.mrfmmm.2011.02.007; Janus P, 2018, CELL SIGNAL, V46, P23, DOI 10.1016/j.cellsig.2018.02.011; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jiao SP, 2017, CLIN CANCER RES, V23, P3711, DOI 10.1158/1078-0432.CCR-16-3215; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kim EJ, 2014, INT J RADIAT BIOL, V90, P306, DOI 10.3109/09553002.2014.886793; Kim TK, 2006, CANCER LETT, V242, P215, DOI 10.1016/j.canlet.2005.11.003; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Labadie BW, 2019, CLIN CANCER RES, V25, P1462, DOI 10.1158/1078-0432.CCR-18-2882; Lafargue A, 2017, FREE RADICAL BIO MED, V108, P750, DOI 10.1016/j.freeradbiomed.2017.04.019; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lang XT, 2019, CANCER DISCOV, V9, P1673, DOI 10.1158/2159-8290.CD-19-0338; Leblond MM, 2017, ONCOTARGET, V8, P72597, DOI 10.18632/oncotarget.19994; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu S, 2015, AM J CANCER RES, V5, P3276; Liu XJ, 2016, ONCOTARGET, V7, P22219, DOI 10.18632/oncotarget.7924; Liu YG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.460; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maeda A, 2017, INT J RADIAT ONCOL, V97, P184, DOI 10.1016/j.ijrobp.2016.09.005; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Merrick A, 2005, BRIT J CANCER, V92, P1450, DOI 10.1038/sj.bjc.6602518; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Moding EJ, 2014, J CLIN INVEST, V124, P3325, DOI 10.1172/JCI73932; Moore K, 2018, NEW ENGL J MED, V379, P2495, DOI 10.1056/NEJMoa1810858; Moreno-Villanueva M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092316; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Mulder WJM, 2019, NAT REV DRUG DISCOV, V18, P553, DOI 10.1038/s41573-019-0025-4; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nadella V, 2018, MOL CARCINOGEN, V57, P1664, DOI 10.1002/mc.22879; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020; Nehs MA, 2011, SURGERY, V150, P1032, DOI 10.1016/j.surg.2011.09.012; Ngwa W, 2018, NAT REV CANCER, V18, P313, DOI 10.1038/nrc.2018.6; Ning XH, 2019, MOL CELL, V74, P19, DOI 10.1016/j.molcel.2019.02.013; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pan XF, 2019, ONCOL LETT, V17, P3001, DOI 10.3892/ol.2019.9888; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1; Pei JM, 2006, CANCER GENET CYTOGEN, V170, P65, DOI 10.1016/j.cancergencyto.2006.05.002; Persa E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082391; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Pugh JL, 2014, J IMMUNOL, V193, P1451, DOI 10.4049/jimmunol.1400434; Qu YY, 2010, RADIAT RES, V173, P148, DOI 10.1667/RR0978.1; Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238; Rodriguez-Ruiz ME, 2017, INT J RADIAT ONCOL, V97, P389, DOI 10.1016/j.ijrobp.2016.10.043; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Rybstein MD, 2018, NAT CELL BIOL, V20, P243, DOI 10.1038/s41556-018-0042-2; Sato H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01883-9; Schaue D, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00119; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Shigematsu A, 2007, J RADIAT RES, V48, P51, DOI 10.1269/jrr.06048; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Snyder AG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2004; Son CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32470; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Song XX, 2016, BIOCHEM BIOPH RES CO, V480, P443, DOI 10.1016/j.bbrc.2016.10.068; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tommelein J, 2018, CANCER RES, V78, P659, DOI 10.1158/0008-5472.CAN-17-0524; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tsai CS, 2007, INT J RADIAT ONCOL, V68, P499, DOI 10.1016/j.ijrobp.2007.01.041; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vanpouille-Box C, 2019, NAT REV DRUG DISCOV, V18, P845, DOI 10.1038/s41573-019-0043-2; Vanpouille-Box C, 2018, CANCER CELL, V34, P361, DOI 10.1016/j.ccell.2018.05.013; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vendetti FP, 2018, J CLIN INVEST, V128, P3926, DOI 10.1172/JCI96519; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Vitale I, 2019, PHARMACOL THERAPEUT, V200, P55, DOI 10.1016/j.pharmthera.2019.04.004; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3359; Wang H, 2018, TRENDS PHARMACOL SCI, V39, P24, DOI 10.1016/j.tips.2017.11.003; Wang HH, 2018, INT J RADIAT ONCOL, V101, P49, DOI 10.1016/j.ijrobp.2018.01.036; Wang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069182; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1; Wang YB, 2017, EBIOMEDICINE, V17, P45, DOI 10.1016/j.ebiom.2017.02.019; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wang ZH, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0362-2; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Wen QR, 2019, BIOCHEM BIOPH RES CO, V510, P278, DOI 10.1016/j.bbrc.2019.01.090; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; Werthmoller N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.129; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wilkins AC, 2019, J PATHOL, V247, P606, DOI 10.1002/path.5232; Xie YC, 2017, CELL REP, V20, P1692, DOI 10.1016/j.celrep.2017.07.055; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yan GF, 2018, CANCER RES, V78, P5586, DOI 10.1158/0008-5472.CAN-17-3962; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yang ZY, 2014, J IMMUNOL, V193, P6114, DOI 10.4049/jimmunol.1400359; Yao ZY, 2011, J IMMUNOL, V187, P4100, DOI 10.4049/jimmunol.1101141; Yard BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11428; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang YL, 2018, NAT CELL BIOL, V20, P1181, DOI 10.1038/s41556-018-0178-0; Zheng XD, 2015, INT J RADIAT ONCOL, V93, P1118, DOI 10.1016/j.ijrobp.2015.08.034	218	121	124	10	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					120	134		10.1038/s41590-019-0561-4	http://dx.doi.org/10.1038/s41590-019-0561-4		DEC 2019	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31873291				2022-12-18	WOS:000507726700004
J	Hammer, Q; Ruckert, T; Romagnani, C				Hammer, Quirin; Rueckert, Timo; Romagnani, Chiara			Natural killer cell specificity for viral infections	NATURE IMMUNOLOGY			English	Review							HUMAN CYTOMEGALOVIRUS-INFECTION; NKG2C(+) NK CELLS; HLA-E BINDS; CUTTING EDGE; HEPATITIS-C; DEPENDENT EXPANSION; SEQUENCE VARIATIONS; INNATE IMMUNITY; RECEPTOR GENES; HIV-1 VIREMIA	Natural killer (NK) cells are lymphocytes that contribute to the early immune responses to viruses. NK cells are innate immune cells that do not express rearranged antigen receptors but sense their environment via receptors for pro-inflammatory cytokines, as well as via germline-encoded activating receptors specific for danger or pathogen signals. A group of such activating receptors is stochastically expressed by certain subsets within the NK cell compartment. After engagement of the cognate viral ligand, these receptors contribute to the specific activation and 'preferential' population expansion of defined NK cell subsets, which partially recapitulate some features of adaptive lymphocytes. In this Review, we discuss the numerous modes for the specific recognition of viral antigens and peptides by NK cells and the implications of this for the composition of the NK cell repertoire as well as for the the selection of viral variants.	[Hammer, Quirin; Rueckert, Timo; Romagnani, Chiara] German Rheumatism Res Ctr, Leibniz Assoc, Innate Immun, Berlin, Germany; [Romagnani, Chiara] Charite Univ Med Berlin, Med Dept 1, Berlin, Germany; [Hammer, Quirin] Karolinska Inst, Karolinska Univ Hosp, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Karolinska Institutet; Karolinska University Hospital	Romagnani, C (corresponding author), German Rheumatism Res Ctr, Leibniz Assoc, Innate Immun, Berlin, Germany.; Romagnani, C (corresponding author), Charite Univ Med Berlin, Med Dept 1, Berlin, Germany.	romagnani@drfz.de	Romagnani, Chiara/E-4708-2016	Romagnani, Chiara/0000-0002-5167-7463; Ruckert, Timo/0000-0003-1433-1372; Hammer, Quirin/0000-0003-2968-6061	Leibniz ScienceCampus Chronic Inflammation; German Research Foundation [SFB-TRR241, RO3565/2-1, RO3565/4-1]; German Research Foundation Heisenberg Program [RO 3565/1-1]; Leibniz Graduate School for Rheumatology	Leibniz ScienceCampus Chronic Inflammation; German Research Foundation(German Research Foundation (DFG)); German Research Foundation Heisenberg Program; Leibniz Graduate School for Rheumatology	Supported by the Leibniz ScienceCampus Chronic Inflammation, the German Research Foundation (SFB-TRR241, RO3565/2-1 and RO3565/4-1 to C.R.), the German Research Foundation Heisenberg Program (RO 3565/1-1 for C.R.) and the Leibniz Graduate School for Rheumatology (Q.H.).	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Azzi T, 2014, BLOOD, V124, P2533, DOI 10.1182/blood-2014-01-553024; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Biassoni R, 2005, J IMMUNOL, V174, P5695, DOI 10.4049/jimmunol.174.9.5695; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bjorkstrom NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027664; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1984, J VIROL, V52, P119, DOI 10.1128/JVI.52.1.119-128.1984; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Chapel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02449-x; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Costa-Garcia M, 2015, J IMMUNOL, V194, P2715, DOI 10.4049/jimmunol.1402281; Davis ZB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005421; Della Chiesa M, 2014, J IMMUNOL, V192, P1471, DOI 10.4049/jimmunol.1302053; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Garrigue I, 2008, TRANSPLANTATION, V86, P826, DOI 10.1097/TP.0b013e3181859edd; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Gondois-Rey F, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.22; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Hammer Q, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01976; Heatley SL, 2013, J BIOL CHEM, V288, P8679, DOI 10.1074/jbc.M112.409672; Holzemer A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001900; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lemmermann NAW, 2010, J VIROL, V84, P1221, DOI 10.1128/JVI.02087-09; Liu LL, 2016, CELL REP, V15, P1088, DOI 10.1016/j.celrep.2016.04.005; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lunemann A, 2013, J IMMUNOL, V191, P4989, DOI 10.4049/jimmunol.1301046; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Lunemann S, 2016, J HEPATOL, V65, P252, DOI 10.1016/j.jhep.2016.03.016; Ma MC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01176; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Malone DFG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00525; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Nabekura T, 2017, J IMMUNOL, V199, P1567, DOI 10.4049/jimmunol.1700799; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Naiyer MM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5296; Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ni J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1219009; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; O'Connor GM, 2011, J IMMUNOL, V187, P2162, DOI 10.4049/jimmunol.1002906; Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Prichard MN, 2001, REV MED VIROL, V11, P191, DOI 10.1002/rmv.315; Pyzik M, 2014, J IMMUNOL, V193, P6061, DOI 10.4049/jimmunol.1401386; Pyzik M, 2011, J EXP MED, V208, P1105, DOI 10.1084/jem.20101831; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Rolle A, 2016, EUR J IMMUNOL, V46, P2420, DOI 10.1002/eji.201646492; Rolle A, 2014, J CLIN INVEST, V124, P5305, DOI 10.1172/JCI77440; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Schlub TE, 2011, J IMMUNOL, V187, P1385, DOI 10.4049/jimmunol.1100416; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith KM, 1998, J IMMUNOL, V161, P7; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Thomas R, 2012, AIDS RES HUM RETROV, V28, P844, DOI [10.1089/aid.2011.0253, 10.1089/AID.2011.0253]; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; van der Ploeg K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00298; van Teijlingen NH, 2014, AIDS, V28, P1399, DOI 10.1097/QAD.0000000000000284; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Walter L, 2017, IMMUNOLOGY, V150, P139, DOI 10.1111/imm.12666; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wang ECY, 2018, P NATL ACAD SCI USA, V115, P4998, DOI 10.1073/pnas.1720950115; Winter CC, 1998, J IMMUNOL, V161, P571; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	125	121	122	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					800	808		10.1038/s41590-018-0163-6	http://dx.doi.org/10.1038/s41590-018-0163-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30026479				2022-12-18	WOS:000439470900017
J	Johansson-Percival, A; He, B; Li, ZJ; Kjellen, A; Russell, K; Li, J; Larma, I; Ganss, R				Johansson-Percival, Anna; He, Bo; Li, Zhi-Jie; Kjellen, Alva; Russell, Karen; Li, Ji; Larma, Irma; Ganss, Ruth			De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors	NATURE IMMUNOLOGY			English	Article							T-CELL INFILTRATION; ESTABLISHED TUMORS; IMMUNE-RESPONSE; REGULATORY T; MICROENVIRONMENT; CANCER; DIFFERENTIATION; COMBINATION; DESTRUCTION; ERADICATION	The tumor microenvironment confers profound resistance to anti-cancer immunotherapy. By targeting LIGHT, a member of the TNF superfamily of cytokines, to tumor vessels via a vascular targeting peptide (VTP), we developed a reagent with the dual ability to modulate the angiogenic vasculature and to induce tertiary lymphoid structures (TLSs). LIGHT-VTP triggered the influx of endogenous T cells into autochthonous or syngeneic tumors, which are resistant to immunotherapy. LIGHT-VTP in combination with checkpoint inhibition generated a large number of intratumoral effector and memory T cells with ensuing survival benefits, while the addition of anti-tumor vaccination achieved maximal therapeutic efficacy. Thus, the combination treatments stimulated the trafficking of pre-existing endogenous effector T cells as well as their intratumoral activation and were more successful than current immunotherapies, which fail due to tumor-intrinsic resistance mechanisms.	[Johansson-Percival, Anna; He, Bo; Li, Zhi-Jie; Kjellen, Alva; Russell, Karen; Li, Ji; Ganss, Ruth] Univ Western Australia, Harry Perkins Inst Med Res, Ctr Med Res, Nedlands, WA, Australia; [Larma, Irma] Univ Western Australia, Ctr Microscopy Characterizat & Anal, Crawley, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Ganss, R (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Ctr Med Res, Nedlands, WA, Australia.	ganss@perkins.uwa.edu.au		Ganss, Ruth/0000-0002-5551-045X; Johansson, Anna/0000-0001-9607-0000	National Health and Medical Research Council [APP1042446, APP1122108]; Cancer Council of Western Australia [APP1098579]; Woodside Energy	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Woodside Energy	We thank S. Tanz (The University of Western Australia) for assistance with laser-dissection microscopy; J. Hamzah (Harry Perkins Institute of Medical Research) for the LIGHT expression plasmid; E. Ingley (Harry Perkins Institute of Medical Research) for the pET-44a plasmid containing a tobacco etch virus cleavage site; and D. Hanahan (Swiss Institute for Experimental Cancer Research) for rabbit polyclonal antibody to Tag. Supported by the National Health and Medical Research Council (APP1042446 and APP1122108 to R.G.), the Cancer Council of Western Australia (APP1098579 to R.G.; fellowship to A.J.-P.) and Woodside Energy (fellowship to R.G.).	Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Allen E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9679; Bento DC, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.974374; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chang YH, 2005, J BIOMED SCI, V12, P363, DOI 10.1007/s11373-005-1360-5; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Dirkx AEM, 2003, CANCER RES, V63, P2322; Dirkx AEM, 2006, FASEB J, V20, P621, DOI 10.1096/fj.05-4493com; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Ganss R, 1998, CANCER RES, V58, P4673; Ganss R, 2002, CANCER RES, V62, P1462; Garbi N, 2004, J IMMUNOL, V172, P5861, DOI 10.4049/jimmunol.172.10.5861; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hamzah J, 2008, J CLIN INVEST, V118, P1691, DOI 10.1172/JCI33201; Hiraoka N, 2015, BRIT J CANCER, V112, P1782, DOI 10.1038/bjc.2015.145; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Johansson A, 2016, BBA-REV CANCER, V1865, P3, DOI 10.1016/j.bbcan.2015.06.001; Johansson A, 2014, TRENDS MOL MED, V20, P16, DOI 10.1016/j.molmed.2013.10.002; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; Johansson-Percival A, 2015, CELL REP, V13, P2687, DOI 10.1016/j.celrep.2015.12.004; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kirk CJ, 2001, CANCER RES, V61, P8794; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Lutz ER, 2014, CANCER IMMUNOL RES, V2, P616, DOI 10.1158/2326-6066.CIR-14-0027; Maldonado L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007323; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Peske JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8114; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Schmittnaegel M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9670; Schrama D, 2001, IMMUNITY, V14, P111, DOI 10.1016/S1074-7613(09)00094-6; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Tang HD, 2016, CANCER CELL, V29, P285, DOI 10.1016/j.ccell.2016.02.004; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029	51	121	126	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1207	+		10.1038/ni.3836	http://dx.doi.org/10.1038/ni.3836			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28892469				2022-12-18	WOS:000413457300007
J	Garris, CS; Wu, LF; Acharya, S; Arac, A; Blaho, VA; Huang, YX; Moon, BS; Axtell, RC; Ho, PP; Steinberg, GK; Lewis, DB; Sobel, RA; Han, DK; Steinman, L; Snyder, MP; Hla, T; Han, MH				Garris, Christopher S.; Wu, Linfeng; Acharya, Swati; Arac, Ahmet; Blaho, Victoria A.; Huang, Yingxiang; Moon, Byoung San; Axtell, Robert C.; Ho, Peggy P.; Steinberg, Gary K.; Lewis, David B.; Sobel, Raymond A.; Han, David K.; Steinman, Lawrence; Snyder, Michael P.; Hla, Timothy; Han, May H.			Defective sphingosine 1-phosphate receptor 1 (S1P(1)) phosphorylation exacerbates T(H)17-mediated autoimmune neuroinflammation	NATURE IMMUNOLOGY			English	Article							MULTIPLE-SCLEROSIS LESIONS; LYMPHOCYTE EGRESS; ORAL FINGOLIMOD; MASS-SPECTROMETRY; T-CELLS; FTY720; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; MICE; TRAFFICKING	Sphingosine 1-phosphate (S1P) signaling regulates lymphocyte egress from lymphoid organs into systemic circulation. The sphingosine phosphate receptor 1 (S1P(1)) agonist FTY-720 (Gilenya) arrests immune trafficking and prevents multiple sclerosis (MS) relapses. However, alternative mechanisms of S1P-S1P(1) signaling have been reported. Phosphoproteomic analysis of MS brain lesions revealed S1P(1) phosphorylation on S351, a residue crucial for receptor internalization. Mutant mice harboring an S1pr1 gene encoding phosphorylation-deficient receptors(S1P(1)(S5A)) developed severe experimental autoimmune encephalomyelitis (EAE) due to autoimmunity mediated by interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) in the peripheral immune and nervous system. S1P(1) directly activated the Jak-STAT3 signal-transduction pathway via IL-6. Impaired S1P(1) phosphorylation enhances T(H)17 polarization and exacerbates autoimmune neuroinflammation. These mechanisms may be pathogenic in MS.	[Garris, Christopher S.; Huang, Yingxiang; Moon, Byoung San; Axtell, Robert C.; Ho, Peggy P.; Steinman, Lawrence; Han, May H.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Garris, Christopher S.] Harvard Univ, Sch Med, Div Med Sci, Grad Program Immunol, Boston, MA USA; [Wu, Linfeng; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Acharya, Swati; Lewis, David B.] Stanford Univ, Dept Pediat, Div Rheumatol Allergy & Immunol, Stanford, CA 94305 USA; [Arac, Ahmet; Steinberg, Gary K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Blaho, Victoria A.; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10021 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Han, David K.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT USA	Stanford University; Harvard University; Harvard Medical School; Stanford University; Stanford University; Stanford University; Cornell University; Stanford University; University of Connecticut	Han, MH (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	mayhan@stanford.edu	Moon, Byoung-San/AAK-1554-2020; Axtell, Robert/AAJ-5053-2021; Hla, Timothy/G-5873-2012	Steinman, Lawrence/0000-0002-2437-2250; Snyder, Michael/0000-0003-0784-7987; /0000-0002-6848-318X; Blaho, Victoria/0000-0001-8499-2278; Steinberg, Gary/0000-0001-6374-1058; Hla, Timothy/0000-0001-8355-4065; Sobel, Raymond/0000-0002-0477-9002	Neurology Department Startup Funds; Guthy-Jackson Charitable Foundation for Neuromyelitis Optica Research; US National Institutes of Health [R37-HL67330, PO1-HL70694, RO1HL89934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067330, R01HL089934, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS075099] Funding Source: NIH RePORTER	Neurology Department Startup Funds; Guthy-Jackson Charitable Foundation for Neuromyelitis Optica Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Saba (Children's Hospital Oakland Research Institute) for providing THI. Supported by Neurology Department Startup Funds, Guthy-Jackson Charitable Foundation for Neuromyelitis Optica Research (M. H. H.), and US National Institutes of Health grants R37-HL67330, PO1-HL70694 and RO1HL89934 (T. H.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Baumruker T, 2007, EXPERT OPIN INV DRUG, V16, P283, DOI 10.1517/13543784.16.3.283; Bourdette D, 2012, NEUROLOGY, V79, P1942, DOI 10.1212/WNL.0b013e3182735edf; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Chun J, 2011, DISCOV MED, V12, P213; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Han MH, 2012, J EXP MED, V209, P1325, DOI 10.1084/jem.20101974; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ingwersen J, 2012, CLIN IMMUNOL, V142, P15, DOI [10.1016/j.clim.2011.05.005, 10.1016/j.clim.2011.10.008]; Jander S, 2012, MULT SCLER J, V18, P1650, DOI 10.1177/1352458512463768; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kieseier BC, 2007, CURR OPIN NEUROL, V20, P286, DOI 10.1097/WCO.0b013e3281568b80; Kohno Takayuki, 2002, Tanpakushitsu Kakusan Koso, V47, P503; KREBS EG, 1958, J BIOL CHEM, V231, P73; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mayya V, 2006, MOL CELL PROTEOMICS, V5, P1146, DOI 10.1074/mcp.T500029-MCP200; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Visser F, 2012, NEUROLOGY, V79, P2000, DOI 10.1212/WNL.0b013e3182735cb3; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Waubant E, 2007, REV NEUROL-FRANCE, V163, P688, DOI 10.1016/S0035-3787(07)90481-6; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901; Zhi L, 2011, J IMMUNOL, V187, P2244, DOI 10.4049/jimmunol.1100670; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	47	121	126	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1166	U128		10.1038/ni.2730	http://dx.doi.org/10.1038/ni.2730			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24076635	Green Accepted, Green Submitted			2022-12-18	WOS:000326023400013
J	Kupz, A; Guarda, G; Gebhardt, T; Sander, LE; Short, KR; Diavatopoulos, DA; Wijburg, OLC; Cao, HW; Waithman, JC; Chen, WS; Fernandez-Ruiz, D; Whitney, PG; Heath, WR; Curtiss, R; Tschopp, J; Strugnell, RA; Bedoui, S				Kupz, Andreas; Guarda, Greta; Gebhardt, Thomas; Sander, Leif E.; Short, Kirsty R.; Diavatopoulos, Dimitri A.; Wijburg, Odilia L. C.; Cao, Hanwei; Waithman, Jason C.; Chen, Weisan; Fernandez-Ruiz, Daniel; Whitney, Paul G.; Heath, William R.; Curtiss, Roy, III; Tschopp, Juerg; Strugnell, Richard A.; Bedoui, Sammy			NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							LISTERIA-MONOCYTOGENES; IMMUNE-RESPONSES; CUTTING EDGE; HOST-DEFENSE; IN-VIVO; SALMONELLA; FLAGELLIN; INNATE; ACTIVATION; SECRETION	Memory T cells exert antigen-independent effector functions, but how these responses are regulated is unclear. We discovered an in vivo link between flagellin-induced NLRC4 inflammasome activation in splenic dendritic cells (DCs) and host protective interferon-gamma (IFN-gamma) secretion by noncognate memory CD8(+) T cells, which could be activated by Salmonella enterica serovar Typhimurium, Yersinia pseudotuberculosis and Pseudomonas aeruginosa. We show that CD8(alpha)(+) DCs were particularly efficient at sensing bacterial flagellin through NLRC4 inflammasomes. Although this activation released interleukin 18 (IL-18) and IL-1 beta, only IL-18 was required for IFN-gamma production by memory CD8(+) T cells. Conversely, only the release of IL-1 beta, but not IL-18, depended on priming signals mediated by Toll-like receptors. These findings provide a comprehensive mechanistic framework for the regulation of noncognate memory T cell responses during bacterial immunity.	[Kupz, Andreas; Gebhardt, Thomas; Short, Kirsty R.; Diavatopoulos, Dimitri A.; Wijburg, Odilia L. C.; Cao, Hanwei; Fernandez-Ruiz, Daniel; Whitney, Paul G.; Heath, William R.; Strugnell, Richard A.; Bedoui, Sammy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Guarda, Greta; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Sander, Leif E.] Charite, Dept Infect Dis & Pulm Med, Berlin, Germany; [Waithman, Jason C.; Chen, Weisan] Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Curtiss, Roy, III] Arizona State Univ, Ctr Infect Dis, Tempe, AZ USA	University of Melbourne; University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ludwig Institute for Cancer Research; Arizona State University; Arizona State University-Tempe	Bedoui, S (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	rastru@unimelb.edu.au; sbedoui@unimelb.edu.au	Guarda, Greta/G-1921-2011; Kupz, Andreas/J-3844-2014; Ruiz, Daniel Fernández/N-2304-2014; Diavatopoulos, Dimitri A/L-4269-2015; Chen, Weisan/E-7828-2012; Sander, Leif Erik/AAI-8619-2020	Ruiz, Daniel Fernández/0000-0002-4040-9121; Diavatopoulos, Dimitri A/0000-0001-7065-7807; Chen, Weisan/0000-0002-5221-9771; BEDOUI, SAMMY/0000-0002-7443-0543; Guarda, Greta/0000-0001-9243-6116; Short, Kirsty/0000-0003-4963-6184; Strugnell, Richard/0000-0003-0614-5641; Whitney, Paul/0000-0003-3836-7601; Heath, William/0000-0001-9670-259X; Sander, Leif Erik/0000-0002-0476-9947; Waithman, Jason/0000-0003-4940-0155; Kupz, Andreas/0000-0002-9259-7873; Gebhardt, Thomas/0000-0002-3768-9468	National Health and Medical Research Council of Australia; Louis-Jeantet Foundation; Gates Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Louis-Jeantet Foundation; Gates Foundation(Bill & Melinda Gates Foundation)	We thank D. Maskell (University of Cambridge) for mutant S. Typhimurium strain SL1344 Delta msbB; R. Robins-Browne (University of Melbourne) for motile E. coli MG1655 and Y. pseudotuberculosis B14; C. Whitchurch (University of Technology, Sydney) for Pseudomonas aeruginosa and P. aeruginosa PAKMS591 (fliC<SUP>-</SUP> P. aeruginosa); A. Walduck (University of Melbourne) for Helicobacter pylori SS1; F. R. Carbone, E. L. Hartland, A. M. Lew, L. Alexopoulou, S. Akira, R. A. Flavell, D. I. Godfrey and A. G. Brooks for reagents, bacteria, mice and discussions; and A. Turner for assistance. Supported by the National Health and Medical Research Council of Australia (Career Development Awards to T. G., O.L.C.W. and S. B.), the Louis-Jeantet Foundation (G. G. and J.T.) and the Gates Foundation, through the Grand Challenges in Health program (R. C., O.L.C.W. and R. A. S.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Minnich SA, 2007, ADV EXP MED BIOL, V603, P298; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Osuka A, 2011, SHOCK, V35, P4; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Salazar-Gonzalez RM, 2005, IMMUNOL LETT, V101, P117, DOI 10.1016/j.imlet.2005.05.004; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	44	121	127	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					162	169		10.1038/ni.2195	http://dx.doi.org/10.1038/ni.2195			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22231517				2022-12-18	WOS:000299315000013
J	Kepp, O; Galluzzi, L; Kroemer, G				Kepp, Oliver; Galluzzi, Lorenzo; Kroemer, Guido			Mitochondrial control of the NLRP3 inflammasome	NATURE IMMUNOLOGY			English	Editorial Material							CELL-DEATH; AUTOPHAGY; IMMUNITY; PROTEIN		[Kepp, Oliver; Galluzzi, Lorenzo] INSERM, U848, Villejuif, France; [Kepp, Oliver; Galluzzi, Lorenzo; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Kepp, Oliver; Galluzzi, Lorenzo] Univ Paris 11, Villejuif, France; [Kroemer, Guido] INSERM, U84s8, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kepp, O (corresponding author), INSERM, U848, Villejuif, France.	kroemer@orange.fr	Kepp, Oliver/GPX-8627-2022; Galluzzi, Lorenzo/AAG-6294-2019; Kepp, Oliver/N-2763-2017; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/K-2709-2012; Kroemer, Guido/AAY-9859-2020	Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; Galluzzi, Lorenzo/0000-0003-2257-8500; 				Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Galluzzi L, 2010, CURR BIOL, V20, pR106, DOI 10.1016/j.cub.2009.12.016; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	12	121	125	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					199	200		10.1038/ni0311-199	http://dx.doi.org/10.1038/ni0311-199			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21321591				2022-12-18	WOS:000287354400005
J	Lazarevic, V; Zullo, AJ; Schweitzer, MN; Staton, TL; Gallo, EM; Crabtree, GR; Glimcher, LH				Lazarevic, Vanja; Zullo, Alfred J.; Schweitzer, Michelle N.; Staton, Tracy L.; Gallo, Elena M.; Crabtree, Gerald R.; Glimcher, Laurie H.			The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells	NATURE IMMUNOLOGY			English	Article							IMMEDIATE-EARLY GENE; CUTTING EDGE; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; FACTOR EGR-1; NKT CELLS; DIFFERENTIATION; DEFICIENT; REGULATORS; MICE	The influence of signals transmitted by the phosphatase calcineurin and the transcription factor NFAT on the development and function of natural killer T (NKT) cells is unclear. In this report, we demonstrate that the transcription factor early growth response 2 (Egr2), a target gene of NFAT, was specifically required for the ontogeny of NKT cells but not that of conventional CD4(+) or CD8(+) T cells. NKT cells developed normally in the absence of Egr1 or Egr3, which suggests that Egr2 is a specific regulator of NKT cell differentiation. We found that Egr2 was important in the selection, survival and maturation of NKT cells. Our findings emphasize the importance of the calcineurin-NFAT-Egr2 pathway in the development of the NKT lymphocyte lineage.	[Lazarevic, Vanja; Zullo, Alfred J.; Schweitzer, Michelle N.; Staton, Tracy L.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Gallo, Elena M.; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Gallo, Elena M.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Lazarevic, Vanja/B-1160-2009	Lazarevic, Vanja/0000-0002-5783-7130	National Institutes of Health [PONS038037, UOAI31541]; Cancer Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for cell sorting; the National Institutes of Health Tetramer Core Facility at Emory University for unloaded and PBS57-loaded CD1d tetramers; J. Milbrandt (Washington University) for Egr2<SUP>+/-</SUP> and Egr3<SUP>-/-</SUP> mice; and M. Brenner (Harvard Medical School) and M. Brigl (Harvard Medical School) for the human NKT cell clone BM2a. 3. Supported by the National Institutes of Health (PONS038037 and UOAI31541 to L. H. G.) and the Cancer Research Institute (V. L.)	AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Eberl G, 1999, J IMMUNOL, V163, P4091; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Koltsova EK, 2007, J IMMUNOL, V179, P4694, DOI 10.4049/jimmunol.179.7.4694; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; Krishnaraju K, 2001, BLOOD, V97, P1298, DOI 10.1182/blood.V97.5.1298; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	47	121	125	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					306	313		10.1038/ni.1696	http://dx.doi.org/10.1038/ni.1696			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19169262	Green Accepted			2022-12-18	WOS:000263456500015
J	Pamer, EG				Pamer, Eric G.			Immune responses to commensal and environmental microbes	NATURE IMMUNOLOGY			English	Review							CLOSTRIDIUM-DIFFICILE TOXIN; HELICOBACTER-PYLORI PERSISTENCE; REGULATORY T-CELLS; RETINOIC-ACID; BACTEROIDES-FRAGILIS; BACTERICIDAL LECTIN; KINASE ACTIVATION; HUMAN INTESTINE; HOST-DEFENSE; IN-VITRO	The mammalian immune system discriminates among microbes, inactivating pathogens while tolerating colonization by commensal organisms. Calibrating immune responses to microbes on this basis, however, is complex, as microbial virulence is often context dependent, being influenced by the host's immune status and the microbial milieu. Many microbial pathogens infecting immunocompromised hosts, for example, are innocuous in immune-competent individuals, and other microbes cause disease only when the commensal flora is compromised by antibiotic therapy. Recent studies have begun to reveal how the immune system tips the balance in favor of some microbes, allowing commensals to persist on mucosal surfaces while eliminating disease-causing pathogens.	Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.	pamere@mskcc.org						Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brubaker JO, 1999, J IMMUNOL, V162, P2235; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Cloud J, 2007, CURR OPIN GASTROEN, V23, P4; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Hartl Dominik, 2006, Inflammation & Allergy Drug Targets, V5, P219, DOI 10.2174/187152806779010972; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huebner ES, 2006, GASTROENTEROL CLIN N, V35, P355, DOI 10.1016/j.gtc.2006.03.005; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee CW, 2007, INFECT IMMUN, V75, P2699, DOI 10.1128/IAI.01788-06; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; POLK BF, 1977, ANN INTERN MED, V86, P569, DOI 10.7326/0003-4819-86-5-569; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rivera A, 2006, BIOL BLOOD MARROW TR, V12, P47, DOI 10.1016/j.bbmt.2005.09.007; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tzianabos AO, 2002, CURR OPIN MICROBIOL, V5, P92, DOI 10.1016/S1369-5274(02)00292-8; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Versalovic J, 2006, PLOS BIOL, V4, P2193, DOI 10.1371/journal.pbio.0040430; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	66	121	134	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1173	1178		10.1038/ni1526	http://dx.doi.org/10.1038/ni1526			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952042				2022-12-18	WOS:000250338900007
J	Wynn, TA				Wynn, TA			T-H-17: a giant step from T(H)1 and T(H)2	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE INFLAMMATION; IL-23; INTERLEUKIN-17; CYTOKINE; RECEPTOR; DISTINCT; IL-12; MICE		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wynn, TA (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021; Wynn, Thomas A/C-2797-2011	Wynn, Thomas A/0000-0002-7244-8731; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000829] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	12	121	138	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1069	1070		10.1038/ni1105-1069	http://dx.doi.org/10.1038/ni1105-1069			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239919				2022-12-18	WOS:000232833300004
J	Harriague, J; Bismuth, G				Harriague, J; Bismuth, G			Imaging antigen-induced PI3K activation in T cells	NATURE IMMUNOLOGY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE-BINDING; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; LIPID PRODUCTS; NEUTROPHIL CHEMOTAXIS; SIGNAL-TRANSDUCTION; DOCKING PROTEIN	Activation of phosphoinositide 3-kinase (PI3K) at the immunological synapse between a T cell and an antigen-presenting cell (APC) has not been demonstrated. Using fluorescent-specific probes, we show here that the formation of an immunological synapse led to sustained production of 3'-phosphoinositides in the T cell, whereby phosphatidylinositol-3,4,5-trisphosphate (PIP(3)) but not phosphatidylinositol-3,4-bisphosphate was localized to the cell membrane. The accumulation Of PIP3 after T cell activation preceded the increase in intracellular calcium. Neither the formation of conjugates between T cells and APCs nor signaling events such as phosphotyrosine accumulation and calcium increase changed substantially when PI3K was inhibited, and only a limited reduction in synthesis of interleukin 2 occurred. in T cell-APC conjugates, PIP3 accumulated at the T cell-APC synapse as well as in the rest of the T cell plasma membrane, which indicated unusual regulation of PI3K activity during antigen presentation.	Univ Paris 05, Dept Biol Cellulaire, Inst Cochin, INSERM U567,CNRS,UMR 7627, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bismuth, G (corresponding author), Univ Paris 05, Dept Biol Cellulaire, Inst Cochin, INSERM U567,CNRS,UMR 7627, 22 Rue Mechain, F-75014 Paris, France.			Harriague, Julie/0000-0001-6824-9169				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Bruyns E, 1998, J EXP MED, V188, P561, DOI 10.1084/jem.188.3.561; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Donnadieu E, 2001, J IMMUNOL, V166, P5540, DOI 10.4049/jimmunol.166.9.5540; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; HAEFNER B, 1995, J BIOL CHEM, V270, P7937, DOI 10.1074/jbc.270.14.7937; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ingham RJ, 2001, J BIOL CHEM, V276, P12257, DOI 10.1074/jbc.M010590200; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; Ni HT, 1996, J IMMUNOL, V157, P2243; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shi J, 1997, J IMMUNOL, V158, P4688; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TRUITT KE, 1995, J IMMUNOL, V155, P4702; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	58	121	128	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1090	1096		10.1038/ni847	http://dx.doi.org/10.1038/ni847			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12389041				2022-12-18	WOS:000179073000017
J	Park, SH; Kang, K; Giannopoulou, E; Qiao, Y; Kang, K; Kim, G; Park-Min, KH; Ivashkiv, LB				Park, Sung Ho; Kang, Kyuho; Giannopoulou, Eugenia; Qiao, Yu; Kang, Keunsoo; Kim, Geonho; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.			Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; CELL IDENTITY; CHROMATIN; ENHANCERS; POLARIZATION; ENVIRONMENT; TOLERANCE; LANDSCAPE; ENDOTOXIN; RESPONSES	Cross-regulation of Toll-like receptor (TLR) responses by cytokines is essential for effective host defense, avoidance of toxicity and homeostasis, but the underlying mechanisms are not well understood. Our comprehensive epigenomics approach to the analysis of human macrophages showed that the proinflammatory cytokines TNF and type I interferons induced transcriptional cascades that altered chromatin states to broadly reprogram responses induced by TLR4. TNF tolerized genes encoding inflammatory molecules to prevent toxicity while preserving the induction of genes encoding antiviral and metabolic molecules. Type I interferons potentiated the inflammatory function of TNF by priming chromatin to prevent the silencing of target genes of the transcription factor NF-kappa B that encode inflammatory molecules. The priming of chromatin enabled robust transcriptional responses to weak upstream signals. Similar chromatin regulation occurred in human diseases. Our findings reveal that signaling crosstalk between interferons and TNF is integrated at the level of chromatin to reprogram inflammatory responses, and identify previously unknown functions and mechanisms of action of these cytokines.	[Park, Sung Ho; Kang, Kyuho; Giannopoulou, Eugenia; Qiao, Yu; Kim, Geonho; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Park, Sung Ho; Kang, Kyuho; Giannopoulou, Eugenia; Qiao, Yu; Kim, Geonho; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Giannopoulou, Eugenia] CUNY, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY 11210 USA; [Kang, Keunsoo] Dankook Univ, Dept Microbiol, Cheonan, Chungnam, South Korea; [Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA	City University of New York (CUNY) System; Dankook University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.; Ivashkiv, LB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.; Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	ivashkivl@hss.edu	Giannopoulou, Evgenia/K-9576-2019; Kang, Kyuho/AAK-1628-2020	Kang, Kyuho/0000-0003-3448-5336; Ivashkiv, Lionel/0000-0002-9951-0646; Kim, Geonho/0000-0002-1552-6932	US National Institutes of Health; Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712, R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR050401] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Pernis and I. Rogatsky for discussions and review of the manuscript, and F. Barrat (Hospital for Special Surgery) for monocytes from donors with SLE. Supported by the US National Institutes of Health and The Tow Foundation (for the David Z. Rosensweig Genomics Center).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ivashkiv LB, 2003, AUTOIMMUNITY, V36, P473, DOI 10.1080/08916930310001605882; Ivashkiv LB, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0010-2015; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan Q, 2012, P NATL ACAD SCI USA, V109, P14140, DOI 10.1073/pnas.1119842109; Zhang Z, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0179-4	47	120	120	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1104	+		10.1038/ni.3818	http://dx.doi.org/10.1038/ni.3818			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28825701	Green Accepted			2022-12-18	WOS:000411134000015
J	Li, X; Zhang, Q; Ding, YY; Liu, YQ; Zhao, DZ; Zhao, K; Shen, QC; Liu, XG; Zhu, XH; Li, N; Cheng, ZY; Fan, GP; Wang, QQ; Cao, XT				Li, Xia; Zhang, Qian; Ding, Yuanyuan; Liu, Yiqi; Zhao, Dezhi; Zhao, Kai; Shen, Qicong; Liu, Xingguang; Zhu, Xuhui; Li, Nan; Cheng, Zhongyi; Fan, Guoping; Wang, Qingqing; Cao, Xuetao			Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity	NATURE IMMUNOLOGY			English	Article							TRIGGERED INFLAMMATORY RESPONSES; IKK-RELATED KINASES; DNA METHYLATION; HISTONE DEACETYLASE; GENE-EXPRESSION; I INTERFERON; NEGATIVE REGULATION; TRANSCRIPTION; ACETYLATION; DEGRADATION	The DNA methyltransferase Dnmt3a has high expression in terminally differentiated macrophages; however, its role in innate immunity remains unknown. Here we report that deficiency in Dnmt3a selectively impaired the production of type I interferons triggered by pattern-recognition receptors (PRRs), but not that of the proinflammatory cytokines TNF and IL-6. Dnmt3a-deficient mice exhibited enhanced susceptibility to viral challenge. Dnmt3a did not directly regulate the transcription of genes encoding type I interferons; instead, it increased the production of type I interferons through an epigenetic mechanism by maintaining high expression of the histone deacetylase HDAC9. In turn, HDAC9 directly maintained the deacetylation status of the key PRR signaling molecule TBK1 and enhanced its kinase activity. Our data add mechanistic insight into the crosstalk between epigenetic modifications and post-translational modifications in the regulation of PRR signaling and activation of antiviral innate immune responses.	[Li, Xia; Ding, Yuanyuan; Liu, Yiqi; Zhao, Dezhi; Wang, Qingqing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xia; Zhang, Qian; Zhao, Kai; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Li, Xia; Zhang, Qian; Zhao, Kai; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; [Zhang, Qian; Shen, Qicong; Liu, Xingguang; Zhu, Xuhui; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Zhang, Qian; Shen, Qicong; Liu, Xingguang; Zhu, Xuhui; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Cheng, Zhongyi] Tongji Univ, Adv Translat Med Inst, Shanghai 200092, Peoples R China; [Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA	Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, QQ; Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.	wqq@zju.edu.cn; caoxt@immunol.org	shen, qicong/GYJ-2803-2022; Liu, Yiqi/AAK-1630-2020; Li, Xia/AAB-9647-2019		National Key Basic Research Program of China [2013CB530502]; National Natural Science Foundation of China [31390431, 31370864, 31200654]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J. Zhu and N. Wang for mass-spectrometry analysis; Z. Chen (University of Texas Southwestern Medical Center) for the L929-shSTING cell line; B. Sun (Chinese Academy of Sciences) for SeV; and Q. Li (Chinese Academy of Medical Sciences) for HSV-1 virus (Kos strain). Supported by the National Key Basic Research Program of China (2013CB530502) and National Natural Science Foundation of China (31390431, 31370864 and 31200654).	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chen C, 2013, VIROLOGY, V441, P57, DOI 10.1016/j.virol.2013.03.005; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Halpern KB, 2014, J BIOL CHEM, V289, P23882, DOI 10.1074/jbc.M114.573469; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Marr AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004419; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rowles DL, 2015, PROTEOMICS, V15, P1968, DOI 10.1002/pmic.201500035; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Saul VV, 2015, BBA-MOL CELL RES, V1853, P136, DOI 10.1016/j.bbamcr.2014.10.008; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vivekanandan P, 2010, J VIROL, V84, P4321, DOI 10.1128/JVI.02280-09; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043756; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351	53	120	128	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					806	+		10.1038/ni.3464	http://dx.doi.org/10.1038/ni.3464			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27240213	Green Published			2022-12-18	WOS:000378283200013
J	Xing, SJ; Li, FY; Zeng, ZH; Zhao, YJ; Yu, SY; Shan, Q; Li, YL; Phillips, FC; Maina, PK; Qi, HH; Liu, CY; Zhu, J; Pope, RM; Musselman, CA; Zeng, C; Peng, WQ; Xue, HH				Xing, Shaojun; Li, Fengyin; Zeng, Zhouhao; Zhao, Yunjie; Yu, Shuyang; Shan, Qiang; Li, Yalan; Phillips, Farrah C.; Maina, Peterson K.; Qi, Hank H.; Liu, Chengyu; Zhu, Jun; Pope, R. Marshall; Musselman, Catherine A.; Zeng, Chen; Peng, Weiqun; Xue, Hai-Hui			Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity	NATURE IMMUNOLOGY			English	Article							HISTONE DEACETYLASES; CRYSTAL-STRUCTURE; LINEAGE CHOICE; SEQ DATA; DIFFERENTIATION; MODEL; SPECIFICATION; PROGENITORS; MECHANISMS; INHIBITORS	The CD4(+) and CD8(+) T cell dichotomy is essential for effective cellular immunity. How individual T cell identity is established remains poorly understood. Here we show that the high-mobility group (HMG) transcription factors Tcf1 and Lef1 are essential for repressing CD4(+) lineage-associated genes including Cd4, Foxp3 and Rorc in CD8(+) T cells. Tcf1(-) and Lef1-deficient CD8(+) T cells exhibit histone hyperacetylation, which can be ascribed to intrinsic histone deacetylase (HDAC) activity in Tcf1 and Lef1. Mutation of five conserved amino acids in the Tcf1 HDAC domain diminishes HDAC activity and the ability to suppress CD4+ lineage genes in CD8(+) T cells. These findings reveal that sequence-specific transcription factors can utilize intrinsic HDAC activity to guard cell identity by repressing lineage-inappropriate genes.	[Xing, Shaojun; Li, Fengyin; Shan, Qiang; Phillips, Farrah C.; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Zeng, Zhouhao; Zhao, Yunjie; Zeng, Chen; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Yu, Shuyang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Yalan; Pope, R. Marshall] Univ Iowa, Prote Facil, Iowa City, IA USA; [Phillips, Farrah C.; Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA USA; [Maina, Peterson K.; Qi, Hank H.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhu, Jun] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Musselman, Catherine A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Phillips, Farrah C.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA	University of Iowa; George Washington University; China Agricultural University; University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Iowa; St Jude Children's Research Hospital	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.; Peng, WQ (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.; Xue, HH (corresponding author), Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA USA.	wpeng@gwu.edu; hai-hui-xue@uiowa.edu	/AAI-2516-2019; Li, Fengyin/AAG-9476-2019	Musselman, Catherine/0000-0002-8356-7971; Xue, Hai-Hui/0000-0002-9163-7669; Peng, Weiqun/0000-0001-5521-9091; Qi, Hank/0000-0002-3401-4940; Shan, Qiang/0000-0002-7089-0278; Xing, Shaojun/0000-0003-0777-2196; Maina, Peterson/0000-0002-5909-190X	American Cancer Society [RSG-11-161-01-MPC]; NIH [AI112579, AI105351, AI115149, AI119160, AI113806]; US National Science Foundation (CAREER Award) [1452411]; Carver Trust Young Investigator Award [01-224]; Intramural Research Program of the NHLBI; Div Of Molecular and Cellular Bioscience [1452411] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL006230, ZICHL005907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113806, R01AI112579, R21AI105351, R21AI115149, R21AI119160] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016199] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (CAREER Award)(National Science Foundation (NSF)); Carver Trust Young Investigator Award; Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank A. Kalen (the Radiation Core facility, University of Iowa) for mouse irradiation and I. Antoshechkin (California Institute of Technology) for RNA-seq. We thank H. Kawamoto (Kyoto University) for Tcf1 antiserum, H. Habelhah for advice on purification of recombinant proteins, and J.T. Harty, J.D. Colgan and A. Bhandoola for critical reading and insightful discussion of the manuscript. We thank the Flow Cytometry Core Facility (J. Fishbaugh, H. Vignes and G. Rasmussen, University of Iowa) for cell sorting; the Flow Cytometry Core Facility is supported by the Carver College of Medicine/Holden Comprehensive Cancer Center (the University of Iowa), the Iowa City Veteran's Administration Medical Center, and the National Center for Research Resources of the NIH (1 S10 OD016199). The Proteomics Facility (University of Iowa) is supported by an endowment from the Carver Family trust. This study is supported by grants from the American Cancer Society (RSG-11-161-01-MPC to H.-H.X.), the NIH (AI112579, AI105351, AI115149 and AI119160 to H.-H.X. and AI113806 to W.P.), the US National Science Foundation (CAREER Award 1452411 to C.A.M.) and the Carver Trust Young Investigator Award (01-224) to H.H.Q.; J.Z. and C.L. are supported by the Intramural Research Program of the NHLBI.	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boucheron N, 2014, NAT IMMUNOL, V15, P439, DOI 10.1038/ni.2864; Cabrero JR, 2006, MOL BIOL CELL, V17, P3435, DOI 10.1091/mbc.E06-01-0008; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fisher AG, 2002, NAT REV IMMUNOL, V2, P977, DOI 10.1038/nri958; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Haery Leila, 2015, Genes Cancer, V6, P184; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Langmead B., 2010, CURR PROTOC BIOINFOR, V11; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Rothenberg EV, 2012, CURR TOP MICROBIOL, V356, P117, DOI 10.1007/82_2011_168; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yankulov K, 2013, BIOCHEM CELL BIOL, V91, P6, DOI 10.1139/bcb-2012-0048; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yu SY, 2012, CELL STEM CELL, V11, P207, DOI 10.1016/j.stem.2012.05.021; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	120	122	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					695	+		10.1038/ni.3456	http://dx.doi.org/10.1038/ni.3456			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27111144	Green Accepted			2022-12-18	WOS:000376162200014
J	Malhotra, D; Linehan, JL; Dileepan, T; Lee, YJ; Purtha, WE; Lu, JV; Nelson, RW; Fife, BT; Orr, HT; Anderson, MS; Hogquist, KA; Jenkins, MK				Malhotra, Deepali; Linehan, Jonathan L.; Dileepan, Thamotharampillai; Lee, You Jeong; Purtha, Whitney E.; Lu, Jennifer V.; Nelson, Ryan W.; Fife, Brian T.; Orr, Harry T.; Anderson, Mark S.; Hogquist, Kristin A.; Jenkins, Marc K.			Tolerance is established in polyclonal CD4(+) T cells by distinct mechanisms, according to self-peptide expression patterns	NATURE IMMUNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; PERIPHERAL TOLERANCE; TRANSCRIPTION FACTOR; NEGATIVE SELECTION; GENE-EXPRESSION; TRANSGENIC MICE; VIRUS-INFECTION; IN-VIVO; REPERTOIRE; IMPACT	Studies of repertoires of mouse monoclonal CD4(+) T cells have revealed several mechanisms of self-tolerance; however, which mechanisms operate in normal repertoires is unclear. Here we studied polyclonal CD4(+) T cells specific for green fluorescent protein expressed in various organs, which allowed us to determine the effects of specific expression patterns on the same epitope-specific T cells. Peptide's presented uniformly by thymic antigen-presenting cells were tolerated by clonal deletion, whereas peptides excluded from the thymus were ignored. Peptides with limited thymic expression induced partial clonal deletion and impaired effector T cell potential but enhanced regulatory T cell potential. These mechanisms were also active for T cell populations specific for endogenously expressed self antigens. Thus, the immunotolerance of polyclonal CD4(+) T cells was maintained by distinct mechanisms, according to self-peptide expression patterns.	[Malhotra, Deepali; Linehan, Jonathan L.; Dileepan, Thamotharampillai; Nelson, Ryan W.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Lee, You Jeong; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Purtha, Whitney E.; Lu, Jennifer V.; Anderson, Mark S.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Fife, Brian T.] Univ Minnesota, Sch Med, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Linehan, Jonathan L.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.	Jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; Lee, You Jeong/T-6086-2019; Fife, Brian/D-2042-2013	Jenkins, Marc K/0000-0001-8009-7655; Fife, Brian/0000-0001-9826-5637; Malhotra, Deepali/0000-0002-8215-7639; Orr, Harry/0000-0001-6118-741X; Nelson, Ryan/0000-0003-2327-9481; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996	US National Institutes of Health [P01 AI35296, F32 AI114050, T32 GM008244, F30 DK093242, T32 AI07313, K99 AI114884]; Wallin Neuroscience Discovery Fund; Juvenile Diabetes Research Foundation [2-2011-662]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI097457, K99AI114884, F32AI114050, T32AI007334, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101622] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallin Neuroscience Discovery Fund; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Mueller for reviewing the manuscript; J. Walter and O. Rainwater for technical assistance; P. Lauer (and Aduro Biotech) for the Lm-eGFP strain PL1113. Supported by the US National Institutes of Health (P01 AI35296 to M.K.J. and K.A.H.; F32 AI114050 to D.M.; T32 GM008244 and F30 DK093242 to R.W.N.; T32 AI07313 to J.L.L.; K99 AI114884 to Y.J.L.), the Wallin Neuroscience Discovery Fund (to H.T.O. and M.K.J.) and the Juvenile Diabetes Research Foundation (2-2011-662 to B.T.F.).	Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Ben-Yehudah A, 2005, GENESIS, V43, P166, DOI 10.1002/gene.20165; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Carreres MI, 2011, J NEUROSCI, V31, P5673, DOI 10.1523/JNEUROSCI.0394-11.2011; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kobayashi A, 2014, STEM CELL REP, V3, P650, DOI 10.1016/j.stemcr.2014.08.008; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Panneck AR, 2014, CELL TISSUE RES, V358, P737, DOI 10.1007/s00441-014-2002-x; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Semana G, 1999, J AUTOIMMUN, V12, P259, DOI 10.1006/jaut.1999.0282; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; WARREN HS, 1986, ANNU REV IMMUNOL, V4, P369, DOI 10.1146/annurev.iy.04.040186.002101; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	50	120	120	0	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					187	195		10.1038/ni.3327	http://dx.doi.org/10.1038/ni.3327			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26726812	Green Accepted, Green Submitted			2022-12-18	WOS:000368571500012
J	Nechanitzky, R; Akbas, D; Scherer, S; Gyory, I; Hoyler, T; Ramamoorthy, S; Diefenbach, A; Grosschedl, R				Nechanitzky, Robert; Akbas, Duygu; Scherer, Stefanie; Gyoery, Ildiko; Hoyler, Thomas; Ramamoorthy, Senthilkumar; Diefenbach, Andreas; Grosschedl, Rudolf			Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells	NATURE IMMUNOLOGY			English	Article							LINEAGE SPECIFICATION; GENE-EXPRESSION; T-CELLS; COMMITMENT; PAX5; FOXO1; STEM; DIFFERENTIATION; REARRANGEMENTS; INTERLEUKIN-7	The transcription factors EBF1 and Pax5 have been linked to activation of the B cell lineage program and irreversible loss of alternative lineage potential (commitment), respectively. Here we conditionally deleted Ebf1 in committed pro-B cells after transfer into alymphoid mice. We found that those cells converted into innate lymphoid cells (ILCs) and T cells with variable-diversity- joining (VDJ) rearrangements of loci encoding both B cell and T cell antigen receptors. As intermediates in lineage conversion, Ebf1-deficient CD19(+) cells expressing Pax5 and transcriptional regulators of the ILC and T cell fates were detectable. In particular, genes encoding the transcription factors Id2 and TCF-1 were bound and repressed by EBF1. Thus, both EBF1 and Pax5 are required for B lineage commitment by repressing distinct and common determinants of alternative cell fates.	[Nechanitzky, Robert; Akbas, Duygu; Scherer, Stefanie; Gyoery, Ildiko; Ramamoorthy, Senthilkumar; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, Freiburg, Germany; [Hoyler, Thomas; Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, Freiburg, Germany.	grosschedl@ie-freiburg.mpg.de	Ramamoorthy, Senthilkumar/E-9325-2017; Ramamoorthy, Senthilkumar/AAT-1088-2021; Diefenbach, Andreas/T-2589-2018	Ramamoorthy, Senthilkumar/0000-0003-3468-4247; Diefenbach, Andreas/0000-0002-9176-9530; Hoyler, Thomas/0000-0003-4798-3692; Nechanitzky, Robert/0000-0002-0429-0688	Max Planck Society; German Research Foundation	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	We thank J.C. Zuniga-Pfucker (University of Toronto) for OP9 and OP9-DL1 cells; J. Kisielow (Eidgenossische Technische Hochschule) for the Beko pre-T cell line; M. Busslinger (Institute of Molecular Pathology, Vienna) for Pax5<SUP>-/-</SUP> mice; H. Singh (Genentech) for discussions and advice about the culture of Ebf1<SUP>-/-</SUP> pre-pro-B cells; I. Falk, S. Fietze and U. Stauffer for help with flow cytometry, genotyping and intravenous injection of mice; A. Rolink, J. Kirberg and F. Savarese and members of the Grosschedl laboratory for discussions; D. van Essen for critical comments on the manuscript; and M. Rott for help in preparing the figures and manuscript. Supported by the Max Planck Society (R.G.) and the German Research Foundation (R.G. and A.D.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ichii M, 2010, IMMUNOL REV, V237, P10, DOI 10.1111/j.1600-065X.2010.00933.x; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; Klose CSN, 2012, CURR OPIN IMMUNOL, V24, P290, DOI 10.1016/j.coi.2012.04.004; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welinder E, 2011, SEMIN IMMUNOL, V23, P335, DOI 10.1016/j.smim.2011.08.005; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109	50	120	121	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					867	+		10.1038/ni.2641	http://dx.doi.org/10.1038/ni.2641			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23812095				2022-12-18	WOS:000322010600016
J	Zhong, B; Liu, XK; Wang, XH; Chang, SH; Liu, XD; Wang, AB; Reynolds, JM; Dong, C				Zhong, Bo; Liu, Xikui; Wang, Xiaohu; Chang, Seon Hee; Liu, Xindong; Wang, Aibo; Reynolds, Joseph M.; Dong, Chen			Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; UNANCHORED POLYUBIQUITIN CHAINS; RECEPTOR-ASSOCIATED FACTOR-6; INTERLEUKIN-17 RECEPTOR; IL-17-PRODUCING CELLS; MESSENGER-RNA; KINASE; ACT1; ACTIVATION; RESPONSES	Interleukin 17 (IL-17) is important in infection and autoimmunity; how it signals remains poorly understood. In this study, we identified the ubiquitin-specific protease USP25 as a negative regulator of IL-17-mediated signaling and inflammation. Overexpression of USP25 inhibited IL-17-triggered signaling, whereas USP25 deficiency resulted in more phosphorylation of the inhibitor I kappa B alpha and kinase Jnk and higher expression of chemokines and cytokines, as well as a prolonged half-life for chemokine CXCL1-encoding mRNA after treatment with IL-17. Consistent with that, Usp25(-/-) mice showed greater sensitivity to IL-17-dependent inflammation and autoimmunity in vivo. Mechanistically, stimulation with IL-17 induced the association of USP25 with the adaptors TRAF5 and TRAF6, and USP25 induced removal of Lys63-linked ubiquitination in TRAF5 and TRAF6 mediated by the adaptor Act1. Thus, our results demonstrate that USP25 is a deubiquitinating enzyme (DUB) that negatively regulates IL-17-triggered signaling.	[Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009; liu, xindong/F-8422-2014; Chang, Seon Hee/AAQ-9521-2020	dong, chen/0000-0002-0084-9130; Chang, Seon Hee/0000-0002-9389-508X; Liu, Xindong/0000-0002-2465-0337; Reynolds, Joseph/0000-0003-3490-0544	US National Institutes of Health; University of Texas MD Anderson Cancer Center; CFP foundation of MD Anderson Cancer Center; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050761, U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; CFP foundation of MD Anderson Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Marfany (University of Barcelona) for rabbit anti-USP25; T. Hamilton (Cleveland Clinic) for Tet-Off HeLa cells and pTRE2-KC Delta 4 plasmid; Z. Chen (UT Southwestern Medical Center) for hemagglutinin-tagged ubiquitin (K48 only and K63 only) and suggestions; H.-B. Shu (Wuhan University) for mouse anti-TRAF6, plasmids encoding TRAF1-TRAF6 and suggestions; and members of Dong laboratory for technical help. Supported by the US National Institutes of Health, the University of Texas MD Anderson Cancer Center, the CFP foundation of MD Anderson Cancer Center (B.Z.) and the Leukemia and Lymphoma Society (CD.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; He JQ, 2007, ADV EXP MED BIOL, V597, P48; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; May MJ, 2011, NAT IMMUNOL, V12, P813, DOI 10.1038/ni.2093; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Valero R, 1999, GENOMICS, V62, P395, DOI 10.1006/geno.1999.6025; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	44	120	130	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1110	1117		10.1038/ni.2427	http://dx.doi.org/10.1038/ni.2427			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23042150	Green Accepted			2022-12-18	WOS:000310091700014
J	Cruz-Munoz, ME; Dong, ZJ; Shi, XC; Zhang, SH; Veillette, A				Cruz-Munoz, Mario-Ernesto; Dong, Zhongjun; Shi, Xiaochu; Zhang, Shaohua; Veillette, Andre			Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function	NATURE IMMUNOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; GENE-PRODUCT SAP/SH2D1A; 2B4 CD244; T-CELLS; SIGNALING PATHWAY; IMMUNE-RESPONSES; CUTTING EDGE; B-CELLS; SAP; MOLECULE	CRACC is a self-associating member of the signaling lymphocytic activation molecule family that is expressed on cells of the immune system, including natural killer cells and activated T cells. Here we examine the function and mechanism of action of CRACC using several complementary approaches, including the generation of a CRACC-deficient mouse. Our results demonstrate that CRACC positively regulated natural killer cell functions by a mechanism dependent on the adaptor EAT-2 but not the related adaptor SAP. However, in the absence of EAT-2, CRACC potently inhibited natural killer cell function. CRACC was also inhibitory in T cells, which are typically devoid of EAT-2. Thus, CRACC can exert activating or inhibitory influences on cells of the immune system depending on cellular context and the availability of effector proteins.	[Cruz-Munoz, Mario-Ernesto; Dong, Zhongjun; Shi, Xiaochu; Zhang, Shaohua; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca			Canadian Institutes of Health Research; Canadian Cancer Society; Howard Hughes Medical Institute; Cancer Research Society; Canada Research Chair Program; Clinical Research Institute of Montreal; Terry Fox Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research Society; Canada Research Chair Program(Canada Research Chairs); Clinical Research Institute of Montreal; Terry Fox Foundation	We thank S. Latour for critical reading of the manuscript; J. Drouin (Clinical Research Institute of Montreal) for pJA1617; and J. Penninger (Institute for Molecular Biotechnology) for pCAGGS- Flpe. Supported by the Canadian Institutes of Health Research (A. V. and Z. D.), the Canadian Cancer Society (A. V. and M.- E. C.- M.), the Howard Hughes Medical Institute (A. V.), the Cancer Research Society (M.- E. C.- M.), the Canada Research Chair Program (A. V.), the Clinical Research Institute of Montreal (Z. D.) and the Terry Fox Foundation M.- E. C.- M.).	Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; HABU S, 1981, J IMMUNOL, V127, P34; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kumaresan PR, 2002, MOL IMMUNOL, V39, P1, DOI 10.1016/S0161-5890(02)00094-9; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li CJ, 2003, J BIOL CHEM, V278, P3852, DOI 10.1074/jbc.M206649200; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; MATHEW PA, 1993, J IMMUNOL, V151, P5328; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Stark S, 2006, INT IMMUNOL, V18, P241, DOI 10.1093/intimm/dxh358; Tai YT, 2007, BLOOD, V110, p732A, DOI 10.1182/blood.V110.11.2481.2481; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tovar V, 2002, IMMUNOGENETICS, V54, P394, DOI 10.1007/s00251-002-0483-3; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Veillette A, 2006, TRENDS IMMUNOL, V27, P228, DOI 10.1016/j.it.2006.03.003; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	42	120	124	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					297	305		10.1038/ni.1693	http://dx.doi.org/10.1038/ni.1693			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19151721				2022-12-18	WOS:000263456500014
J	Groh, V; Smythe, K; Dai, ZP; Spies, T				Groh, Veronika; Smythe, Kimberly; Dai, Zhenpeng; Spies, Thomas			Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity	NATURE IMMUNOLOGY			English	Article							NK CELLS; MIC LIGANDS; ACTIVATION; EXPRESSION; ENGAGEMENT; APOPTOSIS; COSTIMULATION; STIMULATION; RECOGNITION; LYMPHOCYTES	Tumor-associated ligands of the activating NKG2D receptor can effectively stimulate T cell responses at early but not late stages of tumor growth. In late-stage human tumor settings, we observed MIC-driven proliferation of NKG2D(+) CD4(+) T cells that produced the cytokine Fas ligand (FasL) as a result of NKG2D costimulation but were themselves protected from Fas-mediated growth arrest. In contrast, FasL suppressed proliferation of T cells in vitro that did not receive NKG2D costimulation. Similar observations with normal peripheral blood NKG2D(+)CD8(+) T cells demonstrated unrecognized NKG2D-mediated immune functions, whereby FasL release promotes tumor cell death and NKG2D costimulation prolongs T cell survival. These effects, beneficial in conditions of limited NKG2D ligand expression, may be counterweighed when massive expression and shedding of MIC occurs, such as in some late-stage tumors, that causes sustained NKG2D costimulation and population expansion of immunosuppressive T cells.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Groh, V (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA.	vgroh@fhcrc.org; tspies@fhcrc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030581, R37AI030581, R01AI052319] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30581, AI52319] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bosque A, 2005, EUR J IMMUNOL, V35, P1812, DOI 10.1002/eji.200526046; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Ebert EC, 2004, CLIN EXP IMMUNOL, V138, P259, DOI 10.1111/j.1365-2249.2004.02614.x; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Groh V, 2005, P NATL ACAD SCI USA, V102, P6461, DOI 10.1073/pnas.0501953102; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kriegeskorte AK, 2005, P NATL ACAD SCI USA, V102, P11805, DOI 10.1073/pnas.0502026102; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Leibson PJ, 2004, CURR OPIN IMMUNOL, V16, P328, DOI 10.1016/j.coi.2004.03.006; Levings AK, 2005, CURR TOP MICROBIOL, V293, P303; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Maccalli C, 2003, EUR J IMMUNOL, V33, P2033, DOI 10.1002/eji.200323909; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Poggi A, 2005, EUR J IMMUNOL, V35, P2670, DOI 10.1002/eji.200526177; Poggi A, 2005, J IMMUNOL, V174, P2653, DOI 10.4049/jimmunol.174.5.2653; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Rosen DB, 2004, J IMMUNOL, V173, P2470, DOI 10.4049/jimmunol.173.4.2470; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	37	120	127	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					755	762		10.1038/ni1350	http://dx.doi.org/10.1038/ni1350			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16732291				2022-12-18	WOS:000238377700021
J	Ladi, E; Yin, XY; Chtanova, T; Robey, EA				Ladi, E; Yin, XY; Chtanova, T; Robey, EA			Thymic microenvironments for T cell differentiation and selection	NATURE IMMUNOLOGY			English	Review							PROMISCUOUS GENE-EXPRESSION; POSITIVE SELECTION; LYMPHOCYTE DEVELOPMENT; ALPHA-BETA; RECEPTOR GAMMA-DELTA(+); PROGENITOR LOCALIZATION; THYMOCYTE EMIGRATION; EPITHELIAL-CELLS; SELF-TOLERANCE; MIGRATION	The adult thymus provides a variety of specialized microenvironments that support and direct T cell differentiation and selection. In this review, we summarize recent advances in the understanding of the function of microenvironments in shaping a diverse T cell repertoire. In particular, we focus on how thymocytes move in and out of these specialized thymic compartments in response to homing signals, differential chemokine gradients and other factors that regulate T cell migration. In addition, we discuss the diverse developmental signals provided by these microenvironments that contribute to the generation of divergent T cell lineages.	Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robey, EA (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	erobey@berkeley.edu		Chtanova, Tatyana/0000-0003-3419-4483	NIAID NIH HHS [AI053030, AI32985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032985] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Barbee SD, 2005, J IMMUNOL, V174, P1230, DOI 10.4049/jimmunol.174.3.1230; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Choi EY, 1997, HUM IMMUNOL, V54, P15, DOI 10.1016/S0198-8859(97)00012-8; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Clegg CH, 1996, NATURE, V384, P261, DOI 10.1038/384261a0; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Derbinski J, 2005, TRENDS IMMUNOL, V26, P503, DOI 10.1016/j.it.2005.07.006; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dooley J, 2005, J IMMUNOL, V175, P4331, DOI 10.4049/jimmunol.175.7.4331; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Forestier C, 2003, J IMMUNOL, V171, P4096, DOI 10.4049/jimmunol.171.8.4096; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Havran W L, 1991, Semin Immunol, V3, P89; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Li W, 2005, IMMUNITY, V23, P375, DOI 10.1016/j.immuni.2005.09.002; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729, DOI 10.1038/77288; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Ramsey C, 2002, HUM MOL GENET, V11, P3299, DOI 10.1093/hmg/11.26.3299; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Robey E, 2005, IMMUNITY, V22, P533, DOI 10.1016/j.immuni.2005.04.005; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shortman K, 1990, Semin Immunol, V2, P3; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Terra R, 2005, BLOOD, V106, P193, DOI 10.1182/blood-2004-12-4886; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Zerrahn J, 1999, P NATL ACAD SCI USA, V96, P11470, DOI 10.1073/pnas.96.20.11470; Zubkova I, 2005, J IMMUNOL, V175, P2321, DOI 10.4049/jimmunol.175.4.2321; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	90	120	123	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					338	343		10.1038/ni1323	http://dx.doi.org/10.1038/ni1323			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550196				2022-12-18	WOS:000236171000004
J	Turner, SJ; Kedzierska, K; Komodromou, H; La Gruta, NL; Dunstone, MA; Webb, AI; Webby, R; Walden, H; Xie, WD; McCluskey, J; Purcell, AW; Rossjohn, J; Doherty, PC				Turner, SJ; Kedzierska, K; Komodromou, H; La Gruta, NL; Dunstone, MA; Webb, AI; Webby, R; Walden, H; Xie, WD; McCluskey, J; Purcell, AW; Rossjohn, J; Doherty, PC			Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8(+) T cell populations	NATURE IMMUNOLOGY			English	Article							INFLUENZA-A VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RECEPTOR BETA-CHAIN; IMMUNODOMINANCE HIERARCHIES; NUCLEOPROTEIN EPITOPE; ANTIGEN RECEPTOR; STRUCTURAL BASIS; TRANSGENIC MICE; MATRIX PEPTIDE; ALPHA-CHAIN	Using both 'reverse genetics' and structural analysis, we have examined the in vivo relationship between antigenicity and T cell receptor (TCR) repertoire diversity. Influenza A virus infection of C57BL/6 mice induces profoundly different TCR repertoires specific for the nucleoprotein peptide of amino acids 366 - 374 (NP366) and the acid polymerase peptide of amino acids 224 - 233 (PA224) presented by H-2D(b). Here we show the H-2D(b) - NP366 complex with a 'featureless' structure selected a limited TCR repertoire characterized by 'public' TCR usage. In contrast, the prominent H-2D(b) - PA224 complex selected diverse, individually 'private' TCR repertoires. Substitution of the arginine at position 7 of PA224 with an alanine reduced the accessible side chains of the epitope. Infection with an engineered virus containing a mutation at the site encoding the exposed arginine at position 7 of PA224 selected a restricted TCR repertoire similar in diversity to that of the H-2D(b) - NP366 - specific response. Thus, the lack of prominent features in an antigenic complex of peptide and major histocompatibility complex class I is associated with a diminished spectrum of TCR usage.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Monash Univ, Dept Biochem & Mol Biol, Monash Ctr Syn, Protein Crystallog Unit, Clayton, Vic 3800, Australia; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Melbourne; Monash University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Turner, SJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	sjturn@unimelb.edu.au	Purcell, Anthony/AAH-1942-2019; Turner, Stephen/GXM-4654-2022; Webby, Richard J/N-5657-2018; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Dunstone, Michelle/I-2895-2014; Doherty, Peter Charles/C-4185-2013	Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Dunstone, Michelle/0000-0002-6026-648X; Kedzierska, Katherine/0000-0001-6141-335X; Turner, Stephen/0000-0002-1002-0000; Doherty, Peter Charles/0000-0002-5028-3489; La Gruta, Nicole/0000-0001-5358-9363	NIAID NIH HHS [AI29579] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029579, R37AI029579] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AEBISCHER T, 1990, EUR J IMMUNOL, V20, P523, DOI 10.1002/eji.1830200310; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.3.CO;2-Q; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; DAVIS MM, 1999, FUNDAMENTAL IMMUNOLO, P341; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; MAN S, 1994, J IMMUNOL, V153, P4458; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Maryanski JL, 1997, HUM IMMUNOL, V54, P117, DOI 10.1016/S0198-8859(97)00082-7; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Plebanski M, 1999, NAT MED, V5, P565, DOI 10.1038/8444; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Turner SJ, 1997, J IMMUNOL, V159, P2312; Turner SJ, 1996, J IMMUNOL, V157, P4979; Turner SJ, 2004, SEMIN IMMUNOL, V16, P179, DOI 10.1016/j.smim.2004.02.005; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Turner SJ, 2003, IMMUNITY, V18, P549, DOI 10.1016/S1074-7613(03)00087-6; Wang FM, 1998, P NATL ACAD SCI USA, V95, P5217, DOI 10.1073/pnas.95.9.5217; Webb AI, 2004, J IMMUNOL, V173, P402, DOI 10.4049/jimmunol.173.1.402; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; YANAGI Y, 1990, J VIROL, V64, P5919, DOI 10.1128/JVI.64.12.5919-5926.1990; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	48	120	123	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					382	389		10.1038/ni1175	http://dx.doi.org/10.1038/ni1175			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15735650				2022-12-18	WOS:000227860000012
J	Jude, BA; Pobezinskaya, Y; Bishop, J; Parke, S; Medzhitov, RM; Chervonsky, AV; Golovkina, TV				Jude, BA; Pobezinskaya, Y; Bishop, J; Parke, S; Medzhitov, RM; Chervonsky, AV; Golovkina, TV			Subversion of the innate immune system by a retrovirus	NATURE IMMUNOLOGY			English	Article							MAMMARY-TUMOR VIRUS; TOLL-LIKE RECEPTOR-4; B-CELLS; IN-VIVO; T-CELLS; CUTTING EDGE; MOUSE; MICE; INFECTION; GENE	Retroviruses evolve rapidly to avoid the immune response of the infected host. We show here that the wild-type mouse mammary tumor virus MMTV(C3H) persisted indefinitely in C3H/HeN mice. However, it was rapidly lost in mice of the closely related C3H/HeJ strain and was replaced by a virus recombinant with an endogenous Mtv provirus. Maintenance of the wild-type virus was dependent on Toll-like receptor-4 (TLR4) signaling, which triggered production of the immunosuppressive cytokine interleukin-10. In the presence of mutant TLR4 in C3H/HeJ mice, wild-type virus was eliminated by the cytotoxic immune response, promoting selection of the immune escape recombinant MMTV variants. Thus, subversion of the innate immune system is yet another survival strategy used by retroviruses.	Jackson Lab, Bar Harbor, ME 04609 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, HHMI, New Haven, CT 06510 USA	Jackson Laboratory; Yale University; Howard Hughes Medical Institute; Yale University	Golovkina, TV (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.			Chervonsky, Alexander/0000-0001-7547-871X; Jude, Brooke/0000-0003-0384-8173				ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; BEUTNER U, 1994, J EXP MED, V179, P1457, DOI 10.1084/jem.179.5.1457; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Coffin John M., 1996, P763; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; GLODE LM, 1976, J IMMUNOL, V117, P2061; GOLOVKINA TV, 1995, P NATL ACAD SCI USA, V92, P4828, DOI 10.1073/pnas.92.11.4828; Golovkina TV, 1998, J IMMUNOL, V161, P2375; GOLOVKINA TV, 1992, CELL, V69, P637, DOI 10.1016/0092-8674(92)90227-4; GOLOVKINA TV, 1994, J VIROL, V68, P5019, DOI 10.1128/JVI.68.8.5019-5026.1994; HELD W, 1993, J EXP MED, V177, P359, DOI 10.1084/jem.177.2.359; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; Hook LM, 2000, J VIROL, V74, P8876, DOI 10.1128/JVI.74.19.8876-8883.2000; Hoshino K, 1999, J IMMUNOL, V162, P3749; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MACDONALD HR, 1989, IMMUNOL REV, V107, P89, DOI 10.1111/j.1600-065X.1989.tb00004.x; Mach N, 2000, CANCER RES, V60, P3239; MARRACK P, 1991, NATURE, V349, P524, DOI 10.1038/349524a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; OUTZEN HC, 1985, J NATL CANCER I, V75, P917, DOI 10.1093/jnci/75.5.917; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preston BD, 1996, TRENDS MICROBIOL, V4, P16, DOI 10.1016/0966-842X(96)81500-9; PUCILLO C, 1993, J EXP MED, V178, P1441, DOI 10.1084/jem.178.4.1441; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Vogel SN, 1999, J IMMUNOL, V162, P5666	37	120	126	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					573	578		10.1038/ni926	http://dx.doi.org/10.1038/ni926			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12730691				2022-12-18	WOS:000183175500017
J	Kang, HS; Chin, RK; Wang, Y; Yu, P; Wang, J; Newell, KA; Fu, YX				Kang, HS; Chin, RK; Wang, Y; Yu, P; Wang, J; Newell, KA; Fu, YX			Signaling via LT beta R on the lamina propria stromal cells of the gut is required for IgA production	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; PERIPHERAL LYMPHOID ORGANS; ALPHA-DEFICIENT MICE; PEYERS-PATCHES; ORAL TOLERANCE; LYMPHOTOXIN ALPHA/BETA; IMMUNE-RESPONSES; FOLLICLES; TISSUE; RESPONSIVENESS	Peyer's patches (PPs) and/or mesenteric lymph nodes (MLNs) are thought to be essential for immunoglobulin A (IgA) production. We found that the severe IgA deficiency in lymphotoxin-deficient (LT-/-) mice could be fully reversed by reconstitution with LT-expressing bone marrow, despite the absence of both LNs and PPs. The number of IgA precursors from LT-/- mice was not reduced, and they were able to migrate into the lamina propria (LP) of wild-type mice but not of LTbetaR(-/-) mice. Consistently, lymphoid tissue chemokines and adhesion molecules were reduced within the LP of LTalpha(-/-) and LTbetaR(-/-) mice. IgA deficiency in LTalpha(-/-) mice was reversed by the transplantation of a segment of RAG-1 (recombination-activating gene 1)-deficient intestine, which confirmed the dispensability of the MLNs and PPs and the sufficiency of the LT-mediated gut microenvironment for IgA production.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	University of Chicago; University of Chicago; Emory University; Emory University	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland, Chicago, IL 60637 USA.	yfu@midway.uchicago.edu		fu, yang-xin/0000-0001-8441-6617	NICHD NIH HHS [HD-37104] Funding Source: Medline; NIDDK NIH HHS [DK-58897] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058897] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; AUCI DL, 1992, J IMMUNOL, V149, P2241; BANKS TA, 1995, J IMMUNOL, V155, P1685; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Davis IA, 1998, CELL IMMUNOL, V189, P116, DOI 10.1006/cimm.1998.1371; Davis IA, 1998, CLIN IMMUNOL IMMUNOP, V89, P150, DOI 10.1006/clin.1998.4601; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, CURR TOP MICROBIOL, V252, P221; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Griebel PJ, 1996, IMMUNOL TODAY, V17, P30, DOI 10.1016/0167-5699(96)80566-4; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Guo Z, 2001, J IMMUNOL, V167, P4796, DOI 10.4049/jimmunol.167.9.4796; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146; Husband AJ, 1999, VET IMMUNOL IMMUNOP, V72, P135, DOI 10.1016/S0165-2427(99)00126-9; Kroese F G, 1996, Semin Immunol, V8, P11, DOI 10.1006/smim.1996.0003; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LEFRANCOIS L, 1996, CURRENT PROTOCOL IMM, V1; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Ryffel B, 1998, Dev Immunol, V6, P253, DOI 10.1155/1998/76963; SANDLER SG, 1995, TRANSFUS MED REV, V9, P1, DOI 10.1016/S0887-7963(05)80026-4; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; STAATS HF, 1994, CURR OPIN IMMUNOL, V6, P572, DOI 10.1016/0952-7915(94)90144-9; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184	43	120	130	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					576	582		10.1038/ni795	http://dx.doi.org/10.1038/ni795			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12006975				2022-12-18	WOS:000175874700018
J	Bald, T; Krummel, MF; Smyth, MJ; Barry, KC				Bald, Tobias; Krummel, Matthew F.; Smyth, Mark J.; Barry, Kevin C.			The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; MHC CLASS-I; MONOCYTE CHEMOTACTIC PROTEIN-1; PERIPHERAL-BLOOD LYMPHOCYTES; AUTOLOGOUS DENDRITIC CELLS; MINIMAL RESIDUAL DISEASE; TUMOR-NECROSIS-FACTOR; KIR ANTIBODY IPH2101; INTERFERON-GAMMA	Natural killer (NK) cells belong to the innate immune system and contribute to protecting the host through killing of infected, foreign, stressed or transformed cells. Additionally, via cellular cross-talk, NK cells orchestrate antitumor immune responses. Hence, significant efforts have been undertaken to exploit the therapeutic properties of NK cells in cancer. Current strategies in preclinical and clinical development include adoptive transfer therapies, direct stimulation, recruitment of NK cells into the tumor microenvironment (TME), blockade of inhibitory receptors that limit NK cell functions, and therapeutic modulation of the TME to enhance antitumor NK cell function. In this Review, we introduce the NK cell-cancer cycle to highlight recent advances in NK cell biology and to discuss the progress and problems of NK cell-based cancer immunotherapies. In this Review, Smyth and colleagues provide an overview of recent advances in NK cell biology and discuss the progress and problems of NK cell-based cancer immunotherapies.	[Bald, Tobias] QIMR Berghofer Med Res Inst, Oncol & Cellular Immunol Lab, Herston, Qld, Australia; [Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, ImmunoX Initiat, San Francisco, CA 94140 USA; [Krummel, Matthew F.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Barry, Kevin C.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA	QIMR Berghofer Medical Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; QIMR Berghofer Medical Research Institute; Fred Hutchinson Cancer Center	Smyth, MJ (corresponding author), QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia.; Barry, KC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA.	mark.smyth@qimrberghofer.edu.au; kbarry@fredhutch.org	Smyth, Mark/H-8709-2014; Bald, Tobias/H-9525-2018	Smyth, Mark/0000-0001-7098-7240; Krummel, Matthew/0000-0001-7915-3533; Bald, Tobias/0000-0003-0061-235X; Barry, Kevin/0000-0003-1064-5964	National Health and Medical Research Council (NHMRC) Early Career Research Fellowship [1138757, 1124690]; NHMRC [1173958, 1132519]; Cancer Research Institute CLIP grant; Cancer Council of Queensland Project Grant [1140251]; NCI [1RO1 CA197363, UOI CA217864]	National Health and Medical Research Council (NHMRC) Early Career Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Institute CLIP grant; Cancer Council of Queensland Project Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.B. was supported by a National Health and Medical Research Council (NHMRC) Early Career Research Fellowship (1138757) and Project Grant (1124690). M.J.S. was supported by a NHMRC Investigator Award (1173958) and Program Grant (1132519), a Cancer Research Institute CLIP grant and a Cancer Council of Queensland Project Grant (1140251). M.F.K. received NCI grants (1RO1 CA197363, UOI CA217864).	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Afolabi LO, 2019, IMMUNOLOGY, V158, P63, DOI 10.1111/imm.13094; Ali TH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6639; ALLAVENA P, 1994, EUR J IMMUNOL, V24, P3233, DOI 10.1002/eji.1830241249; Alspach E, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028480; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Bachanova V, 2018, CANCER IMMUNOL IMMUN, V67, P483, DOI 10.1007/s00262-017-2100-1; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bander NH, 1997, PROSTATE, V33, P233, DOI 10.1002/(SICI)1097-0045(19971201)33:4<233::AID-PROS2>3.0.CO;2-I; Barkholt L, 2009, IMMUNOTHERAPY, V1, P753, DOI 10.2217/IMT.09.47; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Barrow AD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00909; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Beldi-Ferchiou A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102129; Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009; Benson DM, 2015, CLIN CANCER RES, V21, P4055, DOI 10.1158/1078-0432.CCR-15-0304; Benson DM, 2012, BLOOD, V120, P4324, DOI 10.1182/blood-2012-06-438028; Bentebibel SE, 2019, CANCER DISCOV, V9, P711, DOI 10.1158/2159-8290.CD-18-1495; Bernardini G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00402; Bi JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01999; Bjorklund AT, 2018, CLIN CANCER RES, V24, P1834, DOI 10.1158/1078-0432.CCR-17-3196; Bottcher JP, 2018, TRENDS CANCER, V4, P784, DOI 10.1016/j.trecan.2018.09.001; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Broz ML, 2015, CANCER IMMUNOL RES, V3, P313, DOI 10.1158/2326-6066.CIR-15-0041; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Burke JD, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.05.002; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Carlsten M, 2016, CLIN CANCER RES, V22, P5211, DOI 10.1158/1078-0432.CCR-16-1108; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Castriconi R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02324; Castriconi R, 2013, J IMMUNOL, V190, P5321, DOI 10.4049/jimmunol.1202693; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chang YH, 2013, CANCER RES, V73, P1777, DOI 10.1158/0008-5472.CAN-12-3558; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen EB, 2019, THERANOSTICS, V9, P4779, DOI 10.7150/thno.32543; Chen ZQ, 2019, CANCERS, V11, DOI 10.3390/cancers11071040; Chiang SCC, 2013, BLOOD, V121, P1345, DOI 10.1182/blood-2012-07-442558; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Choi PJ, 2013, P NATL ACAD SCI USA, V110, P6488, DOI 10.1073/pnas.1221312110; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329; Cooley S, 2019, BLOOD ADV, V3, P1970, DOI 10.1182/bloodadvances.2018028332; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Cursons J, 2019, CANCER IMMUNOL RES, V7, P1162, DOI 10.1158/2326-6066.CIR-18-0500; de Andrade LF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133103; de Andrade LF, 2018, SCIENCE, V359, P1537, DOI 10.1126/science.aao0505; Degos C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00877; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doberstein SK, 2019, EXPERT OPIN BIOL TH, V19, P1223, DOI 10.1080/14712598.2019.1685489; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Donskov F, 2018, ACTA ONCOL, V57, P589, DOI 10.1080/0284186X.2018.1433324; Felices M, 2016, CLIN CANCER RES, V22, P5161, DOI 10.1158/1078-0432.CCR-16-1582; Felices M, 2016, METHODS MOL BIOL, V1441, P333, DOI 10.1007/978-1-4939-3684-7_28; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Frey M, 1998, J IMMUNOL, V161, P400; Gaggero S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1470730; Gao JQ, 2009, CANCER IMMUNOL IMMUN, V58, P291, DOI 10.1007/s00262-008-0554-x; Gao JQ, 2003, CANCER RES, V63, P4420; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Guo Y, 2017, CYTOKINE GROWTH F R, V38, P10, DOI 10.1016/j.cytogfr.2017.08.002; Haanen JB, 2018, CELL, V175, P1720, DOI 10.1016/j.cell.2018.11.048; Hagenaars M, 1998, INT J CANCER, V78, P783, DOI 10.1002/(SICI)1097-0215(19981209)78:6<783::AID-IJC17>3.0.CO;2-C; Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Hyakudomi M, 2008, ANN SURG ONCOL, V15, P1775, DOI 10.1245/s10434-008-9876-3; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Imamura M, 2014, BLOOD, V124, P1081, DOI 10.1182/blood-2014-02-556837; Ingegnere T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00957; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Josephs SF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1611-7; Kamiya T, 2019, J CLIN INVEST, V129, P2094, DOI 10.1172/JCI123955; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Korde N, 2014, HAEMATOLOGICA, V99, pE81, DOI 10.3324/haematol.2013.103085; Kremer V, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0275-9; Krzywinska E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01599-w; Kumar S, 2018, IMMUNOLOGY, V154, P383, DOI 10.1111/imm.12921; Labrijn AF, 2019, NAT REV DRUG DISCOV, V18, P585, DOI 10.1038/s41573-019-0028-1; Lee SC, 2011, IMMUNOL RES, V50, P248, DOI 10.1007/s12026-011-8231-0; Lesport E, 2009, HUM IMMUNOL, V70, P1000, DOI 10.1016/j.humimm.2009.07.019; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Lima M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/839684; Lin HY, 2017, INT IMMUNOPHARMACOL, V51, P124, DOI 10.1016/j.intimp.2017.07.018; Lindaman A, 2006, AM J REPROD IMMUNOL, V56, P68, DOI 10.1111/j.1600-0897.2006.00395.x; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Liu J, 2019, ONCOL LETT, V17, P4877, DOI 10.3892/ol.2019.10211; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Lupo KB, 2019, CANCERS, V11, DOI 10.3390/cancers11060769; Margolin K, 2018, CLIN CANCER RES, V24, P5552, DOI 10.1158/1078-0432.CCR-18-0945; Marquardt N, 2010, EUR J IMMUNOL, V40, P1428, DOI 10.1002/eji.200940056; Martinet L, 2015, CELL REP, V11, P85, DOI 10.1016/j.celrep.2015.03.006; Melaiu O, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03038; Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Miller JS, 2018, CLIN CANCER RES, V24, P1525, DOI 10.1158/1078-0432.CCR-17-2451; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Minetto P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02836; Mo XD, 2017, BIOL BLOOD MARROW TR, V23, P1303, DOI 10.1016/j.bbmt.2017.04.023; Mo XD, 2019, FRONT MED-PRC, V13, P354, DOI 10.1007/s11684-018-0665-5; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Molfetta R, 2014, EUR J IMMUNOL, V44, P2761, DOI 10.1002/eji.201444512; Morandi B, 2009, INT IMMUNOL, V21, P599, DOI 10.1093/intimm/dxp029; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Muntasell A, 2019, CLIN CANCER RES, V25, P1535, DOI 10.1158/1078-0432.CCR-18-2365; Nath PR, 2019, CANCER IMMUNOL RES, V7, P1547, DOI 10.1158/2326-6066.CIR-18-0367; Nayyar G, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00051; O'Brien KL, 2019, NAT REV IMMUNOL, V19, P282, DOI 10.1038/s41577-019-0139-2; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; O'Sullivan T, 2014, CELL REP, V7, P989, DOI 10.1016/j.celrep.2014.03.073; Ohta M, 2005, INT J ONCOL, V26, P41; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pan JP, 2004, IMMUNOL LETT, V94, P141, DOI 10.1016/j.imlet.2004.05.003; Parihar R, 2019, CANCER IMMUNOL RES, V7, P363, DOI 10.1158/2326-6066.CIR-18-0572; Park MH, 2012, J SURG ONCOL, V106, P386, DOI 10.1002/jso.23095; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Peritt D, 1998, J IMMUNOL, V161, P5821; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Polentarutti N, 1997, J IMMUNOL, V158, P2689; Ponzetta A, 2015, CANCER RES, V75, P4766, DOI 10.1158/0008-5472.CAN-15-1320; Przewoznik M, 2012, J IMMUNOTHER, V35, P217, DOI 10.1097/CJI.0b013e318247440a; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Qi L, 2020, INT J CANCER, V146, P1421, DOI 10.1002/ijc.32779; Rafiq S, 2020, NAT REV CLIN ONCOL, V17, P147, DOI 10.1038/s41571-019-0297-y; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ravi R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02696-6; Regis S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00868; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Reschner A, 2008, CLIN EXP IMMUNOL, V152, P219, DOI 10.1111/j.1365-2249.2008.03624.x; Rezvani K, 2017, MOL THER, V25, P1769, DOI 10.1016/j.ymthe.2017.06.012; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Romee R, 2018, BLOOD, V131, P2515, DOI 10.1182/blood-2017-12-823757; Rosenberg J, 2018, CURR OPIN CHEM ENG, V19, P9, DOI 10.1016/j.coche.2017.11.006; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Runcie K, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0051-4; Santomasso BD, 2018, CANCER DISCOV, V8, P958, DOI 10.1158/2159-8290.CD-17-1319; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sedlmayr P, 1996, INT ARCH ALLERGY IMM, V110, P308, DOI 10.1159/000237321; Seliger B, 1997, CLIN CANCER RES, V3, P573; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9; Shimasaki N, 2020, NAT REV DRUG DISCOV, V19, P200, DOI 10.1038/s41573-019-0052-1; Simonetti O, 2006, EUR J CANCER, V42, P1181, DOI 10.1016/j.ejca.2006.01.043; Skak K, 2008, IMMUNOLOGY, V123, P575, DOI 10.1111/j.1365-2567.2007.02730.x; Smits ELJM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23619; Smyth MJ, 2003, J IMMUNOL, V171, P515, DOI 10.4049/jimmunol.171.2.515; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Soo Ross A, 2018, Oncotarget, V9, P24801, DOI 10.18632/oncotarget.24835; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Sparrow E, 2020, IMMUNOL LETT, V217, P126, DOI 10.1016/j.imlet.2019.11.005; Stiff A, 2018, CLIN CANCER RES, V24, P1891, DOI 10.1158/1078-0432.CCR-17-0691; Sun C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1264562; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Takanami I, 2001, J THORAC CARDIOV SUR, V121, P1058, DOI 10.1067/mtc.2001.113026; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Urlaub D, 2017, J IMMUNOL, V198, P1944, DOI 10.4049/jimmunol.1601004; Vacca P, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03013; van Hall T, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0761-3; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vanherberghen B, 2013, BLOOD, V121, P1326, DOI 10.1182/blood-2012-06-439851; Vasconcelos Z, 2015, CELL REP, V11, P1474, DOI 10.1016/j.celrep.2015.05.002; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Voshtani R, 2019, CANCER LETT, V465, P24, DOI 10.1016/j.canlet.2019.08.018; Wallace ME, 2005, SPRINGER SEMIN IMMUN, V27, P49, DOI 10.1007/s00281-004-0195-x; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Wilson JL, 1999, J IMMUNOL, V163, P6365; Woan KV, 2019, CANCER IMMUNOL RES, V7, P1742, DOI 10.1158/2326-6066.CIR-19-0404; Wrangle JM, 2018, LANCET ONCOL, V19, P694, DOI 10.1016/S1470-2045(18)30148-7; Wu M, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109637; Yu SN, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1057-4	214	119	125	11	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					835	847		10.1038/s41590-020-0728-z	http://dx.doi.org/10.1038/s41590-020-0728-z		JUL 2020	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32690952	Green Accepted			2022-12-18	WOS:000550625000003
J	Koutsakos, M; Illing, PT; Nguyen, THO; Mifsud, NA; Crawford, JC; Rizzetto, S; Eltahla, AA; Clemens, EB; Sant, S; Chua, BY; Wong, CY; Allen, EK; Teng, D; Dash, P; Boyd, DF; Grzelak, L; Zeng, WG; Hurt, AC; Barr, I; Rockman, S; Jackson, DC; Kotsimbos, TC; Cheng, AC; Richards, M; Westall, GP; Loudovaris, T; Mannering, SI; Elliott, M; Tangye, SG; Wakim, LM; Rossjohn, J; Vijaykrishna, D; Luciani, F; Thomas, PG; Gras, S; Purcell, AW; Kedzierska, K				Koutsakos, Marios; Illing, Patricia T.; Nguyen, Thi H. O.; Mifsud, Nicole A.; Crawford, Jeremy Chase; Rizzetto, Simone; Eltahla, Auda A.; Clemens, E. Bridie; Sant, Sneha; Chua, Brendon Y.; Wong, Chinn Yi; Allen, E. Kaitlynn; Teng, Don; Dash, Pradyot; Boyd, David F.; Grzelak, Ludivine; Zeng, Weiguang; Hurt, Aeron C.; Barr, Ian; Rockman, Steve; Jackson, David C.; Kotsimbos, Tom C.; Cheng, Allen C.; Richards, Michael; Westall, Glen P.; Loudovaris, Thomas; Mannering, Stuart I.; Elliott, Michael; Tangye, Stuart G.; Wakim, Linda M.; Rossjohn, Jamie; Vijaykrishna, Dhanasekaran; Luciani, Fabio; Thomas, Paul G.; Gras, Stephanie; Purcell, Anthony W.; Kedzierska, Katherine			Human CD8(+) T cell cross-reactivity across influenza A, B and C viruses	NATURE IMMUNOLOGY			English	Article							NEURAL-NETWORKS; INFECTION; IMMUNITY; EPITOPES; PROTECTION; RESPONSES; LYMPHOCYTES; REPERTOIRE; PEPTIDES; DISEASE	Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and infect humans, with IAV and IBV causing the most severe disease. CD8(+) T cells confer cross-protection against IAV strains, however the responses of CD8(+) T cells to IBV and ICV are understudied. We investigated the breadth of CD8(+) T cell cross-recognition and provide evidence of CD8(+) T cell cross-reactivity across IAV, IBV and ICV. We identified immunodominant CD8(+) T cell epitopes from IBVs that were protective in mice and found memory CD8(+) T cells directed against universal and influenza-virus-type-specific epitopes in the blood and lungs of healthy humans. Lung-derived CD8(+) T cells displayed tissue-resident memory phenotypes. Notably, CD38(+)Ki67(+)CD8(+) effector T cells directed against novel epitopes were readily detected in IAV- or IBV-infected pediatric and adult subjects. Our study introduces a new paradigm whereby CD8(+) T cells confer unprecedented cross-reactivity across all influenza viruses, a key finding for the design of universal vaccines.	[Koutsakos, Marios; Nguyen, Thi H. O.; Clemens, E. Bridie; Sant, Sneha; Wong, Chinn Yi; Grzelak, Ludivine; Zeng, Weiguang; Hurt, Aeron C.; Barr, Ian; Rockman, Steve; Jackson, David C.; Wakim, Linda M.; Kedzierska, Katherine] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Illing, Patricia T.; Mifsud, Nicole A.; Teng, Don; Rossjohn, Jamie; Vijaykrishna, Dhanasekaran; Gras, Stephanie; Purcell, Anthony W.] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [Illing, Patricia T.; Mifsud, Nicole A.; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Crawford, Jeremy Chase; Allen, E. Kaitlynn; Dash, Pradyot; Boyd, David F.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rizzetto, Simone; Eltahla, Auda A.; Luciani, Fabio] UNSW, Sch Med Sci, Sydney, NSW, Australia; [Rizzetto, Simone; Eltahla, Auda A.; Luciani, Fabio] UNSW, Kirby Inst, Sydney, NSW, Australia; [Chua, Brendon Y.; Jackson, David C.] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Teng, Don; Vijaykrishna, Dhanasekaran] Monash Univ, Biomed Discovery Inst, Dept Microbiol, Clayton, Vic, Australia; [Grzelak, Ludivine] Univ Paris Saclay, Ecole Normale Super Paris Saclay, Dept Biol, Cachan, France; [Hurt, Aeron C.; Barr, Ian] WHO, Collaborating Ctr Reference & Res Influenza, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Barr, Ian] Federat Univ, Sch Appl Biomed Sci, Churchill, Vic, Australia; [Rockman, Steve] Seqirus, Parkville, Vic, Australia; [Kotsimbos, Tom C.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Kotsimbos, Tom C.] Monash Univ, Dept Med, Cent Clin Sch, Alfred Hosp, Melbourne, Vic, Australia; [Cheng, Allen C.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cheng, Allen C.] Alfred Hlth, Infect Prevent & Healthcare Epidemiol Unit, Melbourne, Vic, Australia; [Richards, Michael] Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Westall, Glen P.; Mannering, Stuart I.] Alfred Hosp, Lung Transplant Unit, Melbourne, Vic, Australia; [Loudovaris, Thomas] St Vincents Inst Med Res, Immunol & Diabet Unit, Fitzroy, Vic, Australia; [Elliott, Michael] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Elliott, Michael] Royal Prince Alfred Hosp, Chris OBrien Lifehouse Canc Ctr, Camperdown, NSW, Australia; [Tangye, Stuart G.] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW, Australia; [Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff, S Glam, Wales	University of Melbourne; Monash University; Monash University; St Jude Children's Research Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; Hokkaido University; Monash University; UDICE-French Research Universities; Universite Paris Saclay; World Health Organization; Federation University Australia; CSL; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; St. Vincent's Institute of Medical Research; University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; Monash University; Cardiff University	Kedzierska, K (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia.	kkedz@unimelb.edu.au	Koutsakos, Marios/AAF-4259-2019; Illing, Patricia/AAP-6045-2021; Crawford, Jeremy Chase/G-5711-2013; Dhanasekaran, Vijaykrishna/D-1011-2010; rockman, steve/AAT-5105-2021; Nguyen, Thi Hoang Oanh/AAM-6827-2021; Purcell, Anthony/AAH-1942-2019; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Rossjohn, Jamie/F-9032-2013; Chua, Brendon/A-9755-2012; Rizzetto, Simone/O-6311-2015; Thomas, Paul G./H-1063-2018	Illing, Patricia/0000-0002-3870-0796; Crawford, Jeremy Chase/0000-0003-4096-6048; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Nguyen, Thi Hoang Oanh/0000-0002-9294-7693; Purcell, Anthony/0000-0003-0532-8331; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Rossjohn, Jamie/0000-0002-2020-7522; Mifsud, Nicole/0000-0001-8647-2102; Chua, Brendon/0000-0001-5654-1293; Rizzetto, Simone/0000-0003-3881-8759; Koutsakos, Marios/0000-0001-9994-9723; Kedzierska, Katherine/0000-0001-6141-335X; Eltahla, Auda/0000-0002-2995-8832; Loudovaris, Thomas/0000-0002-7038-2302; Thomas, Paul G./0000-0001-7955-0256; Westall, Glen/0000-0002-3711-068X	Australian National Health and Medical Research Council (NHMRC) NHMRC Program Grant [1071916]; Melbourne International research scholarship; Victoria India doctoral scholarship; ARC laureate fellowship; Australian Government Department of Health; NHMRC principal research fellowship [1137739]; NHMRC project grant [1085018]; US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]; NHMRC Peter Doherty fellowship [1072159]; St. Jude Center of Excellence for Influenza Research and Surveillance (NIAID) [HHSN27220140006C]; American Lebanese Syrian Associated Charities; JDRF Career Development award [5-CDA2014210-A-N]; NHMRC Project [GNT 1123586]; Melbourne International fee remission scholarship; Melbourne International fee remission scholarship, University of Melbourne;  [R01AI107625];  [R01AI136514]	Australian National Health and Medical Research Council (NHMRC) NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International research scholarship; Victoria India doctoral scholarship; ARC laureate fellowship(Australian Research Council); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); NHMRC principal research fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services; NHMRC Peter Doherty fellowship(National Health and Medical Research Council (NHMRC) of Australia); St. Jude Center of Excellence for Influenza Research and Surveillance (NIAID); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); JDRF Career Development award(Juvenile Diabetes Research Foundation); NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International fee remission scholarship; Melbourne International fee remission scholarship, University of Melbourne; ; 	HLA-A2.1 transgenic HHD mice were developed by F. Lemonnier (Pasteur Institute). D227K and Q115E MHC-I constructs were developed and provided by L. Wooldridge (Bristol University). The authors acknowledge the provision of instrumentation, training and technical support by the Monash Biomedical Proteomics Facility. We thank all study participants and organ donors. We are grateful to the coordinators of DonateLife Victoria for obtaining organ tissues, and to L. Mariana and C. Kos (St. Vincent's Institute) for their assistance. The Australian National Health and Medical Research Council (NHMRC) NHMRC Program Grant (1071916) to K.K. supported this work. M.K. is a recipient of a Melbourne International research scholarship and Melbourne International fee remission scholarship. S.S. is a recipient of a Victoria India doctoral scholarship and Melbourne International fee remission scholarship, University of Melbourne. K.K. is an NHMRC senior research level B fellow (1102792). J.R. is supported by an ARC laureate fellowship. S.G. is a Monash senior research fellow. F.L. and A.C.C. are NHMRC CDF2 fellows. E.B.C. and A.A.E. are NHMRC Peter Doherty fellows. The Melbourne WHO Collaborating Centre for Reference Research on Influenza is supported by the Australian Government Department of Health. A.W.P. is supported by an NHMRC principal research fellowship (1137739) and an NHMRC project grant (1085018) to A.W.P., T.C.K. and N.A.M. D.T. and D.V. are supported by contract HHSN272201400006C from the US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services. P.T.I. was supported by a NHMRC Peter Doherty fellowship (1072159). P.G.T. is supported by the St. Jude Center of Excellence for Influenza Research and Surveillance (NIAID contract HHSN27220140006C), R01AI107625, R01AI136514, and American Lebanese Syrian Associated Charities. S.I.M. is supported by a JDRF Career Development award (5-CDA2014210-A-N) and NHMRC Project (GNT 1123586).	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Alexander J, 2010, HUM IMMUNOL, V71, P468, DOI 10.1016/j.humimm.2010.02.014; Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Allen RJ, 2017, AM J CASE REP, V18, P190, DOI 10.12659/AJCR.902172; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Babon JAB, 2012, J VIROL, V86, P9233, DOI 10.1128/JVI.06325-11; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bird NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129768; Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Eltahla AA, 2016, IMMUNOL CELL BIOL, V94, P604, DOI 10.1038/icb.2016.16; Epstein SL, 1998, J IMMUNOL, V160, P322; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fulton BO, 2018, J VIROL, V92, DOI 10.1128/JVI.00754-18; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hayward AC, 2015, AM J RESP CRIT CARE, V191, P1422, DOI 10.1164/rccm.201411-1988OC; Hillaire MLB, 2011, J VIROL, V85, P12057, DOI 10.1128/JVI.05204-11; Huber SKR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156462; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsuzaki Y, 2006, J INFECT DIS, V193, P1229, DOI 10.1086/502973; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nguyen THO, 2018, J LEUKOCYTE BIOL, V103, P321, DOI 10.1189/jlb.5MA0517-207R; Nguyen THO, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.4; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nussing S, 2018, FRONT MED-PRC, V12, P34, DOI 10.1007/s11684-017-0606-8; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Pedersen SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145629; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Quinones-Parra SM, 2016, J VIROL, V90, P6936, DOI 10.1128/JVI.00349-16; Ramarathinam SH, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700253; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; Terajima M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-244; Nguyen TH, 2017, IMMUNOL CELL BIOL, V95, P77, DOI 10.1038/icb.2016.71; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; van de Sandt CE, 2015, J GEN VIROL, V96, P2061, DOI 10.1099/vir.0.000156; Wang LL, 2016, J VIROL, V90, P2938, DOI 10.1128/JVI.02400-15; Wang ZF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03243-7; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Williamson NA, 2005, EXPERT REV PROTEOMIC, V2, P367, DOI 10.1586/14789450.2.3.367; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	59	119	123	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					613	+		10.1038/s41590-019-0320-6	http://dx.doi.org/10.1038/s41590-019-0320-6			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30778243	Bronze, Green Accepted			2022-12-18	WOS:000465084800018
J	Yamada, T; Horimoto, H; Kameyama, T; Hayakawa, S; Yamato, H; Dazai, M; Takada, A; Kida, H; Bott, D; Zhou, AC; Hutin, D; Watts, TH; Asaka, M; Matthews, J; Takaoka, A				Yamada, Taisho; Horimoto, Hiromasa; Kameyama, Takeshi; Hayakawa, Sumio; Yamato, Hiroaki; Dazai, Masayoshi; Takada, Ayato; Kida, Hiroshi; Bott, Debbie; Zhou, Angela C.; Hutin, David; Watts, Tania H.; Asaka, Masahiro; Matthews, Jason; Takaoka, Akinori			Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense	NATURE IMMUNOLOGY			English	Article							MONO-ADP-RIBOSYLTRANSFERASE; CYTOSOLIC DNA SENSOR; HELICASE RIG-I; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POLY(ADP-RIBOSE) POLYMERASE; NEGATIVE REGULATION; IMMUNE-RESPONSES; MICE LACKING; ACTIVATION; RECOGNITION	Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the toxic activity of many environmental xenobiotics. However, its role in innate immune responses during viral infection is not fully understood. Here we demonstrate that constitutive AHR signaling negatively regulates the type I interferon (IFN-I) response during infection with various types of virus. Virus-induced IFN-beta production was enhanced in AHR-deficient cells and mice and resulted in restricted viral replication. We found that AHR upregulates expression of the ADP-ribosylase TIPARP, which in turn causes downregulation of the IFN-I response. Mechanistically, TIPARP interacted with the kinase TBK1 and suppressed its activity by ADP-ribosylation. Thus, this study reveals the physiological importance of endogenous activation of AHR signaling in shaping the IFN-I-mediated innate response and, further, suggests that the AHR-TIPARP axis is a potential therapeutic target for enhancing antiviral responses.	[Yamada, Taisho; Horimoto, Hiromasa; Kameyama, Takeshi; Hayakawa, Sumio; Yamato, Hiroaki; Dazai, Masayoshi; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Horimoto, Hiromasa; Yamato, Hiroaki; Dazai, Masayoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Kameyama, Takeshi; Hayakawa, Sumio; Takaoka, Akinori] Hokkaido Univ, Grad Sch Chem Sci & Engn, Mol Med Biochem Unit, Sapporo, Hokkaido, Japan; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Takada, Ayato; Kida, Hiroshi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Microbiol, Sapporo, Hokkaido, Japan; [Bott, Debbie; Hutin, David; Matthews, Jason] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Zhou, Angela C.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Asaka, Masahiro] Hlth Sci Univ Hokkaido, Toubetu, Japan; [Matthews, Jason] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; University of Toronto; University of Toronto; Health Sciences University of Hokkaido; University of Oslo	Takaoka, A (corresponding author), Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan.; Takaoka, A (corresponding author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Mol Med Biochem Unit, Sapporo, Hokkaido, Japan.	takaoka@igm.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Yamada, Taisho/GPP-5936-2022	da he, hong ming/0000-0002-4643-8302; Yamada, Taisho/0000-0002-2584-9583; Matthews, Jason/0000-0002-9815-8636	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25253030, 25115502, 23112701, 25713032]; IRYO HOJIN SHADAN JIKOKAI; Kato Memorial Bioscience Foundation; Yasuda Medical Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Canadian Institutes of Health Research (CIHR) grant [496441]; Canadian Institutes of Health Research operating grant [MOP-125919]; Canadian Institutes of Health Research New Investigator Award; Early Researcher Award from the Ontario Ministry of Innovation; Waksman Foundation of Japan; Grants-in-Aid for Scientific Research [25253030] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IRYO HOJIN SHADAN JIKOKAI; Kato Memorial Bioscience Foundation; Yasuda Medical Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Akiyama Life Science Foundation; Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Early Researcher Award from the Ontario Ministry of Innovation; Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C.A. Bradfield for Ahr<SUP>+/+</SUP> and Ahr<SUP>-/-</SUP> MEFs, A. Kimura and Y. Fujii-Kuriyama for Ahr<SUP>-/-</SUP> mice, J. Miyazaki for the pCAGGS vector, A. Miyawaki for the pCAGGS-YFP vector, T. Fujita for the p-125Luc vector, the Japan Red Cross society for whole blood samples, T. Kubota for pcDNA3.1(-)IRF-3/5D-FLAG, T. Miyazaki for influenza virus (strain A/Puerto Rico/8/34) and H. Kitamura, D. Kamimura and M. Murakami for technical advice on mouse experiments. We are also grateful for financial support from the Ministry of Health, Labour and Welfare of Japan (grant-in-aid to A. Takaoka); the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant-in-aid for scientific research (A) (25253030) and grant-in-aid for scientific research on innovative areas (25115502, 23112701) to A. Takaoka; grant-in-aid for young scientists (A) (25713032) to S.H.); IRYO HOJIN SHADAN JIKOKAI (granted by H. Tanaka and N. Takayanagi) to A. Takaoka; the Kato Memorial Bioscience Foundation to A. Takaoka; the Yasuda Medical Foundation to A. Takaoka; the Takeda Science Foundation to A. Takaoka; Akiyama Life Science Foundation to S.H.; Canadian Institutes of Health Research (CIHR) grant (496441) to T.H.W.; a Canadian Institutes of Health Research operating grant (MOP-125919) to J. M.; a Canadian Institutes of Health Research New Investigator Award and an Early Researcher Award from the Ontario Ministry of Innovation to J. M. and the Waksman Foundation of Japan to A. Takaoka.	Ahmed S, 2015, J BIOL CHEM, V290, P16824, DOI 10.1074/jbc.M115.660100; Benedict JC, 2000, TOXICOL SCI, V56, P382, DOI 10.1093/toxsci/56.2.382; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Chi HB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-211; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gravel SP, 2005, J BIOL CHEM, V280, P7477, DOI 10.1074/jbc.M410392200; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jin GB, 2014, EUR J IMMUNOL, V44, P1685, DOI 10.1002/eji.201343980; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Laich A, 2002, CLIN CHEM, V48, P579; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Madge DJ, 1996, BIOORG MED CHEM LETT, V6, P857, DOI 10.1016/0960-894X(96)00124-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Murayama T, 2002, BIOCHEM BIOPH RES CO, V296, P651, DOI 10.1016/S0006-291X(02)00921-X; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Nguyen NT, 2013, INT IMMUNOL, V25, P335, DOI 10.1093/intimm/dxt011; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Ohata H, 2003, MICROBIOL IMMUNOL, V47, P363, DOI 10.1111/j.1348-0421.2003.tb03408.x; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vorderstrasse BA, 2003, TOXICOLOGY, V188, P15, DOI 10.1016/S0300-483X(02)00749-7; Warren TK, 2000, TOXICOL SCI, V56, P114, DOI 10.1093/toxsci/56.1.114; Weber M, 2014, CURR OPIN MICROBIOL, V20, P96, DOI 10.1016/j.mib.2014.05.002; Wheeler JLH, 2014, TOXICOL SCI, V137, P324, DOI 10.1093/toxsci/kft255; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052	57	119	133	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					687	+		10.1038/ni.3422	http://dx.doi.org/10.1038/ni.3422			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27089381	Green Submitted			2022-12-18	WOS:000376162200013
J	Guo, LY; Huang, YF; Chen, X; Hu-Li, J; Urban, JF; Paul, WE				Guo, Liying; Huang, Yuefeng; Chen, Xi; Hu-Li, Jane; Urban, Joseph F., Jr.; Paul, William E.			Innate immunological function of T(H)2 cells in vivo	NATURE IMMUNOLOGY			English	Article							CHRONIC HELMINTH INFECTIONS; CYTOKINE PRODUCTION; INTERLEUKIN-13; DISEASE; IL-33; MICE; TH2; MECHANISMS; RESPONSES; ASTHMA	Type 2 helper T cells (T(H)2 cells) produce interleukin 13 (IL-13) when stimulated by papain or house dust mite extract (HDM) and induce eosinophilic inflammation. This innate response is dependent on IL-33 but not T cell antigen receptors (TCRs). While type 2 innate lymphoid cells (ILC2 cells) are the dominant innate producers of IL-13 in naive mice, we found here that helminth-infected mice had more T(H)2 cells compared to uninfected mice, and these cells became major mediators of innate type 2 responses. T(H)2 cells made important contributions to HDM-induced antigen-nonspecific eosinophilic inflammation and protected mice recovering from infection with Ascaris suum against subsequent infection with the phylogenetically distant nematode Nippostrongylus brasiliensis. Our findings reveal a previously unappreciated role for effector T(H)2 cells during TCR-independent innate-like immune responses.	[Guo, Liying; Huang, Yuefeng; Chen, Xi; Hu-Li, Jane; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA)	Guo, LY (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lguo@niaid.nih.gov; wpaul@niaid.nih.gov		Urban, Joseph/0000-0002-1590-8869	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institute of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000926] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institute of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A.N. McKenzie (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for Il1rl1<SUP>-/-</SUP> mice; J.-P. Girard (Centre National de la Recherche Scientifique, Institute de Pharmacology et de Biologie Structurale) for Il33-LacZ gene-trap reporter mice; J. Ward for help with pathology analysis; and J. Edwards and K. Weng for help with cell sorting. Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institute of Health).	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Buijs J, 1997, EUR RESPIR J, V10, P1467, DOI 10.1183/09031936.97.10071467; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Knott ML, 2007, INT J PARASITOL, V37, P1367, DOI 10.1016/j.ijpara.2007.04.006; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lynch NR, 1997, AM J RESP CRIT CARE, V156, P50, DOI 10.1164/ajrccm.156.1.9606081; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Pinelli E, 2008, CLIN EXP ALLERGY, V38, P649, DOI 10.1111/j.1365-2222.2007.02908.x; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schopf L, 2005, INVEST OPHTH VIS SCI, V46, P2772, DOI 10.1167/iovs.04-0899; Schwartz C, 2014, P NATL ACAD SCI USA, V111, pE5169, DOI 10.1073/pnas.1412663111; Shin EH, 1997, INT ARCH ALLERGY IMM, V114, P45, DOI 10.1159/000237717; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yazdanbakhsh M, 2001, TRENDS IMMUNOL, V22, P372, DOI 10.1016/S1471-4906(01)01958-5; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	38	119	122	2	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1051	+		10.1038/ni.3244	http://dx.doi.org/10.1038/ni.3244			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26322482	Green Accepted			2022-12-18	WOS:000361686500010
J	Yoshida, K; Maekawa, T; Zhu, Y; Renard-Guillet, C; Chatton, B; Inoue, K; Uchiyama, T; Ishibashi, KI; Yamada, T; Ohno, N; Shirahige, K; Okada-Hatakeyama, M; Ishii, S				Yoshida, Keisuke; Maekawa, Toshio; Zhu, Yujuan; Renard-Guillet, Claire; Chatton, Bruno; Inoue, Kentaro; Uchiyama, Takeru; Ishibashi, Ken-ichi; Yamada, Takuji; Ohno, Naohito; Shirahige, Katsuhiko; Okada-Hatakeyama, Mariko; Ishii, Shunsuke			The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ANALYSIS REVEALS; CDNA CLONES; BINDING; FAMILY; RECOGNITION; ACTIVATION; PROTECTION; METHYLATION; REINFECTION	Immunological memory is thought to be mediated exclusively by lymphocytes. However, enhanced innate immune responses caused by a previous infection increase protection against reinfection, which suggests the presence of innate immunological memory. Here we identified an important role for the stress-response transcription factor ATF7 in innate immunological memory. ATF7 suppressed a group of genes encoding factors involved in innate immunity in macrophages by recruiting the histone H3K9 dimethyltransferase G9a. Treatment with lipopolysaccharide, which mimics bacterial infection, induced phosphorylation of ATF7 via the kinase p38, which led to the release of ATF7 from chromatin and a decrease in repressive histone H3K9me2 marks. A partially disrupted chromatin structure and increased basal expression of target genes were maintained for long periods, which enhanced resistance to pathogens. ATF7 might therefore be important in controlling memory in cells of the innate immune system.	[Yoshida, Keisuke; Maekawa, Toshio; Zhu, Yujuan; Ishii, Shunsuke] Japan Sci & Technol Agcy, RIKEN Tsukuba Inst, CREST Res Project, Lab Mol Genet, Tsukuba, Ibaraki, Japan; [Zhu, Yujuan; Ishii, Shunsuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Funct Genom, Tsukuba, Ibaraki, Japan; [Renard-Guillet, Claire; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Genome Struct & Funct, Tokyo, Japan; [Chatton, Bruno] Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Illkirch Graffenstaden, France; [Inoue, Kentaro; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Yokohama, Kanagawa, Japan; [Uchiyama, Takeru; Yamada, Takuji] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Ishibashi, Ken-ichi; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tsukuba; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; RIKEN; Tokyo Institute of Technology; Tokyo University of Pharmacy & Life Sciences	Ishii, S (corresponding author), Japan Sci & Technol Agcy, RIKEN Tsukuba Inst, CREST Res Project, Lab Mol Genet, Tsukuba, Ibaraki, Japan.	sishii@rtc.riken.jp	CHATTON, Bruno/R-3813-2019; Ishii, Shunsuke/A-5271-2016; Inoue, Kentaro/P-4920-2016	Ishii, Shunsuke/0000-0002-6530-2478; Inoue, Kentaro/0000-0002-7447-5856; CHATTON, Bruno/0000-0003-4515-7119; Yoshida, Keisuke/0000-0002-5579-9716; Shirahige, Katsuhiko/0000-0002-7862-1144	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Morikawa (University of Tsukuba) for S. aureus; the staff of the Research Resources Center of the RIKEN Brain Science Institute for microarray analysis; and Y. Shinkai (RIKEN) for discussions. Supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Droit A, 2010, BIOINFORMATICS, V26, P678, DOI 10.1093/bioinformatics/btq023; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GORHE DS, 1967, NATURE, V216, P1242, DOI 10.1038/2161242a0; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Hirose N, 2009, BIOCHEM BIOPH RES CO, V385, P72, DOI 10.1016/j.bbrc.2009.05.001; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Ishibashia K, 2002, INT IMMUNOPHARMACOL, V2, P1109, DOI 10.1016/S1567-5769(02)00062-0; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Seong KH, 2012, GENES CELLS, V17, P249, DOI 10.1111/j.1365-2443.2012.01587.x; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	59	119	122	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1034	+		10.1038/ni.3257	http://dx.doi.org/10.1038/ni.3257			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26322480				2022-12-18	WOS:000361686500008
J	Rantakari, P; Auvinen, K; Jappinen, N; Kapraali, M; Valtonen, J; Karikoski, M; Gerke, H; Iftakhar-E-Khuda, I; Keuschnigg, J; Umemoto, E; Tohya, K; Miyasaka, M; Elima, K; Jalkanen, S; Salmi, M				Rantakari, Pia; Auvinen, Kaisa; Jappinen, Norma; Kapraali, Maria; Valtonen, Joona; Karikoski, Marika; Gerke, Heidi; Iftakhar-E-Khuda, Imtiaz; Keuschnigg, Johannes; Umemoto, Eiji; Tohya, Kazuo; Miyasaka, Masayuki; Elima, Kati; Jalkanen, Sirpa; Salmi, Marko			The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes	NATURE IMMUNOLOGY			English	Article							FENESTRAL DIAPHRAGMS; DENDRITIC CELLS; AFFERENT LYMPH; T-CELLS; BLOOD; DIFFERENTIATION; DIAPEDESIS; MECHANISM; MIGRATION; TRANSPORT	In the lymphatic sinuses of draining lymph nodes, soluble lymph-borne antigens enter the reticular conduits in a size-selective manner and lymphocytes transmigrate to the parenchyma. The molecular mechanisms that control these processes are unknown. Here we unexpectedly found that PLVAP, a prototypic endothelial protein of blood vessels, was synthesized in the sinus-lining lymphatic endothelial cells covering the distal conduits. In PLVAP-deficient mice, both small antigens and large antigens entered the conduit system, and the transmigration of lymphocytes through the sinus floor was augmented. Mechanistically, the filtering function of the lymphatic sinus endothelium was dependent on diaphragms formed by PLVAP fibrils in transendothelial channels. Thus, in the lymphatic sinus, PLVAP forms a physical sieve that regulates the parenchymal entry of lymphocytes and soluble antigens.	[Rantakari, Pia; Auvinen, Kaisa; Jappinen, Norma; Kapraali, Maria; Valtonen, Joona; Karikoski, Marika; Iftakhar-E-Khuda, Imtiaz; Keuschnigg, Johannes; Miyasaka, Masayuki; Elima, Kati; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland; [Umemoto, Eiji; Miyasaka, Masayuki] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Tohya, Kazuo] Kansai Univ Hlth Sci, Dept Anat, Osaka, Japan; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Jalkanen, Sirpa; Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Turku; Osaka University; University of Turku; University of Turku	Salmi, M (corresponding author), Univ Turku, MediCity Res Lab, Turku, Finland.	marko.salmi@utu.fi	Umemoto, Eiji/AAX-6562-2021; Miyasaka, Masayuki/AAM-6343-2020	Karikoski, Marika/0000-0001-6512-6331; Valtonen, Joona/0000-0003-2704-4663; Rantakari, Pia/0000-0003-1638-5075	Finnish Academy and Sigrid Juselius Foundation	Finnish Academy and Sigrid Juselius Foundation	We thank E. Butcher (Stanford University) for antibody MECA-367; The Cell Imaging Core at the Centre of Biotechnology and Laboratory of Electron Microscopy in University of Turku for help in imaging; E.-L. Vaananen, R. Sjoroos, S. Maki and M. Pohjansalo for technical assistance; and A. Sovikoski-Georgieva for secretarial assistance. This work benefitted from data assembled by the Immunological Genome Project consortium. Supported by the Finnish Academy and Sigrid Juselius Foundation.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinelli R, 2014, J CELL SCI, V127, P3720, DOI 10.1242/jcs.148619; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; Razani B, 2001, J BIOL CHEM, V276, P38121; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; SAINTEMARIE G, 1982, AM J ANAT, V164, P275, DOI 10.1002/aja.1001640402; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; SCHNITZER JE, 1990, EUR J CELL BIOL, V52, P241; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593; Tkachenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032655; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751	43	119	125	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					386	396		10.1038/ni.3101	http://dx.doi.org/10.1038/ni.3101			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25665101				2022-12-18	WOS:000351333700011
J	Quann, EJ; Liu, X; Altan-Bonnet, G; Huse, M				Quann, Emily J.; Liu, Xin; Altan-Bonnet, Gregoire; Huse, Morgan			A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells	NATURE IMMUNOLOGY			English	Article							MICROTUBULE-ORGANIZING CENTER; IMMUNOLOGICAL SYNAPSE; PKC-THETA; MEDIATED CYTOTOXICITY; CD8(+) CTL; ACTIVATION; POLARITY; DELTA; TCR; DRIVES	Polarization of the T cell microtubule-organizing center (MTOC) toward the antigen-presenting cell (APC) is driven by the accumulation of diacylglycerol (DAG) at the immunological synapse (IS). The mechanisms that couple DAG to the MTOC are not known. By single-cell photoactivation of the T cell antigen receptor (TCR), we found that three distinct isoforms of protein kinase C (PKC) were recruited by DAG to the IS in two steps. PKC-epsilon and PKC-eta accumulated first in a broad region of membrane, whereas PKC-theta arrived later in a smaller zone. Functional experiments indicated that PKC-theta was required for MTOC reorientation and that PKC-epsilon and PKC-eta operated redundantly to promote the recruitment of PKC-theta and subsequent polarization responses. Our results establish a previously uncharacterized role for PKC proteins in T cell polarity.	[Quann, Emily J.; Liu, Xin; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	husem@mskcc.org	Liu, Xin/R-1101-2019	Altan-Bonnet, Gregoire/0000-0002-7283-3162; Liu, Xin/0000-0002-6634-4012	Searle Scholars Program; Cancer Research Institute; US National Institutes of Health [R01-AI087644, R01-AI083408]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644, R01AI083408] Funding Source: NIH RePORTER	Searle Scholars Program; Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Littman (New York University) for PKC-theta-deficient mice; W. Marks and the Memorial Sloan-Kettering Cancer Center Mouse Genetics Core Facility for assistance with generating the C1-GFP mice; R. Wedlich-Soldner (International Max Planck Research School) for Lifeact-RFP; A. Hall (Memorial Sloan-Kettering Cancer Center), S. Rotenberg (Queens College) and M.O. Li (Memorial Sloan-Kettering Cancer Center) for reagents and advice; E. Alonzo for assistance with functional studies; N. Bantilan for technical support; S. S. Yi and the Memorial Sloan-Kettering Cancer Center Microchemistry Core Facility for peptide synthesis; A. Hall for critical reading of the manuscript; and members of the Huse and Li laboratories for helpful comments. Supported by the Searle Scholars Program (M. H.), the Cancer Research Institute (M. H.) and the US National Institutes of Health (Ruth L. Kirschstein National Research Service Award to E.J.Q., R01-AI087644 to M. H. and R01-AI083408 to G.A.-B.).	Abeyweera TP, 2011, J CELL BIOL, V192, P675, DOI 10.1083/jcb.201009135; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bertrand F, 2010, J IMMUNOL, V185, P2887, DOI 10.4049/jimmunol.1000739; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fan JH, 2006, J INVEST DERMATOL, V126, P1233, DOI 10.1038/sj.jid.5700149; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gruber T, 2005, MOL IMMUNOL, V42, P305, DOI 10.1016/j.molimm.2004.07.007; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Jin TQ, 2001, J BIOL CHEM, V276, P12879, DOI 10.1074/jbc.M010513200; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; Martin-Cofreces NB, 2006, J IMMUNOL, V176, P4201, DOI 10.4049/jimmunol.176.7.4201; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yue LL, 2000, J BIOL CHEM, V275, P23948, DOI 10.1074/jbc.M001845200	44	119	120	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					647	U205		10.1038/ni.2033	http://dx.doi.org/10.1038/ni.2033			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21602810	Green Accepted			2022-12-18	WOS:000291936400013
J	Engels, N; Konig, LM; Heemann, C; Lutz, J; Tsubata, T; Griep, S; Schrader, V; Wienands, J				Engels, Niklas; Koenig, Lars Morten; Heemann, Christina; Lutz, Johannes; Tsubata, Takeshi; Griep, Sebastian; Schrader, Verena; Wienands, Juergen			Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells	NATURE IMMUNOLOGY			English	Article							NON-ITAM TYROSINE; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; CA2+ ENTRY; ACTIVATION; CD28; MEMORY; ALPHA; LYMPHOCYTES; TAIL	The improved antibody responses of class-switched memory B cells depend on enhanced signaling from their B cell antigen receptors (BCRs). However, BCRs on both naive and antigen-experienced B cells use the canonical immunoglobulin-associated alpha and beta-protein signaling subunits. Here we identified a BCR isotype-specific signal-amplification mechanism. Whereas immunoglobulin M (IgM)-containing BCRs initiated intracellular signals exclusively through immunoglobulin-associated alpha- and beta-proteins, IgG- and IgE-containing BCRs also used a conserved tyrosine residue in the cytoplasmic segments of immunoglobulin heavy chains. When phosphorylated, this tyrosine recruited the adaptor Grb2, resulting in sustained protein kinase activation and prolonged generation of second messengers, which together culminated in enhanced B cell proliferation. Hence, membrane-bound IgG and IgE exert antigen recognition as well as costimulatory functions, thereby rendering memory B cells less dependent on T cell help.	[Engels, Niklas; Koenig, Lars Morten; Heemann, Christina; Lutz, Johannes; Griep, Sebastian; Schrader, Verena; Wienands, Juergen] Univ Gottingen, Fac Med, Inst Cellular & Mol Immunol, Gottingen, Germany; [Tsubata, Takeshi] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Immunol Lab, Tokyo, Japan	University of Gottingen; Tokyo Medical & Dental University (TMDU)	Wienands, J (corresponding author), Univ Gottingen, Fac Med, Inst Cellular & Mol Immunol, Gottingen, Germany.	jwienan@uni-goettingen.de	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258; Lutz, Johannes/0000-0001-7452-0023; Konig, Lars/0000-0002-8348-7787	Deutsche Forschungsgemeinschaft [FOR 521]; European Community; Medical Faculty of Gottingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); Medical Faculty of Gottingen University	We thank T. Adachi (Tokyo Medical and Dental University), V. Horejsi (Charles University), L. Nitschke (Friedrich-Alexander-University Erlangen, Germany), M. Reth (Max-Planck-Institute of Immunobiology), B. Schraven (Otto-von-Guericke- University) and E. Vigorito (Babraham Institute) for reagents; W. Schuh and H. M. Jack for assistance with retroviral transduction of primary B cells; and H. Scherer for cell sorting. Supported by the Deutsche Forschungsgemeinschaft (FOR 521), the European Community (PADnet) and the Medical Faculty of Gottingen University.	Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dennehy KM, 2007, J IMMUNOL, V178, P1363, DOI 10.4049/jimmunol.178.3.1363; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; Engelke M, 2007, IMMUNOL REV, V218, P235, DOI 10.1111/j.1600-065X.2007.00539.x; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; Fu C, 1997, J BIOL CHEM, V272, P27362, DOI 10.1074/jbc.272.43.27362; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Grabbe A, 2006, BLOOD, V108, P3761, DOI 10.1182/blood-2006-02-005397; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Hebeis BJ, 2004, J EXP MED, V199, P593, DOI 10.1084/jem.20030091; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; HOREJSI V, 1986, FOLIA BIOL-PRAGUE, V32, P12; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; JUSTEMENT LB, 1990, J IMMUNOL, V144, P3272; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; KLINMAN NR, 1973, J EXP MED, V138, P473, DOI 10.1084/jem.138.2.473; Knight AM, 1997, EMBO J, V16, P3842, DOI 10.1093/emboj/16.13.3842; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Putney JW, 2007, BIOCHEM SOC SYMP, V74, P37, DOI 10.1042/BSS2007c04; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Takahashi Y, 2005, IMMUNITY, V23, P127, DOI 10.1016/j.immuni.2005.06.010; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; WIENANDS J, 1990, EMBO J, V9, P449, DOI 10.1002/j.1460-2075.1990.tb08130.x; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	50	119	123	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					1018	1764		10.1038/ni.1764	http://dx.doi.org/10.1038/ni.1764			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19668218				2022-12-18	WOS:000269120900016
J	Wilker, PR; Kohyama, M; Sandau, MM; Albring, JC; Nakagawa, O; Schwarz, JJ; Murphy, KM				Wilker, Peter R.; Kohyama, Masako; Sandau, Michelle M.; Albring, Joern C.; Nakagawa, Osamu; Schwarz, John J.; Murphy, Kenneth M.			Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation	NATURE IMMUNOLOGY			English	Article							MYOCYTE ENHANCER FACTOR-2; GENE-EXPRESSION; T-CELL; NEGATIVE SELECTION; CYCLIN D2; BCL-X; ACTIVATION; LYMPHOCYTES; CALCINEURIN; SIGNALS	Calcineurin is required for B cell receptor (BCR)-induced proliferation of mature B cells. Paradoxically, loss of NFAT transcription factors, themselves calcineurin targets, induces hyperactivity, which suggests that calcineurin targets other than NFAT are required for BCR-induced proliferation. Here we demonstrate a function for the calcineurin-regulated transcription factor Mef2c in B cells. BCR-induced calcium mobilization was intact after Mef2c deletion, but loss of Mef2c caused defects in B cell proliferation and survival after BCR stimulation in vitro and lower T cell-dependent antibody responses and germinal center formation in vivo. Mef2c activity was specific to BCR stimulation, as Toll-like receptor and CD40 signaling induced normal responses in Mef2c-deficient B cells. Mef2c-dependent targets included the genes encoding cyclin D2 and the prosurvival factor Bcl-x(L). Our results emphasize an unrecognized but critical function for Mef2c in BCR signaling.	[Wilker, Peter R.; Kohyama, Masako; Sandau, Michelle M.; Albring, Joern C.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Wilker, Peter R.; Kohyama, Masako; Sandau, Michelle M.; Albring, Joern C.; Murphy, Kenneth M.] Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; [Nakagawa, Osamu] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nakagawa, Osamu] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schwarz, John J.] Albany Med Ctr, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Albany Medical College; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu		Albring, Jorn/0000-0002-5534-7250; Schwarz, John/0000-0002-8713-4778	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060853, T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007317, T32 HL007317-31, 5T32HL007317, R01 HL060853] Funding Source: Medline; NIAID NIH HHS [P01 AI031238, P01 AI031238-16, 5P01AI031238] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Chiles TC, 2004, J IMMUNOL, V173, P2901, DOI 10.4049/jimmunol.173.5.2901; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Deming PB, 2006, CURR DIRECT AUTOIMMU, V9, P95; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5; FANG W, 1994, J IMMUNOL, V153, P4388; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Glynne R, 2000, IMMUNOL REV, V176, P216; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; HUO L, 1995, J IMMUNOL, V154, P3300; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; NORVELL A, 1995, J IMMUNOL, V154, P4404; OSMOND DG, 1993, IMMUNOL TODAY, V14, P34, DOI 10.1016/0167-5699(93)90322-C; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao S, 1998, J BIOL CHEM, V273, P26123, DOI 10.1074/jbc.273.40.26123; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; STIEF A, 1994, J IMMUNOL, V152, P3378; Swanson BJ, 1998, MOL IMMUNOL, V35, P445, DOI 10.1016/S0161-5890(98)00058-3; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0; Zhao M, 1999, MOL CELL BIOL, V19, P21	64	119	120	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					603	612		10.1038/ni.1609	http://dx.doi.org/10.1038/ni.1609			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18438409	Green Accepted			2022-12-18	WOS:000256067900010
J	Yuan, WM; Dasgupta, A; Cresswell, P				Yuan, Weiming; Dasgupta, Anindya; Cresswell, Peter			Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; IMMATURE DENDRITIC CELLS; HOST SHUTOFF PROTEIN; NKT CELLS; DOWN-REGULATION; INFECTION; ACTIVATION; EXPRESSION; MOLECULES; COMPLEX	Natural killer T cells, which are stimulated by lipids presented by CD1d molecules, are crucial in antiviral host defense. How viruses evade natural killer T cell recognition remains unclear. Here we show that infection with herpes simplex virus type 1 (HSV-1) reduced CD1d surface expression on antigen-presenting cells. HSV-1 did not inhibit CD1d protein synthesis or enhance constitutive CD1d endocytosis. Instead, HSV-1 prevented the reappearance of endocytosed CD1d on the cell surface by redistributing endocytosed CD1d to the lysosome limiting membrane. HSV-1 might also inhibit the transport of newly synthesized CD1d to the cell surface. Such inhibition of CD1d surface expression impaired antigen-presenting cell-mediated stimulation of natural killer T cells, supporting the idea that this mechanism may be an important HSV-1 immune evasion strategy.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059167] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI091987, AI059167] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Church GA, 1997, J VIROL, V71, P3603, DOI 10.1128/JVI.71.5.3603-3612.1997; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Dietrich J, 2002, J IMMUNOL, V168, P5434, DOI 10.4049/jimmunol.168.11.5434; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Koppers-Lalic D, 2001, J GEN VIROL, V82, P2071, DOI 10.1099/0022-1317-82-9-2071; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lin YL, 2005, J LEUKOCYTE BIOL, V77, P151, DOI 10.1189/jlb.0704399; Lodoen MB, 2004, J EXP MED, V200, P1075, DOI 10.1084/jem.20040583; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; RAJCANI J, 1983, ACTA VIROL, V27, P442; Roizman B, 2001, FIELDS VIROL, P2381; Samady L, 2003, J VIROL, V77, P3768, DOI 10.1128/JVI.77.6.3768-3776.2003; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Shinya E, 2004, VIROLOGY, V326, P79, DOI 10.1016/j.virol.2004.06.004; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Trgovcich J, 2002, J VIROL, V76, P6974, DOI 10.1128/JVI.76.14.6974-6986.2002; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; van Dommelen SLH, 2003, J VIROL, V77, P1877, DOI 10.1128/JVI.77.3.1877-1884.2003; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	45	119	125	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					835	842		10.1038/ni1364	http://dx.doi.org/10.1038/ni1364			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16845396				2022-12-18	WOS:000239147200019
J	Su, DM; Navarre, S; Oh, WJ; Condie, BG; Manley, NR				Su, DM; Navarre, S; Oh, WJ; Condie, BG; Manley, NR			A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation	NATURE IMMUNOLOGY			English	Article							NUDE GENE; EXPRESSION; MEDULLA; ORGANIZATION; PROGENITORS; MUTATIONS; PROTEIN; GROWTH; MOUSE; STEPS	Thymic epithelial cells (TECs) are required for T cell maturation within the thymus. In the nude (Foxn1(nu/nu))mouse, TECs fail to differentiate. We have generated a hypomorphic allele called Foxn1(Delta), from which an N-terminal domain was deleted. The phenotype was thymus specific, identifying a tissue-specific activity for this domain. Foxn1(Delta/Delta) mice showed abnormal thymic architecture, lacking cortical and medullary domains. In contrast to thymi in mice with the null allele, the Foxn1(Delta/Delta) thymus promoted T cell development, but with specific defects at both the double-negative and double-positive stages. Thus, initiation and progression of TEC differentiation are genetically separable functions of Foxn1, and the N-terminal domain is required for crosstalk-dependent TEC differentiation.	Univ Georgia, Dept Genet, Athens, GA 30602 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Manley, NR (corresponding author), Univ Georgia, Dept Genet, Life Sci Bldg, Athens, GA 30602 USA.				NIAID NIH HHS [AI055001] Funding Source: Medline; NICHD NIH HHS [HD035920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055001] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baxter RM, 2002, J INVEST DERMATOL, V118, P303, DOI 10.1046/j.0022-202x.2001.01662.x; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; HILBERT DM, 1993, EUR J IMMUNOL, V23, P2412, DOI 10.1002/eji.1830231006; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Kaestner KH, 2000, GENE DEV, V14, P142; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Naquet P, 1999, SEMIN IMMUNOL, V11, P47, DOI 10.1006/smim.1998.0149; Naspetti M, 1997, EUR J IMMUNOL, V27, P1392, DOI 10.1002/eji.1830270615; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Penit C, 1996, DEV IMMUNOL, V5, P25, DOI 10.1155/1996/61035; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; Schlake T, 2000, GENE, V256, P29, DOI 10.1016/S0378-1119(00)00344-9; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schorpp M, 2000, DEV DYNAM, V218, P537, DOI 10.1002/1097-0177(200007)218:3<537::AID-DVDY1007>3.0.CO;2-P; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661	32	119	127	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1128	1135		10.1038/ni983	http://dx.doi.org/10.1038/ni983			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14528302				2022-12-18	WOS:000186241100017
J	Feldmann, M				Feldmann, M			Pathogenesis of arthritis: recent research progress	NATURE IMMUNOLOGY			English	News Item							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; T-CELL; SYNOVIUM; PROTEIN	Rheumatoid arthritis affects millions of individuals worldwide. Luckily, it is the autoimmune disease with the most promising clinical results.	Imperial Coll Sch Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Feldmann, M (corresponding author), Imperial Coll Sch Med, Kennedy Inst, Div Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.							Bondeson J, 1999, P NATL ACAD SCI USA, V96, P5668, DOI 10.1073/pnas.96.10.5668; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; EVANS CH, 2000, CLIN ORTHOP S, V379, P300; Feige U, 2000, CELL MOL LIFE SCI, V57, P1457, DOI 10.1007/PL00000629; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FIRESTEIN GS, 1995, J CLIN INVEST, V96, P1631, DOI 10.1172/JCI118202; Fox DA, 1997, ARTHRITIS RHEUM, V40, P598, DOI 10.1002/art.1780400403; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Fugger L, 1996, EUR J IMMUNOL, V26, P928, DOI 10.1002/eji.1830260431; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664	18	119	133	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					771	773		10.1038/ni0901-771	http://dx.doi.org/10.1038/ni0901-771			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526382				2022-12-18	WOS:000170781200008
J	Nagawa, F; Kishishita, N; Shimizu, K; Hirose, S; Miyoshi, M; Nezu, J; Nishimura, T; Nishizumi, H; Takahashi, Y; Hashimoto, S; Takeuchi, M; Miyajima, A; Takemori, T; Otsuka, AJ; Sakano, H				Nagawa, Fumikiyo; Kishishita, Natsuko; Shimizu, Kazumichi; Hirose, Satoshi; Miyoshi, Masato; Nezu, Junnya; Nishimura, Toshinobu; Nishizumi, Hirofumi; Takahashi, Yoshimasa; Hashimoto, Shu-ichi; Takeuchi, Masaki; Miyajima, Atsushi; Takemori, Toshitada; Otsuka, Anthony J.; Sakano, Hitoshi			Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice	NATURE IMMUNOLOGY			English	Article							REARRANGED IMMUNOGLOBULIN GENES; VARIABLE LYMPHOCYTE RECEPTORS; HOMOLOGOUS RECOMBINATION; SOMATIC DIVERSIFICATION; PATHOGEN RECOGNITION; V(D)J RECOMBINATION; MATING-TYPE; CONVERSION; VERTEBRATE; EVOLUTION	Jawless vertebrates have acquired immunity but do not have immunoglobulin-type antigen receptors. Variable lymphocyte receptors (VLRs) have been identified in lamprey that consist of multiple leucine-rich repeat (LRR) modules. An active VLR gene is generated by the assembly of a series of variable gene segments, including many that encode LRRs. Stepwise assembly of the gene segments seems to occur by replacement of the intervening DNA between the 5' and 3' constant-region genes. Here we report that lamprey (Lethenteron japonicum) assemble their VLR genes by a process involving 'copy choice'. Regions of short homology seemed to prime copying of donor LRR-encoding sequences into the recipient gene. Those LRR-encoding germline sequences were abundant and shared extensive sequence homologies. Such genomic organization permits initiation of copying anywhere in an LRR-encoding module for the generation of various hybrid LRRs. Thus, a vast repertoire of recombinant VLR genes could be generated not only by copying of various LRR segments in diverse combinations but also by the use of multiple sites in an LRR gene segment for priming.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; Natl Int Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA	University of Tokyo; National Institute of Infectious Diseases (NIID); University of Tokyo; Illinois State University	Nagawa, F (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.	snagawa@mail.ecc.u-tokyo.ac.jp	Nishimura, Toshinobu/AAZ-7675-2021; Takemori, Toshitada/A-5909-2016; Hirose, Satoshi/CAF-1500-2022	Nishimura, Toshinobu/0000-0002-5425-1708; Hirose, Satoshi/0000-0001-7825-501X; Hashimoto, Shu-ichi/0000-0002-2968-5846; Takahashi, Yoshimasa/0000-0001-6342-4087				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; Brayton KA, 2002, MOL MICROBIOL, V43, P1151, DOI 10.1046/j.1365-2958.2002.02792.x; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; DALENCON E, 1994, EMBO J, V13, P2725, DOI 10.1002/j.1460-2075.1994.tb06563.x; Darlow JM, 2005, IMMUNOLOGY, V114, P155, DOI 10.1111/j.1365-2567.2004.02084.x; Darlow JM, 2006, IMMUNOGENETICS, V58, P511, DOI 10.1007/s00251-006-0113-6; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; FUJII T, 1981, CELL TISSUE RES, V219, P41; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Haber JE, 2004, PHILOS T ROY SOC B, V359, P79, DOI 10.1098/rstb.2003.1367; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Piyamongkol W, 2003, MOL HUM REPROD, V9, P411, DOI 10.1093/molehr/gag051; Prado F, 2003, TRENDS GENET, V19, P428, DOI 10.1016/S0168-9525(03)00173-2; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587	40	118	127	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					206	213		10.1038/ni1419	http://dx.doi.org/10.1038/ni1419			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17187071				2022-12-18	WOS:000243597600019
J	Cullen, BR				Cullen, Bryan R.			Is RNA interference involved in intrinsic antiviral immunity in mammals?	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; NUCLEAR EXPORT; INFLUENZA; MICRORNAS; VIRUSES; HIV-1; SUPPRESSION; BINDING; DIRECTS; DICER	RNA interference constitutes a key component of the innate immune response to viral infection in both plants and invertebrate animals and has been postulated to have a similar protective function in mammals. This perspective reviews the available data addressing whether RNA interference forms part of the mammalian innate immune response and concludes that the popular hypothesis in favor of that possibility remains far from proven and may not be valid.	Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA.	culle002@mc.duke.edu			NIGMS NIH HHS [GM071408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Charpentier B, 1997, J MOL BIOL, V266, P950, DOI 10.1006/jmbi.1996.0858; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cullen BR, 2005, NAT GENET, V37, P1163, DOI 10.1038/ng1105-1163; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Delgadillo MO, 2004, J GEN VIROL, V85, P993, DOI 10.1099/vir.0.19735-0; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Gwizdek C, 2001, J BIOL CHEM, V276, P25910, DOI 10.1074/jbc.M100493200; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johnson KL, 2004, J VIROL, V78, P6698, DOI 10.1128/JVI.78.12.6698-6704.2004; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Roth BM, 2004, VIRUS RES, V102, P97, DOI 10.1016/j.virusres.2004.01.020; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	57	118	134	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					563	567		10.1038/ni1352	http://dx.doi.org/10.1038/ni1352			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715068				2022-12-18	WOS:000237751200010
J	Shen, ZJ; Esnault, S; Malter, JS				Shen, ZJ; Esnault, S; Malter, JS			The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils	NATURE IMMUNOLOGY			English	Article							PERIPHERAL-BLOOD EOSINOPHILS; BRONCHOALVEOLAR LAVAGE FLUID; AU-RICH ELEMENT; AIRWAY EOSINOPHILS; BINDING-PROTEINS; HYALURONIC-ACID; CYCLOSPORINE-A; HNRNP D; GM-CSF; PHOSPHORYLATION	The infiltration, accumulation and degranulation of eosinophils in the lung represents a hallmark of active asthma. In vivo or in vitro eosinophil activation triggers the secretion of the antiapoptotic cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). We now identify Pin1, a cis-trans isomerase, as an essential component of the ribonucleoprotein complex responsible for GM-CSF mRNA stabilization, cytokine secretion and the survival of activated eosinophils. Pin1 regulated the association of the AU-rich element-binding proteins AUF1 and hnRNP C with GM-CSF mRNA, accelerating or slowing decay, respectively. These data indicate Pin1 is a key mediator of GM-CSF production.	Univ Wisconsin, Sch Med, Waisman Ctr Dev Disabilities, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Malter, JS (corresponding author), Univ Wisconsin, Sch Med, Waisman Ctr Dev Disabilities, Madison, WI 53705 USA.	jsmalter@facstaff.wisc.edu	Esnault, Stephane/AAO-4712-2020; Esnault, Stephane/AAJ-4511-2020	Esnault, Stephane/0000-0001-7238-8671; 	NHLBI NIH HHS [P50HL56396] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Basu A, 2002, NEOPLASIA, V4, P218, DOI 10.1038/sj.neo.7900233; Bhattacharya S, 1999, NUCLEIC ACIDS RES, V27, P1464, DOI 10.1093/nar/27.6.1464; Caldenhoven E, 1998, STEM CELLS, V16, P397, DOI 10.1002/stem.160397; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; CARDENAS ME, 1995, EMBO J, V14, P2772, DOI 10.1002/j.1460-2075.1995.tb07277.x; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Esclatine A, 2004, J VIROL, V78, P8582, DOI 10.1128/JVI.78.16.8582-8592.2004; Esnault S, 2003, J IMMUNOL, V171, P6780, DOI 10.4049/jimmunol.171.12.6780; Esnault S, 2002, ARCH IMMUNOL THER EX, V50, P121; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Esnault S, 1999, J IMMUNOL, V163, P5228; Esnault S, 2001, J IMMUNOL, V166, P4658, DOI 10.4049/jimmunol.166.7.4658; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Kay AB, 2004, TRENDS IMMUNOL, V25, P477, DOI 10.1016/j.it.2004.07.006; Khan LN, 2000, AM J RESP CRIT CARE, V162, P1377, DOI 10.1164/ajrccm.162.4.9911117; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Meerschaert J, 1999, AM J RESP CRIT CARE, V159, P619, DOI 10.1164/ajrccm.159.2.9806053; MEISER BM, 1991, LANCET, V338, P1297, DOI 10.1016/0140-6736(91)92594-R; Park CS, 1998, EUR RESPIR J, V12, P872, DOI 10.1183/09031936.98.12040872; RAMESH KS, 1987, J CELL BIOCHEM, V34, P203, DOI 10.1002/jcb.240340306; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sakuma S, 2001, INT IMMUNOPHARMACOL, V1, P1219, DOI 10.1016/S1567-5769(01)00059-5; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Schneider T, 1997, AM J RESP CELL MOL, V17, P702, DOI 10.1165/ajrcmb.17.6.2849; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; TOCCI MJ, 1989, J IMMUNOL, V143, P718; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957	55	118	121	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1280	1287		10.1038/ni1266	http://dx.doi.org/10.1038/ni1266			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16273101				2022-12-18	WOS:000233371900017
J	Kakaradov, B; Arsenio, J; Widjaja, CE; He, ZR; Aigner, S; Metz, PJ; Yu, BF; Wehrens, EJ; Lopez, J; Kim, SH; Zuniga, EI; Goldrath, AW; Chang, JT; Yeo, GW				Kakaradov, Boyko; Arsenio, Janilyn; Widjaja, Christella E.; He, Zhaoren; Aigner, Stefan; Metz, Patrick J.; Yu, Bingfei; Wehrens, Ellen J.; Lopez, Justine; Kim, Stephanie H.; Zuniga, Elina I.; Goldrath, Ananda W.; Chang, John T.; Yeo, Gene W.			Early transcriptional and epigenetic regulation of CD8(+) T cell differentiation revealed by single-cell RNA sequencing	NATURE IMMUNOLOGY			English	Article							CENTRAL-MEMORY; EXPRESSION; EFFECTOR; SEQ; HETEROGENEITY; SIGNATURES; DIVISION; IMMUNE; BETA; EZH2	During microbial infection, responding CD8(+) T lymphocytes differentiate into heterogeneous subsets that together provide immediate and durable protection. To elucidate the dynamic transcriptional changes that underlie this process, we applied a single-cell RNA-sequencing approach and analyzed individual CD8(+) T lymphocytes sequentially throughout the course of a viral infection in vivo. Our analyses revealed a striking transcriptional divergence among cells that had undergone their first division and identified previously unknown molecular determinants that controlled the fate specification of CD8(+) T lymphocytes. Our findings suggest a model for the differentiation of terminal effector cells initiated by an early burst of transcriptional activity and subsequently refined by epigenetic silencing of transcripts associated with memory lymphocytes, which highlights the power and necessity of single-cell approaches.	[Kakaradov, Boyko; He, Zhaoren; Aigner, Stefan; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Arsenio, Janilyn; Widjaja, Christella E.; Metz, Patrick J.; Lopez, Justine; Kim, Stephanie H.; Chang, John T.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Yu, Bingfei; Wehrens, Ellen J.; Zuniga, Elina I.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore	Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA.; Chang, JT (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA.; Yeo, GW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.	changj@ucsd.edu; geneyeo@ucsd.edu	Yeo, Gene/AAE-7676-2019; Aigner, Stefan/D-1272-2017; Aigner, Stefan/AAC-2466-2019	Yeo, Gene/0000-0002-0799-6037; Aigner, Stefan/0000-0002-9511-3328; Chang, John/0000-0003-0873-6218; Goldrath, Ananda/0000-0002-5900-508X	US National Institutes of Health [DK093507, OD008469, AI095277, NS075449, HG004659, MH107367, AI072117, AI096852, AI081923, AI113923, DK007202]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072117, R01AI081923, R01AI095277, R01AI096852, R01AI113923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202, R01DK093507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH107367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chang and Yeo laboratories for discussions and critical reading of the manuscript, and the Sanford Consortium Stem Cell Genomics Core and Institute for Genomic Medicine Genomics Center for single-cell captures and sequencing. Supported by the US National Institutes of Health (DK093507, OD008469, and AI095277 to J.T.C.; NS075449, HG004659 and MH107367 to G.W.Y.; AI072117 and AI096852 to A.W.G; AI081923 and AI113923 to E.I.Z.; DK007202 for C.E.W. and P.J.M.) and the Howard Hughes Medical Institute (J.T.C.).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Ananieva EA, 2014, J BIOL CHEM, V289, P18793, DOI 10.1074/jbc.M114.554113; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chappell C, 2006, J IMMUNOL, V176, P4562, DOI 10.4049/jimmunol.176.8.4562; Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CY, 2015, P NATL ACAD SCI USA, V112, P11013, DOI 10.1073/pnas.1510119112; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Metz PJ, 2015, J IMMUNOL, V194, P2249, DOI 10.4049/jimmunol.1401652; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Ntranos V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0970-8; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schober SL, 1999, J IMMUNOL, V163, P3662; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Van der Maaten L., 2008, J MACH LEARN RES, V9, P2579; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; YU B, NAT IMMUNOL IN PRESS; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313	67	117	121	0	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					422	+		10.1038/ni.3688	http://dx.doi.org/10.1038/ni.3688			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28218746	Green Accepted			2022-12-18	WOS:000396815800010
J	Basu, R; Whitley, SK; Bhaumik, S; Zindl, CL; Schoeb, TR; Benveniste, EN; Pear, WS; Hatton, RD; Weaver, CT				Basu, Rajatava; Whitley, Sarah K.; Bhaumik, Suniti; Zindl, Carlene L.; Schoeb, Trenton R.; Benveniste, Etty N.; Pear, Warren S.; Hatton, Robin D.; Weaver, Casey T.			IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the T(H)17 cell-iT(reg) cell balance	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; TGF-BETA; FOXP3 EXPRESSION; HOST-DEFENSE; DIFFERENTIATION; GENERATION; PLASTICITY; TH17; SOCS3; FLEXIBILITY	Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) and CD4(+) inducible regulatory T cells (iT(reg) cells) emerge from an overlapping developmental program. In the intestines, the vitamin A metabolite retinoic acid (RA) is produced at steady state and acts as an important cofactor to induce iT(reg) cell development while potently inhibiting T(H)17 cell development. Here we found that IL-1 was needed to fully override RA-mediated expression of the transcription factor Foxp3 and induce protective T(H)17 cell responses. By repressing expression of the negative regulator SOCS3 dependent on the transcription factor NF-kappa B, IL-1 increased the amplitude and duration of phosphorylation of the transcription factor STAT3 induced by T(H)17-polarizing cytokines, which led to an altered balance in the binding of STAT3 and STAT5 to shared consensus sequences in developing T cells. Thus, IL-1 signaling modulated STAT activation downstream of cytokine receptors differently to control the T(H)17 cell-iT(reg) cell developmental fate.	[Basu, Rajatava; Whitley, Sarah K.; Bhaumik, Suniti; Zindl, Carlene L.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Schoeb, Trenton R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Benveniste, Etty N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Pear, Warren S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		BASU, RAJATAVA/0000-0003-4029-8043; Weaver, Casey/0000-0002-2180-1793; Hatton, Robin/0000-0002-4797-9899; Zindl, Carlene/0000-0003-4841-3552; BHAUMIK, SUNITI/0000-0003-1434-6929	US National Institutes of Health [PO1DK71176, R01DK093015, R01AI047833]; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA158534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, R01AI047833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093015, P01DK071176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057563] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Qin, L. Xu and members of the Weaver laboratory for advice and comments; G. Frankel and S. Wiles (Imperial College, London) for the bioluminescent C. rodentium strain; T. DeSilva (University of Alabama at Birmingham) for Rosa26<SUP>TdTomato fl/+</SUP> mice; D. O'Quinn for assistance with bioluminiscent imaging; B.J. Parsons for technical assistance; G. Gaskins for editorial assistance; the University of Alabama at Birmingham Small Animal Imaging Facility for imaging studies; the University of Alabama at Birmingham Center for AIDS Research Flow Cytometry Core for sorting cells by flow cytometry; and the University of Alabama at Birmingham Epitope Recognition and Immunoreagent Core Facility for antibody preparation. Supported by the US National Institutes of Health (PO1DK71176 and R01DK093015 to C.T.W. and R.D.H., and R01AI047833 to W.S.P.) and the Crohn's and Colitis Foundation of America (C.T.W. and R.B.).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Babon JJ, 2014, SEMIN IMMUNOL, V26, P13, DOI 10.1016/j.smim.2013.12.004; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XP, 2004, J BIOL CHEM, V279, P45279, DOI 10.1074/jbc.M313072200; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	47	117	121	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					286	U252		10.1038/ni.3099	http://dx.doi.org/10.1038/ni.3099			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25642823	Green Accepted			2022-12-18	WOS:000349842100012
J	A-Gonzalez, N; Guillen, JA; Gallardo, G; Diaz, M; de la Rosa, JV; Hernandez, IH; Casanova-Acebes, M; Lopez, F; Tabraue, C; Beceiro, S; Hong, C; Lara, PC; Andujar, M; Arai, S; Miyazaki, T; Li, SL; Corbi, AL; Tontonoz, P; Hidalgo, A; Castrillo, A				A-Gonzalez, Noelia; Guillen, Jose A.; Gallardo, German; Diaz, Mercedes; de la Rosa, Juan V.; Hernandez, Irene H.; Casanova-Acebes, Maria; Lopez, Felix; Tabraue, Carlos; Beceiro, Susana; Hong, Cynthia; Lara, Pedro C.; Andujar, Miguel; Arai, Satoko; Miyazaki, Toru; Li, Senlin; Corbi, Angel L.; Tontonoz, Peter; Hidalgo, Andres; Castrillo, Antonio			The nuclear receptor LXR alpha controls the functional specialization of splenic macrophages	NATURE IMMUNOLOGY			English	Article							LIVER X RECEPTORS; GENE-EXPRESSION; MYELOID CELLS; MONOCYTES; METABOLISM; PROLIFERATION; INFLAMMATION; RETENTION; REVEALS; PROTEIN	Macrophages are professional phagocytic cells that orchestrate innate immune responses and have considerable phenotypic diversity at different anatomical locations. However, the mechanisms that control the heterogeneity of tissue macrophages are not well characterized. Here we found that the nuclear receptor LXR alpha was essential for the differentiation of macrophages in the marginal zone (MZ) of the spleen. LXR-deficient mice were defective in the generation of MZ and metallophilic macrophages, which resulted in abnormal responses to blood-borne antigens. Myeloid-specific expression of LXR alpha or adoptive transfer of wild-type monocytes restored the MZ microenvironment in LXR alpha-deficient mice. Our results demonstrate that signaling via LXR alpha in myeloid cells is crucial for the generation of splenic MZ macrophages and identify an unprecedented role for a nuclear receptor in the generation of specialized macrophage subsets.	[A-Gonzalez, Noelia; Guillen, Jose A.; Diaz, Mercedes; Hernandez, Irene H.; Beceiro, Susana; Castrillo, Antonio] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols Madrid, Madrid, Spain; [A-Gonzalez, Noelia; Guillen, Jose A.; Gallardo, German; Diaz, Mercedes; de la Rosa, Juan V.; Hernandez, Irene H.; Lopez, Felix; Tabraue, Carlos; Beceiro, Susana; Castrillo, Antonio] Univ Las Palmas Gran Canaria, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols Madrid, Unidad Asociada Biomed, Las Palmas Gran Canaria, Spain; [Casanova-Acebes, Maria; Hidalgo, Andres] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Hong, Cynthia; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Lara, Pedro C.] Hosp Univ Gran Canaria Dr Negrin, Serv Oncol Radioterap, Las Palmas Gran Canaria, Spain; [Andujar, Miguel] Hosp Univ Materno Infantil Las Palmas, Serv Patol, Las Palmas Gran Canaria, Spain; [Arai, Satoko; Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan; [Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Li, Senlin] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Corbi, Angel L.] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Tokyo; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Castrillo, A (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols Madrid, Madrid, Spain.	acastrillo@iib.uam.es	Hidalgo, Andrés/L-5643-2014; Gonzalez, Noelia Alonso/H-4488-2015; Tabraue, Carlos/D-7126-2015; de la Rosa Medina, Juan Vladimir/Z-6150-2019; Corbi, Angel/B-7194-2011; Andújar, Miguel/AAB-7690-2020; Hernández, Irene/N-7551-2016; Acebes, Maria Casanova/AAH-1929-2019; Corbí, Angel L./ABC-8146-2020; Guillen, Jose/Z-5084-2019; Gonzalez, Noelia Alonso/ABC-7381-2021; campos, german gallardo/Z-5267-2019	Hidalgo, Andrés/0000-0001-5513-555X; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Tabraue, Carlos/0000-0001-9920-8116; de la Rosa Medina, Juan Vladimir/0000-0003-1443-7548; Corbi, Angel/0000-0003-1980-5733; Hernández, Irene/0000-0001-7174-7599; Acebes, Maria Casanova/0000-0002-5790-1163; Corbí, Angel L./0000-0003-1980-5733; Gonzalez, Noelia Alonso/0000-0003-0533-5216; campos, german gallardo/0000-0002-1516-1750; Miyazaki, Toru/0000-0003-3842-4362; Lopez Blanco, Felix/0000-0003-1167-9787; ANDUJAR, MIGUEL/0000-0002-4858-6915; Arai, Satoko/0000-0002-6145-8686; Guillen, Jose/0000-0003-4220-2471	Spanish Ministry of Research and Innovation [SAF2008-00057]; Ministry of Economy and Competitiveness [SAF2011-29244, SAF2009-11037]; European Union [IRG246655]; Howard Hughes Medical Institute; US National Institutes of Health [HL-066088, HL-030568]; Subprograma Ramon y Cajal [RYC-2007-00697]; Formacion de Personal Investigador [BES-2010-032828, BES-2009-012191]; Universidad Las Palmas de Gran Canaria; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL030568] Funding Source: NIH RePORTER	Spanish Ministry of Research and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness; European Union(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Subprograma Ramon y Cajal(Spanish Government); Formacion de Personal Investigador; Universidad Las Palmas de Gran Canaria; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Mangelsdorf (University of Texas Southwestern Medical Center) for LXR alpha- and LXR beta-sufficient wild-type (Nr1h3<SUP>+/+</SUP> Nr1h2<SUP>+/+</SUP>) mice, LXR alpha-deficient (Nr1h3<SUP>-/-</SUP>) mice, LXR alpha-deficient (Nr1h2<SUP>-/-</SUP>) mice and LXR-deficient (Nr1h3<SUP>-/-</SUP>Nr1h2<SUP>-/-</SUP>) mice; the Institut Clinique de la Souris for Nr1h3<SUP>fl/fl</SUP> mice; D. Kioussis (Medical Research Council) and S. Gonzalez (Centro Nacional de Investigaciones Cardiovasculares) for Vav-Cre mice; S. Gordon and M. Stacey (University of Oxford) for antibody to F4/80 (anti-F4/80) and anti-CD169; G. Randolph (Washington University St. Louis) for discussions and anti-TREML4 from the R. Steinman laboratory (Rockefeller University); M. Kosco-Vilbois (NovImmune) for anti-FDC-M1 and anti-FDC-M2; J. Collins and T. Willson (GlaxoSmithKline) for the synthetic ligands of LXR (GW3965) and retinoid X receptor (LG268); N. Ruddle, C. Glass, N. Spann, A. Chawla, G. Lemke, D. Hume, L. Hedrick, A. Lazarus and L. Bosca for comments; and Servicio Microscopia Electronica (University of Las Palmas de Gran Canaria) for electron microscopy. Supported by the Spanish Ministry of Research and Innovation (SAF2008-00057 to A.C.), the Ministry of Economy and Competitiveness (SAF2011-29244 to A.C. and SAF2009-11037 to A.H.), Framework Programme 7 of the European Union (International Reintegration Grant IRG246655 to A. H.), the Howard Hughes Medical Institute (P.T.), the US National Institutes of Health (HL-066088 and HL-030568 to P.T.), Subprograma Ramon y Cajal (RYC-2007-00697 to A. H.), Formacion de Personal Investigador (BES-2010-032828 to M. C.-A. and BES-2009-012191 to I.H.H.) and Universidad Las Palmas de Gran Canaria (J.V.d.l.R.).	A-Gonzalez N, 2011, BBA-MOL BASIS DIS, V1812, P982, DOI 10.1016/j.bbadis.2010.12.015; A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; He WJ, 2006, HUM GENE THER, V17, P949, DOI 10.1089/hum.2006.17.949; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Hong C, 2011, J LIPID RES, V52, P531, DOI 10.1194/jlr.M010686; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Li G, 2011, GENE THER, V18, P835, DOI 10.1038/gt.2011.29; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nolte MA, 2004, J IMMUNOL, V172, P3620, DOI 10.4049/jimmunol.172.6.3620; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Swirski FK, 2011, ARTERIOSCL THROM VAS, V31, P1517, DOI 10.1161/ATVBAHA.110.221150; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Watanabe Y, 2005, ARTERIOSCL THROM VAS, V25, P622, DOI 10.1161/01.ATV.0000154489.53077.4e; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	47	117	120	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					831	+		10.1038/ni.2622	http://dx.doi.org/10.1038/ni.2622			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23770640	Green Submitted, Green Accepted			2022-12-18	WOS:000322010600012
J	Pobezinsky, LA; Angelov, GS; Tai, XG; Jeurling, S; Van Laethem, F; Feigenbaum, L; Park, JH; Singer, A				Pobezinsky, Leonid A.; Angelov, Georgi S.; Tai, Xuguang; Jeurling, Susanna; Van Laethem, Francois; Feigenbaum, Lionel; Park, Jung-Hyun; Singer, Alfred			Clonal deletion and the fate of autoreactive thymocytes that survive negative selection	NATURE IMMUNOLOGY			English	Article							DOUBLE-POSITIVE THYMOCYTES; T-CELL DIFFERENTIATION; CD28 COSTIMULATION; INTRAEPITHELIAL LYMPHOCYTES; CD4(+)CD8(+) THYMOCYTES; CENTRAL TOLERANCE; RUNX PROTEINS; THYMUS; EXPRESSION; APOPTOSIS	Clonal deletion of autoreactive thymocytes is important for self-tolerance, but the intrathymic signals that induce clonal deletion have not been clearly identified. We now report that clonal deletion during negative selection required CD28-mediated costimulation of autoreactive thymocytes at the CD4(+)CD8(lo) intermediate stage of differentiation. Autoreactive thymocytes were prevented from undergoing clonal deletion by either a lack of CD28 costimulation or transgenic overexpression of the antiapoptotic factors Bcl-2 or Mcl-1, with surviving thymocytes differentiating into anergic CD4(-)CD8(-) double-negative thymocytes positive for the T cell antigen receptor alpha beta subtype (TCR alpha beta) that 'preferentially' migrated to the intestine, where they re-expressed CD8 alpha and were sequestered as CD8 alpha alpha(+) intraepithelial lymphocytes (IELs). Our study identifies costimulation by CD28 as the intrathymic signal required for clonal deletion and identifies CD8 alpha alpha(+) IELs as the developmental fate of autoreactive thymocytes that survive negative selection.	[Pobezinsky, Leonid A.; Tai, Xuguang; Jeurling, Susanna; Van Laethem, Francois; Park, Jung-Hyun; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Angelov, Georgi S.] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Feigenbaum, Lionel] NCI, Sci Applicat Int Corp Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lausanne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov	Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055	National Cancer Institute Center for Cancer Research of the US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011116, ZIABC011113, ZIABC011112, ZIABC011111, ZIABC011106, ZIABC011214, ZIABC011114, ZIABC011117, ZIABC009273] Funding Source: NIH RePORTER	National Cancer Institute Center for Cancer Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Taylor, J. DiSanto and R. Hodes for critical reading of the manuscript; A. Sharpe (Harvard University) for B7-deficient mice, T. Honjo (Kyoto University) for PD-1-deficient mice; D. Littman (New York University) for Runx3-YFP reporter mice; and S. Sharrow, A. Adams and L. Granger for flow cytometry. Supported by the Intramural Research Program of the National Cancer Institute Center for Cancer Research of the US National Institutes of Health.	Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; CARBONE AM, 1988, SCIENCE, V242, P1174, DOI 10.1126/science.2460926; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Dautigny N, 1999, J IMMUNOL, V162, P1294; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gao JX, 2002, J EXP MED, V195, P959, DOI 10.1084/jem.20011948; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Hu Q, 2009, J IMMUNOL, V183, P7761, DOI 10.4049/jimmunol.0902181; JONES LA, 1993, INT IMMUNOL, V5, P503, DOI 10.1093/intimm/5.5.503; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Kovalovsky D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008675; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McCaughtry TM, 2008, SEMIN IMMUNOPATHOL, V30, P399, DOI 10.1007/s00281-008-0137-0; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIMPSON E, 1993, EUR J IMMUNOGENET, V20, P137; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; Takahama Y, 2011, BLOOD, V118, P2380, DOI 10.1182/blood-2011-05-351734; TAN RS, 1992, J IMMUNOL, V149, P3217; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Walunas TL, 1996, J IMMUNOL, V156, P1006; Wang RF, 2002, P NATL ACAD SCI USA, V99, P2181, DOI 10.1073/pnas.042692799; Yu X, 2000, J IMMUNOL, V164, P3543, DOI 10.4049/jimmunol.164.7.3543	50	117	120	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					569	+		10.1038/ni.2292	http://dx.doi.org/10.1038/ni.2292			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22544394	Green Accepted, Green Submitted			2022-12-18	WOS:000304203900011
J	Trampont, PC; Tosello-Trampont, AC; Shen, YL; Duley, AK; Sutherland, AE; Bender, TP; Littman, DR; Ravichandran, KS				Trampont, Paul C.; Tosello-Trampont, Annie-Carole; Shen, Yuelei; Duley, Amanda K.; Sutherland, Ann E.; Bender, Timothy P.; Littman, Dan R.; Ravichandran, Kodi S.			CXCR4 acts as a costimulator during thymic beta-selection	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; CHEMOKINE RECEPTOR CXCR4; NF-KAPPA-B; PRE-TCR; IN-VIVO; KINASE ACTIVATION; POSTNATAL THYMUS; PROTEIN-KINASE; SURVIVAL; SIGNAL	Passage through the beta-selection developmental checkpoint requires productive rearrangement of segments of the T cell antigen receptor-beta gene (Tcrb) and formation of a pre-TCR on the surface of CD4-CD8-thymocytes. How other receptors influence beta-selection is less well understood. Here we define a new role for the chemokine receptor CXCR4 during T cell development. CXCR4 functionally associated with the pre-TCR and influenced beta-selection by regulating the steady-state localization of immature thymocytes in thymic subregions, by facilitating optimal pre-TCR-induced survival signals, and by promoting thymocyte proliferation. We also characterize functionally relevant signaling molecules downstream of CXCR4 and the pre-TCR in thymocytes. Our data designate CXCR4 as a costimulator of the pre-TCR during beta-selection.	[Trampont, Paul C.; Tosello-Trampont, Annie-Carole; Bender, Timothy P.; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA; [Duley, Amanda K.; Bender, Timothy P.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Sutherland, Ann E.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [Shen, Yuelei; Littman, Dan R.] Howard Hughes Med Inst, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Shen, Yuelei; Littman, Dan R.] NYU, Sch Med, New York, NY USA	University of Virginia; University of Virginia; University of Virginia; Howard Hughes Medical Institute; New York University	Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA.	ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Sutherland, Ann/0000-0003-1925-2825; Trampont, Paul/0000-0002-3643-8472	National Institute of General Medical Sciences; National Cancer Institute; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. C. Zuniga-Pflucker (Sunnybrook Research Institute, University of Toronto) for OP9-DL1 cells; I. Aifantis (New York University School of Medicine) for SCIET27 and SCB29 cells; the flow cytometry and histology core facilities at the University of Virginia for technical assistance; members of the Ravichandran laboratory and specifically I. J. Juncadella and M. R. Elliott for technical assistance; and J. Lysiak and R. Woodson for help with the Apostain technique. Supported by the National Institute of General Medical Sciences (K. S. R.), the National Cancer Institute (T. P. B.) and the Howard Hughes Medical Institute (D. R. L.).	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; Cyster JG, 2002, J CLIN INVEST, V109, P1011, DOI 10.1172/JCI200215511; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kelemen BR, 2002, J BIOL CHEM, V277, P8741, DOI 10.1074/jbc.M108459200; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Trampont P, 2006, MOL CELL BIOL, V26, P9035, DOI 10.1128/MCB.00988-06; Trautmann A, 2005, NAT IMMUNOL, V6, P427, DOI 10.1038/ni0505-427; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Wiest DL, 1999, SEMIN IMMUNOL, V11, P251, DOI 10.1006/smim.1999.0181; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	117	119	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					162	U86		10.1038/ni.1830	http://dx.doi.org/10.1038/ni.1830			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20010845	Green Accepted			2022-12-18	WOS:000273730200014
J	Herzog, S; Hug, E; Meixlsperger, S; Paik, JH; DePinho, RA; Reth, M; Jumaa, H				Herzog, Sebastian; Hug, Eva; Meixlsperger, Sonja; Paik, Ji-Hye; DePinho, Ronald A.; Reth, Michael; Jumaa, Hassan			SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway	NATURE IMMUNOLOGY			English	Article							IMMATURE B-CELLS; PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTORS; NF-KAPPA-B; V(D)J RECOMBINATION; POSITIVE SELECTION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; NEGATIVE SELECTION; RAG-2 ACCUMULATION	Although the essential role of the adaptor protein SLP-65 in pre-B cell differentiation is established, the molecular mechanism underlying its function is poorly understood. In this study, we uncover a link between SLP-65-dependent signaling and the phosphoinositide-3-OH kinase (PI(3)K)-protein kinase B (PKB)-Foxo pathway. We show that the forkhead box transcription factor Foxo3a promotes light chain rearrangement in pre-B cells. Our data suggest that PKB suppresses light chain recombination by phosphorylating Foxo proteins, whereas reconstitution of SLP-65 function counteracts PKB activation and promotes Foxo3a and Foxo1 activity in pre-B cells. Together, these data illuminate a molecular function of SLP-65 and identify a key role for Foxo proteins in the regulation of light chain recombination, receptor editing and B cell selection.	[Herzog, Sebastian; Hug, Eva; Meixlsperger, Sonja; Reth, Michael; Jumaa, Hassan] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Herzog, Sebastian; Hug, Eva; Meixlsperger, Sonja; Reth, Michael; Jumaa, Hassan] Univ Freiburg, Fac Biol, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Appl Canc Sci,Dept Med Oncol Med & Genet, Boston, MA 02115 USA	Max Planck Society; University of Freiburg; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Jumaa, H (corresponding author), Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.	jumaa@immunbio.mpg.de		Herzog, Sebastian/0000-0001-7167-3489; DePinho, Ronald/0000-0002-5625-577X				Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Diamant E, 2005, BLOOD, V105, P3247, DOI 10.1182/blood-2004-08-3165; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hayashi K, 2004, J IMMUNOL, V173, P5980, DOI 10.4049/jimmunol.173.10.5980; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Meade J, 2004, EUR J IMMUNOL, V34, P1102, DOI 10.1002/eji.200324309; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Nemazee D, 2000, CURR TOP MICROBIOL, V245, P57; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Otero DC, 2001, J BIOL CHEM, V276, P1474, DOI 10.1074/jbc.M003918200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shivtiel S, 2002, J IMMUNOL, V168, P5596, DOI 10.4049/jimmunol.168.11.5596; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Spicuglia S, 2006, CURR OPIN IMMUNOL, V18, P158, DOI 10.1016/j.coi.2006.01.003; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967	50	117	118	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					623	631		10.1038/ni.1616	http://dx.doi.org/10.1038/ni.1616			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18488031				2022-12-18	WOS:000256067900012
J	Belz, GT; Bedoui, S; Kupresanin, F; Carbone, FR; Heath, WR				Belz, Gabrielle T.; Bedoui, Sammy; Kupresanin, Fiona; Carbone, Francis R.; Heath, William R.			Minimal activation of memory CD8+T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+T cells	NATURE IMMUNOLOGY			English	Article							CD8(+) T-CELLS; ORIGINAL ANTIGENIC SIN; HERPES-SIMPLEX-VIRUS; INFLUENZA-A VIRUS; IN-VIVO DEPLETION; CUTTING EDGE; LANGERHANS CELLS; IMMUNITY; INFECTION; ESCAPE	Of the many dendritic cell (DC) subsets, DCs expressing the monomorphic coreceptor CD8 alpha-chain (CD8 alpha) are localized permanently in lymphoid organs, whereas 'tissue-derived DCs' remain in nonlymphoid tissues until they 'capture' antigen and then move to local lymph nodes. Here we show that after lung infection, both naive and memory CD8(+) 'killer' T cells responded to influenza virus antigens presented by lymph node-resident CD8 alpha(+) DCs, but only naive cells responded to antigens presented by lung-derived DCs. This difference provides a mechanism for priming naive T cell responses in conditions in which robust memory predominates. Our findings have implications for immunity to pathogens that can mutate their T cell epitopes, such as influenza virus and human immunodeficiency virus, and challenge the long-held view that memory T cells have less-stringent requirements for activation than naive T cells have.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au; heath@wehi.edu.au	Belz, Gabrielle T/C-9350-2013; Carbone, Francis/ABF-2141-2020	Belz, Gabrielle T/0000-0002-9660-9587; Heath, William/0000-0001-9670-259X; BEDOUI, SAMMY/0000-0002-7443-0543	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CROFT M, 1994, J IMMUNOL, V152, P2675; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; FHORTMAN K, 2007, NATURE REV IMMUNOL, V7, P19; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Henri S, 2002, INFECT IMMUN, V70, P3874, DOI 10.1128/IAI.70.7.3874-3880.2002; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Turner SJ, 2001, J IMMUNOL, V167, P2753, DOI 10.4049/jimmunol.167.5.2753; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wong P, 2003, IMMUNITY, V18, P499, DOI 10.1016/S1074-7613(03)00081-5; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	43	117	120	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1060	1066		10.1038/ni1505	http://dx.doi.org/10.1038/ni1505			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17767161	Bronze			2022-12-18	WOS:000249691400020
J	Shui, JW; Boomer, JS; Han, J; Xu, J; Dement, GA; Zhou, GS; Tan, TH				Shui, Jr-Wen; Boomer, Jonathan S.; Han, Jin; Xu, Jun; Dement, Gregory A.; Zhou, Guisheng; Tan, Tse-Hua			Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses	NATURE IMMUNOLOGY			English	Article							N-TERMINAL KINASE; GERMINAL CENTER KINASE; PROTEIN-KINASE; ADAPTER PROTEINS; HEMATOPOIETIC-PROGENITOR-KINASE-1 HPK1; KAPPA-B; ACTIVATION; PATHWAY; TRANSCRIPTION; HIP-55	HPK1 is a Ste20-related serine-threonine kinase that inducibly associates with the adaptors SLP-76 and Gads after T cell receptor ( TCR) signaling. Here, HPK1 deficiency resulted in enhanced TCR-induced phosphorylation of SLP-76, phospholipase C-gamma 1 and the kinase Erk, more-persistent calcium flux, and increased production of cytokines and antigen-specific antibodies. Furthermore, HPK1-deficient mice were more susceptible to experimental autoimmune encephalomyelitis. Although the interaction between SLP-76 and Gads was unaffected, the inducible association of SLP-76 with 14-3-3 tau ( a phosphorylated serine-binding protein and negative regulator of TCR signaling) was reduced in HPK1-deficient T cells after TCR stimulation. HPK1 phosphorylated SLP-76 and induced the interaction of SLP-76 with 14-3-3 tau. Our results indicate that HPK1 negatively regulates TCR signaling and T cell-mediated immune responses.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Tan, TH (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.	ttan@bcm.edu	Shui, Jr-Wen/Q-2617-2018; Tan, Tse-Hua/ABD-7080-2021; Tan, Tse-Hua/E-3983-2010	Shui, Jr-Wen/0000-0002-5243-3727; Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Han, Jin/0000-0003-0662-006X	NATIONAL CANCER INSTITUTE [R01CA087076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532, R01AI066895, T32AI007495] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA87076] Funding Source: Medline; NIAID NIH HHS [R01-AI066895, R01-AI42532, T32-AI07495] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ebinu JO, 2000, BLOOD, V95, P3199; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Erdreich-Epstein A, 1999, J LEUKOCYTE BIOL, V65, P523, DOI 10.1002/jlb.65.4.523; Han J, 2005, MOL CELL BIOL, V25, P6869, DOI 10.1128/MCB.25.16.6869-6878.2005; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Le Bras S, 2004, J BIOL CHEM, V279, P15550, DOI 10.1074/jbc.M312659200; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Meller N, 1996, MOL CELL BIOL, V16, P5782; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Okuda Y, 2003, J NEUROIMMUNOL, V135, P29, DOI 10.1016/S0165-5728(02)00428-9; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2003, BLOOD, V101, P3687, DOI 10.1182/blood-2002-07-2316; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	43	117	132	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					84	91		10.1038/ni1416	http://dx.doi.org/10.1038/ni1416			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17115060				2022-12-18	WOS:000242934400017
J	Lee, GR; Spilianakis, CG; Flavell, RA				Lee, GR; Spilianakis, CG; Flavell, RA			Hypersensitive site 7 of the T(H)2 locus control region is essential for expressing T(H)2 cytokine genes and for long-range intrachromosomal interactions	NATURE IMMUNOLOGY			English	Article							BETA-GLOBIN LOCUS; T-CELL DIFFERENTIATION; OPEN CHROMATIN-STRUCTURE; IMMUNE-SYSTEM; IL-4 GENE; COORDINATE REGULATOR; HISTONE ACETYLATION; LINEAGE COMMITMENT; DNA METHYLATION; TH2 CELLS	Several regulatory regions are important for the expression of genes encoding T helper type 2 (T(H)2) cytokines, including T(H)2-specific DNase I hypersensitivity sites in the T(H)2 cytokine locus control region. Among these sites, Rad50 hypersensitive site 7 (RHS7) shows rapid T(H)2-specific demethylation after antigenic stimulation. To investigate the function of RHS7 in T(H)2 cell differentiation, we have generated RHS7-deficient mice. CD4+ T cells and mast cells showed a notable reduction in T(H)2 cytokine expression in vitro and T(H)2 responses in vivo were considerably impaired in RHS7-deficient mice. Deletion of RHS7 did not affect the expression of a linked Rad50 gene, but it did reduce long-range intrachromosomal interactions between the locus control region and promoters of the T(H)2 cytokine genes. Our findings show that RHS7 is essential for the proper regulation of T(H)2 cytokine gene expression.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923	NHLBI NIH HHS [HL56389] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056389, P01HL056389] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong C, 2001, CURR OPIN HEMATOL, V8, P47, DOI 10.1097/00062752-200101000-00009; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; FIELDS PE, IN PRESS IMMUNITY; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Glimcher LH, 2000, GENE DEV, V14, P1693; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200	38	117	122	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					42	48		10.1038/ni1148	http://dx.doi.org/10.1038/ni1148			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15608641				2022-12-18	WOS:000225888500016
J	Vosshenrich, CAJ; Cumano, A; Muller, W; Di Santo, JP; Vieira, P				Vosshenrich, CAJ; Cumano, A; Muller, W; Di Santo, JP; Vieira, P			Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development	NATURE IMMUNOLOGY			English	Article							RECEPTOR-GAMMA CHAIN; SEVERE COMBINED IMMUNODEFICIENCY; MEDIATED SIGNAL-TRANSDUCTION; MOUSE BONE-MARROW; IN-VITRO; INTERLEUKIN-7 RECEPTOR; LYMPHOID DEVELOPMENT; GROWTH-FACTOR; BIOLOGICAL CHARACTERIZATION; HEMATOPOIETIC-CELLS	Deletions of interleukin 7 (IL-7) or its receptor components permit fetal but not adult B cell development in mice. Mice deficient in IL-7 receptor (IL-7R) had 1% the number of B cells of controls and 10% that of mice deficient in the common chain. As IL-7Ralpha is also a receptor for thymic stromal-derived lymphopoietin (TSLP), we assayed the ability of TSLP to support proliferation of fetal or adult precursor B cells. Only fetal-derived pro-B cells were able to respond to TSLP, although pre-B cells from both origins were TSLP-responsive. Fetal but not adult precursors generated a measurable B cell compartment in the absence of IL-7. The residual B cells found in IL-7Ralpha-deficient mice required fetal liver kinase 2 (Flk-2) for their development. Thus, IL-7Ralpha- and Flk-2-mediated signals account for the generation of almost all mouse B lymphocytes.	Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, F-75724 Paris, France; INSERM Equipe, Unite Cytokines & Dev Lymphoide, F-75724 Paris, France; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; GBF, Dept Expt Immunol, D-38124 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cologne; Helmholtz Association; Helmholtz-Center for Infection Research	Vieira, P (corresponding author), Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, F-75724 Paris, France.		Muller, Werner/B-9044-2008; Vieira, Paulo/D-4500-2013; Di Santo, James P/M-4298-2014; Vosshenrich, Christian AJ/M-6523-2014	Muller, Werner/0000-0002-1297-9725; Vieira, Paulo/0000-0003-1307-5119; Di Santo, James P/0000-0002-7146-1862; Vosshenrich, Christian AJ/0000-0002-4407-8649; Cumano, Ana/0000-0002-4578-959X				Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Akashi K, 1998, IMMUNOL REV, V165, P13, DOI 10.1111/j.1600-065X.1998.tb01226.x; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Colucci F, 1999, J IMMUNOL, V162, P2761; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; FRIEND SL, 1994, EXP HEMATOL, V22, P321; GIMBLE JM, 1989, BLOOD, V74, P303; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GOUGEON ML, 1990, J IMMUNOL, V145, P2873; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Levin SD, 1999, J IMMUNOL, V162, P677; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moore TA, 1996, J IMMUNOL, V157, P2366; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; ROLINK A, 1994, IMMUNOL REV, V137, P185, DOI 10.1111/j.1600-065X.1994.tb00665.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2000, EUR J IMMUNOL, V30, P1614, DOI 10.1002/1521-4141(200006)30:6<1614::AID-IMMU1614>3.0.CO;2-I; Vosshenrich CAJ, 2001, CURR BIOL, V11, pR175, DOI 10.1016/S0960-9822(01)00087-2; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	40	117	121	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					773	779		10.1038/ni956	http://dx.doi.org/10.1038/ni956			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12872121				2022-12-18	WOS:000184441500014
J	Karamitros, D; Stoilova, B; Aboukhalil, Z; Hamey, F; Reinisch, A; Samitsch, M; Quek, L; Otto, G; Repapi, E; Doondeea, J; Usukhbayar, B; Calvo, J; Taylor, S; Goardon, N; Six, E; Pflumio, F; Porcher, C; Majeti, R; Gottgens, B; Vyas, P				Karamitros, Dimitris; Stoilova, Bilyana; Aboukhalil, Zahra; Hamey, Fiona; Reinisch, Andreas; Samitsch, Marina; Quek, Lynn; Otto, Georg; Repapi, Emmanouela; Doondeea, Jessica; Usukhbayar, Batchimeg; Calvo, Julien; Taylor, Stephen; Goardon, Nicolas; Six, Emmanuelle; Pflumio, Francoise; Porcher, Catherine; Majeti, Ravindra; Gottgens, Berthold; Vyas, Paresh			Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; HUMAN CORD BLOOD; BONE-MARROW; MULTIPOTENT PROGENITORS; LINEAGE COMMITMENT; DIFFUSION MAPS; IN-VIVO; DENDRITIC CELLS; RNA-SEQ; DIFFERENTIATION	The hierarchy of human hemopoietic progenitor cells that produce lymphoid and granulocytic-monocytic (myeloid) lineages is unclear. Multiple progenitor populations produce lymphoid and myeloid cells, but they remain incompletely characterized. Here we demonstrated that lympho-myeloid progenitor populations in cord blood - lymphoid-primed multi-potential progenitors (LMPPs), granulocyte-macrophage progenitors (GMPs) and multi-lymphoid progenitors (MLPs) - were functionally and transcriptionally distinct and heterogeneous at the clonal level, with progenitors of many different functional potentials present. Although most progenitors had the potential to develop into only one mature cell type ('uni-lineage potential'), bi- and rarer multi-lineage progenitors were present among LMPPs, GMPs and MLPs. Those findings, coupled with single-cell expression analyses, suggest that a continuum of progenitors execute lymphoid and myeloid differentiation, rather than only uni-lineage progenitors' being present downstream of stem cells.	[Karamitros, Dimitris; Stoilova, Bilyana; Aboukhalil, Zahra; Samitsch, Marina; Quek, Lynn; Otto, Georg; Repapi, Emmanouela; Doondeea, Jessica; Usukhbayar, Batchimeg; Taylor, Stephen; Goardon, Nicolas; Porcher, Catherine; Vyas, Paresh] Univ Oxford, Weatherall Inst Mol Med, MRC, MRC Mol Haematol Unit, Oxford, England; [Karamitros, Dimitris; Stoilova, Bilyana; Quek, Lynn; Doondeea, Jessica; Usukhbayar, Batchimeg; Vyas, Paresh] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Hamey, Fiona; Gottgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge, England; [Hamey, Fiona; Gottgens, Berthold] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Reinisch, Andreas; Majeti, Ravindra] Stanford Inst Stem Cell Biol & Regenerat Med, Div Hematol, Stanford, CA USA; [Quek, Lynn; Vyas, Paresh] OUH NHS Trust, Dept Hematol, Oxford, England; [Calvo, Julien; Pflumio, Francoise] Univ Paris 11, Univ Paris 07, INSERM CEA UMR967, Paris, France; [Six, Emmanuelle] Paris Descartes Sorbonne Paris Cite Univ, UMR1163, Imagine Inst, Paris, France	University of Oxford; University of Oxford; University of Cambridge; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Vyas, P (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC, MRC Mol Haematol Unit, Oxford, England.; Vyas, P (corresponding author), Univ Oxford, Oxford Biomed Res Ctr, Oxford, England.; Vyas, P (corresponding author), OUH NHS Trust, Dept Hematol, Oxford, England.	paresh.vyas@imm.ox.ac.uk	Pflumio, Francoise/E-2074-2017; Calvo, Julien/HCI-0693-2022; Six, Emmanuelle/H-7891-2017	Aboukhalil, Zahra/0000-0002-9936-1564; Gottgens, Berthold/0000-0001-6302-5705; /0000-0001-8085-0731; Stoilova, Bilyana/0000-0001-6192-9145; Reinisch, Andreas/0000-0001-9333-7689; Goardon, Nicolas/0000-0002-5093-0922; Six, Emmanuelle/0000-0001-7806-0968; Majeti, Ravindra/0000-0002-5814-0984; Otto, Georg W/0000-0002-3929-948X; Hamey, Fiona/0000-0001-7299-2860; Pflumio, Francoise/0000-0001-8995-596X; KARAMITROS, DIMITRIS/0000-0002-1072-3101	Wellcome Trust [090532/Z/09/Z]; MRC (MHU) [G1000729]; MRC (MRC Disease Team Award) [4050189188]; MRC (PhD studentship); MRC (Single Cell Award) [MR/M00919X/1]; CRUK [C7893/A12796, C1163/A21762, CRUKDF0176-DK, C5255/A20758]; Bloodwise [13001, 12019]; Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme); US National Institutes of Health [R01CA188055, U01HL099999]; New York Stem Cell Foundation; Leukemia and Lymphoma Society; Austrian Science Fund (FWF); NATIONAL CANCER INSTITUTE [R01CA188055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999] Funding Source: NIH RePORTER; MRC [MC_UU_12009/9, MR/M00919X/1, MC_UU_12009/11, G1000729, MR/L008963/1, MC_UU_00016/9, MC_U137961145] Funding Source: UKRI; Austrian Science Fund (FWF) [J 3358] Funding Source: researchfish; Medical Research Council [1581868, MC_PC_12009, MR/M00919X/1, 1779543, 1514301, G1000729, G1000801c, MC_UU_12009/9, MC_UU_12009/11, MC_U137961145, MR/L008963/1, MC_UU_00016/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0617-10056] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC (MHU)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC (MRC Disease Team Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC (PhD studentship)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC (Single Cell Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Bloodwise; Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J.C. Zuniga-Pflucker for OP9-DL4 cells used for initial experiments; and the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust (090532/Z/09/Z)) for generation of sequencing data. Supported by the MRC (MHU Award G1000729 and MRC Disease Team Award 4050189188 to P.V.; PhD studentship to Z.A. and F.H.; Single Cell Award MR/M00919X/1), CRUK (Program Grant C7893/A12796 to P.V.; Program Grant C1163/A21762 to B.G.; Development Fund CRUKDF0176-DK to D.K. and P.V.; and CRUK Development Fund C5255/A20758 to B.S. and P.V.), Bloodwise (Specialist Program 13001 and Project Grant 12019), the Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme), the US National Institutes of Health (R01CA188055 and U01HL099999 to R.M.), the New York Stem Cell Foundation (Robertson Investigator, R.M.), the Leukemia and Lymphoma Society (Scholar Award to R.M.) and the Austrian Science Fund (FWF) (Erwin-Schroedinger Research fellowship to A.R.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Berardi AC, 1997, BLOOD, V89, P3554, DOI 10.1182/blood.V89.10.3554.3554_3554_3564; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Calvo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050495; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gorgens A, 2015, STEM CELL REP, V5, P154, DOI 10.1016/j.stemcr.2015.06.010; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Ichii M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012954; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Quek L, 2016, J EXP MED, V213, P1513, DOI 10.1084/jem.20151775; Reinisch A, 2016, NAT MED, V22, P812, DOI 10.1038/nm.4103; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Six EM, 2011, BLOOD CELL MOL DIS, V47, P72, DOI 10.1016/j.bcmd.2011.04.001; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045	52	116	116	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					85	+		10.1038/s41590-017-0001-2	http://dx.doi.org/10.1038/s41590-017-0001-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29167569	Green Accepted, Green Submitted			2022-12-18	WOS:000419765300016
J	Bettigole, SE; Lis, R; Adoro, S; Lee, AH; Spencer, LA; Weller, PF; Glimcher, LH				Bettigole, Sarah E.; Lis, Raphael; Adoro, Stanley; Lee, Ann-Hwee; Spencer, Lisa A.; Weller, Peter F.; Glimcher, Laurie H.			The transcription factor XBP1 is selectively required for eosinophil differentiation	NATURE IMMUNOLOGY			English	Article							PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; MAJOR BASIC-PROTEIN; ALTERNATIVELY ACTIVATED MACROPHAGES; BONE-MARROW; ER-STRESS; GENE-EXPRESSION; MESSENGER-RNA; MICE; DISEASE	The transcription factor XBP1 has been linked to the development of highly secretory tissues such as plasma cells and Paneth cells, yet its function in granulocyte maturation has remained unknown. Here we discovered an unexpectedly selective and absolute requirement for XBP1 in eosinophil differentiation without an effect on the survival of basophils or neutrophils. Progenitors of myeloid cells and eosinophils selectively activated the endoribonuclease IRE1 alpha and spliced Xbp1 mRNA without inducing parallel endoplasmic reticulum (ER) stress signaling pathways. Without XBP1, nascent eosinophils exhibited massive defects in the post-translational maturation of key granule proteins required for survival, and these unresolvable structural defects fed back to suppress critical aspects of the transcriptional developmental program. Hence, we present evidence that granulocyte subsets can be distinguished by their differential reliance on secretory-pathway homeostasis.	[Bettigole, Sarah E.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Bettigole, Sarah E.; Adoro, Stanley; Glimcher, Laurie H.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Bettigole, Sarah E.; Adoro, Stanley; Glimcher, Laurie H.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Lis, Raphael] Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY USA; [Lis, Raphael] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY USA; [Lis, Raphael] Weill Cornell Med Coll, Ronald Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Lee, Ann-Hwee] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Spencer, Lisa A.; Weller, Peter F.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Allergy & Inflammat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Cornell University; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Glimcher, LH (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA.	lglimche@med.cornell.edu			US National Institutes of Health [R01DK082448, R01HL095699, R37AI020241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020241, R37AI020241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082448] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Cohen-Gould for assistance with electron microscopy; J. McCormick for assistance with cell sorting; the Starr Foundation Tri-Institutional Stem Cell Derivation Laboratory and Flow Cytometry and Microscopy Core facility for technical assistance, the Weill Cornell Epigenomics Core facility for library preparation and RNA sequencing; J. Cubillos-Ruiz and C. Tan for technical assistance; A. Espinosa, S. Hai and members of the Glimcher laboratory for suggestions and critical reading of this manuscript; A. Doyle for conversations; J.J. Lee and N.A. Lee (Mayo Clinic) for eoCRE mice, antibody to PRG2 and antibody to EPX; C. Gerard (Children's Hospital Medical, Boston) for Il5-transgenic BALB/c mice; and T. Iwawaki (Gunma University) for Ern1f/f mice. Supported by the US National Institutes of Health (R01DK082448 to L.H.G., R01HL095699 to L.A.S. and R37AI020241 to P.F.W.).	Acharya KR, 2014, J BIOL CHEM, V289, P17406, DOI 10.1074/jbc.R113.546218; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BAINTON DF, 1970, J CELL BIOL, V45, P54, DOI 10.1083/jcb.45.1.54; BARKER RL, 1988, J EXP MED, V168, P1493, DOI 10.1084/jem.168.4.1493; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; de Bruin AM, 2010, BLOOD, V116, P2559, DOI 10.1182/blood-2009-12-261339; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fulkerson PC, 2014, J IMMUNOL, V193, P4043, DOI 10.4049/jimmunol.1400732; Furuta GT, 2014, ANN ALLERG ASTHMA IM, V113, P3, DOI 10.1016/j.anai.2014.04.002; GROULS V, 1981, STAIN TECHNOL, V56, P323, DOI 10.3109/10520298109067335; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KROEGEL C, 1987, LANCET, V1, P1380; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Soragni A, 2015, MOL CELL, V57, P1011, DOI 10.1016/j.molcel.2015.01.026; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Uhm TG, 2012, ALLERGY ASTHMA IMMUN, V4, P68, DOI 10.4168/aair.2012.4.2.68; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	50	116	121	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					829	+		10.1038/ni.3225	http://dx.doi.org/10.1038/ni.3225			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147683	Green Accepted, Green Submitted			2022-12-18	WOS:000358299200010
J	de Jong, A; Cheng, TY; Huang, SX; Gras, S; Birkinshaw, RW; Kasmar, AG; Van Rhijn, I; Pena-Cruz, V; Ruan, DT; Altman, JD; Rossjohn, J; Moody, DB				de Jong, Annemieke; Cheng, Tan-Yun; Huang, Shouxiong; Gras, Stephanie; Birkinshaw, Richard W.; Kasmar, Anne G.; Van Rhijn, Ildiko; Pena-Cruz, Victor; Ruan, Daniel T.; Altman, John D.; Rossjohn, Jamie; Moody, D. Branch			CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens	NATURE IMMUNOLOGY			English	Article							HUMAN CD1D MOLECULES; GLYCOLIPID ANTIGENS; SELF ANTIGEN; NKT CELLS; LIPIDS; ACTIVATION; RECEPTOR; COMPLEX; LYMPHOCYTES; REPERTOIRE	T cells autoreactive to the antigen-presenting molecule CD1a are common in human blood and skin, but the search for natural autoantigens has been confounded by background T cell responses to CD1 proteins and self lipids. After capturing CD1a-lipid complexes, we gently eluted ligands while preserving non ligand-bound CD1a for testing lipids from tissues. CD1a released hundreds of ligands of two types. Inhibitory ligands were ubiquitous membrane lipids with polar head groups, whereas stimulatory compounds were apolar oils. We identified squalene and wax esters, which naturally accumulate in epidermis and sebum, as autoantigens presented by CD1a. The activation of T cells by skin oils suggested that headless mini-antigens nest within CD1a and displace non-antigenic resident lipids with large head groups. Oily autoantigens naturally coat the surface of the skin; thus, this points to a previously unknown mechanism of barrier immunity.	[de Jong, Annemieke; Cheng, Tan-Yun; Huang, Shouxiong; Kasmar, Anne G.; Van Rhijn, Ildiko; Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Gras, Stephanie; Birkinshaw, Richard W.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Pena-Cruz, Victor] Boston Univ, Dept Infect Dis, Boston, MA 02215 USA; [Ruan, Daniel T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Gastrointestinal & Gen Surg, Boston, MA 02115 USA; [Altman, John D.] Emory Vaccine Ctr, Atlanta, GA USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Monash University; Utrecht University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University; Cardiff University	Moody, DB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.	ad2952@columbia.edu; bmoody@partners.org	Rossjohn, Jamie/F-9032-2013; Birkinshaw, Richard/AAC-7809-2019	Rossjohn, Jamie/0000-0002-2020-7522; Birkinshaw, Richard/0000-0003-1825-0182; Van Rhijn, Ildiko/0000-0002-1446-5701; de Jong, Annemieke/0000-0001-6707-6585; Huang, Shouxiong/0000-0001-7797-3626; gras, stephanie/0000-0001-7416-038X	Burroughs Wellcome Fund; Mizutani Foundation; US National Institutes of Health [AR R01048632, AI 049313, K08AI089858, HHSN272201300006C]; Dermatology Foundation; American Skin Association; Australian Research Council; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, K08AI089858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Mizutani Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; American Skin Association; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Higgins (Columbia University) for the photo of sebaceous glands; L.L. Tan for technical support for production of the BC2 TCR; and members of the US National Institutes of Health Tetramer Facility for the preparation of CD1a. Supported by the Burroughs Wellcome Fund (D.B.M.), the Mizutani Foundation, the US National Institutes of Health (AR R01048632 and AI 049313 to D.B.M.; K08AI089858 to A.G.K.; Tetramer Facility contract HHSN272201300006C to J.D.A.), the Dermatology Foundation (A.d.J.), the American Skin Association (A.d.J.), the Australian Research Council (S.G.) and the National Health and Medical Research Council of Australia (J.R.).	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barral DC, 2008, TRAFFIC, V9, P1446, DOI 10.1111/j.1600-0854.2008.00781.x; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Haig NA, 2011, J BIOL CHEM, V286, P37692, DOI 10.1074/jbc.M111.267948; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; KELLUM RE, 1967, ARCH DERMATOL, V95, P218, DOI 10.1001/archderm.95.2.218; Kircik Leon H, 2011, J Clin Aesthet Dermatol, V4, P34; LAMPE MA, 1983, J LIPID RES, V24, P120; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MOTTA S, 1993, BIOCHIM BIOPHYS ACTA, V1182, P147, DOI 10.1016/0925-4439(93)90135-N; MURPHY GF, 1981, NEW ENGL J MED, V304, P791; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; TOUCHSTONE JC, 1995, J CHROMATOGR B, V671, P169, DOI 10.1016/0378-4347(95)00232-8; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	47	116	119	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					177	185		10.1038/ni.2790	http://dx.doi.org/10.1038/ni.2790			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24362891	Green Accepted, Green Submitted			2022-12-18	WOS:000330150600012
J	Kuwahara, M; Yamashita, M; Shinoda, K; Tofukuji, S; Onodera, A; Shinnakasu, R; Motohashi, S; Hosokawa, H; Tumes, D; Iwamura, C; Lefebvre, V; Nakayama, T				Kuwahara, Makoto; Yamashita, Masakatsu; Shinoda, Kenta; Tofukuji, Soichi; Onodera, Atsushi; Shinnakasu, Ryo; Motohashi, Shinichiro; Hosokawa, Hiroyuki; Tumes, Damon; Iwamura, Chiaki; Lefebvre, Veronique; Nakayama, Toshinori			The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-beta and suppresses T(H)2 differentiation	NATURE IMMUNOLOGY			English	Article							HELPER TYPE-2 CELLS; T-CELLS; GATA-3 EXPRESSION; GENE-EXPRESSION; ROR-GAMMA; COMPLEX; MAINTENANCE; INHIBITION; DISEASE; TGF-BETA-1	Sox4 is a transcription factor that regulates various developmental processes. Here we show that Sox4 was induced by TGF-beta and negatively regulated the transcription factor GATA-3, the master regulator of function of T helper type 2 (T(H)2) cells, by two distinct mechanisms. First, Sox4 bound directly to GATA-3, preventing its binding to GATA-3 consensus DNA sequences. Second, Sox4 bound to the promoter region of the gene encoding interleukin 5 (IL-5), a T(H)2 cytokine, and prevented binding of GATA-3 to this promoter. T(H)2 cell-driven airway inflammation was modulated by alterations in Sox4 expression. Thus, Sox4 acted as a downstream target of TGF-beta to inhibit GATA-3 function, T(H)2 differentiation and T(H)2 cell-mediated inflammation.	[Kuwahara, Makoto; Yamashita, Masakatsu; Shinoda, Kenta; Tofukuji, Soichi; Onodera, Atsushi; Shinnakasu, Ryo; Motohashi, Shinichiro; Hosokawa, Hiroyuki; Tumes, Damon; Iwamura, Chiaki; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Kuwahara, Makoto; Yamashita, Masakatsu; Tofukuji, Soichi] Kazusa DNA Res Inst, Dept Human Genome Res, Lab Med Genom, Chiba, Japan; [Yamashita, Masakatsu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiba, Japan; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Orthoped Res Ctr, Cleveland, OH 44106 USA; [Nakayama, Toshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiba, Japan	Chiba University; Kazusa DNA Research Institute; Japan Science & Technology Agency (JST); Cleveland Clinic Foundation; Cleveland Clinic Foundation; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Onodera, Atsushi/E-3136-2017; Nakayama, Toshinori/E-1067-2017; Tumes, Damon J/B-9917-2009	Nakayama, Toshinori/0000-0002-1434-2007; Tumes, Damon J/0000-0001-5709-857X; Hosokawa, Hiroyuki/0000-0002-9592-2889; Tofukuji, Soichi/0000-0003-4599-4937	Global Center for Education and Research in Immune System Regulation and Treatment, City Area Program (Kazusa/Chiba Area) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency Core Research for Evolutional Science and Technology; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [22021008, 22021011, 21390147, 23390075]; Ministry of Health, Labor and Welfare of Japan; Uehara Memorial Foundation; Mochida Foundation; Naito Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24790459, 23592624] Funding Source: KAKEN; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER	Global Center for Education and Research in Immune System Regulation and Treatment, City Area Program (Kazusa/Chiba Area) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Foundation; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Loh (Washington University School of Medicine) for DO11.10 mice; R. Kubo, A. Singer and D. Singer for comments and criticisms in the preparation of this manuscript; and K. Sugaya, H. Asou, S. Norikane, M. Kato and T. Ito for technical assistance. Supported by the Global Center for Education and Research in Immune System Regulation and Treatment, City Area Program (Kazusa/Chiba Area) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Science and Technology Agency Core Research for Evolutional Science and Technology, Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology, the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Scientific Research on Priority Areas 22021008 and 22021011; Scientific Research (B) 21390147 and 23390075), the Ministry of Health, Labor and Welfare of Japan, the Uehara Memorial Foundation, the Mochida Foundation, the Naito Foundation and the Takeda Science Foundation.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Murakami A, 2004, J BIOL CHEM, V279, P28564, DOI 10.1074/jbc.M313814200; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Penzo-Mendez A, 2007, GENESIS, V45, P776, DOI 10.1002/dvg.20358; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Ruebel KH, 2008, ENDOCRINE, V33, P62, DOI 10.1007/s12020-008-9060-3; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Smeltz RB, 2005, IMMUNOLOGY, V114, P484, DOI 10.1111/j.1365-2567.2005.02115.x; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	116	119	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					778	+		10.1038/ni.2362	http://dx.doi.org/10.1038/ni.2362			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22751141	Green Accepted			2022-12-18	WOS:000306569600014
J	Talay, O; Yan, DH; Brightbill, HD; Straney, EEM; Zhou, MJ; Ladi, E; Lee, WP; Egen, JG; Austin, CD; Xu, M; Wu, LC				Talay, Oezcan; Yan, Donghong; Brightbill, Hans D.; Straney, Elizabeth E. M.; Zhou, Meijuan; Ladi, Ena; Lee, Wyne P.; Egen, Jackson G.; Austin, Cary D.; Xu, Min; Wu, Lawren C.			IgE(+) memory B cells and plasma cells generated through a germinal-center pathway	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-E; NIPPOSTRONGYLUS-BRASILIENSIS; MICE; MOUSE; GENE; DISEASE; BLOOD; SERUM	Immunoglobulin E (IgE) antibodies are pathogenic in asthma and allergic diseases, but the in vivo biology of IgE-producing (IgE(+)) cells is poorly understood. A model of the differentiation of IgE(+) B cells proposes that IgE(+) cells develop through a germinal-center IgG1(+) intermediate and that IgE memory resides in the compartment of IgG1(+) memory B cells. Here we have used a reporter mouse expressing green fluorescent protein associated with membrane IgE transcripts (IgE-GFP) to assess in vivo IgE responses. In contrast to the IgG1-centered model of IgE switching and memory, we found that IgE+ cells developed through a germinal-center IgE(+) intermediate to form IgE(+) memory B cells and plasma cells. Our studies delineate a new model for the in vivo biology of IgE switching and memory.	[Talay, Oezcan; Brightbill, Hans D.; Ladi, Ena; Egen, Jackson G.; Wu, Lawren C.] Genentech Inc, Dept Immunol, San Francisco, CA USA; [Yan, Donghong; Zhou, Meijuan; Lee, Wyne P.; Xu, Min] Genentech Inc, Dept Translat Immunol, San Francisco, CA USA; [Straney, Elizabeth E. M.; Austin, Cary D.] Genentech Inc, Dept Pathol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wu, LC (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA USA.	lawren@gene.com		Egen, Jackson/0000-0003-2053-0837				Achatz-Straussberger G, 2009, CLIN EXP ALLERGY, V39, P1307, DOI 10.1111/j.1365-2222.2009.03278.x; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; BATISTA FD, 1995, J IMMUNOL, V154, P209; Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; DAVIS FM, 1991, BIO-TECHNOL, V9, P53, DOI 10.1038/nbt0191-53; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Elgueta R, 2010, IMMUNOL REV, V236, P139, DOI 10.1111/j.1600-065X.2010.00924.x; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; HABA S, 1985, J IMMUNOL, V134, P3291; HIRANO T, 1983, INT ARCH ALLER A IMM, V71, P182, DOI 10.1159/000233385; ISHIDA N, 1982, EMBO J, V1, P1117, DOI 10.1002/j.1460-2075.1982.tb01306.x; JUNG S, 1994, J EXP MED, V179, P2023, DOI 10.1084/jem.179.6.2023; KATONA IM, 1985, P NATL ACAD SCI USA, V82, P511, DOI 10.1073/pnas.82.2.511; KATONA IM, 1983, J IMMUNOL, V130, P350; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; LEBRUN P, 1987, J IMMUNOL, V139, P1459; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x; ZHANG K, 1992, J EXP MED, V176, P233, DOI 10.1084/jem.176.1.233	30	116	124	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					396	404		10.1038/ni.2256	http://dx.doi.org/10.1038/ni.2256			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22366892				2022-12-18	WOS:000301886800014
J	Renz, H; von Mutius, E; Brandtzaeg, P; Cookson, WO; Autenrieth, IB; Haller, D				Renz, Harald; von Mutius, Erika; Brandtzaeg, Per; Cookson, William O.; Autenrieth, Ingo B.; Haller, Dirk			Gene-environment interactions in chronic inflammatory disease	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; LINKS INNATE IMMUNITY; EPIGENETIC CONTROL; CROHNS-DISEASE; PATHOGENESIS; MICROBIOTA; ASTHMA; HOMEOSTASIS; EXPRESSION; PROBIOTICS	Chronic inflammatory diseases represent a major challenge for both clinical research and patient care, and evidence indicates that these disorders develop as a result of complex gene-environment interactions. Better understanding of their cause-and-effect relationship is the basis for emerging proposals for therapy and prevention.	[Renz, Harald] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Brandtzaeg, Per] Univ Oslo, Ctr Immune Regulat, Lab Immunohistochem & Immunopathol, Oslo, Norway; [Brandtzaeg, Per] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Cookson, William O.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Autenrieth, Ingo B.] Univ Tubingen Hosp, Inst Med Microbiol & Hyg, Tubingen, Germany; [Haller, Dirk] Tech Univ Munich, Res Ctr Nutr & Food Sci, Sect Biofunct, Munich, Germany; [Haller, Dirk] Tech Univ Munich, Ctr Diet & Dis, Munich, Germany	Philipps University Marburg; University of Munich; University of Oslo; University of Oslo; National Hospital Norway; Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; Technical University of Munich	Renz, H (corresponding author), Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany.	renzh@med.uni-marburg.de	Cookson, William/HHC-1790-2022	Haller, Dirk/0000-0002-6977-4085; von Mutius, Erika/0000-0002-8893-4515	Medical Research Council [G1000758] Funding Source: Medline; Medical Research Council [G0801056B, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Bell JT, 2011, ANN HUM GENET, V75, P10, DOI 10.1111/j.1469-1809.2010.00629.x; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brandtzaeg P, 2010, NAT REV GASTRO HEPAT, V7, P380, DOI 10.1038/nrgastro.2010.80; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Holgate ST, 2010, DISCOV MED, V9, P439; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Johannsen H, 2009, CLIN EXP ALLERGY, V39, P1801, DOI 10.1111/j.1365-2222.2009.03368.x; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Koletzko B, 2009, ADV EXPT MED BIOL, V646; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Kopp MV, 2009, CURR OPIN CLIN NUTR, V12, P298, DOI 10.1097/MCO.0b013e32832989a3; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neu J, 2010, ENDOCRIN METAB CLIN, V39, P563, DOI 10.1016/j.ecl.2010.05.008; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rottiers P, 2009, INT REV IMMUNOL, V28, P465, DOI 10.3109/08830180903197498; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schachter EN, 2009, DRUG TODAY, V45, P533, DOI 10.1358/dot.2009.45.7.1395290; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Willis-Owen SAG, 2009, CURR ALLERGY ASTHM R, V9, P3, DOI 10.1007/s11882-009-0001-x; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	51	116	119	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					273	277		10.1038/ni0411-273	http://dx.doi.org/10.1038/ni0411-273			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21423219				2022-12-18	WOS:000288593400001
J	Collins, BE; Smith, BA; Bengtson, P; Paulson, JC				Collins, BE; Smith, BA; Bengtson, P; Paulson, JC			Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling	NATURE IMMUNOLOGY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ACID-BINDING LECTIN; ANTIGEN RECEPTOR; CD22-DEFICIENT MICE; LIPID RAFTS; IMMUNOGLOBULIN SUPERFAMILY; NEGATIVE REGULATOR; UNMASKED CD22; MURINE CD22; PROTEIN	CD22 is a negative regulator of B cell signaling, an activity modulated by its interaction with glycan ligands containing alpha 2-6-linked sialic acids. B cells deficient in the enzyme (ST6Gal 1) that forms the CD22 ligand show suppressed BCR signaling. Here we report that mice deficient in both CD22 and its ligand (Cd22(-/-) St6gal1(-/-) mice) showed restored B cell receptor ( BCR) signaling, suggesting that the suppressed signaling of St6gal1(-/-) cells is mediated through CD22. Coincident with suppressed BCR signaling, B cells lacking ST6Gal I showed a net redistribution of the BCR to clathrin-rich microdomains containing most of the CD22, resulting in a twofold increase in the localization of CD22 together with the BCR. These studies suggest an important function for the CD22-ligand interaction in regulating BCR signaling and microdomain localization.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Sidney Kimmel Canc Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Paulson, JC (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019		NIAID NIH HHS [R01 AI050143, AI050143] Funding Source: Medline; NIGMS NIH HHS [GM25042] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Collins BE, 2002, GLYCOBIOLOGY, V12, P563, DOI 10.1093/glycob/cwf067; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; Danzer CP, 2003, INT IMMUNOL, V15, P1137, DOI 10.1093/intimm/dxg114; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; John BJ, 2003, J IMMUNOL, V170, P3534, DOI 10.4049/jimmunol.170.7.3534; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Lajaunias F, 2003, ARTHRITIS RHEUM, V48, P1612, DOI 10.1002/art.11021; LAW CL, 1994, IMMUNOL TODAY, V15, P442, DOI 10.1016/0167-5699(94)90275-5; LAW CL, 1995, J IMMUNOL, V155, P3368; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Lo NW, 1999, GLYCOBIOLOGY, V9, P907, DOI 10.1093/glycob/9.9.907; Nadler MJS, 1997, J IMMUNOL, V159, P4233; Nitschke L, 2004, TRENDS IMMUNOL, V25, P543, DOI 10.1016/j.it.2004.08.002; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Poe JC, 2004, J IMMUNOL, V172, P2100, DOI 10.4049/jimmunol.172.4.2100; POWELL LD, 1995, J BIOL CHEM, V270, P7523, DOI 10.1074/jbc.270.13.7523; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SGROI D, 1993, J BIOL CHEM, V268, P7011; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Smith KGC, 2000, CURR TOP MICROBIOL, V245, P195; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Tedder TF, 2005, ADV IMMUNOL, V88, P1, DOI 10.1016/S0065-2776(05)88001-0; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tsubata T, 2001, Int Rev Immunol, V20, P675, DOI 10.3109/08830180109045584; Vallejo J, 2005, FASEB J, V19, P586, DOI 10.1096/fj.04-2380fje; VARKI A, 2005, GLYCOBIOLOGY; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126	55	116	117	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					199	206		10.1038/ni1283	http://dx.doi.org/10.1038/ni1283			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16369536				2022-12-18	WOS:000234801700021
J	Wong, AW; Brickey, WJ; Taxman, DJ; van Deventer, HW; Reed, W; Gao, JX; Zheng, P; Liu, Y; Li, P; Blum, JS; McKinnon, KP; Ting, JPY				Wong, AW; Brickey, WJ; Taxman, DJ; van Deventer, HW; Reed, W; Gao, JX; Zheng, P; Liu, Y; Li, P; Blum, JS; McKinnon, KP; Ting, JPY			CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions	NATURE IMMUNOLOGY			English	Article							CLASS-II TRANSACTIVATOR; MHC CLASS-I; IMMUNOLOGICAL SYNAPSE; AXON GUIDANCE; SEMAPHORIN RECEPTORS; ANTIGEN PRESENTATION; IMMUNE-RESPONSE; NEUROPILIN-I; ACTIVE RAC; EXPRESSION	The major histocompatibility complex (MHC) class II transactivator (CIITA) is the 'master coactivator' of MHC class II genes. To identify new targets of CIITA, we analyzed cDNA microarrays of dendritic cells (DCs) from CIITA-deficient, MHC class II-deficient and control mice. We found the semaphorin receptor plexin-A1 was expressed in DCs, but not in other immune cells, and was strongly induced by CIITA. RNA interference by short hairpin RNA specific for plexin-A1, but not a single-nucleotide mutant, greatly reduced plexin-A1 expression and T cell stimulation by protein- or peptide-antigen-pulsed DCs. Plexin-A1 is not required for peptide binding to MHC. These data indicate involvement of plexin-A1 in T cell-DC interactions but not antigen processing or binding.	Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Environm Med & Lung Biol, Chapel Hill, NC 27599 USA; Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Ting, JPY (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.		Gao, Jian-Xin/B-2242-2008; Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029564, R01AI054309, R56AI029564, R01AI049589, R56AI049589, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038108] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54309, AI29564, AI49589] Funding Source: Medline; NIDDK NIH HHS [DK38108] Funding Source: Medline; NINDS NIH HHS [NS34910] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BISMUTH G, 2002, SCI STKE, pRE4; Brickey WJ, 2002, TRANSPLANTATION, V74, P1341, DOI 10.1097/00007890-200211150-00024; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cresswell P, 1997, CURR OPIN IMMUNOL, V9, P71, DOI 10.1016/S0952-7915(97)80161-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Felix NJ, 2000, J EXP MED, V192, P31, DOI 10.1084/jem.192.1.31; Gao JX, 2003, J IMMUNOL, V170, P5927, DOI 10.4049/jimmunol.170.12.5927; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Mallet-Designe VI, 2003, J IMMUNOL, V170, P123, DOI 10.4049/jimmunol.170.1.123; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Taxman DJ, 2000, J IMMUNOL, V165, P1410, DOI 10.4049/jimmunol.165.3.1410; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; van Deventer HW, 2002, J IMMUNOL, V169, P1634, DOI 10.4049/jimmunol.169.3.1634; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AW, 2002, J IMMUNOL, V169, P3112, DOI 10.4049/jimmunol.169.6.3112; Wulfing C, 2002, NAT IMMUNOL, V3, P418, DOI 10.1038/ni0502-418; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3	49	116	122	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					891	898		10.1038/ni960	http://dx.doi.org/10.1038/ni960			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12910265				2022-12-18	WOS:000185002200016
J	Kelsall, BL; Biron, CA; Sharma, O; Kaye, PM				Kelsall, BL; Biron, CA; Sharma, O; Kaye, PM			Dendritic cells at the host-pathogen interface	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTORS; MOUSE LYMPH-NODES; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; CD8-ALPHA(+); EXPRESSION; ACTIVATION; INFECTION; IMMUNITY		NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; NIAID, Div AIDS, NIH, Bethesda, MD 20892 USA; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Kelsall, BL (corresponding author), NIAID, Clin Invest Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.			Kaye, Paul/0000-0002-8796-4755	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000833, Z01AI000833] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Fortsch D, 2000, J IMMUNOL, V165, P978, DOI 10.4049/jimmunol.165.2.978; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Henderson RA, 1997, J IMMUNOL, V159, P635; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Vidalain PO, 2001, IMMUNOBIOLOGY, V204, P629, DOI 10.1078/0171-2985-00102; Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4	31	116	122	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					699	702		10.1038/ni0802-699	http://dx.doi.org/10.1038/ni0802-699			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145651				2022-12-18	WOS:000177118500003
J	Montoya, MC; Sancho, D; Bonello, G; Collette, Y; Langlet, C; He, HT; Aparicio, P; Alcover, A; Olive, D; Sanchez-Madrid, F				Montoya, MC; Sancho, D; Bonello, G; Collette, Y; Langlet, C; He, HT; Aparicio, P; Alcover, A; Olive, D; Sanchez-Madrid, F			Role of ICAM-3 in the initial interaction of T lymphocytes and APCs	NATURE IMMUNOLOGY			English	Article							INTERCELLULAR-ADHESION MOLECULE-3; CELL ACTIVATION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSES; ADAPTER PROTEIN; DENDRITIC CELLS; NUCLEAR FACTOR; LIPID RAFTS	Antigen-independent adhesive interactions between T lymphocytes and antigen-presenting cells (APCs) are essential for scanning for specific antigens on the APC surface and for initiating the immune response. Here we show, through time-lapse imaging of live cells, that the intercellular adhesion molecule 3 (ICAM-3, also known as CD50) is clustered specifically at the region of the T lymphocyte surface that initiates contact with APCs. We describe the role of ICAM-3 in T cell-APC conjugate formation before antigen recognition, in early intracellular signaling and in cytoskeletal rearrangement. Our data indicate that ICAM-3 is important in the initial scanning of the APC surface by T cells and, therefore, in generating the immune response.	Univ Autonoma Madrid, Hosp Princessa, Serv Inmunol, Madrid 28006, Spain; Univ Mediterranee, Inst Cancerol & Immunol Marseille, Inst J Paoli I Calmettes, INSERM,U119, F-13009 Marseille, France; CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; Univ Murcia, Fac Med, E-30100 Murcia, Spain; Inst Pasteur, CNRS, URA 1960, Unite Biol Interact Cellulaires, F-75724 Paris 15, France	Autonomous University of Madrid; Hospital de La Princesa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Murcia; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Sanchez-Madrid, F (corresponding author), Univ Autonoma Madrid, Hosp Princessa, Serv Inmunol, C Diego de Leon 62, Madrid 28006, Spain.	fsanchez@hlpr.insalud.es	Sancho, David/D-3433-2009; HE, Hai-Tao/O-6551-2016; Sanchez-Madrid, Francisco/M-7889-2016; Montoya, María/N-1558-2014; COLLETTE, Yves/F-2270-2013	Sancho, David/0000-0003-2890-3984; HE, Hai-Tao/0000-0002-6594-290X; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Montoya, María/0000-0001-8878-7028; COLLETTE, Yves/0000-0001-5359-7099; Alcover, Andres/0000-0002-9507-3450; Aparicio, Pedro/0000-0001-9162-1563				Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Bleijs DA, 1999, EUR J IMMUNOL, V29, P2248, DOI 10.1002/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO;2-9; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; CAMPANERO MR, 1994, J CELL BIOL, V127, P867, DOI 10.1083/jcb.127.3.867; CAMPANERO MR, 1993, J CELL BIOL, V123, P1007, DOI 10.1083/jcb.123.4.1007; CERDAN C, 1992, J IMMUNOL, V149, P2255; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DELPOZO MA, 1995, LEUKOCYTE TYPING, V5, P1568; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths CEM, 1995, BRIT J DERMATOL, V133, P823, DOI 10.1111/j.1365-2133.1995.tb06911.x; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; HERNANDEZCASELLES T, 1993, EUR J IMMUNOL, V23, P2799, DOI 10.1002/eji.1830231112; HernandezCaselles T, 1996, J IMMUNOL, V156, P3668; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Millan J, 2001, EUR J IMMUNOL, V31, P467, DOI 10.1002/1521-4141(200102)31:2<467::AID-IMMU467>3.0.CO;2-1; MILLAN J, 2002, IN PRESS BLOOD; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Niedergang F, 1997, J IMMUNOL, V159, P1703; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sperling AI, 1998, J IMMUNOL, V161, P6459; STARLING GC, 1995, EUR J IMMUNOL, V25, P2528, DOI 10.1002/eji.1830250918; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	50	116	120	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					159	168		10.1038/ni753	http://dx.doi.org/10.1038/ni753			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812993				2022-12-18	WOS:000173562400016
J	Yamazaki, T; Kirchmair, A; Sato, A; Buque, A; Rybstein, M; Petroni, G; Bloy, N; Finotello, F; Stafford, L; Manzano, EN; de la Pena, FA; Garcia-Martinez, E; Formenti, SC; Trajanoski, Z; Galluzzi, L				Yamazaki, Takahiro; Kirchmair, Alexander; Sato, Ai; Buque, Aitziber; Rybstein, Marissa; Petroni, Giulia; Bloy, Norma; Finotello, Francesca; Stafford, Lena; Navarro Manzano, Esther; Ayala de la Pena, Francisco; Garcia-Martinez, Elena; Formenti, Silvia C.; Trajanoski, Zlatko; Galluzzi, Lorenzo			Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; RADIOTHERAPY; APOPTOSIS; CANCER	Autophagy supports both cellular and organismal homeostasis. However, whether autophagy should be inhibited or activated for cancer therapy remains unclear. Deletion of essential autophagy genes increased the sensitivity of mouse mammary carcinoma cells to radiation therapy in vitro and in vivo (in immunocompetent syngeneic hosts). Autophagy-deficient cells secreted increased amounts of type I interferon (IFN), which could be limited by CGAS or STING knockdown, mitochondrial DNA depletion or mitochondrial outer membrane permeabilization blockage via BCL2 overexpression orBAXdeletion. In vivo, irradiated autophagy-incompetent mammary tumors elicited robust immunity, leading to improved control of distant nonirradiated lesions via systemic type I IFN signaling. Finally, a genetic signature of autophagy had negative prognostic value in patients with breast cancer, inversely correlating with mitochondrial abundance, type I IFN signaling and effector immunity. As clinically useful autophagy inhibitors are elusive, our findings suggest that mitochondrial outer membrane permeabilization may represent a valid target for boosting radiation therapy immunogenicity in patients with breast cancer. Autophagy controls cellular homeostasis and influences immune responses. Galluzzi and colleagues show that tumor cell autophagy opposes inflammatory cell death following radiation therapy and can be inhibited to enhance antitumor responses.	[Yamazaki, Takahiro; Sato, Ai; Buque, Aitziber; Rybstein, Marissa; Petroni, Giulia; Bloy, Norma; Stafford, Lena; Formenti, Silvia C.; Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Kirchmair, Alexander; Finotello, Francesca; Trajanoski, Zlatko] Med Univ Innsbruck, Inst Bioinformat, Bioctr, Innsbruck, Austria; [Navarro Manzano, Esther; Ayala de la Pena, Francisco; Garcia-Martinez, Elena] Hosp Univ Morales Meseguer, Hematol & Oncol Dept, Murcia, Spain; [Navarro Manzano, Esther; Ayala de la Pena, Francisco; Garcia-Martinez, Elena] Inst Murciano Invest Biosanitaria IMIB Arrixaca, Murcia, Spain; [Navarro Manzano, Esther; Ayala de la Pena, Francisco] Univ Murcia, Murcia, Spain; [Garcia-Martinez, Elena] Univ Catolica San Antonio Murcia, Guadalupe, Spain; [Formenti, Silvia C.; Galluzzi, Lorenzo] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo] Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA; [Galluzzi, Lorenzo] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Galluzzi, Lorenzo] Univ Paris Descartes Paris V, Paris, France	Cornell University; Medical University of Innsbruck; Meseguer General University Hospital Morales; University of Murcia; Universidad Catolica de Murcia; Yale University; UDICE-French Research Universities; Universite Paris Cite	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA.; Galluzzi, L (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.; Galluzzi, L (corresponding author), Univ Paris Descartes Paris V, Paris, France.	deadoc80@gmail.com	Kirchmair, Alexander/AAT-5719-2021; Finotello, Francesca/M-3764-2014; Galluzzi, Lorenzo/AAH-3286-2021; Trajanoski, Zlatko/AAT-6703-2021; Ayala, Francisco/C-5280-2011	Kirchmair, Alexander/0000-0003-2284-7424; Finotello, Francesca/0000-0003-0712-4658; Ayala, Francisco/0000-0001-6311-920X; , Marissa/0000-0002-8225-5319; Petroni, Giulia/0000-0002-0558-5322; , Aitziber/0000-0002-7698-8778	Austrian Science Fund (FWF) [T 974-B30]; FPU fellowship from Ministerio de Educacion Cultura y Deporte of Spain [FPU16/06537]; US Department of Defense Breast Cancer Research Program [BC180476, BC180595, BC180476P1]; National Institutes of Health [RR027619-01]; 2019 Laura Ziskin Prize in Translational Research from Stand Up to Cancer [ZP-6177]; Mantle Cell Lymphoma Research Initiative from the Leukemia and Lymphoma Society; Department of Radiation Oncology at Weill Cornell Medicine; Functional Genomics Initiative; Lytix Biopharma; Phosplatin Therapeutics	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FPU fellowship from Ministerio de Educacion Cultura y Deporte of Spain; US Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2019 Laura Ziskin Prize in Translational Research from Stand Up to Cancer; Mantle Cell Lymphoma Research Initiative from the Leukemia and Lymphoma Society; Department of Radiation Oncology at Weill Cornell Medicine; Functional Genomics Initiative; Lytix Biopharma; Phosplatin Therapeutics	The authors are indebted to B. Vogelstein (Johns Hopkins University) for sharing BAX+/and BAX<SUP>-/-</SUP> HCT 116 cells and the WCM Radiation Biology Core Facility (in particular J. Kraynak) for help with irradiation procedures. F.F. is supported by the Austrian Science Fund (FWF) (project no. T 974-B30). E.N.M. is supported by an FPU fellowship from Ministerio de Educacion Cultura y Deporte of Spain (FPU16/06537). S.C.F. is supported by Breakthrough Level 2 and 3 grants from the US Department of Defense Breast Cancer Research Program (BC180476, PI: Formenti; BC180595, PI: Formenti, Demaria) and by an S10 Instrumentation Grant from National Institutes of Health (RR027619-01). The L.G. laboratory is supported by a Breakthrough Level 2 grant from the US Department of Defense Breast Cancer Research Program (BC180476P1, PI: Galluzzi), by the 2019 Laura Ziskin Prize in Translational Research (ZP-6177, PI: Formenti) from Stand Up to Cancer, by a Mantle Cell Lymphoma Research Initiative (PI: Chen-Kiang) grant from the Leukemia and Lymphoma Society, by a startup grant from the Department of Radiation Oncology at Weill Cornell Medicine, by a Rapid Response Grant from the Functional Genomics Initiative, by industrial collaborations with Lytix Biopharma and Phosplatin Therapeutics and by donations from Phosplatin, the Luke Heller TECPR2 Foundation and Sotio a.s.	Abe T, 2019, INT REV CEL MOL BIO, V344, P91, DOI 10.1016/bs.ircmb.2018.09.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Rodriguez-Ruiz ME, 2020, NAT IMMUNOL, V21, P120, DOI 10.1038/s41590-019-0561-4; Fairlie WD, 2020, INT REV CEL MOL BIO, V352, P115, DOI 10.1016/bs.ircmb.2020.01.003; Fan AXC, 2009, J CANCER RES CLIN, V135, P983, DOI 10.1007/s00432-008-0533-9; Formenti SC, 2018, NAT MED, V24, P1845, DOI 10.1038/s41591-018-0232-2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galluzzi L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000337; Galluzzi L, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7807; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Galluzzi L, 2017, NAT REV CLIN ONCOL, V14, P247, DOI 10.1038/nrclinonc.2016.183; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28518; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Han CH, 2020, NAT IMMUNOL, V21, P546, DOI 10.1038/s41590-020-0641-5; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Jain N, 2019, NEW ENGL J MED, V380, P2095, DOI 10.1056/NEJMoa1900574; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindqvist LM, 2018, CELL DEATH DIFFER, V25, P782, DOI 10.1038/s41418-017-0017-z; Lok SW, 2019, CANCER DISCOV, V9, P354, DOI 10.1158/2159-8290.CD-18-1151; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Michels J, 2013, CANCER RES, V73, P2271, DOI 10.1158/0008-5472.CAN-12-3000; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morselli E, 2011, CELL CYCLE, V10, P2763, DOI 10.4161/cc.10.16.16868; Ngwa W, 2018, NAT REV CANCER, V18, P313, DOI 10.1038/nrc.2018.6; Ning XH, 2019, MOL CELL, V74, P19, DOI 10.1016/j.molcel.2019.02.013; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Ruiz ME, 2016, CANCER RES, V76, P5994, DOI 10.1158/0008-5472.CAN-16-0549; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rybstein MD, 2018, NAT CELL BIOL, V20, P243, DOI 10.1038/s41556-018-0042-2; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Sprooten J, 2019, INT REV CEL MOL BIO, V348, P217, DOI 10.1016/bs.ircmb.2019.06.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Walczak J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14964-y; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	56	115	115	8	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1160	+		10.1038/s41590-020-0751-0	http://dx.doi.org/10.1038/s41590-020-0751-0		AUG 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32747819				2022-12-18	WOS:000555415800003
J	Liu, ZS; Cai, H; Xue, W; Wang, M; Xia, T; Li, WJ; Xing, JQ; Zhao, M; Huang, YJ; Chen, S; Wu, SM; Wang, XZ; Liu, X; Pang, X; Zhang, ZY; Li, TT; Dai, J; Dong, FT; Xia, Q; Li, AL; Zhou, T; Liu, ZG; Zhang, XM; Li, T				Liu, Zhao-Shan; Cai, Hong; Xue, Wen; Wang, Miao; Xia, Tian; Li, Wan-Jin; Xing, Jia-Qing; Zhao, Ming; Huang, Yi-Jiao; Chen, Shuai; Wu, Sheng-Ming; Wang, Xinzheng; Liu, Xin; Pang, Xue; Zhang, Zi-Yu; Li, Tingting; Dai, Jiang; Dong, Fangting; Xia, Qing; Li, Ai-Ling; Zhou, Tao; Liu, Zheng-gang; Zhang, Xue-Min; Li, Tao			G3BP1 promotes DNA binding and activation of cGAS	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; SYNTHASE; 2ND-MESSENGER; GROWTH; IFI16	Cyclic GMP-AMP synthase (cGAS) is a key sensor responsible for cytosolic DNA detection. Here we report that GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is critical for DNA sensing and efficient activation of cGAS. G3BP1 enhanced DNA binding of cGAS by promoting the formation of large cGAS complexes. G3BP1 deficiency led to inefficient DNA binding by cGAS and inhibited cGAS-dependent interferon (IFN) production. The G3BP1 inhibitor epigallocatechin gallate (EGCG) disrupted existing G3BP1-cGAS complexes and inhibited DNA-triggered cGAS activation, thereby blocking DNA-induced IFN production both in vivo and in vitro. EGCG administration blunted self DNA-induced autoinflammatory responses in an Aicardi-Goutieres syndrome (AGS) mouse model and reduced IFN-stimulated gene expression in cells from a patient with AGS. Thus, our study reveals that G3BP1 physically interacts with and primes cGAS for efficient activation. Furthermore, EGCG-mediated inhibition of G3BP1 provides a potential treatment for cGAS-related autoimmune diseases.	[Liu, Zhao-Shan; Dai, Jiang; Zhang, Xue-Min; Li, Tao] Natl Ctr Biomed Anal, Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China; [Liu, Zhao-Shan; Cai, Hong; Xue, Wen; Wang, Miao; Xia, Tian; Li, Wan-Jin; Xing, Jia-Qing; Zhao, Ming; Huang, Yi-Jiao; Chen, Shuai; Wu, Sheng-Ming; Wang, Xinzheng; Liu, Xin; Pang, Xue; Zhang, Zi-Yu; Li, Tingting; Dai, Jiang; Dong, Fangting; Xia, Qing; Li, Ai-Ling; Zhou, Tao; Zhang, Xue-Min; Li, Tao] Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China; [Liu, Zheng-gang] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhang, Xue-Min; Li, Tao] Jilin Univ, Hosp 1, Canc Res Inst, Changchun, Jilin, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jilin University	Zhang, XM; Li, T (corresponding author), Natl Ctr Biomed Anal, Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.; Zhang, XM; Li, T (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China.; Zhang, XM; Li, T (corresponding author), Jilin Univ, Hosp 1, Canc Res Inst, Changchun, Jilin, Peoples R China.	zhangxuemin@cashq.ac.cn; tli@ncba.ac.cn		Zhao, Ming/0000-0002-7401-9332; Wang, Xinzheng/0000-0002-2060-2821; Li, Tao/0000-0002-0746-8322	China National Natural Science Foundation [81771708, 81521064]; NATIONAL CANCER INSTITUTE [ZIABC010783] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We sincerely thank the patient with AGS and his sibling for donating PBMCs. We thank J. Tazi (Universite Montpellier 2) for providing the G3bp1<SUP>+/-</SUP> mice, Cancer Research Technology Limited for providing the Trex1<SUP>+/-</SUP> mice, C. Widmann (University of Lausanne) for providing HA-G3BP1 plasmid, J. W. Chin (Cambridge) for providing pCDF PylT-1 plasmid, J. U. Jung (University of Southern California) for providing cGAS cDNA construct, H. Shu (Wuhan University) for providing STING cDNA construct, J. Han (Xiamen University) for providing HSV-1, M. Yang (Tsinghua University) for help with protein purification. We thank H. Yu (UT Southwestern Medical Center), Y. Zheng (Carnegie Institution for Science) and H. Qi (Tsinghua University) for helpful discussion and critical reading of the manuscript. This work was supported by grants from the China National Natural Science Foundation (No. 81771708 to T.L., No. 81521064 to X.-M.Z.).	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; [郭洪伟 Guo Hongwei], 2014, [中华神经科杂志, Chinese Journal of Neurology], V47, P96; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao JL, 2017, J IMMUNOL, V198, P3627, DOI 10.4049/jimmunol.1601909; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wu C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01945; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoh SM, 2015, CELL, V161, P1293, DOI 10.1016/j.cell.2015.04.050; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026	38	115	123	9	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					18	+		10.1038/s41590-018-0262-4	http://dx.doi.org/10.1038/s41590-018-0262-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30510222	Green Accepted			2022-12-18	WOS:000456273900011
J	Patin, E; Hasan, M; Bergstedt, J; Rouilly, V; Libri, V; Urrutia, A; Alanio, C; Scepanovic, P; Hammer, C; Jonsson, F; Beitz, B; Quach, H; Lim, YW; Hunkapiller, J; Zepeda, M; Green, C; Piasecka, B; Leloup, C; Rogge, L; Huetz, F; Peguillet, I; Lantz, O; Fontes, M; Santo, JP; Thomas, S; Fellay, J; Duffy, D; Quintana-Murci, L; Albert, ML				Patin, Etienne; Hasan, Milena; Bergstedt, Jacob; Rouilly, Vincent; Libri, Valentina; Urrutia, Alejandra; Alanio, Cecile; Scepanovic, Petar; Hammer, Christian; Jonsson, Friederike; Beitz, Benoit; Quach, Helene; Lim, Yoong Wearn; Hunkapiller, Julie; Zepeda, Magge; Green, Cherie; Piasecka, Barbara; Leloup, Claire; Rogge, Lars; Huetz, Francois; Peguillet, Isabelle; Lantz, Olivier; Fontes, Magnus; Santo, James P.; Thomas, Stephanie; Fellay, Jacques; Duffy, Darragh; Quintana-Murci, Lluis; Albert, Matthew L.		Milieu Interieur Consortium	Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; T-CELLS; SYSTEM; INFECTION; INFERENCE; DISEASE; PLINK; LOCI	The quantification and characterization of circulating immune cells provide key indicators of human health and disease. To identify the relative effects of environmental and genetic factors on variation in the parameters of innate and adaptive immune cells in homeostatic conditions, we combined standardized flow cytometry of blood leukocytes and genome-wide DNA genotyping of 1,000 healthy, unrelated people of Western European ancestry. We found that smoking, together with age, sex and latent infection with cytomegalovirus, were the main non-genetic factors that affected variation in parameters of human immune cells. Genome-wide association studies of 166 immunophenotypes identified 15 loci that showed enrichment for disease-associated variants. Finally, we demonstrated that the parameters of innate cells were more strongly controlled by genetic variation than were those of adaptive cells, which were driven by mainly environmental exposure. Our data establish a resource that will generate new hypotheses in immunology and highlight the role of innate immunity in susceptibility to common autoimmune diseases.	[Patin, Etienne; Quach, Helene; Piasecka, Barbara; Quintana-Murci, Lluis] Inst Pasteur, Dept Genomes & Genet, Unit Human Evolutionary Genet, Paris, France; [Patin, Etienne; Quach, Helene; Piasecka, Barbara; Quintana-Murci, Lluis] CNRS, UMR 2000, Paris, France; [Patin, Etienne; Rouilly, Vincent; Quach, Helene; Piasecka, Barbara; Quintana-Murci, Lluis] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France; [Hasan, Milena; Rouilly, Vincent; Libri, Valentina; Urrutia, Alejandra; Alanio, Cecile; Beitz, Benoit; Piasecka, Barbara; Rogge, Lars; Santo, James P.; Thomas, Stephanie; Duffy, Darragh; Albert, Matthew L.] Inst Pasteur, Ctr Translat Res, Paris, France; [Bergstedt, Jacob] Lund Univ, Dept Automat Control, Lund, Sweden; [Bergstedt, Jacob; Fontes, Magnus] Inst Pasteur, Int Grp Data Anal, Paris, France; [Urrutia, Alejandra; Alanio, Cecile; Thomas, Stephanie; Duffy, Darragh; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Lab Dendrit Cell Immunobiol, Paris, France; [Urrutia, Alejandra; Alanio, Cecile; Santo, James P.; Thomas, Stephanie; Duffy, Darragh; Albert, Matthew L.] INSERM, U1223, Paris, France; [Urrutia, Alejandra; Lim, Yoong Wearn; Albert, Matthew L.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Scepanovic, Petar; Hammer, Christian; Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Scepanovic, Petar; Hammer, Christian] Swiss Inst Bioinformat, Lausanne, Switzerland; [Jonsson, Friederike] Inst Pasteur, Dept Immunol, Antibodies Therapy & Pathol, Paris, France; [Jonsson, Friederike] INSERM, U760, Paris, France; [Hunkapiller, Julie; Leloup, Claire] Genentech Inc, Dept Human Genet, San Francisco, CA USA; [Zepeda, Magge] Genentech Inc, Employee Donat Program, San Francisco, CA USA; [Green, Cherie] Genentech Inc, Dept Dev Sci, San Francisco, CA USA; [Rogge, Lars] Inst Pasteur, Dept Immunol, Immunoregulat Unit, Paris, France; [Huetz, Francois] Univ Paris 05, Fac Med, INSERM, U783, Site Necker Enfants Malad, Paris, France; [Huetz, Francois] Inst Pasteur, CNRS, URA 1961, Lymphocyte Populat Biol, Paris, France; [Peguillet, Isabelle; Lantz, Olivier] Ctr Clin Invest CIC BT1428 IGR Curie, Paris, France; [Peguillet, Isabelle; Lantz, Olivier] Inst Curie, Dept Biopathol, Paris, France; [Lantz, Olivier] Inst Curie, Equipe Labellisee Ligue Lutte Canc, Paris, France; [Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Fontes, Magnus] Lund Univ, Ctr Math Sci, Lund, Sweden; [Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Lund University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Roche Holding; Genentech; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Lund University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Patin, E (corresponding author), Inst Pasteur, Dept Genomes & Genet, Unit Human Evolutionary Genet, Paris, France.; Patin, E (corresponding author), CNRS, UMR 2000, Paris, France.; Patin, E (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.; Albert, ML (corresponding author), Inst Pasteur, Ctr Translat Res, Paris, France.; Albert, ML (corresponding author), Inst Pasteur, Dept Immunol, Lab Dendrit Cell Immunobiol, Paris, France.; Albert, ML (corresponding author), INSERM, U1223, Paris, France.; Albert, ML (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	epatin@pasteur.fr; albertm7@gene.com	Demangel, Caroline/H-9570-2014; Boneca, Ivo G/H-1677-2014; Huetz, Francois/T-4708-2019; Pellegrini, Sandra -/G-5546-2015; Hasan, Milena/AAO-6610-2021; Rogge, Lars/GYJ-6142-2022; Bruhns, Pierre/F-5567-2013; Huetz, François/T-3386-2019; BOUSSO, Philippe/M-6547-2014; Jönsson, Friederike/H-7525-2014; Fellay, Jacques/A-6681-2009; Quintana-Murci, Lluis/AAB-7468-2022; Pellegrini, Sandra/Y-6351-2019; Astrom, Kalle/C-2836-2009	Demangel, Caroline/0000-0001-7848-586X; Boneca, Ivo G/0000-0001-8122-509X; Huetz, Francois/0000-0001-8704-1881; Pellegrini, Sandra -/0000-0001-5837-7589; Hasan, Milena/0000-0002-0879-7099; Bruhns, Pierre/0000-0002-4709-8936; BOUSSO, Philippe/0000-0002-6362-561X; Jönsson, Friederike/0000-0002-1667-8065; Fellay, Jacques/0000-0002-8240-939X; Pellegrini, Sandra/0000-0001-5837-7589; Shorte, Spencer/0000-0002-2125-8663; Astrom, Kalle/0000-0002-8689-7810; Alcover, Andres/0000-0002-9507-3450; Alanio, Cecile/0000-0003-2785-7445; Lim, Yoong Wearn/0000-0002-8568-4901; freitas, antonio/0000-0001-6392-7178; Patin, Etienne/0000-0002-9911-4459; Scepanovic, Petar/0000-0002-4686-7422; Lantz, olivier/0000-0003-3161-7719; Eberl, Gerard/0000-0002-1119-5638; Libri, Valentina/0000-0002-2080-1089; Bergstedt, Jacob/0000-0002-9279-6936	Center for Translation Research, Institut Pasteur; OMNI Biomarker Development-Flow Cytometry Biomarker group, Genentech; French government's program 'Investissement d'Avenir' [10-LABX-69-01]; ELLIFT Excellence Center	Center for Translation Research, Institut Pasteur; OMNI Biomarker Development-Flow Cytometry Biomarker group, Genentech; French government's program 'Investissement d'Avenir'; ELLIFT Excellence Center	We thank the Center for Translation Research, Institut Pasteur, and the OMNI Biomarker Development-Flow Cytometry Biomarker group, Genentech, for support. This work benefited from support of the French government's program 'Investissement d'Avenir', managed by the Agence Nationale de la Recherche (reference 10-LABX-69-01). J.B. is a member of the LCCC Linnaeus Center and the ELLIT Excellence Center at Lund University and is supported by the ELLIFT Excellence Center.	Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Bernard C., 1865, INTRO ETUDE MED EXPT; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Casanova JL, 2015, CELL, V160, P13, DOI 10.1016/j.cell.2014.12.029; Cassard L, 2012, J IMMUNOL, V189, P2995, DOI 10.4049/jimmunol.1200968; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hasan M, 2015, CLIN IMMUNOL, V157, P261, DOI 10.1016/j.clim.2014.12.008; Hastie T, 2009, ELEMENTS STAT LEARNI; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Mangino M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13850; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mefford J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003096; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Motohashi T, 2000, BIOCHEM BIOPH RES CO, V276, P244, DOI 10.1006/bbrc.2000.3409; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063429; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Puchta A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005368; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Sauce D, 2011, CURR OPIN IMMUNOL, V23, P543, DOI 10.1016/j.coi.2011.05.001; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shah RD, 2013, J R STAT SOC B, V75, P55, DOI 10.1111/j.1467-9868.2011.01034.x; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Thomas S, 2015, CLIN IMMUNOL, V157, P277, DOI 10.1016/j.clim.2014.12.004; TOLLERUD DJ, 1989, J CLIN IMMUNOL, V9, P214, DOI 10.1007/BF00916817; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Wakefield J., 2013, BAYESIAN FREQUENTIST; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]	73	115	116	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					302	+		10.1038/s41590-018-0049-7	http://dx.doi.org/10.1038/s41590-018-0049-7			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476184	Green Submitted			2022-12-18	WOS:000427007500019
J	Eberl, G; Di Santo, JP; Vivier, E				Eberl, Gerard; Di Santo, James P.; Vivier, Eric			The brave new world of innate lymphoid cells	NATURE IMMUNOLOGY			English	Editorial Material									[Eberl, Gerard; Di Santo, James P.] Inst Pasteur, Paris, France; [Vivier, Eric] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, INSERM, CNRS,UMR7280,U1104, Marseille, France; [Vivier, Eric] AP HM, Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Eberl, G (corresponding author), Inst Pasteur, Paris, France.	geberl@pasteur.fr	Di Santo, James P/M-4298-2014; Eberl, Gerard/A-1160-2013; Vivier, Eric/F-8939-2010	Di Santo, James P/0000-0002-7146-1862; Vivier, Eric/0000-0001-7022-8287; Eberl, Gerard/0000-0002-1119-5638				Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Chen L, 2015, MUCOSAL IMMUNOL, V8, P390, DOI 10.1038/mi.2014.77; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Viant C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6108; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012	26	115	118	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					1	5						5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VC0TQ	25521670				2022-12-18	WOS:000427318200001
J	McFarland, AP; Horner, SM; Jarret, A; Joslyn, RC; Bindewald, E; Shapiro, BA; Delker, DA; Hagedorn, CH; Carrington, M; Gale, M; Savan, R				McFarland, Addle P.; Horner, Stacy M.; Jarret, Abigail; Joslyn, Rochelle C.; Bindewald, Eckart; Shapiro, Bruce A.; Delker, Don A.; Hagedorn, Curt H.; Carrington, Mary; Gale, Michael, Jr.; Savan, Ram			The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; IL28B GENOTYPE; SECONDARY STRUCTURE; ANTIVIRAL DEFENSES; INTERFERON-LAMBDA; INNATE IMMUNITY; EXPRESSION; INFECTION; CLEARANCE	IFNL3, which encodes interferon-lambda 3 (IFN-lambda 3), has received considerable attention in the hepatitis C virus (HCV) field, as many independent genome-wide association studies have identified a strong association between polymorphisms near IFNL3 and clearance of HCV. However, the mechanism underlying this association has remained elusive. In this study, we report the identification of a functional polymorphism (rs4803217) in the 3' untranslated region (UTR) of IFNL3 mRNA that dictated transcript stability. We found that this polymorphism influenced AU-rich element (ARE)-mediated decay (AMD) of IFNL3 mRNA, as well as the binding of HCV-induced microRNAs during infection. Together these pathways mediated robust repression of the unfavorable IFNL3 polymorphism. Our data reveal a previously unknown mechanism by which HCV attenuates the antiviral response and indicate new potential therapeutic targets for HCV treatment.	[McFarland, Addle P.; Horner, Stacy M.; Jarret, Abigail; Joslyn, Rochelle C.; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Bindewald, Eckart] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD USA; [Shapiro, Bruce A.] NCI, Ctr Canc Res Nanobiol Program, Frederick, MD 21701 USA; [Delker, Don A.; Hagedorn, Curt H.] Univ Utah, Sch Med, Div Gastroenterol Hepatol & Nutr, Salt Lake City, UT USA; [Carrington, Mary] Frederick Natl Lab Canc Res, Sci Applicat Int Corp Frederick, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD USA; [Carrington, Mary] MIT, Ragon Inst Massachusetts Gen Hosp, Boston, MA USA; [Carrington, Mary] Harvard Univ, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Savan, R (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	savanram@uw.edu		Savan, Ram/0000-0002-3087-1355; Gale, Michael/0000-0002-6332-7436; Horner, Stacy/0000-0002-9351-7409; McFarland, Adelle/0000-0001-7534-1158	Department of Immunology of the University of Washington; US National Institutes of Health [AI060389, AI88778, CA148068]; Frederick National Laboratory for Cancer Research of the US National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the US National Institutes of Health, Frederick National Laboratory for Cancer Research and the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010791, R21CA148068, ZIABC010792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060389, R01AI060389, U19AI088778] Funding Source: NIH RePORTER	Department of Immunology of the University of Washington; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory for Cancer Research of the US National Institutes of Health; Intramural Research Program of the US National Institutes of Health, Frederick National Laboratory for Cancer Research and the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Fink, D. Stetson, E. Clark and C. Lim for critical reading of the manuscript, and S. Badil and M. Hong for technical assistance. Supported by the Department of Immunology of the University of Washington (R.S.), the US National Institutes of Health (AI060389 and AI88778 to M.G., and CA148068 to C.H.H.) and federal funds from the Frederick National Laboratory for Cancer Research of the US National Institutes of Health (HHSN261200800001E) and the Intramural Research Program of the US National Institutes of Health, Frederick National Laboratory for Cancer Research and the National Cancer Institute, Center for Cancer Research (E.B., B.A.S. and M.C.).	Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lauer B, 2000, J AM COLL CARDIOL, V35, P11, DOI 10.1016/S0735-1097(99)00485-4; Leshkowitz D, 2013, RNA, V19, P527, DOI 10.1261/rna.036475.112; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Matsumori A, 2005, CIRC RES, V96, P144, DOI 10.1161/01.RES.0000156077.54903.67; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Raglow Z, 2013, LIVER INT, V33, P991, DOI 10.1111/liv.12148; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182	45	115	115	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					72	79		10.1038/ni.2758	http://dx.doi.org/10.1038/ni.2758			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24241692	Green Accepted, Green Submitted			2022-12-18	WOS:000328800500014
J	Ochiai, K; Maienschein-Cline, M; Mandal, M; Triggs, JR; Bertolino, E; Sciammas, R; Dinner, AR; Clark, MR; Singh, H				Ochiai, Kyoko; Maienschein-Cline, Mark; Mandal, Malay; Triggs, Joseph R.; Bertolino, Eric; Sciammas, Roger; Dinner, Aaron R.; Clark, Marcus R.; Singh, Harinder			A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; LIGHT-CHAIN RECOMBINATION; GENE REARRANGEMENTS; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; FOXO1; RECEPTOR; EXPRESSION; PATHWAY; PROLIFERATION	The molecular crosstalk between the interleukin 7 receptor (IL-7R) and the precursor to the B cell antigen receptor (pre-BCR) in B lymphopoiesis has not been elucidated. Here we demonstrate that in pre-B cells, the IL-7R but not the pre-BCR was coupled to phosphatidylinositol-3-OH kinase (PI(3) K) and the kinase Akt; signaling by this pathway inhibited expression of recombination-activating gene 1 (Rag1) and Rag2. Attenuation of IL-7 signaling resulted in upregulation of the transcription factors Foxo1 and Pax5, which coactivated many pre-B cell genes, including Rag1, Rag2 and Blnk. Induction of Blnk (which encodes the signaling adaptor BLNK) enabled pre-BCR signaling via the signaling molecule Syk and promoted immunoglobulin light-chain rearrangement. BLNK expression also antagonized Akt activation, thereby augmenting the accumulation of Foxo1 and Pax5. This self-reinforcing molecular circuit seemed to sense limiting concentrations of IL-7 and functioned to constrain the proliferation of pre-B cells and trigger their differentiation.	[Ochiai, Kyoko; Triggs, Joseph R.; Bertolino, Eric; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Maienschein-Cline, Mark; Dinner, Aaron R.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Mandal, Malay; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Sciammas, Roger] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Roche Holding; Genentech	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	harindsi@gene.com			Howard Hughes Medical Institute; US National Institutes of Health [GM088847, GM081892]; US Department of Energy (DOE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, R01GM088847] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Heinz for advice on the preparation of DNA libraries for ChIP-seq; M. Veselitis (University of Chicago) for mouse Blnk cDNA; S. E. Powers for discussions; the Bendelac laboratory for assistance with flow cytometry; R. Duggan, D. Leclerc, M. Olson and J. Cao for assistance with cell sorting; and K. Michelini and J. Zekos for operating the Illumina Genome Analyzer II at the University of Chicago (supported by the Howard Hughes Medical Institute). Supported by Howard Hughes Medical Institute (H. S.), the US National Institutes of Health (GM088847 to M. R. C. and GM081892 to A. R. D.) and the US Department of Energy (DOE) Computational Science Graduate Fellowship Program (M. M.-C.).	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Erlandsson L, 2005, EUR J IMMUNOL, V35, P1969, DOI 10.1002/eji.200425821; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Oda A, 2008, INT IMMUNOL, V20, P1417, DOI 10.1093/intimm/dxn101; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	38	115	116	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					300	U124		10.1038/ni.2210	http://dx.doi.org/10.1038/ni.2210			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22267219	Green Accepted			2022-12-18	WOS:000300510600017
J	Horng, T; Bezbradica, JS; Medzhitov, R				Horng, Tiffany; Bezbradica, Jelena S.; Medzhitov, Ruslan			NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; IMMUNORECEPTOR; ACTIVATION; MULTIPLICITY; HOMEOSTASIS; EXPRESSION; RECEPTORS; MEMBRANE; PROTEINS	The effector functions of natural killer cells are regulated by activating receptors, which recognize stress-inducible ligands expressed on target cells and signal through association with signaling adaptors. Here we developed a mouse model in which a fusion of the signaling adaptor DAP10 and ubiquitin efficiently downregulated expression of the activating receptor NKG2D on the surfaces of natural killer cells. With this system, we identified coupling of the signaling pathways triggered by NKG2D and DAP10 to those initiated by the interleukin 15 receptor. We suggest that this coupling of activating receptors to other receptor systems could function more generally to regulate cell type-specific signaling events in distinct physiological contexts.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Horng, T (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA.	horng@cbrinstitute.org; ruslan.medzhitov@yale.edu		Bezbradica, Jelena/0000-0003-1441-1727	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-055502, AI-0466888] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KARLHOFER FM, 1995, J EXP MED, V181, P1785, DOI 10.1084/jem.181.5.1785; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rosen DB, 2004, J IMMUNOL, V173, P2470, DOI 10.4049/jimmunol.173.4.2470; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Sechler JM, 2004, CELL IMMUNOL, V230, P99, DOI 10.1016/j.cellimm.2004.10.001; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	43	115	130	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1345	1352		10.1038/ni1524	http://dx.doi.org/10.1038/ni1524			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17952078				2022-12-18	WOS:000251267000015
J	Xue, HH; Bollenbacher, J; Rovella, V; Tripuraneni, R; Du, YB; Liu, CY; Williams, A; McCoy, JP; Leonard, WJ				Xue, HH; Bollenbacher, J; Rovella, V; Tripuraneni, R; Du, YB; Liu, CY; Williams, A; McCoy, JP; Leonard, WJ			GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells	NATURE IMMUNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR; UTROPHIN PROMOTER; MEMORY CELLS; ETS FAMILY; COMPLEX; PU.1; DNA; DOMAIN	The interleukin 7 receptor alpha-chain (IL-7Ralpha) is essential for T cell development in both humans and mice and for B cell development in mice. Whereas the transcription factor PU. 1 regulates IL-7Ra expression in mouse pro-B cells via a GGAA motif, we demonstrate here that GA binding protein (GABP) bound to this site and was essential in the regulation of IL-7Ralpha expression in T cells, where PU. 1 is not expressed. Moreover, IL-7Ralpha expression was diminished substantially in thymocytes but was normal on B220(+) fetal liver cells from mouse embryos with diminished expression of GABPalpha. Thus, GABP is essential for the regulation of IL-7Ralpha expression in T cells, and the differential regulation of IL-7Ralpha in distinct lymphoid lineages is achieved at least in part by differential recruitment of factors to the same GGAA motif.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; NHLBI, Transgenic Facil, NIH, Bethesda, MD 20892 USA; NHLBI, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10,Room 7N252, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Rovella, Valentina/AAB-9727-2019; mccoy, john philip/ABD-9348-2021; Leonard, Warren/AAA-1397-2022	Rovella, Valentina/0000-0002-3311-486X; Xue, Hai-Hui/0000-0002-9163-7669	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, Z01HL005402] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 1998, P NATL ACAD SCI USA, V95, P2486, DOI 10.1073/pnas.95.5.2486; Akashi K, 1999, INT J HEMATOL, V69, P217; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Graves BJ, 1998, SCIENCE, V279, P1000, DOI 10.1126/science.279.5353.1000; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Gyrd-Hansen M, 2002, J NEUROL SCI, V197, P27, DOI 10.1016/S0022-510X(02)00038-2; HEMAT F, 1994, BIOCHEM BIOPH RES CO, V205, P475, DOI 10.1006/bbrc.1994.2690; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; JOHN S, 1995, MOL CELL BIOL, V15, P1786; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; KINCADE PW, 1981, ADV IMMUNOL, V31, P177, DOI 10.1016/S0065-2776(08)60921-9; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LIN JX, 1993, MOL CELL BIOL, V13, P6201, DOI 10.1128/MCB.13.10.6201; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; PENIT C, 1989, J IMMUNOL, V142, P3369; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Spain LM, 1999, J IMMUNOL, V163, P2681; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WURSTER AL, 1994, MOL CELL BIOL, V14, P6452, DOI 10.1128/MCB.14.10.6452; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999	47	115	118	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1036	1044		10.1038/ni1117	http://dx.doi.org/10.1038/ni1117			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15361867				2022-12-18	WOS:000224156600027
J	Ablasser, A; Hur, S				Ablasser, Andrea; Hur, Sun			Regulation of cGAS- and RLR-mediated immunity to nucleic acids	NATURE IMMUNOLOGY			English	Review							AICARDI-GOUTIERES-SYNDROME; CYCLIC GMP-AMP; DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNAL ACTIVATION; CGAS/STING-DEPENDENT INNATE; CYTOSOLIC DNA SENSOR; INDUCIBLE GENE-I; RIG-I; STRUCTURAL BASIS; ENDOPLASMIC-RETICULUM	Pathogen-derived nucleic acids are crucial signals for innate immunity. Despite the structural similarity between those and host nucleic acids, mammalian cells have been able to evolve powerful innate immune signaling pathways that originate from the detection of cytosolic nucleic acid species, one of the most prominent being the cGAS-STING pathway for DNA and the RLR-MAVS pathway for RNA, respectively. Recent advances have revealed a plethora of regulatory mechanisms that are crucial for balancing the activity of nucleic acid sensors for the maintenance of overall cellular homeostasis. Elucidation of the various mechanisms that enable cells to maintain control over the activity of cytosolic nucleic acid sensors has provided new insight into the pathology of human diseases and, at the same time, offers a rich and largely unexplored source for new therapeutic targets. This Review addresses the emerging literature on regulation of the sensing of cytosolic DNA and RNA via cGAS and RLRs.	[Ablasser, Andrea] Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland; [Hur, Sun] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hur, Sun] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Ablasser, A (corresponding author), Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland.	andrea.ablasser@epfl.ch; sun.hur@childrens.harvard.edu						Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barnett KC, 2019, CELL, V176, P1432, DOI 10.1016/j.cell.2019.01.049; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Cadena C, 2019, CELL, V177, P1187, DOI 10.1016/j.cell.2019.03.017; Carozza J. A., 2019, BIORXIV PREPRINT, DOI [10.1101/539312, DOI 10.1101/539312]; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005462; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chen YG, 2019, MOL CELL, V76, P96, DOI 10.1016/j.molcel.2019.07.016; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Cuellar TL, 2017, J CELL BIOL, V216, P3535, DOI 10.1083/jcb.201612160; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Devarkar SC, 2018, MOL CELL, V72, P355, DOI 10.1016/j.molcel.2018.08.021; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du J, 2015, J IMMUNOL, V195, P1782, DOI 10.4049/jimmunol.1500588; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Eaglesham JB, 2019, NATURE, V566, P259, DOI 10.1038/s41586-019-0928-6; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720; Fitzgerald ME, 2014, CURR OPIN MICROBIOL, V20, P76, DOI 10.1016/j.mib.2014.05.004; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gentili M, 2019, CELL REP, V26, P3474, DOI 10.1016/j.celrep.2019.03.049; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gluck S, 2019, CURR OPIN IMMUNOL, V56, P31, DOI 10.1016/j.coi.2018.09.013; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gratia M, 2019, J EXP MED, V216, P1199, DOI 10.1084/jem.20181329; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guan K, 2013, MOL CELL BIOL, V33, P3137, DOI 10.1128/MCB.00030-13; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hao Q, 2015, EMBO J, V34, P2903, DOI 10.15252/embj.201591888; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hayman TJ, 2019, IMMUNOL CELL BIOL, V97, P840, DOI 10.1111/imcb.12284; He X, 2019, EMBO J, V38, DOI 10.15252/embj.2018100978; Hooy RM, 2018, ELIFE, V7, DOI 10.7554/eLife.39984; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang YF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004020; Hur S, 2019, ANNU REV IMMUNOL, V37, P349, DOI 10.1146/annurev-immunol-042718-041356; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jiang H, 2019, EMBO J, V38, DOI 10.15252/embj.2019102718; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin SH, 2017, MOL CELL, V68, P308, DOI 10.1016/j.molcel.2017.09.005; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lahaye X, 2018, CELL, V175, P488, DOI 10.1016/j.cell.2018.08.062; Lama L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08620-4; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Liu SW, 2018, NATURE, V561, P551, DOI 10.1038/s41586-018-0534-z; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Mu X, 2018, NUCLEIC ACIDS RES, V46, P5239, DOI 10.1093/nar/gky177; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Nandakumar R, 2019, NAT MICROBIOL, V4, P701, DOI 10.1038/s41564-019-0367-z; Narayan K, 2014, J VIROL, V88, P10748, DOI 10.1128/JVI.02593-13; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pan Y, 2014, J IMMUNOL, V192, P4758, DOI 10.4049/jimmunol.1302632; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Qi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15676; Qin YW, 2017, J VIROL, V91, DOI 10.1128/JVI.01264-17; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice GI, 2018, NEW ENGL J MED, V379, P2275, DOI 10.1056/NEJMc1810983; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Seluanov A, 2018, NAT REV CANCER, V18, P433, DOI 10.1038/s41568-018-0004-9; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Shi YH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8811; Sisquella X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02083-1; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Sohn J, 2016, CURR OPIN STRUC BIOL, V37, P134, DOI 10.1016/j.sbi.2016.01.011; Song T, 2010, FEBS LETT, V584, P33, DOI 10.1016/j.febslet.2009.11.025; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Steinhagen F, 2018, EUR J IMMUNOL, V48, P605, DOI 10.1002/eji.201747338; Stempel M, 2019, MED MICROBIOL IMMUN, V208, P495, DOI 10.1007/s00430-019-00582-0; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takashima K, 2018, J INNATE IMMUN, V10, P44, DOI 10.1159/000480740; Tao JL, 2017, J IMMUNOL, V198, P3627, DOI 10.4049/jimmunol.1601909; Uggenti C, 2019, ANNU REV IMMUNOL, V37, P247, DOI 10.1146/annurev-immunol-042718-041257; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; van der Veen AG, 2018, EMBO J, V37, DOI 10.15252/embj.201797479; Vanpouille-Box C, 2019, NAT REV DRUG DISCOV, V18, P845, DOI 10.1038/s41573-019-0043-2; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vece TJ, 2016, J CLIN IMMUNOL, V36, P377, DOI 10.1007/s10875-016-0271-8; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Volkman HE, 2018, IMMUNOLOGY; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang S, 2016, EMBO REP, V17, P1155, DOI 10.15252/embr.201541703; Wang WD, 2016, P NATL ACAD SCI USA, V113, P9581, DOI 10.1073/pnas.1604277113; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wolf C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11752; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Xie JZ, 2018, CELL HOST MICROBE, V23, P297, DOI 10.1016/j.chom.2018.01.006; Xie W, 2019, P NATL ACAD SCI USA, V116, P11946, DOI 10.1073/pnas.1905013116; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao CY, 2017, CELL REP, V21, P1613, DOI 10.1016/j.celrep.2017.10.020; Zhao K, 2016, J IMMUNOL, V196, P1209, DOI 10.4049/jimmunol.1501224; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	203	114	119	7	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					17	29		10.1038/s41590-019-0556-1	http://dx.doi.org/10.1038/s41590-019-0556-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31819255				2022-12-18	WOS:000515136500010
J	Melandri, D; Zlatareva, I; Chaleil, RAG; Dart, RJ; Chancellor, A; Nussbaumer, O; Polyakova, O; Roberts, NA; Wesch, D; Kabelitz, D; Irving, PM; John, S; Mansour, S; Bates, PA; Vantourout, P; Hayday, AC				Melandri, Daisy; Zlatareva, Iva; Chaleil, Raphael A. G.; Dart, Robin J.; Chancellor, Andrew; Nussbaumer, Oliver; Polyakova, Oxana; Roberts, Natalie A.; Wesch, Daniela; Kabelitz, Dieter; Irving, Peter M.; John, Susan; Mansour, Salah; Bates, Paul A.; Vantourout, Pierre; Hayday, Adrian C.			The gamma delta TCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; CRYSTAL-STRUCTURE; STRESS-SURVEILLANCE; MUTATIONAL ANALYSIS; ALPHA-BETA; RECOGNITION; BINDING; PROTEIN; COMPLEX; LYMPHOCYTES	T lymphocytes expressing gamma delta T cell antigen receptors (TCRs) comprise evolutionarily conserved cells with paradoxical features. On the one hand, clonally expanded gamma delta T cells with unique specificities typify adaptive immunity. Conversely, large compartments of gamma delta TCR+ intraepithelial lymphocytes (gamma delta IELs) exhibit limited TCR diversity and effect rapid, innate-like tissue surveillance. The development of several gamma delta IEL compartments depends on epithelial expression of genes encoding butyrophilin-like (Btnl (mouse) or BTNL (human)) members of the B7 superfamily of T cell co-stimulators. Here we found that responsiveness to Btnl or BTNL proteins was mediated by germline-encoded motifs within the cognate TCR variable gamma-chains (V-gamma chains) of mouse and human gamma delta IELs. This was in contrast to diverse antigen recognition by clonally restricted complementarity-determining regions CDR1-CDR3 of the same gamma delta TCRs. Hence, the gamma delta TCR intrinsically combines innate immunity and adaptive immunity by using spatially distinct regions to discriminate non-clonal agonist-selecting elements from clone-specific ligands. The broader implications for antigen-receptor biology are considered.	[Melandri, Daisy; Zlatareva, Iva; Dart, Robin J.; Roberts, Natalie A.; John, Susan; Vantourout, Pierre; Hayday, Adrian C.] Kings Coll London, Sch Immunol Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Melandri, Daisy; Zlatareva, Iva; Dart, Robin J.; Roberts, Natalie A.; Vantourout, Pierre; Hayday, Adrian C.] Francis Crick Inst, Immunosurveillance Lab, London, England; [Chaleil, Raphael A. G.; Bates, Paul A.] Francis Crick Inst, Biomol Modelling Lab, London, England; [Chancellor, Andrew; Mansour, Salah] Univ Southampton, Acad Unit Clin & Expt Sci, Fac Med, Southampton, Hants, England; [Nussbaumer, Oliver; Polyakova, Oxana] London BioSci Innovat Ctr, GammaDelta Therapeut, London, England; [Wesch, Daniela; Kabelitz, Dieter] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Immunol, Kiel, Germany; [Dart, Robin J.; Irving, Peter M.] Guys & St Thomas Fdn Trust, Dept Gastroenterol, London, England	University of London; King's College London; Francis Crick Institute; Francis Crick Institute; University of Southampton; University of London; University of London Royal Veterinary College; University of Kiel; Schleswig Holstein University Hospital; Guy's & St Thomas' NHS Foundation Trust	Vantourout, P; Hayday, AC (corresponding author), Kings Coll London, Sch Immunol Microbial Sci, Peter Gorer Dept Immunobiol, London, England.; Vantourout, P; Hayday, AC (corresponding author), Francis Crick Inst, Immunosurveillance Lab, London, England.	pierre.vantourout@kcl.ac.uk; adrian.hayday@kcl.ac.uk	Bates, Paul A/AAF-8561-2020; Irving, Peter/AAP-4543-2020; Wesch, Daniela/C-1940-2019; Kabelitz, Dieter/A-2757-2010; Kabelitz, Dieter/AAB-4199-2021; Chaleil, Raphael/Z-2683-2019	Bates, Paul A/0000-0003-0621-0925; Wesch, Daniela/0000-0001-6509-208X; Chaleil, Raphael/0000-0003-2759-2088; Vantourout, Pierre/0000-0001-7287-5517; HAYDAY, ADRIAN/0000-0002-9495-5793; Dart, Robin/0000-0003-3470-8210; /0000-0001-9113-6306; Mansour, Salah/0000-0002-5982-734X; Nussbaumer, Oliver/0000-0002-4017-0990; Irving, Peter/0000-0003-0972-8148; Zlatareva, Iva/0000-0001-8027-8042	Francis Crick Institute from Cancer Research UK (CRUK) [FC001003]; UK Medical Research Council [FC001003]; Wellcome Trust [FC001003, 108745/Z/15/Z, 106292/Z/14/Z, 100156/Z/12/Z]; CRUK King's Cancer Centre; King's Bioscience Institute; Guy's and St. Thomas' Charity Prize PhD program in Biomedical and Translational Science; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; St. Thomas' Wegener's Trust; MRC [MR/P021964/1]; Cluster of Excellence ExC 306 'Inflammationat-Interfaces'; Cancer Research UK [23562]	Francis Crick Institute from Cancer Research UK (CRUK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK King's Cancer Centre; King's Bioscience Institute; Guy's and St. Thomas' Charity Prize PhD program in Biomedical and Translational Science; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; St. Thomas' Wegener's Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cluster of Excellence ExC 306 'Inflammationat-Interfaces'; Cancer Research UK(Cancer Research UK)	We are grateful to D. Kaiserlian (INSERM U1111, Lyon) for MODE-K cells; P. Pereira (Institut Pasteur) for the hybridoma (F2.67) producing antibody to V<INF>gamma</INF>7<SUP>+</SUP>TCR; C. Willcox (University of Birmingham), B. Willcox (University of Birmingham) and P. Barral (The Francis Crick Institute) for cell lines; R.P. Di Marco Barros, A. Jandke, A. Lorenc, D. Ushakov and A. Laing for contributions and discussions; E. Theodoridis, the flow cytometry, genomic equipment park, bio-informatics, experimental histopathology, mass spectrometry and proteomics platform, cell services, and biological service units of the Francis Crick Institute, the Peter Gorer Department of Immunobiology and the Guy's Hospital Biomedical Research Centre (BRC) for outstanding technical support; and the NVIDIA corporation for the donation of a Titan Xp GPU used to run our proteinprotein docking algorithm. The work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (CRUK) (FC001003), the UK Medical Research Council (FC001003), and the Wellcome Trust (FC001003); the CRUK King's Cancer Centre; studentships from the King's Bioscience Institute and the Guy's and St. Thomas' Charity Prize PhD program in Biomedical and Translational Science (D.M.), the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London (to I.Z.), and the Wellcome Trust (108745/Z/15/Z) (R.J.D.); funds from St. Thomas' Wegener's Trust and MRC (MR/P021964/1) (S.J.), the Cluster of Excellence ExC 306 'Inflammationat-Interfaces' (D.W. and D.K.), Cancer Research UK (23562) (S.M.), and the Wellcome Trust (106292/Z/14/Z and 100156/Z/12/Z) (A.C.H.). This manuscript is dedicated to the memory of Dr. Bruno Kyewski, who greatly clarified our insights into T cell tolerance and selection.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Bates PA, 2001, PROTEINS, P39; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Bruder J, 2012, J BIOL CHEM, V287, P20986, DOI 10.1074/jbc.M112.356709; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chancellor A, 2017, P NATL ACAD SCI USA, V114, pE10956, DOI 10.1073/pnas.1708252114; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Davey MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04076-0; Davey MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14760; Fahl SP, 2018, P NATL ACAD SCI USA, V115, P1889, DOI 10.1073/pnas.1718328115; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Green N, 1999, CELL ADHES COMMUN, V7, P167, DOI 10.3109/15419069909010800; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Havran W L, 1991, Semin Immunol, V3, P89; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayday A, 2013, IMMUNITY, V39, P994, DOI 10.1016/j.immuni.2013.11.016; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; HOLNESS CL, 1994, J CELL SCI, V107, P2065; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; Jose ES, 2000, IMMUNITY, V12, P161, DOI 10.1016/S1074-7613(00)80169-7; KABELITZ D, 1994, J IMMUNOL, V152, P3128; Kisielow J, 2011, BLOOD, V118, P6591, DOI 10.1182/blood-2011-05-352732; Komori HK, 2012, J IMMUNOL, V188, P2972, DOI 10.4049/jimmunol.1100887; Kreiss M, 2004, INT IMMUNOL, V16, P655, DOI 10.1093/intimm/dxh068; KYES S, 1989, P NATL ACAD SCI USA, V86, P5527, DOI 10.1073/pnas.86.14.5527; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Mansour S, 2016, P NATL ACAD SCI USA, V113, pE1266, DOI 10.1073/pnas.1519246113; Marlin R, 2017, P NATL ACAD SCI USA, V114, P3163, DOI 10.1073/pnas.1621052114; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Myers DR, 2017, TRENDS IMMUNOL, V38, P844, DOI 10.1016/j.it.2017.06.010; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Salim M, 2016, J BIOL CHEM, V291, P9310, DOI 10.1074/jbc.M116.722066; SOMOZA C, 1993, J EXP MED, V178, P549, DOI 10.1084/jem.178.2.549; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sumaria N, 2017, CELL REP, V19, P2469, DOI 10.1016/j.celrep.2017.05.071; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004	60	114	116	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1352	+		10.1038/s41590-018-0253-5	http://dx.doi.org/10.1038/s41590-018-0253-5			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30420626	Green Accepted, Green Submitted			2022-12-18	WOS:000452873000016
J	Meredith, M; Zemmour, D; Mathis, D; Benoist, C				Meredith, Matthew; Zemmour, David; Mathis, Diane; Benoist, Christophe			Aire controls gene expression in the thymic epithelium with ordered stochasticity	NATURE IMMUNOLOGY			English	Article							CELL RNA-SEQ; SINGLE-CELL; T-CELLS; IMMUNOLOGICAL-TOLERANCE; NEGATIVE SELECTION; TRANSCRIPTION; CHROMATIN; ANTIGEN; PROTEIN; AUTOIMMUNITY	The transcription factor Aire controls immunological tolerance by inducing the ectopic thymic expression of many tissue-specific genes, acting broadly by removing stops on the transcriptional machinery. To better understand Aire's specificity, we performed single-cell RNA-seq and DNA-methylation analysis of Aire-sufficient and Aire-deficient medullary epithelial cells (mTECs). Each of Aire's target genes was induced in only a minority of mTECs, independently of DNA-methylation patterns, as small inter-chromosomal gene clusters activated in concert in a proportion of mTECs. These microclusters differed between individual mice. Thus, our results suggest an organization of the DNA or of the epigenome that results from stochastic determinism but is 'bookmarked' and stable through mTEC divisions, which ensures more effective presentation of self antigens and favors diversity of self-tolerance between individuals.	[Mathis, Diane] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Mathis, D (corresponding author), Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu		Zemmour, David/0000-0002-0990-217X	US National Institutes of Health [DK060027]; US National Institutes of Health (Children's Hospital in Pediatric Gastroenterology); Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060027, R37DK060027] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Children's Hospital in Pediatric Gastroenterology); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Mostafavi for advice on computational analysis; M. Anderson (University of California, San Francisco) for the Aire-GFP line; and K. Hattori, G. Buruzula, and K. Waraska for help with mice, sorting and sequencing. Supported by the US National Institutes of Health (DK060027; and a Children's Hospital in Pediatric Gastroenterology training grant for M.M.) and Boehringer Ingelheim Fonds (D.Z.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Keane P, 2015, BIOINFORMATICS, V31, P986, DOI 10.1093/bioinformatics/btu785; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tao YX, 2006, MOL IMMUNOL, V43, P335, DOI 10.1016/j.molimm.2005.02.018; Taubert R, 2007, EUR J IMMUNOL, V37, P838, DOI 10.1002/eji.200636962; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341	49	114	118	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					942	949		10.1038/ni.3247	http://dx.doi.org/10.1038/ni.3247			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26237550	Green Accepted, Green Submitted			2022-12-18	WOS:000359876900012
J	Thiault, N; Darrigues, J; Adoue, V; Gros, M; Binet, B; Perals, C; Leobon, B; Fazilleau, N; Joffre, OP; Robey, EA; van Meerwijk, JPM; Romagnoli, P				Thiault, Nicolas; Darrigues, Julie; Adoue, Veronique; Gros, Marine; Binet, Benedicte; Perals, Corine; Leobon, Bertrand; Fazilleau, Nicolas; Joffre, Olivier P.; Robey, Ellen A.; van Meerwijk, Joost P. M.; Romagnoli, Paola			Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors	NATURE IMMUNOLOGY			English	Article							CELL DEVELOPMENT; DIFFERENTIAL EXPRESSION; TREG CELLS; SUBSETS; DIVERSITY; IL-2; RECOGNITION; HOMEOSTASIS; DELETION; NICHE	Most T lymphocytes, including regulatory T cells (T-reg cells), differentiate in the thymus. The age-dependent involution of this organ leads to decreasing production of T cells. Here we found that the output of new T-reg cells from the thymus decreased substantially more than that of conventional T cells. Peripheral mouse and human T-reg cells recirculated back to the thymus, where they constituted a large proportion of the pool of T-reg cells and displayed an activated and differentiated phenotype. In the thymus, the recirculating cells exerted their regulatory function by inhibiting interleukin 2 (IL-2)-dependent de novo differentiation of T-reg cells. Thus, T-reg cell development is controlled by a negative feedback loop in which mature progeny cells return to the thymus and restrain development of precursors of T-reg cells.	[Thiault, Nicolas; Darrigues, Julie; Adoue, Veronique; Gros, Marine; Binet, Benedicte; Perals, Corine; Fazilleau, Nicolas; Joffre, Olivier P.; van Meerwijk, Joost P. M.; Romagnoli, Paola] INSERM, U1043, Toulouse, France; [Thiault, Nicolas; Darrigues, Julie; Adoue, Veronique; Gros, Marine; Binet, Benedicte; Perals, Corine; Fazilleau, Nicolas; Joffre, Olivier P.; van Meerwijk, Joost P. M.; Romagnoli, Paola] CNRS, U5282, Toulouse, France; [Thiault, Nicolas; Darrigues, Julie; Adoue, Veronique; Gros, Marine; Binet, Benedicte; Perals, Corine; Fazilleau, Nicolas; Joffre, Olivier P.; van Meerwijk, Joost P. M.; Romagnoli, Paola] Univ Toulouse 3, Univ Toulouse, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Gros, Marine] Ecole Normale Super Lyon, Dept Biol, F-69007 Lyon, France; [Leobon, Bertrand] Univ Hosp Toulouse, Children Hosp, Dept Pediat Cardiol & Cardiovasc Surg, Toulouse, France; [Robey, Ellen A.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); CHU de Toulouse; University of California System; University of California Berkeley	van Meerwijk, JPM (corresponding author), INSERM, U1043, Toulouse, France.	joost.van-meerwijk@inserm.fr; paola.romagnoli@inserm.fr	Fazilleau, Nicolas/J-9883-2014; Joffre, Olivier P/K-1235-2014; van Meerwijk, Joost P.M./K-1345-2014	Joffre, Olivier P/0000-0003-1168-8165; van Meerwijk, Joost P.M./0000-0001-8231-1897; GROS, Marine/0000-0003-3914-7264; Adoue, Veronique/0000-0003-3548-7456; Fazilleau, Nicolas/0000-0002-3574-5614; Darrigues, Julie/0000-0001-7745-5845	Fondation pour la Recherche Medicale; IdEx Toulouse; Region Midi Pyrenees; Agence Nationale pour la Recherche	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); IdEx Toulouse; Region Midi Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Agence Nationale pour la Recherche(French National Research Agency (ANR))	We thank A. Lew (Walter & Eliza Hall Institute of Medical Research) and A. Egle (Salzburg Cancer Research Institute) for GK-transgenic mice; P. Fink (University of Washington, Seattle) for B6 Rag-GFP mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) and A. Liston (University of Leuven) for Foxp3-Thy-1.1 mice; S. Guerder and J.-C. Guery for critical reading of the manuscript; F. Auriol and A. Garnier for help in obtaining human thymuses; F.-E. L'Faqihi-Olive and V. Duplan-Eche for technical assistance at the flow-cytometry facility; S. Allart and A. Canivet for technical assistance at the cellular imaging facility of Inserm U1043, Toulouse; the personnel of the Inserm US006 ANEXPLO/CREFRE animal facility for expert animal care; and the GeT-PlaGe and GenoToul bioinformatics platforms Toulouse Midi-Pyrenees for sequencing, computing and storage resources. Supported by the Fondation pour la Recherche Medicale (O.P.J. and J.P.M.v.M.), the IdEx Toulouse (E.A.R. and P.R.), the Region Midi Pyrenees (O.P.J. and J.P.M.v.M.) and the Agence Nationale pour la Recherche (O.P.J.).	AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Almeida ARM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00125; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arden Bernhard, 1995, Immunogenetics, V42, P501; Attridge K, 2014, IMMUNOL REV, V259, P23, DOI 10.1111/imr.12165; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Chidgey A, 2007, SEMIN IMMUNOL, V19, P331, DOI 10.1016/j.smim.2007.10.006; Cuss SM, 2012, J IMMUNOL, V189, P1717, DOI 10.4049/jimmunol.1200588; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Fazilleau N, 2007, J IMMUNOL, V178, P4865, DOI 10.4049/jimmunol.178.8.4865; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Leng QB, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-51; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; PILARSKI LM, 1984, J CLIN INVEST, V74, P1301, DOI 10.1172/JCI111540; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Romagnoli P, 2012, J IMMUNOL, V189, P3831, DOI 10.4049/jimmunol.1201564; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yang EJ, 2014, EUR J IMMUNOL, V44, P2712, DOI 10.1002/eji.201444529; Yasunaga J, 2001, BLOOD, V97, P3177, DOI 10.1182/blood.V97.10.3177; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhan YF, 2000, XENOTRANSPLANTATION, V7, P267, DOI 10.1034/j.1399-3089.2000.00566.x	45	114	116	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					628	+		10.1038/ni.3150	http://dx.doi.org/10.1038/ni.3150			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25939024				2022-12-18	WOS:000354751900015
J	Persaud, SP; Parker, CR; Lo, WL; Weber, KS; Allen, PM				Persaud, Stephen P.; Parker, Chelsea R.; Lo, Wan-Lin; Weber, K. Scott; Allen, Paul M.			Intrinsic CD4(+) T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; NAIVE; TCR; RECOGNITION; SURVIVAL; ACTIVATION; RECEPTOR; CD5; DIFFERENTIATION; RESPONSIVENESS	Interactions of T cell antigen receptors (TCRs) with complexes of self peptide and major histocompatibility complex (MHC) are crucial to T cell development, but their role in peripheral T cell responses remains unclear. Specific and nonspecific stimulation of LLO56 and LLO118 T cells, which transgenically express a TCR specific for the same Listeria monocytogenes epitope, elicited distinct interleukin 2 (IL-2) and phosphorylated kinase Erk responses, the strength of which was set in the thymus and maintained in the periphery in proportion to the avidity of the binding of the TCR to the self peptide-MHC complex. Deprivation of self peptide-MHC substantially compromised the population expansion of LLO56 T cells in response to L. monocytogenes in vivo. Despite their very different self-reactivity, LLO56 T cells and LLO118 T cells bound cognate peptide-MHC with an identical affinity, which challenges associations made between these parameters. Our findings highlight a crucial role for selecting ligands encountered during thymic 'education' in determining the intrinsic functionality of CD4(+) T cells.	[Persaud, Stephen P.; Parker, Chelsea R.; Lo, Wan-Lin; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Weber, K. Scott] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Washington University (WUSTL); Brigham Young University	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu	Weber, Scott/O-1022-2014	Weber, Scott/0000-0003-3688-2191; Parker Harp, Chelsea/0000-0002-4205-9647; Lo, Wan-Lin/0000-0002-9074-6847; Persaud, Stephen/0000-0002-7733-5509; Allen, Paul/0000-0003-3796-6047	US National Institutes of Health [AI-24157];  [AI-071195]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107753, R37AI024157, P01AI071195, R01AI024157] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Huseby (University of Massachusetts Medical School) for soluble I-A<SUP>b</SUP>; Q.J. Li for generating the LLO56 and LLO118 TCR-encoding transgene constructs; J. Ting (University of North Carolina Chapel Hill School of Medicine) for mice doubly deficient in H-2M and beta<INF>2</INF>-microglobulin; K. Murray (Vanderbilt University School of Medicine) for the SCN5A-green fluorescent protein construct; D. Kreamalmeyer for mouse breeding and care; S. Horvath for peptide synthesis; D. Brinja and E. Lantelme for assistance with sorting by flow cytometry; D. Donermeyer, A. Shaw, E. Unanue and E. Brown for comments on the manuscript; and A. Chalcraborty, M. Davis, M. Dustin, M. Kardar, E. Pamer, A. Perelson, D. Portnoy and A. Shaw (members of the program project (AI-071195) under which this work was initiated). Supported by the US National Institutes of Health (AI-24157).	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Kaye J, 1991, Semin Immunol, V3, P269; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kim C, 2013, IMMUNITY, V39, P508, DOI 10.1016/j.immuni.2013.08.033; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Martin B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3209; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Skoberne M, 2001, J IMMUNOL, V167, P2209, DOI 10.4049/jimmunol.167.4.2209; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhou XY, 2000, J IMMUNOL, V164, P1260, DOI 10.4049/jimmunol.164.3.1260; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	40	114	116	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					266	274		10.1038/ni.2822	http://dx.doi.org/10.1038/ni.2822			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24487322	Green Accepted			2022-12-18	WOS:000331683100012
J	Ying, CY; Dominguez-Sola, D; Fabi, M; Lorenz, IC; Hussein, S; Bansal, M; Califano, A; Pasqualucci, L; Basso, K; Dalla-Favera, R				Ying, Carol Y.; Dominguez-Sola, David; Fabi, Melissa; Lorenz, Ivo C.; Hussein, Shafinaz; Bansal, Mukesh; Califano, Andrea; Pasqualucci, Laura; Basso, Katia; Dalla-Favera, Riccardo			MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER; PROTEIN-KINASE; REGULATORY NETWORKS; SOMATIC MUTATIONS; GENE-EXPRESSION; IN-VITRO; PHOSPHORYLATION; ACTIVATION; PROLIFERATION; IDENTIFICATION	MEF2B encodes a transcriptional activator and is mutated in similar to 11% of diffuse large B cell lymphomas (DLBCLs) and similar to 12% of follicular lymphomas (FLs). Here we found that MEF2B directly activated the transcription of the proto-oncogene BCL6 in normal germinal-center (GC) B cells and was required for DLBCL proliferation. Mutation of MEF2B resulted in enhanced transcriptional activity of MEF2B either through disruption of its interaction with the corepressor CABIN1 or by rendering it insensitive to inhibitory signaling events mediated by phosphorylation and sumoylation. Consequently, the transcriptional activity of Bcl-6 was deregulated in DLBCLs with MEF2B mutations. Thus, somatic mutations of MEF2B may contribute to lymphomagenesis by deregulating BCL6 expression, and MEF2B may represent an alternative target for blocking Bcl-6 activity in DLBCLs.	[Ying, Carol Y.; Dominguez-Sola, David; Fabi, Melissa; Lorenz, Ivo C.; Hussein, Shafinaz; Califano, Andrea; Pasqualucci, Laura; Basso, Katia; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Hussein, Shafinaz; Pasqualucci, Laura; Basso, Katia; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Bansal, Mukesh; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Califano, Andrea; Pasqualucci, Laura; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	rd10@columbia.edu		Califano, Andrea/0000-0003-4742-3679; Dominguez-Sola, David/0000-0001-9569-8402	US National Institutes of Health [PO1-CA092625, RO1-CA37295]; Leukemia and Lymphoma Society; National Cancer Institute of the US National Institutes of Health [5K99 CA151827]; Stewart Trust; NATIONAL CANCER INSTITUTE [R01CA037295, K99CA151827, P01CA092625] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Grunn, M. Fangazio and M. Vasishtha for help with the sequencing analysis; C. Scuoppo for advice on and reagents for the inducible lentiviral vector system; A. Holmes for statistical analysis (analysis of variance); A. Zelent (The Institute of Cancer Research, London) for antibody to HDAC9; E. Yeh (MD Anderson) for depositing the plasmid encoding Ubc9 at Addgene; R. T. Hay (University of Dundee) for the expression plasmid encoding hemagglutinintagged SUMO1; and the Flow Cytometry facility of the Herbert Irving Comprehensive Cancer Center. Supported by the US National Institutes of Health (PO1-CA092625 and RO1-CA37295 to R. D.-F.), the Leukemia and Lymphoma Society (to R. D.-F.), the National Cancer Institute of the US National Institutes of Health (5K99 CA151827 to D. D.-S.) and the Stewart Trust (K. B.). L. P. is on leave from the University of Perugia Medical School, Perugia, Italy.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bieber T, 2001, BIOTECHNIQUES, V30, P74, DOI 10.2144/01301st03; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2013, CURR OPIN HEMATOL, V20, P336, DOI 10.1097/MOH.0b013e3283623d7f; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; SEAMON K, 1981, J BIOL CHEM, V256, P9799; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Stein H, 2008, WHO CLASSIFICATION T, P233; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BHH, 1993, CANCER RES, V53, P2732; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	57	114	121	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1084	+		10.1038/ni.2688	http://dx.doi.org/10.1038/ni.2688			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23974956	Green Accepted			2022-12-18	WOS:000324584700017
J	Le Friec, G; Sheppard, D; Whiteman, P; Karsten, CM; Shamoun, SAT; Laing, A; Bugeon, L; Dallman, MJ; Melchionna, T; Chillakuri, C; Smith, RA; Drouet, C; Couzi, L; Fremeaux-Bacchi, V; Kohl, J; Waddington, SN; McDonnell, JM; Baker, A; Handford, PA; Lea, SM; Kemper, C				Le Friec, Gaelle; Sheppard, Devon; Whiteman, Pat; Karsten, Christian M.; Shamoun, Salley Al-Tilib; Laing, Adam; Bugeon, Laurence; Dallman, Margaret J.; Melchionna, Teresa; Chillakuri, Chandramouli; Smith, Richard A.; Drouet, Christian; Couzi, Lionel; Fremeaux-Bacchi, Veronique; Koehl, Joerg; Waddington, Simon N.; McDonnell, James M.; Baker, Alastair; Handford, Penny A.; Lea, Susan M.; Kemper, Claudia			The CD46-Jagged1 interaction is critical for human T(H)1 immunity	NATURE IMMUNOLOGY			English	Article							HEMOLYTIC-UREMIC SYNDROME; COFACTOR PROTEIN CD46; HELPER-CELL DIFFERENTIATION; T-CELLS; MULTIPLE-SCLEROSIS; ALAGILLE-SYNDROME; CIS-INHIBITION; NOTCH; ACTIVATION; EXPRESSION	CD46 is a complement regulator with important roles related to the immune response. CD46 functions as a pathogen receptor and is a potent costimulator for the induction of interferon-gamma (IFN-gamma)-secreting effector T helper type 1 (T(H)1) cells and their subsequent switch into interleukin 10 (IL-10)-producing regulatory T cells. Here we identified the Notch family member Jagged1 as a physiological ligand for CD46. Furthermore, we found that CD46 regulated the expression of Notch receptors and ligands during T cell activation and that disturbance of the CD46-Notch crosstalk impeded induction of IFN-gamma and switching to IL-10. Notably, CD4(+) T cells from CD46-deficient patients and patients with hypomorphic mutations in the gene encoding Jagged1 (Alagille syndrome) failed to mount appropriate T(H)1 responses in vitro and in vivo, which suggested that CD46-Jagged1 crosstalk is responsible for the recurrent infections in subpopulations of these patients.	[Le Friec, Gaelle; Laing, Adam; Melchionna, Teresa; Smith, Richard A.; Kemper, Claudia] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England; [Sheppard, Devon; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Whiteman, Pat; Chillakuri, Chandramouli; Handford, Penny A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Karsten, Christian M.; Koehl, Joerg] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Shamoun, Salley Al-Tilib; Baker, Alastair] Kings Hlth Partners, Child Hlth Clin Acad Grp, London, England; [Bugeon, Laurence; Dallman, Margaret J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England; [Drouet, Christian] CHU Grenoble, CNRS FRE3405, Grpe Rech & Etude Proc Inflammatoire Age & Imagin, Univ Grenoble 1, F-38043 Grenoble, France; [Couzi, Lionel] CHU Bordeaux, Bordeaux, France; [Fremeaux-Bacchi, Veronique] Cordeliers Res Ctr, Unite Mixte Rech Sante 872, INSERM, Paris, France; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, Paris, France; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Koehl, Joerg] Cincinnati Childrens Hosp, Med Ctr, Div Cellular & Mol Immunol, Cincinnati, OH USA; [Waddington, Simon N.] UCL, Inst Womens Hlth, Gene Transfer Technol Grp, London, England; [McDonnell, James M.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; University of Oxford; University of Lubeck; University of London; King's College London; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of London; University College London; University of London; King's College London	Kemper, C (corresponding author), Kings Coll London, Guys Hosp, MRC Ctr Transplantat, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England.	claudia.kemper@kcl.ac.uk	Koehl, Joerg/C-8531-2011; Waddington, Simon/G-3778-2011; Lea, Susan M/B-7678-2009; DROUET, Christian/AAE-5682-2020; Karsten, Christian/J-4372-2013; Kemper, Claudia/B-1502-2015; DROUET, Christian/J-8775-2019	Koehl, Joerg/0000-0003-1121-3178; Waddington, Simon/0000-0003-4970-4730; Lea, Susan M/0000-0001-9287-8053; DROUET, Christian/0000-0003-1318-4278; DROUET, Christian/0000-0003-1318-4278; Kemper, Claudia/0000-0003-4196-1417; Bugeon, Laurence/0000-0002-6978-2878; Dallman, Margaret/0000-0002-9079-3344; McDonnell, James/0000-0001-9037-2980; Le Friec, Gaelle/0000-0002-2051-3829	Medical Research Council [G1002165]; European Union; Medical Research Council Centre for Transplantation (Guy's Hospital, King's College); Department of Health; National Institute for Health Research Biomedical Research Centre; Wellcome Trust [097928/A/08/Z]; German Research Foundation [GRK1727 TP8, SFB/TR22 A21]; European Research Council ('SomaBio'); Medical Research Council [MR/J006742/1, G0600698B] Funding Source: researchfish; MRC [G1002165] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council Centre for Transplantation (Guy's Hospital, King's College)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); German Research Foundation(German Research Foundation (DFG)); European Research Council ('SomaBio'); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the CD46-deficient patients and patients with Alagille syndrome for their support, and A. Hayday for data discussions. Supported by the Medical Research Council (G1002165 to C.K.), the European Union Framework Programme 7 (Innovative Medicines Initiative "Be The Cure" project with C.K. as lead researcher), the Medical Research Council Centre for Transplantation (Guy's Hospital, King's College), the Department of Health, the National Institute for Health Research Biomedical Research Centre (for Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust), the Wellcome Trust (097928/A/08/Z to S.M.L. and P.A.H.), the German Research Foundation (GRK1727 TP8 and SFB/TR22 A21 to J.K.) and the European Research Council ('SomaBio' to S.N.W.).	Adams WC, 2012, J GEN VIROL, V93, P1339, DOI 10.1099/vir.0.039222-0; Adams WC, 2011, P NATL ACAD SCI USA, V108, P7499, DOI 10.1073/pnas.1017146108; Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Alford SK, 2008, J IMMUNOL, V181, P2544, DOI 10.4049/jimmunol.181.4.2544; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bhavsar P.J., 2012, ONCOGENE; Bikker A, 2012, CURR PHARM DESIGN, V18, P2347, DOI 10.2174/138161212800165979; Cardone J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00028; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Choileain SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016287; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Couzi L, 2008, AM J KIDNEY DIS, V52, pE5, DOI 10.1053/j.ajkd.2008.02.359; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Fang CJ, 2008, BLOOD, V111, P624, DOI 10.1182/blood-2007-04-084533; Fernandez-Centeno E, 2000, J IMMUNOL, V164, P4533, DOI 10.4049/jimmunol.164.9.4533; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Fuchs A, 2009, EUR J IMMUNOL, V39, P3097, DOI 10.1002/eji.200939392; GIBB AL, 1993, BIOCHIM BIOPHYS ACTA, V1180, P313, DOI 10.1016/0925-4439(93)90056-7; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Greig JA, 2009, MOL THER, V17, P1683, DOI 10.1038/mt.2009.152; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Quiros-Tejeira RE, 1999, J PEDIATR GASTR NUTR, V29, P431, DOI 10.1097/00005176-199910000-00011; Riley RC, 2002, J IMMUNOL, V169, P5405, DOI 10.4049/jimmunol.169.10.5405; Robinson M, 1996, EUR J PEDIATR, V155, P535, DOI 10.1007/BF01957900; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Roversi P, 2011, ACTA CRYSTALLOGR F, V67, P739, DOI 10.1107/S1744309111016551; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; Vajro P, 2012, CLIN RES HEPATOL GAS, V36, P275, DOI 10.1016/j.clinre.2012.03.019; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; White J, 2004, PROTEIN SCI, V13, P2406, DOI 10.1110/ps.03455604; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	49	114	116	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1213	+		10.1038/ni.2454	http://dx.doi.org/10.1038/ni.2454			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23086448	Green Accepted, Green Submitted			2022-12-18	WOS:000311217900015
J	Skok, JA; Gisler, R; Novatchkova, M; Farmer, D; de Laat, W; Busslinger, M				Skok, Jane A.; Gisler, Ramiro; Novatchkova, Maria; Farmer, Deborah; de Laat, Wouter; Busslinger, Meinrad			Reversible contraction by looping of the Tcra and Tcrb loci in rearranging thymocytes	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; RECEPTOR-ALPHA-CHAIN; ALLELIC EXCLUSION; HISTONE ACETYLATION; V(D)J RECOMBINATION; BETA REARRANGEMENT; GENE-EXPRESSION; DELTA; ENHANCER; PROTEIN	Reversible contraction of immunoglobulin loci juxtaposes the variable ( V) genes next to the ( diversity)-joining-constant (( D) JC) gene domain, thus facilitating V-( D)J recombination. Here we show that the T cell receptor beta ( Tcrb) and T cell receptor alpha delta ( Tcra-Tcrd) loci also underwent long-range interactions by looping in double-negative and double-positive thymocytes, respectively. Contraction of the Tcrb and Tcra loci occurred in rearranging thymocytes and was reversed at the next developmental stage. Decontraction of the Tcrb locus probably prevented further V-beta-DJ(beta) rearrangements in double- positive thymocytes by separating the V-beta genes from the DJC(beta) domain. In most double-negative cells, one Tcrb allele was recruited to pericentromeric heterochromatin. Such allelic positioning may facilitate asynchronous V-beta-DJ(beta) recombination. Hence, pericentromeric recruitment and locus 'decontraction' seem to contribute to the initiation and maintenance of allelic exclusion at the Tcrb locus.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria; UCL, Dept Immunol & Mol Pathol, Div Infect & Immun, London W1T 4JF, England; Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; University College London; Erasmus University Rotterdam; Erasmus MC	Busslinger, M (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.univie.ac.at	Skok, Jane/ABF-7249-2020; Busslinger, Meinrad J./J-1249-2016	Skok, Jane/0000-0002-4145-1516; Busslinger, Meinrad J./0000-0002-9111-9351; de Laat, Wouter/0000-0002-6393-595X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bosc N, 2000, EXP CLIN IMMUNOGENET, V17, P216, DOI 10.1159/000019141; Bosc N, 2003, DEV COMP IMMUNOL, V27, P465, DOI 10.1016/S0145-305X(03)00027-2; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hawwari A, 2005, J EXP MED, V202, P467, DOI 10.1084/jem.20050680; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Mathieu N, 2003, J BIOL CHEM, V278, P18101, DOI 10.1074/jbc.M212647200; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; PIRCHER H, 1990, EUR J IMMUNOL, V20, P417, DOI 10.1002/eji.1830200227; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Ryu CJ, 2004, MOL CELL BIOL, V24, P7015, DOI 10.1128/MCB.24.16.7015-7023.2004; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sieh P, 2001, J IMMUNOL, V167, P2121, DOI 10.4049/jimmunol.167.4.2121; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sleckman BP, 1998, J EXP MED, V188, P1465, DOI 10.1084/jem.188.8.1465; Splinter E, 2004, METHOD ENZYMOL, V375, P493; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Wang LL, 2002, BIOCHEM BIOPH RES CO, V298, P420, DOI 10.1016/S0006-291X(02)02480-4; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	57	114	119	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					378	387		10.1038/ni1448	http://dx.doi.org/10.1038/ni1448			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17334367				2022-12-18	WOS:000245075900013
J	Yamasaki, S; Ishikawa, E; Sakuma, M; Ogata, K; Sakata-Sogawa, K; Hiroshima, M; Wiest, DL; Tokunaga, M; Saito, T				Yamasaki, S; Ishikawa, E; Sakuma, M; Ogata, K; Sakata-Sogawa, K; Hiroshima, M; Wiest, DL; Tokunaga, M; Saito, T			Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development	NATURE IMMUNOLOGY			English	Article							TCR ALPHA-CHAIN; PT-ALPHA; LYMPHOCYTE DEVELOPMENT; CYTOPLASMIC TAIL; SYNAPSE FORMATION; BETA; CD3-EPSILON; EXPRESSION; MICE; ACTIVATION	The pre-T cell receptor (TCR) is crucial for early T cell development and is proposed to function in a ligand-independent way. However, the molecular mechanism underlying the autonomous signals remains elusive. Here we show that the pre-TCR complex spontaneously formed oligomers. Specific charged residues in the extracellular domain of the pre-TCR alpha-chain mediated formation of the oligomers in vitro. Alteration of these residues eliminated the ability of the pre-TCR alpha-chain to support pre-TCR signaling in vivo. Dimerization but not raft localization of CD3 epsilon was sufficient to simulate pre-TCR function and promote beta-selection. These results suggest that the pre-TCR complex can deliver its signal autonomously through oligomerization of the pre-TCR alpha-chain mediated by charged residues.	RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; Hosp Sick Children, Ctr Computat Biol, Toronto, ON M5G 1X8, Canada; Grad Univ Adv Studies, Struct Biol Ctr, Natl Inst Genet, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Shizuoka 4118540, Japan; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	RIKEN; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Fox Chase Cancer Center	Saito, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan.	saito@rcai.riken.jp	Saito, Takashi/C-9684-2009; Ogata, Koji/H-4925-2019	Saito, Takashi/0000-0001-9495-3547; Ogata, Koji/0000-0001-9002-9621; Tokunaga, Makio/0000-0003-4586-8922; Wiest, David/0000-0002-0792-3188; Yamasaki, Sho/0000-0002-5184-6917				Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Carleton M, 1999, J IMMUNOL, V163, P2576; Carrasco YR, 2003, J BIOL CHEM, V278, P14507, DOI 10.1074/jbc.M204944200; Carrasco YR, 2001, J EXP MED, V193, P1045, DOI 10.1084/jem.193.9.1045; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CORNELL WD, 1992, ABSTR PAP AM CHEM S, V204, pCOMP; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Haks MC, 2003, J IMMUNOL, V170, P2853, DOI 10.4049/jimmunol.170.6.2853; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; HOWARD FD, 1992, J EXP MED, V176, P139, DOI 10.1084/jem.176.1.139; Huang CY, 2004, EUR J IMMUNOL, V34, P1532, DOI 10.1002/eji.200424870; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Kitamura T, 1998, INT J HEMATOL, V67, P351; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Muljo SA, 2000, IMMUNOL REV, V175, P80, DOI 10.1034/j.1600-065X.2000.017509.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; POIRIER G, 1994, IMMUNITY, V1, P385, DOI 10.1016/1074-7613(94)90069-8; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1995, IMMUNITY, V2, P401; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Trop S, 2000, J IMMUNOL, V165, P5566, DOI 10.4049/jimmunol.165.10.5566; Trop S, 1999, EUR J IMMUNOL, V29, P2187, DOI 10.1002/(SICI)1521-4141(199907)29:07<2187::AID-IMMU2187>3.3.CO;2-4; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	50	114	120	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					67	75		10.1038/ni1290	http://dx.doi.org/10.1038/ni1290			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16327787				2022-12-18	WOS:000234139700020
J	Vivier, E; Malissen, B				Vivier, E; Malissen, B			Innate and adaptive immunity: specificities and signaling hierarchies revisited	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; CLASS-I; RECEPTORS; LYMPHOCYTE; RECOGNITION; ACTIVATION; LIGANDS; NKG2D; MEMORY	The conventional classification of known immune responses by specificity may need re-evaluation. The immune system can be classified into two subsystems: the innate and adaptive immune systems. In general, innate immunity is considered a nonspecific response, whereas the adaptive immune system is thought of as being very specific. In addition, the antigen receptors of the adaptive immune response are commonly viewed as 'master sensors' whose engagement dictates lymphocyte function. Here we propose that these ideas do not genuinely reflect the organization of immune responses and that they bias our view of immunity as well as our teaching of immunology. Indeed, the level of specificity and mode of signaling integration used by the main cellular participants in the adaptive and innate immune systems are more similar than previously appreciated.	Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Vivier, E (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, Campus Luminy,Case 906, F-13288 Marseille 09, France.	vivier@ciml.univ-mrs.fr; bernardm@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010; Malissen, Bernard/AAK-4659-2020	Vivier, Eric/0000-0001-7022-8287; Malissen, Bernard/0000-0003-1340-9342				Aoki N, 2000, J IMMUNOL, V165, P3790, DOI 10.4049/jimmunol.165.7.3790; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doucey MA, 2003, J BIOL CHEM, V278, P26983, DOI 10.1074/jbc.M302709200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Olcese L, 1997, J IMMUNOL, V158, P5083; Orwell G., 1945, ANIMAL FARM; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Poe J C, 2001, Int Rev Immunol, V20, P739, DOI 10.3109/08830180109045588; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Renard V, 1997, IMMUNOL REV, V155, P205, DOI 10.1111/j.1600-065X.1997.tb00953.x; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Vely F, 1997, J IMMUNOL, V159, P2075; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Vivier E, 2002, SCIENCE, V296, P1248, DOI 10.1126/science.1072447; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; Zinkernagel RM, 2002, IMMUNOL REV, V185, P103, DOI 10.1034/j.1600-065X.2002.18511.x	61	114	119	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					17	21		10.1038/ni1153	http://dx.doi.org/10.1038/ni1153			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611777	Green Published			2022-12-18	WOS:000225888500013
J	Garg, S; Oran, A; Wajchman, J; Sasaki, S; Maris, CH; Kapp, JA; Jacob, J				Garg, S; Oran, A; Wajchman, J; Sasaki, S; Maris, CH; Kapp, JA; Jacob, J			Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo	NATURE IMMUNOLOGY			English	Article							LANGERHANS CELLS; LYMPH-NODES; IMMUNE-RESPONSES; LIFE-SPAN; EXPRESSION; DNA; IMMUNIZATION; TISSUE; GALACTOSIDASE; ENHANCEMENT	Dendritic cells (DCs) are key regulators of immune responses that activate naive antigen-specific T lymphocytes. In draining lymph nodes, antigen-bearing DCs are reported to be rare and short-lived. How such small numbers of short-lived DCs can activate rare antigen-specific T cells is unclear. Here we show that after immunization of mouse skins by gene gun, the number of antigen-bearing DCs that migrate to draining lymph node is 100-fold higher than previously estimated and that they persist for approximately 2 weeks. The substantial frequency and longevity of DCs in situ ensures ample antigen presentation and stimulation for the rare antigen-specific T cells in draining lymph nodes.	Emory Univ, Yerkes Reg Primate Res Ctr, Vaccine Res Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; Natl Inst Infect Dis, Leprosy Res Ctr, Dept Bioregulat, Tokyo 1820002, Japan	Emory University; Emory University; National Institute of Infectious Diseases (NIID)	Jacob, J (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Vaccine Res Ctr, Dept Microbiol & Immunol, 954 Gatewood Rd, Atlanta, GA 30322 USA.				NATIONAL EYE INSTITUTE [P30EY006360, F32EY006985, R01EY013459] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY06985, P30 EYO06360, EY13459] Funding Source: Medline; NIAID NIH HHS [AI R01524751] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bouloc A, 1999, EUR J IMMUNOL, V29, P446, DOI 10.1002/(SICI)1521-4141(199902)29:02<446::AID-IMMU446>3.0.CO;2-A; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Nopora A, 2002, J IMMUNOL, V169, P3006, DOI 10.4049/jimmunol.169.6.3006; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Ruedl C, 2001, J IMMUNOL, V166, P7178, DOI 10.4049/jimmunol.166.12.7178; Sasaki S, 2001, NAT BIOTECHNOL, V19, P543, DOI 10.1038/89289; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STINGL G, 1990, DERMATOL CLIN, V8, P673; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Torres CAT, 1997, J IMMUNOL, V158, P4529; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Williams IR, 1997, J IMMUNOL, V159, P3044; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	36	114	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					907	912		10.1038/ni962	http://dx.doi.org/10.1038/ni962			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12910266				2022-12-18	WOS:000185002200018
J	Piccolo, V; Curina, A; Genua, M; Ghisletti, S; Simonatto, M; Sabo, A; Amati, B; Ostuni, R; Natoli, G				Piccolo, Viviana; Curina, Alessia; Genua, Marco; Ghisletti, Serena; Simonatto, Marta; Sabo, Arianna; Amati, Bruno; Ostuni, Renato; Natoli, Gioacchino			Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk	NATURE IMMUNOLOGY			English	Article							ACTIVATION; DIVERSITY; MECHANISM; ENHANCERS; IMMUNITY; REVEALS	Stimulation of macrophages with interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) triggers distinct and opposing activation programs. During mixed infections or cancer, macrophages are often exposed to both cytokines, but how these two programs influence each other remains unclear. We found that IFN-gamma and IL-4 mutually inhibited the epigenomic and transcriptional changes induced by each cytokine alone. Computational and functional analyses revealed the genomic bases for gene-specific cross-repression. For instance, while binding motifs for the transcription factors STAT1 and IRF1 were associated with robust and IL-4-resistant responses to IFN-gamma, their coexistence with binding sites for auxiliary transcription factors such as AP-1 generated vulnerability to IL-4-mediated inhibition. These data provide a core mechanistic framework for the integration of signals that control macrophage activation in complex environmental conditions.	[Piccolo, Viviana; Curina, Alessia; Amati, Bruno; Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Genua, Marco; Ostuni, Renato] IRCCS San Raffaele Sci Inst, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Ghisletti, Serena; Simonatto, Marta] Humanitas Clin & Res Ctr, Milan, Italy; [Sabo, Arianna; Amati, Bruno] Fdn Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Milan, Italy; [Natoli, Gioacchino] Humanitas Univ, Sch Med, Dept Biomed Sci, Milan, Italy	IRCCS European Institute of Oncology (IEO); Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Humanitas University	Natoli, G (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.; Ostuni, R (corresponding author), IRCCS San Raffaele Sci Inst, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy, Milan, Italy.; Natoli, G (corresponding author), Humanitas Univ, Sch Med, Dept Biomed Sci, Milan, Italy.	ostuni.renato@hsr.it; gioacchino.natoli@hunimed.eu	Natoli, gioacchino/ABB-8679-2020; Ghisletti, Serena/AAO-6437-2021; Sabò, Arianna/J-9531-2018; Genua, Marco/J-4159-2018; Amati, Bruno/AAM-3418-2020; Simonatto, Marta/AAW-3042-2020; Natoli, gioacchino/J-2100-2018	Sabò, Arianna/0000-0002-9542-0045; Genua, Marco/0000-0002-0764-8163; Simonatto, Marta/0000-0002-3617-4278; Amati, Bruno/0000-0002-2958-1799; Natoli, Gioacchino/0000-0003-0711-2411; Ghisletti, Serena/0000-0002-7087-5553	European Research Council; Italian Ministry of University and Research [FIRB RBAP11H2R9]; Telethon Foundation [TGT16F04]; Cariplo Foundation [2015-0990]; Italian Association for Research on Cancer	European Research Council(European Research Council (ERC)European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro)	We thank Silvia Monticelli for critical feedback on the manuscript; L. Rotta, T. Capra and S. Bianchi for the preparation and processing of the sequencing libraries; F. Cilenti for help with immunofluorescence experiments; I. Amit (Weizmann Institute) for the shRNA vectors targeting Junb and Cebpb; and D. Voehringer (University Hospital Erlangen, Germany for the Stat6-/- bone marrow cells. Supported by the European Research Council (Advanced ERC grant to G.N.), the Italian Ministry of University and Research (FIRB RBAP11H2R9 to G.N.), the Telethon Foundation (SR-Tiget Grant Award TGT16F04 to R.O.), the Cariplo Foundation (Giovani Ricercatori, 2015-0990 to R.O.) and the Italian Association for Research on Cancer (B.A.).	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	30	113	117	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					530	540		10.1038/ni.3710	http://dx.doi.org/10.1038/ni.3710			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28288101	Green Accepted			2022-12-18	WOS:000399378700010
J	Klein, RS; Garber, C; Howard, N				Klein, Robyn S.; Garber, Charise; Howard, Nicole			Infectious immunity in the central nervous system and brain function	NATURE IMMUNOLOGY			English	Review							WEST-NILE-VIRUS; HERPES-SIMPLEX ENCEPHALITIS; NECROSIS-FACTOR-ALPHA; LONG-TERM POTENTIATION; CEREBROSPINAL-FLUID; TOXOPLASMA-GONDII; INTERFERON-GAMMA; TNF-ALPHA; HIPPOCAMPAL NEUROGENESIS; CRYPTOCOCCAL MENINGITIS	Inflammation is emerging as a critical mechanism underlying neurological disorders of various etiologies, yet its role in altering brain function as a consequence of neuroinfectious disease remains unclear. Although acute alterations in mental status due to inflammation are a hallmark of central nervous system (CNS) infections with neurotropic pathogens, post-infectious neurologic dysfunction has traditionally been attributed to irreversible damage caused by the pathogens themselves. More recently, studies indicate that pathogen eradication within the CNS may require immune responses that interfere with neural cell function and communication without affecting their survival. In this Review we explore inflammatory processes underlying neurological impairments caused by CNS infection and discuss their potential links to established mechanisms of psychiatric and neurodegenerative diseases.	[Klein, Robyn S.; Garber, Charise; Howard, Nicole] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA; [Howard, Nicole] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA.	rklein@wustl.edu			US National Institutes of Health [T32 HL007317, R01 NS052632, P01 NS059560, R01 AI126909, R21A1114549, U19 A1083019]; National Multiple Sclerosis society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126909, R21AI114549, R01AI101400, U19AI083019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS059560, R01NS052632, UH2NS100126] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis society(National Multiple Sclerosis Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Williams for critical reading of the manuscript. Funding for this research was provided by the US National Institutes of Health grants T32 HL007317 (N.H.), R01 NS052632, P01 NS059560, R01 AI126909, R21A1114549 and U19 A1083019 (R.S.K.) and a grant from the National Multiple Sclerosis society (R.S.K.).	Ali M, 2005, AM J NEURORADIOL, V26, P289; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Armangue T, 2015, NEUROLOGY, V85, P1736, DOI 10.1212/WNL.0000000000002125; Aurangzeb S, 2008, JCPSP-J COLL PHYSICI, V18, P27, DOI 01.2008/JCPSP.2730; Aydin N, 2016, NEUROSCI LETT, V630, P93, DOI 10.1016/j.neulet.2016.07.013; Banerjee A, 2010, CELL MICROBIOL, V12, P1576, DOI 10.1111/j.1462-5822.2010.01490.x; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barichello T, 2015, CURR NEUROVASC RES, V12, P253, DOI 10.2174/1567202612666150605122200; Beatman EL, 2016, J VIROL, V90, P2767, DOI 10.1128/JVI.02949-15; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Blanchard N, 2015, PARASITE IMMUNOL, V37, P150, DOI 10.1111/pim.12173; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Bloomfield PS, 2016, AM J PSYCHIAT, V173, P44, DOI 10.1176/appi.ajp.2015.14101358; Bradshaw MJ, 2016, NEUROTHERAPEUTICS, V13, P493, DOI 10.1007/s13311-016-0433-7; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Browne TC, 2013, J IMMUNOL, V190, P2241, DOI 10.4049/jimmunol.1200947; Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Chen ZG, 2013, BRAIN BEHAV IMMUN, V30, P45, DOI 10.1016/j.bbi.2013.01.083; Cherian A, 2011, AFR HEALTH SCI, V11, P116; Chien CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151569; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13; Clarkson BD, 2015, J IMMUNOL, V194, P531, DOI 10.4049/jimmunol.1401320; Cooley ID, 2014, GLIA, V62, P818, DOI 10.1002/glia.22644; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Cutando L, 2013, J CLIN INVEST, V123, P2816, DOI 10.1172/JCI67569; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; David CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005643; De Lucia C, 2016, BRAIN BEHAV IMMUN, V55, P179, DOI 10.1016/j.bbi.2015.11.001; De Tiege X, 2003, NEUROLOGY, V61, P241, DOI 10.1212/01.WNL.0000073985.71759.7C; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Durrant DM, 2014, J IMMUNOL, V193, P4095, DOI 10.4049/jimmunol.1401192; Eells JB, 2012, J MOL NEUROSCI, V46, P545, DOI 10.1007/s12031-011-9642-z; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; ERNST JD, 1984, INFECT IMMUN, V46, P81, DOI 10.1128/IAI.46.1.81-86.1984; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Espinosa-Oliva AM, 2014, NEUROTOXICOLOGY, V41, P89, DOI 10.1016/j.neuro.2014.01.006; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Garcia MN, 2014, VIRAL IMMUNOL, V27, P327, DOI 10.1089/vim.2014.0035; Garg RK, 1999, POSTGRAD MED J, V75, P133, DOI 10.1136/pgmj.75.881.133; Geldhoff M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-358; Gerber J, 2010, CURR OPIN NEUROL, V23, P312, DOI 10.1097/WCO.0b013e32833950dd; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Grindborg O, 2015, CLIN MICROBIOL INFEC, V21, P560, DOI 10.1016/j.cmi.2015.02.023; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo M, 2016, FOODBORNE PATHOG DIS, V13, P109, DOI 10.1089/fpd.2015.2070; Gupta K, 2016, J PEDIATR NEUROSCI, V11, P46, DOI 10.4103/1817-1745.181244; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Hamdani N, 2015, J AFFECT DISORDERS, V179, P161, DOI 10.1016/j.jad.2015.03.038; Harden LM, 2015, BRAIN BEHAV IMMUN, V50, P322, DOI 10.1016/j.bbi.2015.07.012; Hikita Norikatsu, 2015, Osaka City Med J, V61, P63; Hoffmann M, 2009, J ALZHEIMERS DIS, V16, P517, DOI 10.3233/JAD-2009-0985; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hoyo-Becerra C, 2014, BRAIN BEHAV IMMUN, V42, P222, DOI 10.1016/j.bbi.2014.06.200; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Iliff Jeffrey J, 2012, Sci Transl Med, V4, p147ra111, DOI 10.1126/scitranslmed.3003748; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Jarvis JN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004754; Jarvis JN, 2013, J INFECT DIS, V207, P1817, DOI 10.1093/infdis/jit099; John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kashyap RS, 2010, NEUROIMMUNOMODULAT, V17, P333, DOI 10.1159/000292023; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim BJ, 2015, J CLIN INVEST, V125, P2473, DOI 10.1172/JCI74159; Kipp M, 2008, J MOL NEUROSCI, V35, P235, DOI 10.1007/s12031-008-9057-7; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kreutzfeldt M, 2013, J EXP MED, V210, P2087, DOI 10.1084/jem.20122143; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lai AY, 2011, NEURON GLIA BIOL, V7, P5, DOI 10.1017/S1740925X12000154; Lallier SW, 2016, NEUROREPORT, V27, P1120, DOI 10.1097/WNR.0000000000000665; Landrith TA, 2015, SEMIN IMMUNOPATHOL, V37, P261, DOI 10.1007/s00281-015-0487-3; LAURITSEN A, 1995, SCAND J INFECT DIS, V27, P431, DOI 10.3109/00365549509047040; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; LEE SC, 1994, J EXP MED, V180, P365, DOI 10.1084/jem.180.1.365; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leypoldt F, 2015, ANN NY ACAD SCI, V1338, P94, DOI 10.1111/nyas.12553; Leypoldt F, 2013, NEUROLOGY, V81, P1637, DOI 10.1212/WNL.0b013e3182a9f531; Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010; Liang CC, 2004, J MED VIROL, V74, P597, DOI 10.1002/jmv.20216; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Liu ZJ, 2013, NEUROL RES, V35, P755, DOI 10.1179/016164113X13703372991516; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mahmoudvand H, 2016, INFLAMMATION, V39, P405, DOI 10.1007/s10753-015-0262-6; Malone KE, 2008, GLIA, V56, P426, DOI 10.1002/glia.20625; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Mettenleiter TC, 2016, J MOL BIOL, V428, P1949, DOI 10.1016/j.jmb.2015.10.001; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Mikasova L, 2012, BRAIN, V135, P1606, DOI 10.1093/brain/aws092; Mildner A, 2008, J IMMUNOL, V181, P2713, DOI 10.4049/jimmunol.181.4.2713; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; Morga E, 1998, J NEUROIMMUNOL, V87, P179, DOI 10.1016/S0165-5728(98)00099-X; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; ODA Y, 1987, J COMP NEUROL, V256, P299, DOI 10.1002/cne.902560209; Panackal AA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004884; Papageorgiou IE, 2016, P NATL ACAD SCI USA, V113, P212, DOI 10.1073/pnas.1513853113; Park KH, 2014, KOREAN J INTERN MED, V29, P793, DOI 10.3904/kjim.2014.29.6.793; Parlog A, 2015, PARASITE IMMUNOL, V37, P159, DOI 10.1111/pim.12157; PELC S, 1981, J NEUROL SCI, V49, P223, DOI 10.1016/0022-510X(81)90080-0; Pettigrew LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154721; Planaguma J, 2015, BRAIN, V138, P94, DOI 10.1093/brain/awu310; Poirotte C, 2016, CURR BIOL, V26, pR98, DOI 10.1016/j.cub.2015.12.020; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Prajapati P, 2015, BBA-MOL BASIS DIS, V1852, P451, DOI 10.1016/j.bbadis.2014.11.019; Prieto GA, 2015, P NATL ACAD SCI USA, V112, pE5078, DOI 10.1073/pnas.1514486112; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Quintana E, 2015, GLIA, V63, P2231, DOI 10.1002/glia.22889; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Riazi K, 2015, J NEUROSCI, V35, P4942, DOI 10.1523/JNEUROSCI.4485-14.2015; Robinson K, 2004, CELL MICROBIOL, V6, P927, DOI 10.1111/j.1462-5822.2004.00410.x; Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939; Schitine C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00076; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schmidt AK, 2015, J NEUROPATH EXP NEUR, V74, P85, DOI 10.1097/NEN.0000000000000152; Schneider H, 2012, VIRUS RES, V170, P66, DOI 10.1016/j.virusres.2012.08.019; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080; Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010; SKOLDENBERG B, 1984, LANCET, V2, P707; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Stahl JP, 2012, EPIDEMIOL INFECT, V140, P372, DOI 10.1017/S0950268811000483; Steinemann A, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00016; Steinmann U, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-31; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stojakovic A., 2016, MOL NEUROBIOL; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ueno N, 2015, CURR OPIN MICROBIOL, V26, P53, DOI 10.1016/j.mib.2015.05.006; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Vlkolinsky R, 2004, J NEUROIMMUNOL, V150, P37, DOI 10.1016/j.jneuroim.2004.01.011; Vu K, 2013, INFECT IMMUN, V81, P3139, DOI 10.1128/IAI.00554-13; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WAAGE A, 1989, J EXP MED, V170, P1859, DOI 10.1084/jem.170.6.1859; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wall AM, 2015, J NEUROSCI RES, V93, P815, DOI 10.1002/jnr.23540; Wang CY, 2015, J GEN VIROL, V96, P3010, DOI 10.1099/jgv.0.000235; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei YM, 2012, WORLD J GASTROENTERO, V18, P5276, DOI 10.3748/wjg.v18.i37.5276; Wen J, 2015, J AUTOIMMUN, V60, P40, DOI 10.1016/j.jaut.2015.03.005; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Williams JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00154; Winkler F, 2001, J INFECT DIS, V183, P1749, DOI 10.1086/320730; Wippel C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003380; Woollacott IOC, 2016, J NEUROCHEM, V138, P6, DOI 10.1111/jnc.13654; Wu MD, 2013, BRAIN BEHAV IMMUN, V32, P9, DOI 10.1016/j.bbi.2013.03.003; Wu Y, 2014, BIOCHEM BIOPH RES CO, V449, P502, DOI 10.1016/j.bbrc.2014.05.025; Yang CS, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-27; Zheng LS, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.015	177	113	116	4	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					132	141		10.1038/ni.3656	http://dx.doi.org/10.1038/ni.3656			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28092376	Green Accepted			2022-12-18	WOS:000392360900004
J	Fischer, A; Hacein-Bey-Abina, S; Cavazzana-Calvo, M				Fischer, Alain; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina			20 years of gene therapy for SCID	NATURE IMMUNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LENTIVIRAL VECTOR; CANCER; DISEASE; TRIALS; RECONSTITUTION; LYMPHOCYTES; DEFICIENCY; DOUBTS; CELLS		[Fischer, Alain; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina] INSERM, Paris, France; [Fischer, Alain; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina] Paris Descartes Univ, Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol Pediat, Paris, France; [Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, AP HP, Ctr Invest Clin Integre Biotherapies, Dept Biotherapy, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fischer, A (corresponding author), INSERM, Paris, France.	alain.fischer@inserm.fr		Cavazzana, Marina/0000-0002-0264-0891				Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Check E, 2005, NATURE, V433, P561, DOI 10.1038/433561a; Check E, 2003, NATURE, V423, P573, DOI 10.1038/423573a; Check E, 2004, NATURE, V429, P587, DOI 10.1038/429587a; Check E, 2003, NATURE, V422, P7, DOI 10.1038/422007a; Check E, 2003, NATURE, V421, P678, DOI 10.1038/421678b; Check E, 2003, NATURE, V421, P305, DOI 10.1038/421305a; Check E, 2002, NATURE, V420, P735, DOI 10.1038/420735b; Check E, 2002, NATURE, V420, P595, DOI 10.1038/420595b; Check E, 2002, NATURE, V419, P545, DOI 10.1038/419545a; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GATTI RA, 1968, LANCET, V2, P1366; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; WANG GP, 2010, BLOOD           0312	30	113	115	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					457	460		10.1038/ni0610-457	http://dx.doi.org/10.1038/ni0610-457			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485269				2022-12-18	WOS:000277821300002
J	Hewitt, SL; Yin, B; Ji, YH; Chaumeil, JK; Marszalek, K; Tenthorey, J; Salvagiotto, G; Steinel, N; Ramsey, LB; Ghysdael, J; Farrar, MA; Sleckman, BP; Schatz, DG; Busslinger, M; Bassing, CH; Skok, JA				Hewitt, Susannah L.; Yin, Bu; Ji, Yanhong; Chaumeil, Julie; Marszalek, Katarzyna; Tenthorey, Jeannette; Salvagiotto, Giorgia; Steinel, Natalie; Ramsey, Laura B.; Ghysdael, Jacques; Farrar, Michael A.; Sleckman, Barry P.; Schatz, David G.; Busslinger, Meinrad; Bassing, Craig H.; Skok, Jane A.			RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci	NATURE IMMUNOLOGY			English	Article							B-CELL-DEVELOPMENT; HEAVY-CHAIN LOCUS; V(D)J RECOMBINATION; X-INACTIVATION; HISTONE H2AX; ALLELIC EXCLUSION; DEFICIENT MICE; ACTIVE-SITE; IGH LOCUS; GENE	Coordinated recombination of homologous antigen receptor loci is thought to be important for allelic exclusion. Here we show that homologous immunoglobulin alleles pair in a stage-specific way that mirrors the recombination patterns of these loci. The frequency of homologous immunoglobulin pairing was much lower in the absence of the RAG-1-RAG-2 recombinase and was restored in Rag1(-/-) developing B cells with a transgene expressing a RAG-1 active-site mutant that supported DNA binding but not cleavage. The introduction of DNA breaks on one immunoglobulin allele induced ATM-dependent repositioning of the other allele to pericentromeric heterochromatin. ATM activated by the cleaved allele acts in trans on the uncleaved allele to prevent biallelic recombination and chromosome breaks or translocations.	[Hewitt, Susannah L.; Chaumeil, Julie; Marszalek, Katarzyna; Tenthorey, Jeannette; Skok, Jane A.] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Yin, Bu; Steinel, Natalie; Bassing, Craig H.] Univ Penn, Sch Med, Abramson Family Canc Res Inst,Childrens Hosp Phil, Dept Pathol & Lab Med,Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Ji, Yanhong; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Salvagiotto, Giorgia; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Ramsey, Laura B.; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Ghysdael, Jacques] Ctr Univ Orsay, Inst Curie, CNRS, UMR 146, F-91405 Orsay, France; [Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, Div Infect & Immun, London, England	New York University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Washington University (WUSTL); Howard Hughes Medical Institute; Yale University; University of London; University College London	Skok, JA (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	jane.skok@med.nyu.edu	Yin, Bu/A-2327-2011; Steinel, Natalie C/R-3682-2018; Busslinger, Meinrad J./J-1249-2016; GHYSDAEL, Jacques/F-3377-2013; Ramsey, Laura/ABD-6113-2020; Farrar, Michael A/M-7802-2013; Skok, Jane/ABF-7249-2020; Schatz, David/A-6748-2013	Busslinger, Meinrad J./0000-0002-9111-9351; Ramsey, Laura/0000-0001-6417-3961; Skok, Jane/0000-0002-4145-1516; Schatz, David/0000-0002-5669-1176; Farrar, Michael/0000-0002-5569-0366; Steinel, Natalie/0000-0002-7585-8402; CHAUMEIL, Julie/0000-0002-8976-2890	Wellcome Trust [085096]; New York University School of Medicine; US National Institutes of Health [R37 AI32524, R01 GM086852A, R01 CA125195, RO1 AI050737]; Pew Scholars Program; Cancer Research Institute; Boehringer Ingelheim; Genome Research in Austria; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524, R01AI050737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); New York University School of Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Cancer Research Institute; Boehringer Ingelheim(Boehringer Ingelheim); Genome Research in Austria; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Nussenzweig (Rockefeller University) for BAC HG and members of the Skok lab for critical reading of this manuscript. Supported by the Wellcome Trust (085096 to J.A.S.), the New York University School of Medicine (J.A.S.), the US National Institutes of Health (R37 AI32524 to D. G. S.; R01 GM086852A to J.A.S.; R01 CA125195 to C. H. B.; and RO1 AI050737 to M. A. F.), the Pew Scholars Program (C. H. B. and M. A. F.), the Cancer Research Institute (M. A. F.), the Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology (B.Y.), Boehringer Ingelheim (M. B.), Genome Research in Austria (M. B.) and the Howard Hughes Medical Institute (D. G. S.).	ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; CAMPBELL R, 1989, STAT BIOL, P107; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chowdhury D, 2004, CURR OPIN IMMUNOL, V16, P235, DOI 10.1016/j.coi.2004.02.003; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Joliot V, 2006, ONCOGENE, V25, P4573, DOI 10.1038/sj.onc.1209480; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Li FB, 2009, J EXP MED, V206, P153, DOI 10.1084/jem.20081202; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Will WM, 2006, J IMMUNOL, V176, P3350, DOI 10.4049/jimmunol.176.6.3350; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yin B, 2008, IMMUNOL RES, V42, P29, DOI 10.1007/s12026-008-8030-4; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	49	113	118	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					655	U131		10.1038/ni.1735	http://dx.doi.org/10.1038/ni.1735			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448632	Green Accepted			2022-12-18	WOS:000266384100018
J	Scheu, S; Stetson, DB; Reinhardt, RL; Leber, JH; Mohrs, M; Locksley, RM				Scheu, Stefanie; Stetson, Daniel B.; Reinhardt, R. Lee; Leber, Jess H.; Mohrs, Markus; Locksley, Richard M.			Activation of the integrated stress response during T helper cell differentiation	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; RIBOSOME ENTRY SITES; TRANSLATION INITIATION; MESSENGER-RNAS; MAMMALIAN-CELLS; MEDIATED TRANSLATION; GENE-EXPRESSION; IN-VIVO; EIF2-ALPHA; KINASE	Adaptive immune responses require clonal expansion and differentiation of naive T cells into cytokine-secreting effector cells. After priming via signals through the T cell receptor, naive T helper cells express cytokine mRNA but do not secrete cytokine protein without additional T cell receptor stimulation. Here we show that primed T cells demonstrated phosphorylation of eukaryotic initiation factor 2-alpha (eIF2 alpha), a 'collapsed' polysome profile, increased expression of stress-response genes and accumulation of cytoplasmic granules associated with RNA-binding proteins, all features of the integrated stress response. Restimulation of the cells resulted in rapid eIF2 alpha dephosphorylation, ribosomal mRNA loading and cytokine secretion. Interference with the function of granule-associated proteins or accumulation of phosphorylated eIF2 alpha enhanced release of interleukin 4 during T helper type 2 priming. Therefore, T lymphocytes require components of the integrated stress response to uncouple differentiation from the execution of effector functions.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Trudeau Institute	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Scheu, Stefanie/H-3670-2019	Scheu, Stefanie/0000-0002-9707-8191	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056385, P01HL056385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56385] Funding Source: Medline; NIAID NIH HHS [AI30663] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson P, 2002, J CELL SCI, V115, P3227; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bertolotti A, 2001, J CELL SCI, V114, P3207; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Fernandez J, 2005, MOL CELL, V17, P405, DOI 10.1016/j.molcel.2004.12.024; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	47	113	116	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					644	651		10.1038/ni1338	http://dx.doi.org/10.1038/ni1338			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16680145				2022-12-18	WOS:000237751200020
J	Roncagalli, R; Taylor, JER; Zhang, SH; Shi, XC; Chen, RY; Cruz-Munoz, ME; Yin, L; Latour, S; Veillette, A				Roncagalli, R; Taylor, JER; Zhang, SH; Shi, XC; Chen, RY; Cruz-Munoz, ME; Yin, L; Latour, S; Veillette, A			Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor	NATURE IMMUNOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; PROTEIN-TYROSINE-PHOSPHATASE; SH2 DOMAIN; SIGNAL-TRANSDUCTION; CUTTING EDGE; INHIBITORY RECEPTOR; IMMUNE REGULATION; ENCODING GENE; SLAM FAMILY; 2B4 CD244	EAT-2 is an adaptor expressed in innate immune cells, including natural killer (NK) cells. It is closely related to the adaptor SAP, which regulates signaling lymphocyte activation molecule (SLAM)- related receptors by recruiting the kinase FynT to the receptors. Here we have studied the function of EAT-2 in NK cells by creating mice lacking or overexpressing EAT-2. Like SAP, EAT-2 was associated with the SLAM-related receptor 2B4 in NK cells. However, unlike SAP, EAT-2 was an inhibitor of NK cell function. EAT-2 repressed natural cytotoxicity and interferon-gamma secretion by a mechanism involving tyrosine phosphorylation of its C terminus. We have demonstrated a similar function for the adaptor ERT, a newly identified SAP family member expressed in mouse NK cells. These data identify a previously unknown mechanism of NK cell inhibition. Moreover, they indicate that EAT-2 and SAP have distinct and at times opposing functions in natural immunity.	Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Program Mol Biol, Montreal, PQ H2W 1R7, Canada; Int Agcy Res Canc, F-69372 Lyon, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; World Health Organization; International Agency for Research on Cancer (IARC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca	Roncagalli, Romain/ABB-8786-2020; Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391; Roncagalli, Romain/0000-0001-7554-0552				Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latchman Y, 1998, J IMMUNOL, V161, P5809; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MATHEW PA, 1993, J IMMUNOL, V151, P5328; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Thompson AD, 1996, ONCOGENE, V13, P2649; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2004, J EXP MED, V199, P1175, DOI 10.1084/jem.20040588; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478	39	113	119	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1002	1010		10.1038/ni1242	http://dx.doi.org/10.1038/ni1242			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16127454				2022-12-18	WOS:000232027200019
J	Yachi, PP; Ampudia, J; Gascoigne, NRJ; Zal, T				Yachi, PP; Ampudia, J; Gascoigne, NRJ; Zal, T			Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; SUPRAMOLECULAR ACTIVATION CLUSTERS; THYMOCYTE POSITIVE SELECTION; CD8(+) T-CELLS; PHYSICAL ASSOCIATION; LYMPHOCYTES-T; LIGAND RECOGNITION; PRESENTING CELLS; CD4; BINDING	It is unclear if the interaction between CD8 and the T cell receptor (TCR)-CD3 complex is constitutive or antigen induced. Here, fluorescence resonance energy transfer microscopy between fluorescent chimeras of CD3 zeta and CD8 beta showed that this interaction was induced by antigen recognition in the immunological synapse. Nonstimulatory endogenous or exogenous peptides presented simultaneously with antigenic peptides increased the CD8-TCR interaction. This finding indicates that the interaction between the intracellular regions of a TCR-CD3 complex recognizing its cognate peptide-major histocompatibility complex (MHC) antigen, and CD8 ( plus the kinase Lck), is enhanced by a noncognate CD8-MHC interaction. Thus, the interaction of CD8 with a nonstimulatory peptide-MHC complex helps mediate T cell recognition of antigen, improving the coreceptor function of CD8.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol, IMM1, La Jolla, CA 92037 USA.	gascoigne@scripps.edu		Zal, Tomasz/0000-0002-3469-4261	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039476, R01GM065230, R01GM039476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290, T32 AI07290, T32 AI007244] Funding Source: Medline; NIDDK NIH HHS [R21 DK061329, DK61329] Funding Source: Medline; NIGMS NIH HHS [R01 GM039476, GM065230, GM039476, R01 GM065230] Funding Source: Medline; NIMH NIH HHS [P30 MH062261, P30MH62261] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; ANDERSON P, 1988, J IMMUNOL, V140, P1732; Anel A, 1997, J IMMUNOL, V158, P19; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; GALLAGHER PF, 1989, P NATL ACAD SCI USA, V86, P10044, DOI 10.1073/pnas.86.24.10044; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; GASCOIGNE NRJ, 2001, EXP REV MOL MED; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Holmberg K, 2003, J IMMUNOL, V171, P2427, DOI 10.4049/jimmunol.171.5.2427; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lim GEK, 1998, EUR J IMMUNOL, V28, P745, DOI 10.1002/(SICI)1521-4141(199802)28:02<745::AID-IMMU745>3.0.CO;2-6; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; Osono E, 1997, SCAND J IMMUNOL, V45, P487, DOI 10.1046/j.1365-3083.1997.d01-427.x; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; SUZUKI S, 1992, EUR J IMMUNOL, V22, P2475, DOI 10.1002/eji.1830221002; TAKADA S, 1987, J IMMUNOL, V139, P3231; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	49	113	116	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					785	792		10.1038/ni1220	http://dx.doi.org/10.1038/ni1220			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	15980863	Green Accepted			2022-12-18	WOS:000230646200019
J	Tewari, MK; Sinnathamby, G; Rajagopal, D; Eisenlohr, LC				Tewari, MK; Sinnathamby, G; Rajagopal, D; Eisenlohr, LC			A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent	NATURE IMMUNOLOGY			English	Article							COMPLEX CLASS-II; INVARIANT CHAIN; CROSS-PRESENTATION; DENDRITIC CELLS; T-CELLS; INFLUENZA HEMAGGLUTININ; ENDOGENOUS ANTIGEN; HLA-DM; MOLECULES; VIRUS	By convention, presentation of major histocompatibility complex (MHC) class I-restricted epitopes involves processing by cytosolic proteasomes, whereas MHC class II-restricted epitopes are generated by endosomal proteases. Here, we show that two MHC class II-restricted epitopes within influenza virus were generated by a proteasome- and TAP-dependent pathway that was accessed by exogenous virus in dendritic cells (DCs) but not cell types with less permeable endosomes. Both epitopes were presented by recycling MHC class II molecules. Challenging mice with influenza or vaccinia viruses demonstrated that a substantial portion of the MHC class II-restricted response was directed against proteasome- dependent epitopes. By complementing endosomal activities, this pathway broadens the array of MHC class II-restricted epitopes available for CD4(+) T cell activation.	Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Eisenlohr, LC (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, 233 S 10th St,BLSB 730, Philadelphia, PA 19107 USA.	L_Eisenlohr@mail.jci.tju.edu			NCI NIH HHS [T32-CA09683] Funding Source: Medline; NIAID NIH HHS [AI036331] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036331] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Chaturvedi P, 2000, INT IMMUNOL, V12, P757, DOI 10.1093/intimm/12.6.757; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Chianese-Bullock KA, 1998, J IMMUNOL, V161, P1599; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; DANG LH, 1993, J IMMUNOL, V150, P4206; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; EISENLOHR LC, 1988, J IMMUNOL, V141, P2581; EISENLOHR LC, 1989, J EXP MED, V169, P921, DOI 10.1084/jem.169.3.921; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HACKETT CJ, 1991, J VIROL, V65, P672, DOI 10.1128/JVI.65.2.672-676.1991; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; KIM KJ, 1979, J IMMUNOL, V122, P549; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; LAMB CA, 1992, J IMMUNOL, V148, P3478; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Lindner R, 1996, EMBO J, V15, P6910, DOI 10.1002/j.1460-2075.1996.tb01083.x; LINDSTEDT R, 1995, IMMUNITY, V3, P561, DOI 10.1016/1074-7613(95)90127-2; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Mukherjee P, 2001, J IMMUNOL, V167, P2632, DOI 10.4049/jimmunol.167.5.2632; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; OKADA CY, 1982, CELL, V29, P33, DOI 10.1016/0092-8674(82)90087-3; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Russell HI, 1999, EUR J IMMUNOL, V29, P905, DOI 10.1002/(SICI)1521-4141(199903)29:03<905::AID-IMMU905>3.0.CO;2-8; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; SETTE A, 1989, J IMMUNOL, V143, P1265; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Sinnathamby G, 2004, J IMMUNOL, V172, P6607, DOI 10.4049/jimmunol.172.11.6607; Sinnathamby G, 2003, J IMMUNOL, V170, P3504, DOI 10.4049/jimmunol.170.7.3504; Stryhn A, 1996, J IMMUNOL, V156, P4191; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	50	113	125	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					287	294		10.1038/ni1171	http://dx.doi.org/10.1038/ni1171			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15711549				2022-12-18	WOS:000227117400021
J	Suzuki, H; Matsuda, S; Terauchi, Y; Fujiwara, M; Ohteki, T; Asano, T; Behrens, TW; Kouro, T; Takatsu, K; Kadowaki, T; Koyasu, S				Suzuki, H; Matsuda, S; Terauchi, Y; Fujiwara, M; Ohteki, T; Asano, T; Behrens, TW; Kouro, T; Takatsu, K; Kadowaki, T; Koyasu, S			PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction	NATURE IMMUNOLOGY			English	Article							BRUTONS TYROSINE KINASE; FACTOR-KAPPA-B; PHOSPHOINOSITIDE 3-KINASE P85-ALPHA; PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; BCL-X; LYMPHOCYTE SURVIVAL; C-AKT; ACTIVATION; PROTEIN	Phosphoinositide-3 kinase (PI3K) is thought to activate the tyrosine kinase Btk. However, through analysis of PI3K(-/-) and Btk(-/-) mice, B cell antigen receptor (BCR)-induced activation of Btk in mouse B cells was found to be unaffected by PI3K inhibitors or by a lack of PI3K. Consistent with this observation, PI3K(-/-) Btk(-/-) double- deficient mice had more severe defects than either single-mutant mouse. NF-kappaB activation along with Bcl-x(L) and cyclin D2 induction were severely blocked in both PI3K(-/-) and Btk(-/-) single-deficient B cells. Transgenic expression of Bcl-x(L) restored the development and BCR-induced proliferation of B cells in PI3K(-/-) mice. Our results indicate that PI3K and Btk have unique roles in proximal BCR signaling and that they have a common target further downstream in the activation of NF-kappaB.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; Univ Minnesota, Ctr Immunol, Dept Med, Minneapolis, MN 55455 USA; Univ Tokyo, Inst Med Sci, Dept Immunol, Tokyo 1088639, Japan	Keio University; Japan Science & Technology Agency (JST); University of Tokyo; University of Minnesota System; University of Minnesota Twin Cities; University of Tokyo	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan.		Koyasu, Shigeo/J-5583-2015; Suzuki, Harumi/L-1271-2013; Terauchi, Yasuo/AAO-4347-2020	Koyasu, Shigeo/0000-0001-9585-3038; Suzuki, Harumi/0000-0003-3616-9361; Kouro, Taku/0000-0003-1526-575X				Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Buhl AM, 1999, J IMMUNOL, V162, P4438; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Coffer PJ, 1998, BIOCHEM J, V335, P1; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Forssell J, 2000, SCAND J IMMUNOL, V52, P30; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Gold MR, 1999, J IMMUNOL, V163, P1894; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Marshall AJ, 2000, IMMUNOL REV, V176, P30; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Solvason N, 1998, J EXP MED, V187, P1081, DOI 10.1084/jem.187.7.1081; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tarakhovsky A, 1997, CURR OPIN IMMUNOL, V9, P319, DOI 10.1016/S0952-7915(97)80076-3; Tedder Thomas F., 2000, Keio Journal of Medicine, V49, P1; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tsukada S, 2001, ADV IMMUNOL, V77, P123, DOI 10.1016/S0065-2776(01)77016-2; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983	49	113	115	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					280	286		10.1038/ni890	http://dx.doi.org/10.1038/ni890			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12563258				2022-12-18	WOS:000181201000018
J	Crowther, MD; Dotlon, G; Legut, M; Caillaud, ME; Lloyd, A; Attaf, M; Galloway, SAE; Rius, C; Farrell, CP; Szomolay, B; Ager, A; Parker, AL; Fuller, A; Donia, M; McCluskey, J; Rossjohn, J; Svane, IM; Phillips, JD; Sewell, AK				Crowther, Michael D.; Dotlon, Garry; Legut, Mateusz; Caillaud, Marine E.; Lloyd, Angharad; Attaf, Meriem; Galloway, Sarah A. E.; Rius, Cristina; Farrell, Colin P.; Szomolay, Barbara; Ager, Ann; Parker, Alan L.; Fuller, Anna; Donia, Marco; McCluskey, James; Rossjohn, Jamie; Svane, Inge Marie; Phillips, John D.; Sewell, Andrew K.			Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1	NATURE IMMUNOLOGY			English	Article							RECEPTOR HETEROGENEITY; IDENTIFICATION; RECOGNITION; ANTIGENS; POLYMORPHISM; EXPRESSION; SYSTEM; GENES	Human leukocyte antigen (HLA)-independent, T cell-mediated targeting of cancer cells would allow immune destruction of malignancies in all individuals. Here, we use genome-wide CRISPR-Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human cancer types via the monomorphic MHC class I-related protein, MR1, while remaining inert to noncancerous cells. Unlike mucosal-associated invariant T cells, recognition of target cells by the TCR was independent of bacterial loading. Furthermore, concentration-dependent addition of vitamin B-related metabolite ligands of MR1 reduced TCR recognition of cancer cells, suggesting that recognition occurred via sensing of the cancer metabolome. An MR1-restricted T cell clone mediated in vivo regression of leukemia and conferred enhanced survival of NSG mice. TCR transfer to T cells of patients enabled killing of autologous and nonautologous melanoma. These findings offer opportunities for HLA-independent, pan-cancer, pan-population immunotherapies. Identifying selective tumor-associated molecules that can act as targets for T cells is a major goal of immunotherapy. Sewell and colleagues demonstrate that the nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted by conventional T cells.	[Crowther, Michael D.; Dotlon, Garry; Legut, Mateusz; Caillaud, Marine E.; Lloyd, Angharad; Attaf, Meriem; Galloway, Sarah A. E.; Rius, Cristina; Szomolay, Barbara; Ager, Ann; Fuller, Anna; Rossjohn, Jamie; Sewell, Andrew K.] Cardiff Univ, Div Infect & Immun, Sch Med, Cardiff, Wales; [Farrell, Colin P.; Phillips, John D.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT USA; [Szomolay, Barbara; Ager, Ann; Rossjohn, Jamie; Sewell, Andrew K.] Cardiff Univ, Syst Immun Res Inst, Cardiff, Wales; [Parker, Alan L.] Cardiff Univ, Div Canc & Genet, Sch Med, Cardiff, Wales; [Donia, Marco; Svane, Inge Marie] Univ Copenhagen, Herlev Hosp, Ctr Canc Immune Therapy, Copenhagen, Denmark; [McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia	Cardiff University; Utah System of Higher Education; University of Utah; Cardiff University; Cardiff University; University of Copenhagen; Herlev & Gentofte Hospital; University of Melbourne; Monash University; Monash University; Monash University	Sewell, AK (corresponding author), Cardiff Univ, Div Infect & Immun, Sch Med, Cardiff, Wales.; Sewell, AK (corresponding author), Cardiff Univ, Syst Immun Res Inst, Cardiff, Wales.	sewellak@cardiff.ac.uk	McCluskey, James/A-1291-2007; Parker, Alan L/B-8187-2009; Sewell, Andrew/GPT-4220-2022; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Parker, Alan L/0000-0002-9302-1761; Sewell, Andrew/0000-0003-3194-3135; Svane, Inge Marie/0000-0002-9451-6037; Crowther, Michael Douglas/0000-0003-4765-2818; Legut, Mateusz/0000-0002-8810-6971; Donia, Marco/0000-0003-4966-9752; Ager, Ann/0000-0002-5763-8908; Galloway, Sarah/0000-0001-9869-0246; Fuller, Anna/0000-0002-8655-6741; Rius Rafael, Cristina/0000-0002-1896-1649; Caillaud, Marine/0000-0001-6636-5713; Szomolay, Barbara/0000-0002-5375-5533; Rossjohn, Jamie/0000-0002-2020-7522	Welsh Assembly Government via a Health and Care Research Wales PhD studentship [WT100327MA]; Wellcome Institutional Strategic Support Fund; Tenovus Cancer Care PhD studentship; National Health and Medical Research Council Australia [APP1113293]; BBSRC [BB/S002480/1] Funding Source: UKRI; MRC [MR/L008742/1] Funding Source: UKRI	Welsh Assembly Government via a Health and Care Research Wales PhD studentship; Wellcome Institutional Strategic Support Fund; Tenovus Cancer Care PhD studentship; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Zhang for deposition of the GeCKO v.2 library at the Addgene plasmid repository (Addgene plasmid no. 1000000048); D. Trono for the deposition of pRRL. sin.cppt.pgk-gfp.wpre (Addgene plasmid no. 12252), envelope plasmid pMD2.G (Addgene plasmid no. 12259), and packaging plasmids pMDLg/pRRE (Addgene plasmid no. 12251) and pRSV-Rev (Addgene plasmid no. 12253); and J. Riley, University of Pennsylvania, who kindly provided the pELNS vector. A.K.S. is a Welcome Senior Investigator (WT100327MA), M.D.C. was funded by the Welsh Assembly Government via a Health and Care Research Wales PhD studentship. M.L. is funded by a Consolidator Award via the Wellcome Institutional Strategic Support Fund to the Cardiff University College of Biomedical and Life Sciences. S.A.E.G. was funded by a Tenovus Cancer Care PhD studentship. J.M. was supported by Program Grant APP1113293 from the National Health and Medical Research Council Australia.	Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Eckle SBG, 2015, J BIOL CHEM, V290, P30204, DOI 10.1074/jbc.R115.685990; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gherardin NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22130-1; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Haney D, 2011, J IMMUNOL METHODS, V369, P33, DOI 10.1016/j.jim.2011.04.003; Hulin-Curtis Sarah L, 2018, Oncotarget, V9, P26328, DOI 10.18632/oncotarget.25242; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Lamichhane R, 2017, J IMMUNOL, V38, P42; Laugel B, 2016, J IMMUNOL, V197, P971, DOI 10.4049/jimmunol.1501402; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lion J, 2013, EUR J IMMUNOL, V43, P1363, DOI 10.1002/eji.201242461; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Maciocia PM, 2017, NAT MED, V23, P1416, DOI 10.1038/nm.4444; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Parra-Cuadrado JF, 2000, TISSUE ANTIGENS, V56, P170, DOI 10.1034/j.1399-0039.2000.560211.x; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seshadri C, 2017, GENES IMMUN, V18, P8, DOI 10.1038/gene.2016.41; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tungatt K, 2015, J IMMUNOL, V194, P463, DOI 10.4049/jimmunol.1401785; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wooldridge L, 2010, J IMMUNOL, V184, P3357, DOI 10.4049/jimmunol.0902398; Young MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053789	37	112	118	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					178	+		10.1038/s41590-019-0578-8	http://dx.doi.org/10.1038/s41590-019-0578-8		JAN 2020	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31959982	Green Accepted			2022-12-18	WOS:000508964100003
J	Baltimore, D				Baltimore, David			NF-kappa B is 25	NATURE IMMUNOLOGY			English	Review							RESPONSES; INDUCTION; MICE; CELL		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu						Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sen R, 2006, J IMMUNOL, V177, P7485; Sen R, 2011, NAT IMMUNOL, V12, P686, DOI 10.1038/ni.2071; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	15	112	114	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					683	685		10.1038/ni.2072	http://dx.doi.org/10.1038/ni.2072			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772275				2022-12-18	WOS:000292870700002
J	Ji, QY; Perchellet, A; Goverman, JM				Ji, Qingyong; Perchellet, Antoine; Goverman, Joan M.			Viral infection triggers central nervous system autoimmunity via activation of CD8(+) T cells expressing dual TCRs	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; EPSTEIN-BARR-VIRUS; RECEPTOR-ALPHA-CHAINS; MULTIPLE-SCLEROSIS; PERSISTENT INFECTION; ALLELIC EXCLUSION; CNS AUTOIMMUNITY; TRANSGENIC MICE; TOLERANCE; ENCEPHALOMYELITIS	Multiple sclerosis is an inflammatory, demyelinating, central nervous system disease mediated by myelin-specific T cells. Environmental triggers that cause the breakdown of myelin-specific T cell tolerance are unknown. Here we found that CD8(+) myelin basic protein (MBP)-specific T cell tolerance was broken and autoimmunity was induced by infection with a virus that did not express MBP cross-reactive epitopes and did not depend on bystander activation. Instead, the virus activated T cells expressing dual T cell antigen receptors (TCRs) that were able to recognize both MBP and viral antigens. Our results demonstrate the importance of dual TCR-expressing T cells in autoimmunity and suggest a mechanism by which a ubiquitous viral infection could trigger autoimmunity in a subset of infected people, as suggested by the etiology of multiple sclerosis.	[Ji, Qingyong; Perchellet, Antoine; Goverman, Joan M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Goverman, JM (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	goverman@u.washington.edu		Goverman, Joan/0000-0002-7361-9424	National Institutes of Health [AI07272737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Mausolf for animal husbandry and technical assistance and S. Lee and E. Pierson for critical comments on the manuscript. Supported by the National Institutes of Health (AI07272737 to J.M.G.).	Alam SM, 1998, J IMMUNOL, V160, P3883; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; BALOMENOS D, 1995, J IMMUNOL, V155, P3308; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Brabb T, 1997, J IMMUNOL, V159, P497; Cabbage SE, 2007, J IMMUNOL, V178, P887, DOI 10.4049/jimmunol.178.2.887; Cermelli C, 2000, VIRAL IMMUNOL, V13, P255, DOI 10.1089/08828240050144590; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; COOK SD, 1980, NEUROLOGY, V30, P80, DOI 10.1212/WNL.30.7_Part_2.80; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Croxford JL, 2006, EUR J IMMUNOL, V36, P2671, DOI 10.1002/eji.200635876; DAVODEAU F, 1995, J EXP MED, V181, P1391, DOI 10.1084/jem.181.4.1391; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Elliott EA, 1996, J CLIN INVEST, V98, P1602, DOI 10.1172/JCI118954; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Govermant Joan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P239, DOI 10.2174/1568010053586264; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HEATH WR, 1993, J EXP MED, V178, P1807, DOI 10.1084/jem.178.5.1807; Hosking Martin P., 2009, Current Immunology Reviews, V5, P267; Hurst SD, 1997, P NATL ACAD SCI USA, V94, P3920, DOI 10.1073/pnas.94.8.3920; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Mokhtarian F, 1999, J NEUROIMMUNOL, V95, P43, DOI 10.1016/S0165-5728(98)00254-9; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Olsen JK, 2001, J CLIN INVEST, V108, P311; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Teague RM, 2008, IMMUNITY, V28, P662, DOI 10.1016/j.immuni.2008.03.012; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Tsunoda I, 2005, J VIROL, V79, P14640, DOI 10.1128/JVI.79.23.14640-14646.2005; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200	50	112	118	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					628	U99		10.1038/ni.1888	http://dx.doi.org/10.1038/ni.1888			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20526343	Green Accepted			2022-12-18	WOS:000278926400019
J	Bolomini-Vittori, M; Montresor, A; Giagulli, C; Staunton, D; Rossi, B; Martinello, M; Constantin, G; Laudanna, C				Bolomini-Vittori, Matteo; Montresor, Alessio; Giagulli, Cinzia; Staunton, Donald; Rossi, Barbara; Martinello, Marianna; Constantin, Gabriela; Laudanna, Carlo			Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module	NATURE IMMUNOLOGY			English	Article							PHOSPHOLIPASE-D ACTIVITY; G-PROTEIN RHOA; CONFORMATIONAL-CHANGES; FUNCTIONAL MODULES; LYMPHOCYTE ARREST; INTERACTION SITES; BRAIN VENULES; AFFINITY; ADHESION; TALIN	Regulation of the affinity of the beta(2) integrin LFA-1 by chemokines is critical to lymphocyte trafficking, but the signaling mechanisms that control this process are not well understood. Here we investigated the signaling events controlling LFA-1 affinity triggering by chemokines in human primary T lymphocytes. We found that the small GTPase Rac1 mediated chemokine-induced LFA-1 affinity triggering and lymphocyte arrest in high endothelial venules. Unexpectedly, another Rho family member, Cdc42, negatively regulated LFA-1 activation. The Rho effectors PLD1 and PIP5KC were also critical to LFA-1 affinity modulation. Notably, PIP5KC was found to specifically control the transition of LFA-1 from an extended low-intermediate state to a high-affinity state, which correlated with lymphocyte arrest. Thus, chemokines control lymphocyte trafficking by triggering a Rho-dependent signaling cascade leading to conformer-specific modulation of LFA-1 affinity	[Bolomini-Vittori, Matteo; Montresor, Alessio; Giagulli, Cinzia; Rossi, Barbara; Martinello, Marianna; Constantin, Gabriela; Laudanna, Carlo] Univ Verona, Sch Med, Dept Pathol, Div Gen Pathol, I-37134 Verona, Italy; [Montresor, Alessio; Giagulli, Cinzia; Laudanna, Carlo] Univ Verona, Ctr Biomed Comp, I-37134 Verona, Italy; [Staunton, Donald] ICOS, Bothell, WA 98021 USA	University of Verona; University of Verona; Icos Corporation	Laudanna, C (corresponding author), Univ Verona, Sch Med, Dept Pathol, Div Gen Pathol, I-37134 Verona, Italy.	carlo.laudanna@univr.it	Bolomini-Vittori, Matteo/Q-5659-2016; Martinello, Marianna/AAE-3863-2021	Bolomini-Vittori, Matteo/0000-0002-5762-0791; Martinello, Marianna/0000-0001-9811-6308; ROSSI, Barbara/0000-0003-4711-1528; Constantin, Gabriela/0000-0001-8978-3539	Italian Association for Cancer Research; Italian Ministry of University and Scientific Research; Fondazione Cariverona (Verona, Italy); National Multiple Sclerosis Society of New York; Fondazione Italiana Sclerosi Multipla	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona (Verona, Italy)(Fondazione Cariverona); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM))	Supported by the Italian Association for Cancer Research, the Italian Ministry of University and Scientific Research, Fondazione Cariverona (Verona, Italy), the National Multiple Sclerosis Society of New York and Fondazione Italiana Sclerosi Multipla.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Bhalla US, 2001, NOVART FDN SYMP, V239, P4; BHALLA US, 2001, NOVART FDN SYMP, V239, P13; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cai SM, 2001, BIOCHEM J, V355, P779, DOI 10.1042/bj3550779; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Ambrosio D, 2002, J IMMUNOL, V169, P2303, DOI 10.4049/jimmunol.169.5.2303; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Henage LG, 2006, J BIOL CHEM, V281, P3408, DOI 10.1074/jbc.M508800200; Isenberg G, 1998, FEBS LETT, V426, P165, DOI 10.1016/S0014-5793(98)00336-6; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Pasvolsky R, 2008, J IMMUNOL, V180, P2815, DOI 10.4049/jimmunol.180.5.2815; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Piccio L, 2005, J IMMUNOL, V174, P5805, DOI 10.4049/jimmunol.174.9.5805; Powner DJ, 2002, FEBS LETT, V531, P62, DOI 10.1016/S0014-5793(02)03410-5; Prochiantz A, 1999, ANN NY ACAD SCI, V886, P172, DOI 10.1111/j.1749-6632.1999.tb09410.x; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhao XX, 2003, J BIOL CHEM, V278, P40788, DOI 10.1074/jbc.M302208200; Zigmond SH, 1998, J CELL BIOL, V142, P1001, DOI 10.1083/jcb.142.4.1001	53	112	115	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					185	194		10.1038/ni.1691	http://dx.doi.org/10.1038/ni.1691			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19136961				2022-12-18	WOS:000263178500012
J	Holst, J; Wang, HP; Eder, KD; Workman, CJ; Boyd, KL; Baquet, Z; Singh, H; Forbes, K; Chruscinski, A; Smeyne, R; van Oers, NSC; Utz, PJ; Vignali, DAA				Holst, Jeff; Wang, Haopeng; Eder, Kelly Durick; Workman, Creg J.; Boyd, Kelli L.; Baquet, Zachary; Singh, Harvir; Forbes, Karen; Chruscinski, Andrzej; Smeyne, Richard; van Oers, Nicolai S. C.; Utz, Paul J.; Vignali, Dario A. A.			Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IN-VIVO; TOLERANCE INDUCTION; THYMOCYTE SELECTION; POSITIVE SELECTION; RETROGENIC MICE; TCR SIGNAL; ZETA; PROTEIN; GENE	The T cell antigen receptor (TCR)-CD3 complex is unique in having ten cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs). The physiological importance of this high TCR ITAM number is unclear. Here we generated 25 groups of mice expressing various combinations of wild-type and mutant ITAMs in TCR-CD3 complexes. Mice with fewer than seven wild-type CD3 ITAMs developed a lethal, multiorgan autoimmune disease caused by a breakdown in central rather than peripheral tolerance. Although there was a linear correlation between the number of wild-type CD3 ITAMs and T cell proliferation, cytokine production was unaffected by ITAM number. Thus, high ITAM number provides scalable signaling that can modulate proliferation yet ensure effective negative selection and prevention of autoimmunity.	[Boyd, Kelli L.] St Jude Childrens Hosp, Anim Resource Ctr, Memphis, TN 38105 USA; [Baquet, Zachary; Smeyne, Richard] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Wang, Haopeng] Univ Tennessee, Hlth Sci Ctr, Interdisciplinary Program, Memphis, TN 38163 USA; [Vignali, Dario A. A.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN 38163 USA; [Singh, Harvir; Chruscinski, Andrzej; Utz, Paul J.] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Holst, Jeff; Wang, Haopeng; Eder, Kelly Durick; Workman, Creg J.; Forbes, Karen; Vignali, Dario A. A.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	Vignali, DAA (corresponding author), Univ Sydney, Gene & Stem Cell Therapy Program, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2042, Australia.	Dario.vignali@stjude.org	Wang, Haopeng/F-3263-2012; Van+Oers, Nicolai/ABA-2437-2021; Holst, Jeff/H-7634-2012	Holst, Jeff/0000-0002-0377-9318; Wang, Haopeng/0000-0002-4995-0838; van Oers, Nicolai/0000-0002-6545-8405; Smeyne, Richard/0000-0002-8459-5472	NCI NIH HHS [CA-21765] Funding Source: Medline; NHLBI NIH HHS [N0I-HV-28183] Funding Source: Medline; NIAID NIH HHS [R56 AI052199, AI-52199] Funding Source: Medline; NIDDK NIH HHS [U19-DK-6134] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052199, R21AI052199, R01AI052199] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hasler P, 2005, CELL IMMUNOL, V233, P102, DOI 10.1016/j.cellimm.2005.04.012; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pitcher LA, 2005, EUR J IMMUNOL, V35, P3643, DOI 10.1002/eji.200535136; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; SZYMCZAKWORKMAN AL, 2006, GENE TRANSFER DELIVE, P137; Takeuchi T, 1998, INT IMMUNOL, V10, P911, DOI 10.1093/intimm/10.7.911; Tsuzaka K, 1998, J AUTOIMMUN, V11, P381, DOI 10.1006/jaut.1998.0223; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; van Oers NSC, 1998, J IMMUNOL, V160, P163; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang BP, 1999, J IMMUNOL, V162, P88; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Xystrakis E, 2006, EXPERT OPIN BIOL TH, V6, P121, DOI 10.1517/14712598.6.2.121; Yamazaki T, 1997, J IMMUNOL, V158, P1634; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	50	112	117	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					658	666		10.1038/ni.1611	http://dx.doi.org/10.1038/ni.1611			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18469818				2022-12-18	WOS:000256067900016
J	Shi, YF; Feng, Y; Kang, JH; Liu, C; Li, ZX; Li, DS; Cao, W; Qiu, J; Guo, ZL; Bi, EG; Zang, L; Lu, CZ; Zhang, JZ; Pei, G				Shi, Yufeng; Feng, Yan; Kang, Jiuhong; Liu, Chang; Li, Zhenxin; Li, Dangsheng; Cao, Wei; Qiu, Ju; Guo, Zhengliang; Bi, Enguang; Zang, Lei; Lu, Chuanzhen; Zhang, Jingwu Z.; Pei, Gang			Critical regulation of CD4(+) T cell survival and autoimmunity by beta-arrestin 1	NATURE IMMUNOLOGY			English	Article							NUCLEAR EXPORT SIGNAL; RECEPTOR-GAMMA CHAIN; MULTIPLE-SCLEROSIS; BETA-ARRESTINS; DOWN-REGULATION; IMMUNE-SYSTEM; PROTEIN; BCL-2; ACTIVATION; EXPRESSION	CD4(+) T cells are important in adaptive immunity, but their dysregulation can cause autoimmunity. Here we demonstrate that the multifunctional adaptor protein beta-arrestin 1 positively regulated naive and activated CD4(+) T cell survival. We found enhanced expression of the proto-oncogene Bcl2 through beta-arrestin 1-dependent regulation of acetylation of histone H4 at the Bcl2 promoter. Mice deficient in the gene encoding beta-arrestin 1 (Arrb1) were much more resistant to experimental autoimmune encephalomyelitis, whereas overexpression of Arrb1 increased susceptibility to this disease. CD4(+) T cells from patients with multiple sclerosis had much higher Arrb1 expression, and 'knockdown' of Arrb1 by RNA-mediated interference in those cells increased apoptosis induced by cytokine withdrawal. Our data demonstrate that beta-arrestin 1 is critical for CD4(+) T cell survival and is a factor in susceptibility to autoimmunity.	Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Joint Immunol Lab, Inst Hlth Sci, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; Fudan Univ, Shanghai Med Coll, Huashan Hosp, Inst Neurol, Shanghai 200040, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; E Inst Shanghai Univ, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Zhang, JZ (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	jwzang@sibs.ac.cn; gpei@sibs.ac.cn	Qiu, Ju/AAW-7301-2021; Riley, Eleanor M/C-8960-2013; BI, ENGUANG/K-4033-2014	Riley, Eleanor M/0000-0003-3447-3570; BI, ENGUANG/0000-0003-0850-8135				Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DiSanto JP, 1996, J EXP MED, V183, P1111, DOI 10.1084/jem.183.3.1111; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jambal P, 2003, J BIOL CHEM, V278, P23055, DOI 10.1074/jbc.M212450200; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Nguyen K, 2002, J IMMUNOL, V168, P4440, DOI 10.4049/jimmunol.168.9.4440; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Rep MHG, 1997, J CLIN INVEST, V99, P2225, DOI 10.1172/JCI119396; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stockinger B, 2004, CURR OPIN IMMUNOL, V16, P775, DOI 10.1016/j.coi.2004.09.003; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vroon A, 2003, J NEUROIMMUNOL, V137, P79, DOI 10.1016/S0165-5728(03)00050-X; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Zang YCQ, 2003, INT IMMUNOL, V15, P1073, DOI 10.1093/intimm/dxg105; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang JW, 2005, ANNU REV MED, V56, P273, DOI 10.1146/annurev.med.56.082103.104739	49	112	126	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					817	824		10.1038/ni1489	http://dx.doi.org/10.1038/ni1489			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17618287				2022-12-18	WOS:000248169400009
J	Gao, L; Wang, L; Dai, T; Jin, K; Zhang, ZK; Wang, S; Xie, F; Fang, PF; Yang, B; Huang, HZ; van Dam, H; Zhou, FF; Zhang, L				Gao, Liang; Wang, Lin; Dai, Tong; Jin, Ke; Zhang, Zhengkui; Wang, Shuai; Xie, Feng; Fang, Pengfei; Yang, Bing; Huang, Huizhe; van Dam, Hans; Zhou, Fangfang; Zhang, Long			Tumor-derived exosomes antagonize innate antiviral immunity	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR; RIG-I; T-CELL; TRANSCRIPTION FACTORS; REGULATORY FACTOR-3; CANCER EXOSOMES; PROTEIN	Malignancies can compromise innate immunity, but the mechanisms of this are largely unknown. Here we found that, via tumor-derived exosomes (TEXs), cancers were able to transfer activated epidermal growth factor receptor ( EGFR) to host macrophages and thereby suppress innate antiviral immunity. Screening of the human kinome identified the kinase MEKK2 in macrophages as an effector of TEX-delivered EGFR that negatively regulated the antiviral immune response. In the context of experimental tumor implantation, MEKK2-deficient mice were more resistant to viral infection than were wild-type mice. Injection of TEXs into mice reduced innate immunity, increased viral load and increased morbidity in an EGFR- and MEKK2-dependent manner. MEKK2 phosphorylated IRF3, a transcription factor crucial for the production of type I interferons; this triggered poly-ubiquitination of IRF3 and blocked its dimerization, translocation to the nucleus and transcriptional activity after viral infection. These findings identify a mechanism by which cancer cells can dampen host innate immunity and potentially cause patients with cancer to become immunocompromised.	[Gao, Liang; Dai, Tong; Jin, Ke; Zhang, Zhengkui; Xie, Feng; Fang, Pengfei; Zhang, Long] Inst Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Liang; Dai, Tong; Jin, Ke; Zhang, Zhengkui; Xie, Feng; Fang, Pengfei; Zhang, Long] Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China; [Gao, Liang; Wang, Lin; Dai, Tong; Wang, Shuai; Xie, Feng; Zhou, Fangfang] Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China; [van Dam, Hans] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Dept Mol Cell Biol, Leiden, Netherlands; [Huang, Huizhe] Chonqing Med Univ, Fac Basic Med Sci, Chongqing, Peoples R China; [Yang, Bing] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Yang, Bing] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Soochow University - China; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Chongqing Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhang, L (corresponding author), Inst Life Sci, Hangzhou, Zhejiang, Peoples R China.; Zhang, L (corresponding author), Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China.; Zhou, FF (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China.	zhoufangfang@suda.edu.cn; l-zhang@zju.edu.cn	Dai, Tong/AHD-4834-2022; Jin, ke/GQG-9869-2022; Zhang, Long/AAT-6571-2021; Wang, Shuai/GXM-5563-2022	Dai, Tong/0000-0002-6295-5449; Jin, ke/0000-0001-5371-3440; Zhang, Long/0000-0001-8139-0474; van Dam, Hans/0000-0002-8307-4325	Ministry of Science and Technology of China [2016YFA0502500]; Chinese National Natural Science Funds [31701232, 31571460, 31471315, 31671457, 31741086, 91753139]; Jiangsu National Science Foundation [BK20150354]; Zhejiang outstanding youth fund [LR14C070001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Jiangsu National Science Foundation; Zhejiang outstanding youth fund	We thank B. Su (Yale University School of Medicine) for Map3k2<SUP>+/-</SUP> mice; and M. Rabeling (Leiden University Medical Center) for shRNA constructs. Supported by the special program from the Ministry of Science and Technology of China (2016YFA0502500 to L.Z.), the Chinese National Natural Science Funds (31701232 to F.X., 31571460 to F.Z., 31471315, 31671457, 31741086 and 91753139 to L.Z.), Jiangsu National Science Foundation (BK20150354 to F.Z.) and Zhejiang outstanding youth fund (LR14C070001 to L.Z.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Benito-Martin A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00066; Chang X, 2011, IMMUNITY, V34, P201, DOI 10.1016/j.immuni.2011.01.017; Chemaly RF, 2012, CANCER-AM CANCER SOC, V118, P4627, DOI 10.1002/cncr.27447; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kesavan K, 2004, J CELL PHYSIOL, V199, P140, DOI 10.1002/jcp.10457; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Song X, 2016, J BIOL CHEM, V291, P8453, DOI 10.1074/jbc.M116.716316; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhu MZ, 2015, J IMMUNOL, V195, P289, DOI 10.4049/jimmunol.1500232	53	111	121	4	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					233	+		10.1038/s41590-017-0043-5	http://dx.doi.org/10.1038/s41590-017-0043-5			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29358709				2022-12-18	WOS:000427007500013
J	Wang, S; Xie, F; Chu, F; Zhang, ZK; Yang, B; Dai, T; Gao, L; Wang, L; Ling, L; Jia, JL; van Dam, H; Jin, J; Zhang, L; Zhou, FF				Wang, Shuai; Xie, Feng; Chu, Feng; Zhang, Zhengkui; Yang, Bing; Dai, Tong; Gao, Liang; Wang, Lin; Ling, Li; Jia, Junling; van Dam, Hans; Jin, Jin; Zhang, Long; Zhou, Fangfang			YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKK epsilon-mediated phosphorylation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; PATTERN-RECOGNITION RECEPTORS; HIPPO PATHWAY; TISSUE HOMEOSTASIS; LOCALIZATION; ONCOPROTEIN; ACTIVATION; MECHANISMS; PROTEIN	The transcription regulator YAP controls organ size by regulating cell growth, proliferation and apoptosis. However, whether YAP has a role in innate antiviral immunity is largely unknown. Here we found that YAP negatively regulated an antiviral immune response. YAP deficiency resulted in enhanced innate immunity, a diminished viral load, and morbidity in vivo. YAP blocked dimerization of the transcription factor IRF3 and impeded translocation of IRF3 to the nucleus after viral infection. Notably, virus-activated kinase IKK epsilon phosphorylated YAP at Ser403 and thereby triggered degradation of YAP in lysosomes and, consequently, relief of YAP-mediated inhibition of the cellular antiviral response. These findings not only establish YAP as a modulator of the activation of IRF3 but also identify a previously unknown regulatory mechanism independent of the kinases Hippo and LATS via which YAP is controlled by the innate immune pathway.	[Wang, Shuai; Chu, Feng; Dai, Tong; Gao, Liang; Wang, Lin; Ling, Li; Zhou, Fangfang] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China; [Wang, Shuai; Chu, Feng; Dai, Tong; Gao, Liang; Wang, Lin; Ling, Li; Zhou, Fangfang] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China; [Xie, Feng; Zhang, Zhengkui; Jia, Junling; Jin, Jin; Zhang, Long] Life Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Xie, Feng; Zhang, Zhengkui; Jia, Junling; Jin, Jin; Zhang, Long] Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China; [Yang, Bing] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Yang, Bing] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [van Dam, Hans] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Canc Genom Ctr Netherlands, Leiden, Netherlands	Soochow University - China; Soochow University - China; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zhou, FF (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China.; Zhou, FF (corresponding author), Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China.; Zhang, L (corresponding author), Life Sci Inst, Hangzhou, Zhejiang, Peoples R China.; Zhang, L (corresponding author), Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China.	l_zhang@zju.edu.cn; zhoufangfang@suda.edu.cn	Zhang, Long/AAT-6571-2021; Dai, Tong/AHD-4834-2022; Wang, Shuai/GXM-5563-2022	Zhang, Long/0000-0001-8139-0474; Dai, Tong/0000-0002-6295-5449; Jin, Jin/0000-0001-7887-5972; van Dam, Hans/0000-0002-8307-4325	Ministry of Science and Technology of China [2016YFA0502500]; Chinese National Natural Science Funds [31571460, 31471315, 31671457]; PCSIRT [IRT1075]; Jiangsu National Science Foundation [BK20150354]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu National Science Foundation	We thank D. Pan (Johns Hopkins University School of Medicine) for Yap1<SUP>fl/fl</SUP> mice; M. Rabelink (Leiden University Medical Center) for shRNA constructs; P. ten Dijke for help with writing; and J. Dai for discussion. Supported by a special program from Ministry of Science and Technology of China (2016YFA0502500 to L.Z.), the Chinese National Natural Science Funds (31571460 to F.Z., 31471315 and 31671457 to L.Z.), PCSIRT (IRT1075 to X.G.) and Jiangsu National Science Foundation (BK20150354 to F.Z.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Boro M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37695; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Dragan AI, 2007, NUCLEIC ACIDS RES, V35, P3525, DOI 10.1093/nar/gkm142; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Meng FS, 2016, GENE DEV, V30, P1086, DOI 10.1101/gad.277533.116; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhu MZ, 2015, J IMMUNOL, V195, P289, DOI 10.4049/jimmunol.1500232	33	111	123	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					733	+		10.1038/ni.3744	http://dx.doi.org/10.1038/ni.3744			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28481329				2022-12-18	WOS:000403676300008
J	Ebihara, T; Song, C; Ryu, SH; Plougastel-Douglas, B; Yang, LP; Levanon, D; Gronert, Y; Bern, MD; Stappenbeck, TS; Colonna, M; Egawa, T; Yokoyama, WM				Ebihara, Takashi; Song, Christina; Ryu, Stacy H.; Plougastel-Douglas, Beatrice; Yang, Liping; Levanon, Ditsa; Gronert, Yoram; Bern, Michael D.; Stappenbeck, Thaddeus S.; Colonna, Marco; Egawa, Takeshi; Yokoyama, Wayne M.			Runx3 specifies lineage commitment of innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; DIFFERENTIATION; DRIVES; FETAL; NOTCH; BET; MODULATION; INTERPLAY; FACTOR-3	Subsets of innate lymphoid cells (ILCs) reside in the mucosa and regulate immune responses to external pathogens. While ILCs can be phenotypically classified into ILC1, ILC2 and ILC3 subsets, the transcriptional control of commitment to each ILC lineage is incompletely understood. Here we report that the transcription factor Runx3 was essential for the normal development of ILC1 and ILC3 cells but not of ILC2 cells. Runx3 controlled the survival of ILC1 cells but not of ILC3 cells. Runx3 was required for expression of the transcription factor ROR gamma t and its downstream target, the transcription factor AHR, in ILC3 cells. The absence of Runx3 in ILCs exacerbated infection with Citrobacter rodentium. Therefore, our data establish Runx3 as a key transcription factor in the lineage-specific differentiation of ILC1 and ILC3 cells.	[Ebihara, Takashi; Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Song, Christina; Ryu, Stacy H.; Stappenbeck, Thaddeus S.; Colonna, Marco; Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Plougastel-Douglas, Beatrice; Yang, Liping; Bern, Michael D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Levanon, Ditsa; Gronert, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Bern, Michael D.] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Weizmann Institute of Science; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	yokoyama@dom.wustl.edu	Plougastel-Douglas, Beatrice/Q-3186-2019	Plougastel-Douglas, Beatrice/0000-0002-6389-561X; Egawa, Takeshi/0000-0001-7489-1051; Colonna, Marco/0000-0001-5222-4987; Ryu, Stacy Hyunji/0000-0002-5448-339X; Ebihara, Takashi/0000-0002-6056-3230	Howard Hughes Medical Institute; US National Institutes of Health [R01AI097244, T32-GM007200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Vivier (Centre d'Immunologie de Marseille-Luminy) for NKp46-Cre mice; D.R. Littman (New York University) for Cbfb<SUP>f/f</SUP>, Runx3<SUP>f/f</SUP> and Runx3d<SUP>+/YFP</SUP> mice; S. Taffner for technical assistance; H. Miyoshi and A. Fuchs for technical advice; and D.K. Sojka, and S. Demehri for discussions. Supported by the Howard Hughes Medical Institute (W.M.Y.) and the US National Institutes of Health (R01AI097244 to T.Eg.; and T32-GM007200 for M.D.B.).	Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hepworth MR, 2014, CURR OPIN IMMUNOL, V27, P75, DOI 10.1016/j.coi.2014.01.013; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Levanon D, 2007, NAT IMMUNOL, V8, P145; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shin JH, 2013, P NATL ACAD SCI USA, V110, P12391, DOI 10.1073/pnas.1302856110; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Weersma RK, 2008, INFLAMM BOWEL DIS, V14, P1615, DOI 10.1002/ibd.20610; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	48	111	113	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1124	1133		10.1038/ni.3272	http://dx.doi.org/10.1038/ni.3272			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26414766	Green Accepted			2022-12-18	WOS:000363096000006
J	Gunawan, M; Venkatesan, N; Loh, JT; Wong, JF; Berger, H; Neo, WH; Li, LYJ; La Win, MK; Yau, YH; Guo, T; See, PCE; Yamazaki, S; Chin, KC; Gingras, AR; Shochat, SG; Ng, LG; Sze, SK; Ginhoux, F; Su, IH				Gunawan, Merry; Venkatesan, Nandini; Loh, Jia Tong; Wong, Jong Fu; Berger, Heidi; Neo, Wen Hao; Li, Liang Yao Jackson; La Win, Myint Khun; Yau, Yin Hoe; Guo, Tiannan; See, Peter Chi Ee; Yamazaki, Sayuri; Chin, Keh Chuang; Gingras, Alexandre R.; Shochat, Susana Geifman; Ng, Lai Guan; Sze, Siu Kwan; Ginhoux, Florent; Su, I-Hsin			The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin	NATURE IMMUNOLOGY			English	Article							BLOOD-BRAIN-BARRIER; LYSINE-METHYLATION; DENDRITIC CELLS; FOCAL ADHESION; NONHISTONE PROTEINS; GENE-EXPRESSION; ACTIVATION; DYNAMICS; BINDING; PHOSPHORYLATION	A cytosolic role for the histone methyltransferase Ezh2 in regulating lymphocyte activation has been suggested, but the molecular mechanisms underpinning this extranuclear function have remained unclear. Here we found that Ezh2 regulated the integrin signaling and adhesion dynamics of neutrophils and dendritic cells (DCs). Ezh2 deficiency impaired the integrin-dependent transendothelial migration of innate leukocytes and restricted disease progression in an animal model of multiple sclerosis. Direct methylation of talin, a key regulatory molecule in cell migration, by Ezh2 disrupted the binding of talin to F-actin and thereby promoted the turnover of adhesion structures. This regulatory effect was abolished by targeted disruption of the interactions of Ezh2 with the cytoskeletal-reorganization effector Vav1. Our studies reveal an unforeseen extranuclear function for Ezh2 in regulating adhesion dynamics, with implications for leukocyte migration, immune responses and potentially pathogenic processes.	[Gunawan, Merry; Venkatesan, Nandini; Loh, Jia Tong; Wong, Jong Fu; Berger, Heidi; Neo, Wen Hao; La Win, Myint Khun; Yau, Yin Hoe; Guo, Tiannan; Shochat, Susana Geifman; Sze, Siu Kwan; Su, I-Hsin] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Singapore 639798, Singapore; [Li, Liang Yao Jackson; See, Peter Chi Ee; Ng, Lai Guan; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Yamazaki, Sayuri] Nagoya City Univ, Dept Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Chin, Keh Chuang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Chin, Keh Chuang] Agcy Sci & Technol Res, Inst Mol & Cell Biol, Singapore, Singapore; [Gingras, Alexandre R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Nagoya City University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego	Su, IH (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Singapore 639798, Singapore.	ihsu@ntu.edu.sg	Hoe, YAU Yin/A-2817-2011; Su, I-hsin/A-2207-2011; Ng, Lai Guan/N-6980-2019; Gingras, Alexandre R/E-1867-2011; Sze, Siu_kwan Newman/A-2199-2011; Guo, Tiannan/AAR-3568-2020; Sze, Siu Kwan/AAO-3342-2020; Ng, Lai Guan/E-5673-2011	Hoe, YAU Yin/0000-0001-8136-2393; Su, I-hsin/0000-0002-5894-9580; Ng, Lai Guan/0000-0003-1905-3586; Gingras, Alexandre R/0000-0002-5373-0176; Sze, Siu_kwan Newman/0000-0002-5652-1687; Guo, Tiannan/0000-0003-3869-7651; Sze, Siu Kwan/0000-0002-5652-1687; Ng, Lai Guan/0000-0003-1905-3586; See, Peter/0000-0003-4428-7763; Wong, Jong Fu/0000-0001-6539-5865; Li, Jackson LiangYao/0000-0001-5197-193X; Neo, Wen Hao/0000-0002-4485-4118; Neo, Wen Hao/0000-0002-6827-3027	Agency for Science, Technology and Research [BMRC 07/1/21/19/545]; Ministry of Education [MOE2009-T2-1-034, MOE2013-T2-2-038]; National Medical Research Council of Singapore [NMRC/CBRG/0057/2014]	Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Ministry of Education; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We thank K. Saijo, C. Schmedt, K. Sadler, P. Droge, N.E. McCarthy and A. Tarakhovsky for critical reading, discussions and comments on the manuscript; C. Ruedl and K.E. Karjalainen for discussions and suggestions; Y. Zhang (Harvard University) for the EZH2, SUZ12 and EED baculovirus expression vectors; L. Nordenskiold (Nanyang Technological University) for the recombinant octamers; L. Mori and A. Urbano for the EAE-induction protocol; M. Poidinger for processing the microarray data; R. Kraut and A. Matsyik for support for imaging by total internal refraction microscopy; G. White (The University of Manchester) for the eGFP-C1-paxillin plasmid; C.L. Chu (National Taiwan University) for the DC2.4 cell line; and A. Sullivan for editing the manuscript. Supported by the Agency for Science, Technology and Research (BMRC 07/1/21/19/545), the Ministry of Education (MOE2009-T2-1-034 and MOE2013-T2-2-038) and the National Medical Research Council of Singapore (NMRC/CBRG/0057/2014).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Egorova KS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P535, DOI 10.1134/S0006297910050019; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jain P, 2010, J IMMUNOL, V184, P7196, DOI 10.4049/jimmunol.0901404; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Pendl GG, 2002, BLOOD, V99, P946, DOI 10.1182/blood.V99.3.946; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Price AA, 1997, J EXP MED, V186, P1725, DOI 10.1084/jem.186.10.1725; Ren XD, 2000, J CELL SCI, V113, P3673; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	50	111	115	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					505	U225		10.1038/ni.3125	http://dx.doi.org/10.1038/ni.3125			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25751747	Green Accepted			2022-12-18	WOS:000353305200013
J	Obata, Y; Furusawa, Y; Endo, TA; Sharif, J; Takahashi, D; Atarashi, K; Nakayama, M; Onawa, S; Fujimura, Y; Takahashi, M; Ikawa, T; Otsubo, T; Kawamura, YI; Dohi, T; Tajima, S; Masumoto, H; Ohara, O; Honda, K; Hori, S; Ohno, H; Koseki, H; Hase, K				Obata, Yuuki; Furusawa, Yukihiro; Endo, Takaho A.; Sharif, Jafar; Takahashi, Daisuke; Atarashi, Koji; Nakayama, Manabu; Onawa, Satoshi; Fujimura, Yumiko; Takahashi, Masumi; Ikawa, Tomokatsu; Otsubo, Takeshi; Kawamura, Yuki I.; Dohi, Taeko; Tajima, Shoji; Masumoto, Hiroshi; Ohara, Osamu; Honda, Kenya; Hori, Shohei; Ohno, Hiroshi; Koseki, Haruhiko; Hase, Koji			The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells	NATURE IMMUNOLOGY			English	Article							GUT MICROBIOTA; FOXP3 EXPRESSION; MAMMALIAN-CELLS; DNA METHYLATION; REG CELLS; IN-VIVO; MICE; INDUCTION; COMMENSAL; RECEPTOR	Intestinal regulatory T cells (T-reg cells) are necessary for the suppression of excessive immune responses to commensal bacteria. However, the molecular machinery that controls the homeostasis of intestinal ireg cells has remained largely unknown. Here we report that colonization of germ-free mice with gut microbiota upregulated expression of the DNA-methylation adaptor Uhrf1 in T-reg cells. Mice with T cell specific deficiency in Uhrf1 (Uhrf1(fl/fl)Cd4-Cre mice) showed defective proliferation and functional maturation of colonic T-reg cells. Uhrf1 deficiency resulted in derepression of the gene (Cdkn1a) that encodes the cyclin-dependent kinase inhibitor p21 due to hypomethylation of its promoter region, which resulted in cell-cycle arrest of T-reg cells. As a consequence, Uhrf1(fl/fl)Cd4-Cre mice spontaneously developed severe colitis. Thus, Uhrf1-dependent epigenetic silencing of Cdknla was required for the maintenance of gut immunological homeostasis. This mechanism enforces symbiotic host-microbe interactions without an inflammatory response.	[Obata, Yuuki; Furusawa, Yukihiro; Fujimura, Yumiko; Hase, Koji] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Mucosal Barriol, Tokyo, Japan; [Obata, Yuuki; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chiba, Japan; [Obata, Yuuki; Furusawa, Yukihiro; Fujimura, Yumiko; Hase, Koji] RIKEN, Ctr Integrat Med Sci, Lab Bioenvironm Epigenet, Yokohama, Kanagawa, Japan; [Obata, Yuuki; Ohno, Hiroshi; Hase, Koji] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan; [Endo, Takaho A.; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci, Lab Integrat Gen, Yokohama, Kanagawa, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Takahashi, Daisuke; Onawa, Satoshi; Takahashi, Masumi; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa, Japan; [Atarashi, Koji; Honda, Kenya] RIKEN, Ctr Integrat Med Sci, Lab Gut Homeostasis, Yokohama, Kanagawa, Japan; [Atarashi, Koji; Ikawa, Tomokatsu; Hase, Koji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Lab Med Genom, Chiba, Japan; [Ikawa, Tomokatsu] RIKEN, Ctr Integrat Med Sci, Lab Immune Regenerat, Yokohama, Kanagawa, Japan; [Otsubo, Takeshi; Kawamura, Yuki I.; Dohi, Taeko] Natl Ctr Global Hlth & Med, Res Inst, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Chiba, Japan; [Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Osaka, Japan; [Masumoto, Hiroshi] Kazusa DNA Res Inst, Dept Frontier Res, Lab Cell Engn, Chiba, Japan; [Honda, Kenya] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Hori, Shohei] RIKEN, Ctr Integrat Med Sci, Lab Immune Homeostasis, Yokohama, Kanagawa, Japan	University of Tokyo; Chiba University; RIKEN; Yokohama City University; RIKEN; RIKEN; RIKEN; RIKEN; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute; RIKEN; National Center for Global Health & Medicine - Japan; Osaka University; Kazusa DNA Research Institute; Japan Science & Technology Agency (JST); RIKEN	Hase, K (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Tokyo, Japan.	hase-kj@pha.keio.ac.jp	Endo, Takaho/B-5763-2017; Atarashi, Koji/I-5363-2014; Ohara, Osamu/G-5448-2015; Ohno, Hiroshi/L-7899-2014; Takahashi, Daisuke/C-3799-2019; Honda, Kenya/N-5297-2015; Otsubo, Takeshi/G-6123-2014; Hori, Shohei/O-6163-2019; Koseki, Haruhiko/I-3825-2014	Endo, Takaho/0000-0002-2801-2463; Atarashi, Koji/0000-0001-5422-0736; Ohara, Osamu/0000-0002-3328-9571; Ohno, Hiroshi/0000-0001-8776-9661; Takahashi, Daisuke/0000-0001-8624-1160; Hori, Shohei/0000-0001-8770-4593; Koseki, Haruhiko/0000-0001-8424-5854; Hase, Koji/0000-0001-9550-2334; Obata, Yuuki/0000-0001-5461-3521	Japan Society for the Promotion of Science [24117723, 25293114, 24890293, 252667]; Japan Science and Technology Agency (PRESTO); RIKEN RCAI-IMS Young Chief Investigator program; RIKEN RCAI-IMS Open Laboratory for Allergy Research Project; Kato Memorial Bioscience Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Toray Science Foundation; National Center for Global Health and Medicine [21-110, 22-205]; Grants-in-Aid for Scientific Research [24689042, 24117723] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); RIKEN RCAI-IMS Young Chief Investigator program; RIKEN RCAI-IMS Open Laboratory for Allergy Research Project; Kato Memorial Bioscience Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Toray Science Foundation(Toray Industries, Inc.); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank P.D. Burrows for critical reading and editing of the manuscript; T. Mukai, M. Yoshida, P. Carnincci, Y. Shinkai and H. Kiyono for comments and suggestions; and S. Fukuda and Y. Koseki for technical support. Supported by the Japan Society for the Promotion of Science (24117723 and 25293114 to K. Ha., 24890293 to Y.F. and 252667 to Y.O.), the Japan Science and Technology Agency (PRESTO to K. Ha.), the RIKEN RCAI-IMS Young Chief Investigator program (K. Ha.), the RIKEN RCAI-IMS Open Laboratory for Allergy Research Project (T.D.), the Kato Memorial Bioscience Foundation (Y.F.), The Uehara Memorial Foundation (K. Ha.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (K. Ha.), the Toray Science Foundation (K. Ha.) and the National Center for Global Health and Medicine (21-110 and 22-205 to T.D.).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Han D, 2013, IMMUNITY, V38, P1211, DOI 10.1016/j.immuni.2013.05.012; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang WC, 2005, ONCOGENE, V24, P2104, DOI 10.1038/sj.onc.1208444; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	45	111	120	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					571	579		10.1038/ni.2886	http://dx.doi.org/10.1038/ni.2886			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24777532				2022-12-18	WOS:000336419300014
J	Kong, KF; Yokosuka, T; Canonigo-Balancio, AJ; Isakov, N; Saito, T; Altman, A				Kong, Kok-Fai; Yokosuka, Tadashi; Canonigo-Balancio, Ann J.; Isakov, Noah; Saito, Takashi; Altman, Amnon			A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; C-THETA; PROTEIN; DIACYLGLYCEROL; COSTIMULATION; SIGNALS; TRANSLOCATION; STIMULATION; SEGREGATION; EXPRESSION	Protein kinase C-theta (PKC-theta) translocates to the center of the immunological synapse, but the underlying mechanism and its importance in T cell activation are unknown. Here we found that the V3 domain of PKC-theta was necessary and sufficient for localization to the immunological synapse mediated by association with the coreceptor CD28 and dependent on the kinase Lck. We identified a conserved proline-rich motif in V3 required for association with CD28 and immunological synapse localization. We found association with CD28 to be essential for PKC-theta-mediated downstream signaling and the differentiation of T helper type 2 cells (T(H)2 cells) and interleukin 17-producing helper T cells (T(H)17 cells) but not of T helper type 1 cells (T(H)1 cells). Ectopic expression of V3 sequestered PKC-theta from the immunological synapse and interfered with its functions. Our results identify a unique mode of CD28 signaling, establish a molecular basis for the immunological synapse localization of PKC-theta and indicate V3-based 'decoys' may be therapeutic modalities for T cell-mediated inflammatory diseases.	[Kong, Kok-Fai; Canonigo-Balancio, Ann J.; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Yokosuka, Tadashi; Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa, Japan; [Yokosuka, Tadashi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Isakov, Noah] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Isakov, Noah] Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; [Saito, Takashi] Osaka Univ, Lab Cell Signaling, World Premiere Int Immunol Frontier Res Ctr, Osaka, Japan	La Jolla Institute for Immunology; RIKEN; Japan Science & Technology Agency (JST); Ben Gurion University; Ben Gurion University; Osaka University	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA.	amnon@liai.org	Saito, Takashi/C-9684-2009; ISAKOV, NOAH/F-1659-2012	Saito, Takashi/0000-0001-9495-3547; Yokosuka, Tadashi/0000-0002-3914-3995; Isakov, Noah/0000-0002-1412-0957	US National Institutes of Health [CA35299]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23113521]; United States-Israel Binational Science Foundation; Grants-in-Aid for Scientific Research [25113725, 19059013, 19109005] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Littman (New York University) for Prkcq<SUP>-/-</SUP> mice; T. So, W. Duan and M. Croft for the MCC-specific T hybridoma DCEK fibroblast system and advice on the allergic airway inflammation model; S. Becart, C. Fos and Y. Harada for discussions and suggestions; and K. Hayashi for some of the PKC-theta constructs. Supported by the US National Institutes of Health (CA35299), by The Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grant-in-Aid for Scientific Research on Innovative Areas 'Fluorescence Live imaging' 23113521) and the United States-Israel Binational Science Foundation. This is manuscript number 1392 from the La Jolla Institute for Allergy and Immunology.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Altman A, 2004, EUR J IMMUNOL, V34, P2001, DOI 10.1002/eji.200324625; Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; Canonigo-Balancio AJ, 2009, J IMMUNOL, V183, P7259, DOI 10.4049/jimmunol.0902573; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Giannoni F, 2005, J VIROL, V79, P6808, DOI 10.1128/JVI.79.11.6808-6813.2005; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hofinger E, 2005, J IMMUNOL, V174, P3839, DOI 10.4049/jimmunol.174.7.3839-a; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Manicassamy S, 2006, J MOL BIOL, V355, P347, DOI 10.1016/j.jmb.2005.10.043; Marsland BJ, 2007, J IMMUNOL, V178, P3466, DOI 10.4049/jimmunol.178.6.3466; Marsland BJ, 2005, P NATL ACAD SCI USA, V102, P14374, DOI 10.1073/pnas.0506250102; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Miller J, 2009, IMMUNOL RES, V45, P159, DOI 10.1007/s12026-009-8097-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sadra A, 1999, J IMMUNOL, V162, P1966; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; Valenzuela JO, 2009, J CLIN INVEST, V119, P3774, DOI 10.1172/JCI39692; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	50	111	117	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1105	U114		10.1038/ni.2120	http://dx.doi.org/10.1038/ni.2120			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21964608	Green Accepted			2022-12-18	WOS:000296500100016
J	Tracey, KJ				Tracey, Kevin J.			Understanding immunity requires more than immunology	NATURE IMMUNOLOGY			English	Article							MOBILITY GROUP BOX-1; BRAIN COMMUNICATION; INFLAMMATION; PATHWAY; NERVE; CELLS; MICE		Feinstein Inst Med Res, Kevin J Ctr Biomed Sci, Manhasset, NY USA	Northwell Health	Tracey, KJ (corresponding author), Feinstein Inst Med Res, Kevin J Ctr Biomed Sci, Manhasset, NY USA.	kjtracey@nshs.edu		Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Goehler LE, 1997, BRAIN RES BULL, V43, P357, DOI 10.1016/S0361-9230(97)00020-8; Labiner DM, 2007, ACTA NEUROL SCAND, V115, P23, DOI 10.1111/j.1600-0404.2006.00732.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Straub RH, 2008, ARTHRITIS RHEUM, V58, P3450, DOI 10.1002/art.24030; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; YANG H, P NATL ACAD IN PRESS	18	111	115	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					561	564		10.1038/ni0710-561	http://dx.doi.org/10.1038/ni0710-561			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562838	Green Accepted			2022-12-18	WOS:000278926400008
J	Le Borgne, M; Ladi, E; Dzhagalov, I; Herzmark, P; Liao, YF; Chakraborty, AK; Robey, EA				Le Borgne, Marie; Ladi, Ena; Dzhagalov, Ivan; Herzmark, Paul; Liao, Ying Fang; Chakraborty, Arup K.; Robey, Ellen A.			The impact of negative selection on thymocyte migration in the medulla	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; REGULATORY T-CELLS; DENDRITIC CELLS; IN-VIVO; 2-PHOTON MICROSCOPY; POSITIVE SELECTION; CENTRAL TOLERANCE; LYMPHOID ORGANS; CLONAL DELETION	Developing thymocytes are screened for self-reactivity before they exit the thymus, but how thymocytes scan the medulla for self antigens is unclear. Using two-photon microscopy, we observed that medullary thymocytes migrated rapidly and made frequent, transient contacts with dendritic cells. In the presence of a negative selecting ligand, thymocytes slowed, became confined to areas of approximately 30 mu m in diameter and had increased contact with dendritic cells surrounding confinement zones. One third of polyclonal medullary thymocytes also showed confined, slower migration and may correspond to autoreactive thymocytes. Our data suggest that many autoreactive thymocytes do not undergo immediate arrest and death after encountering a negative selecting ligand but instead adopt an altered migration program while remaining in the medullary microenvironment.	[Le Borgne, Marie; Ladi, Ena; Dzhagalov, Ivan; Herzmark, Paul; Liao, Ying Fang; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	erobey@berkeley.edu	Le Borgne, Marie/P-2313-2015	Le Borgne, Marie/0000-0002-3439-4867; Dzhagalov, Ivan/0000-0001-9209-4582	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053039, R01AI064227] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI064227-03, R01 AI064227-04, R01 AI064227-01A2, R01 AI064227-02, R01 AI053039-02, R01 AI064227, R01 AI053039, R01 AI053039-03, R01 AI053039-01, R01 AI053039-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; LADI E, 2008, J VIS EXP, V25, P652; Ladi E, 2008, J IMMUNOL, V181, P7014, DOI 10.4049/jimmunol.181.10.7014; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	39	111	112	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					823	U41		10.1038/ni.1761	http://dx.doi.org/10.1038/ni.1761			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19543275	Green Accepted, Green Submitted			2022-12-18	WOS:000268141400010
J	Li, HY; Liu, H; Wang, CH; Zhang, JY; Man, JH; Gao, YF; Zhang, PJ; Li, WH; Zhao, J; Pan, X; Zhou, T; Gong, WL; Li, AL; Zhang, XM				Li, Hui-Yan; Liu, Hui; Wang, Chen-Hui; Zhang, Ji-Yan; Man, Jiang-Hong; Gao, Yan-Fei; Zhang, Pei-Jing; Li, Wei-Hua; Zhao, Jie; Pan, Xin; Zhou, Tao; Gong, Wei-Li; Li, Ai-Ling; Zhang, Xue-Min			Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DIFFERENTIAL REGULATION; BETA-SUBUNIT; TNF; ACTIVATION; COMPLEX; DOMAIN; UBIQUITINATION; DEGRADATION; RECEPTOR-1	Despite rapid progress in elucidating the molecular mechanisms of activation of the kinase IKK, the processes that regulate IKK deactivation are still unknown. Here we demonstrate that CUE domain-containing 2 (CUEDC2) interacted with IKK alpha and IKK beta and repressed activation of the transcription factor NF-kappa B by decreasing phosphorylation and activation of IKK. Notably, CUEDC2 also interacted with GADD34, a regulatory subunit of protein phosphatase 1 (PP1). We found that IKK, CUEDC2 and PP1 existed in a complex and that IKK was released from the complex in response to inflammatory stimuli such as tumor necrosis factor. CUEDC2 deactivated IKK by recruiting PP1 to the complex. Therefore, CUEDC2 acts as an adaptor protein to target IKK for dephosphorylation and inactivation by recruiting PP1.	[Li, Hui-Yan; Liu, Hui; Wang, Chen-Hui; Zhang, Ji-Yan; Man, Jiang-Hong; Gao, Yan-Fei; Zhang, Pei-Jing; Li, Wei-Hua; Zhao, Jie; Pan, Xin; Zhou, Tao; Gong, Wei-Li; Li, Ai-Ling; Zhang, Xue-Min] Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Proteom, Beijing 100850, Peoples R China		Zhang, XM (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Proteom, Beijing 100850, Peoples R China.	lal@proteomics.cn; xmzhang@nic.bmi.ac.cn		Zhang, Jiyan/0000-0001-8011-8719; Pan, Xin/0000-0002-1982-2261; Wang, Chenhui/0000-0002-3186-3066; Zhang, Peijing/0000-0003-1586-8710				Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; JACKMAN J, 1994, CANCER RES, V54, P5656; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Man JH, 2006, NUCLEIC ACIDS RES, V34, P5552, DOI 10.1093/nar/gkl691; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Pan X, 2006, BIOCHEM BIOPH RES CO, V344, P727, DOI 10.1016/j.bbrc.2006.03.194; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	39	111	124	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					533	541		10.1038/ni.1600	http://dx.doi.org/10.1038/ni.1600			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18362886				2022-12-18	WOS:000255153500015
J	Alpan, O; Bachelder, E; Isil, E; Arnheiter, H; Matzinger, P				Alpan, O; Bachelder, E; Isil, E; Arnheiter, H; Matzinger, P			'Educated' dendritic cells act as messengers from memory to naive T helper cells	NATURE IMMUNOLOGY			English	Article							PEYERS PATCH; IMMUNE-RESPONSE; BYSTANDER SUPPRESSION; ORAL TOLERANCE; IL-4; INDUCTION; RECEPTOR; DIFFERENTIATION; INTERLEUKIN-10; MECHANISMS	Ingested antigens lead to the generation of effector T cells that secrete interleukin 4 (IL-4) rather than interferon-gamma (IFN-gamma) and are capable of influencing naive T cells in their immediate environment to do the same. Using chimeric mice generated by aggregation of two genotypically different embryos, we found that the conversion of a naive T cell occurs only if it can interact with the same antigen-presenting cell, although not necessarily the same antigen, as the effector T cell. Using a two-step culture system in vitro, we found that antigen-presenting dendritic cells can act as 'temporal bridges' to relay information from orally immunized memory CD4 T cells to naive CD4 T cells. The orally immunized T cells use IL-4 and IL-10 (but not CD40 ligand) to 'educate' dendritic cells, which in turn induce naive T cells to produce the same cytokines as those produced by the orally immunized memory T cells.	NIAID, Ghost Lab, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; NINDS, Lab Dev Neurogenet, NIH, Bethesda, MD 20892 USA; Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Nebraska System; University of Nebraska Lincoln	Alpan, O (corresponding author), NIAID, Ghost Lab, Cellular & Mol Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	oalpan@niaid.nih.gov		Arnheiter, Heinz/0000-0003-2537-1134	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000581, ZIAAI000581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002790, Z01NS002790] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alpan O, 2001, J IMMUNOL, V166, P4843, DOI 10.4049/jimmunol.166.8.4843; Austin AS, 2003, J IMMUNOL, V171, P1336, DOI 10.4049/jimmunol.171.3.1336; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; CHEN Y, 1994, SCIENCE, V12, P1327; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; DAHLMANHOGLUND A, 1995, IMMUNOLOGY, V86, P128; Everson MP, 1998, J INTERF CYTOK RES, V18, P103, DOI 10.1089/jir.1998.18.103; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; GEARHART JD, 1972, DEV BIOL, V29, P27, DOI 10.1016/0012-1606(72)90040-1; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; HOGAN B, 1994, MANIPULATING MOUSE E, P363; Inobe J, 1998, EUR J IMMUNOL, V28, P2780, DOI 10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kapsenberg ML, 1996, ADV EXP MED BIOL, V409, P305; Kaul D, 1998, Dev Biol Stand, V95, P141; Kelsall BL, 2002, NAT IMMUNOL, V3, P699, DOI 10.1038/ni0802-699; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lardon F, 1997, IMMUNOLOGY, V91, P553, DOI 10.1046/j.1365-2567.1997.00295.x; Liu LM, 1997, ADV EXP MED BIOL, V417, P375; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; RICHMAN LK, 1981, J IMMUNOL, V126, P2079; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sayegh MH, 1996, ANN NY ACAD SCI, V778, P338, DOI 10.1111/j.1749-6632.1996.tb21141.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuhbauer DMS, 2000, EUR J IMMUNOL, V30, P1255; SQUIRE LR, 2002, FUNDAMENTAL NEUROSCI; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; TAYLOR AW, 1994, J IMMUNOL, V153, P1080; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0	40	111	116	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					615	622		10.1038/ni1077	http://dx.doi.org/10.1038/ni1077			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15156140				2022-12-18	WOS:000221664000020
J	Ma, YY; Liu, HT; Tu-Rapp, H; Thiesen, HJ; Ibrahim, SM; Cole, SM; Pope, RM				Ma, YY; Liu, HT; Tu-Rapp, H; Thiesen, HJ; Ibrahim, SM; Cole, SM; Pope, RM			Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; TOLL-LIKE RECEPTOR-4; RHEUMATOID-ARTHRITIS; MEDIATED APOPTOSIS; DEATH DOMAIN; INHIBITORY PROTEIN; GENE-EXPRESSION; TNF-ALPHA; SYSTEMIC AUTOIMMUNITY	The nonapoptotic functions of Fas ligation are incompletely characterized. In contrast to expectations, we show here that Fas-deficient mice developed less-severe collagen-induced arthritis than did control mice. Despite having milder arthritis, Fas-deficient mice had more of the critical pro-inflammatory mediator interleukin-1beta (IL-1beta) in their joints, suggesting inefficient activation through IL-1 receptor 1 (IL-1R1) when Fas signaling is deficient. In primary human macrophages and macrophages from Fas- or Fas ligand (FasL)-deficient mice, interruption of Fas- FasL signaling suppressed nuclear factor-kappaB activation and cytokine expression induced by IL-1beta and lipopolysaccharide. This cross-talk was mediated by the Fas- associated death domain through interaction with myeloid differentiation factor 88. These observations document a unique mechanism whereby Fas- FasL interactions enhance activation through the IL-1R1 or Toll-like receptor 4 pathway, which may contribute to the pathogenesis of chronic arthritis.	Northwestern Univ, Feinberg Sch Med, Integrated Grad Program Life Sci, Chicago, IL 60611 USA; Vet Adm Med Ctr, Lakeside Div, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; Univ Rostock, Dept Immunol, D-18055 Rostock, Germany	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Rostock	Pope, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Integrated Grad Program Life Sci, 300 E Super Ave,Tarry 3-713, Chicago, IL 60611 USA.	rmp158@northwestern.edu	Ibrahim, Saleh/AAO-9541-2020	Ibrahim, Saleh/0000-0001-7827-2290; Tu-Rapp, Hoang/0000-0002-8739-9573; Pope, Richard M./0000-0003-2416-8660	NIAMS NIH HHS [R01-AR049217] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049217] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; Eickelberg O, 1999, CIRCULATION, V99, P2276, DOI 10.1161/01.CIR.99.17.2276; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fukui M, 2003, J IMMUNOL, V171, P1868, DOI 10.4049/jimmunol.171.4.1868; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Ibrahim SM, 2002, J AUTOIMMUN, V18, P159, DOI 10.1006/jaut.2001.0580; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Palmer G, 2003, EUR J IMMUNOL, V33, P434, DOI 10.1002/immu.200310018; Park DR, 2003, J IMMUNOL, V170, P6209, DOI 10.4049/jimmunol.170.12.6209; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Russo MP, 2002, AM J PHYSIOL-CELL PH, V283, pC347, DOI 10.1152/ajpcell.00166.2001; Scaffidi C, 1999, METHODS, V17, P287, DOI 10.1006/meth.1999.0742; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; SINGER GG, 1994, CURR OPIN IMMUNOL, V6, P913, DOI 10.1016/0952-7915(94)90013-2; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; WENDLING D, 1993, J RHEUMATOL, V20, P259; Williams RO, 2000, J IMMUNOL, V165, P7240, DOI 10.4049/jimmunol.165.12.7240; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yoshino S, 1999, J IMMUNOL, V163, P3417; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	53	111	113	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					380	387		10.1038/ni1054	http://dx.doi.org/10.1038/ni1054			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15004557				2022-12-18	WOS:000220515900010
J	Kourtzelis, I; Li, XF; Mitroulis, I; Grosser, D; Kajikawa, T; Wang, BM; Grzybek, M; von Renesse, J; Czogalla, A; Troullinaki, M; Ferreira, A; Doreth, C; Ruppova, K; Chen, LS; Hosur, K; Lim, JH; Chung, KJ; Grossklaus, S; Tausche, AK; Joosten, LAB; Moutsopoulos, NM; Wielockx, B; Castrillo, A; Korostoff, JM; Coskun, U; Hajishengallis, G; Chavakis, T				Kourtzelis, Ioannis; Li, Xiaofei; Mitroulis, Ioannis; Grosser, Daniel; Kajikawa, Tetsuhiro; Wang, Baomei; Grzybek, Michal; von Renesse, Janusz; Czogalla, Aleksander; Troullinaki, Maria; Ferreira, Anaisa; Doreth, Christian; Ruppova, Klara; Chen, Lan-Sun; Hosur, Kavita; Lim, Jong-Hyung; Chung, Kyoung-Jin; Grossklaus, Sylvia; Tausche, Anne Kathrin; Joosten, Leo A. B.; Moutsopoulos, Niki M.; Wielockx, Ben; Castrillo, Antonio; Korostoff, Jonathan M.; Coskun, Uenal; Hajishengallis, George; Chavakis, Triantafyllos			DEL-1 promotes macrophage efferocytosis and clearance of inflammation	NATURE IMMUNOLOGY			English	Article							DEVELOPMENTAL ENDOTHELIAL LOCUS-1; GINGIVAL CREVICULAR FLUID; RESOLVING LIPID MEDIATORS; APOPTOTIC CELLS; RESOLUTION-PHASE; MAST-CELLS; IN-VITRO; RECEPTOR; PERIODONTITIS; MODEL	Resolution of inflammation is essential for tissue homeostasis and represents a promising approach to inflammatory disorders. Here we found that developmental endothelial locus-1 (DEL-1), a secreted protein that inhibits leukocyte-endothelial adhesion and inflammation initiation, also functions as a non-redundant downstream effector in inflammation clearance. In human and mouse periodontitis, waning of inflammation was correlated with DEL-1 upregulation, whereas resolution of experimental periodontitis failed in DEL-1 deficiency. This concept was mechanistically substantiated in acute monosodium-urate-crystalinduced inflammation, where the pro-resolution function of DEL-1 was attributed to effective apoptotic neutrophil clearance (efferocytosis). DEL-1-mediated efferocytosis induced liver X receptor-dependent macrophage reprogramming to a proresolving phenotype and was required for optimal production of at least certain specific pro-resolving mediators. Experiments in transgenic mice with cell-specific overexpression of DEL-1 linked its anti-leukocyte-recruitment action to endothelial cell-derived DEL-1 and its efferocytic/pro-resolving action to macrophage-derived DEL-1. Thus, the compartmentalized expression of DEL-1 facilitates distinct homeostatic functions in an appropriate context that can be harnessed therapeutically.	[Kourtzelis, Ioannis; Mitroulis, Ioannis; von Renesse, Janusz; Troullinaki, Maria; Ferreira, Anaisa; Doreth, Christian; Ruppova, Klara; Chen, Lan-Sun; Lim, Jong-Hyung; Chung, Kyoung-Jin; Grossklaus, Sylvia; Wielockx, Ben; Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Inst Clin Chem & Lab Med, Dresden, Germany; [Kourtzelis, Ioannis; Mitroulis, Ioannis] German Canc Res Ctr, Partner Site Dresden, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kourtzelis, Ioannis; Mitroulis, Ioannis] Tech Univ Dresden, Fac Med, Dresden, Germany; [Kourtzelis, Ioannis; Mitroulis, Ioannis] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Kourtzelis, Ioannis; Mitroulis, Ioannis] Helmholtz Zentrum Dresden Rossendorf, Helmholtz Assoc, Dresden, Germany; [Li, Xiaofei; Kajikawa, Tetsuhiro; Wang, Baomei; Hosur, Kavita; Hajishengallis, George] Univ Penn, Dept Microbiol, Penn Dent Med, Philadelphia, PA 19104 USA; [Grosser, Daniel; Grzybek, Michal; Chung, Kyoung-Jin; Coskun, Uenal] Helmholtz Zentrum Munchen, Fac Med, Paul Langerhans Inst Dresden, Dresden, Germany; [Grosser, Daniel; Grzybek, Michal; Chung, Kyoung-Jin; Coskun, Uenal] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Grosser, Daniel; Grzybek, Michal; Chung, Kyoung-Jin; Coskun, Uenal] German Ctr Diabet Res, Neuherberg, Germany; [Czogalla, Aleksander] Univ Wroclaw, Fac Biotechnol, Lab Cytobiochem, Wroclaw, Poland; [Tausche, Anne Kathrin] Tech Univ Dresden, Fac Med, Div Rheumatol, Med Clin 3, Dresden, Germany; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Moutsopoulos, Niki M.] Natl Inst Dent & Craniofacial Res, Oral Immun & Inflammat Unit, NIH, Bethesda, MD USA; [Castrillo, Antonio] Consejo Super Invest Cient CSIC Madrid, Inst Invest Biomed IIBM Alberto Sols, Madrid, Spain; [Castrillo, Antonio] ULPGC, Inst Univ Invest Biomed & Sanitarias, Unidad Asociada, Unidad Biomed,IIBM,CSIC, Las Palmas Gran Canaria, Spain; [Korostoff, Jonathan M.] Univ Penn, Penn Dent Med, Dept Periodont, Philadelphia, PA 19104 USA	Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Pennsylvania; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wroclaw; Technische Universitat Dresden; Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria; University of Pennsylvania	Kourtzelis, I; Chavakis, T (corresponding author), Tech Univ Dresden, Fac Med, Inst Clin Chem & Lab Med, Dresden, Germany.; Kourtzelis, I (corresponding author), German Canc Res Ctr, Partner Site Dresden, Natl Ctr Tumor Dis, Heidelberg, Germany.; Kourtzelis, I (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.; Kourtzelis, I (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Kourtzelis, I (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Helmholtz Assoc, Dresden, Germany.; Hajishengallis, G (corresponding author), Univ Penn, Dept Microbiol, Penn Dent Med, Philadelphia, PA 19104 USA.	ioannis.kourtzelis@uniklinikum-dresden.de; geoh@upenn.edu; triantafyllos.chavakis@uniklinikum-dresden.de	Korostoff, Jonathan/AAM-1691-2021; Mitroulis, Ioannis/AAB-7915-2021; Wielockx, Ben/AAC-6854-2020; Li, xiaofei/GXF-7187-2022; Joosten, Leo AB/H-3138-2015; Moutsopoulos, Niki/A-9538-2019; Chavakis, Triantafyllos/ABE-8845-2020; Czogalla, Aleksander/M-8504-2019; Korostoff, Jonathan/GRO-5722-2022; Czogalla, Aleksander/A-9752-2014; Grzybek, Michal/D-3802-2017; Coskun, Unal/F-4683-2011	Mitroulis, Ioannis/0000-0002-9991-2362; Wielockx, Ben/0000-0002-4923-2596; Joosten, Leo AB/0000-0001-6166-9830; Chen, Lan-Sun/0000-0002-5917-3083; Hajishengallis, George/0000-0001-7392-8852; Kourtzelis, Ioannis/0000-0003-3006-8885; Czogalla, Aleksander/0000-0003-3035-059X; Kajikawa, Tetsuhiro/0000-0001-8416-9126; Ferreira, Anaisa/0000-0002-6274-0448; Grzybek, Michal/0000-0003-2083-0506; Coskun, Unal/0000-0003-4375-3144	European Research Council (DEMETINL); Deutsche Forschungsgemeinschaft [Transregio-SFB 83, Transregio-SFB 127, Transregio-SFB 205]; National Institutes of Health [AI068730, DE024153, DE024716, DE026152, DE015254]; MeDDriveGrant from Technische Universitat Dresden Medical Faculty [60.400]; Spanish MINECO [SAF2014-56819R, SAF2015-71878-REDT]; National Institute of Dental and Craniofacial Research, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024153, R01DE015254, R01DE024716, R37DE026152] Funding Source: NIH RePORTER	European Research Council (DEMETINL); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MeDDriveGrant from Technische Universitat Dresden Medical Faculty; Spanish MINECO(Spanish Government); National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the European Research Council (DEMETINL to T.C.), the Deutsche Forschungsgemeinschaft (Transregio-SFB 83 to U.C. as well as Transregio-SFB 127 and Transregio-SFB 205 to T.C.), and the National Institutes of Health (AI068730, DE024153, DE024716, DE026152, and DE015254 to G.H.). I.K. was supported by the MeDDriveGrant (60.400) from the Technische Universitat Dresden Medical Faculty. A. Castrillo was supported by Spanish MINECO SAF2014-56819R and SAF2015-71878-REDT. This work was supported in part by intramural National Institute of Dental and Craniofacial Research, National Institutes of Health funding. We thank R. Naumann (Transgenic Core Facility, Max-Planck Institute for Cell Biology and Genetics Dresden, Germany) for microinjections and B. Gercken and M. Schuster (Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universitat Dresden, Dresden, Germany) for technical assistance. Parts of this work are included in the master's theses of C.D. at the Technische Universitat Dresden, Dresden, Germany, and A.F. at the University of Porto, Porto, Portugal.	A-Gonzalez Noelia, 2014, Front Immunol, V5, P211, DOI 10.3389/fimmu.2014.00211; A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Abe T, 2015, J IMMUNOL, V195, P1427, DOI 10.4049/jimmunol.1500496; Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; [Anonymous], 2003, J PERIODONTOL, V74, P1395; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Bostanci N, 2007, J CLIN PERIODONTOL, V34, P370, DOI 10.1111/j.1600-051X.2007.01061.x; Chen LS, 2018, THROMB HAEMOSTASIS, V118, P613, DOI 10.1055/s-0038-1624582; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Choi EY, 2015, MOL PSYCHIATR, V20, P880, DOI 10.1038/mp.2014.146; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Choi JY, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005864; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Folwaczny M, 2017, EUR J ORAL SCI, V125, P258, DOI 10.1111/eos.12357; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Getting SJ, 1997, J PHARMACOL EXP THER, V283, P123; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Griffiths GS, 2003, PERIODONTOL 2000, V31, P32, DOI 10.1034/j.1600-0757.2003.03103.x; Hajishengallis G, 2016, SEMIN IMMUNOL, V28, P146, DOI 10.1016/j.smim.2016.02.002; Hajishengallis G, 2015, VIRULENCE, V6, P229, DOI 10.4161/21505594.2014.990806; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2013, TRENDS IMMUNOL, V34, P1, DOI 10.1016/j.it.2012.08.003; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Hong C, 2011, J LIPID RES, V52, P531, DOI 10.1194/jlr.M010686; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Kajikawa T, 2017, J CLIN PERIODONTOL, V44, P472, DOI 10.1111/jcpe.12707; Kang YY, 2014, BIOCHEM BIOPH RES CO, V445, P369, DOI 10.1016/j.bbrc.2014.02.009; Kantarci A, 2005, J PERIODONTOL, V76, P2168, DOI 10.1902/jop.2005.76.11-S.2168; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Kourtzelis I, 2016, THROMB HAEMOSTASIS, V115, P781, DOI 10.1160/TH15-05-0429; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Maekawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9272; Martin WJ, 2011, ARTHRITIS RHEUM-US, V63, P1322, DOI 10.1002/art.30249; Matsuda S, 2016, J IMMUNOL METHODS, V438, P21, DOI 10.1016/j.jim.2016.08.008; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Mitroulis I, 2014, THROMB HAEMOSTASIS, V111, P1004, DOI 10.1160/TH13-09-0794; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Rebe C, 2009, CIRC RES, V105, P393, DOI 10.1161/CIRCRESAHA.109.201855; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shin J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5380; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Subramanian P, 2017, THROMB HAEMOSTASIS, V117, P2003, DOI 10.1160/TH17-03-0160; Villoutreix BO, 2016, TRENDS PHARMACOL SCI, V37, P641, DOI 10.1016/j.tips.2016.06.003; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772	69	110	114	8	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					40	+		10.1038/s41590-018-0249-1	http://dx.doi.org/10.1038/s41590-018-0249-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30455459	Green Accepted, Green Submitted			2022-12-18	WOS:000456273900013
J	Zhang, Y; Mao, DL; Roswit, WT; Jin, XH; Patel, AC; Patel, DA; Agapov, E; Wang, ZP; Tidwell, RM; Atkinson, JJ; Huang, GM; McCarthy, R; Yu, JS; Yun, NE; Paessler, S; Lawson, TG; Omattage, NS; Brett, TJ; Holtzman, MJ				Zhang, Yong; Mao, Dailing; Roswit, William T.; Jin, Xiaohua; Patel, Anand C.; Patel, Dhara A.; Agapov, Eugene; Wang, Zhepeng; Tidwell, Rose M.; Atkinson, Jeffrey J.; Huang, Guangming; McCarthy, Ronald; Yu, Jinsheng; Yun, Nadezhda E.; Paessler, Slobodan; Lawson, T. Glen; Omattage, Natalie S.; Brett, Tom J.; Holtzman, Michael J.			PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection	NATURE IMMUNOLOGY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY; DNA-DAMAGE RESPONSE; B-CELL LYMPHOMAS; ENCEPHALOMYOCARDITIS VIRUS; INBORN-ERRORS; RNA HELICASE; STAT1; BBAP; TRANSCRIPTION; REPLICATION	Enhancing the response to interferon could offer an immunological advantage to the host. In support of this concept, we used a modified form of the transcription factor STAT1 to achieve hyper-responsiveness to interferon without toxicity and markedly improve antiviral function in transgenic mice and transduced human cells. We found that the improvement depended on expression of a PARP9-DTX3L complex with distinct domains for interaction with STAT1 and for activity as an E3 ubiquitin ligase that acted on host histone H2BJ to promote interferon-stimulated gene expression and on viral 3C proteases to degrade these proteases via the immunoproteasome. Thus, PARP9-DTX3L acted on host and pathogen to achieve a double layer of immunity within a safe reserve in the interferon signaling pathway.	[Zhang, Yong; Mao, Dailing; Roswit, William T.; Jin, Xiaohua; Patel, Anand C.; Patel, Dhara A.; Agapov, Eugene; Wang, Zhepeng; Tidwell, Rose M.; Atkinson, Jeffrey J.; Huang, Guangming; McCarthy, Ronald; Omattage, Natalie S.; Brett, Tom J.; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, Drug Discovery Program,Pulm & Crit Care Med, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Yu, Jinsheng] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yun, Nadezhda E.; Paessler, Slobodan] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Lawson, T. Glen] Bates Coll, Dept Chem, Lewiston, ME 04240 USA; [Brett, Tom J.; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Washington University (WUSTL)	Holtzman, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, Drug Discovery Program,Pulm & Crit Care Med, St Louis, MO 63110 USA.	holtzmanm@wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Atkinson, Jeffrey/0000-0001-9125-7968; Wang, Zhepeng/0000-0003-2835-7098	US National Institutes of Health (National Institute of Allergy and Infectious Diseases Asthma and Allergic Diseases Cooperative Research Center) [U19-AI070489, U54-AI05160, RO1-AI111605, R15-AI099134]; Martin Schaeffer Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111605, U19AI070489, R15AI099134, U54AI057160] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Allergy and Infectious Diseases Asthma and Allergic Diseases Cooperative Research Center); Martin Schaeffer Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A.C. Palmenberg (University of Wisconsin) for mouse monoclonal antibody to EMCV 3D; G. Stark (Cleveland Clinic) for the U3A cell line; A. Winoto (University of California, Berkeley) for plasmid pCI-His-Ub; E. Yeh (University of Texas, Houston) for plasmid pHA-Ubiquitin; J. Gem (University of Wisconsin) for HRV A16; and G. Amarasinghe (Washington University) for respiratory syncytial virus NS1. Supported by the US National Institutes of Health (National Institute of Allergy and Infectious Diseases Asthma and Allergic Diseases Cooperative Research Center U19-AI070489 to M.J.H.; U54-AI05160 to M.J.H.; RO1-AI111605 to M.J.H.; and R15-AI099134 to T.G.L.) and the Martin Schaeffer Fund (M.J.H.).	Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Aminev AG, 2003, VIRUS RES, V95, P59, DOI 10.1016/S0168-1702(03)00163-1; Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0; Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Camicia R, 2013, J CELL SCI, V126, P1969, DOI 10.1242/jcs.118174; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Juszczynski P, 2006, MOL CELL BIOL, V26, P5348, DOI 10.1128/MCB.02351-05; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12; Lidsky PV, 2006, J VIROL, V80, P2705, DOI 10.1128/JVI.80.6.2705-2717.2006; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Ohsaki E, 2004, J VIROL, V78, P9936, DOI 10.1128/JVI.78.18.9936-9946.2004; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pascual V, 2012, IMMUNITY, V36, P7, DOI 10.1016/j.immuni.2012.01.007; Patel DA, 2014, J BIOMOL SCREEN, V19, P119, DOI 10.1177/1087057113496848; Sancho-Shimizu V, 2011, CURR OPIN VIROL, V1, P487, DOI 10.1016/j.coviro.2011.10.016; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schlax PE, 2007, VIROLOGY, V360, P350, DOI 10.1016/j.virol.2006.10.043; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tempera I, 2010, J VIROL, V84, P4988, DOI 10.1128/JVI.02333-09; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Yan QS, 2013, MOL CELL BIOL, V33, P845, DOI 10.1128/MCB.00990-12; Yan QS, 2009, MOL CELL, V36, P110, DOI 10.1016/j.molcel.2009.08.019; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200	43	110	113	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1215	1227		10.1038/ni.3279	http://dx.doi.org/10.1038/ni.3279			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26479788	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000365062100005
J	Kwong, PD; Wilson, IA				Kwong, Peter D.; Wilson, Ian A.			HIV-1 and influenza antibodies: seeing antigens in new ways	NATURE IMMUNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CORECEPTOR-BINDING-SITE; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; TYROSINE SULFATION; B-CELLS; REPERTOIRE DEVELOPMENT; ENVELOPE GLYCOPROTEIN; VARIABLE REGIONS; CD4-BINDING SITE	New modes of humoral recognition have been identified by studies of antibodies that neutralize human immunodeficiency virus type 1 and influenza A viruses. Understanding how such modes of antibody-antigen recognition can occur in the context of sophisticated mechanisms of humoral evasion has implications for the development of effective vaccines. Here we describe eight modes of antibody recognition first observed with human immunodeficiency virus type 1. Similarities to four of these modes have been identified with antibodies to a conserved 'stem' epitope on influenza A viruses. We outline how each of these different modes of antibody recognition is particularly suited to overcoming a specific viral evasion tactic and assess potential routes of re-elicitation in vaccine settings.	[Kwong, Peter D.] NIAID, Vaccine Res Ctr, Natl Inst Hlth, Bethesda, MD 20892 USA; [Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Scripps Research Institute	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov			National Institutes of Health; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Elsliger, G. Nabel and L. Shapiro for comments on the manuscript; D. Ekiert for assistance with Figure 2; J. Stuckey for Figures 1-3; and members of the Structural Biology Section, Vaccine Research Center for comments on the manuscript. Supported by the National Institutes of Health (intramural program and grants) and by the International AIDS Vaccine Initiative.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHANHUI PY, 2009, KEYST S PREV HIV AID, P119; Chen WZ, 2009, CURR OPIN HIV AIDS, V4, P112, DOI 10.1097/COH.0b013e328322f95e; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; GELJTENBEEK TB, 2000, CELL, V100, P587; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; JOHNSON PR, NAT MED IN PRESS; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Ksenofontov A L, 2008, Mol Biol (Mosk), V42, P1093; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pan C, 2009, AIDS, V23, P639, DOI 10.1097/QAD.0b013e328325a4cd; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	61	110	118	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					573	578		10.1038/ni.1746	http://dx.doi.org/10.1038/ni.1746			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448659	Green Accepted			2022-12-18	WOS:000266384100008
J	Pennington, DJ; Silva-Santos, B; Shires, J; Theodoridis, E; Pollitt, C; Wise, EL; Tigelaar, RE; Owen, MJ; Hayday, AC				Pennington, DJ; Silva-Santos, B; Shires, J; Theodoridis, E; Pollitt, C; Wise, EL; Tigelaar, RE; Owen, MJ; Hayday, AC			The inter-relatedness and interdependence of mouse T cell receptor gamma delta(+) and alpha beta(+) cells	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; GAMMA-DELTA CELLS; ALPHA-BETA; INTRAEPITHELIAL LYMPHOCYTES; INTESTINAL EPITHELIUM; TYROSINE KINASES; GUT EPITHELIUM; MICE LACKING; EXPRESSION; SELECTION	Although T cell receptor (TCR)gammadelta(+) and TCRalphabeta(+) cells are commonly viewed as functionally independent, their relatedness and potential interdependence remain enigmatic. Here we have identified a gene profile that distinguishes mouse gammadelta cell populations from conventional alphabeta T cells. However, this profile was also expressed by sets of unconventional alphabeta T cells. Therefore, whereas TCR specificity determines the involvement of a T cell in an immune response, the cell's functional potential, as assessed by gene expression, does not segregate with the TCR. By monitoring the described gene profile, we show that gammadelta T cell development and function in TCRbeta-deficient mice was impaired because of the absence of alphabeta T cell progenitors. Thus, normal gammadelta cell development is dependent on the development of conventional alphabeta T cells.	Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Yale Univ, Dept Dermatol, New Haven, CT 06511 USA; Yale Univ, Immunobiol Sect, New Haven, CT 06511 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; Yale University	Hayday, AC (corresponding author), Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.			HAYDAY, ADRIAN/0000-0002-9495-5793; Pennington, Daniel/0000-0001-7889-9923; Silva-Santos, Bruno/0000-0003-4141-9302				Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Born W, 1999, Adv Immunol, V71, P77; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; BUCY RP, 1988, J IMMUNOL, V141, P2200; CERDAN C, 1995, J IMMUNOL, V154, P1007; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; EISEMAN E, 1992, NATURE, V355, P78; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Heiken H, 1996, EUR J IMMUNOL, V26, P1935, DOI 10.1002/eji.1830260839; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Kohyama M, 1999, P NATL ACAD SCI USA, V96, P7451, DOI 10.1073/pnas.96.13.7451; Laky K, 1997, J IMMUNOL, V158, P1417; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; MUKASA A, 1995, J IMMUNOL, V155, P2047; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; Rabinowich H, 1996, J IMMUNOL, V157, P1485; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Romero P, 2001, J LEUKOCYTE BIOL, V70, P219; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Wen L, 1998, J IMMUNOL, V160, P1965; Wilson A, 1998, J IMMUNOL, V161, P5851	47	110	110	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					991	998		10.1038/ni979	http://dx.doi.org/10.1038/ni979			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14502287				2022-12-18	WOS:000185590100015
J	Benveniste, P; Cantin, C; Hyam, D; Iscove, NN				Benveniste, P; Cantin, C; Hyam, D; Iscove, NN			Hematopoietic stem cells engraft in mice with absolute efficiency	NATURE IMMUNOLOGY			English	Article							BONE-MARROW CELLS; IN-VIVO; MOUSE; REPOPULATION; EXPRESSION; TRANSPLANTATION; DIFFERENTIATION; PROLIFERATION; EXPANSION; CYCLE	The engraftment of murine hematopoietic stem cells (HSCs) into irradiated mice is thought to be an inefficient process, but has yet to be measured directly. We used two independent strategies to test their engraftment efficiency: one measured competition of unpurified donor bone marrow cells with recipient cells in murine hosts and the other tracked the engraftment of one highly purified stem cell injected per recipient. The results showed that stem cells engrafted with near absolute efficiency. Thus, inefficient engraftment cannot explain the low frequency of permanent reconstitutions observed with pure HSC fractions and instead suggests most initially engrafted cells fail to sustain self-renewal.	Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Iscove, NN (corresponding author), Univ Toronto, Ontario Canc Inst, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.			Benveniste, Patricia/0000-0002-5673-0542				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; BOGGS DR, 1984, TRANSPLANTATION, V37, P300, DOI 10.1097/00007890-198403000-00017; BRECHER G, 1982, P NATL ACAD SCI-BIOL, V79, P5085, DOI 10.1073/pnas.79.16.5085; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; FAZEKAS S, 1982, J IMMUNOL METHODS, V49, P11; HARRISON DE, 1992, P NATL ACAD SCI USA, V89, P10134, DOI 10.1073/pnas.89.21.10134; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Hendrikx PJ, 1996, EXP HEMATOL, V24, P129; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ogawa M, 2001, ANN NY ACAD SCI, V938, P139; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Trevisan M, 1996, BLOOD, V88, P4149, DOI 10.1182/blood.V88.11.4149.bloodjournal88114149; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; VOGEL H, 1969, J THEOR BIOL, V22, P249, DOI 10.1016/0022-5193(69)90004-6	32	110	116	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					708	713		10.1038/ni940	http://dx.doi.org/10.1038/ni940			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12766767				2022-12-18	WOS:000183952500020
J	Strieter, RM				Strieter, RM			Chemokines: Not just leukocyte chemoattractants in the promotion of cancer	NATURE IMMUNOLOGY			English	News Item							PROTEIN-COUPLED RECEPTOR; KAPOSIS-SARCOMA; EXPRESSION; ANGIOGENESIS; INTERLEUKIN-8; HERPESVIRUS		Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Strieter, RM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, 900 Vet Ave,14-154 Warren Hall,Box 711922, Los Angeles, CA 90024 USA.							Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Bais C, 1998, NATURE, V392, P210, DOI 10.1038/32472; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Burger M, 1999, J IMMUNOL, V163, P2017; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Luca M, 1997, AM J PATHOL, V151, P1105; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447	11	110	114	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					285	286		10.1038/86286	http://dx.doi.org/10.1038/86286			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276195				2022-12-18	WOS:000167982900006
J	Yu, YR; Imrichova, H; Wang, HP; Chao, T; Xiao, ZT; Gao, M; Rincon-Restrepo, M; Franco, F; Genolet, R; Cheng, WC; Jandus, C; Coukos, G; Jiang, YF; Locasale, JW; Zippelius, A; Liu, PS; Tang, L; Bock, C; Vannini, N; Ho, PC				Yu, Yi-Ru; Imrichova, Hana; Wang, Haiping; Chao, Tung; Xiao, Zhengtao; Gao, Min; Rincon-Restrepo, Marcela; Franco, Fabien; Genolet, Raphael; Cheng, Wan-Chen; Jandus, Camilla; Coukos, George; Jiang, Yi-Fan; Locasale, Jason W.; Zippelius, Alfred; Liu, Pu-Ste; Tang, Li; Bock, Christoph; Vannini, Nicola; Ho, Ping-Chih			Disturbed mitochondrial dynamics in CD8(+)TILs reinforce T cell exhaustion	NATURE IMMUNOLOGY			English	Article							INHIBITORY RECEPTOR PD-1; SET ENRICHMENT ANALYSIS; TUMOR MICROENVIRONMENT; RNA-SEQ; CHECKPOINT; DYSFUNCTION; DIFFERENTIATION; EXPRESSION; MITOPHAGY; ALIGNMENT	Ho and colleagues report that mitochondrial dysfunction and impaired mitophagy triggered by the tumor microenvironment lead to subsequent epigenetic changes and cause permanent T cell exhaustion and dysfunction. The metabolic challenges present in tumors attenuate the metabolic fitness and antitumor activity of tumor-infiltrating T lymphocytes (TILs). However, it remains unclear whether persistent metabolic insufficiency can imprint permanent T cell dysfunction. We found that TILs accumulated depolarized mitochondria as a result of decreased mitophagy activity and displayed functional, transcriptomic and epigenetic characteristics of terminally exhausted T cells. Mechanistically, reduced mitochondrial fitness in TILs was induced by the coordination of T cell receptor stimulation, microenvironmental stressors and PD-1 signaling. Enforced accumulation of depolarized mitochondria with pharmacological inhibitors induced epigenetic reprogramming toward terminal exhaustion, indicating that mitochondrial deregulation caused T cell exhaustion. Furthermore, supplementation with nicotinamide riboside enhanced T cell mitochondrial fitness and improved responsiveness to anti-PD-1 treatment. Together, our results reveal insights into how mitochondrial dynamics and quality orchestrate T cell antitumor responses and commitment to the exhaustion program.	[Yu, Yi-Ru; Wang, Haiping; Chao, Tung; Rincon-Restrepo, Marcela; Franco, Fabien; Genolet, Raphael; Cheng, Wan-Chen; Jandus, Camilla; Coukos, George; Vannini, Nicola; Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Yu, Yi-Ru; Wang, Haiping; Chao, Tung; Rincon-Restrepo, Marcela; Franco, Fabien; Genolet, Raphael; Cheng, Wan-Chen; Jandus, Camilla; Coukos, George; Vannini, Nicola; Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland; [Imrichova, Hana; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Xiao, Zhengtao; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Gao, Min; Tang, Li] Ecole Polytech Fed Lausanne, Inst Mat Sci & Engn, Inst Bioengn, Lausanne, Switzerland; [Jiang, Yi-Fan] Natl Taiwan Univ, Sch Vet Med, Grad Inst Mol & Comparat Pathobiol, Taipei, Taiwan; [Zippelius, Alfred] Univ Hosp, Lab Canc Immunol, Dept Biomed, Basel, Switzerland; [Zippelius, Alfred] Univ Basel, Basel, Switzerland; [Zippelius, Alfred] Univ Basel Hosp, Med Oncol, Basel, Switzerland; [Liu, Pu-Ste] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Miaoli County, Taiwan; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; National Taiwan University; University of Basel; University of Basel; National Health Research Institutes - Taiwan; Medical University of Vienna	Ho, PC (corresponding author), Univ Lausanne, Dept Oncol, Lausanne, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland.	ping-chih.ho@unil.ch	Imrichova, Hana/H-1739-2016; Coukos, George/ABG-7389-2020; Bock, Christoph/AAE-7618-2019; jiang, yifan/GQH-5044-2022; Locasale, Jason W/ABE-6505-2020	Imrichova, Hana/0000-0003-0385-1823; Bock, Christoph/0000-0001-6091-3088; Locasale, Jason W/0000-0002-7766-3502; JIANG, YI-FAN/0000-0002-1692-4385; Yu, Yi-Ru/0000-0002-3562-3502; Xiao, Zhengtao/0000-0002-5535-5381; Gao, Min/0000-0003-2106-0267; Vannini, Nicola/0000-0002-6351-7512; Chao, Tung/0000-0003-3641-4996; Tang, Li/0000-0002-6393-982X; Ho, Ping-Chih/0000-0003-3078-3774	SNSF [31003A_163204, 31003A_182470, 320030_162575, PROOP3_179727]; Swiss Institute for Experimental Cancer Research [ISREC 26075483]; European Research Council (ERC) [802773-MitoGuide]; Kristian Gerhard Jebsen Foundation; Austrian Science Fund (FWF) Special Research Programme grant; Austrian Academy of Sciences; ERC [679146]; Ministry of Science and Technology [MOST-108-2320-B-400-025-MY3]; National Health Research Institute [NHRI-CS-108-PP-09]; Swiss National Science Foundation [315230_173243]; Swiss Cancer League [KFS-4600-08-2018, KFS-3710-08-2015]; Cancer League Switzerland [KFS-3394-02-2014]; Ludwig Institute for Cancer Research	SNSF(Swiss National Science Foundation (SNSF)); Swiss Institute for Experimental Cancer Research; European Research Council (ERC)(European Research Council (ERC)European Commission); Kristian Gerhard Jebsen Foundation; Austrian Science Fund (FWF) Special Research Programme grant(Austrian Science Fund (FWF)); Austrian Academy of Sciences; ERC(European Research Council (ERC)European Commission); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institute(National Health Research Institutes - Taiwan); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Cancer League Switzerland; Ludwig Institute for Cancer Research	We thank W.-L. Lo, S.C.-C. Huang and L.-F. Lu for insightful comments. We thank A. Nemc for preparing the WGBS libraries, V. Gernedl for preparing the ATAC-seq libraries and the Biomedical Sequencing Facility at CeMM for assistance with next-generation sequencing. We also thank M. Bosenberg (Yale University) for providing YUMM1.7 melanoma cells, T. Dawson (Johns Hopkins School of Medicine) for providing Park2<SUP>flox/flox</SUP> mice, I. Ganley (University of Dundee) for providing Mito-QC mice and R. Ahmed (Emory University) for providing the autophagy reporter. We thank the instrumental support from the EM facility of the biomedical sciences and the ASCEM in Academia Sinica. P.-C.H. was supported in part by SNSF project grants (31003A_163204 and 31003A_182470), the Swiss Institute for Experimental Cancer Research (ISREC 26075483) and a European Research Council (ERC) Starting Grant (802773-MitoGuide). N.V. was supported by the Kristian Gerhard Jebsen Foundation. An Austrian Science Fund (FWF) Special Research Programme grant, New Frontiers Group award of the Austrian Academy of Sciences and ERC Starting Grant (679146) was awarded to C.B. P.-S.L. was supported by the Ministry of Science and Technology grant (MOST-108-2320-B-400-025-MY3) and National Health Research Institute grant (NHRI-CS-108-PP-09). L.T. was supported in part by the Swiss National Science Foundation (project grant 315230_173243) and Swiss Cancer League (grant no. KFS-4600-08-2018). A.Z. was supported by Cancer League Switzerland (KFS-3394-02-2014) and an SNSF project grant (320030_162575). C.J. was supported by the Swiss Cancer League (KFS-3710-08-2015), an SNSF grant (PROOP3_179727) and the Ludwig Institute for Cancer Research.	Alfei F, 2017, TRENDS MOL MED, V23, P769, DOI 10.1016/j.molmed.2017.07.006; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Balkhi MY, 2018, ISCIENCE, V2, P105, DOI 10.1016/j.isci.2018.03.009; Barili V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14137-7; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cao Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09263-1; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chao Y, 2018, NAT BIOMED ENG, V2, P611, DOI 10.1038/s41551-018-0262-6; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayashi K, 2016, ADV FUNCT MATER, V26, P1708, DOI 10.1002/adfm.201504215; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Ho PC, 2014, CANCER RES, V74, P3205, DOI 10.1158/0008-5472.CAN-13-3461; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Imrichova H, 2015, NUCLEIC ACIDS RES, V43, pW57, DOI 10.1093/nar/gkv395; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jiang YF, 2017, JOVE-J VIS EXP, V19, P56567; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larsen GA, 2006, BRAIN RES, V1077, P153, DOI 10.1016/j.brainres.2005.10.095; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Merkel A, 2019, BIOINFORMATICS, V35, P737, DOI 10.1093/bioinformatics/bty690; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Pan HY, 2019, ACS APPL MATER INTER, V11, P2782, DOI 10.1021/acsami.8b16517; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rendeiro AF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11938; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Xiao ZT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11738-0; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	76	109	111	9	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1540	+		10.1038/s41590-020-0793-3	http://dx.doi.org/10.1038/s41590-020-0793-3		OCT 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33020660	Green Submitted			2022-12-18	WOS:000575347200002
J	Negishi, H; Yanai, H; Nakajima, A; Koshiba, R; Atarashi, K; Matsuda, A; Matsuki, K; Miki, S; Doi, T; Aderem, A; Nishio, J; Smale, ST; Honda, K; Taniguchi, T				Negishi, Hideo; Yanai, Hideyuki; Nakajima, Akira; Koshiba, Ryuji; Atarashi, Koji; Matsuda, Atsushi; Matsuki, Kosuke; Miki, Shoji; Doi, Takahiro; Aderem, Alan; Nishio, Junko; Smale, Stephen T.; Honda, Kenya; Taniguchi, Tadatsugu			Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; I INTERFERON; RIG-I; DENDRITIC CELLS; STRANDED-RNA; INNATE; INTERLEUKIN-12; RECOGNITION; IMMUNITY	Although the mechanisms by which innate pathogen-recognition receptors enhance adaptive immune responses are increasingly well understood, whether signaling events from distinct classes of receptors affect each other in modulating adaptive immunity remains unclear. We found here that the activation of cytosolic RIG-I-like receptors (RLRs) resulted in the selective suppression of transcription of the gene encoding the p40 subunit of interleukin 12 (Il12b) that was effectively induced by the activation of Toll-like receptors (TLRs). The RLR-activated transcription factor IRF3 bound dominantly, relative to IRF5, to the Il12b promoter, where it interfered with the TLR-induced assembly of a productive transcription-factor complex. The activation of RLRs in mice attenuated TLR-induced responses of the T helper type 1 cell (T(H)1 cell) and interleukin 17-producing helper T cell (T(H)17 cell) subset types and, consequently, viral infection of mice caused death at sublethal doses of bacterial infection. The innate immune receptor cross-interference we describe may have implications for infection-associated clinical episodes.	[Negishi, Hideo; Yanai, Hideyuki; Koshiba, Ryuji; Matsuda, Atsushi; Matsuki, Kosuke; Miki, Shoji; Nishio, Junko; Taniguchi, Tadatsugu] Univ Tokyo, Inst Ind Sci, Dept Mol Immunol, Tokyo, Japan; [Negishi, Hideo; Yanai, Hideyuki; Nakajima, Akira; Koshiba, Ryuji; Atarashi, Koji; Matsuda, Atsushi; Matsuki, Kosuke; Miki, Shoji; Nishio, Junko; Honda, Kenya; Taniguchi, Tadatsugu] Univ Tokyo, Dept Immunol, Grad Sch Med, Tokyo, Japan; [Negishi, Hideo; Yanai, Hideyuki; Nakajima, Akira; Koshiba, Ryuji; Atarashi, Koji; Matsuda, Atsushi; Matsuki, Kosuke; Miki, Shoji; Nishio, Junko; Honda, Kenya; Taniguchi, Tadatsugu] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Negishi, Hideo; Yanai, Hideyuki; Matsuda, Atsushi; Nishio, Junko; Taniguchi, Tadatsugu] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Doi, Takahiro] RIKEN BioResource Ctr, Subteam BioSignal Integrat, Technol & Dev Team BioSignal Program, Tsukuba, Ibaraki, Japan; [Aderem, Alan] Inst Syst Biol, Seattle, WA USA; [Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Atarashi, Koji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; Institute for Systems Biology (ISB); University of California System; University of California Los Angeles; Japan Science & Technology Agency (JST)	Taniguchi, T (corresponding author), Univ Tokyo, Inst Ind Sci, Dept Mol Immunol, Tokyo, Japan.	tada@m.u-tokyo.ac.jp	Yanai, Hideyuki/AGK-5933-2022; Atarashi, Koji/I-5363-2014; Honda, Kenya/N-5297-2015	Yanai, Hideyuki/0000-0002-0115-9000; Atarashi, Koji/0000-0001-5422-0736; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency (Core Research for Evolutional Science and Technology); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (Core Research for Evolutional Science and Technology)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank R. Medzhitov, A. Iwasaki, J. Ravetch, D. Savitsky and H. Rosen for advice; M. Kubo, M. Yoneyama, S. Nakae, S. Kano, F. Ohtake, H. Tani, N. Atarashi, M. Matsumoto, K. Nakayama and T. Negishi for discussions; and T. Ban, N. Endo, T. Kawaguchi, R. Takeda, M. Taniguchi and M. Shishido for technical assistance. Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-In-Aid for Scientific Research on Innovative Areas, Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms'), the Japan Science and Technology Agency (Core Research for Evolutional Science and Technology) and the Japan Society for the Promotion of Science (A.N. and R.K.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bakaletz LO, 2004, NAT REV MICROBIOL, V2, P552, DOI 10.1038/nrmicro928; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Ciavarra RP, 2005, VIROLOGY, V342, P177, DOI 10.1016/j.virol.2005.07.031; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holt PG, 2002, J EXP MED, V196, P1271, DOI 10.1084/jem.20021572; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Nakajima A, 2009, P NATL ACAD SCI USA, V106, P12448, DOI 10.1073/pnas.0905702106; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Oxenius A, 1999, J IMMUNOL, V162, P965; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10	46	109	117	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					659	+		10.1038/ni.2307	http://dx.doi.org/10.1038/ni.2307			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22610141				2022-12-18	WOS:000305483800011
J	Maecker, HT; McCoy, JP				Maecker, Holden T.; McCoy, J. Philip, Jr.		FOCIS Human Immunophenotyping Cons	A model for harmonizing flow cytometry in clinical trials	NATURE IMMUNOLOGY			English	Article							FICOLL-HYPAQUE SEPARATION; BLOOD MONONUCLEAR-CELLS; WHOLE-BLOOD; T-CELLS; LYSIS TECHNIQUE; NORMAL ADULTS; ASSAYS; CRYOPRESERVATION; ANTICOAGULANT; INFORMATION		[Maecker, Holden T.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [McCoy, J. Philip, Jr.] NHLBI, NIH, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Maecker, HT (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	maecker@stanford.edu	Roederer, Mario/G-1887-2011; YEH, JUNG-HUA/I-6084-2017; mccoy, john philip/ABD-9348-2021	Robinson, William/0000-0003-4385-704X; Di Meglio, Paola/0000-0002-2066-7780; Peakman, Mark/0000-0003-3328-3513; Davis, Mark/0000-0001-6868-657X; Field, Elizabeth/0000-0003-4043-7461; Denny, Thomas/0000-0002-7364-8276; Rich, Stephen/0000-0003-3872-7793	Intramural NIH HHS [ZIC HL005905-04, ZIC HL005905-03, ZIC HL005905-02, Z99 HL999999] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appay V, 2006, J IMMUNOL METHODS, V309, P192, DOI 10.1016/j.jim.2005.11.007; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Bollinger T, 2009, CLIN EXP IMMUNOL, V155, P231, DOI 10.1111/j.1365-2249.2008.03822.x; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P341, DOI 10.1016/j.bbi.2003.08.004; Hodge GL, 1999, J IMMUNOL METHODS, V225, P27, DOI 10.1016/S0022-1759(99)00025-3; Hoffmeister B, 2003, EUR J IMMUNOL, V33, P3484, DOI 10.1002/eji.200324223; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kumar P, 2000, CLIN DIAGN LAB IMMUN, V7, P578, DOI 10.1128/CDLI.7.4.578-583.2000; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; LEVI FA, 1988, J CLIN INVEST, V81, P407, DOI 10.1172/JCI113333; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maecker Holden T., 2009, V485, P375, DOI 10.1007/978-1-59745-170-3_25; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2007, CYTOM PART A, V71A, P73, DOI 10.1002/cyto.a.20358; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; ROMEU MA, 1992, J IMMUNOL METHODS, V154, P7; Seale AC, 2008, J CLIN LAB ANAL, V22, P153, DOI 10.1002/jcla.20234; Shalekoff S, 1998, CLIN DIAGN LAB IMMUN, V5, P695, DOI 10.1128/CDLI.5.5.695-702.1998; Suni Maria A, 2003, BMC Immunol, V4, P9, DOI 10.1186/1471-2172-4-9; Wang L, 2008, CYTOM PART A, V73A, P279, DOI 10.1002/cyto.a.20507; Weinberg A, 1998, CLIN DIAGN LAB IMMUN, V5, P804, DOI 10.1128/CDLI.5.6.804-807.1998; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08	26	109	112	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					975	978		10.1038/ni1110-975	http://dx.doi.org/10.1038/ni1110-975			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959798	Green Published, Green Accepted			2022-12-18	WOS:000283127800003
J	Campbell, DJ; Kim, CH; Butcher, EC				Campbell, DJ; Kim, CH; Butcher, EC			Separable effector T cell populations specialized for B cell help or tissue inflammation	NATURE IMMUNOLOGY			English	Article							CXC CHEMOKINE RECEPTOR-5; P-SELECTIN; REGIONAL IMMUNITY; LYMPHOID ORGANS; DENDRITIC CELL; IN-VIVO; EXPRESSION; LYMPHOCYTES; SKIN; PHENOTYPE	We identified specialized B helper and tissue inflammatory CD4(+) T cell subsets that developed concurrently from common naive precursors during the primary immune response. These separable populations were distinguishable by their expression of adhesion and chemoattractant receptors that directed their homing to the appropriate effector sites in vivo and also showed intrinsic differences in their ability to support B cell antibody production and produce effector cytokines in vitro. Thus, our data show a previously unappreciated functional specialization among CD4(+) effector T cells, further defining their diversity and role in adaptive immunity.	Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Campbell, DJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.			Kim, Chang/0000-0003-4618-9139				Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; DEKRUYFF RH, 1989, J IMMUNOL, V142, P2575; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Goebeler M, 1998, J PATHOL, V184, P89, DOI 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kelso A, 1999, INT IMMUNOL, V11, P617, DOI 10.1093/intimm/11.4.617; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Knibbs RN, 1998, J IMMUNOL, V161, P6305; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nanki T, 2000, INT IMMUNOL, V12, P1659, DOI 10.1093/intimm/12.12.1659; Narumi S, 1997, J IMMUNOL, V158, P5536; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Patel DD, 2001, CLIN IMMUNOL, V98, P39, DOI 10.1006/clim.2000.4957; PICKER LJ, 1990, AM J PATHOL, V136, P1053; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Rott LS, 1996, J IMMUNOL, V156, P3727; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Teraki Y, 1997, J IMMUNOL, V159, P6018; Tietz W, 1998, J IMMUNOL, V161, P963; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; WONG RL, 1988, J IMMUNOL, V141, P3329; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zelenika D, 1998, J IMMUNOL, V161, P1868	50	109	117	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					876	881		10.1038/ni0901-876	http://dx.doi.org/10.1038/ni0901-876			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526405				2022-12-18	WOS:000170781200029
J	Chavakis, T; Mitroulis, I; Hajishengallis, G				Chavakis, Triantafyllos; Mitroulis, Ioannis; Hajishengallis, George			Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation	NATURE IMMUNOLOGY			English	Review							STEM-CELLS; CLONAL HEMATOPOIESIS; MYOCARDIAL-INFARCTION; GM-CSF; PROMOTES MYELOPOIESIS; LINEAGE COMMITMENT; ENDOTHELIAL-CELLS; IMMUNE PRIVILEGE; CHRONIC EXPOSURE; SELF-RENEWAL	Recent advances have highlighted the ability of hematopoietic stem and progenitor cells in the bone marrow to sense peripheral inflammation or infection and adapt through increased proliferation and skewing toward the myeloid lineage. Such adaptations can meet the increased demand for innate immune cells and can be beneficial in response to infection or myeloablation. However, the inflammation-induced adaptation of hematopoietic and myeloid progenitor cells toward enhanced myelopoiesis might also perpetuate inflammation in chronic inflammatory or cardio-metabolic diseases by generating a feed-forward loop between inflammation-adapted hematopoietic progenitor cells and the inflammatory disorder. Sustained adaptive responses of progenitor cells in the bone marrow can also contribute to trained immunity, a non-specific memory of earlier encounters that in turn facilitates the heightened response of these cells, as well as that of their progeny, to future challenges. Here we discuss the mechanisms that govern the adaptation of hematopoietic progenitor cells to inflammation and its sequelae in the pathogenesis of human disease.	[Chavakis, Triantafyllos; Mitroulis, Ioannis] Tech Univ Dresden, Inst Clin Chem & Lab Med, Univ Hosp, Dresden, Germany; [Chavakis, Triantafyllos; Mitroulis, Ioannis] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany; [Mitroulis, Ioannis] German Canc Res Ctr, Partner Site Dresden, Natl Ctr Tumor Dis, Heidelberg, Germany; [Mitroulis, Ioannis] Tech Univ Dresden, Fac Med, Dresden, Germany; [Mitroulis, Ioannis] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Mitroulis, Ioannis] Helmholtz Zentrum Dresden Rossendorf, Helmholtz Assoc, Dresden, Germany; [Mitroulis, Ioannis] Democritus Univ Thrace, Dept Haematol, Alexandroupolis, Greece; [Mitroulis, Ioannis] Democritus Univ Thrace, Lab Mol Hematol, Alexandroupolis, Greece; [Hajishengallis, George] Univ Penn, Penn Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Democritus University of Thrace; Democritus University of Thrace; University of Pennsylvania	Chavakis, T (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Univ Hosp, Dresden, Germany.; Chavakis, T (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany.	triantafyllos.chavakis@uniklinikum-dresden.de	Mitroulis, Ioannis/AAB-7915-2021; Chavakis, Triantafyllos/ABE-8845-2020	Mitroulis, Ioannis/0000-0002-9991-2362; Hajishengallis, George/0000-0001-7392-8852	US National Institutes of Health [DE015254, DE024153, DE024716, DE026152]; European Research Council [DEMETINL-683145]; Deutsche Forschungsgemeinschaft [SFB/TRR 205]; National Center for Tumor Diseases, Partner Site Dresden; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015254, R01DE024716, R01DE024153, R37DE026152] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Center for Tumor Diseases, Partner Site Dresden(Deutsche KrebshilfeHelmholtz Association); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by the US National Institutes of Health (DE015254, DE024153 and DE024716 to G.H. and DE026152 to G.H. and T.C.), the European Research Council (DEMETINL-683145 to T.C.), the Deutsche Forschungsgemeinschaft (SFB/TRR 205 to T.C.) and the National Center for Tumor Diseases, Partner Site Dresden (I.M.).	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barrett TJ, 2017, ANN NY ACAD SCI, V1402, P31, DOI 10.1111/nyas.13462; Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Boettcher S, 2014, BLOOD, V124, P1393, DOI 10.1182/blood-2014-04-570762; Bowers E, 2018, NAT MED, V24, P95, DOI 10.1038/nm.4448; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Cai ZG, 2018, CELL STEM CELL, V23, P833, DOI 10.1016/j.stem.2018.10.013; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen C, 2010, J CLIN INVEST, V120, P4091, DOI 10.1172/JCI43873; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; DAMIA G, 1992, CANCER RES, V52, P4082; de Bruin AM, 2013, BLOOD, V121, P3578, DOI 10.1182/blood-2012-05-432906; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dragoljevic D, 2018, EUR HEART J, V39, P2158, DOI 10.1093/eurheartj/ehy119; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Endele M, 2017, BLOOD, V129, P1691, DOI 10.1182/blood-2016-05-714329; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Etzrodt M, 2019, BLOOD, V133, P816, DOI 10.1182/blood-2018-02-832998; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Furusawa J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005507; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Griffin C, 2018, J BIOL CHEM, V293, P8775, DOI 10.1074/jbc.RA117.001526; Gutierrez-Martinez P, 2018, NAT CELL BIOL, V20, P413, DOI 10.1038/s41556-018-0054-y; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Hibbs ML, 2007, J IMMUNOL, V178, P6435, DOI 10.4049/jimmunol.178.10.6435; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Itoh-Nakadai A, 2017, CELL REP, V18, P2401, DOI 10.1016/j.celrep.2017.02.029; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kanayama M, 2017, NAT IMMUNOL, V18, P973, DOI 10.1038/ni.3791; Kandalla PK, 2016, J EXP MED, V213, P2269, DOI 10.1084/jem.20151975; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kourtzelis I, 2019, NAT IMMUNOL, V20, P40, DOI 10.1038/s41590-018-0249-1; Kwak HJ, 2015, IMMUNITY, V42, P159, DOI 10.1016/j.immuni.2014.12.017; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Luo YB, 2015, CELL METAB, V22, P886, DOI 10.1016/j.cmet.2015.08.020; Mann M, 2018, CELL REP, V25, P2992, DOI 10.1016/j.celrep.2018.11.056; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Matatall KA, 2016, CELL REP, V17, P2584, DOI 10.1016/j.celrep.2016.11.031; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; Meisel M, 2018, NATURE, V557, P580, DOI 10.1038/s41586-018-0125-z; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mitroulis I, 2018, J INNATE IMMUN, V10, P365, DOI 10.1159/000489406; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nahrendorf M, 2018, NAT MED, V24, P711, DOI 10.1038/s41591-018-0064-0; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Penkov S, 2019, TRENDS IMMUNOL, V40, P1, DOI 10.1016/j.it.2018.11.002; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043; Pinho S, 2018, DEV CELL, V44, P634, DOI 10.1016/j.devcel.2018.01.016; Prendergast AM, 2017, HAEMATOLOGICA, V102, P445, DOI 10.3324/haematol.2016.151209; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Sager HB, 2015, CIRCULATION, V132, P1880, DOI 10.1161/CIRCULATIONAHA.115.016160; Sallam T, 2018, NAT MED, V24, P304, DOI 10.1038/nm.4479; Sano S, 2018, J AM COLL CARDIOL, V71, P875, DOI 10.1016/j.jacc.2017.12.037; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schurch CM, 2014, CELL STEM CELL, V14, P460, DOI 10.1016/j.stem.2014.01.002; Schultze JL, 2019, IMMUNITY, V50, P288, DOI 10.1016/j.immuni.2019.01.019; Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Wei QZ, 2018, IMMUNITY, V48, P632, DOI 10.1016/j.immuni.2018.03.024; Weisser M, 2016, J ALLERGY CLIN IMMUN, V138, P219, DOI 10.1016/j.jaci.2015.11.028; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Xia PY, 2018, IMMUNITY, V48, P688, DOI 10.1016/j.immuni.2018.03.016; Yamamoto R, 2018, CELL STEM CELL, V22, P600, DOI 10.1016/j.stem.2018.03.013; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	139	108	109	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					802	811		10.1038/s41590-019-0402-5	http://dx.doi.org/10.1038/s41590-019-0402-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213716	Green Accepted			2022-12-18	WOS:000471891900012
J	Liu, MG; O'Connor, RS; Trefely, S; Graham, K; Snyder, NW; Beatty, GL				Liu, Mingen; O'Connor, Roddy S.; Trefely, Sophie; Graham, Kathleen; Snyder, Nathaniel W.; Beatty, Gregory L.			Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal	NATURE IMMUNOLOGY			English	Article							FATTY-ACID OXIDATION; 1ST-LINE TREATMENT; PANCREATIC-CANCER; ACYL-COENZYME; T-CELLS; ACTIVATION; INHIBITION; POLARIZATION; NETWORK; TARGETS	Macrophages enforce antitumor immunity by engulfing and killing tumor cells. Although these functions are determined by a balance of stimulatory and inhibitory signals, the role of macrophage metabolism is unknown. Here, we study the capacity of macrophages to circumvent inhibitory activity mediated by CD47 on cancer cells. We show that stimulation with a CpG oligodeoxynucleotide, a Toll-like receptor 9 agonist, evokes changes in the central carbon metabolism of macrophages that enable anti-tumor activity, including engulfment of CD47(+) cancer cells. CpG activation engenders a metabolic state that requires fatty acid oxidation and shunting of tricarboxylic acid cycle intermediates for de novo lipid biosynthesis. This integration of metabolic inputs is underpinned by carnitine palmitoyltransferase 1A and adenosine tri-phosphate citrate lyase, which, together, impart macrophages with antitumor potential capable of overcoming inhibitory CD47 on cancer cells. Our findings identify central carbon metabolism to be a novel determinant and potential therapeutic target for stimulating antitumor activity by macrophages.	[Liu, Mingen; Graham, Kathleen; Beatty, Gregory L.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [O'Connor, Roddy S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Trefely, Sophie; Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA; [Trefely, Sophie] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Beatty, Gregory L.] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Beatty, GL (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; Beatty, GL (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.	gregory.beatty@uphs.upenn.edu	Trefely, Sophie/AAL-9434-2020	Beatty, Gregory/0000-0001-7165-5993; Snyder, Nathaniel/0000-0001-5643-8747	Molecular Studies in Digestive and Liver Diseases grant from the National Institutes of Health [P30-DK050306]; NIH [R01 CA197916, R03 HD092630, F30 CA196124]; American Medical Association Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD092630] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F30CA196124, R01CA197916, R01CA226983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES026235] Funding Source: NIH RePORTER	Molecular Studies in Digestive and Liver Diseases grant from the National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank all members of the Beatty laboratory for helpful suggestions, and B. Keith, A. Rustgi, A. Minn, T. Ridky and K. Wellen for their scientific critiques. We thank J. Benci and O. Kawalekar for their assistance with CRISPR/Cas9 and Seahorse experiments; M. Stone for her assistance with immunohistochemistry; A. Rech for manuscript review; K. Foskett for sharing his Seahorse bioanalyzer; J. Scholler and A. Posey for assistance with lentivirus production and the Molecular Biology and Molecular Pathology and Imaging Cores of the Penn Center supported by a Molecular Studies in Digestive and Liver Diseases grant (P30-DK050306) from the National Institutes of Health. This work was supported by grants from the NIH (R01 CA197916 to G.L.B., R03 HD092630 to N.W.S., and F30 CA196124 to M.L), and the Seed Grant Program from the American Medical Association Foundation (M. Liu).	Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Cioffi M, 2015, CLIN CANCER RES, V21, P2325, DOI 10.1158/1078-0432.CCR-14-1399; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Frey AJ, 2016, ANAL BIOANAL CHEM, V408, P3651, DOI 10.1007/s00216-016-9448-5; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Ha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077615; Han CZ, 2011, CELL, V147, P1442, DOI 10.1016/j.cell.2011.12.006; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hirsh V, 2011, J CLIN ONCOL, V29, P2667, DOI 10.1200/JCO.2010.32.8971; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; LOKESH BR, 1984, BIOCHIM BIOPHYS ACTA, V792, P141, DOI 10.1016/0005-2760(84)90215-7; Long KB, 2016, CANCER DISCOV, V6, P400, DOI 10.1158/2159-8290.CD-15-1032; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manegold C, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mdr030; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; SASTRY PS, 1966, J BIOL CHEM, V241, P3354; Snyder NW, 2015, ANAL BIOCHEM, V474, P59, DOI 10.1016/j.ab.2014.12.014; Sosale NG, 2015, BLOOD, V125, P542, DOI 10.1182/blood-2014-06-585299; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Trefely S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1360-7; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	53	108	108	7	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					265	+		10.1038/s41590-018-0292-y	http://dx.doi.org/10.1038/s41590-018-0292-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30664738	Green Accepted			2022-12-18	WOS:000458893600012
J	Davis, MM; Tato, CM; Furman, D				Davis, Mark M.; Tato, Cristina M.; Furman, David			Systems immunology: just getting started	NATURE IMMUNOLOGY			English	Review							SEASONAL INFLUENZA; MASS CYTOMETRY; CELL SUBSETS; GENETIC-BASIS; IMMUNE; EXPRESSION; VACCINATION; RESPONSES; SIGNATURES; DECONVOLUTION	Systems-biology approaches in immunology take various forms, but here we review strategies for measuring a broad swath of immunological functions as a means of discovering previously unknown relationships and phenomena and as a powerful way of understanding the immune system as a whole. This approach has rejuvenated the field of vaccine development and has fostered hope that new ways will be found to combat infectious diseases that have proven refractory to classical approaches. Systems immunology also presents an important new strategy for understanding human immunity directly, taking advantage of the many ways the immune system of humans can be manipulated.	[Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.; Tato, Cristina M.; Furman, David] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Furman, David] Jose de San Martin Clin Hosp, Natl Sci & Tech Res Council, Inst Immunogenet, Buenos Aires, DF, Argentina	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Buenos Aires	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X; Tato, Cristina M./0000-0002-0614-756X	Howard Hughes Medical Institute; Parker Institute for Cancer Immunotherapy; US National Institutes of Health [U19 AI 057229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022511, U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Parker Institute for Cancer Immunotherapy; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Howard Hughes Medical Institute, The Parker Institute for Cancer Immunotherapy and the US National Institutes of Health (U19 AI 057229).	Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bendall S. C., 2012, NAT BIOTECHNOL, V6, P39; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blazkova J, 2017, J IMMUNOL, V198, P2479, DOI 10.4049/jimmunol.1601855; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7128, DOI 10.1073/pnas.1521651112; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Fragiadakis GK, 2015, ANESTHESIOLOGY, V123, P1241, DOI 10.1097/ALN.0000000000000887; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Furman D, 2015, VACCINE, V33, P5271, DOI 10.1016/j.vaccine.2015.06.117; Furman D, 2015, EXPERT REV VACCINES, V14, P461, DOI 10.1586/14760584.2015.966694; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gaudillbere D., 2014, SCI TRANSL MED, V6; GineIli M., 2017, BIOINFORMATICS, V33, P951; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Haialambieva I. H., 2016, VACCINE, V34, P3993; Han A., 2011, NAT BIOTECHOOL, V32, P684; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Haralambieva IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160970; Heather J. M., 2017, BRIEF BININFORM; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Kay AW, 2016, METHODS MOL BIOL, V1441, P13, DOI 10.1007/978-1-4939-3684-7_2; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Morrissette NS, 1999, J CELL SCI, V112, P4705; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Ovsyannikova IG, 2016, GENES IMMUN, V17, P371, DOI 10.1038/gene.2016.34; Price JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064555; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220; Romero P, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0685; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32976; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Yao Y, 2014, J IMMUNOL METHODS, V415, P1, DOI 10.1016/j.jim.2014.10.010; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zhong Y, 2012, NAT METHODS, V9, P8, DOI 10.1038/nmeth.1830; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	83	108	108	0	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					725	732		10.1038/ni.3768	http://dx.doi.org/10.1038/ni.3768			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28632713	Green Accepted, hybrid			2022-12-18	WOS:000403676300007
J	Khare, S; Ratsimandresy, RA; de Almeida, L; Cuda, CM; Rellick, SL; Misharin, AV; Wallin, MC; Gangopadhyay, A; Forte, E; Gottwein, E; Perlman, H; Reed, JC; Greaves, DR; Dorfleutner, A; Stehlik, C				Khare, Sonal; Ratsimandresy, Rojo A.; de Almeida, Lucia; Cuda, Carla M.; Rellick, Stephanie L.; Misharin, Alexander V.; Wallin, Melissa C.; Gangopadhyay, Anu; Forte, Eleonora; Gottwein, Eva; Perlman, Harris; Reed, John C.; Greaves, David R.; Dorfleutner, Andrea; Stehlik, Christian			The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses	NATURE IMMUNOLOGY			English	Article							SPECK-LIKE PROTEIN; CASPASE RECRUITMENT DOMAIN; NALP3 INFLAMMASOME; AIM2 INFLAMMASOME; INNATE IMMUNITY; I INTERFERON; HIN DOMAIN; CELL-DEATH; MELANOMA 2; KAPPA-B	The innate immune system responds to infection and tissue damage by activating cytosolic sensory complexes called 'inflammasomes'. Cytosolic DNA is sensed by AIM2-like receptors (ALRs) during bacterial and viral infections and in autoimmune diseases. Subsequently, recruitment of the inflammasome adaptor ASC links ALRs to the activation of caspase-1. A controlled immune response is crucial for maintaining homeostasis, but the regulation of ALR inflammasomes is poorly understood. Here we identified the PYRIN domain (PYD)-only protein POP3, which competes with ASC for recruitment to ALRs, as an inhibitor of DNA virus-induced activation of ALR inflammasomes in vivo. Data obtained with a mouse model with macrophage-specific POP3 expression emphasize the importance of the regulation of ALR inflammasomes in monocytes and macrophages.	[Khare, Sonal; Ratsimandresy, Rojo A.; de Almeida, Lucia; Cuda, Carla M.; Misharin, Alexander V.; Wallin, Melissa C.; Gangopadhyay, Anu; Perlman, Harris; Dorfleutner, Andrea; Stehlik, Christian] Northwestern Univ, Dept Med, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Rellick, Stephanie L.] W Virginia Univ, Hlth Sci Ctr, Program Canc Cell Biol, Morgantown, WV 26506 USA; [Forte, Eleonora; Gottwein, Eva] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Reed, John C.] Sanford Burnham Med Res Inst, Apoptosis & Cell Death Res Program, La Jolla, CA USA; [Reed, John C.] F Hoffmann La Roche, Pharma Res & Early Dev, Basel, Switzerland; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Stehlik, Christian] Northwestern Univ, Interdept Immunobiol Ctr, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Skin Dis Res Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; West Virginia University; Northwestern University; Feinberg School of Medicine; Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; University of Oxford; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Stehlik, C (corresponding author), Northwestern Univ, Dept Med, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA.	a-dorfleutner@northwestern.edu; c-stehlik@northwestern.edu	Misharin, Alexander/AAD-6456-2019; Dorfleutner, Andrea/AAG-5504-2021; Stehlik, Christian/AAG-2132-2021	Dorfleutner, Andrea/0000-0003-4406-2986; Stehlik, Christian/0000-0002-3782-2484; Cuda, Carla/0000-0002-2022-8171; Khare, Sonal/0000-0002-4044-3581; Misharin, Alexander/0000-0003-2879-3789; Greaves, David/0000-0003-2856-9410	National Cancer Institute [CA060553]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; American Heart Association [12GRNT12080035, 11POST585000]; Arthritis Foundation [AF161715]; Solovy/Arthritis Research Society;  [GM071723];  [HL097183];  [AI082406];  [AI099009];  [AR064349];  [AR057532];  [AR050250];  [AR054796];  [AI092490];  [HL108795];  [AR064313];  [T32AR007611]; British Heart Foundation [RG/10/15/28578] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097183, P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099009, R21AI092490, R21AI082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064349, T32AR007611, P30AR057216, K01AR064313, R01AR054796, R03AR057532, R01AR050250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071723] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); Arthritis Foundation; Solovy/Arthritis Research Society; ; ; ; ; ; ; ; ; ; ; ; ; British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B.C. Schaefer (Uniformed Services University of the Health Sciences) for the promoter of the gene encoding ubiquitin C; J. DeGregori (University of Colorado Health Sciences Center) for the plasmid pLXS-hCAR<SUP>Acyt</SUP>; D. Trono (Ecole Polytechnique Federale de Lausanne) for plasmids pMD2. G and psPAX2; K.A. Fitzgerald (University of Massachusetts) for Aim2<SUP>-/-</SUP> mice; the Northwestern University Transgenic and Targeted Mutagenesis Laboratory for assistance in generating transgenic mice; and A.D. Radian for the isolation of human macrophages. Supported by the US National Institutes of Health (GM071723, HL097183, AI092490, AI082406, AI099009 and AR064349 to C.S.; AR057532 to A.D., AR050250, AR054796, AI092490 and HL108795 to H.P.; AR064313 to C.M.C.; and T32AR007611 to L.d.A.), the National Cancer Institute (CA060553), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR057216), the American Heart Association (12GRNT12080035 to C.S.), the Arthritis Foundation (AF161715 to S.K.), the American Heart Association (11POST585000 to L.d.A.) and the Solovy/Arthritis Research Society (H. P.).	Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bryan NB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-23; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Greaves DR, 1998, GENOMICS, V54, P165, DOI 10.1006/geno.1998.5546; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3075; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kaser A, 2002, CLIN EXP IMMUNOL, V129, P332, DOI 10.1046/j.1365-2249.2002.01911.x; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Leon RP, 1998, P NATL ACAD SCI USA, V95, P13159, DOI 10.1073/pnas.95.22.13159; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Pisetsky DS, 2008, AUTOIMMUN REV, V8, P69, DOI 10.1016/j.autrev.2008.07.028; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Sciacca FL, 2000, J NEUROVIROL, V6, pS33; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876	56	108	115	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					343	+		10.1038/ni.2829	http://dx.doi.org/10.1038/ni.2829			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24531343	Green Accepted			2022-12-18	WOS:000333252000009
J	Hasan, M; Koch, J; Rakheja, D; Pattnaik, AK; Brugarolas, J; Dozmorov, I; Levine, B; Wakeland, EK; Lee-Kirsch, MA; Yan, N				Hasan, Maroof; Koch, James; Rakheja, Dinesh; Pattnaik, Asit K.; Brugarolas, James; Dozmorov, Igor; Levine, Beth; Wakeland, Edward K.; Lee-Kirsch, Min Ae; Yan, Nan			Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes	NATURE IMMUNOLOGY			English	Article							AICARDI-GOUTIERES-SYNDROME; DNA EXONUCLEASE TREX1; INNATE IMMUNE SENSOR; VIRUS; REVEALS; CHLOROQUINE; INHIBITION; MUTATIONS; TRANSPORT; DEFENSE	The sensing of viral nucleic acids by the innate immune system triggers the production of type I interferons, which activates interferon-stimulated genes (ISGs) and directs a multifaceted antiviral response. ISGs can also be activated through interferon-independent pathways, although the precise mechanisms remain elusive. Here we found that the cytosolic exonuclease Trex1 regulated the activation of a subset of ISGs independently of interferon. Both Trex1(-/-) mouse cells and Trex1-mutant human cells had high expression of genes encoding antiviral molecules ('antiviral genes') and were refractory to viral infection. The interferon-independent activation of antiviral genes in Trex1(-/-) cells required the adaptor STING, the kinase TBK1 and the transcription factors IRF3 and IRF7. We also found that Trex1-deficient cells had an expanded lysosomal compartment, altered subcellular localization of the transcription factor TFEB and diminished activity of the regulator mTORC1. Together our data identify Trex1 as a regulator of lysosomal biogenesis and interferon-independent activation of antiviral genes and show that dysregulation of lysosomes can elicit innate immune responses.	[Hasan, Maroof; Koch, James; Brugarolas, James; Levine, Beth; Yan, Nan] UT SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Hasan, Maroof; Koch, James; Levine, Beth; Yan, Nan] UT SW Med Ctr, Dept Microbiol, Dallas, TX USA; [Rakheja, Dinesh] UT SW Med Ctr, Childrens Med Ctr, Dept Pathol, Dallas, TX USA; [Pattnaik, Asit K.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Pattnaik, Asit K.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Brugarolas, James] UT SW Med Ctr, Dept Dev Biol, Dallas, TX USA; [Dozmorov, Igor; Wakeland, Edward K.] UT SW Med Ctr, Dept Immunol, Dallas, TX USA; [Brugarolas, James] UT SW Med Ctr, Simmons Canc Ctr, Dallas, TX USA; [Levine, Beth] UT SW Med Ctr, Ctr Autophagy Res, Dallas, TX USA; [Levine, Beth] UT SW Med Ctr, Howard Hughes Med Inst, Dallas, TX USA; [Lee-Kirsch, Min Ae] Tech Univ Dresden, Childrens Hosp, D-01062 Dresden, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technische Universitat Dresden	Yan, N (corresponding author), UT SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu	Lee-Kirsch, Min Ae/C-5769-2018; Pattnaik, Asit K./X-1531-2019	Pattnaik, Asit K./0000-0002-9581-6787; Brugarolas, James/0000-0002-8575-499X	UT Southwestern Medical Center (N.Y.); US National Institutes of Health [AI093795, AI098569, CA129387, AI057156]; Alliance for Lupus Research (N.Y.); Deutsche Forschungsgemeinschaft [LE 1074/4-1]; NATIONAL CANCER INSTITUTE [R01CA129387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098569, K22AI093795, U54AI057156] Funding Source: NIH RePORTER	UT Southwestern Medical Center (N.Y.); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research (N.Y.); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Stetson (University of Washington) for wild-type, Trex1<SUP>-/-</SUP> and Trex1<SUP>-/-</SUP>Irf3<SUP>-/-</SUP> primary MEFs and Trex1<SUP>+/-</SUP> mice, under agreement with D. Barnes and T. Lindahl (Cancer Research UK); R. Orchard and N. Alto for assistance with live cell confocal microscopy; R. Sumpter for assistance with fluorescence microscopy; Z.J. Chen (UT Southwestern Medical Center) for Sendai virus, Ifnar1<SUP>-/-</SUP> MEFs and discussions; M. Gale (University of Washington) for West Nile virus; B. Fontoura (UT Southwestern Medical Center) for influenza virus; Z. Zou for technical assistance; M. Whitt (University of Tennessee Health Science Center) for antibody to VSV; the Electron Microscopy Laboratory at Children's Medical Center for electron microscopy; J. Lieberman for critical reading of the manuscript; and members of the Yan laboratory for discussions. Supported by UT Southwestern Medical Center (N.Y.), the US National Institutes of Health (AI093795 and AI098569 to N.Y.; CA129387 to J.B.; and AI057156 to B.L.), The Alliance for Lupus Research (N.Y.) and Deutsche Forschungsgemeinschaft (LE 1074/4-1 to M.A.L.-K.).	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/nchembio.645, 10.1038/NCHEMBIO.645]; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Migliorini A, 2012, NAT REV NEPHROL, V8, P183, DOI 10.1038/nrneph.2011.197; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	45	108	111	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					61	71		10.1038/ni.2475	http://dx.doi.org/10.1038/ni.2475			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23160154	Green Accepted, Green Submitted			2022-12-18	WOS:000312433800011
J	Wan, FY; Weaver, A; Gao, XF; Bern, M; Hardwidge, PR; Lenardo, MJ				Wan, Fengyi; Weaver, Amanda; Gao, Xiaofei; Bern, Michael; Hardwidge, Philip R.; Lenardo, Michael J.			IKK beta phosphorylation regulates RPS3 nuclear translocation and NF-kappa B function during infection with Escherichia coli strain O157:H7	NATURE IMMUNOLOGY			English	Article							RIBOSOMAL-PROTEIN S3; CASEIN KINASE-II; TYROSINE PHOSPHORYLATION; DNA-REPAIR; ALPHA; ACTIVATION; TRANSCRIPTION; COMPLEXES; SUBUNIT; CELLS	NF-kappa B is a major gene regulator in immune responses, and ribosomal protein S3 (RPS3) is an NF-kappa B subunit that directs specific gene transcription. However, it is unknown how nuclear translocation of RPS3 is regulated. Here we report that phosphorylation of RPS3 Ser209 by the kinase IKK beta was crucial for nuclear localization of RPS3 in response to activating stimuli. Moreover, virulence protein NleH1 of the foodborne pathogen Escherichia coli strain O157:H7 specifically inhibited phosphorylation of RPS3 Ser209 and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but resulting in less mortality in a gnotobiotic piglet-infection model. Thus, the IKK beta-dependent modification of a specific amino acid in RPS3 promoted specific NF-kappa B functions that underlie the molecular pathogenetic mechanisms of E. coli O157:H7.	[Wan, Fengyi; Weaver, Amanda; Bern, Michael; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Wan, Fengyi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Gao, Xiaofei; Hardwidge, Philip R.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Kansas; University of Kansas Medical Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov			US National Institutes of Health [R00CA137171, P20 RR016443, R03AI076227, R56AI087686]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL CANCER INSTITUTE [R00CA137171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000565, R56AI087686, R03AI076227] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Huxford (San Diego State University) and C. Wu (National Cancer Institute) for Flag-tagged SSEE and SSAA IKK beta mutants; U. Siebenlist (National Institute of Allergy and Infectious Diseases) for the hemagglutinin-tagged SSAA I kappa B alpha mutant; M. Biancalana (National Institute of Allergy and Infectious Diseases) for recombinant RPS3 protein with the tag cleaved; S. Porcella for DNA sequencing; O. Schwartz, L. Koo and S. Becker for assistance with fluorescence microscopy; and D. Levens, A. Snow and U. Siebenlist for critical reading of the manuscript. Supported by the US National Institutes of Health (R00CA137171 to F.W., a subaward of P20 RR016443, R03AI076227 and R56AI087686 to P.R.H.) and the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.	Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Chantome A, 2004, J BIOL CHEM, V279, P23953, DOI 10.1074/jbc.M313731200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CORNELIS GR, 2010, BIOL CHEM; Deng WY, 2003, MOL MICROBIOL, V48, P95, DOI 10.1046/j.1365-2958.2003.03429.x; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; GRILLI M, 1993, INT REV CYTOL, V143, P1; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hegde V, 2004, DNA REPAIR, V3, P121, DOI 10.1016/j.dnarep.2003.10.004; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim HD, 2005, BIOCHEM BIOPH RES CO, V333, P110, DOI 10.1016/j.bbrc.2005.05.079; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim TS, 2009, J BIOL CHEM, V284, P21201, DOI 10.1074/jbc.M109.018168; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; LEADER DP, 1980, BIOCHEM J, V189, P241, DOI 10.1042/bj1890241; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Royan SV, 2010, MOL MICROBIOL, V78, P1232, DOI 10.1111/j.1365-2958.2010.07400.x; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Shin HS, 2009, BIOCHEM BIOPH RES CO, V385, P273, DOI 10.1016/j.bbrc.2009.05.055; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Yu M, 2006, CANCER RES, V66, P6722, DOI 10.1158/0008-5472.CAN-05-3758	46	108	110	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					335	U119		10.1038/ni.2007	http://dx.doi.org/10.1038/ni.2007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21399639	Green Accepted			2022-12-18	WOS:000288593400012
J	Cuartero, S; Weiss, FD; Dharmalingam, G; Guo, Y; Ing-Simmons, E; Masella, S; Robles-Rebollo, I; Xiao, XL; Wang, YF; Barozzi, I; Djeghloul, D; Amano, MT; Niskanen, H; Petretto, E; Dowell, RD; Tachibana, K; Kaikkonen, MU; Nasmyth, KA; Lenhard, B; Natoli, G; Fisher, AG; Merkenschlager, M				Cuartero, Sergi; Weiss, Felix D.; Dharmalingam, Gopuraja; Guo, Ya; Ing-Simmons, Elizabeth; Masella, Silvia; Robles-Rebollo, Irene; Xiao, Xiaolin; Wang, Yi-Fang; Barozzi, Iros; Djeghloul, Dounia; Amano, Mariane T.; Niskanen, Henri; Petretto, Enrico; Dowell, Robin D.; Tachibana, Kikue; Kaikkonen, Minna U.; Nasmyth, Kim A.; Lenhard, Boris; Natoli, Gioacchino; Fisher, Amanda G.; Merkenschlager, Matthias			Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; INSULATED NEIGHBORHOODS; TRANSCRIPTION FACTORS; REVEALS PRINCIPLES; CHROMATIN DOMAINS; GENOME; COMPLEX; ACTIVATION; CTCF; ORGANIZATION	Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression. Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and progenitor cells (HPSCs), cohesin mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli. These findings uncover an unexpected dependence of inducible gene expression on cohesin, link cohesin with myeloid differentiation, and may help explain the prevalence of cohesin mutations in human acute myeloid leukemia.	[Cuartero, Sergi; Weiss, Felix D.; Guo, Ya; Ing-Simmons, Elizabeth; Robles-Rebollo, Irene; Djeghloul, Dounia; Amano, Mariane T.; Fisher, Amanda G.; Merkenschlager, Matthias] Imperial Coll London, MRC London Inst Med Sci, Inst Clin Sci, Epigenet Sect,Lymphocyte Dev Grp,Fac Med, London, England; [Ing-Simmons, Elizabeth; Lenhard, Boris] Imperial Coll London, MRC London Inst Med Sci, Computat Regulatory Genom Grp, Integrat Biol Sect,Inst Clin Sci,Fac Med, London, England; [Dharmalingam, Gopuraja; Xiao, Xiaolin; Wang, Yi-Fang; Petretto, Enrico] Imperial Coll London, MRC London Inst Med Sci, Inst Clin Sci, Fac Med, London, England; [Masella, Silvia; Barozzi, Iros] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Barozzi, Iros] Imperial Coll London, Dept Surg & Canc, Dept Med, London, England; [Niskanen, Henri; Kaikkonen, Minna U.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Petretto, Enrico] Duke NUS Med Sch, Cardiovasc & Metab Disorders, Singapore, Singapore; [Dowell, Robin D.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Dowell, Robin D.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Tachibana, Kikue; Nasmyth, Kim A.] Univ Oxford, Dept Biochem, Oxford, England; [Natoli, Gioacchino] Humanitas Clin & Res Ctr, Milan, Italy; [Natoli, Gioacchino] Humanitas Univ, Milan, Italy; [Ing-Simmons, Elizabeth] Max Planck Inst Mol Biomed, Munster, Germany; [Amano, Mariane T.] Hosp Sirio Libanes, Sao Paulo, Brazil; [Tachibana, Kikue] Austrian Acad Sci, Vienna Bioctr, Inst Mol Biotechnol, Vienna, Austria	Imperial College London; Imperial College London; Imperial College London; IRCCS European Institute of Oncology (IEO); Imperial College London; University of Eastern Finland; National University of Singapore; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Oxford; Humanitas University; Max Planck Society; Hospital Sirio Libanes; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Merkenschlager, M (corresponding author), Imperial Coll London, MRC London Inst Med Sci, Inst Clin Sci, Epigenet Sect,Lymphocyte Dev Grp,Fac Med, London, England.	matthias.merkenschlager@lms.mrc.ac.uk	Kaikkonen, Minna U/AAK-3612-2020; Barozzi, Iros/GLQ-8907-2022; AMANO, MARIANE TAMI/D-1361-2012; Betriu, Sergi Cuartero/AAB-9102-2019; Natoli, gioacchino/J-2100-2018; Cuartero, Sergi/B-2203-2017; Natoli, gioacchino/ABB-8679-2020	Kaikkonen, Minna U/0000-0001-6294-0979; Barozzi, Iros/0000-0003-0690-3473; AMANO, MARIANE TAMI/0000-0003-4321-3375; Betriu, Sergi Cuartero/0000-0002-9338-583X; Cuartero, Sergi/0000-0002-9338-583X; Guo, Ya/0000-0001-5350-266X; Niskanen, Henri/0000-0002-8361-5531; Wang, Yi-Fang/0000-0001-7137-2010; Weiss, Felix Daniel/0000-0003-0228-5081; Ing-Simmons, Elizabeth/0000-0002-0394-2429; DOWELL, ROBIN/0000-0001-7665-9985; Petretto, Enrico/0000-0003-2163-5921; Natoli, Gioacchino/0000-0003-0711-2411	Wellcome Investigator Award [099276/Z/12/Z]; Wellcome Project [P55504]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/20861-3]; National Science Foundation [ABI1262410]; Academy of Finland [287478, 294073]; MRC Programme [84637]; Wellcome Trust Programme [078241/Z/05/Z]; ERC [692789]; Medical Research Council UK; MRC [MC_UP_1102/1, MC_EX_MR/S300009/1, MC_U120027516] Funding Source: UKRI	Wellcome Investigator Award; Wellcome Project; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme(Wellcome Trust); ERC(European Research Council (ERC)European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Innes, M. Spivakov, L. Rudolf (FLI, Jena) and D. Odom (CRUK Cambridge) for discussions, G. Sauvageau (University of Montreal) and the Leucegene consortium for early access to AML data, L. Game for sequencing, and J. Elliott and the LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility for cell sorting. This work was funded by Wellcome Investigator Award 099276/Z/12/Z (M.M.), Wellcome Project Grant P55504 (B.L.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/20861-3 (M.T.A.), National Science Foundation grant ABI1262410 (R.D.D.), Academy of Finland grants 287478 and 294073 (M.U.K), MRC Programme Grant ID 84637 and Wellcome Trust Programme Grant Ref 078241/Z/05/Z (K.A.M.), ERC grant 692789 (G. N.), and core support from the Medical Research Council UK to the London Institute of Medical Sciences.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Azofeifa JG, 2017, IEEE ACM T COMPUT BI, V14, P1070, DOI 10.1109/TCBB.2016.2520919; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carroll TS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00075; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Deardorff M. A., 2018, GENEREVIEWS; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dybedal I, 2001, BLOOD, V98, P1782, DOI 10.1182/blood.V98.6.1782; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Fisher JB, 2017, LEUKEMIA, V31, P712, DOI 10.1038/leu.2016.240; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Galeev R, 2016, CELL REP, V14, P2988, DOI 10.1016/j.celrep.2016.02.082; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Harmston N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2140-x; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Jiang Y, 2017, NAT GENET, V49, P1239, DOI 10.1038/ng.3906; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Kruse K, 2016, BIOINFORMATICS, V32, P3190, DOI 10.1093/bioinformatics/btw368; Lavagnolli T, 2015, GENE DEV, V29, P23, DOI 10.1101/gad.251835.114; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun Aaron T L, 2016, F1000Res, V5, P950, DOI 10.12688/f1000research.8759.2; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Matatall KA, 2016, CELL REP, V17, P2584, DOI 10.1016/j.celrep.2016.11.031; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schieber TA, 2016, PHYS LETT A, V380, P359, DOI 10.1016/j.physleta.2015.10.055; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	87	107	107	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					932	+		10.1038/s41590-018-0184-1	http://dx.doi.org/10.1038/s41590-018-0184-1			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127433	Green Accepted, Green Submitted			2022-12-18	WOS:000442365100015
J	Vivier, E; van de Pavert, SA; Cooper, MD; Belz, GT				Vivier, Eric; van de Pavert, Serge A.; Cooper, Max D.; Belz, Gabrielle T.			The evolution of innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							DIFFERENTIATION; SENSITIVITY; REDUNDANCY; IMMUNITY; LINEAGE; IL-22; MOUSE	Innate lymphoid cells (ILCs) are the most recently discovered group of immune cells. Understanding their biology poses many challenges. We discuss here the current knowledge on the appearance of ILC subsets during evolution and propose how the connection between ILCs and T cells contributes to the robustness of immunity and hence to the fitness of the hosts.	[Vivier, Eric; van de Pavert, Serge A.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS UMR7280, UM2,Inserm,U1104, Marseille, France; [Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Marseille, France; [Cooper, Max D.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Belz, Gabrielle T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Emory University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Vivier, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS UMR7280, UM2,Inserm,U1104, Marseille, France.; Vivier, E (corresponding author), Hop Conception, Assistance Publ Hop Marseille, Marseille, France.; Belz, GT (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.; Belz, GT (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	vivier@ciml.univ-mrs.fr; belz@wehi.edu.au	Vivier, Eric/F-8939-2010; Belz, Gabrielle T/C-9350-2013; van de Pavert, Serge A./A-7307-2008	Vivier, Eric/0000-0001-7022-8287; Belz, Gabrielle T/0000-0002-9660-9587; van de Pavert, Serge A./0000-0002-7147-4380	European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee); INSERM; CNRS; Aix-Marseille University; Institut Universitaire de France; A*MIDEX; Fondation pour la Recherche Medicale [AJE20150633331]; Agence Nationale de Recherche (Immunodev); National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences of the US National Institutes of Health; National Health and Medical Research Council of Australia; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council of Australia Independent Research Institutes Infrastructure Support Scheme; Australian Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108838] Funding Source: NIH RePORTER	European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Institut Universitaire de France; A*MIDEX(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de Recherche (Immunodev)(French National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council of Australia Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Carpentier and N. Thakur for comparative transcriptomic analysis; and P. Golstein, Y. Kerdiles and R. Golub for critical reading and advice. Supported by the European Research Council (THINK Advanced Grant; Vivier laboratory), the Ligue Nationale contre le Cancer (Equipe Labellisee; Vivier laboratory), INSERM (Vivier and Van de Pavert laboratories), CNRS (Vivier and Van de Pavert laboratories), Aix-Marseille University (to Centre d'Immunologie de Marseille-Luminy; Vivier and Van de Pavert laboratories), the Institut Universitaire de France (E.V.), A*MIDEX (Van de Pavert laboratory), Fondation pour la Recherche Medicale (AJE20150633331; Van de Pavert laboratory), Agence Nationale de Recherche (Immunodev; Van de Pavert laboratory), the National Institute of Allergy and Infectious Diseases and the National Institute of General Medical Sciences of the US National Institutes of Health (Cooper laboratory), the National Health and Medical Research Council of Australia (Belz laboratory), the Victorian State Government Operational Infrastructure Support (Belz laboratory), the Australian Government National Health and Medical Research Council of Australia Independent Research Institutes Infrastructure Support Scheme (Belz laboratory) and the Australian Research Council (Belz laboratory).	Addison W, 1843, Prov Med J Retrosp Med Sci, V6, P444; Andral G., 1843, ESSAI HEMATOLOGIE PA; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Boehm T, 2012, TRENDS IMMUNOL, V33, P315, DOI 10.1016/j.it.2012.02.005; Bouchery T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7970; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; DiGeorge A. M., 1968, BIRTH DEFECTS OAS, V4, P116; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ehrlich P, 1879, ARCH ANAT PHYSL, V3, P571; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lane PJL, 2009, MUCOSAL IMMUNOL, V2, P472, DOI 10.1038/mi.2009.111; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; NOSSAL GJV, 1968, J EXP MED, V128, P839, DOI 10.1084/jem.128.4.839; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Parrinello N., 1996, Progress in Molecular and Subcellular Biology, V15, P190; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; van de Pavert SA, 2016, INT IMMUNOL, V28, P35, DOI 10.1093/intimm/dxv052; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vondenhoff MFR, 2008, J LEUKOCYTE BIOL, V84, P152, DOI 10.1189/jlb.0907659; WARNER NL, 1962, AUST J EXP BIOL MED, V43, P373; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Yoder JA, 2011, IMMUNOGENETICS, V63, P123, DOI 10.1007/s00251-010-0506-4	50	107	108	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					790	794		10.1038/ni.3459	http://dx.doi.org/10.1038/ni.3459			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328009	Green Accepted			2022-12-18	WOS:000378283200011
J	Goldszmid, RS; Trinchieri, G				Goldszmid, Romina S.; Trinchieri, Giorgio			The price of immunity	NATURE IMMUNOLOGY			English	Review							RECONSTITUTION INFLAMMATORY SYNDROME; GENOME-WIDE ASSOCIATION; CD4(+) T-CELLS; MICROBIAL TRANSLOCATION; INTESTINAL MICROBIOTA; PREVENTS DEVELOPMENT; DENDRITIC CELLS; GUT MICROBIOTA; HIV-INFECTION; HEPATITIS-B	Resistance mechanisms of the innate and adaptive immune responses prevent the colonization of foreign organisms in unwanted anatomical sites and participate in tissue repair and restoration of homeostasis after damage induced either by the invasion of pathogenic microbes or by the organism's response to them. The intensity of the response is controlled and limited by positive and negative feedback circuits that aim at preventing collateral tissue damage. In this Review we will discuss the protective and pathogenic effects of host-commensal microbiota mutualism on the immune response and illustrate some examples of collateral tissue and systemic damage caused by immunity to pathogens.	[Goldszmid, Romina S.; Trinchieri, Giorgio] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,US Natl Inst Hlth, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trinchieri, G (corresponding author), NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,US Natl Inst Hlth, Frederick, MD 21701 USA.	trinchig@mail.nih.gov	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464	NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010793] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bowcock AM, 2010, CRIT REV IMMUNOL, V30, P305, DOI 10.1615/CritRevImmunol.v30.i3.80; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brandon JA, 2011, J IMMUNOL, V186, P3726, DOI 10.4049/jimmunol.1003343; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Byrnes AA, 2001, EUR J IMMUNOL, V31, P2026, DOI 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.3.CO;2-L; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Cohn M, 2012, SCAND J IMMUNOL, V76, P77, DOI 10.1111/j.1365-3083.2012.02721.x; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DOLBERG DS, 1985, SCIENCE, V230, P676, DOI 10.1126/science.2996144; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; ELSON CO, 1977, GASTROENTEROLOGY, V72, P886; Fahlen A, 2012, ARCH DERMATOL RES, V304, P15, DOI 10.1007/s00403-011-1189-x; Fallot G, 2012, CURR OPIN VIROL, V2, P467, DOI 10.1016/j.coviro.2012.05.008; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Fung J, 2009, CLIN MICROBIOL INFEC, V15, P964, DOI 10.1111/j.1469-0691.2009.03035.x; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Germain RN, 2012, NAT IMMUNOL, V13, P902, DOI 10.1038/ni.2404; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Goulding J, 2011, J INFECT DIS, V204, P1086, DOI 10.1093/infdis/jir467; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2010, MUCOSAL IMMUNOL, V3, P209, DOI 10.1038/mi.2010.3; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kamat A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015533; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khatri BO, 2009, NEUROLOGY, V72, P402, DOI 10.1212/01.wnl.0000341766.59028.9d; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leonard JP, 1997, BLOOD, V90, P2541; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; LING PD, 1985, J IMMUNOL, V135, P1857; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Noone CM, 2005, J GEN VIROL, V86, P1885, DOI 10.1099/vir.0.80891-0; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Raz E, 2007, NAT IMMUNOL, V8, P3, DOI 10.1038/ni0107-3; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; STREILEIN JW, 1972, PROG EXP TUMOR RES, V16, P396; Sun HY, 2011, CLIN INFECT DIS, V53, P168, DOI 10.1093/cid/cir276; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Valdimarsson H, 2009, TRENDS IMMUNOL, V30, P494, DOI 10.1016/j.it.2009.07.008; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Wang ZZ, 2008, J IMMUNOL, V181, P4676, DOI 10.4049/jimmunol.181.7.4676; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yanagisawa N., 2011, ISRN GASTROENTEROL, DOI [10.5402/2011/513514, DOI 10.5402/2011/513514]	117	107	114	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					932	938		10.1038/ni.2422	http://dx.doi.org/10.1038/ni.2422			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990891				2022-12-18	WOS:000309038600006
J	Wang, DL; Zhang, SY; Li, LA; Liu, X; Mei, KR; Wang, XQ				Wang, Dongli; Zhang, Senyan; Li, Liang; Liu, Xi; Mei, Kunrong; Wang, Xinquan			Structural insights into the assembly and activation of IL-1 beta with its receptors	NATURE IMMUNOLOGY			English	Article							IL-1 RECEPTOR; ACCESSORY PROTEIN; INTERLEUKIN-1 RECEPTOR; CRYSTAL-STRUCTURE; BINDING MODE; EXPRESSION; CLONING; ANTAGONIST; AGONIST; FAMILY	Interleukin 1 beta (IL-1 beta) is a key orchestrator of inflammation and host defense that exerts its effects through IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). How IL-1RAcP is recruited by IL-1 beta-IL-1RI to form the signaling-competent complex remains elusive. Here we present the crystal structure of IL-1 beta bound to IL-1 receptor type II (IL-1RII) and IL-1RAcP. IL-1 beta-IL-1RII generated a composite binding surface to recruit IL-1RAcP. Biochemical analysis demonstrated that IL-1 beta-IL-1RI and IL-1 beta-IL-1RII interacted similarly with IL-1RAcP. It also showed the importance of two loops of IL-1 receptor antagonist (IL-1Ra) in determining its antagonism. Our results provide a structural basis for assembly and activation of the IL-1 receptor and offer a general cytokine-receptor architecture that governs the IL-1 family of cytokines.	[Wang, Dongli; Zhang, Senyan; Li, Liang; Liu, Xi; Mei, Kunrong; Wang, Xinquan] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Wang, XQ (corresponding author), Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn	Mei, Kunrong/F-4553-2019; zhang, sen/GXH-3513-2022	Mei, Kunrong/0000-0001-7827-2944; 	Tsinghua University; Ministry of Science and Technology [2010CB912402]; Ministry of Health [2008ZX10001-011]; Fok Ying Tung Education Foundation	Tsinghua University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	We thank J.W. Wang and H.P. Gong for assistance with structure determination; J.H. He, S. Huang and L. Tang at Shanghai Synchrotron Research Facility beamline BL-17U for help with data collection; Y.Y. Chen and X.D. Zhao for technical help with BIAcore 3000 at the Institute of Biophysics, Chinese Academy of Sciences; and Y.G. Shi, H.T. Li, L. Yu, N. Yan, M.J. Yang, J.W. Wu, Y.H. Chen and Z. Wang for discussion. Supported by Tsinghua University 985 Phase II funds, the Ministry of Science and Technology (2010CB912402), the Ministry of Health (2008ZX10001-011) and the Fok Ying Tung Education Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 2003, SCI STKE; Argiriadi MA, 2009, J BIOL CHEM, V284, P24478, DOI 10.1074/jbc.M109.023887; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Boraschi Diana, 1996, Frontiers in Bioscience (online), V1, pD270; Boraschi D, 2006, VITAM HORM, V74, P229, DOI 10.1016/S0083-6729(06)74009-2; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Casadio R, 2001, FEBS LETT, V499, P65, DOI 10.1016/S0014-5793(01)02515-7; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cullinan EB, 1998, J IMMUNOL, V161, P5614; DeLano W. L, 2002, PYMOL MOL GENETICS G; DEttorre C, 1997, EUR CYTOKINE NETW, V8, P161; Dinarello CA, 2005, ARTHRITIS RHEUM-US, V52, P1960, DOI 10.1002/art.21107; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GREENFEDER SA, 1995, J BIOL CHEM, V270, P22460, DOI 10.1074/jbc.270.38.22460; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; KAWASHIMA H, 1992, PROTEIN ENG, V5, P171, DOI 10.1093/protein/5.2.171; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Krumm B, 2008, P NATL ACAD SCI USA, V105, P20711, DOI 10.1073/pnas.0809086106; Lang D, 1998, J IMMUNOL, V161, P6871; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; Malinowsky D, 1998, FEBS LETT, V429, P299, DOI 10.1016/S0014-5793(98)00467-0; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; SIMONCSITS A, 1994, CYTOKINE, V6, P206, DOI 10.1016/1043-4666(94)90043-4; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Vigers GPA, 2000, J BIOL CHEM, V275, P36927, DOI 10.1074/jbc.M006071200; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Yoon DY, 1998, J IMMUNOL, V160, P3170	55	107	127	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					905	U52		10.1038/ni.1925	http://dx.doi.org/10.1038/ni.1925			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20802483				2022-12-18	WOS:000281926900009
J	Palsson-McDermott, EM; Doyle, SL; McGettrick, AF; Hardy, M; Husebye, H; Banahan, K; Gong, M; Golenbock, D; Espevik, T; O'Neill, LAJ				Palsson-McDermott, Eva M.; Doyle, Sarah L.; McGettrick, Anne F.; Hardy, Matthew; Husebye, Harald; Banahan, Kathy; Gong, Mei; Golenbock, Douglas; Espevik, Terje; O'Neill, Luke A. J.			TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; RECEPTOR; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE; ACTIVATION; RECRUITMENT; MOLECULE; FAMILY	Toll-like receptor 4 (TLR4) signals the induction of transcription factor IRF3-dependent genes from the early endosome via the adaptor TRAM. Here we report a splice variant of TRAM, TAG ('TRAM adaptor with GOLD domain'), which has a Golgi dynamics domain coupled to TRAM's Toll-interleukin 1 receptor domain. After stimulation with lipopolysaccharide, TRAM and TAG localized to late endosomes positive for the GTPase Rab7a. TAG inhibited activation of IRF3 by lipopolysaccharide. Knockdown of TAG with small interfering RNA enhanced induction of the chemokine CCL5 (RANTES), but not of interleukin 8, by lipopolysaccharide in human peripheral blood mononuclear cells. TAG displaced the adaptor TRIF from TRAM. TAG is therefore an example of a specific inhibitor of the adaptor MyD88-independent pathway activated by TLR4. Targeting TAG could be useful in the effort to boost the immunostimulatory effect of TLR4 without causing unwanted inflammation.	[Palsson-McDermott, Eva M.; Doyle, Sarah L.; McGettrick, Anne F.; Banahan, Kathy; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Hardy, Matthew] CSL, Parkville, Vic, Australia; [Husebye, Harald; Espevik, Terje] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7034 Trondheim, Norway; [Gong, Mei; Golenbock, Douglas] Univ Massachusetts, Sch Med, Worcester, MA USA	Trinity College Dublin; CSL; Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Doyle, Sarah/C-1453-2014	Husebye, Harald/0000-0002-8828-1059; Doyle, Sarah/0000-0002-6294-9380; O'Neill, Luke/0000-0002-4333-2748	Health Research Board Ireland; Science Foundation Ireland	Health Research Board Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank K. Fitzgerald (University of Massachusetts) for TRAM-GFP and TRAM-CFP; M. Zerial (Max Planck Institute of Molecular Cell Biology and Genetics) for Rab7a-CFP and Rab7a-GFP; H. Stanmark (The Norweigen Radium Hospital) for EEA1-GFP; C. Basler (Mount Sinai School of Medicine) for hemagglutinin-tagged-TRIF; R.Y. Tsien (University of California Davis) for pRSET-B-mCherry; and E. Latz (University of Massachusetts) and E. Samstad (University of Massachusetts) for mCherry-tagged TLR4-HEK293 cells. M. H. and H. H. contributed equally to this work. Supported by the Health Research Board Ireland and Science Foundation Ireland.	Anantharaman V, 2002, GENOME BIOL, P3, DOI [10.1186/gb-2002-3-5-research0023, 10.1186/gb-2002-3-11-research0061, DOI 10.1186/GB-2002-3-5-RESEARCH0023]; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	30	107	116	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					579	U30		10.1038/ni.1727	http://dx.doi.org/10.1038/ni.1727			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19412184				2022-12-18	WOS:000266384100009
J	Caraux, A; Lu, QX; Fernandez, N; Riou, S; Di Santo, JP; Raulet, DH; Lemke, G; Roth, C				Caraux, Anouk; Lu, Qingxian; Fernandez, Nadine; Riou, Sylvain; Di Santo, James P.; Raulet, David H.; Lemke, Greg; Roth, Claude			Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA EXPRESSION; DEVELOPING NK CELLS; DENDRITIC CELLS; IN-VITRO; CLONAL ACQUISITION; PROGENITOR CELLS; LY49 RECEPTORS; GENE-COMPLEX; CROSS-TALK; ACTIVATION	Although understanding of the function and specificity of many natural killer (NK) cell receptors is increasing, the molecular mechanisms regulating their expression during late development of NK cells remain unclear. Here we use representational difference analysis to identify molecules required for late NK cell differentiation. Axl protein tyrosine kinase, together with the structurally related receptors Tyro3 and Mer, were essential for NK cell functional maturation and normal expression of inhibitory and activating NK cell receptors. Also, all three receptors were expressed in maturing NK cells, the ligands of these receptors were produced by bone marrow stromal cells, and recombinant versions of these ligands drove NK cell differentiation in vitro. These results collectively suggest that Axl, Tyro3 and Mer transmit signals that are essential for the generation of a functional NK cell repertoire.	Inst Pasteur, Dept Immunol, Lab Immun Cellulaire Antivirale, F-75724 Paris 15, France; Inst Pasteur, Dept Immunol, Lab Cytokines & Dev Lymphoide, F-75724 Paris 15, France; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Salk Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Roth, C (corresponding author), Inst Pasteur, Dept Immunol, Lab Immun Cellulaire Antivirale, F-75724 Paris 15, France.	clroth@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862; Raulet, David/0000-0002-1257-8649				Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Behrens EM, 2003, EUR J IMMUNOL, V33, P2160, DOI 10.1002/eji.200324076; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Brown MG, 2001, IMMUNOGENETICS, V53, P584, DOI 10.1007/s002510100365; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2002, IMMUNOL REV, V188, P9, DOI 10.1034/j.1600-065X.2002.18802.x; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kunz B, 2001, J IMMUNOL, V166, P6181, DOI 10.4049/jimmunol.166.10.6181; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lauwerys BR, 2000, J IMMUNOL, V165, P1847, DOI 10.4049/jimmunol.165.4.1847; Lian RH, 2002, J IMMUNOL, V168, P4980, DOI 10.4049/jimmunol.168.10.4980; Lian RH, 2004, EUR J IMMUNOL, V34, P2699, DOI 10.1002/eji.200425394; Lian RH, 2002, SEMIN IMMUNOL, V14, P453, DOI 10.1016/S1044532302000805; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; McNerney ME, 2005, BLOOD, V106, P1337, DOI 10.1182/blood-2005-01-0357; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Sivakumar PV, 1997, EUR J IMMUNOL, V27, P3100, DOI 10.1002/eji.1830271204; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Tanamachi DM, 2001, J EXP MED, V193, P307, DOI 10.1084/jem.193.3.307; Toomey JA, 1999, J IMMUNOL, V163, P3176; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Williams NS, 2000, EUR J IMMUNOL, V30, P2074, DOI 10.1002/1521-4141(200007)30:7<2074::AID-IMMU2074>3.0.CO;2-#; Williams NS, 1999, J IMMUNOL, V163, P2648; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	52	107	118	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					747	754		10.1038/ni1353	http://dx.doi.org/10.1038/ni1353			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16751775				2022-12-18	WOS:000238377700020
J	Vincent, MS; Gumperz, JE; Brenner, MB				Vincent, MS; Gumperz, JE; Brenner, MB			Understanding the function of CD1-restricted T cells	NATURE IMMUNOLOGY			English	Review							MHC CLASS-II; NONOBESE DIABETIC MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; V(ALPHA)14 NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; DENDRITIC CELLS; CUTTING EDGE; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; LIPID ANTIGENS	CD1 molecules bind foreign lipid antigens as they survey the endosomal compartments of infected antigen-presenting cells. Unlike T cells that recognize CD1-restricted foreign lipids, CD1-restricted T cells that are self-antigen-reactive function as 'auto-effectors' that are rapidly stimulated to carry out helper and effector functions upon interaction with CD1-expressing antigen-presenting cells. The functional distinctions between subsets of CD1-restricted T cells, and the pathways by which these cells both influence the inflammatory and tolerogenic effects of dendritic cells and activate natural killer cells and other lymphocytes, provide insight into how CD1-restricted T cells regulate antimicrobial responses, antitumor immunity and the balance between tolerance and autoimmunity.	Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Brenner, MB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 1 Jimmy Fund Way, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR048037] Funding Source: NIH RePORTER; NIAMS NIH HHS [R21AR48037] Funding Source: Medline; PHS HHS [R37AL29873] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; BALK SP, 1991, J IMMUNOL, V146, P768; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Brossay L, 1997, J IMMUNOL, V159, P1216; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chackerian A, 2002, INFECT IMMUN, V70, P6302, DOI 10.1128/IAI.70.11.6302-6309.2002; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dascher CC, 1999, J IMMUNOL, V163, P5478; DASCHER CC, IN PRESS INT IMMUNOL; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Duthie MS, 2002, J IMMUNOL, V168, P5778, DOI 10.4049/jimmunol.168.11.5778; Duthie MS, 2002, INFECT IMMUN, V70, P36, DOI 10.1128/IAI.70.1.36-48.2002; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; Falcone M, 1999, J EXP MED, V190, P963, DOI 10.1084/jem.190.7.963; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Hiromatsu K, 2002, J IMMUNOL, V169, P330, DOI 10.4049/jimmunol.169.1.330; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kawakami K, 2001, INFECT IMMUN, V69, P213, DOI 10.1128/IAI.69.1.213-220.2001; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KAWASHIMA T, IN PRESS J IMMUNOL; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mempel M, 2002, J IMMUNOL, V168, P365, DOI 10.4049/jimmunol.168.1.365; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Molano A, 2000, J IMMUNOL, V164, P5005, DOI 10.4049/jimmunol.164.10.5005; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Ostrand-Rosenberg S, 2002, J IMMUNOL, V169, P5796, DOI 10.4049/jimmunol.169.10.5796; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Procopio DO, 2002, J IMMUNOL, V169, P3926, DOI 10.4049/jimmunol.169.7.3926; Ronet C, 2001, J IMMUNOL, V166, P1755, DOI 10.4049/jimmunol.166.3.1755; Rosat JP, 1999, J IMMUNOL, V162, P366; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Toura I, 1999, J IMMUNOL, V163, P2387; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wilson SB, 1999, NATURE, V399, P84, DOI 10.1038/20007; Wilson SB, 2000, P NATL ACAD SCI USA, V97, P7411, DOI 10.1073/pnas.120161297; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; YOKOYAMA WM, 1991, J IMMUNOL, V147, P3229; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711	111	107	113	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					517	523		10.1038/ni0603-517	http://dx.doi.org/10.1038/ni0603-517			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774075				2022-12-18	WOS:000183175500009
J	Green, DR; Schuler, M				Green, DR; Schuler, M			T cell development: Some cells get all the breaks	NATURE IMMUNOLOGY			English	News Item							DNA-DAMAGE RESPONSE; EXPRESSION; BRCA1; MICE; APOPTOSIS; PATHWAYS; MOUSE; BCL-2; TCR; P53	Without Brca I, T cells are lacking in numbers and maturity, but surprisingly not because of a lack of repair of rearranged TCR genes,The defects involve more than one p53-dependent mechanism.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	DGreen5240@aol.com	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Yasutomo K, 1997, J IMMUNOL, V158, P4729; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	15	107	108	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					15	17		10.1038/76868	http://dx.doi.org/10.1038/76868			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881167				2022-12-18	WOS:000089814800007
J	Adrover, JM; Aroca-Crevillen, A; Crainiciuc, G; Ostos, F; Rojas-Vega, Y; Rubio-Ponce, A; Cilloniz, C; Bonzon-Kulichenko, E; Calvo, E; Rico, D; Moro, MA; Weber, C; Lizasoain, I; Torres, A; Ruiz-Cabello, J; Vazquez, J; Hidalgo, A				Adrover, Jose M.; Aroca-Crevillen, Alejandra; Crainiciuc, Georgiana; Ostos, Fernando; Rojas-Vega, Yeny; Rubio-Ponce, Andrea; Cilloniz, Catia; Bonzon-Kulichenko, Elena; Calvo, Enrique; Rico, Daniel; Moro, Maria A.; Weber, Christian; Lizasoain, Ignacio; Torres, Antoni; Ruiz-Cabello, Jesus; Vazquez, Jesus; Hidalgo, Andres			Programmed 'disarming' of the neutrophil proteome reduces the magnitude of inflammation	NATURE IMMUNOLOGY			English	Article							CIRCADIAN VARIATION; SECRETORY VESICLES; SERINE PROTEASES; GRANULE SUBSETS; MARROW; PATHOGENESIS; PLATELETS; ELASTASE; EFFECTOR; TRAPS	The antimicrobial functions of neutrophils are facilitated by a defensive armamentarium of proteins stored in granules, and by the formation of neutrophil extracellular traps (NETs). However, the toxic nature of these structures poses a threat to highly vascularized tissues, such as the lungs. Here, we identified a cell-intrinsic program that modified the neutrophil proteome in the circulation and caused the progressive loss of granule content and reduction of the NET-forming capacity. This program was driven by the receptor CXCR2 and by regulators of circadian cycles. As a consequence, lungs were protected from inflammatory injury at times of day or in mouse mutants in which granule content was low. Changes in the proteome, granule content and NET formation also occurred in human neutrophils, and correlated with the incidence and severity of respiratory distress in pneumonia patients. Our findings unveil a 'disarming' strategy of neutrophils that depletes protein stores to reduce the magnitude of inflammation. Hidalgo and colleagues describe a cell-intrinsic program that induces changes in the proteome, granule content and NET-forming capacity of neutrophils and is driven by the chemokine receptor CXCR2 and regulators of the circadian clock.	[Adrover, Jose M.; Aroca-Crevillen, Alejandra; Crainiciuc, Georgiana; Rubio-Ponce, Andrea; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc, Area Cell & Dev Biol, Madrid, Spain; [Ostos, Fernando; Moro, Maria A.; Lizasoain, Ignacio] Univ Complutense, Fac Med, Dept Pharmacol, Unidad Invest Neurovasc, Madrid, Spain; [Ostos, Fernando; Moro, Maria A.; Lizasoain, Ignacio] Hosp 12 Octubre I 12, Inst Invest, Madrid, Spain; [Rojas-Vega, Yeny; Ruiz-Cabello, Jesus] Fdn Ctr Nacl Invest Cardiovasc, Adv Imaging Unit, Madrid, Spain; [Cilloniz, Catia; Torres, Antoni] Univ Barcelona, Ciber Enfermedades, Hosp Clin Barcelona, Dept Pneumol,Inst Clin Respiratori, Barcelona, Spain; [Cilloniz, Catia; Torres, Antoni] Univ Barcelona, Ciber Enfermedades, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc Carlos III, Cardiovasc Prote Lab, Madrid, Spain; [Bonzon-Kulichenko, Elena; Calvo, Enrique; Vazquez, Jesus] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain; [Rico, Daniel] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Weber, Christian; Hidalgo, Andres] Ludwig Maximillians Univ, Inst Cardiovasc Prevent, Munich, Germany; [Weber, Christian] German Cardiovasc Res Ctr DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Weber, Christian] Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Ruiz-Cabello, Jesus] CIC BiomaGUNE, Donostia San Sebastian, Spain; [Ruiz-Cabello, Jesus] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Ruiz-Cabello, Jesus] Ciber Enfermedades Resp, Madrid, Spain; [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Newcastle University - UK; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Maastricht University; CIC biomaGUNE; Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid	Hidalgo, A (corresponding author), Fdn Ctr Nacl Invest Cardiovasc, Area Cell & Dev Biol, Madrid, Spain.; Hidalgo, A (corresponding author), Ludwig Maximillians Univ, Inst Cardiovasc Prevent, Munich, Germany.	ahidalgo@cnic.es	Rubio-Ponce, Andrea/AAR-4205-2020; Weber, Christian/AAW-2153-2020; Ruiz-Cabello, Jesus/A-9570-2012; Hidalgo, Andrés/L-5643-2014; Adrover, Jose M/G-9741-2017; Vazquez, Jesus/B-7697-2015; Moro, María Ángeles/K-6396-2014; Rico, Daniel/I-2049-2013; Lizasoain, Ignacio/K-9844-2014	Rubio-Ponce, Andrea/0000-0002-4275-8835; Weber, Christian/0000-0003-4610-8714; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Hidalgo, Andrés/0000-0001-5513-555X; Adrover, Jose M/0000-0002-1395-5477; Vazquez, Jesus/0000-0003-1461-5092; Moro, María Ángeles/0000-0003-1010-8237; Rico, Daniel/0000-0002-6561-2310; Crainiciuc, Georgiana/0000-0002-0912-7425; Lizasoain, Ignacio/0000-0002-6028-7379	Intramural grants from the Severo Ochoa program (IGP-SO); Fundacio La Marato de TV3 [120/C/2015-20153032]; Ministerio de Ciencia, Investigacion y Universidades (MCIU) [SAF2015-65607-R]; Fondo Europeo de Desarrollo Regional; MCIU [RTI2018-095497-B-I00, BES-2013-065550, SAF2015-68632-R]; Fundacion La Caixa [HR17_00527]; La Caixa Foundation [100010434, LCF/BQ/DR19/11740022]; Instituto de Salud Carlos III [FIS PI17/01601]; Wellcome Trust [206103/Z/17/Z]; Deutsche Forschungsgemeinschaft [SFB1123-A1/A10]; ERC-AdG [692511]; Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion [SAF2017-84494-C2-R, 2018-CIEN-000058-01]; Spanish State Research Agency [MDM-2017-0720]; MCIU; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MEIC) [SEV-2015-0505]	Intramural grants from the Severo Ochoa program (IGP-SO); Fundacio La Marato de TV3; Ministerio de Ciencia, Investigacion y Universidades (MCIU); Fondo Europeo de Desarrollo Regional(European Commission); MCIU; Fundacion La Caixa(La Caixa Foundation); La Caixa Foundation(La Caixa Foundation); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC-AdG; Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion; Spanish State Research Agency(Spanish Government); MCIU; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MEIC)	We thank members of the Comparative Medicine Unit and Advanced Microscopy Unit at CNIC. This study was supported by Intramural grants from the Severo Ochoa program (IGP-SO), a grant from Fundacio La Marato de TV3 (120/C/2015-20153032), grant SAF2015-65607-R from Ministerio de Ciencia, Investigacion y Universidades (MCIU) with cofunding from Fondo Europeo de Desarrollo Regional, grant RTI2018-095497-B-I00 from MCIU and HR17_00527 from Fundacion La Caixa (to A.H.), and fellowship BES-2013-065550 from MCIU (to J.M.A.), fellowship from La Caixa Foundation (ID 100010434, code LCF/BQ/DR19/11740022, to A.A.-C.) and fellowship Health-PERIS 2016-2020 (to C.C.) Funds were also obtained from Instituto de Salud Carlos III (FIS PI17/01601, to I.L.) and SAF2015-68632-R from MCIU (to M.A.M.); Wellcome Trust Seed Award in Science (206103/Z/17/Z, to D.R.), SFB1123-A1/A10 from Deutsche Forschungsgemeinschaft and ERC-AdG 692511 (to C.W.); SAF2017-84494-C2-R and Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion 2018-CIEN-000058-01 (to J.R.-C.). Work at CIC biomaGUNE was performed under the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (MDM-2017-0720). C.W. is a van de Laar professor of atherosclerosis. The CNIC is supported by the MCIU and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505).	Adrover JM, 2019, IMMUNITY, V51, P966, DOI 10.1016/j.immuni.2019.11.001; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cilloniz C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02215-2017; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Csepregi JZ, 2018, J IMMUNOL, V201, P3793, DOI 10.4049/jimmunol.1701803; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; DOERSCHUK CM, 1992, AM J RESP CELL MOL, V7, P140, DOI 10.1165/ajrcmb/7.2.140; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Garcia-Marques F, 2016, MOL CELL PROTEOMICS, V15, P1740, DOI 10.1074/mcp.M115.055905; Grassi L, 2018, CELL REP, V24, P2784, DOI 10.1016/j.celrep.2018.08.018; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; LeCabec V, 1996, P NATL ACAD SCI USA, V93, P6454, DOI 10.1073/pnas.93.13.6454; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Looney MR, 2010, CURR OPIN HEMATOL, V17, P418, DOI 10.1097/MOH.0b013e32833c07d3; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MULLER JE, 1991, NEW ENGL J MED, V325, P1038, DOI 10.1056/NEJM199110033251410; Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Suarez-Barrientos A, 2011, HEART, V97, P970, DOI 10.1136/hrt.2010.212621; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Trevisan-Herraz M, 2019, BIOINFORMATICS, V35, P1594, DOI 10.1093/bioinformatics/bty815; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	48	106	109	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					135	+		10.1038/s41590-019-0571-2	http://dx.doi.org/10.1038/s41590-019-0571-2		JAN 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31932813	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000508182300001
J	Joshi, I; Yoshida, T; Jena, N; Qi, XQ; Zhang, JW; Van Etten, RA; Georgopoulos, K				Joshi, Ila; Yoshida, Toshimi; Jena, Nilamani; Qi, Xiaoqing; Zhang, Jiangwen; Van Etten, Richard A.; Georgopoulos, Katia			Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia	NATURE IMMUNOLOGY			English	Article							FOCAL ADHESION KINASE; TYROSINE KINASE; IG-BETA; TRANSCRIPTION FACTOR; GENE RECOMBINATION; TUMOR-SUPPRESSOR; BONE-MARROW; DIFFERENTIATION; RECEPTOR; EXPRESSION	Deletion of the DNA-binding domain of the transcription factor Ikaros generates dominant-negative isoforms that interfere with its activity and correlate with poor prognosis in human precursor B cell acute lymphoblastic leukemia (B-ALL). Here we found that conditional inactivation of the Ikaros DNA-binding domain in early pre-B cells arrested their differentiation at a stage at which integrin-dependent adhesion to niches augmented signaling via mitogen-activated protein kinases, proliferation and self-renewal and attenuated signaling via the pre-B cell signaling complex (pre-BCR) and the differentiation of pre-B cells. Transplantation of polyclonal Ikaros-mutant pre-B cells resulted in long-latency oligoclonal pre-B-ALL, which demonstrates that loss of Ikaros contributes to multistep B cell leukemogenesis. Our results explain how normal pre-B cells transit from a highly proliferative and stroma-dependent phase to a stroma-independent phase during which differentiation is enabled, and suggest potential therapeutic strategies for Ikaros-mutant B-ALL.	[Joshi, Ila; Yoshida, Toshimi; Qi, Xiaoqing; Georgopoulos, Katia] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02138 USA; [Jena, Nilamani; Van Etten, Richard A.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Zhang, Jiangwen] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Harvard University; Massachusetts General Hospital; Tufts Medical Center; University of Hong Kong	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02138 USA.	vanetten@uci.edu; katia.georgopoulos@cbrc2.mgh.harvard.edu	Zhang, Jiangwen/A-7654-2013; Yoshida, Toshimi/GSN-8717-2022	Zhang, Jiangwen/0000-0002-2911-8446; Yoshida, Toshimi/0000-0001-7080-6913	US National Institutes of Allergy and Infectious Diseases [5R01AI 42254-14]; National Cancer Institute [5R01CA162092-20, CA090576]; NATIONAL CANCER INSTITUTE [R01CA090576, R01CA162092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254] Funding Source: NIH RePORTER	US National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Czyzewski for mouse husbandry; K. White, J.M. Park, B. Morgan, R. Bakshi, E. Alonzo and J. Seavitt for critical review of the manuscript; R. Bakshi for assistance with statistical analysis; and R. Arya for assistance with confocal microscopy. High-throughput DNA sequencing was done at the Bauer Center for Genomic Research (Harvard University). Supported by the US National Institutes of Allergy and Infectious Diseases (American Recovery and Reinvestment Act supplement to 5R01AI 42254-14) and the National Cancer Institute (5R01CA162092-20 to K.G. and CA090576 to R.A.V.E.).	CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2009, NEW ENGL J MED, V360, P524, DOI 10.1056/NEJMe0809819; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; HAYASHI SI, 1990, J EXP MED, V171, P1683, DOI 10.1084/jem.171.5.1683; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Iacobucci I, 2009, BLOOD, V114, P2159, DOI 10.1182/blood-2008-08-173963; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615; KIERNEY PC, 1987, BLOOD, V70, P1418; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Middendorp S, 2005, BLOOD, V105, P259, DOI 10.1182/blood-2004-07-2708; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Park SY, 2013, J IMMUNOL, V190, P1094, DOI 10.4049/jimmunol.1202639; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; ROLINK A, 1991, EUR J IMMUNOL, V21, P2609, DOI 10.1002/eji.1830211044; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Waanders E, 2011, LEUKEMIA, V25, P254, DOI 10.1038/leu.2010.275; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128	50	106	114	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					294	304		10.1038/ni.2821	http://dx.doi.org/10.1038/ni.2821			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24509510	Green Submitted, Green Accepted			2022-12-18	WOS:000331683100015
J	Kidd, BA; Peters, LA; Schadt, EE; Dudley, JT				Kidd, Brian A.; Peters, Lauren A.; Schadt, Eric E.; Dudley, Joel T.			Unifying immunology with informatics and multiscale biology	NATURE IMMUNOLOGY			English	Review							DIFFERENTIAL EXPRESSION ANALYSIS; CHIP-SEQ EXPERIMENTS; HLA CLASS-I; GENE-EXPRESSION; SYSTEMS-BIOLOGY; HIGH-THROUGHPUT; REGULATORY NETWORKS; ENRICHMENT ANALYSIS; MASS CYTOMETRY; RNA-SEQ	The immune system is a highly complex and dynamic system. Historically, the most common scientific and clinical practice has been to evaluate its individual components. This kind of approach cannot always expose the interconnecting pathways that control immune-system responses and does not reveal how the immune system works across multiple biological systems and scales. High-throughput technologies can be used to measure thousands of parameters of the immune system at a genome-wide scale. These system-wide surveys yield massive amounts of quantitative data that provide a means to monitor and probe immune-system function. New integrative analyses can help synthesize and transform these data into valuable biological insight. Here we review some of the computational analysis tools for high-dimensional data and how they can be applied to immunology.	[Kidd, Brian A.; Schadt, Eric E.; Dudley, Joel T.] Dept Genet & Genom Sci, New York, NY 10029 USA; [Kidd, Brian A.; Schadt, Eric E.; Dudley, Joel T.] Icahn Inst Genom & Multiscale Biol, New York, NY USA; [Kidd, Brian A.; Peters, Lauren A.; Schadt, Eric E.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, New York, NY USA; [Peters, Lauren A.] Grad Sch Biomed Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Dudley, JT (corresponding author), Dept Genet & Genom Sci, New York, NY 10029 USA.	joel.dudley@mssm.edu		Kidd, Brian/0000-0003-2110-1145; , Lauren/0000-0002-3747-0474	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK098242]; Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098242] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Berin, B. Brown, R. Kosoy, B. Readhead and C. Tato for critical reading and feedback on the manuscript. This work was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK098242) and the Pharmaceutical Research and Manufacturers of America Foundation.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; Ahn J, 2013, BIOINFORMATICS, V29, P1865, DOI 10.1093/bioinformatics/btt301; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, SCI TRANSL MED; Arazi A, 2013, SEMIN IMMUNOL, V25, P193, DOI 10.1016/j.smim.2012.11.003; Barak M, 2008, J IMMUNOL METHODS, V338, P67, DOI 10.1016/j.jim.2008.06.006; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boyd SD, 2013, ANNU REV PATHOL-MECH, V8, P381, DOI 10.1146/annurev-pathol-020712-164026; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casanova J.-L., 2013, COLD SPRING HARB SYM, V4; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chiche L, 2013, ARTHRITIS RHEUM-US, V65, P1407, DOI 10.1002/art.37909; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dudley JT, 2010, NAT BIOTECHNOL, V28, P1181, DOI 10.1038/nbt1110-1181; Dudley JT, 2010, GENOME MED, V2, DOI 10.1186/gm172; Dudley JT, 2011, SCI TRANSL MED, V3; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Engreitz JM, 2011, BIOINFORMATICS, V27, P3317, DOI 10.1093/bioinformatics/btr548; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Goris A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007260; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jee J, 2011, BIOINFORMATICS, V27, P1152, DOI 10.1093/bioinformatics/btr092; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2012, NAT METHODS, V9, P855, DOI 10.1038/nmeth.2147; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Law GL, 2013, NAT REV MICROBIOL, V11, P455, DOI 10.1038/nrmicro3036; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qian Y, 2010, FRONT ENVIRON SCI EN, V4, P1, DOI 10.1007/s11783-010-1000-9; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Siebert JC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-62; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Srivas R, 2011, NAT PROTOC, V6, P1308, DOI 10.1038/nprot.2011.368; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan CM, 2013, BIOINFORMATICS, V29, P1872, DOI 10.1093/bioinformatics/btt319; Thomas N, 2013, BIOINFORMATICS, V29, P542, DOI 10.1093/bioinformatics/btt004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2012, CURR OPIN IMMUNOL, V24, P552, DOI 10.1016/j.coi.2012.07.013; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	137	106	108	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					118	127		10.1038/ni.2787	http://dx.doi.org/10.1038/ni.2787			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448569	Green Accepted			2022-12-18	WOS:000330150600003
J	Bertolino, E; Reddy, K; Medina, KL; Parganas, E; Ihle, J; Singh, H				Bertolino, E; Reddy, K; Medina, KL; Parganas, E; Ihle, J; Singh, H			Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; COMMON LYMPHOID PROGENITORS; V(D)J RECOMBINATION; HISTONE ACETYLATION; IL-7 RECEPTOR; RAG PROTEINS; MICE; ACTIVATION; LOCUS; PAX5	Rearrangement of immunoglobulin heavy-chain variable (V-H) gene segments has been suggested to be regulated by interleukin 7 signaling in pro-B cells. However, the genetic evidence for this recombination pathway has been challenged. Furthermore, no molecular components that directly control V-H gene rearrangement have been elucidated. Using mice deficient in the interleukin 7-activated transcription factor STAT5, we demonstrate here that STAT5 regulated germline transcription, histone acetylation and DNA recombination of distal V-H gene segments. STAT5 associated with V-H gene segments in vivo and was recruited as a coactivator with the transcription factor Oct-1. STAT5 did not affect the nuclear repositioning or compaction of the immunoglobulin heavy-chain locus. Therefore, STAT5 functions at a distinct step in regulating distal V-H recombination in relation to the transcription factor Pax5 and histone methyltransferase Ezh2.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Biochem, Memphis, TN 38105 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	hsingh@uchicago.edu		Reddy, Karen/0000-0003-4548-5999				Bertolino E, 2002, MOL CELL, V10, P397, DOI 10.1016/S1097-2765(02)00597-X; BERTOLINO E, 2000, TRANSCRIPTION FACTOR, P294; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Haines BB, 2001, MOL IMMUNOL, V38, P9, DOI 10.1016/S0161-5890(01)00049-9; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; Lord JD, 1998, J IMMUNOL, V161, P4627; Magne S, 2003, MOL CELL BIOL, V23, P8934, DOI 10.1128/MCB.23.24.8934-8945.2003; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Riblet R., 2004, MOL BIOL B CELLS, P19, DOI DOI 10.1016/B978-012053641-2/50003-4; ROIDAN E, 2005, NAT IMMUNOL, V6, P31; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SMITHSON G, 1995, J IMMUNOL, V155, P3409; Solovei I., 2002, FISH PRACTICAL APPRO, P119; Spector DL, 1998, CELLS LAB MANUAL, V3; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	49	106	107	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					836	843		10.1038/ni1226	http://dx.doi.org/10.1038/ni1226			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16025120				2022-12-18	WOS:000230646200025
J	Jaeckel, E; Lipes, MA; von Boehmer, H				Jaeckel, E; Lipes, MA; von Boehmer, H			Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes	NATURE IMMUNOLOGY			English	Article							GLUTAMIC-ACID DECARBOXYLASE; REGULATORY T-CELLS; NOD MICE; IN-VIVO; INSULIN EXPRESSION; TRANSGENIC MICE; IMMUNE-RESPONSE; HUMAN THYMUS; IDDM2 LOCUS; B CHAIN	Although autoimmune diseases can be initiated by immunization with a single antigen, it is not clear whether a single self antigen is essential for the initiation and, perhaps, the perpetuation of spontaneous autoimmunity. Some studies have suggested that insulin may represent an essential autoantigen in type 1 diabetes. Here we show that unlike tolerance to glutamic acid decarboxylase, tolerance to transgenically overexpressed preproinsulin 2 substantially reduced the onset and severity of type 1 diabetes in nonobese diabetic mice. However, some mice still developed type 1 diabetes, suggesting that insulin is a key, but not absolutely essential, autoantigen. The results are consistent with the idea that the human IDDM2 locus controls susceptibility to type 1 diabetes by regulating intrathymic preproinsulin expression.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu			NIAID NIH HHS [N01-AI-75320] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI075320] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; BOITARD C, 1989, J EXP MED, V169, P1669, DOI 10.1084/jem.169.5.1669; Bonifacio E, 2001, DIABETES, V50, P2451, DOI 10.2337/diabetes.50.11.2451; Bot A, 2001, J IMMUNOL, V167, P2950, DOI 10.4049/jimmunol.167.5.2950; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Duvillie B, 2002, ENDOCRINOLOGY, V143, P1530, DOI 10.1210/en.143.4.1530; Faideau B, 2004, J IMMUNOL, V172, P25, DOI 10.4049/jimmunol.172.1.25; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; GHEBAULTBAUMONT K, 2003, J CLIN INVEST, V111, P851; GLIMCHER LH, 1983, J IMMUNOL, V131, P2868; GOTTLIEB PA, 1991, DIABETOLOGIA, V34, P296, DOI 10.1007/BF00404999; Gottlieb PA, 2002, CLIN IMMUNOL, V102, P2, DOI 10.1006/clim.2001.5142; Halbout P, 2002, J IMMUNOL, V169, P2436, DOI 10.4049/jimmunol.169.5.2436; Homann D, 1999, J IMMUNOL, V163, P1833; HURTENBACH U, 1989, J AUTOIMMUN, V2, P151, DOI 10.1016/0896-8411(89)90151-0; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; MUIR A, 1995, J CLIN INVEST, V95, P628, DOI 10.1172/JCI117707; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Semana G, 1999, J AUTOIMMUN, V12, P259, DOI 10.1006/jaut.1999.0282; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Steptoe RJ, 2003, J CLIN INVEST, V111, P1357, DOI 10.1172/JCI200315995; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van Santen HM, 2000, J IMMUNOL METHODS, V245, P133, DOI 10.1016/S0022-1759(00)00276-3; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Winter J, 2002, ANAL BIOCHEM, V310, P148, DOI 10.1016/S0003-2697(02)00287-7; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	48	106	107	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1028	1035		10.1038/ni1120	http://dx.doi.org/10.1038/ni1120			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15378058				2022-12-18	WOS:000224156600026
J	LeibundGut-Landmann, S; Waldburger, JM; Sousa, CRE; Acha-Orbea, H; Reith, W				LeibundGut-Landmann, S; Waldburger, JM; Sousa, CRE; Acha-Orbea, H; Reith, W			MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells	NATURE IMMUNOLOGY			English	Article							INTERFERON-PRODUCING CELLS; COLONY-STIMULATING FACTOR; BARE LYMPHOCYTE SYNDROME; TRANSACTIVATOR CIITA; T-CELLS; IFN-GAMMA; PROMOTER-IV; B-CELL; HEMATOPOIETIC PRECURSORS; INFLUENZA-VIRUS	Major histocompatibility complex (MHC) class II-restricted antigen presentation is essential for the function of dendritic cells (DCs). We show here that plasmacytoid DCs (pDCs) differ from all other DC subsets with respect to expression of CIITA, the 'master regulator' of MHC class II genes. The gene encoding CIITA is controlled by three cell type-specific promoters: pI, pIII and pIV. With gene targeting in mice, we demonstrate that pDCs rely strictly on the B cell promoter pIII, whereas macrophages and all other DCs depend on pI. The molecular mechanisms driving MHC class II expression in pDCs are thus akin to those operating in lymphoid rather than myeloid cells.	Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England; Univ Lausanne, Fac Biol & Med, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Geneva; Cancer Research UK; University of Lausanne	Reith, W (corresponding author), Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland.	Walter.Reith@medecine.unige.ch	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; LeibundGut-Landmann, Salome/0000-0002-5724-4837				Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briere F, 2002, HUM IMMUNOL, V63, P1081, DOI 10.1016/S0198-8859(02)00746-2; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dong YS, 1999, J IMMUNOL, V162, P4731; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; JUHLIN L, 1977, ACTA DERM-VENEREOL, V57, P289; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Lennon AM, 1998, IMMUNOGENETICS, V48, P283, DOI 10.1007/s002510050433; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mach N, 2000, CANCER RES, V60, P3239; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piskurich JF, 1998, J IMMUNOL, V160, P233; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Soos JM, 2001, GLIA, V36, P391, DOI 10.1002/glia.1125; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Suter T, 2000, EUR J IMMUNOL, V30, P794, DOI 10.1002/1521-4141(200003)30:3<794::AID-IMMU794>3.3.CO;2-H; Takamura Y, 2004, GLIA, V45, P392, DOI 10.1002/glia.10343; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Torres RM, 1997, LAB PROTOCOLS CONDIT; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	59	106	106	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					899	908		10.1038/ni1109	http://dx.doi.org/10.1038/ni1109			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15322541				2022-12-18	WOS:000223612500018
J	Nakamura, A; Kobayashi, E; Takai, T				Nakamura, A; Kobayashi, E; Takai, T			Exacerbated graft-versus-host disease in Pirb(-/-) mice	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; MHC CLASS-I; IMMUNOGLOBULIN-LIKE RECEPTORS; CELL INHIBITORY RECEPTORS; PIR-B; DENDRITIC CELLS; MYELOID CELLS; FC-RECEPTORS; GAMMA-CHAIN; MYELOMONOCYTIC CELLS	Immune responses are often regulated by opposing receptor pairs that recognize the same ligand but deliver either activating or inhibitory signals. Paired immunoglobulin-like receptors (PIRs) expressed on B cells and myeloid cells comprise a major histocompatibility complex class I recognition system that regulates the responsiveness of these cells. Here, activating PIR-A and inhibitory PIR-B bound various mouse major histocompatibility complex class I (H-2) molecules, and in vitro H-2 tetramer stimulation of PIR-B on B cells or PIR-A on macrophages induced intracellular phosphotyrosine signaling. After transfer of allogeneic splenocytes into PIR-B-deficient mice, the mice showed exacerbated graft-versus-host disease, which was due to augmented activation of recipient dendritic cells with concomitant upregulation of PIR-A and increased interferongamma-production. PIR-A-induced dendritic cell activation also led to increased proliferation of donor cytotoxic T cells. Thus, PIR-A and PIR-B are counteracting receptors that are essential for successful tissue transplantation and may regulate irrelevant reaction to autologous tissues in a constitutive way in physiological conditions.	Tohoku Univ, Dept Expt Immunol & Core Res, Evolutional Sci & Technol Program, Japan Sci & Technol Agcy,Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	Japan Science & Technology Agency (JST); Tohoku University	Takai, T (corresponding author), Tohoku Univ, Dept Expt Immunol & Core Res, Evolutional Sci & Technol Program, Japan Sci & Technol Agcy,Inst Dev Aging & Canc, Seiryo 4-1, Sendai, Miyagi 9808575, Japan.	tostakai@idac.tohoku.ac.jp		Kobayashi, Eiji/0000-0002-7303-2797				Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dulphy N, 2002, INT IMMUNOL, V14, P471, DOI 10.1093/intimm/14.5.471; Hart G, 2003, J IMMUNOL, V171, P4630, DOI 10.4049/jimmunol.171.9.4630; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kogure T, 2001, ANN RHEUM DIS, V60, P166, DOI 10.1136/ard.60.2.166; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kubagawa H, 1999, CURR TOP MICROBIOL, V244, P137; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Laferte S, 2000, J CELL BIOCHEM, V77, P540, DOI 10.1002/(SICI)1097-4644(20000615)77:4<540::AID-JCB3>3.0.CO;2-I; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Mul Al-F, 1995, EMBO J, V14, P1166; Nakajima H, 1999, J IMMUNOL, V162, P5; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Pedersen AE, 1996, CELL IMMUNOL, V173, P295, DOI 10.1006/cimm.1996.0281; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Yamashita Y, 1998, J IMMUNOL, V161, P4042; Yamashita Y, 1998, J BIOCHEM-TOKYO, V123, P358, DOI 10.1093/oxfordjournals.jbchem.a021945	43	106	120	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					623	629		10.1038/ni1074	http://dx.doi.org/10.1038/ni1074			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15146181				2022-12-18	WOS:000221664000021
J	Ryeom, S; Greenwald, RJ; Sharpe, AH; McKeon, F				Ryeom, S; Greenwald, RJ; Sharpe, AH; McKeon, F			The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin	NATURE IMMUNOLOGY			English	Article							SYNDROME CRITICAL REGION; INDUCED CELL-DEATH; DOWN-SYNDROME; TRANSCRIPTION FACTOR; CYCLOSPORINE-A; FAS LIGAND; LINEAGE COMMITMENT; STRIATED-MUSCLES; IMMUNE-RESPONSES; T-CELLS	Calcineurin links calcium signaling to transcriptional responses in the immune, nervous and cardiovascular systems. To determine the function of the calcipressins, a family of putative calcineurin inhibitors, we assessed the calcineurin-dependent process of T cell activation in mice engineered to lack the gene encoding calcipressin 1 (Csp1). Csp1 regulated calcineurin in vivo, and genes triggered in an immune response had unique transactivation thresholds for T cell receptor stimulation. In the absence of Csp1, the apparent transactivation thresholds for all these genes were shifted because of enhanced calcineurin activity. This unbridled calcineurin activity drove Fas ligand expression, which normally requires high T cell receptor stimulation and results in the premature death of T helper type 1 cells. Thus, calcipressins modulate the pattern of calcineurin-dependent transcription, and may influence calcineurin activity beyond calcium to integrate a broad array of signals into the cellular response.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.							Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BILLIAU A, 1998, ANN NY ACAD SCI, V29, P856; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dzialo-Hatton R, 2001, J IMMUNOL, V166, P4534, DOI 10.4049/jimmunol.166.7.4534; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Glimcher LH, 2000, GENE DEV, V14, P1693; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kung L, 2001, AM J TRANSPLANT, V1, P325, DOI 10.1034/j.1600-6143.2001.10407.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MILAN D, 1994, CELL, V79, P437, DOI 10.1016/0092-8674(94)90253-4; Miyazaki T, 1996, J BIOL CHEM, V271, P14567, DOI 10.1074/jbc.271.24.14567; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Nguyen T, 2001, IMMUNOLOGY, V103, P426, DOI 10.1046/j.1365-2567.2001.01264.x; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Strippoli P, 2000, GENE, V257, P223, DOI 10.1016/S0378-1119(00)00407-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	41	106	109	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					874	881		10.1038/ni966	http://dx.doi.org/10.1038/ni966			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12925851				2022-12-18	WOS:000185002200014
J	Sugai, M; Gonda, H; Kusunoki, T; Katakai, T; Yokota, Y; Shimizu, A				Sugai, M; Gonda, H; Kusunoki, T; Katakai, T; Yokota, Y; Shimizu, A			Essential role of Id2 in negative regulation of IgE class switching	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; LOOP-HELIX PROTEINS; TRANSCRIPTION; RECOMBINATION; REGION; ACTIVATION; STAT6; DIFFERENTIATION; DISRUPTION; CYTOKINES	Serum concentrations of immunoglobulin E (IgE) in normal circumstances are kept much lower than those of other Ig isotypes to avoid allergic reactions. B cells lacking Id2 have increased E2A activity, which leads to specific enhancement of germline transcription of the immunoglobulin locus. As a consequence, Id2-deficient B cells undergo class switch recombination (CSR) to IgE at a much higher frequency than wild-type B cells. In contrast, Id2 is induced in wild-type B cells by transforming growth factor-beta1 (TGF-beta1) and suppresses IgE CSR. Our results provide evidence for the inhibitory and selective role of Id2 in IgE CSR in response to TGF-beta1. Id2 might act as molecular safeguard to suppress IgE CSR to prevent serious complications such as allergic hypersensitivity during the normal course of immune responses.	Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan; Fukui Med Univ, Dept Biochem, Matsuoka, Fukui 9101193, Japan	Kyoto University; Kyoto University; Kyoto University; University of Fukui	Shimizu, A (corresponding author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Shogoin Kawahara Cho, Kyoto 6068507, Japan.	shimizu@virus.kyoto-u.ac.jp	Katakai, Tomoya/AAX-1434-2021	Sugai, Manabu/0000-0003-1668-7647; Katakai, Tomoya/0000-0002-4290-7028				BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Corry DB, 1999, NATURE, V402, pB18; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; GAUCHAT JF, 1992, INT IMMUNOL, V4, P397, DOI 10.1093/intimm/4.3.397; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; JUNG S, 1994, J EXP MED, V179, P2023, DOI 10.1084/jem.179.6.2023; Kamogawa Y, 1998, J IMMUNOL, V161, P1074; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUSUNOKI T, 2003, IN PRESS J ALLERGY C; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; LUNDGREN M, 1994, J IMMUNOL, V153, P2983; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; PURKERSON JM, 1994, J EXP MED, V179, P1877, DOI 10.1084/jem.179.6.1877; Qiu G, 1998, J IMMUNOL, V161, P2906; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SHOCKETT P, 1991, J IMMUNOL, V147, P4374; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sugai M, 1998, NUCLEIC ACIDS RES, V26, P911, DOI 10.1093/nar/26.4.911; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235	39	106	106	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					25	30		10.1038/ni874	http://dx.doi.org/10.1038/ni874			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12483209				2022-12-18	WOS:000180053000010
J	Schwartz, JCD; Zhang, XW; Nathenson, SG; Almo, SC				Schwartz, JCD; Zhang, XW; Nathenson, SG; Almo, SC			Structural mechanisms of costimulation	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; ERYTHROPOIETIN RECEPTOR; NEGATIVE REGULATION; COMPLEX REVEALS; CO-STIMULATION; SOLUBLE FORM; CD80 B7-1; CTLA-4	Recent studies have highlighted the structural requirements for T cell costimulation and have revealed unusual modes of dimerization for the cytolytic T lymphocyte-associated antigen 4 (CTLA-4) costimulatory receptor and its B7 ligands. These distinctive quaternary structures potentially endow both receptor and ligand with bivalent binding properties, which suggests a number of mechanistic features relevant to signaling. These include the potential to form a highly ordered, alternating network of CTLA-4 and B7 homodimers that may represent the organization of these molecules and their associated signaling partners within the immunological synapse. Primary sequence and structural considerations suggest that some aspects of the organizational and mechanistic features associated with the CTLA-4-B7 complexes may extend to other members of the costimulatory receptor-ligand family. An examination of the signaling mechanisms within the costimulatory receptor-ligand family provides an excellent framework to consider the general principles that are relevant to cell surface receptor-mediated signaling events.	Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Synchrotron Biosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Almo, SC (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	almo@aecom.yu.edu						BAJORATH J, 1994, PROTEIN SCI, V3, P2148, DOI 10.1002/pro.5560031128; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARTON GJ, 1990, METHOD ENZYMOL, V183, P403; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chikuma S, 2000, J CELL BIOCHEM, V78, P241, DOI 10.1002/(SICI)1097-4644(20000801)78:2<241::AID-JCB7>3.3.CO;2-B; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; EVANS SV, 1993, J MOL GRAPHICS, V11, P127; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hirokawa M, 1996, IMMUNOL LETT, V50, P95, DOI 10.1016/0165-2478(96)02526-6; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jeannin P, 1997, J BIOL CHEM, V272, P15613, DOI 10.1074/jbc.272.25.15613; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MARTIN PJ, 1986, J IMMUNOL, V136, P3282; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Morton PA, 1996, J IMMUNOL, V156, P1047; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; ZHANG X, 2002, IN PRESS PROTEIN EXP; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	73	106	128	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					427	434		10.1038/ni0502-427	http://dx.doi.org/10.1038/ni0502-427			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976720				2022-12-18	WOS:000175411200010
J	de Lima, KA; Rustenhoven, J; Da Mesquita, S; Wall, M; Salvador, AF; Smirnov, I; Cebinelli, GM; Mamuladze, T; Baker, W; Papadopoulos, Z; Lopes, MB; Cao, WS; Xie, XS; Herz, J; Kipnis, J				Alves de Lima, Kalil; Rustenhoven, Justin; Da Mesquita, Sandro; Wall, Morgan; Salvador, Andrea Francesca; Smirnov, Igor; Martelossi Cebinelli, Guilherme; Mamuladze, Tornike; Baker, Wendy; Papadopoulos, Zach; Lopes, Maria Beatriz; Cao, William Sam; Xie, Xinmin Simon; Herz, Jasmin; Kipnis, Jonathan			Meningeal gamma delta T cells regulate anxiety-like behavior via IL-17a signaling in neurons	NATURE IMMUNOLOGY			English	Article							HOMEOSTASIS; IMMUNITY; PACKAGE; GENE	IL-17a is an evolutionarily conserved cytokine with behavior-modulating roles in the central nervous system. Kipnis and colleagues characterize a population of meningeal gamma delta 17 T cells that use IL-17a to elicit anxiety-like behavior through cortical glutamatergic neurons. Interleukin (IL)-17a has been highly conserved during evolution of the vertebrate immune system and widely studied in contexts of infection and autoimmunity. Studies suggest that IL-17a promotes behavioral changes in experimental models of autism and aggregation behavior in worms. Here, through a cellular and molecular characterization of meningeal gamma delta 17 T cells, we defined the nearest central nervous system-associated source of IL-17a under homeostasis. Meningeal gamma delta T cells express high levels of the chemokine receptor CXCR6 and seed meninges shortly after birth. Physiological release of IL-17a by these cells was correlated with anxiety-like behavior in mice and was partially dependent on T cell receptor engagement and commensal-derived signals. IL-17a receptor was expressed in cortical glutamatergic neurons under steady state and its genetic deletion decreased anxiety-like behavior in mice. Our findings suggest that IL-17a production by meningeal gamma delta 17 T cells represents an evolutionary bridge between this conserved anti-pathogen molecule and survival behavioral traits in vertebrates.	[Alves de Lima, Kalil; Rustenhoven, Justin; Da Mesquita, Sandro; Wall, Morgan; Salvador, Andrea Francesca; Smirnov, Igor; Martelossi Cebinelli, Guilherme; Mamuladze, Tornike; Baker, Wendy; Papadopoulos, Zach; Herz, Jasmin; Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22903 USA; [Alves de Lima, Kalil; Rustenhoven, Justin; Da Mesquita, Sandro; Wall, Morgan; Salvador, Andrea Francesca; Smirnov, Igor; Martelossi Cebinelli, Guilherme; Mamuladze, Tornike; Baker, Wendy; Papadopoulos, Zach; Herz, Jasmin; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Alves de Lima, Kalil; Rustenhoven, Justin; Salvador, Andrea Francesca; Smirnov, Igor; Mamuladze, Tornike; Papadopoulos, Zach; Herz, Jasmin; Kipnis, Jonathan] Washington Univ, Div Immunobiol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Martelossi Cebinelli, Guilherme] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Res Inflammatory Dis CRID, Sao Paulo, Brazil; [Lopes, Maria Beatriz] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Cao, William Sam; Xie, Xinmin Simon] AfaSci Res Labs, Redwood City, CA USA	University of Virginia; University of Virginia; Washington University (WUSTL); Universidade de Sao Paulo; University of Virginia	de Lima, KA; Kipnis, J (corresponding author), Univ Virginia, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22903 USA.; de Lima, KA; Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.; de Lima, KA; Kipnis, J (corresponding author), Washington Univ, Div Immunobiol, Dept Pathol & Immunol, St Louis, MO 63110 USA.	alvesdelima@wustl.edu; kipnis@wustl.edu	Kipnis, Jonathan/AGG-9735-2022; Cebinelli, Guilherme Cesar Martelossi/H-5434-2016; Da Mesquita, Sandro/A-7365-2010; Lopes, Maria/GXF-7507-2022	Kipnis, Jonathan/0000-0002-3714-517X; Cebinelli, Guilherme Cesar Martelossi/0000-0001-7593-1035; Da Mesquita, Sandro/0000-0002-0786-5010; Alves de Lima, Kalil/0000-0002-9149-168X; Salvador, Andrea Francesca/0000-0002-9197-7575; Mamuladze, Tornike/0000-0002-7088-3967	National Institutes of Health [MH108156, AT010416, AG034113]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Smith for editing the manuscript, J. Sokolowski for help with the collection of human samples and M. Beenhakker for help with interpreting the electrophysiology studies. We thank all members of the Kipnis laboratory and members of the Center for Brain Immunology and Glia (BIG) for valuable comments during multiple discussions of this work. We also thank the UVA Flow Cytometry Core for help with cell sorting, the Genome Analysis and Technology Core for help with library preparation and sequencing, and J. Graham from the Virginia Commonwealth University School of Nursing for performing the Meso Scale Discovery assay. This work was supported by grants from the National Institutes of Health (MH108156, AT010416 and AG034113) to J.K.	Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; de Lima KA, 2020, ANNU REV IMMUNOL, V38, P597, DOI 10.1146/annurev-immunol-102319-103410; de Lima KA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1107-7; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Haase R, 2020, NAT METHODS, V17, P5, DOI 10.1038/s41592-019-0650-1; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Homdli CNS, 2019, CELL REP, V28, P1814, DOI 10.1016/j.celrep.2019.07.038; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Lun Aaron T L, 2016, F1000Res, V5, P2122; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Ringstad G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14195-x; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Spijker S, 2019, NEUROMETHODS, V146, P7, DOI 10.1007/978-1-4939-9662-9_2; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou Y, 2012, J BIOL CHEM, V287, P35733, DOI 10.1074/jbc.M112.368175	39	105	106	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1421	+		10.1038/s41590-020-0776-4	http://dx.doi.org/10.1038/s41590-020-0776-4		SEP 2020	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32929273	Green Accepted			2022-12-18	WOS:000569299600001
J	Akkaya, B; Oya, Y; Akkaya, M; Al Souz, J; Holstein, AH; Kamenyeva, O; Kabat, J; Matsumura, R; Dorward, DW; Glass, DD; Shevach, EM				Akkaya, Billur; Oya, Yoshihiro; Akkaya, Munir; Al Souz, Jafar; Holstein, Amanda H.; Kamenyeva, Olena; Kabat, Juraj; Matsumura, Ryutaro; Dorward, David W.; Glass, Deborah D.; Shevach, Ethan M.			Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells	NATURE IMMUNOLOGY			English	Article							IN-VITRO; ANTIGEN; RECEPTOR; EXPRESSION; TCR; MICROCLUSTERS; TROGOCYTOSIS; COMPLEXES; ADHESION; INHIBIT	Regulatory T cells (T-reg cells) can activate multiple suppressive mechanisms in vitro after activation via the T cell antigen receptor, resulting in antigen-independent suppression. However, it remains unclear whether similar pathways operate in vivo. Here we found that antigen-specific T-reg cells activated by dendritic cells (DCs) pulsed with two antigens suppressed conventional naive T cells (T-naive cells) specific for both cognate antigens and non-cognate antigens in vitro but suppressed only Tnaive cells specific for cognate antigen in vivo. Antigen-specific T-reg cells formed strong interactions with DCs, resulting in selective inhibition of the binding of T-naive cells to cognate antigen yet allowing bystander T-naive cell access. Strong binding resulted in the removal of the complex of cognate peptide and major histocompatibility complex class II (pMHCII) from the DC surface, reducing the capacity of DCs to present antigen. The enhanced binding of T-reg cells to DCs, coupled with their capacity to deplete pMHCII, represents a novel pathway for T-reg cell-mediated suppression and may be a mechanism by which T-reg cells maintain immune homeostasis.	[Akkaya, Billur; Oya, Yoshihiro; Al Souz, Jafar; Holstein, Amanda H.; Glass, Deborah D.; Shevach, Ethan M.] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Oya, Yoshihiro; Matsumura, Ryutaro] Natl Hosp Org Chiba East Natl Hosp, Dept Rheumatol Allergy & Clin Immunol, Chiba, Japan; [Akkaya, Munir] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Kamenyeva, Olena; Kabat, Juraj] NIAID, Res Technol Branch, NIH, Bethesda, MD USA; [Dorward, David W.] NIAID, Res Technol Branch, NIH, Rocky Mt Labs, Hamilton, MT 59840 USA; [Holstein, Amanda H.] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Glass, Deborah D.] Rapa Therapeut, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University System of Florida; University of South Florida	Akkaya, B; Shevach, EM (corresponding author), NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	billur.akkaya@nih.gov; eshevach@niaid.nih.gov	AKKAYA, BILLUR/AAC-6499-2021; Akkaya, Munir/J-3975-2019	AKKAYA, BILLUR/0000-0002-6808-3776; Akkaya, Munir/0000-0002-9949-9424; Al Souz, Jafar/0000-0003-2345-2803; Oya, Yoshihiro/0000-0002-7645-598X	Intramural Program, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000224] Funding Source: NIH RePORTER	Intramural Program, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is funded by the Intramural Program, NIAID, NIH. We thank A. Athman and R. Kissinger (Visual Medical Arts, NIAID) for colorizing the electron microscopy images and various illustrations; A. Gangaplara, NIAID, for providing the SMARTA mice for the adoptive transfer experiments; A. Kumarpanda, NIAID, for providing the reagents for the in vivo T<INF>reg</INF> cell expansion; and M. Pena, NIAID, for technical assistance.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Akkaya B, 2017, J IMMUNOL METHODS, V441, P67, DOI 10.1016/j.jim.2016.11.013; Akkaya B, 2016, J IMMUNOL, V197, P2027, DOI 10.4049/jimmunol.1600727; Akkaya M, 2018, NAT IMMUNOL, V19, P255, DOI 10.1038/s41590-018-0052-z; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chatila TA, 2017, EUR J IMMUNOL, V47, P2039, DOI 10.1002/eji.201747359; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chen JH, 2017, J EXP MED, V214, P327, DOI 10.1084/jem.20160620; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Doh J, 2010, CURR TOP MICROBIOL, V340, P25, DOI 10.1007/978-3-642-03858-7_2; Hashimoto-Tane A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00255; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kumar S, 2016, MOL CELL, V62, P21, DOI 10.1016/j.molcel.2016.03.009; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Matheu MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7219; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Patel DM, 1999, J IMMUNOL, V163, P5201; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rossy J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00352; Samy ET, 2006, IMMUNOL REV, V212, P170, DOI 10.1111/j.0105-2896.2006.00404.x; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schmidt AM, 2015, J IMMUNOL, V194, P4362, DOI 10.4049/jimmunol.1402384; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yan JC, 2017, J EXP MED, V214, P319, DOI 10.1084/jem.20160629; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	49	105	107	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					218	+		10.1038/s41590-018-0280-2	http://dx.doi.org/10.1038/s41590-018-0280-2			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643268	Green Accepted			2022-12-18	WOS:000456279100019
J	Wang, YF; Shi, JW; Yan, JC; Xiao, ZT; Hou, XX; Lu, PW; Hou, SY; Mao, TY; Liu, WL; Ma, YW; Zhang, LF; Yang, XR; Qi, H				Wang, Yifeng; Shi, Jingwen; Yan, Jiacong; Xiao, Zhengtao; Hou, Xiaoxiao; Lu, Peiwen; Hou, Shiyue; Mao, Tianyang; Liu, Wanli; Ma, Yuanwu; Zhang, Lianfeng; Yang, Xuerui; Qi, Hai			Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells	NATURE IMMUNOLOGY			English	Article							DIFFERENTIATION; RECEPTOR; EXPRESSION; PROLIFERATION; ACTIVATION; INDUCTION; SELECTION; DYNAMICS; PHOSPHORYLATION; TRANSCRIPTION	Germinal centers (GCs) support high-affinity, long-lived humoral immunity. How memory B cells develop in GCs is not clear. Through the use of a cell-cycle-reporting system, we identified GC-derived memory precursor cells (GC-MP cells) that had quit cycling and reached G0 phase while in the GC, exhibited memory-associated phenotypes with signs of affinity maturation and localized toward the GC border. After being transferred into adoptive hosts, GC-MP cells reconstituted a secondary response like genuine memory B cells. GC-MP cells expressed the interleukin 9 (IL-9) receptor and responded to IL-9. Acute treatment with IL-9 or antibody to IL-9 accelerated or retarded the positioning of GC-MP cells toward the GC edge and exit from the GC, and enhanced or inhibited the development of memory B cells, which required B cell-intrinsic responsiveness to IL-9. Follicular helper T cells (T-FH cells) produced IL-9, and deletion of IL-9 from T cells or, more specifically, from GC T-FH cells led to impaired memory formation of B cells. Therefore, the GC development of memory B cells is promoted by T-FH cell-derived IL-9.	[Wang, Yifeng; Shi, Jingwen; Yan, Jiacong; Xiao, Zhengtao; Hou, Xiaoxiao; Lu, Peiwen; Hou, Shiyue; Mao, Tianyang; Yang, Xuerui; Qi, Hai] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Wang, Yifeng; Shi, Jingwen; Yan, Jiacong; Hou, Xiaoxiao; Lu, Peiwen; Hou, Shiyue; Mao, Tianyang; Qi, Hai] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China; [Wang, Yifeng; Shi, Jingwen; Yan, Jiacong; Hou, Xiaoxiao; Lu, Peiwen; Hou, Shiyue; Mao, Tianyang; Qi, Hai] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China; [Wang, Yifeng; Shi, Jingwen; Yan, Jiacong; Xiao, Zhengtao; Hou, Xiaoxiao; Hou, Shiyue; Mao, Tianyang; Liu, Wanli; Yang, Xuerui; Qi, Hai] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Chinese Acad Med Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Inst Lab Anim Sci, Beijing, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Yan, Jiacong] First Peoples Hosp Yunnan Prov, Reprod Med Ctr, Kunming, Yunnan, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, H (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.	qihai@tsinghua.edu.cn	liu, wanli/H-5690-2011; Xiao, Zhengtao/AAD-3052-2019	liu, wanli/0000-0003-2624-6802; Xiao, Zhengtao/0000-0002-5535-5381; Liu, Wanli/0000-0003-0395-2800; Yan, Jiacong/0000-0002-2429-036X; Qi, Hai/0000-0001-5475-3989; Ma, Yuanwu/0000-0002-1882-1777; Mao, Tianyang/0000-0001-9251-8592; Lu, Peiwen/0000-0001-6118-872X; Shi, Jingwen/0000-0002-4802-0727; Yang, Xuerui/0000-0002-7731-2147	Ministry of Science and Technology "973" program [2014CB542501]; National Natural Science Foundation of China [81330070, 81425011, 81621002]; Tsinghua-Peking Center for Life Sciences; Bayer endowed chair professorship	Ministry of Science and Technology "973" program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Bayer endowed chair professorship	We thank P. Schwartzberg (US National Institutes of Health) for the SAP-knockout mice; M. Nussenzweig (Rockefeller University) for the B1-8<SUP>hi</SUP> knock-in mice; and S. Crotty (La Jolla Institute of Allergy and Immunology) and Y.-C. Liu (Tsinghua University) for the MSCV-LMP vector. Supported by the Ministry of Science and Technology "973" program (2014CB542501), National Natural Science Foundation of China (81330070, 81425011, 81621002), the Tsinghua-Peking Center for Life Sciences and a Bayer endowed chair professorship (H.Q.).	Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; COICO RF, 1983, J IMMUNOL, V131, P2254; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fawaz LM, 2007, J ALLERGY CLIN IMMUN, V120, P1208, DOI 10.1016/j.jaci.2007.08.022; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; GERDES J, 1984, J IMMUNOL, V133, P1710; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gomez-Rodriguez J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10857; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lefebvre C, 2007, LECT NOTES COMPUT SC, V4532, P42; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	56	105	109	4	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					921	+		10.1038/ni.3788	http://dx.doi.org/10.1038/ni.3788			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28650481				2022-12-18	WOS:000405821100015
J	Upadhyay, V; Poroyko, V; Kim, TJ; Devkota, S; Fu, S; Liu, D; Tumanov, AV; Koroleva, EP; Deng, LF; Nagler, C; Chang, EB; Tang, H; Fu, YX				Upadhyay, Vaibhav; Poroyko, Valeriy; Kim, Tae-jin; Devkota, Suzanne; Fu, Sherry; Liu, Donald; Tumanov, Alexei V.; Koroleva, Ekaterina P.; Deng, Liufu; Nagler, Cathryn; Chang, Eugene B.; Tang, Hong; Fu, Yang-Xin			Lymphotoxin regulates commensal responses to enable diet-induced obesity	NATURE IMMUNOLOGY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; GUT MICROBIOME; MICE; INFLAMMATION; ALPHA; PROGRESSION; PROTECTION; RESISTANCE; PATHWAY; GENOME	Microbiota are essential for weight gain in mouse models of diet-induced obesity (DIO), but the pathways that cause the microbiota to induce weight gain are unknown. We report that mice deficient in lymphotoxin, a key molecule in gut immunity, were resistant to DIO. Ltbr(-/-) mice had different microbial community composition compared to their heterozygous littermates, including an overgrowth of segmented filamentous bacteria (SFB). Furthermore, cecal transplantation conferred leanness to germ-free recipients. Housing Ltbr(-/-) mice with their obese siblings rescued weight gain in Ltbr(-/-) mice, demonstrating the communicability of the obese phenotype. Ltbr(-/-) mice lacked interleukin 23 (IL-23) and IL-22, which can regulate SFB. Mice deficient in these pathways also resisted DIO, demonstrating that intact mucosal immunity guides diet-induced changes to the microbiota to enable obesity.	[Upadhyay, Vaibhav; Kim, Tae-jin; Fu, Sherry; Tumanov, Alexei V.; Koroleva, Ekaterina P.; Deng, Liufu; Nagler, Cathryn; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Upadhyay, Vaibhav; Kim, Tae-jin; Fu, Sherry; Tumanov, Alexei V.; Koroleva, Ekaterina P.; Deng, Liufu; Nagler, Cathryn; Fu, Yang-Xin] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Poroyko, Valeriy; Liu, Donald] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Devkota, Suzanne; Chang, Eugene B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Tang, Hong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yfu@uchicago.edu	Tumanov, Alexei/AAR-1607-2021; Deng, Liufu/I-4443-2013; Deng, Liufu/AAG-7244-2021; Devkota, Suzanne/AAG-1958-2021	Tumanov, Alexei/0000-0001-6042-0152; Deng, Liufu/0000-0002-1164-6777; Devkota, Suzanne/0000-0001-5575-9362; fu, yang-xin/0000-0001-8441-6617; Fu, Sherry/0000-0002-9004-3164; Upadhyay, Vaibhav/0000-0002-7652-1043	American Heart Association (AHA) [11PRE7320015]; US National Institutes of Health Medical Scientist Training Program grant [GM007281]; Digestive Diseases Research Core Center [p30 DK42086]; University of Chicago Institutional Translational Medicine [UL1 RR024999]; US National Institutes of Health [AI090392, DK080736, CA134563]; Korea Foundation for International Cooperation of Science & Technology (KICOS) [K20702001994-11A0500-03610]; NATIONAL CANCER INSTITUTE [R01CA134563] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080736, P30DK042086, R01DK097268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); US National Institutes of Health Medical Scientist Training Program grant; Digestive Diseases Research Core Center; University of Chicago Institutional Translational Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Foundation for International Cooperation of Science & Technology (KICOS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript is dedicated to the memory of Dr. Donald Liu, who provided critical efforts and support. We thank B. Becher (University of Zurich) for IL-23-Ig, C. Dong (MD Anderson Cancer Center) for IL-17, O. Wenjun (Genentech) for IL-22. V.U. was supported by the American Heart Association (AHA Predoctoral 11PRE7320015) and the US National Institutes of Health Medical Scientist Training Program grant GM007281 to the University of Chicago Pritzker School of Medicine. This research was supported by pilot grants from Digestive Diseases Research Core Center (p30 DK42086), the University of Chicago Institutional Translational Medicine (UL1 RR024999), and US National Institutes of Health grants, AI090392, DK080736 and CA134563 to Y.-X.F. T.J.K. was partially funded by the Korea Foundation for International Cooperation of Science & Technology (KICOS) grant (K20702001994-11A0500-03610).	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Centers for Disease Control and Prevention, 2010, AD OB FACTS; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Mahajan A, 2010, J MOL MED, V88, P515, DOI 10.1007/s00109-010-0594-5; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Pamir N, 2012, AM J PHYSIOL-ENDOC M, V302, pE961, DOI 10.1152/ajpendo.00447.2011; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	36	105	112	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					947	953		10.1038/ni.2403	http://dx.doi.org/10.1038/ni.2403			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22922363	Green Accepted			2022-12-18	WOS:000309038600010
J	Zaru, R; Ronkina, N; Gaestel, M; Arthur, JSC; Watts, C				Zaru, Rossana; Ronkina, Natalia; Gaestel, Matthias; Arthur, J. Simon C.; Watts, Colin			The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways	NATURE IMMUNOLOGY			English	Article							RIBOSOMAL S6 KINASE; MHC CLASS-II; STRESS-INDUCED PHOSPHORYLATION; TNF-ALPHA BIOSYNTHESIS; TUMOR-NECROSIS-FACTOR; ISOFORMS IN-VITRO; PROTEIN-KINASE; P38 MAPK; REGULATORY PHOSPHORYLATION; ANTIGEN PRESENTATION	Most dendritic cell (DC) responses to Toll-like receptor (TLR) ligands depend on the activation of mitogen-activated protein kinases (MAPKs), but the contributions of the many MAPK-activated kinases (MKs) that act 'downstream' of the MAPKs Erk and p38 are not known. Here we sought to determine which MKs are required for acute TLR-driven, MAPK-dependent DC endocytic responses. Two specific and structurally different inhibitors of the MK Rsk suppressed TLR-induced endocytosis, thus defining in DCs a specific requirement for MKs in TLR responses. In addition, we identify in DCs a previously unknown configuration of the MAPK system whereby Rsk is activated not only by Erk but also by p38 through the intermediates MK2 and MK3. Thus, in DCs, p38 contributes to the activation of all known MK families.	Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Med Sch Hanover, Dept Biochem, D-30625 Hannover, Germany; Univ Dundee, Sir James Black Ctr, Med Res Council Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Watts, C (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; Gaestel, Matthias/A-6560-2013	Arthur, J. Simon/0000-0002-8135-1958; Gaestel, Matthias/0000-0002-4944-4652; Zaru, Rossana/0000-0002-3358-4423; Watts, Colin/0000-0001-6183-2087	MRC [G0100536, MC_U127015387, MC_U127081014] Funding Source: UKRI; Medical Research Council [MC_U127081014, MC_U127015387, G0100536] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Smith JA, 2005, CANCER RES, V65, P1027; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200	58	105	114	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1227	1235		10.1038/ni1517	http://dx.doi.org/10.1038/ni1517			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17906627				2022-12-18	WOS:000250338900015
J	Abarrategui, I; Krangel, MS				Abarrategui, Iratxe; Krangel, Michael S.			Regulation of T cell receptor-alpha gene recombination by transcription	NATURE IMMUNOLOGY			English	Article							RNA-POLYMERASE-II; CLASS-SWITCH RECOMBINATION; V(D)J RECOMBINATION; INTERGENIC TRANSCRIPTION; HISTONE ACETYLATION; H3 METHYLATION; BETA-GLOBIN; IN-VITRO; PROMOTER; ACCESSIBILITY	Despite the longstanding correlation between transcription and variable-(diversity)-joining (V(D)J) recombination, it is unknown whether transcription itself can direct recombinase targeting. Here we show that blockade of transcriptional elongation through the mouse T cell receptor-alpha (Tcra) locus suppressed V-alpha-to-J(alpha) recombination and chromatin remodeling of J(alpha) segments. Transcriptional blockade also derepressed cryptic J(alpha) promoters. Our results demonstrate two key functions for transcription in Tcra locus regulation. Transcription increases the recombination of J(alpha) segments located within several kilobases of a promoter and prevents the activation of downstream promoters through transcriptional interference. These influences promote an ordered progression of Tcra locus recombination events and selection of a robust Tcra repertoire.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	krang001@mc.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052, R01GM041052] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM041052, GM41052] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Buch T, 2002, IMMUNITY, V16, P707, DOI 10.1016/S1074-7613(02)00312-6; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; CHENKIANG S, 1989, METHOD ENZYMOL, V180, P82; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; DEUSCHLE U, 1990, SCIENCE, V248, P480, DOI 10.1126/science.2158670; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FERNEX C, 1995, MOL CELL BIOL, V15, P3217; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mauvieux L, 2003, EUR J IMMUNOL, V33, P2216, DOI 10.1002/eji.200323867; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; Tripathi RK, 2000, MOL CELL BIOL, V20, P42, DOI 10.1128/MCB.20.1.42-53.2000; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	50	105	110	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1109	1115		10.1038/ni1379	http://dx.doi.org/10.1038/ni1379			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16936730				2022-12-18	WOS:000241437100020
J	Lu, BF; Ferrandino, AF; Flavell, RA				Lu, BF; Ferrandino, AF; Flavell, RA			Gadd45 is important for perpetuating cognate and inflammatory signals in T cells	NATURE IMMUNOLOGY			English	Article							RECOMBINANT LISTERIA-MONOCYTOGENES; P38 MAP KINASE; GENOMIC INSTABILITY; CYCLE CHECKPOINTS; TERMINAL KINASE; GENE-EXPRESSION; ACTIVATION; PROTEIN; JNK; GROWTH	Gadd45beta (growth arrest and DNA damage-inducible, beta) is involved in cell cycle arrest, apoptosis, signal transduction and cell survival. In T cells, Gadd45b was rapidly induced by T cell receptor (TCR) and inflammatory signals. Deficiency of Gadd45beta in CD4(+) T cells impaired their responses to TCR stimulation or inflammatory cytokines. ERK, p38 and JNK activation were all substantially suppressed in Gadd45beta-deficient CD4(+) T cells. Cytokine production by Gadd45beta-deficient CD4(+) T cells was also impaired. Furthermore, Gadd45beta mediated inflammatory cytokine production by dendritic cells, and Gadd45beta-deficient mice showed an impaired T helper type 1 response during Listeria monocytogenes infection. Gadd45beta is therefore a critical feedback regulator that perpetuates both cognate and inflammatory signals.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 310 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu			NIAID NIH HHS [1 P01 AI36529] Funding Source: Medline; NIAMS NIH HHS [1 K01 AR48854] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048854] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Chakravarty D, 2002, AM J PHYSIOL-RENAL, V283, pF1020, DOI 10.1152/ajprenal.00118.2002; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hildesheim J, 2002, CANCER RES, V62, P7305; Hoffmeyer A, 2001, MOL CELL BIOL, V21, P3137, DOI 10.1128/MCB.21.9.3137-3143.2001; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jin RG, 2002, DNA CELL BIOL, V21, P491, DOI 10.1089/104454902320219059; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Liebermann DA, 2002, ONCOGENE, V21, P3391, DOI 10.1038/sj.onc.1205312; LU B, IN PRESS P NATL ACAD; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; PAN ZK, 1995, NAT MED, V1, P471, DOI 10.1038/nm0595-471; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vairapandi M, 1996, ONCOGENE, V12, P2579; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wang XT, 1999, J BIOL CHEM, V274, P29599, DOI 10.1074/jbc.274.42.29599; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906	42	105	110	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					38	44		10.1038/ni1020	http://dx.doi.org/10.1038/ni1020			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14691480				2022-12-18	WOS:000187635800012
J	Barata, JT; Durum, SK; Seddon, B				Barata, Joao T.; Durum, Scott K.; Seddon, Benedict			Flip the coin: IL-7 and IL-7R in health and disease	NATURE IMMUNOLOGY			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; OF-FUNCTION MUTATIONS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; JAK/STAT PATHWAY INHIBITION; CD8 T-CELLS; RECEPTOR-ALPHA; INTERLEUKIN-7 IL-7; HIGH-RISK; IN-VIVO; IL-7-MEDIATED VIABILITY	The cytokine IL-7 and its receptor, IL-7R, are critical for T cell and, in the mouse, B cell development, as well as differentiation and survival of naive Tcells, and generation and maintenance of memory Tcells. They are also required for innate lymphoid cell (ILC) development and maintenance, and consequently for generation of lymphoid structures and barrier defense. Here we discuss the central role of IL-7 and IL-7R in the lymphoid system and highlight the impact of their deregulation, placing a particular emphasis on their 'dark side' as promoters of cancer development. We also explore therapeutic implications and opportunities associated with either positive or negative modulation of the IL-7-IL-7R signaling axis.	[Barata, Joao T.] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Durum, Scott K.] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA; [Seddon, Benedict] UCL, Inst Immun & Transplantat, Div Infect & Immun, London, England	Universidade de Lisboa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; University College London	Barata, JT (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal.	joao_barata@medicina.ulisboa.pt	Barata, Joao/D-9181-2015	Barata, Joao/0000-0002-4826-8976; durum, scott/0000-0003-1307-9582; Seddon, Benedict/0000-0003-4352-3373	European Research Council, under the European Union's Horizon 2020 research and innovation programme [ERC CoG648455]; Fundacao para a Ciencia e a Tecnologia, Portugal [FAPESP/20015/2014, PTDC/MEC-HEM/31588/2017]; US National Cancer Institute, National Institutes of Health; Children's Cancer Foundation; MRC (United Kingdom) [U117573801, MR/P011225/1]; MRC [MR/P011225/1] Funding Source: UKRI	European Research Council, under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); US National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Cancer Foundation; MRC (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Morre (Revimmune), R. Hotchkiss (Washington University), M. Cheever (University of Washington), R. Gress (NCI), I. Sereti (NIAID), N. Poirier (OSE Immunotherapeutics), C. Foley and A. Veradhachary (Fannin LLC) and E. Schafer (Baylor University) for sharing information on clinical trials, and M. Fernandes for help with draft figure preparation. J.T.B. is funded by the consolidator grant ERC CoG648455 from the European Research Council, under the European Union's Horizon 2020 research and innovation programme, and the FAPESP/20015/2014 and PTDC/MEC-HEM/31588/2017 grants from Fundacao para a Ciencia e a Tecnologia, Portugal; S.K.D. is funded by the intramural program of the US National Cancer Institute, National Institutes of Health, and the Children's Cancer Foundation; B.S. is funded by the MRC (United Kingdom) under U117573801 and MR/P011225/1.	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Akkapeddi P, 2019, LEUKEMIA, V33, P2155, DOI 10.1038/s41375-019-0434-8; Al-Rawi MAA, 2004, BRIT J SURG, V91, P61, DOI 10.1002/bjs.4449; Al-Rawi MAA, 2004, EUR J CANCER, V40, P494, DOI 10.1016/j.ejca.2003.10.016; Alsadeq A, 2018, BLOOD, V132, P1614, DOI 10.1182/blood-2018-04-844209; Alstadhaug KB, 2014, JAMA NEUROL, V71, P1030, DOI 10.1001/jamaneurol.2014.825; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Belarif L, 2019, J CLIN INVEST, V129, P1910, DOI 10.1172/JCI121668; Belarif L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06804-y; Boesch M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1414129; Boudil A, 2015, NAT IMMUNOL, V16, P397, DOI 10.1038/ni.3122; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Buentke E, 2006, BLOOD, V108, P1949, DOI 10.1182/blood-2006-04-016857; Campos LW, 2019, BLOOD, V133, P1259, DOI 10.1182/blood-2018-09-872945; Cante-Barrett K, 2016, LEUKEMIA, V30, P1832, DOI 10.1038/leu.2016.83; Cattaruzza L, 2009, INT J CANCER, V125, P1092, DOI 10.1002/ijc.24389; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; Chen HC, 2019, EMBO REP, V20, DOI 10.15252/embr.201847379; Cheng Y, 2016, J CLIN INVEST, V126, P1267, DOI 10.1172/JCI81468; Churchman SM, 2008, RHEUMATOLOGY, V47, P753, DOI 10.1093/rheumatology/ken053; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Cramer SD, 2018, LEUKEMIA, V32, P1795, DOI 10.1038/s41375-017-0001-0; Cramer SD, 2016, BLOOD, V128, P473, DOI 10.1182/blood-2016-03-679209; Cui L, 2012, CANCER BIOL THER, V13, P496, DOI 10.4161/cbt.19592; DALLOUL A, 1992, J CLIN INVEST, V90, P1054, DOI 10.1172/JCI115920; Delgado-Martin C, 2017, LEUKEMIA, V31, P2568, DOI 10.1038/leu.2017.136; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; DIBIRDIK I, 1991, BLOOD, V78, P564, DOI 10.1182/blood.V78.3.564.bloodjournal783564; DIGEL W, 1991, BLOOD, V78, P753; Fistonich C, 2018, J EXP MED, V215, P2586, DOI 10.1084/jem.20180778; Francois B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98960; FRISHMAN J, 1993, J EXP MED, V177, P955, DOI 10.1084/jem.177.4.955; Girardi T, 2018, LEUKEMIA, V32, P809, DOI 10.1038/leu.2017.225; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Goossens S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6794; Gracey E, 2016, ANN RHEUM DIS, V75, P2124, DOI 10.1136/annrheumdis-2015-208902; Grenningloh R, 2011, J IMMUNOL, V186, P969, DOI 10.4049/jimmunol.1002099; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hixon JA, 2020, LEUKEMIA, V34, P35, DOI 10.1038/s41375-019-0531-8; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karawajew L, 2000, BLOOD, V96, P297, DOI 10.1182/blood.V96.1.297.013k24_297_306; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kern B, 2016, CYTOM PART B-CLIN CY, V90, P191, DOI 10.1002/cyto.b.21247; Kibe R, 2012, CELL DEATH DIFFER, V19, P1139, DOI 10.1038/cdd.2011.203; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Kim J-H, 2019, CANCER RES, V79, P4991, DOI [10.1158/1538-7445.AM2019-4991, DOI 10.1158/1538-7445.AM2019-4991]; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krzystek-Korpacka M, 2017, CANCER IMMUNOL IMMUN, V66, P171, DOI 10.1007/s00262-016-1933-3; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Leung GA, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176180; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Li J, 2014, INFLAMMATION, V37, P1444, DOI 10.1007/s10753-014-9869-2; Li Y, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002200; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Loosveld M, 2014, GENE CHROMOSOME CANC, V53, P52, DOI 10.1002/gcc.22117; Maeurer MJ, 1997, SCAND J IMMUNOL, V45, P182, DOI 10.1046/j.1365-3083.1997.d01-384.x; Martin CE, 2017, IMMUNITY, V47, P171, DOI 10.1016/j.immuni.2017.07.005; Martin-Lorenzo A, 2015, CANCER DISCOV, V5, P1328, DOI 10.1158/2159-8290.CD-15-0892; Matheson EC, 2019, HAEMATOLOGICA, V104, P1804, DOI 10.3324/haematol.2017.185975; Maude SL, 2015, BLOOD, V125, P1759, DOI 10.1182/blood-2014-06-580480; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Mengus C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-162; Merchant MS, 2016, CLIN CANCER RES, V22, P3182, DOI 10.1158/1078-0432.CCR-15-2550; Ming J, 2012, CANCER IMMUNOL IMMUN, V61, P79, DOI 10.1007/s00262-011-1078-3; Ming J, 2009, EUR J CANCER, V45, P866, DOI 10.1016/j.ejca.2008.12.006; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; Moors M, 2010, GENES IMMUN, V11, P11, DOI 10.1038/gene.2009.77; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Nayar S, 2016, J IMMUNOL, V197, P1957, DOI 10.4049/jimmunol.1500686; Oliveira Mariana L., 2019, Advances in Biological Regulation, V71, P88, DOI 10.1016/j.jbior.2018.09.012; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359; Pearson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033998; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Qu H, 2016, INT IMMUNOPHARMACOL, V40, P203, DOI 10.1016/j.intimp.2016.08.017; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Ribeiro D, 2018, BLOOD ADV, V2, P2199, DOI 10.1182/bloodadvances.2018021063; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Richter-Pechanska P, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.3; Roato I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-12; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Sakre N, 2017, ONCOTARGET, V8, P5992, DOI 10.18632/oncotarget.13362; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Senkevitch Emilee, 2018, Oncotarget, V9, P22605, DOI 10.18632/oncotarget.25194; Seol MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43294-4; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sharma ND, 2019, CANCER SCI, V110, P1931, DOI 10.1111/cas.14021; Sheikh V, 2016, BLOOD, V127, P977, DOI 10.1182/blood-2015-05-645077; Shinoda K, 2016, P NATL ACAD SCI USA, V113, pE2842, DOI 10.1073/pnas.1512600113; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Shochat C, 2014, BLOOD, V124, P106, DOI 10.1182/blood-2013-10-529685; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Sinclair C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002246; Sortino O, 2018, AIDS, V32, P825, DOI [10.1097/QAD.0000000000001760, 10.1097/qad.0000000000001760]; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Swainson L, 2007, BLOOD, V109, P1034, DOI 10.1182/blood-2006-06-027912; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Thampy LK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199497; Treanor LM, 2014, J EXP MED, V211, P701, DOI 10.1084/jem.20122727; Tredan O, 2015, ANN ONCOL, V26, P1353, DOI 10.1093/annonc/mdv173; Tremblay CS, 2016, LEUKEMIA, V30, P1993, DOI 10.1038/leu.2016.100; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Webb LV, 2019, IMMUNITY, V50, P348, DOI 10.1016/j.immuni.2019.01.004; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang J, 2018, J EXP MED, V215, P1069, DOI 10.1084/jem.20170518; Yang J, 2014, HISTOCHEM CELL BIOL, V142, P401, DOI 10.1007/s00418-014-1222-1; Yokoyama K, 2013, BLOOD, V122, P4259, DOI 10.1182/blood-2012-08-451278; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang W, 2015, INFECT IMMUN, V83, P3213, DOI 10.1128/IAI.00320-15	141	104	107	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1584	1593		10.1038/s41590-019-0479-x	http://dx.doi.org/10.1038/s41590-019-0479-x			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745336	Green Submitted			2022-12-18	WOS:000497949800013
J	Zundler, S; Becker, E; Spocinska, M; Slawik, M; Parga-Vidal, L; Stark, R; Wiendl, M; Atreya, R; Rath, T; Leppkes, M; Hildner, K; Lopez-Posadas, R; Lukassen, S; Ekici, AB; Neufert, C; Atreya, I; van Gisbergen, KPJM; Neurath, MF				Zundler, Sebastian; Becker, Emily; Spocinska, Marta; Slawik, Monique; Parga-Vidal, Loreto; Stark, Regina; Wiendl, Maximilian; Atreya, Raja; Rath, Timo; Leppkes, Moritz; Hildner, Kai; Lopez-Posadas, Rocio; Lukassen, Soeren; Ekici, Arif B.; Neufert, Clemens; Atreya, Imke; van Gisbergen, Klaas P. J. M.; Neurath, Markus F.			Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation	NATURE IMMUNOLOGY			English	Article							ULCERATIVE-COLITIS; ACTIVATION; INFECTION; IMMUNITY; PATHOGENESIS; PROTECTION; INDUCTION; CYTOKINES; PROGRAMS; THERAPY	Although tissue-resident memory T cells (T-RM cells) have been shown to regulate host protection in infectious disorders, their function in inflammatory bowel disease (IBD) remains to be investigated. Here we characterized T-RM cells in human IBD and in experimental models of intestinal inflammation. Pro-inflammatory T-RM cells accumulated in the mucosa of patients with IBD, and the presence of CD4(+)CD69(+)CD103(+) T-RM cells was predictive of the development of flares. In vivo, functional impairment of T-RM cells in mice with double knockout of the T-RM-cell-associated transcription factors Hobit and Blimp-1 attenuated disease in several models of colitis, due to impaired cross-talk between the adaptive and innate immune system. Finally, depletion of T-RM cells led to a suppression of colitis activity. Together, our data demonstrate a central role for T-RM cells in the pathogenesis of chronic intestinal inflammation and suggest that these cells could be targets for future therapeutic approaches in IBD.	[Zundler, Sebastian; Becker, Emily; Spocinska, Marta; Slawik, Monique; Wiendl, Maximilian; Atreya, Raja; Rath, Timo; Leppkes, Moritz; Hildner, Kai; Lopez-Posadas, Rocio; Neufert, Clemens; Atreya, Imke; Neurath, Markus F.] Friedrich Alexander Univ FAU Erlangen Nurnberg, Kussmaul Campus Med Res & Translat Res Ctr, Dept Med 1, Erlangen, Germany; [Zundler, Sebastian; Parga-Vidal, Loreto; Stark, Regina; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Amsterdam UMC, Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands; [Lukassen, Soeren; Ekici, Arif B.] Friedrich Alexander Univ FAU Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands	University of Erlangen Nuremberg; University of Amsterdam; University of Erlangen Nuremberg; University of Amsterdam	Neurath, MF (corresponding author), Friedrich Alexander Univ FAU Erlangen Nurnberg, Kussmaul Campus Med Res & Translat Res Ctr, Dept Med 1, Erlangen, Germany.	markus.neurath@uk-erlangen.de	Lukassen, Soeren/A-3737-2019; Ekici, Arif B/C-3971-2013; Leppkes, Moritz/ABG-7617-2020; Leppkes, Moritz/N-2932-2017	Lukassen, Soeren/0000-0001-7045-6327; Ekici, Arif B/0000-0001-6099-7066; Leppkes, Moritz/0000-0003-2311-090X; Stark, Regina/0000-0001-7693-799X; Parga-Vidal, Loreto/0000-0003-4348-1679; Rath, Timo/0000-0002-7728-9338; van Gisbergen, Klaas/0000-0003-3623-7555	German Research foundation [ZU 377/1-1]; Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; ELAN program of the University Erlangen-Nuremberg; Fritz-Bender-Stiftung; Else Kroner-Fresenius-Stiftung; German Crohn's and Colitis Foundation (DCCV); Clinical Research Group CEDER of the German Research Council (DFG); DFG topic program on Microbiota; Emerging Field Initiative; DFG Collaborative Research Centers [643, 796, 1181]; Litwin IBD Pioneers program of the Crohn's and Colitis Foundation of America (CCFA)	German Research foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; ELAN program of the University Erlangen-Nuremberg; Fritz-Bender-Stiftung; Else Kroner-Fresenius-Stiftung; German Crohn's and Colitis Foundation (DCCV); Clinical Research Group CEDER of the German Research Council (DFG); DFG topic program on Microbiota; Emerging Field Initiative; DFG Collaborative Research Centers; Litwin IBD Pioneers program of the Crohn's and Colitis Foundation of America (CCFA)	This work was funded by a grant of the German Research foundation to S.Z. (ZU 377/1-1). The research of S.Z., R.A., T.R., M.L., K.H., R.L.-P., C.N., I. A., and M.F.N. was supported by the Interdisciplinary Center for Clinical Research (IZKF) and the ELAN program of the University Erlangen-Nuremberg, the Fritz-Bender-Stiftung, the Else Kroner-Fresenius-Stiftung, the German Crohn's and Colitis Foundation (DCCV), the Clinical Research Group CEDER of the German Research Council (DFG), the DFG topic program on Microbiota, the Emerging Field Initiative, the DFG Collaborative Research Centers 643, 796 and 1181 and the Litwin IBD Pioneers program of the Crohn's and Colitis Foundation of America (CCFA). The authors thank J. Derdau, D. Dziony, J. Schuster, A. Marosan, and K. Enderle for excellent technical assistance. This work was performed in partial fulfillment of the requirements for obtaining the degree "Dr. rer. biol. hum." for S. Z.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ashouri JF, 2017, J IMMUNOL, V198, P657, DOI 10.4049/jimmunol.1601301; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fischer A, 2016, GUT, V65, P1642, DOI 10.1136/gutjnl-2015-310022; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaser A, 2008, EXPERT OPIN THER TAR, V12, P553, DOI [10.1517/14728222.12.5.553, 10.1517/14728222.12.5.553 ]; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Klingberg A, 2017, J AM SOC NEPHROL, V28, P452, DOI 10.1681/ASN.2016020232; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Lopez-Posadas R, 2016, J CLIN INVEST, V126, P611, DOI 10.1172/JCI80997; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Oja AE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00325; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stelma F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06352-3; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Thom JT, 2015, CELL REP, V13, P1125, DOI 10.1016/j.celrep.2015.09.082; Turner DL, 2018, J IMMUNOL, V200, P1561, DOI 10.4049/jimmunol.1700257; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Ullrich E, 2018, J CLIN INVEST, V128, P916, DOI 10.1172/JCI89242; van Gisbergen KPJM, 2012, NAT IMMUNOL, V13, P864, DOI 10.1038/ni.2393; Vermeire S, 2014, LANCET, V384, P309, DOI 10.1016/S0140-6736(14)60661-9; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Zundler S, 2017, GASTROENTEROLOGY, V153, P898, DOI 10.1053/j.gastro.2017.07.022; Zundler S, 2017, IMMUNOL REV, V278, P263, DOI 10.1111/imr.12544; Zundler S, 2017, INFLAMM BOWEL DIS, V23, P617, DOI 10.1097/MIB.0000000000001067; Zundler S, 2017, GUT, V66, P1936, DOI 10.1136/gutjnl-2016-312439	54	104	106	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					288	+		10.1038/s41590-018-0298-5	http://dx.doi.org/10.1038/s41590-018-0298-5			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30692620				2022-12-18	WOS:000458893600014
J	Owen, DL; Mahmud, SA; Sjaastad, LE; Williams, JB; Spanier, JA; Simeonov, DR; Ruscher, R; Huang, WS; Proekt, I; Miller, CN; Hekim, C; Jeschke, JC; Aggarwal, P; Broeckel, U; LaRue, RS; Henzler, CM; Alegre, ML; Anderson, MS; August, A; Marson, A; Zheng, Y; Williams, CB; Farrar, MA				Owen, David L.; Mahmud, Shawn A.; Sjaastad, Louisa E.; Williams, Jason B.; Spanier, Justin A.; Simeonov, Dimitre R.; Ruscher, Roland; Huang, Weishan; Proekt, Irina; Miller, Corey N.; Hekim, Can; Jeschke, Jonathan C.; Aggarwal, Praful; Broeckel, Ulrich; LaRue, Rebecca S.; Henzler, Christine M.; Alegre, Maria-Luisa; Anderson, Mark S.; August, Avery; Marson, Alexander; Zheng, Ye; Williams, Calvin B.; Farrar, Michael A.			Thymic regulatory T cells arise via two distinct developmental programs	NATURE IMMUNOLOGY			English	Article							FOXP3 TRANSCRIPTION FACTOR; GAMMA-DELTA-T; NF-KAPPA-B; COSTIMULATORY REQUIREMENTS; THYMOCYTE DEVELOPMENT; SIGNAL STRENGTH; SELF-PEPTIDES; RECEPTOR; TOLERANCE; GENE	The developmental programs that generate a broad repertoire of regulatory T cells (T-reg cells) able to respond to both self antigens and non-self antigens remain unclear. Here we found that mature T-reg cells were generated through two distinct developmental programs involving CD25(+) T-reg cell progenitors (CD25(+) TregP cells) and Foxp3(lo) T-reg cell progenitors (Foxp3(lo) TregP cells). CD25(+) TregP cells showed higher rates of apoptosis and interacted with thymic self antigens with higher affinity than did Foxp3(lo) TregP cells, and had a T cell antigen receptor repertoire and transcriptome distinct from that of Foxp3(lo) TregP cells. The development of both CD25(+) TregP cells and Foxp3(lo) TregP cells was controlled by distinct signaling pathways and enhancers. Transcriptomics and histocytometric data suggested that CD25(+) TregP cells and Foxp3(lo) TregP cells arose by coopting negative-selection programs and positive-selection programs, respectively. T-reg cells derived from CD25(+) TregP cells, but not those derived from Foxp3(lo) TregP cells, prevented experimental autoimmune encephalitis. Our findings indicate that T-reg cells arise through two distinct developmental programs that are both required for a comprehensive T-reg cell repertoire capable of establishing immunotolerance.	[Owen, David L.; Mahmud, Shawn A.; Sjaastad, Louisa E.; Ruscher, Roland; Hekim, Can; Farrar, Michael A.] Univ Minnesota, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Owen, David L.; Mahmud, Shawn A.; Sjaastad, Louisa E.; Ruscher, Roland; Hekim, Can; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Williams, Jason B.; Jeschke, Jonathan C.; Williams, Calvin B.] Med Coll Wisconsin, Dept Pediat, Sect Rheumatol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Spanier, Justin A.] Univ Minnesota, Dept Med, Ctr Immunol, Box 736 UMHC, Minneapolis, MN 55455 USA; [Simeonov, Dimitre R.; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Proekt, Irina; Miller, Corey N.; Anderson, Mark S.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Huang, Weishan; August, Avery] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Huang, Weishan] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Aggarwal, Praful; Broeckel, Ulrich] Med Coll Wisconsin, Dept Pediat, Sect Genom Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [LaRue, Rebecca S.; Henzler, Christine M.] Univ Minnesota, Supercomputing Inst Adv Computat Res, Minneapolis, MN USA; [Alegre, Maria-Luisa] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Anderson, Mark S.; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA USA; [Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Salk Institute	Farrar, MA (corresponding author), Univ Minnesota, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Farrar, MA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	farra005@umn.edu	Ruscher, Roland/AAQ-1219-2020; Farrar, Michael A/M-7802-2013; Anderson, Mark/AAZ-4992-2020; Owen, David/AAU-5966-2020; Huang, Weishan/J-3127-2014	Ruscher, Roland/0000-0002-8600-6985; Anderson, Mark/0000-0002-3093-4758; Mahmud, Shawn/0000-0001-5169-651X; Miller, Corey/0000-0002-1291-0074; Huang, Weishan/0000-0002-1330-1131; Williams, Calvin/0000-0002-5492-8475; Simeonov, Dimitre/0000-0002-1693-8664; Owen, David/0000-0002-1099-0605	University of Minnesota academic health center; National Institutes of Health (NIH) [F30DK096844]; University of Minnesota Medical Foundation [UMF0020624]; NIH [5U24AI118635, R01AI106791, R01AI107027, R01AI085090-07A1, DP3DK111914-01, R01AI115716, R37 AI097457, AI108958, AI120701, AI126814, AI129422, AI29422, GM110760, AI124512, AI113138, AI061165, CA154998, CA151845, CA185062]; Children's Hospital of Wisconsin; Burroughs Wellcome Fund; American Association of Immunologists, a Faculty Development Award; Louisiana State University;  [2T32AI007313]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124512, R37AI097457, R21AI129422, R01AI115716, U24AI118635, R01AI107027, T32AI007334, R01AI120701, R01AI106791, R21AI126814, R01AI085090, P01AI097113, P01AI035296, T32AI007313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK111914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110760] Funding Source: NIH RePORTER	University of Minnesota academic health center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Medical Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Wisconsin; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Association of Immunologists, a Faculty Development Award; Louisiana State University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hubbard, A. Rost, A. Meskic, D. Duerre and H. Wiesolek for technical assistance; T. Martin, N. Shah, J. Motl and P. Champoux for cell sorting and maintenance of the Flow Cytometry Core Facility at the University of Minnesota (5P01AI035296); S. Hamilton, M. Pierson and funding from the University of Minnesota academic health center for maintaining the NME mouse facility; P. Fink for providing initial Rag2-GFP thymi; B. Burbach and Y. Shimizu for Adap<SUP>-/-</SUP> mice; M. Jenkins for the MOG: I-A<SUP>b</SUP> tetramer; and C. Katerndahl and L. Heltemes-Harris for helpful commentary and reviewing the manuscript. D.L.O. and S. A. M. were supported by an immunology training grant (no. 2T32AI007313). S. A. M. was also supported by an individual predoctoral F30 fellowship from the National Institutes of Health (NIH; no. F30DK096844). J.A.S. was supported by University of Minnesota Medical Foundation grant no. UMF0020624 and NIH grants nos 5U24AI118635 and R01AI106791. Y.Z. was supported by NIH grant no. R01AI107027. U.B. and C.B.W. were supported by grants from the Children's Hospital of Wisconsin, and C.B.W. was also supported by NIH grant no. R01AI085090-07A1. A.M. and M.S.A were supported by NIH grant no. DP3DK111914-01. A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is an investigator at the Chan Zuckerberg Biohub. M.A. was supported by NIH grant no. R01AI115716. M.S.A. was supported by NIH grant no. R37 AI097457. A.A. was supported by NIH grants nos AI108958, AI120701, AI126814 and AI129422 to A.A. and W.H. W.H. was supported by NIH grant no. AI29422 (to W.H. and A.A.), a Careers in Immunology Fellowship from the American Association of Immunologists, a Faculty Development Award and a competitive research grant from Louisiana State University, and a pilot award from the LSU-Tulane Center for Experimental Infectious Diseases Research funded by NIH grant no. GM110760. M.A.F. was supported by NIH grants nos AI124512, AI113138, AI061165, CA154998, CA151845 and CA185062.	Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blair-Handon R, 2010, LAB ANIMAL, V39, P248, DOI 10.1038/laban0810-248; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; FENTON RG, 1988, SCIENCE, V241, P1089, DOI 10.1126/science.2970670; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Huang WS, 2014, J IMMUNOL, V193, P2267, DOI 10.4049/jimmunol.1400968; Huang WS, 2014, J LEUKOCYTE BIOL, V96, P55, DOI 10.1189/jlb.1AB0913-484RR; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10.1016/j.molimm.2007.05.016; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Ruscher R, 2017, NAT IMMUNOL, V18, P771, DOI 10.1038/ni.3751; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Spanier JA, 2015, J NEUROIMMUNOL, V286, P48, DOI 10.1016/j.jneuroim.2015.06.015; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhan YF, 2007, INT IMMUNOL, V19, P455, DOI 10.1093/intimm/dxm010; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	56	104	105	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					195	+		10.1038/s41590-018-0289-6	http://dx.doi.org/10.1038/s41590-018-0289-6			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643267	Green Accepted			2022-12-18	WOS:000456279100017
J	Machiels, B; Dourcy, M; Xiao, X; Javaux, J; Mesnil, C; Sabatel, C; Desmecht, D; Lallemand, F; Martinive, P; Hammad, H; Guilliams, M; Dewals, B; Vanderplasschen, A; Lambrecht, BN; Bureau, F; Gillet, L				Machiels, Benedicte; Dourcy, Mickael; Xiao, Xue; Javaux, Justine; Mesnil, Claire; Sabatel, Catherine; Desmecht, Daniel; Lallemand, Francois; Martinive, Philippe; Hammad, Hamida; Guilliams, Martin; Dewals, Benjamin; Vanderplasschen, Alain; Lambrecht, Bart N.; Bureau, Fabrice; Gillet, Laurent			A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes	NATURE IMMUNOLOGY			English	Article							AGE-SPECIFIC PREVALENCE; BARR-VIRUS INFECTION; HUMAN IMMUNE-SYSTEM; DENDRITIC CELLS; FETAL MONOCYTES; INDUCTION; RESPONSES; DEVELOP; ORIGIN; NICHE	The hygiene hypothesis postulates that the recent increase in allergic diseases such as asthma and hay fever observed in Western countries is linked to reduced exposure to childhood infections. Here we investigated how infection with a gammaherpesvirus affected the subsequent development of allergic asthma. We found that murid herpesvirus 4 (MuHV-4) inhibited the development of house dust mite (HDM)-induced experimental asthma by modulating lung innate immune cells. Specifically, infection with MuHV-4 caused the replacement of resident alveolar macrophages (AMs) by monocytes with regulatory functions. Monocyte-derived AMs blocked the ability of dendritic cells to trigger a HDM-specific response by the T(H)2 subset of helper T cells. Our results indicate that replacement of embryonic AMs by regulatory monocytes is a major mechanism underlying the long-term training of lung immunity after infection.	[Machiels, Benedicte; Dourcy, Mickael; Xiao, Xue; Javaux, Justine; Dewals, Benjamin; Vanderplasschen, Alain; Gillet, Laurent] Univ Liege, Fac Vet Med FARAH, Dept Infect & Parasit Dis, Immunol Vaccinol, Liege, Belgium; [Mesnil, Claire; Sabatel, Catherine; Bureau, Fabrice] Univ Liege, Fac Vet Med GIGA, Dept Funct Sci, Cellular & Mol Immunol, Liege, Belgium; [Desmecht, Daniel] Univ Liege, Fac Vet Med FARAH, Dept Pathol, Liege, Belgium; [Lallemand, Francois; Martinive, Philippe] Univ Hosp Liege, Dept Radiol, Liege, Belgium; [Hammad, Hamida; Guilliams, Martin; Lambrecht, Bart N.] Univ Ghent, VIB Ctr Inflammat Res, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	University of Liege; University of Liege; University of Liege; University of Liege; Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC	Gillet, L (corresponding author), Univ Liege, Fac Vet Med FARAH, Dept Infect & Parasit Dis, Immunol Vaccinol, Liege, Belgium.	l.gillet@ulg.ac.be	Lambrecht, Bart N/K-2484-2014; Guilliams, Martin/N-7803-2013; Dewals, Benjamin G./AAL-5754-2021; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Guilliams, Martin/0000-0003-3525-7570; Dewals, Benjamin G./0000-0003-1497-0799; Hammad, Hamida/0000-0003-3762-8603; Machiels, Benedicte/0000-0003-1326-3865; , Xue (River)/0000-0003-1384-9954; Gillet, Laurent/0000-0002-1047-2525	University of Liege (VIR-IMPRINT ARC); Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique [J007515F, T.0195.16]; Institut MERIEUX (starting grant)	University of Liege (VIR-IMPRINT ARC); Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Institut MERIEUX (starting grant)	We thank U. Eriksson (Center for Molecular Cardiology, University of Zurich) for BALB/c CD45.1<SUP>+</SUP> genitor mice; A. Osterhaus, T. Marichal and C. Desmet for critical discussions; and L. Dams, C. Delforge, E. Deglaire, C. Espert, A. Guillaume, M. Sarlet and A. Vanderlinden for technical and secretary assistance. Supported by the University of Liege (VIR-IMPRINT ARC), "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" ("credit de recherche" J007515F; "projet de recherche" T.0195.16; research associate support for B.D.) and Institut MERIEUX (starting grant).	Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cadwell K, 2015, IMMUNITY, V42, P805, DOI 10.1016/j.immuni.2015.05.003; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Cesarman E, 2014, ANNU REV PATHOL-MECH, V9, P349, DOI 10.1146/annurev-pathol-012513-104656; Condon LM, 2014, CLIN INFECT DIS, V59, P501, DOI 10.1093/cid/ciu342; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HOLT PG, 1994, J IMMUNOL, V153, P256; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Latif MB, 2016, J VIROL, V90, P2455, DOI 10.1128/JVI.02942-15; Lauzon-Joset JF, 2014, MUCOSAL IMMUNOL, V7, P155, DOI 10.1038/mi.2013.34; Lawler C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004761; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; Machiels B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003753; Mesnil C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053242; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Peacock JW, 2001, IMMUNOLOGY, V104, P109, DOI 10.1046/j.1365-2567.2001.01286.x; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van Helden MJ, 2013, CURR OPIN IMMUNOL, V25, P745, DOI 10.1016/j.coi.2013.10.002; van Rift LS, 2004, J ALLERGY CLIN IMMUN, V114, P166, DOI 10.1016/j.jaci.2004.03.044; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Webley WC, 2015, TRENDS MICROBIOL, V23, P389, DOI 10.1016/j.tim.2015.05.006	53	104	105	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1310	+		10.1038/ni.3857	http://dx.doi.org/10.1038/ni.3857			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29035391				2022-12-18	WOS:000415324900009
J	Goto, Y; Uematsu, S; Kiyono, H				Goto, Yoshiyuki; Uematsu, Satoshi; Kiyono, Hiroshi			Epithelial glycosylation in gut homeostasis and inflammation	NATURE IMMUNOLOGY			English	Review							BLOOD-GROUP ANTIGENS; GROUP ALPHA(1,2)FUCOSYLTRANSFERASE GENE; HELICOBACTER-PYLORI ADHESION; HUMAN INTESTINAL DEFENSIN; INNATE LYMPHOID-CELLS; NON-SECRETOR STATUS; MOLECULAR-CLONING; VAGINAL CANDIDIASIS; FUT2-NULL MICE; CROHNS-DISEASE	Intestinal epithelial cells apically express glycans, especially alpha 1,2-fucosyl linkages, which work as a biological interface for the host microbe interaction. Emerging studies have shown that epithelial alpha 1,2-fucosylation is regulated by microbes and by group 3 innate lymphoid cells (ILC3s). Dysregulation of the gene (FUT2) encoding fucosyltransferase 2, an enzyme governing epithelial alpha 1,2-fucosylation, is associated with various human disorders, including infection and chronic inflammatory diseases. This suggests a critical role for an interaction between microbes, epithelial cells and ILC3s mediated via glycan residues. In this Review, using alpha 1,2-fucose and Fut2 gene expression as an example, we describe how epithelial glycosylation is controlled by immune cells and luminal microbes. We also address the pathophysiological contribution of epithelial alpha 1,2-fucosylation to pathogenic and commensal microbes as well as the potential of alpha 1,2-fucose and its regulatory pathway as previously unexploited targets in the development of new therapeutic approaches for human diseases.	[Goto, Yoshiyuki] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Goto, Yoshiyuki; Uematsu, Satoshi; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Uematsu, Satoshi] Chiba Univ, Grad Sch Med, Dept Mucosal Immunol, Chiba, Japan; [Kiyono, Hiroshi] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan	Chiba University; University of Tokyo; Chiba University; Chiba University; University of Tokyo	Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan.; Kiyono, H (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.; Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan.	kiyono@ims.u-tokyo.ac.jp	Goto, Yoshiyuki/H-9860-2017; Kiyono, Hiroshi/AAC-6735-2022	Goto, Yoshiyuki/0000-0001-8552-4839; 	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [15H01367, 23229004, 15H06159, 16H06229]; Challenging Exploratory Research grant from the JSPS; Ministry of Health, Labor and Welfare (MHLW); Japan Agency for Medical Research and Development (AMED); Uehara Memorial Foundation; Naito Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research grant from the JSPS; Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work is financially supported by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (JSPS; to H.K.); a Grant-in-Aid for Scientific Research on Innovative Areas (Homeostatic regulation by various types of cell death) (15H01367 to S.U.); a Scientific Research (S) grant (23229004 to H.K.); a Research Activity Start-up grant (15H06159 to Y.G.); a Young Scientists (A) grant (16H06229 to Y.G.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Challenging Exploratory Research grant from the JSPS (to S.U.); a grant (Adjuvant database) from The Ministry of Health, Labor and Welfare (MHLW) and the Japan Agency for Medical Research and Development (AMED) (to S.U. and H.K.); The Uehara Memorial Foundation (to Y.G.); The Naito Foundation (to Y.G.); the Astellas Foundation for Research on Metabolic Disorders (to Y.G.); and the Takeda Science Foundation (to Y.G.).	Aghdassi AA, 2015, PANCREATOLOGY, V15, pS23, DOI 10.1016/j.pan.2015.05.476; Aigal S, 2015, BBA-MOL CELL RES, V1853, P858, DOI 10.1016/j.bbamcr.2014.11.014; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Avent ND, 1997, BRIT J BIOMED SCI, V54, P16; Azevedo M, 2008, J PATHOL, V215, P308, DOI 10.1002/path.2363; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BLACKWELL CC, 1986, LANCET, V2, P284; BLACKWELL CC, 1986, LANCET, V2, P687; Blondel CJ, 2016, CELL HOST MICROBE, V20, P226, DOI 10.1016/j.chom.2016.06.010; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chaim W, 1997, J INFECT DIS, V176, P828, DOI 10.1086/517314; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Domino SE, 1997, BIOCHEM J, V327, P105, DOI 10.1042/bj3270105; Domino SE, 2001, J BIOL CHEM, V276, P23748, DOI 10.1074/jbc.M100735200; Engevik MA, 2013, AM J PHYSIOL-GASTR L, V305, pG697, DOI 10.1152/ajpgi.00184.2013; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; Goto Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15918; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gunaydin G, 2016, VIRUS RES, V211, P64, DOI 10.1016/j.virusres.2015.10.005; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; HOSKINS LC, 1967, ANN NY ACAD SCI, V140, P848, DOI 10.1111/j.1749-6632.1967.tb51007.x; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Imbert-Marcille BM, 2014, J INFECT DIS, V209, P1227, DOI 10.1093/infdis/jit655; Ishitoya S, 2002, BJU INT, V89, P851, DOI 10.1046/j.1464-410X.2002.02782.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kambhampati A., 2015, CLIN INFECT DIS; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0; Koda Y, 1996, AM J HUM GENET, V59, P343; Kurashima Y, 2013, EUR J IMMUNOL, V43, P3108, DOI 10.1002/eji.201343782; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu YH, 1998, HUM GENET, V103, P204, DOI 10.1007/s004390050808; Liu ZP, 2009, MICROBES INFECT, V11, P374, DOI 10.1016/j.micinf.2008.12.013; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Michalski JC, 1999, BBA-MOL BASIS DIS, V1455, P69, DOI 10.1016/S0925-4439(99)00077-0; Miyoshi J, 2011, J GASTROENTEROL, V46, P1056, DOI 10.1007/s00535-011-0425-7; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; Nanthakumar NN, 2002, FASEB J, V16, P44, DOI 10.1096/fj.02-0031fje; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Payne DC, 2015, JAMA PEDIATR, V169, P1040, DOI 10.1001/jamapediatrics.2015.2002; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rayes A, 2015, BIOL BLOOD MARROW TR; Rodriguez-Diaz J, 2013, APPL ENVIRON MICROB, V79, P3847, DOI 10.1128/AEM.00229-13; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; ROUQUIER S, 1995, J BIOL CHEM, V270, P4632, DOI 10.1074/jbc.270.9.4632; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Smilowitz JT, 2013, J NUTR, V143, P1709, DOI 10.3945/jn.113.178772; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Svensson L, 2000, TRANSFUSION, V40, P856, DOI 10.1046/j.1537-2995.2000.40070856.x; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Terahara K, 2011, BIOCHEM BIOPH RES CO, V404, P822, DOI 10.1016/j.bbrc.2010.12.067; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; UMESAKI Y, 1989, BIOCHIM BIOPHYS ACTA, V1001, P163; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Xavier JM, 2015, ANN RHEUM DIS, V74, P618, DOI 10.1136/annrheumdis-2013-204475; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; YU LC, 1995, BIOCHEM J, V312, P329, DOI 10.1042/bj3120329; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	97	104	109	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1244	1251		10.1038/ni.3587	http://dx.doi.org/10.1038/ni.3587			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27760104				2022-12-18	WOS:000386193200004
J	Li, S; Zhu, MZ; Pan, RG; Fang, T; Cao, YY; Chen, SL; Zhao, XL; Lei, CQ; Guo, L; Chen, Y; Li, CM; Jokitalo, E; Yin, YX; Shu, HB; Guo, DY				Li, Shun; Zhu, Mingzhu; Pan, Ruangang; Fang, Ting; Cao, Yuan-Yuan; Chen, Shuliang; Zhao, Xiaolu; Lei, Cao-Qi; Guo, Lin; Chen, Yu; Li, Chun-Mei; Jokitalo, Eija; Yin, Yuxin; Shu, Hong-Bing; Guo, Deyin			The tumor suppressor PTEN has a critical role in antiviral innate immunity	NATURE IMMUNOLOGY			English	Article							INTERFERON REGULATORY FACTOR-3; DOUBLE-STRANDED-RNA; PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; DENDRITIC CELLS; NUCLEAR IMPORT; I INTERFERON; NEGATIVE REGULATION; GENE INDUCTION	The gene encoding PTEN is one of the most frequently mutated tumor suppressor-encoding genes in human cancer. While PTEN's function in tumor suppression is well established, its relationship to anti-microbial immunity remains unknown. Here we found a pivotal role for PTEN in the induction of type I interferon, the hallmark of antiviral innate immunity, that was independent of the pathway of the kinases PI(3)K and Akt. PTEN controlled the import of IRF3, a master transcription factor responsible for IFN-beta production, into the nucleus. We further identified a PTEN-controlled negative phosphorylation site at Ser97 of IRF3 and found that release from this negative regulation via the phosphatase activity of PTEN was essential for the activation of IRF3 and its import into the nucleus. Our study identifies crosstalk between PTEN and IRF3 in tumor suppression and innate immunity.	[Li, Shun; Zhu, Mingzhu; Pan, Ruangang; Fang, Ting; Cao, Yuan-Yuan; Zhao, Xiaolu; Lei, Cao-Qi; Guo, Lin; Chen, Yu; Shu, Hong-Bing; Guo, Deyin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Li, Shun; Zhu, Mingzhu; Pan, Ruangang; Fang, Ting; Cao, Yuan-Yuan; Zhao, Xiaolu; Lei, Cao-Qi; Guo, Lin; Chen, Yu; Shu, Hong-Bing; Guo, Deyin] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China; [Chen, Shuliang; Guo, Deyin] Wuhan Univ, Sch Basic Med Sci, Med Res Inst, Wuhan 430072, Peoples R China; [Li, Chun-Mei; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China	Wuhan University; Wuhan University; Wuhan University; University of Helsinki; Peking University	Guo, DY (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.; Guo, DY (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China.	dguo@whu.edu.cn	Guo, Deyin/A-9498-2011; Li, Chang Ming/N-8811-2019; cao, yuan/GRR-9461-2022; Li, Chang Ming/F-9340-2017; Jokitalo, Eija/C-8375-2009	Guo, Deyin/0000-0002-8297-0814; Li, Chang Ming/0000-0002-4041-2574; Li, Chang Ming/0000-0002-4041-2574; Jokitalo, Eija/0000-0002-4159-6934; Chen, Yu/0000-0003-1300-4652				Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gunzl P, 2008, IMMUNOBIOLOGY, V213, P759, DOI 10.1016/j.imbio.2008.07.028; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Moussavi M, 2010, CANCER RES, V70, P1367, DOI 10.1158/0008-5472.CAN-09-2377; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhu MZ, 2015, J IMMUNOL, V195, P289, DOI 10.4049/jimmunol.1500232	39	104	112	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					241	249		10.1038/ni.3311	http://dx.doi.org/10.1038/ni.3311			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26692175				2022-12-18	WOS:000370469300008
J	Overstreet, MG; Gaylo, A; Angermann, BR; Hughson, A; Hyun, YM; Lambert, K; Acharya, M; Billroth-MacLurg, AC; Rosenberg, AF; Topham, DJ; Yagita, H; Kim, M; Lacy-Hulbert, A; Meier-Schellersheim, M; Fowell, DJ				Overstreet, Michael G.; Gaylo, Alison; Angermann, Bastian R.; Hughson, Angela; Hyun, Young-Min; Lambert, Kris; Acharya, Mridu; Billroth-MacLurg, Alison C.; Rosenberg, Alexander F.; Topham, David J.; Yagita, Hideo; Kim, Minsoo; Lacy-Hulbert, Adam; Meier-Schellersheim, Martin; Fowell, Deborah J.			Inflammation-induced interstitial migration of effector CD4(+) T cells is dependent on integrin alpha(V)	NATURE IMMUNOLOGY			English	Article							DELAYED-TYPE HYPERSENSITIVITY; LEUKOCYTE MIGRATION; FIBRONECTIN; EXPRESSION; MOTILITY; DIFFERENTIATION; RECOGNITION; ADHESION; ABSENCE; VLA-1	Leukocytes must traverse inflamed tissues to effectively control local infection. Although motility in dense tissues seems to be integrin independent and based on actomyosin-mediated protrusion and contraction, during inflammation, changes to the extracellular matrix (ECM) may necessitate distinct motility requirements. Indeed, we found that the interstitial motility of T cells was critically dependent on Arg-Gly-Asp (RGD)-binding integrins in the inflamed dermis. Inflammation-induced deposition of fibronectin was functionally linked to higher expression of integrin alpha(V) on effector CD4(+) T cells. By intravital multiphoton imaging, we found that the motility of CD4(+) T cells was dependent on alpha(V) expression. Selective blockade or knockdown of alpha(V) arrested T helper type 1 (T(H)1) cells in the inflamed tissue and attenuated local effector function. Our data demonstrate context-dependent specificity of lymphocyte movement in inflamed tissues that is essential for protective immunity.	[Overstreet, Michael G.; Gaylo, Alison; Hughson, Angela; Hyun, Young-Min; Lambert, Kris; Billroth-MacLurg, Alison C.; Topham, David J.; Kim, Minsoo; Fowell, Deborah J.] Univ Rochester, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA; [Overstreet, Michael G.; Gaylo, Alison; Hyun, Young-Min; Billroth-MacLurg, Alison C.; Topham, David J.; Kim, Minsoo; Fowell, Deborah J.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Angermann, Bastian R.; Meier-Schellersheim, Martin] NIAID, Computat Biol Unit, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Acharya, Mridu; Lacy-Hulbert, Adam] Massachusetts Gen Hosp, Dept Pediat, Program Dev Immunol, Boston, MA 02114 USA; [Acharya, Mridu; Lacy-Hulbert, Adam] Harvard Univ, Sch Med, Boston, MA USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Tokyo, Japan	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Rochester; Juntendo University	Fowell, DJ (corresponding author), Univ Rochester, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA.	deborah_fowell@urmc.rochester.edu		Lacy-Hulbert, Adam/0000-0003-2162-0156; Hyun, Young-Min/0000-0002-0567-2039; Overstreet, Michael/0000-0001-7450-7929	US National Institutes of Health [AI072690, AI088427, HL018208, HL087088, AI089079]; American Heart Association [11SDG7520018]; National Institute of Allergy and Infectious Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018208, R01HL087088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053746, F32AI089079, R01AI072690, ZIAAI001076, R21AI088427, R01AI070826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093695] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Killeen (University of California, San Francisco) for WT15 mice; R. Locksley (University of California, San Francisco) for IFN-gamma reporter mice (Yeti mice); M. Nussenzweig (The Rockefeller University) for CD11c-YFP mice; R. Hynes (MIT) for Itga<SUP>5fl/fl</SUP> mice; B. Leon and F. Lund (University of Alabama) for H. polygyrus-infected tissue; R. Germain and J. Egen for technical assistance; K. Kasischke, L. Callahan, E. Brown and the University of Rochester Medical Center Multiphoton Core for support; Kihong Lim for technical assistance; J. Miller and S. Georas for comments on the manuscript; and members of the Fowell and Kim laboratories for discussions and support. Supported by the US National Institutes of Health (AI072690 and AI088427 to D. J. F.; HL018208 and HL087088 to M. K.; and AI089079 to M.G.O.), the American Heart Association (11SDG7520018 to Y.-M.H.) and the intramural program of the National Institute of Allergy and Infectious Diseases (B. R. A. and M.M.-S.).	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell ID, 2011, COLD SPRING HARB PER, V3, P1; CLARK RAF, 1984, J CLIN INVEST, V74, P1011, DOI 10.1172/JCI111468; CLARK RAF, 1981, J IMMUNOL, V126, P787; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; DeNucci CC, 2011, J IMMUNOL, V186, P4019, DOI 10.4049/jimmunol.1003566; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kusubata M, 1999, J INVEST DERMATOL, V113, P906, DOI 10.1046/j.1523-1747.1999.00802.x; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Okada T, 2010, SEMIN IMMUNOPATHOL, V32, P215, DOI 10.1007/s00281-010-0210-3; Paidassi H, 2011, GASTROENTEROLOGY, V141, P1813, DOI 10.1053/j.gastro.2011.06.076; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sandig H, 2009, J ALLERGY CLIN IMMUN, V124, P528, DOI 10.1016/j.jaci.2009.04.036; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sojka DK, 2011, P NATL ACAD SCI USA, V108, P18336, DOI 10.1073/pnas.1110566108; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; Wang Q, 2001, J IMMUNOL, V167, P4311, DOI 10.4049/jimmunol.167.8.4311; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	55	104	104	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					949	+		10.1038/ni.2682	http://dx.doi.org/10.1038/ni.2682			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23933892	Green Submitted, Green Accepted			2022-12-18	WOS:000323377700012
J	Rui, LX; Schmitz, R; Ceribelli, M; Staudt, LM				Rui, Lixin; Schmitz, Roland; Ceribelli, Michele; Staudt, Louis M.			Malignant pirates of the immune system	NATURE IMMUNOLOGY			English	Review							B-CELL LYMPHOMA; NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; GERMINAL-CENTER FORMATION; RESPONSIVE INHIBITORY DOMAIN; ONCOGENIC CARD11 MUTATIONS; TUMOR-SUPPRESSOR GENE; HODGKIN LYMPHOMA; DOWN-REGULATION; MATURE B	At great human cost, cancer is the largest genetic experiment ever conducted. This review highlights how lymphoid malignancies have genetically perverted normal immune signaling and regulatory mechanisms for their selfish oncogenic goals of unlimited proliferation, perpetual survival and evasion of the immune response.	[Rui, Lixin; Schmitz, Roland; Ceribelli, Michele; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; rui, li/GYR-3791-2022; li, rui/GSD-4367-2022		US National Institutes of Health, National Cancer Institute, Center for Cancer Research; Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); National Health and Medical Research Council of Australia	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research, the Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe; R.S.) and the National Health and Medical Research Council of Australia (L.R.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chu CC, 2010, BLOOD, V115, P3907, DOI 10.1182/blood-2009-09-244251; CI W, 2009, BLOOD; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Engels N, 2011, CURR OPIN IMMUNOL, V23, P324, DOI 10.1016/j.coi.2011.01.005; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Gross AJ, 2009, J IMMUNOL, V182, P5382, DOI 10.4049/jimmunol.0803941; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; ISAACSON PG, 1987, LANCET, V2, P1488; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lossos IS, 2000, P NATL ACAD SCI USA, V97, P10209, DOI 10.1073/pnas.180316097; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Ruminy P, 2011, LEUKEMIA, V25, P681, DOI 10.1038/leu.2010.302; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Schmidlin H, 2008, BLOOD, V112, P1804, DOI 10.1182/blood-2008-01-136440; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vaandrager JW, 1998, BLOOD, V92, P2871, DOI 10.1182/blood.V92.8.2871.420k08_2871_2878; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	114	104	105	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					933	940		10.1038/ni.2094	http://dx.doi.org/10.1038/ni.2094			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934679				2022-12-18	WOS:000295084500008
J	Konkel, JE; Maruyama, T; Carpenter, AC; Xiong, YM; Zamarron, BF; Hall, BE; Kulkarni, AB; Zhang, P; Bosselut, R; Chen, WJ				Konkel, Joanne E.; Maruyama, Takashi; Carpenter, Andrea C.; Xiong, Yumei; Zamarron, Brian F.; Hall, Bradford E.; Kulkarni, Ashok B.; Zhang, Pin; Bosselut, Remy; Chen, WanJun			Control of the development of CD8 alpha alpha(+) intestinal intraepithelial lymphocytes by TGF-beta	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; LINEAGE DIFFERENTIATION; EXPRESSION; CD8; GROWTH; ACTIVATION; PRECURSORS; CONVERSION; REACTIVITY; INDUCTION	The molecular mechanisms that direct the development of TCR alpha beta(+)CD8 alpha alpha(+) intestinal intraepithelial lymphocytes (IELs) are not thoroughly understood. Here we show that transforming growth factor-beta (TGF-beta) controls the development of TCR alpha beta(+)CD8 alpha alpha(+) IELs. Mice with either a null mutation in the gene encoding TGF-beta 1 or T cell-specific deletion of TGF-beta receptor I lacked TCR alpha beta(+)CD8 alpha alpha(+) IELs, whereas mice with transgenic overexpression of TGF-beta 1 had a larger population of TCR alpha beta(+)CD8 alpha alpha(+) IELs. We observed defective development of the TCR alpha beta(+)CD8 alpha alpha(+) IEL thymic precursors (CD4(-)CD8(-)TCR alpha beta(+)CD5(+)) in the absence of TGF-beta. In addition, we found that TGF-beta signaling induced CD8 alpha expression in TCR alpha beta(+)CD8 alpha alpha(+) IEL thymic precursors and induced and maintained CD8 alpha expression in peripheral populations of T cells. Our data demonstrate a previously unrecognized role for TGF-beta in the development of TCR alpha beta(+)CD8 alpha alpha(+) IELs and the expression of CD8 alpha in T cells.	[Konkel, Joanne E.; Maruyama, Takashi; Zamarron, Brian F.; Zhang, Pin; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD USA; [Carpenter, Andrea C.; Xiong, Yumei; Bosselut, Remy] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Hall, Bradford E.; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD USA.	wchen@dir.nidcr.nih.gov	MaruYama, Takashi/N-5994-2014	MaruYama, Takashi/0000-0003-0820-3219; Bohrer, Andrea/0000-0003-4268-4853; Zamarron, Brian/0000-0001-6549-4230	National Institutes of Health, National Institute of Dental and Craniofacial Research; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank G. McGrady and S. Wahl (National Institute of Dental and Craniofacial Research, National Institutes of Health) for Tgfb1<SUP>-/-</SUP> mice, and E. Stregevsky and J. Simone for technical assistance. Supported by the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research and National Cancer Institute, Center for Cancer Research.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; BLANC D, 1988, EUR J IMMUNOL, V18, P613, DOI 10.1002/eji.1830180419; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHRIST M, 1994, J IMMUNOL, V153, P1936; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Guy-Grand D, 2004, SCIENCE, V305, P185, DOI 10.1126/science.1100890; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hostert A, 1997, J IMMUNOL, V158, P4270; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kuo S, 2001, PEDIATR RES, V49, P543, DOI 10.1203/00006450-200104000-00017; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Ma LJ, 2009, J IMMUNOL, V183, P1044, DOI 10.4049/jimmunol.0900420; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mintern JD, 2004, J IMMUNOL, V172, P699, DOI 10.4049/jimmunol.172.1.699; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; Podd BS, 2004, AUTOIMMUNITY, V37, P537, DOI 10.1080/08916930400027094; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Saurer L, 2004, J IMMUNOL, V172, P4176, DOI 10.4049/jimmunol.172.7.4176; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; van Wijk F, 2009, SEMIN IMMUNOL, V21, P130, DOI 10.1016/j.smim.2009.03.003; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024	49	104	105	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					312	U118		10.1038/ni.1997	http://dx.doi.org/10.1038/ni.1997			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21297643	Green Accepted			2022-12-18	WOS:000288593400009
J	Belyaev, NN; Brown, DE; Diaz, AIG; Rae, A; Jarra, W; Thompson, J; Langhorne, J; Potocnik, AJ				Belyaev, Nikolai N.; Brown, Douglas E.; Diaz, Ana-Isabel Garcia; Rae, Aaron; Jarra, William; Thompson, Joanne; Langhorne, Jean; Potocnik, Alexandre J.			Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria	NATURE IMMUNOLOGY			English	Article							PLASMODIUM-CHABAUDI-CHABAUDI; HEMATOPOIETIC STEM-CELLS; COMMON LYMPHOID PROGENITORS; INTERFERON-GAMMA; BONE-MARROW; BACTERIAL-INFECTION; LINEAGE COMMITMENT; REGULATOR LEVELS; B-LYMPHOPOIESIS; SELF-RENEWAL	Although the relationship between hematopoietic stem cells and progenitor populations has been investigated extensively under steady-state conditions, the dynamic response of the hematopoietic compartment during acute infection is largely unknown. Here we show that after infection of mice with Plasmodium chabaudi, a c-Kit(hi) progenitor subset positive for interleukin 7 receptor-alpha (IL-7R alpha) emerged that had both lymphoid and myeloid potential in vitro. After being transferred into uninfected alymphoid or malaria-infected hosts, IL-7R alpha(+)c-Kit(hi) progenitors generated mainly myeloid cells that contributed to the clearance of infected erythrocytes in infected hosts. The generation of these infection-induced progenitors was critically dependent on interferon-gamma (IFN-gamma) signaling in hematopoietic progenitors. Thus, IFN-gamma is a key modulator of hematopoiesis and innate and adaptive immunity during acute malaria infection.	[Belyaev, Nikolai N.; Brown, Douglas E.; Diaz, Ana-Isabel Garcia; Potocnik, Alexandre J.] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Jarra, William; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Rae, Aaron] Natl Inst Med Res, MRC, Flow Cytometry Core Facil, London NW7 1AA, England; [Thompson, Joanne] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Edinburgh	Potocnik, AJ (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England.	apotocn@nimr.mrc.ac.uk		Potocnik, Alexandre/0000-0002-4730-8593; Langhorne, Jean/0000-0002-2257-9733; Thompson, joanne/0000-0002-3343-2278; Garcia Diaz, Ana Isabel/0000-0001-6941-6272	European Commission [LSHP-CT-2004-503578, LSHG-CT-2005-005203]; Medical Research Council UK [U117584248, U117569359]; Medical Research Council [MC_U117584248, G0600845, MC_U117565359] Funding Source: researchfish; MRC [MC_U117584248, G0600845, MC_U117565359] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the European Commission Framework Programme 6 Network of Excellence (BioMalPar LSHP-CT-2004-503578 to J.L. and MUGEN LSHG-CT-2005-005203 to A.J.P.) and the Medical Research Council UK (U117584248 to J.L. and U117569359 to A.J.P.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; ASAMI M, 1992, INT J PARASITOL, V22, P43, DOI 10.1016/0020-7519(92)90078-Y; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Favre N, 1997, PARASITE IMMUNOL, V19, P375, DOI 10.1046/j.1365-3024.1997.d01-227.x; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Iida S, 2008, GENES CELLS, V13, P313, DOI 10.1111/j.1365-2443.2008.01173.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; SILVERMAN PH, 1987, BLOOD, V69, P408; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; VILLEVAL JL, 1990, EXP PARASITOL, V71, P375, DOI 10.1016/0014-4894(90)90063-I; VILLEVAL JL, 1990, EXP PARASITOL, V71, P364, DOI 10.1016/0014-4894(90)90062-H; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YAP GS, 1992, EXP PARASITOL, V75, P340, DOI 10.1016/0014-4894(92)90219-Z; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; ZHU JD, 1994, LEUKEMIA, V8, P717	47	104	106	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					477	U41		10.1038/ni.1869	http://dx.doi.org/10.1038/ni.1869			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20431620				2022-12-18	WOS:000277821300008
J	Park, SR; Zan, H; Pal, Z; Zhang, JS; Al-Qahtani, A; Pone, EJ; Xu, ZM; Mai, T; Casali, P				Park, Seok-Rae; Zan, Hong; Pal, Zsuzsanna; Zhang, Jinsong; Al-Qahtani, Ahmed; Pone, Egest J.; Xu, Zhenming; Mai, Thach; Casali, Paolo			HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation	NATURE IMMUNOLOGY			English	Article							HUMAN B-CELLS; ACTIVATION-INDUCED DEAMINASE; GERMINAL CENTER; DEPENDENT GENERATION; TARGETED DISRUPTION; CD40 LIGAND; T-CELL; IG; BREAKS; TRANSLOCATIONS	The cytidine deaminase AID (encoded by Aicda in mice and AICDA in humans) is critical for immunoglobulin class-switch recombination (CSR) and somatic hypermutation (SHM). Here we show that AID expression was induced by the HoxC4 homeodomain transcription factor, which bound to a highly conserved HoxC4-Oct site in the Aicda or AICDA promoter. This site functioned in synergy with a conserved binding site for the transcription factors Sp1, Sp3 and NF-kappa B. HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4. HoxC4 deficiency resulted in impaired CSR and SHM because of lower AID expression and not some other putative HoxC4-dependent activity. Enforced expression of AID in Hoxc4(-/-) B cells fully restored CSR. Thus, HoxC4 directly activates the Aicda promoter, thereby inducing AID expression, CSR and SHM.	[Park, Seok-Rae; Zan, Hong; Pal, Zsuzsanna; Zhang, Jinsong; Al-Qahtani, Ahmed; Pone, Egest J.; Xu, Zhenming; Mai, Thach; Casali, Paolo] Univ Calif Irvine, Sch Med, Inst Immunol, Irvine, CA 92717 USA; [Park, Seok-Rae; Zan, Hong; Pal, Zsuzsanna; Zhang, Jinsong; Al-Qahtani, Ahmed; Pone, Egest J.; Xu, Zhenming; Mai, Thach; Casali, Paolo] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Casali, P (corresponding author), Univ Calif Irvine, Sch Med, Inst Immunol, Irvine, CA 92717 USA.	pcasali@uci.edu	Casali, Paolo/F-6579-2010; ZHANG, JINSONG/E-1656-2011; Xu, Zhenming/C-4134-2012	ZHANG, JINSONG/0000-0002-2195-2997; Park, Seok-Rae/0000-0002-1407-4495	US National Institutes of Health [AI 045011, AI 079705, AI 060573]; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045011, R56AI079705, R56AI045011, T32AI060573, R01AI079705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. R. Capecchi and A. M. Boulet (University of Utah) for Hoxc4<SUP>+/-</SUP> frozen mouse sperm; T. Fielder for technical efforts; L. Khidr, L. Phan, B. Gupta, J. Feng and Y. Zhong for handling Hoxc4<SUP>+/-</SUP> mice; C. Murre (University of California, San Diego) for the Aicda retroviral construct, T. Honjo (Kyoto University) for CH12F3-2A cells; C. M. Snapper (Uniformed Services University of the Health Sciences) for dextran-conjugated mAb to delta-chain; Z. Yu for statistic analysis; A. Schaffer for discussions; and S. Sabet and M. Kang for technical assistance. Supported by the US National Institutes of Health (AI 045011, AI 079705 and AI 060573 to P. C.).	Bijl J, 1996, BLOOD, V87, P1737, DOI 10.1182/blood.V87.5.1737.bloodjournal8751737; Bijl JJ, 1997, BLOOD, V90, P4116, DOI 10.1182/blood.V90.10.4116; Boulet AM, 1996, DEV BIOL, V177, P232, DOI 10.1006/dbio.1996.0159; Casali P, 2006, TRENDS IMMUNOL, V27, P313, DOI 10.1016/j.it.2006.05.001; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Diaz M, 2002, CURR OPIN IMMUNOL, V14, P235, DOI 10.1016/S0952-7915(02)00327-8; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Guilkema DEJ, 2005, BLOOD, V105, P2997, DOI 10.1182/blood-2004-09-3473; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jiang CC, 2009, IMMUNOLOGY, V126, P102, DOI 10.1111/j.1365-2567.2008.02882.x; Kim EC, 2004, J BIOL CHEM, V279, P42258, DOI 10.1074/jbc.M407496200; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MEAZZA R, 1995, BLOOD, V85, P2084, DOI 10.1182/blood.V85.8.2084.bloodjournal8582084; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Saegusa H, 1996, DEV BIOL, V174, P55, DOI 10.1006/dbio.1996.0051; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schaffer A, 1999, J IMMUNOL, V162, P5327; Schaffer A, 2003, J BIOL CHEM, V278, P23141, DOI 10.1074/jbc.M212952200; Schoetz U, 2006, J IMMUNOL, V177, P395, DOI 10.4049/jimmunol.177.1.395; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; Xu ZM, 2005, ANN NY ACAD SCI, V1050, P146, DOI 10.1196/annals.1313.119; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zan H, 2000, J IMMUNOL, V165, P830, DOI 10.4049/jimmunol.165.2.830; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zan H, 1998, J IMMUNOL, V161, P5217; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554	55	104	105	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					540	550		10.1038/ni.1725	http://dx.doi.org/10.1038/ni.1725			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19363484	Green Submitted, Green Accepted			2022-12-18	WOS:000265394400016
J	Hong, S; Lim, S; Li, AG; Lee, C; Lee, YS; Lee, EK; Park, SH; Wang, XJ; Kim, SJ				Hong, Suntaek; Lim, Seunghwan; Li, Allen G.; Lee, Chan; Lee, Youn Sook; Lee, Eun-Kyung; Park, Seok Hee; Wang, Xiao-Jing; Kim, Seong-Jin			Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; BREAST-CANCER CELLS; TGF-BETA; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; IKK ACTIVATION; NULL MOUSE; IN-VIVO	Transforming growth factor-beta 1 (TGF-beta 1) regulates inflammation and can inhibit activation of the transcription factor NF-kappa B in certain cell types. Here we show that the TGF-beta-induced signaling protein Smad7 bound to TAB2 and TAB3, which are adaptors that link the kinase TAK1 to 'upstream' regulators in the proinflammatory tumor necrosis factor (TNF) signaling pathway. Smad7 thereby promoted TGF-beta-mediated anti-inflammatory effects. The formation of Smad7-TAB2 and Smad7-TAB3 complexes resulted in the suppression of TNF signaling through the adaptors TRAF2, TAB2 and/or TAB3, and TAK1. Furthermore, expression of a transgene encoding Smad7 in mouse skin suppressed inflammation and NF-kappa B nuclear translocation substantially and disrupted the formation of endogenous TRAF2-TAK1-TAB2 and TRAF2-TAK1-TAB3 complexes. Thus, Smad7 is a critical mediator of TGF-beta signals that block proinflammatory TNF signals.	NCI, Lab Cell Regulat & Carcinogenesis, Bethesda, MD 20892 USA; Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97239 USA; Inha Univ, Coll Med, Dept Pathol, Inchon 400712, South Korea; Inha Res Inst Med Sci, Inchon 400712, South Korea; Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon Health & Science University; Oregon Health & Science University; Inha University; Inha University; Gachon University	Kim, SJ (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, Bethesda, MD 20892 USA.	kims@mail.nih.gov		Lim, Seunghwan/0000-0001-8920-0890	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Benus GFJD, 2005, MOL BIOL CELL, V16, P3501, DOI 10.1091/mbc.E04-11-1033; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; GEISER AG, 1993, P NATL ACAD SCI USA, V90, P9944, DOI 10.1073/pnas.90.21.9944; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gross DJ, 2003, CLIN CANCER RES, V9, P3788; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Han SH, 1998, J PHARMACOL EXP THER, V287, P1105; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Lee BI, 2001, CANCER RES, V61, P931; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200; McCartney-Francis NL, 2002, J IMMUNOL, V169, P5941, DOI 10.4049/jimmunol.169.10.5941; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pulaski L, 2001, J BIOL CHEM, V276, P14344, DOI 10.1074/jbc.M011019200; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Vodovotz Y, 1996, J EXP MED, V183, P2337, DOI 10.1084/jem.183.5.2337; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; XIA ZP, 2005, SCI STKE, pE7; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004	49	104	112	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					504	513		10.1038/ni1451	http://dx.doi.org/10.1038/ni1451			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17384642				2022-12-18	WOS:000245831600015
J	Filippi, MD; Harris, CE; Meller, J; Gu, Y; Zheng, Y; Williams, DA				Filippi, MD; Harris, CE; Meller, J; Gu, Y; Zheng, Y; Williams, DA			Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils	NATURE IMMUNOLOGY			English	Article							PLASMA-MEMBRANE; PROTEIN PRENYLATION; RHO-GTPASE; ACTIVATION; RAS; COMPLEX; FAMILY; CDC42; GENE; EXPRESSION	Despite having a high degree of sequence similarity, the Rho guanosine triphosphatases Rac1 and Rac2 regulate distinct functions in neutrophils. Here we demonstrate that the unique Rac2 localization and functions in neutrophils are regulated by two separate C-terminal motifs, the hypervariable domain and aspartic acid 150, one of which has not previously been linked to the function of Rho GTPases. In addition, we show an unexpected dependence of Rac1 localization on Rac2 activity in these same cells, demonstrating a degree of crosstalk between two closely related Rho GTPases. Thus, we have defined specific sequences in Rac that specify subcellular localization and determine the specificity of Rac2 in neutrophil chemotaxis and superoxide generation.	Univ Cincinnati, Coll Med, Div Expt Hematol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Pediat Informat, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Williams, DA (corresponding author), Univ Cincinnati, Coll Med, Div Expt Hematol, Cincinnati, OH 45229 USA.	david.williams@cchmc.org	Meller, Jaroslaw/A-1971-2011; Zheng, Yi/J-7235-2015	Meller, Jaroslaw/0000-0002-1162-8253; Zheng, Yi/0000-0001-7089-6074	NIDDK NIH HHS [R01 DK62757] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Gelb MH, 1998, CURR OPIN CHEM BIOL, V2, P40, DOI 10.1016/S1367-5931(98)80034-3; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JOSEPH G, 1994, J BIOL CHEM, V269, P29024; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MOLL J, 1991, ONCOGENE, V6, P863; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tao W, 2002, BLOOD, V100, P1679, DOI 10.1182/blood.V100.5.1679.h81702001679_1679_1688; VAN AL, 1997, GENE DEV, V11, P2295; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Williams DA, 2000, BLOOD, V96, P1646; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	37	104	107	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					744	751		10.1038/ni1081	http://dx.doi.org/10.1038/ni1081			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15170212				2022-12-18	WOS:000222331200028
J	Cullen, BR				Cullen, BR			RNA interference: antiviral defense and genetic tool	NATURE IMMUNOLOGY			English	Editorial Material							SMALL TEMPORAL RNAS; EXPRESSION	Higher eukaryotes can mount antiviral immune responses induced by dsRNA. This process, called RNA interference, is sequence specific and can therefore be used to target gene expression.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3025, Durham, NC 27710 USA.	culle002@mc.duke.edu						Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZENG Y, 2002, IN PRESS MOL CELL	16	104	152	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					597	599		10.1038/ni0702-597	http://dx.doi.org/10.1038/ni0702-597			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087412				2022-12-18	WOS:000176441700004
J	Rocklov, J; Dubrow, R				Rocklov, Joacim; Dubrow, Robert			Climate change: an enduring challenge for vector-borne disease prevention and control	NATURE IMMUNOLOGY			English	Article							LYME-DISEASE; DENGUE; TRANSMISSION; SPREAD; MODEL	Climate change is already affecting vector-borne disease transmission and spread, and its impacts are likely to worsen. In the face of ongoing climate change, we must intensify efforts to prevent and control vector-borne diseases.	[Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Dubrow, Robert] Yale Univ, Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Dubrow, Robert] Yale Univ, Yale Sch Med, New Haven, CT 06520 USA; [Dubrow, Robert] Yale Univ, Yale Ctr Climate Change & Hlth, New Haven, CT 06520 USA	Umea University; Yale University; Yale University; Yale University	Dubrow, R (corresponding author), Yale Univ, Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA.; Dubrow, R (corresponding author), Yale Univ, Yale Sch Med, New Haven, CT 06520 USA.; Dubrow, R (corresponding author), Yale Univ, Yale Ctr Climate Change & Hlth, New Haven, CT 06520 USA.	robert.dubrow@yale.edu		Dubrow, Robert/0000-0002-5071-7742; Rocklov, Joacim/0000-0003-4030-0449	Swedish Research Council Formas [2018-01754, 2017-01300]; ZikaPlan project - European Union research and innovation program Horizon 2020 [734584]; High Tide Foundation	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); ZikaPlan project - European Union research and innovation program Horizon 2020; High Tide Foundation	J.R. received funding from the Swedish Research Council Formas (grant nos. 2018-01754 and 2017-01300) and the ZikaPlan project funded by the European Union research and innovation program Horizon 2020 (grant agreement no. 734584). R.D. received funding from the High Tide Foundation.	Allen M.R., 2018, GLOBAL WARMING 15 C; Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; International Health Conference, 2002, Bull World Health Organ, V80, P983; IPCC, 2014, CLIMATE CHANGE 2014; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Johansson MA, 2019, P NATL ACAD SCI USA, V116, P24268, DOI 10.1073/pnas.1909865116; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lillepold K, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz017; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Liyanage P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111087; Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8; Moore SM, 2014, AM J TROP MED HYG, V90, P486, DOI 10.4269/ajtmh.13-0180; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Rocklov J, 2019, EMERG INFECT DIS, V25, P1041, DOI 10.3201/eid2506.180138; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Roy-Dufresne E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080724; Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204, 10.3201/eid2204.151073]; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; Wuebbles D. J., 2017, CLIMATE SCI SPECIAL, VI, P470, DOI 10.7930/J0J964J6	27	103	106	12	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					479	483		10.1038/s41590-020-0648-y	http://dx.doi.org/10.1038/s41590-020-0648-y		APR 2020	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32313242	Green Published, Bronze			2022-12-18	WOS:000527507900006
J	Dress, RJ; Dutertre, CA; Giladi, A; Schlitzer, A; Low, I; Shadan, NB; Tay, A; Lum, J; Kairi, MFB; Hwang, YY; Becht, E; Cheng, Y; Chevrier, M; Larbi, A; Newell, EW; Amit, I; Chen, JM; Ginhoux, F				Dress, Regine J.; Dutertre, Charles-Antoine; Giladi, Amir; Schlitzer, Andreas; Low, Ivy; Shadan, Nurhidaya Binte; Tay, Alicia; Lum, Josephine; Kairi, Muhammad Faris Bin Mohd; Hwang, You Yi; Becht, Etienne; Cheng, Yang; Chevrier, Marion; Larbi, Anis; Newell, Evan W.; Amit, Ido; Chen, Jinmiao; Ginhoux, Florent			Plasmacytoid dendritic cells develop from Ly6D(+) lymphoid progenitors distinct from the myeloid lineage	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR E2-2; HIGH-DIMENSIONAL ANALYSIS; LANGERHANS CELLS; STEADY-STATE; RNA-SEQ; B-CELL; IDENTIFICATION; EXPRESSION; DIVERSIFICATION; MONOCYTES	Dendritic cells (DC) are currently classified as conventional DCs (cDCs) and plasmacytoid DCs (pDCs). Through a combination of single-cell transcriptomic analysis, mass cytometry, in vivo fate mapping and in vitro clonal assays, here we show that, at the single-cell level, the priming of mouse hematopoietic progenitor cells toward the pDC lineage occurs at the common lymphoid progenitor stage, indicative of early divergence of the pDC and cDC lineages. We found the transcriptional signature of a pDC precursor stage, defined here, in the IL-7R alpha(+) common lymphoid progenitor population and identified Ly6D, IL-7R alpha, CD81 and CD2 as key markers of pDC differentiation, which distinguish pDC precursors from cDC precursors. In conclusion, pDCs developed in the bone marrow from a Ly6D(h)(i)CD2(h)(i) lymphoid progenitor cell and differentiated independently of the myeloid cDC lineage.	[Dress, Regine J.; Dutertre, Charles-Antoine; Schlitzer, Andreas; Low, Ivy; Shadan, Nurhidaya Binte; Tay, Alicia; Lum, Josephine; Kairi, Muhammad Faris Bin Mohd; Hwang, You Yi; Becht, Etienne; Cheng, Yang; Chevrier, Marion; Larbi, Anis; Newell, Evan W.; Chen, Jinmiao; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Dutertre, Charles-Antoine] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Giladi, Amir; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Schlitzer, Andreas] Univ Bonn, Life & Med Sci Inst, Myeloid Cell Biol, Bonn, Germany; [Ginhoux, Florent] Singhlth Translat Immunol & Inflammat Ctr, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Weizmann Institute of Science; University of Bonn	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.; Ginhoux, F (corresponding author), Singhlth Translat Immunol & Inflammat Ctr, Singapore, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012; Larbi, Anis/ABE-5868-2020; Chen, Jinmiao/ABE-5601-2021	Newell, Evan W/0000-0002-2889-243X; Dutertre, Charles-Antoine/0000-0001-7950-3652; Becht, Etienne/0000-0003-1859-9202; Dress, Regine J./0000-0001-8785-5471	Singapore Immunology Network (SIgN); Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; BMRC [IAF 311006]; BMRC transition funds [H16/99/b0/011]	Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore); BMRC(Agency for Science Technology & Research (A*STAR)); BMRC transition funds(Agency for Science Technology & Research (A*STAR))	We thank L. Robinson of Insight Editing London for critical review and editing of the manuscript. F.G. is an EMBO YIP awardee and is supported by Singapore Immunology Network (SIgN) core funding, as well as Singapore National Research Foundation Senior Investigatorship (NRFI) NRF2016NRF-NRFI001-02. The CyTOF, bioinformatics and immunogenomics platforms are part of the SIgN Immunomonitoring platform (supported by a BMRC IAF 311006 grant and BMRC transition funds H16/99/b0/011).	Alculumbre SG, 2018, NAT IMMUNOL, V19, P63, DOI 10.1038/s41590-017-0012-z; Baerenwaldt A, 2016, J IMMUNOL, V196, P2561, DOI 10.4049/jimmunol.1501380; Bauer J, 2016, J IMMUNOL, V196, P4447, DOI 10.4049/jimmunol.1500383; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Briseno CG, 2014, CURR OPIN IMMUNOL, V29, P69, DOI 10.1016/j.coi.2014.04.006; Bryant C, 2016, IMMUNOL CELL BIOL, V94, P447, DOI 10.1038/icb.2015.116; Chen JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11988; Chow KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075891; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dress RJ, 2018, IMMUNOL CELL BIOL, V96, P463, DOI 10.1111/imcb.12028; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; McInnes L., 2018, ARXIV PREPRINT ARXIV, DOI DOI 10.21105/JOSS.00861; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sanyal M, 2009, INT IMMUNOL, V21, P1225, DOI 10.1093/intimm/dxp090; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siegemund S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124661; Soumelis V, 2006, EUR J IMMUNOL, V36, P2286, DOI 10.1002/eji.200636026; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	50	103	105	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					852	+		10.1038/s41590-019-0420-3	http://dx.doi.org/10.1038/s41590-019-0420-3			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213723				2022-12-18	WOS:000471891900016
J	Hollande, C; Boussier, J; Ziai, J; Nozawa, T; Bondet, V; Phung, W; Lu, BF; Duffy, D; Paradis, V; Mallet, V; Eberl, G; Sandoval, W; Schartner, JM; Pol, S; da Silva, RB; Albert, ML				Hollande, Clemence; Boussier, Jeremy; Ziai, James; Nozawa, Tamaki; Bondet, Vincent; Phung, Wilson; Lu, Binfeng; Duffy, Darragh; Paradis, Valerie; Mallet, Vincent; Eberl, Gerard; Sandoval, Wendy; Schartner, Jill M.; Pol, Stanislas; da Silva, Rosa Barreira; Albert, Matthew L.			Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth	NATURE IMMUNOLOGY			English	Article							AMINO-TERMINAL TRUNCATION; CD8(+) T; EPITHELIAL-CELLS; IL-33; INFLAMMATION; EOTAXIN; ROLES; IV; CHEMOTAXIS; EXPRESSION	Post-translational modification of chemokines mediated by the dipeptidyl peptidase DPP4 (CD26) has been shown to negatively regulate lymphocyte trafficking, and its inhibition enhances T cell migration and tumor immunity by preserving functional chemokine CXCL10. By extending those initial findings to pre-clinical models of hepatocellular carcinoma and breast cancer, we discovered a distinct mechanism by which inhibition of DPP4 improves anti-tumor responses. Administration of the DPP4 inhibitor sitagliptin resulted in higher concentrations of the chemokine CCL11 and increased migration of eosinophils into solid tumors. Enhanced tumor control was preserved in mice lacking lymphocytes and was ablated after depletion of eosinophils or treatment with degranulation inhibitors. We further demonstrated that tumor-cell expression of the alarmin IL-33 was necessary and sufficient for eosinophil-mediated anti-tumor responses and that this mechanism contributed to the efficacy of checkpoint-inhibitor therapy. These findings provide insight into IL-33- and eosinophil-mediated tumor control, revealed when endogenous mechanisms of DPP4 immunoregulation are inhibited.	[Hollande, Clemence; Boussier, Jeremy; Bondet, Vincent; Duffy, Darragh; Pol, Stanislas] Inst Pasteur, Immunobiol Dendrit Cells, Paris, France; [Hollande, Clemence; Boussier, Jeremy; Bondet, Vincent; Duffy, Darragh; Pol, Stanislas] Inst Pasteur, INSERM, U1223, Paris, France; [Hollande, Clemence] Univ Paris 06, Ecole Doctorale Physiol Physiopathol & Therapeut, Paris, France; [Ziai, James] Genentech Inc, Dept Res Pathol, San Francisco, CA USA; [Nozawa, Tamaki; Schartner, Jill M.] Genentech Inc, Dept Translat Oncol, San Francisco, CA USA; [Phung, Wilson; Sandoval, Wendy] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA USA; [Lu, Binfeng] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Duffy, Darragh] Inst Pasteur, INSERM, UMS20, Ctr Translat Res, Paris, France; [Paradis, Valerie] Hop Beaujon, Dept Pathol Physiol & Imaging, Clichy, France; [Mallet, Vincent; Pol, Stanislas] Univ Paris 05, Hop Cochin, AP HP, Dept Hepatol, Paris, France; [Eberl, Gerard] Inst Pasteur, INSERM, U1224, Microenvironm & Immun Unit, Paris, France; [da Silva, Rosa Barreira; Albert, Matthew L.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roche Holding; Genentech	Albert, ML (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	albertm7@gene.com	Paradis, Valerie/X-9097-2019; Eberl, Gerard/A-1160-2013; Mallet, Vincent/G-4623-2011	Eberl, Gerard/0000-0002-1119-5638; Boussier, Jay/0000-0002-2249-377X; Mallet, Vincent/0000-0003-2219-9201; Phung, Wilson/0000-0001-7793-3931	Fondation ARC pour la recherche sur le cancer; Institut national de la sante et de la recherche medicale (Inserm); Fondation pour la recherche medicale (FRM) [FDM 40432]; LabEx Immuno-Onco (ANR)	Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Institut national de la sante et de la recherche medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); LabEx Immuno-Onco (ANR)	Funding for the work was provided by Fondation ARC pour la recherche sur le cancer, Institut national de la sante et de la recherche medicale (Inserm), Fondation pour la recherche medicale (FRM, FDM 40432) and LabEx Immuno-Onco (ANR). Thanks to H. Saklani, M. A. Ingersoll and T. Canton for their help with mouse experimental work and ethical statement.	Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Carretero R, 2015, NAT IMMUNOL, V16, P609, DOI 10.1038/ni.3159; Caruso RA, 2011, ULTRASTRUCT PATHOL, V35, P145, DOI 10.3109/01913123.2011.578233; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cho SY, 2010, CANCER RES, V70, P3402, DOI 10.1158/0008-5472.CAN-09-3977; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Costello R, 2005, REV MED INTERNE, V26, P479, DOI 10.1016/j.revmed.2005.02.013; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Dorta RG, 2002, HISTOPATHOLOGY, V41, P152, DOI 10.1046/j.1365-2559.2002.01437.x; Fernandez-Acenero MJ, 2000, CANCER, V88, P1544, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S; Forssmann U, 2008, J IMMUNOL, V181, P1120, DOI 10.4049/jimmunol.181.2.1120; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Gatault S, 2012, CANCER IMMUNOL IMMUN, V61, P1527, DOI 10.1007/s00262-012-1288-3; Griesenauer B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00475; Johnston LK, 2016, J IMMUNOL, V197, P3445, DOI 10.4049/jimmunol.1600611; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Kim J, 2016, J IMMUNOL, V196, P2410, DOI 10.4049/jimmunol.1501730; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Kubo H, 1999, INT ARCH ALLERGY IMM, V118, P426, DOI 10.1159/000024154; Lam CSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098582; Liang PI, 2017, ONCOTARGET, V8, P2995, DOI 10.18632/oncotarget.13820; Lu BF, 2016, J MOL MED, V94, P535, DOI 10.1007/s00109-016-1397-0; Lucarini V, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1317420; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Munitz A, 2004, ALLERGY, V59, P268, DOI 10.1111/j.1398-9995.2003.00442.x; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Reichman H, 2016, TRENDS CANCER, V2, P664, DOI 10.1016/j.trecan.2016.10.002; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Samoszuk M, 2004, AM J PATHOL, V165, P449, DOI 10.1016/S0002-9440(10)63310-X; Shiobara T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0342-7; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Stenfeldt AL, 2004, IMMUNOLOGY, V112, P605, DOI 10.1111/j.1365-2567.2004.01906.x; Struyf S, 1999, J IMMUNOL, V162, P4903; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Vanheule V, 2018, CYTOKINE, V109, P29, DOI 10.1016/j.cyto.2018.02.026; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wasmer MH, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00682; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xiao P, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1063772; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Zhang H, 2013, J CLIN INVEST, V123, P2306, DOI 10.1172/JCI67554; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	50	103	105	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					257	+		10.1038/s41590-019-0321-5	http://dx.doi.org/10.1038/s41590-019-0321-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30778250				2022-12-18	WOS:000458893600011
J	Sobolev, O; Binda, E; O'Farrell, S; Lorenc, A; Pradines, J; Huang, YQ; Duffner, J; Schulz, R; Cason, J; Zambon, M; Malim, MH; Peakman, M; Cope, A; Capila, I; Kaundinya, GV; Hayday, AC				Sobolev, Olga; Binda, Elisa; O'Farrell, Sean; Lorenc, Anna; Pradines, Joel; Huang, Yongqing; Duffner, Jay; Schulz, Reiner; Cason, John; Zambon, Maria; Malim, Michael H.; Peakman, Mark; Cope, Andrew; Capila, Ishan; Kaundinya, Ganesh V.; Hayday, Adrian C.			Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events	NATURE IMMUNOLOGY			English	Article							T-CELL RESPONSES; GENE-EXPRESSION; IMMUNE-RESPONSE; SEASONAL INFLUENZA; B-CELLS; SYSTEMS; IMMUNOLOGY; PATTERNS; AS03	Adjuvanted vaccines afford invaluable protection against disease, and the molecular and cellular changes they induce offer direct insight into human immunobiology. Here we show that within 24 h of receiving adjuvanted swine flu vaccine, healthy individuals made expansive, complex molecular and cellular responses that included overt lymphoid as well as myeloid contributions. Unexpectedly, this early response was subtly but significantly different in people older than similar to 35 years. Wide-ranging adverse clinical events can seriously confound vaccine adoption, but whether there are immunological correlates of these is unknown. Here we identify a molecular signature of adverse events that was commonly associated with an existing B cell phenotype. Thus immunophenotypic variation among healthy humans may be manifest in complex pathophysiological responses.	[Sobolev, Olga; Binda, Elisa; O'Farrell, Sean; Peakman, Mark; Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Sobolev, Olga; Binda, Elisa; O'Farrell, Sean; Peakman, Mark; Hayday, Adrian C.] Francis Crick Inst, Lincolns Inn Labs, ImmunoSurveillance Lab, London, England; [Sobolev, Olga; O'Farrell, Sean; Hayday, Adrian C.] Guys & St Thomas Hosp, Biomed Res Ctr, London SE1 9RT, England; [Sobolev, Olga; O'Farrell, Sean; Lorenc, Anna; Schulz, Reiner; Malim, Michael H.; Peakman, Mark; Cope, Andrew; Hayday, Adrian C.] Kings Coll London, London WC2R 2LS, England; [Binda, Elisa] Univ Pavia, IRCCS Policlin San Matteo, Div Rheumatol, Rheumatol & Translat Immunol Res Labs LaRIT, Via Palestro 3, I-27100 Pavia, Italy; [Pradines, Joel; Huang, Yongqing; Duffner, Jay; Capila, Ishan; Kaundinya, Ganesh V.] Momenta Pharmaceut, Cambridge, MA USA; [Schulz, Reiner] Kings Coll London, Dept Genet, London WC2R 2LS, England; [Cason, John; Malim, Michael H.] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Zambon, Maria] Hlth Protect Agcy, Salisbury, Wilts, England; [Cope, Andrew] Kings Coll London, Ctr Mol & Cell Biol Inflammat, Acad Dept Rheumatol, London WC2R 2LS, England	University of London; King's College London; Francis Crick Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; IRCCS Fondazione San Matteo; University of Pavia; University of London; King's College London; University of London; King's College London; Health Protection Agency; University of London; King's College London	Hayday, AC (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England.	adrian.hayday@kcl.ac.uk	Lorenc, Anna/AAA-3138-2022; Schulz, Reiner/A-5940-2011	Lorenc, Anna/0000-0002-1406-7607; Peakman, Mark/0000-0003-3328-3513; Malim, Michael/0000-0002-7699-2064; HAYDAY, ADRIAN/0000-0002-9495-5793; Cope, Andrew/0000-0001-6735-5496; Schulz, Reiner/0000-0001-5047-7921	Cancer Research UK; UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Wellcome Trust; Cancer Research UK [19309] Funding Source: researchfish; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish; Versus Arthritis [20265] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Versus Arthritis(Versus Arthritis)	We thank S. Steiner, Z. Kozlakidis, and K. Thornberry for invaluable assistance in study setup and sample collection; D. Dunn-Walters, J. Spencer, J.-C. Weill (Institut Necker), A. Skowera, M. Shankar Hari and S. Sabbah for helpful advice and feedback; King's College London and Guy's Hospital Biobank, the Clinical Transplantation Lab, GSTS and King's Pathology and the Biomedical Research Centre Flow Cytometry and Bioinformatics facilities for outstanding clinical and technical support. Supported by Cancer Research UK and the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. A.C.H. and M.H.M. are supported by Wellcome Trust Investigator awards.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bolognese JA, 2003, OSTEOARTHR CARTILAGE, V11, P499, DOI 10.1016/S1063-4584(03)00082-7; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028; Duffy D, 2014, IMMUNITY, V40, P436, DOI 10.1016/j.immuni.2014.03.002; Engel P, 2011, PHARMACOL REV, V63, P127, DOI 10.1124/pr.109.002006; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Fulop T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00271; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Oswald M, 2015, ARTHRITIS RHEUMATOL, V67, P344, DOI 10.1002/art.38947; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Roman F, 2011, CLIN VACCINE IMMUNOL, V18, P835, DOI 10.1128/CVI.00480-10; Shin MS, 2013, CYTOKINE, V61, P485, DOI 10.1016/j.cyto.2012.11.024; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang M, 2013, CELL MOL IMMUNOL, V10, P122, DOI 10.1038/cmi.2012.60; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	39	103	104	0	179	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					204	213		10.1038/ni.3328	http://dx.doi.org/10.1038/ni.3328			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26726811	Green Accepted, Green Submitted			2022-12-18	WOS:000368571500014
J	Nguyen, LP; Pan, JL; Dinh, TT; Hadeiba, H; O'Hara, E; Ebtikar, A; Hertweck, A; Gokmen, MR; Lord, GM; Jenner, RG; Butcher, EC; Habtezion, A				Nguyen, Linh P.; Pan, Junliang; Dinh, Thanh Theresa; Hadeiba, Husein; O'Hara, Edward, III; Ebtikar, Ahmad; Hertweck, Arnulf; Goekmen, M. Refik; Lord, Graham M.; Jenner, Richard G.; Butcher, Eugene C.; Habtezion, Aida			Role and species-specific expression of colon T cell homing receptor GPR15 in colitis	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR FOXP3; ULCERATIVE-COLITIS; CROHNS-DISEASE; TH17 CELLS; IN-VITRO; GATA3; CHEMOKINES; BINDING; MODELS	Lymphocyte recruitment maintains intestinal immune homeostasis but also contributes to inflammation. The orphan chemoattractant receptor GPR15 mediates regulatory T cell homing and immunosuppression in the mouse colon. We show that GPR15 is also expressed by mouse T(H)17 and T(H)1 effector cells and is required for colitis in a model that depends on the trafficking of these cells to the colon. In humans GPR15 is expressed by effector cells, including pathogenic T(H)2 cells in ulcerative colitis, but is expressed poorly or not at all by colon regulatory T (T-reg) cells. The T(H)2 transcriptional activator GATA-3 and the T-reg-associated transcriptional repressor FOXP3 robustly bind human, but not mouse, GPR15 enhancer sequences, correlating with receptor expression. Our results highlight species differences in GPR15 regulation and suggest it as a potential therapeutic target for colitis.	[Nguyen, Linh P.; Habtezion, Aida] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Nguyen, Linh P.; Pan, Junliang; Hadeiba, Husein; O'Hara, Edward, III; Ebtikar, Ahmad; Butcher, Eugene C.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA; [Nguyen, Linh P.; Pan, Junliang; Hadeiba, Husein; O'Hara, Edward, III; Ebtikar, Ahmad; Butcher, Eugene C.] Palo Alto Vet Inst Res, Palo Alto, CA USA; [Dinh, Thanh Theresa; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Hertweck, Arnulf; Jenner, Richard G.] UCL, UCL Canc Inst, London, England; [Goekmen, M. Refik; Lord, Graham M.] Guys & St Thomas Hosp, Dept Expt Immunobiol, London SE1 9RT, England; [Goekmen, M. Refik; Lord, Graham M.] Guys & St Thomas Hosp, NIHR Comprehens Biomed Res Ctr, London SE1 9RT, England; [Goekmen, M. Refik; Lord, Graham M.] Kings Coll London, London WC2R 2LS, England	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Butcher, EC (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA.	ebutcher@stanford.edu; aidah@stanford.edu	Abraham, Sabu/E-1144-2019; Jenner, Richard/J-8683-2012	Abraham, Sabu/0000-0002-0916-5827; Jenner, Richard/0000-0002-2946-6811; Lord, Graham/0000-0003-2069-4743	US National Institute of Health (NIH) [R37 AI047822]; NIH [K08 DK069385, R03 DK085426, AI109452A]; Stanford Digestive Disease Center (NIH Digestive Disease Center) [DK56339]; VA Palo Alto Health Care System; Wellcome Trust [091009]; Medical Research Council [G0802068]; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; NIHR Biomedical Research Centre based at Guy's; St Thomas' National Health Service (NHS) Foundation Trust; King's College London; NIH Training grant [T32 AI07290]; NIH postdoctoral fellowship [1F32 AI082924]; Cardiovascular Institute Fellowship [NIH T32 HL098049]; CIRM; Academy of Medical Sciences (AMS) [AMS-SGCL7-G�kmen] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/L009277/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, T32AI007290, R01AI109452, F32AI082924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; BBSRC [BB/L009277/1] Funding Source: UKRI; MRC [G0802068] Funding Source: UKRI	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Digestive Disease Center (NIH Digestive Disease Center); VA Palo Alto Health Care System(US Department of Veterans Affairs); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; NIHR Biomedical Research Centre based at Guy's; St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); NIH Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Institute Fellowship; CIRM(California Institute for Regenerative Medicine); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by US National Institute of Health (NIH) grant R37 AI047822 to E.C.B., NIH grants K08 DK069385 and R03 DK085426 to A. Habtezion, the FACS Core facility of the Stanford Digestive Disease Center (NIH Digestive Disease Center grants DK56339) and the VA Palo Alto Health Care System. Research was also supported by the Wellcome Trust (R.G.J. and G.M.L., grant number 091009), the Medical Research Council (G.M.L., grant number G0802068), the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre and the NIHR Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NIH, NHS, the NIHR or the Department of Health. L.P.N., H.H. and T.T.D. were recipients of fellowships under NIH Training grant T32 AI07290. L.P.N. was also a recipient of NIH postdoctoral fellowship grant 1F32 AI082924. T.T.D. is supported by a Cardiovascular Institute Fellowship under NIH T32 HL098049. H.H. is funded by NIH grant AI109452A, was a recipient of an Investigator Career Award from the Arthritis Foundation and was supported in part by a CIRM grant. We thank J. Xue (Stanford University) for assistance with the RT- PCR experiments, J. Chen (Stanford University) for technical assistance with the animal work and the Stanford Tissue Bank for providing the human colon specimens. We thank D. Littman (NYU) for recovering his cryopreserved Gpr15gfp mouse embryos for us in response to our request for collaboration to test our hypothesis that GPR15 mediates colon lymphocyte homing.	Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258; Fiocchi C., 2001, CURR PROTOC IMMUNOL; Fitch Frank W, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0313s72; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gokmen MR, 2013, J IMMUNOL, V191, P5925, DOI 10.4049/jimmunol.1202254; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Joost P, 2002, GENOME BIOL, V3; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lahl K, 2014, EUR J IMMUNOL, V44, P2577, DOI 10.1002/eji.201444628; Lee AY, 2008, EUR J IMMUNOL, V38, P1127, DOI 10.1002/eji.200737442; Lefrancois L., 2001, CURR PROTOC IMMUNOL; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; MARINE J, 1991, P NATL ACAD SCI USA, V88, P7284, DOI 10.1073/pnas.88.16.7284; Miura Soichiro, 2012, Ann Vasc Dis, V5, P275, DOI 10.3400/avd.ra.12.00059; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Picarella D, 1997, J IMMUNOL, V158, P2099; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rani A, 2011, J IMMUNOL, V187, P3721, DOI 10.4049/jimmunol.1002354; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shigematsu T, 2001, AM J PHYSIOL-GASTR L, V281, pG1309, DOI 10.1152/ajpgi.2001.281.5.G1309; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2006, ADV EXP MED BIOL, V579, P55; Sydora BC, 2002, CLIN EXP IMMUNOL, V129, P35, DOI 10.1046/j.1365-2249.2002.01892.x; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang CH, 2010, INFLAMM BOWEL DIS, V16, P1751, DOI 10.1002/ibd.21266; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zabel BA, 2015, ANNU REV PATHOL-MECH, V10, P51, DOI 10.1146/annurev-pathol-012513-104640; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	57	103	105	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					207	+		10.1038/ni.3079	http://dx.doi.org/10.1038/ni.3079			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25531831	Green Accepted			2022-12-18	WOS:000348143100013
J	Chang, JH; Xiao, YC; Hu, HB; Jin, J; Yu, JY; Zhou, XF; Wu, XF; Johnson, HM; Akira, SZ; Pasparakis, M; Cheng, XH; Sun, SC				Chang, Jae-Hoon; Xiao, Yichuan; Hu, Hongbo; Jin, Jin; Yu, Jiayi; Zhou, Xiaofei; Wu, Xuefeng; Johnson, Howard M.; Akira, Shizuo; Pasparakis, Manolis; Cheng, Xuhong; Sun, Shao-Cong			Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; CUTTING EDGE; TH17 CELLS; IFN-GAMMA; IN-VIVO; FOXP3; ACTIVATION; EXPRESSION; INHIBITION	The maintenance of immune homeostasis requires regulatory T cells (T-reg cells). Here we found that T-reg cell-specific ablation of Ubc13, a Lys63 (K63)-specific ubiquitin-conjugating enzyme, caused aberrant T cell activation and autoimmunity. Although Ubc13 deficiency did not affect the survival of T-reg cells or expression of the transcription factor Foxp3, it impaired the in vivo suppressive function of T-reg cells and rendered them sensitive to the acquisition of T helper type 1 (T(H)1) cell-and interleukin 17 (IL-17)-producing helper T (T(H)17) cell-like effector phenotypes. This function of Ubc13 involved its downstream target, the kinase IKK. The Ubc13-IKK signaling axis controlled the expression of specific T-reg cell effector molecules, including IL-10 and SOCS1. Collectively, our findings suggest that the Ubc13-IKK signaling axis regulates the molecular program that maintains T-reg cell function and prevents T-reg cells from acquiring inflammatory phenotypes.	[Chang, Jae-Hoon; Xiao, Yichuan; Hu, Hongbo; Jin, Jin; Yu, Jiayi; Zhou, Xiaofei; Wu, Xuefeng; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Johnson, Howard M.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Akira, Shizuo] Osaka Univ, Lab Host Def, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med, Cologne, Germany; [Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida; Osaka University; University of Cologne; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	zhou, xiaofei/A-9844-2013; Pasparakis, Manolis/H-9292-2017; Yu, Jiayi/I-5923-2014; Pasparakis, Manolis/N-4350-2019; Hu, Hongbo/J-8059-2016	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Hu, Hongbo/0000-0002-8177-7641; Jin, Jin/0000-0001-7887-5972	US National Institutes of Health [AI057555, AI064639, GM84459]; G.S. Hogan Gastrointestinal Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G.S. Hogan Gastrointestinal Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Karin (University of California, San Diego) for the IKK2(CA) expression vector; T. Kishimoto (Osaka University) for the mouse Socs1-luc reporter; and personnel from the flow cytometry, DNA analysis, and histology core facilities at MD Anderson Cancer Center for technical assistance. This work is supported by the US National Institutes of Health (AI057555, AI064639 and GM84459) and the G.S. Hogan Gastrointestinal Cancer Research Fund.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Collins EL, 2011, J IMMUNOL, V187, P2666, DOI 10.4049/jimmunol.1003819; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510; Harhaj EW, 1996, ONCOGENE, V12, P2385; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; O Flowers L, 2005, ONCOGENE, V24, P2114, DOI 10.1038/sj.onc.1208437; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pillemer BBL, 2007, EUR J IMMUNOL, V37, P2082, DOI 10.1002/eji.200737193; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Saito H, 2000, J IMMUNOL, V164, P5833, DOI 10.4049/jimmunol.164.11.5833; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	45	103	110	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					481	U84		10.1038/ni.2267	http://dx.doi.org/10.1038/ni.2267			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22484734	Green Accepted			2022-12-18	WOS:000303048400012
J	Miyazaki, M; Rivera, RR; Miyazaki, K; Lin, YC; Agata, Y; Murre, C				Miyazaki, Masaki; Rivera, Richard R.; Miyazaki, Kazuko; Lin, Yin C.; Agata, Yasutoshi; Murre, Cornelis			The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX PROTEIN; BETA; DIFFERENTIATION; SELECTION; MUTATION; DISTINCT; NETWORK; ZAP-70; E47; CD4	It is established that the transcription factor E2A and its antagonist Id3 modulate the checkpoints consisting of the precursor to the T cell antigen receptor (pre-TCR) and the TCR. Here we demonstrate that Id3 expression was higher beyond the pre-TCR checkpoint, remained high in naive T cells and showed a bimodal pattern in the effector-memory population. We show how E2A promoted T lineage specification and how pre-TCR-mediated signaling affected E2A genome-wide occupancy. Thymi in Id3-deficient mice had aberrant development of effector-memory cells, higher expression of the chemokine receptor CXCR5 and the transcriptional repressor Bcl-6 and, unexpectedly, T cell-B cell conjugates and B cell follicles. Collectively, our data show how E2A acted globally to orchestrate development into the T lineage and that Id3 antagonized E2A activity beyond the pre-TCR checkpoint to enforce the naive fate of T cells.	[Miyazaki, Masaki; Rivera, Richard R.; Miyazaki, Kazuko; Lin, Yin C.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Agata, Yasutoshi] Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan	University of California System; University of California San Diego; Kyoto University	Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu		Agata, Yasutoshi/0000-0001-9642-6994; Lin, Yin/0000-0003-4925-5453	American Recovery and Investment Act [27775A]; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R37CA054198, R01CA078384] Funding Source: NIH RePORTER	American Recovery and Investment Act; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Goldrath and members of the Murre laboratory for critical reading of the manuscript; G. Hardiman, M. Harabaglia, J. Sprague and C. Ludka for help with Solexa DNA sequencing; N. Varki and the University of California, San Diego Histology Core for histology; and Y. Zhuang (Duke University) for E2a/GFP and E2a<SUP>f/f</SUP> mice. Supported by the American Recovery and Investment Act (27775A to Y.C.L.) and the US National Institutes of Health (C.M.).	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Murre C, 2009, GENE DEV, V23, P2366, DOI 10.1101/gad.1861709; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Palacios EH, 2007, J EXP MED, V204, P1703, DOI 10.1084/jem.20070405; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Ueda-Hayakawa I, 2009, J IMMUNOL, V182, P5306, DOI 10.4049/jimmunol.0804249; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937	46	103	104	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					992	U103		10.1038/ni.2086	http://dx.doi.org/10.1038/ni.2086			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21857655	Green Accepted			2022-12-18	WOS:000295084500015
J	Yip, LD; Su, L; Sheng, DQ; Chang, P; Atkinson, M; Czesak, M; Albert, PR; Collier, AR; Turley, SJ; Fathman, CG; Creusot, RJ				Yip, Linda; Su, Leon; Sheng, Deqiao; Chang, Pearl; Atkinson, Mark; Czesak, Margaret; Albert, Paul R.; Collier, Ai-Ris; Turley, Shannon J.; Fathman, C. Garrison; Creusot, Remi J.			Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; MESSENGER-RNA; SELF; TOLERANCE; PROTEIN; MICE; AUTOIMMUNITY; TRANSCRIPTION; POLYMORPHISM; FIBRONECTIN	Type 1 diabetes may result from a breakdown in peripheral tolerance that is partially controlled by the expression of peripheral tissue antigens (PTAs) in lymph nodes. Here we show that the transcriptional regulator Deaf1 controls the expression of genes encoding PTAs in the pancreatic lymph nodes (PLNs). The expression of canonical Deaf1 was lower, whereas that of an alternatively spliced variant was higher, during the onset of destructive insulitis in the PLNs of nonobese diabetic (NOD) mice. We identified an equivalent variant Deaf1 isoform in the PLNs of patients with type 1 diabetes. Both the NOD mouse and human Deaf1 variant isoforms suppressed PTA expression by inhibiting the transcriptional activity of canonical Deaf1. Lower PTA expression resulting from the alternative splicing of DEAF1 may contribute to the pathogenesis of type 1 diabetes.	[Yip, Linda; Su, Leon; Sheng, Deqiao; Chang, Pearl; Fathman, C. Garrison; Creusot, Remi J.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Czesak, Margaret; Albert, Paul R.] Univ Ottawa, Ottawa Hlth Res Inst Neurosci, Ottawa, ON, Canada; [Czesak, Margaret; Albert, Paul R.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Collier, Ai-Ris; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Stanford University; State University System of Florida; University of Florida; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Harvard University; Dana-Farber Cancer Institute	Fathman, CG (corresponding author), Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA.	cfathman@stanford.edu	Albert, Paul/E-4804-2010; Creusot, Remi/M-2642-2019	Albert, Paul/0000-0002-1809-3554; Su, Leon/0000-0001-7654-9997; Creusot, Remi/0000-0002-8328-8155	US National Institutes of Health [U01 DK078123-03, U19-DK 61934, U19-AI050864]; Canadian Institutes of Health Research; American Diabetes Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083628, U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123, U19DK061934] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Iwai and C. Taylor for technical assistance; J. Visvader (The Walter and Eliza Hall Institute of Medical Research) for Deaf1-deficient mice; and the Network for Pancreatic Organ Donors with Diabetes (Juvenile Diabetes Research Foundation) and the National Disease Research Interchange for human PLNs and spleen samples. Supported by the US National Institutes of Health (U01 DK078123-03, U19-DK 61934 and U19-AI050864 to C. G. F.), the Canadian Institutes of Health Research (P. R. A. and M. C.) and the American Diabetes Association (L. Y.).	Adorini L, 2002, TRENDS MOL MED, V8, P31, DOI 10.1016/S1471-4914(01)02193-1; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Avichezer D, 2003, J EXP MED, V198, P1665, DOI 10.1084/jem.20030413; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BORSI L, 1990, FEBS LETT, V261, P175, DOI 10.1016/0014-5793(90)80664-5; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Cowling RT, 2005, AM J PHYSIOL-HEART C, V289, pH1176, DOI 10.1152/ajpheart.00088.2005; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Kasai M, 2000, EUR J IMMUNOL, V30, P3542, DOI 10.1002/1521-4141(200012)30:12<3542::AID-IMMU3542>3.0.CO;2-N; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Lambe T, 2007, J IMMUNOL, V178, P4276, DOI 10.4049/jimmunol.178.7.4276; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Planas R, 2006, DIABETOLOGIA, V49, P2379, DOI 10.1007/s00125-006-0365-6; Togo S, 2003, FEBS LETT, V535, P205, DOI 10.1016/S0014-5793(02)03891-7; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105	31	103	116	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					1026	U107		10.1038/ni.1773	http://dx.doi.org/10.1038/ni.1773			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19668219	Green Accepted			2022-12-18	WOS:000269120900017
J	Hayday, AC; Pennington, DJ				Hayday, Adrian C.; Pennington, Daniel J.			Key factors in the organized chaos of early T cell development	NATURE IMMUNOLOGY			English	Review							GAMMA-DELTA-TCR; CHAIN GENE REARRANGEMENT; ALPHA-BETA-LINEAGE; RECEPTOR-BETA; PRE-TCR; LYMPHOCYTE DEVELOPMENT; FATE SPECIFICATION; THYMIC DEVELOPMENT; MOUSE THYMOCYTES; PROGENITOR CELLS	A fundamental issue in T cell development is what controls whether a thymocyte differentiates into gamma delta T cell or an alpha beta T cell, each defined by their distinct T cell receptor. Most likely, lessons learned in studying that issue will also provide insight into how the thymus produces T cell subsets with distinct functional and regulatory potentials. Here we review recent experiments, focusing on three factors that regulate thymocyte differentiation up to and including the expression of the first products of antigen receptor gene rearrangements. Those factors are the archetypal developmental regulator Notch, intrinsic signals emanating from antigen-receptor complexes, and trans conditioning, which reflects communication between different subsets of thymocytes. We also review new findings on the positive selection of gamma delta T cells and on extrathymic T cell development.	Guys Hosp, Kings Coll, Sch Med, London SE1 9RT, England; Queen Mary Univ London, London & Barts Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London	Hayday, AC (corresponding author), Guys Hosp, Kings Coll, Sch Med, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk; d.pennington@qmul.ac.uk		Pennington, Daniel/0000-0001-7889-9923	Wellcome Trust [071534] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; BONNEVILLE M, 1990, J EXP MED, V171, P1015, DOI 10.1084/jem.171.4.1015; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Boucontet L, 2005, J IMMUNOL, V174, P3912, DOI 10.4049/jimmunol.174.7.3912; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; De Smedt M, 2002, J IMMUNOL, V169, P3021, DOI 10.4049/jimmunol.169.6.3021; Denzel A, 2003, J IMMUNOL, V171, P519, DOI 10.4049/jimmunol.171.2.519; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fritsch M, 1998, EUR J IMMUNOL, V28, P828, DOI 10.1002/(SICI)1521-4141(199803)28:03&lt;828::AID-IMMU828&gt;3.0.CO;2-X; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Garcia-Peydro M, 2003, BLOOD, V102, P2444, DOI 10.1182/blood-2002-10-3261; Gerber D, 2004, J IMMUNOL, V173, P2516, DOI 10.4049/jimmunol.173.4.2516; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Goetz CA, 2005, J IMMUNOL, V174, P7753, DOI 10.4049/jimmunol.174.12.7753; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Hayday A, 2006, NAT IMMUNOL, V7, P9, DOI 10.1038/ni0106-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2006, IMMUNOL REV, V209, P170, DOI 10.1111/j.0105-2896.2006.00356.x; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Krotkova A, 2004, J IMMUNOL, V173, P25, DOI 10.4049/jimmunol.173.1.25; Krueger A, 2006, J EXP MED, V203, P1977, DOI 10.1084/jem.20060731; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Laurent J, 2004, INT IMMUNOL, V16, P1069, DOI 10.1093/intimm/dxh108; Lauritsen JPH, 2006, IMMUNOL REV, V209, P176, DOI 10.1111/j.0105-2896.2006.00349.x; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Livak F, 1999, J IMMUNOL, V162, P2575; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Mehr R, 1996, J THEOR BIOL, V181, P157, DOI 10.1006/jtbi.1996.0122; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; Mulroy T, 2001, EUR J IMMUNOL, V31, P3056, DOI 10.1002/1521-4141(2001010)31:10<3056::AID-IMMU3056>3.0.CO;2-B; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Petersson K, 2001, J IMMUNOL, V166, P6616, DOI 10.4049/jimmunol.166.11.6616; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Westermann J, 2001, IMMUNOL REV, V184, P20, DOI 10.1034/j.1600-065x.2001.1840103.x; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691	80	103	107	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					137	144		10.1038/ni1436	http://dx.doi.org/10.1038/ni1436			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242687				2022-12-18	WOS:000243597600010
J	Krishnamurty, AT; Turley, SJ				Krishnamurty, Akshay T.; Turley, Shannon J.			Lymph node stromal cells: cartographers of the immune system	NATURE IMMUNOLOGY			English	Review							FIBROBLASTIC RETICULAR CELLS; FOLLICULAR DENDRITIC CELLS; HIGH ENDOTHELIAL VENULES; GERMINAL CENTER DARK; LYMPHOTOXIN-ALPHA; B-CELLS; AUTOANTIBODY PRODUCTION; DEPENDENT DEVELOPMENT; ABNORMAL-DEVELOPMENT; ANTIBODY-PRODUCTION	Turley and Krishnamurty review new insights into lymph node stromal cells, a heterogeneous cell population that serves distinct functions during development, in maintaining lymphocyte homeostasis, and in coordinating immune responses. Lymph nodes (LNs) are strategically positioned at dedicated sites throughout the body to facilitate rapid and efficient immunity. Central to the structural integrity and framework of LNs, and the recruitment and positioning of leukocytes therein, are mesenchymal and endothelial lymph node stromal cells (LNSCs). Advances in the last decade have expanded our understanding and appreciation of LNSC heterogeneity, and the role they play in coordinating immunity has grown rapidly. In this review, we will highlight the functional contributions of distinct stromal cell populations during LN development in maintaining immune homeostasis and tolerance and in the activation and control of immune responses.	[Krishnamurty, Akshay T.; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Krishnamurty, AT; Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	krishnamurty.akshay@gene.com; turley.shannon@gene.com						Abe J, 2014, J IMMUNOL, V193, P1636, DOI 10.4049/jimmunol.1302946; Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Aguzzi A, 2014, TRENDS IMMUNOL, V35, P105, DOI 10.1016/j.it.2013.11.001; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; BANKS TA, 1995, J IMMUNOL, V155, P1685; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Barone F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00477; Barone F, 2015, P NATL ACAD SCI USA, V112, P11024, DOI 10.1073/pnas.1503315112; Benahmed F, 2014, J IMMUNOL, V192, P4153, DOI 10.4049/jimmunol.1301765; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Brendolan A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00381; Brown FD, 2019, NAT IMMUNOL, V20, P1668, DOI 10.1038/s41590-019-0515-x; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang JE, 2019, NAT IMMUNOL, V20, P1506, DOI 10.1038/s41590-019-0505-z; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Cohen JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087740; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Cording S, 2014, MUCOSAL IMMUNOL, V7, P359, DOI 10.1038/mi.2013.54; Cottrell TR, 2018, ANN ONCOL, V29, P1853, DOI 10.1093/annonc/mdy218; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; Dasoveanu DC, 2016, TRENDS IMMUNOL, V37, P764, DOI 10.1016/j.it.2016.08.013; Denton AE, 2019, J EXP MED, V216, P2242, DOI 10.1084/jem.20181705; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Dertschnig S, 2020, J CLIN INVEST, V130, P1896, DOI 10.1172/JCI133102; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Disson O, 2018, J EXP MED, V215, P2936, DOI 10.1084/jem.20181210; Dubey LK, 2016, CELL REP, V15, P1527, DOI 10.1016/j.celrep.2016.04.023; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fasnacht N, 2014, J EXP MED, V211, P2265, DOI 10.1084/jem.20132528; Fleige H, 2014, J EXP MED, V211, P643, DOI 10.1084/jem.20131737; Fletcher AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009377; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Furtado GC, 2014, MUCOSAL IMMUNOL, V7, P602, DOI 10.1038/mi.2013.79; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Gil-Cruz C, 2016, NAT IMMUNOL, V17, P1388, DOI 10.1038/ni.3566; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Gregory JL, 2017, CELL REP, V18, P406, DOI 10.1016/j.celrep.2016.12.038; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Grewal JS, 2011, FASEB J, V25, P1680, DOI 10.1096/fj.10-174656; Grogan JL, 2012, EUR J IMMUNOL, V42, P2255, DOI 10.1002/eji.201242656; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Hoorweg K, 2008, SEMIN IMMUNOL, V20, P164, DOI 10.1016/j.smim.2008.02.003; Hoorweg K, 2015, J IMMUNOL, V195, P4257, DOI 10.4049/jimmunol.1402584; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Jones GW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00401; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Knoblich K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005046; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Koning JJ, 2016, J IMMUNOL, V197, P2686, DOI 10.4049/jimmunol.1501162; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Lee YGE, 2016, DEV DYNAM, V245, P1189, DOI 10.1002/dvdy.24456; LeHir M, 1996, J INFLAMM, V47, P76; Li CL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1027; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Majumder S, 2019, NAT IMMUNOL, V20, P534, DOI 10.1038/s41590-019-0367-4; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinet L, 2011, CANCER RES, V71, P5678, DOI 10.1158/0008-5472.CAN-11-0431; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Nayar S, 2019, P NATL ACAD SCI USA, V116, P13490, DOI 10.1073/pnas.1905301116; Novkovic M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002515; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Pasztoi M, 2017, EUR J IMMUNOL, V47, P2142, DOI 10.1002/eji.201746960; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pezoldt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06423-7; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rouhani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7771; Ruddle NH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00491; Sabin FR, 1909, AM J ANAT, V9, P43, DOI 10.1002/aja.1000090104; Saito Y, 2017, P NATL ACAD SCI USA, V114, pE10151, DOI 10.1073/pnas.1711345114; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schaeuble K, 2017, CELL REP, V21, P2500, DOI 10.1016/j.celrep.2017.10.119; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Suenaga F, 2015, J IMMUNOL, V194, P398, DOI 10.4049/jimmunol.1401022; Takeda A, 2019, IMMUNITY, V51, P561, DOI 10.1016/j.immuni.2019.06.027; Tan KW, 2012, J IMMUNOL, V188, P4065, DOI 10.4049/jimmunol.1101854; Thierry GR, 2018, J EXP MED, V215, P2972, DOI 10.1084/jem.20180344; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; TREPEL F, 1974, KLIN WOCHENSCHR, V52, P511, DOI 10.1007/BF01468720; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MF, 2009, DEVELOPMENT, V136, P29, DOI 10.1242/dev.028456; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; White A, 2007, BLOOD, V110, P1950, DOI 10.1182/blood-2007-01-070003; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yamazaki T, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00078; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	156	102	103	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					369	380		10.1038/s41590-020-0635-3	http://dx.doi.org/10.1038/s41590-020-0635-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205888				2022-12-18	WOS:000521274700012
J	Zhu, PP; Zhu, XX; Wu, JY; He, LY; Lu, TK; Wang, YY; Liu, BY; Ye, BQ; Sun, L; Fan, DD; Wang, J; Yang, LL; Qin, XW; Du, Y; Li, C; He, L; Ren, WZ; Wu, X; Tian, Y; Fan, ZS				Zhu, Pingping; Zhu, Xiaoxiao; Wu, Jiayi; He, Luyun; Lu, Tiankun; Wang, Yanying; Liu, Benyu; Ye, Buqing; Sun, Lei; Fan, Dongdong; Wang, Jing; Yang, Liuliu; Qin, Xiwen; Du, Ying; Li, Chong; He, Lei; Ren, Weizheng; Wu, Xin; Tian, Yong; Fan, Zusen			IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3	NATURE IMMUNOLOGY			English	Article							IN-VITRO; RECEPTOR; TRANSLATION; BIOGENESIS; EXPANSION; MARKER; ROLES; COLON; CRYPT	Intestinal stem cells (ISCs) are maintained by stemness signaling for precise modulation of self-renewal and differentiation under homeostasis. However, the way in which intestinal immune cells regulate the self-renewal of ISCs remains elusive. Here we found that mouse and human Lgr5(+) ISCs showed high expression of the immune cell-associated circular RNA circPan3 (originating from the Pan3 gene transcript). Deletion of circPan3 in Lgr5(+) ISCs impaired their self-renewal capacity and the regeneration of gut epithelium in a manner dependent on immune cells. circPan3 bound mRNA encoding the cytokine IL-13 receptor subunit IL-13R alpha 1 (Il13r alpha 1) in ISCs to increase its stability, which led to the expression of IL-13R alpha 1 in ISCs. IL-13 produced by group 2 innate lymphoid cells in the crypt niche engaged IL-13R alpha 1 on crypt ISCs and activated signaling mediated by IL-13-IL-13R, which in turn initiated expression of the transcription factor Foxp1. Foxp1 is associated with beta-catenin in rendering its nuclear translocation, which caused activation of the beta-catenin pathway and the maintenance of Lgr5(+) ISCs.	[Zhu, Pingping; Wu, Jiayi; He, Luyun; Lu, Tiankun; Wang, Yanying; Liu, Benyu; Ye, Buqing; Wang, Jing; Yang, Liuliu; Qin, Xiwen; Du, Ying; Li, Chong; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, CAS Key Lab Infect & Immun, Beijing, Peoples R China; [Zhu, Xiaoxiao; Fan, Dongdong; Tian, Yong] Chinese Acad Sci, Inst Biophys, CAS Key Lab RNA Biol, Beijing, Peoples R China; [Wu, Jiayi; He, Luyun; Lu, Tiankun; Wang, Jing; Yang, Liuliu; Qin, Xiwen; Tian, Yong; Fan, Zusen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Lei] Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, Beijing, Peoples R China; [He, Lei; Ren, Weizheng] Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Wu, Xin] Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, CAS Key Lab Infect & Immun, Beijing, Peoples R China.; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Key Lab RNA Biol, Beijing, Peoples R China.; Tian, Y; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	ytian@ibp.ac.cn; fanz@moon.ibp.ac.cn	吴, 家怡/GSI-7419-2022; yang, liuliu/AGB-4947-2022; TIAN, YONG/ABF-4406-2021; TIAN, YONG/L-2414-2019; Zhu, Xiaoxiao/AAD-1561-2019	TIAN, YONG/0000-0002-8790-1148; Yang, Liuliu/0000-0003-0121-4214; Zhu, Pingping/0000-0002-8009-2923	National Natural Science Foundation of China [91640203, 31530093, 31771638, 81672897, 81672956, 81472413, 81572433, 81772646, 31601189]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDB19030203, XDA12020219]; Beijing Natural Science Foundation [7181006]; Postdoctoral Innovative Talent Support Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Postdoctoral Innovative Talent Support Program	We thank Y. Xu and Y. Teng for technical support. We thank J. Li (Cnkingbio Company) for technical support. This work was supported by the National Natural Science Foundation of China (grants 91640203, 31530093, 31771638, 81672897, 81672956, 81472413, 81572433, 81772646 and 31601189), Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203 and XDA12020219) and Beijing Natural Science Foundation (grant 7181006); and a Postdoctoral Innovative Talent Support Program to P.Z.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Dong R, 2017, RNA BIOL, V14, P1064, DOI 10.1080/15476286.2016.1269999; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Guarnerio J, 2016, CELL, V166, P1055, DOI 10.1016/j.cell.2016.07.035; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liu BY, 2017, NAT IMMUNOL, V18, P499, DOI 10.1038/ni.3712; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; McDermott JR, 2005, J IMMUNOL, V175, P3207, DOI 10.4049/jimmunol.175.5.3207; Meran L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7970385; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Noben-Trauth N, 1999, J IMMUNOL, V162, P6132; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shao YY, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00025; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Vicens Q, 2014, CELL, V159, P13, DOI 10.1016/j.cell.2014.09.005; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Woytschak J, 2016, IMMUNITY, V45, P172, DOI 10.1016/j.immuni.2016.06.025; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhu PP, 2018, NAT CELL BIOL, V20, P1134, DOI 10.1038/s41556-018-0194-0; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608; Zhu PP, 2016, NAT STRUCT MOL BIOL, V23, P631, DOI 10.1038/nsmb.3235; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	44	102	106	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					183	+		10.1038/s41590-018-0297-6	http://dx.doi.org/10.1038/s41590-018-0297-6			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643264				2022-12-18	WOS:000456279100016
J	Chung, KJ; Chatzigeorgiou, A; Economopoulou, M; Garcia-Martin, R; Alexaki, VI; Mitroulis, I; Nati, M; Gebler, J; Ziemssen, T; Goelz, SE; Phieler, J; Lim, JH; Karalis, KP; Papayannopoulou, T; Bluher, M; Hajishengallis, G; Chavakis, T				Chung, Kyoung-Jin; Chatzigeorgiou, Antonios; Economopoulou, Matina; Garcia-Martin, Ruben; Alexaki, Vasileia I.; Mitroulis, Ioannis; Nati, Marina; Gebler, Janine; Ziemssen, Tjalf; Goelz, Susan E.; Phieler, Julia; Lim, Jong-Hyung; Karalis, Katia P.; Papayannopoulou, Thalia; Blueher, Matthias; Hajishengallis, George; Chavakis, Triantafyllos			A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity	NATURE IMMUNOLOGY			English	Article							ADIPOSE-TISSUE INFLAMMATION; BROWN FAT; INSULIN-RESISTANCE; PROTEIN-KINASE; CELLS; MACROPHAGES; WHITE; ACTIVATION; EXPRESSION; ADHESION	In obesity, inflammation of white adipose tissue (AT) is associated with diminished generation of beige adipocytes ('beige adipogenesis'), a thermogenic and energy-dissipating function mediated by beige adipocytes that express the uncoupling protein UCP1. Here we delineated an inflammation-driven inhibitory mechanism of beige adipogenesis in obesity that required direct adhesive interactions between macrophages and adipocytes mediated by the integrin alpha(4) and its counter-receptor VCAM-1, respectively; expression of the latter was upregulated in obesity. This adhesive interaction reciprocally and concomitantly modulated inflammatory activation of macrophages and downregulation of UCP1 expression dependent on the kinase Erk in adipocytes. Genetic or pharmacological inactivation of the integrin alpha(4) in mice resulted in elevated expression of UCP1 and beige adipogenesis of subcutaneous AT in obesity. Our findings, established in both mouse systems and human systems, reveal a self-sustained cycle of inflammation-driven impairment of beige adipogenesis in obesity.	[Chung, Kyoung-Jin; Chatzigeorgiou, Antonios; Garcia-Martin, Ruben; Alexaki, Vasileia I.; Mitroulis, Ioannis; Nati, Marina; Gebler, Janine; Phieler, Julia; Lim, Jong-Hyung; Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Inst Clin Chem & Lab Med, Dept Clin Pathobiochem, Dresden, Germany; [Chung, Kyoung-Jin; Chavakis, Triantafyllos] Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany; [Chung, Kyoung-Jin; Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Dresden, Germany; [Chung, Kyoung-Jin; Chavakis, Triantafyllos] German Ctr Diabet Res, Neuherberg, Germany; [Economopoulou, Matina] Tech Univ Dresden, Fac Med, Dept Ophthalmol, Dresden, Germany; [Ziemssen, Tjalf] Tech Univ Dresden, Fac Med, Dept Neurol, Dresden, Germany; [Goelz, Susan E.] ELAN Pharmaceut, San Francisco, CA USA; [Karalis, Katia P.] Acad Athens, Biomed Res Fdn, Dev Biol Sect, Athens, Greece; [Papayannopoulou, Thalia] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Blueher, Matthias] Univ Leipzig, Dept Endocrinol & Nephrol, Leipzig, Germany; [Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Academy of Athens; University of Washington; University of Washington Seattle; Leipzig University; University of Pennsylvania	Chung, KJ; Chavakis, T (corresponding author), Tech Univ Dresden, Fac Med, Inst Clin Chem & Lab Med, Dept Clin Pathobiochem, Dresden, Germany.; Chung, KJ; Chavakis, T (corresponding author), Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany.; Chung, KJ; Chavakis, T (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.; Chung, KJ; Chavakis, T (corresponding author), German Ctr Diabet Res, Neuherberg, Germany.	kyoung-jin.chung@uniklinikum-dresden.de; triantafyllos.chavakis@uniklinikum-dresden.de	Alexaki, Vasileia Ismini/K-5527-2019; Chavakis, Triantafyllos/ABE-8845-2020; Ziemssen, Tjalf/J-2017-2019; Mitroulis, Ioannis/AAB-7915-2021; Hajishengallis, George N./K-1117-2019; Martin, Ruben Garcia/AAA-8538-2021	Ziemssen, Tjalf/0000-0001-8799-8202; Mitroulis, Ioannis/0000-0002-9991-2362; Hajishengallis, George N./0000-0001-7392-8852; Martin, Ruben Garcia/0000-0003-2049-4960; Chatzigeorgiou, Antonios/0000-0002-7039-4223; Alexaki, Vasileia Ismini/0000-0003-3935-8985	German Center for Diabetes Research; Deutsche Forschungsgemeinschaft [CH279/5-1]; European Research Council; US National Institutes of Health [DE024716, DE026152]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024716, R37DE026152] Funding Source: NIH RePORTER	German Center for Diabetes Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S. Grossklaus, B. Gercken, M. Prucnal and K. Bar for technical assistance; T. Yednock for discussions; and C. Ballantyne (Baylor College of Medicine) for alpha<INF>L</INF>-integrin-deficient mice. Supported by the German Center for Diabetes Research (T. C.), Deutsche Forschungsgemeinschaft (CH279/5-1 to T. C.), the European Research Council (DEMETINL to T. C.) and the US National Institutes of Health (DE024716 to G.H.; and DE026152 to G.H. and T.C.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bosanska L, 2010, PHYSIOL RES, V59, P79, DOI 10.33549/physiolres.931705; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Caroline G, 2010, J NEUROIMMUNOL, V228, P92; Chatzigeorgiou A, 2014, HEPATOLOGY, V60, P1196, DOI 10.1002/hep.27233; Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chmelar J, 2013, THROMB HAEMOSTASIS, V109, P399, DOI 10.1160/TH12-09-0703; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Ding ZM, 1999, J IMMUNOL, V163, P5029; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Garcia-Martin R, 2016, MOL CELL BIOL, V36, P376, DOI 10.1128/MCB.00430-15; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jinn S, 2015, CELL METAB, V21, P855, DOI 10.1016/j.cmet.2015.04.010; Kim D, 2014, DIABETOLOGIA, V57, P1456, DOI 10.1007/s00125-014-3237-5; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Neu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066898; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Ulyanova T, 2007, EXP HEMATOL, V35, P565, DOI 10.1016/j.exphem.2007.01.031; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034	67	102	106	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					654	+		10.1038/ni.3728	http://dx.doi.org/10.1038/ni.3728			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28414311	Green Accepted			2022-12-18	WOS:000401520900010
J	Song, GH; Liu, BY; Li, ZH; Wu, HF; Wang, P; Zhao, K; Jiang, GS; Zhang, L; Gao, CJ				Song, Guanhua; Liu, Bingyu; Li, Zhihui; Wu, Haifeng; Wang, Peng; Zhao, Kai; Jiang, Guosheng; Zhang, Lei; Gao, Chengjiang			E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; IFN-BETA PRODUCTION; RIG-I; GRAIL; ACTIVATION; TRANSCRIPTION; RECOGNITION; DEGRADATION; PROTEOLYSIS; IRF-3	TBK1 is essential for interferon-beta (IFN-beta) production and innate antiviral immunity. Here we identified the T cell anergy-related E3 ubiquitin ligase RNF128 as a positive regulator of TBK1 activation. RNF128 directly interacted with TBK1 through its protease-associated (PA) domain and catalyzed the K63-linked polyubiquitination of TBK1, which led to TBK1 activation, IRF3 activation and IFN-beta production. Deficiency of RNF128 expression attenuated IRF3 activation, IFN-beta production and innate antiviral immune responses to RNA and DNA viruses, in vitro and in vivo. Our study identified RNF128 as an E3 ligase for K63-linked ubiquitination and activation of TBK1 and delineated a previously unrecognized function for RNF128.	[Song, Guanhua; Liu, Bingyu; Wu, Haifeng; Wang, Peng; Zhao, Kai; Zhang, Lei; Gao, Chengjiang] Shandong Univ, Sch Med, Dept Immunol, Jinan, Peoples R China; [Song, Guanhua; Liu, Bingyu; Wu, Haifeng; Wang, Peng; Zhao, Kai; Zhang, Lei; Gao, Chengjiang] Shandong Univ, Sch Med, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China; [Song, Guanhua; Li, Zhihui; Jiang, Guosheng] Shandong Acad Med Sci, Inst Basic Med, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Gao, CJ (corresponding author), Shandong Univ, Sch Med, Dept Immunol, Jinan, Peoples R China.; Gao, CJ (corresponding author), Shandong Univ, Sch Med, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China.	cgao@sdu.edu.cn	WANG, Peng/GSN-5263-2022	Gao, Chengjiang/0000-0002-9365-4497; Zhao, Kai/0000-0003-1894-5347	Natural Science Foundation of China [81525012, 81471538, 81273219]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130131130010]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	We thank G.C. Fathman (Stanford University School of Medicine), K.A. Fitzgerald (University of Massachusetts Medical School) and H.-b. Shu (Wuhan University) for providing RNF128 expression plasmids, IFN-beta reporter and TBK1 mutant plasmid S172A, respectively. We thank B. Sun (Institut Pasteur of Shanghai, Chinese Academy of Sciences) for providing TBK1-deficient MEFs, and H. Meng (Institute of Basic Medicine, Shandong Academy of Medical Sciences) for VSV and HSV-1. This work was supported in part by grants from the Natural Science Foundation of China (81525012, 81471538, 81273219) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130131130010) to C.G. G.J. is a Taishan Scholar of Shandong, China.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; [李帅 Li Shuai], 2011, [水文, Hydrology], V31, P35; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sahoo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5732; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Su LL, 2009, J IMMUNOL, V183, P438, DOI 10.4049/jimmunol.0900204; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang L, 2014, J IMMUNOL, V193, P2230, DOI 10.4049/jimmunol.1302634; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024	34	102	113	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1342	1351		10.1038/ni.3588	http://dx.doi.org/10.1038/ni.3588			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27776110				2022-12-18	WOS:000388056400004
J	Xing, Y; Wang, XD; Jameson, SC; Hogquist, KA				Xing, Yan; Wang, Xiaodan; Jameson, Stephen C.; Hogquist, Kristin A.			Late stages of T cell maturation in the thymus involve NF-kappa B and tonic type I interferon signaling	NATURE IMMUNOLOGY			English	Article							NEGATIVE SELECTION; MEDULLA MIGRATION; THYMOCYTES; RECEPTOR; ACTIVATION; COMMITMENT; EXPRESSION; COMMENSAL; REQUIRES; INNATE	Positive selection occurs in the thymic cortex, but critical maturation events occur later in the medulla. Here we defined the precise stage at which T cells acquired competence to proliferate and emigrate. Transcriptome analysis of late gene changes suggested roles for the transcription factor NF-kappa B and interferon signaling. Mice lacking the inhibitor of NF-kappa B (I kappa B) kinase (IKK) kinase TAK1 underwent normal positive selection but exhibited a specific block in functional maturation. NF-kappa B signaling provided protection from death mediated by the cytokine TNF and was required for proliferation and emigration. The interferon signature was independent of NF-kappa B; however, thymocytes deficient in the interferon-alpha (IFN-alpha) receptor IFN-alpha R showed reduced expression of the transcription factor STAT1 and phenotypic abnormality but were able to proliferate. Thus, both NF-kappa B and tonic interferon signals are involved in the final maturation of thymocytes into naive T cells.	[Xing, Yan; Wang, Xiaodan; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146	NIH [R01 AI088209, P01 AI35296]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088209, P01AI035296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Chi (St. Jude Children's Hospital) for Rag2<SUP>GFP</SUP> mice; M. Mescher (University of Minnesota) for Ifnar1<SUP>-/-</SUP> mice; A. Strasser (Walter and Eliza Hall Institute) for Bcl2l11<SUP>-/-</SUP> mice; K. Hayakawa (Fox Chase Cancer Center) for monoclonal antibody SM6C10; and M.A. Farrar for comments and review of the manuscript. Supported by the NIH (R01 AI088209 and P01 AI35296 to K.A.H.).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aliahmad P, 2006, IMMUNOL REV, V209, P253, DOI 10.1111/j.0105-2896.2006.00345.x; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chen WJ, 2015, EUR J IMMUNOL, V45, P958, DOI 10.1002/eji.201444999; Cowan JE, 2014, J IMMUNOL, V193, P1204, DOI 10.4049/jimmunol.1400993; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Dong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056378; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hoffmann R, 2003, CURR OPIN IMMUNOL, V15, P239, DOI 10.1016/S0952-7915(03)00047-5; Hogquist KA, 2015, J IMMUNOL, V195, P1351, DOI 10.4049/jimmunol.1501050; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Jost PJ, 2007, J IMMUNOL, V178, P953, DOI 10.4049/jimmunol.178.2.953; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Metidji A, 2015, J IMMUNOL, V194, P4265, DOI 10.4049/jimmunol.1500036; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Otero DC, 2013, J IMMUNOL, V190, P3289, DOI 10.4049/jimmunol.1203086; Priyadharshini B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015038; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Sinclair C, 2014, J IMMUNOL, V192, P5151, DOI 10.4049/jimmunol.1303085; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	53	102	106	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					565	+		10.1038/ni.3419	http://dx.doi.org/10.1038/ni.3419			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27043411	Green Accepted			2022-12-18	WOS:000374323100016
J	Lesourne, R; Uehara, S; Lee, J; Song, KD; Li, LQ; Pinkhasov, J; Zhang, YQ; Weng, NP; Wildt, KF; Wang, L; Bosselut, R; Love, PE				Lesourne, Renaud; Uehara, Shoji; Lee, Jan; Song, Ki-Duk; Li, LiQi; Pinkhasov, Julia; Zhang, Yongqing; Weng, Nan-Ping; Wildt, Kathryn F.; Wang, Lie; Bosselut, Remy; Love, Paul E.			Themis, a T cell-specific protein important for late thymocyte development	NATURE IMMUNOLOGY			English	Article							CD4-CD8 LINEAGE COMMITMENT; POSITIVE SELECTION SIGNALS; IN-VIVO; CORECEPTOR EXPRESSION; TRANSCRIPTION FACTORS; DIFFERENTIATION; CD4; TCR; RECEPTOR; THYMUS	During positive selection, thymocytes transition through a stage during which T cell antigen receptor (TCR) signaling controls CD4-versus-CD8 lineage 'choice' and subsequent maturation. Here we describe a previously unknown T cell-specific protein, Themis, that serves a distinct function during this stage. In Themis(-/-) mice, thymocyte selection was impaired and the number of transitional CD4(+)CD8(int) thymocytes as well as CD4(+) or CD8(+) single-positive thymocytes was lower. Notably, although we detected no overt TCR-proximal signaling deficiencies, Themis(-/-) CD4(+)CD8(int) thymocytes showed developmental defects consistent with attenuated signaling that were reversible by TCR stimulation. Our results identify Themis as a critical component of the T cell developmental program and suggest that Themis functions to sustain and/or integrate signals required for proper lineage commitment and maturation.	[Lesourne, Renaud; Uehara, Shoji; Lee, Jan; Song, Ki-Duk; Li, LiQi; Pinkhasov, Julia; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Mammalian Genes & Dev, Bethesda, MD USA; [Zhang, Yongqing] NIMH, Intramural Res Program, DNA Array Unit, Bethesda, MD 20892 USA; [Weng, Nan-Ping] NIA, Immunol Lab, Bethesda, MD 20892 USA; [Wildt, Kathryn F.; Wang, Lie; Bosselut, Remy] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Love, PE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Mammalian Genes & Dev, Bethesda, MD USA.	lovep@mail.nih.gov	Lesourne, Renaud/M-1855-2014; Weng, Nan-ping/AAC-5037-2020	Lesourne, Renaud/0000-0003-3816-7087	Intramural NIH HHS [Z01 AG000757-10] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000757] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aliahmad P, 2006, IMMUNOL REV, V209, P253, DOI 10.1111/j.0105-2896.2006.00345.x; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Hare KJ, 2000, J IMMUNOL, V165, P2410, DOI 10.4049/jimmunol.165.5.2410; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Kappes DJ, 2006, IMMUNOL REV, V209, P237, DOI 10.1111/j.0105-2896.2006.00344.x; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Nasreen M, 2003, J IMMUNOL, V171, P3394, DOI 10.4049/jimmunol.171.7.3394; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	37	102	104	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					840	U53		10.1038/ni.1768	http://dx.doi.org/10.1038/ni.1768			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19597498	Green Accepted			2022-12-18	WOS:000268141400012
J	Mohammed, F; Cobbold, M; Zarling, AL; Salim, M; Barrett-Wilt, GA; Shabanowitz, J; Hunt, DF; Engelhard, VH; Willcox, BE				Mohammed, Fiyaz; Cobbold, Mark; Zarling, Angela L.; Salim, Mahboob; Barrett-Wilt, Gregory A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Engelhard, Victor H.; Willcox, Benjamin E.			Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self	NATURE IMMUNOLOGY			English	Article							CELL-CYCLE; BINDING; DEGRADATION; PROTEINS; UBIQUITINATION; COMPLEXES; AFFINITY; MODEL	Protein phosphorylation generates a source of phosphopeptides that are presented by major histocompatibility complex class I molecules and recognized by T cells. As deregulated phosphorylation is a hallmark of malignant transformation, the differential display of phosphopeptides on cancer cells provides an immunological signature of 'transformed self'. Here we demonstrate that phosphorylation can considerably increase peptide binding affinity for HLA-A2. To understand this, we solved crystal structures of four phosphopeptide-HLA-A2 complexes. These identified a novel peptide-binding motif centered on a solvent-exposed phosphate anchor. Our findings indicate that deregulated phosphorylation can create neoantigens by promoting binding to major histocompatibility complex molecules or by affecting the antigenic identity of presented epitopes. These results highlight the potential of phosphopeptides as novel targets for cancer immunotherapy.	[Cobbold, Mark; Zarling, Angela L.; Engelhard, Victor H.] Univ Virginia, Sch Med, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Cobbold, Mark; Zarling, Angela L.; Engelhard, Victor H.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Mohammed, Fiyaz; Salim, Mahboob; Willcox, Benjamin E.] Univ Birmingham, Sch Canc Sci, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Cobbold, Mark] Univ Birmingham, Sch Immun Infect & Inflammat, Birmingham B15 2TT, W Midlands, England; [Barrett-Wilt, Gregory A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; Cancer Research UK; University of Birmingham; University of Birmingham; University of Virginia	Engelhard, VH (corresponding author), Univ Virginia, Sch Med, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	vhe@virginia.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Engelhard, Victor/0000-0002-1741-0925	US Public Health Service [AI20963, AI33993]; Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Sidney Kimmel Foundation; BBSRC [BB/E009417/1] Funding Source: UKRI; MRC [G120/768, G108/574] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009417/1] Funding Source: researchfish; Medical Research Council [G120/768, G108/574, G9818340B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA134060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033993, R37AI020963, R01AI020963, R01AI033993, T32AI007496] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sidney Kimmel Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. White and K. Futterer for help with X-ray data collection, and P. Hornbeck (Cell Signaling Technology; PhosphoSites) and F. Diella (European Molecular Biology Laboratory, Heidelberg; Phospho. ELM) for data sets of identified human phosphorylation sites. Supported by US Public Health Service (AI20963 to V. H. E. and AI33993 to D. F. H.), the Medical Research Council (B. E. W. and M. C.), the Wellcome Trust (B. E. W.), the Biotechnology and Biological Sciences Research Council (F. M.) and the Sidney Kimmel Foundation (A. L. Z.).	Andersen MH, 1999, J IMMUNOL, V163, P3812; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Easty DJ, 2000, MELANOMA RES, V10, P401, DOI 10.1097/00008390-200010000-00001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; HENDRICKSON RC, 1996, IMMUNOLOGY METHODS M, P605; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SETTE A, 1994, J IMMUNOL, V153, P5586; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755; Zarling AL, 2006, P NATL ACAD SCI USA, V103, P14889, DOI 10.1073/pnas.0604045103	40	102	110	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1236	1243		10.1038/ni.1660	http://dx.doi.org/10.1038/ni.1660			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18836451	Green Accepted			2022-12-18	WOS:000260248600010
J	Dam, J; Guan, RJ; Natarajan, K; Dimasi, N; Chlewicki, LK; Kranz, DM; Schuck, P; Margulies, DH; Mariuzza, RA				Dam, J; Guan, RJ; Natarajan, K; Dimasi, N; Chlewicki, LK; Kranz, DM; Schuck, P; Margulies, DH; Mariuzza, RA			Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b)	NATURE IMMUNOLOGY			English	Article							LIGAND-SPECIFIC OLIGOMERIZATION; YEAST SURFACE-DISPLAY; NK CELLS; HUMAN CD4; COMPLEX; BINDING; RECOGNITION; ACTIVATION; NKG2D; MOLECULES	The Ly49 family of natural killer (NK) receptors regulates NK cell function by sensing major histocompatibility complex (MHC) class I. Ly49 receptors show complex patterns of MHC class I cross-reactivity and, in certain cases, peptide selectivity. To investigate whether specificity differences result from topological differences in MHC class I engagement, we determined the structure of the peptide-selective receptor Ly49C in complex with H-2K(b). The Ly49C homodimer binds two MHC class I molecules in symmetrical way, a mode distinct from that of Ly49A, which binds MHC class I asymmetrically. Ly49C does not directly contact the MHC-bound peptide. In addition, MHC crosslinking by Ly49C was demonstrated in solution. We propose a dynamic model for Ly49-MHC class I interactions involving conformational changes in the receptor, whereby variations in Ly49 dimerization mediate different MHC-binding modes.	NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; NIH, Div Bioengn & Phys Sci, Off Res Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	dhm@nih.gov; mariuzza@carb.nist.gov	Dam, Julie/O-1625-2018; Schuck, Peter/AAA-6888-2020	Dam, Julie/0000-0001-6871-2678; Schuck, Peter/0000-0002-8859-6966; Margulies, David/0000-0001-8530-7375	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000394, ZIAAI000622, Z01AI000394, Z01AI000622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD010485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anderson SK, 2001, IMMUNOL REV, V181, P79, DOI 10.1034/j.1600-065X.2001.1810106.x; Andersson M, 1998, J IMMUNOL, V161, P6475; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Chung DH, 2000, J IMMUNOL, V165, P6922, DOI 10.4049/jimmunol.165.12.6922; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dimasi N, 2002, J MOL BIOL, V320, P573, DOI 10.1016/S0022-2836(02)00498-9; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Kase A, 1998, J IMMUNOL, V161, P6133; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Natarajan K, 1999, IMMUNITY, V11, P591, DOI 10.1016/S1074-7613(00)80134-X; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SAKIHAMA T, 1995, P NATL ACAD SCI USA, V92, P6444, DOI 10.1073/pnas.92.14.6444; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sundback J, 2002, J IMMUNOL, V168, P793, DOI 10.4049/jimmunol.168.2.793; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Wang J, 2002, J BIOL CHEM, V277, P1433, DOI 10.1074/jbc.M110316200; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zimmer J, 2001, J EXP MED, V194, P1531, DOI 10.1084/jem.194.10.1531	50	102	105	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1213	1222		10.1038/ni1006	http://dx.doi.org/10.1038/ni1006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14595439				2022-12-18	WOS:000186769500015
J	Vardhana, SA; Hwee, MA; Berisa, M; Wells, DK; Yost, KE; King, B; Smith, M; Herrera, PS; Chang, HY; Satpathy, AT; van den Brink, MRM; Cross, JR; Thompson, CB				Vardhana, Santosha A.; Hwee, Madeline A.; Berisa, Mirela; Wells, Daniel K.; Yost, Kathryn E.; King, Bryan; Smith, Melody; Herrera, Pamela S.; Chang, Howard Y.; Satpathy, Ansuman T.; van den Brink, Marcel R. M.; Cross, Justin R.; Thompson, Craig B.			Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen	NATURE IMMUNOLOGY			English	Article							ELECTRON-TRANSPORT CHAIN; PD-1; CANCER; IMMUNOTHERAPY; BIOSYNTHESIS; DYSFUNCTION; ACTIVATION; EXHAUSTION	Thompson and colleagues show that repetitive antigenic stimulation within the tumor environment triggers mitochondrial dysfunction by inhibiting oxidative phosphorylation, which leads to T cell exhaustion. The majority of tumor-infiltrating T cells exhibit a terminally exhausted phenotype, marked by a loss of self-renewal capacity. How repetitive antigenic stimulation impairs T cell self-renewal remains poorly defined. Here, we show that persistent antigenic stimulation impaired ADP-coupled oxidative phosphorylation. The resultant bioenergetic compromise blocked proliferation by limiting nucleotide triphosphate synthesis. Inhibition of mitochondrial oxidative phosphorylation in activated T cells was sufficient to suppress proliferation and upregulate genes linked to T cell exhaustion. Conversely, prevention of mitochondrial oxidative stress during chronic T cell stimulation allowed sustained T cell proliferation and induced genes associated with stem-like progenitor T cells. As a result, antioxidant treatment enhanced the anti-tumor efficacy of chronically stimulated T cells. These data reveal that loss of ATP production through oxidative phosphorylation limits T cell proliferation and effector function during chronic antigenic stimulation. Furthermore, treatments that maintain redox balance promote T cell self-renewal and enhance anti-tumor immunity.	[Vardhana, Santosha A.; Hwee, Madeline A.; King, Bryan; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Vardhana, Santosha A.; Hwee, Madeline A.; King, Bryan; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Vardhana, Santosha A.; Wells, Daniel K.; Satpathy, Ansuman T.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Berisa, Mirela; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Yost, Kathryn E.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA USA; [Smith, Melody; Herrera, Pamela S.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Smith, Melody; Herrera, Pamela S.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Herrera, Pamela S.] Weill Cornell Med Coll, New York, NY USA; [Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Stanford University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Stanford University; Stanford University	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA.	thompsonc@mskcc.org	Yost, Kathryn/X-2171-2019; van den Brink, Marcel R. M./HGB-9434-2022	Yost, Kathryn/0000-0001-6807-950X; Satpathy, Ansuman/0000-0002-5167-537X; Smith, Melody/0000-0002-2702-0381; Berisa, Mirela/0000-0001-7347-9823; van den Brink, Marcel/0000-0003-0696-4401	Burroughs Wellcome Fund Career Award for Medical Scientists; Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund; Memorial Sloan Kettering Cancer Center Support Grant [P30 CA008748, AI140472-01A1]	Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Memorial Sloan Kettering Cancer Center Support Grant	We thank members of the Thompson and Finley laboratories for discussion and critical feedback. S.A.V. is a Senior Fellow with the Parker Institute of Cancer Immunotherapy and is supported by a Burroughs Wellcome Fund Career Award for Medical Scientists. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy and a Career Award for Medical Scientists from the Burroughs Wellcome Fund. This work was additionally supported by the Memorial Sloan Kettering Cancer Center Support Grant no. P30 CA008748 and R25 Training Grant no. AI140472-01A1.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; BEVAN MJ, 1974, J EXP MED, V139, P1025, DOI 10.1084/jem.139.4.1025; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Ghosh A, 2017, NAT MED, V23, P242, DOI 10.1038/nm.4258; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Liang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06890-y; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schworer S, 2020, EMBO J, V39, DOI 10.15252/embj.2019103334; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Taylor A, 2018, CANCER RES, V78, P706, DOI 10.1158/0008-5472.CAN-17-0491; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; van der Windt G. J. W., 2016, CURR PROTOC IMMUNOL, V113, P3; Vardhana SA, 2019, NAT METAB, V1, P676, DOI 10.1038/s42255-019-0082-3; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004	61	101	103	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1022	+		10.1038/s41590-020-0725-2	http://dx.doi.org/10.1038/s41590-020-0725-2		JUL 2020	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32661364	Green Accepted			2022-12-18	WOS:000555034000004
J	Baumann, T; Dunkel, A; Schmid, C; Schmitt, S; Hiltensperger, M; Lohr, K; Laketa, V; Donakonda, S; Ahting, U; Lorenz-Depiereux, B; Heil, JE; Schredelseker, J; Simeoni, L; Fecher, C; Koerber, N; Bauer, T; Hueser, N; Hartmann, D; Laschinger, M; Eyerich, K; Eyerich, S; Anton, M; Streeter, M; Wang, T; Schraven, B; Spiegel, D; Assaad, F; Misgeld, T; Zischka, H; Murray, PJ; Heine, A; Heikenwaelder, M; Korn, T; Dawid, C; Hofmann, T; Knolle, PA; Hoechst, B				Baumann, Tobias; Dunkel, Andreas; Schmid, Christian; Schmitt, Sabine; Hiltensperger, Michael; Lohr, Kerstin; Laketa, Vibor; Donakonda, Sainitin; Ahting, Uwe; Lorenz-Depiereux, Bettina; Heil, Jan E.; Schredelseker, Johann; Simeoni, Luca; Fecher, Caroline; Koerber, Nina; Bauer, Tanja; Hueser, Norbert; Hartmann, Daniel; Laschinger, Melanie; Eyerich, Kilian; Eyerich, Stefanie; Anton, Martina; Streeter, Matthew; Wang, Tina; Schraven, Burkhart; Spiegel, David; Assaad, Farhah; Misgeld, Thomas; Zischka, Hans; Murray, Peter J.; Heine, Annkristin; Heikenwaelder, Mathias; Korn, Thomas; Dawid, Corinna; Hofmann, Thomas; Knolle, Percy A.; Hoechst, Bastian			Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal	NATURE IMMUNOLOGY			English	Article							HEPATOCELLULAR-CARCINOMA PATIENTS; SUPPRESSOR-CELLS; DICARBONYL STRESS; AMINE OXIDASE; EFFECTOR; IMMUNOTHERAPY; AMINOACETONE; INHIBITION; GLYCATION; PROTEINS	Regulatory myeloid immune cells, such as myeloid-derived suppressor cells (MDSCs), populate inflamed or cancerous tissue and block immune cell effector functions. The lack of mechanistic insight into MDSC suppressive activity and a marker for their identification has hampered attempts to overcome T cell inhibition and unleash anti-cancer immunity. Here, we report that human MDSCs were characterized by strongly reduced metabolism and conferred this compromised metabolic state to CD8(+) T cells, thereby paralyzing their effector functions. We identified accumulation of the dicarbonyl radical methylglyoxal, generated by semicarbazide-sensitive amine oxidase, to cause the metabolic phenotype of MDSCs and MDSC-mediated paralysis of CD8(+) T cells. In a murine cancer model, neutralization of dicarbonyl activity overcame MDSC-mediated T cell suppression and, together with checkpoint inhibition, improved the efficacy of cancer immune therapy. Our results identify the dicarbonyl methylglyoxal as a marker metabolite for MDSCs that mediates T cell paralysis and can serve as a target to improve cancer immune therapy. Myeloid-derived suppressor cells (MDSCs) residing within tumors can impede immune responses. Knolle and colleagues show that MDSCs poison immune cells by producing methylglyoxal, which functionally alters their cellular metabolism and hence their effector responses.	[Baumann, Tobias; Lohr, Kerstin; Donakonda, Sainitin; Anton, Martina; Knolle, Percy A.] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Dunkel, Andreas; Hofmann, Thomas] TUM, Leibniz Inst Food Syst Biol, Munich, Germany; [Schmid, Christian; Dawid, Corinna; Hofmann, Thomas] TUM, Food Chem & Mol Sensory Sci, Munich, Germany; [Schmitt, Sabine; Zischka, Hans] TUM, Sch Med, Inst Toxicol & Environm Hyg, Munich, Germany; [Hiltensperger, Michael; Korn, Thomas] TUM, Sch Med, Klinikum Rechts Isar, Dept Expt Neuroimmunol, Munich, Germany; [Laketa, Vibor] Heidelberg Univ, German Ctr Infect Res, Dept Infect Dis, Heidelberg, Germany; [Ahting, Uwe] TUM, Sch Med, Klinikum Rechts Isar, Inst Human Genet,Stoffwechselzentrum, Munich, Germany; [Lorenz-Depiereux, Bettina] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Heil, Jan E.] Carl Zeiss Microscopy, Gottingen, Germany; [Schredelseker, Johann] Ludwig Maximilians Univ Munchen, Fac Med, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany; [Simeoni, Luca; Schraven, Burkhart] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Fecher, Caroline; Misgeld, Thomas] TUM, Inst Neuronal Cell Biol, Munich Cluster Syst Neurol, Munich, Germany; [Fecher, Caroline; Misgeld, Thomas] German Ctr Neurodegenerat Dis, Munich, Germany; [Koerber, Nina; Bauer, Tanja] Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Hueser, Norbert; Hartmann, Daniel; Laschinger, Melanie] TUM, Sch Med, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Eyerich, Kilian] TUM, Dept Dermatol & Allergy, Munich, Germany; [Eyerich, Stefanie] TUM, Ctr Allergy & Environm, Munich, Germany; [Eyerich, Stefanie] Helmholtz Zentrum Munchen, Munich, Germany; [Streeter, Matthew; Spiegel, David] Yale Univ, Dept Chem, New Haven, CT USA; [Wang, Tina] Broad Inst Harvard & MIT, Cambridge, MA USA; [Spiegel, David] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Assaad, Farhah] TUM, Ctr Life Sci, Res Dept Plant Sci, Munich, Germany; [Zischka, Hans] Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Neuherberg, Germany; [Murray, Peter J.] Max Planck Inst Biochem, Munich, Germany; [Heine, Annkristin] Univ Hosp Bonn, Med Clin Oncol Hematol & Rheumatol 3, Bonn, Germany; [Heine, Annkristin] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Heikenwaelder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Knolle, Percy A.; Hoechst, Bastian] TUM, Sch Life Sci, Inst Mol Immunol, Munich, Germany; [Knolle, Percy A.] German Ctr Infect Res, Munich, Germany	Technical University of Munich; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; German Center for Infection Research; Ruprecht Karls University Heidelberg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Otto von Guericke University; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; University of Bonn; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; German Center for Infection Research	Knolle, PA (corresponding author), Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Inst Mol Immunol & Expt Oncol, Munich, Germany.; Knolle, PA; Hoechst, B (corresponding author), TUM, Sch Life Sci, Inst Mol Immunol, Munich, Germany.; Knolle, PA (corresponding author), German Ctr Infect Res, Munich, Germany.	Percy.Knolle@tum.de; Bastian.Hoechst@tum.de	Murray, Peter J/K-4725-2018; Höchst, Bastian/ABG-2094-2020; Korn, Thomas/AAE-6960-2019; Zischka, Hans/M-1490-2017	Murray, Peter J/0000-0001-6329-9802; Höchst, Bastian/0000-0002-5567-1173; Korn, Thomas/0000-0002-3633-0955; Hiltensperger, Michael/0000-0003-4600-1394; Fecher, Caroline/0000-0002-7179-7323; Laketa, Vibor/0000-0002-9472-2738; Donakonda, Sainitin/0000-0003-3216-8759; Dunkel, Andreas/0000-0002-4445-6144; Zischka, Hans/0000-0002-4047-1566				Agarwal A, 2017, NEURON, V93, P587, DOI 10.1016/j.neuron.2016.12.034; Ahmed N, 2002, BIOCHEM J, V364, P1; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Beisswenger P, 2003, DIABETES METAB, V29, pS95; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Cheng CT, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0178-4; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Frank O, 2014, J AGR FOOD CHEM, V62, P2506, DOI 10.1021/jf405529b; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gao XH, 2017, HEPATOL RES, V47, P1061, DOI 10.1111/hepr.12831; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hochst B, 2013, J HEPATOL, V59, P528, DOI 10.1016/j.jhep.2013.04.033; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Kinsky OR, 2016, CHEM RES TOXICOL, V29, P227, DOI 10.1021/acs.chemrestox.5b00497; Knier B, 2018, NAT IMMUNOL, V19, P1341, DOI 10.1038/s41590-018-0237-5; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lu ZM, 2018, TRENDS BIOCHEM SCI, V43, P301, DOI 10.1016/j.tibs.2018.01.006; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Mizukoshi E, 2016, CANCER IMMUNOL IMMUN, V65, P715, DOI 10.1007/s00262-016-1837-2; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nemet I, 2007, AMINO ACIDS, V32, P291, DOI 10.1007/s00726-006-0337-7; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Ohmori S, 1989, Prog Clin Biol Res, V290, P397; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Rabbani N, 2016, CLIN SCI, V130, P1677, DOI 10.1042/CS20160025; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; RAY S, 1983, J BIOL CHEM, V258, P3461; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Salomon T, 2017, CELL CHEM BIOL, V24, P935, DOI 10.1016/j.chembiol.2017.07.012; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Taheri F, 2001, CLIN CANCER RES, V7, p958S; Tcyganov E, 2018, CURR OPIN IMMUNOL, V51, P76, DOI 10.1016/j.coi.2018.03.009; TETTER ME, 1969, BIOCHIM BIOPHYS ACTA, V172, P331, DOI 10.1016/0005-2728(69)90076-0; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wang TN, 2013, J AM CHEM SOC, V135, P12429, DOI 10.1021/ja406077j; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Weiskirchen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075692; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	69	101	104	9	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					555	+		10.1038/s41590-020-0666-9	http://dx.doi.org/10.1038/s41590-020-0666-9			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32327756	Green Submitted			2022-12-18	WOS:000528265700018
J	Kanekiyo, M; Joyce, MG; Gillespie, RA; Gallagher, JR; Andrews, SF; Yassine, HM; Wheatley, AK; Fisher, BE; Ambrozak, DR; Creanga, A; Leung, K; Yang, ES; Boyoglu-Barnum, S; Georgiev, IS; Tsybovsky, Y; Prabhakaran, MS; Andersen, H; Kong, WP; Baxa, U; Zephir, KL; Ledgerwood, JE; Koup, RA; Kwong, PD; Harris, AK; McDermott, AB; Mascola, JR; Graham, BS				Kanekiyo, Masaru; Joyce, M. Gordon; Gillespie, Rebecca A.; Gallagher, John R.; Andrews, Sarah F.; Yassine, Hadi M.; Wheatley, Adam K.; Fisher, Brian E.; Ambrozak, David R.; Creanga, Adrian; Leung, Kwanyee; Yang, Eun Sung; Boyoglu-Barnum, Seyhan; Georgiev, Ivelin S.; Tsybovsky, Yaroslav; Prabhakaran, Madhu S.; Andersen, Hanne; Kong, Wing-Pui; Baxa, Ulrich; Zephir, Kathryn L.; Ledgerwood, Julie E.; Koup, Richard A.; Kwong, Peter D.; Harris, Audray K.; McDermott, Adrian B.; Mascola, John R.; Graham, Barney S.			Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses	NATURE IMMUNOLOGY			English	Article							BEAM-INDUCED MOTION; NEUTRALIZING EPITOPE; ANTIBODY RECOGNITION; GLOBULAR HEAD; ANTIGENIC STRUCTURE; VACCINE; STEM; DESIGN; IG; MECHANISMS	The present vaccine against influenza virus has the inevitable risk of antigenic discordance between the vaccine and the circulating strains, which diminishes vaccine efficacy. This necessitates new approaches that provide broader protection against influenza. Here we designed a vaccine using the hypervariable receptor-binding domain (RBD) of viral hemagglutinin displayed on a nanoparticle (np) able to elicit antibody responses that neutralize H1N1 influenza viruses spanning over 90 years. Co-display of RBDs from multiple strains across time, so that the adjacent RBDs are heterotypic, provides an avidity advantage to cross-reactive B cells. Immunization with the mosaic RBD-np elicited broader antibody responses than those induced by an admixture of nanoparticles encompassing the same set of RBDs as separate homotypic arrays. Furthermore, we identified a broadly neutralizing monoclonal antibody in a mouse immunized with mosaic RBD-np. The mosaic antigen array signifies a unique approach that subverts monotypic immunodominance and allows otherwise subdominant cross-reactive B cell responses to emerge.	[Kanekiyo, Masaru; Joyce, M. Gordon; Gillespie, Rebecca A.; Andrews, Sarah F.; Yassine, Hadi M.; Wheatley, Adam K.; Fisher, Brian E.; Ambrozak, David R.; Creanga, Adrian; Leung, Kwanyee; Yang, Eun Sung; Boyoglu-Barnum, Seyhan; Georgiev, Ivelin S.; Prabhakaran, Madhu S.; Kong, Wing-Pui; Zephir, Kathryn L.; Ledgerwood, Julie E.; Koup, Richard A.; Kwong, Peter D.; McDermott, Adrian B.; Mascola, John R.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gallagher, John R.; Harris, Audray K.] NIAID, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Electron Microscope Lab, Frederick, MD USA; [Andersen, Hanne] Bioqual Inc, Rockville, MD USA; [Joyce, M. Gordon] Walter Reed Army Inst Res, Henry M Jackson Fdn Adv Mil Med, US Mil HIV Res Program, Silver Spring, MD USA; [Yassine, Hadi M.] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Wheatley, Adam K.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Baxa, Ulrich] Frederick Natl Lab Canc Res, Canc Res Technol Program, Cryo EM Facil, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); BIOQUAL Inc.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Qatar University; University of Melbourne; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kanekiyo, M; Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kanekiyom@nih.gov; bgraham@nih.gov	Kanekiyo, Masaru/Y-9820-2018; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021; McDermott, Adrian B/E-7306-2011; YASSINE, HADI M./AAW-6475-2020; Prabhakaran, Madhu/AEY-7127-2022	Kanekiyo, Masaru/0000-0001-5767-1532; Graham, Barney S./0000-0001-8112-0853; YASSINE, HADI M./0000-0001-7592-2788; Baxa, Ulrich/0000-0002-7263-5078; Wheatley, Adam/0000-0002-5593-9387; McDermott, Adrian/0000-0003-0616-9117; Gallagher, John/0000-0002-1954-8872	US Department of Energy, Office of Science, Basic Energy Sciences [W-31-109-Eng-38]; NIAID; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]	US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research, NIH	We thank J. Weir (Food and Drug Administration) for providing influenza viruses; R. Webby (St Jude Children's Research Hospital) for influenza reverse genetics plasmids; M. Dillon, K. Wuddie, G. Sarbador, C. Chiedi, A. Taylor, H. Bao and D. Scorpio (VRC) for help with animal studies; A. Kumar (VRC) for help with protein production; V. Nair and E. Fischer (NIAID) for cryo-electron microscopy data collection; M. Chen (VRC), D. Angeletti and J. Yewdell (NIAID) for help with initial epitope mapping. This work used the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov) and also the Office of Cyber Infrastructure and Computational Biology (OCICB) High Performance Computing (HPC) cluster at the NIAID, NIH. Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Basic Energy Sciences (under contract W-31-109-Eng-38). Support for this work was provided by the NIAID Intramural Research Program to the VRC and Division of Intramural Research. This work was also supported in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH (under contract HHSN261200800001E).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Air GM, 2015, CURR OPIN VIROL, V11, P113, DOI 10.1016/j.coviro.2015.03.006; Andrews SF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2676; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carter DM, 2017, J VIROL, V91, DOI [10.1128/JVI.01283-17, 10.1128/jvi.01283-17]; Carter DM, 2016, J VIROL, V90, P4720, DOI 10.1128/JVI.03152-15; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chai N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14234; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kanekiyo M, 2015, CELL, V162, P1090, DOI 10.1016/j.cell.2015.07.043; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lanzavecchia A, 2016, CURR OPIN IMMUNOL, V41, P62, DOI 10.1016/j.coi.2016.06.001; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P327, DOI 10.1111/j.1750-2659.2010.00148.x; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Shen CG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5752; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xiong XL, 2015, P NATL ACAD SCI USA, V112, P9430, DOI 10.1073/pnas.1510816112; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	72	101	103	9	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					362	+		10.1038/s41590-018-0305-x	http://dx.doi.org/10.1038/s41590-018-0305-x			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30742080	Green Accepted			2022-12-18	WOS:000458893600020
J	Nowosad, CR; Spillane, KM; Tolar, P				Nowosad, Carla R.; Spillane, Katelyn M.; Tolar, Pavel			Germinal center B cells recognize antigen through a specialized immune synapse architecture	NATURE IMMUNOLOGY			English	Article							LYMPH-NODE; SUBCAPSULAR SINUS; DENDRITIC CELLS; ACTIVATION; SELECTION; REVEALS; FORCES; DISCRIMINATION; MAINTENANCE; REPORTER	B cell activation is regulated by B cell antigen receptor (BCR) signaling and antigen internalization in immune synapses. Using large-scale imaging across B cell subsets, we found that, in contrast with naive and memory B cells, which gathered antigen toward the synapse center before internalization, germinal center (GC) B cells extracted antigen by a distinct pathway using small peripheral clusters. Both naive and GC B cell synapses required proximal BCR signaling, but GC cells signaled less through the protein kinase C-beta-NF-kappa B pathway and produced stronger tugging forces on the BCR, thereby more stringently regulating antigen binding. Consequently, GC B cells extracted antigen with better affinity discrimination than naive B cells, suggesting that specialized biomechanical patterns in B cell synapses regulate T cell-dependent selection of high-affinity B cells in GCs.	[Nowosad, Carla R.; Spillane, Katelyn M.; Tolar, Pavel] Francis Crick Inst, Lab Activat Immune Receptors, Mill Hill Lab, London, England; [Spillane, Katelyn M.; Tolar, Pavel] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, London, England	Francis Crick Institute; Imperial College London	Tolar, P (corresponding author), Francis Crick Inst, Lab Activat Immune Receptors, Mill Hill Lab, London, England.; Tolar, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, London, England.	pavel.tolar@crick.ac.uk		Tolar, Pavel/0000-0003-4693-7299	European Research Council [648228]; EMBO Young Investigator Programme; Francis Crick Institute from Cancer Research UK; Francis Crick Institute from UK Medical Research Council; Francis Crick Institute from Wellcome Trust; Medical Research Council [1226960, MC_U117597138] Funding Source: researchfish; The Francis Crick Institute [10185] Funding Source: researchfish; MRC [MC_U117597138] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); Francis Crick Institute from Cancer Research UK; Francis Crick Institute from UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute from Wellcome Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the European Research Council (Consolidator Grant 648228 to K.M.S. and P.T.), the EMBO Young Investigator Programme (P.T.), and the Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council and the Wellcome Trust (C.R.N., K.M.S. and P.T.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Blakely BL, 2014, NAT METHODS, V11, P1229, DOI [10.1038/NMETH.3145, 10.1038/nmeth.3145]; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Liu CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001704; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Seeley-Fallen MK, 2014, P NATL ACAD SCI USA, V111, P9881, DOI 10.1073/pnas.1321971111; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tolar P, 2014, ADV IMMUNOL, V123, P69, DOI 10.1016/B978-0-12-800266-7.00002-9; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wan ZP, 2013, J IMMUNOL, V190, P4661, DOI 10.4049/jimmunol.1202976; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6167	41	101	101	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					870	+		10.1038/ni.3458	http://dx.doi.org/10.1038/ni.3458			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27183103	Green Submitted, Green Accepted			2022-12-18	WOS:000378283200020
J	Xin, A; Masson, F; Liao, Y; Preston, S; Guan, TX; Gloury, R; Olshansky, M; Lin, JX; Li, P; Speed, TP; Smyth, GK; Ernst, M; Leonard, WJ; Pellegrini, M; Kaech, SM; Nutt, SL; Shi, W; Belz, GT; Kallies, A				Xin, Annie; Masson, Frederick; Liao, Yang; Preston, Simon; Guan, Tianxia; Gloury, Renee; Olshansky, Moshe; Lin, Jian-Xin; Li, Peng; Speed, Terence P.; Smyth, Gordon K.; Ernst, Matthias; Leonard, Warren J.; Pellegrini, Marc; Kaech, Susan M.; Nutt, Stephen L.; Shi, Wei; Belz, Gabrielle T.; Kallies, Axel			A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; EXPRESSION; IL-2; ID2; EXPANSION; AFFINITY; VIRUS; HOMEOSTASIS; GENERATION; REGULATORS	T cell responses are guided by cytokines that induce transcriptional regulators, which ultimately control differentiation of effector and memory T cells. However, it is unknown how the activities of these molecular regulators are coordinated and integrated during the differentiation process. Using genetic approaches and transcriptional profiling of antigen-specific CD8(+) T cells, we reveal a common program of effector differentiation that is regulated by IL-2 and IL-12 signaling and the combined activities of the transcriptional regulators Blimp-1 and T-bet. The loss of both T-bet and Blimp-1 leads to abrogated cytotoxic function and ectopic IL-17 production in CD8(+) T cells. Overall, our data reveal two major overlapping pathways of effector differentiation governed by the availability of Blimp-1 and T-bet and suggest a model for cytokine-induced transcriptional changes that combine, quantitatively and qualitatively, to promote robust effector CD8(+) T cell differentiation.	[Xin, Annie; Masson, Frederick; Liao, Yang; Preston, Simon; Gloury, Renee; Olshansky, Moshe; Speed, Terence P.; Smyth, Gordon K.; Ernst, Matthias; Pellegrini, Marc; Nutt, Stephen L.; Shi, Wei; Belz, Gabrielle T.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Xin, Annie; Masson, Frederick; Liao, Yang; Preston, Simon; Gloury, Renee; Ernst, Matthias; Pellegrini, Marc; Nutt, Stephen L.; Belz, Gabrielle T.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Guan, Tianxia] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Olshansky, Moshe; Kaech, Susan M.] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Lin, Jian-Xin; Li, Peng; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lin, Jian-Xin; Li, Peng; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Speed, Terence P.; Smyth, Gordon K.; Shi, Wei] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Masson, Frederick; Ernst, Matthias] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Masson, Frederick; Ernst, Matthias] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Yale University; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Melbourne; Howard Hughes Medical Institute; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.; Kallies, A (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	kallies@wehi.edu.au	Smyth, Gordon/B-5276-2008; Belz, Gabrielle T/C-9350-2013; Ernst, Matthias/D-5111-2012; Leonard, Warren/AAA-1397-2022; Guan, Tianxia/B-5559-2017; Nutt, Stephen L/C-9256-2013	Smyth, Gordon/0000-0001-9221-2892; Belz, Gabrielle T/0000-0002-9660-9587; Ernst, Matthias/0000-0002-6399-1177; Guan, Tianxia/0000-0001-6187-5431; Nutt, Stephen L/0000-0002-0020-6637; Preston, Simon/0000-0001-8969-8297; Pellegrini, Marc/0000-0003-3627-3126; Masson, Frederic/0000-0001-9909-2985; Olshansky, Moshe/0000-0003-2085-9851; Kallies, Axel/0000-0002-6312-6968; , Yang/0000-0002-9746-2839	National Health and Medical Research Council of Australia [1054618, 1058892, 1023454, 637345, 1042582, 603122]; Sylvia and Charles Viertel Foundation; Australian Research Council; US National Institutes of Health (NIH) [R01AI066232, R0O1AI074699]; Howard Hughes Medical Institute; Howard Hughes Medical Institute International Student Fellowship; Division of Intramural Research; DNA Sequencing Core, National Heart, Lung, and Blood Institute, NIH; Australian Academy of Science; NIH; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005401, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, R01AI074699] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Australian Research Council(Australian Research Council); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Howard Hughes Medical Institute International Student Fellowship; Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DNA Sequencing Core, National Heart, Lung, and Blood Institute, NIH; Australian Academy of Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Camilleri and L. Mackiewicz for technical support, and M. Ghisi (Peter MacCallum Cancer Centre) for assistance with MetaCore bioinformatics analysis. Supported by the National Health and Medical Research Council of Australia (program grant 1054618 to T.P.S. and G.K.S.; fellowship 1058892 to G.K.S.; project grant 1023454 to G.K.S. and W.S.; project grant 637345 to A.K. and G.T.B.; project grant 1042582 to G.T.B. and M.P.; project grant 603122 to M.E.), the Sylvia and Charles Viertel Foundation (A.K. and G.T.B.), the Australian Research Council (S.L.N., G.T.B. and A.K.), the US National Institutes of Health (NIH) (R01AI066232 and R0O1AI074699 to S.M.K.), the Howard Hughes Medical Institute (S.M.K.), the Howard Hughes Medical Institute International Student Fellowship (T.G.), the Division of Intramural Research and the DNA Sequencing Core, National Heart, Lung, and Blood Institute, NIH (W.J.L.), the Adam J. Berry Memorial Fund, jointly provided by the Australian Academy of Science and NIH (A.X.) and the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Belz GT, 2010, CURR OPIN IMMUNOL, V22, P279, DOI 10.1016/j.coi.2010.03.008; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Boulet S, 2014, J IMMUNOL, V193, P1847, DOI 10.4049/jimmunol.1302365; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Denton AE, 2007, EUR J IMMUNOL, V37, P368, DOI 10.1002/eji.200636766; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kim MT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00295; Knell J, 2013, J IMMUNOL, V190, P1501, DOI 10.4049/jimmunol.1200750; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Masson F, 2014, BLOOD, V123, P3420, DOI 10.1182/blood-2014-03-561456; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Santner-Nanan B, 2006, SIGNAL TRANSDUCT, V6, P268, DOI 10.1002/sita.200500062; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	64	101	105	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					422	+		10.1038/ni.3410	http://dx.doi.org/10.1038/ni.3410			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26950239	Green Accepted			2022-12-18	WOS:000372508000016
J	Ishizuka, IE; Chea, S; Gudjonson, H; Constantinides, MG; Dinner, AR; Bendelac, A; Golub, R				Ishizuka, Isabel E.; Chea, Sylvestre; Gudjonson, Herman; Constantinides, Michael G.; Dinner, Aaron R.; Bendelac, Albert; Golub, Rachel			Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; DIFFERENTIATION; IMMUNITY; INFLAMMATION; COMMITMENT; GENERATION; PROGENITOR; ALPHA; NFIL3; FATE	The precise lineage relationship between innate lymphoid cells (ILCs) and lymphoid tissue-inducer (LTi) cells is poorly understood. Using single-cell multiplex transcriptional analysis of 100 lymphoid genes and single-cell cultures of fetal liver precursor cells, we identified the common proximal precursor to these lineages and found that its bifurcation was marked by differential induction of the transcription factors PLZF and TCF1. Acquisition of individual effector programs specific to the ILC subsets ILC1, ILC2 and ILC3 was initiated later, at the common ILC precursor stage, by transient expression of mixed ILC1, ILC2 and ILC3 transcriptional patterns, whereas, in contrast, the development of LTi cells did not go through multilineage priming. Our findings provide insight into the divergent mechanisms of the differentiation of the ILC lineage and LTi cell lineage and establish a high-resolution 'blueprint' of their development.	[Ishizuka, Isabel E.; Gudjonson, Herman; Constantinides, Michael G.; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Ishizuka, Isabel E.; Constantinides, Michael G.; Bendelac, Albert] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Chea, Sylvestre; Golub, Rachel] Univ Paris Diderot, Inst Pasteur, Dept Immunol, Lymphopoiesis Unit,Inserm U668, Paris, France; [Gudjonson, Herman; Dinner, Aaron R.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Gudjonson, Herman; Dinner, Aaron R.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Chicago; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	GOLUB, rachel/X-8717-2019; Rachel, GOLUB/M-7188-2014	GOLUB, rachel/0000-0002-2306-5363; Rachel, GOLUB/0000-0002-2306-5363; CHEA, Sylvestre/0000-0002-0498-8429; Constantinides, Michael/0000-0003-4770-7751	US National Institutes of Health [R01 HL118092, AI038339, AI108643]; Digestive Diseases Research Center of Excellence [P30DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339, R37AI038339, R01AI108643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Center of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J.C. Zuniga-Pflucker (University of Toronto) for stocks of OP9 and OP9-DL1 stromal cells. Supported by the US National Institutes of Health (R01 HL118092, AI038339 and AI108643) and by the Digestive Diseases Research Center of Excellence (P30DK42086).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Moro K, 2015, SEMIN IMMUNOPATHOL, V37, P27, DOI 10.1007/s00281-014-0470-4; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N., 2015, NAT REV IMMUNOL, V7, P1217; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	39	101	106	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					269	276		10.1038/ni.3344	http://dx.doi.org/10.1038/ni.3344			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26779601	Green Accepted			2022-12-18	WOS:000370469300011
J	Pobezinsky, LA; Etzensperger, R; Jeurling, S; Alag, A; Kadakia, T; McCaughtry, TM; Kimura, MY; Sharrow, SO; Guinter, TI; Feigenbaum, L; Singer, A				Pobezinsky, Leonid A.; Etzensperger, Ruth; Jeurling, Susanna; Alag, Amala; Kadakia, Tejas; McCaughtry, Tom M.; Kimura, Motoko Y.; Sharrow, Susan O.; Guinter, Terry I.; Feigenbaum, Lionel; Singer, Alfred			Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function	NATURE IMMUNOLOGY			English	Article							VITAMIN-D-RECEPTOR; MESSENGER-RNAS; T-CELLS; CD4; REQUIREMENTS; RECOGNITION; PHENOTYPE; PRECURSOR; PROTEINS; MEDIATE	Lethal-7 (let-7) microRNAs (miRNAs) are the most abundant miRNAs in the genome, but their role in developing thymocytes is unclear. We found that let-7 miRNAs targeted Zbtb16 mRNA, which encodes the lineage-specific transcription factor PLZF, to post-transcriptionally regulate PLZF expression and thereby the effector functions of natural killer T cells (NKT cells). Dynamic upregulation of let-7 miRNAs during the development of NKT thymocytes downregulated PLZF expression and directed their terminal differentiation into interferon-gamma (IFN-gamma)-producing NKT1 cells. Without upregulation of let-7 miRNAs, NKT thymocytes maintained high PLZF expression and terminally differentiated into interleukin 4 (IL-4)-producing NKT2 cells or IL-17-producing NKT17 cells. Upregulation of let-7 miRNAs in developing NKT thymocytes was signaled by IL-15, vitamin D and retinoic acid. Such targeting of a lineage-specific transcription factor by miRNA represents a previously unknown level of developmental regulation in the thymus.	[Pobezinsky, Leonid A.; Etzensperger, Ruth; Jeurling, Susanna; Alag, Amala; Kadakia, Tejas; McCaughtry, Tom M.; Kimura, Motoko Y.; Sharrow, Susan O.; Guinter, Terry I.; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov			Intramural Research Program of the US National Institutes of Health; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011113, ZIABC009273, ZIABC011114, ZIABC011117, ZIABC011112, ZIABC011106, ZIABC011111] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K08524] Funding Source: KAKEN	Intramural Research Program of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Taylor and J.-H. Park for critical reading of the manuscript; G.Q. Daley (Harvard Medical School) for iLet7<SUP>Delta LIN28</SUP> and M2rtTA double-transgenic mice; A. Bendelac (University of Chicago) for Zbtb16<SUP>+/LU</SUP> mice; the Tetramer Core Facility of the US National Institutes of Health for tetramer reagents; A. Adams and L. Granger for flow cytometry; and J.A. Williams (National Cancer Institute) for cDNA reagents. Supported by the Intramural Research Program of the US National Institutes of Health, the National Cancer Institute, Center for Cancer Research.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Elewaut D, 2003, J EXP MED, V197, P1623, DOI 10.1084/jem.20030141; Faehnle CR, 2014, NATURE, V514, P252, DOI 10.1038/nature13553; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; McVoy LA, 2005, J IMMUNOL, V175, P4754, DOI 10.4049/jimmunol.175.7.4754; MENEELY PM, 1979, GENETICS, V92, P99; Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seo KH, 2010, CELL MOL IMMUNOL, V7, P447, DOI 10.1038/cmi.2010.49; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; Yu SH, 2011, J IMMUNOL, V187, P4907, DOI 10.4049/jimmunol.1101519; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	46	101	104	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					517	U234		10.1038/ni.3146	http://dx.doi.org/10.1038/ni.3146			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25848867	Green Accepted			2022-12-18	WOS:000353305200014
J	Aaby, P; Kollmann, TR; Benn, CS				Aaby, Peter; Kollmann, Tobias R.; Benn, Christine Stabell			Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges	NATURE IMMUNOLOGY			English	Article							BACILLUS-CALMETTE-GUERIN; DIPHTHERIA-TETANUS-PERTUSSIS; RANDOMIZED CONTROLLED-TRIAL; BIRTH-WEIGHT CHILDREN; BCG VACCINATION; TUBERCULIN REACTION; FEMALE MORTALITY; MEASLES-VACCINE; GUINEA-BISSAU; RESPONSES	Vaccines can have nonspecific effects through their modulation of responses to infections not specifically targeted by the vaccine. However, lack of knowledge about the underlying immunological mechanisms and molecular cause-and-effect relationships prevent use of this potentially powerful early-life intervention to its greatest benefit. The World Health Organization has identified investigations into the molecular basis of nonspecific vaccine effects as a research priority.	[Aaby, Peter; Benn, Christine Stabell] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Aaby, Peter; Benn, Christine Stabell] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, OPEN, Odense, Denmark; [Aaby, Peter; Benn, Christine Stabell] Statens Serum Inst, Res Ctr Vitamins & Vaccines, Bandim Hlth Project, DK-2300 Copenhagen, Denmark; [Kollmann, Tobias R.] Univ British Columbia, Child & Family Res Inst, Dept Pediat, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada	University of Southern Denmark; Odense University Hospital; Statens Serum Institut; Child & Family Research Institute; University of British Columbia	Aaby, P (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	p.aaby@bandim.org		Aaby, Peter/0000-0001-8331-1389; Kollmann, Tobias/0000-0003-2403-9762				Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2006, VACCINE, V24, P5718, DOI 10.1016/j.vaccine.2006.04.045; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000761; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707; Aaby P, 2012, ARCH DIS CHILD, V97, P685, DOI 10.1136/archdischild-2011-300646; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Benn CS, 2009, INT J EPIDEMIOL, V38, P586, DOI 10.1093/ije/dyn364; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; Clemens J, 2010, NAT IMMUNOL, V11, P1069, DOI 10.1038/ni1210-1069; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; JPT Higgins KS-W. A Reingold, 2014, SYSTEMATIC REV NONSP; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Mathurin KS, 2009, J VIROL, V83, P3528, DOI 10.1128/JVI.02393-08; Mendez-Samperio P, 2008, CLIN VACCINE IMMUNOL, V15, P1450, DOI 10.1128/CVI.00178-08; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Roth A, 2006, EPIDEMIOLOGY, V17, P562, DOI 10.1097/01.ede.0000231546.14749.ab; Shey MS, 2014, J IMMUNOL, V192, P4833, DOI 10.4049/jimmunol.1400062; Sorup S, 2014, JAMA-J AM MED ASSOC, V311, P826, DOI 10.1001/jama.2014.470; Steenhuis TJ, 2008, CLIN EXP ALLERGY, V38, P79, DOI 10.1111/j.1365-2222.2007.02859.x; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; WHO, 2014, WKLY EPIDEMIOL REC, V89, P221; WHO(World Health Organization), 1946, CONST	29	101	104	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					895	899		10.1038/ni.2961	http://dx.doi.org/10.1038/ni.2961			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232810	Bronze			2022-12-18	WOS:000342564800001
J	Lee, M; Kiefel, H; LaJevic, MD; Macauley, MS; O'Hara, E; Pan, J; Paulson, JC; Butcher, EC				Lee, Mike; Kiefel, Helena; LaJevic, Melissa D.; Macauley, Matthew S.; O'Hara, Edward; Pan, Junliang; Paulson, James C.; Butcher, Eugene C.			Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing	NATURE IMMUNOLOGY			English	Article							L-SELECTIN; FUNCTIONAL-CHARACTERIZATION; CELL-ADHESION; VENULES; GLYCOSYLATION; TRAFFICKING; ACTIVATION; MIGRATION; LIGANDS; ACID	Lymphocytes are recruited from blood by high-endothelial venules (HEVs). We performed transcriptomic analyses and identified molecular signatures that distinguish HEVs from capillary endothelium and that define tissue-specific HEV specialization. Capillaries expressed gene programs for vascular development. HEV-expressed genes showed enrichment for genes encoding molecules involved in immunological defense and lymphocyte migration. We identify capillary and HEV markers and candidate mechanisms for regulated recruitment of lymphocytes, including a lymph node HEV-selective transmembrane mucin; transcriptional control of functionally specialized carbohydrate ligands for lymphocyte L-selectin; HEV expression of molecules for transendothelial migration; and metabolic programs for lipid mediators of lymphocyte motility and chemotaxis. We also elucidate a carbohydrate-recognition pathway that targets B cells to intestinal lymphoid tissues, defining CD22 as a lectin-homing receptor for mucosal HEVs.	[Lee, Mike; Kiefel, Helena; LaJevic, Melissa D.; Butcher, Eugene C.] Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Macauley, Matthew S.; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Macauley, Matthew S.; Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [O'Hara, Edward; Pan, Junliang; Butcher, Eugene C.] Palo Alto Vet Inst Res, Palo Alto, CA USA; [Butcher, Eugene C.] Ctr Mol Biol & Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Scripps Research Institute; Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Butcher, EC (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	ebutcher@stanford.edu	Paulson, James/AAG-3565-2019	Macauley, Matthew/0000-0003-4579-1048	US National Institutes of Health [R37 GM37734, R37 AI047822, R01 AI093981, R01 DK084647, 5T32AI007290, 5T32CA009151, F32CA180415, R01 AI50143]; US Department of Veterans Affairs; Klaus Bensch Professorship; Deutsche Forschungsgemeinschaft [KI1646/1-2]; Stanford Institute for Immunity, Transplantation and Infection; American Heart Association; Crohn's and Colitis Foundation of America [3782]; NATIONAL CANCER INSTITUTE [T32CA009151, F32CA180415] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, T32AI007290, R01AI093981, R01AI050143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734, R01GM037734] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Klaus Bensch Professorship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stanford Institute for Immunity, Transplantation and Infection; American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kawashima (University of Shizuoka) for the S2 hybridoma; J. Sweere, A. Scholz, C. Czupalla and B. Arlian for help with experiments; J. Jang for antibody production; L. Rott for assistance with cell sorting; all members of the Butcher laboratory for discussions; B. Yoo (Stanford University) and T.A. Rando (Stanford University) for tissues from Hes1-EmGFP<SUP>SAT</SUP> mice; M. Salmi and M. Miyasaka for critical review of the manuscript; and the UniProt Consortium, the Kyoto Encyclopedia of Genes and Genomes, Enrichr software (E.Y. Chen, C.M. Tan, Y. Kou, Q. Duan, Z. Wang, G.V. Meirelles, N.R. Clark and Ma'ayan A. of the Icahn School of Medicine at Mount Sinai), iHOP (Information Hyperlinked over Proteins) online gene-guided access to PubMed abstracts, and the Immunological Genome Project for their informatics tools and compendia of data. Supported by the US National Institutes of Health (R37 GM37734, R37 AI047822, R01 AI093981 and R01 DK084647 to E.C.B.; 5T32AI007290 to M. L.; 5T32CA009151, 5T32AI007290 and F32CA180415 to M.D.L.; and R01 AI50143 to J.C.P.), the US Department of Veterans Affairs (E.C.B.), the Klaus Bensch Professorship (E.C.B.), Deutsche Forschungsgemeinschaft (KI1646/1-2 to H.K.), the Stanford Institute for Immunity, Transplantation and Infection (H.K.), the American Heart Association (H.K.) and the Crohn's and Colitis Foundation of America (Ref. 3782 to M.L.).	Ahn SY, 2004, AM J PATHOL, V164, P1663, DOI 10.1016/S0002-9440(10)63725-X; ANDERSON ND, 1976, IMMUNOLOGY, V31, P455; ANDREWS P, 1982, J CELL SCI, V57, P277; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Charfi C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-84; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Demyanets S, 2012, VASC PHARMACOL, V56, P34, DOI 10.1016/j.vph.2011.12.004; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Gauguet J. M., 2007, ENDOTHELIAL BIOMEDIC; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; JUTILA MA, 1988, EUR J IMMUNOL, V18, P1819, DOI 10.1002/eji.1830181125; Kannagi R., 2011, MOL IMMUNOLOGY COMPL; Karikoski M, 2009, EUR J IMMUNOL, V39, P3477, DOI 10.1002/eji.200939896; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Kitagawa M, 2013, MECH DEVELOP, V130, P458, DOI 10.1016/j.mod.2013.07.001; Kruse A, 1999, BIOL REPROD, V61, P1393, DOI 10.1095/biolreprod61.6.1393; Limaye V, 2009, CELL MOL BIOL LETT, V14, P411, DOI 10.2478/s11658-009-0008-2; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Ortolan E, 2006, BLOOD, V108, P4214, DOI 10.1182/blood-2006-04-017160; Patnode ML, 2013, GLYCOBIOLOGY, V23, P381, DOI 10.1093/glycob/cws166; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; Preuss I, 2014, BIOCHEM BIOPH RES CO, V446, P663, DOI 10.1016/j.bbrc.2014.01.069; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; STEVENS SK, 1982, J IMMUNOL, V128, P844; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40; Verkman AS, 2002, J ANAT, V200, P617, DOI 10.1046/j.1469-7580.2002.00058.x; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wang CC, 2000, DEV BIOL, V224, P152, DOI 10.1006/dbio.2000.9749; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zhang G, 2008, FEBS LETT, V582, P2957, DOI 10.1016/j.febslet.2008.07.031; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	59	101	102	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					982	U129		10.1038/ni.2983	http://dx.doi.org/10.1038/ni.2983			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25173345	Green Accepted			2022-12-18	WOS:000342564800014
J	Agudo, J; Ruzo, A; Tung, N; Salmon, H; Leboeuf, M; Hashimoto, D; Becker, C; Garrett-Sinha, LA; Baccarini, A; Merad, M; Brown, BD				Agudo, Judith; Ruzo, Albert; Tung, Navpreet; Salmon, Helene; Leboeuf, Marylene; Hashimoto, Daigo; Becker, Christian; Garrett-Sinha, Lee-Ann; Baccarini, Alessia; Merad, Miriam; Brown, Brian D.			The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; I INTERFERON; PREDENDRITIC CELLS; MICRORNAS; RECEPTOR; EXPRESSION; INDUCTION; MECHANISMS; CROSSTALK; INFECTION	miR-126 is a microRNA expressed predominately by endothelial cells and controls angiogenesis. We found miR-126 was required for the innate response to pathogen-associated nucleic acids and that miR-126-deficient mice had greater susceptibility to infection with pseudotyped HIV. Profiling of miRNA indicated that miR-126 had high and specific expression by plasmacytoid dendritic cells (pDCs). Moreover, miR-126 controlled the survival and function of pDCs and regulated the expression of genes encoding molecules involved in the innate response, including Tlr7, Tlr9 and Nfkb1, as well as Kdr, which encodes the growth factor receptor VEGFR2. Deletion of Kdr in DCs resulted in reduced production of type I interferon, which supports the proposal of a role for VEGFR2 in miR-126 regulation of pDCs. Our studies identify the miR-126 VEGFR2 axis as an important regulator of the innate response that operates through multiscale control of pDCs.	[Agudo, Judith; Ruzo, Albert; Tung, Navpreet; Baccarini, Alessia; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Salmon, Helene; Leboeuf, Marylene; Hashimoto, Daigo; Becker, Christian; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA; [Salmon, Helene; Leboeuf, Marylene; Hashimoto, Daigo; Becker, Christian; Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Mt Sinai Immunol Inst, New York, NY USA; [Garrett-Sinha, Lee-Ann] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA.	brian.brown@mssm.edu	Garrett-Sinha, Lee Ann/K-5911-2019; Hashimoto, Daigo/O-1013-2013	Hashimoto, Daigo/0000-0001-9489-9704; Garrett-Sinha, Lee Ann/0000-0001-7806-4352	US National Institutes of Health [DP2DK083052, 1R01AI104848, CA154947A, AI10008, AI089987]; Beatriu de Pinos program; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, U19AI089987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083052] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beatriu de Pinos program; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C.J. Kuo (Stanford University) for Mir126<SUP>-/-</SUP> mice; P. Sathe, R. Sachidanandam, L. Naldini and B. Gentner for discussions; J. Ochando for reading the manuscript; and the Mount Sinai Mouse Genetics and Mouse Targeting facility, the Flow Cytometry Core and the Mount Sinai Genomics Core for technical assistance. Supported by the US National Institutes of Health (DP2DK083052 and 1R01AI104848 to B.D.B., and CA154947A, AI10008 and AI089987 to M.M.), the Beatriu de Pinos program (J.A.), and the Juvenile Diabetes Research Foundation (J.A.).	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown B, 2007, DES ISSUES, V23, P1; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HYS, 2012, BLOOD, V120, P4363, DOI 10.1182/blood-2012-07-441311; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Plas DR, 2009, CURR OPIN CELL BIOL, V21, P230, DOI 10.1016/j.ceb.2008.12.013; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stepkowski SM, 2008, TRANSPLANTATION, V85, P1372, DOI 10.1097/TP.0b013e3181739d25; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vitour Damien, 2007, Sci STKE, V2007, ppe20, DOI 10.1126/stke.3842007pe20; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	48	101	113	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					54	62		10.1038/ni.2767	http://dx.doi.org/10.1038/ni.2767			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24270517	Green Accepted			2022-12-18	WOS:000328800500012
J	Chen, BB; Coon, TA; Glasser, JR; McVerry, BJ; Zhao, J; Zhao, YT; Zou, CB; Ellis, B; Sciurba, FC; Zhang, YZ; Mallampalli, RK				Chen, Bill B.; Coon, Tiffany A.; Glasser, Jennifer R.; McVerry, Bryan J.; Zhao, Jing; Zhao, Yutong; Zou, Chunbin; Ellis, Bryon; Sciurba, Frank C.; Zhang, Yingze; Mallampalli, Rama K.			A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation	NATURE IMMUNOLOGY			English	Article							RECEPTOR-ASSOCIATED FACTOR-3; SCF UBIQUITIN LIGASE; DEGRADATION; FAMILY; IDENTIFICATION; ACTIVATION; SUBUNIT; FBXL2	Uncontrolled activation of tumor necrosis factor receptor-associated factor (TRAF) proteins may result in profound tissue injury by linking surface signals to cytokine release. Here we show that a ubiquitin E3 ligase component, Fbxo3, potently stimulates cytokine secretion from human inflammatory cells by destabilizing a sentinel TRAF inhibitor, Fbxl2. Fbxo3 and TRAF protein in circulation positively correlated with cytokine responses in subjects with sepsis, and we identified a polymorphism in human Fbxo3, with one variant being hypofunctional. A small-molecule inhibitor targeting Fbxo3 was sufficient to lessen severity of cytokine-driven inflammation in several mouse disease models. These studies identified a pathway of innate immunity that may be useful to detect subjects with altered immune responses during critical illness or provide a basis for therapeutic intervention targeting TRAF protein abundance.	[Chen, Bill B.; Coon, Tiffany A.; Glasser, Jennifer R.; McVerry, Bryan J.; Zhao, Jing; Zhao, Yutong; Zou, Chunbin; Ellis, Bryon; Sciurba, Frank C.; Zhang, Yingze; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA.	chenb@upmc.edu; mallampallirk@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Zou, Chunbin/L-7488-2019; McVerry, Bryan/AAS-7790-2021	Zou, Chunbin/0000-0003-1355-4726; McVerry, Bryan/0000-0002-1175-4874; sciurba, frank/0000-0001-7468-2225	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; Merit Review Award from the US Department of Veterans Affairs; National Institutes [HL096376, HL097376, HL081784, HL068135, HL098174, HL116472, HL01916, P50HL084948]; American Heart Association [12SDG9050005, 12SDG12040330, 12GRNT11820019]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, R01HL068135, R01HL081784, R01HL098174, R01HL112791, R01HL097376, R01HL116472, R01HL096376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Merit Review Award from the US Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes(National Health Research Institutes - Taiwan); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	We thank A. Lagneaux and S. Barge for assistance with studies. This material is based upon work supported, in part, by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported by a Merit Review Award from the US Department of Veterans Affairs and National Institutes of Health R01 grants HL096376, HL097376, HL081784, HL068135 and HL098174 (to R. K. M.), HL116472 (to B. B. C.), HL01916 (to Y.Z.) and P50HL084948 (F. C. S.), American Heart Association awards 12SDG9050005 (to J.Z.) and 12SDG12040330 (to C.Z.), and American Heart Association Grant-in-Aid 12GRNT11820019 (B.J.M.). The contents presented do not represent the views of the Department of Veterans Affairs or the United States Government.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen BB, 2012, ONCOGENE, V31, P2566, DOI 10.1038/onc.2011.432; Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911; Chen BB, 2011, CELL CYCLE, V10, P3487, DOI 10.4161/cc.10.20.17742; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Chin KH, 2005, ACTA CRYSTALLOGR F, V61, P700, DOI 10.1107/S1744309105018956; DODGE JA, 1975, LANCET, V1, P572; Ebong SJ, 1999, SHOCK, V12, P118, DOI 10.1097/00024382-199908000-00005; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geva A, 2004, NEW ENGL J MED, V351, P1532, DOI 10.1056/NEJMoa040771; Ha H., 2009, CURR PROTOC IMMUNOL, V11; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Harrison C, 2010, NAT REV DRUG DISCOV, V9, P360, DOI 10.1038/nrd3162; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; MONTH SR, 1990, J CLIN INVEST, V85, P364, DOI 10.1172/JCI114447; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Eyndhoven WG, 1999, MOL IMMUNOL, V36, P647, DOI 10.1016/S0161-5890(99)00079-6; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zhang J, 2007, ASIAN J ANDROL, V9, P809, DOI 10.1111/j.1745-7262.2007.00305.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu LJ, 2010, CYTOKINE, V49, P201, DOI 10.1016/j.cyto.2009.10.004	43	101	107	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					470	+		10.1038/ni.2565	http://dx.doi.org/10.1038/ni.2565			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23542741	Green Accepted			2022-12-18	WOS:000317732100012
J	Chuang, HC; Lan, JL; Chen, DY; Yang, CY; Chen, YM; Li, JP; Huang, CY; Liu, PE; Wang, XH; Tan, TH				Chuang, Huai-Chia; Lan, Joung-Liang; Chen, Der-Yuan; Yang, Chia-Yu; Chen, Yi-Ming; Li, Ju-Pi; Huang, Ching-Yu; Liu, Pao-En; Wang, Xiaohong; Tan, Tse-Hua			The kinase GLK controls autoimmunity and NF-kappa B signaling by activating the kinase PKC-theta in T cells	NATURE IMMUNOLOGY			English	Article							C-THETA; DIFFERENTIAL REQUIREMENT; DEFICIENT MICE; ENCEPHALOMYELITIS; RECRUITMENT; RECEPTOR; PATHWAY; COMPLEX; CARMA1; DEPEND	Protein kinase C-theta (PKC-theta) is required for activation of the transcription factor NF-kappa B induced by signaling via the T cell antigen receptor (TCR); however, the direct activator of PKC-theta is unknown. We report that the kinase GLK (MAP4K3) directly activated PKC-theta during TCR signaling. TCR signaling activated GLK by inducing its direct interaction with the upstream adaptor SLP-76. GLK-deficient mice had impaired immune responses and were resistant to experimental autoimmune encephalomyelitis. Consistent with that, people with systemic lupus erythematosus had considerable enhanced GLK expression and activation of PKC-theta and the kinase IKK in T cells, and the frequency of GLK-overexpressing T cells was directly correlated with disease severity. Thus, GLK is a direct activator of PKC-theta, and activation of GLK-PKC-theta-IKK could be used as new diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.	[Chuang, Huai-Chia; Yang, Chia-Yu; Li, Ju-Pi; Huang, Ching-Yu; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan; Chen, Yi-Ming; Liu, Pao-En] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan; Chen, Yi-Ming] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Wang, Xiaohong; Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Baylor College of Medicine	Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan.	ttan@nhri.org.tw	Chen, Yi-Ming/AAV-3806-2021; Huang, Ching-Yu/E-3981-2010; Li, Ju-Pi/AAS-8866-2021; Tan, Tse-Hua/ABD-7080-2021; Chuang, Huai-Chia/E-9486-2016; Tan, Tse-Hua/E-3983-2010	Chen, Yi-Ming/0000-0001-7593-3065; Li, Ju-Pi/0000-0003-3406-4865; Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Huang, Ching-yu/0000-0002-5758-281X	National Health Research Institutes of Taiwan [98A1-IMPP01-014]; Taichung Veterans General Hospital of Taiwan [TCVGH-NHRI01]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Taichung Veterans General Hospital of Taiwan	We thank the Core Facilities of the National Health Research Institutes (Taiwan) for confocal microscopy. Supported by National Health Research Institutes of Taiwan (98A1-IMPP01-014 to T.-H.T.) and Taichung Veterans General Hospital of Taiwan (TCVGH-NHRI01 to J.-L.L.).	Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Healy AM, 2006, J IMMUNOL, V177, P1886, DOI 10.4049/jimmunol.177.3.1886; Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Sakaki K, 2008, AUTOPHAGY, V4, P841, DOI 10.4161/auto.6607; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	24	101	105	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1113	U121		10.1038/ni.2121	http://dx.doi.org/10.1038/ni.2121			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21983831				2022-12-18	WOS:000296500100017
J	Dong, ZJ; Cruz-Munoz, ME; Zhong, MC; Chen, RY; Latour, S; Veillette, A				Dong, Zhongjun; Cruz-Munoz, Mario-Ernesto; Zhong, Ming-Chao; Chen, Riyan; Latour, Sylvain; Veillette, Andre			Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells	NATURE IMMUNOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; ACTIVATION MOLECULE FAMILY; TYROSINE-PROTEIN-KINASE; NK-CELL; CUTTING EDGE; TERMINAL MATURATION; NEGATIVE REGULATION; T-CELLS; IMMUNE-RESPONSES; DENDRITIC CELLS	The adaptors SAP, EAT-2 and ERT are specific to cells of the immune system and belong to the SAP family. All three are expressed in natural killer (NK) cells. Here we examined the global function of the SAP family using mice lacking SAP, EAT-2 and ERT. These adaptors acted together in a mechanism that was essential for the elimination of hematopoietic but not nonhematopoietic cells by NK cells. This function was mediated by many receptors of the SLAM family on NK cells that were engaged by ligands found solely on hematopoietic cells. In the absence of SAP-related adaptors, SLAM receptors lost their activating function and became inhibitory receptors that repressed other activating receptors, such as NKG2D. Hence, the SAP family is essential for the elimination of unwanted hematopoietic cells by NK cells.	[Dong, Zhongjun; Cruz-Munoz, Mario-Ernesto; Zhong, Ming-Chao; Chen, Riyan; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Latour, Sylvain] Hop Necker Enfants Malad, INSERM, U768, Paris, France; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca	Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391	Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche; Ligue Nationale Contre le Cancer-Ile de France; Clinical Research Institute of Montreal; Canada Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer-Ile de France(Ligue nationale contre le cancer); Clinical Research Institute of Montreal; Canada Research Chair Program(Canada Research Chairs)	We thank D. Davidson for critical reading of the manuscript. Supported by the Canadian Institutes of Health Research (Veillette laboratory and Z. D.), the Canadian Cancer Society Research Institute (Veillette laboratory and M.-E. C.-M.), the Howard Hughes Medical Institute (Veillette laboratory and A. V.), the Institut National de la Sante et de la Recherche Medicale (Latour laboratory), the Agence Nationale de la Recherche (Latour laboratory), the Ligue Nationale Contre le Cancer-Ile de France (Latour laboratory), the Clinical Research Institute of Montreal (Z. D.), the Centre National de la Recherche Scientifique (S. L.) and Canada Research Chair Program (A. V.).	Awasthi A, 2008, GENES IMMUN, V9, P522, DOI 10.1038/gene.2008.45; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Castro AG, 1999, J IMMUNOL, V163, P5860; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; CONNER DA, 2001, CURR PROTOC MOL BIOL, P1; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; DAVIDSON D, 1994, MOL CELL BIOL, V14, P4554, DOI 10.1128/MCB.14.7.4554; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; HABU S, 1981, J IMMUNOL, V127, P34; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; MATHEW PA, 1993, J IMMUNOL, V151, P5328; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sandrin MS, 1996, IMMUNOGENETICS, V43, P13; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Vaidya SV, 2006, IMMUNOL LETT, V105, P180, DOI 10.1016/j.imlet.2006.02.006; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019; Wahle JA, 2007, J IMMUNOL, V179, P8009, DOI 10.4049/jimmunol.179.12.8009; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	50	101	106	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					973	U62		10.1038/ni.1763	http://dx.doi.org/10.1038/ni.1763			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19648922				2022-12-18	WOS:000269120900011
J	Felix, NJ; Donermeyer, DL; Horvath, S; Walters, JJ; Gross, ML; Suri, A; Allen, PM				Felix, Nathan J.; Donermeyer, David L.; Horvath, Stephen; Walters, James J.; Gross, Michael L.; Suri, Anish; Allen, Paul M.			Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II; ENDOGENOUS PEPTIDES; MOLECULAR-BASIS; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; IN-VIVO; RECOGNITION; ANTIGEN; TCR	The molecular basis underlying the specificity of alloreactive T cells for peptide-major histocompatibility complex ligands has been elusive. Here we describe a screen of 60 I-E-k-alloreactive T cells and 83 naturally processed peptides that identified 9 reactive T cells. Three of the T cells responded to multiple, distinct peptides that shared no sequence homology. These T cells recognized each peptide-major histocompatibility complex ligand specifically and used a distinct constellation of I-E-k contact residues for each interaction. Our studies show that alloreactive T cells have a 'germline-encoded' capacity to recognize multiple, distinct ligands and thus show 'polyspecificity', not degeneracy. Our findings help to explain the high frequency of alloreactive T cells and provide insight into the nature of T cell specificity.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu			NCRR NIH HHS [2P41RR00954] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALEXANDERMILLER MA, 1993, J IMMUNOL, V151, P1; ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Basu D, 2001, J IMMUNOL, V166, P4005, DOI 10.4049/jimmunol.166.6.4005; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; CRUMPACKER DB, 1992, J IMMUNOL, V148, P3004; Csencsits KL, 2003, AM J TRANSPLANT, V3, P107, DOI 10.1034/j.1600-6143.2003.00036.x; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DEMOTZ S, 1991, P NATL ACAD SCI USA, V88, P8730, DOI 10.1073/pnas.88.19.8730; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Eisen HN, 2001, ANNU REV IMMUNOL, V19, P1, DOI 10.1146/annurev.immunol.19.1.1; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; Felix NJ, 2006, J IMMUNOL, V176, P1062, DOI 10.4049/jimmunol.176.2.1062; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; HEATH WR, 1991, EUR J IMMUNOL, V21, P153, DOI 10.1002/eji.1830210123; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; Hong SC, 1997, J IMMUNOL, V159, P4395; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Marrack P, 2001, J IMMUNOL, V167, P617, DOI 10.4049/jimmunol.167.2.617; Masteller EL, 2003, J IMMUNOL, V171, P5587, DOI 10.4049/jimmunol.171.10.5587; MATIS LA, 1987, CELL, V51, P59, DOI 10.1016/0092-8674(87)90010-9; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Mendiratta SK, 1999, INT IMMUNOL, V11, P351, DOI 10.1093/intimm/11.3.351; Obst R, 1998, EUR J IMMUNOL, V28, P2432, DOI 10.1002/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; PANINABORDIGNON P, 1991, SCIENCE, V252, P1548, DOI 10.1126/science.1710827; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sayegh MH, 2003, AM J TRANSPLANT, V3, P381, DOI 10.1034/j.1600-6143.2003.00062.x; Schild H, 1995, INT IMMUNOL, V7, P1957, DOI 10.1093/intimm/7.12.1957; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Vidal K, 1999, J IMMUNOL, V163, P4811; Wang JH, 2000, CURR OPIN STRUC BIOL, V10, P656, DOI 10.1016/S0959-440X(00)00150-0; WEBER DA, 1995, J IMMUNOL, V154, P5153	50	101	102	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					388	397		10.1038/ni1446	http://dx.doi.org/10.1038/ni1446			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17322886				2022-12-18	WOS:000245075900014
J	Zewinger, S; Reiser, J; Jankowski, V; Alansary, D; Hahm, E; Triem, S; Klug, M; Schunk, SJ; Schmit, D; Kramann, R; Korbel, C; Ampofo, E; Laschke, MW; Selejan, SR; Paschen, A; Herter, T; Schuster, S; Silbernagel, G; Sester, M; Sester, U; Assmann, G; Bals, R; Kostner, G; Jahnen-Dechent, W; Menger, MD; Rohrer, L; Marz, W; Bohm, M; Jankowski, J; Kopf, M; Latz, E; Niemeyer, BA; Fliser, D; Laufs, U; Speer, T				Zewinger, Stephen; Reiser, Jochen; Jankowski, Vera; Alansary, Dalia; Hahm, Eunsil; Triem, Sarah; Klug, Mira; Schunk, Stefan J.; Schmit, David; Kramann, Rafael; Koerbel, Christina; Ampofo, Emmanuel; Laschke, Matthias W.; Selejan, Simina-Ramona; Paschen, Anna; Herter, Tobias; Schuster, Susanne; Silbernagel, Guenther; Sester, Martina; Sester, Urban; Assmann, Gunter; Bals, Robert; Kostner, Gerhard; Jahnen-Dechent, Willi; Menger, Michael D.; Rohrer, Lucia; Maerz, Winfried; Boehm, Michael; Jankowski, Joachim; Kopf, Manfred; Latz, Eicke; Niemeyer, Barbara A.; Fliser, Danilo; Laufs, Ulrich; Speer, Thimoteus			Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation	NATURE IMMUNOLOGY			English	Article							OF-FUNCTION MUTATIONS; NLRP3 INFLAMMASOME; ENDOTHELIAL DYSFUNCTION; PATTERN-RECOGNITION; CELL-DEATH; APOC-III; PROTEIN; RECEPTOR; ADAPTER; CIII	NLRP3-inflammasome-driven inflammation is involved in the pathogenesis of a variety of diseases. Identification of endogenous inflammasome activators is essential for the development of new anti-inflammatory treatment strategies. Here, we identified that apolipoprotein C3 (ApoC3) activates the NLRP3 inflammasome in human monocytes by inducing an alternative NLRP3 inflammasome via caspase-8 and dimerization of Toll-like receptors 2 and 4. Alternative inflammasome activation in human monocytes is mediated by the Toll-like receptor adapter protein SCIMP. This triggers Lyn/Syk-dependent calcium entry and the production of reactive oxygen species, leading to activation of caspase-8. In humanized mouse models, ApoC3 activated human monocytes in vivo to impede endothelial regeneration and promote kidney injury in an NLRP3- and caspase-8-dependent manner. These data provide new insights into the regulation of the NLRP3 inflammasome and the pathophysiological role of triglyceride-rich lipoproteins containing ApoC3. Targeting ApoC3 might prevent organ damage and provide an anti-inflammatory treatment for vascular and kidney diseases.	[Zewinger, Stephen; Triem, Sarah; Klug, Mira; Schunk, Stefan J.; Schmit, David; Paschen, Anna; Herter, Tobias; Sester, Urban; Fliser, Danilo; Speer, Thimoteus] Univ Saarland, Dept Internal Med 4 Nephrol & Hypertens, Homburg, Germany; [Reiser, Jochen; Hahm, Eunsil] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL USA; [Jankowski, Vera] RWTH Aachen Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany; [Alansary, Dalia; Niemeyer, Barbara A.] Univ Saarland, Sch Med, Ctr Integrat Physiol & Mol Med CIPMM, Mol Biophys, Homburg, Germany; [Kramann, Rafael] RWTH Aachen Univ Hosp, Dept Nephrol, Aachen, Germany; [Kramann, Rafael] Erasmus MC, Div Nephrol & Transplantat, Dept Internal Med, Rotterdam, Netherlands; [Koerbel, Christina; Ampofo, Emmanuel; Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany; [Selejan, Simina-Ramona; Boehm, Michael] Univ Saarland, Dept Internal Med Cardiol 3, Homburg, Germany; [Schuster, Susanne; Laufs, Ulrich] Univ Hosp Leipzig, Dept Cardiol, Leipzig, Germany; [Silbernagel, Guenther] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Sester, Martina] Univ Saarland, Dept Transplant & Infect Immunol, Homburg, Germany; [Assmann, Gunter] Univ Saarland, Dept Internal Med Oncol Hematol Clin Immunol & Rh, Homburg, Germany; [Bals, Robert] Univ Saarland, Dept Internal Med Pneumol & Intens Care Med, Homburg, Germany; [Kostner, Gerhard] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, Graz, Austria; [Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Biointerface Lab, Aachen, Germany; [Rohrer, Lucia] Univ Zurich Hosp, Inst Clin Chem, Zurich, Switzerland; [Menger, Michael D.; Maerz, Winfried] Heidelberg Univ, Med Clin Nephrol Rheumatol Hypertensiol Endocrino, Mannheim Med Fac, Mannheim, Germany; [Maerz, Winfried] Synlab Acad, Synlab Holding Deutschland, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Jankowski, Joachim] Maastricht Univ, CARIM Sch Cardiovac Dis, Maastricht, Netherlands; ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Kopf, Manfred] Univ Massachusetts, Dept Med, Div Infect Dis & Immunol, Med Sch, Worcester, MA USA; German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Saarland University; Rush University; RWTH Aachen University; RWTH Aachen University Hospital; Saarland University; RWTH Aachen University; RWTH Aachen University Hospital; Erasmus University Rotterdam; Erasmus MC; Saarland University; Saarland University; Leipzig University; Medical University of Graz; Saarland University; Saarland University; Saarland University; Medical University of Graz; RWTH Aachen University; RWTH Aachen University Hospital; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg; SYNLAB Group; Medical University of Graz; Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Speer, T (corresponding author), Univ Saarland, Dept Internal Med 4 Nephrol & Hypertens, Homburg, Germany.	timo.speer@uks.eu	Kopf, Manfred/B-6907-2009; Aßmann, Gunter/AAM-7734-2021; Assmann, Gunter/AAM-7173-2021; Niemeyer, Barbara A./AAL-8972-2021; Sester, Martina/AAA-3383-2022; Kramann, Rafael/K-7995-2013; Latz, Eicke/H-3951-2014	Kopf, Manfred/0000-0002-0628-7140; Gaul, Susanne/0000-0003-4780-1844; Silbernagel, Guenther/0000-0001-9323-329X; Kramann, Rafael/0000-0003-4048-6351; /0000-0002-1886-5657; Niemeyer, Barbara A./0000-0002-6963-0575; Alansary, Dalia/0000-0002-7541-6057; Speer, Thimoteus/0000-0002-2491-6393; Latz, Eicke/0000-0003-1488-5666	Deutsche Forschungsgemeinschaft [SFB/TRR 219, SFB894, SFB1027, SFB TRR 219]; Else-Kroener Fresenius Foundation; Deutsche Nierenstiftung; European Uremic Toxin Work Group of the ERA-EDTA; European Community's program 'European Regional Development Fund Interreg' to 'EURIPIDS'	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroener Fresenius Foundation; Deutsche Nierenstiftung; European Uremic Toxin Work Group of the ERA-EDTA; European Community's program 'European Regional Development Fund Interreg' to 'EURIPIDS'	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR 219), Else-Kroener Fresenius Foundation, Deutsche Nierenstiftung and European Uremic Toxin Work Group of the ERA-EDTA. This study was supported by funding from the European Community's program 'European Regional Development Fund Interreg' to 'EURIPIDS' and the Deutsche Forschungsgemeinschaft (SFB894 A2, SFB1027 C4 and SFB TRR 219).	Amoui M, 1997, EUR J IMMUNOL, V27, P321, DOI 10.1002/eji.1830270146; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Fredenrich A, 1997, J LIPID RES, V38, P1421; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Jankowski V, 2013, J MOL MED, V91, P1095, DOI 10.1007/s00109-013-1036-y; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Juntti-Berggren L, 2004, P NATL ACAD SCI USA, V101, P10090, DOI 10.1073/pnas.0403551101; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Khetarpal SA, 2017, NAT MED, V23, P1086, DOI 10.1038/nm.4390; Kralova J, 2016, J BIOL CHEM, V291, P16530, DOI 10.1074/jbc.M116.717157; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lepedda AJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/385214; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Luo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14133; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Shridas P, 2018, J BIOL CHEM, V293, P13257, DOI 10.1074/jbc.RA118.002428; Shroff R, 2014, J AM SOC NEPHROL, V25, P2658, DOI 10.1681/ASN.2013111212; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; Tseng HHL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35016; von Ballmoos MCW, 2015, J CLIN LIPIDOL, V9, P498, DOI 10.1016/j.jacl.2015.05.002; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Westerterp M, 2017, CELL METAB, V25, P1294, DOI 10.1016/j.cmet.2017.04.005; Winkelmann B R, 2001, Pharmacogenomics, V2, pS1, DOI 10.1517/14622416.2.1.S1; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Zewinger S, 2017, LANCET DIABETES ENDO, V5, P534, DOI 10.1016/S2213-8587(17)30096-7; Zewinger S, 2015, EUR HEART J, V36, P3007, DOI 10.1093/eurheartj/ehv352; Zewinger S, 2014, J AM SOC NEPHROL, V25, P1073, DOI 10.1681/ASN.2013050482; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	54	100	102	4	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					30	+		10.1038/s41590-019-0548-1	http://dx.doi.org/10.1038/s41590-019-0548-1			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31819254				2022-12-18	WOS:000515136500011
J	He, SD; Wang, XD				He, Sudan; Wang, Xiaodong			RIP kinases as modulators of inflammation and immunity	NATURE IMMUNOLOGY			English	Review							RECEPTOR-INTERACTING PROTEIN; KAPPA-B ACTIVATION; TUMOR-NECROSIS-FACTOR; MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; NECROPTOTIC CELL-DEATH; PROGRAMMED NECROSIS; NLRP3 INFLAMMASOME; CANCER-CELLS; STAPHYLOCOCCUS-AUREUS	Receptor-interacting protein (RIP) kinases, in particular RIPK1, RIPK2 and RIPK3, have emerged as pleiotropic modulators of inflammatory responses that act either by directly regulating intracellular inflammatory signaling pathways or by causing apoptotic or necrotic cell death. In this Review, we discuss the signaling pathways and immunological functions of these RIP kinases in the inflammatory response to microbial infection and tissue injury, as well as their potential roles in the pathogenesis of inflammatory disease and aging.	[He, Sudan] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China; [He, Sudan] Peking Union Medial Coll, Beijing, Peoples R China; [He, Sudan] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China; [He, Sudan] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [He, Sudan] Soochow Univ, State Key Lab Radiat Med & Protect, Collaborat Innovat Ctr Hematol, Suzhou, Jiangsu, Peoples R China; [He, Sudan] Soochow Univ, Key Lab Stem Cells & Biomed Mat Jiangsu Prov, Suzhou, Jiangsu, Peoples R China; [He, Sudan] Soochow Univ, Chinese Minist Sci & Technol, Suzhou, Jiangsu, Peoples R China; [Wang, Xiaodong] Natl Inst Biol Sci, Beijing, Peoples R China; [Wang, Xiaodong] Zhongguancun Life Sci Pk, Beijing, Peoples R China; [Wang, Xiaodong] Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; National Institute of Biological Sciences, Beijing; Tsinghua University	He, SD (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.; He, SD (corresponding author), Peking Union Medial Coll, Beijing, Peoples R China.; He, SD (corresponding author), Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.; He, SD (corresponding author), Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China.; He, SD (corresponding author), Soochow Univ, State Key Lab Radiat Med & Protect, Collaborat Innovat Ctr Hematol, Suzhou, Jiangsu, Peoples R China.; He, SD (corresponding author), Soochow Univ, Key Lab Stem Cells & Biomed Mat Jiangsu Prov, Suzhou, Jiangsu, Peoples R China.; He, SD (corresponding author), Soochow Univ, Chinese Minist Sci & Technol, Suzhou, Jiangsu, Peoples R China.; Wang, XD (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.; Wang, XD (corresponding author), Zhongguancun Life Sci Pk, Beijing, Peoples R China.; Wang, XD (corresponding author), Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China.	hesudan@suda.edu.cn; wangxiaodong@nibs.ac.cn		Wang, Xiaodong/0000-0001-9885-356X; He, Sudan/0000-0002-0846-1210	National Basic Research (973) Program of China [2013CB910102]; National Natural Science Foundation of China [31471303, 31671436]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Fok Ying Tung Education Foundation [151020]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2017NL31002, 2017NL31004]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences	Supported by the National Basic Research (973) Program of China (2013CB910102), the National Natural Science Foundation of China (31471303 and 31671436), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Fok Ying Tung Education Foundation for Young Teachers (151020) and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2017NL31002,2017NL31004).	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen WZ, 2015, NAT CELL BIOL, V17, P434, DOI 10.1038/ncb3120; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cougnoux A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.16; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Dara L, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.89; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Dovey CM, 2018, MOL CELL, V70, P936, DOI 10.1016/j.molcel.2018.05.010; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feng X, 2015, NEOPLASMA, V62, P592, DOI 10.4149/neo_2015_071; Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Goncharov T, 2018, MOL CELL, V69, P551, DOI 10.1016/j.molcel.2018.01.016; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Greenlee-Wacker MC, 2014, J IMMUNOL, V192, P4709, DOI 10.4049/jimmunol.1302692; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hockendorf U, 2016, ONCOTARGET, V7, P57483, DOI 10.18632/oncotarget.11195; Hockendorf U, 2016, CANCER CELL, V30, P75, DOI 10.1016/j.ccell.2016.06.002; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang ZJ, 2018, CELL DEATH DIFFER, V25, P180, DOI 10.1038/cdd.2017.141; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitur K, 2016, CELL REP, V16, P2219, DOI 10.1016/j.celrep.2016.07.039; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Koehler H, 2017, P NATL ACAD SCI USA, V114, P11506, DOI 10.1073/pnas.1700999114; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li D., 2017, ELIFE, V6, P6; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Liu ZY, 2015, AM J CANCER RES, V5, P3174; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Nugues AL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.347; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2017, P NATL ACAD SCI USA, V114, pE8788, DOI 10.1073/pnas.1714175114; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Omoto S, 2015, J BIOL CHEM, V290, P11635, DOI 10.1074/jbc.M115.646042; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Pavlosky A, 2014, AM J TRANSPLANT, V14, P1778, DOI 10.1111/ajt.12779; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Pouwels SD, 2016, AM J PHYSIOL-LUNG C, V310, P1377, DOI 10.1152/ajplung.00174.2015; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Schmidt SV, 2015, ONCOTARGET, V6, P8635, DOI 10.18632/oncotarget.3249; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sharma A, 2014, CRIT CARE, V18, DOI 10.1186/cc13970; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vucur M, 2013, CELL REP, V4, P776, DOI 10.1016/j.celrep.2013.07.035; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang HB, 2017, P NATL ACAD SCI USA, V114, P11944, DOI 10.1073/pnas.1715742114; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Witt A, 2017, CELL DEATH DIFFER, V24, P1160, DOI 10.1038/cdd.2017.33; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Xia BQ, 2016, CELL RES, V26, P517, DOI 10.1038/cr.2016.26; Xin J, 2017, LEUKEMIA, V31, P1154, DOI 10.1038/leu.2016.287; Yang CK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.483; Yang H, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1149673; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Yu XL, 2016, J VIROL, V90, P1088, DOI 10.1128/JVI.02446-15; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	169	100	100	4	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					912	922		10.1038/s41590-018-0188-x	http://dx.doi.org/10.1038/s41590-018-0188-x			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30131615				2022-12-18	WOS:000442365100013
J	Johnson, LA; Banerji, S; Lawrance, W; Gileadi, U; Prota, G; Holder, KA; Roshorm, YM; Hanke, T; Cerundolo, V; Gale, NW; Jackson, DG				Johnson, Louise A.; Banerji, Suneale; Lawrance, William; Gileadi, Uzi; Prota, Gennaro; Holder, Kayla A.; Roshorm, Yaowaluck M.; Hanke, Tomas; Cerundolo, Vincenzo; Gale, Nicholas W.; Jackson, David G.			Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1	NATURE IMMUNOLOGY			English	Article							MIGRATION; CD44; TRANSMIGRATION; LEUKOCYTES; REGULATOR; SECRETION; TRANSIT; BINDING; CCL21; MOUSE	Trafficking of tissue dendritic cells (DCs) via lymph is critical for the generation of cellular immune responses in draining lymph nodes (LNs). In the current study we found that DCs docked to the basolateral surface of lymphatic vessels and transited to the lumen through hyaluronan-mediated interactions with the lymph-specific endothelial receptor LYVE-1, in dynamic transmigratory-cup-like structures. Furthermore, we show that targeted deletion of the gene Lyve1, antibody blockade or depletion of the DC hyaluronan coat not only delayed lymphatic trafficking of dermal DCs but also blunted their capacity to prime CD8(+) T cell responses in skin-draining LNs. Our findings uncovered a previously unknown function for LYVE-1 and show that transit through the lymphatic network is initiated by the recognition of leukocyte-derived hyaluronan.	[Johnson, Louise A.; Banerji, Suneale; Lawrance, William; Gileadi, Uzi; Prota, Gennaro; Holder, Kayla A.; Cerundolo, Vincenzo; Jackson, David G.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford, England; [Roshorm, Yaowaluck M.] King Monkuts Univ Technol, Sch Bioresources & Technol, Div Biotechnol, Thonburi, Thailand; [Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England; [Hanke, Tomas] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Gale, Nicholas W.] Regeneron Pharmaceut, Tarrytown, NY USA	University of Oxford; University of Oxford; Jenner Institute; Kumamoto University; Regeneron	Johnson, LA; Jackson, DG (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford, England.	louise.johnson@imm.ox.ac.uk; david.jackson@imm.ox.ac.uk	Holder, Kayla/Y-2127-2019	, david/0000-0002-4133-9364; Gileadi, Uzi/0000-0001-7348-9204; Johnson, Louise/0000-0001-6667-8912; Hanke, Tomas/0000-0002-6076-9546	UK Medical Research Council through MRC Human Immunology Unit [MR/L008610/1]; MRC [G1001757, MR/N023668/1, MC_UU_00008/2, G1000800, MC_U137884179, MC_UU_12010/2, MC_U137884182, G0701669, MC_UU_00008/1] Funding Source: UKRI; Cancer Research UK [17722, 11331] Funding Source: researchfish; Medical Research Council [MR/N023668/1, G1000800, MC_UU_00008/2, MC_UU_00008/1, G1000800e, 1093777, G1001757, G0701669, MC_U137884179, MC_U137884182, MC_UU_12010/2] Funding Source: researchfish	UK Medical Research Council through MRC Human Immunology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council through MRC Human Immunology Unit core funding and Project Grant MR/L008610/1 (to D.G.J.). Lyve1<SUP>-/-</SUP> mice on the C57BL/6 background were kindly provided by Regeneron Pharmaceuticals (Tarrytown, New York, USA). F5 TCR-transgenic mice recognizing the H-2D<SUP>b</SUP>-restricted influenza virus nucleoprotein epitope ASNENMDAM (Flu-NP<INF>366-374</INF>) were kindly provided by D. Kioussis (National Institute of Medical Research, London, UK). CD11c-GFP reporter mice were a kind gift from F. Powrie (Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK). The authors acknowledge the now deceased M. Puklavec (Sir William Dunn School of Pathology, Oxford, UK) for his invaluable technical advice on making rat monoclonal antibodies, and the Wolfson Imaging Centre, Weatherall Institute of Molecular Medicine (Oxford, UK), for access to the fluorescence microscopy equipment used in this project. The authors also thank P. Sopp, C. Waugh, K. Clark and S.-A. Clark at the WIMM Flow Cytometry Facility for their excellent technical assistance and advice.	Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Bano F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34176; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909; Cumberbatch M, 2003, APMIS, V111, P797, DOI 10.1034/j.1600-0463.2003.11107811.x; Curraterbatch M., 2001, IMMUNOLOGY, V102, P323; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 2011, J HISTOCHEM CYTOCHEM, V59, P252, DOI 10.1369/0022155410397760; Fstcourt M. J., 2005, EUR J IMMUNOL, V35, P3464; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Hou WH, 2011, J CELL SCI, V124, P1231, DOI 10.1242/jcs.078154; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Jackson David G, 2014, J Clin Cell Immunol, V5; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McDonald B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00068; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Protin U, 1999, J IMMUNOL, V163, P4917; Randolph G. J., 2017, ANN REV IMMUNOL, V35; Rigby DA, 2015, J LEUKOCYTE BIOL, V98, P897, DOI 10.1189/jlb.1HI0415-149R; Russo E, 2016, CELL REP, V14, P1723, DOI 10.1016/j.celrep.2016.01.048; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Stoitzner P, 2010, METHODS MOL BIOL, V595, P235, DOI 10.1007/978-1-60761-421-0_16; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Teijeira A, 2013, J INVEST DERMATOL, V133, P2276, DOI 10.1038/jid.2013.152; Teoh D, 2009, J IMMUNOL, V182, P2425, DOI 10.4049/jimmunol.0803661; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019	50	100	101	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					762	+		10.1038/ni.3750	http://dx.doi.org/10.1038/ni.3750			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28504698	Green Submitted			2022-12-18	WOS:000403676300011
J	Kim, JH; Hu, Y; Tang, YQ; Kim, J; Hughes, VA; Le Nours, J; Marquez, EA; Purcell, AW; Wan, Q; Sugita, M; Rossjohn, J; Winau, F				Kim, Ji Hyung; Hu, Yu; Tang Yongqing; Kim, Jessica; Hughes, Victoria A.; Le Nours, Jerome; Marquez, Elsa A.; Purcell, Anthony W.; Wan, Qi; Sugita, Masahiko; Rossjohn, Jamie; Winau, Florian			CD1a on Langerhans cells controls inflammatory skin disease	NATURE IMMUNOLOGY			English	Article							ALLERGIC CONTACT-DERMATITIS; T-CELLS; ANTIGEN PRESENTATION; ALPHA; RECOGNITION; URUSHIOL; GAMMA; IDENTIFICATION; LIPIDS	CD1a is a lipid-presenting molecule that is abundantly expressed on Langerhans cells. However, the in vivo role of CD1a has remained unclear, principally because CD1a is lacking in mice. Through the use of mice with transgenic expression of CD1a, we found that the plant-derived lipid urushiol triggered CD1a-dependent skin inflammation driven by CD4(+) helper T cells that produced the cytokines IL-17 and IL-22 (T(H)17 cells). Human subjects with poison-ivy dermatitis had a similar cytokine signature following CD1a-mediated recognition of urushiol. Among various urushiol congeners, we identified diunsaturated pentadecylcatechol (C15:2) as the dominant antigen for CD1a-restricted T cells. We determined the crystal structure of the CD1a-urushiol (C15:2) complex, demonstrating the molecular basis of urushiol interaction with the antigen-binding cleft of CD1a. In a mouse model and in patients with psoriasis, CD1a amplified inflammatory responses that were mediated by TH17 cells that reacted to self lipid antigens. Treatment with blocking antibodies to CD1a alleviated skin inflammation. Thus, we propose CD1a as a potential therapeutic target in inflammatory skin diseases.	[Kim, Ji Hyung; Hu, Yu; Kim, Jessica; Wan, Qi; Winau, Florian] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Tang Yongqing; Hughes, Victoria A.; Le Nours, Jerome; Marquez, Elsa A.; Purcell, Anthony W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Tang Yongqing; Hughes, Victoria A.; Le Nours, Jerome; Marquez, Elsa A.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Sugita, Masahiko] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Imm, Clayton, Vic, Australia; [Rossjohn, Jamie] Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto, Japan; [Kim, Ji Hyung; Hu, Yu] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, S Glam, Wales	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Monash University; Monash University; Monash University; Kyoto University; Cardiff University	Winau, F (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto, Japan.	jamie.rossjohn@monash.edu; florian.winau@childrens.harvard.edu	Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019	Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Hu, Yu/0000-0002-9511-9383; Kim, JI HYUNG/0000-0001-6785-2345; Le Nours, Jerome/0000-0002-2221-7636; Sugita, Masahiko/0000-0001-5511-1304	National Research Foundation of Korea [2012R1A6A3A03040248]; AMOREPACIFIC Research Scholar Program; National Health and Medical Research Council of Australia; Australian Research Council; US National Institutes of Health [R01 AI083426]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083426, R56AI122291] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); AMOREPACIFIC Research Scholar Program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Brenner (Brigham and Women's Hospital, Boston) for anti-CD1a; B. Moody and T.-Y. Cheng (Brigham and Women's Hospital, Boston) for K562 cells and advice on human T cell assays; A. Del Grosso (Food and Drug Administration) for natural urushiols; U. von Andrian and J. Ordovas-Montanes for advice on the preparation of skin tissue; the US National Institutes of Health (NIH) tetramer facility for CD1a monomers; and the staff at the Australian synchrotron for assistance with data collection. Supported by the National Research Foundation of Korea (2012R1A6A3A03040248 to J.H.K.), the AMOREPACIFIC Research Scholar Program (to J.H.K.), National Health and Medical Research Council of Australia (J.R. and A.W.P.), the Australian Research Council (J.R.) and the US National Institutes of Health (R01 AI083426 to F.W.).	Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Alshehry ZH, 2015, METABOLITES, V5, P389, DOI 10.3390/metabo5020389; Birkinshaw RW, 2015, NAT IMMUNOL, V16, P258, DOI 10.1038/ni.3098; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bourgeois EA, 2015, J EXP MED, V212, P149, DOI 10.1084/jem.20141505; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Igyarto BZ, 2013, CURR OPIN IMMUNOL, V25, P115, DOI 10.1016/j.coi.2012.11.007; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jarrett R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6833; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; KALISH RS, 1990, J INVEST DERMATOL, V94, pS108, DOI 10.1111/1523-1747.ep12876061; KALISH RS, 1990, J IMMUNOL, V145, P3706; KALISH RS, 1994, J CLIN INVEST, V93, P2039, DOI 10.1172/JCI117198; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kobayashi C, 2012, J INVEST DERMATOL, V132, P241, DOI 10.1038/jid.2011.280; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Pena-Cruz V, 2003, J INVEST DERMATOL, V121, P517, DOI 10.1046/j.1523-1747.2003.12429.x; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Smart O. S., 2011, GRADE VERSION 1 2 20; Stoitzner P, 2010, METHODS MOL BIOL, V595, P235, DOI 10.1007/978-1-60761-421-0_16; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Wakabayashi T, 2005, IMMUNOL CELL BIOL, V83, P18, DOI 10.1111/j.1440-1711.2005.01310.x; Walker SL, 2006, INT J DERMATOL, V45, P810, DOI 10.1111/j.1365-4632.2006.02825.x; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	43	100	103	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1159	+		10.1038/ni.3523	http://dx.doi.org/10.1038/ni.3523			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27548435	Green Submitted, Green Accepted			2022-12-18	WOS:000384302900007
J	Steinke, FC; Yu, SY; Zhou, XY; He, B; Yang, WJ; Zhou, B; Kawamoto, H; Zhu, J; Tan, K; Xue, HH				Steinke, Farrah C.; Yu, Shuyang; Zhou, Xinyuan; He, Bing; Yang, Wenjing; Zhou, Bo; Kawamoto, Hiroshi; Zhu, Jun; Tan, Kai; Xue, Hai-Hui			TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS TCF-1; LINEAGE CHOICE; THYMOCYTE DIFFERENTIATION; CYTOTOXIC-LINEAGE; GENE-EXPRESSION; DEFICIENT MICE; THPOK; SPECIFICATION; COMMITMENT; REPRESSION	The transcription factors TCF-1 and LEF-1 are essential for early T cell development, but their roles beyond the CD4(+)CD8(+) double-positive (DP) stage are unknown. By specific ablation of these factors in DP thymocytes, we demonstrated that deficiency in TCF-1 and LEF-1 diminished the output of CD4(+) T cells and redirected CD4(+) T cells to a CD8(+) T cell fate. The role of TCF-1 and LEF-1 in the CD4-versus-CD8 lineage 'choice' was mediated in part by direct positive regulation of the transcription factor Th-POK. Furthermore, loss of TCF-1 and LEF-1 unexpectedly caused derepression of CD4 expression in T cells committed to the CD8(+) lineage without affecting the expression of Runx transcription factors. Instead, TCF-1 physically interacted with Runx3 to cooperatively silence Cd4. Thus, TCF-1 and LEF-1 adopted distinct genetic 'wiring' to promote the CD4(+) T cell fate and establish CD8(+) T cell identity.	[Steinke, Farrah C.; Zhou, Bo; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Steinke, Farrah C.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA; [Yu, Shuyang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhou, Xinyuan] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China; [He, Bing] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA; [Yang, Wenjing; Zhu, Jun] NHLBI, Ctr Dev Biol, NIH, Bethesda, MD 20892 USA; [Kawamoto, Hiroshi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunol, Kyoto, Japan; [Tan, Kai] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; China Agricultural University; Army Medical University; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kyoto University; University of Iowa	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	hai-hui-xue@uiowa.edu	Zhou, Xinyuan/AFS-9817-2022	Tan, Kai/0000-0002-9104-5567; Zhou, Xinyuan/0000-0002-1374-8240; Xue, Hai-Hui/0000-0002-9163-7669	American Cancer Society [RSG-11-161-01-MPC]; US National Institutes of Health [HL095540, AI105351, HG006130, AI007485, P30CA086862, 1S10 RR027219]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027219] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104369] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Bosselut (National Cancer Institute of the US National Institutes of Health) for mice expressing the transgene encoding Th-POK; S.-C. Bae (Chungbuh National University) for the Myc-tagged Runx3 expression plasmid; B.J. Fowlkes for input and discussions; Y. Wakabayashi and Y. Luo (NHLBI) for high-throughput sequencing and data processing; T. Zhao for animal husbandry; the Flow Cytometry Core facility at the University of Iowa (J. Fishbaugh, H. Vignes and G. Rasmussen) for support for cell sorting; and Radiation Core facility at the University of Iowa (A. Kalen) for mouse irradiation. Supported by the American Cancer Society (RSG-11-161-01-MPC to H.-H.X.) and the US National Institutes of Health (HL095540 and AI105351 to H.-H.X.; HG006130 to K.T.; AI007485 (for support of F.C.S.); and P30CA086862 and 1S10 RR027219 to the Flow Core Facility at the University of Iowa). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu SY, 2013, BLOOD, V121, P4008, DOI 10.1182/blood-2013-01-477349; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	47	100	103	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					646	656		10.1038/ni.2897	http://dx.doi.org/10.1038/ni.2897			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24836425	Green Accepted			2022-12-18	WOS:000337715600011
J	Pang, IK; Ichinohe, T; Iwasaki, A				Pang, Iris K.; Ichinohe, Takeshi; Iwasaki, Akiko			IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8(+) T cell responses to influenza A virus	NATURE IMMUNOLOGY			English	Article							SINGLE-STRANDED RNA; ANTIGEN PRESENTATION; ANTIVIRAL RESPONSES; ADAPTIVE IMMUNITY; ACTIVATION; INTERLEUKIN-1; INNATE; POPULATIONS; INDUCTION; INFECTION	Immune responses to vaccines require direct recognition of pathogen-associated molecular patterns (PAMPs) through pattern-recognition receptors (PRRs) on dendritic cells (DCs). Unlike vaccination, infection by a live pathogen often impairs DC function and inflicts additional damage on the host. Here we found that after infection with live influenza A virus, signaling through the interleukin 1 receptor (IL-1R) was required for productive priming of CD8(+) T cells, but signaling through the PRRs TLR7 and RIG-I was not. DCs activated by IL-1 in trans were both required and sufficient for the generation of virus-specific CD8(+) T cell immunity. Our data demonstrate a critical role for a bystander cytokine in the priming of CD8(+) T cells during infection with a live virus.	[Pang, Iris K.; Ichinohe, Takeshi; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	US National Institutes of Health [AI062428, U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062428, U54AI057160, R01AI062428] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Kaech (Yale University) for P14 mice, and H. Dong for technical support. Supported by the US National Institutes of Health (AI062428 and U54 AI057160 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research).	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Blander JM, 2008, ANN RHEUM DIS, V67, P44, DOI 10.1136/ard.2008.097964; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Heer AK, 2008, J IMMUNOL, V181, P6984, DOI 10.4049/jimmunol.181.10.6984; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; Smed-Sorensen A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002572; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006	37	100	103	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					246	253		10.1038/ni.2514	http://dx.doi.org/10.1038/ni.2514			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23314004	Green Accepted			2022-12-18	WOS:000315065400014
J	Zhao, J; Wei, JX; Mialki, RK; Mallampalli, DF; Chen, BB; Coon, T; Zou, CB; Mallampalli, RK; Zhao, YT				Zhao, Jing; Wei, Jianxin; Mialki, Rachel K.; Mallampalli, Daniel F.; Chen, Bill B.; Coon, Tiffany; Zou, Chunbin; Mallampalli, Rama K.; Zhao, Yutong			F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation	NATURE IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; INTERLEUKIN-33; EXPRESSION; CORTACTIN; GENE; INHIBITION; ACTIVATION; CELLS	The ST2L receptor for interleukin 33 (IL-33) mediates pulmonary inflammation and immune system-related disorders, such as asthma and rheumatoid arthritis. At present, very little is known about the molecular regulation of ST2L expression. Here we found that FBXL19, an 'orphan' member of the Skp1-Cullin-F-box family of E3 ubiquitin ligases, selectively bound to ST2L to mediate its polyubiquitination and elimination in the proteasome. Degradation of ST2L involved phosphorylation of ST2L at Ser442 catalyzed by the kinase GSK3 beta. Overexpression of FBXL19 abrogated the proapoptotic and inflammatory effects of IL-33 and lessened the severity of lung injury in mouse models of pneumonia. Our results suggest that modulation of the IL-33-ST2L axis by ubiquitin ligases might serve as a unique strategy for lessening pulmonary inflammation.	[Zhao, Jing; Wei, Jianxin; Mialki, Rachel K.; Mallampalli, Daniel F.; Chen, Bill B.; Coon, Tiffany; Zou, Chunbin; Mallampalli, Rama K.; Zhao, Yutong] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Zhao, Jing; Wei, Jianxin; Mialki, Rachel K.; Mallampalli, Daniel F.; Chen, Bill B.; Coon, Tiffany; Zou, Chunbin; Mallampalli, Rama K.; Zhao, Yutong] Univ Pittsburgh, Sch Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA USA; [Mallampalli, Rama K.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zhao, YT (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	zhaoy3@upmc.edu	Zou, Chunbin/L-7488-2019; Wei, Jianxin/P-5431-2016	Zou, Chunbin/0000-0003-1355-4726; 	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; US Department of Veterans Affairs; US National Institutes of Health [R01 HL01916, R01 HL096376, R01 HL097376, R01 HL098174]; American Heart Association [12SDG9050005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL091916, R01HL098174, R01HL112791, R01HL097376, R01HL096376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	We thank L. Wallace for technical assistance. This study is based on work supported in part by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. Supported by the US Department of Veterans Affairs (Merit Review Award), the US National Institutes of Health (R01 HL01916 to Y.Z. and R01 HL096376, R01 HL097376 and R01 HL098174 to R. K. M.) and the American Heart Association (12SDG9050005 to J.Z.). The contents presented do not represent the views of the Department of Veterans Affairs or the United States Government.	Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Chen YR, 2001, BIOCHEM BIOPH RES CO, V288, P981, DOI 10.1006/bbrc.2001.5862; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gesbert F, 2005, BIOCHEM BIOPH RES CO, V334, P474, DOI 10.1016/j.bbrc.2005.06.121; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Jadhav Trafina, 2009, J Proteomics Bioinform, V2, P316; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Katoh M, 2004, INT J MOL MED, V14, P1109; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kurowska-Stolarska M, 2011, J INTERN MED, V269, P29, DOI 10.1111/j.1365-2796.2010.02316.x; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Li HJ, 2000, GENOMICS, V67, P284, DOI 10.1006/geno.2000.6269; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; MUELLER SG, 1995, J BIOL CHEM, V270, P10439, DOI 10.1074/jbc.270.18.10439; Na HJ, 2012, CYTOKINE, V57, P169, DOI 10.1016/j.cyto.2011.10.007; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nguyen CQ, 2011, LAB INVEST, V91, P54, DOI 10.1038/labinvest.2010.164; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rong ZL, 2007, CELL SIGNAL, V19, P1514, DOI 10.1016/j.cellsig.2007.01.025; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Timpson P, 2007, CANCER RES, V67, P9304, DOI 10.1158/0008-5472.CAN-07-0798; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yin H, 2011, CLIN EXP IMMUNOL, V164, P248, DOI 10.1111/j.1365-2249.2011.04326.x; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	44	100	107	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					651	+		10.1038/ni.2341	http://dx.doi.org/10.1038/ni.2341			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22660580	Green Accepted			2022-12-18	WOS:000305483800010
J	Hugues, S; Scholer, A; Boissonnas, A; Nussbaum, A; Combadiere, C; Amigorena, S; Fetler, L				Hugues, Stephanie; Scholer, Alix; Boissonnas, Alexandre; Nussbaum, Alexander; Combadiere, Christophe; Amigorena, Sebastian; Fetler, Luc			Dynamic imaging of chemokine-dependent CD8(+) T cell help for CD8(+) T cell responses	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; LYMPH-NODES; NK-CELLS; TUMOR-GROWTH; CROSS-TALK; MOTILITY; ANTIGEN; LYMPHOCYTES; MATURATION; INDUCTION	Naive T lymphocytes move efficiently in lymphoid tissues while scanning dendritic cells in search of cognate complexes of peptide in major histocompatibility molecules. However, T cell migration ceases after recognition of cognate antigen. We show here that during the initiation of antigen-specific CD8(+) T cell responses, naive CD8(+) polyclonal T cells 'preferentially' interacted in an antigen-independent way with mature dendritic cells competent to present antigen to antigen-specific CD8(+) T cells. These antigen-independent interactions required expression of the chemokine receptor CCR5 on polyclonal T cells and increased the efficiency of the induction of naive, low-precursor-frequency CD8(+) T cell responses. Thus, antigen-specific CD8(+) T cells favor the priming of naive CD8(+) T cells by promoting the CCR5-dependent recruitment of polyclonal CD8(+) T cells to mature dendritic cells.	Ctr Rech, Inst Curie, F-75248 Paris, France; Inst Curie, U653, Inst Natl Sante & Rech Med, F-75248 Paris, France; Hop La Pitie Salpetriere, Lab Immunol Cellulaire, U543, Inst Natl Sante & Rech Med, F-75013 Paris, France; Inst Curie, Lab Physicochim Curie, UMR 168, CNRS, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite	Hugues, S (corresponding author), Ctr Rech, Inst Curie, F-75248 Paris, France.	sebastian.amigorena@curie.fr; luc.fetler@curie.fr	Fetler, luc/M-9034-2018; Scholer-Dahirel, Alix/G-5858-2014; Boissonnas, Alexandre/A-2801-2016; Combadiere, Christophe/I-5639-2013	Boissonnas, Alexandre/0000-0002-7770-7210; Combadiere, Christophe/0000-0002-1755-4531; hugues, stephanie/0000-0002-1031-5909; Amigorena, Sebastian/0000-0001-8583-8416				Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Assarsson E, 2004, J IMMUNOL, V173, P174, DOI 10.4049/jimmunol.173.1.174; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Hadjantonakis AK, 2001, HISTOCHEM CELL BIOL, V115, P49, DOI 10.1007/s004180000233; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lavergne E, 2004, J IMMUNOL, V173, P3755, DOI 10.4049/jimmunol.173.6.3755; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Serre K, 2006, EUR J IMMUNOL, V36, P1386, DOI 10.1002/eji.200526193; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	40	100	100	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					921	930		10.1038/ni1495	http://dx.doi.org/10.1038/ni1495			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17660821				2022-12-18	WOS:000248918200015
J	Krieg, C; Boyman, O; Fu, YX; Kaye, J				Krieg, Carsten; Boyman, Onur; Fu, Yang-Xin; Kaye, Jonathan			B and T lymphocyte attenuator regulates CD8(+) T cell-intrinsic homeostasis and memory cell generation	NATURE IMMUNOLOGY			English	Article							HERPESVIRUS ENTRY MEDIATOR; IN-VIVO; POSITIVE SELECTION; TNF SUPERFAMILY; CUTTING EDGE; PROLIFERATION; RECEPTOR; LIGHT; EXPRESSION; SURVIVAL	B and T lymphocyte attenuator (BTLA) is a negative regulator of T cell activation, but its function in vivo is not well characterized. Here we show that mice deficient in full-length BTLA or its ligand, herpesvirus entry mediator, had increased number of memory CD8(+) T cells. The memory CD8(+) T cell phenotype resulted from a T cell-intrinsic perturbation of the CD8(+) T cell pool. Naive BTLA-deficient CD8(+) T cells were more efficient than wild-type cells at generating memory in a competitive antigen-specific system. This effect was independent of the initial expansion of the responding antigen-specific T cell population. In addition, BTLA negatively regulated antigen-independent homeostatic expansion of CD4(+) and CD8(+) T cells. These results emphasize two central functions of BTLA in limiting T cell activity in vivo.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Lausanne Hosp, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Scripps Research Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Chicago	Kaye, J (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkaye@scripps.edu	Krieg, Carsten/ABA-6734-2020	Krieg, Carsten/0000-0002-5145-7591; Kaye, Jonathan/0000-0002-1634-9069; Boyman, Onur/0000-0001-8279-5545; fu, yang-xin/0000-0001-8441-6617	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031231, R29AI031231] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-31231, R01 AI031231-14, R01 AI031231] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chemnitz JM, 2006, J IMMUNOL, V176, P6603, DOI 10.4049/jimmunol.176.11.6603; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ge Q, 2001, P NATL ACAD SCI USA, V98, P1728, DOI 10.1073/pnas.98.4.1728; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lefrancois L, 2002, ADV EXP MED BIOL, V512, P141; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Margolick J B, 1997, Semin Immunol, V9, P381, DOI 10.1006/smim.1997.0096; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Otsuki N, 2006, BIOCHEM BIOPH RES CO, V344, P1121, DOI 10.1016/j.bbrc.2006.03.242; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Reed AJ, 2005, IMMUNOLOGY, V116, P400, DOI 10.1111/j.1365-2567.2005.02240.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sedgmen BJ, 2006, INT IMMUNOL, V18, P797, DOI 10.1093/intimm/dxl016; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P2268, DOI 10.1073/pnas.96.5.2268; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tamada K, 2000, NAT MED, V6, P283; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Wang J, 2005, J IMMUNOL, V174, P8173, DOI 10.4049/jimmunol.174.12.8173; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	60	100	106	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					162	171		10.1038/ni1418	http://dx.doi.org/10.1038/ni1418			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17206146				2022-12-18	WOS:000243597600014
J	Song, JX; Salek-Ardakani, S; So, T; Croft, M				Song, Jianxun; Salek-Ardakani, Shahram; So, Takanori; Croft, Michael			The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes	NATURE IMMUNOLOGY			English	Article							SURVIVIN EXPRESSION; SPINDLE CHECKPOINT; CLONAL EXPANSION; GROWTH ARREST; APOPTOSIS; RAPAMYCIN; ANERGY; PHOSPHORYLATION; PROTEIN; ACTIVATION	CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin ( mTOR). Expression of aurora B in Cd28(-/-) T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28(-/-) T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA; Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China	La Jolla Institute for Immunology; Army Medical University	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA.	mick@liai.org	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526	NIAID NIH HHS [AI49453, AI50498] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049453, P01AI050498] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; MORICE WG, 1993, J BIOL CHEM, V268, P22737; MORICE WG, 1993, J BIOL CHEM, V268, P3734; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Powell JD, 1999, J IMMUNOL, V162, P2775; Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO;2-G; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen WH, 2004, J BIOL CHEM, V279, P7438, DOI 10.1074/jbc.M310264200; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tamm I, 1998, CANCER RES, V58, P5315; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Wall NR, 2003, CANCER RES, V63, P230; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y	49	100	102	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					64	73		10.1038/ni1413	http://dx.doi.org/10.1038/ni1413			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17128276				2022-12-18	WOS:000242934400015
J	Maloy, KJ; Powrie, F				Maloy, KJ; Powrie, F			Fueling regulation: IL-2 keeps CD4(+) T-reg cells fit	NATURE IMMUNOLOGY			English	Editorial Material							INTERLEUKIN-2; IL-2R-ALPHA; EXPRESSION; TOLERANCE; MICE		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Maloy, KJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk; fiona.powrie@path.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688	Wellcome Trust [070361] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T	12	100	109	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1071	1072		10.1038/ni1105-1071	http://dx.doi.org/10.1038/ni1105-1071			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239920				2022-12-18	WOS:000232833300005
J	Wipke, BT; Wang, Z; Kim, J; McCarthy, TJ; Allen, PM				Wipke, BT; Wang, Z; Kim, J; McCarthy, TJ; Allen, PM			Dynamic visualization of a joint-specific autoimmune response through positron emission tomography	NATURE IMMUNOLOGY			English	Article							AUTOCRINE MOTILITY FACTOR; COLLAGEN-INDUCED ARTHRITIS; PASSIVE TRANSFER; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; NEUROLEUKIN; IMMUNOGLOBULIN; EXPRESSION; ANTIBODIES; MODEL	In the K/BxN mouse model of rheumatoid arthritis, the transfer of autoantibodies specific for glucose-6-phosphate isomerase (GPI) into naive mice rapidly induces joint-specific inflammation similar to that seen in human rheumatoid arthritis. The ubiquitous expression of GPI and the systemic circulation of anti-GPI immunoglobulin G (IgG) seem incongruous with the tissue specificity of this disease. By using PET (positron emission tomography), we show here that purified anti-GPI IgG localizes specifically to distal joints in the front and rear limbs within minutes of intravenous injection, reaches saturation by 20 min and remains localized for at least 24 h. In contrast, control IgG does not localize to joints or cause inflammation. The rapid kinetics of anti-GPI IgG joint localization supports a model in which autoantibodies bind directly to pre-existing extracellular GPI in normal healthy mouse joints.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	allen@pathbox.wustl.edu			NATIONAL CANCER INSTITUTE [R24CA083060, R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238] Funding Source: NIH RePORTER; NCI NIH HHS [R24CA086307, R24CA083060] Funding Source: Medline; NIAID NIH HHS [P01AI31238] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; BREEDVELD FC, 1989, J NUCL MED, V30, P2017; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Cherry SR, 1997, IEEE T NUCL SCI, V44, P1161, DOI 10.1109/23.596981; FALK P, 1988, NATURE, V332, P455; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; HOLLISTER JR, 1973, ARTHRITIS RHEUM-US, V16, P10; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; JUWEID M, 1992, EUR J NUCL MED, V19, P159; KERWAR SS, 1983, CLIN IMMUNOL IMMUNOP, V29, P318, DOI 10.1016/0090-1229(83)90033-8; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Leclerc N, 2000, J NEUROSCI RES, V60, P602, DOI 10.1002/(SICI)1097-4547(20000601)60:5<602::AID-JNR5>3.0.CO;2-F; LEWIS MR, 1994, BIOCONJUGATE CHEM, V5, P565, DOI 10.1021/bc00030a012; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; LOUTIS N, 1988, AGENTS ACTIONS, V25, P352, DOI 10.1007/BF01965042; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Niinaka Y, 1998, CANCER RES, V58, P2667; Phelps ME, 2000, J NUCL MED, V41, P661; RUBIN RH, 1994, SEMIN NUCL MED, V24, P169, DOI 10.1016/S0001-2998(05)80230-2; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SODOYEZGOFFAUX F, 1987, J CLIN INVEST, V80, P466, DOI 10.1172/JCI113094; STUART JM, 1982, J EXP MED, V155, P1, DOI 10.1084/jem.155.1.1; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Watanabe H, 1996, CANCER RES, V56, P2960; WATANABE H, 1991, J BIOL CHEM, V266, P13442; WATSON WC, 1987, ARTHRITIS RHEUM, V30, P460, DOI 10.1002/art.1780300418; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; ZIMMERMAN HJ, 1965, J LAB CLIN MED, V66, P961	33	100	101	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					366	372		10.1038/ni775	http://dx.doi.org/10.1038/ni775			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11896393				2022-12-18	WOS:000174623600018
J	Masuda, T; Amann, L; Sankowski, R; Staszewski, O; Lenz, M; d'Errico, P; Snaidero, N; Jordao, MJC; Bottcher, C; Kierdorf, K; Jung, SF; Priller, J; Misgeld, T; Vlachos, A; Luehmann, MM; Knobeloch, KP; Prinz, M				Masuda, Takahiro; Amann, Lukas; Sankowski, Roman; Staszewski, Ori; Lenz, Maximilian; d'Errico, Paolo; Snaidero, Nicolas; Costa Jordao, Marta Joana; Boettcher, Chotima; Kierdorf, Katrin; Jung, Steffen; Priller, Josef; Misgeld, Thomas; Vlachos, Andreas; Luehmann, Melanie Meyer; Knobeloch, Klaus-Peter; Prinz, Marco			Novel Hexb-based tools for studying microglia in the CNS	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELOID CELLS; REVEALS; MOUSE; FATE; NEURONS; MACROPHAGES; ACTIVATION; MONOCYTES; RECEPTOR	Microglia have key roles in central nervous system (CNS) disease and homeostasis but their study can be challenging. Prinz and colleagues identify hexosaminidase subunit beta (Hexb) to be specifically expressed by microglia and stable even under inflammatory conditions. Microglia and central nervous system (CNS)-associated macrophages (CAMs), such as perivascular and meningeal macrophages, are implicated in virtually all diseases of the CNS. However, little is known about their cell-type-specific roles in the absence of suitable tools that would allow for functional discrimination between the ontogenetically closely related microglia and CAMs. To develop a new microglia gene targeting model, we first applied massively parallel single-cell analyses to compare microglia and CAM signatures during homeostasis and disease and identified hexosaminidase subunit beta (Hexb)as a stably expressed microglia core gene, whereas other microglia core genes were substantially downregulated during pathologies. Next, we generatedHexb(tdTomato)mice to stably monitor microglia behavior in vivo. Finally, theHexblocus was employed for tamoxifen-inducible Cre-mediated gene manipulation in microglia and for fate mapping of microglia but not CAMs. In sum, we provide valuable new genetic tools to specifically study microglia functions in the CNS.	[Masuda, Takahiro; Amann, Lukas; Sankowski, Roman; Staszewski, Ori; Costa Jordao, Marta Joana; Kierdorf, Katrin; Knobeloch, Klaus-Peter; Prinz, Marco] Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany; [Masuda, Takahiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Japan; [Amann, Lukas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Sankowski, Roman; Staszewski, Ori] Univ Freiburg, Fac Med, Berta Ottenstein Programme Clinician Scientists, Freiburg, Germany; [Lenz, Maximilian; Vlachos, Andreas] Univ Freiburg, Fac Med, Inst Anat & Cell Biol, Dept Neuroanat, Freiburg, Germany; [d'Errico, Paolo; Luehmann, Melanie Meyer] Univ Freiburg, Med Ctr, Dept Neurol, Freiburg, Germany; [d'Errico, Paolo; Luehmann, Melanie Meyer] Univ Freiburg, Fac Med, Freiburg, Germany; [Snaidero, Nicolas] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Boettcher, Chotima; Priller, Josef] Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany; [Boettcher, Chotima; Priller, Josef] Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany; [Kierdorf, Katrin; Vlachos, Andreas; Luehmann, Melanie Meyer; Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany; [Kierdorf, Katrin] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Priller, Josef] DZNE, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Priller, Josef] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Priller, Josef] UK DRI, Edinburgh, Midlothian, Scotland; [Misgeld, Thomas] German Ctr Neurodegenerat Dis, Munich, Germany; [Misgeld, Thomas] Munich Cluster Syst Neurol, Munich, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany	University of Freiburg; Kyushu University; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; University of Freiburg; Weizmann Institute of Science; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health; University of Edinburgh; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Freiburg; University of Freiburg	Masuda, T; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany.; Masuda, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Japan.; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany.	masuda@phar.kyushu-u.ac.jp; marco.prinz@uniklinik-freiburg.de	Masuda, Takahiro/AAY-6719-2021; Priller, Josef/ABW-3835-2022; Kierdorf, Katrin/AAO-6288-2021; Jung, Steffen/K-1409-2012; Lenz, Maximilian/GOK-0031-2022	Masuda, Takahiro/0000-0003-3687-452X; Jung, Steffen/0000-0003-4290-5716; Sankowski, Roman/0000-0001-9215-8021; Snaidero, Nicolas/0000-0003-1148-6926; Priller, Josef/0000-0001-7596-0979; Kierdorf, Katrin/0000-0002-9272-4780; Amann, Lukas/0000-0002-8363-373X; Bottcher, Chotima/0000-0002-6226-586X	KANAE Foundation for the Promotion of Medical Science; Japan Society for the Promotion of Science (JSPS); Sobek Foundation; Ernst-Jung Foundation; German Research Foundation (DFG) [SFB 992, SFB1160, SFB/TRR167]; Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie 'Neuroinflammation'); DFG under Germany's Excellence Strategy [CIBSS-EXC-2189, 390939984]; DFG [SFB/TRR167]; UK DRI Momentum Award; MRC [MC_PC_16031] Funding Source: UKRI	KANAE Foundation for the Promotion of Medical Science; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sobek Foundation; Ernst-Jung Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie 'Neuroinflammation'); DFG under Germany's Excellence Strategy(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); UK DRI Momentum Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Barleon for excellent technical assistance and the Center for Animal Resource and Development (CARD, Kumamoto University) for providing research material. T. Masuda was supported by the KANAE Foundation for the Promotion of Medical Science and the Japan Society for the Promotion of Science (JSPS) as the JSPS Postdoctoral Fellow for Research Abroad. M.P. was supported by the Sobek Foundation, the Ernst-Jung Foundation, the German Research Foundation (DFG) (grant nos. SFB 992, SFB1160, SFB/TRR167, Reinhart-Koselleck-Grant and the Gottfried Wilhelm Leibniz-Prize) and the Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie 'Neuroinflammation'). This study was supported by the DFG under Germany's Excellence Strategy (grant no. CIBSS-EXC-2189, Project ID390939984). J.P. was supported by the DFG (grant nos. SFB/TRR167 B05 and B07), and the UK DRI Momentum Award. C.B. was supported by the DFG (grant no. SFB/TRR167 B05).	Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chappell-Maor L, 2020, EUR J IMMUNOL, V50, P353, DOI 10.1002/eji.201948342; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaiser T, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0448-18.2019; Kierdorf K, 2019, NAT REV NEUROSCI, V20, P547, DOI 10.1038/s41583-019-0201-x; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Priller J, 2019, SCIENCE, V365, P32, DOI 10.1126/science.aau9100; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Siao CJ, 2003, J NEUROSCI, V23, P3234; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Van Hove H, 2020, EUR J IMMUNOL, V50, P459, DOI 10.1002/eji.201948162; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zehntner SP, 2003, FASEB J, V17, P1910, DOI 10.1096/fj.03-0199fje; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhan LH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000134; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	58	99	100	3	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					802	+		10.1038/s41590-020-0707-4	http://dx.doi.org/10.1038/s41590-020-0707-4		JUN 2020	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32541832				2022-12-18	WOS:000540408200002
J	Zhang, YF; Yao, YK; Qiu, XX; Wang, GD; Hu, Z; Chen, SY; Wu, ZX; Yuan, N; Gao, HC; Wang, JR; Song, HH; Girardin, SE; Qian, YC				Zhang, Yifan; Yao, Yikun; Qiu, Xiaoxu; Wang, Guodong; Hu, Zheng; Chen, Siyuan; Wu, Zhengxi; Yuan, Na; Gao, Hanchao; Wang, Jianrong; Song, Houhui; Girardin, Stephen E.; Qian, Youcun			Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; CELL-DEATH; MONOCYTOGENES; NLRX1; RECOGNITION; AUTOPHAGY; AUTOINHIBITION; PATHOGENESIS; MECHANISMS; MITOCHONDRIA	Cells use mitophagy to remove damaged or unwanted mitochondria to maintain homeostasis. Here we report that the intracellular bacterial pathogen Listeria monocytogenes exploits host mitophagy to evade killing. We found that L. monocytogenes induced mitophagy in macrophages through the virulence factor listeriolysin O (LLO). We discovered that NLRX1, the only Nod-like receptor (NLR) family member with a mitochondrial targeting sequence, contains an LC3-interacting region (LIR) and directly associated with LC3 through the LIR. NLRX1 and its LIR motif were essential for L. monocytogenes-induced mitophagy. NLRX1 deficiency and use of a mitophagy inhibitor both increased mitochondrial production of reactive oxygen species and thereby suppressed the survival of L. monocytogenes. Mechanistically, L. monocytogenes and LLO induced oligomerization of NLRX1 to promote binding of its LIR motif to LC3 for induction of mitophagy. Our study identifies NLRX1 as a novel mitophagy receptor and discovers a previously unappreciated strategy used by pathogens to hijack a host cell homeostasis system for their survival.	[Zhang, Yifan; Yao, Yikun; Qiu, Xiaoxu; Wang, Guodong; Hu, Zheng; Chen, Siyuan; Wu, Zhengxi; Gao, Hanchao; Qian, Youcun] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor,Shanghai, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Nut, Shanghai, Peoples R China; [Yuan, Na; Wang, Jianrong] Soochow Univ, Sch Med, Hematol Ctr Cyrus Tang Med Inst,Key Lab Stem Cell, Jiangsu Inst Hematol,Collaborat Innovat Ctr Hemat, Suzhou, Peoples R China; [Yuan, Na; Wang, Jianrong] Soochow Univ, Sch Med, Chinese Minist Sci & Technol, State Key Lab Radiat Med & Radioprotect, Suzhou, Peoples R China; [Song, Houhui] Zhejiang A&F Univ, Coll Anim Sci & Technol, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Linan, Peoples R China; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Qian, Youcun] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Soochow University - China; Soochow University - China; Zhejiang A&F University; University of Toronto; ShanghaiTech University	Qian, YC (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor,Shanghai, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Nut, Shanghai, Peoples R China.; Qian, YC (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	ycqian@sibs.ac.cn	CHEN, SI/GZL-4800-2022; Gao, Hanchao/AGW-6043-2022; Yao, Yikun/AAH-9197-2021	Zhang, Yifan/0000-0002-9314-6353; Yao, Yikun/0000-0002-8890-2409	National Natural Science Foundation of China [91842306, 81430036, 81830018, 91429307, 91542119, 31470179]; National Key R&D Program of China [2018YFA0507402]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (91842306, 81430036, 81830018, 91429307, 91542119 and 31470179), the National Key R&D Program of China (2018YFA0507402) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000). GFP-LC3 vector was provided by Q. Chen (Nan Kai University). Bacterial strains of DP-L4317 and DP-L6173 were provided by D. A. Portnoy (University of California).	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Barsig J, 1997, INFECT IMMUN, V65, P4075, DOI 10.1128/IAI.65.10.4075-4081.1997; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Chuenchor W, 2014, CURR OPIN IMMUNOL, V26, P14, DOI 10.1016/j.coi.2013.10.009; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gomez-Sanchez R, 2014, NEUROBIOL DIS, V62, P426, DOI 10.1016/j.nbd.2013.10.021; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Ho PC, 2012, NAT IMMUNOL, V13, P379, DOI 10.1038/ni.2238; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mitchell G, 2015, INFECT IMMUN, V83, P2175, DOI 10.1128/IAI.00110-15; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nemani N, 2018, CELL CALCIUM, V74, P86, DOI 10.1016/j.ceca.2018.06.006; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Philipson CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137839; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Van Acker H, 2017, TRENDS MICROBIOL, V25, P456, DOI 10.1016/j.tim.2016.12.008; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	47	99	112	6	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					433	+		10.1038/s41590-019-0324-2	http://dx.doi.org/10.1038/s41590-019-0324-2			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30804553				2022-12-18	WOS:000461904200014
J	Akkaya, M; Traba, J; Roesler, AS; Miozzo, P; Akkaya, B; Theall, BP; Sohn, H; Pena, M; Smelkinson, M; Kabat, J; Dahlstrom, E; Dorward, DW; Skinner, J; Sack, MN; Pierce, SK				Akkaya, Munir; Traba, Javier; Roesler, Alexander S.; Miozzo, Pietro; Akkaya, Billur; Theall, Brandon P.; Sohn, Haewon; Pena, Mirna; Smelkinson, Margery; Kabat, Juraj; Dahlstrom, Eric; Dorward, David W.; Skinner, Jeff; Sack, Michael N.; Pierce, Susan K.			Second signals rescue B cells from activation-induced mitochondrial dysfunction and death	NATURE IMMUNOLOGY			English	Article							PLASMA-MEMBRANE; TARGET-CELLS; ANTIGEN; ENGAGEMENT; CA2+; MECHANISMS; RESPONSES; SURVIVAL; CAPTURE; ENERGY	B cells are activated by two temporally distinct signals, the first provided by the binding of antigen to the B cell antigen receptor (BCR), and the second provided by helper T cells. Here we found that B cells responded to antigen by rapidly increasing their metabolic activity, including both oxidative phosphorylation and glycolysis. In the absence of a second signal, B cells progressively lost mitochondrial function and glycolytic capacity, which led to apoptosis. Mitochondrial dysfunction was a result of the gradual accumulation of intracellular calcium through calcium response-activated calcium channels that, for approximately 9 h after the binding of B cell antigens, was preventable by either helper T cells or signaling via the receptor TLR9. Thus, BCR signaling seems to activate a metabolic program that imposes a limited time frame during which B cells either receive a second signal and survive or are eliminated.	[Akkaya, Munir; Roesler, Alexander S.; Miozzo, Pietro; Theall, Brandon P.; Sohn, Haewon; Pena, Mirna; Skinner, Jeff; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Traba, Javier; Sack, Michael N.] NHLBI, Lab Mitochondrial Biol & Metab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Akkaya, Billur] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Smelkinson, Margery; Kabat, Juraj] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dahlstrom, Eric] NIAID, Genom Unit, Rocky Mt Labs, Res Technol Branch,NIH, Hamilton, MT USA; [Dorward, David W.] NIAID, Microscopy Unit, Rocky Mt Labs, Res Technol Branch,NIH, Hamilton, MT USA; [Roesler, Alexander S.] Duke Univ, Sch Med, Durham, NC USA; [Miozzo, Pietro] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; University of Massachusetts System; University of Massachusetts Worcester	Akkaya, M; Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	munir.akkaya@nih.gov; spierce@nih.gov	Traba, Javier/AAA-9287-2020; AKKAYA, BILLUR/AAC-6499-2021; Akkaya, Munir/J-3975-2019; Sack, Michael/AAG-1000-2020	Traba, Javier/0000-0002-7855-3540; AKKAYA, BILLUR/0000-0002-6808-3776; Akkaya, Munir/0000-0002-9949-9424; Theall, Brandon/0000-0003-3852-5139; Roesler, Alexander/0000-0001-5768-1589; Skinner, Jeff/0000-0001-5697-0442; Smelkinson, Margery/0000-0001-7777-5574; Miozzo, Pietro/0000-0003-3486-4061	National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases and National Heart, Lung, Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005199, ZIAHL005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI000975, ZICAI001052, ZIAAI000898] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases and National Heart, Lung, Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Bolland (National Institutes of Health) for TLR9-deficient mice; I. Gery (National Institutes of Health) for 3A9mice; O. Voss (National Institutes of Health) for the NIH3T3 mouse fibroblast cell line; P. Allen (Washington University) for the 3A9 mouse T cell hybridoma line; R. Kissinger for preparing the illustration in Supplementary Fig. 2; and RW. Sheehan, T. Leto, J. Brzostowski and J. Manzella-Lapeira for assistance and advice in various experiments. Supported by the National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases and National Heart, Lung, Blood Institute.	Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2; Akkaya B, 2017, J IMMUNOL METHODS, V441, P67, DOI 10.1016/j.jim.2016.11.013; Akkaya B, 2016, J IMMUNOL, V197, P2027, DOI 10.4049/jimmunol.1600727; Akkaya M, 2018, NAT IMMUNOL, V19, P255, DOI 10.1038/s41590-018-0052-z; Akkaya M, 2017, J IMMUNOL, V199, P931, DOI 10.4049/jimmunol.1700348; Akkaya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063325; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Choi H, 2015, P NATL ACAD SCI USA, V112, pE303, DOI 10.1073/pnas.1417703112; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Donjerkovic D, 2000, CELL RES, V10, P179, DOI 10.1038/sj.cr.7290047; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Lagresle C, 1996, J EXP MED, V183, P1377, DOI 10.1084/jem.183.4.1377; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912; Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016; Onesto E, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0316-5; Rae MG, 2012, NEUROCHEM INT, V60, P543, DOI 10.1016/j.neuint.2012.02.014; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654; Sohn HW, 2010, METHODS MOL BIOL, V591, P159, DOI 10.1007/978-1-60761-404-3_10; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2017, J BIOL CHEM, V292, P12153, DOI 10.1074/jbc.M117.791715; Traba J, 2016, JOVE-J VIS EXP, DOI 10.3791/54918; Tze LE, 2000, J IMMUNOL, V165, P6796, DOI 10.4049/jimmunol.165.12.6796; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Yuseff MI, 2013, NAT REV IMMUNOL, V13, P475, DOI 10.1038/nri3469	56	99	103	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					871	+		10.1038/s41590-018-0156-5	http://dx.doi.org/10.1038/s41590-018-0156-5			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ6CZ	29988090	Green Accepted			2022-12-18	WOS:000457272600003
J	Nachbagauer, R; Choi, A; Hirsh, A; Margine, I; Iida, S; Barrera, A; Ferres, M; Albrecht, RA; Garcia-Sastre, A; Bouvier, NM; Ito, K; Medina, RA; Palese, P; Krammer, F				Nachbagauer, Raffael; Choi, Angela; Hirsh, Ariana; Margine, Irina; Iida, Sayaka; Barrera, Aldo; Ferres, Marcela; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Bouvier, Nicole M.; Ito, Kimihito; Medina, Rafael A.; Palese, Peter; Krammer, Florian			Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins	NATURE IMMUNOLOGY			English	Article							HEMAGGLUTININ STALK ANTIBODIES; DEPENDENT CELLULAR CYTOTOXICITY; INFECTION; VACCINE; NEURAMINIDASE; PROTECTION; HUMANS; CELLS	Infection with influenza virus induces antibodies to the viral surface glycoproteins hemagglutinin and neuraminidase, and these responses can be broadly protective. To assess the breadth and magnitude of antibody responses, we sequentially infected mice, guinea pigs and ferrets with divergent H1N1 or H3N2 subtypes of influenza virus. We measured antibody responses by ELISA of an extensive panel of recombinant glycoproteins representing the viral diversity in nature. Guinea pigs developed high titers of broadly cross-reactive antibodies; mice and ferrets exhibited narrower humoral responses. Then, we compared antibody responses after infection of humans with influenza virus H1N1 or H3N2 and found markedly broad responses and cogent evidence for 'original antigenic sin'. This work will inform the design of universal vaccines against influenza virus and can guide pandemic-preparedness efforts directed against emerging influenza viruses.	[Nachbagauer, Raffael; Choi, Angela; Hirsh, Ariana; Margine, Irina; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Bouvier, Nicole M.; Medina, Rafael A.; Palese, Peter; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Choi, Angela] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Iida, Sayaka; Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Kita Ku, Sapporo, Hokkaido, Japan; [Barrera, Aldo; Ferres, Marcela; Medina, Rafael A.] Pontificia Univ Catolica Chile, Sch Med, Dept Enfermedades Infecciosas & Inmunol Pediat, Santiago, Chile; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Bouvier, Nicole M.; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Medina, Rafael A.] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Santiago, Chile	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Hokkaido University; Pontificia Universidad Catolica de Chile; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pontificia Universidad Catolica de Chile	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019; Albrecht, Randy A./H-5119-2019; Nachbagauer, Raffael/H-7798-2019; Medina, Rafael A./AAW-4418-2020; Ito, Kimihito/E-9975-2012	Krammer, Florian/0000-0003-4121-776X; Albrecht, Randy A./0000-0003-4008-503X; Nachbagauer, Raffael/0000-0001-5568-5420; Medina, Rafael A./0000-0002-5013-6884; Ito, Kimihito/0000-0003-4986-1795	US National Institutes of Health [U19 AI109946-01, R01 AI117287-01A1]; Centers of Excellence in Influenza Virus Research and Surveillance of the US National Institutes of Health [HHSN272201400008C]; Comision Nacional de Investigacion Cientifica y Tecnologica [FONDECYT 1121172, 1161791, PIA ACT 1408]; Chilean Ministry of Economy, Development and Tourism [P09/016-F]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117287, U19AI109946] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Excellence in Influenza Virus Research and Surveillance of the US National Institutes of Health; Comision Nacional de Investigacion Cientifica y Tecnologica; Chilean Ministry of Economy, Development and Tourism; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Aguado for cloning of several of the HA expression vectors; J. Runstadler (Massachusetts Institute of Technology) for making several avian influenza viruses available to us; F. Amanat for IgG purification; P. E. Leon (Icahn School of Medicine at Mount Sinai) for the H3N8 and H9N4 viruses; C. Marizzi for reviewing the manuscript; BEI Resources for sequences of influenza virus HA and NA; and R. Fouchier (Erasmus MC) for depositing plasmids encoding HA and NA at BEI Resources. Supported by the US National Institutes of Health (U19 AI109946-01 to P.P. and F.K.; and R01 AI117287-01A1 to F.K. and N.M.B.), Centers of Excellence in Influenza Virus Research and Surveillance of the US National Institutes of Health (HHSN272201400008C to A.G.S., P.P., F.K., R.A.M. and N.M.B.), Comision Nacional de Investigacion Cientifica y Tecnologica (FONDECYT 1121172 and 1161791 to R.A.M.; and PIA ACT 1408 to R.A.M.), and the Chilean Ministry of Economy, Development and Tourism (P09/016-F to R.A.M.).	BORG I., 2005, MODERN MULTIDIMENSIO, P207; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Easterbrook JD, 2012, VIROLOGY, V432, P39, DOI 10.1016/j.virol.2012.06.003; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; HENRY D, 2000, CELL HOST MICROBE, V19, P800; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025953; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Krammer F, 2014, NAT IMMUNOL, V15, P3, DOI 10.1038/ni.2761; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Martinez-Sobrido Luis, 2010, J Vis Exp, DOI 10.3791/2057; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Nachbagauer R, 2014, J VIROL, V88, P13260, DOI 10.1128/JVI.02133-14; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Yang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110026; YEWDELL JW, 1979, NATURE, V279, P246, DOI 10.1038/279246a0; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	45	99	100	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					464	+		10.1038/ni.3684	http://dx.doi.org/10.1038/ni.3684			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28192418	Bronze, Green Accepted			2022-12-18	WOS:000396815800014
J	Zuklys, S; Handel, A; Zhanybekova, S; Govani, F; Keller, M; Maio, S; Mayer, CE; Teh, HY; Hafen, K; Gallone, G; Barthlott, T; Ponting, CP; Hollander, GA				Zuklys, Saulius; Handel, Adam; Zhanybekova, Saule; Govani, Fatima; Keller, Marcel; Maio, Stefano; Mayer, Carlos E.; Teh, Hong Ying; Hafen, Katrin; Gallone, Giuseppe; Barthlott, Thomas; Ponting, Chris P.; Hollander, Georg A.			Foxn1 regulates key target genes essential for T cell development in postnatal thymic epithelial cells	NATURE IMMUNOLOGY			English	Article							EXPRESSION; SELECTION; PROTEIN; REPERTOIRE; PROLIFERATION; CCR7	Thymic epithelial cell differentiation, growth and function depend on the expression of the transcription factor Foxn1; however, its target genes have never been physically identified. Using static and inducible genetic model systems and chromatin studies, we developed a genome-wide map of direct Foxn1 target genes for postnatal thymic epithelia and defined the Foxn1 binding motif. We determined the function of Foxn1 in these cells and found that, in addition to the transcriptional control of genes involved in the attraction and lineage commitment of T cell precursors, Foxn1 regulates the expression of genes involved in antigen processing and thymocyte selection. Thus, critical events in thymic lympho-stromal cross-talk and T cell selection are indispensably choreographed by Foxn1.	[Zuklys, Saulius; Keller, Marcel; Mayer, Carlos E.; Teh, Hong Ying; Hafen, Katrin; Barthlott, Thomas; Hollander, Georg A.] Univ Childrens Hosp, Dept Biomed, Basel, Switzerland; [Zuklys, Saulius; Keller, Marcel; Mayer, Carlos E.; Teh, Hong Ying; Hafen, Katrin; Barthlott, Thomas; Hollander, Georg A.] Univ Basel, Basel, Switzerland; [Handel, Adam; Gallone, Giuseppe; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England; [Govani, Fatima; Maio, Stefano; Hollander, Georg A.] Univ Oxford, Dept Paediat, Oxford, England; [Govani, Fatima; Maio, Stefano; Hollander, Georg A.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Zhanybekova, Saule] Univ Basel, Dept Chem, Basel, Switzerland; [Keller, Marcel] Actel Pharmaceut Ltd, Allschwil, Switzerland; [Ponting, Chris P.] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Basel; University of Oxford; University of Oxford; University of Oxford; University of Basel; Actelion Pharmaceuticals Ltd; University of Edinburgh	Zuklys, S; Hollander, GA (corresponding author), Univ Childrens Hosp, Dept Biomed, Basel, Switzerland.; Hollander, GA (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.; Hollander, GA (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	saulius.zuklys@unibas.ch; georg.hollander@paediatrics.ox.ac.uk	Ponting, Chris/AAV-2621-2021	Hollander, Georg/0000-0002-8790-0874; Maio, Stefano/0000-0001-9518-6466; Handel, Adam/0000-0001-8385-6346	Swiss National Foundation [3100-68310.02, 3100-122558]; Wellcome Trust [105045/Z/14/Z, 100643/Z/12/Z]; European Commission [261387]; Medical Research Council [MC_UU_12008/1] Funding Source: researchfish; National Institute for Health Research [ACF-2011-18-008, CL-2016-13-001] Funding Source: researchfish; MRC [MC_UU_12008/1] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Christen, R. Recinos, A. Offinger, D. Nebenius-Oosthulzen and A. Klewe-Nebenius for technical support, M. Gaio and S. Harris for secretarial assistance, and J. Lopez-Rios and M. Osterwalder for help establishing ChIP and provision of plasmids. Supported by the Swiss National Foundation (3100-68310.02 and 3100-122558 to G.A.H.), The Wellcome Trust (105045/Z/14/Z to G.A.H. and C.P.P.; 100643/Z/12/Z to A.H.) the MRC (C.P.P.) and the European Commission within the Seventh Framework Programme (FP7 project 261387 to G.H.).	Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Burnley P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.460; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Flomerfelt FA, 2010, J EXP MED, V207, P2521, DOI 10.1084/jem.20092759; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Ki S, 2014, CELL REP, V9, P402, DOI 10.1016/j.celrep.2014.08.070; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mayer CE, 2016, EUR J IMMUNOL, V46, P846, DOI 10.1002/eji.201545995; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rode I, 2015, J IMMUNOL, V195, P5678, DOI 10.4049/jimmunol.1502010; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	46	99	104	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1206	+		10.1038/ni.3537	http://dx.doi.org/10.1038/ni.3537			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27548434	Green Accepted			2022-12-18	WOS:000384302900012
J	Pelletier, N; McHeyzer-Williams, LJ; Wong, KA; Urich, E; Fazilleau, N; McHeyzer-Williams, MG				Pelletier, Nadege; McHeyzer-Williams, Louise J.; Wong, Kurt A.; Urich, Eduard; Fazilleau, Nicolas; McHeyzer-Williams, Michael G.			Plasma cells negatively regulate the follicular helper T cell program	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; GERMINAL-CENTERS; IN-VIVO; DENDRITIC CELLS; BONE-MARROW; LYMPH-NODE; BLIMP-1; DIFFERENTIATION; EXPRESSION; ANTIBODY	B lymphocytes differentiate into antibody-secreting cells under the antigen-specific control of follicular helper T cells (T-FH cells). Here we demonstrate that isotype-switched plasma cells expressed major histocompatibility complex (MHC) class II, the costimulatory molecules CD80 and CD86, and the intracellular machinery required for antigen presentation. Antigen-specific plasma cells accessed, processed and presented sufficient antigen in vivo to induce multiple helper T cell functions. Notably, antigen-primed plasma cells failed to induce interleukin 21 (IL-21) or the transcriptional repressor Bcl-6 in naive helper T cells and actively decreased these key molecules in antigen-activated T-FH cells. Mice lacking plasma cells showed altered T-FH cell activity, which provided evidence of this negative feedback loop. Hence, antigen presentation by plasma cells defines a previously unknown layer of cognate regulation that limits the antigen-specific T-FH cell program that controls ongoing B cell immunity.	[Pelletier, Nadege; McHeyzer-Williams, Louise J.; Wong, Kurt A.; Urich, Eduard; Fazilleau, Nicolas; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Fazilleau, Nicolas/J-9883-2014	Fazilleau, Nicolas/0000-0002-3574-5614	German Academic Exchange Service; German Research Foundation; Canadian Institutes of Health Research [MFE-98574]; US National Institutes of Health [AI047231, AI040215, AI071182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040215, R01AI071182, R01AI047231] Funding Source: NIH RePORTER	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Denzin (Memorial Sloan Kettering Cancer Center) for antibodies 2C3A and Ob1; A. Rudensky (Memorial Sloan Kettering Cancer Center) for monoclonal antibody 15G4; E. Unanue (Washington University) for the Aw3.18 cell line; K. Calame (Columbia University) for mice with loxP-flanked Prdm1 alleles excised by Cre recombinase expressed from a CD19 promoter; and K. Spencer for help with confocal imaging. Supported by the German Academic Exchange Service (E. U.), the German Research Foundation (E. U.), the Canadian Institutes of Health Research (MFE-98574 to K. A. W.) and the US National Institutes of Health (AI047231, AI040215 and AI071182 to M.G.M.-W.). This is The Scripps Research Institute manuscript 20113.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Ellyard JI, 2004, BLOOD, V103, P3805, DOI 10.1182/blood-2003-09-3109; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MCHEYZERWILLIAM.MG, 1993, 19EXP MED, V178, P295; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yi Q, 1997, BLOOD, V90, P1960, DOI 10.1182/blood.V90.5.1960; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	50	99	103	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1110	U132		10.1038/ni.1954	http://dx.doi.org/10.1038/ni.1954			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21037578	Green Accepted			2022-12-18	WOS:000284262200010
J	Fredslund, F; Laursen, NS; Roversi, P; Jenner, L; Oliveira, CLP; Pedersen, JS; Nunn, MA; Lea, SM; Discipio, R; Sottrup-Jensen, L; Andersen, GR				Fredslund, Folmer; Laursen, Nick S.; Roversi, Pietro; Jenner, Lasse; Oliveira, Cristiano L. P.; Pedersen, Jan S.; Nunn, Miles A.; Lea, Susan M.; Discipio, Richard; Sottrup-Jensen, Lars; Andersen, Gregers R.			Structure of and influence of a tick complement inhibitor on human complement component 5	NATURE IMMUNOLOGY			English	Article							MEMBRANE-ATTACK-COMPLEX; FACTOR-I MODULES; C5 CONVERTASE; ORNITHODOROS-MOUBATA; C5B-7 COMPLEX; C345C DOMAIN; ACTIVATION; PATHWAY; C3B; ANAPHYLATOXIN	To provide insight into the structural and functional properties of human complement component 5 (C5), we determined its crystal structure at a resolution of 3.1 angstrom. The core of C5 adopted a structure resembling that of C3, with the domain arrangement at the position corresponding to the C3 thioester being very well conserved. However, in contrast to C3, the convertase cleavage site in C5 was ordered and the C345C domain flexibly attached to the core of C5. Binding of the tick C5 inhibitor OmCI to C5 resulted in stabilization of the global conformation of C5 but did not block the convertase cleavage site. The structure of C5 may render possible a structure-based approach for the design of new selective complement inhibitors.	[Fredslund, Folmer; Laursen, Nick S.; Jenner, Lasse; Sottrup-Jensen, Lars; Andersen, Gregers R.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3ER, England; [Oliveira, Cristiano L. P.; Pedersen, Jan S.] Univ Aarhus, Dept Chem, DK-8000 Aarhus, Denmark; [Oliveira, Cristiano L. P.; Pedersen, Jan S.; Andersen, Gregers R.] Univ Aarhus, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark; [Nunn, Miles A.] Ctr Ecol & Hydrol Oxford, Oxford OX1 3SR, England; [Discipio, Richard] La Jolla Inst Expt Med, La Jolla, CA 92037 USA	Aarhus University; University of Oxford; Aarhus University; Aarhus University; UK Centre for Ecology & Hydrology (UKCEH)	Andersen, GR (corresponding author), Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark.	gra@mb.au.dk	Lea, Susan M/B-7678-2009; Laursen, Nick Stub/Q-5051-2017; Oliveira, Cristiano L P/B-4403-2008; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008; Roversi, Pietro/AAK-4241-2021; Nunn, Miles/E-9233-2010; Fredslund, Folmer/ABH-5821-2020; Roversi, Pietro/F-8925-2011; Jenner, Lasse/H-1584-2017	Lea, Susan M/0000-0001-9287-8053; Laursen, Nick Stub/0000-0002-7512-2649; Oliveira, Cristiano L P/0000-0002-3426-6507; Pedersen, Jan Skov/0000-0002-7768-0206; Roversi, Pietro/0000-0001-9280-9437; Fredslund, Folmer/0000-0003-0881-1927; Roversi, Pietro/0000-0001-9280-9437; Jenner, Lasse/0000-0003-3917-8853; Andersen, Gregers Rom/0000-0001-6292-3319	Biotechnology and Biological Sciences Research Council [BB/D003628/1] Funding Source: Medline; Medical Research Council [G0400775] Funding Source: Medline; BBSRC [BB/D003628/1] Funding Source: UKRI; MRC [G0400775] Funding Source: UKRI; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; BHAKDI S, 1980, J IMMUNOL, V124, P2451; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Discipio RG, 1998, ACTA CRYSTALLOGR D, V54, P643, DOI 10.1107/S0907444997015011; DISCIPIO RG, 1988, J BIOL CHEM, V263, P549; DISCIPIO RG, 1992, J BIOL CHEM, V267, P17087; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1983, J BIOL CHEM, V258, P629; DISCIPIO RG, 1981, BIOCHEM J, V199, P497, DOI 10.1042/bj1990497; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hagemann IS, 2008, J BIOL CHEM, V283, P7763, DOI 10.1074/jbc.M709467200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Isaac L, 1998, BIOCHEM J, V329, P705, DOI 10.1042/bj3290705; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JENNER L, 2000, STRUCTURAL STUDIES P; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; PERKINS SJ, 1990, BIOCHEMISTRY-US, V29, P1175, DOI 10.1021/bi00457a012; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; PODACK ER, 1984, J BIOL CHEM, V259, P8641; PODACK ER, 1982, J EXP MED, V156, P268, DOI 10.1084/jem.156.1.268; RAMM LE, 1982, J IMMUNOL, V129, P1143; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Sandoval A, 2000, J IMMUNOL, V165, P1066, DOI 10.4049/jimmunol.165.2.1066; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TAKATA Y, 1987, J EXP MED, V165, P1494, DOI 10.1084/jem.165.6.1494; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; TSCHOPP J, 1982, P NATL ACAD SCI-BIOL, V79, P7474, DOI 10.1073/pnas.79.23.7474; VOGT W, 1978, IMMUNOLOGY, V34, P29; Wang H, 2005, TRANSPLANTATION, V79, P1121, DOI 10.1097/01.TP.0000161218.58276.9A; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P172, DOI 10.1021/bi00427a025	50	99	112	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					753	760		10.1038/ni.1625	http://dx.doi.org/10.1038/ni.1625			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18536718				2022-12-18	WOS:000256904900012
J	Choi, KC; Lee, YS; Lim, S; Choi, HK; Lee, CH; Lee, EK; Hong, S; Kim, IH; Kim, SJ; Park, SH				Choi, Kyung-Chul; Lee, Youn Sook; Lim, Seunghwan; Choi, Hyo Kyoung; Lee, Chang-Hun; Lee, Eun-Kyung; Hong, Suntaek; Kim, In-Hoo; Kim, Seong-Jin; Park, Seok Hee			Smad6 negatively regulates interleukin 1-receptor Toll-like receptor signaling through direct interaction with the adaptor Pellino-1	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; INHIBITORY SMADS; CELL ACTIVATION; INNATE IMMUNITY; HUMAN-DISEASE; HOST-DEFENSE; PROTEIN; MECHANISM; MICE	Transforming growth factor-beta 1 (TGF-beta 1) is a potent cytokine with pleiotropic effects, including anti-inflammatory activity. Here we show that the signaling protein Smad6 bound to Pellino-1, an adaptor protein of mammalian interleukin 1 receptor (IL-1R) associated kinase 1 ( IRAK1), and thereby promoted TGF-beta-mediated anti-inflammatory effects. Smad6-Pellino-1 interaction abrogated signaling mediated by a complex of IRAK1, Pellino-1 and adaptor protein TRAF6 that formed after stimulation by IL-1 beta treatment. Blockade of IRAK1-Pellino-1-TRAF6 signaling prevented degradation of the inhibitor I kappa B alpha and subsequent nuclear translocation of transcription factor NF-kappa B and thus expression of proinflammatory genes. 'Knockdown' of endogenous Smad6 expression by RNA interference reduced anti-inflammatory activity mediated by TGF-beta 1 or the TGF-beta family member BMP-4. Thus Smad6 is a critical mediator of the TGF-beta-BMP pathway that mediates anti-inflammatory activity and negatively regulates IL-1R-Toll-like receptor signals.	Inha Univ, Coll Med, Dept Pathol, BK Project 21,Ctr Adv Med Educ, Inchon 400712, South Korea; Inha Univ, Coll Med, Inha Res Inst Med Sci, Inchon 400712, South Korea; NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Natl Canc Ctr, Res Inst, Goyang 411769, Gyeonggi, South Korea	Inha University; Inha University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Korea (NCC)	Park, SH (corresponding author), Inha Univ, Coll Med, Dept Pathol, BK Project 21,Ctr Adv Med Educ, Inchon 400712, South Korea.	kims@mail.nih.gov; parksh@inha.ac.kr		Lim, Seunghwan/0000-0001-8920-0890	NATIONAL CANCER INSTITUTE [Z01BC005617] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Bitzer M, 2000, GENE DEV, V14, P187; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jensen LE, 2003, J IMMUNOL, V171, P1500, DOI 10.4049/jimmunol.171.3.1500; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Ju EM, 2005, BIOCHEM BIOPH RES CO, V328, P1170, DOI 10.1016/j.bbrc.2005.01.078; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Park SH, 2001, CELL GROWTH DIFFER, V12, P9; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075	56	99	116	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1057	1065		10.1038/ni1383	http://dx.doi.org/10.1038/ni1383			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16951688				2022-12-18	WOS:000241437100011
J	Hinton, HJ; Alessi, DR; Cantrell, DA				Hinton, HJ; Alessi, DR; Cantrell, DA			The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development	NATURE IMMUNOLOGY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN-KINASE; ANTIGEN RECEPTOR; ALLELIC EXCLUSION; TCR SIGNALS; C-DELTA; B-CELL; ACTIVATION; DIFFERENTIATION; DISRUPTION; EXPRESSION	T lymphocyte activation is associated with activation of diverse AGC serine kinases (named after family members protein kinase A, protein kinase G and protein kinase C). It has been difficult to assess the function of these molecules in T cell development with simple gene-deletion strategies because different isoforms of AGC kinases are coexpressed in the thymus and have overlapping, redundant functions. To circumvent these problems, we explored the consequences of genetic manipulation of phosphoinositide-dependent kinase 1 (PDK1), a rate-limiting 'upstream' activator of AGC kinases. Here we analyzed the effect of PDK1 deletion on T lineage development. We also assessed the consequences of reducing PDK1 levels to 10% of normal. Complete PDK1 loss blocked T cell differentiation in the thymus, whereas reduced PDK1 expression allowed T cell differentiation but blocked proliferative expansion. These studies show that AGC family kinases are essential for T cell development.	Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Canc Res UK London Res Inst, Lymphocyte Activat Lab, London WC2A 3PX, England	University of Dundee; University of Dundee; Cancer Research UK	Cantrell, DA (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, MSI-WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk		Cantrell, Doreen/0000-0001-7525-3350; Alessi, Dario/0000-0002-2140-9185				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; Cantrell DA, 2003, CURR OPIN IMMUNOL, V15, P294, DOI 10.1016/S0952-7915(03)00052-9; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Cantrell DA, 2001, J CELL SCI, V114, P1439; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Costello PS, 2000, J EXP MED, V192, P77, DOI 10.1084/jem.192.1.77; Galandrini R, 1997, IMMUNITY, V7, P163, DOI 10.1016/S1074-7613(00)80519-1; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Koretzky GA, 2003, IMMUNOL RES, V27, P357, DOI 10.1385/IR:27:2-3:357; Lafont V, 2000, FEBS LETT, V486, P38, DOI 10.1016/S0014-5793(00)02235-3; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Michie AM, 2001, P NATL ACAD SCI USA, V98, P609, DOI 10.1073/pnas.021288598; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Okkenhaug K, 2002, SCIENCE, V297, P1031; Parker PJ, 2001, BIOCHEM SOC T, V29, P860, DOI 10.1042/0300-5127:0290860; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Rodriguez-Borlado L, 2003, J IMMUNOL, V170, P4475, DOI 10.4049/jimmunol.170.9.4475; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Trigueros C, 2003, EUR J IMMUNOL, V33, P1968, DOI 10.1002/eji.200323831; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8	45	99	102	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					539	545		10.1038/ni1062	http://dx.doi.org/10.1038/ni1062			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15077109				2022-12-18	WOS:000221101100019
J	Meffre, E; Davis, E; Schiff, C; Cunningham-Rundles, C; Ivashkiv, LB; Staudt, LM; Young, JW; Nussenzweig, MC				Meffre, E; Davis, E; Schiff, C; Cunningham-Rundles, C; Ivashkiv, LB; Staudt, LM; Young, JW; Nussenzweig, MC			Circulating human B cells that express surrogate light chains and edited receptors	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN BONE-MARROW; IMMUNOGLOBULIN HEAVY; SOMATIC MUTATION; VARIABLE REGION; V(D)J RECOMBINATION; SURFACE EXPRESSION; RHEUMATOID FACTORS; ESCAPE TOLERANCE; GERMINAL-CENTERS	Immunoglobulin gene recombination can result in the assembly of self-reactive antibodies. Deletion, anergy or receptor editing normally silence B cells that produce these autoantibodies. Receptor editing is highly efficient in mouse B cells that carry pre-recombined autoantibody transgenes or gene "knock-ins". However, it has been difficult to identify cells that have edited receptors in unmanipulated mice and humans. To try to identify such cells we isolated and characterized B cells that coexpress surrogate and conventional light chains (V-preB(+)L(+)) from the blood of normal human donors. V-preB(+)L(+) B cells express RAG mRNA, display an unusual heavy and light chain antibody repertoire consistent with antiself reactivity, and show evidence of receptor editing. These cells accumulate in the joints of patients with rheumatoid arthritis, consistent with a role for V-preB(+)L(+) B cells and receptor editing in autoimmune disease.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Div Clin Sci, NIH, Bethesda, MD 20892 USA; Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; Mt Sinai Med Ctr, Dept Med & Pediat, New York, NY 10029 USA; Hosp Special Surg, Dept Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Allogen Bone Marrow Transplant Serv, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Clin Immunol Serv, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Icahn School of Medicine at Mount Sinai; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Staudt, Louis/AAC-5324-2019; Nussenzweig, Michel/AAE-7292-2019	Young, James/0000-0002-0032-6559				Brard F, 1999, J EXP MED, V190, P691, DOI 10.1084/jem.190.5.691; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; BRIDGES SL, 1995, J CLIN INVEST, V96, P831, DOI 10.1172/JCI118129; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CONLEY ME, 1985, J IMMUNOL, V134, P3070; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; CROUZIER R, 1995, J IMMUNOL, V154, P4526; de Wildt RMT, 1999, J MOL BIOL, V285, P895, DOI 10.1006/jmbi.1998.2396; Dorner T, 1999, J IMMUNOL, V163, P1027; Dorner T, 1998, J CLIN INVEST, V102, P688, DOI 10.1172/JCI3113; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Foster SJ, 1997, J CLIN INVEST, V99, P1614, DOI 10.1172/JCI119324; Gauthier L, 1999, J IMMUNOL, V162, P41; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217; Giachino C, 1998, EUR J IMMUNOL, V28, P3506, DOI 10.1002/(SICI)1521-4141(199811)28:11<3506::AID-IMMU3506>3.0.CO;2-J; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GUELPAFONLUPT V, 1994, EUR J IMMUNOL, V24, P257, DOI 10.1002/eji.1830240140; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; Hikida M, 1997, J IMMUNOL, V158, P2509; Hikida M, 1996, SCIENCE, V274, P2092, DOI 10.1126/science.274.5295.2092; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Klein U, 1999, CURR TOP MICROBIOL, V246, P141; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klonowski KD, 1999, J IMMUNOL, V162, P1566; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; Lemmers B, 1999, BLOOD, V93, P4336, DOI 10.1182/blood.V93.12.4336.412k28_4336_4346; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; ManheimerLory AJ, 1997, J CLIN INVEST, V100, P2538, DOI 10.1172/JCI119796; MEEK KD, 1989, J EXP MED, V170, P39, DOI 10.1084/jem.170.1.39; Meffre E, 1996, J CLIN INVEST, V98, P1519, DOI 10.1172/JCI118943; Meffre E, 1998, J EXP MED, V188, P765, DOI 10.1084/jem.188.4.765; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Nemazee D, 1995, ANN NY ACAD SCI, V764, P397; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Radic MZ, 1995, ANN NY ACAD SCI, V764, P384; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RANDEN I, 1995, SCAND J IMMUNOL, V41, P481, DOI 10.1111/j.1365-3083.1995.tb03596.x; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SCHABLE KF, 1993, BIOL CHEM H-S, V374, P1001; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; UCKUN FM, 1990, BLOOD, V76, P1908; VICTOR KD, 1991, J CLIN INVEST, V87, P1603, DOI 10.1172/JCI115174; Wang YH, 1998, J IMMUNOL, V161, P1132; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	63	99	101	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					207	213		10.1038/79739	http://dx.doi.org/10.1038/79739			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973277				2022-12-18	WOS:000089815100018
J	Phetsouphanh, C; Darley, D; Wilson, DB; Howe, A; Munier, CML; Patel, SK; Juno, JA; Burrell, LM; Kent, SJ; Dore, GJ; Kelleher, AD; Matthews, GV				Phetsouphanh, Chansavath; Darley, David; Wilson, Daniel B.; Howe, Annett; Munier, C. Mee Ling; Patel, Sheila K.; Juno, Jennifer A.; Burrell, Louise M.; Kent, Stephen J.; Dore, Gregory J.; Kelleher, Anthony D.; Matthews, Gail, V			Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article							COVID-19	Phetsouphanh and colleagues show that individuals with long COVID have persistent activation of the innate and adaptive immune system at 8 months after infection and define a set of analytes associated with long COVID. A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we studied individuals with LC compared to age- and gender-matched recovered individuals without LC, unexposed donors and individuals infected with other coronaviruses. Patients with LC had highly activated innate immune cells, lacked naive T and B cells and showed elevated expression of type I IFN (IFN-beta) and type III IFN (IFN-lambda 1) that remained persistently high at 8 months after infection. Using a log-linear classification model, we defined an optimal set of analytes that had the strongest association with LC among the 28 analytes measured. Combinations of the inflammatory mediators IFN-beta, PTX3, IFN-gamma, IFN-lambda 2/3 and IL-6 associated with LC with 78.5-81.6% accuracy. This work defines immunological parameters associated with LC and suggests future opportunities for prevention and treatment.	[Phetsouphanh, Chansavath; Howe, Annett; Munier, C. Mee Ling; Dore, Gregory J.; Kelleher, Anthony D.; Matthews, Gail, V] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Darley, David; Dore, Gregory J.; Kelleher, Anthony D.; Matthews, Gail, V] St Vincents Hosp, Darlinghurst, NSW, Australia; [Wilson, Daniel B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Patel, Sheila K.; Burrell, Louise M.] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic, Australia; [Juno, Jennifer A.; Kent, Stephen J.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Infect Dis Dept,Alfred Hlth, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Boston University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University	Phetsouphanh, C; Kelleher, AD; Matthews, GV (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.; Kelleher, AD; Matthews, GV (corresponding author), St Vincents Hosp, Darlinghurst, NSW, Australia.	cphetsouphanh@kirby.unsw.edu.au; akelleher@kirby.unsw.edu.au; gmatthews@kirby.unsw.edu.au	matthews, gail/AFL-8501-2022; Phetsouphanh, Chansavath/AAS-4832-2020; matthews, gail/AAG-8626-2022	Kent, Stephen/0000-0002-8539-4891; Juno, Jennifer/0000-0002-9072-1017; Munier, Cynthia/0000-0002-6419-142X; Burrell, Louise/0000-0003-1863-7539; Darley, David/0000-0002-9721-101X	St Vincent's Clinic Foundation; Curran Foundation; Rapid Response Research Fund; Medical Research Futures Fund (Australia); National Health and Medical Research Council (NHMRC) program [APP 1055214]; Medical Research Future Fund [GNT 1175865]; Austin Medical Research Foundation grant; NSF-DMA [1902854]; Victorian Government, MRFF [2005544]; NHMRC program [1149990]; NHMRC fellowships [1136322, 1123673]	St Vincent's Clinic Foundation; Curran Foundation; Rapid Response Research Fund; Medical Research Futures Fund (Australia); National Health and Medical Research Council (NHMRC) program(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Future Fund(Medical Research Future Fund (MRFF)); Austin Medical Research Foundation grant; NSF-DMA; Victorian Government, MRFF; NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia)	We thank the staff at the St Vincent's Institute for Applied Medical Research-Clinical Trials Unit for their expertise in specimen processing and biobanking. We thank E. Johansson Beves for assistance with Cytek Aurora and V. Klemm for proofreading the manuscript. We appreciate grant support from the St Vincent's Clinic Foundation, the Curran Foundation, the Rapid Response Research Fund and the Medical Research Futures Fund (Australia). S.K.P. and L.M.B. were supported by National Health and Medical Research Council (NHMRC) program grant APP 1055214 (L.M.B.), Medical Research Future Fund award GNT 1175865 and an Austin Medical Research Foundation grant. D.B.W. was supported by NSF-DMA grant 1902854. S.J.K. and J.A.J. were supported by the Victorian Government, MRFF award 2005544, NHMRC program grant 1149990 (S.J.K. and A.D.K.) and NHMRC fellowships (1136322 to S.J.K. and 1123673 to J.A.J.).	Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Brunetta E, 2021, NAT IMMUNOL, V22, P19, DOI 10.1038/s41590-020-00832-x; Carvalho T, 2021, NAT REV IMMUNOL, V21, P245, DOI 10.1038/s41577-021-00522-1; Cortinovis M, 2021, LANCET, V397, P173, DOI 10.1016/S0140-6736(21)00039-8; Darley DR, 2021, MED J AUSTRALIA, V214, P279, DOI 10.5694/mja2.50963; Darley DR, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00384-2021; Dunn P. K., 2005, ENCY SOCIAL MEASUREM, P585; Gregorova M, 2020, ELIFE, V9, DOI 10.7554/eLife.63430; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Kelly A, 2016, J INTERF CYTOK RES, V36, P671, DOI 10.1089/jir.2015.0169; Keskinen P, 1997, IMMUNOLOGY, V91, P421, DOI 10.1046/j.1365-2567.1997.00258.x; Kimura S, 2014, CIRC J, V78, P159, DOI 10.1253/circj.CJ-13-0329; Koutsakos M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100208; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Patel SK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03730-2020; Peluso M. J., RAPID IMPLEMENTATION, DOI [10.1101/2021.03.11.21252311(2021, DOI 10.1101/2021.03.11.21252311(2021]; Sousa C. P., 2020, Brazilian Journal of Infectious Diseases, V24, P428, DOI 10.1016/j.bjid.2020.07.011; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; Sudre Carole Helene, 2020, medRxiv, DOI 10.1101/2020.12.15.20248096; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P841, DOI 10.15585/mmwr.mm6926e3; Ueland T, 2021, J ALLERGY CLIN IMMUN, V147, P92, DOI 10.1016/j.jaci.2020.09.007; Wang ZF, 2020, AM J RESP CRIT CARE, V202, P606, DOI 10.1164/rccm.202005-1701LE; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	35	98	101	16	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					210	+		10.1038/s41590-021-01113-x	http://dx.doi.org/10.1038/s41590-021-01113-x		JAN 2022	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35027728	Green Submitted, Bronze			2022-12-18	WOS:000742322600001
J	Keiran, N; Ceperuelo-Mallafre, V; Calvo, E; Hernandez-Alvarez, MI; Ejarque, M; Nunez-Roa, C; Horrillo, D; Maymo-Masip, E; Rodriguez, MM; Fradera, R; de la Rosa, JV; Jorba, R; Megia, A; Zorzano, A; Medina-Gomez, G; Serena, C; Castrillo, A; Vendrell, J; Fernandez-Veledo, S				Keiran, Noelia; Ceperuelo-Mallafre, Victoria; Calvo, Enrique; Isabel Hernandez-Alvarez, Maria; Ejarque, Miriam; Nunez-Roa, Catalina; Horrillo, Daniel; Maymo-Masip, Elsa; Mar Rodriguez, M.; Fradera, Rosa; Vladimir de la Rosa, Juan; Jorba, Rosa; Megia, Ana; Zorzano, Antonio; Medina-Gomez, Gema; Serena, Carolina; Castrillo, Antonio; Vendrell, Joan; Fernandez-Veledo, Sonia			SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity	NATURE IMMUNOLOGY			English	Article							SUCCINATE RECEPTOR GPR91; ADIPOSE-TISSUE MACROPHAGES; ALTERNATIVE ACTIVATION; EXPRESSION; CELLS; ACCUMULATION; MITOCHONDRIA; MODULATION; SIGNAL; ALPHA	Succinate is a signaling metabolite sensed extracellularly by succinate receptor 1 (SUNCR1). The accumulation of succinate in macrophages is known to activate a pro-inflammatory program; however, the contribution of SUCNR1 to macrophage phenotype and function has remained unclear. Here we found that activation of SUCNR1 had a critical role in the anti-inflammatory responses in macrophages. Myeloid-specific deficiency in SUCNR1 promoted a local pro-inflammatory phenotype, disrupted glucose homeostasis in mice fed a normal chow diet, exacerbated the metabolic consequences of diet-induced obesity and impaired adipose-tissue browning in response to cold exposure. Activation of SUCNR1 promoted an anti-inflammatory phenotype in macrophages and boosted the response of these cells to type 2 cytokines, including interleukin-4. Succinate decreased the expression of inflammatory markers in adipose tissue from lean human subjects but not that from obese subjects, who had lower expression of SUCNR1 in adipose-tissue-resident macrophages. Our findings highlight the importance of succinate-SUCNR1 signaling in determining macrophage polarization and assign a role to succinate in limiting inflammation.	[Keiran, Noelia; Ceperuelo-Mallafre, Victoria; Calvo, Enrique; Isabel Hernandez-Alvarez, Maria; Ejarque, Miriam; Nunez-Roa, Catalina; Maymo-Masip, Elsa; Mar Rodriguez, M.; Megia, Ana; Serena, Carolina; Vendrell, Joan; Fernandez-Veledo, Sonia] Hosp Univ Tarragona Joan XXIII, Unitat Recerca, Inst Invest Sanitaria Pere Virgili, Tarragona, Spain; [Keiran, Noelia; Ceperuelo-Mallafre, Victoria; Calvo, Enrique; Isabel Hernandez-Alvarez, Maria; Ejarque, Miriam; Nunez-Roa, Catalina; Maymo-Masip, Elsa; Mar Rodriguez, M.; Megia, Ana; Zorzano, Antonio; Serena, Carolina; Vendrell, Joan; Fernandez-Veledo, Sonia] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain; [Isabel Hernandez-Alvarez, Maria] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Horrillo, Daniel; Medina-Gomez, Gema] Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Bioquim & Biol Mol, Madrid, Spain; [Fradera, Rosa] Hosp St Pau & Sta Tecla, Gen & Digest Surg Serv, Inst Invest Sanitaria Pere Virgili, Tarragona, Spain; [Vladimir de la Rosa, Juan; Castrillo, Antonio] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Vladimir de la Rosa, Juan; Castrillo, Antonio] Univ Las Palmas Gran Canaria, Unidad Biomed, Unidad Asociada, CSIC,IUBIS, Las Palmas Gran Canaria, Spain; [Jorba, Rosa] Hosp Univ Tarragona Joan XXIII, Gen & Digest Surg Serv, Inst Invest Sanitaria Pere Virgili, Tarragona, Spain; [Zorzano, Antonio] Fac Biol, Dept Bioquim & Biomed Mol, Barcelona, Spain; [Vendrell, Joan] Univ Rovira & Virgili, Tarragona, Spain	Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universidad Rey Juan Carlos; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Las Palmas de Gran Canaria; Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Barcelona; Universitat Rovira i Virgili	Vendrell, J; Fernandez-Veledo, S (corresponding author), Hosp Univ Tarragona Joan XXIII, Unitat Recerca, Inst Invest Sanitaria Pere Virgili, Tarragona, Spain.; Vendrell, J; Fernandez-Veledo, S (corresponding author), Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain.; Vendrell, J (corresponding author), Univ Rovira & Virgili, Tarragona, Spain.	jvo@comt.es; sonia.fernandezveledo@gmail.com	Megia, Ana/W-5556-2019; Medina-Gomez, Gema/CAI-1063-2022; de la Rosa Medina, Juan Vladimir/Z-6150-2019; Serena, Carolina/J-5687-2014; Fernández-Veledo, Sonia/V-4625-2018; Serena, Carolina/AAQ-6831-2021; Medina-Gomez, Gema/F-5667-2016; Ejarque, Miriam/H-1503-2015; Zorzano, Antonio/R-5479-2018; JORBA, ROSA/GYR-1809-2022; Medina-Gomez, Gema/CAF-4668-2022; Calvo, Enrique/K-8680-2014; Hernández-Alvarez, María Isabel/Z-4830-2019; Ceperuelo Mallafre, Victoria/A-4615-2017; Maymo Masip, Elsa/T-1828-2017	Medina-Gomez, Gema/0000-0001-8169-681X; de la Rosa Medina, Juan Vladimir/0000-0003-1443-7548; Serena, Carolina/0000-0003-2251-0856; Fernández-Veledo, Sonia/0000-0003-2906-3788; Serena, Carolina/0000-0003-2251-0856; Medina-Gomez, Gema/0000-0001-8169-681X; Ejarque, Miriam/0000-0003-0545-9817; Medina-Gomez, Gema/0000-0001-8169-681X; Calvo, Enrique/0000-0002-2468-0931; Megia, Ana/0000-0002-5101-9452; Ceperuelo Mallafre, Victoria/0000-0002-4460-9761; Maymo Masip, Elsa/0000-0002-9133-3120; Hernandez-Alvarez, Maria Isabel/0000-0003-2483-7000; JORBA, Rosa/0000-0003-3307-4340; Keiran, Noelia/0000-0002-8914-665X	Spanish Ministry of Science, Innovation and Universities - European Regional Development Fund (ERDF) [PI14/00228, PI17/01503, SAF2015-65019-R, SAF2014-56819-R, SAF2015-71878-REDT, BFU2016-78951-R, PI15/00143, PI15/01562, BFU2015-70454-REDT, BFU2017-90578-REDT]; MINECO, Spain (FPI) [BES-2016-077745]; 'Ramon y Cajal' program from MINECO [RYC2013-13186]; Miguel Servet tenure-track program from the Fondo de Investigacion Sanitaria [CP10/00438, CPII16/00008]; ERDF; BioBank IISPV [PT17/0015/0029]	Spanish Ministry of Science, Innovation and Universities - European Regional Development Fund (ERDF); MINECO, Spain (FPI); 'Ramon y Cajal' program from MINECO; Miguel Servet tenure-track program from the Fondo de Investigacion Sanitaria; ERDF(European Commission); BioBank IISPV	This study was supported by grants from the Spanish Ministry of Science, Innovation and Universities (PI14/00228 and PI17/01503 to J.V., SAF2015-65019-R to S.F.-V., SAF2014-56819-R and SAF2015-71878-REDT to A.C., BFU2016-78951-R to G.M.-M., PI15/00143 to C.S. and PI15/01562 to A.M., BFU2015-70454-REDT and BFU2017-90578-REDT to S.F.-V. and G.M.-M.) co-financed by the European Regional Development Fund (ERDF). The Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. N.K. is recipient of a predoctoral fellowship from MINECO, Spain (FPI, BES-2016-077745). C.S. acknowledges support from the 'Ramon y Cajal' program from MINECO (RYC2013-13186) and S.F.-V. the Miguel Servet tenure-track program (CP10/00438 and CPII16/00008) from the Fondo de Investigacion Sanitaria, co-financed by the ERDF. We want to particularly acknowledge the patients and the BioBank IISPV (PT17/0015/0029) integrated in the Spanish National Biobanks Network for its collaboration. We also thank K. McCreath and A. Cervera for kindly providing the C57BL/6 Sucnr1<SUP>fl/fl</SUP> mice and for their helpful comments on the manuscript. Finally, we thank IRB Barcelona Functional Genomics Core Facility for Microarray processing and IRB Barcelona Biostatistics and Bioinformatics facility.	Aguiar CJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0078-2; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Carobbio S, 2017, ADV EXP MED BIOL, V960, P161, DOI 10.1007/978-3-319-48382-5_7; Ceperuelo-Mallafre V, 2016, MOL METAB, V5, P5, DOI 10.1016/j.molmet.2015.10.001; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Fonseca MD, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0126-1; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heber S, 2006, OMICS, V10, P358, DOI 10.1089/omi.2006.10.358; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOCHACHKA PW, 1976, EUR J APPL PHYSIOL O, V35, P235, DOI 10.1007/BF00423282; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Kwok KHM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Li YH, 2015, BIOCHEM BIOPH RES CO, V463, P853, DOI 10.1016/j.bbrc.2015.06.023; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Manieri E, 2015, J MOL ENDOCRINOL, V55, pR11, DOI 10.1530/JME-15-0146; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Maymo-Masip E, 2013, J CLIN ENDOCR METAB, V98, pE1323, DOI 10.1210/jc.2012-4177; McCreath KJ, 2015, DIABETES, V64, P1154, DOI 10.2337/db14-0346; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Peruzzotti-Jametti L., 2018, CELL STEM CELL, V22; Peti-Peterdi J, 2013, PFLUG ARCH EUR J PHY, V465, P53, DOI 10.1007/s00424-012-1130-y; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Reilly SM, 2014, NAT IMMUNOL, V15, P410, DOI 10.1038/ni.2874; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Rubic-Schneider T, 2017, ALLERGY, V72, P444, DOI 10.1111/all.13005; Ryan DG, 2017, FEBS LETT, V591, P2992, DOI 10.1002/1873-3468.12744; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Saraiva A. L., 2018, FASEB J, V12; Serena C, 2018, ISME J, V12, P1642, DOI 10.1038/s41396-018-0068-2; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Trauelsen M, 2017, MOL METAB, V6, P1585, DOI 10.1016/j.molmet.2017.09.005; Trouplin V., 2013, JOVE-J VIS EXP, V81, P50966; van Diepen JA, 2017, DIABETOLOGIA, V60, P1304, DOI 10.1007/s00125-017-4261-z; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Virtue S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00128; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	69	98	103	8	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					581	+		10.1038/s41590-019-0372-7	http://dx.doi.org/10.1038/s41590-019-0372-7			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30962591	Green Submitted			2022-12-18	WOS:000465084800015
J	Xing, JJ; Weng, LY; Yuan, B; Wang, Z; Jia, L; Jin, R; Lu, HB; Li, XC; Liu, YJ; Zhang, ZG				Xing, Junji; Weng, Leiyun; Yuan, Bin; Wang, Zhuo; Jia, Li; Jin, Rui; Lu, Hongbo; Li, Xian Chang; Liu, Yong-Jun; Zhang, Zhigiang			Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; INTERFERON ANTIVIRAL RESPONSE; NF-KAPPA-B; ALVEOLAR MACROPHAGES; GM-CSF; INFECTION; NEMO; PATHWAY; PROTEIN; MICE	The respiratory tract is heavily populated with innate immune cells, but the mechanisms that control such cells are poorly defined. Here we found that the E3 ubiquitin ligase TRIM29 was a selective regulator of the activation of alveolar macrophages, the expression of type I interferons and the production of proinflammatory cytokines in the lungs. We found that deletion of TRIM29 enhanced macrophage production of type I interferons and protected mice from infection with influenza virus, while challenge of Trim29(-/-) mice with Haemophilus influenzae resulted in lethal lung inflammation due to massive production of proinflammatory cytokines by macrophages. Mechanistically, we demonstrated that TRIM29 inhibited interferon-regulatory factors and signaling via the transcription factor NF-kappa B by degrading the adaptor NEMO and that TRIM29 directly bound NEMO and subsequently induced its ubiquitination and proteolytic degradation. These data identify TRIM29 as a key negative regulator of alveolar macrophages and might have important clinical implications for local immunity and immunopathology.	[Xing, Junji; Yuan, Bin; Wang, Zhuo; Jia, Li; Jin, Rui; Li, Xian Chang; Zhang, Zhigiang] Houston Methodist Res Inst, Immunobiol & Transplant Res Ctr, Houston, TX 77030 USA; [Weng, Leiyun; Lu, Hongbo; Liu, Yong-Jun] Medimmune, Gaithersburg, MD USA; [Li, Xian Chang; Zhang, Zhigiang] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA; [Liu, Yong-Jun] Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Jilin, Peoples R China; [Liu, Yong-Jun] Sanofi, Cambridge, MA USA	The Methodist Hospital System; The Methodist Hospital - Houston; AstraZeneca; Medimmune; Cornell University; Jilin University; Sanofi-Aventis	Zhang, ZG (corresponding author), Houston Methodist Res Inst, Immunobiol & Transplant Res Ctr, Houston, TX 77030 USA.; Liu, YJ (corresponding author), Medimmune, Gaithersburg, MD USA.; Zhang, ZG (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA.; Liu, YJ (corresponding author), Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Jilin, Peoples R China.; Liu, YJ (corresponding author), Sanofi, Cambridge, MA USA.	yong-jun.liu@sanofi.com; zzhang@houstonmethodist.org	Xing, Junji/H-8259-2019	Xing, Junji/0000-0002-3392-5427	US National Institutes of Health [R01AI080779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080779, R56AI080779] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Wellcome Trust Sanger Institute Mouse Genetics Project (Sanger MGP) and its funders for the mutant mouse line Trim29, and the European Mouse Mutant Archive (http://www.emmanet.org) partner from which the mouse line was received. Funding and associated primary phenotypic information is provided at the Sanger website (http://www.sanger.ac.uk/mouseportal). We also thank L. Minze for operational support. Supported by the US National Institutes of Health (R01AI080779 to X.C.L.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzpatrick AM, 2008, J ALLERGY CLIN IMMUN, V121, P1372, DOI 10.1016/j.jaci.2008.03.008; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jin W, 2012, CELL MOL IMMUNOL, V9, P113, DOI 10.1038/cmi.2011.60; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; LEMARIE E, 1984, THORAX, V39, P448, DOI 10.1136/thx.39.6.448; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Masuda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8299; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Murphy SL, 2013, NATL VITAL STAT REP, P61; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Palmbos PL, 2015, CANCER RES, V75, P5155, DOI 10.1158/0008-5472.CAN-15-0603; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Vlahos R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00435; Wang RF, 2008, ONCOGENE, V27, P181, DOI 10.1038/sj.onc.1210906; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	48	98	102	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1373	1380		10.1038/ni.3580	http://dx.doi.org/10.1038/ni.3580			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27695001	Green Accepted			2022-12-18	WOS:000388056400007
J	Henault, J; Riggs, JM; Karnell, JL; Liarski, VM; Li, JQ; Shirinian, L; Xu, LD; Casey, KA; Smith, MA; Khatry, DB; Izhak, L; Clarke, L; Herbst, R; Ettinger, R; Petri, M; Clark, MR; Mustelin, T; Kolbeck, R; Sanjuan, MA				Henault, Jill; Riggs, Jeffrey M.; Karnell, Jodi L.; Liarski, Vladimir M.; Li, Jianqing; Shirinian, Lena; Xu, Linda; Casey, Kerry A.; Smith, Michael A.; Khatry, Deepak B.; Izhak, Liat; Clarke, Lorraine; Herbst, Ronald; Ettinger, Rachel; Petri, Michelle; Clark, Marcus R.; Mustelin, Tomas; Kolbeck, Roland; Sanjuan, Miguel A.			Self-reactive IgE exacerbates interferon responses associated with autoimmunity	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; TRANSCRIPTION FACTORS; I INTERFERON; ANTIBODIES; NEPHRITIS; CHILDREN; RECEPTOR; ANTIGENS	Canonically, immunoglobulin E (IgE) mediates allergic immune responses by triggering mast cells and basophils to release histamine and type 2 helper cytokines. Here we found that in human systemic lupus erythematosus (SLE), IgE antibodies specific for double-stranded DNA (dsDNA) activated plasmacytoid dendritic cells (pDCs), a type of cell of the immune system linked to viral defense, which led to the secretion of substantial amounts of interferon-alpha (IFN-alpha). The concentration of dsDNA-specific IgE found in patient serum correlated with disease severity and greatly potentiated pDC function by triggering phagocytosis via the high-affinity Fc epsilon RI receptor for IgE, followed by Toll-like receptor 9 (TLR9)-mediated sensing of DNA in phagosomes. Our findings expand the known pathogenic mechanisms of IgE-mediated inflammation beyond those found in allergy and demonstrate that IgE can trigger interferon responses capable of exacerbating self-destructive autoimmune responses.	[Henault, Jill; Riggs, Jeffrey M.; Karnell, Jodi L.; Li, Jianqing; Casey, Kerry A.; Smith, Michael A.; Khatry, Deepak B.; Izhak, Liat; Herbst, Ronald; Ettinger, Rachel; Mustelin, Tomas; Kolbeck, Roland; Sanjuan, Miguel A.] Medimmune Inc, Res Dept, Gaithersburg, MD 20878 USA; [Liarski, Vladimir M.; Clark, Marcus R.] Univ Chicago, Sect Rheumatol, Chicago, IL 60637 USA; [Liarski, Vladimir M.; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Shirinian, Lena; Xu, Linda; Clarke, Lorraine] Medimmune Inc, Antibody Discovery & Prot Engn Dept, Gaithersburg, MD 20878 USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA	AstraZeneca; Medimmune; University of Chicago; University of Chicago; AstraZeneca; Medimmune; Johns Hopkins University	Sanjuan, MA (corresponding author), Medimmune Inc, Res Dept, Gaithersburg, MD 20878 USA.	sanjuanm@medimmune.com	Sanjuán, Miguel AF/B-7709-2011; Casey, Kerry A/B-5274-2011	Sanjuán, Miguel AF/0000-0003-3515-0837; Casey, Kerry A/0000-0001-7194-8585; Mustelin, Tomas/0000-0001-5912-8840; Khatry, Deepak/0000-0002-2388-9434; Liarski, Vladimir/0000-0001-7533-0491	US National Institutes of Health [AR-43727]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055646, R01AR043727, R55AR043727] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Cohen (MedImmune) for antibody to IgE; M. Rebelatto, M. Czapiga, K. Dacosta, W. King and H. Koelkebeck for discussions; E. Grant and K. Stover for critical manuscript review; E. Grant and M. Parker and the Autoimmunity Molecular Medicine Group (Medimmune) for assistance with clinical samples; and K. Zerrouki for assistance with manuscript editing. Supported by the US National Institutes of Health (AR-43727).	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; ELKAYAM O, 1995, ALLERGY, V50, P94; Fitzsimmons CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00061; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lit LCW, 2007, J RHEUMATOL, V34, P89; Livingston B, 2012, SEMIN ARTHRITIS RHEU, V42, P271, DOI 10.1016/j.semarthrit.2012.05.001; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Morton S, 1998, ANN RHEUM DIS, V57, P660, DOI 10.1136/ard.57.11.660; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nossent H, 2000, LUPUS, V9, P504, DOI 10.1177/096120330000900705; Novak N, 2004, J ALLERGY CLIN IMMUN, V114, P364, DOI 10.1016/j.jaci.2004.05.038; Pellegrino MG, 2002, AIDS RES HUM RETROV, V18, P363, DOI 10.1089/088922202753519142; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; RUSSI JC, 1993, J CLIN MICROBIOL, V31, P819, DOI 10.1128/JCM.31.4.819-823.1993; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Satoskar AA, 2011, LUPUS, V20, P1396, DOI 10.1177/0961203311416533; Secord EA, 1996, J ALLERGY CLIN IMMUN, V98, P979, DOI 10.1016/S0091-6749(96)80015-7; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; SHARP GC, 1976, NEW ENGL J MED, V295, P1149, DOI 10.1056/NEJM197611182952101; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smith-Norowitz TA, 2011, INT J MED SCI, V8, P239, DOI 10.7150/ijms.8.239; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Wozniacka A, 2003, MEDIAT INFLAMM, V12, P95, DOI 10.1080/0962935031000097709	41	98	102	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					196	203		10.1038/ni.3326	http://dx.doi.org/10.1038/ni.3326			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26692173	Green Accepted			2022-12-18	WOS:000368571500013
J	Liu, J; Han, CF; Xie, B; Wu, Y; Liu, SX; Chen, K; Xia, M; Zhang, Y; Song, LJ; Li, ZQ; Zhang, T; Ma, F; Wang, QQ; Wang, JL; Deng, KJ; Zhuang, Y; Wu, XH; Yu, YZ; Xu, T; Cao, XT				Liu, Juan; Han, Chaofeng; Xie, Bin; Wu, Yue; Liu, Shuxun; Chen, Kun; Xia, Meng; Zhang, Yuan; Song, Lijun; Li, Zhiqing; Zhang, Ting; Ma, Feng; Wang, Qingqing; Wang, Jianli; Deng, Kejing; Zhuang, Yuan; Wu, Xiaohui; Yu, Yizhi; Xu, Tian; Cao, Xuetao			Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; T-CELLS; NEGATIVE REGULATOR; ACTIVATION; RECOGNITION; A20; EXPRESSION; INNATE; UBIQUITYLATION	Excessive activation of dendritic cells (DCs) leads to the development of autoimmune and inflammatory diseases, which has prompted a search for regulators of DC activation. Here we report that Rhbdd3, a member of the rhomboid family of proteases, suppressed the activation of DCs and production of interleukin 6 (IL-6) triggered by Toll-like receptors (TLRs). Rhbdd3-deficient mice spontaneously developed autoimmune diseases characterized by an increased abundance of the T(H)17 subset of helper T cells and decreased number of regulatory T cells due to the increase in IL-6 from DCs. Rhbdd3 directly bound to Lys27 (K27)linked polyubiquitin chains on Lys302 of the modulator NEMO (IKK gamma) via the ubiquitin-binding association (UBA) domain in endosomes. Rhbdd3 further recruited the deubiquitinase A20 via K27-linked polyubiquitin chains on Lys268 to inhibit K63-linked polyubiquitination of NEMO and thus suppressed activation of the transcription factor NF-kappa B in DCs. Our data identify Rhbdd3 as a critical regulator of DC activation and indicate K27-linked polyubiquitination is a potent ubiquitin-linked pattern involved in the control of autoimmunity.	[Liu, Juan; Han, Chaofeng; Liu, Shuxun; Song, Lijun; Yu, Yizhi; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Liu, Juan; Han, Chaofeng; Liu, Shuxun; Song, Lijun; Yu, Yizhi; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Liu, Juan; Zhang, Yuan; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xie, Bin; Chen, Kun; Xia, Meng; Li, Zhiqing; Zhang, Ting; Ma, Feng; Wang, Qingqing; Wang, Jianli; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Yue; Deng, Kejing; Zhuang, Yuan; Wu, Xiaohui; Xu, Tian] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Zhejiang University; Fudan University	Cao, XT (corresponding author), Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China.	xutian@fudan.edu.cn; caoxt@immunol.org	Ma, Feng/E-7927-2015; yu, yizhi/ADP-7854-2022; song, lijun/ABB-7049-2021	xia, meng/0000-0001-5223-7390; zhuang, yuan/0000-0002-2964-3654; Zhang, Yuan/0000-0003-3770-0046; Han, Chaofeng/0000-0002-8489-6478	National Key Basic Research Program of China [2013CB530503, 2012CB910202]; National Natural Science Foundation of China [81230074, 81123006, 81172787]; National 125 Key Project [2012AA020901]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project	We thank J. Jiang for technical assistance; C. Dong (MD Anderson Cancer Center) for Il17<SUP>-/-</SUP> mice; S. Jung (Weizmann Institute of Science) for CD11c-DTR mice; and J. Jung (Harvard Medical School) for the pEBG plasmid. Supported by the National Key Basic Research Program of China (2013CB530503 and 2012CB910202), the National Natural Science Foundation of China (81230074, 81123006 and 81172787) and the National 125 Key Project (2012AA020901).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Bahar A, 2004, MOL ENDOCRINOL, V18, P1827, DOI 10.1210/me.2004-0087; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu J, 2013, P NATL ACAD SCI USA, V110, P7814, DOI 10.1073/pnas.1220466110; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu R, 2008, CELL RES, V18, P1114, DOI 10.1038/cr.2008.295; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zahn A, 2007, WORLD J GASTROENTERO, V13, P1687, DOI 10.3748/wjg.v13.i11.1687; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	43	98	105	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					612	622		10.1038/ni.2898	http://dx.doi.org/10.1038/ni.2898			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24859449				2022-12-18	WOS:000337715600007
J	Lee, MS; Kim, B; Oh, GT; Kim, YJ				Lee, Myeong Sup; Kim, Byungil; Oh, Goo Taeg; Kim, Young-Joon			OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; SYNTHETASE GENE FAMILY; DOUBLE-STRANDED-RNA; 2'-5'-OLIGOADENYLATE SYNTHETASE; ANTIVIRAL RESPONSE; 2',5'-OLIGOADENYLATE SYNTHETASE; IMMUNE-SYSTEM; ACTIVATION	The production of type I interferon is essential for viral clearance but is kept under tight control to avoid unnecessary tissue damage from hyperinflammatory responses. Here we found that OASL1 inhibited translation of IRF7, the master transcription factor for type I interferon, and thus negatively regulated the robust production of type I interferon during viral infection. OASL1 inhibited the translation of IRF7 mRNA by binding to the 5' untranslated region (UTR) of IRF7 and possibly by inhibiting scanning of the 43S preinitiation complex along the message. Oasl1(-/-) mice were resistant to viral infection because of the greater abundance of type I interferon, which suggests that OASL1 could be a potential therapeutic target for boosting the production of type I interferon during viral infection.	[Lee, Myeong Sup; Kim, Byungil; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Yonsei University; Ewha Womans University	Kim, YJ (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Oh, Goo Taeg/AAQ-9995-2021	Kim, Byungil/0000-0002-1743-2657	Global Research Laboratory program of the Ministry of Education, Science and Technology of Korea (MEST) [K20704000006-10A0500-00610]; World Class University program; Korean government (MEST) through the National Research Foundation of Korea [R312010000100860]; National Research Foundation of Korea; Korean government (MEST) [2012028272]; Korea Genetically Engineered Mouse Center Program of the National Research Foundation of the Korean government (MEST) [2011-0020603]	Global Research Laboratory program of the Ministry of Education, Science and Technology of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University program; Korean government (MEST) through the National Research Foundation of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Genetically Engineered Mouse Center Program of the National Research Foundation of the Korean government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea)	We thank S. Park and Y. Seo for technical support in the microinjection of embryonic stem cells; J. Ahn and H. Jung for technical help in mouse maintenance; J. Kang and Q. Zhang for technical help in the molecular studies; and G. Dranoff (Harvard Medical School) for the melanoma cell lines B16-FLT3L and B16-GM-CSF. Supported by the Global Research Laboratory program of the Ministry of Education, Science and Technology of Korea (MEST; K20704000006-10A0500-00610 to Y.-J.K.), the World Class University program funded by the Korean government (MEST) through the National Research Foundation of Korea (R312010000100860 to Y.-J.K.), the National Research Foundation of Korea funded by the Korean government (MEST; 2012028272 to Y.-J.K.) and the Korea Genetically Engineered Mouse Center Program of the National Research Foundation of the Korean government (MEST; 2011-0020603 to G.T.O.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bonnefoy F, 2011, J IMMUNOL, V186, P5696, DOI 10.4049/jimmunol.1001523; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Eskildsen S, 2003, NUCLEIC ACIDS RES, V31, P3166, DOI 10.1093/nar/gkg427; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kadeppagari RK, 2012, VIRUS RES, V167, P273, DOI 10.1016/j.virusres.2012.05.010; Kakuta S, 2002, J INTERF CYTOK RES, V22, P981, DOI 10.1089/10799900260286696; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Perelygin AA, 2006, J MOL EVOL, V63, P562, DOI 10.1007/s00239-006-0073-3; Richards KH, 2011, MICROBES INFECT, V13, P291, DOI 10.1016/j.micinf.2010.12.007; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yan W, 2005, MOL CELL BIOL, V25, P4615, DOI 10.1128/MCB.25.11.4615-4624.2005	43	98	101	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					346	355		10.1038/ni.2535	http://dx.doi.org/10.1038/ni.2535			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23416614				2022-12-18	WOS:000316648700009
J	Girardi, E; Maricic, I; Wang, J; Mac, TT; Iyer, P; Kumar, V; Zajonc, DM				Girardi, Enrico; Maricic, Igor; Wang, Jing; Mac, Thien-Thi; Iyer, Pooja; Kumar, Vipin; Zajonc, Dirk M.			Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens	NATURE IMMUNOLOGY			English	Article							NKT CELLS; CUTTING EDGE; STRUCTURAL BASIS; CD1D; GLYCOLIPIDS; REPERTOIRE; ACTIVATION; BINDING	Glycolipids presented by the major histocompatibility complex (MHC) class I homolog CD1d are recognized by natural killer T cells (NKT cells) characterized by either a semi-invariant T cell antigen receptor (TCR) repertoire (type I NKT cells or iNKT cells) or a relatively variable TCR repertoire (type II NKT cells). Here we describe the structure of a type II NKT cell TCR in complex with CD1d-lysosulfatide. Both TCR alpha-chains and TCR beta-chains made contact with the CD1d molecule with a diagonal footprint, typical of MHC-TCR interactions, whereas the antigen was recognized exclusively with a single TCR chain, similar to the iNKT cell TCR. Type II NKT cell TCRs, therefore, recognize CD1d-sulfatide complexes by a distinct recognition mechanism characterized by the TCR-binding features of both iNKT cells and conventional peptide-reactive T cells.	[Maricic, Igor; Kumar, Vipin] Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA USA; [Girardi, Enrico; Wang, Jing; Mac, Thien-Thi; Iyer, Pooja; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA	Torrey Pines Institute for Molecular Studies, California; La Jolla Institute for Immunology	Kumar, V (corresponding author), Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA USA.	vkumar@tpims.org; dzajonc@liai.org	Wang, Jing/L-5095-2013; Girardi, Enrico/AAD-2260-2020; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723	US National Institutes of Health [AI074952, CA100660]; Juvenile Diabetes Research Foundation; Multiple Sclerosis National Research Institute; NATIONAL CANCER INSTITUTE [R01CA100660] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R56AI074952] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Multiple Sclerosis National Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Stanford Synchrotron Radiation Lightsource (beamline 7-1) and the Advanced Light Source (beamline 5.0.3) for support during remote collection of data; M. Kronenberg (La Jolla Institute for Allergy & Immunology) for several CD1d mutants; R. Stanfield (The Scripps Research Institute) for computer scripts used for the measurement of docking angles; and N. Vu and J. Nourblin (La Jolla Institute for Allergy & Immunology) for help during cloning and protein expression. Supported by the US National Institutes of Health (AI074952 to D.M.Z. and CA100660 to V.K.), the Juvenile Diabetes Research Foundation (V.K.) and the Multiple Sclerosis National Research Institute (V.K.).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Arrenberg P, 2011, GASTROENTEROLOGY, V140, P646, DOI 10.1053/j.gastro.2010.10.003; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Exley MA, 2002, J IMMUNOL, V168, P1519, DOI 10.4049/jimmunol.168.4.1519; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Shin JH, 2012, J IMMUNOL, V188, P2235, DOI 10.4049/jimmunol.1100236; Subramanian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037771; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; TODA K, 1990, J NEUROCHEM, V55, P1585, DOI 10.1111/j.1471-4159.1990.tb04942.x; Yang SH, 2011, J AM SOC NEPHROL, V22, P1305, DOI 10.1681/ASN.2010080815; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zimmer MI, 2009, P NATL ACAD SCI USA, V106, P1909, DOI 10.1073/pnas.0808476106	37	98	100	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					851	856		10.1038/ni.2371	http://dx.doi.org/10.1038/ni.2371			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22820602	Green Accepted			2022-12-18	WOS:000307863600013
J	Kano, SI; Sato, K; Morishita, Y; Vollstedt, S; Kim, S; Bishop, K; Honda, K; Kubo, M; Taniguchi, T				Kano, Shin-ichi; Sato, Kojiro; Morishita, Yasyuki; Vollstedt, Sabine; Kim, Sunhwa; Bishop, Keith; Honda, Kenya; Kubo, Masato; Taniguchi, Tadatsugu			The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and T(H)1 versus T-H-17 differentiation of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							REGULATORY FACTOR-I; IFN-GAMMA; AUTOIMMUNE INFLAMMATION; LINEAGE COMMITMENT; IL-12 RECEPTOR; TARGETED DISRUPTION; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; TH1 DEVELOPMENT	Interleukin-12 (IL-12) and interferon-gamma (IFN-gamma) drive T helper type 1 (T(H)1) differentiation, but the mechanisms underlying the regulation of the complicated gene networks involved in this differentiation are not fully understood. Here we show that the IFN-gamma-induced transcription factor IRF1 was essential in TO differentiation by acting on II12rb1, the gene encoding the IL-12 receptor beta 1 subunit (IL-12R beta 1). IRF1 directly interacted with and activated the II12rb1 promoter in CD4(+) T cells. Notably, the IRF1-dependent induction of IL-12R beta 1 was essential for IFN-gamma-IL-12 signaling but was dispensable for IL-23-IL-17 signaling. Because both IL-12 and IL-23 bind to and transmit signals through IL-12R beta 1, our data suggest that distinct thresholds of IL-12R beta 1 expression are required for T(H)1 versus T-H-17 differentiation.	[Kano, Shin-ichi; Sato, Kojiro; Vollstedt, Sabine; Kim, Sunhwa; Honda, Kenya; Taniguchi, Tadatsugu] Univ Tokyo, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Morishita, Yasyuki] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Morishita, Yasyuki] Univ Tokyo, Fac Med, Tokyo 1130033, Japan; [Bishop, Keith] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Bishop, Keith] Univ Michigan, Sch Med, Dept Surg, Sect Gen Surg, Ann Arbor, MI 48109 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Res Ctr Allergey & Immunol, Lab Signal Network,Tsurumi Ku, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; RIKEN	Taniguchi, T (corresponding author), Univ Tokyo, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Kano, Shinichi/F-4144-2015; Kubo, Masato/A-5918-2016; Honda, Kenya/N-5297-2015	Kano, Shinichi/0000-0002-5171-3436; Sato, Kojiro/0000-0003-4105-3726				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Clavell M, 2000, J PEDIATR GASTR NUTR, V30, P43, DOI 10.1097/00005176-200001000-00016; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5; Glimcher LH, 2000, GENE DEV, V14, P1693; Harries-Rees K, 2005, CHEM WORLD-UK, V2, P6; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; McElligott DL, 1997, J IMMUNOL, V159, P4180; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Park SH, 2005, CHEM MATER, V17, P6, DOI 10.1021/cm048433e; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Silverberg MS, 2007, EUR J HUM GENET, V15, P328, DOI 10.1038/sj.ejhg.5201756; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takasu Junichiro, 2002, BMC Blood Disord, V2, P3, DOI 10.1186/1471-2326-2-3; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wenner CA, 1996, J IMMUNOL, V156, P1442; Wu CY, 1997, J IMMUNOL, V159, P1658; Yamane H, 2000, EUR J IMMUNOL, V30, P3171; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066	50	98	102	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					34	41		10.1038/ni1538	http://dx.doi.org/10.1038/ni1538			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18059273				2022-12-18	WOS:000251820800009
J	Phan, UT; T Waldron, T; Springer, TA				Phan, Uyen T.; T Waldron, Travis; Springer, Timothy A.			Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force	NATURE IMMUNOLOGY			English	Article							LIGAND RECOGNITION; LYMPHOCYTE RECIRCULATION; GLYCOPROTEIN LIGAND-1; S128R POLYMORPHISM; CYTOPLASMIC DOMAIN; TRAFFIC SIGNALS; CELL-ADHESION; RECEPTOR; BINDING; BONDS	Crystal structures of the lectin and epidermal growth factor (EGF)-like domains of P-selectin show 'bent' and 'extended' conformations. An extended conformation would be 'favored' by forces exerted on a selectin bound at one end to a ligand and at the other end to a cell experiencing hydrodynamic drag forces. To determine whether the extended conformation has higher affinity for ligand, we introduced an N-glycosylation site to 'wedge open' the interface between the lectin and EGF-like domains of P-selectin. This alteration increased the affinity of P-selectin for its ligand P-selectin glycoprotein 1 (PSGL-1) and thereby the strength of P-selectin-mediated rolling adhesion. Similarly, an asparagine-to-glycine substitution in the lectin-EGF-like domain interface of L-selectin enhanced rolling adhesion under shear flow. Our results demonstrate that force, by 'favoring' an extended selectin conformation, can strengthen selectin-ligand bonds.	Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI052851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM073529] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48675, P01 HL048675] Funding Source: Medline; NIAID NIH HHS [F32 AI052851] Funding Source: Medline; NIGMS NIH HHS [F32 GM073529] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Dwir O, 2000, J BIOL CHEM, V275, P18682, DOI 10.1074/jbc.M001103200; ERBE DV, 1993, J CELL BIOL, V120, P1227, DOI 10.1083/jcb.120.5.1227; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; KANSAS GS, 1991, J CELL BIOL, V114, P351, DOI 10.1083/jcb.114.2.351; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lu CF, 1997, J IMMUNOL, V159, P268; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Patel KD, 1995, J CELL BIOL, V131, P1893, DOI 10.1083/jcb.131.6.1893; Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101; Rao RM, 2002, J IMMUNOL, V169, P5860, DOI 10.4049/jimmunol.169.10.5860; Rao RM, 2002, EUR J IMMUNOL, V32, P251, DOI 10.1002/1521-4141(200201)32:1<251::AID-IMMU251>3.0.CO;2-0; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Revelle BM, 1996, J BIOL CHEM, V271, P16160, DOI 10.1074/jbc.271.27.16160; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Wenzel K, 1996, HUM GENET, V97, P15; WENZEL K, 1994, HUM GENET, V94, P452; WU G, 1990, NOUV REV FR HEMATOL, V32, P231; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041	49	98	107	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					883	889		10.1038/ni1366	http://dx.doi.org/10.1038/ni1366			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16845394	Green Accepted			2022-12-18	WOS:000239147200025
J	Casares, S; Hurtado, A; McEvoy, RC; Sarukhan, A; von Boehmer, H; Brumeanu, TD				Casares, S; Hurtado, A; McEvoy, RC; Sarukhan, A; von Boehmer, H; Brumeanu, TD			Down-regulation of diabetogenic CD4(+) T cells by a soluble dimeric peptide MHC class II chimera	NATURE IMMUNOLOGY			English	Article							DEPENDENT DIABETES-MELLITUS; NOD MICE; L-SELECTIN; AUTOIMMUNE; INSULIN; MOUSE; LYMPHOCYTES; INDUCTION; TOLERANCE; RESPONSES	Type I diabetes is an organ-specific autoimmune disease that is mediated by autoreactive T cells. We show here that administration of a soluble dimeric peptide major histocompatibility complex (pMHC) class II chimera (DEF) to prediabetic double-transgenic mice prevents the onset of disease or, in animals that are already diabetic, restores normoglycemia. The antidiabetogenic effects of DEF rely on the induction of anergy in splenic autoreactive CD4(+) T cells via alteration of early T cell receptor signaling and stimulation of interleukin 10 secreting T regulatory type I cells in the pancreas. Soluble dimeric pMHC class II may be useful in the development of immunospecific therapies for type I diabetes.	CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Childrens Hosp & Clin, Ctr Diabet, Minneapolis, MN 55102 USA; Inst Necker, INSERM 373, Paris, France; Dana Farber Canc Inst, Boston, MA 02115 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Children's Hospitals & Clinics of Minnesota; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute	Casares, S (corresponding author), CUNY Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	casars01@doc.mssm.edu	Brumeanu, Teodor/AAB-1965-2020	Sarukhan, Adelaida/0000-0003-3747-6304	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK055744, R01DK061927, R21DK061326] Funding Source: NIH RePORTER; NIDDK NIH HHS [1R01DK061927, 1R21DK61326, 1R55DK55744] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Appel H, 2001, J IMMUNOL, V166, P5279, DOI 10.4049/jimmunol.166.8.5279; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Balasa B, 1997, J IMMUNOL, V159, P4620; Bockova J, 1997, J AUTOIMMUN, V10, P323, DOI 10.1006/jaut.1997.0150; Bot A, 1998, J IMMUNOL, V160, P4500; BOWMAN MA, 1994, IMMUNOL TODAY, V15, P115, DOI 10.1016/0167-5699(94)90154-6; Brumeanu T D, 2001, Int Rev Immunol, V20, P301, DOI 10.3109/08830180109043041; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V119, P433, DOI 10.1046/j.1365-2249.2000.01146.x; Buzzetti R, 1998, DIABETES METAB REV, V14, P111, DOI 10.1002/(SICI)1099-0895(199806)14:2<111::AID-DMR211>3.3.CO;2-U; Cameron MJ, 1997, J IMMUNOL, V159, P4686; Casares S, 1997, PROTEIN ENG, V10, P1295, DOI 10.1093/protein/10.11.1295; Casares S, 1998, BIOTECHNOL GENET ENG, V15, P159, DOI 10.1080/02648725.1998.10647955; Casares S, 2001, PROTEIN ENG, V14, P195, DOI 10.1093/protein/14.3.195; Casares S, 1999, J EXP MED, V190, P543, DOI 10.1084/jem.190.4.543; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Endl J, 1997, J CLIN INVEST, V99, P2405, DOI 10.1172/JCI119423; Faith A, 1999, J IMMUNOL, V162, P1836; Frey M, 1998, J IMMUNOL, V161, P400; Funda DP, 1998, APMIS, V106, P1009, DOI 10.1111/j.1699-0463.1998.tb00253.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; HEROLD KC, 1992, J EXP MED, V176, P1107, DOI 10.1084/jem.176.4.1107; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; ISHIOKA GY, 1994, J IMMUNOL, V152, P4310; Kuttler B, 1999, J MOL MED-JMM, V77, P226, DOI 10.1007/s001090050342; LaFace DM, 1997, J IMMUNOL, V158, P2057; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; LIKE AA, 1982, SCIENCE, V216, P644, DOI 10.1126/science.7041259; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; Maron R, 1999, J AUTOIMMUN, V12, P251, DOI 10.1006/jaut.1999.0278; MIGITA K, 1995, J IMMUNOL, V155, P5083; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Nicoletti F, 1999, DIABETES, V48, P2333, DOI 10.2337/diabetes.48.12.2333; Nitta Y, 1998, HUM GENE THER, V9, P1701, DOI 10.1089/hum.1998.9.12-1701; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Petersen JS, 1997, AUTOIMMUNITY, V25, P129, DOI 10.3109/08916939709008019; PETERSON JD, 1994, J IMMUNOL, V153, P2800; Piccirillo CA, 1998, J IMMUNOL, V161, P3950; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V; Radu DL, 1999, AUTOIMMUNITY, V30, P199, DOI 10.3109/08916939908993801; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Sarukhan A, 1998, EMBO J, V17, P71, DOI 10.1093/emboj/17.1.71; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Seddon B, 1996, EUR J IMMUNOL, V26, P2702, DOI 10.1002/eji.1830261123; SERREZE DV, 1988, DIABETES, V37, P252, DOI 10.2337/diabetes.37.2.252; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; TIAN R, 1996, NAT MED, V2, P1384; Tisch R, 1999, J IMMUNOL, V163, P1178; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Wang Y, 1987, DIABETES, V36, P535, DOI 10.2337/diabetes.36.4.535; Weil R, 1996, CURR TOP MICROBIOL, V205, P63; Wicker LS, 1996, J CLIN INVEST, V98, P2597, DOI 10.1172/JCI119079; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; Zaccone P, 1999, DIABETES, V48, P1522, DOI 10.2337/diabetes.48.8.1522; Zekzer D, 1997, DIABETES, V46, P1124, DOI 10.2337/diabetes.46.7.1124	65	98	103	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					383	391		10.1038/ni770	http://dx.doi.org/10.1038/ni770			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11862219				2022-12-18	WOS:000174623600020
J	Colucci, F; Schweighoffer, E; Tomasello, E; Turner, M; Ortaldo, JR; Vivier, E; Tybulewicz, VLJ; Di Santo, JP				Colucci, F; Schweighoffer, E; Tomasello, E; Turner, M; Ortaldo, JR; Vivier, E; Tybulewicz, VLJ; Di Santo, JP			Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases	NATURE IMMUNOLOGY			English	Article							NK CELL-DIFFERENTIATION; TYROSINE KINASE; KILLER-CELLS; NKG2D RECEPTOR; MICE LACKING; T-CELLS; ACTIVATION; MOUSE; COMPLEX; FAMILY	The intracellular signals that trigger natural cytotoxicity have not been clearly determined. The Syk and ZAP-70 tyrosine kinases are essential for cellular activation initiated by B and T cell antigen receptors and may drive natural killer (NK) cell cytotoxicity via receptors bearing immunoreceptor tyrosine-based activation motifs (ITAMs). However, we found that, unlike B and T cells, NK cells developed in Syk(-/-)ZAP-70(-/-) mice and, despite their nonfunctional ITAMs, lysed various tumor targets in vitro and eliminated tumor cells in vivo, including those without NKG2D ligands. The simultaneous inhibition of phosphotidyl inositol 3 kinase and Src kinases abrogated the cytolytic activity of Syk(-/-)ZAP-70(-/-) NK cells and strongly reduced that of wild-type NK cells. This suggests that distinct and redundant signaling pathways act synergistically to trigger natural cytotoxicity.	Inst Pasteur, Lab Cytokines & Lymphoid Dev, Paris, France; Natl Inst Med Res, London NW7 1AA, England; CNRS Marseille Luminy, INSERM, Ctr Immunol, Marseille, France; Babraham Inst, Cambridge CB2 4AT, England; NCI, Frederick, MD 21702 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Colucci, F (corresponding author), Inst Pasteur, Lab Cytokines & Lymphoid Dev, Paris, France.		Turner, Martin/N-9976-2014; Di Santo, James P/M-4298-2014; Colucci, Francesco/F-2844-2010; Vivier, Eric/F-8939-2010	Turner, Martin/0000-0002-3801-9896; Di Santo, James P/0000-0002-7146-1862; Colucci, Francesco/0000-0001-5193-6376; Vivier, Eric/0000-0001-7022-8287; Tomasello, Elena/0000-0002-6839-5219; Tybulewicz, Victor/0000-0003-2439-0798				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Colucci F, 1999, J IMMUNOL, V163, P1769; Colucci F, 1999, J IMMUNOL, V162, P2761; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; HOGLUND P, 1991, J EXP MED, V174, P327, DOI 10.1084/jem.174.2.327; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Isakov N, 1998, ADV IMMUNOL, V69, P183, DOI 10.1016/S0065-2776(08)60608-2; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	34	98	100	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					288	294		10.1038/ni764	http://dx.doi.org/10.1038/ni764			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11836527				2022-12-18	WOS:000174074000018
J	Haimon, Z; Volaski, A; Orthgiess, J; Boura-Halfon, S; Varol, D; Shemer, A; Yona, S; Zuckerman, B; David, E; Chappell-Maor, L; Bechmann, I; Gericke, M; Ulitsky, I; Jung, S				Haimon, Zhana; Volaski, Alon; Orthgiess, Johannes; Boura-Halfon, Sigalit; Varol, Diana; Shemer, Anat; Yona, Simon; Zuckerman, Binyamin; David, Eyal; Chappell-Maor, Louise; Bechmann, Ingo; Gericke, Martin; Ulitsky, Igor; Jung, Steffen			Re-evaluating microglia expression profiles using RiboTag and cell isolation strategies	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA; IN-VIVO; TISSUE MACROPHAGES; REVEALS; SEQ; TRANSCRIPTOME; FRACTALKINE; IDENTITIES; RETENTION; DYNAMICS	Transcriptome profiling is widely used to infer functional states of specific cell types, as well as their responses to stimuli, to define contributions to physiology and pathophysiology. Focusing on microglia, the brain's macrophages, we report here a side-by-side comparison of classical cell-sorting-based transcriptome sequencing and the 'RiboTag' method, which avoids cell retrieval from tissue context and yields translatome sequencing information. Conventional whole-cell microglial transcriptomes were found to be significantly tainted by artifacts introduced by tissue dissociation, cargo contamination and transcripts sequestered from ribosomes. Conversely, our data highlight the added value of RiboTag profiling for assessing the lineage accuracy of Cre recombinase expression in transgenic mice. Collectively, this study indicates method-based biases, reveals observer effects and establishes RiboTag-based translatome profiling as a valuable complement to standard sorting-based profiling strategies.	[Haimon, Zhana; Volaski, Alon; Boura-Halfon, Sigalit; Varol, Diana; Shemer, Anat; Yona, Simon; David, Eyal; Chappell-Maor, Louise; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Orthgiess, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Zuckerman, Binyamin; Ulitsky, Igor] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Bechmann, Ingo; Gericke, Martin] Univ Leipzig, Inst Anat, Leipzig, Germany	Weizmann Institute of Science; Leipzig University; Weizmann Institute of Science; Leipzig University	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	s.jung@weizmann.ac.il	Gericke, Martin/AAI-8637-2020; Ulitsky, Igor/HCH-7453-2022; Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012	Ulitsky, Igor/0000-0003-0555-6561; Jung, Steffen/0000-0003-4290-5716; Zuckerman, Binyamin/0000-0002-6216-011X; Yona, Simon/0000-0002-3984-2008	Israeli Science Foundation [887/11]; Infect-ERA grant; European Research Council [Adv ERC 340345]; Deutsche Forschungsgemeinschaft [CRC/TRR167 'NeuroMac', DFG-SFB 1052/1]; Deutsche Forschungsgemeinschaft	Israeli Science Foundation(Israel Science Foundation); Infect-ERA grant; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank all members of the Jung laboratory for discussion, the staff of the Weizmann Animal Facility, members of the FACS facility for expert advice, G. Friedlander for help with bioinformatics, and C. Glass for sharing sequencing data. S.J. was supported by the Israeli Science Foundation (887/11), an Infect-ERA grant, the European Research Council (Adv ERC 340345), and the Deutsche Forschungsgemeinschaft (CRC/TRR167 'NeuroMac'). I.B and M.G. were supported by the Deutsche Forschungsgemeinschaft DFG-SFB 1052/1: 'Obesity mechanisms' (projects A09 and B09).	A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Boutej H, 2017, CELL REP, V21, P3220, DOI 10.1016/j.celrep.2017.11.058; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fonseca MI, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0814-9; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hubstenberger A, 2017, MOL CELL, V68, P144, DOI 10.1016/j.molcel.2017.09.003; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	30	97	97	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					636	+		10.1038/s41590-018-0110-6	http://dx.doi.org/10.1038/s41590-018-0110-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777220	Green Submitted, Green Accepted			2022-12-18	WOS:000433041500029
J	Martin, BN; Wang, CH; Zhang, CJ; Kang, ZZ; Gulen, MF; Zepp, JA; Zhao, JJ; Bian, GL; Do, JS; Min, B; Pavicic, PG; El-Sanadi, C; Fox, PL; Akitsu, A; Iwakura, Y; Sarkar, A; Wewers, MD; Kaiser, WJ; Mocarski, ES; Rothenberg, ME; Hise, AG; Dubyak, GR; Ransohoff, RM; Li, XX				Martin, Bradley N.; Wang, Chenhui; Zhang, Cun-jin; Kang, Zizhen; Gulen, Muhammet Fatih; Zepp, Jarod A.; Zhao, Junjie; Bian, Guanglin; Do, Jeong-su; Min, Booki; Pavicic, Paul G., Jr.; El-Sanadi, Caroline; Fox, Paul L.; Akitsu, Aoi; Iwakura, Yoichiro; Sarkar, Anasuya; Wewers, Mark D.; Kaiser, William J.; Mocarski, Edward S.; Rothenberg, Marc E.; Hise, Amy G.; Dubyak, George R.; Ransohoff, Richard M.; Li, Xiaoxia			T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis	NATURE IMMUNOLOGY			English	Article							INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; MULTIPLE-SCLEROSIS; MICE DEFICIENT; T(H)17 CELLS; CASPASE-8; CYTOKINE; IL-1-BETA; DIFFERENTIATION; APOPTOSIS	Interleukin 1 beta (IL-1 beta) is critical for the in vivo survival, expansion and effector function of IL-17-producing helper T (T(H)17) cells during autoimmune responses, including experimental autoimmune encephalomyelitis (EAE). However, the spatiotemporal role and cellular source of IL-1 beta during EAE pathogenesis are poorly defined. In the present study, we uncovered a T cell-intrinsic inflammasome that drives IL-1 beta production during T(H)17-mediated EAE pathogenesis. Activation of T cell antigen receptors induced expression of pro-IL-1 beta, whereas ATP stimulation triggered T cell production of IL-1 beta via ASC-NLRP3-dependent caspase-8 activation. IL-1R was detected on T(H)17 cells but not on type 1 helper T (T(H)1) cells, and ATP-treated T(H)17 cells showed enhanced survival compared with ATP-treated T(H)1 cells, suggesting autocrine action of T(H)17-derived IL-1 beta. Together these data reveal a critical role for IL-1 beta produced by a T(H)17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome during inflammation of the central nervous system.	[Martin, Bradley N.; Wang, Chenhui; Zhang, Cun-jin; Gulen, Muhammet Fatih; Zepp, Jarod A.; Zhao, Junjie; Bian, Guanglin; Do, Jeong-su; Min, Booki; Pavicic, Paul G., Jr.; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Martin, Bradley N.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Chenhui] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Zhang, Cun-jin] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Zhang, Cun-jin] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Immunol, Tianjin, Peoples R China; [Kang, Zizhen] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China; [El-Sanadi, Caroline; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Akitsu, Aoi; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Sarkar, Anasuya; Wewers, Mark D.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Kaiser, William J.; Mocarski, Edward S.] Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA USA; [Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Hise, Amy G.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Biogen Idec Inc, Cambridge, MA USA	Cleveland Clinic Foundation; Case Western Reserve University; Huazhong University of Science & Technology; Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Case Western Reserve University; Cleveland Clinic Foundation; Tokyo University of Science; University System of Ohio; Ohio State University; Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Case Western Reserve University; Cleveland Clinic Foundation; Biogen	Li, XX (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA.; Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA.; Ransohoff, RM (corresponding author), Biogen Idec Inc, Cambridge, MA USA.	rransohoff@gmail.com; lix@ccf.org	Zhao, Junjie/AAH-1152-2021; Martin, Bradley/AAM-5041-2020; Mocarski, Edward/ABC-2893-2020; Wewers, Mark/AAB-6202-2021; Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Do, Jeong-su/0000-0002-2375-2585; Dubyak, George/0000-0001-9720-4226; , Zizhen/0000-0001-5621-8912; Martin, Bradley/0000-0002-8902-8805; Wang, Chenhui/0000-0002-3186-3066; Zhang, Cun-Jin/0000-0001-7996-7246; Gulen, Muhammet/0000-0002-7139-6781	National Multiple Sclerosis Society [RG5130A2/1]; US National Institutes of Health [5R01NS071996-05, 1RO1AA023722, MSTP-T32GM007250]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007843, P01HL029582, P01HL103453, U10HL109250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM036387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023722] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002607] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This investigation was supported by the National Multiple Sclerosis Society (grant RG5130A2/1 to X.L.) and the US National Institutes of Health (grants 5R01NS071996-05, 1RO1AA023722 and MSTP-T32GM007250 to X.L.).	Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Frohman EM, 2003, MED CLIN N AM, V87, P867, DOI 10.1016/S0025-7125(03)00008-7; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gulen MF, 2012, IMMUNITY, V37, P800, DOI 10.1016/j.immuni.2012.08.019; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin BN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5977; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Suzuki S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003926; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413	47	97	101	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					583	+		10.1038/ni.3389	http://dx.doi.org/10.1038/ni.3389			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26998763	Green Accepted			2022-12-18	WOS:000374323100018
J	McWilliam, HEG; Eckle, SBG; Theodossis, A; Liu, LG; Chen, ZJ; Wubben, JM; Fairlie, DP; Strugnell, RA; Mintern, JD; McCluskey, J; Rossjohn, J; Villadangos, JA				McWilliam, Hamish E. G.; Eckle, Sidonia B. G.; Theodossis, Alex; Liu, Ligong; Chen, Zhenjun; Wubben, Jacinta M.; Fairlie, David P.; Strugnell, Richard A.; Mintern, Justine D.; McCluskey, James; Rossjohn, Jamie; Villadangos, Jose A.			The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1	NATURE IMMUNOLOGY			English	Article							INVARIANT T-CELLS; MHC CLASS-I; RECEPTOR HETEROGENEITY; SALMONELLA-TYPHIMURIUM; MAIT CELLS; RECOGNITION; METABOLITES; GENERATION; PRODUCTS; STEP	The antigen-presenting molecule MR1 presents vitamin B-related antigens (VitB antigens) to mucosal-associated invariant T (MAIT) cells through an uncharacterized pathway. We show that MR1, unlike other antigen-presenting molecules, does not constitutively present self-ligands. In the steady state it accumulates in a ligand-receptive conformation within the endoplasmic reticulum. VitB antigens reach this location and form a Schiff base with MR1, triggering a 'molecular switch' that allows MR1-VitB antigen complexes to traffic to the plasma membrane. These complexes are endocytosed with kinetics independent of the affinity of the MR1-ligand interaction and are degraded intracellularly, although some MR1 molecules acquire new ligands during passage through endosomes and recycle back to the surface. MR1 antigen presentation is characterized by a rapid 'off-on-off' mechanism that is strictly dependent on antigen availability.	[McWilliam, Hamish E. G.; Eckle, Sidonia B. G.; Chen, Zhenjun; Strugnell, Richard A.; McCluskey, James; Villadangos, Jose A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [McWilliam, Hamish E. G.; Theodossis, Alex; Wubben, Jacinta M.; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [McWilliam, Hamish E. G.; Wubben, Jacinta M.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [McWilliam, Hamish E. G.; Wubben, Jacinta M.; Rossjohn, Jamie] Monash Univ, Australian Res Council ARC Ctr Excellence Adv Mol, Clayton, Vic, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld, Australia; [Mintern, Justine D.; Villadangos, Jose A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	University of Melbourne; Monash University; Monash University; Monash University; University of Queensland; University of Queensland; University of Melbourne; Cardiff University	McCluskey, J; Villadangos, JA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.; Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council ARC Ctr Excellence Adv Mol, Clayton, Vic, Australia.; Villadangos, JA (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales.	jamesm1@unimelb.edu.au; jamie.rossjohn@monash.edu; j.villadangos@unimelb.edu.au	liu, ligong/B-1690-2010; Eckle, Sidonia BG/O-8146-2014; McWilliam, Hamish EG/AAM-8665-2021; Villadangos, Jose A/AAU-1404-2020; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Fairlie, David P/F-8865-2014	liu, ligong/0000-0002-2693-1896; Eckle, Sidonia BG/0000-0003-0766-171X; McWilliam, Hamish EG/0000-0003-3479-3419; Villadangos, Jose A/0000-0001-6771-8891; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Fairlie, David P/0000-0002-7856-8566; Mintern, Justine/0000-0002-3797-8577; Strugnell, Richard/0000-0003-0614-5641	University of Melbourne; Australian National Health and Medical Research Council (NHMRC); Australian Research Council	University of Melbourne(University of Melbourne); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank T. Hansen (University of Washington) and W.J. Yankelevich (US Food and Drug Administration) for the gift of the 8F2.F9 hybridoma; L. Knodler (Washington State University College) for mCherry reagents; C. Dumont (University of Melbourne) for assistance with the internalization and recycling assays; H. Reid (Monash University) for assistance in cloning the MR1 K43R mutant; S. Londrigan (University of Melbourne) for assistance with the bronchial epithelial cells; and the Biological Optical Microscopy Platform (University of Melbourne) for microscopy expertise. S.B.G.E. is supported by an Early Career Research award from The University of Melbourne. This research was supported by the Australian National Health and Medical Research Council (NHMRC) (D.P.F., R.A.S., J.M., J.R. and J.A.V.) and the Australian Research Council (D.P.F. and J.R.).	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eckle SBG, 2015, J BIOL CHEM, V290, P30204, DOI 10.1074/jbc.R115.685990; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Liu HY, 2013, ANGEW CHEM INT EDIT, V52, P5744, DOI 10.1002/anie.201301243; McWilliam HEG, 2015, CURR OPIN IMMUNOL, V34, P28, DOI 10.1016/j.coi.2014.12.004; Morris AJ, 1996, PROTEIN ENG, V9, P61, DOI 10.1093/protein/9.1.61; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Reuter A, 2015, J IMMUNOL, V194, P2696, DOI 10.4049/jimmunol.1402535; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; STRUGNELL R, 1992, INFECT IMMUN, V60, P3994, DOI 10.1128/IAI.60.10.3994-4002.1992; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Villadangos JA, 2001, MOL IMMUNOL, V38, P329, DOI 10.1016/S0161-5890(01)00069-4	34	97	98	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					531	+		10.1038/ni.3416	http://dx.doi.org/10.1038/ni.3416			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27043408	Green Accepted			2022-12-18	WOS:000374323100012
J	Roth, S; Rottach, A; Lotz-Havla, AS; Laux, V; Muschaweckh, A; Gersting, SW; Muntau, AC; Hopfner, KP; Jin, L; Vanness, K; Petrini, JHJ; Drexler, I; Leonhardt, H; Ruland, J				Roth, Susanne; Rottach, Andrea; Lotz-Havla, Amelie S.; Laux, Verena; Muschaweckh, Andreas; Gersting, Soren W.; Muntau, Ania C.; Hopfner, Karl-Peter; Jin, Lei; Vanness, Katelynd; Petrini, John H. J.; Drexler, Ingo; Leonhardt, Heinrich; Ruland, Juergen			Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1 beta production	NATURE IMMUNOLOGY			English	Article							VACCINIA VIRUS ANKARA; ADAPTER PROTEIN CARD9; CYCLIC GMP-AMP; INNATE IMMUNITY; I INTERFERON; AIM2 INFLAMMASOME; DAMAGE RESPONSE; DENDRITIC CELLS; RIG-I; RECEPTORS	Double-stranded DNA (dsDNA) in the cytoplasm triggers the production of interleukin 1 beta (IL-1 beta) as an antiviral host response, and deregulation of the pathways involved can promote inflammatory disease. Here we report a direct cytosolic interaction between the DNA-damage sensor Rad50 and the innate immune system adaptor CARD9. Transfection of dendritic cells with dsDNA or infection of dendritic cells with a DNA virus induced the formation of dsDNA-Rad50-CARD9 signaling complexes for activation of the transcription factor NF-kappa B and the generation of pro-IL-1 beta. Primary cells conditionally deficient in Rad50 or lacking CARD9 consequently exhibited defective DNA-induced production of IL-1 beta, and Card9(-/-) mice had impaired inflammatory responses after infection with a DNA virus in vivo. Our results define a cytosolic DNA-recognition pathway for inflammation and a physical and functional connection between a conserved DNA-damage sensor and the innate immune response to pathogens.	[Roth, Susanne; Laux, Verena; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany; [Rottach, Andrea; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Martinsried, Germany; [Rottach, Andrea; Hopfner, Karl-Peter; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Martinsried, Germany; [Lotz-Havla, Amelie S.; Gersting, Soren W.; Muntau, Ania C.] Univ Munich, Kinderklin, D-80539 Munich, Germany; [Lotz-Havla, Amelie S.; Muntau, Ania C.] Univ Munich, Dr Von Haunerschen Kinderspital, Kinderpoliklin, D-80337 Munich, Germany; [Muschaweckh, Andreas; Drexler, Ingo] Tech Univ Munich, Klinikum Rechts Isar, Inst Virol, D-80290 Munich, Germany; [Muschaweckh, Andreas; Drexler, Ingo] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Jin, Lei] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Vanness, Katelynd; Petrini, John H. J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Drexler, Ingo] Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Virol, Dusseldorf, Germany	Technical University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Albany Medical College; Memorial Sloan Kettering Cancer Center; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany.	jruland@lrz.tum.de	Leonhardt, Heinrich/B-2791-2014; Hopfner, Karl-Peter/B-6864-2014; Ruland, Jürgen/Q-6680-2018; Gersting, Soeren/D-4612-2011	Hopfner, Karl-Peter/0000-0002-4528-8357; Ruland, Jürgen/0000-0002-8381-3597; jin, lei/0000-0001-6836-1142; Gersting, Soeren/0000-0001-7482-4748; Petrini, John/0000-0001-5102-5679; Muschaweckh, Andreas/0000-0002-6870-1378	Bavarian Genome Research Network; Ludwig-Maximilians-Universitat Excellence Initiative [42595-6]; Deutsche Forschungsgemeinschaft [SFB684, SFB1054]; US National Institutes of Health [U19A1083025, GM56888]; European Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059413, R01GM056888] Funding Source: NIH RePORTER	Bavarian Genome Research Network; Ludwig-Maximilians-Universitat Excellence Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Thome (University of Lausanne) for the antibody to CARD9; S. Essbauer (Bundeswehr Institute of Microbiology) for cowpox virus; and R. Ljapoci for technical assistance. Supported by the Bavarian Genome Research Network (A.C.M.), the Ludwig-Maximilians-Universitat Excellence Initiative (42595-6 to A.C.M.), Deutsche Forschungsgemeinschaft (SFB684 to H.L. and J.R. and SFB1054 to J.R.), the US National Institutes of Health (U19A1083025 to K.-PH. and GM56888 to J.H.J.P.) and the European Research Council (J.R.).	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Alcami A, 1996, P NATL ACAD SCI USA, V93, P11029, DOI 10.1073/pnas.93.20.11029; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; BOSWELL JM, 1988, J IMMUNOL, V141, P3050; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Epperson ML, 2012, IMMUNOL REV, V250, P199, DOI 10.1111/imr.12009; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Gersting SW, 2012, METHODS MOL BIOL, V815, P253, DOI 10.1007/978-1-61779-424-7_19; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Popovic K, 2005, ARTHRITIS RHEUM, V52, P3639, DOI 10.1002/art.21398; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zimmerling S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-34	44	97	100	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					538	545		10.1038/ni.2888	http://dx.doi.org/10.1038/ni.2888			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24777530	Green Accepted			2022-12-18	WOS:000336419300010
J	Marcoe, JP; Lim, JR; Schaubert, KL; Fodil-Cornu, N; McCubbrey, AL; Farr, AR; Vidal, SM; Laouar, Y				Marcoe, Jeffrey P.; Lim, James R.; Schaubert, Keri L.; Fodil-Cornu, Nassima; McCubbrey, Alexandra L.; Farr, Alexander R.; Vidal, Silvia M.; Laouar, Yasmina			TGF-beta is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; GROWTH-FACTOR-BETA; MURINE BONE-MARROW; CORD BLOOD; T-CELLS; GRANZYME-B; IN-VIVO; INTERFERON-GAMMA; MESSENGER-RNAS; DEFICIENT MICE	A large gap in our understanding of infant immunity is why natural killer (NK) cell responses are deficient, which makes infants more prone to viral infection. Here we demonstrate that transforming growth factor-beta (TGF-beta) was responsible for NK cell immaturity during infancy. We found more fully mature NK cells in CD11c(dnR) mice, whose NK cells lack TGF-beta receptor (TGF-beta R) signaling. Ontogenic maturation of NK cells progressed faster in the absence of TGF-beta signaling, which results in the formation of a mature NK cell pool early in life. As a consequence, infant CD11c(dnR) mice efficiently controlled viral infections. These data thus demonstrate an unprecedented role for TGF-beta in ontogeny that can explain why NK cell responses are deficient early in life.	[Marcoe, Jeffrey P.; Lim, James R.; Schaubert, Keri L.; McCubbrey, Alexandra L.; Farr, Alexander R.; Laouar, Yasmina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Fodil-Cornu, Nassima; Vidal, Silvia M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	University of Michigan System; University of Michigan; McGill University	Laouar, Y (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ylaouar@umich.edu		Lim, James Ray/0000-0003-2582-4578	US National Institute of Health [T32 AI007413-17, R01 AI083642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083642, T32AI007413] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Laouar for critical reading of the manuscript; I. Maillard (University of Michigan) for OP9 cell line; D. Kovarcik and B. Oliver for assistance with gene expression analysis; and members of the flow cytometry core facility for cell sorting. Supported by the US National Institute of Health (T32 AI007413-17 to K.L.S. and R01 AI083642 to Y.L.).	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Futata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934; HALL WG, 1986, DEV PSYCHOBIOL, V19, P211, DOI 10.1002/dev.420190307; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kataoka TR, 2005, LAB INVEST, V85, P146, DOI 10.1038/labinvest.3700188; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; SU HC, 1991, J IMMUNOL, V147, P2717; SU HC, 1993, J IMMUNOL, V151, P4874; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; UKSILA J, 1983, J IMMUNOL, V130, P153; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; Williams NS, 1999, J IMMUNOL, V163, P2648; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006	46	97	100	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					843	850		10.1038/ni.2388	http://dx.doi.org/10.1038/ni.2388			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22863752	Green Accepted			2022-12-18	WOS:000307863600012
J	Casadevall, A; Pirofski, LA				Casadevall, Arturo; Pirofski, Liise-Anne			A new synthesis for antibody-mediated immunity	NATURE IMMUNOLOGY			English	Article							CRYPTOCOCCUS-NEOFORMANS INFECTION; HOST-PATHOGEN INTERACTIONS; RELAPSING FEVER BORRELIA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNOGLOBULIN-M; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; VARIABLE-REGION; B-CELLS	The view that immunoglobulins function largely by potentiating neutralization, cytotoxicity or phagocytosis is being replaced by a new synthesis whereby antibodies participate in all aspects of the immune response, from protecting the host at the earliest time of encounter with a microbe to later challenges. Perhaps the most transformative concept is that immunoglobulins manifest emergent properties, from their structure and function as individual molecules to their interactions with microbial targets and the host immune system. Given that emergent properties are neither reducible to first principles nor predictable, there is a need for new conceptual approaches for understanding antibody function and mechanisms of antibody immunity.	[Casadevall, Arturo; Pirofski, Liise-Anne] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Casadevall, Arturo; Pirofski, Liise-Anne] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	arturo.casadevall@einstein.yu.edu			US National Institutes of Health [AI45459, AI44374, AI033774, HL059842]; Northeastern Biodefense Center [5U54AI057158-08 - Lipkin]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI033774, R01AI035370, R01AI044374, R01AI045459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern Biodefense Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M.D. Scharff for critical reading of this manuscript and suggestions. Supported by the US National Institutes of Health (AI45459, AI44374, AI033774 and HL059842) and the Northeastern Biodefense Center (5U54AI057158-08 - Lipkin to A.D.).	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Alblowitz R, 1939, PHILOS SCI, V6, P1, DOI [10.1086/286529, DOI 10.1086/286529]; Alviano DS, 2004, INFECT IMMUN, V72, P229, DOI 10.1128/IAI.72.1.229-237.2004; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baylis C. A, 1929, PHILOS REV, V38, P372; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Brena S, 2011, ANTIMICROB AGENTS CH, V55, P3156, DOI 10.1128/AAC.00892-10; Burns T, 2005, INFECT IMMUN, V73, P4530, DOI 10.1128/IAI.73.8.4530-4538.2005; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Casadevall A, 2005, CURR MOL MED, V5, P421, DOI 10.2174/1566524054022567; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2003, TRENDS IMMUNOL, V24, P474, DOI 10.1016/S1471-4906(03)00228-X; Casadevall A, 2003, INFECT IMMUN, V71, P4225, DOI 10.1128/IAI.71.8.4225-4228.2003; CASADEVALL A, 1995, INFECT IMMUN, V63, P4211, DOI 10.1128/IAI.63.11.4211-4218.1995; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Casadevall A, 2006, ADV IMMUNOL, V91, P1, DOI 10.1016/S0065-2776(06)91001-3; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Coleman JR, 2011, J INFECT DIS, V203, P1264, DOI 10.1093/infdis/jir010; Connolly SE, 2004, J IMMUNOL, V172, P1191, DOI 10.4049/jimmunol.172.2.1191; DesplanqueS AS, 2007, VIROLOGY, V362, P60, DOI 10.1016/j.virol.2006.12.018; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; DROMER F, 1987, INFECT IMMUN, V55, P749, DOI 10.1128/IAI.55.3.749-752.1987; Edelson BT, 1999, J IMMUNOL, V163, P4087; Edelson BT, 2001, IMMUNITY, V14, P503, DOI 10.1016/S1074-7613(01)00139-X; Fabrizio K, 2007, CLIN VACCINE IMMUNOL, V14, P382, DOI 10.1128/CVI.00374-06; Feldmesser M, 2002, INFECT IMMUN, V70, P1571, DOI 10.1128/IAI.70.3.1571-1580.2002; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HEBERT J, 1990, J IMMUNOL, V144, P4256; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; LAMPERT PW, 1975, J VIROL, V15, P1248, DOI 10.1128/JVI.15.5.1248-1255.1975; LaRocca TJ, 2008, J IMMUNOL, V180, P6222, DOI 10.4049/jimmunol.180.9.6222; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Lendvai N, 2000, J IMMUNOL, V164, P4367, DOI 10.4049/jimmunol.164.8.4367; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Magliani W, 2005, CURR MOL MED, V5, P443, DOI 10.2174/1566524054022558; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; McClelland EE, 2010, J CLIN INVEST, V120, P1355, DOI 10.1172/JCI38322; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nosanchuk JD, 2003, J CLIN INVEST, V112, P1164, DOI [10.1172/JCI200319361, 10.1172/JCI19361]; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pirofski LA, 2010, J CLIN INVEST, V120, P3099, DOI 10.1172/JCI44312; Ponge JF, 2005, BIOL REV, V80, P403, DOI 10.1017/S146479310500672X; Rajan B, 2005, J IMMUNOL, V175, P1827, DOI 10.4049/jimmunol.175.3.1827; Rivera J, 2005, J IMMUNOL, V174, P8017, DOI 10.4049/jimmunol.174.12.8017; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Russo RT, 2010, IMMUNOBIOLOGY, V215, P1005, DOI 10.1016/j.imbio.2010.01.003; SCHLAGETER AM, 1990, INFECT IMMUN, V58, P1914, DOI 10.1128/IAI.58.6.1914-1918.1990; SILVERSTEIN AM, 1979, CELL IMMUNOL, V48, P208, DOI 10.1016/0008-8749(79)90113-8; Skurnik D, 2010, J CLIN INVEST, V120, P3220, DOI 10.1172/JCI42748; Subramaniam K, 2009, J INFECT DIS, V200, P244, DOI 10.1086/599318; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Taborda CP, 2001, J IMMUNOL, V166, P2100, DOI 10.4049/jimmunol.166.3.2100; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Tian H, 2009, INFECT IMMUN, V77, P1502, DOI 10.1128/IAI.01075-08; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Vouldoukis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018289; WATSON DA, 1993, CLIN INFECT DIS, V17, P913, DOI 10.1093/clinids/17.5.913; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Yano M., 2011, MBIO, V2, DOI DOI 10.1128/MBI0.00176-11	82	97	98	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					21	28		10.1038/ni.2184	http://dx.doi.org/10.1038/ni.2184			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179281	Green Accepted			2022-12-18	WOS:000298412800007
J	Chervonsky, AV				Chervonsky, Alexander V.			Influence of microbial environment on autoimmunity	NATURE IMMUNOLOGY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; ARYL-HYDROCARBON RECEPTOR; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; T-CELL RESPONSES; ADAPTIVE IMMUNITY; DENDRITIC CELLS; NOD MOUSE; ANKYLOSING ENTHESOPATHY	During protective immune responses, the adaptive arm of the immune system requires activation by signals provided by innate immunity and driven by microbial stimuli. Whether the same rules apply to autoimmune diseases involving clonal self-reactive T and B lymphocytes-a process referred to here as 'adaptive autoimmunity'-is not quite clear. Nevertheless, in these diseases, the innate-adaptive connection is likely to be influenced by the microbial environment. This review integrates the results of experiments analyzing autoimmunity in sterile versus nonsterile conditions and experiments testing the role of innate immune receptor signaling in autoimmunity. It proposes that autoimmune diseases can be divided into two groups, the pathogenesis of which either follows the rules of innate-adaptive connection or does not.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu		Chervonsky, Alexander/0000-0001-7547-871X	Juvenile Diabetes Research Foundation [2005-204, 2007-353]; US National Institutes of Health [DK063452]; NIH National Institute of Diabetes and Digestive; Kidney Diseases Digestive Disease Research Core Center [DK42086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R21DK063452] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Kidney Diseases Digestive Disease Research Core Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank R. Medzhitov for discussions and J. Pickard for suggestions on the manuscript. Supported by the Juvenile Diabetes Research Foundation (2005-204 and 2007-353), US National Institutes of Health (NIH; DK063452) and an NIH National Institute of Diabetes and Digestive and Kidney Diseases Digestive Disease Research Core Center grant (DK42086).	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BAUER H, 1963, AM J PATHOL, V42, P471; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BJORK J, 1994, SCAND J IMMUNOL, V40, P648, DOI 10.1111/j.1365-3083.1994.tb03518.x; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Garza KM, 2002, EUR J IMMUNOL, V32, P885, DOI 10.1002/1521-4141(200203)32:3<885::AID-IMMU885>3.0.CO;2-E; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kovalchin JT, 2006, WOUND REPAIR REGEN, V14, P129, DOI 10.1111/j.1743-6109.2006.00102.x; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LEY R, 2006, NATURE, V444, P1023; Lien E, 2009, CURR MOL MED, V9, P52, DOI 10.2174/156652409787314453; LO SSS, 1991, DIABETES METAB REV, V7, P223, DOI 10.1002/dmr.5610070403; Loeser S, 2007, SEMIN IMMUNOL, V19, P206, DOI 10.1016/j.smim.2007.02.004; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Maldonado MA, 1999, J IMMUNOL, V162, P6322; Malkiel S, 2000, INFECT IMMUN, V68, P5803, DOI 10.1128/IAI.68.10.5803-5808.2000; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Muntoni S, 1999, DIABETES-METAB RES, V15, P133; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Rehakova Z, 2000, HUM IMMUNOL, V61, P555, DOI 10.1016/S0198-8859(00)00122-1; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Richez C, 2009, J IMMUNOL, V182, P820, DOI 10.4049/jimmunol.182.2.820; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; ROSSINI AA, 1979, DIABETES, V28, P1031, DOI 10.2337/diabetes.28.11.1031; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Sinkorova Z, 2008, HUM IMMUNOL, V69, P845, DOI 10.1016/j.humimm.2008.08.296; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stockinger B, 2009, EUR J IMMUNOL, V39, P652, DOI 10.1002/eji.200839134; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42; Suzuki T, 1987, IMMUNE DEFICIENT ANI, P112, DOI DOI 10.1159/000413303; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Yamanaka T, 2003, J IMMUNOL, V170, P816, DOI 10.4049/jimmunol.170.2.816; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693; Zipris D, 2009, CLIN IMMUNOL, V131, P11, DOI 10.1016/j.clim.2008.12.011	139	97	104	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					28	35		10.1038/ni.1801	http://dx.doi.org/10.1038/ni.1801			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016507				2022-12-18	WOS:000272855300006
J	Park, SG; Schulze-Luehrman, J; Hayden, MS; Hashimoto, N; Ogawa, W; Kasuga, M; Ghosh, S				Park, Sung-Gyoo; Schulze-Luehrman, Jan; Hayden, Matthew S.; Hashimoto, Naoko; Ogawa, Wataru; Kasuga, Masato; Ghosh, Sankar			The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappa B and activate T cells	NATURE IMMUNOLOGY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; IMMUNOLOGICAL SYNAPSE; CD28-DEFICIENT MICE; PHOSPHORYLATION; CARMA1; BETA; COSTIMULATION; LYMPHOCYTES; EXPRESSION; SURVIVAL	In addition to ligation of the T cell antigen receptor (TCR), activation of the CD28 coreceptor by the costimulatory molecule B7 is required for induction of the transcription factor NF-kappa B and robust T cell activation, although the contribution of CD28 to this process remains incompletely understood. We show here that phosphoinositide-dependent kinase 1 (PDK1) is essential for integrating the TCR and CD28 signals. After we deleted PDK1 from T cells, TCR-CD28 signals were unable to induce activation of NF-kappa B or phosphorylation of protein kinase C-theta, although T cell survival and pathways dependent on the kinases p38 and Jnk or the transcription factor NFAT were unaffected. CD28 facilitated NF-kappa B activation by regulating recruitment and phosphorylation of PDK1, which are necessary for efficient binding of PDK1 to protein kinase C-theta and the adaptor CARMA1 and thus for NF-kappa B induction.	[Park, Sung-Gyoo; Schulze-Luehrman, Jan; Hayden, Matthew S.; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Hashimoto, Naoko; Ogawa, Wataru; Kasuga, Masato] Kobe Univ, Grad Sch Med, Div Diabet & Digest & Kidney Dis, Dept Clin Mol Med, Kobe, Hyogo 6500017, Japan; [Ghosh, Sankar] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Kobe University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	sankar.ghosh@yale.edu	Hayden, Matthew/C-1263-2008; OGAWA, Wataru/AAQ-9586-2020; Park, Sung-Gyoo/H-8652-2019	Park, Sung-Gyoo/0000-0003-3702-5765	National Institutes of Health [R01-AI59440]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059440, R01AI068977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Wan (Yale University) for help with the Cre transgenic mice, C. Wilson (University of Washington) for the CD4-Cre mice, T. K. Harris (University of Miami) for antibody to Thr513-phosphorylated PDK1 and D. R. Littman (New York University) for the Prkcq knockout mice. Supported by the National Institutes of Health (R01-AI59440).	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gao XX, 2006, BIOORG CHEM, V34, P200, DOI 10.1016/j.bioorg.2006.05.002; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nakagawa M, 2005, BLOOD, V106, P4210, DOI 10.1182/blood-2004-12-4785; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856	32	97	107	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					158	166		10.1038/ni.1687	http://dx.doi.org/10.1038/ni.1687			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19122654	Green Accepted			2022-12-18	WOS:000263178500009
J	Zampieri, CA; Sullivan, NJ; Nabel, GJ				Zampieri, Carisa A.; Sullivan, Nancy J.; Nabel, Gary J.			Immunopathology of highly virulent pathogens: insights from Ebola virus	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; I INTERFERON RESPONSE; TUMOR-NECROSIS-FACTOR; HEMORRHAGIC-FEVER; DENDRITIC CELLS; MARBURG VIRUSES; VP35 PROTEIN; CYNOMOLGUS MACAQUES; ENDOTHELIAL-CELLS; INFECTED PATIENTS	Ebola virus is a highly virulent pathogen capable of inducing a frequently lethal hemorrhagic fever syndrome. Accumulating evidence indicates that the virus actively subverts both innate and adaptive immune responses and triggers harmful inflammatory responses as it inflicts direct tissue damage. The host immune system is ultimately overwhelmed by a combination of inflammatory factors and virus-induced cell damage, particularly in the liver and vasculature, often leading to death from septic shock. We summarize the mechanisms of immune dysregulation and virus-mediated cell damage in Ebola virus-infected patients. Future approaches to prevention and treatment of infection will be guided by answers to unresolved questions about interspecies transmission, molecular mechanisms of pathogenesis, and protective adaptive and innate immune responses to Ebola virus.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Room 4502,Bldg 40,MSC-3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov						Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Alazard-Dany N, 2006, J GEN VIROL, V87, P1247, DOI 10.1099/vir.0.81361-0; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Barrientos LG, 2007, VIROLOGY, V358, P1, DOI 10.1016/j.virol.2006.08.018; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Bosio CM, 2003, J INFECT DIS, V188, P1630, DOI 10.1086/379199; BOWEN ETW, 1977, LANCET, V1, P571; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Bray M, 2001, J GEN VIROL, V82, P1365, DOI 10.1099/0022-1317-82-6-1365; Bukreyev A, 2007, J VIROL, V81, P6379, DOI 10.1128/JVI.00105-07; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Dietrich M., 1978, EBOLA VIRUS HAEMORRH, P37; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Feldmann H, 1996, J VIROL, V70, P2208, DOI 10.1128/JVI.70.4.2208-2214.1996; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Feng ZD, 2007, J VIROL, V81, P182, DOI 10.1128/JVI.01006-06; FISHERHOCH SP, 1992, J INFECT DIS, V166, P753, DOI 10.1093/infdis/166.4.753; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Gupta M, 2007, VIROLOGY, V364, P45, DOI 10.1016/j.virol.2007.02.017; Harcourt BH, 1998, VIROLOGY, V252, P179, DOI 10.1006/viro.1998.9446; Harcourt BH, 1999, J VIROL, V73, P3491, DOI 10.1128/JVI.73.4.3491-3496.1999; Hensley LE, 2002, IMMUNOL LETT, V80, P169, DOI 10.1016/S0165-2478(01)00327-3; Ito H, 2001, J VIROL, V75, P1576, DOI 10.1128/JVI.75.3.1576-1580.2001; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; JOHNSON KM, 1977, LANCET, V1, P569; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Mahanty S, 2003, VIROLOGY, V312, P415, DOI 10.1016/S0042-6822(03)00233-2; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Murphy Frederick A., 1997, P433; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Reed DS, 2004, VIRAL IMMUNOL, V17, P390, DOI 10.1089/vim.2004.17.390; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; STOLPEN AH, 1986, AM J PATHOL, V123, P16; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2005, J VIROL, V79, P547, DOI 10.1128/JVI.79.1.547-553.2005; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	67	97	104	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1159	1164		10.1038/ni1519	http://dx.doi.org/10.1038/ni1519			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952040	Green Published, Bronze			2022-12-18	WOS:000250338900005
J	Kim, T; Yoon, J; Cho, HS; Lee, WB; Kim, J; Song, YH; Kim, SN; Yoon, JH; Kim-Ha, J; Kim, YJ				Kim, T; Yoon, J; Cho, HS; Lee, WB; Kim, J; Song, YH; Kim, SN; Yoon, JH; Kim-Ha, J; Kim, YJ			Downregulation of lipopolysaccharide response in drosophila by negative crosstalk between the AP1 and NF-kappa B signaling modules	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; DEFICIENCY IMD; JNK; TOLL; ACTIVATION; PEPTIDOGLYCAN; REQUIRES; GENE; RECOGNITION; PATHWAYS	IkappaB kinase (IKK) and Jun N-terminal kinase (Jnk) signaling modules are important in the synthesis of immune effector molecules during innate immune responses against lipopolysaccharide and peptidoglycan. However, the regulatory mechanisms required for specificity and termination of these immune responses are unclear. We show here that crosstalk occurred between the drosophila Jnk and IKK pathways, which led to downregulation of each other's activity. The inhibitory action of Jnk was mediated by binding of drosophila activator protein 1 (AP1) to promoters activated by the transcription factor NF-kappaB. This binding led to recruitment of the histone deacetylase dHDAC1 to the promoter of the gene encoding the antibacterial protein Attacin-A and to local modification of histone acetylation content. Thus, AP1 acts as a repressor by recruiting the deacetylase complex to terminate activation of a group of NF-kappaB target genes.	Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; Digital Genom, Seoul 120749, South Korea; Sejong Univ, Dept Mol Biol, Seoul 143747, South Korea	Yonsei University; Sejong University	Kim, YJ (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr						Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Ciapponi L, 2002, MECH DEVELOP, V115, P35, DOI 10.1016/S0925-4773(02)00093-X; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dushay MS, 2000, GENE, V246, P49, DOI 10.1016/S0378-1119(00)00041-X; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Goberdhan DCI, 1998, BIOESSAYS, V20, P1009, DOI 10.1002/(SICI)1521-1878(199812)20:12<1009::AID-BIES7>3.0.CO;2-D; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang XJ, 2001, J BIOL CHEM, V276, P12497, DOI 10.1074/jbc.C100034200; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imler JL, 2002, CURR TOP MICROBIOL, V270, P63; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Smith ER, 1998, NUCLEIC ACIDS RES, V26, P2948, DOI 10.1093/nar/26.12.2948; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tingvall TO, 2001, EMBO REP, V2, P239; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uvell H, 2003, MOL CELL BIOL, V23, P8272, DOI 10.1128/MCB.23.22.8272-8281.2003; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; WASSERMAN SA, 1993, MOL BIOL CELL, V4, P767, DOI 10.1091/mbc.4.8.767; Wasserman SA, 2000, CURR OPIN GENET DEV, V10, P497, DOI 10.1016/S0959-437X(00)00118-0; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364	50	97	102	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					211	218		10.1038/ni1159	http://dx.doi.org/10.1038/ni1159			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15640802				2022-12-18	WOS:000226468100025
J	Finger, EB; Bluestone, JA				Finger, EB; Bluestone, JA			When ligand becomes receptor - tolerance via B7 signaling on DCs	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSING INDOLEAMINE 2,3-DIOXYGENASE; T-CELL COSTIMULATION; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; CTLA-4; CD28/B7; MICE	CTLA-4-Ig is used to block the costimulation of T cells to interfere with their activation. This reagent may actually be working by provoking DCs to catabolize tryptophan, thereby depriving T cells and contributing to their demise.	Univ Calif San Francisco, Ctr Diabet, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Finger, EB (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	jbluest@diabetes.ucsf.edu	Finger, Erik/AFP-0406-2022	Finger, Erik/0000-0003-3899-6985				Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Kaufman KA, 1999, MOL HUM REPROD, V5, P84, DOI 10.1093/molehr/5.1.84; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schwarz A, 2000, J IMMUNOL, V165, P1824, DOI 10.4049/jimmunol.165.4.1824; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698	13	97	102	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1056	1057		10.1038/ni1102-1056	http://dx.doi.org/10.1038/ni1102-1056			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407416				2022-12-18	WOS:000179073000011
J	Drummond, RA; Swamydas, M; Oikonomou, V; Zhai, B; Dambuza, IM; Schaefer, BC; Bohrer, AC; Mayer-Barber, KD; Lira, SA; Iwakura, Y; Filler, SG; Brown, GD; Hube, B; Naglik, JR; Hohl, TM; Lionakis, MS				Drummond, Rebecca A.; Swamydas, Muthulekha; Oikonomou, Vasileios; Zhai, Bing; Dambuza, Ivy M.; Schaefer, Brian C.; Bohrer, Andrea C.; Mayer-Barber, Katrin D.; Lira, Sergio A.; Iwakura, Yoichiro; Filler, Scott G.; Brown, Gordon D.; Hube, Bernhard; Naglik, Julian R.; Hohl, Tobias M.; Lionakis, Michail S.			CARD9(+) microglia promote antifungal immunity via IL-1 beta- and CXCL1-mediated neutrophil recruitment	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY MONOCYTES; ASPARTYL PROTEINASES; FUNGAL-INFECTIONS; HOST PROTECTION; ASTROCYTES; CELL; SUSCEPTIBILITY; DEFICIENCY; ACTIVATION	The C-type lectin receptor-Syk (spleen tyrosine kinase) adaptor CARD9 facilitates protective antifungal immunity within the central nervous system (CNS), as human deficiency in CARD9 causes susceptibility to fungus-specific, CNS-targeted infection. CARD9 promotes the recruitment of neutrophils to the fungus-infected CNS, which mediates fungal clearance. In the present study we investigated host and pathogen factors that promote protective neutrophil recruitment during invasion of the CNS by Candida albicans. The cytokine IL-1 beta served an essential function in CNS antifungal immunity by driving production of the chemokine CXCL1, which recruited neutrophils expressing the chemokine receptor CXCR2. Neutrophil-recruiting production of IL-1 beta and CXCL1 was induced in microglia by the fungus-secreted toxin Candidalysin, in a manner dependent on the kinase p38 and the transcription factor c-Fos. Notably, microglia relied on CARD9 for production of IL-1 beta, via both transcriptional regulation of Il1b and inflammasome activation, and of CXCL1 in the fungus-infected CNS. Microglia-specific Card9 deletion impaired the production of IL-1 beta and CXCL1 and neutrophil recruitment, and increased fungal proliferation in the CNS. Thus, an intricate network of host-pathogen interactions promotes antifungal immunity in the CNS; this is impaired in human deficiency in CARD9, which leads to fungal disease of the CNS.	[Drummond, Rebecca A.; Swamydas, Muthulekha; Oikonomou, Vasileios; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhai, Bing; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA; [Dambuza, Ivy M.; Brown, Gordon D.] Univ Aberdeen, MRC, Ctr Med Mycol, Aberdeen Fungal Grp,Inst Med Sci, Aberdeen, Scotland; [Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA; [Bohrer, Andrea C.; Mayer-Barber, Katrin D.] NIAID, Inflammat & Innate Immun Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lira, Sergio A.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Filler, Scott G.] Los Angeles Biomed Res Inst Harbor UCLA, Div Infect Dis, Dept Med, Torrance, CA USA; [Hube, Bernhard] Hans Knoll Inst Jena, Dept Microbial Pathogen Mech, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hube, Bernhard] Friedrich Schiller Univ, Jena, Germany; [Naglik, Julian R.] Kings Coll London, Ctr Host Microbiome Interact, Fac Dent Oral & Craniofacial Sci, London, England; [Drummond, Rebecca A.] Univ Birmingham, Inst Immunol & Immunotherapy, Inst Microbiol & Infect, Birmingham, W Midlands, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Memorial Sloan Kettering Cancer Center; University of Aberdeen; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; Tokyo University of Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of London; King's College London; University of Birmingham	Drummond, RA; Lionakis, MS (corresponding author), NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Drummond, RA (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Inst Microbiol & Infect, Birmingham, W Midlands, England.	r.drummond@bham.ac.uk; lionakism@niaid.nih.gov	Lionakis, Michail/J-8840-2017; Drummond, Rebecca/I-3155-2019; Oikonomou, Vasileios/ABC-7703-2021; iwakura, yoichiro/E-5457-2011	Lionakis, Michail/0000-0003-4994-9500; Drummond, Rebecca/0000-0001-5424-7074; iwakura, yoichiro/0000-0002-9934-5775; Naglik, Julian/0000-0002-8072-7917; Mayer-Barber, Katrin/0000-0002-0311-3233; Zhai, Bing/0000-0001-6571-7465; Oikonomou, Vasileios/0000-0002-7553-0159	Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health; NIH [R01 093808, R01AI124566, R01CA161373]; Burroughs Wellcome Fund; Wellcome Trust [102705, 097377]; MRC Centre for Medical Mycology; University of Aberdeen [MR/N006364/1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175, R01AI124566, R01AI093808, ZIAAI001207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110352] Funding Source: NIH RePORTER; MRC [MR/N006364/2, MR/N006364/1, MR/M011372/1] Funding Source: UKRI	Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Medical Mycology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health, as well as NIH grants awarded to T.M.H. (no. R01 093808), S.G.F. (no. R01AI124566) and S.A.L. (no. R01CA161373). Additional funding was provided by the Burroughs Wellcome Fund (awarded to T.M.H.), the Wellcome Trust (nos. 102705 and 097377; awarded to G.D.B.), the MRC Centre for Medical Mycology and the University of Aberdeen (no. MR/N006364/1; awarded to G.D.B.). The authors additionally thank C. Huaman for care and screening of the Malt1<SUP>-/-</SUP> mice, which were a kind gift to B.C.S. from T. Mak and the University Health Network (Canada), and D. McGavern and F. Crews for providing the murine glial cell lines.	Altmeier S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005882; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Cetinkaya PG, 2018, CLIN IMMUNOL, V191, P21, DOI 10.1016/j.clim.2018.01.002; Cougnoux A, 2018, HUM MOL GENET, V27, P2076, DOI 10.1093/hmg/ddy112; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Drummond RA, 2018, CURR FUNGAL INFECT R, V12, P92, DOI 10.1007/s12281-018-0316-y; Drummond RA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00039; Drummond RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005293; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Flynn R, 2015, BLOOD, V125, P4085, DOI 10.1182/blood-2014-08-595470; Gabrielli E, 2016, VIRULENCE, V7, P819, DOI 10.1080/21505594.2016.1184385; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kasper L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06607-1; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lee EKS, 2018, CELL HOST MICROBE, V23, P121, DOI 10.1016/j.chom.2017.11.009; Levesque SA, 2016, J EXP MED, V213, P929, DOI 10.1084/jem.20151437; Li X, 2011, CELL HOST MICROBE, V10, P603, DOI 10.1016/j.chom.2011.10.009; Lionakis MS, 2018, ANNU REV IMMUNOL, V36, P157, DOI 10.1146/annurev-immunol-042617-053318; Lionakis MS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019638; Lionakis MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002865; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Mao LM, 2014, INFECT IMMUN, V82, P882, DOI 10.1128/IAI.01097-13; McCarthy MW, 2017, J PEDIAT INF DIS SOC, V6, pE123, DOI 10.1093/jpids/pix059; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nemeth T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11004; Ngo LY, 2014, J INFECT DIS, V209, P109, DOI 10.1093/infdis/jit413; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pereira M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12874; Pericolini E, 2015, MBIO, V6, DOI 10.1128/mBio.00724-15; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Richardson JP, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00645-17; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Swamydas M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7718; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Verma AH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8834; Wang XW, 2018, J INVEST DERMATOL, V138, P607, DOI 10.1016/j.jid.2017.10.009; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	54	96	101	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					559	+		10.1038/s41590-019-0377-2	http://dx.doi.org/10.1038/s41590-019-0377-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30996332	Green Submitted, Green Accepted			2022-12-18	WOS:000465084800013
J	Locci, M; Wu, JE; Arumemi, F; Mikulski, Z; Dahlberg, C; Miller, AT; Crotty, S				Locci, Michela; Wu, Jennifer E.; Arumemi, Fortuna; Mikulski, Zbigniew; Dahlberg, Carol; Miller, Andrew T.; Crotty, Shane			Activin A programs the differentiation of human T-FH cells	NATURE IMMUNOLOGY			English	Article							FOLLICULAR-HELPER-CELLS; EXPRESSION; T-HELPER-1; RESPONSES; CYTOKINE; PROMOTE; ACTIVATION; GENERATION; REGULATORS; INHIBITOR	Follicular helper T cells (T-FH cells) are CD4(+) T cells specialized in helping B cells and are associated both with protective antibody responses and autoimmune diseases. The promise of targeting T-FH cells therapeutically has been limited by fragmentary understanding of extrinsic signals that regulate the differentiation of human T-FH cells. A screen of a human protein library identified activin A as a potent regulator of T-FH cell differentiation. Activin A orchestrated the expression of multiple genes associated with the T-FH program, independently or in concert with additional signals. T-FH cell programming by activin A was antagonized by the cytokine IL-2. Activin A's ability to drive T-FH cell differentiation in vitro was conserved in non-human primates but not in mice. Finally, activin-A-induced T-FH programming was dependent on signaling via SMAD2 and SMAD3 and was blocked by pharmacological inhibitors.	[Locci, Michela; Wu, Jennifer E.; Arumemi, Fortuna; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Mikulski, Zbigniew] La Jolla Inst Allergy & Immunol, Microscopy Core Facil, La Jolla, CA USA; [Dahlberg, Carol; Miller, Andrew T.] Novartis Res Fdn, Genom Inst, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Crotty, Shane] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Novartis; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.; Crotty, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Crotty, S (corresponding author), Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.	shane@lji.org	Wu, Jennifer/GRX-1831-2022; Crotty, Shane/AAE-8446-2019; Mikulski, Zbigniew/AAB-4447-2020; Crotty, Shane/AAC-6703-2019	Mikulski, Zbigniew/0000-0002-1918-9216; Crotty, Shane/0000-0002-6484-6262	US National Institutes of Health [UM1-AI100663]; La Jolla Institute; Genomics Institute of the Novartis Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096187, UM1AI100663, R01AI072543] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Jolla Institute; Genomics Institute of the Novartis Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Protein Sciences Group at Genomics Institute of the Novartis Research Foundation for protein production; G. Silvestri (Emory University) for the peripheral blood mononuclear cell samples from non-human primates; the sequencing core at La Jolla Institute for the generation of RNA-seq data; and the National Disease Resource Interchange for tonsil samples. The contents of the secretomics collection of the Genomics Institute of the Novartis Research Foundation are proprietary. Access to the collection may be considered for further research collaboration agreements on a case-by-case basis. Supported by the US National Institutes of Health (UM1-AI100663 to S.C.) and internal funding from the La Jolla Institute (S.C.) and the Genomics Institute of the Novartis Research Foundation (A.M.).	Abe Y, 2004, GROWTH FACTORS, V22, P105, DOI 10.1080/08977190410001704688; Aleman-Muench GR, 2012, IMMUNOL CELL BIOL, V90, P137, DOI 10.1038/icb.2011.32; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; ERAMAA M, 1992, J EXP MED, V176, P1449, DOI 10.1084/jem.176.5.1449; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gold E, 2012, MOL CELL ENDOCRINOL, V359, P107, DOI 10.1016/j.mce.2011.07.005; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Huber S, 2009, J IMMUNOL, V182, P4633, DOI 10.4049/jimmunol.0803143; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Marshall HD, 2015, ELIFE, V4, DOI 10.7554/eLife.04851; McCarron MJ, 2014, J CLIN INVEST, V124, P4375, DOI 10.1172/JCI76179; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; Muttukrishna S, 2004, MOL CELL ENDOCRINOL, V225, P45, DOI 10.1016/j.mce.2004.02.012; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Ogawa K, 2000, J IMMUNOL, V165, P2997, DOI 10.4049/jimmunol.165.6.2997; Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; de Guinoa JS, 2011, BLOOD, V118, P1560, DOI 10.1182/blood-2011-01-332106; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; SHEN MM, 1994, EMBO J, V13, P1375, DOI 10.1002/j.1460-2075.1994.tb06391.x; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001	50	96	100	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					976	+		10.1038/ni.3494	http://dx.doi.org/10.1038/ni.3494			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27376469	Green Accepted			2022-12-18	WOS:000380647000015
J	Samie, M; Cresswell, P				Samie, Mohammad; Cresswell, Peter			The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; DENDRITIC CELL MATURATION; CROSS-PRESENTATION; LYSOSOMAL EXOCYTOSIS; T-CELLS; KAPPA-B; ACTIVATION; AUTOPHAGY; VIVO; MACROPHAGES	Dendritic cells (DCs) can initiate immune responses by presenting exogenous antigens to T cells via both major histocompatibility complex (MHC) class I pathways and MHC class II pathways. Lysosomal activity has an important role in modulating the balance between these two pathways. The transcription factor TFEB regulates lysosomal function by inducing lysosomal activation. Here we report that TFEB expression inhibited the presentation of exogenous antigen by MHC class I while enhancing presentation via MHC class II. TFEB promoted phagosomal acidification and protein degradation. Furthermore, we found that the activation of TFEB was regulated during DC maturation and that phagosomal acidification was impaired in DCs in which the gene encoding TFEB was silenced. Our data indicate that TFEB is a key participant in the differential regulation of the presentation of exogenous antigens by DCs.	[Samie, Mohammad; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute; US National Institutes of Health [RO1-AI097206, T32 HL007974]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097206] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Ferguson (Yale School of Medicine) for the TFEB-EGFP and TFEB(mNLS)-EGFP constructs; A. Iwasaki (Yale School of Medicine) for the gBT and CD11c-DTR mice; W. Shlomchik (Yale School of Medicine) for H-2Kb-SIINFEKL tetramers; R. Medzhitov (Yale School of Medicine) for YM201636, lipoteichoic acid and CpG; R. Leonhadt and J. Grotzke for comments on an earlier version of the manuscript; and the members of the Cresswell laboratory for encouragement and comments. Supported by the Howard Hughes Medical Institute and the US National Institutes of Health (RO1-AI097206 to P.C., and T32 HL007974 to M.S.).	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Geuze HJ, 1998, IMMUNOL TODAY, V19, P282, DOI 10.1016/S0167-5699(98)01269-9; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Majewski M, 2007, INT IMMUNOL, V19, P719, DOI 10.1093/intimm/dxm034; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Segura E, 2013, J EXP MED, V210, P1035, DOI 10.1084/jem.20121103; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Uchida K, 2014, J TOXICOL PATHOL, V27, P153, DOI 10.1293/tox.2014-0004; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Visvikis O, 2014, IMMUNITY, V40, P896, DOI 10.1016/j.immuni.2014.05.002; Wagner CS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00138; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	49	96	100	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					729	+		10.1038/ni.3196	http://dx.doi.org/10.1038/ni.3196			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26030023	Green Accepted			2022-12-18	WOS:000356445600009
J	Bandala-Sanchez, E; Zhang, YX; Reinwald, S; Dromey, JA; Lee, BH; Qian, JY; Bohmer, RM; Harrison, LC				Bandala-Sanchez, Esther; Zhang, Yuxia; Reinwald, Simone; Dromey, James A.; Lee, Bo-Han; Qian, Junyan; Boehmer, Ralph M.; Harrison, Leonard C.			T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE-DISEASE; CAMPATH-1 ANTIGEN; FOXP3; EXPRESSION; IDENTIFICATION; LYMPHOCYTES; ACTIVATION; ANTIBODIES; MOLECULE; CLONING	Functionally diverse T cell populations interact to maintain homeostasis of the immune system. We found that human and mouse antigen-activated T cells with high expression of the lymphocyte surface marker CD52 suppressed other T cells. CD52(hi)CD4(+) T cells were distinct from CD4(+)CD25(+)Foxp3(+) regulatory T cells. Their suppression was mediated by soluble CD52 released by phospholipase C. Soluble CD52 bound to the inhibitory receptor Siglec-10 and impaired phosphorylation of the T cell receptor-associated kinases Lck and Zap70 and T cell activation. Humans with type 1 diabetes had a lower frequency and diminished function of CD52(hi)CD4(+)T cells responsive to the autoantigen GAD65. In diabetes-prone mice of the nonobese diabetic (NOD) strain, transfer of lymphocyte populations depleted of CD52(hi) cells resulted in a substantially accelerated onset of diabetes. Our studies identify a ligand-receptor mechanism of T cell regulation that may protect humans and mice from autoimmune disease.	[Bandala-Sanchez, Esther; Zhang, Yuxia; Reinwald, Simone; Dromey, James A.; Lee, Bo-Han; Qian, Junyan; Boehmer, Ralph M.; Harrison, Leonard C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Bandala-Sanchez, Esther; Zhang, Yuxia; Reinwald, Simone; Lee, Bo-Han; Qian, Junyan; Boehmer, Ralph M.; Harrison, Leonard C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Harrison, Leonard C.] Royal Melbourne Hosp, Burnet Clin Res Unit, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital	Harrison, LC (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.	harrison@wehi.edu.au			National Health and Medical Research Council of Australia [637301, 516700]; Australian Government National Health; Medical Research Council Independent Research Institutes Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council Independent Research Institutes Infrastructure Support Scheme	We thank M. R. Clark (University of Cambridge) for DNA encoding immunoglobulin G1 Fc; and L. Belov, K. Ngui, A. Neale, J. Butler, D. Mittag, M. Herold, N. Stone, N. Lynch, H. Thomas, S. Finch and T. Adams for technical assistance and advice. Supported by the National Health and Medical Research Council of Australia (637301 to L. C. H. and 516700) and facilitated by the Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Adorini L, 2002, TRENDS MOL MED, V8, P31, DOI 10.1016/S1471-4914(01)02193-1; Armour KL, 2003, MOL IMMUNOL, V40, P585, DOI 10.1016/j.molimm.2003.08.004; Augstein P, 1998, MOL MED, V4, P495, DOI 10.1007/BF03401754; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Belov L, 2003, PROTEOMICS, V3, P2147, DOI 10.1002/pmic.200300599; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Clatworthy MR, 2008, NEW ENGL J MED, V359, P768, DOI 10.1056/NEJMc0800484; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Cossburn M, 2011, NEUROLOGY, V77, P573, DOI 10.1212/WNL.0b013e318228bec5; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dromey JA, 2011, J AUTOIMMUN, V36, P47, DOI 10.1016/j.jaut.2010.10.005; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; Hale G, 2001, J BIOL REG HOMEOS AG, V15, P386; Harrison LC, 2008, IMMUNOL CELL BIOL, V86, P139, DOI 10.1038/sj.icb.7100151; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; KORTY PE, 1991, J IMMUNOL, V146, P4092; KUBOTA H, 1990, J IMMUNOL, V145, P3924; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; MACDONALD HR, 1985, EUR J IMMUNOL, V15, P495, DOI 10.1002/eji.1830150514; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; ROWAN WC, 1995, INT IMMUNOL, V7, P69, DOI 10.1093/intimm/7.1.69; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; THOMPSON LF, 1989, J IMMUNOL, V143, P1815; Tone M, 1999, BBA-GENE STRUCT EXPR, V1446, P334, DOI 10.1016/S0167-4781(99)00103-7; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2009, GLYCOBIOLOGY, V19, P810, DOI 10.1093/glycob/cwp063; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Watanabe T, 2006, CLIN IMMUNOL, V120, P247, DOI 10.1016/j.clim.2006.05.006; XIA MQ, 1991, EUR J IMMUNOL, V21, P1677, DOI 10.1002/eji.1830210714; XIA MQ, 1993, BIOCHEM J, V293, P633, DOI 10.1042/bj2930633	46	96	120	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					741	+		10.1038/ni.2610	http://dx.doi.org/10.1038/ni.2610			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23685786				2022-12-18	WOS:000320509100016
J	Jin, J; Xiao, YC; Chang, JH; Yu, JY; Hu, HB; Starr, R; Brittain, GC; Chang, M; Cheng, XH; Sun, SC				Jin, Jin; Xiao, Yichuan; Chang, Jae-Hoon; Yu, Jiayi; Hu, Hongbo; Starr, Robyn; Brittain, George C.; Chang, Mikyoung; Cheng, Xuhong; Sun, Shao-Cong			The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-kappa B signaling	NATURE IMMUNOLOGY			English	Article							ANTIVIRAL RESPONSE; INNATE IMMUNITY; CROSS-TALK; RECEPTOR; ACTIVATION; EXPRESSION; DEFICIENT; FAMILY; CELLS; MOUSE	Immunoglobulin class switching is crucial for the generation of antibody diversity in humoral immunity and, when deregulated, also has severe pathological consequences. How the magnitude of immunoglobulin isotype switching is controlled is still poorly understood. Here we identify the kinase TBK1 as a pivotal negative regulator of class switching to the immunoglobulin A (IgA) isotype. B cell specific ablation of TBK1 in mice resulted in uncontrolled production of IgA and the development of nephropathy-like disease signs. TBK1 negatively regulated IgA class switching by attenuating noncanonical signaling via the transcription factor NF-kappa B, an action that involved TBK1-mediated phosphorylation and subsequent degradation of the NF-kappa B-inducing kinase NIK. Our findings establish TBK1 as a pivotal negative regulator of the noncanonical NF-kappa B pathway and identify a unique mechanism that controls IgA production.	[Jin, Jin; Xiao, Yichuan; Chang, Jae-Hoon; Yu, Jiayi; Hu, Hongbo; Brittain, George C.; Chang, Mikyoung; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Starr, Robyn] St Vincents Inst, Fitzroy, Vic, Australia; [Sun, Shao-Cong] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; St. Vincent's Institute of Medical Research	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Hu, Hongbo/J-8059-2016; Yu, Jiayi/I-5923-2014	Hu, Hongbo/0000-0002-8177-7641; Jin, Jin/0000-0001-7887-5972	US National Institutes of Health [AI057555, AI064639, GM084459, T32CA009598]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amgen for Map3k14-deficent mice; the Water Eliza Hall Institute of Medical Research for Nfkb2<SUP>Lyml</SUP> mice; S.S. Watowich (University of Texas MD Anderson Cancer Center) for 1fnarI<SUP>-/-</SUP> mice; S. Akira (Osaka University) for Flag-tagged IKK epsilon (IKKi); G. Cheng (University of California, Los Ageles) for Flag-tagged mouse NIK and mouse NIK(S809A,S812A,S815A) expressed by a pcDNA vector; M. Karin (University of California, San Diego) for hemagglutinin-tagged IKK alpha and IKK alpha(SSEE); X. Qin (Sun Yat-Sen University) for packaging vectors psPAX2 and pMD2; C. Wang (Shanghai Institutes for Biological Sciences) for Flag-tagged TBK1 and TBK1(K38A); M.P. Cancro (University of Pennsylvania) for NIH3T3 cell lines; and personnel of the animal facility, flow cytometry, DNA analysis and histology core facilities at MD Anderson Cancer Center for technical assistance. Supported by the US National Institutes of Health (AI057555, AI064639, GM084459 and T32CA009598).	Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim RJ, 2007, BIOCHEM BIOPH RES CO, V361, P398, DOI 10.1016/j.bbrc.2007.07.022; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; McCarthy DD, 2006, CELL IMMUNOL, V241, P85, DOI 10.1016/j.cellimm.2006.08.002; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papista C, 2011, CELL MOL IMMUNOL, V8, P126, DOI 10.1038/cmi.2010.69; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Snapper CM, 1996, J EXP MED, V184, P1537, DOI 10.1084/jem.184.4.1537; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Tomino Y, 2008, J NEPHROL, V21, P463; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453	46	96	100	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1101	1109		10.1038/ni.2423	http://dx.doi.org/10.1038/ni.2423			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23023393	Green Accepted			2022-12-18	WOS:000310091700013
J	Luc, S; Luis, TC; Boukarabila, H; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Won, PS; Loughran, SJ; Mead, AJ; Hultquist, A; Brown, J; Mizukami, T; Matsuoka, S; Ferry, H; Anderson, K; Duarte, S; Atkinson, D; Soneji, S; Domanski, A; Farley, A; Sanjuan-Pla, A; Carella, C; Patient, R; de Bruijn, M; Enver, T; Nerlov, C; Blackburn, C; Godin, I; Jacobsen, SEW				Luc, Sidinh; Luis, Tiago C.; Boukarabila, Hanane; Macaulay, Iain C.; Buza-Vidas, Natalija; Bouriez-Jones, Tiphaine; Lutteropp, Michael; Won, Petter S.; Loughran, Stephen J.; Mead, Adam J.; Hultquist, Anne; Brown, John; Mizukami, Takuo; Matsuoka, Sahoko; Ferry, Helen; Anderson, Kristina; Duarte, Sara; Atkinson, Deborah; Soneji, Shamit; Domanski, Aniela; Farley, Alison; Sanjuan-Pla, Alejandra; Carella, Cintia; Patient, Roger; de Bruijn, Marella; Enver, Tariq; Nerlov, Claus; Blackburn, Clare; Godin, Isabelle; Jacobsen, Sten Eirik W.			The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; HEMATOPOIETIC PROGENITORS; DENDRITIC CELLS; IDENTIFICATION; MARKS; SPECIFICATION; PRECURSORS; MPL; MAP	The stepwise commitment from hematopoietic stem cells in the bone marrow to T lymphocyte-restricted progenitors in the thymus represents a paradigm for understanding the requirement for distinct extrinsic cues during different stages of lineage restriction from multipotent to lineage-restricted progenitors. However, the commitment stage at which progenitors migrate from the bone marrow to the thymus remains unclear. Here we provide functional and molecular evidence at the single-cell level that the earliest progenitors in the neonatal thymus had combined granulocyte-monocyte, T lymphocyte and B lymphocyte lineage potential but not megakaryocyte-erythroid lineage potential. These potentials were identical to those of candidate thymus-seeding progenitors in the bone marrow, which were closely related at the molecular level. Our findings establish the distinct lineage-restriction stage at which the T cell lineage-commitment process transits from the bone marrow to the remote thymus.	[Luc, Sidinh; Luis, Tiago C.; Boukarabila, Hanane; Macaulay, Iain C.; Buza-Vidas, Natalija; Bouriez-Jones, Tiphaine; Lutteropp, Michael; Won, Petter S.; Loughran, Stephen J.; Mead, Adam J.; Mizukami, Takuo; Matsuoka, Sahoko; Ferry, Helen; Duarte, Sara; Atkinson, Deborah; Domanski, Aniela; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Luc, Sidinh; Hultquist, Anne; Anderson, Kristina; Jacobsen, Sten Eirik W.] Lund Univ, Hematopoiet Stem Cell Lab, Lund Stem Cell Ctr, Lund, Sweden; [Luc, Sidinh; Lutteropp, Michael; Brown, John; Soneji, Shamit; Patient, Roger; de Bruijn, Marella; Enver, Tariq; Jacobsen, Sten Eirik W.] Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford, England; [Buza-Vidas, Natalija; Farley, Alison; Sanjuan-Pla, Alejandra; Nerlov, Claus; Blackburn, Clare] Univ Edinburgh, Inst Stem Cell Res, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Carella, Cintia] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Godin, Isabelle] INSERM, U1009, Villejuif, France; [Godin, Isabelle] Inst Gustave Roussy, Villejuif, France; [Godin, Isabelle] Univ Paris 11, Orsay, France	University of Oxford; Lund University; University of Oxford; University of Edinburgh; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Jacobsen, SEW (corresponding author), Univ Oxford, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	sten.jacobsen@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Blackburn, Clare/B-2847-2009; Sanjuan-Pla, Alejandra/GRX-9588-2022; carella, Cintia/K-3227-2018; Mizukami, Takuo/F-9248-2016; Blackburn, Clare/AAM-7954-2020; Mead, Adam/A-8796-2012; GODIN, Isabelle/K-5769-2013	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Blackburn, Clare/0000-0002-6326-640X; Sanjuan-Pla, Alejandra/0000-0002-0170-5542; carella, Cintia/0000-0001-9557-3300; Mizukami, Takuo/0000-0001-6105-6049; Blackburn, Clare/0000-0002-6326-640X; Mead, Adam/0000-0001-8522-1002; Macaulay, Iain/0000-0002-6761-757X; Duarte, Sara/0000-0002-7641-175X; Luc, Sidinh/0000-0001-7006-6169; GODIN, Isabelle/0000-0001-8577-8388; Cunha Luis, Tiago/0000-0002-6305-1257; Woll, Petter S./0000-0002-2340-2526	Medical Research Council, UK [H4RPLK0]; Leukaemia and Lymphoma Research; Crafoord Foundation; George Danielsson Foundation; EU; Swedish Society for Medicine; Swedish Cancer Foundation; MRC [G0801073, MC_UU_12009/2, MC_UU_12009/5, G0501838, G84/6443, MC_U137970202, MC_UU_12009/8] Funding Source: UKRI; Medical Research Council [G0801073, MC_UU_12009/5, MC_UU_12009/8, G0501838, G1000801h, MC_UU_12009/2, MC_U137970202, G84/6443, G0700711B] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23791093] Funding Source: KAKEN	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; Crafoord Foundation; George Danielsson Foundation; EU(European Commission); Swedish Society for Medicine; Swedish Cancer Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Sakaguchi (Kumamoto University) for mice with Rag1-driven GFP expression; T. Graf (Center for Genomic Regulation) for mice with expression of enhanced GIP (eGFP) driven by the gene encoding lysozyrne M<SUP>4</SUP>; S. Cory (Walter and Eliza Hall Institute of Medical Research) for vavP-Mcl1-trangenic mice; M. Reth (Max Planck Institute of Immunobiology) for Cd79a<SUP>tm1(cre)Reth</SUP> mice; S. Srinivas (University of Oxford) for mice expressing enhanced yellow fluorescent protein from the Rosa26 locus; A. Cumano (Institut Pasteur) for OP9 and OP9-DLI stromal cells; Biomedical Services at Oxford University for animal support; S. Clark, T. Furey and B. Wu for technical assistance; and E. Zuo and M. Eckart at the Stanford Protein and Nucleic Acid Facility for gene array services. Supported by the Medical Research Council, UK (H4RPLK0 to SEW). and EU-FP7 EuroSyStem Integrated projects to S.E.W.J., C.B. and AL), Leukaemia and Lymphoma Research (GB., A.F. and AIM.), the Crafoord Foundation (A.H.), The George Danielsson Foundation (A.H.) and Swedish Society for Medicine and Swedish Cancer Foundation (A.H.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Campbell KJ, 2010, BLOOD, V116, P3197, DOI 10.1182/blood-2010-04-281071; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Chi AWS, 2011, BLOOD, V118, P2723, DOI 10.1182/blood-2010-09-309989; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Petrie HT, 2005, J EXP MED, V202, P11, DOI 10.1084/jem.20050990; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	44	96	97	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					412	419		10.1038/ni.2255	http://dx.doi.org/10.1038/ni.2255			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22344248	Green Accepted			2022-12-18	WOS:000301886800016
J	Maul, RW; Saribasak, H; Martomo, SA; McClure, RL; Yang, W; Vaisman, A; Gramlich, HS; Schatz, DG; Woodgate, R; Wilson, DM; Gearhart, PJ				Maul, Robert W.; Saribasak, Huseyin; Martomo, Stella A.; McClure, Rhonda L.; Yang, William; Vaisman, Alexandra; Gramlich, Hillary S.; Schatz, David G.; Woodgate, Roger; Wilson, David M., III; Gearhart, Patricia J.			Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions	NATURE IMMUNOLOGY			English	Article							DNA GLYCOSYLASE ACTIVITY; SINGLE-STRANDED-DNA; LIGHT-CHAIN GENE; SOMATIC HYPERMUTATION; R-LOOPS; RECOMBINATION; CONVERSION; CELLS; DIVERSIFICATION; DEOXYCYTIDINE	Activation-induced deaminase (AID) initiates diversity of immunoglobulin genes through deamination of cytosine to uracil. Two opposing models have been proposed for the deamination of DNA or RNA by AID. Although most data support DNA deamination, there is no physical evidence of uracil residues in immunoglobulin genes. Here we demonstrate their presence by determining the sensitivity of DNA to digestion with uracil DNA glycosylase (UNG) and abasic endonuclease. Using several methods of detection, we identified uracil residues in the variable and switch regions. Uracil residues were generated within 24 h of B cell stimulation, were present on both DNA strands and were found to replace mainly cytosine bases. Our data provide direct evidence for the model that AID functions by deaminating cytosine residues in DNA.	[Maul, Robert W.; Saribasak, Huseyin; Martomo, Stella A.; McClure, Rhonda L.; Yang, William; Wilson, David M., III; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Vaisman, Alexandra; Woodgate, Roger] NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [Gramlich, Hillary S.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, New Haven, CT 06510 USA; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Gearhart, PJ (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	gearhartp@mail.nih.gov	Schatz, David/A-6748-2013; Saribasak, Huseyin/C-9331-2012; Gearhart, Patricia/Y-7227-2019; Wilson, David M/AAK-5409-2021; Vaisman, Alexandra/C-3766-2013; Martomo, Stella/GXW-0213-2022; Maul, Robert W./Y-6818-2019	Schatz, David/0000-0002-5669-1176; Saribasak, Huseyin/0000-0003-0055-062X; Wilson, David M/0000-0002-8945-0395; Vaisman, Alexandra/0000-0002-2521-1467; Woodgate, Roger/0000-0001-5581-4616; Maul, Robert/0000-0002-6958-8514	Howard Hughes Medical Institute; National Institute on Aging; National Institute of Child Health and Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000743, ZIAAG000715] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Stivers (John Hopkins University) for UNG; S. Wilson (National Institute of Environmental Health Sciences, National Institutes of Health) for polymerase beta-lyase; R. Kohli (University of Pennsylvania), J. Buerstedde and H. Arakawa (Max Planck Institute of Biochemistry) for reagents and advice; S. Fugmann and R. Sen for discussions; T. Wolf, C. Nguyen and R. Wersto for assistance in flow cytometry; and the Comparative Medicine Section for mouse maintenance. Supported by the National Institute on Aging and the National Institute of Child Health and Human Development of the National Institutes of Health (Intramural Research Program) and Howard Hughes Medical Institute (D.G.S.).	ANDERSSON J, 1977, CELL, V10, P27, DOI 10.1016/0092-8674(77)90136-2; Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Begum NA, 2009, P NATL ACAD SCI USA, V106, P2752, DOI 10.1073/pnas.0813252106; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martomo SA, 2005, J IMMUNOL, V174, P7787, DOI 10.4049/jimmunol.174.12.7787; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, pR108, DOI 10.1016/S0960-9822(02)00674-7; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Roche B, 2010, J IMMUNOL, V185, P4777, DOI 10.4049/jimmunol.1001459; Sabouri Z, 2009, INT IMMUNOL, V21, P947, DOI 10.1093/intimm/dxp061; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sharbeen G, 2010, NUCLEIC ACIDS RES, V38, P8120, DOI 10.1093/nar/gkq682; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stivers JT, 2004, SCIENCE, V306, p2042A, DOI 10.1126/science.1104396; Taneyhill LA, 2008, METHOD CELL BIOL, V87, P367, DOI 10.1016/S0091-679X(08)00219-7; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	55	96	97	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					70	U93		10.1038/ni.1970	http://dx.doi.org/10.1038/ni.1970			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21151102	Green Accepted			2022-12-18	WOS:000285465100015
J	D'Cruz, LM; Knell, J; Fujimoto, JK; Goldrath, AW				D'Cruz, Louise M.; Knell, Jamie; Fujimoto, Jessica K.; Goldrath, Ananda W.			An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells	NATURE IMMUNOLOGY			English	Article							V(D)J RECOMBINATION; ROR-GAMMA; E2A; PROLIFERATION; GENE; PROTEINS; RECEPTOR; LINEAGE; REQUIREMENT; ACTIVATION	E proteins are basic helix-loop-helix transcription factors that regulate many key aspects of lymphocyte development. Thymocytes express multiple E proteins that are thought to provide cooperative and compensatory functions crucial for T cell differentiation. Contrary to that, we report here that the E protein HEB was uniquely required at the CD4(+)CD8(+) double-positive (DP) stage of T cell development. Thymocytes lacking HEB showed impaired survival, failed to make rearrangements of variable-alpha (V-alpha) segments to distal joining-alpha (J(alpha)) segments in the gene encoding the T cell antigen receptor alpha-chain (Tcra) and had a profound, intrinsic block in the development of invariant natural killer T cells (iNKT cells) at their earliest progenitor stage. Thus, our results show that HEB is a specific and essential factor in T cell development and in the generation of the iNKT cell lineage, defining a unique role for HEB in the regulation of lymphocyte maturation.	[D'Cruz, Louise M.; Knell, Jamie; Fujimoto, Jessica K.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu			Cancer Research Institute; Pew Charitable Trusts; National Institutes of Health [AI067545, AI072117]; Leukemia & Lymphoma Society; University of California San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067545, R01AI072117] Funding Source: NIH RePORTER	Cancer Research Institute; Pew Charitable Trusts; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); University of California San Diego(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Murre (University of California San Diego) for discussions, reagents and mice; Y. Zhuang (Duke University) for Tcf12<SUP>-/-</SUP>, Tcf12<SUP>f/f</SUP> and Tcfe2a<SUP>f/f</SUP> mouse lines; A. Bendelac (Howard Hughes Medical Institute) and M. Kronenberg (La Jolla Institute for Allergy and Immunology) for V<INF>alpha</INF>14-J<INF>alpha</INF>18 TCR-transgenic mice; A. Abbas (University of California San Francisco) for the constructs MSCV2.2-Bcl-x<INF>L</INF>-IRES-Thy-1.1 and MSCV2.2-empty-IRES-Thy-1.1; M. Kronenberg for advice; I. Ch'en for advice and assistance; and J. Hamerman, G. Barton, E. Zuniga and S. Hedrick and members of the Goldrath laboratory for critical review of the manuscript. Supported by the Cancer Research Institute, the Pew Charitable Trusts, the National Institutes of Health (AI067545 and AI072117 to A.W.G.), the Leukemia & Lymphoma Society (L.M.D.) and University of California San Diego undergraduate research scholarship program (J.K.F.).	Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt R, 1999, J IMMUNOL, V163, P3331; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Guo WJ, 2002, WORLD J GASTROENTERO, V8, P476, DOI 10.3748/wjg.v8.i3.476; Hager E, 2007, J IMMUNOL, V179, P2228, DOI 10.4049/jimmunol.179.4.2228; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ohteki T, 1997, J IMMUNOL, V159, P5931; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615; Riegert P, 1999, J IMMUNOL, V162, P3471; Rolf J, 2008, MOL IMMUNOL, V45, P2607, DOI 10.1016/j.molimm.2007.12.022; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tupin E, 2006, METHOD ENZYMOL, V417, P185, DOI 10.1016/S0076-6879(06)17014-7; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	45	96	96	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					240	U8		10.1038/ni.1845	http://dx.doi.org/10.1038/ni.1845			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20154672	Green Accepted			2022-12-18	WOS:000274605800012
J	Tran, TH; Nakata, M; Suzuki, K; Begum, NA; Shinkura, R; Fagarasan, S; Honjo, T; Nagaoka, H				Tran, Thinh Huy; Nakata, Mikiyo; Suzuki, Keiichiro; Begum, Nasim A.; Shinkura, Reiko; Fagarasan, Sidonia; Honjo, Tasuku; Nagaoka, Hitoshi			B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers	NATURE IMMUNOLOGY			English	Article							INDUCED-CYTIDINE-DEAMINASE; CLASS-SWITCH RECOMBINATION; NF-KAPPA-B; ACTIVATION-INDUCED DEAMINASE; SOMATIC HYPERMUTATION; AID EXPRESSION; GENE-EXPRESSION; TRANSGENIC MICE; FACTOR-BINDING; DNA CLEAVAGE	Activation-induced cytidine deaminase (AID) is essential for the generation of antibody memory but also targets oncogenes, among other genes. We investigated the transcriptional regulation of Aicda (which encodes AID) in class switch-inducible CH12F3-2 cells and found that Aicda regulation involved derepression by several layers of positive regulatory elements in addition to the 5' promoter region. The 5' upstream region contained functional motifs for the response to signaling by cytokines, the ligand for the costimulatory molecule CD40 or stimuli that activated the transcription factor NF-kappa B. The first intron contained functional binding elements for the ubiquitous silencers c-Myb and E2f and for the B cell-specific activator Pax5 and E-box-binding proteins. Our results show that Aicda is regulated by the balance between B cell-specific and stimulation-responsive elements and ubiquitous silencers.	[Tran, Thinh Huy; Nakata, Mikiyo; Begum, Nasim A.; Shinkura, Reiko; Honjo, Tasuku; Nagaoka, Hitoshi] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Tran, Thinh Huy; Suzuki, Keiichiro; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa, Japan	Kyoto University; RIKEN	Tran, TH (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402; Begum, Nasim/0000-0001-7177-188X	Ministry of Education, Culture, Sports, Science and Technology of Japan [17002015]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank I. Taniuchi for critical comments and Y. Shiraki and T. Kanda for help in the preparation of the manuscript. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Specially Promoted Research 17002015).	Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; DeGregori J, 2006, CURR MOL MED, V6, P739; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Ganter B, 1997, ONCOGENE, V15, P193, DOI 10.1038/sj.onc.1201173; Gao N, 2001, J IMMUNOL, V167, P2011, DOI 10.4049/jimmunol.167.4.2011; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Gourzi P, 2007, J EXP MED, V204, P259, DOI 10.1084/jem.20061801; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; MIZUGUCHI G, 1995, J BIOL CHEM, V270, P9384, DOI 10.1074/jbc.270.16.9384; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nagy SR, 2002, BIOCHEM BIOPH RES CO, V296, P799, DOI 10.1016/S0006-291X(02)00945-2; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Park HJ, 1998, MOL IMMUNOL, V35, P239, DOI 10.1016/S0161-5890(98)00022-4; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rucci F, 2006, GENE, V377, P150, DOI 10.1016/j.gene.2006.03.024; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; van Dijk TB, 1999, J IMMUNOL, V163, P2674; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007	48	96	96	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					148	U67		10.1038/ni.1829	http://dx.doi.org/10.1038/ni.1829			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	19966806	Green Submitted, Green Published			2022-12-18	WOS:000273730200012
J	Di Santo, JP				Di Santo, James P.			Natural killer cells: diversity in search of a niche	NATURE IMMUNOLOGY			English	Review							CLASS-I MOLECULES; DEVELOPMENTAL PATHWAYS; INHIBITORY RECEPTORS; DENDRITIC CELLS; MISSING SELF; NK-CELLS; RECOGNITION; SPECIFICITY; TOLERANCE; SUBSETS	Over the years, the enigmatic lifestyle of natural killer (NK) cells has fascinated immunologists. Elucidating the principles governing NK cell biology is a constant source of surprise, as these lymphocytes often break the rules of lymphocyte `behavior' established by their T and B cell counterparts. In this Focus issue, experts address how NK cells have secured a fundamental place in the immune system, how they `see' their targets and how they participate in and influence immune responses. We now need to understand how environmental `niches' condition the generation and function of distinct NK cell subsets in vivo. Ultimately, we can hope that unraveling the mysteries of how these atypical lymphocytes function will have an impact on human disease therapies.	[Di Santo, James P.] Inst Pasteur, INSERM, U668, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris		disanto@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862				Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Di Santo JP, 2006, IMMUNOL REV, V214, P35, DOI 10.1111/j.1600-065X.2006.00461.x; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; LANIER LL, 1986, J IMMUNOL, V137, P2735; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yokoyama WM, 2008, NAT IMMUNOL, V9, P481, DOI 10.1038/ni1583; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006	36	96	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					473	475		10.1038/ni.f.201	http://dx.doi.org/10.1038/ni.f.201			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425102				2022-12-18	WOS:000255153500007
J	Ansel, KM; Greenwald, RJ; Agarwal, S; Bassing, CH; Monticelli, S; Interlandi, J; Djuretic, IM; Lee, DU; Sharpe, AH; Walt, F; Rao, A				Ansel, KM; Greenwald, RJ; Agarwal, S; Bassing, CH; Monticelli, S; Interlandi, J; Djuretic, IM; Lee, DU; Sharpe, AH; Walt, F; Rao, A			Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity	NATURE IMMUNOLOGY			English	Article							SPECIES SEQUENCE COMPARISONS; CYTOKINE GENE-EXPRESSION; IL-4 GENE; CELL-DIFFERENTIATION; LEISHMANIA-MAJOR; MAST-CELLS; HYPERSENSITIVE SITES; COORDINATE REGULATOR; TRANSCRIPTION FACTOR; HISTONE ACETYLATION	Helper T cell differentiation involves silencing as well as activation of gene expression. We have identified a conserved silencer of the gene encoding interleukin 4 (Il4) marked by DNase I hypersensitivity (HS IV) and permissive chromatin structure in all helper T cells. Deletion of HS IV increased Il4 and Il13 transcription by naive T cells and led to T helper type 2 skewing in vitro. HS IV controlled Il4 silencing during T helper type 1 differentiation, as HS IV-deficient T helper type 1 cells that expressed interferon-gamma also produced abundant interleukin 4 in vitro and in vivo. Despite mounting a vigorous interferon-gamma response, HS IV-deficient mice were more susceptible to Leishmania major infection than were wild-type littermate control mice, showing a critical function for Il4 silencing in T helper type 1-mediated immunity.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Milan, Div Biotechnol Appl Med Sci, I-20133 Milan, Italy; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Milan; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Monticelli, Silvia/ABE-7054-2020	Monticelli, Silvia/0000-0002-5909-8802	NHLBI NIH HHS [HL67664] Funding Source: Medline; NIAID NIH HHS [AI35714, AI38310, AI44432, AI20047] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067664, P50HL067664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038310, R37AI020047, R01AI038310, R01AI044432, P01AI035714, R01AI020047] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Brown JA, 2002, EUR J IMMUNOL, V32, P1764, DOI 10.1002/1521-4141(200206)32:6<1764::AID-IMMU1764>3.0.CO;2-V; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Feng Q, 2001, GENE DEV, V15, P827; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; LEE DU, IN PRESS P NATL ACAD; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Satoskar A, 1997, J INFECT DIS, V176, P1649, DOI 10.1086/517348; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	50	96	98	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1251	1259		10.1038/ni1135	http://dx.doi.org/10.1038/ni1135			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15516924				2022-12-18	WOS:000225353500014
J	McGavern, DB; Christen, U; Oldstone, MBA				McGavern, DB; Christen, U; Oldstone, MBA			Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TIME-LAPSE MICROCINEMATOGRAPHY; MEDIATED CYTOTOXICITY; IMMUNOLOGICAL SYNAPSE; TARGET-CELLS; MICE; COMPLEX; ACTIVATION; INFECTION; RECEPTOR	Antigen-specific CD8(+) T cells are required for the clearance of most viral infections and several cancers. However, it is not clear in vivo whether CD8(+) T cells can engage multiple targets simultaneously, engagement results in the formation of an immunologic synapse or molecules involved in CD8 function are redistributed to the synapse. We used here high-resolution microscopy to visualize interactions between virus-specific effectors and target cells in vivo. Using either in situ tetramer staining or green fluorescent protein-labeled virus-specific T cells, we have shown that a single CD8(+) T cell can engage two or three targets, a synapse occurs at the site of engagement and molecules involved in attachment (lymphocyte function-associated antigen 1), signaling (Lck) and lytic activity (perforin) are differentially positioned on the T cell. In addition, we have established an in vivo approach for assessing the intricacies of antigen-specific T cell activation, migration, engagement, memory and other defining elements of adaptive immunity.	Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA	Scripps Research Institute	McGavern, DB (corresponding author), Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA.	mcgad@scripps.edu	McGavern, Dorian/HCH-3601-2022; Christen, Urs/A-7338-2009	McGavern, Dorian/0000-0001-9568-545X; Christen, Urs/0000-0003-4165-7976	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009484, R37AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000080] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI009484-32, R01 AI009484, AI09484] Funding Source: Medline; NIA NIH HHS [AG00080, T32 AG000080] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLAN JE, 1987, CURR TOP MICROBIOL, V134, P131; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Gallimore A, 1998, EUR J IMMUNOL, V28, P3301, DOI 10.1002/(SICI)1521-4141(199810)28:10<3301::AID-IMMU3301>3.0.CO;2-Q; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; HAHN K, 1994, VIROLOGY, V201, P330, DOI 10.1006/viro.1994.1298; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; SANDERSON CJ, 1976, PROC R SOC SER B-BIO, V192, P241, DOI 10.1098/rspb.1976.0011; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; YANNELLI JR, 1986, J IMMUNOL, V136, P377; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	35	96	100	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					918	925		10.1038/ni843	http://dx.doi.org/10.1038/ni843			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352968	Green Accepted			2022-12-18	WOS:000178242100011
J	Lin, HY; Jiang, MH; Liu, L; Yang, ZH; Ma, ZF; Liu, S; Ma, YW; Zhang, LF; Cao, XT				Lin, Hongyu; Jiang, Minghong; Liu, Lun; Yang, Zongheng; Ma, Zhongfei; Liu, Shuo; Ma, Yuanwu; Zhang, Lianfeng; Cao, Xuetao			The long noncoding RNA Lnczc3h7a promotes a TRIM25-mediated RIG-I antiviral innate immune response	NATURE IMMUNOLOGY			English	Article							STRUCTURAL BASIS; PROTEIN; OLIGOMERIZATION; RECOGNITION; ACTIVATION; SENSORS; LIGASE; TRIM25	The helicase RIG-I initiates an antiviral immune response after recognition of pathogenic RNA. TRIM25, an E3 ubiquitin ligase, mediates K63-linked ubiquitination of RIG-I, which is crucial for RIG-I downstream signaling and the antiviral innate immune response. The components and mode of the RIG-I-initiated innate signaling remain to be fully understood. Here we identify a novel long noncoding RNA (Lnczc3h7a) that binds to TRIM25 and promotes RIG-I-mediated antiviral innate immune responses. Depletion of Lnczc3h7a impairs RIG-I signaling and the antiviral innate response to RNA viruses in vitro and in vivo. Mechanistically, Lnczc3h7a binds to both TRIM25 and activated RIG-I, serving as a molecular scaffold for stabilization of the RIG-I-TRIM25 complex at the early stage of viral infection. Lnczc3h7a facilitates TRIM25-mediated K63-linked ubiquitination of RIG-I and thus promotes downstream signaling transduction. Our findings reveal that host RNAs can enhance the response of innate immune sensors to foreign RNAs, ensuring effective antiviral defense.	[Lin, Hongyu; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou, Zhejiang, Peoples R China; [Lin, Hongyu; Jiang, Minghong; Liu, Lun; Yang, Zongheng; Ma, Zhongfei; Liu, Shuo; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Lin, Hongyu; Jiang, Minghong; Liu, Lun; Yang, Zongheng; Ma, Zhongfei; Liu, Shuo; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Chinese Acad Med Sci, Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Peking Union Medical College; Naval Medical University; Naval Medical University; Nankai University	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	caoxt@immunol.org		Ma, Yuanwu/0000-0002-1882-1777	National Natural Science Foundation of China [81788101, 31390431, 81871236]; National 135 Mega Program of China [2017ZX10102032-001, 2017ZX10202203-002]; National Key Research and Development Program of China [2018YFA0507403]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 135 Mega Program of China; National Key Research and Development Program of China; CAMS Innovation Fund for Medical Sciences	This work is supported by grants from the National Natural Science Foundation of China (81788101, 31390431 and 81871236), National 135 Mega Program of China (2017ZX10102032-001, 2017ZX10202203-002), National Key Research and Development Program of China (2018YFA0507403) and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chen YG, 2017, NAT IMMUNOL, V18, P962, DOI 10.1038/ni.3771; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Choudhury NR, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0444-9; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Jiang MH, 2018, CELL, V173, P906, DOI 10.1016/j.cell.2018.03.064; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Koliopoulos MG, 2016, EMBO J, V35, P1204, DOI 10.15252/embj.201593741; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu BY, 2017, NAT IMMUNOL, V18, P499, DOI 10.1038/ni.3712; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu S, 2018, NAT IMMUNOL, V19, P41, DOI 10.1038/s41590-017-0003-0; Louber J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0166-9; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Pauli EK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004577; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Sanchez JG, 2018, J MOL BIOL, V430, P5280, DOI 10.1016/j.jmb.2018.10.003; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang WD, 2016, P NATL ACAD SCI USA, V113, P9581, DOI 10.1073/pnas.1604277113; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang Y, 2016, CELL MOL IMMUNOL, V13, P138, DOI 10.1038/cmi.2015.68; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao K, 2016, J IMMUNOL, V196, P1209, DOI 10.4049/jimmunol.1501224	46	95	105	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					812	+		10.1038/s41590-019-0379-0	http://dx.doi.org/10.1038/s41590-019-0379-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31036902				2022-12-18	WOS:000471891900013
J	Ugolini, M; Gerhard, J; Burkert, S; Jensen, KJ; Georg, P; Ebner, F; Volkers, SM; Thada, S; Dietert, K; Bauer, L; Schafer, A; Helbig, ET; Opitz, B; Kurth, F; Sur, S; Dittrich, N; Gaddam, S; Conrad, ML; Benn, CS; Blohm, U; Gruber, AD; Hutloff, A; Hartmann, S; Boekschoten, MV; Muller, M; Jungersen, G; Schumann, RR; Suttorp, N; Sander, LE				Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Jensen, Kristoffer Jarlov; Georg, Philipp; Ebner, Friederike; Volkers, Sarah M.; Thada, Shruthi; Dietert, Kristina; Bauer, Laura; Schafer, Alexander; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Gaddam, Sumanlatha; Conrad, Melanie L.; Benn, Christine S.; Blohm, Ulrike; Gruber, Achim D.; Hutloff, Andreas; Hartmann, Susanne; Boekschoten, Mark V.; Muller, Michael; Jungersen, Gregers; Schumann, Ralf R.; Suttorp, Norbert; Sander, Leif E.			Recognition of microbial viability via TLR8 drives T-FH cell differentiation and vaccine responses	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELLS; CXC CHEMOKINE RECEPTOR-5; HUMAN DENDRITIC CELLS; INNATE IMMUNE-SYSTEM; B-CELLS; RNA; DEFICIENCY; TOLL-LIKE-RECEPTOR-8; TUBERCULOSIS; PERSPECTIVE	Live attenuated vaccines are generally highly efficacious and often superior to inactivated vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify recognition of microbial viability as a potent stimulus for follicular helper T cell (T-FH cell) differentiation and vaccine responses. Antigen-presenting cells (APCs) distinguished viable bacteria from dead bacteria through Toll-like receptor 8 (TLR8)-dependent detection of bacterial RNA. In contrast to dead bacteria and other TLR ligands, live bacteria, bacterial RNA and synthetic TLR8 agonists induced a specific cytokine profile in human and porcine APCs, thereby promoting T-FH cell differentiation. In domestic pigs, immunization with a live bacterial vaccine induced robust T-FH cell and antibody responses, but immunization with its heat-killed counterpart did not. Finally, a hypermorphic TLR8 polymorphism was associated with protective immunity elicited by vaccination with bacillus Calmette-Gudrin (BCG) in a human cohort. We have thus identified TLR8 as an important driver of T-FH cell differentiation and a promising target for T-FH cell-skewing vaccine adjuvants.	[Ugolini, Matteo; Gerhard, Jenny; Georg, Philipp; Volkers, Sarah M.; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Suttorp, Norbert; Sander, Leif E.] Charite, Dept Infect Dis & Pulm Med, Berlin, Germany; [Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Georg, Philipp; Volkers, Sarah M.; Thada, Shruthi; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Conrad, Melanie L.; Schumann, Ralf R.; Suttorp, Norbert; Sander, Leif E.] Free Univ Berlin, Berlin, Germany; [Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Georg, Philipp; Volkers, Sarah M.; Thada, Shruthi; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Conrad, Melanie L.; Schumann, Ralf R.; Suttorp, Norbert; Sander, Leif E.] Humboldt Univ, Berlin, Germany; [Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Georg, Philipp; Volkers, Sarah M.; Thada, Shruthi; Helbig, Elisa T.; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Conrad, Melanie L.; Schumann, Ralf R.; Suttorp, Norbert; Sander, Leif E.] Berlin Inst Hlth, Berlin, Germany; [Burkert, Sanne; Thada, Shruthi; Sur, Saubashya; Dittrich, Nickel; Schumann, Ralf R.] Charite, Inst Microbiol & Hyg, Berlin, Germany; [Jensen, Kristoffer Jarlov; Benn, Christine S.] Statens Serum Inst, Res Ctr Vitamins & Vaccines, Bandim Hlth Project, Copenhagen, Denmark; [Jensen, Kristoffer Jarlov; Jungersen, Gregers] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Ebner, Friederike; Hartmann, Susanne] Free Univ Berlin, Inst Immunol, Dept Vet Med, Berlin, Germany; [Thada, Shruthi; Gaddam, Sumanlatha] Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Prades, India; [Dietert, Kristina; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Dept Vet Med, Berlin, Germany; [Bauer, Laura; Hutloff, Andreas] German Rheumatism Res Ctr, Chron Immune React, Berlin, Germany; [Schafer, Alexander; Blohm, Ulrike] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, Greifswald, Germany; [Suttorp, Norbert; Sander, Leif E.] German Ctr Lung Res DZL, Berlin, Germany; [Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad, Andhra Prades, India; [Conrad, Melanie L.] Charite, Div Psychosomat Med, Dept Internal Med & Dermatol, Berlin, Germany; [Benn, Christine S.] Univ Southern Denmark, Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, Dept Clin Res, Odense, Denmark; [Boekschoten, Mark V.; Muller, Michael] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, Wageningen, Netherlands; [Muller, Michael] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Statens Serum Institut; Technical University of Denmark; Free University of Berlin; Free University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Friedrich Loeffler Institute; Osmania University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southern Denmark; Odense University Hospital; Wageningen University & Research; University of East Anglia	Sander, LE (corresponding author), Charite, Dept Infect Dis & Pulm Med, Berlin, Germany.; Sander, LE (corresponding author), Free Univ Berlin, Berlin, Germany.; Sander, LE (corresponding author), Humboldt Univ, Berlin, Germany.; Sander, LE (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Sander, LE (corresponding author), German Ctr Lung Res DZL, Berlin, Germany.	leif-erik.sander@charite.de	Bauer, Laura/AFR-7236-2022; Schäfer, Alexander/M-5897-2019; Conrad, Melanie/AAH-8431-2019; Gruber, Achim D./ABA-4514-2021; Schäfer, Alexander/I-8853-2018; Muller, Michael/M-5724-2019; Hutloff, Andreas/D-1781-2014; Muller, Michael/B-5795-2008; Jungersen, Gregers/C-3940-2011; Blohm, Ulrike/AAW-1851-2020; Sander, Leif Erik/AAI-8619-2020; Boekschoten, Mark/AAS-4597-2021; Ebner, Friederike/AAX-9789-2021; Jungersen, Gregers/P-9767-2019; Kurth, Florian/H-7427-2012	Bauer, Laura/0000-0002-1435-8121; Schäfer, Alexander/0000-0002-4258-0651; Schäfer, Alexander/0000-0002-4258-0651; Muller, Michael/0000-0002-5930-9905; Hutloff, Andreas/0000-0002-0572-8151; Muller, Michael/0000-0002-5930-9905; Jungersen, Gregers/0000-0003-3147-6960; Blohm, Ulrike/0000-0003-4597-248X; Boekschoten, Mark/0000-0002-2139-0795; Jungersen, Gregers/0000-0003-3147-6960; Kurth, Florian/0000-0002-3807-473X; Ebner, Friederike/0000-0002-3485-4077; Jensen, Kristoffer Jarlov/0000-0001-9687-5706; Sander, Leif Erik/0000-0002-0476-9947; Helbig, Elisa Theresa/0000-0003-4276-7974; Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X; Conrad, Melanie Lynn/0000-0002-8811-5536; Volkers, Sarah Maria/0000-0003-0354-5252; Dietert, Kristina/0000-0002-5667-6750				Barbet G., IMMUNITY IN PRESS; Barquet N, 1997, ANN INTERN MED, V127, P635, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00010; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; De Gregorio E, 2014, NAT REV IMMUNOL, V14, P505, DOI 10.1038/nri3694; Dittrich N, 2015, TUBERCULOSIS, V95, P328, DOI 10.1016/j.tube.2015.02.045; Dowling DJ, 2017, J ALLERGY CLIN IMMUN, V140, P1339, DOI 10.1016/j.jaci.2016.12.985; Dowling DJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91020; Eigenbrod T, 2015, J IMMUNOL, V195, P1092, DOI 10.4049/jimmunol.1403173; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Irizarry R. A., 2017, BIOSTATISTICS, V4; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jones SC, 2010, J IMMUNOL, V185, P6783, DOI 10.4049/jimmunol.0901296; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Plotkin SA, 2011, NAT REV MICROBIOL, V9, P889, DOI 10.1038/nrmicro2668; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; RAUH LW, 1965, AM J DIS CHILD, V109, P232, DOI 10.1001/archpedi.1965.02090020234007; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Sinkora M, 2013, DEV COMP IMMUNOL, V39, P409, DOI 10.1016/j.dci.2012.10.010; Springer S, 2001, BERL MUNCH TIERARZTL, V114, P342; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026235; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Zhu JZ, 2008, MOL IMMUNOL, V45, P3238, DOI 10.1016/j.molimm.2008.02.028	55	95	97	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					386	+		10.1038/s41590-018-0068-4	http://dx.doi.org/10.1038/s41590-018-0068-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29556002	Green Accepted, Green Submitted			2022-12-18	WOS:000428151000018
J	Wang, J; Li, BX; Ge, PP; Li, J; Wang, Q; Gao, GF; Qiu, XB; Liu, CH				Wang, Jing; Li, Bing-Xi; Ge, Pu-Pu; Li, Jie; Wang, Qi; Gao, George Fu; Qiu, Xiao-Bo; Liu, Cui Hua			Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TYROSINE-PHOSPHATASE PTPA; POLYUBIQUITIN CHAINS; MACROPHAGES; EXPRESSION; INFECTION; PATHOGENESIS; APOPTOSIS; VIRULENCE; PROTEINS	Mycobacterium tuberculosis PtpA, a secreted tyrosine phosphatase essential for tuberculosis pathogenicity, could be an ideal target for a drug against tuberculosis, but its active-site inhibitors lack selectivity over human phosphatases. Here we found that PtpA suppressed innate immunity dependent on pathways of the kinases Jnk and p38 and the transcription factor NF-kappa B by exploiting host ubiquitin. Binding of PtpA to ubiquitin via a region with no homology to human proteins activated it to dephosphorylate phosphorylated Jnk and p38, leading to suppression of innate immunity. Furthermore, the host adaptor TAB3 mediated NF-kappa B signaling by sensing ubiquitin chains, and PtpA blocked this process by competitively binding the ubiquitin-interacting domain of TAB3. Our findings reveal how pathogens subvert innate immunity by coopting host ubiquitin and suggest a potential tuberculosis treatment via targeting of ubiquitin-PtpA interfaces.	[Wang, Jing; Li, Bing-Xi; Ge, Pu-Pu; Li, Jie; Wang, Qi; Gao, George Fu; Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Qiu, Xiao-Bo] Beijing Normal Univ, Dept Cell Biol, Coll Life Sci, Minist Educ,Key Lab Cell Proliferat & Regulat Bio, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Beijing Normal University	Liu, CH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn; xqiu@bnu.edu.cn; liucuihua@im.ac.cn	Gao, George Fu/ABD-5229-2021	Qiu, Xiao-Bo/0000-0003-2608-9376	National Basic Research Programs of China [2012CB518700, 2014CB744400, 2012CB910300]; National Natural Science Foundation of China [81371769, 91319303]; Ministry of Health and the Ministry of Science and Technology of China [2013ZX10003006]; Chinese Academy of Sciences [KJZD-EW-L02]	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health and the Ministry of Science and Technology of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank J. Han (Xiamen University), W.R. Jacobs (Albert Einstein College of Medicine) and F. Shao (National Institute of Biological Sciences, Beijing, China) for plasmids. Supported by the National Basic Research Programs of China (2012CB518700, 2014CB744400 and 2012CB910300), National Natural Science Foundation of China (81371769 and 91319303), the Ministry of Health and the Ministry of Science and Technology of China (2013ZX10003006) and the Chinese Academy of Sciences (KJZD-EW-L02).	[Anonymous], 2013, 2013 WHO; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2006, INFECT IMMUN, V74, P6540, DOI 10.1128/IAI.01106-06; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; Bordon J, 2011, CYTOKINE, V56, P325, DOI 10.1016/j.cyto.2011.08.018; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Cho JE, 2012, BMB REP, V45, P583, DOI 10.5483/BMBRep.2012.45.10.120; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Cowley SC, 2002, RES MICROBIOL, V153, P233, DOI 10.1016/S0923-2508(02)01309-8; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Fischer EH, 2013, BIOCHEM BIOPH RES CO, V430, P865, DOI 10.1016/j.bbrc.2012.10.024; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Harlow E LD, 1988, ANTIBODIES LAB MANUA; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Liu X, 2013, CYTOKINE GROWTH F R, V24, P559, DOI 10.1016/j.cytogfr.2013.07.002; Mascarello A, 2010, BIOORGAN MED CHEM, V18, P3783, DOI 10.1016/j.bmc.2010.04.051; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Welin A, 2011, J INNATE IMMUN, V3, P508, DOI 10.1159/000325297; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu GH, 2014, PROTEIN CELL, V5, P728, DOI 10.1007/s13238-014-0077-5; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	43	95	107	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					237	U189		10.1038/ni.3096	http://dx.doi.org/10.1038/ni.3096			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25642820				2022-12-18	WOS:000349842100007
J	Patel, O; Pellicci, DG; Gras, S; Sandoval-Romero, ML; Uldrich, AP; Mallevaey, T; Clarke, AJ; Le Nours, J; Theodossis, A; Cardell, SL; Gapin, L; Godfrey, DI; Rossjohn, J				Patel, Onisha; Pellicci, Daniel G.; Gras, Stephanie; Sandoval-Romero, Maria L.; Uldrich, Adam P.; Mallevaey, Thierry; Clarke, Andrew J.; Le Nours, Jerome; Theodossis, Alex; Cardell, Susanna L.; Gapin, Laurent; Godfrey, Dale I.; Rossjohn, Jamie			Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor	NATURE IMMUNOLOGY			English	Article							STRUCTURAL BASIS; NKT CELLS; CUTTING EDGE; CD1D; BINDING; GLYCOLIPIDS; POPULATION; REPERTOIRE; SELECTION; DISTINCT	Natural killer T cells (NKT cells) are divided into type I and type II subsets on the basis of differences in their T cell antigen receptor (TCR) repertoire and CD1d-antigen specificity. Although the mode by which type I NKT cell TCRs recognize CD1d-antigen has been established, how type II NKT cell TCRs engage CD1d-antigen is unknown. Here we provide a basis for how a type II NKT cell TCR, XV19, recognized CD1d-sulfatide. The XV19 TCR bound orthogonally above the A' pocket of CD1d, in contrast to the parallel docking of type I NKT cell TCRs over the F' pocket of CD1d. At the XV19 TCR-CD1d-sulfatide interface, the TCR alpha and TCR beta chains sat centrally on CD1d, where the malleable CDR3 loops dominated interactions with CD1d-sulfatide. Accordingly, we highlight the diverse mechanisms by which NKT cell TCRs can bind CD1d and account for the distinct antigen specificity of type II NKT cells.	[Patel, Onisha; Gras, Stephanie; Sandoval-Romero, Maria L.; Clarke, Andrew J.; Le Nours, Jerome; Theodossis, Alex; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Mallevaey, Thierry; Gapin, Laurent] Univ Colorado Denver, Dept Immunol, Denver, CO USA; [Mallevaey, Thierry; Gapin, Laurent] Natl Jewish Hlth, Denver, CO USA; [Cardell, Susanna L.] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Pellicci, Daniel G.; Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Monash University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Gothenburg; Cardiff University; University of Melbourne	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Uldrich, Adam/AAX-3785-2020; Cardell, Susanna/ABC-4944-2021; Mallevaey, Thierry/AAH-4499-2020; gras, stephanie/C-8307-2013; Rossjohn, Jamie/F-9032-2013; Pellicci, Daniel/AAX-8539-2020	Rossjohn, Jamie/0000-0002-2020-7522; gras, stephanie/0000-0001-7416-038X; Patel, Onisha/0000-0001-6701-7139; Le Nours, Jerome/0000-0002-2221-7636; Godfrey, Dale/0000-0002-3009-5472; ULDRICH, ADAM/0000-0002-6350-5976; Pellicci, Daniel/0000-0001-5305-2398	National Health and Medical Research Council of Australia; Australian Research Council; Cancer Council of Victoria; US National Institutes of Health [AI090450, AI092108]; Swedish Research Council; Swedish Cancer Society; Monash University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090450, R01AI092108] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Monash University(Monash University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection and Monash Macromolecular Crystallisation Facility for crystallization experiments. Supported by the National Health and Medical Research Council of Australia (D.I.G. and J.R.), the Australian Research Council, the Cancer Council of Victoria, the US National Institutes of Health (AI090450 and AI092108 to L.G.), the Swedish Research Council (S.L.C.), the Swedish Cancer Society (S.L.C.) and Monash University (S.C. and J.R.).	Adams EJ, 2011, IMMUNITY, V34, P281, DOI 10.1016/j.immuni.2011.03.006; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Monzon-Casanova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013089; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Patel O, 2011, P NATL ACAD SCI USA, V108, P19007, DOI 10.1073/pnas.1109066108; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	46	95	98	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					857	863		10.1038/ni.2372	http://dx.doi.org/10.1038/ni.2372			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22820603				2022-12-18	WOS:000307863600014
J	Yabas, M; Teh, CE; Frankenreiter, S; Lal, D; Roots, CM; Whittle, B; Andrews, DT; Zhang, YF; Teoh, NC; Sprent, J; Tze, LE; Kucharska, EM; Kofler, J; Farell, GC; Broer, S; Goodnow, CC; Enders, A				Yabas, Mehmet; Teh, Charis E.; Frankenreiter, Sandra; Lal, Dennis; Roots, Carla M.; Whittle, Belinda; Andrews, Daniel T.; Zhang, Yafei; Teoh, Narci C.; Sprent, Jonathan; Tze, Lina E.; Kucharska, Edyta M.; Kofler, Jennifer; Farell, Geoffrey C.; Broeer, Stefan; Goodnow, Christopher C.; Enders, Anselm			ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes	NATURE IMMUNOLOGY			English	Article							CELL-RECEPTOR ACTIVATION; ANNEXIN-V BINDS; P-TYPE ATPASES; PRO-B; LIPID RAFTS; IL-7; EXPRESSION; TRANSITION; SURVIVAL; MICE	Subcompartments of the plasma membrane are believed to be critical for lymphocyte responses, but few genetic tools are available to test their function. Here we describe a previously unknown X-linked B cell-deficiency syndrome in mice caused by mutations in Atp11c, which encodes a member of the P4 ATPase family thought to serve as 'flippases' that concentrate aminophospholipids in the cytoplasmic leaflet of cell membranes. Defective ATP11C resulted in a lower rate of phosphatidylserine translocation in pro-B cells and much lower pre-B cell and B cell numbers despite expression of pre-rearranged immunoglobulin transgenes or enforced expression of the prosurvival protein Bcl-2 to prevent apoptosis and abolished pre-B cell population expansion in response to a transgene encoding interleukin 7. The only other abnormalities we noted were anemia, hyperbilirubinemia and hepatocellular carcinoma. Our results identify an intimate connection between phospholipid transport and B lymphocyte function.	[Yabas, Mehmet; Teh, Charis E.; Frankenreiter, Sandra; Lal, Dennis; Kucharska, Edyta M.; Goodnow, Christopher C.; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Ramaciotti Immunizat Genom Lab, Canberra, ACT 2601, Australia; [Whittle, Belinda; Zhang, Yafei] Australian Natl Univ, John Curtin Sch Med Res, Australian Phen Facil, Canberra, ACT 2601, Australia; [Teoh, Narci C.; Farell, Geoffrey C.] Australian Natl Univ, Sch Med, Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia; [Sprent, Jonathan] St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Sprent, Jonathan] Pohang Univ Sci & Technol, World Class Univ Integrat Biosci & Biotechnol Pro, Pohang, South Korea; [Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Pohang University of Science & Technology (POSTECH); Australian National University	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Ramaciotti Immunizat Genom Lab, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au; anselm.enders@anu.edu.au	Enders, Anselm/B-1165-2011; Goodnow, Christopher C/V-8108-2018; Andrews, Dan/ABG-4815-2020; Yabas, Mehmet/D-9513-2012; Broer, Stefan/A-1286-2008	Enders, Anselm/0000-0001-5933-6463; Goodnow, Christopher C/0000-0001-5296-6155; Yabas, Mehmet/0000-0002-3462-5389; Broer, Stefan/0000-0002-8040-1634; Andrews, Dan/0000-0003-3922-6376	National Institutes of Health; Wellcome Trust; Australian Research Council; National Health and Medical Research Council; Ramaciotti Foundation; Ministry of National Education, Republic of Turkey; Deutsche Forschungsgemeinschaft [EN 790/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti Foundation; Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff of the Australian National University Bioscience Research Services for animal husbandry; the Australian Phenomics Facility genotyping and mapping team for genetic analysis; D. Howard for help with the bone marrow chimeras; A. Broer for help with the flippase assay; staff of the John Curtin School of Medical Research microscopy and flow cytometry resource facility for help with flow cytometry; the Biomolecular Resource Facility of the Australian Cancer Research Foundation and the Australian Genome Research Facility for DNA sequencing; and K. Peng (Biomolecular Resource Facility of the Australian Cancer Research Foundation), John Curtin School of Medical Research and the Australian Genome Research Facility Next Generation Sequencing and Bioinformatics teams, Brisbane, for preparing and running samples in parallel for next-generation sequencing. Supported by the National Institutes of Health (C. C. G.), Wellcome Trust (C. C. G.), the Australian Research Council (C. C. G.), the National Health and Medical Research Council (C. C. G.), the Ramaciotti Foundation (C. C. G. and A. E.), the Ministry of National Education, Republic of Turkey (M.Y.) and Deutsche Forschungsgemeinschaft (EN 790/1-1 to A. E.).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dillon SR, 2001, J IMMUNOL, V166, P58, DOI 10.4049/jimmunol.166.1.58; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Holder MJ, 2006, LEUKEMIA RES, V30, P77, DOI 10.1016/j.leukres.2005.05.018; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Mertsching E, 1996, EUR J IMMUNOL, V26, P28, DOI 10.1002/eji.1830260105; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Paulusma CC, 2010, FEBS LETT, V584, P2708, DOI 10.1016/j.febslet.2010.04.071; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Rose T, 2010, J BIOL CHEM, V285, P14898, DOI 10.1074/jbc.M110.104232; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, BIOCHEM J, V431, P1, DOI 10.1042/BJ20100644; Wei CJ, 2000, J IMMUNOL, V164, P1961, DOI 10.4049/jimmunol.164.4.1961; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	50	95	99	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					441	U100		10.1038/ni.2011	http://dx.doi.org/10.1038/ni.2011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21423173	Green Accepted			2022-12-18	WOS:000289666600015
J	Fu, G; Vallee, S; Rybakin, V; McGuire, MV; Ampudia, J; Brockmeyer, C; Salek, M; Fallen, PR; Hoerter, JAH; Munshi, A; Huang, YH; Hu, JF; Fox, HS; Sauer, K; Acuto, O; Gascoigne, NRJ				Fu, Guo; Vallee, Sebastien; Rybakin, Vasily; McGuire, Marielena V.; Ampudia, Jeanette; Brockmeyer, Claudia; Salek, Mogjiborahman; Fallen, Paul R.; Hoerter, John A. H.; Munshi, Anil; Huang, Yina H.; Hu, Jianfang; Fox, Howard S.; Sauer, Karsten; Acuto, Oreste; Gascoigne, Nicholas R. J.			Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling	NATURE IMMUNOLOGY			English	Article							THYMIC POSITIVE SELECTION; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; NEGATIVE SELECTION; ALLELIC EXCLUSION; FAMILY KINASES; IMMUNE-SYSTEM; IN-VIVO; ACTIVATION; DIFFERENTIATION	Themis (thymocyte-expressed molecule involved in selection), a member of a family of proteins with unknown functions, is highly conserved among vertebrates. Here we found that Themis had high expression in thymocytes between the pre-T cell antigen receptor (pre-TCR) and positive-selection checkpoints and low expression in mature T cells. Themis-deficient thymocytes showed defective positive selection, which resulted in fewer mature thymocytes. Negative selection was also impaired in Themis-deficient mice. A greater percentage of Themis-deficient T cells had CD4(+)CD25(+)Foxp3(+) regulatory and CD62L(lo)CD44(hi) memory phenotypes than did wild-type T cells. In support of the idea that Themis is involved in TCR signaling, this protein was phosphorylated quickly after TCR stimulation and was needed for optimal TCR-driven calcium mobilization and activation of the kinase Erk.	[Fu, Guo; Vallee, Sebastien; Rybakin, Vasily; McGuire, Marielena V.; Ampudia, Jeanette; Fallen, Paul R.; Hoerter, John A. H.; Munshi, Anil; Huang, Yina H.; Hu, Jianfang; Sauer, Karsten; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Brockmeyer, Claudia; Salek, Mogjiborahman; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, T Cell Signalling Lab, Oxford OX1 3RE, England; [Fox, Howard S.] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute; University of Oxford; Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	gascoigne@scripps.edu	Rybakin, Vasily/J-6310-2019	Rybakin, Vasily/0000-0002-5093-1757; Salek, Mogjiborahman/0000-0002-6664-4752; Fox, Howard/0000-0003-2032-374X; Huang, Yina/0000-0002-0125-9351	US National Institutes of Health [GM048002, AI073870, T32 AI07244]; American Chemical Society; Wellcome Trust [GR076558MA]; Sir William Dunn School of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073870, T32AI007244, R01AI073870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048002] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Wellcome Trust(Wellcome TrustEuropean Commission); Sir William Dunn School of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bradley, A. Field, Y. Mondal, S. Rose, W. Sakati, V. Sharma, J. Shepherd and J. Vasquez for technical help. Supported by the US National Institutes of Health (GM048002 and AI073870 to N. R. J. G. and T32 AI07244 to M. V. M. and J. A. H. H.), the Concern Foundation for Cancer Research (S. V.), American Chemical Society (Irving S. Sigal Fellowship to J. A. H. H.), the Wellcome Trust (GR076558MA to O. A., C. B. and M. S.), the Sir William Dunn School of Pathology (O. A., C. B. and M. S.) and Lincoln College, Oxford (Sloane Robinson Graduate Award to C. B.). This is manuscript 19524 from The Scripps Research Institute.	Alam SM, 1998, J IMMUNOL, V160, P3883; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; IRWIN MJ, 1993, J LEUKOCYTE BIOL, V54, P495, DOI 10.1002/jlb.54.5.495; JOHNSON AL, 2009, NAT IMMUNOL     0713, DOI DOI 10.1038/NI1769; Kane LP, 1996, J IMMUNOL, V156, P4594; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; LESOURNE R, 2009, NAT IMMUNOL     0713, DOI DOI 10.1038/NI1768; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Malissen Bernard, 1995, P352; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McGuire MV, 2001, MAMM GENOME, V12, P664, DOI 10.1007/s003350020036; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Niederberger N, 2003, J IMMUNOL, V170, P4557, DOI 10.4049/jimmunol.170.9.4557; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Treeck O, 1998, FEBS LETT, V425, P426, DOI 10.1016/S0014-5793(98)00278-6; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	47	95	101	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					848	U71		10.1038/ni.1766	http://dx.doi.org/10.1038/ni.1766			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19597499	Green Accepted			2022-12-18	WOS:000268141400013
J	Bronstein-Sitton, N; Cohen-Daniel, L; Vaknin, I; Ezernitchi, AV; Leshem, B; Halabi, A; Houri-Hadad, Y; Greenbaum, E; Zakay-Rones, Z; Shapira, L; Baniyash, M				Bronstein-Sitton, N; Cohen-Daniel, L; Vaknin, I; Ezernitchi, AV; Leshem, B; Halabi, A; Houri-Hadad, Y; Greenbaum, E; Zakay-Rones, Z; Shapira, L; Baniyash, M			Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor down-regulation and impaired T cell function	NATURE IMMUNOLOGY			English	Article							TUMOR-BEARING MICE; NATURAL-KILLER-CELLS; SIGNAL-TRANSDUCTION MOLECULES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; ZETA-CHAIN; PORPHYROMONAS-GINGIVALIS; DECREASED EXPRESSION; HYDROGEN-PEROXIDE; CANCER-PATIENTS	T cell antigen receptor zeta chain down-regulation and impaired in vitro T cell function have been described in cancer and autoimmune and infectious diseases. However, the immunological basis for this phenomenon is unknown. Sustained exposure to antigen and chronic systemic inflammation, factors shared by the various pathologies, might account for this phenomenon. We developed an in vivo experimental system that mimics these conditions and show that sustained exposure of mice to bacterial antigens was sufficient to induce T cell antigen receptor zeta chain down-regulation and impair T cell function, provided an interferon-gamma-dependent T helper type 1 immune response developed. This indicates zeta chain down-regulation could be a physiological response that attenuates an exacerbated immune response. However, it can act as a 'double-edged sword', impairing immune responses to chronic diseases.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Fac Dent Med, Dept Periodontol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Baniyash, M (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel.		Shapira, Lior/AAJ-9130-2020	Shapira, Lior/0000-0001-9145-5155; Baniyash, Michal/0000-0002-1579-3192				AbdulHai A, 1997, BONE MARROW TRANSPL, V19, P539, DOI 10.1038/sj.bmt.1700706; ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Bronstein-Sitton N, 1999, J BIOL CHEM, V274, P23659, DOI 10.1074/jbc.274.33.23659; Caplan S, 1996, J BIOL CHEM, V271, P20705, DOI 10.1074/jbc.271.34.20705; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; Correa MR, 1997, J IMMUNOL, V158, P5292; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; FINKE JH, 1993, CANCER RES, V53, P5613; FRANCO JL, 1995, CANCER RES, V55, P3840; Frolov I, 1998, IMMUNOLOGY, V93, P323; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; GENCO CA, 1994, METHOD ENZYMOL, V235, P120; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Harlow, 1999, USING ANTIBODIES LAB; Healy CG, 1998, CYTOMETRY, V32, P109, DOI 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G; Houri-Haddad Y, 2002, J DENT RES, V81, P395, DOI 10.1177/154405910208100608; Houri-Haddad Y, 2000, IMMUNOLOGY, V99, P215, DOI 10.1046/j.1365-2567.2000.00965.x; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KESAVALU L, 1992, INFECT IMMUN, V60, P1455, DOI 10.1128/IAI.60.4.1455-1464.1992; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kono K, 1996, CLIN CANCER RES, V2, P1825; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kurt RA, 1998, INT J CANCER, V78, P16, DOI 10.1002/(SICI)1097-0215(19980925)78:1<16::AID-IJC4>3.0.CO;2-#; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Kuss I, 1999, CLIN CANCER RES, V5, P329; Lai P, 1996, CLIN CANCER RES, V2, P161; Leshem B, 1998, IMMUNOLOGY, V95, P409; Leshem B, 1999, J IMMUNOL METHODS, V223, P249, DOI 10.1016/S0022-1759(98)00214-2; Liossis SNC, 1998, J CLIN INVEST, V101, P1448, DOI 10.1172/JCI1457; MATSUDA M, 1995, INT J CANCER, V61, P765, DOI 10.1002/ijc.2910610605; Maurice MM, 1997, J IMMUNOL, V159, P2973; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; NAKAGOMI H, 1993, CANCER RES, V53, P5610; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROZDZIAL MM, 1994, J IMMUNOL, V153, P1563; SAMELSON LE, 1986, J IMMUNOL, V137, P3254; Schmielau J, 2001, CANCER RES, V61, P4756; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WELLS MA, 1981, J IMMUNOL, V126, P1042; Zea AH, 1998, INFECT IMMUN, V66, P499, DOI 10.1128/IAI.66.2.499-504.1998	49	95	101	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					957	964		10.1038/ni975	http://dx.doi.org/10.1038/ni975			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14502285				2022-12-18	WOS:000185590100011
J	Wang, HY; Moon, EY; Azouz, A; Wu, X; Smith, A; Schneider, H; Hogg, N; Rudd, CE				Wang, HY; Moon, EY; Azouz, A; Wu, X; Smith, A; Schneider, H; Hogg, N; Rudd, CE			SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE KINASE; ADAPTER PROTEIN; MOLECULAR-CLONING; CUTTING EDGE; LIPID RAFTS; FYN; BINDING; ACTIVATION; SKAP55; SUBSTRATE	Src kinase-associated phosphoprotein of 55 kDa (SKAP-55; encoded by SCAP1) is a T cell adaptor protein of unknown function that contains a pleckstrin homology and an SH3 domain. Here we show that SKAP-55 regulates integrin-mediated adhesion and conjugate formation between T cells and antigen-presenting cells (APCs). SKAP-55 enhances adhesion to fibronectin and intercellular adhesion molecule-1 (ICAM-1), colocalizes with actin at the T cell-APC synapse and promotes the clustering of lymphocyte-associated antigen-1 (LFA-1). Enhanced conjugation is comparable to that induced by adhesion and degranulation-promoting adaptor protein (ADAP), a binding partner of SKAP-55, and is abrogated by deletion of the SKAP-55 SH3 domain. Conjugate formation is accompanied by the translocation of SKAP-55 to membrane rafts, an event that is regulated by both LFA-1 and T cell receptor ligation. Our findings identify a mechanism by which SKAP-55 modulates T cell responses to antigen.	Hammersmith Hosp, Imperial Coll London, Fac Med, Div Invest Sci,Dept Haematol, London W12 0NN, England; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Immunol & AIDS, Boston, MA 02115 USA; Canc Res UK, London Res Inst, London W2A3PX, England	Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cancer Research UK	Rudd, CE (corresponding author), Hammersmith Hosp, Imperial Coll London, Fac Med, Div Invest Sci,Dept Haematol, Du Cane Rd, London W12 0NN, England.	c.rudd@imperial.ac.uk	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019; Smith, Andrew/0000-0002-4691-5973				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cefai D, 1998, J IMMUNOL, V160, P2223; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; daSilva AJ, 1997, J IMMUNOL, V158, P2007; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; GENG L, 2001, BIOCHEM BIOPH RES CO, V289, P2042; Geng LP, 1999, J IMMUNOL, V163, P5753; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Harder T, 2001, ADV IMMUNOL, V77, P45, DOI 10.1016/S0065-2776(01)77014-9; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leitinger B, 2002, J CELL SCI, V115, P963; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Martin M, 2001, J EXP MED, V194, P1675, DOI 10.1084/jem.194.11.1675; Michel F, 1996, CELL IMMUNOL, V173, P165, DOI 10.1006/cimm.1996.0264; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; ROGERS W, 1996, J CELL BIOL, V135, P1515; Rossetti G, 2002, IMMUNOL REV, V186, P189, DOI 10.1034/j.1600-065X.2002.18616.x; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Samelson LE, 1999, PROG BIOPHYS MOL BIO, V71, P393, DOI 10.1016/S0079-6107(98)00050-9; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Tabassam F H, 1999, J Osaka Dent Univ, V33, P43; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Wu LT, 2002, MOL CELL BIOL, V22, P2673, DOI 10.1128/MCB.22.8.2673-2686.2002; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	50	95	103	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					366	374		10.1038/ni913	http://dx.doi.org/10.1038/ni913			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12652296				2022-12-18	WOS:000181987700017
J	Cella, M; Gamini, R; Secca, C; Collins, PL; Zhao, SR; Peng, V; Robinette, ML; Schettini, J; Zaitsev, K; Gordon, W; Bando, JK; Yomogida, K; Cortez, V; Fronick, C; Fulton, R; Lin, LL; Gilfillan, S; Flavell, RA; Shan, L; Artyomov, MN; Bowman, M; Oltz, EM; Jelinsky, SA; Colonna, M				Cella, Marina; Gamini, Ramya; Secca, Cristiane; Collins, Patrick L.; Zhao, Shanrong; Peng, Vincent; Robinette, Michelle L.; Schettini, Jorge; Zaitsev, Konstantin; Gordon, William; Bando, Jennifer K.; Yomogida, Kentaro; Cortez, Victor; Fronick, Catrina; Fulton, Robert; Lin, Lih-Ling; Gilfillan, Susan; Flavell, Richard A.; Shan, Liang; Artyomov, Maxim N.; Bowman, Michael; Oltz, Eugene M.; Jelinsky, Scott A.; Colonna, Marco			Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues	NATURE IMMUNOLOGY			English	Article							T-BET; PLASTICITY; AIOLOS; DIFFERENTIATION; IKAROS; HETEROGENEITY; PATHWAYS	Innate lymphoid cells (ILCs) are tissue-resident lymphocytes categorized on the basis of their core regulatory programs and the expression of signature cytokines. Human ILC3s that produce the cytokine interleukin-22 convert into ILC1-like cells that produce interferon-gamma in vitro, but whether this conversion occurs in vivo remains unclear. In the present study we found that ILC3s and ILC1s in human tonsils represented the ends of a spectrum that included additional discrete subsets. RNA velocity analysis identified an intermediate ILC3-ILC1 cluster, which had strong directionality toward ILC1s. In humanized mice, the acquisition of ILC1 features by ILC3s showed tissue dependency. Chromatin studies indicated that the transcription factors Aiolos and T-bet cooperated to repress regulatory elements active in ILC3s. A transitional ILC3-ILC1 population was also detected in the human intestine. We conclude that ILC3s undergo conversion into ILC1-like cells in human tissues in vivo, and that tissue factors and Aiolos were required for this process.	[Cella, Marina; Secca, Cristiane; Collins, Patrick L.; Peng, Vincent; Robinette, Michelle L.; Zaitsev, Konstantin; Bando, Jennifer K.; Yomogida, Kentaro; Cortez, Victor; Gilfillan, Susan; Artyomov, Maxim N.; Oltz, Eugene M.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Gamini, Ramya; Zhao, Shanrong; Schettini, Jorge; Gordon, William; Lin, Lih-Ling; Bowman, Michael; Jelinsky, Scott A.] Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA; [Fronick, Catrina; Fulton, Robert] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Shan, Liang] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Collins, Patrick L.; Oltz, Eugene M.] Ohio State Univ, Wexner Sch Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Robinette, Michelle L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg, Russia; [Gordon, William] Cogen Therapeut, Cambridge, MA USA; [Cortez, Victor] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lin, Lih-Ling; Bowman, Michael] Sanofi, Immunol & Inflammat, Cambridge, MA USA	Washington University (WUSTL); Pfizer; Washington University (WUSTL); Yale University; Howard Hughes Medical Institute; Yale University; Washington University (WUSTL); University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; ITMO University; University of California System; University of California San Francisco; Sanofi-Aventis	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Jelinsky, SA (corresponding author), Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA.	Scott.Jelinsky@pfizer.com; mcolonna@wustl.edu	Collins, Patrick/AAN-7599-2020; da Silva, Cristiane Sécca/AAV-5468-2021; Shan, Liang/ABB-9210-2021; Zaitsev, Konstantin/AAU-5733-2021; Cella, Marina/ABA-8564-2020	Collins, Patrick/0000-0003-4550-4272; da Silva, Cristiane Sécca/0000-0003-4433-8962; Zaitsev, Konstantin/0000-0003-3749-0886; Robinette, Michelle/0000-0003-0965-5225; Bando, Jennifer/0000-0002-1331-7424; Peng, Vincent/0000-0002-0301-2985; Cella, Marina/0000-0003-1230-1313; Yomogida, Kentaro/0000-0003-4171-6606	NCI Cancer Center Support grant [P30 CA91842]; ICTS/CTSA from the National Center for Research Resources [UL1 TR000448]; Washington University Digestive Disease Research Core (NIDDK) [P30 DK052574]; Howard Hughes Institute;  [UO1 AI095542];  [RO1 DE025884];  [RO1 AI134035]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542, P01AI106697, R01AI134035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR073752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK118110, P30DK052574] Funding Source: NIH RePORTER	NCI Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA from the National Center for Research Resources; Washington University Digestive Disease Research Core (NIDDK); Howard Hughes Institute(Howard Hughes Medical Institute); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support grant no. P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant no. UL1 TR000448 from the National Center for Research Resources. We thank E. Lantelme and D. Brinja, and the Pathology and Immunology Flow Cytometry Core for cell sorting. We thank O. Malkova, R. Lin and S. Oh, and the Center for Human Immunology at Washington University for help in processing the samples for mass spectrometry and for advice on analysis. We thank the Washington University Digestive Disease Research Core (NIDDK P30 DK052574) for support. We thank Regeneron for providing MISTRG-6 and IL-15 humanized mice. We thank S. Henikoff (Fred Hutchison Cancer Research Center, Seattle, USA) for providing protein-A-Mnase. This work was in part supported by grant nos UO1 AI095542 and RO1 DE025884 (to M. Colonna) and RO1 AI134035 (to M. Colonna and E.M.O.). R.A.F. is supported by the Howard Hughes Institute.	Allan DSJ, 2015, MUCOSAL IMMUNOL, V8, P340, DOI 10.1038/mi.2014.71; Allan DSJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03256-0; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bando JK, 2018, IMMUNITY, V48, P1208, DOI 10.1016/j.immuni.2018.04.012; Bernink JH, 2017, IMMUNITY, V46, P756, DOI 10.1016/j.immuni.2017.05.001; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Herndler-Brandstetter D, 2017, P NATL ACAD SCI USA, V114, pE9626, DOI 10.1073/pnas.1705301114; Holmes ML, 2014, EMBO J, V33, P2721, DOI 10.15252/embj.201487900; Holmes TD, 2016, SEMIN IMMUNOL, V28, P368, DOI 10.1016/j.smim.2016.05.008; Huang QT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01569; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Johnson JL, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028779; Kioussis D, 2007, IMMUNITY, V26, P275, DOI 10.1016/j.immuni.2007.03.003; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mazzurana L., EUR J IMMUNOL; Mikami Y, 2018, EUR J IMMUNOL, V48, P1174, DOI 10.1002/eji.201847480; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Simoni Y, 2018, IMMUNITY, V48, P1060, DOI 10.1016/j.immuni.2018.04.028; Simoni Y, 2017, IMMUNITY, V46, P760, DOI 10.1016/j.immuni.2017.04.026; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang JJ, 2017, 2017 INTERNATIONAL CONFERENCE ON SENSING, DIAGNOSTICS, PROGNOSTICS, AND CONTROL (SDPC), P7, DOI 10.1109/SDPC.2017.11; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x	50	94	97	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					980	+		10.1038/s41590-019-0425-y	http://dx.doi.org/10.1038/s41590-019-0425-y			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31209406	Green Accepted			2022-12-18	WOS:000476621200013
J	Cameron, AM; Castoldi, A; Sanin, DE; Flachsmann, LJ; Field, CS; Puleston, DJ; Kyle, RL; Patterson, AE; Hassler, F; Buescher, JM; Kelly, B; Pearce, EL; Pearce, EJ				Cameron, Alanna M.; Castoldi, Angela; Sanin, David E.; Flachsmann, Lea J.; Field, Cameron S.; Puleston, Daniel J.; Kyle, Ryan L.; Patterson, Annette E.; Haessler, Fabian; Buescher, Joerg M.; Kelly, Beth; Pearce, Erika L.; Pearce, Edward J.			Inflammatory macrophage dependence on NAD(+) salvage is a consequence of reactive oxygen species-mediated DNA damage	NATURE IMMUNOLOGY			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; DENDRITIC CELL; METABOLISM; INHIBITION; CANCER; BIOSYNTHESIS; MITOCHONDRIA; HOMEOSTASIS; GENERATION; MECHANISM	The adoption of Warburg metabolism is critical for the activation of macrophages in response to lipopolysaccharide. Macrophages stimulated with lipopolysaccharide increase their expression of nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD+ salvage, and loss of NAMPT activity alters their inflammatory potential. However, the events that lead to the cells' becoming dependent on NAD(+) salvage remain poorly defined. We found that depletion of NAD(+) and increased expression of NAMPT occurred rapidly after inflammatory activation and coincided with DNA damage caused by reactive oxygen species (ROS). ROS produced by complex III of the mitochondrial electron-transport chain were required for macrophage activation. DNA damage was associated with activation of poly(ADP-ribose) polymerase, which led to consumption of NAD(+). In this setting, increased NAMPT expression allowed the maintenance of NAD(+) pools sufficient for glyceraldehyde-3-phosphate dehydrogenase activity and Warburg metabolism. Our findings provide an integrated explanation for the dependence of inflammatory macrophages on the NAD(+) salvage pathway.	[Cameron, Alanna M.; Castoldi, Angela; Sanin, David E.; Flachsmann, Lea J.; Field, Cameron S.; Puleston, Daniel J.; Kyle, Ryan L.; Patterson, Annette E.; Haessler, Fabian; Buescher, Joerg M.; Kelly, Beth; Pearce, Erika L.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany; [Puleston, Daniel J.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Pearce, Edward J.] Univ Freiburg, Fac Biol, Freiburg, Germany	Max Planck Society; University of Oxford; University of Freiburg	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Castoldi, Angela/K-1889-2015; Sanin, David E/CAA-0391-2022; Sanin, David E/CAA-0373-2022	Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Puleston, Daniel/0000-0002-8437-0732; Buescher, Joerg/0000-0002-6547-0076; Castoldi, Angela/0000-0002-8434-7989; Kelly, Beth/0000-0002-3195-6860; Kyle, Ryan/0000-0002-8146-7504	National Institutes of Health [AI 110481, CA18125]; Capes Humboldt Research Fellowship; Sir Henry Wellcome Fellowship - Wellcome Trust; Max Planck Society	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Capes Humboldt Research Fellowship; Sir Henry Wellcome Fellowship - Wellcome Trust(Wellcome Trust); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank members of the Pearce laboratories for support and discussions, and B. Sleckman and A. Morales at Cornell Weill and E. Latz and M. Lauterbach at University of Bonn for their generous advice during these studies. We also thank D. Braas and the UCLA Metabolomics Centre and the DeepSequencing facility at the Max Planck Institute of Immunobiology and Epigenetics for their technical support. This work was funded by National Institutes of Health grants AI 110481 (E.J.P.) and CA18125 (E.L.P.), a Capes Humboldt Research Fellowship (A.C.), a Sir Henry Wellcome Fellowship awarded by The Wellcome Trust (D.J.P.), and the Max Planck Society (E.J.P and E.L.P).	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; CONRADT P, 1989, J ANTIBIOT, V42, P1158, DOI 10.7164/antibiotics.42.1158; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dockery LE, 2017, ONCOTARGETS THER, V10, P3029, DOI 10.2147/OTT.S114714; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Gerner RR, 2018, GUT, V67, P1813, DOI 10.1136/gutjnl-2017-314241; Halvorsen B, 2015, ATHEROSCLEROSIS, V243, P204, DOI 10.1016/j.atherosclerosis.2015.09.010; Hasmann M, 2003, CANCER RES, V63, P7436; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Herrtwich L, 2016, CELL, V167, P1264, DOI 10.1016/j.cell.2016.09.054; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Leung AKL, 2012, RNA BIOL, V9, P542, DOI 10.4161/rna.19899; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014; Matalonga J, 2017, CELL REP, V18, P1241, DOI 10.1016/j.celrep.2017.01.007; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Morales AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.24655; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Pereira-Lopes S, 2015, BLOOD, V126, P2502, DOI 10.1182/blood-2015-04-637371; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Sampath D, 2015, PHARMACOL THERAPEUT, V151, P16, DOI 10.1016/j.pharmthera.2015.02.004; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Schilling E, 2012, INNATE IMMUN-LONDON, V18, P518, DOI 10.1177/1753425911423853; Singh I, 2015, CELL RES, V25, P837, DOI 10.1038/cr.2015.67; Tan B, 2015, J BIOL CHEM, V290, P15812, DOI 10.1074/jbc.M114.632141; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zingarelli B, 1996, J IMMUNOL, V156, P350	54	94	96	8	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					420	+		10.1038/s41590-019-0336-y	http://dx.doi.org/10.1038/s41590-019-0336-y			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30858618				2022-12-18	WOS:000461904200013
J	Maruhashi, T; Okazaki, IM; Sugiura, D; Takahashi, S; Maeda, TK; Shimizu, K; Okazaki, T				Maruhashi, Takumi; Okazaki, Il-Mi; Sugiura, Daisuke; Takahashi, Suzuka; Maeda, Takeo K.; Shimizu, Kenji; Okazaki, Taku			LAG-3 inhibits the activation of CD4(+) T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII	NATURE IMMUNOLOGY			English	Article							MHC CLASS-II; NONOBESE DIABETIC MICE; CUTTING EDGE; AMINO-ACID; PD-1; MOLECULES; PEPTIDES; UNIQUE; GLYCOPROTEIN; EXPRESSION	The success of tumor immunotherapy targeting the inhibitory co-receptors PD-1 and CTLA-4 has indicated that many other co-receptors might be potential druggable targets, despite limited information about their functional differences. Here we identified a unique target selectivity for the inhibitory co-receptor LAG-3 that was intrinsic to its immunoregulatory roles. Although LAG-3 has been reported to recognize major histocompatibility complex (MHC) class II, it did not recognize MHC class II universally; instead, we found that it selectively recognized stable complexes of peptide and MHC class II (pMHCII). LAG-3 did not directly interfere with interactions between the co-receptor CD4 and MHC class II or between the T cell antigen receptor and MHC class II. Instead, LAG-3 preferentially suppressed T cells responsive to stable pMHCII by transducing inhibitory signals via its intracellular region. Thus, LAG-3 might function more selectively than previously thought and thereby maintain tolerance to dominant autoantigens.	[Maruhashi, Takumi; Okazaki, Il-Mi; Sugiura, Daisuke; Takahashi, Suzuka; Maeda, Takeo K.; Shimizu, Kenji; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, Tokushima, Japan	Tokushima University	Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, Tokushima, Japan.	tokazaki@genome.tokushima-u.ac.jp		Okazaki, Taku/0000-0003-4790-1925; Shimizu, Kenji/0000-0003-4204-555X; Maruhashi, Takumi/0000-0003-2944-1611; Sugiura, Daisuke/0000-0002-3865-3889; Okazaki, Il-mi/0000-0001-8644-0100	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417]; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank H. Kozono and O. Kanagawa for critical reading of the manuscript; L. Ignatowicz, M. Hattori, T. Kurosaki, and T. Kitamura for kindly providing BW-1100.129.237, CH27, IIA1.6, and Plat-E cells, respectively; T. Honjo for kindly providing DO11.10, 2B4.11, WEHI-231, P815, and SP2/o cells; K. Murphy for kindly providing DO11.10 Tg mice; A. Otsuka, Y. Okamoto, M. Aoki, and H. Tsuduki for technical assistance; and the other members of our laboratory for helpful discussions. This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development (JP18am0301007), Grant-in-Aid by the Japan Society for the Promotion of Science (JP18H05417), the Tokyo Biochemical Research Foundation, and Uehara Memorial Foundation.	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Alli R, 2011, J IMMUNOL, V187, P5521, DOI 10.4049/jimmunol.1102202; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Baumgartner CK, 2010, J IMMUNOL, V184, P573, DOI 10.4049/jimmunol.0902107; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Ford ML, 2003, J IMMUNOL, V171, P1247, DOI 10.4049/jimmunol.171.3.1247; Gardiner A, 2007, INT IMMUNOL, V19, P1103, DOI 10.1093/intimm/dxm081; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Lovitch SB, 2003, J IMMUNOL, V170, P4155, DOI 10.4049/jimmunol.170.8.4155; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; Wang XX, 2011, P NATL ACAD SCI USA, V108, P15960, DOI 10.1073/pnas.1109438108; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WHITE J, 1989, J IMMUNOL, V143, P1822; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	50	94	96	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1415	+		10.1038/s41590-018-0217-9	http://dx.doi.org/10.1038/s41590-018-0217-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30349037				2022-12-18	WOS:000452873000021
J	Kim, BH; Chee, JD; Bradfield, CJ; Park, ES; Kumar, P; MacMicking, JD				Kim, Bae-Hoon; Chee, Jonathan D.; Bradfield, Clinton J.; Park, Eui-Soon; Kumar, Pradeep; MacMicking, John D.			Interferon-induced guanylate-binding proteins in inflammasome activation and host defense	NATURE IMMUNOLOGY			English	Article							PATHOGEN-CONTAINING VACUOLES; IFN-INDUCIBLE GTPASES; NLRP3 INFLAMMASOME; CELL-DEATH; AIM2 INFLAMMASOME; INCREASES SUSCEPTIBILITY; MGBP2 CONTROLS; GAMMA; CASPASE-11; IMMUNITY	Traditional views of the inflammasome highlight the assembly of pre-existing core components shortly after infection or tissue damage. Emerging work, however, suggests that the inflammasome machinery is also subject to 'tunable' or inducible signals that might accelerate its autocatalytic properties and dictate where inflammasome assembly takes place in the cell. Many of these signals operate downstream of interferon receptors to elicit inflammasome regulators, including a new family of interferon-induced GTPases called 'guanylate-binding proteins' (GBPs). Here we investigate the critical roles of interferon-induced GBPs in directing inflammasome subtype-specific responses and their consequences for cell-autonomous immunity to a wide variety of microbial pathogens. We discuss emerging mechanisms of action and the potential effect of these GBPs on predisposition to sepsis and other infectious or inflammatory diseases.	[Kim, Bae-Hoon; MacMicking, John D.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Kim, Bae-Hoon; Chee, Jonathan D.; Bradfield, Clinton J.; Park, Eui-Soon; Kumar, Pradeep; MacMicking, John D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [MacMicking, John D.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; MacMicking, JD (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.; MacMicking, JD (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.	john.macmicking@yale.edu	Kim, Bae-Hoon/F-3289-2012; Kim, Bae-Hoon/A-8847-2014		HHMI Investigator Program, NIH NIAID [R01 AI068041-10, R01 AI108834-02]; American Asthma Foundation Research Program [14-0073]; Rainin Foundation [14H7]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041, R01AI108834] Funding Source: NIH RePORTER	HHMI Investigator Program, NIH NIAID; American Asthma Foundation Research Program; Rainin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the HHMI Investigator Program, NIH NIAID (R01 AI068041-10 and R01 AI108834-02), the American Asthma Foundation Research Program (14-0073) and the Rainin Foundation (14H7).	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Abdullah N, 2009, J MOL BIOL, V386, P690, DOI 10.1016/j.jmb.2008.12.060; Angosto D, 2012, INNATE IMMUN-LONDON, V18, P815, DOI 10.1177/1753425912441956; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Finethy R, 2015, INFECT IMMUN, V83, P4740, DOI 10.1128/IAI.00856-15; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Haldar AK, 2015, P NATL ACAD SCI USA, V112, pE5628, DOI 10.1073/pnas.1515966112; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hett EC, 2013, NAT CHEM BIOL, V9, P398, DOI [10.1038/nchembio.1236, 10.1038/NCHEMBIO.1236]; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin TC, 2013, ACTA CRYSTALLOGR F, V69, P855, DOI 10.1107/S1744309113015558; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Lee Y, 2015, CELL REP, V13, P223, DOI 10.1016/j.celrep.2015.09.005; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Marty-Roix R, 2016, J BIOL CHEM, V291, P1123, DOI 10.1074/jbc.M115.683011; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Niedelman W, 2013, INFECT IMMUN, V81, P4341, DOI 10.1128/IAI.00416-13; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Ohtsuka S, 2014, EUR J IMMUNOL, V44, P1084, DOI 10.1002/eji.201344091; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Pierini R, 2013, J IMMUNOL, V191, P3847, DOI 10.4049/jimmunol.1203326; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3; Strittmatter GE, 2016, J INVEST DERMATOL, V136, P610, DOI 10.1016/j.jid.2015.12.022; Syguda A, 2012, FEBS J, V279, P2544, DOI 10.1111/j.1742-4658.2012.08637.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wehner M, 2010, FEBS J, V277, P1597, DOI 10.1111/j.1742-4658.2010.07586.x; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789	92	94	98	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					481	U189		10.1038/ni.3440	http://dx.doi.org/10.1038/ni.3440			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092805	Green Accepted			2022-12-18	WOS:000374323100006
J	Gonzalez-Martin, A; Adams, BD; Lai, MY; Shepherd, J; Salvador-Bernaldez, M; Salvador, JM; Lu, J; Nemazee, D; Xiao, CC				Gonzalez-Martin, Alicia; Adams, Brian D.; Lai, Maoyi; Shepherd, Jovan; Salvador-Bernaldez, Maria; Salvador, Jesus M.; Lu, Jun; Nemazee, David; Xiao, Changchun			The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; NEGATIVE SELECTION; LYMPHOMA MODELS; HUMAN LUPUS; ACTIVATION; EXPRESSION; BIM; APOPTOSIS; RESPONSES; WEHI-231	Autoreactive B cells have critical roles in a large diversity of autoimmune diseases, but the molecular pathways that control these cells remain poorly understood. We performed an in vivo functional screen of a lymphocyte-expressed microRNA library and identified miR-148a as a potent regulator of B cell tolerance. Elevated miR-148a expression impaired B cell tolerance by promoting the survival of immature B cells after engagement of the B cell antigen receptor by suppressing the expression of the autoimmune suppressor Gadd45 alpha, the tumor suppressor PTEN and the pro-apoptotic protein Bim. Furthermore, increased expression of miR-148a, which occurs frequently in patients with lupus and lupus-prone mice, facilitated the development of lethal autoimmune disease in a mouse model of lupus. Our studies demonstrate a function for miR-148a as a regulator of B cell tolerance and autoimmunity.	[Gonzalez-Martin, Alicia; Lai, Maoyi; Shepherd, Jovan; Nemazee, David; Xiao, Changchun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Gonzalez-Martin, Alicia; Lai, Maoyi; Shepherd, Jovan; Nemazee, David; Xiao, Changchun] Yale Univ, Yale Canc Ctr, Yale Stem Cell Ctr, Dept Genet, New Haven, CT USA; [Lu, Jun] Yale Univ, Yale Ctr RNA Sci & Med, New Haven, CT USA; [Salvador-Bernaldez, Maria; Salvador, Jesus M.] Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain	Scripps Research Institute; Yale University; Yale University	Nemazee, D; Xiao, CC (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	nemazee@scripps.edu; cxiao@scripps.edu	Gonzalez-Martin, Alicia/B-1702-2017; Adams, Brian D./D-9476-2017	Gonzalez-Martin, Alicia/0000-0002-6179-089X; Adams, Brian D./0000-0001-8372-2970; Salvador, Jesus Maria/0000-0002-1087-9675; Shepherd, Jovan/0000-0003-2067-550X; Xiao, Changchun/0000-0001-8754-3208	Pew Charitable Trusts; Cancer Research Institute; Lupus Research Institute; US National Institutes of Health [R01 AI089854, R01 AI59714, RC4 AI092763]; TSRI Flow Cytometry and Genomics Core Facilities; NATIONAL CANCER INSTITUTE [R01CA149109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092763, R37AI059714, R01AI059714, R01AI089854] Funding Source: NIH RePORTER	Pew Charitable Trusts; Cancer Research Institute; Lupus Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TSRI Flow Cytometry and Genomics Core Facilities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Kono for advice on the analysis of MRL-lpr mice; L. Sherman (The Scripps Research Institute, La Jolla) for Bcl2l11<SUP>-/-</SUP> mice; members of the Xiao and Nemazee laboratories for advice and technical assistance; and the TSRI Flow Cytometry and Genomics Core Facilities for support. Supported by the Pew Charitable Trusts (C.X.), the Cancer Research Institute, the Lupus Research Institute and the US National Institutes of Health (R01 AI089854 to C.X.; R01 AI59714 to D.N.; and RC4 AI092763 to C.X. and D.N.).	Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Duong BH, 2011, J IMMUNOL, V187, P5596, DOI 10.4049/jimmunol.1102479; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Browne CD, 2009, IMMUNITY, V31, P749, DOI 10.1016/j.immuni.2009.08.026; Chauhan SK, 2014, J CLIN IMMUNOL, V34, P491, DOI 10.1007/s10875-014-0008-5; Cheng SH, 2009, CELL RES, V19, P196, DOI 10.1038/cr.2008.284; Dai RJ, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-19; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Haftmann C, 2015, EUR J IMMUNOL, V45, P1192, DOI 10.1002/eji.201444633; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kinnunen T, 2013, J CLIN INVEST, V123, P2737, DOI 10.1172/JCI68775; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lindberg RLP, 2010, EUR J IMMUNOL, V40, P888, DOI 10.1002/eji.200940032; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oliver PM, 2006, J EXP MED, V203, P731, DOI 10.1084/jem.20051407; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Qin HH, 2013, CLIN EXP RHEUMATOL, V31, P472; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156; SCOTT DW, 1985, CELL IMMUNOL, V93, P124, DOI 10.1016/0008-8749(85)90393-4; Shen N, 2012, NAT REV RHEUMATOL, V8, P701, DOI 10.1038/nrrheum.2012.142; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Stagakis E, 2011, ANN RHEUM DIS, V70, P1496, DOI 10.1136/ard.2010.139857; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	50	94	102	1	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					433	+		10.1038/ni.3385	http://dx.doi.org/10.1038/ni.3385			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26901150	Green Accepted			2022-12-18	WOS:000372508000017
J	Price, JG; Idoyaga, J; Salmon, H; Hogstad, B; Bigarella, CL; Ghaffari, S; Leboeuf, M; Merad, M				Price, Jeremy G.; Idoyaga, Juliana; Salmon, Helene; Hogstad, Brandon; Bigarella, Carolina L.; Ghaffari, Saghi; Leboeuf, Marylene; Merad, Miriam			CDKN1A regulates Langerhans cell survival and promotes T-reg cell generation upon exposure to ionizing irradiation	NATURE IMMUNOLOGY			English	Article							DNA-DAMAGE RESPONSE; DENDRITIC CELL; STEADY-STATE; INHIBITOR P21; COMET ASSAY; RADIATION; CANCER; SKIN; P21(WAF1/CIP1); MIGRATION	Treatment with ionizing radiation (IR) can lead to the accumulation of tumor-infiltrating regulatory T cells (T-reg cells) and subsequent resistance of tumors to radiotherapy. Here we focused on the contribution of the epidermal mononuclear phagocytes Langerhans cells (LCs) to this phenomenon because of their ability to resist depletion by high-dose IR. We found that LCs resisted apoptosis and rapidly repaired DNA damage after exposure to IR. In particular, we found that the cyclin-dependent kinase inhibitor CDKN1A (p21) was overexpressed in LCs and that Cdkn1a(-/-) LCs underwent apoptosis and accumulated DNA damage following IR treatment. Wild-type LCs upregulated major histocompatibility complex class II molecules, migrated to the draining lymph nodes and induced an increase in T-reg cell numbers upon exposure to IR, but Cdkn1a(-/-) LCs did not. Our findings suggest a means for manipulating the resistance of LCs to IR to enhance the response of cutaneous tumors to radiotherapy.	[Price, Jeremy G.; Idoyaga, Juliana; Salmon, Helene; Hogstad, Brandon; Ghaffari, Saghi; Leboeuf, Marylene; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Price, Jeremy G.; Idoyaga, Juliana; Salmon, Helene; Hogstad, Brandon; Ghaffari, Saghi; Leboeuf, Marylene; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Price, Jeremy G.; Idoyaga, Juliana; Salmon, Helene; Hogstad, Brandon; Leboeuf, Marylene; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Idoyaga, Juliana] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; [Idoyaga, Juliana] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; [Bigarella, Carolina L.; Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol, Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu	Price, Jeremy G/G-1612-2013	Price, Jeremy G/0000-0003-0491-3176	US National Institutes of Health [T32 CA078207-14, T32 GM007280]; American Medical Association; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the US National Institutes of Health [R00 AR062595]; National Cancer Institute of the US National Institutes of Health [R01 CA173861, R01 CA154947]; NATIONAL CANCER INSTITUTE [T32CA078207, R01CA173861, R01CA154947, R01CA190400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, R01AI080884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR062595] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Manfredi and S. Aronson (Icahn School of Medicine at Mount Sinai) for Trp53<SUP>-/-</SUP> mice; P. Heeger (Icahn School of Medicine at Mount Sinai) for FoxP3-DTR mice; M.C. Nussenzweig (The Rockefeller University) for Ly75<SUP>-/-</SUP> mice; S. Ghaffari (Icahn School of Medicine at Mount Sinai) for Foxo3<SUP>-/-</SUP> mice; C. Rivera for help in maintaining mouse colonies; R. Bagnell (University of North Carolina) for the Image-J CometScore module; A. Nussenzweig for input on the manuscript; the Flow Cytometry, Microscopy, and Irradiator Shared Resource Facilities of the Icahn School of Medicine at Mount Sinai for contributions; and the Immunological Genome Project Consortium for resources. Supported by the US National Institutes of Health (T32 CA078207-14 and T32 GM007280 to J.G.P.), the American Medical Association (J.G.P.), the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the US National Institutes of Health (R00 AR062595 to J.I.) and the National Cancer Institute of the US National Institutes of Health (R01 CA173861 and R01 CA154947 to M.M.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahrendt SA, 2000, SURGERY, V128, P520, DOI 10.1067/msy.2000.108052; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Chakraverty R, 2007, BLOOD, V110, P9, DOI 10.1182/blood-2006-12-022038; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cummings RJ, 2012, J IMMUNOL, V189, P4247, DOI 10.4049/jimmunol.1201371; Cummings RJ, 2009, RADIAT RES, V171, P687, DOI 10.1667/RR1600.1; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Duez P, 2003, MUTAGENESIS, V18, P159, DOI 10.1093/mutage/18.2.159; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hon H, 2004, J IMMUNOL, V173, P4425, DOI 10.4049/jimmunol.173.7.4425; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Kachikwu EL, 2011, INT J RADIAT ONCOL, V81, P1128, DOI 10.1016/j.ijrobp.2010.09.034; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kuo LJ, 2008, IN VIVO, V22, P305; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang QW, 2013, J IMMUNOL, V190, P3246, DOI 10.4049/jimmunol.1201484; Wouters BG, 1997, CANCER RES, V57, P4703; Wouters BG, 1999, ONCOGENE, V18, P6540, DOI 10.1038/sj.onc.1203053	50	94	98	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1060	+		10.1038/ni.3270	http://dx.doi.org/10.1038/ni.3270			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26343536	Green Accepted			2022-12-18	WOS:000361686500011
J	Cohen, NR; Brennan, PJ; Shay, T; Watts, GF; Brigl, M; Kang, J; Brenner, MB				Cohen, Nadia R.; Brennan, Patrick J.; Shay, Tal; Watts, Gerald F.; Brigl, Manfred; Kang, Joonsoo; Brenner, Michael B.		Immunological	Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells	NATURE IMMUNOLOGY			English	Article							INVARIANT NKT CELLS; KILLER T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; GENE-EXPRESSION; DENDRITIC CELLS; MICROBIAL INFECTION; TERMINAL MATURATION; EFFECTOR FUNCTIONS; IMMUNE-RESPONSES; VIRAL-INFECTION	Invariant natural killer T cells (iNKT cells) are innate-like T lymphocytes that act as critical regulators of the immune response. To better characterize this population, we profiled gene expression in iNKT cells during ontogeny and in peripheral subsets as part of the Immunological Genome Project. High-resolution comparative transcriptional analyses defined developmental and subset-specific programs of gene expression by iNKT cells. In addition, we found that iNKT cells shared an extensive transcriptional program with NK cells, similar in magnitude to that shared with major histocompatibility complex (MHC)-restricted T cells. Notably, the program shared by NK cells and iNKT cells also operated constitutively in gamma delta T cells and in adaptive T cells after activation. Together our findings highlight a core effector program regulated distinctly in innate and adaptive lymphocytes.	[Cohen, Nadia R.; Brennan, Patrick J.; Watts, Gerald F.; Brigl, Manfred; Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Shay, Tal] Broad Inst MIT & Harvard, Cambridge, MA USA; [Brigl, Manfred] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Shay, Tal/J-4028-2016; Gautier, Emmanuel L./E-2259-2017; Mingueneau, Michael/O-5313-2019; Heng, Tracy/B-9847-2015; Heng, Tracy/AAR-5712-2021; Gazit, Roi/J-3352-2017	Shay, Tal/0000-0003-0755-1350; Gautier, Emmanuel L./0000-0003-2976-7566; Mingueneau, Michael/0000-0002-3873-7329; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Tata, Nageswara Rao/0000-0002-9928-5944; Malhotra, Deepali/0000-0002-8215-7639; Watts, Gerald/0000-0003-2276-1524; Gazit, Roi/0000-0002-0548-2147; kang, joonsoo/0000-0001-8419-7995; Kim, Charles/0000-0001-6474-8227; Monach, Paul/0000-0003-4937-0515; Fletcher, Anne/0000-0003-1534-1142	US National Institutes of Health [R01AI063428, T32AI007306, R24AI072073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028973, R24AI072073, R01AI063428, T32AI007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, P30DK026743] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the tetramer facility of the US National Institutes of Health for ongoing support; and S. Raychaudhuri, X. Hu and H. Li for advice, discussions and technical assistance. Supported by the US National Institutes of Health (R01 AI063428 to M.B.B., T32AI007306 to P.J.B, and R24AI072073 to the ImmGen Project consortium).	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; InagakiOhara K, 1997, EUR J IMMUNOL, V27, P2885, DOI 10.1002/eji.1830271121; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Maeda M, 2001, J IMMUNOL, V167, P4180, DOI 10.4049/jimmunol.167.8.4180; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Reschner A, 2008, CLIN EXP IMMUNOL, V152, P219, DOI 10.1111/j.1365-2249.2008.03624.x; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; Yue XJ, 2011, P NATL ACAD SCI USA, V108, P17105, DOI 10.1073/pnas.1109095108	56	94	96	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					90	99		10.1038/ni.2490	http://dx.doi.org/10.1038/ni.2490			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23202270	Green Accepted, Green Submitted			2022-12-18	WOS:000312433800014
J	Pellicci, DG; Clarke, AJ; Patel, O; Mallevaey, T; Beddoe, T; Le Nours, J; Uldrich, AP; McCluskey, J; Besra, GS; Porcelli, SA; Gapin, L; Godfrey, DI; Rossjohn, J				Pellicci, Daniel G.; Clarke, Andrew J.; Patel, Onisha; Mallevaey, Thierry; Beddoe, Travis; Le Nours, Jerome; Uldrich, Adam P.; McCluskey, James; Besra, Gurdyal S.; Porcelli, Steven A.; Gapin, Laurent; Godfrey, Dale I.; Rossjohn, Jamie			Recognition of beta-linked self glycolipids mediated by natural killer T cell antigen receptors	NATURE IMMUNOLOGY			English	Article							INVARIANT NKT CELLS; IN-VIVO; CD1D; ISOGLOBOTRIHEXOSYLCERAMIDE; GLYCOSYLATION; STIMULATION; CERAMIDE; AGONIST; FOREIGN; COMPLEX	The most potent foreign antigens for natural killer T cells (NKT cells) are alpha-linked glycolipids, whereas NKT cell self-reactivity involves weaker recognition of structurally distinct beta-linked glycolipid antigens. Here we provide the mechanism for the autoreactivity of T cell antigen receptors (TCRs) on NKT cells to the mono- and tri-glycosylated beta-linked agonists beta-galactosylceramide (beta-GalCer) and isoglobotrihexosylceramide (iGb3), respectively. In binding these disparate antigens, the NKT cell TCRs docked onto CD1d similarly, achieving this by flattening the conformation of the beta-linked ligands regardless of the size of the glycosyl head group. Unexpectedly, the antigenicity of iGb3 was attributable to its terminal sugar group making compensatory interactions with CD1d. Thus, the NKT cell TCR molds the beta-linked self ligands to resemble the conformation of foreign alpha-linked ligands, which shows that induced-fit molecular mimicry can underpin the self-reactivity of NKT cell TCRs to beta-linked antigens.	[Pellicci, Daniel G.; Uldrich, Adam P.; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Clarke, Andrew J.; Patel, Onisha; Beddoe, Travis; Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, Australian Res Council Ctr Excellence Struct & Fu, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic, Australia; [Mallevaey, Thierry; Gapin, Laurent] Univ Colorado Denver & Natl Jewish Hlth, Dept Immunol, Denver, CO USA; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	University of Melbourne; Monash University; University of Colorado System; University of Colorado Denver; University of Birmingham; Yeshiva University; Albert Einstein College of Medicine	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Mallevaey, Thierry/AAH-4499-2020; Pellicci, Daniel/AAX-8539-2020; Uldrich, Adam/AAX-3785-2020; McCluskey, James/A-1291-2007; Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Besra, Gurdyal/0000-0002-5605-0395; Patel, Onisha/0000-0001-6701-7139; ULDRICH, ADAM/0000-0002-6350-5976; Le Nours, Jerome/0000-0002-2221-7636; Pellicci, Daniel/0000-0001-5305-2398; Godfrey, Dale/0000-0002-3009-5472	Cancer Council of Victoria; National Health and Medical Research Council of Australia; Australian Research Council; The Royal Society; The Wellcome Trust [084923/B/08/Z]; Medical Research Council [G1001750]; US National Institutes of Health [AI45889, AI076463, AI078246]; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, R56AI078246, R21AI076463] Funding Source: NIH RePORTER; MRC [G0400421] Funding Source: UKRI	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); The Royal Society(Royal Society of London); The Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Carbone for critically reading the manuscript; K. Wun, R. Koh and M. Sandoval for assistance; and J. Vivian and the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. Supported by the Cancer Council of Victoria, the National Health and Medical Research Council of Australia, the Australian Research Council, The Royal Society (G.S.B.), The Wellcome Trust (084923/B/08/Z to G.S.B.), the Medical Research Council (G1001750 to G.S.B.) and the US National Institutes of Health (AI45889 to S.A.P., and AI076463 and AI078246 to L.G.).	Arden Bernhard, 1995, Immunogenetics, V42, P455; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2011, J EXP MED, V208, P1121, DOI 10.1084/jem.20110983; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Xia C, 2007, J MED CHEM, V50, P3489, DOI 10.1021/jm0701066; Yin N, 2009, ACS CHEM BIOL, V4, P191, DOI 10.1021/cb800277n; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	50	94	95	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					827	U3		10.1038/ni.2076	http://dx.doi.org/10.1038/ni.2076			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21804559	Green Accepted			2022-12-18	WOS:000294461200006
J	Fallang, LE; Bergseng, E; Hotta, K; Berg-Larsen, A; Kim, CY; Sollid, LM				Fallang, Lars-Egil; Bergseng, Elin; Hotta, Kinya; Berg-Larsen, Axel; Kim, Chu-Young; Sollid, Ludvig M.			Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation	NATURE IMMUNOLOGY			English	Article							PEPTIDE BINDING CHARACTERISTICS; CLASS-II; CRYSTAL-STRUCTURE; HLA-DM; BETA-1-ASTERISK-0201) MOLECULE; KINETIC STABILITY; STRUCTURAL BASIS; T-CELLS; DQ; SUSCEPTIBILITY	Celiac disease driven by an antigluten T cell response is strongly associated with the histocompatibility antigen HLA-DQ2.5 but is barely associated with HLA-DQ2.2. Yet these molecules have very similar peptide-binding motifs and both present gluten T cell epitopes. We found that DQ2.5(+) antigen-presenting cells (APCs) had greater stability of bound peptides and protracted gluten presentation relative to that of DQ2.2(+) cells. The improved ability of DQ2.5 to retain its peptide cargo can be ascribed to a polymorphism of DQ alpha 22 whereby DQ2.5 (tyrosine) can establish a hydrogen bond to the peptide main chain but DQ2.2 (phenylalanine) cannot. Our findings suggest that the kinetic stability of complexes of peptide and major histocompatibility complex (MHC) is of importance for the association of HLA with disease.	[Fallang, Lars-Egil; Bergseng, Elin; Berg-Larsen, Axel; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway; [Fallang, Lars-Egil; Bergseng, Elin; Berg-Larsen, Axel; Sollid, Ludvig M.] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [Hotta, Kinya; Kim, Chu-Young] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Oslo; University of Oslo; National Hospital Norway; National University of Singapore	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway.	l.m.sollid@medisin.uio.no	Sollid, Ludvig/N-9691-2015; Hotta, Kinya/A-2574-2009; Kim, Chu-Young/D-8849-2012	Sollid, Ludvig/0000-0001-8860-704X; Hotta, Kinya/0000-0002-9427-0081; Kim, Chu-Young/0000-0003-3744-7802	Research Council of Norway; Biomedical Research Council of Singapore; Life Sciences Institute, National University of Singapore	Research Council of Norway(Research Council of Norway); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Life Sciences Institute, National University of Singapore(National University of Singapore)	We thank E. Mellins (Stanford University) for 8.1.6 BLCLs and S2 cells expressing soluble HLADM;B. Roep (Leiden University Medical Center) for 721.82 BLCLs; H. Soltani for flowassisted cell sorting; T. Svingerud for assistance in making the sDQ2.2 and sDQ2.2 F alpha 22Y constructs; C. Khosla (Stanford University) and U. Juse (University of Oslo) for fluorescence-labeled peptides; and B. Jabri and S. Buus for critical reading of the manuscript. Supported by the Research Council of Norway (L.M.S.), the Biomedical Research Council of Singapore (C.-Y.K.) and the Life Sciences Institute, National University of Singapore (C.-Y.K).	Bergseng E, 2008, HUM IMMUNOL, V69, P94, DOI 10.1016/j.humimm.2008.01.002; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; ERLICH H, 1986, HUM IMMUNOL, V16, P205, DOI 10.1016/0198-8859(86)90049-2; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Johansen BH, 1996, IMMUNOGENETICS, V45, P142, DOI 10.1007/s002510050182; JOHANSEN BH, 1994, INT IMMUNOL, V6, P453, DOI 10.1093/intimm/6.3.453; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Nelson C A, 1999, Rev Immunogenet, V1, P47; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Shishova EY, 2009, BIOCHEMISTRY-US, V48, P121, DOI 10.1021/bi801911v; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; vandeWal Y, 1997, IMMUNOGENETICS, V46, P484, DOI 10.1007/s002510050309; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; VIKEN HD, 1995, HUM IMMUNOL, V42, P319, DOI 10.1016/0198-8859(94)00110-C; Wiesner M, 2008, IMMUNOGENETICS, V60, P551, DOI 10.1007/s00251-008-0310-6	37	94	98	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1096	U73		10.1038/ni.1780	http://dx.doi.org/10.1038/ni.1780			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19718029				2022-12-18	WOS:000270006900013
J	Slevogt, H; Zabel, S; Opitz, B; Hocke, A; Eitel, J; N'Guessan, PD; Lucka, L; Riesbeck, K; Zimmermann, W; Zweigner, J; Temmesfeld-Wollbrueck, B; Suttorp, N; Singer, BB				Slevogt, Hortense; Zabel, Solveig; Opitz, Bastian; Hocke, Andreas; Eitel, Julia; N'Guessan, Philippe D.; Lucka, Lothar; Riesbeck, Kristian; Zimmermann, Wolfgang; Zweigner, Janine; Temmesfeld-Wollbrueck, Bettina; Suttorp, Norbert; Singer, Bernhard B.			CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells	NATURE IMMUNOLOGY			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; KAPPA-B ACTIVATION; MORAXELLA-CATARRHALIS; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; NEISSERIA-MENINGITIDIS; BACTERIAL-COLONIZATION; INFLAMMATORY RESPONSE; AIRWAY INFLAMMATION; ADHESION MOLECULE	Although Moraxella catarrhalis and Neisseria meningitidis are important human pathogens, they often colonize the human respiratory tract without causing overt clinical symptoms. Both pathogens express structurally unrelated proteins that share the ability to stimulate the adhesion molecule CEACAM1 expressed on human cells. Here we demonstrate that the interaction of CEACAM1 with ubiquitous surface protein A1 expressed on M. catarrhalis or with opacity-associated proteins on N. meningitidis resulted in reduced Toll-like receptor 2-initiated transcription factor NF-kappa B-dependent inflammatory responses of primary pulmonary epithelial cells. These inhibitory effects were mediated by tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif of CEACAM1 and by recruitment of the phosphatase SHP-1, which negatively regulated Toll-like receptor 2-dependent activation of the phosphatidylinositol 3-OH kinase-Akt kinase pathway. Our results identify a CEACAM1-dependent immune-evasion strategy.	[Slevogt, Hortense; Zabel, Solveig; Opitz, Bastian; Hocke, Andreas; Eitel, Julia; N'Guessan, Philippe D.; Temmesfeld-Wollbrueck, Bettina; Suttorp, Norbert] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Lucka, Lothar; Singer, Bernhard B.] Charite, Inst Biochem & Mol Biol, D-14195 Berlin, Germany; [Riesbeck, Kristian] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, SE-20502 Malmo, Sweden; [Zimmermann, Wolfgang] Univ Munich, Univ Hosp Grosshadern, Tumor Immunol Lab, D-81377 Munich, Germany; [Zweigner, Janine] Charite, Dept Microbiol & Hyg, D-12203 Berlin, Germany; [Singer, Bernhard B.] Univ Hosp Essen, Inst Anat, D-45147 Essen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Lund University; Skane University Hospital; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen	Slevogt, H (corresponding author), Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany.	hortense.slevogt@charite.de	Zimmermann, Wolfgang/L-9277-2013; Singer, Bernhard B./AAP-9999-2020	Riesbeck, Kristian/0000-0001-6274-6965; Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alamoudi OS, 2007, RESPIROLOGY, V12, P283, DOI 10.1111/j.1440-1843.2006.01002.x; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; Bergman MA, 2005, INFECT IMMUN, V73, P1350, DOI 10.1128/IAI.73.3.1350-1356.2005; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Bousquet C, 2006, EMBO J, V25, P3943, DOI 10.1038/sj.emboj.7601279; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; de Jonge MI, 2003, MOL MICROBIOL, V50, P1005, DOI 10.1046/j.1365-2958.2003.03749.x; de Jonge MI, 2002, EUR J BIOCHEM, V269, P5215, DOI 10.1046/j.1432-1033.2002.03228.x; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; Massengale ARD, 1999, AM J RESP CELL MOL, V20, P1073, DOI 10.1165/ajrcmb.20.5.3243; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Murphy TF, 2000, CHEST, V118, P204, DOI 10.1378/chest.118.1.204; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; N'Guessan PD, 2007, EUR RESPIR J, V30, P443, DOI 10.1183/09031936.00008707; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Nordstrom T, 2002, J BIOL CHEM, V277, P34692, DOI 10.1074/jbc.M203858200; O'Neill LAJ, 2005, NAT MED, V11, P1161, DOI 10.1038/nm1105-1161; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Slevogt H, 2007, CELL MICROBIOL, V9, P694, DOI 10.1111/j.1462-5822.2006.00821.x; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Strassheim D, 2005, J IMMUNOL, V174, P8064, DOI 10.4049/jimmunol.174.12.8064; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x	46	94	95	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1270	1278		10.1038/ni.1661	http://dx.doi.org/10.1038/ni.1661			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18836450				2022-12-18	WOS:000260248600014
J	Cooper, AB; Sawai, CM; Sicinska, E; Powers, SE; Sicinski, P; Clark, MR; Aifantis, I				Cooper, AB; Sawai, CM; Sicinska, E; Powers, SE; Sicinski, P; Clark, MR; Aifantis, I			A unique function for cyclin D3 in early B cell development	NATURE IMMUNOLOGY			English	Article							COMMON LYMPHOID PROGENITORS; ADAPTER PROTEIN SLP-65; RECEPTOR-GAMMA CHAIN; TRANSCRIPTIONAL ACTIVATION; MOUSE DEVELOPMENT; HEAVY-CHAIN; BONE-MARROW; D2; INTERLEUKIN-7; D1	During hematopoiesis, stem cell proliferation is dependent on expression of the D-type cyclins. However, little is known about how each cyclin D contributes to the development of specific hematopoietic lineages. Here, analysis of Ccnd1(-/-), Ccnd2(-/-), Ccnd3(-/-) and Ccnd2(-/-) Ccnd3(-/-) mice showed that cyclin D3 was uniquely required for the development of pre-B cells. Transcription of Ccnd3 was dependent on expression of the common gamma-chain. In contrast, expression of the pre-B cell receptor and activation of 'downstream' signaling pathways prevented proteasome-mediated degradation of cyclin D3. Cyclin D3 has a key function in B cell development by integrating cytokine and pre-B cell receptor-dependent signals to expand the pool of pre-B cells that have successfully rearranged immunoglobulin heavy chain.	Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA	University of Chicago; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu; iaifanti@medicine.bsd.uchicago.edu	Sawai, Catherine M/E-5023-2018	Sawai, Catherine M/0000-0002-2509-474X; Powers, Sarah/0000-0002-6812-4312	NCI NIH HHS [R01CA105129] Funding Source: Medline; NIGMS NIH HHS [R01GM52736] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052736] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Chiles TC, 2004, J IMMUNOL, V173, P2901, DOI 10.4049/jimmunol.173.5.2901; Chow KNB, 1996, MOL CELL BIOL, V16, P7173; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; Glassford J, 2005, EUR J IMMUNOL, V35, P2748, DOI 10.1002/eji.200425812; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nagaoka H, 2000, J EXP MED, V192, P171, DOI 10.1084/jem.192.2.171; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; XIONG Y, 1992, GENOMICS, V13, P575, DOI 10.1016/0888-7543(92)90127-E; Zhao F, 2001, MOL CELL BIOL, V21, P6346, DOI 10.1128/MCB.21.18.6346-6357.2001	49	94	97	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					489	497		10.1038/ni1324	http://dx.doi.org/10.1038/ni1324			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16582912				2022-12-18	WOS:000237008800014
J	Laouar, A; Haridas, V; Vargas, D; Xia, ZN; Chaplin, D; van Lier, RAW; Manjunath, N				Laouar, A; Haridas, V; Vargas, D; Xia, ZN; Chaplin, D; van Lier, RAW; Manjunath, N			CD70(+) antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa	NATURE IMMUNOLOGY			English	Article							INTRAEPITHELIAL LYMPHOCYTES; LAMINA PROPRIA; LISTERIA-MONOCYTOGENES; DENDRITIC CELLS; TRANSGENIC MICE; PEYERS PATCH; IFN-GAMMA; IMMUNE-RESPONSES; EXPRESSION; TOLERANCE	One unresolved issue in gut immunity is how mucosal T lymphocytes are activated and which antigen-presenting cell (APC) is critical for the regulation of this process. We have identified a unique population of APCs that is exclusively localized in the lamina propria. These APCs constitutively expressed the costimulatory molecule CD70 and had antigen-presenting functions. After oral infection of mice with Listeria monocytogenes, proliferation and differentiation of antigen-specific T cells occurred in the gut mucosa in situ and blockade of CD70 costimulation abrogated the mucosal T cell proliferation and effector functions. Thus, a potent CD70-dependent stimulation via specialized tissue-specific APCs is required for the proliferation and differentiation of gut mucosal T cells after oral infection.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Acad Med Ctr, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	swamy@cbr.med.harvard.edu	Laouar, Amale/AAO-2903-2020	Chaplin, David/0000-0002-1354-3069; van Lier, Rene/0000-0002-3201-7144	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046566, R21AI046566] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI046566, AI46566, R21 AI046566] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; BANKS TA, 1995, J IMMUNOL, V155, P1685; Beagley KW, 1998, CRIT REV IMMUNOL, V18, P237, DOI 10.1615/CritRevImmunol.v18.i3.40; Belyakov IM, 1998, P NATL ACAD SCI USA, V95, P1709, DOI 10.1073/pnas.95.4.1709; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Castellaneta A, 2004, HUM IMMUNOL, V65, P104, DOI 10.1016/j.humimm.2003.10.006; Davis IA, 1998, CLIN IMMUNOL IMMUNOP, V89, P150, DOI 10.1006/clin.1998.4601; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gonsky R, 2000, J IMMUNOL, V164, P1399, DOI 10.4049/jimmunol.164.3.1399; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kim SK, 1999, J IMMUNOL, V163, P4125; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Kim SK, 1997, J IMMUNOL, V159, P4295; KLEIN JR, 1986, J EXP MED, V164, P309, DOI 10.1084/jem.164.1.309; LE AXT, 1989, J IMMUNOL, V142, P1366; LEFRANCOIS L, 1996, CURRENT PROTOCOLS IM; MacDonald TT, 1999, CURR TOP MICROBIOL, V236, P113; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Marco AJ, 1997, MICROB PATHOGENESIS, V23, P255, DOI 10.1006/mpat.1997.0144; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Meyer AL, 2001, J IMMUNOL, V166, P5773, DOI 10.4049/jimmunol.166.9.5773; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Newberry RD, 2002, J IMMUNOL, V168, P4988, DOI 10.4049/jimmunol.168.10.4988; OFFIT PA, 1991, J VIROL, V65, P1318, DOI 10.1128/JVI.65.3.1318-1324.1991; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PIRZER UC, 1990, EUR J IMMUNOL, V20, P2339, DOI 10.1002/eji.1830201025; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; TARGAN SR, 1995, J IMMUNOL, V154, P664; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; Tesselaar K, 2003, J IMMUNOL, V170, P33, DOI 10.4049/jimmunol.170.1.33; Thompson RJ, 1998, INFECT IMMUN, V66, P3552, DOI 10.1128/IAI.66.8.3552-3561.1998; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wang HC, 2001, J IMMUNOL, V167, P6717, DOI 10.4049/jimmunol.167.12.6717; Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606; Wilson HL, 2003, IMMUNOL CELL BIOL, V81, P239, DOI 10.1046/j.1440-1711.2003.t01-1-01165.x; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; ZHOU Z, 1994, IMMUNOL LETT, V41, P177, DOI 10.1016/0165-2478(94)90129-5	57	94	97	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					698	706		10.1038/ni1212	http://dx.doi.org/10.1038/ni1212			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15937486	Green Accepted			2022-12-18	WOS:000229975500013
J	Hornef, MW; Putsep, K; Karlsson, J; Refai, E; Andersson, M				Hornef, MW; Putsep, K; Karlsson, J; Refai, E; Andersson, M			Increased diversity of intestinal antimicrobial peptides by covalent dimer formation	NATURE IMMUNOLOGY			English	Article							CYSTEINE-RICH PEPTIDES; PANETH CELL DEFENSINS; ALPHA-DEFENSINS; BETA-DEFENSINS; FAMILY; ACTIVATION; IMMUNITY	Antimicrobial peptides are essential effector molecules of the innate immune system. Here we describe the structure, function and diversity of cryptdin-related sequence (CRS) peptides, a large family of antimicrobial molecules. We identified the peptides as covalent dimers in mouse intestinal tissue in amounts comparable to those of Paneth cell-derived enteric alpha-defensins. CRS peptides caused rapid and potent killing of commensal and pathogenic bacteria. The CRS peptides formed homo- and heterodimers in vivo, thereby expanding the repertoire of antimicrobial peptides and increasing the peptide diversity of Paneth cell secretions. CRS peptides might therefore be important in the maintenance of the microbial homeostasis within the intestinal tract.	Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; Swedish Inst Infect Dis Control SMI, SE-17182 Solna, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	Karolinska Institutet; University of Freiburg; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Andersson, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden.	mats.andersson@mtc.ki.se	; Andersson, Mats/M-9124-2014	Hornef, Mathias/0000-0001-6096-9110; Andersson, Mats/0000-0001-7582-8791; Refai, Essam/0000-0002-8926-3856				Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Batista CVF, 2001, FEBS LETT, V494, P85, DOI 10.1016/S0014-5793(01)02324-9; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Darmoul D, 1997, AM J PHYSIOL-GASTR L, V272, pG197, DOI 10.1152/ajpgi.1997.272.1.G197; Dempsey CE, 2003, BIOCHEMISTRY-US, V42, P402, DOI 10.1021/bi026328h; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; HULTMARK D, 1983, EMBO J, V2, P571, DOI 10.1002/j.1460-2075.1983.tb01465.x; HUTTNER KM, 1994, GENOMICS, V19, P448, DOI 10.1006/geno.1994.1093; HUTTNER KM, 1994, GENOMICS, V24, P99, DOI 10.1006/geno.1994.1586; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yomogida S, 1996, ARCH BIOCHEM BIOPHYS, V328, P219, DOI 10.1006/abbi.1996.0166; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012	40	94	102	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					836	843		10.1038/ni1094	http://dx.doi.org/10.1038/ni1094			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15235601				2022-12-18	WOS:000222955600015
J	Woolsey, C; Borisevich, V; Prasad, AN; Agans, KN; Deer, DJ; Dobias, NS; Heymann, JC; Foster, SL; Levine, CB; Medina, L; Melody, K; Geisbert, JB; Fenton, KA; Geisbert, TW; Cross, RW				Woolsey, Courtney; Borisevich, Viktoriya; Prasad, Abhishek N.; Agans, Krystle N.; Deer, Daniel J.; Dobias, Natalie S.; Heymann, John C.; Foster, Stephanie L.; Levine, Corri B.; Medina, Liana; Melody, Kevin; Geisbert, Joan B.; Fenton, Karla A.; Geisbert, Thomas W.; Cross, Robert W.			Establishment of an African green monkey model for COVID-19 and protection against re-infection	NATURE IMMUNOLOGY			English	Article							ACUTE RESPIRATORY SYNDROME; PRIMATE MODEL; SARS-COV-2; INFECTION; VACCINE; MERS; RHESUS; SARS	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an unprecedented global pandemic of COVID-19. Animal models are urgently needed to study the pathogenesis of COVID-19 and to screen vaccines and treatments. We show that African green monkeys (AGMs) support robust SARS-CoV-2 replication and develop pronounced respiratory disease, which may more accurately reflect human COVID-19 cases than other nonhuman primate species. SARS-CoV-2 was detected in mucosal samples, including rectal swabs, as late as 15 days after exposure. Marked inflammation and coagulopathy in blood and tissues were prominent features. Transcriptome analysis demonstrated stimulation of interferon and interleukin-6 pathways in bronchoalveolar lavage samples and repression of natural killer cell- and T cell-associated transcripts in peripheral blood. Despite a slight waning in antibody titers after primary challenge, enhanced antibody and cellular responses contributed to rapid clearance after re-challenge with an identical strain. These data support the utility of AGM for studying COVID-19 pathogenesis and testing medical countermeasures. Geisbert and colleagues report that African green monkeys infected with the SARS-CoV-2 virus develop disease symptoms that closely resemble those seen in infected humans, making this animal model a useful surrogate to investigate immune responses to coronavirus infection.	[Woolsey, Courtney; Borisevich, Viktoriya; Prasad, Abhishek N.; Agans, Krystle N.; Deer, Daniel J.; Dobias, Natalie S.; Foster, Stephanie L.; Levine, Corri B.; Medina, Liana; Melody, Kevin; Geisbert, Joan B.; Fenton, Karla A.; Geisbert, Thomas W.; Cross, Robert W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Woolsey, Courtney; Borisevich, Viktoriya; Prasad, Abhishek N.; Agans, Krystle N.; Deer, Daniel J.; Dobias, Natalie S.; Foster, Stephanie L.; Levine, Corri B.; Medina, Liana; Melody, Kevin; Geisbert, Joan B.; Fenton, Karla A.; Geisbert, Thomas W.; Cross, Robert W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Heymann, John C.] Univ Texas Med Branch, Dept Radiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.	twgeisbe@utmb.edu	Prasad, Abhishek N/K-6450-2019; cross, bob/AAB-9461-2021; Cross, PhD, MPH, Robert W/ABD-6575-2021	Prasad, Abhishek N/0000-0002-4147-2077; Cross, PhD, MPH, Robert W/0000-0001-7718-1522; Foster, Stephanie/0000-0002-3097-1129; Levine, Corri/0000-0003-0405-5191; Woolsey, Courtney/0000-0003-3389-0137	European Union [653316]; Department of Microbiology and Immunology, UTMB; National Institute of Allergy and Infectious Diseases/National Institutes of Health [UC7AI094660]	European Union(European Commission); Department of Microbiology and Immunology, UTMB; National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the UTMB Animal Resource Center for veterinary support and surgical implantation of temperature data loggers, as well as husbandry support. We thank V. Menachery, S. Makino, C.-T. Tseng, T. Ksiazek and K. Narayanan for their valuable insight and technical assistance with coronavirus protocols. The virus used in this publication was kindly provided by the European Virus Archive Goes Global project that has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 653316. We thank L. Branco and M. Boisen (Zalgen Labs) for generously providing the SARS-CoV-2 anti-nucleoprotein ELISA assays. The following reagent was produced under HHSN272201400008C and obtained through BEI Resources, National Institute of Allergy and Infectious Diseases, National Institutes of Health: spike glycoprotein RBD from SARS-Related Coronavirus 2, Wuhan-Hu-1 with C-terminal histidine tag, recombinant from HEK293F cells, NR-52366. This study was supported by funds from the Department of Microbiology and Immunology, UTMB, to T.W.G. Operations support of the Galveston National Laboratory was provided by National Institute of Allergy and Infectious Diseases/National Institutes of Health grant UC7AI094660.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; American College of Radiology, 2020, ACR REC US CHEST RAD; [Anonymous], 2020, CANCER DISCOV, DOI [DOI 10.1038/S41379-019-0362-1, DOI 10.1038/S41421-020-0168-9]; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Capobianchi MR, 2020, CLIN MICROBIOL INFEC, V26, P954, DOI 10.1016/j.cmi.2020.03.025; Caswell J. L., 2007, PALMERIS PATHOL DOME, V2, P523; Centers for Disease Control and Prevention, 2020, CDC 2019 NCOV REAL T; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen X, 2020, CHINA PERSPECT-SER, P1; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Diao B., 2020, HUMAN KIDNEY IS TARG, DOI 10.1101/2020.03.04.20031120; Durbin AP, 2000, VACCINE, V18, P2462, DOI 10.1016/S0264-410X(99)00575-7; Galanti M, 2020, J INFECT DIS, DOI [10.1101/2020.04.27.20082032, 10.1093/infdis/jiaa392, DOI 10.1093/INFDIS/JIAA392]; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Harris C.R., 2020, NATURE 0609, V585, P357, DOI [10.1038/s41586-020-2649-2, DOI 10.1038/S41586-020-2423-5, DOI 10.1038/S41586-020-2649-2]; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; KAKUK TJ, 1993, J INFECT DIS, V167, P553, DOI 10.1093/infdis/167.3.553; Kanevsky I., 2020, BIORXIV, DOI [10.1101/2020.09.08.280818, DOI 10.1101/2020.09.08.280818, DOI 10.1101/2020.09.08.280818V1]; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Martines RB, 2020, EMERG INFECT DIS, V26, P2005, DOI 10.3201/eid2609.202095; McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Nalca A, 2019, INT J INFECT DIS, V79, P99, DOI 10.1016/j.ijid.2018.11.249; Prasad AN, 2020, J INFECT DIS, V221, pS436, DOI 10.1093/infdis/jiz613; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Shan C, 2020, CELL RES, V30, P670, DOI 10.1038/s41422-020-0364-z; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Weingartl H, 2004, J VIROL, V78, P12672, DOI 10.1128/JVI.78.22.12672-12676.2004; Weinstock MB., 2020, J URGENT CARE MED, V14, P13; World Health Organization, 2020, COR DIS COVID 19; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; ZHOU YY, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-09234-6; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	46	93	93	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					86	98		10.1038/s41590-020-00835-8	http://dx.doi.org/10.1038/s41590-020-00835-8		NOV 2020	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33235385	Bronze, Green Accepted			2022-12-18	WOS:000592575000001
J	Wandel, MP; Kim, BH; Park, ES; Boyle, KB; Nayak, K; Lagrange, B; Herod, A; Henry, T; Zilbauer, M; Rohde, J; MacMicking, JD; Randow, F				Wandel, Michal P.; Kim, Bae-Hoon; Park, Eui-Soon; Boyle, Keith B.; Nayak, Komal; Lagrange, Brice; Herod, Adrian; Henry, Thomas; Zilbauer, Matthias; Rohde, John; MacMicking, John D.; Randow, Felix			Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms	NATURE IMMUNOLOGY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; SHIGELLA-FLEXNERI; RECOGNITION; PYROPTOSIS; EFFECTOR; CELLS; DEGRADATION; RECEPTORS; MECHANISM; AUTOPHAGY	Bacterial lipopolysaccharide triggers human caspase-4 (murine caspase-11) to cleave gasdermin-D and induce pyroptotic cell death. How lipopolysaccharide sequestered in the membranes of cytosol-invading bacteria activates caspases remains unknown. Here we show that in interferon-gamma-stimulated cells guanylate-binding proteins (GBPs) assemble on the surface of Gram-negative bacteria into polyvalent signaling platforms required for activation of caspase-4. Caspase-4 activation is hierarchically controlled by GBPs; GBP1 initiates platform assembly, GBP2 and GBP4 control caspase-4 recruitment, and GBP3 governs caspase-4 activation. In response to cytosol-invading bacteria, activation of caspase-4 through the GBP platform is essential to induce gasdermin-D-dependent pyroptosis and processing of interleukin-18, thereby destroying the replicative niche for intracellular bacteria and alerting neighboring cells, respectively. Caspase-11 and GBPs epistatically protect mice against lethal bacterial challenge. Multiple antagonists of the pathway encoded byShigella flexneri, a cytosol-adapted bacterium, provide compelling evolutionary evidence for the importance of the GBP-caspase-4 pathway in antibacterial defense. How lipopolysaccharide embedded in bacterial membranes is sensed by intracellular defense mechanisms has been puzzling. Randow and colleagues show that guanylate-binding proteins assemble on the surface of Gram-negative bacteria to initiate downstream pyroptosis.	[Wandel, Michal P.; Boyle, Keith B.; Randow, Felix] MRC Lab Mol Biol, Div & Nucle Acid Chem, Cambridge, England; [Kim, Bae-Hoon; Park, Eui-Soon; MacMicking, John D.] Yale Univ, Howard Hughes Med Inst, West Haven, CT USA; [Kim, Bae-Hoon; Park, Eui-Soon; MacMicking, John D.] Yale Univ, Syst Biol Inst, West Haven, CT USA; [Kim, Bae-Hoon; Park, Eui-Soon; MacMicking, John D.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Bae-Hoon; Park, Eui-Soon; MacMicking, John D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Nayak, Komal; Zilbauer, Matthias] Univ Cambridge, Dept Paediat, Cambridge, England; [Nayak, Komal; Zilbauer, Matthias] Addenbrookes Hosp, Cambridge Univ Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge, England; [Lagrange, Brice; Henry, Thomas] Univ Lyon, Univ Claude Bernard Lyon 1, Ctr Int Rech Infectiol, Univ Lyon,Inserm,CNRS,ENS Lyon,UMR5308,U1111, Lyon, France; [Herod, Adrian; Rohde, John] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Randow, Felix] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge, England	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Dalhousie University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wandel, MP; Randow, F (corresponding author), MRC Lab Mol Biol, Div & Nucle Acid Chem, Cambridge, England.; Randow, F (corresponding author), Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge, England.	mwandel@mrc-lmb.cam.ac.uk; randow@mrc-lmb.cam.ac.uk	Kim, Bae-Hoon/F-3289-2012; Zilbauer, Matthias/AAZ-2740-2020; Wandel, Michal/AAL-7946-2021; henry, thomas/G-3160-2013	Zilbauer, Matthias/0000-0002-7272-0547; Wandel, Michal/0000-0002-5275-5881; henry, thomas/0000-0002-0687-8565	MRC [U105170648]; Wellcome Trust [WT104752MA]; NIH National Institutes of Allergy and Infectious Diseases [R01AI068041-13, R01AI108834-05]; MRC [MR/T001917/1, MC_U105170648] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH National Institutes of Allergy and Infectious Diseases; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Kendrick-Jones (MRC Laboratory of Molecular Biology, Cambridge) for providing antiserum against NDP52. This work was supported by the MRC (grant no. U105170648) and the Wellcome Trust (grant no. WT104752MA) to F.R., and by the NIH National Institutes of Allergy and Infectious Diseases (grant nos. R01AI068041-13 and R01AI108834-05) to J.D.M. J.D.M. is an investigator of the Howard Hughes Medical Institute.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Fisch D, 2019, EMBO J, V38, DOI 10.15252/embj.2018100926; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Jorgensen I, 2016, J EXP MED, V213, P2113, DOI 10.1084/jem.20151613; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Koestler Benjamin J, 2018, Curr Protoc Microbiol, V50, pe57, DOI 10.1002/cpmc.57; Kraiczy J, 2019, GUT, V68, P49, DOI 10.1136/gutjnl-2017-314817; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mitchell G, 2017, CELL HOST MICROBE, V22, P166, DOI 10.1016/j.chom.2017.07.005; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Piro AS, 2017, MBIO, V8, DOI 10.1128/mBio.01979-17; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Randow Felix, 2006, Subcell Biochem, V40, P383; Ravenhill BJ, 2019, MOL CELL, V74, P320, DOI 10.1016/j.molcel.2019.01.041; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sidik S, 2014, G3-GENES GENOM GENET, V4, P2493, DOI 10.1534/g3.114.014381; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thurston TLM, 2016, EMBO J, V35, P1779, DOI 10.15252/embj.201694491; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tretina K, 2019, J EXP MED, V216, P482, DOI 10.1084/jem.20182031; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007	50	93	94	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					880	+		10.1038/s41590-020-0697-2	http://dx.doi.org/10.1038/s41590-020-0697-2		JUN 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32541830	Green Accepted			2022-12-18	WOS:000540408200001
J	Leavenworth, JW; Verbinnen, B; Yin, J; Huang, HC; Cantor, H				Leavenworth, Jianmei W.; Verbinnen, Bert; Yin, Jie; Huang, Huicong; Cantor, Harvey			A p85 alpha-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells	NATURE IMMUNOLOGY			English	Article							COSTIMULATOR MESSENGER-RNA; PHOSPHOINOSITIDE 3-KINASE; DENDRITIC CELLS; B-CELL; SIGNALING PATHWAYS; WIDE PREDICTION; DIFFERENTIATION; OSTEOPONTIN; MECHANISMS; INDUCTION	Follicular helper T cells (T-FH cells) and follicular regulatory T cells (T-FR cells) regulate the quantity and quality of humoral immunity. Although both cell types express the costimulatory receptor ICOS and require the transcription factor Bcl-6 for their differentiation, the ICOS-dependent pathways that coordinate their responses are not well understood. Here we report that activation of ICOS in CD4(+) T cells promoted interaction of the p85 alpha regulatory subunit of the signaling kinase PI(3)K and intracellular osteopontin (OPN-i), followed by translocation of OPN-i to the nucleus, its interaction with Bcl-6 and protection of Bcl-6 from ubiquitin-dependent proteasome degradation. Post-translational protection of Bcl-6 by OPN-i was essential for sustained responses of T-FH cells and T-FR cells and regulation of the germinal center B cell response to antigen. Thus, the p85 alpha-OPN-i axis represents a molecular bridge that couples activation of ICOS to Bcl-6-dependent functional differentiation of T-FH cells and T-FR cells; this suggests new therapeutic avenues to manipulate the responses of these cells.	[Leavenworth, Jianmei W.; Verbinnen, Bert; Yin, Jie; Huang, Huicong; Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Leavenworth, Jianmei W.; Verbinnen, Bert; Cantor, Harvey] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA USA; [Yin, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Cell Biol, Tianjin, Peoples R China; [Huang, Huicong] Wenzhou Med Coll, Dept Parasitol, Wenzhou, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tianjin Medical University; Wenzhou Medical University	Cantor, H (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu		Leavenworth, Jianmei/0000-0002-4100-9883	US National Institutes of Health [AI48125, T32 CA070083]; LeRoy Schecter Research Foundation; Benacerraf Society; Belgian-American Educational Foundation; NATIONAL CANCER INSTITUTE [T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048125] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeRoy Schecter Research Foundation; Benacerraf Society; Belgian-American Educational Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. von Boehmer (Dana-Farber Cancer Institute) for B6.Foxp3GFP mice; L. Cantley (Weill Cornell Medical College) for p85 alpha and Flag-p85 alpha plasmids; T. Dawson (Johns Hopkins University) for the HA-Ub plasmid; S. Yamanaka (Kyoto University) for the HA-p110 delta plasmid; J. Zhao (Dana-Farber Cancer Institute) for the HA-p110 alpha plasmid; K. Wucherpfennig for critical reading; L. Cameron for help with image preparation and analysis; Y. Shao for microarray analysis; and A. Angel for preparation of the manuscript and figures. Supported by the US National Institutes of Health (AI48125 to H.C.; and T32 CA070083 to J.W.L.), The LeRoy Schecter Research Foundation (H.C.), the Benacerraf Society (J.W.L.) and the Belgian-American Educational Foundation (B.V.).	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bunting KL, 2013, CURR OPIN IMMUNOL, V25, P339, DOI 10.1016/j.coi.2013.05.003; Cantor H, 2009, NAT REV IMMUNOL, V9, P137, DOI 10.1038/nri2460; Cerchietti LC, 2009, NAT MED, V15, P1369, DOI 10.1038/nm.2059; Chang JH, 2014, J EXP MED, V211, P137, DOI 10.1084/jem.20131019; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Leavenworth JW, 2013, J CLIN INVEST, V123, P1382, DOI 10.1172/JCI66938; Leavenworth JW, 2011, P NATL ACAD SCI USA, V108, P14584, DOI 10.1073/pnas.1112188108; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; PATARCA R, 1990, J EXP MED, V172, P1177, DOI 10.1084/jem.172.4.1177; PATARCA R, 1991, P NATL ACAD SCI USA, V88, P2736, DOI 10.1073/pnas.88.7.2736; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rolf J, 2010, J IMMUNOL, V184, P6563, DOI 10.4049/jimmunol.1000202; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	52	93	103	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					96	+		10.1038/ni.3050	http://dx.doi.org/10.1038/ni.3050			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25436971	Green Accepted, Green Submitted			2022-12-18	WOS:000346494200013
J	Roncagalli, R; Hauri, S; Fiore, F; Liang, YM; Chen, Z; Sansoni, A; Kanduri, K; Joly, R; Malzac, A; Lahdesmaki, H; Lahesmaa, R; Yamasaki, S; Saito, T; Malissen, M; Aebersold, R; Gstaiger, M; Malissen, B				Roncagalli, Romain; Hauri, Simon; Fiore, Frederic; Liang, Yinming; Chen, Zhi; Sansoni, Amandine; Kanduri, Kartiek; Joly, Rachel; Malzac, Aurelie; Lahdesmaki, Harri; Lahesmaa, Riitta; Yamasaki, Sho; Saito, Takashi; Malissen, Marie; Aebersold, Ruedi; Gstaiger, Matthias; Malissen, Bernard			Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub	NATURE IMMUNOLOGY			English	Article							TYROSINE PHOSPHORYLATION; ACTIVATION; EXPRESSION; RECONSTITUTION; RECRUITMENT; ENGAGEMENT; COMPLEXES; RESPONSES; PROTEINS; MUTATION	T cell antigen receptor (TCR)-mediated activation of T cells requires the interaction of dozens of proteins. Here we used quantitative mass spectrometry and activated primary CD4(+) T cells from mice in which a tag for affinity purification was knocked into several genes to determine the composition and dynamics of multiprotein complexes that formed around the kinase Zap70 and the adaptors Lat and SLP-76. Most of the 112 high-confidence time-resolved protein interactions we observed were previously unknown. The surface receptor CD6 was able to initiate its own signaling pathway by recruiting SLP-76 and the guanine nucleotide-exchange factor Vav1 regardless of the presence of Lat. Our findings provide a more complete model of TCR signaling in which CD6 constitutes a signaling hub that contributes to the diversification of TCR signaling.	[Roncagalli, Romain; Liang, Yinming; Joly, Rachel; Malzac, Aurelie; Malissen, Marie; Malissen, Bernard] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Roncagalli, Romain; Liang, Yinming; Joly, Rachel; Malzac, Aurelie; Malissen, Marie; Malissen, Bernard] INSERM, U1104, F-13258 Marseille, France; [Roncagalli, Romain; Liang, Yinming; Joly, Rachel; Malzac, Aurelie; Malissen, Marie; Malissen, Bernard] CNRS, UMR7280, Marseille, France; [Hauri, Simon; Aebersold, Ruedi; Gstaiger, Matthias] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Hauri, Simon; Aebersold, Ruedi; Gstaiger, Matthias] ETH, Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Fiore, Frederic; Sansoni, Amandine; Malissen, Bernard] UM2 Aix Marseille Univ, Ctr Immunophen, Marseille, France; [Fiore, Frederic; Sansoni, Amandine; Malissen, Bernard] INSERM, US012, F-13258 Marseille, France; [Fiore, Frederic; Sansoni, Amandine; Malissen, Bernard] CNRS UMS3367, Marseille, France; [Chen, Zhi; Kanduri, Kartiek; Lahdesmaki, Harri; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Chen, Zhi; Kanduri, Kartiek; Lahdesmaki, Harri; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Aalto, Finland; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 812, Japan; [Saito, Takashi] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Turku; Abo Akademi University; Aalto University; Kyushu University; RIKEN; University of Zurich	Malissen, B (corresponding author), UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France.	matthias.gstaiger@imsb.biol.ethz.ch; bernardm@ciml.univ-mrs.fr	Liang, Yinming/AAM-6226-2020; Saito, Takashi/C-9684-2009; Roncagalli, Romain/ABB-8786-2020; Malissen, Bernard/AAK-4659-2020	Liang, Yinming/0000-0001-9174-4037; Saito, Takashi/0000-0001-9495-3547; Malissen, Bernard/0000-0003-1340-9342; Malissen, Marie/0000-0003-2331-1445; Roncagalli, Romain/0000-0001-7554-0552; Kanduri, Kartiek/0000-0002-5639-0701; Chen, Zhi/0000-0002-4658-7463; FIORE, FREDERIC/0000-0001-7955-6594; Hauri, Simon/0000-0002-7249-2011	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; GIS-IBISA; PHENOMIN; ANR; European Communities; Academy of Finland Centre for Excellence in Molecular Systems Immunology and Physiology Research; Sigrid Juselius Foundation; European Union; European Research Council; China Scholarship Council	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); GIS-IBISA; PHENOMIN; ANR(French National Research Agency (ANR)); European Communities(European Commission); Academy of Finland Centre for Excellence in Molecular Systems Immunology and Physiology Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); China Scholarship Council(China Scholarship Council)	We thank A. Weiss (University of California, San Francisco) for the Jurkat T cell lines E6.1, P116 and JCaM2.5; members of the SYBILLA consortium; O. Acuto, M. Brown, K. Reginald and A.-M. Schmitt-Verhulst for discussions; and E. Caccomo, A.-M. Mura, F. Danjan and M. Richelme and the Finnish Microarray and Sequencing Centre at Turku for technical assistance. Supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, GIS-IBISA, PHENOMIN, ANR (ADAPT project to M. M. and iSa project to B. M.), the European Communities (SYBILLA project to B. M., M. G., H. L. and R. L., and MASTERSWITCH project to B. M.), the Academy of Finland Centre for Excellence in Molecular Systems Immunology and Physiology Research, the Sigrid Juselius Foundation (R. L. and H. L.), the European Union 7th Framework project PROSPECTS, the European Research Council ('Proteomics v3.0' to R. A., and 'Integrate' to B. M.) and the China Scholarship Council (Y.L.).	Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; DONNADIEU E, 1994, J BIOL CHEM, V269, P32828; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Fermin D, 2011, PROTEOMICS, V11, P1340, DOI 10.1002/pmic.201000650; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gregoire C, 2007, EUR J IMMUNOL, V37, P3259, DOI 10.1002/eji.200737563; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kobarg J, 1997, EUR J IMMUNOL, V27, P2971, DOI 10.1002/eji.1830271133; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; May RM, 2013, BLOOD, V121, P3135, DOI 10.1182/blood-2012-12-474361; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; Ou-Yang CW, 2012, MOL CELL BIOL, V32, P2674, DOI 10.1128/MCB.00356-12; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Roncagalli R, 2010, TRENDS IMMUNOL, V31, P253, DOI 10.1016/j.it.2010.05.001; SALMERON A, 1995, J IMMUNOL, V154, P1675; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/nmeth.2400, 10.1038/NMETH.2400]; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; WEE SF, 1993, J EXP MED, V177, P219, DOI 10.1084/jem.177.1.219; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	53	93	102	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					384	+		10.1038/ni.2843	http://dx.doi.org/10.1038/ni.2843			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24584089	Green Accepted			2022-12-18	WOS:000333252000013
J	Myles, IA; Fontecilla, NM; Valdez, PA; Vithayathil, PJ; Naik, S; Belkaid, Y; Ouyang, WJ; Datta, SK				Myles, Ian A.; Fontecilla, Natalia M.; Valdez, Patricia A.; Vithayathil, Paul J.; Naik, Shruti; Belkaid, Yasmine; Ouyang, Wenjun; Datta, Sandip K.			Signaling via the IL-20 receptor inhibits cutaneous production of IL-1 beta and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus	NATURE IMMUNOLOGY			English	Article							RHEUMATOID-ARTHRITIS; HOST-DEFENSE; KAPPA-B; IMMUNE-RESPONSES; GENE-EXPRESSION; T-CELLS; INNATE; CYTOKINES; INTERLEUKIN-20; IDENTIFICATION	Staphylococcus aureus causes most infections of human skin and soft tissue and is a major infectious cause of mortality. Host defense mechanisms against S. aureus are incompletely understood. Interleukin 19 (IL-19), IL-20 and IL-24 signal through type I and type II IL-20 receptors and are associated with inflammatory skin diseases such as psoriasis and atopic dermatitis. We found here that those cytokines promoted cutaneous infection with S. aureus in mice by downregulating IL-1 beta- and IL-17A-dependent pathways. We noted similar effects of those cytokines in human keratinocytes after exposure to S. aureus, and antibody blockade of the IL-20 receptor improved outcomes in infected mice. Our findings identify an immunosuppressive role for IL-19, IL-20 and IL-24 during infection that could be therapeutically targeted to alter susceptibility to infection.	[Myles, Ian A.; Fontecilla, Natalia M.; Valdez, Patricia A.; Vithayathil, Paul J.; Datta, Sandip K.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Naik, Shruti; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Roche Holding; Genentech	Datta, SK (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dattas@niaid.nih.gov	Myles, Ian/AAE-7623-2019; Ouyang, Wenjun/ABA-8763-2020	Myles, Ian/0000-0001-9316-3703; Ouyang, Wenjun/0000-0002-1811-5864; Belkaid, Yasmine/0000-0001-9962-3571; Datta, Sandip/0000-0003-0243-7815	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001043, ZIAAI001115, ZIAAI001132] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Iwakura (University of Tokyo) for Il17a<SUP>-/-</SUP> mice; J. O'Shea (National Institute of Arthritis, Musculoskeletal and Skin Diseases) for Stat3<SUP>WT/Delta V463</SUP> mice; F. DeLeo (Rocky Mountain Labs, National Institute of Allergy and Infectious Diseases) for the clinical isolate of MRSA USA300 (LAC strain); A. Costanzo and J. Jameson (The Scripps Research Institute) for PAM 2-12 cells; A. Coxon (National Cancer Institute) for foreskin samples; and F. DeLeo and J. O'Shea for critical reading of the manuscript. Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health).	Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Azuma YT, 2011, CURR PHARM DESIGN, V17, P3776, DOI 10.2174/138161211798357845; Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cassat JE, 2012, SEMIN IMMUNOPATHOL, V34, P215, DOI 10.1007/s00281-011-0294-4; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gaidamakova EK, 2012, CELL HOST MICROBE, V12, P117, DOI 10.1016/j.chom.2012.05.011; He M, 2010, J IMMUNOL, V184, P1793, DOI 10.4049/jimmunol.0901829; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; Kragstrup TW, 2008, CYTOKINE, V41, P16, DOI 10.1016/j.cyto.2007.10.004; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Liu FL, 2007, RHEUMATOLOGY, V46, P1266, DOI 10.1093/rheumatology/kem055; Logsdon NJ, 2012, P NATL ACAD SCI USA, V109, P12704, DOI 10.1073/pnas.1117551109; Ma YF, 2011, MICROBES INFECT, V13, P1099, DOI 10.1016/j.micinf.2011.06.012; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Myles IA, 2012, SEMIN IMMUNOPATHOL, V34, P181, DOI 10.1007/s00281-011-0301-9; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nograles KE, 2011, EXP CELL RES, V317, P1293, DOI 10.1016/j.yexcr.2011.01.024; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rizek CF, 2011, FOODBORNE PATHOG DIS, V8, P561, DOI 10.1089/fpd.2010.0706; ROGERS DE, 1965, ANN NY ACAD SCI, V128, P274, DOI 10.1111/j.1749-6632.1965.tb11644.x; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Schmaler M, 2011, J IMMUNOL, V186, P443, DOI 10.4049/jimmunol.1001407; Straccia M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-156; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Tokura Yoshiki, 2010, Journal of UOEH, V32, P317; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	50	93	99	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					804	+		10.1038/ni.2637	http://dx.doi.org/10.1038/ni.2637			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23793061	Green Accepted			2022-12-18	WOS:000322010600009
J	Gerard, A; Khan, O; Beemiller, P; Oswald, E; Hu, J; Matloubian, M; Krummel, MF				Gerard, Audrey; Khan, Omar; Beemiller, Peter; Oswald, Erin; Hu, Joyce; Matloubian, Mehrdad; Krummel, Matthew F.			Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							LYMPH-NODES; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; IMMUNE-RESPONSE; NAIVE CELLS; MEMORY; EFFECTOR; INFECTION; DYNAMICS; PROLIFERATION	Immunization results in the differentiation of CD8(+) T cells, such that they acquire effector abilities and convert into a memory pool. Priming of T cells takes place via an immunological synapse formed with an antigen-presenting cell (APC). By disrupting synaptic stability at different times, we found that the differentiation of CD8(+) T cells required cell interactions beyond those made with APCs. We identified a critical differentiation period that required interactions between primed T cells. We found that T cell-T cell synapses had a major role in the generation of protective CD8(+) T cell memory. T cell-T cell synapses allowed T cells to polarize critical secretion of interferon-gamma (IFN-gamma) toward each other. Collective activation and homotypic clustering drove cytokine sharing and acted as regulatory stimuli for T cell differentiation.	[Gerard, Audrey; Khan, Omar; Beemiller, Peter; Oswald, Erin; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Hu, Joyce; Matloubian, Mehrdad] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gerard, A (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	audrey.gerard@ucsf.edu; matthew.krummel@ucsf.edu		Beemiller, Peter/0000-0002-2736-3405; Khan, Omar/0000-0002-7641-6163	Juvenile Diabetes Foundation; US National Institutes of Health [R01AI52116]; NATIONAL CANCER INSTITUTE [U01CA141451] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER	Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Nussenzeig (Rockefeller University) for CD11c-YFP mice; M. Coles (Medial Research Council, York) for CD2-RFP mice; R. Locksley (University of California at San Francisco) for YETI mice; and personnel of the Biological Imaging Development Center for technical assistance with imaging. Supported by the Juvenile Diabetes Foundation (M.F.K.) and the US National Institutes of Health (R01AI52116 to M.F.K.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Doh J, 2010, CURR TOP MICROBIOL, V340, P25, DOI 10.1007/978-3-642-03858-7_2; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Maldonado RA, 2009, J EXP MED, V206, P877, DOI 10.1084/jem.20082900; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Sercan O, 2010, J IMMUNOL, V184, P2855, DOI 10.4049/jimmunol.0902708; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Thaventhiran JED, 2012, P NATL ACAD SCI USA, V109, pE2223, DOI 10.1073/pnas.1209115109; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	46	93	95	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					356	363		10.1038/ni.2547	http://dx.doi.org/10.1038/ni.2547			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23475183	Green Accepted			2022-12-18	WOS:000316648700010
J	Vinuesa, CG; Chang, PP				Vinuesa, Carola G.; Chang, Pheh-Ping			Innate B cell helpers reveal novel types of antibody responses	NATURE IMMUNOLOGY			English	Review							SPLENIC MARGINAL ZONE; INDEPENDENT GERMINAL-CENTERS; TOLL-LIKE RECEPTORS; T-CELLS; DENDRITIC CELLS; MAST-CELLS; SOMATIC HYPERMUTATION; FORMING-CELLS; COGNATE HELP; BONE-MARROW	Antibody responses are classified according to whether B cells receive help from T cells that is, whether they are thymus-dependent (TD) responses or thymus-independent (TI) responses. The latter can be elicited by microbial ligands (TI type 1) or by extensive crosslinking of the B cell antigen receptor (BCR; TI type 2). The hallmark of a TD response is the induction of germinal centers in which follicular helper T cells (T-FH cells) select B cells with somatically mutated high-affinity BCRs to become memory cells. Studies have shown that B cells can also receive innate TD help from natural killer T cells (NKT cells) and innate TI help from cells such as neutrophils but that the outcome of such help differs from conventional TD and TI responses. Here we update the classification of antibody responses to take into account these emerging types of B cell helpers.	[Vinuesa, Carola G.; Chang, Pheh-Ping] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298; Chang, Pheh Ping/0000-0002-3395-4746				Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BRALEYMULLEN H, 1978, J EXP MED, V147, P1824, DOI 10.1084/jem.147.6.1824; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chorny A, 2010, ADV IMMUNOL, V107, P31, DOI [10.1016/S0065-2776(10)07006-9, 10.1016/B978-0-12-381300-8.00002-2]; Chu VT, 2012, EUR J IMMUNOL, V42, P130, DOI 10.1002/eji.201141953; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Craxton A, 2003, BLOOD, V101, P4464, DOI 10.1182/blood-2002-10-3123; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Day N, 2004, J PEDIATR-US, V144, P524, DOI 10.1016/j.jpeds.2003.11.025; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Detre C, 2012, BLOOD, V120, P122, DOI 10.1182/blood-2011-11-395913; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fujii S., 2007, IMMUNOL REV, V220, P183; Gaspal FMC, 2006, EUR J IMMUNOL, V36, P1665, DOI 10.1002/eji.200535339; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Henz BM, 2001, EXP DERMATOL, V10, P1, DOI 10.1034/j.1600-0625.2001.100101.x; Hsu MC, 2006, P NATL ACAD SCI USA, V103, P5905, DOI 10.1073/pnas.0601502103; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Kim S, 2009, J IMMUNOL, V183, P3033, DOI 10.4049/jimmunol.0900332; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lentz VM, 2001, J IMMUNOL, V167, P15, DOI 10.4049/jimmunol.167.1.15; Leon B, 2008, IMMUNOL CELL BIOL, V86, P320, DOI 10.1038/icb.2008.14; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Merluzzi S, 2010, BLOOD, V115, P2810, DOI 10.1182/blood-2009-10-250126; Minguet S, 2008, EUR J IMMUNOL, V38, P2475, DOI 10.1002/eji.200738094; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; MOSIER DE, 1982, IMMUNOL TODAY, V3, P217, DOI 10.1016/0167-5699(82)90095-0; MOSIER DE, 1977, J IMMUNOL, V119, P1874; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; NOELLE RJ, 1990, IMMUNOL TODAY, V11, P361, DOI 10.1016/0167-5699(90)90142-V; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Snapper CM, 2001, TRENDS IMMUNOL, V22, P308, DOI 10.1016/S1471-4906(01)01926-3; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Spencer LA, 2010, IMMUNOL CELL BIOL, V88, P250, DOI 10.1038/icb.2009.115; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Taillardet M, 2009, BLOOD, V114, P4432, DOI 10.1182/blood-2009-01-200014; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Tonti E, 2012, J IMMUNOL, V188, P3217, DOI 10.4049/jimmunol.1103501; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wang HB, 2008, J LEUKOCYTE BIOL, V83, P817, DOI 10.1189/jlb.0607392; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Zietara N, 2011, EUR J IMMUNOL, V41, P3125, DOI 10.1002/eji.201041092	106	93	94	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					119	126		10.1038/ni.2511	http://dx.doi.org/10.1038/ni.2511			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334833				2022-12-18	WOS:000313918400006
J	Yamane, H; Paul, WE				Yamane, Hidehiro; Paul, William E.			Cytokines of the gamma(c) family control CD4(+) T cell differentiation and function	NATURE IMMUNOLOGY			English	Review							FOLLICULAR HELPER-CELL; TRANSCRIPTION FACTOR GATA-3; CXC CHEMOKINE RECEPTOR-5; NF-KAPPA-B; TGF-BETA; RETINOIC-ACID; IN-VIVO; DENDRITIC CELLS; MOLECULAR-MECHANISMS; IMMUNE-RESPONSES	Naive CD4(+) T cells undergo massive proliferation and differentiation into at least four distinct helper T cell subsets after recognition of foreign antigen-derived peptides presented by dendritic cells. Each helper T cell subset expresses a distinct set of genes that encode unique transcription factor(s), as well as hallmark cytokines. The cytokine environment created by activated CD4(+) T cells, dendritic cells and/or other cell types during the course of differentiation is a major determinant for the helper T cell fate. This Review focuses on the role of cytokines of the common gamma-chain (gamma(c)) family in the determination of the effector helper T cell phenotype that naive CD4(+) T cells adopt after being activated and in the function of these helper T cells.	[Yamane, Hidehiro; Paul, William E.] NIAID, Cytokine Biol Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yamane, H (corresponding author), NIAID, Cytokine Biol Unit, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hyamane@niaid.nih.gov; wpaul@niaid.nih.gov			Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000969, ZIAAI000493] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health).	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Altin JA, 2011, J ALLERGY CLIN IMMUN, V127, P1277, DOI 10.1016/j.jaci.2010.12.1081; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chang JT, 2000, J IMMUNOL, V164, P100, DOI 10.4049/jimmunol.164.1.100; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Crotty S., 2011, ANNU REV IMMUNOL, V29, P621; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; M'Hidi H, 2009, AM J CLIN PATHOL, V132, P589, DOI 10.1309/AJCPPHKGYYGGL39C; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Molinero LL, 2011, J IMMUNOL, V186, P4609, DOI 10.4049/jimmunol.1002361; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vicente R, 2010, SEMIN IMMUNOL, V22, P270, DOI 10.1016/j.smim.2010.04.016; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamane H, 2012, CELL MOL LIFE SCI, V69, P1577, DOI 10.1007/s00018-012-0966-9; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	100	93	96	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1037	1044		10.1038/ni.2431	http://dx.doi.org/10.1038/ni.2431			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23080204	Green Accepted			2022-12-18	WOS:000310091700006
J	Round, JL; Humphries, LA; Tomassian, T; Mittelstadt, P; Zhang, M; Miceli, MC				Round, June L.; Humphries, Lisa A.; Tomassian, Tamar; Mittelstadt, Paul; Zhang, Min; Miceli, M. Carrie			Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappa B transcription factors	NATURE IMMUNOLOGY			English	Article							WISKOTT-ALDRICH-SYNDROME; IMMUNE-RESPONSES; NUCLEAR FACTOR; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE-ACTIVATION; ACTIN POLYMERIZATION; PLASMA-MEMBRANE; GENE-EXPRESSION; MAGUK FAMILY; C-THETA	Tyrosine kinases couple the T cell receptor (TCR) to discrete signaling cascades, each of which is capable of inducing a distinct functional outcome. Precisely how TCR signals are channeled toward specific targets remains unclear. TCR stimulation triggers 'alternative' activation of the mitogen-activated protein kinase p38, whereby the Lck and Zap70 tyrosine kinases directly activate p38. Here we report that alternatively activated p38 associated with the Dlgh1 MAGUK scaffold protein. 'Knockdown' of Dlgh1 expression blocked TCR-induced activation of p38 and the transcription factor NFAT but not of the mitogen-activated protein kinase Jnk or transcription factor NF-kappa B. A Dlgh1 mutant incapable of binding p38 failed to activate NFAT. Along with reports that the CARMA1 MAGUK scaffold protein coordinates activation of Jnk and NF-kappa B but not of p38 or NFAT, our findings identify MAGUK scaffold proteins as 'orchestrators' of TCR signal specificity.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90066 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90066 USA; NCI, Ctr Canc Res, Lab Immune Cell Biol, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Miceli, MC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90066 USA.	cmiceli@ucla.edu			NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, T32AI007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16042] Funding Source: Medline; NIAID NIH HHS [2-T32-AI07323, AI-28697, AI07126-30] Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline; PHS HHS [R01A1056155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abbas AK, 2003, IMMUNITY, V18, P721, DOI 10.1016/S1074-7613(03)00143-2; Attar RM, 1998, MOL CELL BIOL, V18, P477, DOI 10.1128/MCB.18.1.477; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Geng LP, 2002, BRIT J HAEMATOL, V116, P19, DOI 10.1046/j.1365-2141.2002.03243.x; GOMEZ DA, 2000, J BIOL CHEM, V275, P13872; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Im SH, 2004, MOL CELLS, V18, P1; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Rudd CE, 2005, NAT IMMUNOL, V6, P368, DOI 10.1038/ni0405-368; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; San-Antonio B, 2002, J BIOL CHEM, V277, P27073, DOI 10.1074/jbc.M106983200; Serfling E, 2004, INT J BIOCHEM CELL B, V36, P1166, DOI 10.1016/j.biocel.2003.07.002; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wu CC, 2003, MOL CELL BIOL, V23, P6442, DOI 10.1128/MCB.23.18.6442-6454.2003; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	49	93	98	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					154	161		10.1038/ni1422	http://dx.doi.org/10.1038/ni1422			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17187070				2022-12-18	WOS:000243597600013
J	Nunez-Cruz, S; Aguado, E; Richelme, S; Chetaille, B; Mura, AM; Richelme, M; Pouyet, L; Jouvin-Marche, E; Xerri, L; Malissen, B; Malissen, M				Nunez-Cruz, S; Aguado, E; Richelme, S; Chetaille, B; Mura, AM; Richelme, M; Pouyet, L; Jouvin-Marche, E; Xerri, L; Malissen, B; Malissen, M			LAT regulates gamma delta T cell homeostasis and differentiation	NATURE IMMUNOLOGY			English	Article							PHOSPHOLIPASE C-GAMMA-1; THYMOCYTE DEVELOPMENT; DEFAULT PRODUCTION; TYROSINE RESIDUES; IFN-GAMMA; ACTIVATION; TCR; EXPRESSION; MICE; MUTATION	LAT (linker for activation of T cells) is essential for T cell receptor signaling. Mice homozygous for a mutation of the three C-terminal LAT tyrosine residues showed a block in alphabeta T cell development and a partially impaired gammadelta T cell development. Without intentional immunization, they accumulated gammadelta T cells in the spleen and lymph nodes that chronically produced T helper type 2 cytokines in large amounts, and caused the maturation of plasma cells secreting immunoglobulin E (IgE) and IgG1. These effects are very similar to that triggered in the alphabeta lineage by a mutation involving a distinct LAT tyrosine. Thus, LAT is an essential regulator of T cell homeostasis and terminal differentiation.	Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille 9, France; Inst J Paoli I Calmettes, F-13009 Marseille 9, France; Univ Grenoble 1, INSERM, U548, Commissariat Energie Atom,Lab Immunochim, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Malissen, B (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Aguado, Enrique/L-4908-2014; JOUVIN MARCHE, Evelyne/L-8648-2013; Malissen, Bernard/AAK-4659-2020	Aguado, Enrique/0000-0002-7232-2661; JOUVIN MARCHE, Evelyne/0000-0001-8616-138X; Malissen, Marie/0000-0003-2331-1445; Malissen, Bernard/0000-0003-1340-9342				Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Arnulf B, 1998, BLOOD, V91, P1723; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bhan A K, 2000, Int Rev Immunol, V19, P123, DOI 10.3109/08830180009048393; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Egan PJ, 2000, J EXP MED, V191, P2145, DOI 10.1084/jem.191.12.2145; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239; JAFFE SE, 2001, WHO CLASSIFICATION T; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Leduc I, 2000, J IMMUNOL, V165, P1364, DOI 10.4049/jimmunol.165.3.1364; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Malissen B, 1999, ADV IMMUNOL, V72, P103, DOI 10.1016/S0065-2776(08)60018-8; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; MUNK ME, 1995, INFECT IMMUN, V63, P1608, DOI 10.1128/IAI.63.4.1608-1610.1995; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Perron H, 2001, VIROLOGY, V287, P321, DOI 10.1006/viro.2001.1045; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Sallusto F, 2002, ARTHRITIS RES THER, V4, pS127, DOI 10.1186/ar567; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Swat W, 2003, INT IMMUNOL, V15, P215, DOI 10.1093/intimm/dxg021; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wen L, 1998, J IMMUNOL, V160, P1965; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yamasaki S, 2003, MOL CELL BIOL, V23, P2515, DOI 10.1128/MCB.23.7.2515-2529.2003; Yin ZN, 2000, J IMMUNOL, V164, P3056, DOI 10.4049/jimmunol.164.6.3056; Yin ZN, 2002, J IMMUNOL, V168, P1566, DOI 10.4049/jimmunol.168.4.1566; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325; ZORBAS M, 1993, EUR J IMMUNOL, V23, P1655, DOI 10.1002/eji.1830230739	51	93	94	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					999	1008		10.1038/ni977	http://dx.doi.org/10.1038/ni977			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12970761				2022-12-18	WOS:000185590100016
J	Clement, RL; Daccache, J; Mohammed, MT; Diallo, A; Blazar, BR; Kuchroo, VK; Lovitch, SB; Sharpe, AH; Sage, PT				Clement, Rachel L.; Daccache, Joe; Mohammed, Mostafa T.; Diallo, Alos; Blazar, Bruce R.; Kuchroo, Vijay K.; Lovitch, Scott B.; Sharpe, Arlene H.; Sage, Peter T.			Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses	NATURE IMMUNOLOGY			English	Article							HELPER; GENERATION; PLAYS	Follicular regulatory T (T-FR) cells have specialized roles in modulating follicular helper T (T-FH) cell activation of B cells. However, the precise role of T-FR cells in controlling antibody responses to foreign antigens and autoantigens in vivo is still unclear due to a lack of specific tools. A T-FR cell-deleter mouse was developed that selectively deletes T-FR cells, facilitating temporal studies. T-FR cells were found to regulate early, but not late, germinal center (GC) responses to control antigen-specific antibody and B cell memory. Deletion of T-FR cells also resulted in increased self-reactive immunoglobulin (Ig) G and IgE. The increased IgE levels led us to interrogate the role of T-FR cells in house dust mite models. T-FR cells were found to control T(FH)13 cell-induced IgE. In vivo, loss of T-FR cells increased house-dust-mite-specific IgE and lung inflammation. Thus, T-FR cells control IgG and IgE responses to vaccines, allergens and autoantigens, and exert critical immunoregulatory functions before GC formation.	[Clement, Rachel L.; Daccache, Joe; Mohammed, Mostafa T.; Sage, Peter T.] Harvard Med Sch, Transplantat Res Ctr, Renal Div, Brigham & Womens Hosp, Boston, MA 02115 USA; [Diallo, Alos; Sharpe, Arlene H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Kuchroo, Vijay K.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Broad Inst, Cambridge, MA USA; [Kuchroo, Vijay K.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Lovitch, Scott B.; Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Sage, PT (corresponding author), Harvard Med Sch, Transplantat Res Ctr, Renal Div, Brigham & Womens Hosp, Boston, MA 02115 USA.	psage@bwh.harvard.edu		Diallo, Alos/0000-0002-6471-4630; Clement, Rachel/0000-0003-1422-9140; Sharpe, Arlene/0000-0002-9736-2109; Sage, Peter/0000-0002-7287-0326; Lovitch, Scott/0000-0001-9013-0105	US National Institutes of Health [K22AI132937, P01AI056299, R37AI34495, R01HL11879]; Evergrande Center for Immunologic Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI132937, P01AI056299, R37AI034495] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evergrande Center for Immunologic Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank T. Chatila, R. Anthony, D. Wesemann and M. Carroll for helpful discussions, the MICRON imaging core for help with microscopy and H. Wekerle and S. Zamvil for reagents. This work was supported by the US National Institutes of Health through grant nos. K22AI132937 (P. T. S.), P01AI056299 (A. H. S.), R37AI34495 (B.R.B.) and R01HL11879 (B.R.B.), and the Evergrande Center for Immunologic Diseases.	Ballesteros-Tato A, 2016, IMMUNITY, V44, P259, DOI 10.1016/j.immuni.2015.11.017; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Crawford G, 2018, NAT IMMUNOL, V19, P859, DOI 10.1038/s41590-018-0161-8; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Hou S, 2019, J EXP MED, V216, P605, DOI 10.1084/jem.20181134; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Laidlaw BJ, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan4767; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Maceiras AR, 2017, IMMUNOLOGY, V152, P25, DOI 10.1111/imm.12774; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mulero P, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418773025; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Sage PT, 2018, J IMMUNOL, V200, P2592, DOI 10.4049/jimmunol.1701231; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sage PT, 2015, METHODS MOL BIOL, V1291, P151, DOI 10.1007/978-1-4939-2498-1_13; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sayin I, 2018, J EXP MED, V215, P1531, DOI 10.1084/jem.20171940; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103	43	92	96	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1360	+		10.1038/s41590-019-0472-4	http://dx.doi.org/10.1038/s41590-019-0472-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31477921	Green Accepted			2022-12-18	WOS:000486615900019
J	Wang, F; Beck-Garcia, K; Zorzin, C; Schamel, WWA; Davis, MM				Wang, Feng; Beck-Garcia, Katharina; Zorzin, Carina; Schamel, Wolfgang W. A.; Davis, Mark M.			Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol	NATURE IMMUNOLOGY			English	Article							CLONAL DELETION; IN-SITU; TCR; SELECTION; LIGAND; SENSITIVITY; ACTIVATION; EFFECTOR; AVIDITY; ORGANIZATION	Most adaptive immune responses require the activation of specific T cells through the T cell antigen receptor (TCR)-CD3 complex. Here we show that cholesterol sulfate (CS), a naturally occurring analog of cholesterol, inhibits CD3 ITAM phosphorylation, a crucial first step in T cell activation. In biochemical studies, CS disrupted TCR multimers, apparently by displacing cholesterol, which is known to bind TCR beta. Moreover, CS-deficient mice showed heightened sensitivity to a self-antigen, whereas increasing CS content by intrathymic injection inhibited thymic selection, indicating that this molecule is an intrinsic regulator of thymocyte development. These results reveal a regulatory role for CS in TCR signaling and thymic selection, highlighting the importance of the membrane microenvironment in modulating cell surface receptor activation.	[Wang, Feng; Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Wang, Feng; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Beck-Garcia, Katharina; Zorzin, Carina; Schamel, Wolfgang W. A.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Hugstetter Str 55, D-79106 Freiburg, Germany; [Beck-Garcia, Katharina; Zorzin, Carina; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Beck-Garcia, Katharina; Zorzin, Carina; Schamel, Wolfgang W. A.] Univ Freiburg, Ctr Chron Immunodeficiency, Hugstetter Str 55, D-79106 Freiburg, Germany; [Beck-Garcia, Katharina] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Hugstetter Str 55, D-79106 Freiburg, Germany; [Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X	US National Institutes of Health [R01 AI022511, U19 AI 090019, U19-AI057229]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [EXC294, SCHA 976/2-1]; Excellence Initiative of the Deutsche Forschungsgemeinschaft (Spemann Graduate School) [GSC-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI022511] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the Deutsche Forschungsgemeinschaft (Spemann Graduate School); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y.-H. Chien, A. Habtezion, Y. Wong and M. Lozano for helpful discussions; X. Zeng, E.W. Newell, W.O. Gorman, L. Wagar, J. Xie, K.H. Roh, A. Morath, M. Swamy, J. Huppa and J. Huang for experimental assistance; D. Russell for providing Sult2b1<SUP>-/-</SUP> mouse embryos. Supported by the US National Institutes of Health (R01 AI022511, U19 AI 090019 and U19-AI057229 to M.M.D.) and the Howard Hughes Medical Institute (M.M.D.). W.W.A.S. received grants from the Deutsche Forschungsgemeinschaft through EXC294 and SCHA 976/2-1. This study was also supported in part by the Excellence Initiative of the Deutsche Forschungsgemeinschaft (GSC-4, Spemann Graduate School).	Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Beck-Garcia E, 2013, ANAL BIOCHEM, V436, P75, DOI 10.1016/j.ab.2013.01.026; BERGNER EA, 1981, J CLIN ENDOCR METAB, V53, P221, DOI 10.1210/jcem-53-1-220; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; EPSTEIN EH, 1981, SCIENCE, V214, P659, DOI 10.1126/science.6945674; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fuda H, 2002, J BIOL CHEM, V277, P36161, DOI 10.1074/jbc.M207165200; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; HOGQUIST KA, 1994, CURR OPIN IMMUNOL, V6, P273, DOI 10.1016/0952-7915(94)90101-5; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Schaffert SA, 2015, J IMMUNOL, V195, P1470, DOI 10.4049/jimmunol.1401587; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WILLIAMS ML, 1981, J CLIN INVEST, V68, P1404, DOI 10.1172/JCI110391; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	50	92	95	7	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					844	+		10.1038/ni.3462	http://dx.doi.org/10.1038/ni.3462			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27213689	Green Accepted			2022-12-18	WOS:000378283200017
J	Beringer, DX; Kleijwegt, FS; Wiede, F; van der Slik, AR; Loh, KL; Petersen, J; Dudek, NL; Duinkerken, G; Laban, S; Joosten, A; Vivian, JP; Chen, ZJ; Uldrich, AP; Godfrey, DI; McCluskey, J; Price, DA; Radford, KJ; Purcell, AW; Nikolic, T; Reid, HH; Tiganis, T; Roep, BO; Rossjohn, J				Beringer, Dennis X.; Kleijwegt, Fleur S.; Wiede, Florian; van der Slik, Arno R.; Loh, Khai Lee; Petersen, Jan; Dudek, Nadine L.; Duinkerken, Gaby; Laban, Sandra; Joosten, Antoinette; Vivian, Julian P.; Chen, Zhenjun; Uldrich, Adam P.; Godfrey, Dale I.; McCluskey, James; Price, David A.; Radford, Kristen J.; Purcell, Anthony W.; Nikolic, Tatjana; Reid, Hugh H.; Tiganis, Tony; Roep, Bart O.; Rossjohn, Jamie			T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex	NATURE IMMUNOLOGY			English	Article							STRUCTURAL BASIS; DENDRITIC CELLS; GERMLINE BIAS; CLASS-I; MHC; TCR; TOLERANCE; RESPONSES; USAGE; CD4	Central to adaptive immunity is the interaction between the alpha beta T cell receptor (TCR) and peptide presented by the major histocompatibility complex (MHC) molecule. Presumably reflecting TCR-MHC bias and T cell signaling constraints, the TCR universally adopts a canonical polarity atop the MHC. We report the structures of two TCRs, derived from human induced T regulatory (iT(reg)) cells, complexed to an MHC class II molecule presenting a proinsulin-derived peptide. The ternary complexes revealed a 1800 polarity reversal compared to all other TCR-peptide-MHC complex structures. Namely, the iT(reg) TCR alpha-chain and beta-chain are overlaid with the alpha-chain and beta-chain of MHC class II, respectively. Nevertheless, this TCR interaction elicited a peptide-reactive, MHC-restricted T cell signal. Thus TCRs are not 'hardwired' to interact with MHC molecules in a stereotypic manner to elicit a T cell signal, a finding that fundamentally challenges our understanding of TCR recognition.	[Beringer, Dennis X.; Wiede, Florian; Loh, Khai Lee; Petersen, Jan; Dudek, Nadine L.; Vivian, Julian P.; Purcell, Anthony W.; Reid, Hugh H.; Tiganis, Tony; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [Beringer, Dennis X.; Wiede, Florian; Loh, Khai Lee; Petersen, Jan; Dudek, Nadine L.; Vivian, Julian P.; Purcell, Anthony W.; Reid, Hugh H.; Tiganis, Tony; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Kleijwegt, Fleur S.; van der Slik, Arno R.; Duinkerken, Gaby; Laban, Sandra; Joosten, Antoinette; Nikolic, Tatjana; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Petersen, Jan; Vivian, Julian P.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Chen, Zhenjun; Uldrich, Adam P.; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Parkville, Vic 3052, Australia; [Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia; [Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Price, David A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Radford, Kristen J.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Radford, Kristen J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Monash University; Monash University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University; University of Melbourne; University of Melbourne; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mater Research; University of Queensland; University of Queensland	Reid, HH (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia.	tony.tiganis@monash.edu; B.O.Roep@lumc.nl; jamie.rossjohn@monash.edu	Radford, Kristen J/B-5550-2011; McCluskey, James/A-1291-2007; Tiganis, Tony/AAV-3495-2020; Purcell, Anthony/AAH-1942-2019; Roep, Bart/AAD-7609-2021; Uldrich, Adam/AAX-3785-2020; NIkolic, Tatjana/I-2162-2012; Rossjohn, Jamie/F-9032-2013; Price, David A/C-7876-2013	Radford, Kristen J/0000-0001-6512-6323; McCluskey, James/0000-0002-8597-815X; Tiganis, Tony/0000-0002-8065-9942; Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; Price, David A/0000-0001-9416-2737; Laban, Sandra/0000-0003-2710-4531; Wiede, Florian/0000-0001-5145-7180; Vivian, Julian/0000-0002-9400-4437; van der Slik, Arno/0000-0002-8920-0118; Loh, Khai Lee/0000-0002-2211-2404; Godfrey, Dale/0000-0002-3009-5472; Beringer, Dennis/0000-0002-5986-1134; ULDRICH, ADAM/0000-0002-6350-5976	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); Netherlands Organization for Scientific Research [VICI 918.86.611]; European Union [241447]; National Diabetes Expert Center - Dutch Diabetes Research Foundation (DEN); Diabetes Research Netherlands (DON) Foundation; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); National Diabetes Expert Center - Dutch Diabetes Research Foundation (DEN); Diabetes Research Netherlands (DON) Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank staff at the Australian synchrotron, the Leiden University Medical Center, the Monash Macromolecular Crystallization Facility, T. Beddoe, J. Teeler, C. van der Torren, S. Scally, M. Tran, S. Gras, K. Ladell, G. Dolton, R. Ayala-Perez and R. Berry for assistance. This work was supported by the Australian Research Council (ARC) and the National Health and Medical Research Council of Australia (NHMRC). A.P.U. is an ARC Future Fellow, D.I.G. is an NHMRC Senior Principal Research Fellow, D.A.P. is a Wellcome Trust Senior Investigator, K.J.R. is an NHMRC Career Development Fellow, A.W.P. is an NHMRC Senior Research Fellow, T.T. is an NHMRC Principal Research Fellow and K.J.R. is an NHMRC Australia Fellow. F.S.K., A.J. and B.O.R. are supported by the Netherlands Organization for Scientific Research (VICI 918.86.611), T.N. and S.L. are supported by the European Union 7th Framework Program (FP7/2007-2013) under Grant No. 241447 (Novel Immunotherapies for Type I Diabetes (NIAMIT)) and G.D. and A.R.v.d.S. are supported by the National Diabetes Expert Center funded by the Dutch Diabetes Research Foundation (DFN) and the Diabetes Research Netherlands (DON) Foundation.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Ferreira GB, 2015, CELL REP, V10, P711, DOI 10.1016/j.celrep.2015.01.013; Ferreira GB, 2012, J PROTEOME RES, V11, P941, DOI 10.1021/pr200724e; Fuchs EJ, 2014, IMMUNOL REV, V258, P64, DOI 10.1111/imr.12154; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kleijwegt FS, 2011, J IMMUNOL, V187, P6357, DOI 10.4049/jimmunol.1101638; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Scott-Browne JP, 2011, IMMUNITY, V35, P526, DOI 10.1016/j.immuni.2011.09.005; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	39	92	94	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1153	1161		10.1038/ni.3271	http://dx.doi.org/10.1038/ni.3271			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26437244				2022-12-18	WOS:000363096000009
J	McLaren, PJ; Carrington, M				McLaren, Paul J.; Carrington, Mary			The impact of host genetic variation on infection with HIV-1	NATURE IMMUNOLOGY			English	Review							HLA-C EXPRESSION; GENOME-WIDE ASSOCIATION; CELL-SURFACE EXPRESSION; CLASS-I; UNINFECTED INDIVIDUALS; SEX-DIFFERENCES; VIRAL LOAD; MHC; PROGRESSION; VARIANTS	The outcome after infection with the human immunodeficiency virus type 1 (HIV-1) is a complex phenotype determined by interactions among the pathogen, the human host and the surrounding environment. An impact of host genetic variation on HIV-1 susceptibility was identified early in the pandemic, with a major role attributed to the genes encoding class I human leukocyte antigens (HLA) and the chemokine receptor CCR5. Studies using genome-wide data sets have underscored the strength of these associations relative to variants located throughout the rest of the genome. However, the extent to which additional polymorphisms influence HIV-1 disease progression, and how much of the variability in outcome can be attributed to host genetics, remain largely unclear. Here we discuss findings concerning the functional impact of associated variants, outline methods for quantifying the host genetic component and examine how available genome-wide data sets may be leveraged to discover gene variants that affect the outcome of HIV-1 infection.	[McLaren, Paul J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Carrington, Mary] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD USA; [Carrington, Mary] Ragon Inst MGH & Harvard, Cambridge, MA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	McLaren, PJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.	paul.mclaren@epfl.ch; carringm@mail.nih.gov		McLaren, Paul/0000-0001-6019-7018	Frederick National Laboratory for Cancer Research [HHSN261200800001E]; National Institutes of Health, Frederick National Laboratory, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Frederick National Laboratory, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Bashirova and I. Bartha for helpful suggestions. This project was funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the National Institutes of Health, Frederick National Laboratory, Center for Cancer Research.	Akashi H, 2012, GENETICS, V192, P15, DOI 10.1534/genetics.112.140178; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bartha I, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-6; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Carrington M, 2013, AIDS, V27, P2831, DOI 10.1097/01.aids.0000432536.85335.c8; Chang J, 2011, AIDS, V25, P715, DOI 10.1097/QAD.0b013e328343c186; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaufman J, 1997, HEREDITAS, V127, P67, DOI 10.1111/j.1601-5223.1997.t01-1-00067.x; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Konttinen Y, 2009, IMMUNOTHERAPY-UK, V1, P929, DOI 10.2217/IMT.09.71; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lane J, 2013, HUM MOL GENET, V22, P1903, DOI 10.1093/hmg/ddt033; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lodi S, 2012, ARCH INTERN MED, V172, P1252, DOI 10.1001/archinternmed.2012.2719; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mackelprang RD, 2015, J VIROL, V89, P2104, DOI 10.1128/JVI.01573-14; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Prentice HA, 2014, IMMUNOGENETICS, V66, P299, DOI 10.1007/s00251-014-0765-6; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Pyo CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-89; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Regoes RR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001951; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Dorp CH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003899; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031	73	92	92	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					577	583		10.1038/ni.3147	http://dx.doi.org/10.1038/ni.3147			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988890	Green Accepted			2022-12-18	WOS:000354751900006
J	Beaulieu, AM; Zawislak, CL; Nakayama, T; Sun, JC				Beaulieu, Aimee M.; Zawislak, Carolyn L.; Nakayama, Toshinori; Sun, Joseph C.			The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER FORMATION; DELTA T-CELLS; ZINC-FINGER; LINEAGE FATE; ACTIVATION; EXPRESSION; CYTOMEGALOVIRUS; REPRESSOR; BLIMP-1; BCL6	Natural killer (NK) cells are innate lymphocytes that exhibit many features of adaptive immunity, including clonal proliferation and long-lived memory. Here we demonstrate that the BTB-ZF transcription factor Zbtb32 (also known as ROG, FAZF, TZFP and PLZP) was essential for the proliferative burst and protective capacity of virus-specific NK cells. Signals from proinflammatory cytokines were both necessary and sufficient to induce high expression of Zbtb32 in NK cells. Zbtb32 facilitated NK cell proliferation during infection by antagonizing the anti-proliferative factor Blimp-1 (Prdm1). Our data support a model in which Zbtb32 acts as a cellular 'hub' through which proinflammatory signals instruct a 'proliferation-permissive' state in NK cells, thereby allowing their prolific expansion in response to viral infection.	[Beaulieu, Aimee M.; Zawislak, Carolyn L.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan	Memorial Sloan Kettering Cancer Center; Chiba University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	sunj@mskcc.org	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007	US National Institutes of Health [CA009149]; Searle Scholars Program; Cancer Research Institute; National Institutes of Health [AI085034, AI100874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100874, R00AI085034, K04AI000874] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26221305] Funding Source: KAKEN	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Sun lab for technical support and experimental assistance, members of the Memorial Sloan-Kettering NK club for insightful comments and helpful discussions, A. Rudensky, M. van den Brink, M. Li, L. Lanier (University of California San Francisco), D. Sant'Angelo (Rutgers University) and L. Denzin (Rutgers University) for sharing antibodies and flow cytometry resources and for providing expertise critical to this study and manuscript, G. Gasteiger, K. Schluns (M.D. Anderson) and U. Koszinowski (Max von Pettenkofer-Institute) for providing many of the parent and recombinant viruses used in our study, S. Way (University of Minnesota) for providing femurs from Il12rb2<SUP>-/-</SUP> x Ifnar1<SUP>-/-</SUP> mice for use in making bone marrow chimeras, the Immunological Genome Consortium for providing the microarray data used in this study<SUP>26</SUP>, and J.P. Houchins and his team at R&D Systems for providing the experimental anti-Zbtb32 flow cytometry antibody used in this study. A.M.B. was supported by US National Institutes of Health T32 award (CA009149). J.C.S. was supported by the Searle Scholars Program, the Cancer Research Institute, and grants from the National Institutes of Health (AI085034 and AI100874).	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beaulieu AM, 2011, J IMMUNOL, V187, P2841, DOI 10.4049/jimmunol.1004006; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dunkle A, 2013, J IMMUNOL, V190, P940, DOI 10.4049/jimmunol.1103481; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Hirasaki Y, 2011, CLIN IMMUNOL, V139, P267, DOI 10.1016/j.clim.2011.02.009; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Miaw SC, 2004, J IMMUNOL, V172, P170, DOI 10.4049/jimmunol.172.1.170; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Sakurai N, 2011, J CLIN INVEST, V121, P2583, DOI 10.1172/JCI45682; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shin HM, 2013, IMMUNITY, V39, P661, DOI 10.1016/j.immuni.2013.08.032; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	53	92	98	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					546	553		10.1038/ni.2876	http://dx.doi.org/10.1038/ni.2876			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24747678	Green Accepted			2022-12-18	WOS:000336419300011
J	Kong, KF; Fu, G; Zhang, YY; Yokosuka, T; Casas, J; Canonigo-Balancio, AJ; Becart, S; Kim, G; Yates, JR; Kronenberg, M; Saito, T; Gascoigne, NRJ; Altman, A				Kong, Kok-Fai; Fu, Guo; Zhang, Yaoyang; Yokosuka, Tadashi; Casas, Javier; Canonigo-Balancio, Ann J.; Becart, Stephane; Kim, Gisen; Yates, John R., III; Kronenberg, Mitchell; Saito, Takashi; Gascoigne, Nicholas R. J.; Altman, Amnon			Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function	NATURE IMMUNOLOGY			English	Article							TCR STOP-SIGNAL; IMMUNOLOGICAL SYNAPSE; DENDRITIC CELLS; CTLA-4 FUNCTION; IN-VITRO; ACTIVATION; ANTIGEN; LOCALIZATION; COLITIS; FOXP3	Regulatory T (T-reg) cells, which maintain immune homeostasis and self-tolerance, form an immunological synapse (IS) with antigen-presenting cells (APCs). However, signaling events at the T-reg cell IS remain unknown. Here we show that the kinase PKC-eta associated with CTLA-4 and was recruited to the T-reg cell IS. PKC-eta-deficient T-reg cells displayed defective suppressive activity, including suppression of tumor immunity but not of autoimmune colitis. Phosphoproteomic and biochemical analysis revealed an association between CTLA-4-PKC-eta and the GIT2-alpha PIX-PAK complex, an IS-localized focal adhesion complex. Defective activation of this complex in PKC-eta-deficient T-reg cells was associated with reduced depletion of CD86 from APCs by T-reg cells. These results reveal a CTLA-4-PKC-eta signaling axis required for contact-dependent suppression and implicate this pathway as a potential cancer immunotherapy target.	[Kong, Kok-Fai; Canonigo-Balancio, Ann J.; Becart, Stephane; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Fu, Guo; Casas, Javier; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Zhang, Yaoyang; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Yokosuka, Tadashi; Saito, Takashi] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Yokosuka, Tadashi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Kim, Gisen; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	La Jolla Institute for Immunology; Scripps Research Institute; Scripps Research Institute; RIKEN; Japan Science & Technology Agency (JST); La Jolla Institute for Immunology; National University of Singapore	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	kfkong@liai.org; michead@nus.edu.sg; amnon@liai.org	Casas, Javier/K-7190-2015; Saito, Takashi/C-9684-2009; Kronenberg, Mitchell/AAT-6078-2021	Casas, Javier/0000-0002-6413-8127; Saito, Takashi/0000-0001-9495-3547; Zhang, Yaoyang/0000-0001-5363-9834; Yokosuka, Tadashi/0000-0002-3914-3995	US National Institutes of Health [CA35299, GM065230, P01AI089624]; LIAI-T1D-CRF 2012 Fellowship [270056]; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM065230] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIAI-T1D-CRF 2012 Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge H. Cheroutre and Y.-C. Liu for helpful discussions, the excellent services provided by members of the Flow Cytometry Core Unit at the La Jolla Institute for Allergy and Immunology, as well as the Animal Husbandry Units at LIAI and the Scripps Research Institute. This is publication number 1552 from the La Jolla Institute for Allergy and Immunology and 21923 from The Scripps Research Institute. This work was supported by US National Institutes of Health grants CA35299 (A.A.), GM065230 (N.R.J.G.) and P01AI089624 (M.K.). K.-F.K. was supported by LIAI-T1D-CRF 2012 Fellowship and Young Investigator Award # 270056 from the Melanoma Research Alliance.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002058; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kataoka H, 2005, INT IMMUNOL, V17, P421, DOI 10.1093/intimm/dxh221; Kim G, 2008, J IMMUNOL, V181, P5278, DOI 10.4049/jimmunol.181.8.5278; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Kong KF, 2013, TRENDS IMMUNOL, V34, P234, DOI 10.1016/j.it.2013.01.002; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; Lu YN, 2012, BLOOD, V120, P4560, DOI 10.1182/blood-2012-04-421420; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Matsuda JL, 2000, J IMMUNOL, V164, P2797, DOI 10.4049/jimmunol.164.5.2797; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Peggs KS, 2009, CLIN EXP IMMUNOL, V157, P9, DOI 10.1111/j.1365-2249.2009.03912.x; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shimizu J, 1999, J IMMUNOL, V163, P5211; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	51	92	97	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					465	+		10.1038/ni.2866	http://dx.doi.org/10.1038/ni.2866			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24705298	Green Accepted			2022-12-18	WOS:000334667900012
J	Yang, XXO; Zhang, HY; Kim, BS; Niu, XY; Peng, J; Chen, YH; Kerketta, R; Lee, YH; Chang, SH; Corry, DB; Wang, DM; Watowich, SS; Dong, C				Yang, Xuexian O.; Zhang, Huiyuan; Kim, Byung-Seok; Niu, Xiaoyin; Peng, Juan; Chen, Yuhong; Kerketta, Romica; Lee, Young-Hee; Chang, Seon Hee; Corry, David B.; Wang, Demin; Watowich, Stephanie S.; Dong, Chen			The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation	NATURE IMMUNOLOGY			English	Article							TH2 DIFFERENTIATION; LINEAGE COMMITMENT; STAT5 ACTIVATION; TRANSGENIC MICE; INDUCIBLE GENE; INTERLEUKIN-4 RECEPTOR; CYTOKINE SIGNALING-1; LYMPHOID-CELLS; HELPER-CELLS; TGF-BETA	Transcription factors of the STAT family are critical in the cytokine-mediated functional differentiation of CD4(+) helper T cells. Signaling inhibitors of the SOCS family negatively regulate the activation of STAT proteins; however, their roles in the differentiation and function of helper T cells are not well understood. Here we found that the SOCS protein CIS, which was substantially induced by interleukin 4 (IL-4), negatively regulated the activation of STAT3, STAT5 and STAT6 in T cells. CIS-deficient mice spontaneously developed airway inflammation, and CIS deficiency in T cells led to greater susceptibility to experimental allergic asthma. CIS-deficient T cells showed enhanced differentiation into the TH2 and TH9 subsets of helper T cells. STAT5 and STAT6 regulated IL-9 expression by directly binding to the Il9 promoter. Our data thus demonstrate a critical role for CIS in controlling the proallergic generation of helper T cells.	[Yang, Xuexian O.; Zhang, Huiyuan; Kim, Byung-Seok; Niu, Xiaoyin; Peng, Juan; Lee, Young-Hee; Chang, Seon Hee; Watowich, Stephanie S.; Dong, Chen] MD Anderson Canc Ctr, Dept Immunobiol, Houston, TX 77030 USA; [Yang, Xuexian O.; Zhang, Huiyuan; Kim, Byung-Seok; Niu, Xiaoyin; Peng, Juan; Lee, Young-Hee; Chang, Seon Hee; Watowich, Stephanie S.; Dong, Chen] MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX USA; [Yang, Xuexian O.; Kerketta, Romica] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Niu, Xiaoyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Niu, Xiaoyin] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Peng, Juan] Wuhan Univ, Coll Basic Med, Wuhan 430072, Peoples R China; [Chen, Yuhong; Wang, Demin] Blood Res Inst, Blood Ctr Wisconsin, Milwaukee, WI USA; [Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of New Mexico; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Wuhan University; Versiti Blood Center of Wisconsin; Baylor College of Medicine; Baylor College of Medicine; Tsinghua University	Dong, C (corresponding author), MD Anderson Canc Ctr, Dept Immunobiol, Houston, TX 77030 USA.	xyang@salud.unm.edu; cdong@mdanderson.org	Zhang, Huiyuan/J-2784-2016; Wang, Demin/AAX-4449-2020; dong, chen/B-3181-2009; Chang, Seon Hee/AAQ-9521-2020; Yang, Xuexian/Y-2472-2019	Wang, Demin/0000-0001-5549-3795; dong, chen/0000-0002-0084-9130; Chang, Seon Hee/0000-0002-9389-508X; Yang, Xuexian/0000-0001-6816-7024; Watowich, Stephanie/0000-0003-1969-659X; Zhang, Huiyuan/0000-0002-1532-2462	US National Institutes of Health; Leukemia and Lymphoma Society; MD Anderson Cancer Center; Biology of Inflammation Center at Baylor College of Medicine; American Heart Association; American Cancer Society; Shanghai Board of Health Foundation; Shanghai Jiao Tong University; Ministry of Education of China; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MD Anderson Cancer Center; Biology of Inflammation Center at Baylor College of Medicine; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Shanghai Board of Health Foundation; Shanghai Jiao Tong University; Ministry of Education of China(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Rivera and J. Parker-Thornburg of the MD Anderson Genetic Engineered Mouse Facility for help in generating gene-targeted mice; A.Y. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3-GFP and Foxp3-Cre mice; C. B. Wilson (University of Washington) for CD4-Cre mice; M. Kaplan (Indiana University School of Medicine) for the STAT6VT-expressing construct; and members of the Dong laboratory for help and discussion. Supported by the US National Institutes of Health (C. D., S. S. W., D. W. and D. B. C.), the Leukemia and Lymphoma Society (C. D. and D. W.), MD Anderson Cancer Center (C. D.), the Biology of Inflammation Center at Baylor College of Medicine (D. B. C.), the American Heart Association, the American Cancer Society (X.O.Y.), the Shanghai Board of Health Foundation, Shanghai Jiao Tong University (X.N.) and the Ministry of Education of China (J.P.).	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Brender C, 2004, MOL CELL BIOL, V24, P6094, DOI 10.1128/MCB.24.13.6094-6103.2004; Bruns HA, 2003, J IMMUNOL, V170, P3478, DOI 10.4049/jimmunol.170.7.3478; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Dong C, 2009, MICROBES INFECT, V11, P584, DOI 10.1016/j.micinf.2009.04.001; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Evans KR, 2007, CANCER LETT, V249, P1, DOI 10.1016/j.canlet.2006.12.033; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Glimcher LH, 2000, GENE DEV, V14, P1693; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Hwang ES, 2002, P NATL ACAD SCI USA, V99, P13026, DOI 10.1073/pnas.202474499; Iwatsuki K, 1997, J BIOL CHEM, V272, P8149, DOI 10.1074/jbc.272.13.8149; Kasaian MT, 2008, BIOCHEM PHARMACOL, V76, P147, DOI 10.1016/j.bcp.2008.04.002; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Kubo M, 2006, CURR OPIN ALLERGY CL, V6, P361, DOI 10.1097/01.all.0000244797.48981.6d; Kubo M, 2006, CURR ALLERGY ASTHM R, V6, P32, DOI 10.1007/s11882-006-0007-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McLane MP, 1998, AM J RESP CELL MOL, V19, P713, DOI 10.1165/ajrcmb.19.5.3457; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voice J, 2004, J IMMUNOL, V172, P7289, DOI 10.4049/jimmunol.172.12.7289; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821; Ying S, 2002, CLIN EXP ALLERGY, V32, P866, DOI 10.1046/j.1365-2222.2002.01376.x; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	67	92	100	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					732	+		10.1038/ni.2633	http://dx.doi.org/10.1038/ni.2633			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23727894	Green Accepted			2022-12-18	WOS:000320509100015
J	Honda, F; Kano, H; Kanegane, H; Nonoyama, S; Kim, ES; Lee, SK; Takagi, M; Mizutani, S; Morio, T				Honda, Fumiko; Kano, Hirotsugu; Kanegane, Hirokazu; Nonoyama, Shigeaki; Kim, Eun-Sung; Lee, Sang-Kyou; Takagi, Masatoshi; Mizutani, Shuki; Morio, Tomohiro			The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils	NATURE IMMUNOLOGY			English	Article							BRUTONS-TYROSINE-KINASE; X-LINKED AGAMMAGLOBULINEMIA; B-CELL DEVELOPMENT; NADPH OXIDASE; SIGNAL-TRANSDUCTION; INHIBITOR; FAMILY; ACTIVATION; LYN; DEFICIENCY	The function of the kinase Btk in neutrophil activation is largely unexplored. Here we found that Btk-deficient neutrophils had more production of reactive oxygen species (ROS) after engagement of Toll-like receptors (TLRs) or receptors for tumor-necrosis factor (TNF), which was associated with more apoptosis and was reversed by transduction of recombinant Btk. Btk-deficient neutrophils in the resting state showed hyperphosphorylation and activation of phosphatidylinositol-3-OH kinase (PI(3)K) and protein tyrosine kinases (PTKs) and were in a 'primed' state with plasma membrane associated GTPase Rac2. In the absence of Btk, the adaptor Mal was associated with PI(3)K and PTKs at the plasma membrane, whereas in control resting neutrophils, Btk interacted with and confined Mal in the cytoplasm. Our data identify Btk as a critical gatekeeper of neutrophil responses.	[Honda, Fumiko; Takagi, Masatoshi; Mizutani, Shuki; Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kano, Hirotsugu] Teikyo Univ, Dept Pediat, Sch Med Hosp, Kawasaki, Kanagawa, Japan; [Kanegane, Hirokazu] Toyama Univ, Dept Pediat, Sch Med, Toyama 930, Japan; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 359, Japan; [Kim, Eun-Sung; Lee, Sang-Kyou] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Tokyo Medical & Dental University (TMDU); Teikyo University; University of Toyama; National Defense Medical College - Japan; Yonsei University	Morio, T (corresponding author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan.	tmorio.ped@tmd.ac.jp		Morio, Tomohiro/0000-0002-9259-1025	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Research Foundation of Korea (National Creative Research Initiatives); Grants-in-Aid for Scientific Research [21591350] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Foundation of Korea (National Creative Research Initiatives); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank E. Tsitsikov, E. Rachlin, K. Imai and J. Yata for discussions; all patients who participated in this study; S. Goo Rhee (Ewha Womans University) for antibody to Prxl phosphorylated at Tyr 194; and J.A. Lindquist (Otto-von-Guericke University) for antibody to Cbp (PAG) phosphorylated at Tyr317. Supported by the Ministry of Health, Labour and Welfare of Japan (H. Kane, S.N. and TM.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.M. and T.M.) and by the National Research Foundation of Korea (National Creative Research Initiatives grant to S.-K.L.).	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fiedler K, 2011, BLOOD, V117, P1329, DOI 10.1182/blood-2010-04-281170; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Honda F, 2012, BIOCHEM BIOPH RES CO, V417, P162, DOI 10.1016/j.bbrc.2011.11.077; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Lai JYQ, 2003, BIOORG MED CHEM LETT, V13, P3111, DOI 10.1016/S0960-894X(03)00658-9; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Marron TU, 2010, CLIN IMMUNOL, V137, P74, DOI 10.1016/j.clim.2010.06.011; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Morris AC, 2011, BLOOD, V117, P5178, DOI 10.1182/blood-2010-08-304667; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Singh A, 2009, J IMMUNOL, V182, P6410, DOI 10.4049/jimmunol.0802512; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Uckun FM, 2007, BIOORGAN MED CHEM, V15, P800, DOI 10.1016/j.bmc.2006.10.050; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	48	92	94	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					369	378		10.1038/ni.2234	http://dx.doi.org/10.1038/ni.2234			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22366891				2022-12-18	WOS:000301886800011
J	Tanaka, S; Motomura, Y; Suzuki, Y; Yagi, R; Inoue, H; Miyatake, S; Kubo, M				Tanaka, Shinya; Motomura, Yasutaka; Suzuki, Yoshie; Yagi, Ryoji; Inoue, Hiromasa; Miyatake, Shoichiro; Kubo, Masato			The enhancer HS2 critically regulates GATA-3-mediated Il4 transcription in T(H)2 cells	NATURE IMMUNOLOGY			English	Article							LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; CYTOKINE GENE-EXPRESSION; HELPER T-CELLS; IL-4 GENE; CUTTING EDGE; COORDINATE REGULATOR; HISTONE ACETYLATION; TH2 DEVELOPMENT; FACTOR GATA-3	GATA-3 is a master regulator of T helper type 2 (T(H)2) differentiation. However, the molecular basis of GATA-3-mediated T(H)2 lineage commitment is poorly understood. Here we identify the DNase I-hypersensitive site 2 (HS2) element located in the second intron of the interleukin 4 locus (Il4) as a critical enhancer strictly controlled by GATA-3 binding. Mice lacking HS2 showed substantial impairment in their asthmatic responses and their production of IL-4 but not of other T(H)2 cytokines. Overexpression of Gata3 in HS2-deficient T cells failed to restore Il4 expression. HS2 deletion impaired the trimethylation of histone H3 at Lys4 and acetylation of histone H3 at Lys9 and Lys14 in the Il4 locus. Our results indicate that HS2 is the target of GATA-3 in regulating chromosomal modification of the Il4 locus and is independent of the Il5 and Il13 loci.	[Tanaka, Shinya; Motomura, Yasutaka; Suzuki, Yoshie; Yagi, Ryoji; Kubo, Masato] RIKEN Yokohama Inst, Lab Signal Network, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Inoue, Hiromasa] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan; [Miyatake, Shoichiro] Tokyo Metropolitan Inst Med Sci, Cytokine Project, Tokyo 113, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Chiba, Japan	RIKEN; Kyushu University; Tokyo Metropolitan Institute of Medical Science; Tokyo University of Science	Kubo, M (corresponding author), RIKEN Yokohama Inst, Lab Signal Network, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan.	raysolfc@rcai.riken.jp	Kubo, Masato/A-5918-2016		Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation; RIKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); RIKEN	We thank R. Locksley (University of California, San Francisco) for CNS-1-deficient mice on the BALB/c background; R. Abe (Tokyo University of Science) for the PV-1 mAb to CD28; T. Kitamura (Tokyo University) for Platinum-E packaging cells; and H. Fujimoto, Y. Hachiman, E. Hayashi and K. Ikari for technical assistance. Supported by a Grant-in-Aid-of-Scientific Research in Priority Areas of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; and RIKEN (Y.M.).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Hayashida T, 2006, J IMMUNOL, V176, P5446, DOI 10.4049/jimmunol.176.9.5446; HENKEL G, 1992, J IMMUNOL, V149, P3239; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; SMIRNOV DV, 1995, GENE, V155, P277, DOI 10.1016/0378-1119(94)00720-D; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	92	95	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					77	U103		10.1038/ni.1966	http://dx.doi.org/10.1038/ni.1966			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21131966				2022-12-18	WOS:000285465100016
J	Feng, CG; Zheng, LX; Jankovic, D; Bafica, A; Cannons, JL; Watford, WT; Chaussabel, D; Hieny, S; Caspar, P; Schwartzberg, PL; Lenardo, MJ; Sher, A				Feng, Carl G.; Zheng, Lixin; Jankovic, Dragana; Bafica, Andre; Cannons, Jennifer L.; Watford, Wendy T.; Chaussabel, Damien; Hieny, Sara; Caspar, Patricia; Schwartzberg, Pamela L.; Lenardo, Michael J.; Sher, Alan			The immunity-related GTPase Irgm1 promotes the expansion of activated CD4(+) T cell populations by preventing interferon-gamma-induced cell death	NATURE IMMUNOLOGY			English	Article							RECEPTOR-BETA CHAIN; MYCOBACTERIAL INFECTION; CYTOKINE SIGNALING-1; MICE DEFICIENT; AUTOPHAGY; TUBERCULOSIS; INDUCTION; PROTEINS; SUPPRESSOR; APOPTOSIS	Mice deficient in the interferon-gamma (IFN-gamma)-inducible, immunity-related GTPase Irgm1 have defective host resistance to a variety of intracellular pathogens. This greater susceptibility to infection is associated with impaired IFN-gamma-dependent macrophage microbicidal activity in vitro. Here we show that Irgm1 also regulated the survival of mature effector CD4(+) T lymphocytes by protecting them from IFN-gamma-induced autophagic cell death. Mice deficient in both IFN-gamma and Irgm1 were 'rescued' from the lymphocyte depletion and greater mortality that occurs in mice singly deficient in Irgm1 after mycobacterial infection. Our studies identify a feedback mechanism in the T helper type 1 response that limits the detrimental effects of IFN-gamma on effector T lymphocyte survival while promoting the antimicrobial functions of IFN-gamma.	[Feng, Carl G.; Jankovic, Dragana; Bafica, Andre; Hieny, Sara; Caspar, Patricia; Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Zheng, Lixin; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Watford, Wendy T.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX 75204 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Baylor Scott & White Health	Feng, CG (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	cfeng@niaid.nih.gov	Chaussabel, Damien/AAX-1909-2020; Bafica, Andre/ABF-5986-2020	Bafica, Andre/0000-0002-5148-600X; Watford, Wendy/0000-0003-4261-5399; feng, carl/0000-0003-4301-4640; Chaussabel, Damien/0000-0002-6131-7242	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; National Institutes of Health, Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000843, Z01AI001044, ZIAAI000717, Z01AI000579] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Taylor ( Duke University) for Irgm1<SUP>-/-</SUP> mice backcrossed more than 12 times to C57BL/6 mice; S. White, C. Henry and C. Eigsti for technical assistance; J. Zhu and L. Yu for advice and discussions; K. Nagashima ( Electron Microscope Facility, Image Analysis Laboratory, Science Applications International Corporation-National Cancer Institute, Frederick) for the electron microscopy studies; A. Cheever ( Biomedical Research Institute) for assessing tissue fibrosis and pathology in S. mansoni infection experiments; R. Donnelly ( Center for Biologics Evaluation and Research, Food and Drug Administration) for initial help in measuring STAT1 phosphorylation; and H. Young and D. L. Barber for critical reading of the manuscript. Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Boehm U, 1998, J IMMUNOL, V161, P6715; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Doherty TM, 1997, J IMMUNOL, V158, P4822; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Foulds KE, 2008, J IMMUNOL, V180, P842, DOI 10.4049/jimmunol.180.2.842; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; GONDA MA, 1976, J NATL CANCER I, V56, P245, DOI 10.1093/jnci/56.2.245; Green DR, 2008, IMMUNITY, V28, P141, DOI 10.1016/j.immuni.2008.01.004; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li XJ, 2007, J IMMUNOL, V179, P939, DOI 10.4049/jimmunol.179.2.939; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; SORACE JM, 1995, J LEUKOCYTE BIOL, V58, P477, DOI 10.1002/jlb.58.4.477; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Van de Wiele CJ, 2004, J INTERF CYTOK RES, V24, P169, DOI 10.1089/jir.2004.24.169; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Whitmire JK, 2005, J IMMUNOL, V175, P5624, DOI 10.4049/jimmunol.175.9.5624; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	49	92	92	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1279	1287		10.1038/ni.1653	http://dx.doi.org/10.1038/ni.1653			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18806793	Green Accepted			2022-12-18	WOS:000260248600015
J	Quatrini, L; Wieduwild, E; Escaliere, B; Filtjens, J; Chasson, L; Laprie, C; Vivier, E; Ugolini, S				Quatrini, Linda; Wieduwild, Elisabeth; Escaliere, Bertrand; Filtjens, Jessica; Chasson, Lionel; Laprie, Caroline; Vivier, Eric; Ugolini, Sophie			Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells	NATURE IMMUNOLOGY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; LYMPHOID-CELLS; RESPONSES; CYTOKINE; DEFENSE; INNATE; GAMMA; MECHANISMS	Controlling the balance between immunity and immunopathology is crucial for host resistance to pathogens. After infection, activation of the hypothalamic-pituitary-adrenal (HPA) axis leads to the production of glucocorticoids. However, the pleiotropic effects of these steroid hormones make it difficult to delineate their precise role(s) in vivo. Here we found that the regulation of natural killer (NK) cell function by the glucocorticoid receptor (GR) was required for host survival after infection with mouse cytomegalovirus (MCMV). Mechanistically, endogenous glucocorticoids produced shortly after infection induced selective and tissue-specific expression of the checkpoint receptor PD-1 on NK cells. This glucocorticoid-PD-1 pathway limited production of the cytokine IFN-gamma by spleen NK cells, which prevented immunopathology. Notably, this regulation did not compromise viral clearance. Thus, the fine tuning of NK cell functions by the HPA axis preserved tissue integrity without impairing pathogen elimination, which reveals a novel aspect of neuroimmune regulation.	[Quatrini, Linda; Wieduwild, Elisabeth; Escaliere, Bertrand; Filtjens, Jessica; Chasson, Lionel; Laprie, Caroline; Vivier, Eric; Ugolini, Sophie] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France; [Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Vivier, Eric] Hop la Timone, AP HM, Serv Immunol Marseille Immunopole, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ugolini, S (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France.	ugolini@ciml.univ-mrs.fr	Quatrini, Linda/AAA-4580-2019; Vivier, Eric/F-8939-2010	Quatrini, Linda/0000-0002-6994-2595; Vivier, Eric/0000-0001-7022-8287; Wieduwild, Elisabeth/0000-0002-8550-7665; Ugolini, Sophie/0000-0003-4041-0103	European Research Council under the European Union [648768]; Agence Nationnale de la Recherche [ANR-14-CE14-0009-01]; ARC foundation [PGA120140200817]; INSERM, CNRS, Aix-Marseille University; Marseille-Immunopole	European Research Council under the European Union(European Research Council (ERC)); Agence Nationnale de la Recherche; ARC foundation(Australian Research Council); INSERM, CNRS, Aix-Marseille University; Marseille-Immunopole	We thank F. Tronche (Sorbonne Universites, Universite Pierre et Marie Curie, UMR_CR18, Neuroscience, Paris-Seine) for Nr3c1<SUP>loxP/loxP</SUP> mice; J. Galluso and P. Morganti for mouse breeding and genotyping; G. Bessou (Centre d'Immunologie de Marseille-Luminy) for the plasmid containing the Ie1 gene; and the Centre d'Immunologie de Marseille-Luminy mouse house and core cytometry facilities. This project received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program, under grant agreement 648768; from the Agence Nationnale de la Recherche (ANR-14-CE14-0009-01) and from the ARC foundation (PGA120140200817). This work was also supported by institutional grants from INSERM, CNRS, Aix-Marseille University and Marseille-Immunopole to the Centre d'Immunologie de Marseille-Luminy.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen YW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001347; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Della Chiesa M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00351; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Li CYC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002269; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Norris S, 2012, VIRAL IMMUNOL, V25, P329, DOI 10.1089/vim.2011.0096; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; Orange JS, 1996, J IMMUNOL, V156, P1138; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Orange JS, 1996, J IMMUNOL, V156, P4746; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Quatrini L, 2017, J EXP MED, V214, P3531, DOI 10.1084/jem.20171048; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052	40	91	94	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					954	+		10.1038/s41590-018-0185-0	http://dx.doi.org/10.1038/s41590-018-0185-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127438	Green Accepted			2022-12-18	WOS:000442365100017
J	Barwick, BG; Scharer, CD; Bally, APR; Boss, JM				Barwick, Benjamin G.; Scharer, Christopher D.; Bally, Alexander P. R.; Boss, Jeremy M.			Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER B; METHYLATION ANALYSIS; SECRETING CELLS; SEQ DATA; TRANSCRIPTION; EXPRESSION; PROTEIN; LYMPHOCYTES; ACTIVATION; ELEMENTS	The epigenetic processes that regulate antibody-secreting plasma cells are not well understood. Here, analysis of plasma cell differentiation revealed DNA hypomethylation of 10% of CpG loci that were overrepresented at enhancers. Inhibition of DNA methylation enhanced plasma cell commitment in a cell-division-dependent manner. Analysis of B cells differentiating in vivo stratified by cell division revealed a fivefold increase in mRNA transcription coupled to DNA hypomethylation. Demethylation occurred first at binding motifs for the transcription factors NF-kappa B and AP-1 and later at those for the transcription factors IRF and Oct-2 and was coincident with activation and differentiation gene-expression programs in a cell-division-dependent manner. These data provide mechanistic insight into cell-division-coupled transcriptional and epigenetic reprogramming and suggest that DNA hypomethylation reflects the cis-regulatory history of plasma cell differentiation.	[Barwick, Benjamin G.; Scharer, Christopher D.; Bally, Alexander P. R.; Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jmboss@emory.edu	Barwick, Benjamin/O-5185-2019	Barwick, Benjamin/0000-0001-9810-3566; Scharer, Christopher/0000-0001-7716-8504	Emory University School of Medicine; US National Institutes of Health [R01 GM47310, R01 AI123733, U19 AI110483, F31 AI112261, T32 GM008490, T32 AI007610]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI112261, T32AI007610, R01AI123733, U19AI110483, R37AI049660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490, R01GM047310] Funding Source: NIH RePORTER	Emory University School of Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Martinez for flow cytometry; R. Butler for mouse care; P.M. Vertino, P.A. Wade, L.H. Boise and H.D. Kondilis-Mangum for comments and critique in reading the manuscript; K.N. Conneely and H. Wu for statistical advice; the Genome Technology Center at NYU for Illumina sequencing; the Emory Flow Cytometry Core for flow cytometry; and the Emory Integrated Genomics Core for high-sensitivity DNA Bioanalyzer analysis. Supported by Emory University School of Medicine (institutional funds to J.M.B.) and the US National Institutes of Health (R01 GM47310, R01 AI123733 and U19 AI110483 to J.M.B.; F31 AI112261 to B.G.B.; T32 GM008490 to J.M.B. and B.G.B.; and T32 AI007610 to A.P.R.B.).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bruni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064670; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chernova I, 2014, J IMMUNOL, V193, P4971, DOI 10.4049/jimmunol.1401264; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Emslie D, 2008, J EXP MED, V205, P409, DOI 10.1084/jem.20072049; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grotsch B, 2014, J EXP MED, V211, P2199, DOI 10.1084/jem.20130795; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hu MJ, 2013, BIOCHEM J, V453, P381, DOI 10.1042/BJ20121829; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Park Y, 2016, BIOINFORMATICS, V32, P1446, DOI 10.1093/bioinformatics/btw026; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	91	91	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1216	+		10.1038/ni.3519	http://dx.doi.org/10.1038/ni.3519			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27500631	Green Accepted			2022-12-18	WOS:000384302900013
J	Pulko, V; Davies, JS; Martinez, C; Lanteri, MC; Busch, MP; Diamond, MS; Knox, K; Bush, EC; Sims, PA; Sinari, S; Billheimer, D; Haddad, EK; Murray, KO; Wertheimer, AM; Nikolich-Zugich, J				Pulko, Vesna; Davies, John S.; Martinez, Carmine; Lanteri, Marion C.; Busch, Michael P.; Diamond, Michael S.; Knox, Kenneth; Bush, Erin C.; Sims, Peter A.; Sinari, Shripad; Billheimer, Dean; Haddad, Elias K.; Murray, Kristy O.; Wertheimer, Anne M.; Nikolich-Zugich, Janko			Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses	NATURE IMMUNOLOGY			English	Article							CD4(+); DIFFERENTIATION; DIVERSITY; EFFECTOR; SUBSETS; MICE; REPERTOIRE; INFECTION; CYTOMETRY; TURNOVER	The number of naive T cells decreases and susceptibility to new microbial infections increases with age. Here we describe a previously unknown subset of phenotypically naive human CD8(+) T cells that rapidly secreted multiple cytokines in response to persistent viral antigens but differed transcriptionally from memory and effector T cells. The frequency of these CD8(+) T cells, called 'memory T cells with a naive phenotype' (T-MNP cells), increased with age and after severe acute infection and inversely correlated with the residual capacity of the immune system to respond to new infections with age. CD8(+) T-MNP cells represent a potential new target for the immunotherapy of persistent infections and should be accounted for and subtracted from the naive pool if truly naive T cells are needed to respond to antigens.	[Pulko, Vesna; Davies, John S.; Martinez, Carmine; Knox, Kenneth; Wertheimer, Anne M.; Nikolich-Zugich, Janko] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Pulko, Vesna; Davies, John S.; Martinez, Carmine; Wertheimer, Anne M.; Nikolich-Zugich, Janko] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA; [Lanteri, Marion C.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Diamond, Michael S.] Washington Univ, Dept Med, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Knox, Kenneth; Nikolich-Zugich, Janko] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA; [Bush, Erin C.; Sims, Peter A.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Sims, Peter A.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY USA; [Sims, Peter A.] Columbia Univ, Med Ctr, Sulzburger Columbia Genome Ctr, New York, NY USA; [Sinari, Shripad; Billheimer, Dean] Univ Arizona, Bio5, Stat Consulting Lab, Tucson, AZ USA; [Haddad, Elias K.] Drexel Univ, Coll Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA; [Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Murray, Kristy O.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Murray, Kristy O.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Arizona; University of Arizona; Vitalant; Vitalant Research Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Arizona; Columbia University; Columbia University; Columbia University; University of Arizona; Drexel University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.; Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA.; Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA.	nikolich@email.arizona.edu	Diamond, Michael/AAH-1733-2019; Wertheimer, Anne/ABF-7802-2021; Wertheimer, Anne/E-5132-2019	Diamond, Michael/0000-0002-8791-3165; Wertheimer, Anne/0000-0002-6627-4974; Sims, Peter/0000-0002-3921-4837; Davies, John/0000-0002-9482-1066	Arizona Cancer Center Support Grant (NCI) [CA 023074]; US National Institutes of Health (NIAID) [N01-AI00017]; US National Institutes of Health (NHLBI) [RC2HL101]; US National Institutes of Health (NIA) [R01 AG-048021, P30 AG008017]; Bowman Endowed Professorship in Medical Research; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048021, P30AG008017] Funding Source: NIH RePORTER	Arizona Cancer Center Support Grant (NCI); US National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bowman Endowed Professorship in Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Campbell of the Arizona Cancer Center, Arizona Research Laboratory Flow Cytometry Core Facility for cell sorting; the Arizona Cancer Center Support Grant (NCI grant CA 023074) for facility support; NIH Tetramer Facility for reagent preparation; K. Kedzierska (University of Melbourne) for tetramer reagents (HLA-A2 INF-GIL tetramers); and the members of the Nikolich, Kuhns, Frelinger, Wu and Schenten laboratories for insight and discussions. Supported by the US National Institutes of Health (NIAID (N01-AI00017), NHLBI (RC2HL101) and NIA (R01 AG-048021 and P30 AG008017) and by the Bowman Endowed Professorship in Medical Research (J.N.-Z.).	Albright J.F., 2003, AGING IMMUNITY INFEC; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Cambier J, 2005, IMMUNOL REV, V205, P5, DOI 10.1111/j.0105-2896.2005.00276.x; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; Koshkin AA, 1998, J AM CHEM SOC, V120, P13252, DOI 10.1021/ja9822862; Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Miller RA, 2000, VACCINE, V18, P1654, DOI 10.1016/S0264-410X(99)00502-2; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Riddell NE, 2015, IMMUNOLOGY, V144, P549, DOI 10.1111/imm.12409; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Warnes G.R., 2015, GPLOTS VARIOUS R PRO; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3	51	91	94	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					966	+		10.1038/ni.3483	http://dx.doi.org/10.1038/ni.3483			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27270402	Green Accepted			2022-12-18	WOS:000380647000014
J	Harikumar, KB; Yester, JW; Surace, MJ; Oyeniran, C; Price, MM; Huang, WC; Hait, NC; Allegood, JC; Yamada, A; Kong, XQ; Lazear, HM; Bhardwaj, R; Takabe, K; Diamond, MS; Luo, C; Milstien, S; Spiegel, S; Kordula, T				Harikumar, Kuzhuvelil B.; Yester, Jessie W.; Surace, Michael J.; Oyeniran, Clement; Price, Megan M.; Huang, Wei-Ching; Hait, Nitai C.; Allegood, Jeremy C.; Yamada, Akimitsu; Kong, Xiangqian; Lazear, Helen M.; Bhardwaj, Reetika; Takabe, Kazuaki; Diamond, Michael S.; Luo, Cheng; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; REGULATORY FACTOR-I; SYNERGISTIC ACTIVATION; EXPRESSION; KINASE; IL-1; SPHINGOSINE-1-PHOSPHATE; LIPOPOLYSACCHARIDE; UBIQUITINATION; INHIBITOR	Although interleukin 1 (IL-1) induces expression of the transcription factor IRF1 (interferon-regulatory factor 1), the roles of IRF1 in immune and inflammatory responses and mechanisms of its activation remain elusive. Here we found that IRF1 was essential for IL-1-induced expression of the chemokines CXCL10 and CCL5, which recruit mononuclear cells into sites of sterile inflammation. Newly synthesized IRF1 acquired Lys63 (K63)-linked polyubiquitination mediated by the apoptosis inhibitor cIAP2 that was enhanced by the bioactive lipid SIP. In response to IL-1, cIAP2 and the sphingosine kinase SphK1 (the enzyme that generates S1P) formed a complex with IRF1, which led to its activation. Thus, IL-1 triggered a hitherto unknown signaling cascade that controlled the induction of IRF1-dependent genes that encode molecules important for sterile inflammation.	[Harikumar, Kuzhuvelil B.; Yester, Jessie W.; Surace, Michael J.; Oyeniran, Clement; Price, Megan M.; Huang, Wei-Ching; Hait, Nitai C.; Allegood, Jeremy C.; Yamada, Akimitsu; Bhardwaj, Reetika; Takabe, Kazuaki; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23284 USA; [Harikumar, Kuzhuvelil B.; Yester, Jessie W.; Surace, Michael J.; Oyeniran, Clement; Price, Megan M.; Huang, Wei-Ching; Hait, Nitai C.; Allegood, Jeremy C.; Yamada, Akimitsu; Bhardwaj, Reetika; Takabe, Kazuaki; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA USA; [Yamada, Akimitsu; Takabe, Kazuaki] Virginia Commonwealth Univ, Dept Surg, Sch Med, Richmond, VA USA; [Kong, Xiangqian; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Washington University (WUSTL); Washington University (WUSTL)	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23284 USA.	tkordula@vcu.edu	Diamond, Michael/AAH-1733-2019; Kong, Xiangqian/J-4500-2017; Harikumar, Kuzhuvelil/AAC-2407-2020	Diamond, Michael/0000-0002-8791-3165; Kong, Xiangqian/0000-0002-9596-7825; Harikumar, Kuzhuvelil/0000-0002-1763-4179; Takabe, Kazuaki/0000-0002-6435-4241; Lazear, Helen/0000-0002-8649-4579	US National Institutes of Health [1R01AI093718, 5R37GM043880, 1U19AI077435, R01CA160688, 5P30NS047463, P30CA16059]; National Natural Science Foundation of China [91029704]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA160688, R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050094, R01AI093718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Darnay (MD Anderson) for the plasmid encoding wild-type TRAF2; X.-Y. Wang (Virginia Commonwealth University) for the plasmid encoding histidine-tagged TRAF6; Z. Chen (University of Texas Southwestern Medical Center) for the plasmids encoding hemagglutinin-tagged ubiquitins; C. Duckett (University of Michigan) for the plasmid encoding hemagglutinin-tagged cIAP2 and for Birc3<SUP>-/-</SUP> MEFs; X. Wang (University of Texas Southwestern Medical Center) for the mimetic SMAC; R. Proia (US National Institutes of Health) for Sphk1<SUP>-/-</SUP> mice; A. Lamer (Virginia Commonwealth University) for Stat1<SUP>-/-</SUP> mice; K. Fitzgerald (University of Massachusetts) for the INF-beta reporter gene; P. Knapp (Virginia Commonwealth University) for mouse astrocytes; and J. Almenara for tissue processing, sectioning and staining. Supported by the US National Institutes of Health (1R01AI093718 to T.K.; 5R37GM043880 and 1U19AI077435 to S.S.; R01CA160688 to K.T.; 5P30NS047463 to the Virginia Commonwealth University Microscopy Facility; and P30CA16059 to the Massey Cancer Center for support of the Lipidomics Developing Shared Resource and the Flow Cytometry Cores) and the National Natural Science Foundation of China (91029704 to C.L.).	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; [Anonymous], 2008, NAT IMMUNOL, V9, P1371; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Leon LR, 1996, AM J PHYSIOL-REG I, V271, pR1668, DOI 10.1152/ajpregu.1996.271.6.R1668; Lin RT, 1999, MOL CELL BIOL, V19, P959; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Shultz DB, 2009, J INTERF CYTOK RES, V29, P817, DOI 10.1089/jir.2009.0034; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	44	91	94	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					231	238		10.1038/ni.2810	http://dx.doi.org/10.1038/ni.2810			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24464131	Green Accepted			2022-12-18	WOS:000331683100008
J	Cherry, S; Perrimon, N				Cherry, S; Perrimon, N			Entry is a rate-limiting step for viral infection in a Drosophila melanogaster model of pathogenesis	NATURE IMMUNOLOGY			English	Article							C-VIRUS; SYNAPTOTAGMIN MUTANTS; ENDOCYTOSIS; DYNAMIN; SUSCEPTIBILITY; RELEASE; INNATE; PICORNAVIRUS; MECHANISMS; POLIOVIRUS	The identification of host factors that control susceptibility to infection has been hampered by a lack of amenable genetic systems. We established an in vivo model to determine the host factors that control pathogenesis and identified viral entry as a rate-limiting step for infection. We infected Drosophila melanogaster cells and adults with drosophila C virus and found that the clathrin-mediated endocytotic pathway is essential for both infection and pathogenesis. Heterozygosity for mutations in genes involved in endocytosis is sufficient to protect flies from pathogenicity, indicating the exquisite sensitivity and dependency of the virus on this pathway. Thus, this virus model provides a sensitive and efficient approach for identifying components required for pathogenesis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cherry, S (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	scherry@genetics.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X; cherry, sara/0000-0003-3956-6610	NIAID NIH HHS [R01-AI51365-01A1, R01 AI051365] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051365] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; CARRASCO L, 1994, PHARMACOL THERAPEUT, V64, P215, DOI 10.1016/0163-7258(94)90040-X; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FIELDS B, 2001, VIROLOGY; GOMARIZZILBER E, 1995, J INVERTEBR PATHOL, V65, P243, DOI 10.1006/jipa.1995.1037; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; JOUSSET FX, 1972, CR ACAD SCI D NAT, V275, P3043; Kandolf Reinhard, 2002, P405; Klasse PJ, 1998, ADV DRUG DELIVER REV, V34, P65, DOI 10.1016/S0169-409X(98)00002-7; Koyama AH, 2001, J GEN VIROL, V82, P2965, DOI 10.1099/0022-1317-82-12-2965; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Marsh M, 2000, TRAFFIC, V1, P525, DOI 10.1034/j.1600-0854.2000.010701.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miller LK, 1998, VIRUSES, P91; Moline MM, 1999, DEVELOPMENT, V126, P4375; MOORE NF, 1982, ARCH VIROL, V74, P21, DOI 10.1007/BF01320779; Narayanan R, 2001, EXP CELL RES, V271, P28, DOI 10.1006/excr.2001.5370; Nomoto Akio, 1994, Trends in Microbiology, V2, P47, DOI 10.1016/0966-842X(94)90125-2; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; PLUS N, 1978, J INVERTEBR PATHOL, V31, P296, DOI 10.1016/0022-2011(78)90219-7; PLUS N, 1975, ANN INST PASTEUR MIC, VA126, P107; Rueckert R., 1996, FIELDS VIROLOGY, P609; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; THOMASORILLARD M, 1995, GENETICS, V140, P1289; TUCKER SP, 1993, J VIROL, V67, P4274, DOI 10.1128/JVI.67.7.4274-4282.1993; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200	48	91	100	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					81	87		10.1038/ni1019	http://dx.doi.org/10.1038/ni1019			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14691479	Green Accepted			2022-12-18	WOS:000187635800017
J	Tang, C; Kakuta, S; Shimizu, K; Kadoki, M; Kamiya, T; Shimazu, T; Kubo, S; Saijo, S; Ishigame, H; Nakae, S; Iwakura, Y				Tang, Ce; Kakuta, Shigeru; Shimizu, Kenji; Kadoki, Motohiko; Kamiya, Tomonori; Shimazu, Tomoyuki; Kubo, Sachiko; Saijo, Shinobu; Ishigame, Harumichi; Nakae, Susumu; Iwakura, Yoichiro			Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T-reg cells through modification of the intestinal microbiota	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL ROLES; INTERLEUKIN-17; CYTOKINE; RECEPTOR; IDENTIFICATION; INDUCTION; DEFENSE; MICE; SKIN	The cytokines IL-17A and IL-17F have 50% amino-acid identity and bind the same receptor; however, their functional differences have remained obscure. Here we found that 1117f(-/)-mice resisted chemically induced colitis, but 1117a(-1)-mice did not, and that 1117f(-/)-CD45RB(hi)CD4(+) T cells induced milder colitis in lymphocyte-deficient Rag2(-/)-mice, accompanied by an increase in intestinal regulatory T cells ( T-reg cells). Clostridium cluster XIVa in colonic microbiota capable of inducing T-reg cells was increased in both 1117f (-/)-mice and mice given transfer 1117f(-/)-T cells, due to decreased expression of a group of antimicrobial proteins. There was substantial production of IL-17F, but not of IL-17A, not only by naive T cells but also by various colon-resident cells under physiological conditions. Furthermore, antibody to IL-17F suppressed the development of colitis, but antibody to IL-17A did not. These observations suggest that IL-17F is an effective target for the treatment of colitis.	[Tang, Ce; Shimizu, Kenji; Kadoki, Motohiko; Kamiya, Tomonori; Shimazu, Tomoyuki; Kubo, Sachiko; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba, Japan; [Tang, Ce; Kakuta, Shigeru; Shimizu, Kenji; Kadoki, Motohiko; Kamiya, Tomonori; Kubo, Sachiko; Saijo, Shinobu; Ishigame, Harumichi; Nakae, Susumu; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Minato Ku, Tokyo, Japan; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo, Japan; [Shimizu, Kenji] Tokushima Univ, Inst Genome Res, Div Immune Regulat, Tokushima, Tokushima, Japan; [Kadoki, Motohiko] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Kamiya, Tomonori] Osaka City Univ, Grad Sch Med, Dept Pathophysiol, Osaka, Osaka, Japan; [Shimazu, Tomoyuki] Miyagi Univ, Dept Food Agr & Environm, Sendai, Miyagi, Japan; [Saijo, Shinobu] Chiba Univ, Med Mycobiol Res Ctr, Chiba, Chiba, Japan; [Ishigame, Harumichi] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Tokyo University of Science; University of Tokyo; University of Tokyo; Tokushima University; Harvard University; Massachusetts General Hospital; Osaka Metropolitan University; Miyagi University; Chiba University; RIKEN	Iwakura, Y (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba, Japan.; Iwakura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Minato Ku, Tokyo, Japan.	iwakura@rs.tus.ac.jp	Kakuta, Shigeru/L-2241-2018; iwakura, yoichiro/E-5457-2011	Kakuta, Shigeru/0000-0002-5900-1425; iwakura, yoichiro/0000-0002-9934-5775; Kadoki, Motohiko/0000-0002-0124-7406; Shimizu, Kenji/0000-0003-4204-555X	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Shinkai (Kyoto University) for Rag2<SUP>-/-</SUP> mice. Supported the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (VI.); by CREST (Y.I.); and by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Y.I. and C.T.).	Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; COOPER HS, 1993, LAB INVEST, V69, P238; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kawaguchi M, 2001, J IMMUNOL, V167, P4430, DOI 10.4049/jimmunol.167.8.4430; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Li CR, 2013, J BIOL CHEM, V288, P19127, DOI 10.1074/jbc.M113.453357; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Macpherson AJ, 2015, TRENDS IMMUNOL, V36, P460, DOI 10.1016/j.it.2015.06.006; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Obermeier F, 2002, EUR J IMMUNOL, V32, P2084, DOI 10.1002/1521-4141(200207)32:7<2084::AID-IMMU2084>3.0.CO;2-Q; Okai S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.103, 10.1038/nmicrobiol.2016.103]; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	41	90	91	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					755	+		10.1038/s41590-018-0134-y	http://dx.doi.org/10.1038/s41590-018-0134-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29915298				2022-12-18	WOS:000436341300020
J	Reth, M				Reth, Michael			Matching cellular dimensions with molecular sizes	NATURE IMMUNOLOGY			English	Article							RECEPTOR MICROCLUSTERS; ANTIGEN RECEPTOR; ORGANIZATION; ACTIVATION; MICROSCOPY; SELECTION; PROTEINS; DOMAINS; ACTIN; CELLS	This Commentary discusses the spatial perception of receptors and their nanoscale organization at the surface of the lymphocyte membrane.	[Reth, Michael] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Reth, Michael] Univ Freiburg, Dept Mol Immunol, Fac Biol, D-79106 Freiburg, Germany; [Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Reth, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany.	michael.reth@bioss.uni-freiburg.de						Blanco R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00115; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Kamiyama D, 2012, DEV CELL, V23, P1103, DOI 10.1016/j.devcel.2012.10.003; Kasuboski J.M., 2012, CURRENT PROTOCOLS CY; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Mcdonald KL, 2009, J MICROSC-OXFORD, V235, P273, DOI 10.1111/j.1365-2818.2009.03218.x; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; METZGER H, 1992, J IMMUNOL, V149, P1477; Mueller NS, 2012, MOL MEMBR BIOL, V29, P186, DOI 10.3109/09687688.2012.687461; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Reth M, 2000, IMMUNOL REV, V176, P10; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002	26	90	92	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					765	767		10.1038/ni.2621	http://dx.doi.org/10.1038/ni.2621			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23867923				2022-12-18	WOS:000322010600001
J	Tiwari, S; Choi, HP; Matsuzawa, T; Pypaert, M; MacMicking, JD				Tiwari, Sangeeta; Choi, Han-Pil; Matsuzawa, Takeshi; Pypaert, Marc; MacMicking, John D.			Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P-2 and PtdIns(3,4,5)P-3 promotes immunity to mycobacteria	NATURE IMMUNOLOGY			English	Article							CLASS-I; TUBERCULOSIS; ACTIVATION; AUTOPHAGY; KINASE; SURVIVAL; CARDIOLIPIN; MACROPHAGE; MECHANISM; PROTEINS	Vertebrate immunity to infection enlists a newly identified family of 47-kilodalton immunity-related GTPases (IRGs). One IRG in particular, Irgm1, is essential for macrophage host defense against phagosomal pathogens, including Mycobacterium tuberculosis (Mtb). Here we show that Irgm1 targets the mycobacterial phagosome through lipid-mediated interactions with phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P-2) and PtdIns(3,4,5)P-3. An isolated Irgm1 amphipathic helix conferred lipid binding in vitro and in vivo. Substitutions in this region blocked phagosome recruitment and failed to complement the antimicrobial defect in Irgm1(-/-) macrophages. Removal of PtdIns(3,4,5)P-3 or inhibition of class I phosphatidylinositol-3-OH kinase (PI(3)K) mimicked this effect in wild-type cells. Cooperation between Irgm1 and PI(3)K further facilitated the engagement of Irgm1 with its fusogenic effectors at the site of infection, thereby ensuring pathogen-directed responses during innate immunity.	[Tiwari, Sangeeta; Choi, Han-Pil; Matsuzawa, Takeshi; MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Pypaert, Marc] Yale Univ, Sch Med, Dept Cell Biol, Ctr Cell & Mol Imaging, New Haven, CT USA	Yale University; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA.	john.macmicking@yale.edu	tiwari, sangeeta/T-5810-2019; Tiwari, Sangeeta/GWV-0350-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI068041, R01 AI068041-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BUXTON P, 2003, BIOCHEM J, V15, P433; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fischer K, 2001, J IMMUNOL, V167, P2187, DOI 10.4049/jimmunol.167.4.2187; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lu L, 2009, BIOSCIENCE REP, V29, P261, DOI 10.1042/BSR20090043; Luo Y, 1996, CLIN DIAGN LAB IMMUN, V3, P761, DOI 10.1128/CDLI.3.6.761-768.1996; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SHENOY AR, 2008, IMMUNOBIOLOGY, V8, P771; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Taguchi T, 2003, TRAFFIC, V4, P344, DOI 10.1034/j.1600-0854.2003.00091.x; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	50	90	92	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					907	U144		10.1038/ni.1759	http://dx.doi.org/10.1038/ni.1759			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19620982	Green Accepted			2022-12-18	WOS:000268141400021
J	Brewer, JW; Hendershot, LM				Brewer, JW; Hendershot, LM			Building an antibody factory: a job for the unfolded protein response	NATURE IMMUNOLOGY			English	Review							ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; INDUCED GENE-EXPRESSION; CHAIN BINDING-PROTEIN; ER STRESS; MESSENGER-RNA; B-CELLS; TRANSMEMBRANE PROTEIN; TRANSLATIONAL CONTROL	Plasma cells are highly specialized, terminally differentiated secretory cells that produce tremendous quantities of a single product, the antibody molecule. In differentiating from a quiescent B cell, the plasma cell must undergo a dramatic architectural metamorphosis. This process entails augmenting the secretory organelles and the proteins that populate them, upregulating their energy and translation potential, and increasing the quality control system to do the job. This transformation is accomplished by an interplay between B lineage-specific transcriptional programs that control plasma cell differentiation and an unfolded protein response.	St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA	St Jude Children's Research Hospital; Loyola University Chicago	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274				Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunn KE, 2004, MOL IMMUNOL, V41, P919, DOI 10.1016/j.molimm.2004.04.023; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LEWIS MJ, 1985, J BIOL CHEM, V260, P3050; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; MORI K, 1993, CELL, V74, P743; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reddy PS, 1999, IMMUNOL TODAY, V20, P582, DOI 10.1016/S0167-5699(99)01542-X; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; SHOHAT M, 1973, EUR J IMMUNOL, V3, P680, DOI 10.1002/eji.1830031106; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Welihinda AA, 1998, MOL CELL BIOL, V18, P1967, DOI 10.1128/MCB.18.4.1967; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	61	90	95	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					23	29		10.1038/ni1149	http://dx.doi.org/10.1038/ni1149			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611778				2022-12-18	WOS:000225888500014
J	Johnson, K; Pflugh, DL; Yu, DN; Hesslein, DGT; Lin, KI; Bothwell, ALM; Thomas-Tikhonenko, A; Schatz, DG; Calame, K				Johnson, K; Pflugh, DL; Yu, DN; Hesslein, DGT; Lin, KI; Bothwell, ALM; Thomas-Tikhonenko, A; Schatz, DG; Calame, K			B cell-specific loss of histone 3 lysine 9 methylation in the V-H locus depends on Pax5	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN GENE REARRANGEMENT; V(D)J RECOMBINASE ACTIVITY; DJ RECOMBINATION; BONE-MARROW; ALLELIC EXCLUSION; MICE LACKING; CHROMATIN; TRANSCRIPTION; DIFFERENTIATION; ACCESSIBILITY	Immunoglobulin heavy chain rearrangement (V-H-to-DJ(H)) occurs only in B cells, suggesting it is inhibited in other lineages. Here we found that in the mouse V-H locus, methylation of lysine 9 on histone H3 (H3-K9), a mark of inactive chromatin, was present in non-B lineage cells but was absent in B cells. As others have shown that H3-K9 methylation can inhibit V(D)J recombination on engineered substrates, our data support the idea that H3-K9 methylation inhibits endogenous V-H-to-DJ(H) recombination. We also show that Pax5, a transcription factor required for B cell commitment, is necessary and sufficient for the removal of H3-K9 methylation in the V-H locus and provide evidence that one function of Pax5 is to remove this inhibitory modification by a mechanism of histone exchange, thus allowing B cell-specific V-H-to-DJ(H) recombination.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Yale Univ Med, Immunobiol Sect, New Haven, CT 06520 USA; Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Yale Univ Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Yale University; University of Pennsylvania; Yale University; Howard Hughes Medical Institute; Yale University; Columbia University	Calame, K (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	klc1@columbia.edu	Lin, KUO-I/C-6928-2009; Thomas-Tikhonenko, Andrei/E-5329-2011; Schatz, David/A-6748-2013	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206; Schatz, David/0000-0002-5669-1176	NATIONAL CANCER INSTITUTE [R01CA102709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043576, R01AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040924] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102709] Funding Source: Medline; NIAID NIH HHS [R01 AI043576, R01 AI032524, R01 AI32524, R01 AI43576] Funding Source: Medline; NIGMS NIH HHS [GM40924, R01 GM040924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Haines BB, 1998, EUR J IMMUNOL, V28, P4228, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;4228::AID-IMMU4228&gt;3.0.CO;2-H; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Ji YH, 2003, P NATL ACAD SCI USA, V100, P7557, DOI 10.1073/pnas.0932635100; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Love VA, 2000, MOL IMMUNOL, V37, P29, DOI 10.1016/S0161-5890(00)00023-7; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rothenberg EV, 2002, DEV BIOL, V246, P29, DOI 10.1006/dbio.2002.0667; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; SU IH, 2002, NAT IMMUNOL, V4, P142; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; tenBoekel E, 1997, IMMUNITY, V7, P357; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244	55	90	92	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					853	861		10.1038/ni1099	http://dx.doi.org/10.1038/ni1099			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15258579	Green Accepted			2022-12-18	WOS:000222955600017
J	Osipovich, O; Milley, R; Meade, A; Tachibana, M; Shinkai, Y; Krangel, MS; Oltz, EM				Osipovich, O; Milley, R; Meade, A; Tachibana, M; Shinkai, Y; Krangel, MS; Oltz, EM			Targeted inhibition of V(D)J recombination by a histone methyltransferase	NATURE IMMUNOLOGY			English	Article							DNA METHYLATION PATTERNS; T-CELL DEVELOPMENT; DEVELOPMENTAL REGULATION; LYSINE-9 METHYLATION; ORDERED RECRUITMENT; ALLELIC EXCLUSION; IMMUNE-SYSTEM; DOMINANT ROLE; GENE; PROMOTER	The tissue- and stage-specific assembly of antigen receptor genes by V(D)J recombination is regulated by changes in the chromatin accessibility of target gene segments. This dynamic remodeling process is coordinated by cis-acting promoters and enhancers, which function as accessibility control elements. The basic epigenetic mechanisms that activate or repress chromatin accessibility to V(D)J recombinase remain unclear. We now demonstrate that a histone methyltransferase overrides accessibility control element function and cripples V(D)J recombination of chromosomal gene segments. The recruited histone methyltransferase induces extensive revisions in the local chromatin environment, including altered histone modifications and de novo methylation of DNA. These findings indicate a key function for histone methyltransferases in the tissue- and stage-specific suppression of antigen receptor gene assembly during lymphocyte development.	Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 6068507, Japan	Vanderbilt University; Duke University; Kyoto University	Oltz, EM (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	eugene.oltz@vanderbilt.edu	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	NCI NIH HHS [P30 CA 68485] Funding Source: Medline; NHLBI NIH HHS [P01 HL 68744] Funding Source: Medline; NIAID NIH HHS [AI 49934] Funding Source: Medline; NIGMS NIH HHS [GM 41052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052, R01GM041052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Demengeot J, 1995, INT IMMUNOL, V7, P1995, DOI 10.1093/intimm/7.12.1995; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES SC, 1991, SOCIOBIOLOGY, V19, P187; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 2003, NAT IMMUNOL, V4, P603, DOI 10.1038/ni0703-603; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oltz EM, 2001, IMMUNOL RES, V23, P121, DOI 10.1385/IR:23:2-3:121; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Zeschnigk M, 1997, HUM MOL GENET, V6, P387, DOI 10.1093/hmg/6.3.387	50	90	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					309	316		10.1038/ni1042	http://dx.doi.org/10.1038/ni1042			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985714				2022-12-18	WOS:000189344600014
J	Veiga-Fernandes, H; Rocha, B				Veiga-Fernandes, H; Rocha, B			High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division	NATURE IMMUNOLOGY			English	Article							T-CELLS; INHIBITOR P18(INK4C); MICE LACKING; IN-VIVO; P27(KIP1); PROLIFERATION; CYCLE; HYPERPLASIA; LYMPHOCYTES; P21(CIP1)	Antigen-driven CD8 memory T cell proliferation is more rapid than that of naive T cells, ensuring efficient control of the pathogen after reinfection. We show here that naive and memory cells are in different states of G0/G1 arrest. Naive cells are in a classical state of G0/G1 arrest, with high expression of p27(Kip1) and low CDK6 and CDK2 kinase activity. In contrast, memory cells have low expression of p27(Kip1) and high CDK6 kinase activity. This preactivated kinase is associated with cyclin D3 in the cytoplasm, and neutralization of these complexes with antibody to cyclin D3 blocks the rapid division of memory cells. Therefore G0/G1 memory cells are at a unique preactivated state that favors rapid division after antigen stimulation.	Inst necker, INSERM, U591, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Veiga-Fernandes, H (corresponding author), Inst necker, INSERM, U591, 156 Rue Vaugirard, F-75015 Paris, France.			Veiga-Fernandes, Henrique/0000-0001-6216-1836				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Mohapatra S, 2001, J BIOL CHEM, V276, P21976, DOI 10.1074/jbc.M009788200; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; OLASHAW N, 2002, SCI STKE, pRE7; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Parry D, 1999, MOL CELL BIOL, V19, P1775; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; Sherr CJ, 2000, CANCER RES, V60, P3689; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; TRIPP RA, 1995, J IMMUNOL, V155, P3719; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907	29	90	92	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					31	37		10.1038/ni1015	http://dx.doi.org/10.1038/ni1015			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14647273				2022-12-18	WOS:000187635800011
J	Leonard, WJ				Leonard, WJ			TSLP: finally in the limelight	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC STROMAL LYMPHOPOIETIN; IGM(+) B-CELLS; MOLECULAR-CLONING; INTERLEUKIN-7 RECEPTOR; GROWTH-FACTOR; GAMMA-CHAIN; IN-VITRO; CYTOKINE; EXPRESSION	TSLP is now revealed to be an important regulator of DC-mediated control of T(H)2-based human allergic responses, identifying a potentially new species-specific function for this cytokine.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10,Rm 7N252, Bethesda, MD 20892 USA.		Leonard, Warren/AAA-1397-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005401] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fujio K, 2000, BLOOD, V95, P2204; Hiroyama T, 2000, BIOCHEM BIOPH RES CO, V272, P224, DOI 10.1006/bbrc.2000.2764; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Levin SD, 1999, J IMMUNOL, V162, P677; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941	14	90	105	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					605	607		10.1038/ni0702-605	http://dx.doi.org/10.1038/ni0702-605			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087416				2022-12-18	WOS:000176441700008
J	Aegerter, H; Kulikauskaite, J; Crotta, S; Patel, H; Kelly, G; Hessel, EM; Mack, M; Beinke, S; Wack, A				Aegerter, Helena; Kulikauskaite, Justina; Crotta, Stefania; Patel, Harshil; Kelly, Gavin; Hessel, Edith M.; Mack, Matthias; Beinke, Soren; Wack, Andreas			Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection	NATURE IMMUNOLOGY			English	Article							GM-CSF; FETAL MONOCYTES; TISSUE; CELLS; LIFE; REPLACEMENT; DEVELOP; ORIGIN; NICHE	Respiratory infections occur throughout life but how this shapes the lung immune system through time is unclear. Wack and colleagues show that a previous influenza infection recruits monocytes to the lung, which then assume an alveolar macrophage-like phenotype and mediate long-term antibacterial protection. Despite the prevalence and clinical importance of influenza, its long-term effect on lung immunity is unclear. Here we describe that following viral clearance and clinical recovery, at 1 month after infection with influenza, mice are better protected from Streptococcus pneumoniae infection due to a population of monocyte-derived alveolar macrophages (AMs) that produce increased interleukin-6. Influenza-induced monocyte-derived AMs have a surface phenotype similar to resident AMs but display a unique functional, transcriptional and epigenetic profile that is distinct from resident AMs. In contrast, influenza-experienced resident AMs remain largely similar to naive AMs. Thus, influenza changes the composition of the AM population to provide prolonged antibacterial protection. Monocyte-derived AMs persist over time but lose their protective profile. Our results help to understand how transient respiratory infections, a common occurrence in human life, can constantly alter lung immunity by contributing monocyte-derived, recruited cells to the AM population.	[Aegerter, Helena; Kulikauskaite, Justina; Crotta, Stefania; Wack, Andreas] Francis Crick Inst, Immunoregulat Lab, London, England; [Patel, Harshil; Kelly, Gavin] Francis Crick Inst, Bioinformat & Biostat, London, England; [Hessel, Edith M.; Beinke, Soren] GlaxoSmithKline, Resp Therapy Area, Refractory Resp Inflammat Discovery Performance U, Stevenage, Herts, England; [Mack, Matthias] Univ Klinikum Regensburg, Innere Med Nephrol 2, Regensburg, Germany	Francis Crick Institute; Francis Crick Institute; GlaxoSmithKline; University of Regensburg	Wack, A (corresponding author), Francis Crick Inst, Immunoregulat Lab, London, England.	andreas.wack@crick.ac.uk	Kelly, Gavin/ABG-2715-2021; Hessel, Edith M/AAB-6002-2021	Kelly, Gavin/0000-0001-7219-560X; Hessel, Edith M/0000-0002-2339-4482; Patel, Harshil/0000-0003-2707-7940; Wack, Andreas/0000-0001-5226-2991; Crotta, Stefania/0000-0003-4676-8616	Francis Crick Institute; Cancer Research UK [FC001206]; UK Medical Research Council [FC001206]; Wellcome Trust [FC001206]; MRC [U117597139]; BBSRC-GSK-funded case studentship [BB/L502315/1]; MRC [MC_U117597139] Funding Source: UKRI	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-GSK-funded case studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to S. Rose-John (Kiel University) for the kind gift of anti-IL-6, to C. Reis e Sousa and G. Stockinger for reading the manuscript and A. Warnatsch for initial help with reactive oxygen species measurements. This work benefited from data assembled by the ImmGen consortium. We thank the Advanced Sequencing, Flow Cytometry, Biological Research and Histopathology facilities of the Francis Crick Institute for excellent support. This study was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001206), the UK Medical Research Council (FC001206) and the Wellcome Trust (FC001206). Support by MRC grant U117597139 (S.C. and A.W.) and a BBSRC-GSK-funded case studentship BB/L502315/1 (H.A.) is gratefully acknowledged.	Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Halstead ES, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0708-5; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kumar A, 2018, LANCET RESP MED, V6, P554, DOI 10.1016/S2213-2600(18)30043-2; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Schett G, 2018, RHEUMATOLOGY, V57, P43, DOI 10.1093/rheumatology/kex513; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sever-Chroneos Z, 2011, ANTIVIR RES, V92, P319, DOI 10.1016/j.antiviral.2011.08.022; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	52	89	89	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					145	+		10.1038/s41590-019-0568-x	http://dx.doi.org/10.1038/s41590-019-0568-x		JAN 2020	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31932810	Green Submitted, Green Accepted			2022-12-18	WOS:000508182300004
J	Patel, S; Fu, S; Mastio, J; Dominguez, GA; Purohit, A; Kossenkov, A; Lin, C; Alicea-Torres, K; Sehgal, M; Nefedova, Y; Zhou, J; Languino, LR; Clendenin, C; Vonderheide, RH; Mulligan, C; Nam, B; Hockstein, N; Masters, G; Guarino, M; Schug, ZT; Altieri, DC; Gabrilovich, DI				Patel, Sima; Fu, Shuyu; Mastio, Jerome; Dominguez, George A.; Purohit, Abhilasha; Kossenkov, Andrew; Lin, Cindy; Alicea-Torres, Kevin; Sehgal, Mohit; Nefedova, Yulia; Zhou, Jie; Languino, Lucia R.; Clendenin, Cynthia; Vonderheide, Robert H.; Mulligan, Charles; Nam, Brian; Hockstein, Neil; Masters, Gregory; Guarino, Michael; Schug, Zachary T.; Altieri, Dario C.; Gabrilovich, Dmitry I.			Unique pattern of neutrophil migration and function during tumor progression	NATURE IMMUNOLOGY			English	Article							SUPPRESSOR-CELLS; LUNG METASTASIS; MYELOID CELLS; IMMUNE CELL; T-CELLS; CANCER; POLARIZATION; CHEMOTAXIS; RESPONSES; MODEL	Although neutrophils have been linked to the formation of the pre-metastatic niche, the mechanism of their migration to distant, uninvolved tissues has remained elusive. We report that bone marrow neutrophils from mice with early-stage cancer exhibited much more spontaneous migration than that of control neutrophils from tumor-free mice. These cells lacked immunosuppressive activity but had elevated rates of oxidative phosphorylation and glycolysis, and increased production of ATP, relative to that of control neutrophils. Their enhanced spontaneous migration was mediated by autocrine ATP signaling through purinergic receptors. In ectopic tumor models and late stages of cancer, bone marrow neutrophils demonstrated potent immunosuppressive activity. However, these cells had metabolic and migratory activity indistinguishable from that of control neutrophils. A similar pattern of migration was observed for neutrophils and polymorphonuclear myeloid-derived suppressor cells from patients with cancer. These results elucidate the dynamic changes that neutrophils undergo in cancer and demonstrate the mechanism of neutrophils' contribution to early tumor dissemination.	[Patel, Sima; Fu, Shuyu; Mastio, Jerome; Dominguez, George A.; Purohit, Abhilasha; Kossenkov, Andrew; Lin, Cindy; Alicea-Torres, Kevin; Sehgal, Mohit; Nefedova, Yulia; Altieri, Dario C.; Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis, 3601 Spruce St, Philadelphia, PA 19104 USA; [Fu, Shuyu; Zhou, Jie] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Languino, Lucia R.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Clendenin, Cynthia; Vonderheide, Robert H.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Mulligan, Charles; Nam, Brian; Hockstein, Neil; Masters, Gregory; Guarino, Michael] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Wilmington, DE USA; [Schug, Zachary T.] Wistar Inst Anat & Biol, Mol Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Schug, Zachary T.] Wistar Inst Anat & Biol, Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Patel, Sima] Bristol Myers Squibb, Lawrenceville, NJ USA; [Dominguez, George A.] ITUS Corp, San Jose, CA USA	The Wistar Institute; Sun Yat Sen University; Jefferson University; University of Pennsylvania; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; The Wistar Institute; The Wistar Institute; Bristol-Myers Squibb	Gabrilovich, DI (corresponding author), Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis, 3601 Spruce St, Philadelphia, PA 19104 USA.	dgabrilovich@wistar.org	Purohit, Abhilasha/AAM-3881-2021; Lin, Cindy/P-7043-2015; Fu, Shuyu/AAM-6361-2020; Gabrilovich, Dmitry/ABE-7122-2020	Purohit, Abhilasha/0000-0002-0792-6610; Lin, Cindy/0000-0002-9930-0411; Fu, Shuyu/0000-0003-3249-6269; Dominguez, George/0000-0003-3046-4001; Schug, Zachary/0000-0003-4197-8227; Alicea-Torres, Kevin/0000-0002-2971-167X; Nefedova, Yulia/0000-0002-5121-9294	Wistar Institute Animal and Bioinformatics core facilities; US National Institutes of Health [P01 CA140043, T32 CA09171]; International Program for Ph.D Candidates, Sun Yat-Sen University, China; NATIONAL CANCER INSTITUTE [P30CA010815, P01CA140043, T32CA009171, R50CA221838, R50CA211199] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023586, S10OD023658, S10OD021669] Funding Source: NIH RePORTER	Wistar Institute Animal and Bioinformatics core facilities; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Program for Ph.D Candidates, Sun Yat-Sen University, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Ramakrishnan (H. Lee Moffitt Cancer Center) for the luciferase expressing LL2 tumor cell line; and D. Laxminarasimha for help in animal experiments. This work was supported by the Wistar Institute Animal and Bioinformatics core facilities and by the US National Institutes of Health (P01 CA140043 and T32 CA09171). S.Y. was supported by International Program for Ph.D Candidates, Sun Yat-Sen University, China.	Achberger S, 2014, MOL IMMUNOL, V58, P182, DOI 10.1016/j.molimm.2013.11.018; Biswas SK, 2015, IMMUNITY, V43, P435, DOI 10.1016/j.immuni.2015.09.001; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Evans RA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88328; FARRELL BE, 1990, CELL MOTIL CYTOSKEL, V16, P279, DOI 10.1002/cm.970160407; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hammami I, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-18; Hind LE, 2016, DEV CELL, V38, P161, DOI 10.1016/j.devcel.2016.06.031; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Junger WG, 2008, CELL MOL LIFE SCI, V65, P2528, DOI 10.1007/s00018-008-8095-1; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mocsai A, 2015, CARDIOVASC RES, V107, P373, DOI 10.1093/cvr/cvv159; Ortiz ML, 2015, J EXP MED, V212, P351, DOI 10.1084/jem.20140835; Ortiz ML, 2014, CANCER IMMUNOL RES, V2, P50, DOI 10.1158/2326-6066.CIR-13-0129; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Toh B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001162; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Weide B, 2014, CLIN CANCER RES, V20, P1601, DOI 10.1158/1078-0432.CCR-13-2508; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhou J, 2018, SEMIN IMMUNOL, V35, P19, DOI 10.1016/j.smim.2017.12.004	47	89	90	5	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1236	+		10.1038/s41590-018-0229-5	http://dx.doi.org/10.1038/s41590-018-0229-5			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323345	Green Accepted			2022-12-18	WOS:000447632200018
J	Miyazaki, M; Miyazaki, K; Chen, SW; Itoi, M; Miller, M; Lu, LF; Varki, N; Chang, AN; Broide, DH; Murre, C				Miyazaki, Masaki; Miyazaki, Kazuko; Chen, Shuwen; Itoi, Manami; Miller, Marina; Lu, Li-Fan; Varki, Nissi; Chang, Aaron N.; Broide, David H.; Murre, Cornelis			Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; GERMINAL CENTER; HELPER-CELL; DNA-BINDING; B-CELLS; DIFFERENTIATION; E2A; FOXP3; ENTEROPATHY	Regulatory T (T-reg) cells suppress the development of inflammatory disease, but our knowledge of transcriptional regulators that control this function remains incomplete. Here we show that expression of Id2 and Id3 in T-reg cells was required to suppress development of fatal inflammatory disease. We found that T cell antigen receptor (TCR)-driven signaling initially decreased the abundance of Id3, which led to the activation of a follicular regulatory T (T-FR) cell-specific transcription signature. However, sustained lower abundance of Id2 and Id3 interfered with proper development of T-FR cells. Depletion of Id2 and Id3 expression in T-reg cells resulted in compromised maintenance and localization of the T-reg cell population. Thus, Id2 and Id3 enforce T-FR cell checkpoints and control the maintenance and homing of T-reg cells.	[Miyazaki, Masaki; Miyazaki, Kazuko; Chen, Shuwen; Lu, Li-Fan; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Itoi, Manami] Meiji Univ Integrat Med, Dept Immunol & Microbiol, Hiyoshi, Kyoto, Japan; [Miller, Marina; Broide, David H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Nissi] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Chang, Aaron N.] Univ Calif San Diego, Inst Genom Med, Ctr Computat Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu		Broide, David/0000-0001-8405-9090; Miyazaki, Masaki/0000-0002-9543-624X; Lu, Li-Fan/0000-0002-9727-0036	US National Institutes of Health [AI 38425, AI 70535, AI 7211, CA054198, CA78384, 1P01AI102853]; NATIONAL CANCER INSTITUTE [R01CA078384, R37CA054198, R01CA054198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R37AI038425, P01AI102853, R01AI038425] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Bortnick for critical reading of the manuscript, S. Kuan, B. Lin and Z. Ye for help with Illumina DNA sequencing, B. Ren for access to the Illumina Hi-Seq instrumentation, A. Goldrath (University of California San Diego) for Id2-YFP mice, Y. Zhuang for Id3<SUP>fl/fl</SUP> mice (Duke University), A. Lasorella (Columbia University) for Id2<SUP>fl/fl</SUP> mice, Y. Zheng (Salk Institute) for Foxp3-deficient organs, C. Katayama, M. Suzukawa, L. Deng, P. Rosenthal, T. Katakai, A. Beppu and A. Coddington for technical advice, J. Lee (Mayo Clinic) for providing the MBP antibodies, and members of the University of California, San Diego Histology Core for performing histology. This work was supported by US National Institutes of Health (AI 38425, AI 70535 and AI 7211 to D.H.B. and CA054198, CA78384 and 1P01AI102853 to C.M.).	Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Knell J, 2013, J IMMUNOL, V190, P1501, DOI 10.4049/jimmunol.1200750; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Suzukawa M, 2013, J IMMUNOL, V190, P5939, DOI 10.4049/jimmunol.1203455; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	53	89	94	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					767	+		10.1038/ni.2928	http://dx.doi.org/10.1038/ni.2928			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24973820	Green Accepted			2022-12-18	WOS:000339323000012
J	Veerman, KM; Williams, MJ; Uchimura, K; Singer, MS; Merzaban, JS; Naus, S; Carlow, DA; Owen, P; Rivera-Nieves, J; Rosen, SD; Ziltener, HJ				Veerman, Krystle M.; Williams, Michael J.; Uchimura, Kenji; Singer, Mark S.; Merzaban, Jasmeen S.; Naus, Silvia; Carlow, Douglas A.; Owen, Philip; Rivera-Nieves, Jesus; Rosen, Steven D.; Ziltener, Hermann J.			Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; P-SELECTIN; GLYCOPROTEIN LIGAND-1; TYROSINE-PHOSPHORYLATION; HUMAN NEUTROPHILS; B-LYMPHOCYTE; IN-VIVO; INFLAMMATION; RECRUITMENT; NODES	P-selectin glycoprotein ligand 1 (PSGL-1) is central to the trafficking of immune effector cells to areas of inflammation through direct interactions with P-selectin, E-selectin and L-selectin. Here we show that PSGL-1 was also required for efficient homing of resting T cells to secondary lymphoid organs but functioned independently of selectin binding. PSGL-1 mediated an enhanced chemotactic T cell response to the secondary lymphoid organ chemokines CCL21 and CCL19 but not to CXCL12 or to inflammatory chemokines. Our data show involvement of PSGL-1 in facilitating the entry of T cells into secondary lymphoid organs, thereby demonstrating the bifunctional nature of this molecule.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA; Univ Virginia, Hlth Sci Ctr, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Virginia; University of British Columbia	Ziltener, HJ (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada.	hermann@brc.ubc.ca	Uchimura, Kenji/AFV-1802-2022; Merzaban, Jasmeen/V-3147-2018; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Merzaban, Jasmeen/0000-0002-7276-2907; Uchimura, Kenji/0000-0003-3009-248X; Rosen, Steven/0000-0002-6245-701X	NIGMS NIH HHS [R01GM57411, R01GM23547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057411, R01GM023547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ba XQ, 2005, J CELL BIOCHEM, V94, P365, DOI 10.1002/jcb.20213; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Carlow DA, 2001, J IMMUNOL, V166, P256, DOI 10.4049/jimmunol.166.1.256; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hicks AER, 2003, BLOOD, V101, P3249, DOI 10.1182/blood-2002-07-2329; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Hirata T, 2004, J BIOL CHEM, V279, P51775, DOI 10.1074/jbc.M409868200; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Merzaban JS, 2005, J IMMUNOL, V174, P4051, DOI 10.4049/jimmunol.174.7.4051; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Pilkington KR, 2004, J BIOL CHEM, V279, P40276, DOI 10.1074/jbc.M405808200; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Sumariwalla PF, 2004, CLIN EXP IMMUNOL, V136, P67, DOI 10.1111/j.1365-2249.2004.02421.x; Tang MLK, 1998, J IMMUNOL, V160, P5113; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	46	89	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					532	539		10.1038/ni1456	http://dx.doi.org/10.1038/ni1456			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17401367				2022-12-18	WOS:000245831600018
J	Hoare, HL; Sullivan, LC; Pietra, G; Clements, CS; Lee, EJ; Ely, LK; Beddoe, T; Falco, M; Kjer-Nielsen, L; Reid, HH; McCluskey, J; Moretta, L; Rossjohn, J; Brooks, AG				Hoare, HL; Sullivan, LC; Pietra, G; Clements, CS; Lee, EJ; Ely, LK; Beddoe, T; Falco, M; Kjer-Nielsen, L; Reid, HH; McCluskey, J; Moretta, L; Rossjohn, J; Brooks, AG			Structural basis for a major histocompatibility complex class Ib-restricted T cell response	NATURE IMMUNOLOGY			English	Article							PEPTIDE-BINDING-SPECIFICITY; KILLER INHIBITORY RECEPTOR; HLA-E; HUMAN CYTOMEGALOVIRUS; SURFACE EXPRESSION; RECOGNITION; LIGAND; MOLECULES; ANTIGEN; IDENTIFICATION	In contrast to antigen-specific immunity orchestrated by major histocompatibility complex (MHC) class Ia molecules, the ancestrally related nonclassical MHC class Ib molecules generally mediate innate immune responses. Here we have demonstrated the structural basis by which the MHC class Ib molecule HLA-E mediates an adaptive MHC-restricted cytotoxic T lymphocyte response to human cytomegalovirus. Highly constrained by host genetics, the response showed notable fine specificity for position 8 of the viral peptide, which is the sole discriminator of self versus nonself. Despite the evolutionary divergence of MHC class Ia and class Ib molecules, the structure of the T cell receptor-MHC class Ib complex was very similar to that of conventional T cell receptor-MHC class Ia complexes. These results emphasize the evolutionary 'ambiguity' of HLA-E, which not only interacts with innate immune receptors but also has the functional capacity to mediate virus-specific cytotoxic T lymphocyte responses during adaptive immunity.	Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Univ Genoa, Dept Expt Med, Genoa, Italy; Ist Giannina Gaslini, I-16148 Genoa, Italy	Monash University; University of Melbourne; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; agbrooks@unimelb.edu.au	pietra, gabriella/J-7204-2016; Moretta, Lorenzo/AAA-7239-2020; Beddoe, Travis/F-3415-2014; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Falco, Michela/K-1574-2016	pietra, gabriella/0000-0002-7080-531X; Moretta, Lorenzo/0000-0003-4658-1747; Beddoe, Travis/0000-0003-4550-2277; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Falco, Michela/0000-0002-0317-9830; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ely LK, 2005, IUBMB LIFE, V57, P575, DOI 10.1080/15216540500215556; Ely LK, 2005, J IMMUNOL, V174, P5593, DOI 10.4049/jimmunol.174.9.5593; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Knapp LA, 1998, J IMMUNOL, V160, P189; KOLLER BH, 1988, J IMMUNOL, V141, P897; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Llano M, 2003, EUR J IMMUNOL, V33, P2744, DOI 10.1002/eji.200324182; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Romagnani C, 2004, HUM IMMUNOL, V65, P437, DOI 10.1016/j.humimm.2004.02.001; Romagnani C, 2002, P NATL ACAD SCI USA, V99, P11328, DOI 10.1073/pnas.172369799; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114	54	89	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					256	264		10.1038/ni1312	http://dx.doi.org/10.1038/ni1312			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16474394				2022-12-18	WOS:000235360400010
J	Fecteau, S; Basadonna, GP; Freitas, A; Ariyan, C; Sayegh, MH; Rothstein, DM				Fecteau, S; Basadonna, GP; Freitas, A; Ariyan, C; Sayegh, MH; Rothstein, DM			CTLA-4 up-regulation plays a role in tolerance mediated by CD45	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; T-CELL ACTIVATION; IN-VIVO; INTERLEUKIN-2 SECRETION; NEGATIVE REGULATOR; DISTINCT ISOFORMS; EXPRESSION; INDUCTION; ANTIBODY	Cytolytic T lymphocyte-associated antigen 4 (CTLA-4) is a critical down-regulatory molecule in T cells that plays a major role in peripheral tolerance. Although the CD45 protein tyrosine phosphatase is a potent immunomodulatory target, the mechanisms by which antibody against CD45RB isoforms (anti-CD45RB) induces allograft tolerance remain unclear. We show here that anti-CD45RB treatment alters CD45 isoform expression on T cells, which is associated with rapid up-regulation of CTLA-4 expression. These effects appear specific and occur without up-regulation of other activation markers. Administration of a blocking monoclonal antibody to CTLA-4 at the time of transplantation prevents anti CD45RB therapy from prolonging islet allograft survival. In addition, treatment with cyclosporin A blocks anti-CD45RB-induced CTLA-4 expression and promotes acute rejection. These data suggest that anti-CD45RB acts through mechanisms that include CTLA-4 up-regulation and demonstrate a link between CD45 and CTLA-4 that depends on calcineurin-mediated signaling. They demonstrate also that CTLA-4 expression may be specifically targeted to enhance allograft acceptance.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rothstein, DM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.			Ariyan, Charlotte/0000-0003-0818-3895	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, R01AI045485, R01AI036317] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45485, AI-41521, AI-36317] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alegre ML, 1996, J IMMUNOL, V157, P4762; Basadonna GP, 1998, P NATL ACAD SCI USA, V95, P3821, DOI 10.1073/pnas.95.7.3821; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; Chuang E, 1997, J IMMUNOL, V159, P144; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Finn PW, 1997, J IMMUNOL, V158, P4074; Judge TA, 1999, J IMMUNOL, V162, P1947; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Kashio N, 1998, J BIOL CHEM, V273, P33856, DOI 10.1074/jbc.273.50.33856; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LEE WT, 1990, J IMMUNOL, V144, P3288; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; LEITENBERG D, 1995, EUR J IMMUNOL, V25, P2445, DOI 10.1002/eji.1830250906; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; MCKENNEY DW, 1995, J BIOL CHEM, V270, P24949, DOI 10.1074/jbc.270.42.24949; Metzger H, 1998, ANNU REV IMMUNOL, V16, P1, DOI 10.1146/annurev.immunol.16.1.1; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; MORIMOTO C, 1985, J IMMUNOL, V134, P1508; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perkins D, 1996, J IMMUNOL, V156, P4154; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; ROTHSTEIN DM, 1991, J IMMUNOL, V146, P1175; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider H, 1999, J IMMUNOL, V163, P1868; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SPARSHOTT SM, 1994, EUR J IMMUNOL, V24, P2573, DOI 10.1002/eji.1830241102; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TEDDER TF, 1985, J IMMUNOL, V134, P2983; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	44	89	94	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					58	63		10.1038/83175	http://dx.doi.org/10.1038/83175			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135579				2022-12-18	WOS:000166261500015
J	Bernink, JH; Ohne, Y; Teunissen, MBM; Wang, JY; Wu, JC; Krabbendam, L; Guntermann, C; Volckmann, R; Koster, J; van Tol, S; Ramirez, I; Shrestha, Y; de Rie, MA; Spits, H; Ros, XR; Humbles, AA				Bernink, Jochem H.; Ohne, Yoichiro; Teunissen, Marcel B. M.; Wang, Jingya; Wu, Jincheng; Krabbendam, Lisette; Guntermann, Christine; Volckmann, Richard; Koster, Jan; van Tol, Sophie; Ramirez, Ivan; Shrestha, Yashaswi; de Rie, Menno A.; Spits, Hergen; Ros, Xavier Romero; Humbles, Alison A.			c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR GATA3; DIFFERENTIATION; PLASTICITY; IL-1-BETA; INFLAMMATION; MECHANISMS; EXPRESSION; T-H-17; FATE	Here we identify a group 2 innate lymphoid cell (ILC2) subpopulation that can convert into interleukin-17 (IL-17)-producing NKp44(-) ILC3-like cells. c-Kit and CCR6 define this ILC2 subpopulation that exhibits ILC3 features, including ROR gamma t, enabling the conversion into IL-17-producing cells in response to IL-1 beta and IL-23. We also report a role for transforming growth factor-beta in promoting the conversion of c-Kit-ILC2s into ROR gamma t-expressing cells by inducing the upregulation of IL23R, CCR6 and KIT messenger RNA in these cells. This switch was dependent on ROR gamma t and the downregulation of GATA-3. IL-4 was able to reverse this event, supporting a role for this cytokine in maintaining ILC2 identity. Notably, this plasticity has physiological relevance because a subset of ROR gamma t(+) ILC2s express the skin-homing receptor CCR10, and the frequencies of IL-17-producing ILC3s are increased at the expense of ILC2s within the lesional skin of patients with psoriasis.	[Bernink, Jochem H.; Krabbendam, Lisette; van Tol, Sophie; Ramirez, Ivan; Spits, Hergen; Ros, Xavier Romero] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Ohne, Yoichiro; Wang, Jingya; Ros, Xavier Romero; Humbles, Alison A.] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [Teunissen, Marcel B. M.; de Rie, Menno A.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Wu, Jincheng] MedImmune LLC, Dept Res Bioinformat, Gaithersburg, MD USA; [Guntermann, Christine] Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat Dis Area, Basel, Switzerland; [Volckmann, Richard; Koster, Jan] Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [Shrestha, Yashaswi] MedImmune LLC, Dept Translat Med & Pharmacogen, Gaithersburg, MD USA	University of Amsterdam; Academic Medical Center Amsterdam; AstraZeneca; Medimmune; University of Amsterdam; Academic Medical Center Amsterdam; AstraZeneca; Medimmune; Novartis; University of Amsterdam; Academic Medical Center Amsterdam; AstraZeneca; Medimmune	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.; Humbles, AA (corresponding author), MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA.	hergen.spits@amc.uva.nl; alisonhumbles@gmail.com	de Rie, Menno/GSD-4660-2022; Ohne, Yoichiro/AGE-6061-2022	Koster, Jan/0000-0002-0890-7585; de Rie, Menno/0000-0002-1867-3559; Ramirez-Moral, Ivan/0000-0002-6302-0020; guntermann, christine/0000-0001-8220-2578				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bielecki P., 2018, BIORXIV, DOI [10.1101/461228v2, DOI 10.1101/461228V2]; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Dang MH, 2014, PROTEIN CELL, V5, P692, DOI 10.1007/s13238-014-0087-3; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Golebski K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09883-7; Haque A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0467-4; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McCully ML, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00033; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2017, NEW ENGL J MED, V376, P1551, DOI 10.1056/NEJMoa1607017; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Silver JS, 2016, NAT IMMUNOL, V17, P1005, DOI 10.1038/ni0816-1005c; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Ullrich E, 2018, J CLIN INVEST, V128, P916, DOI 10.1172/JCI89242; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029	47	88	89	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					992	+		10.1038/s41590-019-0423-0	http://dx.doi.org/10.1038/s41590-019-0423-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31263279				2022-12-18	WOS:000476621200014
J	Ryu, JK; Rafalski, VA; Meyer-Franke, A; Adams, RA; Poda, SB; Coronado, PER; Pedersen, LO; Menon, V; Baeten, KM; Sikorski, SL; Bedard, C; Hanspers, K; Bardehle, S; Mendiola, AS; Davalos, D; Machado, MR; Chan, JP; Plastira, I; Petersen, MA; Pfaff, SJ; Ang, KK; Hallenbeck, KK; Syme, C; Hakozaki, H; Ellisman, MH; Swanson, RA; Zamvil, SS; Arkin, MR; Zorn, SH; Pico, AR; Mucke, L; Freedman, SB; Stavenhagen, JB; Nelson, RB; Akassoglou, K				Ryu, Jae Kyu; Rafalski, Victoria A.; Meyer-Franke, Anke; Adams, Ryan A.; Poda, Suresh B.; Coronado, Pamela E. Rios; Pedersen, Lars Ostergaard; Menon, Veena; Baeten, Kim M.; Sikorski, Shoana L.; Bedard, Catherine; Hanspers, Kristina; Bardehle, Sophia; Mendiola, Andrew S.; Davalos, Dimitrios; Machado, Michael R.; Chan, Justin P.; Plastira, Ioanna; Petersen, Mark A.; Pfaff, Samuel J.; Ang, Kenny K.; Hallenbeck, Kenneth K.; Syme, Catriona; Hakozaki, Hiroyuki; Ellisman, Mark H.; Swanson, Raymond A.; Zamvil, Scott S.; Arkin, Michelle R.; Zorn, Stevin H.; Pico, Alexander R.; Mucke, Lennart; Freedman, Stephen B.; Stavenhagen, Jeffrey B.; Nelson, Robert B.; Akassoglou, Katerina			Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration	NATURE IMMUNOLOGY			English	Article							MULTIPLE-SCLEROSIS LESIONS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NADPH OXIDASE; OXIDATIVE STRESS; BLEEDING EVENTS; INFLAMMATION; ACTIVATION; MICROGLIA; DAMAGE	Activation of innate immunity and deposition of blood-derived fibrin in the central nervous system (CNS) occur in autoimmune and neurodegenerative diseases, including multiple sclerosis (MS) and Alzheimer's disease (AD). However, the mechanisms that link disruption of the blood-brain barrier (BBB) to neurodegeneration are poorly understood, and exploration of fibrin as a therapeutic target has been limited by its beneficial clotting functions. Here we report the generation of monoclonal antibody 5B8, targeted against the cryptic fibrin epitope. gamma(377-395), to selectively inhibit fibrin-induced inflammation and oxidative stress without interfering with clotting. 5B8 suppressed fibrin-induced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation and the expression of proinflammatory genes. In animal models of MS and AD, 5B8 entered the CNS and bound to parenchymal fibrin, and its therapeutic administration reduced the activation of innate immunity and neurodegeneration. Thus, fibrin-targeting immunotherapy inhibited autoimmunity- and amyloid-driven neurotoxicity and might have clinical benefit without globally suppressing innate immunity or interfering with coagulation in diverse neurological diseases.	[Ryu, Jae Kyu; Rafalski, Victoria A.; Meyer-Franke, Anke; Coronado, Pamela E. Rios; Baeten, Kim M.; Bedard, Catherine; Hanspers, Kristina; Bardehle, Sophia; Mendiola, Andrew S.; Davalos, Dimitrios; Machado, Michael R.; Chan, Justin P.; Plastira, Ioanna; Petersen, Mark A.; Syme, Catriona; Pico, Alexander R.; Mucke, Lennart; Freedman, Stephen B.; Akassoglou, Katerina] Gladstone Inst, San Francisco, CA 94158 USA; [Adams, Ryan A.; Sikorski, Shoana L.; Akassoglou, Katerina] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Poda, Suresh B.; Menon, Veena; Zorn, Stevin H.; Nelson, Robert B.] Lundbeck Res USA, Paramus, NJ USA; [Pedersen, Lars Ostergaard; Stavenhagen, Jeffrey B.] H Lundbeck & Co AS, Copenhagen, Denmark; [Plastira, Ioanna] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Petersen, Mark A.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA USA; [Pfaff, Samuel J.; Ang, Kenny K.; Hallenbeck, Kenneth K.; Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Small Mol Discovery Ctr, San Francisco, CA USA; [Hakozaki, Hiroyuki; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Swanson, Raymond A.] San Francisco VA Med Ctr, Neurol Serv, San Francisco, CA USA; [Swanson, Raymond A.; Zamvil, Scott S.; Mucke, Lennart; Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Davalos, Dimitrios] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego; Lundbeck Corporation; Medical University of Graz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Cleveland Clinic Foundation	Akassoglou, K (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	kakassoglou@gladstone.ucsf.edu	Pico, Alexander/HCH-4305-2022; Machado, Michael/AAR-7722-2020; Arkin, Michelle/AAO-2009-2021; Petersen, Mark/AAN-5634-2020; arkin, michelle/AAN-4298-2021; Davalos, Dimitrios/G-8627-2011	Machado, Michael/0000-0001-6538-6408; arkin, michelle/0000-0002-9366-6770; Davalos, Dimitrios/0000-0001-9038-6688; Baeten, Kim/0000-0001-7745-3882; RYU, JAE KYU/0000-0002-3992-4011; Mucke, Lennart/0000-0001-6256-9559; Akassoglou, Katerina/0000-0002-2632-1465; Mendiola, Andrew/0000-0002-2897-3299; Plastira, Ioanna/0000-0003-2403-9973; Hallenbeck, Kenneth/0000-0001-8662-2537	H. Lundbeck A/S; S.D. Bechtel, Jr. Foundation; Conrad N. Hilton Foundation [17348]; National Center for Microscopy and Imaging Research [P41 GM10341]; NIH/NCRR [RR18928]; Mouse Pathology Core of the UCSF Helen Diller Family Comprehensive Cancer Center [CA082103]; National Multiple Sclerosis Society (NMSS) Postdoctoral Fellowships; Race to Erase MS Young Investigator Awards; American Heart Association (AHA) Scientist Development Grants; AHA; NIH/NINDS [F32 NS096920, R01 NS052189, R21 NS082976, R35 NS097976]; NIAID [T32AI733429]; NMSS [FG-1708-28925, RG1701-26628, RG 5179A10/2, RG3782]; NSF [DGE-0648991/1144247]; NIH/NICHD [K12-HD072222]; NIH [R01 NS092835, R21 NS108159, R01 NS081149]; Weill Institute; Maisin Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD072222, P01HD084387] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS108159, R01NS081149, R35NS097976, R21NS082976, R01NS092835, F32NS096920, R01NS052189] Funding Source: NIH RePORTER	H. Lundbeck A/S; S.D. Bechtel, Jr. Foundation; Conrad N. Hilton Foundation; National Center for Microscopy and Imaging Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mouse Pathology Core of the UCSF Helen Diller Family Comprehensive Cancer Center; National Multiple Sclerosis Society (NMSS) Postdoctoral Fellowships; Race to Erase MS Young Investigator Awards; American Heart Association (AHA) Scientist Development Grants; AHA(American Heart Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NMSS(National Multiple Sclerosis Society); NSF(National Science Foundation (NSF)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Institute; Maisin Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I.F. Charo (Gladstone Institutes) for Ccr2<SUP>RFP/RFP</SUP> mice on a C57BL/6 background; J.L. Degen for advice and critical reading of the manuscript; S. Pintchovski, I. Kadiu, J. Palop and J. Egebjerg for discussions; B. Cabriga, R. Meza Acevedo, L. Ta and A. Williams for technical assistance; G. Maki for graphics; and G. Howard and K. Claiborne for editorial assistance. The Gladstone Center for In vivo Imaging Research was supported in part by grants from H. Lundbeck A/S, the S.D. Bechtel, Jr. Foundation, and the Conrad N. Hilton Foundation (17348 to K.A.). The microscopy studies were carried out in part at facilities adapted for this project at the National Center for Microscopy and Imaging Research, which is supported by grant P41 GM10341 (awarded to M.H.E.). Gladstone Institutes was supported by NIH/NCRR grant RR18928. The Mouse Pathology Core of the UCSF Helen Diller Family Comprehensive Cancer Center was supported by CA082103. J.K.R., D.D. and A.S.M. were supported by National Multiple Sclerosis Society (NMSS) Postdoctoral Fellowships; J.K.R. and D.D. were supported by Race to Erase MS Young Investigator Awards and American Heart Association (AHA) Scientist Development Grants; V.A.R. was supported by postdoctoral fellowships from AHA and NIH/NINDS F32 NS096920; A.S.M. was supported by NIAID T32AI733429 and NMSS FG-1708-28925; K.K.H. was supported by NSF pre-doctoral fellowship DGE-0648991/1144247; M.A.P. was supported by a NIH/NICHD K12-HD072222; L.M. was supported by a gift from the Dolby Family; S.S.Z. was supported by NIH R01 NS092835; R21 NS108159, NMSS RG1701-26628, RG 5179A10/2, the Weill Institute and the Maisin Foundation; and R.A.S was supported by NIH R01 NS081149. This work was also supported by grants to K A. from NMSS (RG3782), H. Lundbeck A/S, the Conrad N. Hilton Foundation (17348), a gift from the Levine Family, and NIH/NINDS (R01 NS052189, R21 NS082976 and R35 NS097976).	Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200; Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; CHEN R, 1971, BIOCHEMISTRY-US, V10, P4486, DOI 10.1021/bi00800a021; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; Cortes-Canteli M, 2015, NEUROBIOL AGING, V36, P608, DOI 10.1016/j.neurobiolaging.2014.10.030; Cummings J, 2018, CTS-CLIN TRANSL SCI, V11, P147, DOI 10.1111/cts.12491; Davalos D, 2014, ANN NEUROL, V75, P303, DOI 10.1002/ana.24078; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Haslund-Vinding J, 2017, BRIT J PHARMACOL, V174, P1733, DOI 10.1111/bph.13425; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jensen MR, 2016, J BIOL CHEM, V291, P16963, DOI 10.1074/jbc.M116.732222; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Koseki-Kuno S, 2003, BLOOD, V102, P4410, DOI 10.1182/blood-2003-05-1467; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Lak M, 1999, BRIT J HAEMATOL, V107, P204; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Lee NJ, 2018, BRAIN, V141, P1637, DOI 10.1093/brain/awy082; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OKA A, 1993, J NEUROSCI, V13, P1441; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Petersen MA, 2017, NEURON, V96, P1003, DOI 10.1016/j.neuron.2017.10.008; Rabin JS, 2018, JAMA NEUROL, V75, P1124, DOI 10.1001/jamaneurol.2018.1123; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schuh C, 2014, ACTA NEUROPATHOL, V128, P247, DOI 10.1007/s00401-014-1263-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Shoeb M, 2013, J THROMB THROMBOLYS, V35, P312, DOI 10.1007/s11239-013-0899-7; Strickland S, 2018, J CLIN INVEST, V128, P556, DOI 10.1172/JCI97509; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Ugarova TP, 2003, BIOCHEMISTRY-US, V42, P9365, DOI 10.1021/bi034057k; Vemuri P, 2015, BRAIN, V138, P761, DOI 10.1093/brain/awu393; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	66	88	90	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1212	+		10.1038/s41590-018-0232-x	http://dx.doi.org/10.1038/s41590-018-0232-x			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323343	Green Submitted, Green Accepted			2022-12-18	WOS:000447632200016
J	Gundra, UM; Girgis, NM; Gonzalez, MA; Tang, MS; Van Der Zande, HJP; Lin, JD; Ouimet, M; Ma, LJ; Poles, J; Vozhilla, N; Fisher, EA; Moore, KJ; Loke, P				Gundra, Uma Mahesh; Girgis, Natasha M.; Gonzalez, Michael A.; Tang, Mei San; Van Der Zande, Hendrik J. P.; Lin, Jian-Da; Ouimet, Mireille; Ma, Lily J.; Poles, Jordan; Vozhilla, Nikollaq; Fisher, Edward A.; Moore, Kathryn J.; Loke, P'ng			Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation	NATURE IMMUNOLOGY			English	Article							POLARIZATION; RECRUITMENT; ENVIRONMENT; PERITONEAL; INFECTION; ALIGNMENT; PROGRAM	It remains unclear whether activated inflammatory macrophages can adopt features of tissue-resident macrophages, or what mechanisms might mediate such a phenotypic conversion. Here we show that vitamin A is required for the phenotypic conversion of interleukin 4 (IL-4)-activated monocyte-derived F4/80(int)CD206(+)PD-L2(+)MHCII(+) macrophages into macrophages with a tissue-resident F4/80(hi)CD206(-)PD-L2(-)MHCII(-)UCP1(+) phenotype in the peritoneal cavity of mice and during the formation of liver granulomas in mice infected with Schistosoma mansoni. The phenotypic conversion of F4/80(int)CD206(+) macrophages into F4/80(hi)CD206(-) macrophages was associated with almost complete remodeling of the chromatin landscape, as well as alteration of the transcriptional profiles. Vitamin A-deficient mice infected with S. mansoni had disrupted liver granuloma architecture and increased mortality, which indicates that failure to convert macrophages from the F4/80(int)CD206(+) phenotype to F4/80(hi)CD206(-) may lead to dysregulated inflammation during helminth infection.	[Gundra, Uma Mahesh; Girgis, Natasha M.; Gonzalez, Michael A.; Tang, Mei San; Van Der Zande, Hendrik J. P.; Lin, Jian-Da; Ma, Lily J.; Poles, Jordan; Vozhilla, Nikollaq; Fisher, Edward A.; Loke, P'ng] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ouimet, Mireille; Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Dept Med, New York, NY USA; [Ouimet, Mireille; Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Dept Cell Biol, New York, NY USA	New York University; New York University; New York University	Loke, P (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	png.loke@nyumc.org	Fisher, Edward/ABE-7469-2020; Loke, Png/X-2278-2019; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Poles, Jordan/0000-0002-0668-8673; Fisher, Edward/0000-0001-9802-143X; Lin, Jian-Da/0000-0003-3697-4766	Cancer Center at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NIH [T32 AI007180, 104220]; NIAID [AI093811, AI094166]; NIDDK [DK103788]; Ruth L. Kirschstein NRSA fellowship [F32AI102502]; Vilcek Foundation; AAI; NIH-NIAID contract [HHSN272201000005I]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094166, T32AI007180, F32AI102502, R01AI093811, T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103788] Funding Source: NIH RePORTER	Cancer Center at the Laura and Isaac Perlmutter Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Foundation; AAI; NIH-NIAID contract; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Cadwell and members of the K. Cadwell, J. Ernst and E. Fisher laboratories for their reading of this manuscript. We thank W. Gan and D. Littman (New York University Medical Center, Skirball Institute of Biomolecular Medicine, New York, New York, USA) for generously providing the Cx3cr1<SUP>CreERT2-IRES-EYFP</SUP> mice, and J. Collins (UT Southwestern, Dallas, Texas, USA) for providing S. mansoni eggs. We thank the NYUMC Genome Technology Core, NYUMC Flow Cytometry Core, NYUMC Microscopy Core and NYUMC Histopathology Core facilities for their assistance; these shared resources are partially supported by the Cancer Center (support grant P30CA016087) at the Laura and Isaac Perlmutter Cancer Center. This work was supported by the NIH (T32 microbiology training grant T32 AI007180 to U.M.G. and M.A.G.; T32 cardiology grant 104220 to U.M.G.), NIAID (grants AI093811 and AI094166 to P.L.), NIDDK (grant DK103788 to P.L.), a Ruth L. Kirschstein NRSA fellowship (F32AI102502 to N.M.G.), the Vilcek Foundation (U.M.G.) and AAI (M.S.T.). Biomphalaria glabrata snails were provided by the NIAID Schistosomiasis Resource Center of the Biomedical Research Institute (Rockville, Maryland, USA) through NIH-NIAID contract HHSN272201000005I for distribution through BEI Resources.	Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2016, NAT IMMUNOL, V17, P1, DOI 10.1038/ni.3351; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002883; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Girgis NM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004080; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Joyce KL, 2012, JOVE-J VIS EXP, DOI 10.3791/3905; Kaufman L., 2009, FINDING GROUPS DATA; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy MT, 2014, BIOINFORMATICS, V30, P1302, DOI 10.1093/bioinformatics/btt774; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nascimento M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004282; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stark R., 2011, R PACKAGE VERSION, V100, P1; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	49	88	88	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					642	+		10.1038/ni.3734	http://dx.doi.org/10.1038/ni.3734			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28436955	Green Accepted			2022-12-18	WOS:000401520900009
J	Heinzel, S; Giang, TB; Kan, A; Marchingo, JM; Lye, BK; Corcoran, LM; Hodgkin, PD				Heinzel, Susanne; Tran Binh Giang; Kan, Andrey; Marchingo, Julia M.; Lye, Bryan K.; Corcoran, Lynn M.; Hodgkin, Philip D.			A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses	NATURE IMMUNOLOGY			English	Article							C-MYC; LYMPHOCYTE-PROLIFERATION; SURVIVAL; AFFINITY; EXPRESSION; EFFECTOR; FATES	T lymphocytes and B lymphocytes integrate activating signals to control the size of their proliferative response. Here we report that such control was achieved by timed changes in the production rate of cell-cycle-regulating proto-oncoprotein Myc, with division cessation occurring when Myc levels fell below a critical threshold. The changing pattern of the level of Myc was not affected by cell division, which identified the regulating mechanism as a cell-intrinsic, heritable temporal controller. Overexpression of Myc in stimulated T cells and B cells did not sustain cell proliferation indefinitely, as a separate 'time-to-die' mechanism, also heritable, was programmed after lymphocyte activation and led to eventual cell loss. Together the two competing cell-intrinsic timed fates created the canonical T cell and B cell immune-response pattern of rapid growth followed by loss of most cells. Furthermore, small changes in these timed processes by regulatory signals, or by oncogenic transformation, acted in synergy to greatly enhance cell numbers over time.	[Heinzel, Susanne; Tran Binh Giang; Kan, Andrey; Marchingo, Julia M.; Lye, Bryan K.; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Heinzel, Susanne; Tran Binh Giang; Kan, Andrey; Marchingo, Julia M.; Lye, Bryan K.; Corcoran, Lynn M.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Corcoran, Lynn M.] Walter & Eliza Hall Inst Med Res, Div Mol Immunol, Parkville, Vic, Australia; [Marchingo, Julia M.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; University of Dundee	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.; Hodgkin, PD (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	hodgkin@wehi.edu.au	Giang, Tran Binh/S-6164-2019; Giang, Tran Binh/B-6306-2017; Marchingo, Julia/AAQ-6970-2021	Giang, Tran Binh/0000-0001-8820-5913; Giang, Tran Binh/0000-0001-8820-5913; Heinzel, Susanne/0000-0001-9524-2835; Marchingo, Julia/0000-0001-8823-9718; Lye, Bryan/0000-0001-5058-7469; Hodgkin, Philip/0000-0002-8604-1940	National Health and Medical Research Council of Australia [1010654, 1057831, 1054925]; Victorian State Government Operational Infrastructure Support, an Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme [361646]; Australian Department of Education and Training (Australian Postgraduate Award); Walter and Eliza Hall Institute (Edith Moffat Scholarship); Cancer Council of Victoria (Sydney Parker Smith Postdoctoral Research Fellowship); University of Melbourne (Melbourne International Research Scholarship); University of Melbourne (Melbourne International Fee Remission Scholarship)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support, an Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme; Australian Department of Education and Training (Australian Postgraduate Award)(Australian GovernmentDepartment of Industry, Innovation and Science); Walter and Eliza Hall Institute (Edith Moffat Scholarship); Cancer Council of Victoria (Sydney Parker Smith Postdoctoral Research Fellowship)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); University of Melbourne (Melbourne International Research Scholarship); University of Melbourne (Melbourne International Fee Remission Scholarship)	We thank S. Cory (The Walter and Eliza Hall Institute) for vav-myc10 mice; P. Bouillet (The Walter and Eliza Hall Institute) for Bcl-2-Tg, Bcl2l11<SUP>-/-</SUP> and E mu-Myc mice; M. Hancock and T. Kratina for technical assistance; J. Zhou for help in figure preparation; and S. Cory, M. Dowling, K. Duffy and A. Strasser for critical review of the manuscript. Supported by the National Health and Medical Research Council of Australia (Project Grants 1010654 and 1057831 and Program Grant 1054925; and fellowships to P.D.H. and L.M.C.), Victorian State Government Operational Infrastructure Support, an Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme (361646), The Australian Department of Education and Training (Australian Postgraduate Award to J.M.M.), The Walter and Eliza Hall Institute (Edith Moffat Scholarship to J.M.M.), the Cancer Council of Victoria (Sydney Parker Smith Postdoctoral Research Fellowship to J.M.M.) and The University of Melbourne (Melbourne International Research Scholarship for B.K.L. and Melbourne International Fee Remission Scholarship for B.K.L.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Burton PBJ, 1999, DEV BIOL, V216, P659, DOI 10.1006/dbio.1999.9524; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Donnelly RP, 2015, MOL IMMUNOL, V68, P513, DOI 10.1016/j.molimm.2015.07.034; Duffy KR, 2012, TRENDS CELL BIOL, V22, P457, DOI 10.1016/j.tcb.2012.05.004; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Link JM, 2015, BBA-GENE REGUL MECH, V1849, P554, DOI 10.1016/j.bbagrm.2014.04.004; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Marchingo J.M, NAT COMMUN; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Raff M, 2006, BIOCHEM SOC T, V34, P663, DOI 10.1042/BST0340663; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	32	88	89	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					96	103		10.1038/ni.3598	http://dx.doi.org/10.1038/ni.3598			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27820810				2022-12-18	WOS:000390080000014
J	Larghi, P; Williamson, DJ; Carpier, JM; Dogniaux, S; Chemin, K; Bohineust, A; Danglot, L; Gaus, K; Galli, T; Hivroz, C				Larghi, Paola; Williamson, David J.; Carpier, Jean-Marie; Dogniaux, Stephanie; Chemin, Karine; Bohineust, Armelle; Danglot, Lydia; Gaus, Katharina; Galli, Thierry; Hivroz, Claire			VAMP7 controls T cell activation by regulating the recruitment and phosphorylation of vesicular Lat at TCR-activation sites	NATURE IMMUNOLOGY			English	Article							MICROTUBULE-ORGANIZING CENTER; IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; SIGNALING MOLECULES; ANTIGEN RECEPTORS; SNARE COMPLEXES; PLASMA-MEMBRANE; PROTEIN LAT; ADAPTER LAT; CLUSTER	The mechanisms by which Lat (a key adaptor in the T cell antigen receptor (TCR) signaling pathway) and the TCR come together after TCR triggering are not well understood. We investigate here the role of SNARE proteins, which are part of protein complexes involved in the docking, priming and fusion of vesicles with opposing membranes, in this process. Here we found, by silencing approaches and genetically modified mice, that the vesicular SNARE VAMP7 was required for the recruitment of Lat-containing vesicles to TCR-activation sites. Our results indicated that this did not involve fusion of Lat-containing vesicles with the plasma membrane. VAMP7, which localized together with Lat on the subsynaptic vesicles, controlled the phosphorylation of Lat, formation of the TCR-Lat-signaling complex and, ultimately, activation of T cells. Our findings suggest that the transport and docking of Lat-containing vesicles with target membranes containing TCRs regulates TCR-induced signaling.	[Larghi, Paola; Carpier, Jean-Marie; Dogniaux, Stephanie; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire] Inst Curie, Ctr Rech, Paris, France; [Larghi, Paola; Carpier, Jean-Marie; Dogniaux, Stephanie; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire] Inst Natl Sante & Rech Med, Unite 932, Paris, France; [Williamson, David J.; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Williamson, David J.; Gaus, Katharina] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia; [Danglot, Lydia; Galli, Thierry] Univ Paris Diderot, Sorbonne Paris Cite, Ctr Natl Rech Sci, Inst Jacques Monod,Unite Mixte Rech 7592, Paris, France; [Danglot, Lydia; Galli, Thierry] Inst Natl Sante Rech Med Equipe Rech Labelisee, U950, Membrane Traffic Neuronal & Epithelial Morphogene, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of New South Wales Sydney; University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hivroz, C (corresponding author), Inst Curie, Ctr Rech, Pavillon Pasteur, Paris, France.	claire.hivroz@curie.fr	Williamson, David J/G-2265-2012; Galli, Thierry/G-8842-2011; Galli, Thierry/Q-2249-2019; Hivroz, Claire/H-2711-2014; DANGLOT, Lydia/G-5684-2013; Larghi, Paola/K-6061-2016	Williamson, David J/0000-0002-6222-6297; Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455; Hivroz, Claire/0000-0002-6794-2890; DANGLOT, Lydia/0000-0001-6190-6605; Bohineust, Armelle/0000-0002-9734-0049; Chemin, Karine/0000-0002-2597-7809; Larghi, Paola/0000-0001-7074-1590; DOGNIAUX, Stephanie/0000-0003-3309-1204; Gaus, Katharina/0000-0002-8009-9658	Fondation pour la Recherche Medicale; la Ligue contre le Cancer; DC-Biol Labex; Institut National de la Sante et de la Recherche Medicale; Mairie de Paris Medical Research and Health Program	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); la Ligue contre le Cancer(Ligue nationale contre le cancer); DC-Biol Labex; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mairie de Paris Medical Research and Health Program	We thank A.-M. Lennon and S. Amigorena for discussions; and P. Pierobon, V. Fraisier, P. Paul-Gilloteaux, L. Sengmanivong and the Nikon Imaging Centre at Institut Curie (Centre National de la Recherche Scientifique) for technical assistance with microscopy and image analysis. Supported by Fondation pour la Recherche Medicale (P. L. and K. C., and T.G.'s group), la Ligue contre le Cancer (J.-M.C. and A. B.), DC-Biol Labex (C.H.'s group), Institut National de la Sante et de la Recherche Medicale (T.G.'s group) and the Mairie de Paris Medical Research and Health Program (T.G.'s group).	Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Alonso R, 2011, CELL DEATH DIFFER, V18, P1161, DOI 10.1038/cdd.2010.184; Anton OM, 2011, J IMMUNOL, V186, P6345, DOI 10.4049/jimmunol.1003771; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156; Danglot L, 2012, J NEUROSCI, V32, P1962, DOI 10.1523/JNEUROSCI.4436-11.2012; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Marcet-Palacios M, 2008, BIOCHEM BIOPH RES CO, V366, P617, DOI 10.1016/j.bbrc.2007.11.079; Martin-Cofreces NB, 2012, EMBO J, V31, P4140, DOI 10.1038/emboj.2012.242; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Roncagalli R, 2010, SEMIN IMMUNOPATHOL, V32, P117, DOI 10.1007/s00281-009-0195-y; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	50	88	89	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					723	+		10.1038/ni.2609	http://dx.doi.org/10.1038/ni.2609			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23666293				2022-12-18	WOS:000320509100014
J	Uldrich, AP; Patel, O; Cameron, G; Pellicci, DG; Day, EB; Sullivan, LC; Kyparissoudis, K; Kjer-Nielsen, L; Vivian, JP; Cao, B; Brooks, AG; Williams, SJ; Illarionov, P; Besra, GS; Turner, SJ; Porcelli, SA; McCluskey, J; Smyth, MJ; Rossjohn, J; Godfrey, DI				Uldrich, Adam P.; Patel, Onisha; Cameron, Garth; Pellicci, Daniel G.; Day, E. Bridie; Sullivan, Lucy C.; Kyparissoudis, Konstantinos; Kjer-Nielsen, Lars; Vivian, Julian P.; Cao, Benjamin; Brooks, Andrew G.; Williams, Spencer J.; Illarionov, Petr; Besra, Gurdyal S.; Turner, Stephen J.; Porcelli, Steven A.; McCluskey, James; Smyth, Mark J.; Rossjohn, Jamie; Godfrey, Dale I.			A semi-invariant V(alpha)10(+) T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties	NATURE IMMUNOLOGY			English	Article							NKT CELLS; ALPHA-BETA; BINDING; GLYCOSPHINGOLIPIDS; RESPONSES; SELECTION; SUPPRESS; CD4(+)	Type I natural killer T cells (NKT cells) are characterized by an invariant variable region 14-joining region 18 (V(alpha)14-J(alpha)18) T cell antigen receptor (TCR) alpha-chain and recognition of the glycolipid alpha-galactosylceramide (alpha-GalCer) restricted to the antigen-presenting molecule CD1d. Here we describe a population of alpha-GalCer-reactive NKT cells that expressed a canonical V(alpha)10-J(alpha)50 TCR alpha-chain, which showed a preference for alpha-glucosylceramide (alpha-GlcCer) and bacterial a-glucuronic acid-containing glycolipid antigens. Structurally, despite very limited TCR alpha sequence identity, the V(alpha)10 TCR-CD1d-alpha-GlcCer complex had a docking mode similar to that of type I TCR-CD1d-alpha-GalCer complexes, although differences at the antigen-binding interface accounted for the altered antigen specificity. Our findings provide new insight into the structural basis and evolution of glycolipid antigen recognition and have notable implications for the scope and immunological role of glycolipid-specific T cell responses.	[Patel, Onisha; Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Uldrich, Adam P.; Cameron, Garth; Pellicci, Daniel G.; Day, E. Bridie; Sullivan, Lucy C.; Kyparissoudis, Konstantinos; Kjer-Nielsen, Lars; Brooks, Andrew G.; Turner, Stephen J.; McCluskey, James; Smyth, Mark J.; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Cao, Benjamin; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Cao, Benjamin; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Illarionov, Petr; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Smyth, Mark J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Monash University; University of Melbourne; University of Melbourne; University of Melbourne; University of Birmingham; Yeshiva University; Albert Einstein College of Medicine; Peter Maccallum Cancer Center	Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	jamie.rossjohn@monash.edu; godfrey@unimelb.edu.au	Turner, Stephen/GXM-4654-2022; Cao, Benjamin/E-1574-2011; Williams, Spencer/C-3545-2009; Uldrich, Adam/AAX-3785-2020; Cao, Benjamin/AAI-1626-2021; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Smyth, Mark J/H-8709-2014; Pellicci, Daniel/AAX-8539-2020	Cao, Benjamin/0000-0002-3024-3893; Williams, Spencer/0000-0001-6341-4364; Cao, Benjamin/0000-0002-3024-3893; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Smyth, Mark J/0000-0001-7098-7240; Pellicci, Daniel/0000-0001-5305-2398; ULDRICH, ADAM/0000-0002-6350-5976; Brooks, Andrew/0000-0002-4085-9683; Besra, Gurdyal/0000-0002-5605-0395; Sullivan, Lucy/0000-0003-2907-4989; Cameron, Garth/0000-0003-0778-3506; Godfrey, Dale/0000-0002-3009-5472; Vivian, Julian/0000-0002-9400-4437; Turner, Stephen/0000-0002-1002-0000; Patel, Onisha/0000-0001-6701-7139	Cancer Council of Victoria; National Health and Medical Research Council of Australia; Australian Research Council; Cancer Research Institute; US National Institutes of Health [AI45889]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889] Funding Source: NIH RePORTER	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Taniguchi (Chiba University Graduate School of Medicine) for J<INF>alpha</INF>18<SUP>-/-</SUP> mice; M. Kronenberg (La Jolla Institute for Allergy and Immunology) for the baculovirus-based CD1d expression system; P. Savage (Brigham Young University) for alpha-GalCer (C<INF>24:1</INF> PBS-44 analog); the Australian Synchrotron staff at the MX1 and MX2 beamlines of the Australian synchrotron for assistance with data collection; S. Mattarollo, S. Doak, S. Berzins and A. Denton for discussions and assistance with some experiments; K. Field, N. Sanders and M. Reitsma for assistance with flow cytometry; and M. Stirling and the staff of the Peter MacCallum Cancer Centre Animal House and D. Maksel from the Protein Crystallography Unit at Monash University for technical assistance. Supported by the Cancer Council of Victoria, the National Health and Medical Research Council of Australia (A. P. U., L. C. S., M. J. S. and D. I. G.), the Australian Research Council (D. I. G., O. P. and J. R.), the Cancer Research Institute (G. C.) and the US National Institutes of Health (AI45889 to S. A. P.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berzins SP, 2005, CURR OPIN IMMUNOL, V17, P448, DOI 10.1016/j.coi.2005.05.012; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Day EB, 2007, J IMMUNOL, V179, P2187, DOI 10.4049/jimmunol.179.4.2187; Dias BR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Jervis PJ, 2010, BIOORG MED CHEM LETT, V20, P3475, DOI 10.1016/j.bmcl.2010.05.010; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kim JH, 2007, J IMMUNOL, V179, P6579, DOI 10.4049/jimmunol.179.10.6579; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Lefranc MP, 1998, NUCLEIC ACIDS RES, V26, P297, DOI 10.1093/nar/26.1.297; Leslie A. G. W., 1992, RECENT CHANGES MOSFL, V26; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Long XT, 2007, NAT CHEM BIOL, V3, P559, DOI 10.1038/nchembio.2007.19; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Stenstrom M, 2005, IMMUNOLOGY, V114, P336, DOI 10.1111/j.1365-2567.2004.02111.x; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; WOLUCKA BA, 1993, BIOCHIM BIOPHYS ACTA, V1170, P131, DOI 10.1016/0005-2760(93)90062-E; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	51	88	88	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					616	U168		10.1038/ni.2051	http://dx.doi.org/10.1038/ni.2051			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21666690	Green Accepted			2022-12-18	WOS:000291936400009
J	Limnander, A; Depeille, P; Freedman, TS; Liou, J; Leitges, M; Kurosaki, T; Roose, JP; Weiss, A				Limnander, Andre; Depeille, Philippe; Freedman, Tanya S.; Liou, Jen; Leitges, Michael; Kurosaki, Tomohiro; Roose, Jeroen P.; Weiss, Arthur			STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development	NATURE IMMUNOLOGY			English	Article							KINASE-C-DELTA; ACTIVATES CRAC CHANNELS; CA2+ STORE DEPLETION; PLASMA-MEMBRANE; ANTIGEN RECEPTOR; T-CELLS; PROTEIN; TOLERANCE; PHOSPHORYLATION; DIACYLGLYCEROL	Clonal deletion of autoreactive B cells is crucial for the prevention of autoimmunity, but the signaling mechanisms that regulate this checkpoint remain undefined. Here we characterize a previously unrecognized Ca(2+)-driven pathway for activation of the kinase Erk, which was proapoptotic and biochemically distinct from Erk activation induced by diacylglycerol (DAG). This pathway required protein kinase C-delta (PKC-delta) and the guanine nucleotide-exchange factor RasGRP and depended on the concentration of the Ca(2+) sensor STIM1, which controls the magnitude of Ca(2+) entry. Developmental regulation of these proteins was associated with selective activation of the pathway in B cells prone to negative selection. This checkpoint was impaired in PKC-delta-deficient mice, which developed B cell autoimmunity. Conversely, overexpression of STIM1 conferred a competitive disadvantage to developing B cells. Our findings establish Ca(2+)-dependent Erk signaling as a critical proapoptotic pathway that mediates the negative selection of B cells.	[Limnander, Andre; Freedman, Tanya S.; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Depeille, Philippe; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Liou, Jen] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Leitges, Michael] Hannover Med Sch, Dept Med, Div Nephrol, D-3000 Hannover, Germany; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Kurosaki, Tomohiro] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka, Japan; [Kurosaki, Tomohiro] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hannover Medical School; University of Oslo; Osaka University; RIKEN	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Liou, Jen/AAN-1105-2021; Freedman, Tanya/T-4660-2019; Kurosaki, Tomohiro/D-1306-2009; Leitges, Michael/AAN-1953-2021	Freedman, Tanya/0000-0001-5168-5829; Kurosaki, Tomohiro/0000-0002-6352-304X; Leitges, Michael/0000-0003-4203-6995; Roose, Jeroen/0000-0003-4746-2811	Sandler Family Foundation; Gordon and Betty Moore Foundation; National Cancer Institute of the US National Institutes of Health [P30 CA82103]; Howard Hughes Medical Institute; Sidney Kimmel Foundation; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095292] Funding Source: NIH RePORTER	Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sidney Kimmel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Sandler-Moore Mass Spectrometry Core Facility at the University of California at San Francisco (funded by the Sandler Family Foundation, the Gordon and Betty Moore Foundation and the National Cancer Institute of the US National Institutes of Health (P30 CA82103)) for assistance in protein identification; the Flow Cytometry Core Facility at the Department of Pathology and Diabetes Center of the University of California at San Francisco for assistance; G. Koretzky (University of Pennsylvania) for the pEF-Flag-hDGK-zeta plasmid; A. Roque for assistance with animal husbandry; H. Phee and M. Hermiston for critical reading of the manuscript and suggestions; B. Au-Yeung and H. Wang for help with tail-vein injections; and members of the Weiss laboratory for discussions. Supported by the Howard Hughes Medical Institute and the Sidney Kimmel Foundation (J.P.R.).	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Benschop RJ, 2001, J IMMUNOL, V167, P4172, DOI 10.4049/jimmunol.167.8.4172; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Freedman TS, 2009, STRUCTURE, V17, P41, DOI 10.1016/j.str.2008.11.004; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gross AJ, 2009, J IMMUNOL, V182, P5382, DOI 10.4049/jimmunol.0803941; Guilbault B, 2004, J BIOL CHEM, V279, P19523, DOI 10.1074/jbc.M314273200; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hoek KL, 2006, J IMMUNOL, V177, P5405, DOI 10.4049/jimmunol.177.8.5405; King LB, 1999, J IMMUNOL, V162, P2655; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stang SL, 2009, EXP HEMATOL, V37, P122, DOI 10.1016/j.exphem.2008.09.008; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	51	88	91	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					425	U81		10.1038/ni.2016	http://dx.doi.org/10.1038/ni.2016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21441934	Green Accepted, Green Submitted			2022-12-18	WOS:000289666600013
J	Stehling-Sun, S; Dade, J; Nutt, SL; DeKoter, RP; Camargo, FD				Stehling-Sun, Sandra; Dade, Jessica; Nutt, Stephen L.; DeKoter, Rodney P.; Camargo, Fernando D.			Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; HEMATOPOIETIC PROGENITORS; SELF-RENEWAL; BONE-MARROW; C/EBP-ALPHA; STEM-CELLS; PU.1; EXPRESSION; ENHANCER; GENE	Despite advances in the identification of lymphoid-restricted progenitor cells, the transcription factors essential for their generation remain to be identified. Here we describe an unexpected function for the myeloid oncogene product Mef2c in lymphoid development. Mef2c deficiency was associated with profound defects in the production of B cells, T cells, natural killer cells and common lymphoid progenitor cells and an enhanced myeloid output. In multipotent progenitors, Mef2c was required for the proper expression of several key lymphoid regulators and restriction of the myeloid fate. Our studies also show that Mef2c was a critical transcriptional target of the transcription factor PU.1 during lymphopoiesis. Thus, Mef2c is a crucial component of the transcriptional network that regulates cell fate 'choice' in multipotent progenitors.	[Stehling-Sun, Sandra; Camargo, Fernando D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Dade, Jessica; DeKoter, Rodney P.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Ohio; University of Cincinnati; Walter & Eliza Hall Institute	Camargo, FD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	camargo@wi.mit.edu	Nutt, Stephen L/C-9256-2013; DeKoter, Rodney/A-9415-2009	Nutt, Stephen L/0000-0002-0020-6637; DeKoter, Rodney/0000-0002-9201-1983	Whitehead Institute Fellows; National Institutes of Health [AI052175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052175] Funding Source: NIH RePORTER	Whitehead Institute Fellows; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Schwartz (Albany Medical College) and Brian Black (University of California, San Francisco) for mutant mice; G. Bell and P. Thiru for microarray data analysis; members of the Jaenisch laboratory for discussions; R. Jimenez for mouse handling and technical support; and L. Lawton (Whitehead Institute for Biomedical Research) for reagents. Supported by the Whitehead Institute Fellows (F. D. C.) and the National Institutes of Health (AI052175 to R. P. D.).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Houston IB, 2007, EXP HEMATOL, V35, P1056, DOI 10.1016/j.exphem.2007.04.005; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kamath MB, 2008, LEUKEMIA, V22, P1214, DOI 10.1038/leu.2008.67; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Rao S, 1998, J BIOL CHEM, V273, P26123, DOI 10.1074/jbc.273.40.26123; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Swanson BJ, 1998, MOL IMMUNOL, V35, P445, DOI 10.1016/S0161-5890(98)00058-3; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	40	88	89	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					289	296		10.1038/ni.1694	http://dx.doi.org/10.1038/ni.1694			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19169261				2022-12-18	WOS:000263456500013
J	Menon, S; Chi, H; Zhang, H; Deng, XW; Flavell, RA; Wei, N				Menon, Suchithra; Chi, Hongbo; Zhang, Huiyong; Deng, Xing Wang; Flavell, Richard A.; Wei, Ning			COP9 signalosome subunit 8 is essential for peripheral T cell homeostasis and antigen receptor-induced entry into the cell cycle from quiescence	NATURE IMMUNOLOGY			English	Article							C-MYC; COP9/SIGNALOSOME SUBUNITS; RETINOBLASTOMA PROTEIN; GENE-EXPRESSION; PROLIFERATION; DEGRADATION; PHOSPHORYLATION; PATHWAYS; TRANSDUCTION; PROGRESSION	Engagement of antigen receptors triggers the proliferation and functional activation of lymphocytes. Here we report that T cell homeostasis and antigen-induced responses require the COP9 signalosome (CSN), a regulator of the ubiquitin-proteasome system. Conditional deletion of the CSN subunit Csn8 in peripheral T lymphocytes disrupted formation of the CSN complex, reduced T cell survival and proliferation in vivo and impaired antigen-induced production of interleukin 2. Moreover, Csn8-deficient T cells showed defective entry into the cell cycle from the G0 quiescent state. This phenotype was associated with a lack of signal-induced expression of cell cycle-related genes, including G1 cyclins and cyclin-dependent kinases, and with excessive induction of p21(Cip1). Our data define a CSN-dependent pathway of transcriptional control that is essential for antigen-induced initiation of T cell proliferation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Yale University; Howard Hughes Medical Institute; Yale University; St Jude Children's Research Hospital	Wei, N (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	ning.wei@yale.edu	Chi, Hongbo/M-9397-2018; Deng, Xing Wang/ABF-4107-2020	Chi, Hongbo/0000-0002-9997-2496; Wei, Ning/0000-0001-8827-1320	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850, R01GM061812] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37-GM047850, R01-GM61812] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bech-Otschir D, 2002, J CELL SCI, V115, P467; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Boylan JF, 1999, EXP CELL RES, V248, P110, DOI 10.1006/excr.1999.4389; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; COPE GA, 2006, BMC BIOCH, V9, P1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Oron E, 2002, DEVELOPMENT, V129, P4399; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Ruland J, 2003, SEMIN IMMUNOL, V15, P177, DOI 10.1016/S1044-5323(03)00034-4; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang XP, 2002, MOL BIOL CELL, V13, P646, DOI 10.1091/mbc.01-08-0427; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1992, PLANT CELL, V4, P1507, DOI 10.1105/tpc.4.12.1507; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	51	88	90	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1236	1245		10.1038/ni1514	http://dx.doi.org/10.1038/ni1514			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17906629				2022-12-18	WOS:000250338900016
J	Ueno, H; Sakita-Ishikawa, M; Morikawa, Y; Nakano, T; Kitamura, T; Saito, M				Ueno, H; Sakita-Ishikawa, M; Morikawa, Y; Nakano, T; Kitamura, T; Saito, M			A stromal cell-derived membrane protein that supports hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							BONE-MARROW CULTURES; LONG-TERM CULTURES; EX-VIVO EXPANSION; IN-VITRO; EXPRESSION CLONING; CYTOKINE; LIGAND; FUSION; LINE; CDNA	Hematopoietic stem cells cannot be maintained in vitro without stromal cells, even if they are provided with growth factors, and it is likely that supportive cells in the bone marrow express membrane or secreted proteins that maintain hematopoiesis. Here we show that mKirre, a mammalian homolog of the gene kirre of Drosophila melanogaster, encodes a type la membrane protein that is involved in the hematopoietic supportive capacity of OP9 mouse stromal cells. Repressing mKirre expression with a short interfering RNA significantly reduced this supportive capacity. Our data suggest that mKirre is cleaved by metalloproteinases and that the extracellular domain of mKirre is responsible for supporting hematopoietic stem cells. These results contribute to our understanding of the mechanisms by which the hematopoietic microenvironment regulates hematopoiesis.	Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan; Wakayama Sch Med, Dept Anat & Neurobiol, Wakayama 6418509, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; Meiji Pharmaceut Univ, Dept Oncol & Pharmacodynam, Kiyose, Tokyo 2048588, Japan	National Cancer Center - Japan; Wakayama Medical University; Osaka University; University of Tokyo; Meiji Pharmaceutical University	Ueno, H (corresponding author), Stanford Univ, Sch Med, Dept Pathol & Dev Biol, Stanford, CA 94305 USA.	hirueno@gan2.res.ncc.go.jp						Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Breems DA, 1998, BLOOD, V91, P111, DOI 10.1182/blood.V91.1.111.111_111_117; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; HARRISON B, 1984, BLOOD CELLS, V10, P451; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; LIU YC, 1993, P NATL ACAD SCI USA, V90, P8957, DOI 10.1073/pnas.90.19.8957; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; MIYAZAKI J, 1989, GENE, V79, P269; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagasawa A, 1997, GENOMICS, V44, P273, DOI 10.1006/geno.1997.4889; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Namikawa R, 1996, BLOOD, V87, P1881; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Onishi M, 1996, EXP HEMATOL, V24, P324; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; PAUL SR, 1991, BLOOD, V77, P1723; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih CC, 1999, BLOOD, V94, P1623, DOI 10.1182/blood.V94.5.1623.417k34_1623_1636; Shih CC, 2000, BLOOD, V95, P1957, DOI 10.1182/blood.V95.6.1957; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; SUTHERLAND HJ, 1991, BLOOD, V78, P666, DOI 10.1182/blood.V78.3.666.bloodjournal783666; Szilvassy SJ, 1996, BLOOD, V87, P4618, DOI 10.1182/blood.V87.11.4618.bloodjournal87114618; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; UENO H, 1995, J BIOL CHEM, V270, P20135, DOI 10.1074/jbc.270.34.20135; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	46	88	102	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					457	463		10.1038/ni916	http://dx.doi.org/10.1038/ni916			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12665856				2022-12-18	WOS:000182665400013
J	Honey, K; Benlagha, K; Beers, C; Forbush, K; Teyton, L; Kleijmeer, MJ; Rudensky, AY; Bendelac, A				Honey, K; Benlagha, K; Beers, C; Forbush, K; Teyton, L; Kleijmeer, MJ; Rudensky, AY; Bendelac, A			Thymocyte expression of cathepsin L is essential for NKT cell development	NATURE IMMUNOLOGY			English	Article							T-CELLS; ANTIGEN PRESENTATION; INVARIANT CHAIN; TRAFFICKING; CD1D; SELECTION; MOLECULES; RECEPTOR; MICE; DEGRADATION	CD1d antigen presentation to natural killer T (NKT) cells expressing the semi-invariant T cell receptor V(alpha)14J(alpha)18 requires CD1d trafficking through endosomal compartments; however, the endosomal events remain undefined. We show that mice lacking the endosomal protease cathepsin L (catL) have greatly reduced numbers of V(alpha)14(+)NK1.1(+) T cells. In addition, catL expression in thymocytes is critical not only for selection of these cells in vivo but also for stimulation of V(a)14(+)NK1.1(+)T cells in vitro. CD1d cell-surface expression and intracellular localization appear normal in catL-deficient thymocytes, as does the lysosomal morphology; this implies a specific role for catL in regulating presentation of natural CD1d ligands mediating V(alpha)14(+)NK1.1(+)T cell selection. These data implicate lysosomal proteases as key regulators of not only classical major histocompatibility complex class II antigen presentation but also nonclassical CD1d presentation.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; UMC Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Princeton University; Scripps Research Institute; Utrecht University; Utrecht University Medical Center	Rudensky, AY (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA.	aruden@u.washington.edu	Benlagha, Kamel/GLQ-8342-2022; Benlagha, Kamel/I-5035-2016	benlagha, kamel/0000-0002-3251-9195				Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Dittmer F, 1999, J CELL SCI, V112, P1591; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Heylen N, 2002, INT J ONCOL, V20, P761; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Honey K, 2001, J BIOL CHEM, V276, P22573, DOI 10.1074/jbc.M101851200; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Lee DJ, 1998, J EXP MED, V187, P433, DOI 10.1084/jem.187.3.433; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; RAPOSO G, 1997, WEIRS HDB EXPT IMMUN, V4; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	34	88	97	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1069	1074		10.1038/ni844	http://dx.doi.org/10.1038/ni844			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12368909				2022-12-18	WOS:000179073000014
J	Inlay, M; Alt, FW; Baltimore, D; Xu, Y				Inlay, M; Alt, FW; Baltimore, D; Xu, Y			Essential roles of the kappa light chain intronic enhancer and 3 ' enhancer in kappa rearrangement and demethylation	NATURE IMMUNOLOGY			English	Article							CELL-SPECIFIC DEMETHYLATION; MARROW B-CELLS; IG-KAPPA; GENE REARRANGEMENT; REGION; LOCUS; LYMPHOCYTES; REPERTOIRE; DOWNSTREAM; TOLERANCE	The kappa intronic (MiE(kappa)) and 3' (3'E-kappa) enhancers are both quantitatively important to, but not essential for, immunoglobulin kappa rearrangement. To determine the functional redundancy between these two enhancers, B cells derived from mutant embryonic stem cells-in which both MiE(kappa) and 3'E-kappa were deleted on both kappa alleles-were analyzed for kappa rearrangement. Our findings indicate that these double-mutant B cells have essentially no kappa rearrangement but do rearrange and express lambda. Therefore, these two kappa enhancers share essential roles in activatingV(kappa)J(kappa) rearrangement. Our findings also indicate that the two kappa enhancers play overlapping and distinct roles in the demethylation of kappa in B cells.	Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Ctr Blood Res, Boston, MA 02115 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; California Institute of Technology	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Xu, Yang/0000-0001-5574-921X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044838] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44838] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BLACKWELL TK, 1989, ANNU REV GENET, V23, P605, DOI 10.1146/annurev.ge.23.120189.003133; Cherry SR, 2000, P NATL ACAD SCI USA, V97, P8467, DOI 10.1073/pnas.150218497; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; SHAPIRO MA, 1987, MOL CELL BIOL, V7, P4130, DOI 10.1128/MCB.7.11.4130; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; Yi M, 1999, J IMMUNOL, V162, P6029	26	88	105	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					463	468		10.1038/ni790	http://dx.doi.org/10.1038/ni790			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11967540				2022-12-18	WOS:000175411200015
J	He, X; Janeway, CA; Levine, M; Robinson, E; Preston-Hurlburt, P; Viret, C; Bottomly, K				He, X; Janeway, CA; Levine, M; Robinson, E; Preston-Hurlburt, P; Viret, C; Bottomly, K			Dual receptor T cells extend the immune repertoire for foreign antigens	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; ALLELIC EXCLUSION; TRANSGENIC MICE; ALPHA-CHAINS; BETA-CHAIN; SELF-PEPTIDES; IN-VITRO; EXPRESSION; TCR; GENES	Since the discovery of T cells that express two T cell receptors (TCRs), termed dual TCR cells, most studies have focused on their autoimmune potential, while their beneficial roles remained elusive. We identified, in normal mice, dual TCR cells that participated in the immune response to a foreign antigen. Unlike single TCR cells, dual TCR cells used the nonselected TCR to respond in the periphery, but relied on coexpression of a second TCR for intrathymic selection. We found that they were selected at low frequency in the naive repertoire, but dominated the response to antigen through clonal expansion. Thus, dual TCR cells can extend the TCR repertoire for foreign antigens by rescuing functional TCRs that cannot be selected on single TCR cells; they can, therefore, benefit the immune system.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	He, X (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 310 Cedar St, New Haven, CT 06520 USA.		Levine, Matthew/O-4809-2015; VIRET, Christophe/M-4590-2014	Levine, Matthew/0000-0003-4525-5827; VIRET, CHRISTOPHE/0000-0003-1874-3489	NATIONAL CANCER INSTITUTE [R01CA028250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014579, R01AI026791, R01AI014579, R37AI026791] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28250] Funding Source: Medline; NIAID NIH HHS [AI-26791, AI-14579] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1998, J IMMUNOL, V160, P3883; BALOMENOS D, 1995, J IMMUNOL, V155, P3308; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; BURNET FM, 1959, DONAL SELECTION THEO; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DAVODEAU F, 1995, J EXP MED, V181, P1391, DOI 10.1084/jem.181.4.1391; Elliott JI, 1998, EUR J IMMUNOL, V28, P2115, DOI 10.1002/(SICI)1521-4141(199807)28:07<2115::AID-IMMU2115>3.0.CO;2-6; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Fossati G, 1999, J EXP MED, V190, P577, DOI 10.1084/jem.190.4.577; Fukui Y, 1998, J EXP MED, V188, P897, DOI 10.1084/jem.188.5.897; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kersh GJ, 1998, J IMMUNOL, V161, P585; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; KOUSKOFF V, 1995, EUR J IMMUNOL, V25, P54, DOI 10.1002/eji.1830250111; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; Lee WT, 1998, J IMMUNOL, V161, P4513; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Malissen Bernard, 1995, P352; MASON D, 1994, INT IMMUNOL, V6, P881, DOI 10.1093/intimm/6.6.881; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MURRAY JS, 1992, EUR J IMMUNOL, V22, P559, DOI 10.1002/eji.1830220239; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Ridgway W, 1998, J IMMUNOL, V161, P714; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; SIMPSON E, 1995, EUR J IMMUNOL, V25, P2813, DOI 10.1002/eji.1830251015; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Viret C, 2000, J IMMUNOL, V165, P3004, DOI 10.4049/jimmunol.165.6.3004; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	50	88	89	1	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					127	134		10.1038/ni751	http://dx.doi.org/10.1038/ni751			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812989				2022-12-18	WOS:000173562400012
J	James, KR; Gomes, T; Elmentaite, R; Kumar, N; Gulliver, EL; King, HW; Stares, MD; Bareham, BR; Ferdinand, JR; Petrova, VN; Polanski, K; Forster, SC; Jarvis, LB; Suchanek, O; Howlett, S; James, LK; Jones, JL; Meyer, KB; Clatworthy, MR; Saeb-Parsy, K; Lawley, TD; Teichmann, SA				James, Kylie R.; Gomes, Tomas; Elmentaite, Rasa; Kumar, Nitin; Gulliver, Emily L.; King, Hamish W.; Stares, Mark D.; Bareham, Bethany R.; Ferdinand, John R.; Petrova, Velislava N.; Polanski, Krzysztof; Forster, Samuel C.; Jarvis, Lorna B.; Suchanek, Ondrej; Howlett, Sarah; James, Louisa K.; Jones, Joanne L.; Meyer, Kerstin B.; Clatworthy, Menna R.; Saeb-Parsy, Kourosh; Lawley, Trevor D.; Teichmann, Sarah A.			Distinct microbial and immune niches of the human colon	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; FOXP3 EXPRESSION; LYMPHOID-TISSUE; DENDRITIC CELL; HUMAN B; INDUCTION; RESPONSES; MUCOSA; TH17; REPERTOIRE	Gastrointestinal microbiota and immune cells interact closely and display regional specificity; however, little is known about how these communities differ with location. Here, we simultaneously assess microbiota and single immune cells across the healthy, adult human colon, with paired characterization of immune cells in the mesenteric lymph nodes, to delineate colonic immune niches at steady state. We describe distinct helper T cell activation and migration profiles along the colon and characterize the transcriptional adaptation trajectory of regulatory T cells between lymphoid tissue and colon. Finally, we show increasing B cell accumulation, clonal expansion and mutational frequency from the cecum to the sigmoid colon and link this to the increasing number of reactive bacterial species. The gut microbiota and their proximate immune cells engage in a dialog of reciprocal regulation. James and colleagues describe how immune cell and microbiotal populations vary along the length of the human colon.	[James, Kylie R.; Gomes, Tomas; Elmentaite, Rasa; Kumar, Nitin; Stares, Mark D.; Petrova, Velislava N.; Polanski, Krzysztof; Forster, Samuel C.; Meyer, Kerstin B.; Clatworthy, Menna R.; Lawley, Trevor D.; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Gulliver, Emily L.; Forster, Samuel C.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [King, Hamish W.; James, Louisa K.] Queen Mary Univ London, Blizard Inst, Ctr Immunobiol, London, England; [Bareham, Bethany R.; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Cambridge, England; [Bareham, Bethany R.; Saeb-Parsy, Kourosh] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Ferdinand, John R.; Suchanek, Ondrej; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, MRC Lab Mol Biol, Cambridge, England; [Forster, Samuel C.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Jarvis, Lorna B.; Howlett, Sarah; Jones, Joanne L.] Dept Haematol, Clifford Allbutt Bldg, Cambridge, England; [Jones, Joanne L.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Theory Condensed Matter, Cambridge, England; [Teichmann, Sarah A.] European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England	Wellcome Trust Sanger Institute; Monash University; University of London; Queen Mary University London; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Hudson Institute of Medical Research; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	James, KR; Teichmann, SA (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England.; Teichmann, SA (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Theory Condensed Matter, Cambridge, England.; Teichmann, SA (corresponding author), European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England.	kj7@sanger.ac.uk; st9@sanger.ac.uk	Forster, Samuel C/F-4206-2014; King, Hamish/U-9808-2019; James, Louisa/C-9831-2010	Forster, Samuel C/0000-0003-4144-2537; King, Hamish/0000-0001-5972-8926; Elmentaite, Rasa/0000-0001-7366-5466; Gulliver, Emily/0000-0002-1820-6619; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Bareham, Bethany/0000-0003-1892-8256; James, Louisa/0000-0002-2252-4636; Ferdinand, John Robert/0000-0003-0936-0128; Suchanek, Ondrej/0000-0003-1048-5251; Clatworthy, Menna/0000-0002-3340-9828; Polanski, Krzysztof/0000-0002-2586-9576; Jones, Joanne/0000-0003-4974-1371; Kumar, Nitin/0000-0002-2140-4923; James, Kylie/0000-0002-7107-0650	Wellcome Trust [WT206194]; European Research Council [646794 ThDEFINE]; Christ's College, University of Cambridge; European Union's H2020 research and innovation programme `ENLIGHT-TEN' under Marie Sklodowska-Curie grant [675395]; Sir Henry Wellcome Postdoctoral Fellowship [213555/Z/18/Z]; NIHR Cambridge Biomedical Research Centre [RG92051]	Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Christ's College, University of Cambridge; European Union's H2020 research and innovation programme `ENLIGHT-TEN' under Marie Sklodowska-Curie grant; Sir Henry Wellcome Postdoctoral Fellowship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	We acknowledge the support received from the Wellcome Sanger Cytometry Core Facility, Cellular Genetics Informatics team and Core DNA Pipelines. We thank F. Rouhani and T. Castro-Dopico for insightful discussions about project and experimental design and K. Mahbubani for help with the collection of human tissue. We acknowledge J. Eliasova for the graphical images. This research was supported by funding from the Wellcome Trust (grant no. WT206194 to S.A.T.) and the European Research Council (grant no. 646794 ThDEFINE to S.A.T.). K.R.J. holds a Non-Stipendiary Junior Research Fellowship from Christ's College, University of Cambridge. T. G. was funded by the European Union's H2020 research and innovation programme `ENLIGHT-TEN' under Marie Sklodowska-Curie grant agreement no. 675395. H.W.K. was funded by a Sir Henry Wellcome Postdoctoral Fellowship (grant no. 213555/Z/18/Z). B.R.B. was funded by the NIHR Cambridge Biomedical Research Centre (grant no. RG92051). We thank the deceased organ donors, donor families and the Cambridge Biorepository for Translational Medicine for access to the tissue samples. This publication is part of the Human Cell Atlas (https://www.humancellatlas.org/publications/).	Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Caraux A, 2010, HAEMATOL-HEMATOL J, V95, P1016, DOI 10.3324/haematol.2009.018689; Castro-Dopico T, 2019, IMMUNITY, V50, P1099, DOI 10.1016/j.immuni.2019.02.006; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; DunnWalters DK, 1997, EUR J IMMUNOL, V27, P2959, DOI 10.1002/eji.1830271131; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Ferreira RC, 2017, J AUTOIMMUN, V84, P75, DOI 10.1016/j.jaut.2017.07.009; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Imam T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01212; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jones RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22408-4; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Krzysiek R, 1999, J IMMUNOL, V162, P4455; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kyewski B., 2005, CD4 CD25 REG T CELLS; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lonnberg Tapio, 2017, Sci Immunol, V2, DOI 10.1126/sciimmunol.aal2192; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mencarelli A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30802; Meng WZ, 2017, NAT BIOTECHNOL, V35, P879, DOI 10.1038/nbt.3942; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Petrova VN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01784; Polanski K, 2020, BIOINFORMATICS, V36, P964, DOI 10.1093/bioinformatics/btz625; Povoleri GAM, 2018, NAT IMMUNOL, V19, P1403, DOI 10.1038/s41590-018-0230-z; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Toribio-Fernandez R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0007-6; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang W, 2017, J IMMUNOL, V198, P3719, DOI 10.4049/jimmunol.1602039; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	57	87	93	7	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					343	+		10.1038/s41590-020-0602-z	http://dx.doi.org/10.1038/s41590-020-0602-z		FEB 2020	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066951	Green Submitted, Green Accepted			2022-12-18	WOS:000514067400003
J	Turner, M; Diaz-Munoz, MD				Turner, Martin; Diaz-Munoz, Manuel D.			RNA-binding proteins control gene expression and cell fate in the immune system	NATURE IMMUNOLOGY			English	Review							SPECIFICITY PHOSPHATASE 1; CD4(+) T-CELLS; MESSENGER-RNA; B-CELL; INTRON RETENTION; ALTERNATIVE POLYADENYLATION; MECHANISTIC INSIGHTS; NEGATIVE REGULATOR; IRON HOMEOSTASIS; 3' URIDYLATION	RNA-binding proteins (RBPs) are essential for the development and function of the immune system. They interact dynamically with RNA to control its biogenesis and turnover by transcription-dependent and transcription-independent mechanisms. In this Review, we discuss the molecular mechanisms by which RBPs allow gene expression changes to occur at different speeds and to varying degrees, and which RBPs regulate the diversity of the transcriptome and proteome. These proteins are nodes for integration of transcriptional and signaling networks and are intimately linked to intermediary metabolism. They are essential components of regulatory feedback mechanisms that maintain immune tolerance and limit inflammation. The role of RBPs in malignancy and autoimmunity has led to their emergence as targets for the development of new therapeutic modalities.	[Turner, Martin; Diaz-Munoz, Manuel D.] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Diaz-Munoz, Manuel D.] INSERM UMR1043 CNRS U5282, Ctr Physiopathol Toulouse Purpan, Toulouse, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Diaz-Munoz, Manuel D./AAB-6518-2020; Diaz-Munoz, Manuel D/H-2080-2018; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D./0000-0002-9227-7474; Diaz-Munoz, Manuel D/0000-0002-9227-7474; Turner, Martin/0000-0002-3801-9896	Biotechnology and Biological Sciences Research Council; Medical Research Council; Bloodwise; Wellcome; BBSRC [BBS/E/B/000C0427, BBS/E/B/000C0428, BB/J00152X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise; Wellcome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Glasmacher for allowing us to discuss her unpublished findings, and our many colleagues who have provided feedback and support during our preparation of this manuscript. We also thank E. Werbenko for providing images for Fig. 2. The Biotechnology and Biological Sciences Research Council, the Medical Research Council, Bloodwise and Wellcome support work in M.T.'s laboratory.	Ajith S, 2016, RNA BIOL, V13, P569, DOI 10.1080/15476286.2016.1176663; Andrianne M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92979; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Beisang D, 2014, GENE, V550, P93, DOI 10.1016/j.gene.2014.08.021; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Brannan KW, 2016, MOL CELL, V64, P282, DOI 10.1016/j.molcel.2016.09.003; Cano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9670; Castello A, 2016, MOL CELL, V63, P696, DOI 10.1016/j.molcel.2016.06.029; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Chen YG, 2017, NAT IMMUNOL, V18, P962, DOI 10.1038/ni.3771; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Clingman CC, 2014, ELIFE, V3, DOI 10.7554/eLife.02848; Collart MA, 2016, WIRES RNA, V7, P438, DOI 10.1002/wrna.1332; da Gloria VG, 2014, J IMMUNOL, V193, P391, DOI 10.4049/jimmunol.1400038; Dejure FR, 2017, EMBO J, V36, P1854, DOI 10.15252/embj.201796662; DeMicco A, 2016, CELL CYCLE, V15, P2882, DOI 10.1080/15384101.2016.1198861; DeMicco A, 2015, J IMMUNOL, V195, P3449, DOI 10.4049/jimmunol.1500512; Dhanraj S, 2015, J MED GENET, V52, P738, DOI 10.1136/jmedgenet-2015-103292; Diaz-Munoz MD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00454-2; Diaz-Munoz MD, 2015, NAT IMMUNOL, V16, P415, DOI 10.1038/ni.3115; Dolezal E, 2017, NAT IMMUNOL, V18, P911, DOI 10.1038/ni.3774; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Ebner F, 2017, J CLIN INVEST, V127, P2051, DOI 10.1172/JCI80631; Elbarbary RA, 2017, SCIENCE, V356, P859, DOI 10.1126/science.aai9372; Enders A, 2014, P NATL ACAD SCI USA, V111, P4513, DOI 10.1073/pnas.1402739111; Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129; Galarza-Munoz G, 2017, CELL, V169, P72, DOI 10.1016/j.cell.2017.03.007; Galloway A., 2017, REV RNA, V8, pe1419; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Garg AV, 2015, IMMUNITY, V43, P475, DOI 10.1016/j.immuni.2015.07.021; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gruber AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6465; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Gutierrez-Vazquez C, 2017, RNA, V23, P882, DOI 10.1261/rna.060095.116; Haneklaus M, 2017, J BIOL CHEM, V292, P6869, DOI 10.1074/jbc.M116.772947; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Hodge DL, 2014, J AUTOIMMUN, V53, P33, DOI 10.1016/j.jaut.2014.02.003; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horvilleur E, 2014, LEUKEMIA, V28, P1092, DOI 10.1038/leu.2013.295; Hu GW, 2015, NAT CELL BIOL, V17, P930, DOI 10.1038/ncb3189; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Hubstenberger A, 2017, MOL CELL, V68, P144, DOI 10.1016/j.molcel.2017.09.003; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; Inoue T, 2015, J EXP MED, V212, P1465, DOI 10.1084/jem.20150384; Ivshina M, 2015, MOL CELL BIOL, V35, P610, DOI 10.1128/MCB.00800-14; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; Jin ZG, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006672; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Kawaguchi Y, 2017, BIOCHEM BIOPH RES CO, V485, P261, DOI 10.1016/j.bbrc.2017.02.097; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kesarwani M, 2017, NAT MED, V23, P472, DOI 10.1038/nm.4310; Kozlowski E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179797; Kristiansen TA, 2016, IMMUNITY, V45, P346, DOI 10.1016/j.immuni.2016.07.014; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; La Porta J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158708; Laffleur B, 2017, J MOL BIOL, V429, P3230, DOI 10.1016/j.jmb.2016.12.021; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Liepelt A, 2016, MOL CELL PROTEOMICS, V15, P2699, DOI 10.1074/mcp.M115.056564; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Maeda K, 2017, INT IMMUNOL, V29, P149, DOI 10.1093/intimm/dxx015; Mallory MJ, 2015, P NATL ACAD SCI USA, V112, pE2139, DOI 10.1073/pnas.1423695112; Mallory MJ, 2011, MOL CELL BIOL, V31, P2184, DOI 10.1128/MCB.05170-11; Manfrini N, 2017, DEV COMP IMMUNOL, V77, P69, DOI 10.1016/j.dci.2017.07.022; Marina RJ, 2016, EMBO J, V35, P335, DOI 10.15252/embj.201593235; Martinez NM, 2015, GENE DEV, V29, P2054, DOI 10.1101/gad.267245.115; Maruyama T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004822; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Middleton R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1184-4; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Monin L, 2017, J IMMUNOL, V198, P767, DOI 10.4049/jimmunol.1601551; Monzon-Casanova E., NAT IMMUNOL IN PRESS; Morgan M, 2017, NATURE, V548, P347, DOI 10.1038/nature23318; Movassat M, 2016, RNA BIOL, V13, P646, DOI 10.1080/15476286.2016.1191727; Newman R, 2017, NAT IMMUNOL, V18, P683, DOI 10.1038/ni.3724; Newton R, 2017, J BIOL CHEM, V292, P7163, DOI 10.1074/jbc.R117.777318; Ni T, 2016, NUCLEIC ACIDS RES, V44, P6817, DOI 10.1093/nar/gkw591; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Olejniczak SH, 2016, MOL CELL BIOL, V36, P2360, DOI 10.1128/MCB.01011-15; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Patial S, 2016, P NATL ACAD SCI USA, V113, P1865, DOI 10.1073/pnas.1519906113; Pefanis E, 2015, ADV IMMUNOL, V127, P257, DOI 10.1016/bs.ai.2015.04.002; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pioli PD, 2014, J IMMUNOL, V193, P2546, DOI 10.4049/jimmunol.1401275; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ramiscal RR, 2015, ELIFE, V4, DOI 10.7554/eLife.08698; Rentas S, 2016, NATURE, V532, P508, DOI 10.1038/nature17665; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Ross EA, 2015, J IMMUNOL, V195, P265, DOI 10.4049/jimmunol.1402826; Sakai S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005667; Salerno F., 2017, P NATL ACAD SCI USA, V159; Salerno F, 2016, J IMMUNOL, V196, P3695, DOI 10.4049/jimmunol.1501997; Schaub A, 2017, INT IMMUNOL, V29, P173, DOI 10.1093/intimm/dxx026; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schmiedel D, 2016, ELIFE, V5, DOI 10.7554/eLife.13426; Sedlyarov V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156628; Shah S, 2016, J BIOL CHEM, V291, P110, DOI 10.1074/jbc.M115.697599; Sharma S, 2016, MOL CELL, V63, P927, DOI 10.1016/j.molcel.2016.08.030; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Shin J, 2017, NUCLEIC ACIDS RES, V45, P6793, DOI 10.1093/nar/gkx239; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Tang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04100-1; Tarling EJ, 2017, J CLIN INVEST, V127, P3741, DOI 10.1172/JCI94029; Techasintana Patsharaporn, 2017, Immunohorizons, V1, P109, DOI 10.4049/immunohorizons.1700017; Techasintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129321; Tenekeci U, 2016, MOL CELL, V62, P943, DOI 10.1016/j.molcel.2016.05.017; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Tijchon E, 2016, HAEMATOLOGICA, V101, P272, DOI 10.3324/haematol.2015.139675; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Van Nostrand E. L., 2017, PREPRINT; Vantourout P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007579; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Vogel KU, 2016, J IMMUNOL, V197, P2673, DOI 10.4049/jimmunol.1600854; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang KT, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0088-x; Wawro M, 2017, J CELL BIOCHEM, V118, P487, DOI 10.1002/jcb.25665; White MR, 2016, WIRES RNA, V7, P53, DOI 10.1002/wrna.1315; Wong JJL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15134; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Xing Z, 2017, RNA, V23, P1125, DOI 10.1261/rna.060335.116; Yang CY, 2016, GENE DEV, V30, P2310, DOI 10.1101/gad.285452.116; YANG HD, 1995, MOL CELL BIOL, V15, P6770; Yoshinaga M, 2017, CELL REP, V19, P1614, DOI 10.1016/j.celrep.2017.05.009; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep15660; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510; Zinder JC, 2017, GENE DEV, V31, P88, DOI 10.1101/gad.294769.116	149	87	89	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					120	129		10.1038/s41590-017-0028-4	http://dx.doi.org/10.1038/s41590-017-0028-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348497				2022-12-18	WOS:000423435200012
J	Martins, R; Maier, J; Gorki, AD; Huber, KVM; Sharif, O; Starkl, P; Saluzzo, S; Quattrone, F; Gawish, R; Lakovits, K; Aichinger, MC; Radic-Sarikas, B; Lardeau, CH; Hladik, A; Korosec, A; Brown, M; Vaahtomeri, K; Duggan, M; Kerjaschki, D; Esterbauer, H; Colinge, J; Eisenbarth, SC; Decker, T; Bennett, KL; Kubicek, S; Sixt, M; Superti-Furga, G; Knapp, S				Martins, Rui; Maier, Julia; Gorki, Anna-Dorothea; Huber, Kilian V. M.; Sharif, Omar; Starkl, Philipp; Saluzzo, Simona; Quattrone, Federica; Gawish, Riem; Lakovits, Karin; Aichinger, Michael C.; Radic-Sarikas, Branka; Lardeau, Charles-Hugues; Hladik, Anastasiya; Korosec, Ana; Brown, Markus; Vaahtomeri, Kari; Duggan, Michelle; Kerjaschki, Dontscho; Esterbauer, Harald; Colinge, Jacques; Eisenbarth, Stephanie C.; Decker, Thomas; Bennett, Keiryn L.; Kubicek, Stefan; Sixt, Michael; Superti-Furga, Giulio; Knapp, Sylvia			Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions	NATURE IMMUNOLOGY			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MACROPHAGES; HEMOGLOBIN; IRON; HAPTOGLOBIN; PROTECTION; HEMOPEXIN; IMMUNITY; CHILDREN; CDC42	Hemolysis drives susceptibility to bacterial infections and predicts poor outcome from sepsis. These detrimental effects are commonly considered to be a consequence of heme-iron serving as a nutrient for bacteria. We employed a Gram-negative sepsis model and found that elevated heme levels impaired the control of bacterial proliferation independently of heme-iron acquisition by pathogens. Heme strongly inhibited phagocytosis and the migration of human and mouse phagocytes by disrupting actin cytoskeletal dynamics via activation of the GTP-binding Rho family protein Cdc42 by the guanine nucleotide exchange factor DOCKS. A chemical screening approach revealed that quinine effectively prevented heme effects on the cytoskeleton, restored phagocytosis and improved survival in sepsis. These mechanistic insights provide potential therapeutic targets for patients with sepsis or hemolytic disorders.	[Martins, Rui; Maier, Julia; Gorki, Anna-Dorothea; Huber, Kilian V. M.; Sharif, Omar; Starkl, Philipp; Saluzzo, Simona; Quattrone, Federica; Gawish, Riem; Radic-Sarikas, Branka; Lardeau, Charles-Hugues; Hladik, Anastasiya; Korosec, Ana; Colinge, Jacques; Bennett, Keiryn L.; Kubicek, Stefan; Superti-Furga, Giulio; Knapp, Sylvia] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Martins, Rui; Maier, Julia; Gorki, Anna-Dorothea; Sharif, Omar; Starkl, Philipp; Saluzzo, Simona; Quattrone, Federica; Gawish, Riem; Lakovits, Karin; Hladik, Anastasiya; Korosec, Ana; Knapp, Sylvia] Med Univ Vienna, Dept Med 1, Lab Infect Biol, Vienna, Austria; [Aichinger, Michael C.; Decker, Thomas] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Brown, Markus; Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Vaahtomeri, Kari; Duggan, Michelle; Sixt, Michael] IST Austria, Klosterneuburg, Austria; [Esterbauer, Harald] Med Univ Vienna, Clin Dept Med & Chem Lab Diagnost, Vienna, Austria; [Eisenbarth, Stephanie C.] Yale Univ Sch Med, Department Lab Med, New Haven, CT USA; [Eisenbarth, Stephanie C.] Yale Univ Sch Med, Dept Immunobiol, New Haven, CT USA; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Gawish, Riem] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Institute of Science & Technology - Austria; Medical University of Vienna; Yale University; Yale University; Medical University of Vienna; University of Veterinary Medicine Vienna	Knapp, S (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.	sylvia.knapp@meduniwien.ac.at	Huber, Kilian V. M./L-6921-2015; Knapp, Sylvia/J-3973-2013; Gawish, Riem/AAZ-2302-2020; Kubicek, Stefan/C-2089-2017; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Martins, Rui/M-9606-2016	Huber, Kilian V. M./0000-0002-1103-5300; Knapp, Sylvia/0000-0001-9016-5244; Gawish, Riem/0000-0003-4267-2131; Kubicek, Stefan/0000-0003-0855-8343; Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Martins, Rui/0000-0001-8106-6324; Saluzzo, Simona/0000-0003-2675-4014; Starkl, Philipp/0000-0001-7521-129X; Radic Sarikas, Branka/0000-0002-3597-0483; Esterbauer, Harald/0000-0001-7343-7455; Sharif, Omar/0000-0001-7899-2343; Gorki, Anna-Dorothea/0000-0002-2521-0333; Korosec, Ana/0000-0001-6551-6727; Bennett, Keiryn L./0000-0001-9356-7708; Sixt, Michael/0000-0002-6620-9179; Maier, Julia/0000-0001-9814-523X	Austrian Academy of Sciences; Science Fund of the Austrian National Bank [14107]; Austrian Science Fund FWF in the Infect-ERA framework [I1620 -B22]; Austrian Science Fund (FWF) [I 1620, I 1674] Funding Source: researchfish	Austrian Academy of Sciences; Science Fund of the Austrian National Bank; Austrian Science Fund FWF in the Infect-ERA framework(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Y. Fukui (Medical Institute of Bioregulation, Kyushu University) and). Stein (Theodor Kocher Institute, University of Bern) are acknowledged for providing the DOCK8 deficient bone marrow. and H. Hacker (St. Judes Children's Research Hospital) for providing the ERHBD-HoxB8-encoding retroviral construct. pSpCas9(BB)-2a-Puro (PX459) was a gift from F. Zhang (Massachusetts Institute of Technology) (Addgene plasmid # 48139) and pGRG36 was a gift from N. Craig (Johns Hopkins University School of Medicine) (Addgene plasmid # 16666). LifeAct-GFP-encoding retrovirus was kindly provided by A. Leithner (Institute of Science and Technology Austria). pSIM8 and TKC E. coli were gifts from D.L. Court (Center for Cancer Research, National Cancer Institute). We acknowledge M. Groger and S. Rauscher for excellent technical support (Core imaging facility, Medical University of Vienna). We thank D.P. Barlow and L.R. Cheever for critical reading of the manuscript. This work was supported by the Austrian Academy of Sciences, the Science Fund of the Austrian National Bank (14107) and the Austrian Science Fund FWF (I1620 -B22) in the Infect-ERA framework (to S.Knapp).	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Cober Mary Petrea, 2010, J Pediatr Pharmacol Ther, V15, P152; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Dutra FF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00115; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HILL GB, 1978, INFECT IMMUN, V19, P443, DOI 10.1128/IAI.19.2.443-449.1978; Hirst C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003427.pub3; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Moulding DA, 2013, IMMUNOL REV, V256, P282, DOI 10.1111/imr.12114; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nishikimi A, 2013, EXP CELL RES, V319, P2343, DOI 10.1016/j.yexcr.2013.07.024; Ramakrishnan M, 2010, LANCET INFECT DIS, V10, P329, DOI 10.1016/S1473-3099(10)70055-4; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sarantis H, 2012, CELL HOST MICROBE, V12, P419, DOI 10.1016/j.chom.2012.09.001; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wiener Edith, 2003, Hematology, V8, P35, DOI 10.1080/1024533031000081414; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	47	87	90	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1361	1372		10.1038/ni.3590	http://dx.doi.org/10.1038/ni.3590			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27798618	Green Submitted			2022-12-18	WOS:000388056400006
J	Riedel, A; Shorthouse, D; Haas, L; Hall, BA; Shields, J				Riedel, Angela; Shorthouse, David; Haas, Lisa; Hall, Benjamin A.; Shields, Jacqueline			Tumor-induced stromal reprogramming drives lymph node transformation	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; HIGH ENDOTHELIAL VENULES; DENDRITIC CELLS; CONDUIT SYSTEM; T-CELLS; CHEMOKINE; PROMOTES; LYMPHANGIOGENESIS; MIGRATION; ANTIGEN	Lymph node (LN) stromal cells, particularly fibroblastic reticular cells (FRCs), provide critical structural support and regulate immunity, tolerance and the transport properties of LNs. For many tumors, metastasis to the LNs is predictive of poor prognosis. However, the stromal contribution to the evolving microenvironment of tumor-draining LNs (TDLNs) remains poorly understood. Here we found that FRCs specifically of TDLNs proliferated in response to tumor-derived cues and that the network they formed was remodeled. Comparative transcriptional analysis of FRCs from non-draining LNs and TDLNs demonstrated reprogramming of key pathways, including matrix remodeling, chemokine and/or cytokine signaling, and immunological functions such as the recruitment, migration and activation of leukocytes. In particular, downregulation of the expression of FRC-derived chemokine CCL21 and cytokine IL-7 were accompanied by altered composition and aberrant localization of immune-cell populations. Our data indicate that following exposure to tumor-derived factors, the stroma of TDLNs adapts on multiple levels to exhibit features typically associated with immunosuppression.	[Riedel, Angela; Shorthouse, David; Haas, Lisa; Hall, Benjamin A.; Shields, Jacqueline] Univ Cambridge, MRC Canc Unit, Cambridge, England	University of Cambridge	Hall, BA; Shields, J (corresponding author), Univ Cambridge, MRC Canc Unit, Cambridge, England.	bh418@mrc-cu.cam.ac.uk; js970@mrc-cu.cam.ac.uk	Riedel, Angela/ABC-7207-2020; Hall, Ben/AAA-4981-2020	Hall, Ben/0000-0003-0355-2946; Shorthouse, David/0000-0002-3207-3584	Medical Research Council; Royal Society [UF130039]; MRC [MC_UU_12022/9, MC_UU_12022/5, MC_UP_1101/2] Funding Source: UKRI; Medical Research Council [MR/N501876/1, MC_UU_12022/9, MC_UP_1101/2, MC_UU_12022/5] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Shields Group for comments and discussions; members of the Ares Facility QU, E23 and T29 staff for animal husbandry and technical assistance; R. Butler for support with image analysis and algorithm development; Cambridge Genomic Services for microarray services and post-analysis advice; and the CIMR flow cytometry core facility for advice and-support in flow cytometry and cell-sorting applications. Supported by Medical Research Council core funding (J.S.) and the Royal Society (UF130039 to B.A.H.).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Augsten M, 2014, CANCER RES, V74, P2999, DOI 10.1158/0008-5472.CAN-13-2740; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; Carriere V, 2005, CANCER RES, V65, P11639, DOI 10.1158/0008-5472.CAN-05-1190; Cox TR, 2014, CLIN CANCER RES, V20, P3637, DOI 10.1158/1078-0432.CCR-13-1059; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hompland T, 2012, CANCER RES, V72, P4899, DOI 10.1158/0008-5472.CAN-12-0903; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Rohner NA, 2015, FASEB J, V29, P4512, DOI 10.1096/fj.15-274761; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Soudja SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022639; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	47	87	87	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1118	+		10.1038/ni.3492	http://dx.doi.org/10.1038/ni.3492			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27400148	Green Accepted			2022-12-18	WOS:000381832000016
J	Kueh, HY; Yui, MA; Ng, KKH; Pease, SS; Zhang, JLA; Damle, SS; Freedman, G; Siu, S; Bernstein, ID; Elowitz, MB; Rothenberg, EV				Kueh, Hao Yuan; Yui, Mary A.; Ng, Kenneth K. H.; Pease, Shirley S.; Zhang, Jingli A.; Damle, Sagar S.; Freedman, George; Siu, Sharmayne; Bernstein, Irwin D.; Elowitz, Michael B.; Rothenberg, Ellen V.			Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; LINEAGE COMMITMENT; STEM-CELLS; GENE-EXPRESSION; SPECIFICATION; DIFFERENTIATION; NOTCH; PU.1; REPRESSION; IDENTITY	During T cell development, multipotent progenitors relinquish competence for other fates and commit to the T cell lineage by turning on Bcl11b, which encodes a transcription factor. To clarify lineage commitment mechanisms, we followed developing T cells at the single-cell level using Bcl11b knock-in fluorescent reporter mice. Notch signaling and Notch-activated transcription factors collaborate to activate Bcl11b expression irrespectively of Notch-dependent proliferation. These inputs work via three distinct, asynchronous mechanisms: an early locus 'poising' function dependent on TCF-1 and GATA-3, a stochastic-permissivity function dependent on Notch signaling, and a separate amplitude-control function dependent on Runx1, a factor already present in multipotent progenitors. Despite their necessity for Bcl11b expression, these inputs act in a stage-specific manner, providing a multitiered mechanism for developmental gene regulation.	[Kueh, Hao Yuan; Yui, Mary A.; Ng, Kenneth K. H.; Pease, Shirley S.; Zhang, Jingli A.; Damle, Sagar S.; Freedman, George; Siu, Sharmayne; Elowitz, Michael B.; Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kueh, Hao Yuan] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Zhang, Jingli A.] Genentech Inc, San Francisco, CA USA; [Damle, Sagar S.] ISIS Pharmaceut, Antisense Drug Discovery, Dept Bioinformat, 2280 Faraday Ave, Carlsbad, CA 92008 USA; [Freedman, George] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA	California Institute of Technology; Fred Hutchinson Cancer Center; California Institute of Technology; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Genentech; Isis Pharmaceuticals Inc; University of California System; University of California San Francisco	Kueh, HY; Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Kueh, HY (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	kueh@uw.edu; evroth@its.caltech.edu		Yui, Mary/0000-0002-3136-2181; Rothenberg, Ellen/0000-0002-3901-347X; , Sharmayne/0000-0001-7284-1907	CRI/Irvington Postdoctoral Fellowship; US National Institutes of Health (NIH) [K99HL119638A]; California Institute for Regenerative Medicine Bridges to Stem-Cell Research award [TB1-01176]; NIH [R01 AI083514, R01 AI095943, RC2 CA148278, R33 HL089123, R01 CA90233, R01 HL119102, R01 AI064590]; NIH/HHS [U01HL100395]; Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE [RC2CA148278, R01CA090233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119638, U01HL100395, R00HL119638, R01HL119102, R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064590, R01AI083514, R01AI095943] Funding Source: NIH RePORTER	CRI/Irvington Postdoctoral Fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Bridges to Stem-Cell Research award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Lerica Gutierrez Quiloan for assistance with mouse genotyping and maintenance; N. Verduzco and I. Soto for animal husbandry; J. Longmate for help with statistical analysis of alternate-lineage-potential experiments; R.A. Diamond, K. Beadle, J. Grimm, D. Perez and J. Verceles for cell sorting; N. Feng for initial flow cytometric analysis; J. Hahn for advice on BAC recombineering; S. Qin for assistance with qPCR experiments; X. Wang for performing pilot studies with microwell arrays; and J. Ungerback for assistance with visualizing genome track data. We also thank A. Bhandoola, L. Xu and W. Pear (University of Pennsylvania); J. Telfer (University of Massachusetts) and N. Masuyama (University of Tokyo) for constructs. This work was funded by a CRI/Irvington Postdoctoral Fellowship and a US National Institutes of Health (NIH) K99/R00 Award (K99HL119638A) to H.Y.K.; a California Institute for Regenerative Medicine Bridges to Stem-Cell Research award to K.K.H.N. (TB1-01176); NIH grants to E.V.R. (R01 AI083514, R01 AI095943, RC2 CA148278, R33 HL089123, R01 CA90233 and R01 HL119102) and M.A.Y. (R01 AI064590); NIH/HHS grant U01HL100395 (I.D.B.); the Albert Billings Ruddock Professorship to E.V.R.; and the Al Sherman Foundation and the Louis A. Garfinkle Memorial Laboratory Fund to E.V.R.'s lab.	Avram D, 2014, J IMMUNOL, V193, P2059, DOI 10.4049/jimmunol.1400930; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Ebina W, 2015, EMBO J, V34, P694, DOI 10.15252/embj.201490804; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Guo Y, 2008, BLOOD, V112, P480, DOI 10.1182/blood-2007-10-120261; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Kawazu M, 2005, J IMMUNOL, V174, P3526, DOI 10.4049/jimmunol.174.6.3526; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Manesso E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0774; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Peter I. S., 2015, GENOMIC CONTROL PROC; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/nmeth.1577, 10.1038/NMETH.1577]; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10; Zhang DX, 2013, J MOL ENDOCRINOL, V51, pT37, DOI 10.1530/JME-13-0216; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	52	87	87	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					956	+		10.1038/ni.3514	http://dx.doi.org/10.1038/ni.3514			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27376470	Green Accepted			2022-12-18	WOS:000380647000013
J	Diaz-Munoz, MD; Bell, SE; Fairfax, K; Monzon-Casanova, E; Cunningham, AF; Gonzalez-Porta, M; Andrews, SR; Bunik, VI; Zarnack, K; Curk, T; Heggermont, WA; Heymans, S; Gibson, GE; Kontoyiannis, DL; Ule, J; Turner, M				Diaz-Munoz, Manuel D.; Bell, Sarah E.; Fairfax, Kirsten; Monzon-Casanova, Elisa; Cunningham, Adam F.; Gonzalez-Porta, Mar; Andrews, Simon R.; Bunik, Victoria I.; Zarnack, Kathi; Curk, Tomaz; Heggermont, Ward A.; Heymans, Stephane; Gibson, Gary E.; Kontoyiannis, Dimitris L.; Ule, Jernej; Turner, Martin			The RNA-binding protein HuR is essential for the B cell antibody response	NATURE IMMUNOLOGY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DIFFERENTIATION; PROLIFERATION; COMPLEX; MAINTENANCE; GENERATION; SIGNAL; MICRORNA-155	Post-transcriptional regulation of mRNA by the RNA-binding protein HuR (encoded by Elavl1) is required in B cells for the germinal center reaction and for the production of class-switched antibodies in response to thymus-independent antigens. Transcriptome-wide examination of RNA isoforms and their abundance and translation in HuR-deficient B cells, together with direct measurements of HuR-RNA interactions, revealed that HuR-dependent splicing of mRNA affected hundreds of transcripts, including that encoding dihydrolipoamide S-succinyltransferase (Dlst), a subunit of the 2-oxoglutarate dehydrogenase (alpha-KGDH) complex. In the absence of HuR, defective mitochondrial metabolism resulted in large amounts of reactive oxygen species and B cell death. Our study shows how post-transcriptional processes control the balance of energy metabolism required for the proliferation and differentiation of B cells.	[Diaz-Munoz, Manuel D.; Bell, Sarah E.; Monzon-Casanova, Elisa; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Fairfax, Kirsten] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Cunningham, Adam F.] Univ Birmingham, Sch Immun & Infect, Inst Microbiol & Infect, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Gonzalez-Porta, Mar] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Andrews, Simon R.] Babraham Inst, Bioinformat Grp, Cambridge, England; [Bunik, Victoria I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst PhysicoChem Biol, Moscow, Russia; [Bunik, Victoria I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Zarnack, Kathi] Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Heggermont, Ward A.; Heymans, Stephane] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Heymans, Stephane] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Gibson, Gary E.] Weill Cornell Med Coll, Brain & Mind Res Inst, Burke Med Res Inst, White Plains, NY USA; [Kontoyiannis, Dimitris L.] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Vari, Greece; [Ule, Jernej] UCL, UCL Genet Inst, Dept Genet Environm & Evolut, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Birmingham; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Lomonosov Moscow State University; Lomonosov Moscow State University; University of Ljubljana; KU Leuven; Maastricht University; Cornell University; Alexander Fleming Biomedical Sciences Research Center; University of London; University College London	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Diaz-Munoz, Manuel D./AAB-6518-2020; Curk, Tomaž/D-9836-2015; Bunik, Victoria/E-3427-2012; Ule, Jernej/C-6315-2013; Diaz-Munoz, Manuel D/H-2080-2018; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D./0000-0002-9227-7474; Curk, Tomaž/0000-0003-4888-7256; Bunik, Victoria/0000-0002-2552-8560; Ule, Jernej/0000-0002-2452-4277; Diaz-Munoz, Manuel D/0000-0002-9227-7474; Monzon-Casanova, Elisa/0000-0001-6617-6138; Kontoyiannis, Dimitris/0000-0003-4682-9490; Turner, Martin/0000-0002-3801-9896; Fairfax, Kirsten/0000-0002-8394-137X; Zarnack, Kathi/0000-0003-3527-3378; Heymans, Stephane/0000-0001-9477-7803; Cunningham, Adam/0000-0003-0248-964X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J001457/1, BB/J00152X/1]; National Health and Medical Research Council of Australia [516786]; Victorian State Government Operational Infrastructure Support; Australian Government (National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme); European Molecular Biology Laboratory (EMBL Interdisciplinary Postdocs initiative fellowship); Russian Science Foundation [14-15-00133]; Slovenian Research Agency [J7-5460]; Biotechnology and Biological Sciences Research Council [BB/J00152X/1, BB/J001457/1, BB/L009986/1, BBS/E/B/000C0409, BBS/E/B/000C0407] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0407, BB/J001457/1, BB/J00152X/1, BB/L009986/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government (National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme)(National Health and Medical Research Council (NHMRC) of Australia); European Molecular Biology Laboratory (EMBL Interdisciplinary Postdocs initiative fellowship); Russian Science Foundation(Russian Science Foundation (RSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Bates, D. Sanger, N. Evans, S. Walker, K. Tabbada, G. Morgan, R. Walker and the Babraham Institute Biological Support Unit for technical assistance. Supported by the Biotechnology and Biological Sciences Research Council (BBSRC BB/J001457/1 and BB/J00152X/1), the National Health and Medical Research Council of Australia (516786 to K.F.), the Victorian State Government Operational Infrastructure Support and Australian Government (National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme; K.F.), the European Molecular Biology Laboratory (EMBL Interdisciplinary Postdocs initiative fellowship to. K.Z.), the Russian Science Foundation (14-15-00133 to V.I.B. for work with the phosphonate analogs of 2-oxo acids) and the Slovenian Research Agency (J7-5460 for J.U. and T.C.).	Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Blair D, 2012, BIOCHEM J, V448, P165, DOI 10.1042/BJ20121225; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; BUTTKE TM, 1995, FREE RADICAL RES, V22, P389, DOI 10.3109/10715769509147548; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Crump KE, 2013, J VIROL, V87, P2577, DOI 10.1128/JVI.02714-12; de Yebenes VG, 2013, IMMUNOL REV, V253, P25, DOI 10.1111/imr.12046; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Gibson GE, 1998, ANN NEUROL, V44, P676, DOI 10.1002/ana.410440414; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Guikema JEJ, 2010, J IMMUNOL, V184, P6177, DOI 10.4049/jimmunol.0904085; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Labet V, 2008, CHEMPHYSCHEM, V9, P1195, DOI 10.1002/cphc.200800154; LARDY HA, 1952, J BIOL CHEM, V195, P215; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Richards SM, 2009, EUR J IMMUNOL, V39, P3395, DOI 10.1002/eji.200939587; Sadri N, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-1; Shi QL, 2005, J BIOL CHEM, V280, P10888, DOI 10.1074/jbc.M409064200; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Stuart SD, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-4; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2000, J NEUROSCI, V20, P8972; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wheeler ML, 2012, J IMMUNOL, V189, P4405, DOI 10.4049/jimmunol.1201433; Xu SL, 2012, BLOOD, V119, P767, DOI 10.1182/blood-2011-05-355412; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513	50	87	90	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					415	425		10.1038/ni.3115	http://dx.doi.org/10.1038/ni.3115			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25706746	Green Accepted, Green Submitted, Green Published			2022-12-18	WOS:000351333700014
J	Chen, WJ				Chen, WanJun			IDO: more than an enzyme	NATURE IMMUNOLOGY			English	Editorial Material							PLASMACYTOID DENDRITIC CELLS; TRYPTOPHAN CATABOLISM	In addition to its recognized function as an enzyme that catalyzes tryptophan, indoleamine 2,3-dioxygenase (IDO) acts as an intracellular signal transducer, in response to transforming growth factor-beta (TGF-beta), to induce a stably regulatory phenotype in plasmacytoid dendritic cells.	Natl Inst Dent & Craniofacial Res, Mucosal Immunol Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Mucosal Immunol Sect, NIH, Bethesda, MD USA.	wchen@dir.nidcr.nih.gov			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X	11	87	94	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					809	U		10.1038/ni.2088	http://dx.doi.org/10.1038/ni.2088			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21852775				2022-12-18	WOS:000294461200001
J	Steinman, L				Steinman, Lawrence			Mixed results with modulation of T-H-17 cells in human autoimmune diseases	NATURE IMMUNOLOGY			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; CD4(+) T-CELLS; CROHNS-DISEASE; OSTEOPONTIN LEVELS; TH17 CELLS; IFN-GAMMA; PSORIASIS; RECEPTOR	The outcomes of clinical trials provide the most convincing data to clarify the role of particular cytokines in the pathogenesis of human diseases. The immunology community, for a variety of practical reasons, spends most of its research time and funds on studies in model systems, mainly mice. In this perspective I discuss results of clinical trials assessing the effect of blocking the differentiation and/or function of interleukin-17-producing CD4(+) T cells on human autoimmune disease, and devote more limited attention to corroborating preclinical studies from animal models. Thus far, these outcomes in human trials have been mixed, with notable success in psoriasis and Crohn's disease but a negative result in relapsing-remitting multiple sclerosis.	[Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol Sci, Stanford, CA 94305 USA; [Steinman, Lawrence] Stanford Univ, Sch Med, Interdepartmental Program Immunol, Beckman Ctr Mol Med, Stanford, CA USA	Stanford University; Stanford University	Steinman, L (corresponding author), Stanford Univ, Sch Med, Dept Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250	NINDS NIH HHS [R01 NS055997] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; DUREZ P, 2009, ANN RHEUM DIS S3, V68; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Ferber IA, 1996, J IMMUNOL, V156, P5; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; GENOVESE MC, 2009, ANN RHEUM DIS S3, V68; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li YH, 2007, BRAIN, V130, P490, DOI 10.1093/brain/awl273; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Longbrake EE, 2009, EXPERT REV NEUROTHER, V9, P319, DOI 10.1586/14737175.9.3.319; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Molloy ES, 2009, NAT REV RHEUMATOL, V5, P418, DOI 10.1038/nrrheum.2009.142; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Nishimoto N., 2008, V181, P151; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2009, EUR J IMMUNOL, V39, P2358, DOI 10.1002/eji.200939814; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; t'Hart BA, 2005, J IMMUNOL, V175, P4761; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	53	87	90	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					41	44		10.1038/ni.1803	http://dx.doi.org/10.1038/ni.1803			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016509				2022-12-18	WOS:000272855300008
J	Mandal, M; Powers, SE; Ochiai, K; Georgopoulos, K; Kee, BL; Singh, H; Clark, MR				Mandal, Malay; Powers, Sarah E.; Ochiai, Kyoko; Georgopoulos, Katia; Kee, Barbara L.; Singh, Harinder; Clark, Marcus R.			Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; TRANSCRIPTION FACTOR; PRE-BCR; RECEPTOR; ACTIVATION; PROTEINS; E2A; EXPRESSION; ENHANCER; IKAROS	Signals through the pre-B cell antigen receptor (pre-BCR) and interleukin 7 receptor (IL-7R) coordinate pre-B cell population expansion with subsequent recombination of the locus encoding immunoglobulin kappa-chain (Igk). Although many 'downstream' effectors of each receptor are known, how they integrate to mediate development has remained unclear. Here we report that pre-BCR-mediated activation of the Ras-MEK-Erk signaling pathway silenced transcription of Ccnd3 (encoding cyclin D3) and coordinated exit from the cell cycle with induction of the transcription factor E2A and the initiation of Igk recombination. IL-7R-mediated activation of the transcription factor STAT5 opposed this pathway by promoting Ccnd3 expression and concomitantly inhibiting Igk transcription by binding to the Igk intronic enhancer and preventing E2A recruitment. Our data show how pre-BCR signaling poises pre-B cells to undergo differentiation after escape from IL-7R signaling.	[Mandal, Malay; Powers, Sarah E.; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Ochiai, Kyoko; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Georgopoulos, Katia] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Harvard University; Massachusetts General Hospital; University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu		Powers, Sarah/0000-0002-6812-4312	NIGMS NIH HHS [R01 GM088847, R01 GM067772-04S1, R01 GM052736-11, R01 GM067772-04, R01 GM052736, R01 GM052736-10, R01 GM067772, R01 GM088847-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067772, R01GM088847, R01GM052736] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Clark MR, 2005, CURR TOP MICROBIOL, V290, P87; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; Erlandsson L, 2005, EUR J IMMUNOL, V35, P1969, DOI 10.1002/eji.200425821; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Georgopoulos K, 1997, CURR OPIN IMMUNOL, V9, P222, DOI 10.1016/S0952-7915(97)80139-2; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Halcomb KE, 2007, EUR J IMMUNOL, V37, P1033, DOI 10.1002/eji.200636451; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; MEYER KB, 1995, EUR J IMMUNOL, V25, P1770, DOI 10.1002/eji.1830250643; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Xu SL, 2007, BLOOD, V109, P3377, DOI 10.1182/blood-2006-07-036418; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	45	87	88	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1110	U91		10.1038/ni.1785	http://dx.doi.org/10.1038/ni.1785			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19734904	Green Accepted			2022-12-18	WOS:000270006900015
J	Martincic, K; Alkan, SA; Cheatle, A; Borghesi, L; Milcarek, C				Martincic, Kathleen; Alkan, Serkan A.; Cheatle, Alys; Borghesi, Lisa; Milcarek, Christine			Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing	NATURE IMMUNOLOGY			English	Article							INFLUENCE GENE-EXPRESSION; POLY(A) SITE SELECTION; CHAIN MESSENGER-RNA; POLYMERASE-II; B-CELL; POLYADENYLATION FACTOR; FACTOR CSTF-64; HNRNP-F; CLEAVAGE; DIFFERENTIATION	Immunoglobulin secretion is modulated by competition between the use of a weak promoter-proximal poly(A) site and a nonconsensus splice site in the final secretory-specific exon of the heavy chain pre-mRNA. The RNA polymerase II transcription elongation factor ELL2, which is induced in plasma cells, enhanced both polyadenylation and exon skipping with the gene encoding the immunoglobulin heavy-chain complex (Igh) and reporter constructs. Lowering ELL2 expression by transfection of heterogenous ribonucleoprotein F (hnRNP F) or small interfering RNA resulted in lower abundance of secretory-specific forms of immunoglobulin heavy-chain mRNA. ELL2 and the polyadenylation factor CstF-64 tracked together with RNA polymerase II across the Igh mu- and gamma-gene segments; the association of both factors was blocked by ELL2-specific small interfering RNA. Thus, loading of ELL2 and CstF-64 on RNA polymerase II was linked, caused enhanced use of the proximal poly(A) site and was necessary for processing of immunoglobulin heavy-chain mRNA.	[Martincic, Kathleen; Alkan, Serkan A.; Cheatle, Alys; Borghesi, Lisa; Milcarek, Christine] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Milcarek, C (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.	milcarek@pitt.edu		Cheatle Jarvela, Alys/0000-0003-0042-8616	US National Institutes of Health [CA86433, AI079047]; National Science Foundation [MCB-8842725]; NATIONAL CANCER INSTITUTE [R01CA086433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079047, R56AI079047] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Shilatifard (Stowers Institute for Medical Research) for monoclonal antibody to ELL2; A. Kornblihtt (University of Buenos Aires) for splicing reporter plasmids; C. Webb (University of Oklahoma) for Igh promoters; J. Fink for assistance in constructing COOH ELL2; S. Eghtesad for cloning ELL2-specific shRNA; J. Heakins for mouse spleen cell chromatin; and B. Junker and Y. Lin for help with statistical analyses. Supported by the US National Institutes of Health (CA86433 to C. M. and AI079047 to L. B.) and the National Science Foundation (MCB-8842725 to C. M.).	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Auboeuf D, 2005, MOL CELL BIOL, V25, P5307, DOI 10.1128/MCB.25.13.5307-5316.2005; Bruce SR, 2003, RNA, V9, P1264, DOI 10.1261/rna.5820103; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gendra E, 2007, J BIOL CHEM, V282, P11648, DOI 10.1074/jbc.M611126200; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; KELLEY DE, 1986, NUCLEIC ACIDS RES, V14, P5431, DOI 10.1093/nar/14.13.5431; KOBRIN BJ, 1986, MOL CELL BIOL, V6, P1687, DOI 10.1128/MCB.6.5.1687; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Ma JL, 2006, RNA, V12, P122, DOI 10.1261/rna.2159506; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Matis SA, 1996, NUCLEIC ACIDS RES, V24, P4684, DOI 10.1093/nar/24.23.4684; Milcarek C, 1996, MOL IMMUNOL, V33, P691, DOI 10.1016/0161-5890(96)00009-0; MILCAREK C, 1985, MOL CELL BIOL, V5, P2514, DOI 10.1128/MCB.5.10.2514; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Qu XP, 2007, J BIOL CHEM, V282, P2101, DOI 10.1074/jbc.M609981200; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; SEIPELT RL, 1995, MOL IMMUNOL, V32, P277, DOI 10.1016/0161-5890(94)00141-M; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shell SA, 2007, J IMMUNOL, V179, P7663, DOI 10.4049/jimmunol.179.11.7663; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Underhill GH, 2003, BLOOD, V101, P4013, DOI 10.1182/blood-2002-08-2673; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001	43	87	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1102	U82		10.1038/ni.1786	http://dx.doi.org/10.1038/ni.1786			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19749764	Green Accepted			2022-12-18	WOS:000270006900014
J	Goswami, S; Angkasekwinai, P; Shan, M; Greenlee, KJ; Barranco, WT; Polikepahad, S; Seryshev, A; Song, LZ; Redding, D; Singh, B; Sur, S; Woodruff, P; Dong, C; Corry, DB; Kheradmand, F				Goswami, Sangeeta; Angkasekwinai, Pornpimon; Shan, Ming; Greenlee, Kendra J.; Barranco, Wade T.; Polikepahad, Sumanth; Seryshev, Alexander; Song, Li-zhen; Redding, David; Singh, Bhupinder; Sur, Sanjiv; Woodruff, Prescott; Dong, Chen; Corry, David B.; Kheradmand, Farrah			Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY CELL EGRESSION; DENDRITIC CELLS; VITAMIN-A; ALVEOLAR MACROPHAGE; LUNG; EXPRESSION; IL-13; DIFFERENTIATION; EOSINOPHILIA; MATRILYSIN	The innate immune response of airway epithelial cells to airborne allergens initiates the development of T cell responses that are central to allergic inflammation. Although proteinase allergens induce the expression of interleukin 25, we show here that epithelial matrix metalloproteinase 7 (MMP7) was expressed during asthma and was required for the maximum activity of interleukin 25 in promoting the differentiation of T helper type 2 cells. Allergen-challenged Mmp7(-/-) mice had less airway hyper-reactivity and production of allergic inflammatory cytokines and higher expression of retinal dehydrogenase 1. Inhibition of retinal dehydrogenase 1 restored the asthma phenotype of Mmp7(-/-) mice and inhibited the responses of lung regulatory T cells, whereas exogenous administration of retinoic acid attenuated the asthma phenotype. Thus, MMP7 coordinates allergic lung inflammation by activating interleukin 25 while simultaneously inhibiting retinoid-dependent development of regulatory T cells.	[Goswami, Sangeeta; Shan, Ming; Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Angkasekwinai, Pornpimon; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Greenlee, Kendra J.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Barranco, Wade T.; Polikepahad, Sumanth; Seryshev, Alexander; Song, Li-zhen; Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Redding, David; Singh, Bhupinder; Sur, Sanjiv] Univ Texas Med Branch Galveston, Dept Med, Galveston, TX USA; [Woodruff, Prescott] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; North Dakota State University Fargo; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Francisco	Kheradmand, F (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.	dcorry@bcm.edu; farrahk@bcm.edu	greenlee, kendra/W-3466-2019; Angkasekwinai, Pornpimon/AAX-6124-2020; Singh, Bhupinder/G-3267-2012; dong, chen/B-3181-2009; Shan, Ming/D-8582-2012	dong, chen/0000-0002-0084-9130; Angkasekwinai, Pornpimon/0000-0003-0303-9544; Goswami, Sangeeta/0000-0001-9201-4503; Singh, Bhupinder/0000-0002-9185-7944	US National Institutes of Health [AI070973, HL082487, AI071130, AR050772, HL075243, AI057696]; American Lung Association; Leukemia and Lymphoma Society; MD Anderson Cancer Center; EPSCoR [0814442] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL075243, R01HL082487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070973, P01AI062885, U19AI071130, R01AI057696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MD Anderson Cancer Center; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Woo Park (Children's Hospital, Harvard School of Medicine) for Mmp7<SUP>-/-</SUP> mice backcrossed to C57BL/6 mice; D. A. Engler, R. K. Matsunami and K. Gonzalez for technical help with proteomics analysis; N. Barrows for editorial support; and all members of the Kheradmand and Corry laboratory for comments and criticisms. Supported by the US National Institutes of Health (AI070973 and HL082487 to F. K.; AI071130 and AR050772 to C. D.; and HL075243, AI057696 and AI070973 to D. B. C.), the American Lung Association (C. D.), the Leukemia and Lymphoma Society (C. D.) and MD Anderson Cancer Center (C. D.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Careau E, 2006, AM J PHYSIOL-LUNG C, V290, pL871, DOI 10.1152/ajplung.00219.2005; Cheung PFY, 2006, ALLERGY, V61, P878, DOI 10.1111/j.1398-9995.2006.01102.x; CONNOR MJ, 1987, BIOCHEM J, V244, P489, DOI 10.1042/bj2440489; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Corry DB, 1999, CURR OPIN IMMUNOL, V11, P610, DOI 10.1016/S0952-7915(99)00025-4; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; GEARING AJH, 1995, J LEUKOCYTE BIOL, V57, P774, DOI 10.1002/jlb.57.5.774; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Greenlee KJ, 2006, J IMMUNOL, V177, P7312, DOI 10.4049/jimmunol.177.10.7312; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim MR, 2002, BLOOD, V100, P2330, DOI 10.1182/blood-2002-01-0012; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Li L, 1999, J IMMUNOL, V162, P2477; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Maret M, 2007, J NUTR, V137, P2730, DOI 10.1093/jn/137.12.2730; McGowan SE, 2004, AM J PHYSIOL-LUNG C, V286, pL437, DOI 10.1152/ajplung.00158.2003; McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586; Montes M, 2006, J IMMUNOL METHODS, V317, P45, DOI 10.1016/j.jim.2006.09.013; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Takamura K, 2004, AM J PHYSIOL-LUNG C, V286, pL777, DOI 10.1152/ajplung.00289.2003; Upham JW, 2002, J ALLERGY CLIN IMMUN, V109, P307, DOI 10.1067/mai.2002.121527; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu J, 2001, AM J RESP CRIT CARE, V164, P109, DOI 10.1164/ajrccm.164.1.2007050	48	87	88	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					496	503		10.1038/ni.1719	http://dx.doi.org/10.1038/ni.1719			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19329997	Green Accepted, Green Submitted			2022-12-18	WOS:000265394400011
J	Raz, E				Raz, Eyal			Organ-specific regulation of innate immunity	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION	Immune responses to microbial challenge in various tissues are not the same. Organ-specific immune responses are adapted to maintain organ physiology.	Univ Calif San Diego, Dept Med 0663, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Raz, E (corresponding author), Univ Calif San Diego, Dept Med 0663, La Jolla, CA 92093 USA.	eraz@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL079449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI040682, R01AI057709] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL79449] Funding Source: Medline; NIAID NIH HHS [AI40682, AI57709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cross AS, 2002, J ENDOTOXIN RES, V8, P83, DOI 10.1179/096805102125000227; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Lee CA, 1996, INFECT AGENT DIS, V5, P1; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126	11	87	88	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					3	4		10.1038/ni0107-3	http://dx.doi.org/10.1038/ni0107-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179960				2022-12-18	WOS:000242934400002
J	Jun, JE; Goodnow, CC				Jun, JE; Goodnow, CC			Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; E3 UBIQUITIN LIGASE; T-CELL; CBL-B; LIPID RAFTS; TYROSINE KINASE; ADAPTER PROTEIN; C-CBL; PROTOONCOGENE PRODUCT; NEGATIVE REGULATION	Lymphocyte antigen receptors are responsible for inducing the opposite responses of immunity or tolerance. How the correct polarity of antigen receptor signaling is encoded has been an enduring enigma. Here we summarize recent advances defining key scaffolding molecules, CARMA1 (also known as CARD11) and the Cbl family of ubiquitin ligases, required for either immunogenic or tolerogenic signaling by antigen receptors. These scaffolding proteins may determine the polarity of response to antigen by promoting assembly around antigen receptors of competing multiprotein signal complexes: immunosomes versus tolerosomes. Each of the factors that influence immunogenicity or tolerogenicity-stage of lymphocyte differentiation, concurrent engagement of inhibitory or costimulatory receptors, extent of receptor crosslinking, and prior antigen experience-may be integrated in lymphocytes through their capacity to influence the probability of assembling immunosomes versus tolerosomes.	Australian Natl Univ, John Curtin Sch Med Res, Genet Lab, Australian Canc Res Fdn, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Genet Lab, Australian Canc Res Fdn, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Asai K, 2002, J IMMUNOL, V169, P4723, DOI 10.4049/jimmunol.169.9.4723; Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; BRUNSWICK M, 1989, P NATL ACAD SCI USA, V86, P6724, DOI 10.1073/pnas.86.17.6724; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; BURNET FM, 1950, AUST J EXP BIOL MED, V28, P291, DOI 10.1038/icb.1950.29; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burnet FM, 1949, PRODUCTION ANTIBODIE; CALNAN BJ, 1995, IMMUNITY, V3, P273; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dresser D W, 1968, Adv Immunol, V8, P129, DOI 10.1016/S0065-2776(08)60466-6; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Eisenbraun MD, 2000, J IMMUNOL, V164, P6105, DOI 10.4049/jimmunol.164.12.6105; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; GOLUB ES, 1967, J IMMUNOL, V98, P1241; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Horejsi V, 2002, TRENDS IMMUNOL, V23, P562, DOI 10.1016/S1471-4906(02)02330-X; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kimura M, 2000, INT IMMUNOL, V12, P817, DOI 10.1093/intimm/12.6.817; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Mondino A, 1996, J IMMUNOL, V157, P2048; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; NOSSAL G. J. V., 1957, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V35, P549, DOI 10.1038/icb.1957.57; Oved S, 2002, NATURE, V416, P133, DOI 10.1038/416133a; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Raiborg C, 2001, J CELL SCI, V114, P2255; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 1999, J IMMUNOL, V162, P7133; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Zhang WY, 2003, J BIOL CHEM, V278, P23978, DOI 10.1074/jbc.M212671200; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	111	87	89	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1057	1064		10.1038/ni1001	http://dx.doi.org/10.1038/ni1001			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586424				2022-12-18	WOS:000186241100009
